PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Krasny-Pacini, A; Limond, J; Evans, J; Hiebel, J; Bendjelida, K; Chevignard, M				Krasny-Pacini, Agata; Limond, Jennifer; Evans, Jonathan; Hiebel, Jean; Bendjelida, Karim; Chevignard, Mathilde			Self-awareness assessment during cognitive rehabilitation in children with acquired brain injury: a feasibility study and proposed model of child anosognosia	DISABILITY AND REHABILITATION			English	Article						Brain injury; children; cognitive rehabilitation; executive functions; model; self-awareness	EXECUTIVE DYSFUNCTION; AUTOBIOGRAPHICAL MEMORY; CONTROLLED-TRIAL; DEFICITS; METACOGNITION; MIND; TBI; COMMUNICATION; QUESTIONNAIRE; STRATEGIES	Purpose: To compare three ways of assessing self-awareness in children with traumatic brain injury (TBI) and to propose a model of child anosognosia. Method: Five single cases of children with severe TBI, aged 8-14, undergoing metacognitive training. Awareness was assessed using three different measures: two measures of metacognitive knowledge/intellectual awareness (a questionnaire and illustrated stories where child characters have everyday problems related to their executive dysfunction) and one measure of on-line/emergent awareness (post-task appraisal of task difficulty). Results: All three measures showed good feasibility. Analysis of awareness deficit scores indicated large variability (1-100%). Three children showed dissociated scores. Conclusions: Based on these results, we propose a model of child self-awareness and anosognosia and a framework for awareness assessment for rehabilitation purposes. The model emphasizes (1) the role of on-line error detection in the construction of autobiographical memories that allow a child to build a self-knowledge of his/her strengths and difficulties; (2) the multiple components of awareness that need to be assessed separately; (3) the implications for rehabilitation: errorless versus error-based learning, rehabilitation approaches based on metacognition, rationale for rehabilitation intervention based on child's age and impaired awareness component, ethical and developmental consideration of confrontational methods. Implications for RehabilitationSelf-awareness has multiple components that need to be assessed separately, to better adapt cognitive rehabilitation.Using questionnaires and discrepancy scores are not sufficient to assess awareness, because it does not include on-line error detection, which can be massively impaired in children, especially those with impaired executive functions.On-line error detection is important to promote and error-based learning is useful to allow a child to build a self-knowledge of his/her strengths and difficulties, in the absence of severe episodic memory problems.Metacognitive trainings may not be appropriate for younger children who have age appropriate developmentally immature self-awareness, nor for patients with brain injury if they suffer anosognosia because of their brain injury.	[Krasny-Pacini, Agata; Hiebel, Jean] Inst Univ Readaptat Clemenceau Strasbourg, 45 Bd Clemenceau, F-67082 Strasbourg, France; [Krasny-Pacini, Agata; Hiebel, Jean] Hautepierre Strasbourg Univ Hosp, Dept Paediat Surg, Strasbourg, France; [Krasny-Pacini, Agata; Chevignard, Mathilde] Univ Paris 06, Sorbonne Univ, UMR 7371, CNRS,LIB, F-75006 Paris, France; [Limond, Jennifer; Evans, Jonathan] Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, Deaprtment Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Bendjelida, Karim] Hop Hasenrain, EMOI TC 68, Mulhouse, France; [Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France		Krasny-Pacini, A (corresponding author), Inst Univ Readaptat Clemenceau Strasbourg, 45 Bd Clemenceau, F-67082 Strasbourg, France.	agata.krasny@ugecam-alsace.fr			"SOFMER" (French Society of Physical and Rehabilitation Medicine); "SFERHE" (French Research Society against Children's handicap); Fondation Gueules Cassees	This study was supported by scholarships, from the "SOFMER" (French Society of Physical and Rehabilitation Medicine), the "SFERHE" (French Research Society against Children's handicap) and the "Fondation Gueules Cassees". Results of this work were presented at the joined 29th SOFMER - 19th ESPRM congress in Marseille in May 2014.	Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Bertens D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-64; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Bjorklund D., 2012, CHILDRENS THINKING C, V5; BORKOWSKI JG, 1989, LEARN DISABILITY Q, V12, P57, DOI 10.2307/1510252; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen MJ, 2001, ECHELLE MEMOIRE ENFA; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Crowther JE, 2011, J HEAD TRAUMA REHAB, V26, P192, DOI 10.1097/HTR.0b013e318218dd22; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dermitzaki I, 2005, PSYCHOL REP, V97, P759, DOI 10.2466/pr0.97.3.759-768; Desoete A, 2001, J LEARN DISABIL-US, V34, P435, DOI 10.1177/002221940103400505; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Emslie H., 2003, BEHAV ASSESSMENT DYS; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Garrett Adia J, 2006, Learn Disabil Res Pract, V21, P77, DOI 10.1111/j.1540-5826.2006.00208.x; Gioia GA, 2014, ADAPTATION FRANCAISE; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hacker DJ, 1998, EDUC PSYCHO, P1; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hoffmann-Biencourt A, 2010, BRIT J DEV PSYCHOL, V28, P767, DOI 10.1348/026151009X479042; JACOBS JE, 1987, EDUC PSYCHOL, V22, P255, DOI 10.1207/s15326985ep2203&4_4; JACOBS MP, 1993, NEUROPSYCHOL REHABIL, V3, P341, DOI 10.1080/09602019308401446; Josman N, 2000, OCCUP THER J RES, V20, P241, DOI 10.1177/153944920002000402; Josman Naomi, 2000, Physical and Occupational Therapy in Pediatrics, V19, P39, DOI 10.1300/J006v19n03_04; Koriat A, 2008, MEM COGNITION, V36, P416, DOI 10.3758/MC.36.2.416; Koriat A, 2010, CONSCIOUS COGN, V19, P251, DOI 10.1016/j.concog.2009.12.010; Koriat A, 2009, J EXP CHILD PSYCHOL, V102, P265, DOI 10.1016/j.jecp.2008.10.005; Krasny-Pacini A., 2013, GOAL MANAGEMENT TRAI; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P61, DOI 10.1016/j.ijpsycho.2011.02.001; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lyons KE, 2011, ADV CHILD DEV BEHAV, V40, P379; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; NELSON TO, 1990, PSYCHOL LEARN MOTIV, P1; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Perner J, 2003, CONSCIOUS COGN, V12, P63, DOI 10.1016/S1053-8100(02)00010-7; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Robertson IH, GOAL MANAGEMENT TRAI; Roebers CM, 2007, J EXP CHILD PSYCHOL, V97, P117, DOI 10.1016/j.jecp.2006.12.006; Roebers CM, 2009, BRIT J EDUC PSYCHOL, V79, P749, DOI 10.1348/978185409X429842; Rosenzweig C, 2011, J LEARN DISABIL-US, V44, P508, DOI 10.1177/0022219410378445; Roy A, FONCTIONS EXEC UNPUB; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Viguier D, 2001, BRAIN INJURY, V15, P263; Wales L, 2013, BRIT J OCCUP THER, V76, P325, DOI 10.4276/030802213X13729279115013; Wechsler D, 2005, WISC 6 ECHELLE INTEL; Williams D, 2010, AUTISM, V14, P474, DOI 10.1177/1362361310366314; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, Vxiv, P246; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669	77	14	15	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2015	37	22					2092	2106		10.3109/09638288.2014.998783			15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DD2JM	WOS:000369748600008	25673145	Green Submitted			2022-02-06	
J	Henry, LC; Sandel, N				Henry, Luke C.; Sandel, Natalie			Adolescent Subtest Norms for the ImPACT Neurocognitive Battery	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescent; concussion; neuropsychology; normative data	SPORTS-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ONLINE VERSION; SYMPTOMS; RECOVERY; PERFORMANCE	The neurocognitive testing of sports concussion for injury management and return-to-play decisions has long been considered the gold standard in evaluation of the injury. Computerized testing batteries are frequently employed, with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) being the most used of all the current testing platforms to evaluate concussion. ImPACT's clinical report yields four normed composite scores (Verbal Memory, Visual Memory, Visual Motor Speed, and Reaction Time) and another composite score that is not normed but is used as a validity measure (Impulse Control), as well as their corresponding subtest scores, which are not normed. The current study provides normative data on each of the subtests used to calculate the composite scores. Normative data are separated by gender for athletes aged 13 to 21 years old and are stratified by the norm age brackets already employed by the ImPACT. These norms may be helpful in the interpretation of the ImPACT clinical report and further delineation of areas of neurocognitive dysfunction.	[Henry, Luke C.] Univ Pittsburgh, Med Ctr, Orthopaed Surg, Pittsburgh, PA 15203 USA; [Sandel, Natalie] Widener Univ, Inst Grad Clin Psychol, Chester, PA 19013 USA		Henry, LC (corresponding author), Univ Pittsburgh, Med Ctr, Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.	henryl@upmc.edu	Meijer, Anna/K-5118-2016				Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; BARTH J, 1989, J COGNITIVE NEUROREH, V26, P451; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cohen R, 2006, CLIN NEUROPSYCHOLOGY, P572; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Henry L. C., 2010, HDB SPORT NEUROPSYCH, V1, P153; Ikeda Y, 2013, RES DEV DISABIL, V34, P2391, DOI 10.1016/j.ridd.2013.04.019; ImPACT Applications, 2011, IMM POST CONC ASS TE; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; National Academy of Neuropsychology, 2013, CONC LEG; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	39	14	14	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 2	2015	4	4					266	276		10.1080/21622965.2014.911094			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CT2QT	WOS:000362649000006	25412432				2022-02-06	
J	Pan, T; Liao, K; Roenigk, K; Daly, JJ; Walker, MF				Pan, Tao; Liao, Ke; Roenigk, Kristen; Daly, Janis J.; Walker, Mark F.			Static and dynamic postural stability in veterans with combat-related mild traumatic brain injury	GAIT & POSTURE			English	Article						Concussion; Post-concussive; Balance; Posture; Blast exposure	CONCUSSION; IRAQ; DISORDERS; SYMPTOMS	Persistent post-concussive symptoms are reported by 10-15% of individuals who suffer mild traumatic brain injury (mTBI), but their basis is often uncertain. One such symptom is disequilibrium, a sensation of impaired balance during standing and walking. The hypothesis for this study was that this subjective symptom is associated with objective and measurable deficits in static and dynamic postural stability. An infrared motion tracking system was used to record body motion during quiet standing and in response to waist perturbations in fourteen veterans (age 22-40 years, 13 male) of the Operations Enduring Freedom (OEF) and Iraqi Freedom (OIF), who had a history of mTBI that occurred 7 months to 7 years prior to testing. We compared body sway between veterans with mTBI reporting persistent disequilibrium (T-D, n = 8) and those with no vestibular symptoms (n = 6), as well as to a group of non-veterans with no balance symptoms (n = 10). Static postural stability was reduced in T-D veterans in comparison to each of the other two groups (p < 0.0002), most notably on a compliant surface with eyes closed. The T-D group also had decreased dynamic stability of the upper trunk (p < 0.05) and enhanced postural oscillations (p < 0.02) following waist perturbations. Our findings support a physiological basis for persistent disequilibrium after mTBI and are consistent with impaired vestibular processing. Disruption of semicircular canal inputs is unlikely to be the cause, as head impulse responses were normal in all groups. The unexpected finding of dynamic postural oscillations requires further study but may indicate enhanced instability in sensorimotor networks responsible for postural control. Published by Elsevier B.V.	[Pan, Tao; Liao, Ke; Daly, Janis J.; Walker, Mark F.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Pan, Tao; Liao, Ke; Roenigk, Kristen; Daly, Janis J.; Walker, Mark F.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Pan, Tao; Liao, Ke; Roenigk, Kristen; Daly, Janis J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Walker, Mark F.] Case Western Reserve Univ, Adv Platform Technol Ctr, Cleveland, OH 44106 USA; [Roenigk, Kristen; Daly, Janis J.; Walker, Mark F.] Case Western Reserve Univ, Funct Elect Stimulat Ctr, Cleveland, OH 44106 USA		Walker, MF (corresponding author), Cleveland VAMC, Dept Neurol, 10701 East Blvd,127W, Cleveland, OH 44106 USA.	mark.walker@case.edu			Department of DefenseUnited States Department of Defense [CDMRP W81XWH-08-2-0188]; Department of Veterans AffairsUS Department of Veterans Affairs; Armington Fund (University Hospitals of Cleveland)	This study was supported by the Department of Defense (CDMRP W81XWH-08-2-0188), by the Department of Veterans Affairs, and by the Armington Fund (University Hospitals of Cleveland).	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dichgans J, 1983, Adv Neurol, V39, P633; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	31	14	14	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2015	42	4					550	557		10.1016/j.gaitpost.2015.08.012			8	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	CY0BP	WOS:000366071500025	26374930	Bronze			2022-02-06	
J	Rezapour, T; Hatami, J; Farhoudian, A; Sofuoglu, M; Noroozi, A; Daneshmand, R; Samiei, A; Ekhtiari, H				Rezapour, Tara; Hatami, Javad; Farhoudian, Ali; Sofuoglu, Mehmet; Noroozi, Alireza; Daneshmand, Reza; Samiei, Ahmadreza; Ekhtiari, Hamed			NEuro COgnitive REhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial	BASIC AND CLINICAL NEUROSCIENCE			English	Article						Cognitive enhancers; Drug addiction; NECOREDA; Treatment	STROKE	Despite extensive evidence for cognitive deficits associated with drug use and multiple publications supporting the efficacy of cognitive rehabilitation treatment (CRT) services for drug addictions, there are a few well-structured tools and organized programs to improve cognitive abilities in substance users. Most published studies on cognitive rehabilitation for drug dependent patients used rehabilitation tools, which have been previously designed for other types of brain injuries such as schizophrenia or traumatic brain injuries and not specifically designed for drug dependent patients. These studies also suffer from small sample size, lack of follow-up period assessments and or comprehensive treatment outcome measures. To address these limitations, we decided to develop and investigate the efficacy of a paper and pencil cognitive rehabilitation package called NECOREDA (Neurocognitive Rehabilitation for Disease of Addiction) to improve neurocognitive deficits associated with drug dependence particularly caused by stimulants (e.g. amphetamine type stimulants and cocaine) and opiates. To evaluate the feasibility of NECOREDA program, we conducted a pilot study with 10 opiate and methamphetamine dependent patients for 3 months in outpatient setting. NECOREDA was revised based on qualitative comments received from clients and treatment providers. Final version of NECOREDA is composed of brain training exercises called "Brain Gym" and psychoeducational modules called "Brain Treasures" which is implemented in 16 training sessions interleaved with 16 review and practice sessions. NECOREDA will be evaluated as an add-on intervention to methadone maintenance treatment in a randomized clinical trial among opiate dependent patients starting from August 2015. We discuss methodological features of NECOREDA development and evaluation in this article.	[Rezapour, Tara; Hatami, Javad; Ekhtiari, Hamed] Inst Cognit Sci Studies, Translat Neurosci Program, Tehran, Iran; [Rezapour, Tara; Noroozi, Alireza; Ekhtiari, Hamed] Univ Tehran Med Sci, Iranian Inst Reduct High Risk Behav, Iranian Natl Ctr Addict Studies, Neurocognit Lab, Tehran 1336616357, Iran; [Hatami, Javad] Univ Tehran, Fac Psychol & Educ, Dept Psychol, Tehran, Iran; [Farhoudian, Ali; Daneshmand, Reza] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Tehran, Iran; [Sofuoglu, Mehmet] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Sofuoglu, Mehmet] VA Connecticut Healthcare Syst, West Haven, CT USA; [Noroozi, Alireza] Minist Hlth & Med Educ, Mental Hlth Social Hlth & Addict Dept MEHSHAD, Subst Abuse Prevent & Treatment Off SAPTO, Tehran, Iran; [Samiei, Ahmadreza] Arak Univ Med Sci, Sch Med, Clin Dept, Arak, Iran; [Ekhtiari, Hamed] Univ Tehran Med Sci, Res Ctr Mol & Cellular Imaging, Tehran 1336616357, Iran		Ekhtiari, H (corresponding author), Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Neurocognit Lab, Tehran 1336616357, Iran.	H_Ekhtiari@razi.tums.ac.ir	Hatami, Javad/L-4750-2019; Ekhtiari, Hamed/L-3639-2013; Noroozi, Alireza/M-7119-2019; Farhoudian, Ali/M-4188-2017; Rezapour, Tara/S-2976-2018; Noroozi, Alireza/AAZ-9306-2021	Ekhtiari, Hamed/0000-0001-6902-8798; Noroozi, Alireza/0000-0002-5838-4348; Daneshmand, Reza/0000-0002-0988-678X			Ahmadi-Soleimani A., 2016, PROGR BRAIN RES, DOI [10.1177/0268355513518912, DOI 10.1177/0268355513518912]; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Davis PE, 2002, DRUG ALCOHOL DEPEN, V67, P105, DOI 10.1016/S0376-8716(02)00012-1; Eack S. M., 2013, SOC WORK, V57, P235; Ekhtiari H., 2014, ASIA PACIFIC J MED T, V3, P7; Fals-Stewart W, 2010, EXP CLIN PSYCHOPHARM, V18, P87, DOI 10.1037/a0018058; Gould Thomas J, 2010, Addict Sci Clin Pract, V5, P4; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; HEWER RL, 1990, Q J MED, V76, P659; Fernandez-Serrano MJ, 2012, PSYCHOPHARMACOLOGY, V219, P673, DOI 10.1007/s00213-011-2485-z; Kaneko Yoshio, 2012, Clin Psychopharmacol Neurosci, V10, P125, DOI 10.9758/cpn.2012.10.3.125; Landau WM, 2005, ANN NEUROL, V57, P465, DOI 10.1002/ana.20411; Mehrjerdi ZA, 2012, BASIC CLIN NEUROSCI, V3, P5; Milot M. H., 2012, CURRENT OPINION NEUR, V29, P997, DOI [10.1016/j.biotechadv.2011.08.021, DOI 10.1016/J.BIOTECHADV.2011.08.021.]; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Prosser J, 2006, DRUG ALCOHOL DEPEN, V84, P240, DOI 10.1016/j.drugalcdep.2006.02.006; Rezapour T., 2016, PROGR BRAIN RE UNPUB, P1; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Twamley EW, 2008, AM J PSYCHIATR REHAB, V11, P144, DOI 10.1080/15487760801963678	22	14	15	0	7	NEGAH INST SCIENTIFIC COMMUNICATION	TEHRAN	UNIT 2, NO 108, SOUTHERN JAMALZADEH ST, ENGHELAB SQ, TEHRAN, 00000, IRAN	2008-126X	2228-7442		BASIC CLIN NEUROSCI	Basic Clin. Neurosci.	OCT	2015	6	4					291	298					8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DU9XY	WOS:000382572700009	26649167				2022-02-06	
J	Gonzalez, OC; Krishnan, GP; Chauvette, S; Timofeev, I; Sejnowski, T; Bazhenov, M				Gonzalez, Oscar C.; Krishnan, Giri P.; Chauvette, Sylvain; Timofeev, Igor; Sejnowski, Terrence; Bazhenov, Maxim			Modeling of Age-Dependent Epileptogenesis by Differential Homeostatic Synaptic Scaling	JOURNAL OF NEUROSCIENCE			English	Article						epileptic seizures; homeostatic plasticity; ion concentration dynamics; network models; synaptic plasticity	PARTIAL CORTICAL DEAFFERENTATION; TRAUMATIC BRAIN-INJURY; V PYRAMIDAL NEURONS; IN-VIVO; POSTTRAUMATIC EPILEPSY; EXCITATORY SYNAPSES; QUANTAL AMPLITUDE; SEIZURES; PLASTICITY; CORTEX	Homeostatic synaptic plasticity (HSP) has been implicated in the development of hyperexcitability and epileptic seizures following traumatic brain injury (TBI). Our in vivo experimental studies in cats revealed that the severity of TBI-mediated epileptogenesis depends on the age of the animal. To characterize mechanisms of these differences, we studied the properties of the TBI-induced epileptogenesis in a biophysically realistic cortical network model with dynamic ion concentrations. After deafferentation, which was induced by dissection of the afferent inputs, there was a reduction of the network activity and upregulation of excitatory connections leading to spontaneous spike-and-wave type seizures. When axonal sprouting was implemented, the seizure threshold increased in the model of young but not the older animals, which had slower or unidirectional homeostatic processes. Our study suggests that age-related changes in the HSP mechanisms are sufficient to explain the difference in the likelihood of seizure onset in young versus older animals.	[Gonzalez, Oscar C.; Bazhenov, Maxim] Univ Calif Riverside, Grad Program Neurosci, Riverside, CA 92521 USA; [Gonzalez, Oscar C.; Krishnan, Giri P.; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Chauvette, Sylvain; Timofeev, Igor] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; [Timofeev, Igor] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ G1V 0A6, Canada; [Sejnowski, Terrence] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Sejnowski, Terrence] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA		Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 900 Univ Ave, Riverside, CA 92521 USA.	maksim.bazhenov@ucr.edu	Timofeev, Igor/E-8828-2012; Sejnowski, Terrence/AAV-5558-2021; Timofeev, Igor/AAP-7529-2021	Timofeev, Igor/0000-0002-1389-5857; Gonzalez, Oscar/0000-0003-1302-1911	National Institutes of Health GrantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EB009282, R01NS081243]; Office of Naval Research Multidisciplinary University Research Initiative Grant [N000141310672]; Canadian Institutes of Health Research GrantsCanadian Institutes of Health Research (CIHR) [201403MOP-325213, 201403MOP-324941]; National Science Foundation Graduate Research Fellowship Grant [DGE-1326120]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081243] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants R01EB009282 and R01NS081243, Office of Naval Research Multidisciplinary University Research Initiative Grant N000141310672, and Canadian Institutes of Health Research Grants 201403MOP-325213 and 201403MOP-324941. O.C.G. was supported by the National Science Foundation Graduate Research Fellowship Grant DGE-1326120.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dinner Dudley S., 1993, P654; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Frohlich F, 2008, NEUROSCIENTIST, V14, P422, DOI 10.1177/1073858408317955; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Frohlich F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031922; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Frohlich Flavio, 2005, Thalamus & Related Systems, V3, P147, DOI 10.1017/S1472928807000155; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Grand L, 2013, J NEUROSCI METH, V212, P237, DOI 10.1016/j.jneumeth.2012.10.008; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Jaerve A, 2011, EXP NEUROL, V231, P284, DOI 10.1016/j.expneurol.2011.07.002; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jyoti A, 2009, NEUROSCI LETT, V453, P86, DOI 10.1016/j.neulet.2009.01.082; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Kusmierczak M, 2015, NEUROSCIENCE, V284, P153, DOI 10.1016/j.neuroscience.2014.09.079; Lee KFH, 2014, NEUROPHARMACOLOGY, V78, P31, DOI 10.1016/j.neuropharm.2013.03.016; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Remme MWH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002494; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Salin P, 1995, J NEUROSCI, V15, P8234; SCHAUWECKER PE, 1995, J NEUROSCI, V15, P2462, DOI 10.1523/JNEUROSCI.15-03-02462.1995; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Temkin N R, 1995, New Horiz, V3, P518; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00154; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Volman V, 2011, J NEUROPHYSIOL, V106, P1933, DOI 10.1152/jn.00458.2011; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Xiong W, 2011, J VIS EXP, V55	63	14	14	0	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 30	2015	35	39					13448	13462		10.1523/JNEUROSCI.5038-14.2015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV2RN	WOS:000364104700016	26424890	Green Published, Bronze, Green Accepted			2022-02-06	
J	Chen, Y; Bao, Y; Zhang, JP; Woehrle, T; Sumi, Y; Ledderose, S; Li, XO; Ledderose, C; Junger, WG				Chen, Yu; Bao, Yi; Zhang, Jingping; Woehrle, Tobias; Sumi, Yuka; Ledderose, Stephan; Li, Xiaoou; Ledderose, Carola; Junger, Wolfgang G.			Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases	SHOCK			English	Article							TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE P38; HEMORRHAGIC-SHOCK; ATP RELEASE; OXIDATIVE BURST; CELL-ACTIVATION; RESUSCITATION; RECEPTORS; HEMICHANNELS; HYPOTENSION	Hypertonic saline (HS) resuscitation has been studied as a possible strategy to reduce polymorphonuclear neutrophil (PMN) activation and tissue damage in trauma patients. Hypertonic saline blocks PMNs by adenosine triphosphate (ATP) release and stimulation of A2a adenosine receptors. Here, we studied the underlying mechanisms in search of possible reasons for the inconsistent results of recent clinical trials with HS resuscitation. Purified human PMNs or PMNs in whole blood were treated with HS to simulate hypertonicity levels found after HS resuscitation (40 mmol/L beyond isotonic levels). Adenosine triphosphate release was measured with a luciferase assay. Polymorphonuclear neutrophil activation was assessed by measuring oxidative burst. The pannexin-1 (panx1) inhibitor (10)panx1 and the gap junction inhibitor carbenoxolone (CBX) blocked ATP release from PMNs in purified and whole blood preparations, indicating that HS releases ATP via panx1 and gap junction channels. Hypertonic saline blocked N-formyl-Met-Leu-Phe-induced PMN activation by 40% in purified PMN preparations and by 60% in whole blood. These inhibitory effects were abolished by (10)panx1 but only partially reduced by CBX, which indicates that panx1 has a central role in the immunomodulatory effects of HS. Inhibition of the ectonucleotidases CD39 and CD73 abolished the suppressive effect of HS on purified PMN cultures but only partially reduced the effect of HS in whole blood. These findings suggest redundant mechanisms in whole blood that may strengthen the immunomodulatory effect of HS in vivo. We conclude that HS resuscitation exerts anti-inflammatory effects that involve panx1, CD39, CD73, and other ectonucleotidases, which produce the adenosine that blocks PMNs by stimulating their A2a receptors. Our findings shed new light on the immunomodulatory mechanisms of HS and suggest possible new strategies to improve the clinical efficacy of hypertonic resuscitation.	[Chen, Yu; Bao, Yi; Zhang, Jingping; Woehrle, Tobias; Sumi, Yuka; Ledderose, Stephan; Li, Xiaoou; Ledderose, Carola; Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, Vienna, Austria		Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; Zhang, Jingping/ABA-4179-2020	Junger, Wolfgang G/0000-0003-3350-8452; Zhang, Jingping/0000-0002-7800-9617; Bao, Yi/0000-0003-0748-1575	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM-51477, GM-60475, AI-072287, AI-080582, T32 GM-103702]; CDMRPUnited States Department of Defense [PR043034]; Shock Society/Nova Nordisk research grant for Early Career Investigators; German Research FoundationGerman Research Foundation (DFG) [LE-3209/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI072287, R01AI080582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM116162, R29GM051477, T32GM103702, R01GM060475, R01GM051477] Funding Source: NIH RePORTER	This work received financial support through the National Institute of Health grants GM-51477, GM-60475, AI-072287, AI-080582, and T32 GM-103702, a grant from CDMRP (PR043034; W.G.J.), a Shock Society/Nova Nordisk research grant for Early Career Investigators (Y.C.), and a grant from the German Research Foundation (LE-3209/1-1; C.L.).	Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Bao Y, 2014, J BIOL CHEM, V289, P26794, DOI 10.1074/jbc.M114.572495; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Bulger Eileen M, 2012, Adv Surg, V46, P73; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Dubick MA, 2013, CLINICS, V68, P883, DOI 10.6061/clinics/2013(06)25; HAMPTON MB, 1994, J INFECT DIS, V169, P839, DOI 10.1093/infdis/169.4.839; Hashiguchi N, 2007, J TRAUMA, V62, P299, DOI 10.1097/01.ta.0000222956.88760.33; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Junger WG, 2013, SHOCK, V40, P366, DOI 10.1097/SHK.0000000000000038; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Murao Y, 2000, SHOCK, V14, P18, DOI 10.1097/00024382-200014010-00004; Murao Y, 2003, SHOCK, V20, P29, DOI 10.1097/01.shk.0000071060.78689.f1; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	35	14	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2015	44	3					221	227		10.1097/SHK.0000000000000402			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CP6FU	WOS:000359981300005	26009814	Green Accepted			2022-02-06	
J	Kelly, ML; Roach, MJ; Banerjee, A; Steinmetz, MP; Claridge, JA				Kelly, Michael L.; Roach, Mary Jo; Banerjee, Aman; Steinmetz, Michael P.; Claridge, Jeffrey A.			Functional and long-term outcomes in severe traumatic brain injury following regionalization of a trauma system	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery28th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	SEP 09-13, 2014JAN 13-17, 2015	Philadelphia, PALake Buena Vista, FL	Amer Assoc Surg TraumaEastern Assoc Surg Trauma		Traumatic brain injury; regionalization; health systems; outcomes; mortality	HOSPITAL SYSTEMS; UNITED-STATES; LEVEL I; CARE; MORTALITY	BACKGROUND: We previously demonstrated that regionalization of trauma (RT) significantly reduced in-hospital mortality from 19% to 14% in patients with severe traumatic brain injury (sTBI). However, functional and long-term outcomes had not been assessed. We hypothesized that RT would be associated with improved functional and long-term outcomes in sTBI patients. METHODS: All TBI patients older than 14 years with a head Abbreviated Injury Scale (AIS) score of 3 or greater were identified from the RT database and matched to the state death index and the regional TBI rehabilitation (TBIr) database. Data from 2008 through 2012 were analyzed before and after RT in 2010. For patients discharged to the TBIr unit, overall Functional Independence Measure (FIM) scores and FIM score gains were compared before and after RT. RESULTS: A total of 3,496 patients with sTBI were identified in the RT database, 1,359 in the pre-RT and 2,137 in the post-RT period. The mortality rate after discharge decreased significantly after RT from 21% to 16% (p < 0.0001) at 30 days and from 24% to 20% (p = 0.004) at 6 months. Multivariable logistic regression demonstrated RT to be an independent predictor against mortality at 30 days (odds ratio, 0.74; 95% confidence interval, 0.60-0.91; C statistic, 0.84) and 6 months (odds ratio, 0.82; 95% confidence interval, 0.67-0.99; C statistic, 0.82). Discharges to the TBIr unit increased from 117 (9%) in the pre-RT to 297 (14%) in the post-RT period (p < 0.0001), while discharges to home and non-TBIr units remained similar. Injury Severity Score (ISS) and Glasgow Coma Scale (GCS) score for all discharged patients remained similar. FIM admission scores were similar in the pre-RT (median, 54; interquartile range [IQR], 30-65) and post-RT period (median, 48; IQR, 31-61) (p = 0.2) and remained similar at discharge in the pre-RT (median, 92; IQR, 75-102) and post-RT period (median, 89; IQR, 73-100) (p = 0.1). TBIr patients showed similar FIM score gains in the pre-RT (median, 37; IQR, 26-46) and post-RT period (median, 36; IQR, 24-49) (p = 0.6). CONCLUSION: RT was associated with reduced long-term mortality, increased TBIr admissions, and similar FIM score improvements for patients with sTBI. (J Trauma Acute Care Surg. 2015;79: 372-377. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Kelly, Michael L.] Cleveland Clin, Dept Neurosurg, Neurol Inst, Cleveland, OH 44106 USA; [Roach, Mary Jo; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Ctr Healthcare Res & Policy, Cleveland, OH 44109 USA; [Banerjee, Aman; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Northern Ohio Trauma Syst, Cleveland, OH 44109 USA; [Steinmetz, Michael P.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Surg, Cleveland, OH 44109 USA; [Steinmetz, Michael P.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Neurosurg, Cleveland, OH 44109 USA		Claridge, JA (corresponding author), Case Western Reserve Univ, Div Trauma Crit Care Burns & Acute Care Surg, MetroHlth Med Ctr, Northern Ohio Trauma Syst,Dept Surg,Sch Med, Cleveland, OH 44109 USA.	jclaridge@metrohealth.org					Bailey J, 2012, SURG CLIN N AM, V92, P1009, DOI 10.1016/j.suc.2012.04.008; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Claridge JA, 2013, SURGERY, V154, P875, DOI 10.1016/j.surg.2013.07.013; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Kelly ML, 2015, J TRAUMA ACUTE CARE, V78, P715, DOI 10.1097/TA.0000000000000590; NICE, HEAD INJ TRIAG ASS I; Ohio trauma registry, 2010, OH TRAUM REG ANN DAT; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; Sanchez AI, 2012, J HEAD TRAUMA REHAB, V27, P159, DOI 10.1097/HTR.0b013e3182074c41; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; The Uniform Data System for Medical Rehabilitation, FIM INSTR ITS BACKGR; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2	17	14	14	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2015	79	3					372	377		10.1097/TA.0000000000000762			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	CQ4JV	WOS:000360571900009	26307868				2022-02-06	
J	Whiteside, DM; Gaasedelen, OJ; Hahn-Ketter, AE; Luu, H; Miller, ML; Persinger, V; Rice, L; Basso, MR				Whiteside, Douglas M.; Gaasedelen, Owen J.; Hahn-Ketter, Amanda E.; Luu, Hien; Miller, Michelle L.; Persinger, Virginia; Rice, Linda; Basso, Michael R.			Derivation of a Cross-Domain Embedded Performance Validity Measure in Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity test; Traumatic brain injury; California Verbal Learning Test; Boston Naming Test; Brief Test of Attention	VERBAL-LEARNING TEST; BOSTON NAMING TEST; TEST-RETEST RELIABILITY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; WECHSLER-MEMORY-SCALE; CARD SORTING TEST; CLASSIFICATION ACCURACY; SUSPECT EFFORT; TEST-II	Objective: Performance validity assessment is increasingly considered standard practice in neuropsychological evaluations. The current study extended research on logistically derived performance validity tests (PVTs) by utilizing neuropsychological measures from multiple cognitive domains instead of from a single measure or a single cognitive domain.Method: A logistic-derived PVT was calculated using several measures from multiple cognitive domains, including verbal memory (California Verbal Learning Test-II Trial 5, Total Hits, and False Positives), attention (Brief Test of Attention Total score), and language (Boston Naming Test T-score, and Animal Fluency T-score). Due to its cross-domain nature, the cross-domain logistic-derived embedded PVT was hypothesized to have excellent classification accuracy for non-credible performance. Participants included 224 patients who completed all measures and were moderate to severe traumatic brain injury (STBI) patients (N=66), possible mild TBI (MTBI-FAIL) patients who failed at least 2 independent PVTs (N=67), and possible mild TBI patients who passed all PVTs (MTBI-PASS; N=91). Logistic regression and ROC analyses were conducted on the MTBI-FAIL group and the STBI group.Results: Multivariate analysis of variance indicated that the MTBI-FAIL group was significantly lower on all measures than the MTBI-PASS and the STBI groups. Using logistic regression, CVLT Total Hits, BTA, and the CVLT False Positives best differentiated between the MTBI-FAIL and STBI groups. The logistically derived PVT had excellent classification accuracy (area under the curve [AUC]=.84), with sensitivity at .54 when specificity was set at .90, higher than any individual variable.Conclusions: Findings support the use of this logistical-derived variable as an embedded PVT and support further research with this type of methodology.	[Whiteside, Douglas M.; Luu, Hien] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Gaasedelen, Owen J.] Univ Iowa, Dept Psychol & Quantitat Fdn, Counseling Psychol, Iowa City, IA 52242 USA; [Hahn-Ketter, Amanda E.] Mt Sinai Hosp, Dept Rehabil Med, New York, NY 10029 USA; [Miller, Michelle L.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Persinger, Virginia] Southern Oregon Vet Affairs Rehabil Ctr & Clin, Dept Psychol, Medford, MA USA; [Rice, Linda] Rehabil Inst Chicago, Dept Psychol, Chicago, IL 60611 USA; [Basso, Michael R.] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA		Whiteside, DM (corresponding author), Univ Iowa, Dept Psychiat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	douglas-whiteside@uiowa.edu	Basso, Michael/S-9587-2019; Whiteside, Douglas/AAK-6396-2020	Basso, Michael/0000-0002-0217-662X; Whiteside, Douglas/0000-0002-8454-4413; Hahn-Ketter, Amanda/0000-0002-0226-3598; Miller, Michelle/0000-0001-6150-0242			Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bird CM, 2004, BRIT J CLIN PSYCHOL, V43, P197, DOI 10.1348/014466504323088051; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Flanagan JL, 1997, J COMMUN DISORD, V30, P33, DOI 10.1016/S0021-9924(96)00039-1; FRANZEN MD, 1995, CLIN NEUROPSYCHOL, V9, P225, DOI 10.1080/13854049508400484; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P., 2005, MED SYMPTOM VALIDIDY; Green P., 1996, WORD MEMORY TEST USE; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, CLIN NEUROPSYCHOL, V21, P318, DOI 10.1080/13854040500488552; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Hosmer D.W., 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kaplan E, 1983, BOSTON NAMING TEST; Laine M., 2006, ANOMIA THEORETICAL C; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee G. L., 2007, ASSESSMENT MALINGERE, P100; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Menard S.W., 1995, APPL LOGISTIC REGRES; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Millis SR., 2009, AM ACAD CLIN NEUROPS, P21; NICHOLAS LE, 1989, APHASIOLOGY, V3, P569, DOI 10.1080/02687038908249023; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pearson Education Inc., 2008, WECHSL MEM SCAL; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Schretlen, 1996, BRIEF TEST ATTENTION; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; VANGORP WG, 1986, J CLIN EXP NEUROPSYC, V8, P702, DOI 10.1080/01688638608405189; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Whittle C, 2007, J CLIN EXP NEUROPSYC, V29, P290, DOI 10.1080/13803390600678038; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	65	14	14	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 18	2015	29	6					788	803		10.1080/13854046.2015.1093660			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CV8SA	WOS:000364556800004	26430920				2022-02-06	
J	Bernhard, M; Bein, B; Bottiger, BW; Bohn, A; Fischer, M; Grasner, JT; Hinkelbein, J; Kill, C; Lott, C; Popp, E; Roessler, M; Schaumberg, A; Wenzel, V; Hossfeld, B				Bernhard, M.; Bein, B.; Boettiger, B. W.; Bohn, A.; Fischer, M.; Graesner, J. T.; Hinkelbein, J.; Kill, C.; Lott, C.; Popp, E.; Roessler, M.; Schaumberg, A.; Wenzel, V.; Hossfeld, B.			Practice management guideline on prehospital emergency anaesthesia. Working group "Prehospital emergency anaesthesia" of the scientific working group on emergency medicine of the German Society of Anaesthesiology and Intensive Care Medicine	NOTFALL & RETTUNGSMEDIZIN			German	Article						Guideline; Emergency medicine; Emergency anaesthesia; Management; Complications	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; AIRWAY-MANAGEMENT; TRACHEAL INTUBATION; SUCCESS RATES; ADRENAL INSUFFICIENCY; VIDEO LARYNGOSCOPES; ETOMIDATE; MULTICENTER; INDUCTION	Inducing anaesthesia outside the hospital is an important therapeutic intervention in emergency medicine; it is much more difficult to accomplish than inside the hospital. Its primary goals include hypnosis and analgesia which enable airway management to achieve mechanical ventilation and adequate oxygenation. Secondary goals of emergency anaesthesia include amnesia, anxiolysis, reduced oxygen consumption and work of breathing, and thus protection of vital organs and avoidance of secondary myocardial injury or cerebral injuries. Prior to prehospital induction of anaesthesia, patient-, scene- and operator-specific factors need to be considered. The rapid sequence induction includes basic monitoring, pre-oxygenation, standardized preparation of drugs and equipment, administration of drugs, removal of the cervical collar and manual in-line stabilization during intubation attempt (if needed), intubation and confirmation of endotracheal intubation. Every spontaneously breathing emergency patient should receive pre-oxygenation for at least 3-4 min with 12-15 l oxygen per min and a tight-sealing facemask, or a demand valve. The standardized preparation process includes preparation and labeling drugs/syringes, checking the bag-valve mask, preparing the endotracheal tube with a stylet and blocking syringe, as well as having a stethoscope and material to secure the tube at hand, as well as alternative airway devices. It also includes immediate access to alternative means of airway management, as well as a suction unit, ventilator and monitoring devices including capnography. Basic monitoring for prehospital emergency anaesthesia includes ECG, an automatic/manual blood pressure cuff, and pulse oximetry. Continuous capnography is used without exception to confirm ventilation, to detect possible disconnections/dislocations, and for indirect monitoring of hemodynamics. Prior to induction of prehospital emergency anaesthesia, two peripheral intravenous catheters should be placed if possible.	[Bernhard, M.] Univ Klinikum Leipzig AoR, Zentrale Notaufnahme, D-04103 Leipzig, Germany; [Bein, B.] Asklepios Klin St Georg, Klin Anasthesiol & Operat Intens Med, Hamburg, Germany; [Boettiger, B. W.; Hinkelbein, J.] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Cologne, Germany; [Bohn, A.] Feuerwehr Munster, Munster, Germany; [Fischer, M.] ALB FILS KLINIKEN GmbH, Klin Anasthesiol & Operat Intens Med, Klin Eichert, Goppingen, Germany; [Graesner, J. T.] Univ Klinikum Kiel, Klin Anasthesiol & Operat Intens Med, Kiel, Germany; [Kill, C.] Univ Klinikum Giessen & Marburg GmbH, Zentrum Notfallmed, Marburg, Germany; [Lott, C.] Johannes Gutenberg Univ Mainz, Klin Anasthesiol Univ Med, D-55122 Mainz, Germany; [Popp, E.] Univ Klinikum Heidelberg, Anasthesiol Klin, Sekt Notfallmed, Heidelberg, Germany; [Roessler, M.] Univ Gottingen, Anasthesiol Klin, Zentrum Anasthesiol Rettungs & Intens Med, D-37073 Gottingen, Germany; [Schaumberg, A.] Standort Giessen Justus Liebig Univ Giessen, Univ Klinikum Giessen & Marburg, Klin Anasthesiol & Operat Intens Med, Giessen, Germany; [Wenzel, V.] Med Univ Innsbruck, Univ Klin Anasthesie & Intens Med, A-6020 Innsbruck, Austria; [Hossfeld, B.] Bundeswehrkrankenhaus, Klin Anasthesiol & Intens Med, Ulm, Germany		Bernhard, M (corresponding author), Univ Klinikum Leipzig AoR, Zentrale Notaufnahme, Liebigstr 26, D-04103 Leipzig, Germany.	michael.bernhard@medizin.uni-leipig.de	Roessler, Markus Soeren/I-7834-2013; Grasner, Jan-Thorsten/G-1934-2014	Grasner, Jan-Thorsten/0000-0001-8143-0376			Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; [Anonymous], 2009, ANASTH INTENSIVMED, V50, pS489; Barnard EBG, 2015, EMERG MED J, V32, P449, DOI 10.1136/emermed-2014-203740; Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bernhard M, 2006, ANAESTHESIST, V55, P1157, DOI 10.1007/s00101-006-1106-4; Bernhard M, 2014, ANAESTHESIST, V63, P589, DOI 10.1007/s00101-014-2348-1; Bernhard M, 2011, NOTFALL RETTUNGSMED, V14, P554, DOI 10.1007/s10049-010-1402-z; Bernhard M, 2010, ANASTH INTENSIVMED, V51, pS615; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; Braun P, 2010, CURR OPIN ANESTHESIO, V23, P500, DOI 10.1097/ACO.0b013e32833bc135; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; Bretschneider I, 2011, NOTARZT, V27, P270, DOI 10.1055/s-0031-1276960; Cavus E, 2011, EMERG MED J, V28, P650, DOI 10.1136/emj.2010.098707; Chan CM, 2012, CRIT CARE MED, V40, P2945, DOI 10.1097/CCM.0b013e31825fec26; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Christ M, 2011, INTENSIVMED, V47, P83; Connor CW, 2014, ANESTH ANALG, V118, P419, DOI 10.1213/ANE.0000000000000012; Cook T, 2012, CURR OPIN ANESTHESIO, V25, P461, DOI 10.1097/ACO.0b013e32835528b1; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; Cowan GM, 2012, EMERG MED J, V29, P136, DOI 10.1136/emj.2010.105304; Deutsche_Interdisziplinare_Vereinigung_Fur_Intensiv- Und Notfallmedizin (Divi), 2012, EMPF KENNZ SPRITZ IN; Easby J, 2004, J TRAUMA, V6, P217; Edlow JA, 2014, LANCET, V384, P2064, DOI 10.1016/S0140-6736(13)62184-4; Eich C, 2009, RESUSCITATION, V80, P1371, DOI 10.1016/j.resuscitation.2009.09.004; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; ELBEHEIRY H, 1995, CAN J ANAESTH, V42, P875, DOI 10.1007/BF03011034; Genzwurker HV, 2010, ANASTH INTENSIVMED, V51, P202; Grasner JT, 2007, NOTFALLMEDIZIN UP2DA, V2, P197; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hedenstierna G, 2005, INTENS CARE MED, V31, P1327, DOI 10.1007/s00134-005-2761-7; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Helm M, 2010, ANAESTHESIST, V59, P896, DOI 10.1007/s00101-010-1759-x; Helm M, 2005, BEST PRACT RES-CLIN, V19, P623, DOI 10.1016/j.bpa.2005.06.002; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Herff H, 2009, ANESTH ANALG, V109, P303, DOI 10.1213/ane.0b013e3181ad8a1e; Heuer JF, 2012, ANAESTH INTENS CARE, V40, P120, DOI 10.1177/0310057X1204000113; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P15, DOI 10.1007/s10049-010-1355-2; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P10, DOI 10.1007/s10049-010-1354-3; HUGG CJ, 1993, ANESTH ANALG       S, V25, P77; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Kheterpal S, 2013, ANESTHESIOLOGY, V119, P1360, DOI 10.1097/ALN.0000435832.39353.20; Koenig SJ, 2014, J INTENSIVE CARE MED; Kuhnigk H, 2007, NARKOSE NOTFALLMEDIZ; Liccardi G, 2009, CURR MED RES OPIN, V25, P1621, DOI 10.1185/03007990903010474; Lockey D, AAGBI SAFETY GUIDELI; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Luxen J, 2014, ANAESTHESIST, V63, P331, DOI 10.1007/s00101-014-2303-1; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Messelken M, 2010, DTSCH ARZTEBL INT, V107, P523, DOI 10.3238/arztebl.2010.0523; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MRUGALLA H, 2003, NOTFALL RETTUNGSMED, V6, P233; Neumayr A, 2014, NOTFALL RETTUNGSMED, V17, P25, DOI 10.1007/s10049-013-1816-5; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Niven AS, 2013, CURR OPIN CRIT CARE, V19, P9, DOI 10.1097/MCC.0b013e32835c6014; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Patanwala AE, 2014, ACAD EMERG MED, V21, P87, DOI 10.1111/acem.12292; Pehbock D, 2010, ANESTHESIOLOGY, V113, P593, DOI 10.1097/ALN.0b013e3181e73f07; Perry JJ, 2008, COCHRANE DB SYST REV, V2; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Rortgen D, 2011, ANAESTHESIST, V60, P312, DOI 10.1007/s00101-010-1812-9; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Schlechtriemen T, 2004, NOTFALL RETTUNGSMED, V7, P231; Schmidt J, 2007, ANASTH INTENSIVMED, V48, pS88; Sefrin P, 2014, NOTARZT, V30, P73, DOI 10.1055/s-0034-1369910; SITZWOHL C, 2010, BMJ-BRIT MED J, V341, P5943; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Steinmann D, 2009, ANAESTHESIST, V58, P695, DOI 10.1007/s00101-009-1548-6; Stollings JL, 2014, ANN PHARMACOTHER, V48, P62, DOI 10.1177/1060028013510488; Swanson Eric R, 2004, Prehosp Emerg Care, V8, P273; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2012, ANASTH INTENSIVMED, V53, P294; Timmermann A, 2009, ANAESTHESIST, V58, P663, DOI 10.1007/s00101-009-1570-8; van den Heuvel I, 2013, CURR OPIN ANESTHESIO, V26, P404, DOI 10.1097/ACO.0b013e328362a84c; VANDERWALT J, 1995, PAEDIATR ANAESTH, V5, P257; Voelckel WG, 2004, ANAESTHESIST, V53, P1151, DOI 10.1007/s00101-004-0771-4; von Goedecke A, 2007, ANESTH ANALG, V104, P481, DOI 10.1213/01.ane.0000255964.86086.63; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Weller D, 2006, AKTUEL NEUROL, V33, pP532; Werdan K, 2011, KARDIOLOGE, V5, P166, DOI 10.1007/s12181-011-0349-8; Wetsch WA, 2013, EUR J ANAESTH, V30, P537, DOI 10.1097/EJA.0b013e3283614119; Wetsch WA, 2011, EUR J ANAESTH, V28, P849, DOI 10.1097/EJA.0b013e32834c7c7f; Wilbur K, 2001, CJEM, V3, P302; Zollinger A, 2012, DIE ANASTHESIOLOGIE	90	14	14	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	AUG	2015	18	5					395	+		10.1007/s10049-015-0041-9			17	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CN7HF	WOS:000358604300011					2022-02-06	
J	Lee, JY; Lee, CY; Kim, HR; Lee, CH; Kim, HW; Kim, JH				Lee, Jae Yoon; Lee, Cheol Young; Kim, Hong Rye; Lee, Chang-Hyun; Kim, Hyun Woo; Kim, Jong Hyun			A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries; Biological markers; S100 Calcium Binding Protein beta Subunit; Glial fibrillary acidic protein; Ubiquitin thiolesterase	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE; KINASE-BB ISOENZYME; CREATINE-KINASE; CEREBROSPINAL-FLUID; S-100 PROTEIN; ENOLASE; BLOOD; S100B; INFARCTION	Objective : Optimal treatment decision and estimation of the prognosis in traumatic brain injury (TBI) is currently based on demographic and clinical predictors. But sometimes, there are limitations in these factors. In this study, we analyzed three central nervous system biomarkers in TBI patients, will discuss the roles and clinical applications of biomarkers in TBI. Methods : From July on 2013 to August on 2014, a total of 45 patients were included. The serum was obtained at the time of hospital admission, and biomarkers were extracted with centrifugal process. It was analyzed for the level of S-100 beta (S100B), glial fibrillary acidic protein (GFAP), and ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1). Results : This study included 33 males and 12 females with a mean age of 58.5 (19-84) years. TBI patients were classified into two groups. Group A was severe TBI with Glasgow Coma Scale (GCS) score 3-5 and Group B was mild TBI with GCS score 13-15. The median serum concentration of S100B, GFAP, and UCH-L1 in severe TBI were raised 5.1 fold, 5.5 fold, and 439.1 fold compared to mild injury, respectively. The serum levels of these markers correlated significantly with the injury severity and clinical outcome (p<0.001). Increased level of markers was strongly predicted poor outcomes. Conclusion : S100B, GFAP, and UCH-L1 serum level of were significantly increased in TBI according to severity and associated clinical outcomes. Biomarkers have potential utility as diagnostic, prognostic, and therapeutic adjuncts in the setting of TBI.	[Lee, Jae Yoon; Lee, Cheol Young; Kim, Hong Rye; Lee, Chang-Hyun; Kim, Hyun Woo; Kim, Jong Hyun] Konyang Univ Hosp, Dept Neurosurg, Taejon 35365, South Korea; [Lee, Cheol Young] Kyung Hee Univ, Grad Sch Med, Seoul, South Korea; [Lee, Cheol Young] Konyang Univ, Myunggok Med Res Inst, Taejon, South Korea		Lee, CY (corresponding author), Konyang Univ Hosp, Dept Neurosurg, 158 Gwanjeodong Ro, Taejon 35365, South Korea.	leecy009@hanmail.net		Lee, Chang-Hyun/0000-0003-0134-2101	Konyang University Myunggok Research Fund	This work was supported (in part) by Konyang University Myunggok Research Fund of 2013.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-71; HAMM CW, 1995, CURR OPIN CARDIOL, V10, P355, DOI 10.1097/00001573-199507000-00003; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; HANS P, 1987, J NEUROSURG, V66, P714, DOI 10.3171/jns.1987.66.5.0714; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kleiman NS, 2002, J AM COLL CARDIOL, V40, P1044, DOI 10.1016/S0735-1097(02)02119-8; KRUSE A, 1991, ACTA NEUROCHIR, V110, P106, DOI 10.1007/BF01400675; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mishra A, 2012, J PEDIATR NEUROSCI, V7, P71, DOI 10.4103/1817-1745.97633; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Park JE, 2009, J KOREAN NEUROSURG S, V45, P90, DOI 10.3340/jkns.2009.45.2.90; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; USUI A, 1989, CLIN CHEM, V35, P1942; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yoon KH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-71; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	36	14	15	0	3	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	AUG	2015	58	2					93	100		10.3340/jkns.2015.58.2.93			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CX1ZT	WOS:000365495300001	26361523	gold, Green Submitted, Green Published			2022-02-06	
J	Sima, AP; Wehman, PH; Chan, F; West, MD; Leucking, RG				Sima, Adam P.; Wehman, Paul H.; Chan, Fong; West, Michael D.; Leucking, Richard G.			An Evaluation of Risk Factors Related to Employment Outcomes for Youth With Disabilities	CAREER DEVELOPMENT AND TRANSITION FOR EXCEPTIONAL INDIVIDUALS			English	Article						disabilities; youth; transition; employment; classification tree; NLTS2	TRAUMATIC BRAIN-INJURY; VOCATIONAL-REHABILITATION; WORK PARTICIPATION; TREE ANALYSIS; YOUNG-ADULTS; CLASSIFICATION; PREDICTORS; TRANSITION; ADOLESCENTS; EDUCATION	This study explores non-modifiable risk factors associated with poor post-school competitive employment outcomes for students with disabilities. A classification tree analysis was used with a sample of 2,900 students who were in the second National Longitudinal Transition Study-2 (NLTS2) up to 6 years following school exit to identify groups of youth with poor employment outcomes based on characteristics that are unable to be modified through an intervention. Post-school employment was related to the disability characteristics of the student (disability type, ability to understand what is being said, general health status), family characteristics (yearly income, community setting), and youth characteristics (race). The classification tree analysis identified four groups of students who were at greatest risk for poor outcomes. Future research will be directed toward modifiable variables that mitigate risks for those groups that may potentially lead to school-and home-based interventions.	[Sima, Adam P.; Wehman, Paul H.; Chan, Fong; West, Michael D.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Leucking, Richard G.] TransCen Inc, Rockville, MD USA		West, MD (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr, POB 842011, Richmond, VA 23284 USA.	mdwest@vcu.edu		Sima, Adam/0000-0001-8426-9987			Achterberg TJ, 2009, J OCCUP REHABIL, V19, P129, DOI 10.1007/s10926-009-9169-0; Achterberg TJ, 2012, DISABIL REHABIL, V34, P1519, DOI 10.3109/09638288.2011.650311; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Breiman L., 1984, CLASSIFICATION REGRE; Camp NJ, 2002, CANCER CAUSE CONTROL, V13, P813, DOI 10.1023/A:1020611416907; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Carter EW, 2011, J SPEC EDUC, V45, P89, DOI 10.1177/0022466909353204; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chan F, 2006, DISABIL REHABIL, V28, P257, DOI 10.1080/09638280500158307; Chan F., 2005, J APPL REHABILITATIO, V36, P3; Chan JYC, 2011, REHABIL RES POL EDUC, V25, P135, DOI 10.1891/216866511805001019; Chang LY, 2013, SAFETY SCI, V51, P17, DOI 10.1016/j.ssci.2012.06.017; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; Doren B, 1998, J SPEC EDUC, V31, P425, DOI 10.1177/002246699803100402; Gan XM, 2011, J NEUROL SCI, V306, P108, DOI 10.1016/j.jns.2011.03.032; Grobman WA, 2006, AM J OBSTET GYNECOL, V194, P888, DOI 10.1016/j.ajog.2005.09.002; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hand D, 2001, ADAP COMP MACH LEARN; Hasnain R, 2009, J VOCAT REHABIL, V31, P175, DOI 10.3233/JVR-2009-0487; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Kohler PA, 2003, J SPEC EDUC, V37, P174, DOI 10.1177/00224669030370030701; Kolakowsky-Hayner SA, 2010, BRAIN INJURY, V24, P1428, DOI 10.3109/02699052.2010.523039; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Lindsay R, 2007, BONE, V40, pS32, DOI 10.1016/j.bone.2007.03.004; Lindsay S, 2011, DISABIL REHABIL, V33, P843, DOI 10.3109/09638288.2010.514018; McMahon BT, 2008, J OCCUP REHABIL, V18, P133, DOI 10.1007/s10926-008-9136-1; Michon H, 2005, SOC PSYCH PSYCH EPID, V40, P408, DOI 10.1007/s00127-005-0910-5; Newman L., 2011, 20113005 NCSER; Rabren K., 2002, CAREER DEV EXCEPTION, V25, P25, DOI DOI 10.1177/088572880202500103; Reker DM, 2005, J REHABIL RES DEV, V42, P77, DOI 10.1682/JRRD.2003.11.0164; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Wagner M, 2005, J EMOT BEHAV DISORD, V13, P25, DOI 10.1177/10634266050130010301; Wehman P., 2013, PREDICTORS TRA UNPUB; West M., 2008, MONOGRAPH WORKPLACE, P191	34	14	14	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2165-1434	2165-1442		CAREER DEV TRANSIT E	Career Dev. Transit. Except. Individ.	AUG	2015	38	2					89	100		10.1177/2165143414534887			12	Education, Special; Rehabilitation	Emerging Sources Citation Index (ESCI)	Education & Educational Research; Rehabilitation	CQ1WP	WOS:000360391200004					2022-02-06	
J	das Nair, R; Martin, KJ; Sinclair, EJ				das Nair, Roshan; Martin, Kristy-Jane; Sinclair, Emma J.			A meta-synthesis of qualitative research on perceptions of people with long-term neurological conditions about group-based memory rehabilitation	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Cognitive rehabilitation; Meta-synthesis; Memory; Qualitative analysis; Neurological conditions	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; MULTIPLE-SCLEROSIS; IMPROVING MEMORY; ISSUES; DISABILITIES; PERFORMANCE; DEMENTIA; THERAPY; STROKE	The effectiveness of memory rehabilitation based on randomised controlled trials and meta-analyses has been inconclusive, but patient reports based on qualitative studies have been largely positive. We conducted a meta-synthesis of qualitative studies of group-based memory rehabilitation programmes for people with neurological conditions. Based on systematic searches of electronic databases and reference lists, five papers (87 participants) were selected. Quality appraisal of papers was conducted by two independent reviewers using the Critical Appraisal Skills Programme tool. Data synthesis was guided by the meta-ethnography approach. Five higher order themes were elicited. These suggested that memory rehabilitation was associated with insight and acceptance of participants' neurological condition and resultant cognitive deficits. The therapeutic effects of the groups, with social support and leisure activities, helped with participants' confidence. There were improvements in memory related to better self-awareness and learning to use new skills and strategies to compensate for memory deficits. These improvements also related to other psychological effects, in terms of positively affected mood, confidence and fatigue. Ultimately, these changes had a positive impact on daily life, with changes seen in the personal, inter-personal and professional spheres. Therefore, this synthesis of qualitative studies suggests that memory rehabilitation offers positive outcomes for people with long-term neurological conditions.	[das Nair, Roshan; Martin, Kristy-Jane] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2UH, England; [das Nair, Roshan; Sinclair, Emma J.] Nottingham Univ Hosp NHS Trust, Dept Clin Psychol & Neuropsychol, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Trent Doctorate Clin Psychol, Nottingham NG7 2UH, England		das Nair, R (corresponding author), Univ Nottingham, Div Rehabil & Ageing, Sch Med, Queens Med Ctr, B98,B Floor, Nottingham NG7 2UH, England.	Roshan.Nair@nottingham.ac.uk		das Nair, Roshan/0000-0001-8143-7893			[Anonymous], 1993, NEUROPSYCHOLOGY, V7, P364, DOI [DOI 10.1037/0894-4105.7.3.364, 10.1037/0894-4105.7.3.364]; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Banningh LWAJW, 2013, DEMENTIA-LONDON, V12, P81, DOI 10.1177/1471301211420332; Bhaskar R., 2013, CRITICAL REALISM ESS; Brissart H, 2011, REV NEUROL-FRANCE, V167, P280, DOI 10.1016/j.neurol.2010.07.039; Cappa SF, 2005, EUR J NEUROL, V12, P665; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; CASP, 2010, CRIT APPR SKILLS PRO; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; das Nair R. D., 2007, COCHRANE DATABASE SY; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; Dixon-Woods M., 2007, QUAL RES, V7, P375, DOI DOI 10.1177/1468794107078517; Ferguson H., 2012, COCHRANE DATABASE SY, V3; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Gilbert T, 2004, HEALTH SOC CARE COMM, V12, P298, DOI 10.1111/j.1365-2524.2004.00499.x; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; HAMMELL KRW, 1994, INT J REHABIL RES, V17, P319; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; Hoon C, 2013, ORGAN RES METHODS, V16, P522, DOI 10.1177/1094428113484969; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Montenegro M, 2013, REV NEUROLOGIA, V57, P396, DOI 10.33588/rn.5709.2013047; Moore TF, 2003, NURS SCI QUART, V16, P163, DOI 10.1177/0894318403251793251793; Motl RW, 2009, PSYCHOL HEALTH MED, V14, P111, DOI 10.1080/13548500802241902; National Audit Office, 2005, NAT SERV FRAM LONG T; National Audit Office, 2011, SERV PEOPL NEUR COND; Neurological Alliance, 2003, BRIEF REV NUMB PEOP; Neurological Commissioning Support, 2010, HALFW AR WE HALFW TH; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Noblit GW, 1988, META ETHNOGRAPHY SYN; Noyes J, 2008, COCHRANE HDB SYSTEMA, P571, DOI [DOI 10.1002/9780470712184.CH20, 10.1002/9780470712184.ch20]; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Rapport F, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-54; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Seale C., 2002, QUAL SOC WORK, V1, P97, DOI [10.1177/147332500200100107, DOI 10.1177/147332500200100107]; Selmes T., 2007, ADV PSYCHIAT TREATME, V13, P423, DOI DOI 10.1192/APT.BP.106.003202; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Spector A, 2011, AGING MENT HEALTH, V15, P945, DOI 10.1080/13607863.2011.586622; Stuifbergen AK, 2012, CLIN REHABIL, V26, P882, DOI 10.1177/0269215511434997; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Thorne S, 2004, QUAL HEALTH RES, V14, P1342, DOI 10.1177/1049732304269888; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; WILKINSON H, 2013, BRIT J NEUROSCIENCE, V9, P172, DOI DOI 10.12968/BJNN.2013.9.4.172; Wilson B., 2002, ESSENTIAL HDB MEMORY; Wilson B, 2009, MEMORY REHABILITATIO	56	14	14	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 4	2015	25	4					479	502		10.1080/09602011.2014.971820			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CK6QJ	WOS:000356352400001	25366270	Green Submitted, Green Accepted			2022-02-06	
J	Dretsch, M; Parish, R; Kelly, M; Coldren, R; Russell, M				Dretsch, Michael; Parish, Robert; Kelly, Mark; Coldren, Rodney; Russell, Michael			Eight-Day Temporal Stability of the Automated Neuropsychological Assessment Metric (ANAM) in a Deployment Environment	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						ANAM; military; neurocognitive; test-retest reliability	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; US ARMY SOLDIERS; MILITARY PERSONNEL; TEST-PERFORMANCE; REACTION-TIME; SYMPTOM-FREE; SPECIFICITY; BATTERY	Automated neurocognitive tests are commonly used by military providers for making clinical decisions about the recovery of postconcussive cognitive sequelae. This practice often utilizes baseline assessments that precede the concussive injury. As such, investigating and establishing the psychometrics of an instrument is necessary to minimize confounds for interpreting assessment scores. Test-retest reliability (TRR) values for an 8.3 +/- 2-day retest window for the Automated Neuropsychological Assessment Metrics-Version 4 (ANAM) were calculated in 86 healthy U.S. Army soldiers deployed to Iraq. After removal of outliers, all but 1 subtest, Simple Reaction Time, had adequate or greater TRR values (intraclass correlation coefficient=0.72-0.86). The findings suggest that overall, the ANAM has good temporal stability when the retesting intertrial interval is less than 11 days while in a deployed environment.	[Dretsch, Michael] Natl Intrepid Ctr Excellence, Res, Bethesda, MD 20889 USA; [Parish, Robert] Irwin Army Community Hosp, Behav Hlth, Ft Riley, KS USA; [Kelly, Mark] Walter Reed Natl Mil Med Ctr, Psychol, Bethesda, MD USA; [Coldren, Rodney] Uniformed Serv Univ Hlth Sci, Preventat Med & Biometr, Bethesda, MD 20814 USA; [Russell, Michael] Vet Hlth Adm, VISN Ctr Excellence Res Returning War Vet 17, Waco, TX USA		Dretsch, M (corresponding author), Natl Intrepid Ctr Excellence, Res, 4860 South Palmer Rd, Bethesda, MD 20889 USA.	dr.dretsch1@yahoo.com			U.S. Army Medical Research Acquisition Activity [W81XWIH-09-2-0057]	This work was supported by the U.S. Army Medical Research Acquisition Activity [Grant Number W81XWIH-09-2-0057].	ANASTASI A, 1998, PSYCHOL TESTING; Barr W., 2008, TXB CLIN NEUROPSYCHO, P660; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Bey T, 2009, WEST J EMERG MED, V10, P6; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Coldren R., 2011, THE ANAM STOPLIGHT; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Dretsch MN, 2013, APPL NEUROPSYCH-ADUL, V20, P272, DOI 10.1080/09084282.2012.715110; Dretsch MN, 2012, MIL MED, V177, P1011, DOI 10.7205/MILMED-D-12-00129; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Epstein D., 2013, THE SPORTS GENE; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Kaida K, 2014, NEUROPSYCH DIS TREAT, V10, P19, DOI 10.2147/NDT.S53633; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marczinski CA, 2012, EXP CLIN PSYCHOPHARM, V20, P129, DOI 10.1037/a0026136; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; McNeil J., 2010, MILITARY NEUROPSYCHO, P361; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; ORR JM, 1991, PERS PSYCHOL, V44, P473; Osborne JW, 2004, PRACT ASSESS RES EVA, V9, P1, DOI DOI 10.7275/QF69-7K43; Portney L. G., 1993, FDN CLIN RES APPL PR, P557; Randolph C, 2005, J ATHL TRAINING, V40, P139; Riccio CA, 2001, ANN NY ACAD SCI, V931, P113; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Strigo IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015093; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	51	14	14	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 4	2015	22	4					304	310		10.1080/23279095.2014.926454			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CL5SF	WOS:000357020100009	25531697				2022-02-06	
J	Khanna, NK; Baumgartner, K; LaBella, CR				Khanna, Neil K.; Baumgartner, Katherine; LaBella, Cynthia R.			Balance Error Scoring System Performance in Children and Adolescents With No History of Concussion	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; traumatic brain injury; pediatrics; balance; postural stability	MILD HEAD-INJURY; POSTURAL STABILITY; BRAIN-INJURY	Background: The Balance Error Scoring System (BESS) is a useful means of measuring postural stability, which frequently exhibits deficits after a concussion. However, it has limited applicability for children since there is insufficient normative data available for the BESS in the pediatric population. The purposes of this study were to report scores for the BESS in children 10 to 17 years old with no history of concussion and to identify whether BESS score is correlated with age, sex, sports participation, height, weight, or body mass index. Hypothesis: Baseline BESS scores will be related to age and sports participation. Study Design: Descriptive laboratory study. Level of Evidence: Level 3. Methods: One examiner recruited 100 participants 10 to 17 years old over a period of 4 months; performed all of the BESS tests; surveyed participants regarding age, sex, and sports participation; recorded participants' heights and weights; and calculated body mass indices. Intrarater reliability was measured. The main outcome measures were total, firm, and foam surface BESS scores. We assessed data for normality using the Shapiro-Wilk test and used the Spearman rank test to determine whether BESS scores correlated with sex, age, sports participation, height, weight, or body mass index. Results: There was no correlation between the BESS firm surface (5.37 +/- 4.4), BESS foam surface (12.28 +/- 4.43), or total surface scores (17.64 +/- 7.52) and age, anthropometrics, or sports participation. Male and female subjects had similar scores except in the 10-to 13-year-old age group on the foam surface, where girls performed better than boys (10.42 +/- 4.53 vs 13.07 +/- 4.23; P = 0.02). Conclusion: Baseline BESS scores in children aged 10 to 17 years were normally distributed and were not related to age, sex, height, weight, body mass index, or sports participation.	[Khanna, Neil K.; LaBella, Cynthia R.] Northwestern Univ Feinberg Sch Med, Chicago, IL USA; [Khanna, Neil K.; Baumgartner, Katherine; LaBella, Cynthia R.] Ann Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 69, Chicago, IL 60611 USA		Khanna, NK (corresponding author), Ann Robert H Lurie Childrens Hosp Chicago, 225 East Chicago Ave,Box 69, Chicago, IL 60611 USA.	khanna@fsm.northwestern.edu			Northwestern University Feinberg School of Medicine	The authors reported the following potential conflicts of interest: Funding was provided by Northwestern University's Feinberg School of Medicine.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HYTONEN M, 1993, ACTA OTO-LARYNGOL, V113, P119, DOI 10.3109/00016489309135778; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Riemann BL, 2000, J ATHL TRAINING, V35, P19	17	14	14	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2015	7	4					341	345		10.1177/1941738115571508			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	V20NJ	WOS:000214893000009	26137180	Green Published			2022-02-06	
J	Massey, JS; Meares, S; Batchelor, J; Bryant, RA				Massey, Jessica S.; Meares, Susanne; Batchelor, Jennifer; Bryant, Richard A.			An Exploratory Study of the Association of Acute Posttraumatic Stress, Depression, and Pain to Cognitive Functioning in Mild Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						psychopathology; neuropsychology; cognition; concussion; pain	ATTENTIONAL CONTROL-THEORY; HEAD-INJURY; POSTCONCUSSION SYNDROME; PSYCHOMETRIC PROPERTIES; METAANALYTIC METHODS; WORKING-MEMORY; VERBAL FLUENCY; NORMATIVE DATA; PERFORMANCE; ANXIETY	Objective: Few studies have examined whether psychological distress and pain affect cognitive functioning in the acute to subacute phase (up to 30 days postinjury) following mild traumatic brain injury (mTBI). The current study explored whether acute posttraumatic stress, depression, and pain were associated with performance on a task of selective and sustained attention completed under conditions of increasing cognitive demands (standard, auditory distraction, and dual-task), and on tests of working memory, memory, processing speed, reaction time (RT), and verbal fluency. Method: At a mean of 2.87 days (SD = 2.32) postinjury, 50 adult mTBI participants, consecutive admissions to a Level 1 trauma hospital, completed neuropsychological tests and self-report measures of acute posttraumatic stress, depression, and pain. A series of canonical correlation analyses was used to explore the relationships of a common set of psychological variables to various sets of neuropsychological variables. Results: Significant results were found on the task of selective and sustained attention. Strong relationships were found between psychological variables and speed (r(c) = .56, p = .02) and psychological variables and accuracy (r(c) = .68, p = .002). Pain and acute posttraumatic stress were associated with higher speed scores (reflecting more correctly marked targets) under standard conditions. Acute posttraumatic stress was associated with lower accuracy scores across all task conditions. Moderate but nonsignificant associations were found between psychological variables and most cognitive tasks. Conclusions: Acute posttraumatic stress and pain show strong associations with selective and sustained attention following mTBI.	[Massey, Jessica S.; Meares, Susanne; Batchelor, Jennifer] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Meares, S (corresponding author), Macquarie Univ, Dept Psychol, Balaclava Rd, N Ryde, NSW 2109, Australia.	sue.meares@mq.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; Batchelor, Jennifer/0000-0003-4438-4993; Meares, Susanne/0000-0002-3859-9974			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anil AE, 2003, CLIN NEUROPSYCHOL, V17, P159, DOI 10.1076/clin.17.2.159.16510; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Babiloni C, 2004, BEHAV NEUROSCI, V118, P925, DOI 10.1037/0735-7044.118.5.925; BATCHELOR J, 1995, CLIN NEUROPSYCHOL, V9, P180, DOI 10.1080/13854049508401600; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cohen J., 2013, STAT POWER ANAL BEHA; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; De Groot RHM, 2006, PSYCHOL MED, V36, P1023, DOI 10.1017/S0033291706007380; Delis D.C., 2000, CALIFORNIA VERBAL LE; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; EDENS JL, 1995, BEHAV THER, V26, P197, DOI 10.1016/S0005-7894(05)80102-9; Eichstaedt KE, 2013, NEUROREHABILITATION, V32, P693, DOI 10.3233/NRE-130893; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gerhardt A, 2011, PAIN MED, V12, P1231, DOI 10.1111/j.1526-4637.2011.01190.x; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Good M, 2001, J Nurs Meas, V9, P219; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; JANIG W, 1995, EUR J ANAESTH, V12, P53; Jensen MP, 2011, HDB PAIN ASSESSMENT, V3rd, P19; Kahneman D., 1973, ATTENTION EFFORT; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; LaGarde G, 2010, PSYCHIAT RES, V177, P144, DOI 10.1016/j.psychres.2009.02.002; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCGAUGH JL, 1989, BRAIN RES BULL, V23, P339, DOI 10.1016/0361-9230(89)90220-7; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mertens VB, 2006, ARCH CLIN NEUROPSYCH, V21, P733, DOI 10.1016/j.acn.2006.08.005; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Moore DJ, 2013, PAIN, V154, P1840, DOI 10.1016/j.pain.2013.06.006; Mounce C, 2010, J PAIN, V11, P710, DOI 10.1016/j.jpain.2009.10.014; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; Robertson I., 1994, TEST EVERYDAY ATTENT; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; RUFF RM, 1994, PERCEPT MOTOR SKILL, V78, P63, DOI 10.2466/pms.1994.78.1.63; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Salthouse TA, 2012, EMOTION, V12, P1075, DOI 10.1037/a0025615; Sanchez CA, 2011, MEMORY, V19, P226, DOI 10.1080/09658211.2010.547861; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEIBERT PS, 1991, MEM COGNITION, V19, P507, DOI 10.3758/BF03199574; Seminowicz DA, 2007, CEREB CORTEX, V17, P1412, DOI 10.1093/cercor/bhl052; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Smith A., 1991, SYMBOL DIGIT MODALIT; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Tabachnick B.G., 2013, USING MULTIVARIATE S; Thompson B., 2000, READING UNDERSTANDIN, P285; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2008, COMPUTERIZED TEST IN; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tsushima WT, 1996, HEADACHE, V36, P613, DOI 10.1046/j.1526-4610.1996.3610613.x; Urbaniak G. C., 2011, RES RANDOMIZER VERSI; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005	110	14	14	0	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2015	29	4					530	542		10.1037/neu0000192			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CL5CA	WOS:000356976200004	25822464				2022-02-06	
J	Shen, X; Dutcher, SK; Palmer, J; Liu, XG; Kiptanui, Z; Khokhar, B; Al-Jawadi, MH; Zhu, Y; Zuckerman, IH				Shen, Xian; Dutcher, Sarah K.; Palmer, Jacqueline; Liu, Xinggang; Kiptanui, Zippora; Khokhar, Bilal; Al-Jawadi, Mohammad H.; Zhu, Yue; Zuckerman, Ilene H.			A Systematic Review of the Benefits and Risks of Anticoagulation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							DEEP VENOUS THROMBOSIS; BLUNT CEREBROVASCULAR INJURIES; MOLECULAR-WEIGHT HEPARIN; THROMBOEMBOLISM PROPHYLAXIS; VEIN THROMBOSIS; ENOXAPARIN PROPHYLAXIS; INTRACRANIAL HEMORRHAGE; COMPRESSION DEVICES; SAFETY; HEAD	Objective: To synthesize the existing literature on benefits and risks of anticoagulant use after traumatic brain injury (TBI). Design: Systematic review. A literature search was performed in MEDLINE, International Pharmaceutical Abstracts, Health Star, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) on October 11, 2012, and updated on September 2, 2013, using terms related to TBI and anticoagulants. Main Measures: Human studies evaluating the effects of post-TBI anticoagulation on venous thromboembolism, hemorrhage, mortality, or coagulation parameters with original analyses were eligible for the review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline was followed throughout the conduct of the review. Results: Thirty-nine eligible studies were identified from the literature, of which 23 studies with complete information on post-TBI anticoagulant use and patient outcomes were summarized in this review. Meta-analysis was unwarranted because of varying methodological design and quality of the studies. Twenty-one studies focused on the effects of pharmacological thromboprophylaxis (PTP) post-TBI on venous thromboembolism and/or progression of intracranial hemorrhage, whereas 2 randomized controlled trials analyzed coagulation parameters as the result of anticoagulation. Conclusion: Pharmacological thromboprophylaxis appears to be safe among TBI patients with stabilized hemorrhagic patterns. More evidence is needed regarding effectiveness of PTP in preventing venous thromboembolism as well as preferred agent, dose, and timing for PTP.	[Shen, Xian; Dutcher, Sarah K.; Palmer, Jacqueline; Liu, Xinggang; Kiptanui, Zippora; Khokhar, Bilal; Al-Jawadi, Mohammad H.; Zuckerman, Ilene H.] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Zhu, Yue] Univ Maryland, Dept Surg, Baltimore, MD 21201 USA; [Zuckerman, Ilene H.] IMPAQ Int, Columbia, MD 21044 USA		Zuckerman, IH (corresponding author), IMPAQ Int, 10420 Little Patuxent Pkwy,Suite 300, Columbia, MD 21044 USA.	izuckerman@impaqint.com	Aljawadi, Mohammad H/R-7589-2017	Aljawadi, Mohammad H/0000-0002-5114-1343; Kiptanui, Zippora/0000-0003-1212-7642	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R21 AG042768-01]; NIA Epidemiology of Aging Training Program [2T32AG000262-16]; Ruth L. Kirschstein NRSA predoctoral fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 AG044091]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262, F31AG044091, R21AG042768] Funding Source: NIH RePORTER	The project was supported by National Institutes of Health 1 R21 AG042768-01. Bilal R. Khokhar is supported by NIA Epidemiology of Aging Training Program (2T32AG000262-16). Sarah K. Dutcher is supported by a Ruth L. Kirschstein NRSA predoctoral fellowship (F31 AG044091).	Arnold JD, 2010, AM SURGEON, V76, P563; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Brandt MM, 2007, AM J SURG, V193, P383; BRATHWAITE CEM, 1993, CHEST, V104, P718, DOI 10.1378/chest.104.3.718; Carlile M, 2010, J TRAUMA, V68, P916, DOI 10.1097/TA.0b013e3181b16d2d; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; David M, 2009, INT J SURG, V8, P336; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Depew AJ, 2008, AM SURGEON, V74, P906; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Faul M, 2010, TRAUMATIC BRAIN INJU; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Kim KS, 2009, NEUROCRIT CARE, V11, P28, DOI 10.1007/s12028-009-9201-4; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Maxwell RA, 2002, J TRAUMA, V52, P902, DOI 10.1097/00005373-200205000-00013; MEYER CS, 1995, ANN VASC SURG, V9, P109, DOI 10.1007/BF02015324; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Nickele CM, 2013, NEUROCRIT CARE, V18, P184, DOI 10.1007/s12028-012-9786-x; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; O'Brien Sarah H, 2012, J Trauma Nurs, V19, P117, DOI 10.1097/JTN.0b013e31825629c4; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; RADECKI RT, 1994, ARCH PHYS MED REHAB, V75, P248, DOI 10.1016/0003-9993(94)90023-X; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Schweizer M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2743; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Shackford SR, 2004, ANN SURG, V240, P496; Sharma S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-385; Spain DA, 1998, AM SURGEON, V64, P522; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Wahl WL, 2011, J TRAUMA, V71, P399; Zhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058821	56	14	15	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					E29	E37		10.1097/HTR.0000000000000077			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JB	WOS:000357944800004	24992639	Green Accepted			2022-02-06	
J	Winter, C; Bell, C; Whyte, T; Cardinal, J; Macfarlane, D; Rose, S				Winter, Craig; Bell, Christopher; Whyte, Timothy; Cardinal, John; Macfarlane, David; Rose, Stephen			Blood-brain barrier dysfunction following traumatic brain injury: correlation of K-trans (DCE-MRI) and SUVR (99mTc-DTPA SPECT) but not serum S100B	NEUROLOGICAL RESEARCH			English	Article						Blood-brain barrier; 99mTc-DTPA SPECT; S100B; Traumatic brain injury; DCE-MRI	PROTEIN; PERMEABILITY; S100-BETA; MARKER; DISRUPTION; BREAKDOWN; RELEASE; LEAKAGE; DAMAGE	Objective: Damage to the blood-brain barrier (BBB) is an important secondary mechanism that occurs following traumatic brain injury (TBI) and may provide a potential therapeutic target to improve patient outcome. For such a progress to be realised, an accurate assessment of BBB compromise needs to be established. Methods: Fourteen patients with TBI were prospectively recruited. Post-traumatic BBB dysfunction was assessed using dynamic contrast-enhanced MRI (DCE-MRI), single-photon emission computerised tomography (SPECT) and serum S100B levels. Results: A statistically significant correlation between standardised uptake value ratio (SUVR) calculated from 99mTc-DTPA SPECT and K-trans (a volume transfer constant) from DCE-MRI was found for those eight patients who had concurrent scans. The positive correlation persisted when the data were corrected for patient age, number of days following trauma and both parameters combined. We found no statistically significant correlation between either of the imaging modalities and concurrent serum S100B levels. Discussion: The correlation of SPECT with DCE-MRI suggests that either scan may be used to assess post-traumatic BBB damage. We could not support serum S100B to be an accurate measure of BBB damage when sampled a number of days following injury but the small number of patients, the heterogeneity in TBI patients and the delay following injury makes any firm conclusions regarding S100B and BBB difficult.	[Winter, Craig; Whyte, Timothy] Royal Brisbane & Womens Hosp, Kenneth Jamieson Dept Neurosurg, Herston, Qld 4029, Australia; [Winter, Craig; Bell, Christopher] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Bell, Christopher; Rose, Stephen] CSIRO, Computat Informat, Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Cardinal, John] Royal Brisbane & Womens Hosp, Dept Chem Pathol, Herston, Qld, Australia; [Macfarlane, David] Royal Brisbane & Womens Hosp, Dept Nucl Med, Herston, Qld, Australia		Winter, C (corresponding author), Royal Brisbane & Womens Hosp, Kenneth Jamieson Dept Neurosurg, Level 7,Ned Hanlon Bldg,Butterfield St, Herston, Qld 4029, Australia.	craigdw1@gmail.com	Rose, Stephen/C-8044-2009	Rose, Stephen/0000-0003-1558-6297; WINTER, Craig/0000-0003-4626-7280	Neurosurgical Trust Fund at the Royal Brisbane and Women's Hospital	Neurosurgical Trust Fund at the Royal Brisbane and Women's Hospital.	Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; BARGER SW, 1992, J BIOL CHEM, V267, P9689; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Bezerra FJ, 2014, NEUROL RES, V36, P847, DOI 10.1179/1743132814Y.0000000341; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; BULLOCK R, 1990, ACT NEUR S, V51, P286; Cha S, 2006, AM J NEURORADIOL, V27, P409; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Cotton BA, 2007, SHOCK, V27, P338, DOI 10.1097/01.shk.0000239756.59841.29; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Duru S, 2012, NEUROL NEUROCHIR POL, V46, P450, DOI 10.5114/ninp.2012.31355; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Gilad R, 2012, J NEUROL, V259, P2041, DOI 10.1007/s00415-012-6445-2; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Liu HS, 2013, STROKE, V44, P1872, DOI 10.1161/STROKEAHA.113.001558; Lorberboym M, 2003, J NUCL MED, V44, P1898; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marks W, 2006, Neuroradiol J, V19, P569; Masdeu JC, 2008, SEMIN NEUROL, V28, P423, DOI 10.1055/s-0028-1083683; McArthur C, 2011, CLIN RADIOL, V66, P651, DOI 10.1016/j.crad.2010.12.015; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Wei XE, 2014, NEUROL SCI, V35, P295, DOI 10.1007/s10072-013-1514-6; Winter C, 2013, WORLD J NEUROSCI, V3, P93; Zhang N, 2012, J MAGN RESON IMAGING, V36, P355, DOI 10.1002/jmri.23675; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	48	14	15	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2015	37	7					599	606		10.1179/1743132815Y.0000000018			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ7FI	WOS:000355659500006	25749458				2022-02-06	
J	Zhang, QH; Li, AM; He, SL; Yao, XD; Zhu, J; Zhang, ZW; Sheng, ZY; Yao, YM				Zhang, Qing-Hong; Li, An-Min; He, Sai-Lin; Yao, Xu-Dong; Zhu, Jing; Zhang, Zhi-Wen; Sheng, Zhi-Yong; Yao, Yong-Ming			Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury	PLOS ONE			English	Article							DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; CLASSIFICATION-SYSTEM; CHOLINERGIC SYSTEM; STROKE PATIENTS; ORGAN FAILURE; MORTALITY; ACETYLCHOLINE; INFLAMMATION; RECOVERY	Background Traumatic brain injury (TBI) is one of the leading causes of neurological disability. In this retrospective study, serum total cholinesterase (ChE) activities were analyzed in 188 patients for diagnostic as well as predictive values for mortality. Methods and Findings Within 72 hours after injury, serum ChE activities including both acetylcholinesterase and butyrylcholinesterase were measured. Disease severity was evaluated with Acute Physiology and Chronic Health Evaluation (APACHE) II score, Glasgow Coma Score, length of coma, post-traumatic amnesia and injury feature. Neurocognitive and functional scores were assessed using clinical records. Of 188 patients, 146 (77.7%) survived and 42 (22.3%) died within 90 days. Lower ChE activities were noted in the non-survivors vs. survivors (5.94 +/- 2.19 vs. 7.04 +/- 2.16 kU/L, p= 0.023), in septic vs. non-infected patients (5.93 +/- 1.89 vs. 7.31 +/- 2.45 kU/L, p=0.0005) and in patients with extremely severe injury vs. mild injury (6.3 +/- 1.98 vs. 7.57 +/- 2.48 kU/L, p=0.049). The trajectories of serum ChE levels were also different between non-survivors and survivors, septic and non-infected patients, mild and severely injured patients, respectively. Admission ChE activities were closely correlated with blood cell counts, neurocognitive and functional scores both on admission and at discharge. Receiver operating characteristic analysis showed that the area under the curve for ChE was inferior to that for either APACHE II or white blood cell (WBC) count. However, at the optimal cutoff value of 5 kU/L, the sensitivity of ChE for correct prediction of 90-day mortality was 65.5% and the specificity was 86.4%. Kaplan-Meier analysis showed that lower ChE activity (<5 kU/L) was more closely correlated with poor survival than higher ChE activity (>5 kU/L) (p=0.04). After adjusting for other variables, ChE was identified as a borderline independent predictor for mortality as analyzed by Binary logistic regression (P=0.078).	[Zhang, Qing-Hong; Sheng, Zhi-Yong; Yao, Yong-Ming] Chinese Peoples Liberat Army Gen Hosp, Key Res Lab Tissue Repair & Regenerat PLA, Hosp 1, Beijing 100048, Peoples R China; [Zhang, Qing-Hong; Sheng, Zhi-Yong; Yao, Yong-Ming] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Res Lab Skin Injury Repair & Regenera, Hosp 1, Beijing 100048, Peoples R China; [Li, An-Min] Hainan Branch Chinese PLA Gen Hosp, Dept Neurosurg, Sanya 572013, Hainan, Peoples R China; [He, Sai-Lin; Zhang, Zhi-Wen] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Hosp 1, Beijing 100048, Peoples R China; [Yao, Xu-Dong] Wenzhou Med Univ, Dept Emergency, Hosp 1, Wenzhou 325000, Peoples R China; [Zhu, Jing] Chinese Peoples Liberat Army Gen Hosp, Dept Lab Med, Hosp 1, Beijing 100048, Peoples R China		Zhang, QH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Key Res Lab Tissue Repair & Regenerat PLA, Hosp 1, Beijing 100048, Peoples R China.	z_qinghong@aliyun.com; c_ff@sina.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81272089, 81130035, 81372054, 81121004]; National Basic Research Program of ChinaNational Basic Research Program of China [2012CB518102]; Twelve-Five Plan for Military Scientific Foundation [BWS12J050]	This study was supported by National Natural Science Foundation (81272089, 81130035, 81372054, 81121004) for QHZ and YMY in the collection and analysis of data, the National Basic Research Program of China (2012CB518102) for YMY in the writing of the manuscript and decision to submit the manuscript, and Twelve-Five Plan for Military Scientific Foundation (BWS12J050) for QHZ in the design and in the collection of data.	Adabag AS, 2008, AM J CARDIOL, V101, P1437, DOI 10.1016/j.amjcard.2008.01.021; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Ben Assayag E, 2010, MOL MED, V16, P278, DOI 10.2119/molmed.2010.00015; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Cunningham C, 2013, BRAIN BEHAV IMMUN, V28, P1, DOI 10.1016/j.bbi.2012.07.012; Da Silva AS, 2011, EXP PARASITOL, V127, P475, DOI 10.1016/j.exppara.2010.10.017; da Silva CB, 2012, J MED MICROBIOL, V61, P278, DOI 10.1099/jmm.0.035501-0; De Filippis S, 2008, J HEADACHE PAIN, V9, P349, DOI 10.1007/s10194-008-0072-4; Field RH, 2012, J NEUROSCI, V32, P6288, DOI 10.1523/JNEUROSCI.4673-11.2012; Gilboa-Geffen A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00030; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hu T, 2009, J NEUROIMMUNOL, V211, P84, DOI 10.1016/j.jneuroim.2009.04.002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Kang J, 2014, J STROKE, V16, P36, DOI 10.5853/jos.2014.16.1.36; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; KAWASHIMA K, 1980, J PHARMACOL METHOD, V3, P115, DOI 10.1016/0160-5402(80)90022-4; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; Kiguchi T, 2013, CRIT CARE MED, V41, P1443, DOI 10.1097/CCM.0b013e31827ca960; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li DJ, 2011, HYPERTENSION, V57, P298, DOI 10.1161/HYPERTENSIONAHA.110.160077; LOEWENSTEINLICHTENSTEIN Y, 1995, NAT MED, V1, P1082, DOI 10.1038/nm1095-1082; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Ofek K, 2007, J MOL MED, V85, P1239, DOI 10.1007/s00109-007-0226-x; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RAO CJ, 1978, INDIAN J MED RES, V68, P668; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Seong JW, 2014, ANN REHABIL MED-ARM, V38, P13, DOI 10.5535/arm.2014.38.1.13; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Veysey BM, 1998, LAW HUMAN BEHAV, V22, P205, DOI 10.1023/A:1025794104048; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wolkmer P, 2010, EXP PARASITOL, V125, P251, DOI 10.1016/j.exppara.2010.01.024; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	62	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129082	10.1371/journal.pone.0129082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	WOS:000356932500040	26107885	Green Published, gold, Green Submitted			2022-02-06	
J	Fraas, MR; Coughlan, GF; Hart, EC; McCarthy, C				Fraas, M. R.; Coughlan, G. F.; Hart, E. C.; McCarthy, C.			Concussion knowledge and management practices among coaches and medical staff in Irish professional rugby teams	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Concussion; Rugby; Coaches knowledge; Medical management; Ireland	INJURIES; PLAYERS	Self-reported concussion rates among U-20 and elite rugby union players in Ireland are 45-48 %. Half of these injuries go unreported. Accurate knowledge of concussion signs and symptoms and appropriate management practices among coaches and medical staff is important to improve the welfare of players. Examine concussion knowledge among coaches, and management techniques among medical staff of professional Irish rugby teams. Surveys were administered to 11 coaches and 12 medical staff at the end of the 2010-2011 season. Coaches demonstrated an accurate knowledge of concussion with a good understanding of concussion-related symptoms. Medical staff reported using a variety of methods for assessing concussion and making return-to-play decisions. Reliance on subjective clinical methods was evident, with less reliance on objective postural stability performance. Overall, the coaches in this investigation have accurate knowledge of concussion and medical staff use effective techniques for managing this injury. On-going education is needed to assist coaches in identifying concussion signs and symptoms. It is recommended that medical staff increase their reliance on objective methods for assessment and return-to-play decision making.	[Fraas, M. R.] Western Washington Univ, Dept Commun Sci & Disorders, Bellingham, WA 98225 USA; [Fraas, M. R.; Hart, E. C.] Elmhurst Coll, Dept Commun Arts & Sci, Chicago, IL USA; [Coughlan, G. F.; McCarthy, C.] Irish Rugby Football Union, Dept Med, Dublin, Ireland; [Hart, E. C.] Chicago Sch Profess Psychol, Dept Psychol, Chicago, IL USA		Fraas, MR (corresponding author), Western Washington Univ, Dept Commun Sci & Disorders, 516 High St, Bellingham, WA 98225 USA.	Michael.fraas@wwu.edu					Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Council for International Organizations of Medical Sciences, 2002, INT ETH GUID BIOM RE; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Holtzhausen LJ, 2006, SAMJ S AFR MED J, V96, P1260; International Rugby Board, 2010, LAWS GAM RUGB UN 201; International Rugby Board, 2011, PUTT PLAYERS FIRST I; IRFU, 2011, 20102011 IRFU; Irish Rugby Football Union, 2013, STAND APPR FIELD EM; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TV, 2009, J FAM PRACTICE, V58, P512; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Tommasone BA, 2006, J ATHL TRAINING, V41, P470	22	14	14	0	30	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	JUN	2015	184	2					425	430		10.1007/s11845-014-1137-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3EL	WOS:000353160800028	24852661				2022-02-06	
J	Kang, WH; Morrison, B				Kang, Woo Hyeun; Morrison, Barclay, III			Functional tolerance to mechanical deformation developed from organotypic hippocampal slice cultures	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Hippocampus; Tolerance criteria; Electrophysiology; Paired-pulse; In vitro	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; PAIRED-PULSE FACILITATION; DENTATE GYRUS; PROFESSIONAL FOOTBALL; RAT HIPPOCAMPUS; HEAD-INJURY; AREA CA1; IN-VIVO; CONCUSSION	In this study, we measured changes in electrophysiological activity after mechanical deformation of living organotypic hippocampal brain slice cultures at tissue strains and strain rates relevant to traumatic brain injury (TBI). Electrophysiological activity was measured throughout the hippocampus with a 60-electrode microelectrode array. Electrophysiological parameters associated with unstimulated spontaneous activity (neural event firing rate, duration, and magnitude), stimulated evoked responses (the maximum response , the stimulus current necessary for a half-maximal response , and the electrophysiological parameter m that is representative of firing uniformity), and paired-pulse responses (paired-pulse ratio at varying interstimulus intervals) were quantified for each hippocampal region (CA1, CA3, and DG). We present functional tolerance criteria for the hippocampus in the form of mathematical relationships between the input tissue-level injury parameters (strain and strain rate) and altered neuronal network function. Most changes in electrophysiology were dependent on strain and strain rate in a complex fashion, independent of hippocampal anatomy, with the notable exception of . Until it becomes possible to directly measure brain tissue deformation in vivo, finite element (FE) models will be necessary to simulate and predict the in vivo consequences of TBI. One application of our study is to provide functional relationships that can be incorporated into these FE models to enhance their biofidelity of accident and collision reconstructions by predicting biological outcomes in addition to mechanical responses.	[Kang, Woo Hyeun; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Highway Traffic Safety Administration [DTNH22-08-C-00088]; Multidisciplinary University Research Initiative from the Army Research Office [W911MF-10-1-0526]	The authors would like to thank Shruthi Nammalwar for assisting in preparing and maintaining slice cultures and Chaitanya Rastogi for help with statistical analysis and fitting the raw data. Funding for this research was provided by the National Highway Traffic Safety Administration (DTNH22-08-C-00088) and by a Multidisciplinary University Research Initiative from the Army Research Office (W911MF-10-1-0526).	Akaike H., 1973, P 2 INT S INF THEOR, V1973, P267, DOI 10.1007/978-1-4612-1694-0; Allen M.P., 1997, UNDERSTANDING REGRES; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP., 2002, MODEL SELECTION MULT; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Commins S, 1998, NEUROREPORT, V9, P4109, DOI 10.1097/00001756-199812210-00019; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; DISCENNA PG, 1994, HIPPOCAMPUS, V4, P569, DOI 10.1002/hipo.450040506; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Egert U, 2005, PRACTICAL METHODS IN CARDIOVASCULAR RESEARCH, P432, DOI 10.1007/3-540-26574-0_22; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Exo J, 2009, Ped Health, V3, P533, DOI 10.2217/phe.09.54; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fueta Y, 1998, BRAIN RES, V779, P324, DOI 10.1016/S0006-8993(97)01214-6; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Guo Y, 2008, HUM BRAIN MAPP, V29, P1092, DOI 10.1002/hbm.20450; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Ji K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/627325; JOY RM, 1993, BRAIN RES, V604, P273, DOI 10.1016/0006-8993(93)90379-2; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; KETTENMANN H, 1993, GLIA, V7, P93, DOI 10.1002/glia.440070115; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lea PM, 2002, PHARMACOL BIOCHEM BE, V73, P287, DOI 10.1016/S0091-3057(02)00825-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Maugineanu DG, 2000, BRAIN RES BULL, V51, P69, DOI 10.1016/S0361-9230(99)00209-9; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Moss WC, 2014, COMPUT METHOD BIOMEC, V17, P1173, DOI 10.1080/10255842.2012.739162; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Navarrete M, 2013, CEREB CORTEX, V23, P1240, DOI 10.1093/cercor/bhs122; Nirula R, 2004, J TRAUMA, V57, P779, DOI 10.1097/01.TA.0000106506.34691.B6; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Ommaya A. k., 1967, SAE TECHNICAL PAPERS; Ounpraseuth Songthip, 2012, BMC Res Notes, V5, P656, DOI 10.1186/1756-0500-5-656; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Savanthrapadian S, 2013, HIPPOCAMPUS, V23, P1395, DOI 10.1002/hipo.22193; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Sloviter R S, 1991, Hippocampus, V1, P31, DOI 10.1002/hipo.450010105; STANFORD IM, 1995, EUR J PHARMACOL, V277, P229, DOI 10.1016/0014-2999(95)00083-W; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viskontas IV, 2006, J COGNITIVE NEUROSCI, V18, P1654, DOI 10.1162/jocn.2006.18.10.1654; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	92	14	14	1	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2015	14	3					561	575		10.1007/s10237-014-0622-4			15	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CI0ED	WOS:000354408100009	25236799				2022-02-06	
J	Phillips, S; Woessner, D				Phillips, Shawn; Woessner, Derek			Sports-Related Traumatic Brain Injury	PRIMARY CARE			English	Article						Sports-related; Mild traumatic brain injury; MTBI; Mild TBI guidelines; Sideline Concussion Assessment Tool 3 (SCAT3); Postconcussive syndrome	CONCUSSION; EDUCATION	Concussions have garnered more attention in the medical literature, media, and social media. As such, in the nomenclature according to the Centers for Disease Control and Prevention, the term concussion has been supplanted by the term mild traumatic brain injury. Current numbers indicate that 1.7 million TBIs are documented annually, with estimates around 3 million annually (173,285 sports- and recreation-related TBIs among children and adolescents). The Sideline Concussion Assessment Tool 3 and the NFL Sideline Concussion Assessment Tool are commonly used sideline tools.	[Woessner, Derek] Lancaster Gen Hosp, Lancaster, PA 17602 USA		Woessner, D (corresponding author), Lancaster Gen Hosp, 555 North Duke St, Lancaster, PA 17602 USA.	dwoessner2@lghealth.org	Meijer, Anna/K-5118-2016				Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR, P2; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Wrightson P, 2000, J CLIN NEUROSCI, V7, P384, DOI 10.1054/jocn.1999.0678	12	14	14	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0095-4543	1558-299X		PRIMARY CARE	Primary Care	JUN	2015	42	2					243	+		10.1016/j.pop.2015.01.010			7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1ZC	WOS:000354542900010	25979585				2022-02-06	
J	Shumway-Cook, A; Matsuda, PN; Taylor, C				Shumway-Cook, Anne; Matsuda, Patricia Noritake; Taylor, Catherine			Investigating the Validity of the Environmental Framework Underlying the Original and Modified Dynamic Gait Index	PHYSICAL THERAPY			English	Article								Background. The modified Dynamic Gait Index (mDGD, developed from a person-environment model of mobility disability, measures mobility function relative to specific environmental demands. The framework for interpreting mDGI scores relative to specific environmental dimensions has not been investigated. Objective. The aim of this study was to examine the person-environmental model underlying the development and interpretation of mDGI scores. Design. This was a cross-sectional, descriptive study. Methods. There were 794 participants in the study, Including 140 controls. Out of the total study population, 239 had sustained a stroke, 140 had vestibular dysfunction, 100 had sustained a traumatic brain injury, 91 had gait abnormality, and 84 had Parkinson disease. Exploratory factor analysis was used to investigate whether mDGI scores supported the 4 environmental dimensions. Results. Factor analysis showed that, with some exceptions, tasks loaded on 4 underlying factors, partially supporting the underlying environmental model. Limitations. Limitations of this study included the uneven sample sizes in the 6 groups. Conclusions. Support for the environmental framework underlying the mDGI extends its usefulness as a clinical measure of functional mobility by providing a rationale for interpretation of scores that can be used to direct treatment and infer change in mobility function.	[Shumway-Cook, Anne; Matsuda, Patricia Noritake] Univ Washington, Dept Rehabil Med, Div Phys Therapy, Seattle, WA 98195 USA; [Taylor, Catherine] Univ Washington, Coll Educ, Seattle, WA 98195 USA		Shumway-Cook, A (corresponding author), Univ Washington, Dept Rehabil Med, Div Phys Therapy, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA.	ashumway@uw.edu	Matsuda, Patricia/T-3606-2019		Walter C. and Anita Stolov Research Fund, Department of Rehabilitation Medicine, University of Washington	This study was supported by a grant from the Walter C. and Anita Stolov Research Fund, Department of Rehabilitation Medicine, University of Washington.	Dye DC, 2013, PHYS THER, V93, P809, DOI 10.2522/ptj.20120163; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; Matsuda PN, 2014, PHYS THER, V94, P996, DOI 10.2522/ptj.20130294; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; Pett MA., 2003, MAKING SENSE FACTOR; Portney LG., 2008, FDN CLIN RES APPL PR, V3rd ed; Shumway-Cook A, 2002, PHYS THER, V82, P670, DOI 10.1093/ptj/82.7.670; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL, V4th; Shumway-Cook A, 2013, PHYS THER, V93, P1493, DOI 10.2522/ptj.20130035; World Health Organization, 2014, INT CLASS DIS ICD 10; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0	11	14	14	1	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUN	2015	95	6					864	870		10.2522/ptj.20140047			7	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	CJ3MQ	WOS:000355388500005	25524870				2022-02-06	
J	Sun, LQ; Gao, JL; Cui, Y; Zhao, MM; Bin Jing, X; Li, R; Tian, YX; Cui, JZ; Wu, ZX				Sun, Li Qian; Gao, Jun Ling; Cui, Ying; Zhao, Man Man; Bin Jing, Xiao; Li, Ran; Tian, Yan Xia; Cui, Jian Zhong; Wu, Zhong-Xue			Neuronic autophagy contributes to p-connexin 43 degradation in hippocampal astrocytes following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						autophagy; gap junction; microtubule-associated protein 1 light chain 3; p-connexin-43; traumatic brain injury	ANNULAR GAP-JUNCTIONS; COMMUNICATION; REDUCTION; DEFICITS; DEATH; CELLS; MODEL	Connexins, gap junction proteins, have short half-lives of only a few hours; therefore, degradation of these proteins can rapidly modulate their function. Autophagy is a type of degradation pathway that has been implicated in several diseases and was reported to be induced following traumatic brain injury (TBI). The aim of the present study was to investigate the involvement of neuronic autophagy in proteolysis of phosphorylated connexin 43 (p-Cx43) in hippocampal astrocytes following TBI in rats. Western blot analysis and immunofluorescence showed a TBI-induced increase in levels of astrocytic p-Cx43 following treatment with 3-methyladenine, an inhibitor of autophagy, in the hippocampus. Internalized gap junctions were observed in the neuronic cytoplasm using transmission electron microscopy. These results demonstrated that neuronic autophagy may regulate cellular levels of p-Cx43 in hippocampal astrocytes following TBI. This therefore indicated that the persistence of p-Cx43 accumulation was due to insufficient degradation capacity of constitutive autophagy.	[Sun, Li Qian; Wu, Zhong-Xue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China; [Sun, Li Qian; Wu, Zhong-Xue] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Gao, Jun Ling; Cui, Ying; Zhao, Man Man; Li, Ran; Tian, Yan Xia] Hebei United Univ, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China; [Bin Jing, Xiao] Tangshan Ophthalmol Hosp, Dept Ophthalmol, Tangshan 063000, Hebei, Peoples R China; [Cui, Jian Zhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China		Wu, ZX (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	zhongxuewu@yeah.net			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401071]	The present study was supported by a grant from the Natural Science Foundation of Hebei Province (no. H2012401071).	Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; De Bock M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00120; De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108; LEACH DH, 1984, ACTA ANAT, V120, P214, DOI 10.1159/000145923; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Pozuelo-Rubio M, 2011, CELL DEATH DIFFER, V18, P479, DOI 10.1038/cdd.2010.118; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; SASAKI T, 1986, CELL TISSUE RES, V246, P523, DOI 10.1007/BF00215192; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	19	14	14	1	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUN	2015	11	6					4419	4423		10.3892/mmr.2015.3264			5	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CJ4ZL	WOS:000355497100059	25626126	Bronze			2022-02-06	
J	van Ierssel, SH; Conraads, VM; Van Craenenbroeck, EM; Liu, Y; Maas, AIR; Parizel, PM; Hoymans, VY; Vrints, CJ; Jorens, PG				van Ierssel, Sabrina H.; Conraads, Viviane M.; Van Craenenbroeck, Emeline M.; Liu, Yin; Maas, Andrew I. R.; Parizel, Paul M.; Hoymans, Vicky Y.; Vrints, Christiaan J.; Jorens, Philippe G.			Endothelial Dysfunction in Acute Brain Injury and the Development of Cerebral Ischemia	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						endothelial dysfunction; subarachnoid hemorrhage; cerebral ischemia; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; PROGENITOR CELLS; VASOSPASM; MICROPARTICLES; MECHANISMS; INFARCTION; DEFICITS	Cerebral ischemia (CeI) is a major complicating event after acute brain injury (ABI) in which endothelial dysfunction is a key player. This study evaluates cellular markers of endothelial function and in vivo reactive hyperemia in patients with ABI and their relationship to the development of cerebral ischemia. We studied cellular markers of endothelial dysfunction and the peripheral reactive hyperemia index (RHI) in 26 patients with ABI at admission and after 6 and 12 days, and compared these with those of healthy volunteers (n=15). CeI was determined clinically or by computer tomography. In patients with ABI, RHI at admission was significantly reduced compared with healthy subjects (P=0.003), coinciding with a decrease in circulating endothelial progenitor cells (EPC; P=0.002). The RHI recovered in eight patients without development of CeI, but failed to fully recover by day 12 in three of four patients who developed CeI. Despite recovery of the RHI within 12 days in these patients (P=0.003), EPC count remained significantly lower after 12 days in patients with ABI (P=0.022). CD31(+) T cells and endothelial microparticles were not different between controls and patients. No differences were noted in cellular markers of endothelial dysfunction in patients developing CeI and those not. In conclusion, patients with ABI exhibit impaired microvascular endothelial function measured as RHI and a decreased circulating level of EPC. (c) 2015 Wiley Periodicals, Inc.	[van Ierssel, Sabrina H.; Jorens, Philippe G.] Univ Antwerp, Univ Antwerp Hosp, Dept Crit Care Med, Edegem, Belgium; [van Ierssel, Sabrina H.; Conraads, Viviane M.; Van Craenenbroeck, Emeline M.; Hoymans, Vicky Y.; Vrints, Christiaan J.] Univ Antwerp, Univ Antwerp Hosp, Lab Cellular & Mol Cardiol, Edegem, Belgium; [van Ierssel, Sabrina H.] Univ Antwerp, Univ Antwerp Hosp, Dept Internal Med, Edegem, Belgium; [Conraads, Viviane M.; Van Craenenbroeck, Emeline M.; Hoymans, Vicky Y.; Vrints, Christiaan J.] Univ Antwerp, Univ Antwerp Hosp, Dept Cardiol, Edegem, Belgium; [Liu, Yin; Parizel, Paul M.] Univ Antwerp, Univ Antwerp Hosp, Dept Radiol, Edegem, Belgium; [Liu, Yin] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [Maas, Andrew I. R.] Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium		van Ierssel, SH (corresponding author), Univ Antwerp Hosp, Wilrijkstr 10, B-2650 Edegem, Belgium.	sabrina.vanierssel@uantwerpen.be	Van Craenenbroeck, Emeline/AAG-4540-2020	Parizel, Paul M./0000-0002-0221-2854; van Ierssel, Sabrina H./0000-0003-2955-4130	Research Foundation-Flanders, BelgiumFWO; Agency for Innovation by Science and Technology	Contract grant sponsor: The Research Foundation-Flanders, Belgium (to S.H.v.I., V.M.C.); Contract grant sponsor: The Agency for Innovation by Science and Technology.	Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Bergstrom A, 2014, BRIT J ANAESTH, V112, P311, DOI 10.1093/bja/aet331; Brown RJ, 2013, NEUROSURGERY, V72, P702, DOI 10.1227/NEU.0b013e318285c3db; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; de Rooij NK, 2013, STROKE, V44, P1288, DOI 10.1161/STROKEAHA.113.001125; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fan HK, 2012, INFLAMMATION, V35, P130, DOI 10.1007/s10753-011-9297-5; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Kolias AG, 2009, J NEUROSCI RES, V87, P1, DOI 10.1002/jnr.21823; Kozniewska E, 2006, J PHYSIOL PHARMACOL, V57, P145; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Sanborn MR, 2012, J NEUROSURG, V117, P579, DOI 10.3171/2012.6.JNS111163; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Van Craenenbroeck EMF, 2008, J IMMUNOL METHODS, V332, P31, DOI 10.1016/j.jim.2007.12.006; van Ierssel SH, 2010, THROMB RES, V125, P332, DOI 10.1016/j.thromres.2009.12.019; vansIerssel SH, 2013, PLOS ONE, V8; vansIerssel SH, 2012, PLOS ONE, V7; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vergouwen MDI, 2009, J CEREBR BLOOD F MET, V29, P1734, DOI 10.1038/jcbfm.2009.88; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wei HJ, 2011, NEUROSCI LETT, V498, P114, DOI 10.1016/j.neulet.2011.04.061; Wei HJ, 2011, J NEUROSCI RES, V89, P1822, DOI 10.1002/jnr.22696	34	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2015	93	6					866	872		10.1002/jnr.23566			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CF9TN	WOS:000352909800004	25677574				2022-02-06	
J	Wang, IK; Cheng, YK; Lin, CL; Peng, CL; Chou, CY; Chang, CT; Yen, TH; Huang, CC; Sung, FC; Hsu, CY				Wang, I-Kuan; Cheng, Yu-Kai; Lin, Cheng-Li; Peng, Chiao-Ling; Chou, Che-Yi; Chang, Chiz-Tzung; Yen, Tzung-Hai; Huang, Chiu-Ching; Sung, Fung-Chang; Hsu, Chung Y.			Comparison of Subdural Hematoma Risk between Hemodialysis and Peritoneal Dialysis Patients with ESRD	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							STAGE RENAL-DISEASE; TRAUMATIC BRAIN-INJURY; CHRONIC KIDNEY-DISEASE; OLDER-ADULTS; FALLS; COMPLICATIONS; MORTALITY; MODALITY; FAILURE; IMPACT	Background and objectives This study compared the risk of subdural hematoma (SDH) and subsequent mortality in hemodialysis (HD) and peritoneal dialysis (PD) patients with ESRD. Design, setting, participants, & measurements Claims data were obtained from the National Health Insurance Administration Research Database in Taiwan. This retrospective cohort study comprised 10,136 PD patients and 10,136 HD patients with newly diagnosed ESRD from 1998 to 2010. Patients were matched by propensity score and year of dialysis initiation. Incidence rates and hazard ratios of SDH as well as odds ratios of subsequent 30-day deaths from SDH were evaluated from the date of the first dialysis session to the date when SDH was diagnosed, or the date of renal transplantation, death, withdraw from insurance, or the end of the follow-up period (December 31, 2011). Results Median (25th percentile, 75th percentile) follow-up times for SDH events were 3.61 years (1.91, 6.33) and 3.33 years (1.83, 5.66) in the HD and PD cohorts, respectively. The overall SDH incidence rate (95% confidence interval [95% CID was 61.4% higher in the HD cohort than in the PD cohort (34.7 [95% CI, 31.4 to 35.4] versus 21.5 [95% CI, 20.2 to 22.9] per 10,000 person-years, with an adjusted hazard ratio of 1.62 [95% CI, 1.17 to 2.33]). Approximately 152 of 253 (60%) of SDH events were associated with trauma. Subsequent 30-day SDH-related mortality was not statistically higher in HD patients than in PD patients (29.1% versus 25.3%; adjusted odds ratio, 1.30; 95% CI, 0.70 to 2.41). Conclusions HD patients have a higher risk of developing SDH than PD patients. Both patient groups have a high risk of mortality. Routine education on fall prevention is needed for dialysis patients.	[Wang, I-Kuan] China Med Univ, Coll Med, Dept Internal Med, Taichung 404, Taiwan; [Wang, I-Kuan; Sung, Fung-Chang; Hsu, Chung Y.] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung 404, Taiwan; [Wang, I-Kuan; Chou, Che-Yi; Chang, Chiz-Tzung; Huang, Chiu-Ching] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Cheng, Yu-Kai] China Med Univ Hosp, Div Neurosurg, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Peng, Chiao-Ling] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan		Sung, FC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	fcsung1008@yahoo.com	Yen, Tzung-Hai/AAQ-4525-2020; Chou, Che-Yi/N-8887-2015	Yen, Tzung-Hai/0000-0002-0907-1505; Chou, Che-Yi/0000-0003-4029-9097; Hsu, Chung Y./0000-0002-5632-2733	National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1, DMR-100-101, DMR-101-016, DMR-103-013, DMR-104-015]; Research Laboratory of Pediatrics, Children's Hospital of China Medical University; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Academia Sinica Taiwan Biobank; Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM103010096]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation; Taiwan Brain Disease Foundation; Katsuzo Aoshima Memorial Fund; Kiyo Aoshima Memorial Fund	This study was supported by grants from the National Sciences Council, Executive Yuan (NSC 100-2621-M-039-001), China Medical University Hospital (1MS1, DMR-100-101, DMR-101-016, DMR-103-013, and DMR-104-015), Research Laboratory of Pediatrics, Children's Hospital of China Medical University, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM103010096), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039 -006), Tseng-Lien Lin Foundation, Taiwan Brain Disease Foundation, and Katsuzo and Kiyo Aoshima Memorial Funds.	Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buoncristiani U, 1993, Perit Dial Int, V13 Suppl 2, pS202; Burn DJ, 1998, J NEUROL NEUROSUR PS, V65, P810, DOI 10.1136/jnnp.65.6.810; Chen YJ, 2014, OSTEOPOROSIS INT, V25, P1513, DOI 10.1007/s00198-014-2632-6; Cook WL, 2006, CLIN J AM SOC NEPHRO, V1, P1197, DOI 10.2215/CJN.01650506; Desmet C, 2005, AM J KIDNEY DIS, V45, P148, DOI 10.1053/j.ajkd.2004.09.027; Farragher J, 2014, CLIN J AM SOC NEPHRO, V9, P1248, DOI 10.2215/CJN.11001013; Gottesman RF, 2003, INT REV PSYCHIATR, V15, P302, DOI 10.1080/09540260310001606683; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Huang KW, 2014, DIGEST DIS SCI, V59, P807, DOI 10.1007/s10620-013-2973-6; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Kimmel PL, 1998, AM J MED, V105, P214, DOI 10.1016/S0002-9343(98)00245-9; Kopitnik Jr TA, 1989, SURG NEUROL, V32, P289; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Nordstrom A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001151; Power A, 2010, NEPHROL DIAL TRANSPL, V25, P2272, DOI 10.1093/ndt/gfq013; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; RODBY RA, 1994, AM J KIDNEY DIS, V23, P401, DOI 10.1016/S0272-6386(12)81003-1; Rossier A, 2012, NEPHROL DIAL TRANSPL, V27, P352, DOI 10.1093/ndt/gfr326; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sood P, 2007, CLIN J AM SOC NEPHRO, V2, P956, DOI 10.2215/CJN.03781106; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Takeda K, 1997, NEPHROL DIAL TRANSPL, V12, P952, DOI 10.1093/ndt/12.5.952; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Wang HH, 2014, AM J KIDNEY DIS, V63, P604, DOI 10.1053/j.ajkd.2013.10.013; Wang IK, 2014, EUR J NEUROL, V21, P894, DOI 10.1111/ene.12406; Wang IK, 2013, J NEPHROL, V26, P331, DOI 10.5301/jn.5000149; WOLCOTT DL, 1988, AM J KIDNEY DIS, V12, P275, DOI 10.1016/S0272-6386(88)80220-8	33	14	14	0	2	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1555-9041	1555-905X		CLIN J AM SOC NEPHRO	Clin. J. Am. Soc. Nephrol.	JUN	2015	10	6					994	1001		10.2215/CJN.08140814			8	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	CJ8XV	WOS:000355787700014	25825482	Bronze, Green Published			2022-02-06	
J	Larson, JCG; Flaro, L; Peterson, RL; Connery, AK; Baker, DA; Kirkwood, MW				Larson, Jennifer C. Gidley; Flaro, Lloyd; Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			The Medical Symptom Validity Test Measures Effort Not Ability in Children: A Comparison Between Mild TBI and Fetal Alcohol Spectrum Disorder Samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Performance validity testing; MSVT; Traumatic brain injury; Children	NONCREDIBLE EFFORT; TEST FAILURE; PERFORMANCE; INDICATORS; STATEMENT; CAPACITY; ACADEMY; ADULTS; EXAM	Inadequate effort during neuropsychological examination results in inaccurate representations of an individual's true abilities and difficulties. As such, performance validity tests (PVTs) are strongly recommended as standard practice during adult-based evaluations. One concern with using PVTs with children is that failure reflects immature cognitive ability rather than non-credible effort. The current study examined performance on the Medical Symptom Validity Test (MSVT) in two large pediatric clinical samples with strikingly different neuropsychological profiles: (1) mild traumatic brain injury (mTBI; n = 510) and (2) fetal alcohol spectrum disorder (FASD; n = 120). Despite higher IQ scores and reading ability, the mTBI group performed significantly worse than the FASD group on all effort indices. Sixteen percent of the mTBI group failed the MSVT, whereas only 5% of the FASD group did. Our findings support the idea that the MSVT measures effort, not ability, in most cases and help to justify incorporating PVTs into pediatric neuropsychological batteries.	[Larson, Jennifer C. Gidley] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO 80045 USA		Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	michael.kirkwood@childrenscolorado.org					Adams W., 1998, TEST ACAD PERFORMANC; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green CM, 2014, J CLIN EXP NEUROPSYC, V36, P261, DOI 10.1080/13803395.2013.879096; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry G. K., 2005, FORENSIC NEUROPSYCHO, P205; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Kaufman, 2009, ESSENTIALS WISC 4 AS; Kirk JW, 2014, ASSESSMENT, V21, P562, DOI 10.1177/1073191114520626; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; McCaffrey R. J., 2009, NEUROPSYCHOLOGY MALI, P377; Salekin R. T., 2008, CLIN ASSESSMENT MALI; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2003, MANUAL WECHSLER INTE; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wilkenson G.S., 2006, WIDE RANGE ACHIEVEME; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; [No title captured]	39	14	14	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2015	30	3					192	199		10.1093/arclin/acv012			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CH1ZO	WOS:000353822600003	25787156	Green Published			2022-02-06	
J	Osler, T; Glance, LG; Li, WJ; Buzas, JS; Wetzel, ML; Hosmer, DW				Osler, Turner; Glance, Laurent G.; Li, Wenjun; Buzas, Jeffery S.; Wetzel, Megan L.; Hosmer, David W.			Trauma care does not discriminate: The association of race and health insurance with mortality following traumatic injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Race; health insurance; mortality; survivor treatment assignment bias	FUNCTIONAL OUTCOMES; BRAIN-INJURY; DISPARITIES; SURVIVAL; CHILDREN; BIAS; REGISTRY; CANCER; HEAD	BACKGROUND: Previous studies have reported that black race and lack of health insurance coverage are associated with increased mortality following traumatic injury. However, the association of race and insurance status with trauma outcomes has not been examined using contemporary, national, population-based data. METHODS: We used data from the National Inpatient Sample on 215,615 patients admitted to 1 of 836 hospitals following traumatic injury in 2010. We examined the effects of race and insurance coverage on mortality using two logistic regression models, one for patients younger than 65 years and the other for older patients. RESULTS: Unadjusted mortality was low for white (2.71%), black (2.54%), and Hispanic (2.03%) patients. We found no difference in adjusted survival for nonelderly black patients compared with white patients (adjusted odds ratio [AOR], 1.04; 95% confidence interval [CI], 0.90-1.19; p = 0.550). Elderly black patients had a 25% lower odds of mortality compared with elderly white patients (AOR, 0.75; 95% CI, 0.63-0.90; p = 0.002). After accounting for survivor bias, insurance coverage was not associated with improved survival in younger patients (AOR, 0.91; 95% CI, 0.77-1.07; p = 0.233). CONCLUSION: Black race is not associated with higher mortality following injury. Health insurance coverage is associated with lower mortality, but this may be the result of hospitals' inability to quickly obtain insurance coverage for uninsured patients who die early in their hospital stay. Increasing insurance coverage may not improve survival for patients hospitalized following injury. (J Trauma Acute Care Surg. 2015; 78: 1026-1033. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Osler, Turner] Univ Vermont, Dept Surg, Colchester, VT 05446 USA; [Buzas, Jeffery S.] Univ Vermont, Dept Math & Stat, Colchester, VT 05446 USA; [Wetzel, Megan L.] Univ Vermont, Coll Med, Colchester, VT 05446 USA; [Glance, Laurent G.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA; [Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA USA; [Hosmer, David W.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Worcester, MA 01605 USA		Osler, T (corresponding author), Univ Vermont, Dept Surg, 789 Orchard Shore Rd, Colchester, VT 05446 USA.	tosler@uvm.edu	Li, Wenjun/F-5634-2015	Li, Wenjun/0000-0001-5335-7386	National Institute on Minority Health and Health Disparities of the National Institutes of Health [R01MD006231]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [R01MD006231] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number R01MD006231.	[Anonymous], 2012, INC POV HLTH INS COV; Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; Austin PC, 2006, J EVAL CLIN PRACT, V12, P601, DOI 10.1111/j.1365-2753.2005.00624.x; Barnett H, 2010, PROF CASE MANAG, V15, P280, DOI 10.1097/NCM.0b013e3181e2d114; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hicks CW, 2014, JAMA SURG, V149, P642, DOI 10.1001/jamasurg.2014.166; Martin CA, 2010, AM J SURG, V199, P210, DOI 10.1016/j.amjsurg.2009.05.001; McCann J, 2005, CHEST, V128, P3440, DOI 10.1378/chest.128.5.3440; Millham F, 2009, WORLD J SURG, V33, P23, DOI 10.1007/s00268-008-9745-z; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Stallion A, 2007, J TRAUMA, V62, P1262; Subramanian S, 2013, JAMA OTOLARYNGOL, V139, P489, DOI 10.1001/jamaoto.2013.2549; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	22	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2015	78	5					1026	1033		10.1097/TA.0000000000000593			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CH3KR	WOS:000353930100020	25909426	Green Accepted			2022-02-06	
J	Young, EJ; Macias, CR; Stephens, L				Young, Eliot J.; Macias, C. Roger; Stephens, Lindsay			Common Dental Injury Management in Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						sports-related dental injury; tooth fracture; tooth avulsion; mouth guard	INTERNATIONAL ASSOCIATION; TRAUMATOLOGY GUIDELINES; PERMANENT TEETH; MOUTH GUARDS; SPORTS; MOUTHGUARDS; CONCUSSIONS; BASKETBALL; EQUIPMENT; AVULSION	Context: Orofacial and dental trauma continues to be a commonly encountered issue for the sports medicine team. All sports have some risk for dental injury, but "contact sports" presumably incur more risk. Immediate evaluation and proper management of the most common injuries to dentition can result in saving or restoration of tooth structure. Despite the growing body of evidence, mouth guard use and dental protection have not paralleled the increase in sports participation. Evidence Acquisition: A PubMed search from 1960 through April 2012 was conducted, as well as a review of peerreviewed online publications. Results: Common dental injuries in sports include tooth (crown) fractures; tooth intrusion, extrusion, and avulsion; and temporomandibular joint dislocation. Mouth guards help prevent most injuries and do not significantly affect ventilation or speech if fitted properly. Conclusion: A working knowledge of the presentation as well as management of commonly encountered dental trauma in sports is essential to the immediate care of an athlete and returning to play. Mouth guard use should be encouraged for athletes of all ages in those sports that incur significant risk.	[Young, Eliot J.] CHRISTUS Santa Rosa Primary Care Sports Med Fello, 21 Spurs Lane,Suite 300, San Antonio, TX 78240 USA; [Macias, C. Roger] San Antonio Rampage AHL Hockey, San Antonio, TX USA; [Stephens, Lindsay] CHRISTUS Santa Rosa Family Med Residency, San Antonio, TX USA		Young, EJ (corresponding author), CHRISTUS Santa Rosa Primary Care Sports Med Fello, 21 Spurs Lane,Suite 300, San Antonio, TX 78240 USA.	eliot.young@christushealth.org					ADA, 2006, J AM DENT ASSOC, V137, P1712; Akinbami BO, 2011, HEAD FACE MED, V7, DOI 10.1186/1746-160X-7-10; American Academy of Pediatric Dentistry, GUID MAN AC DENT TRA; Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; Beachy G, 2004, J ATHL TRAINING, V39, P310; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; *BUR DENT HLTH ED, 1963, J AM DENT ASSOC, V66, P539; Coalter F., LONDON 2012 SUSTAINA; Cohenca N, 2007, J AM DENT ASSOC, V138, P1121, DOI 10.14219/jada.archive.2007.0326; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; DiAngelis AJ, 2012, DENT TRAUMATOL, V28, P2, DOI 10.1111/j.1600-9657.2011.01103.x; Emerich K, 2010, SPORTS MED, V40, P361, DOI 10.2165/11530750-000000000-00000; Fariniuk LF, 2010, J APPL ORAL SCI, V18, P343, DOI 10.1590/S1678-77572010000400004; Gebauer DP, 2011, CLIN J SPORT MED, V21, P95, DOI 10.1097/JSM.0b013e31820428b0; HEINTZ WD, 1968, J AM DENT ASSOC, V77, P632; Hinckfuss SE, 2009, DENT TRAUMATOL, V25, P150, DOI 10.1111/j.1600-9657.2008.00761.x; Hinckfuss SE, 2009, DENT TRAUMATOL, V25, P158, DOI 10.1111/j.1600-9657.2008.00736.x; Huffman EA, 2008, J ATHL TRAINING, V43, P624, DOI 10.4085/1062-6050-43.6.624; Kececi AD, 2005, DENT TRAUMATOL, V21, P276, DOI 10.1111/j.1600-9657.2005.00354.x; Klossner D., 2011 2012 NCAA SPORT; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; LUYK NH, 1989, AM J EMERG MED, V7, P329, DOI 10.1016/0735-6757(89)90181-2; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Muhtarogullari M, 2004, DENT TRAUMATOL, V20, P338, DOI 10.1111/j.1600-9657.2004.00267.x; Padilla R, 1996, J Calif Dent Assoc, V24, P30; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Policy on prevention of sports-related orofacial injuries, PEDIATR DENT S7, V30, P58; RANALLI D N, 1991, Dental Clinics of North America, V35, P627; Ranalli Dennis N, 2005, Curr Sports Med Rep, V4, P12; Ranalli DN, 2002, SPORTS MED, V32, P409, DOI 10.2165/00007256-200232070-00001; REED RV, 1994, BRIT DENT J, V176, P478, DOI 10.1038/sj.bdj.4808485; Rosenberg H, 2011, ANN EMERG MED, V57, P375, DOI 10.1016/j.annemergmed.2010.06.004; Shirani Gholamreza, 2010, J Emerg Trauma Shock, V3, P314, DOI 10.4103/0974-2700.70744; Smith WS, 2011, CREST ORAL B CONTINU; Spinas E, 2007, Eur J Paediatr Dent, V8, P193; Tulunoglu I, 2006, DENT TRAUMATOL, V22, P242, DOI 10.1111/j.1600-9657.2006.00386.x; Welch Cara L., 2010, New Zealand Dental Journal, V106, P137; Woodmansey K F, 1999, Gen Dent, V47, P64	39	14	16	2	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2015	7	3					250	255		10.1177/1941738113486077			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	V20MO	WOS:000214890900008	26131303	Green Published			2022-02-06	
J	Graber, DJ; Costine, BA; Hickey, WF				Graber, David J.; Costine, Beth A.; Hickey, William F.			Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets	JOURNAL OF NEUROINFLAMMATION			English	Article						Cytokines; Cerebral cortex; Chemokines; Injury; Mouse; Pig; Prostaglandin-endoperoxide synthase-2; Slice	CLOSED-HEAD INJURY	Background: The immunological response during the first 24 hours after traumatic brain injury (TBI) may be a critical therapeutic interval for limiting the secondary neuronal damage that is influenced by enhanced inflammatory mediator expression. Methods: To gain further insight of the early injury response, we examined the expression of several inflammatory genes by real-time qPCR as a function of time or distance from injury in two distinct mammalian models: an ex vivo mouse cortical slice injury system and an in vivo piglet model of brain injury. Results: Interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), chemokine ligands 2 (CCL2), 3 (CCL3), 4 (CCL4), and prostaglandin-endoperoxide synthase 2 (PTGS2) mRNAs increased within 5 h after injury in mouse cortical slices. Chemokine and PTGS2 mRNAs remained elevated in slices at 24 h, whereas IL-1 beta and TNF-alpha expressions decreased from earlier peak levels. At 24 h after cortical injury in 1-month-old piglets, the expression of CCL2 mRNA was significantly increased in the lesion core and in the penumbra region. The expression of PTGS2, IL-1 beta, and TNF-alpha was variable among the piglets. Conclusions: These in vitro and large animal models of cortical injury expand our understanding of the early timing and spread of the immunological response and can serve as preclinical systems to facilitate the discovery of therapeutic agents for TBI aimed at regulating inflammatory mediator expression.	[Graber, David J.; Hickey, William F.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH 03756 USA; [Costine, Beth A.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Costine, Beth A.] Harvard Univ, Sch Med, Boston, MA 02114 USA		Graber, DJ (corresponding author), Geisel Sch Med Dartmouth, Dept Pathol, One Med Ctr Dr, Lebanon, NH 03756 USA.	David.J.Graber@Dartmouth.Edu			Hitchcock Foundation (Geisel School of Medicine at Dartmouth); Nicholas T. Zervas Chair Fund (Harvard Medical School); Hitchcock Foundation (Dartmouth-Hitchcock Medical Center)	This research was supported in part by a grant from the Hitchcock Foundation (Geisel School of Medicine at Dartmouth and the Dartmouth-Hitchcock Medical Center) and Nicholas T. Zervas Chair Fund (Harvard Medical School).	Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Costine B, 2015, DEV NEUROSCI, V37; Costine BA, 2012, J NEUROTRAUM, V29, P2689, DOI 10.1089/neu.2012.2428; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Graber DJ, 2012, J NEUROIMMUNE PHARM, V7, P266, DOI 10.1007/s11481-011-9338-8; Graber DJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-122; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rice T, 2007, J NEUROPATH EXP NEUR, V66, P184, DOI 10.1097/01.jnen.0000248552.07338.7f; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229	30	14	14	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 18	2015	12								76	10.1186/s12974-015-0298-4			8	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CG4PQ	WOS:000353269000002	25895671	Green Published, gold			2022-02-06	
J	Elbin, RJ; Beatty, A; Covassin, T; Schatz, P; Hydeman, A; Kontos, AP				Elbin, R. J.; Beatty, Amanda; Covassin, Tracey; Schatz, Philip; Hydeman, Ana; Kontos, Anthony P.			A Preliminary Examination of Neurocognitive Performance and Symptoms Following a Bout of Soccer Heading in Athletes Wearing Protective Soccer Headbands	RESEARCH IN SPORTS MEDICINE			English	Article						soccer heading; soccer headgear; neurocognitive performance	INJURY SURVEILLANCE SYSTEM; TEST-RETEST RELIABILITY; DESCRIPTIVE EPIDEMIOLOGY; ONLINE VERSION; HIGH-SCHOOL; IMPACT; SPECIFICITY; SENSITIVITY; CONCUSSIONS; HEADGEAR	This study compared changes in neurocognitive performance and symptom reports following an acute bout of soccer heading among athletes with and without protective soccer headgear. A total of 25 participants headed a soccer ball 15 times over a 15-minute period, using a proper linear heading technique. Participants in the experimental group completed the heading exercise while wearing a protective soccer headband and controls performed the heading exercise without wearing the soccer headband. Neurocognitive performance and symptom reports were assessed before and after the acute bout of heading. Participants wearing the headband showed significant decreases on verbal memory (p = 0.02) compared with the no headband group, while the no headband group demonstrated significantly faster reaction time (p = 0.03) than the headband group following the heading exercise. These findings suggest that protective soccer headgear likely does not mitigate the subtle neurocognitive effects of acute soccer heading.	[Elbin, R. J.; Hydeman, Ana] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Beatty, Amanda] Carolina Sports Concuss Clin, Cary, NC USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Kontos, Anthony P.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15261 USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA.	rjelbin@uark.edu		Kontos, Anthony/0000-0002-3749-4310			Agel J, 2007, J ATHL TRAINING, V42, P270; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dick R, 2007, J ATHL TRAINING, V42, P278; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Muller NG, 2002, J COGNITIVE NEUROSCI, V14, P673, DOI 10.1162/08989290260138582; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Tysvaer A, 1981, Br J Sports Med, V15, P163; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174	24	14	14	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	APR 3	2015	23	2					203	214		10.1080/15438627.2015.1005293			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	CH0PH	WOS:000353723600008	25666112				2022-02-06	
J	Aadal, L; Mortensen, J; Nielsen, JF				Aadal, Lena; Mortensen, Jesper; Nielsen, Jorgen Feldbaek			Weight Reduction After Severe Brain Injury: A Challenge During the Rehabilitation Course	JOURNAL OF NEUROSCIENCE NURSING			English	Article						acquired brain injury; malnutrition; nursing care; nutritional risk factors; rehabilitation; weight loss	NUTRITIONAL ASSESSMENT; ENERGY-EXPENDITURE; STROKE; MALNUTRITION; PREVALENCE; MODERATE	Background: There is a paucity of studies, which have described malnutrition in patients with acquired brain injury (ABI) across etiology. This study describes weight change, malnutrition, and potential associations in patients with ABI at a subacute inpatient rehabilitation hospital. Method: This is a descriptive cohort study. Ninety-eight patients were admitted in a 3-month period, of whom n = 76 met inclusion criteria. The Malnutrition Universal Screening Tool was used for categorizing patients according to risk of malnutrition. Results: Patients had experienced weight loss of 5.59% +/- 5.89% (p < .001) at admission at the rehabilitation hospital, and patients with traumatic brain injury had experienced a greater weight loss than patients with stroke (p < .01). Thirty percent of patients were at high risk for malnutrition, and 52% of these patients received enteral or parenteral nutrition at admission at the rehabilitation hospital. No association was found between risk of malnutrition and severity of injury, complications, functional outcome, or length of stay. Conclusion: Results underline the importance that nurses, especially in acute care, adhere to clinical guidelines to minimize weight loss. Special attention should be on patients with traumatic brain injury. Weight gain in the following course of rehabilitation may facilitate positive rehabilitation outcomes.	[Aadal, Lena] Hammel Neurorehabil & Res Ctr, Clin Nursing Res, Hammel, Denmark; [Mortensen, Jesper; Nielsen, Jorgen Feldbaek] Hammel Neurorehabil & Res Ctr, Hammel, Denmark		Aadal, L (corresponding author), Hammel Neurorehabil & Res Ctr, Clin Nursing Res, Hammel, Denmark.	lena.aadal@hammel.rm.dk	Fabricius, Jesper/AAO-1202-2021; Nielsen, Jorgen Feldbak/AAR-6384-2021; Aadal, Lena/R-3444-2019	Fabricius, Jesper/0000-0001-7285-3422; Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Aadal, Lena/0000-0001-7365-3916			Badjatia N, 2010, JPEN-PARENTER ENTER, V34, P64, DOI 10.1177/0148607109348797; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; da Rocha EEM, 2005, CURR OPIN CLIN NUTR, V8, P319, DOI 10.1097/01.mco.0000165012.77567.1e; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; Donaldson J, 2000, Crit Care Nurs Clin North Am, V12, P465; Erdman J., 2011, NUTR TRAUMATIC BRAIN; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Foley NC, 2009, STROKE, V40, pE66, DOI 10.1161/STROKEAHA.108.518910; Frankenfield DC, 2012, NUTRITION, V28, P906, DOI 10.1016/j.nut.2011.12.008; Fuhrman MP, 2002, NUTRITION, V18, P199, DOI 10.1016/S0899-9007(01)00729-8; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Jonsson AC, 2008, STROKE, V39, P918, DOI 10.1161/STROKEAHA.107.497602; Kirkwood B. R., 2006, MED STAT, V2; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Krakau K, 2010, SCAND J CARING SCI, V24, P3, DOI 10.1111/j.1471-6712.2008.00677.x; Kyle UG, 2006, CLIN NUTR, V25, P409, DOI 10.1016/j.clnu.2005.11.001; Mosselman MJ, 2013, J NEUROSCI NURS, V45, P194, DOI 10.1097/JNN.0b013e31829863cb; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Perel P., 2008, COMPETENCIA COMUNICA, P1; Perry L, 2013, WORLDV EVID-BASED NU, V10, P17, DOI 10.1111/j.1741-6787.2012.00255.x; Poels BJJ, 2006, DISABIL REHABIL, V28, P637, DOI 10.1080/09638280500276612; Raguso CA, 2003, CURR OPIN CLIN NUTR, V6, P211, DOI 10.1097/00075197-200303000-00010; Sundhedsstyrelsen, 2008, VEJL LOEG SYG SOC OG; Uniform Data System for Medical Rehabilitation, 1993, AD FIM COMP PROGR; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]	30	14	16	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2015	47	2					85	90		10.1097/JNN.0000000000000121			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	CC7VU	WOS:000350577300005	25700193				2022-02-06	
J	Mioni, G; Rendell, PG; Terrett, G; Stablum, F				Mioni, Giovanna; Rendell, Peter G.; Terrett, Gill; Stablum, Franca			Prospective Memory Performance in Traumatic Brain Injury Patients: A Study of Implementation Intentions	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Implementation intentions; Prospective memory; Event-based; Time-based; Virtual Week	CLOSED-HEAD-INJURY; EXECUTIVE FUNCTIONS; OLDER-ADULTS; REHABILITATION; INVOLVEMENT; DISORDERS; STRATEGY; PEOPLE; COMA	Traumatic brain injury (TBI) patients often present with prospective memory (PM) dysfunction. Forgetting to complete tasks may result in a loss of independence, limited employment prospects and anxiety, therefore, it is important to develop programs to improve PM performance in TBI patients. A strategy which may improve PM performance is implementation intentions. It involves making explicit plans specifying when, where and how one will perform a task in the future. In the present study, a group of 36 TBI patients and a group of 34 controls performed Virtual Week using either implementation intentions or no strategy. The results showed that the PM performance of TBI patients was less accurate than controls, in particular when the PM cue was time-based. No effect of implementation intentions was observed for TBI patients, however, controls improved their PM performance when the task was time-based. The findings suggest that strategies to improve PM in this clinical group are likely to be more complex than those that benefit healthy adults and may involve targeting phases of the PM process other than, or in addition to, the intention formation phase.	[Mioni, Giovanna; Stablum, Franca] Univ Padua, Dept Gen Psychol, I-35131 Padua, Italy; [Rendell, Peter G.; Terrett, Gill] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia		Mioni, G (corresponding author), Univ Padua, Dept Gen Psychol, Via Venezia 12, I-35131 Padua, Italy.	mioni.giovanna@gmail.com	Rendell, Peter/E-7539-2010; Terrett, Gill/D-7165-2019	Rendell, Peter/0000-0002-4829-4322; Terrett, Gill/0000-0003-2500-6428; Stablum, Franca/0000-0003-0123-5090; mioni, Giovanna/0000-0002-1212-4591			BELLEZZA FS, 1981, REV EDUC RES, V51, P247, DOI 10.3102/00346543051002247; Carlesimo GA, 2009, BEHAV NEUROL, V22, P101, DOI [10.3233/ben-2009-0251, 10.3233/BEN-2009-0251]; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; COHEN AL, 2008, PROSPECTIVE MEMORY C, P367; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gollwitzer PM, 1997, J PERS SOC PSYCHOL, V73, P186, DOI 10.1037/0022-3514.73.1.186; Kardiasmenos KS, 2008, NEUROPSYCHOLOGY, V22, P746, DOI 10.1037/a0013211; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M., 2008, PROSPECTIVE MEMORY C; Lengfelder A, 2001, NEUROPSYCHOLOGY, V15, P80, DOI 10.1037//0894-4105.15.1.80; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McFarland C, 2012, MEM COGNITION, V40, P62, DOI 10.3758/s13421-011-0126-8; McFarland CP, 2011, AGING NEUROPSYCHOL C, V18, P633, DOI 10.1080/13825585.2011.613449; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Meeks JT, 2010, PSYCHOL RES-PSYCH FO, V74, P82, DOI 10.1007/s00426-008-0223-x; Mioni G., 2014, TRAUMATIC BRAIN INJU, P401, DOI [10.5772/5730, DOI 10.5772/57307]; Mioni G, 2015, NEUROPSYCHOL REHABIL, V25, P419, DOI 10.1080/09602011.2014.941295; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Paivio A., 1971, IMAGERY VERBAL PROCE; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; Schmidt IW, 2001, PERCEPT MOTOR SKILL, V93, P761, DOI 10.2466/PMS.93.7.761-776; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto A. I. T., 2008, PROSPECTIVE MEMORY C, P321; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Webb TL, 2007, J EXP SOC PSYCHOL, V43, P295, DOI 10.1016/j.jesp.2006.02.001; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; [No title captured]	50	14	18	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2015	21	4					305	313		10.1017/S1355617715000211			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	CK2EI	WOS:000356023000005	26028246				2022-02-06	
J	Rockett, H; Thompson, HJ; Blissitt, PA				Rockett, Hannah; Thompson, Hilaire J.; Blissitt, Patricia A.			Fever Management Practices of Neuroscience Nurses: What Has Changed?	JOURNAL OF NEUROSCIENCE NURSING			English	Article						clinical decision making; fever; hyperthermia; nursing intervention	ELEVATED BODY-TEMPERATURE; BRAIN TEMPERATURE; SUBARACHNOID HEMORRHAGE; RISK-FACTORS; ACUTE STROKE; CARE; HYPERTHERMIA; IMPACT; INJURY; ACETAMINOPHEN	Current evidence shows that fever and hyperthermia are especially detrimental to patients with neurologic injury, leading to higher rates of mortality, greater disability, and longer lengths of stay. Although clinical practice guidelines exist for ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury, they lack specificity in their recommendations for fever management, making it difficult to formulate appropriate protocols for care. Using survey methods, the aims of this study were to (a) describe how nursing practices for fever management in this population have changed over the last several years, (b) assess if institutional protocols and nursing judgment follow published national guidelines for fever management in neuroscience patients, and (c) explore whether nurse or institutional characteristics influence decision making. Compared with the previous survey administered in 2007, there was a small increase (8%) in respondents reporting having an institutional fever protocol specific to neurologic patients. Temperatures to initiate treatment either based on protocols or nurse determination did not change from the previous survey. However, nurses with specialty certification and/or working in settings with institutional awards (e.g., Magnet status or Stroke Center Designation) initiated therapy at a lower temperature. Oral acetaminophen continues to be the primary choice for fever management, followed by ice packs and fans. This study encourages the development of a stepwise approach to neuro-specific protocols for fever management. Furthermore, it shows the continuing need to promote further education and specialty training among nurses and encourage collaboration with physicians to establish best practices.	[Rockett, Hannah] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; [Blissitt, Patricia A.] Univ Washington, Sch Nursing, Biobehav Nursing Hlth Syst, Seattle, WA 98195 USA; [Blissitt, Patricia A.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Blissitt, Patricia A.] Swedish Med Ctr, Seattle, WA USA		Thompson, HJ (corresponding author), Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA.	hilairet@uw.edu	Viani, Rafael/V-1196-2018				Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; ALEXANDER SE, 2007, CARE PATIENT ANEURYS; Balas MC, 2012, CRIT CARE NURSE, V32, P35, DOI 10.4037/ccn2012229; Blegen Mary A, 2012, Evid Based Nurs, V15, P54, DOI 10.1136/ebnurs.2011.100228; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS21; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs C, 2010, FRONT NEUROL, V146, P1; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; CLASEN RA, 1974, J NEUROSURG, V41, P576, DOI 10.3171/jns.1974.41.5.0576; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Grau AJ, 1999, J NEUROL SCI, V171, P115, DOI 10.1016/S0022-510X(99)00261-0; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Jaunch E. C., 2013, STROKE, V44, P870, DOI DOI 10.1161/STR.0B013E318284056A; Karaszewski B, 2013, J CEREBR BLOOD F MET, V33, P1083, DOI 10.1038/jcbfm.2013.52; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kendall-Gallagher D, 2011, J NURS SCHOLARSHIP, V43, P188, DOI 10.1111/j.1547-5069.2011.01391.x; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Laws C., 2010, JEFFERSON HOSP NEURO, V5, P22; Mackowiak PA, 2000, CLIN INFECT DIS, V31, pS185, DOI 10.1086/317511; Mcilvoy L., 2008, NURSING MANAGEMENT A; Mcilvoy L, 2012, AACN ADV CRIT CARE, V23, P204, DOI 10.1097/NCI.0b013e31824db1c6; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Morimoto T, 1997, BRAIN RES, V746, P43, DOI 10.1016/S0006-8993(96)01154-7; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; National Association of Clinical Nurse Specialists, 2013, CNS FAQS; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Pugh S., 2008, GUIDE CARE HOSP PATI; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Schulman Carl I, 2005, Surg Infect (Larchmt), V6, P369; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sulter G, 2004, CEREBROVASC DIS, V17, P118, DOI 10.1159/000075779; Summers D, 2009, STROKE, V40, P2911, DOI 10.1161/STROKEAHA.109.192362; Takagi K., 1994, AM J PHYSIOL, V267, pH170; The Joint Commission, 2012, FACTS PRIM STROK CTR; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P151; Thompson HJ, 2011, J ADV NURS, V67, P359, DOI 10.1111/j.1365-2648.2010.05506.x; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	51	14	15	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2015	47	2					66	75		10.1097/JNN.0000000000000118			10	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	CC7VU	WOS:000350577300003	25634653				2022-02-06	
J	Holzinger, U; Brunner, R; Losert, H; Fuhrmann, V; Herkner, H; Madl, C; Sterz, F; Schneeweiss, B				Holzinger, Ulrike; Brunner, Richard; Losert, Heidrun; Fuhrmann, Valentin; Herkner, Harald; Madl, Christian; Sterz, Fritz; Schneeweiss, Bruno			Resting energy expenditure and substrate oxidation rates correlate to temperature and outcome after cardiac arrest - a prospective observational cohort study	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; OXYGEN-CONSUMPTION; INDIRECT CALORIMETRY; COMATOSE SURVIVORS; METABOLISM; INSULIN; HYPOTHERMIA; MANAGEMENT; GLUCOSE; RESUSCITATION	Introduction: Targeted temperature management improves outcome after cardiopulmonary resuscitation. Reduction of resting energy expenditure might be one mode of action. The aim of this study was to correlate resting energy expenditure and substrate oxidation rates with targeted temperature management at 33 degrees C and outcome in patients after cardiac arrest. Methods: This prospective, observational cohort study was performed at the department of emergency medicine and a medical intensive care unit of a university hospital. Patients after successful cardiopulmonary resuscitation undergoing targeted temperature management at 33 degrees C for 24 hours with subsequent rewarming to 36 degrees C and standardized sedation, analgesic and paralytic medication were included. Indirect calorimetry was performed five times within 48 h after cardiac arrest. Measurements were correlated to outcome with repeated measures ANOVA, linear and logistic regression analysis. Results: In 25 patients resting energy expenditure decreased 20 (18 to 27) % at 33 degrees C compared to 36 degrees C without differences between outcome groups (favourable vs. unfavourable: 25 (21 to 26) vs. 21 (16 to 26); P = 0.5). In contrast to protein oxidation rate (favourable vs. unfavourable: 35 (11 to 68) g/day vs. 39 (7 to 75) g/day, P = 0.8) patients with favourable outcome had a significantly higher fat oxidation rate (139 (104 to 171) g/day vs. 117 (70 to 139) g/day, P < 0.05) and a significantly lower glucose oxidation rate (30 (-34 to 88) g/day vs. 77 (19 to 138) g/day; P < 0.05) as compared to patients with unfavourable neurological outcome. Conclusions: Targeted temperature management at 33 degrees C after cardiac arrest reduces resting energy expenditure by 20% compared to 36 degrees C. Glucose and fat oxidation rates differ significantly between patients with favourable and unfavourable neurological outcome.	[Holzinger, Ulrike; Brunner, Richard; Madl, Christian; Schneeweiss, Bruno] Med Univ Vienna, ICU 13H1, Dept Med 3, Div Gastroenterol & Hepatol, A-1090 Vienna, Austria; [Losert, Heidrun; Herkner, Harald; Sterz, Fritz] Med Univ Vienna, Dept Emergency Med, A-1090 Vienna, Austria; [Fuhrmann, Valentin] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care, D-20246 Hamburg, Germany		Holzinger, U (corresponding author), Med Univ Vienna, ICU 13H1, Dept Med 3, Div Gastroenterol & Hepatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	ulrike.holzinger@meduniwien.ac.at		Losert, Heidrun/0000-0003-1951-2682			[Anonymous], 1991, Resuscitation, V22, P1; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BURSZTEIN S, 1977, J APPL PHYSIOL, V42, P117, DOI 10.1152/jappl.1977.42.1.117; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; HAMER J, 1978, ACTA NEUROCHIR, V44, P151, DOI 10.1007/BF01402057; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Holzer M, 2010, NEW ENGL J MED, V363, P1256, DOI 10.1056/NEJMct1002402; HOOPARIS R, 1988, AM J PHYSIOL, V255, pR1035, DOI 10.1152/ajpregu.1988.255.6.R1035; KURPAD AV, 1994, AM J PHYSIOL, V266, pE877, DOI 10.1152/ajpendo.1994.266.6.E877; LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608; Magistretti Pierre J., 1995, P657; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P210, DOI 10.1164/ajrccm.151.1.7812556; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P10, DOI 10.1164/ajrccm.151.1.7812538; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; MARSH WH, 1965, CLIN CHEM, V11, P624; NATALI A, 1990, DIABETES, V39, P490, DOI 10.2337/diabetes.39.4.490; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Poblete B, 1997, BRIT J ANAESTH, V78, P123, DOI 10.1093/bja/78.2.123; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; SCHNEEWEISS B, 1993, GASTROENTEROLOGY, V105, P1515, DOI 10.1016/0016-5085(93)90159-A; SCHNEEWEISS B, 1990, HEPATOLOGY, V11, P387, DOI 10.1002/hep.1840110309; SCHNEEWEISS B, 1992, METABOLISM, V41, P125, DOI 10.1016/0026-0495(92)90138-Z; SCHNEEWEISS B, 1990, AM J CLIN NUTR, V52, P596, DOI 10.1093/ajcn/52.4.596; Sessler DI, 2009, CRIT CARE MED, V37, pS203, DOI 10.1097/CCM.0b013e3181aa5568; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Terao Y, 2003, CRIT CARE MED, V31, P830, DOI 10.1097/01.CCM.0000054868.93459.E1; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Urabe T, 1996, J NEUROCHEM, V67, P265; Vallerand AL, 1999, AVIAT SPACE ENVIR MD, V70, P42; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; WELLE S, 1988, J CLIN ENDOCR METAB, V66, P593, DOI 10.1210/jcem-66-3-593	38	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	MAR 29	2015	19								128	10.1186/s13054-015-0856-2			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SD	WOS:000353199000002	25888299	Green Published, gold			2022-02-06	
J	Cui, T; Zhu, GY				Cui, Tao; Zhu, Gangyi			Ulinastatin Attenuates Brain Edema After Traumatic Brain Injury in Rats	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						TBI; Brain edema; UTI; AQP-4	URINARY TRYPSIN-INHIBITOR; SEVERE HEAD-INJURY; NF-KAPPA-B; OXIDATIVE STRESS; PROTEASE INHIBITORS; REACTIVE ASTROCYTES; AQUAPORIN-4; EXPRESSION; MICE; ACTIVATION	Traumatic brain injury (TBI) remains the leading cause of injury-related death and disability. Brain edema, one of the most major complications of TBI, contributes to elevated intracranial pressure, and poor prognosis following TBI. The objective of this study was to evaluate whether Ulinastatin (UTI), a serine protease inhibitor, attenuates brain edema following TBI. Our results showed that treatment with UTI at a dose of 50,000 U/kg attenuated the brain edema, as assayed by water content 24 h after TBI induction. This attenuation was associated with a significant decrease of the expression level of aquaporin-4. In addition, we showed that UTI treatment also markedly inhibited the expression of pro-inflammatory cytokines including IL-1 beta and TNF-alpha as well as activity of NF-kappa B. Collectively, our findings suggested that UTI may be a promising strategy to treat brain edema following TBI.	[Cui, Tao; Zhu, Gangyi] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang 471003, Henan, Peoples R China		Cui, T (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang 471003, Henan, Peoples R China.	drtaocui@163.com					Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Duris K, 2011, TRANSL STROKE RES, V2, P232, DOI 10.1007/s12975-010-0063-z; ENDO S, 1993, RES COMMUN CHEM PATH, V82, P27; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hirashima Y, 2001, J BIOL CHEM, V276, P13650, DOI 10.1074/jbc.M009906200; Iseri SO, 2008, REGUL PEPTIDES, V146, P73, DOI 10.1016/j.regpep.2007.08.014; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Koga Y, 2010, NEUROL RES, V32, P925, DOI 10.1179/016164110X12645013515133; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nakatani K, 2001, J LEUKOCYTE BIOL, V69, P241; Nielsen S, 1997, J NEUROSCI, V17, P171; NIETOSAMPEDRO M, 1987, J NEUROSCI RES, V17, P214, DOI 10.1002/jnr.490170303; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yano T, 2003, ANESTHESIOLOGY, V98, P465, DOI 10.1097/00000542-200302000-00028	37	14	22	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	MAR	2015	71	2					595	600		10.1007/s12013-014-0239-3			6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CA9KF	WOS:000349241400012	25209743				2022-02-06	
J	Feldman, A; Hart, KW; Lindsell, CJ; McMullan, JT				Feldman, Amanda; Hart, Kimberly W.; Lindsell, Christopher J.; McMullan, Jason T.			Randomized Controlled Trial of a Scoring Aid to Improve Glasgow Coma Scale Scoring by Emergency Medical Services Providers	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; INTERRATER RELIABILITY; MOTOR SCORE; PREDICTION; VALIDATION	Study objective: Emergency medical services (EMS) personnel frequently use the Glasgow Coma Scale (GCS) to assess injured and critically ill patients. This study assesses the accuracy of EMS providers' GCS scoring, as well as the improvement in GCS score assessment with the use of a scoring aid. Methods: This randomized, controlled study was conducted in the emergency department (ED) of an urban academic trauma center. Emergency medical technicians or paramedics who transported a patient to the ED were randomly assigned one of 9 written scenarios, either with or without a GCS scoring aid. Scenarios were created by consensus of expert attending emergency medicine, EMS, and neurocritical care physicians, with universal consensus agreement on GCS scores. chi(2) And Student's t tests were used to compare groups. Results: Of 180 participants, 178 completed the study. Overall, 73 of 178 participants (41%) gave a GCS score that matched the expert consensus score. GCS score was correct in 22 of 88 (25%) cases without the scoring aid. GCS was correct in 51 of 90 (57%) cases with the scoring aid. Most (69%) of the total GCS scores fell within 1 point of the expert consensus GCS score. Differences in accuracy were most pronounced in scenarios with a correct GCS score of 12 or below. Subcomponent accuracy was eye 62%, verbal 70%, and motor 51%. Conclusion: In this study, 60% of EMS participants provided inaccurate GCS score estimates. Use of a GCS scoring aid improved accuracy of EMS GCS score assessments.	[Feldman, Amanda] Northeast Ohio Med Univ, Akron, OH USA; [Feldman, Amanda; Hart, Kimberly W.; Lindsell, Christopher J.; McMullan, Jason T.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA		McMullan, JT (corresponding author), Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA.	jason.mcmullan@uc.edu	McMullan, Jason/ABB-9691-2020	McMullan, Jason/0000-0002-7656-7447	Institutional Clinical and Translational Science Award, NIH/NCRR grant [5UL1RR026314-03]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist and provided the following details: This project was supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR grant 5UL1RR026314-03.	Baez AA, 2007, PREHOSP DISASTER MED, V22, P230, DOI 10.1017/S1049023X00004726; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Caroline NL., 1991, STUDY GUIDE EMERGENC, P94; Dalton A, 1999, MOSSBYS PARAMEDIC RE, P295; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heim C, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-39; Hsieh A, 2008, PARAMEDIC COMPANION, P240; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lane Peter L, 2002, Prehosp Disaster Med, V17, P142; Takahashi C, 2011, AM J EMERG MED, V29, P196, DOI 10.1016/j.ajem.2009.09.018; TEASDALE G, 1974, LANCET, V2, P81; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	20	14	14	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	MAR	2015	65	3					325	329		10.1016/j.annemergmed.2014.07.454			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CC9QN	WOS:000350705800018	25199613	Green Accepted			2022-02-06	
J	Harvey, HH; Koller, DL; Lowrey, KM				Harvey, Hosea H.; Koller, Dionne L.; Lowrey, Kerri M.			The Four Stages of Youth Sports TBI Policymaking: Engagement, Enactment, Research, and Reform	JOURNAL OF LAW MEDICINE & ETHICS			English	Article; Proceedings Paper	National Public Health Law Conference - Intersection of Law, Policy and Prevention	OCT, 2014	Atlanta, GA	Network Public Hlth Law, Ame Soc Law, Med & Eth			TRAUMATIC BRAIN-INJURY; STATE LAWS; EDUCATION; IMPACT	Drawing from research on a variety of public health law interventions, this article frames such interventions as developing in four key stages: engagement, enactment, research, and reform. Here, we apply this four-stage framework to youth sports TBI laws, while postulating connections to past interventions and predicting future outcomes.	[Harvey, Hosea H.] Temple Univ, Beasley Sch Law, Law, Philadelphia, PA 19122 USA; [Koller, Dionne L.] Univ Baltimore, Sch Law, Law, Baltimore, MD 21201 USA; [Koller, Dionne L.] Univ Baltimore, Sch Law, Ctr Sport & Law, Baltimore, MD 21201 USA; [Lowrey, Kerri M.] Network Publ Hlth Law, Baltimore, MD USA; [Lowrey, Kerri M.] Univ Maryland, Francis King Carey Sch Law, Baltimore, MD 21201 USA		Harvey, HH (corresponding author), Temple Univ, Beasley Sch Law, Law, Philadelphia, PA 19122 USA.						[Anonymous], 2014, J LAW MED ETHICS, V42; Brownson RC, 2009, AM J PUBLIC HEALTH, V99, P1576, DOI 10.2105/AJPH.2008.156224; Cantu R., 2012, CONCUSSIONS OUR KIDS; Carter W. Burlette, 1999, VA J SPORTS L, V1, p[235, 244]; Carter W. Burlette, 1999, VA J SPORTS L, V1, p[235, 235]; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Davis, 2001, MARQUETTE SPORTS LAW, V11, P211; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI [10.2105/AJPH.2003.033563, 10.2105/AJPH.2003.031310]; Davis T., 2001, MARQUETTE SPORTS LAW, V11, p[211, 234]; Davis T., 2001, MARQUETTE SPORTS LAW, V11, p[211, 212]; Harper S, 2014, J POLICY ANAL MANAG, V33, P141, DOI 10.1002/pam.21735; Harvey Hosea H, 2014, Yale J Health Policy Law Ethics, V14, P66; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Ibrahim JK, 2011, AM J PREV MED, V40, P659, DOI 10.1016/j.amepre.2011.02.024; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowrey K. M., 2014, J BUSINESS TECHNOLOG, V10, P61; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; National Federation of State High School Associations, 2013, NFHS HDB 2013 2014; Rivara F. P., 2014, AM J SPORTS MED, V1187, p[1197, 1202]; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Williams J, 2014, J HEALTH ECON, V36, P20, DOI 10.1016/j.jhealeco.2014.03.006	21	14	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	SPR	2015	43			1	SI		87	90		10.1111/jlme.12225			4	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	CF5CS	WOS:000352573600021	25846174	Green Submitted			2022-02-06	
J	Johnston, JM; Ning, HB; Kim, JE; Kim, YH; Soni, B; Reynolds, R; Cooper, L; Andrews, JB; Vaidya, U				Johnston, James M.; Ning, Haibin; Kim, Jong-Eun; Kim, Young-Ho; Soni, Bharat; Reynolds, Richard; Cooper, Lloyd; Andrews, J. Barry; Vaidya, Uday			Simulation, fabrication and impact testing of a novel football helmet padding system that decreases rotational acceleration	SPORTS ENGINEERING			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION; BIOMECHANICS; EXPOSURES; DISEASE; PLAYER; SPORT	Recent studies suggest that concussion may be associated with long-term neurological sequelae. Both linear impact and rotational acceleration have been identified as contributors to concussion and traumatic brain injury (TBI). Modern football helmets are designed according to the National Operating Committee on Standards for Athletic Equipment (NOCSAE) standard for protection from linear impact, without consideration of protection from rotational injury. A multidisciplinary team was assembled with expertise in brain injury, computational modeling, and materials engineering to design, fabricate and impact test a novel helmet padding system. A rotational fixture with magnesium headform and linear impactor was constructed using a rotary encoder to enable measurement of z axis rotational angle, velocity and acceleration. Helmet padding material designs were evaluated using finite element (FE) computational modeling, fabricated to specification and then impact tested. Models from two different manufacturers were retrofit with prototype pads and then compared with unmodified versions for attenuation of rotational acceleration. The helmets were then tested using a standard NOCSAE drop apparatus and headform for linear acceleration performance. Large-size Riddell Revolution and Schutt ION4D helmets retrofit with prototype padding demonstrated 21.6 and 33.6 % decreased peak z axis rotational acceleration following a 3.2 m/s side impact compared with their respective unmodified commercial models (717.7 vs. 914.0 rad/s(2) and 768.4 vs. 1,158.6 rad/s(2), p < 0.0001, respectively). The improved performance effect appeared consistent over at least 50 impacts without evidence of early material degradation or helmet damage. Compared with unmodified versions, drop test performance for hybridized helmets, measured by Peak G and severity index (SI), were comparable for most, but were worse for rear (Riddell Revolution) and side (Schutt ION4D) impact conditions. Rotational acceleration from side impacts may be attenuated by directed helmet design while maintaining acceptable linear impact performance. Future work will focus on optimization and durability testing of prototype padding for larger impacts.	[Johnston, James M.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35233 USA; [Ning, Haibin; Andrews, J. Barry; Vaidya, Uday] Univ Alabama Birmingham, Dept Mat Sci, Birmingham, AL 35233 USA; [Kim, Jong-Eun; Kim, Young-Ho; Soni, Bharat] Univ Alabama Birmingham, Dept Mech Engn, Birmingham, AL 35233 USA; [Reynolds, Richard] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cooper, Lloyd] PUSH Prod Design, Birmingham, AL USA		Johnston, JM (corresponding author), Univ Alabama Birmingham, Dept Neurosurg, 1600 7th Ave South,Lowder 400, Birmingham, AL 35233 USA.	James.johnston@childrensal.org		Johnston, James/0000-0001-8564-1808			[Anonymous], 2011, CDC SPORTS REL CONC, P60; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0	28	14	14	0	15	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	MAR	2015	18	1					11	20		10.1007/s12283-014-0160-4			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	CY8RJ	WOS:000366675700002					2022-02-06	
J	Luo, TD; Clarke, MJ; Zimmerman, AK; Quinn, M; Daniels, DJ; McIntosh, AL				Luo, T. David; Clarke, Michelle J.; Zimmerman, Amy K.; Quinn, Michael; Daniels, David J.; McIntosh, Amy L.			Concussion symptoms in youth motocross riders: a prospective, observational study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; symptoms; motocross; pediatric; return to play; trauma	SPORT-RELATED CONCUSSION; 2ND IMPACT SYNDROME; ADOLESCENT SPORT; INJURY; CHILDREN; POPULATION; MANAGEMENT	OBJECT Action motorsports, including motocross, have been gaining popularity among children and adolescents, raising concerns for increased risk of concussions in participating youth. The authors undertook this study to test the following hypotheses: 1) that there is a high rate of concussion symptoms associated with a number of preventable or adjustable risk factors, and 2) that a high percentage of these symptoms are not be reported to adults and medical personnel. METHODS The authors identified all motocross riders under the age of 18 at a regional racetrack during the riding season between May and October 2010. The participants completed questionnaires pertaining to demographic characteristics and variables associated with motocross. The questionnaire results were compared with the incidence of self-reported concussion symptoms. RESULTS Two hundred two riders were identified who met the criteria for participation in the study, and 139 of them completed the study questionnaire. Of these 139 riders, 67 (48%) reported at least 1 concussion symptom during the season. The majority of riders (98%) reported "always" wearing a helmet, and 72% received professional help with fitting of their helmets. Proper helmet fitting was associated with a 41% decreased risk of concussion symptoms (RR 0.59, 95% CI 0.44-0.81, p < 0.01). Sixty-six riders (47%) reported having received sponsor support for motocross participation. Sponsor support conferred a relative risk for concussion symptoms of 1.48 (95% CI 1.05-2.08, p = 0.02). CONCLUSIONS Nearly half of all motocross competitors under the age of 18 reported concussion symptoms. Preventive measures are necessary to limit the negative impact from concussions. The risk of concussive injury can be decreased for pediatric motocross riders if they receive professional help with proper helmet fitting and through implementation of stricter guidelines regarding sponsorship.	[Luo, T. David; Zimmerman, Amy K.; McIntosh, Amy L.] Mayo Clin, Mayo Clin Coll Med, Dept Orthoped Surg, Rochester, MN 55905 USA; [Clarke, Michelle J.; Daniels, David J.] Mayo Clin, Mayo Clin Coll Med, Dept Neurosurg, Rochester, MN 55905 USA; [Quinn, Michael] Mayo Clin, Mayo Clin Coll Med, Dept Anesthesia, Rochester, MN 55905 USA		Clarke, MJ (corresponding author), Mayo Clin, Dept Neurol Surg, 200 1st St SW, Rochester, MN 55905 USA.	clarke.michelle@mayo.edu		McIntosh, Amy/0000-0002-3660-4901			Abernethy L, 2007, BRIT J SPORT MED, V41, P627, DOI 10.1136/bjsm.2007.035691; American Academy of Pediatrics Committee on Accident and Poison Prevention, 1987, PEDIATRICS, V79, P306; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Daniels DJ, 2015, J NEUROSURG PEDIAT, DOI [10.3171/2014.9.PEDS14153, DOI 10.3171/2014.9.PEDS14153]]; Daniels DJ, 2015, J NEUROSURG PEDIAT, DOI [10.3171/2014.9.PEDS14149, DOI 10.3171/2014.9.PEDS14149]]; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Grace MT, 2013, J PEDIATR HEALTH CAR, V27, P377, DOI 10.1016/j.pedhc.2012.10.004; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kennedy RD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001848; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; MX Sports Pro Racing, 2014, COMP B 20141 IMPACT; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343	27	14	14	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2015	15	3					255	260		10.3171/2014.11.PEDS14127			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CC3RL	WOS:000350266900005	25555121	Bronze			2022-02-06	
J	Ross, PE; Ponsford, JL; Di Stefano, M; Spitz, G				Ross, Pamela E.; Ponsford, Jennie L.; Di Stefano, Marilyn; Spitz, Gershon			Predictors of On-Road Driver Performance Following Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	World Congress of NeuroRehabilitation	MAY 17, 2012	Melbourne, AUSTRALIA			Automobile driving; Brain injuries; Glasgow Coma Scale; Rehabilitation	HEAD-INJURY; COMMUNITY INTEGRATION; DRIVING ASSESSMENT; FITNESS; RETURN; RECOMMENDATIONS; POSTINJURY; IMPAIRMENT; CLINICIAN; EXPOSURE	Objective: To examine assessment outcomes and factors associated with passing an occupational therapy (OT) on-road driver assessment after traumatic brain injury (TBI). Design: Retrospective analysis of outcomes of on-road driver assessment completed by persons with TBI over an 8-year period. Setting: Inpatient and outpatient rehabilitation hospital. Participants: A consecutive sample of individuals (N=207) with mild to severe TBI who completed an on-road driver assessment and were assessed at least 3 months postinjury. Intervention: Not applicable. Main Outcome Measure: Outcome of on-road driver assessment. Results: Of the drivers with TBI, 66% (n=137) passed the initial on-road driver assessment (pass group), whereas 34% (n=70) required on-road driver rehabilitation and/or >= 1 on-road assessment (rehabilitation group). After driver rehabilitation, only 3 participants of the group did not resume driving. Participants who were men, had shorter posttraumatic amnesia (PTA) duration, had no physical and/or visual impairment, and had faster reaction times were significantly more likely to be in the pass group. In combination, these variables correctly classified 87.6% of the pass group and 71.2% of the rehabilitation group. Conclusions: PTA duration proved to be a better predictor of driver assessment outcome than Glasgow Coma Scale score. In combination with the presence of physical/visual impairment and slowed reaction times, PTA could assist clinicians to determine referral criteria for OT driver assessment. On-road driver rehabilitation followed by on-road reassessment were associated with a high probability of return to driving after TBI. (C) 2015 by the American Congress of Rehabilitation Medicine	[Ross, Pamela E.] Epworth HlthCare, Occupat Therapy Dept, Melbourne, Vic, Australia; [Ponsford, Jennie L.; Spitz, Gershon] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie L.; Spitz, Gershon] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Di Stefano, Marilyn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia		Ross, PE (corresponding author), Epworth HlthCare, Occupat Therapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	pam.ross@epworth.org.au	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480			[Anonymous], 1999, POLA CRIT; Austroads, 2012, ASS FITN DRIV COMM P; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Di Stefano M., 2006, DRIVER REHABILITATIO, P297, DOI [10.1016/B978-032302937-7.50019-8, DOI 10.1016/B978-032302937-7.50019-8]; Di Stefano M., 2006, DRIVER REHABILITATIO, P255, DOI DOI 10.1016/B978-032302937-7.50018-6; Di Stefano M, 2010, AM J OCCUP THER, V64, P325, DOI 10.5014/ajot.64.2.325; Dimarco F, 2001, EURA MEDICOPHYS, V37, P215; Duquette J, 2010, AM J OCCUP THER, V64, P279, DOI 10.5014/ajot.64.2.279; Fisk GD, 1998, BRAIN INJURY, V12, P683; FORMISANO R, 2001, EUROPA MEDICOPHYSICA, V37, P257; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES R, 1983, AM J OCCUP THER, V37, P754, DOI 10.5014/ajot.37.11.754; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Marshall SC, 1999, CAN MED ASSOC J, V160, P1701; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Roads Corporation (Vic), 1998, COMP STAND OCC THER; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schulte T, 1999, AM J PHYS MED REHAB, V78, P136, DOI 10.1097/00002060-199903000-00010; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SHUTE RH, 1990, OPHTHAL PHYSL OPT, V10, P327, DOI 10.1111/j.1475-1313.1990.tb00878.x; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Transport Accident Commission, 2010, TRANSP ACC COM SAF S; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90	48	14	14	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2015	96	3					440	446		10.1016/j.apmr.2014.09.027			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	CC3QZ	WOS:000350265400009	25316183				2022-02-06	
J	Sivertsen, M; Normann, B				Sivertsen, Marianne; Normann, Britt			Embodiment and self in reorientation to everyday life following severe traumatic brain injury	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Embodiment; phenomenology; physiotherapy; self; traumatic brain injury	QUALITY-OF-LIFE; PEOPLE; PARTICIPATION; REHABILITATION; SATISFACTION; REFLECTIONS; EXPERIENCE; NARRATIVES; MODERATE; ISSUES	People with severe traumatic brain injury (sTBI) are often young and need long-term follow-up as many suffer complex motor, sensory, perceptual and cognitive impairments. This paper aims to introduce phenomenological notions of embodiment and self as a framework to help understand how people with sTBI experience reorientation to everyday life, and to inform clinical practice in neurological physiotherapy. The impairments caused by the sTBI may lead to a sense of alienation of one's own body and changes in operative intentionality and in turn disrupt the reorganization of self, identity, everyday life and integration/co-construction of meaning with others. Applying a first-person conception of the body may extend insights into the importance of an adapted and individualized approach to strengthen the sensory, perceptual and motor body functions, which underpin the pre-reflective and reflective aspects of the self. It seems important to integrate these aspects, while also paying attention to optimizing co-construction of meaning for the person with sTBI in the treatment context. This requires understanding the patient as an experiencing and expressive body, a lived body (body-as-subject) and not just the body-as-object as is favored in more traditional frameworks of physiotherapy.	[Sivertsen, Marianne; Normann, Britt] Nordland Hosp Trust, Dept Physiotherapy, N-8092 Bodo, Norway; [Normann, Britt] UiT Arctic Univ Tromso, Dept Hlth & Care Sci, Tromso, Norway		Sivertsen, M (corresponding author), Nordland Hosp Trust, Dept Physiotherapy, N-8092 Bodo, Norway.	marianne.sivertsen2@nordlandssykehuset.no		Sivertsen, Marianne/0000-0003-0895-1081			Antetius E, 2007, MED ANTHROPOL Q, V21, P324, DOI 10.1525/MAQ.2007.21.3.324; Bischofberger W, 2004, MOVEMENT ACTION LEAR, P213; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Brodal P., 2010, CENTRAL NERVOUS SYST, V4th; Brough JB, 2001, HDB PHENOMENOLOGY ME; Carr JH., 2010, NEUROLOGICAL REHABIL, V2nd; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; De Jaegher H., 2007, PHENOMENOL COGN SCI, V6, P485, DOI [10.1007/s11097-007-9076-9, DOI 10.1007/S11097-007-9076-9]; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Fuchs T, 2009, PHENOMENOL COGN SCI, V8, P465, DOI 10.1007/s11097-009-9136-4; Gallagher S, 2000, J CONSCIOUSNESS STUD, V7, P45; Gallagher S., 2012, PHENOMENOLOGY; Gallagher S., 2008, PHENOMENOLOGICAL MIN; Gallagher S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00443; Gallagher Shaun, 2005, BODY SHAPES MIND; Gibson BE, 2010, PHYSIOTHER CAN, V62, P98, DOI 10.3138/physio.62.2.98; Gibson J. J., 1979, ECOLOGICAL APPROACH; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Leder Drew, 1990, ABSENT BODY; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Lund LB, 2013, J NOVEL PHYSIOTHERAP, V4, P1; Meadows L, 2009, BOBATH CONCEPT THEOR; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nicholls David A., 2010, Physiotherapy Theory and Practice, V26, P497, DOI 10.3109/09593981003710316; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Normann B, 2013, PHYSIOTHER THEOR PR, V29, P19, DOI 10.3109/09593985.2012.698717; Normann Britt, 2012, Physiotherapy Theory and Practice, V28, P108, DOI 10.3109/09593985.2011.574782; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Roth C, 2013, NEUROCRIT CARE, V18, P33, DOI 10.1007/s12028-012-9799-5; Rowland LP, 2010, MERRITS NEUROLOGY; Schutz A., 2005, HVERDAGSLIVETS SOCIO; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Smith C., 2008, PHENOMENOLOGY PERCEP; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432	51	14	14	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	MAR	2015	31	3					153	159		10.3109/09593985.2014.986350			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CF9CD	WOS:000352858300001	25431992				2022-02-06	
J	Suehiro, E; Koizumi, H; Fujisawa, H; Fujita, M; Kaneko, T; Oda, Y; Yamashita, S; Tsuruta, R; Maekawa, T; Suzuki, M				Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Fujita, Motoki; Kaneko, Tadashi; Oda, Yasutaka; Yamashita, Susumu; Tsuruta, Ryosuke; Maekawa, Tsuyoshi; Suzuki, Michiyasu			Diverse Effects of Hypothermia Therapy in Patients with Severe Traumatic Brain Injury Based on the Computed Tomography Classification of the Traumatic Coma Data Bank	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; hypothermia; Traumatic Coma Data Bank; multicenter randomized controlled trial; heterogeneous pathophysiology; CT classification	POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; AXONAL INJURY; HEAD-INJURY; INDUCTION; GLUTAMATE; DAMAGE; RAT	A multicenter randomized controlled trial of patients with severe traumatic brain injury who received therapeutic hypothermia or fever control was performed from 2002 to 2008 in Japan (BHYPO). There was no difference in the therapeutic effect on traumatic brain injury between the two groups. The efficacy of hypothermia treatment and the objective of the treatment were reexamined based on a secondary analysis of the BHYPO trial in 135 patients (88 treated with therapeutic hypothermia and 47 with fever control). This analysis was performed to examine clinical outcomes according to the CT classification of the Traumatic Coma Data Bank on admission. Clinical outcomes were evaluated with the Glasgow Outcome Scale and mortality at 6 months after injury. Good recovery and moderate disability were defined as favorable outcomes. Favorable outcomes in young patients (<= 50 years old) with evacuated mass lesions significantly increased from 33.3% with fever control to 77.8% with therapeutic hypothermia. Patients with diffuse injury III who were treated with therapeutic hypothermia, however, had significantly higher mortality than patients treated with fever control. It was difficult to control intracranial pressure with hypothermia for patients with diffuse injury III, but hypothermia was effective for young patients with an evacuated mass lesion.	[Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi; Fujita, Motoki; Kaneko, Tadashi; Oda, Yasutaka; Yamashita, Susumu; Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan; [Maekawa, Tsuyoshi] Yamaguchi Grand Med Ctr, Hofu, Yamaguchi, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019; Kaneko, Tadashi/AAD-1516-2022	Kaneko, Tadashi/0000-0002-7171-7231	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare, H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001, and by the Japanese Human Science Association, 2002-2004.	Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Delbarre B, 1992, EXS, V62, P199; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Holzer M, 2002, NEW ENGL J MED, V346, P549; *JAP SOC NEUR, 2001, GUID MAN SEV HEAD IN, P1; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KURODA Y, 1992, NEUROSURGERY, V30, P687; Maekawa T., 2014, J NEUROTRAU IN PRESS; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906	25	14	17	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					353	358		10.1089/neu.2014.3584			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700007	25233298	Green Published			2022-02-06	
J	Whitney, KA; Davis, JJ				Whitney, Kriscinda A.; Davis, Jeremy J.			The Non-Credible Score of the Rey Auditory Verbal Learning Test: Is It Better at Predicting Non-Credible Neuropsychological Test Performance Than the RAVLT Recognition Score?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Test validity; Neuropsychology; Malingering; Military veterans; Memory	RESPONSE BIAS SCALE; SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; MEMORY PERFORMANCE; TEST FAILURE; HEAD-INJURY; VALIDATION; MMPI-2; INDEX	The ability of both the non-credible score of the Rey Auditory Verbal Learning Test (RAVLT NC) and the recognition score of the RAVLT (RAVLTRecog) to predict credible versus non-credible neuropsychological test performance was examined. Credible versus non-credible group membership was determined according to diagnostic criteria with consideration of performance on two stand-alone performance validity tests. Findings from this retrospective data analysis of outpatients seen for neuropsychological testing within a Veterans Affairs Medical Center (N = 175) showed that RAVLT Recog demonstrated better classification accuracy than RAVLT NC in predicting credible versus non-credible neuropsychological test performance. Specifically, an RAVLT Recog cutoff of <= 9 resulted in reasonable sensitivity (48%) and acceptable specificity (91%) in predicting non-credible neuropsychological test performance. Implications for clinical practice are discussed. Note: The views contained here within are those of the authors and not representative of the institutions with which they are associated.	[Whitney, Kriscinda A.] Richard L Roudebush Vet Affairs Med Ctr, Dept Psychiat, Indianapolis, IN 46202 USA; [Whitney, Kriscinda A.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA		Whitney, KA (corresponding author), Richard L Roudebush Vet Affairs Med Ctr 116P, 1481 W 10th St, Indianapolis, IN 46202 USA.	kamarks@iupui.edu					Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Green P., 1996, MANUAL COMPUTARIZED; Green P., 2004, GREENS MED SYMPTON V; Green P., 2009, ADV INTERPRETATION P; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Lemeshow S, 2000, APPL LOGISTIC REGRES; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCaffrey R. J., 2003, PRACTITIONERS GUIDE; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Schmidt M., 1996, REY AUDITORY VERBAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Suhr JA, 2002, ARCH CLIN NEUROPSYCH, V17, P69, DOI 10.1016/S0887-6177(00)00102-5; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	37	14	14	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2015	30	2					130	138		10.1093/arclin/acu094			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CF0JP	WOS:000352230000005	25599723	hybrid, Green Submitted			2022-02-06	
J	Baltazar, GA; Pate, AJ; Panigrahi, B; LaBoy, S; Prosniak, R; Mody, A; Chendrasekhar, A				Baltazar, Gerard A.; Pate, Amy J.; Panigrahi, Benita; LaBoy, Shannon; Prosniak, Roman; Mody, Armaiti; Chendrasekhar, Akella			Malnutrition as Measured by Albumin and Prealbumin on Admission Is Associated with Poor Outcomes after Severe Traumatic Brain Injury	AMERICAN SURGEON			English	Article									[Baltazar, Gerard A.; Pate, Amy J.; Panigrahi, Benita; Chendrasekhar, Akella] Univ Richmond, Med Ctr, Staten Isl, NY USA; [Panigrahi, Benita; LaBoy, Shannon; Prosniak, Roman; Mody, Armaiti] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA		Baltazar, GA (corresponding author), Univ Richmond, Med Ctr, Surg, 220 Manhattan Ave,Suite 3J, New York, NY 10025 USA.	gerardbaltazar@gmail.com		Baltazar, Gerard/0000-0001-6109-3843			Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1	4	14	14	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2015	81	2					E61	E63					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CI6TK	WOS:000354894700008	25642858				2022-02-06	
J	de Lanerolle, NC; Kim, JH; Bandak, FA				de Lanerolle, Nihal C.; Kim, Jung H.; Bandak, Faris A.			Neuropathology of Traumatic Brain Injury: Comparison of Penetrating, Nonpenetrating Direct Impact and Explosive Blast Etiologies	SEMINARS IN NEUROLOGY			English	Article						traumatic brain Injury; neuropathology; penetrating injury; closed head injury; explosive blast; concussion; microglia; astrocytes; diffuse axonal injury	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; MILD HEAD-INJURY; WAR VETERANS; ALZHEIMERS-DISEASE; GUNSHOT WOUNDS; BETA-APP; DAMAGE; RISK; ENCEPHALOPATHY	The neuropathology of traumatic brain injury (TBI) from various causes in humans is not as yet fully understood. The authors review and compare the known neuropathology in humans with severe, moderate, and mild TBI (mTBI) from nonpenetrating closed head injury (CHI) from blunt impacts and explosive blasts, as well as penetrating head injury (PHI). Penetrating head injury and CHI that are moderate to severe are more likely than mTBI to cause gross disruption of the cerebral vasculature. Axonal injury is classically exhibited as diffuse axonal injury (DAI) in severe to moderate CHI. Diffuse axonal injury is also prevalent in PHI. It is less so in mTBI. There may be a unique pattern of periventricular axonal injury in explosive blast mTBI. Neuronal injury is more prevalent in PHI and moderate to severe CHI than mTBI. Astrocyte and microglial activation and proliferation are found in all forms of animal TBI models and in severe to moderate TBI in humans. Their activation in mTBI in the human brain has not yet been studied.	[de Lanerolle, Nihal C.] Yale Univ, Sch Med, Dept Neurosurg & Neurobiol, New Haven, CT 06520 USA; [Kim, Jung H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bandak, Faris A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA		de Lanerolle, NC (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, FMB414,333 Cedar St, New Haven, CT 06520 USA.	Nihal.delanerolle@yale.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blissitt Patricia A, 2006, Crit Care Nurs Clin North Am, V18, P321, DOI 10.1016/j.ccell.2006.05.006; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; Campbell GA, 1999, MISSILE WOUNDS HEAD, P73; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hetherington HP, 2015, HDB CLIN NE IN PRESS; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; HOF PR, 1992, ACTA NEUROPATHOL, V84, P45, DOI 10.1007/BF00427214; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Koszyca B, 1998, J NEUROTRAUM, V15, P675, DOI 10.1089/neu.1998.15.675; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Ling G, 2015, HDB CLIN NEUROLOGY; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mott FW, 1917, J ROY ARMY MED CORPS, V29, P662; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Oehmichen M, 2004, FORENSIC SCI INT, V146, P111, DOI 10.1016/j.forsciint.2004.06.023; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Oehmichen M, 2001, FORENSIC SCI INT, V115, P189, DOI 10.1016/S0379-0738(00)00335-2; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; TEASDALE G, 1974, LANCET, V2, P81; Tsao JW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004595; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	63	14	15	0	10	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					12	19		10.1055/s-0035-1544240			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300004	25714863				2022-02-06	
J	Eastman, CL; Fender, JS; Temkin, NR; D'Ambrosio, R				Eastman, Clifford L.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo			Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Drug development; Preclinical drug screening; Focal epilepsy; Non-convulsive seizure; Pharmacoresistance; Statistical power analysis	FLUID PERCUSSION INJURY; SPONTANEOUS RECURRENT SEIZURES; COMPLEX PARTIAL SEIZURES; KAINATE-INDUCED EPILEPSY; TEMPORAL-LOBE EPILEPSY; SPRAGUE-DAWLEY RATS; POSTTRAUMATIC EPILEPSY; BRAIN-INJURY; HEAD-INJURY; EPILEPTOGENESIS	Conventionally developed antiseizure drugs fail to control epileptic seizures in about 30% of patients, and no treatment prevents epilepsy. New etiologically realistic, syndrome-specific epilepsy models are expected to identify better treatments by capturing currently unknown ictogenic and epileptogenic mechanisms that operate in the corresponding patient populations. Additionally, the use of electrocorticography permits better monitoring of epileptogenesis and the full spectrum of acquired seizures, including focal nonconvulsive seizures that are typically difficult to treat in humans. Thus, the combined use of etiologically realistic models and electrocorticography may improve our understanding of the genesis and progression of epilepsy, and facilitate discovery and translation of novel treatments. However, this approach is labor intensive and must be optimized. To this end, we used an etiologically realistic rat model of posttraumatic epilepsy, in which the initiating fluid percussion injury closely replicates contusive closed-head injury in humans, and has been adapted to maximize epileptogenesis and focal non-convulsive seizures. We obtained week-long 5-electrode electrocorticography 1 month post-injury, and used a Monte-Carlo-based non-parametric bootstrap strategy to test the impact of. electrode montage design, duration-based seizure definitions, group size and duration of recordings on the assessment of posttraumatic epilepsy, and on statistical power to detect antiseizure and antiepileptogenic treatment effects. We found that use of seizure definition based on clinical criteria rather than event duration, and of recording montages closely sampling the activity of epileptic foci, maximize the power to detect treatment effects. Detection of treatment effects was marginally improved by prolonged recording, and 24 h recording epochs were sufficient to provide 80% power to detect clinically interesting seizure control or prevention of seizures with small groups of animals. We conclude that appropriate electrode montage and clinically relevant seizure definition permit convenient deployment of fluid percussion injury and electrocorticography for epilepsy therapy development. (C) 2014 Elsevier Inc. All rights reserved.	[Eastman, Clifford L.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98104 USA; [D'Ambrosio, Raimondo] Univ Washington, Sch Med, Reg Epilepsy Ctr, Seattle, WA 98104 USA		D'Ambrosio, R (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA.	raid@u.washington.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS076570]; Citizens United for Research in Epilepsy (Prevention of Acquired Epilepsies Award); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS076570] Funding Source: NIH RePORTER	National Institutes of Health (NS076570) and Citizens United for Research in Epilepsy (Prevention of Acquired Epilepsies Award) provided funding to R.D.	Bancaud J, 1992, Adv Neurol, V57, P3; Bialer M, 2010, EPILEPSY RES, V92, P89, DOI 10.1016/j.eplepsyres.2010.09.001; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Butler T, 2013, J NEUROIMAGING, V23, P129, DOI 10.1111/j.1552-6569.2010.00572.x; Curia G., 2015, FRONTIERS N IN PRESS; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Eastman CL, 2010, EXP NEUROL, V224, P369, DOI 10.1016/j.expneurol.2010.04.013; Efron B, 1998, INTRO BOOTSTRAP, V2nd; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gilliam F, 2004, NEUROLOGY, V63, pS9, DOI 10.1212/WNL.63.10_suppl_4.S9; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Grabenstatter HL, 2008, EPILEPSIA, V49, P1787, DOI 10.1111/j.1528-1167.2008.01657.x; Grabenstatter HL, 2007, EPILEPSIA, V48, P2287; Gupta P., 2014, J NEUROTRAUMA; Ikeda A, 2009, EPILEPSIA, V50, P2072, DOI 10.1111/j.1528-1167.2009.02097.x; JUULJENSEN P, 1986, INTRACTABLE EPILEPSY, P5; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2012, EPILEPSIA, V53, P1841, DOI 10.1111/j.1528-1167.2012.03647.x; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Mattson RH, 1996, NEUROLOGY, V47, P68, DOI 10.1212/WNL.47.1.68; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Smith M, 2007, NEUROTHERAPEUTICS, V4, P12, DOI 10.1016/j.nurt.2006.11.009; Stewart KAA, 2010, J NEUROPATH EXP NEUR, V69, P1210, DOI 10.1097/NEN.0b013e3181ffc420; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; White H.S., 1998, NEUROPHARMACOLOGY ME, P27; Williams PA, 2007, NEUROSCIENCE, V149, P943, DOI 10.1016/j.neuroscience.2007.07.067; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; WILLIAMSON PD, 1986, EPILEPSIA, V27, pS46, DOI 10.1111/j.1528-1157.1986.tb05740.x; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413; WILLOUGHBY JO, 1992, LAB ANIM SCI, V42, P551	45	14	14	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2015	264						150	162		10.1016/j.expneurol.2014.12.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB4IC	WOS:000349590400016	25523813	Green Accepted			2022-02-06	
J	Schorr, B; Schlee, W; Arndt, M; Lule, D; Kolassa, IT; Lopez-Rolon, A; Bender, A				Schorr, Barbara; Schlee, Winfried; Arndt, Marion; Lule, Dorothee; Kolassa, Iris-Tatjana; Lopez-Rolon, Alexander; Bender, Andreas			Stability of auditory event-related potentials in coma research	JOURNAL OF NEUROLOGY			English	Article						Disorders of consciousness; Minimally conscious state; Unresponsive wakefulness syndrome; P300; ERPs; EEG	MINIMALLY CONSCIOUS STATES; VEGETATIVE STATE; RETEST RELIABILITY; BRAIN-INJURY; DISORDERS; RECOVERY; P300; PSYCHOPHYSIOLOGY; REHABILITATION; ERPS	Patients with unresponsive wakefulness syndrome (UWS) or in minimally conscious state (MCS) after brain injury show significant fluctuations in their behavioural abilities over time. As the importance of event-related potentials (ERPs) in the detection of traces of consciousness increases, we investigated the retest reliability of ERPs with repeated tests at four different time points. Twelve healthy controls and 12 inpatients (8 UWS, 4 MCS; 6 traumatic, 6 non-traumatic) were tested twice a day (morning, afternoon) for 2 days with an auditory oddball task. ERPs were recorded with a 256-channel-EEG system, and correlated with behavioural test scores in the Coma Recovery Scale-revised (CRS-R). The number of identifiable P300 responses varied between zero and four in both groups. Reliabilities varied between Krippendorff's alpha = 0.43 for within-day comparison, and alpha = 0.25 for between-day comparison in the patient group. Retest reliability was strong for the CRS-R scores for all comparisons (alpha = 0.83-0.95). The stability of auditory information processing in patients with disorders of consciousness is the basis for other, even more demanding tasks and cognitive potentials. The relatively low ERP-retest reliability suggests that it is necessary to perform repeated tests, especially when probing for consciousness with ERPs. A single negative ERP test result may be mistaken for proof that a UWS patient truly is unresponsive.	[Schorr, Barbara; Arndt, Marion; Bender, Andreas] Therapiezentrum Burgau, D-89331 Burgau, Germany; [Schorr, Barbara; Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany; [Schlee, Winfried] Univ Regensburg, Inst Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Lule, Dorothee] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [Lopez-Rolon, Alexander; Bender, Andreas] Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany		Schorr, B (corresponding author), Univ Ulm, Inst Psychol & Educ, Albert Einstein Allee 47, D-89069 Ulm, Germany.	barbara.schorr@uni-ulm.de	Kolassa, Iris Tatjana/Y-3032-2018	Lopez-Rolon, Alex/0000-0002-6366-2015; Bender, Andreas/0000-0002-6328-7104			Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein TA, 2009, BRAIN INJURY, V23, P915, DOI 10.1080/02699050903283197; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Donchin E., 1986, PSYCHOPHYSIOL SYST P, P244; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grill E, 2013, ARCH PHYS MED REHAB, V94, P1870, DOI 10.1016/j.apmr.2012.10.040; Guldenmund P, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/624724; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Krippendorff K., 2011, COMPUTING KRIPPENDOR; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pinheiro J., 2013, NLME LINEAR NONLINEA; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9	34	14	15	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	FEB	2015	262	2					307	315		10.1007/s00415-014-7561-y			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB8OI	WOS:000349889200007	25381459				2022-02-06	
J	Shulman, BS; Lee, JH; Liporace, FA; Ego, KA				Shulman, Brandon S.; Lee, James H.; Liporace, Frank A.; Ego, Kenneth A.			Minimally Displaced Radial Head/Neck Fractures (Mason Type-I, OTA Types 21A2.2 and 21B2.1): Are We "Over Treating" Our Patients?	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						radial head; Mason type-I; cost; radiograph; orthopaedic trauma; elbow	HEAD FRACTURES; NECK FRACTURES; CLASSIFICATION; EPIDEMIOLOGY; TRIAL; ELBOW	Objective: The purpose of this study was to investigate the nonoperative treatment strategies for Mason-Johnson type-I radial head fractures. Design and Setting: Retrospective review of every patient with a closed radial head/neck fracture who presented to our tertiary care specialty institution in the past 2 years. Patients/Participants: A search of ICD-9 code 813.05, closed fracture of the radial head/neck, in our electronic record system yielded 82 consecutive patients. Main Outcome Measurements: Complications and treatment interventions were recorded. Demographic, radiographic, and physical examination data were collected for all patients treated non-operatively and analyzed for association with recommendation for continued follow-up and radiographic assessment. Results: Fifty-four patients (68%) had 56 nondisplaced or minimally displaced (<2 mm) radial head or neck fractures without an additional injury to the affected limb. All patients were treated nonoperatively, and no patient in this cohort developed a complication or had any medical or surgical intervention other than physical therapy. No radiographic or physical examination measure was significantly associated with recommendation for the second outpatient follow-up, third outpatient follow-up, or with the number of additional radiographs ordered beyond the initial examination. An average of 4.4 (SD, 3.3) additional x-rays were taken of each affected elbow after initial outpatient presentation. Conclusions: Orthopaedic surgeons are likely over treating patients with Mason-Johnson type-I radial head fractures by recommending frequent radiographic follow-up without modifying treatment, leading to unnecessary patient visits, radiation exposure, and increased costs.	[Shulman, Brandon S.; Lee, James H.; Liporace, Frank A.; Ego, Kenneth A.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA		Ego, KA (corresponding author), NYU, Hosp Joint Dis, 301 East 17th St,Suite 1402, New York, NY 10003 USA.	Kennth.Egol@nyumc.org			Biomet; Synthes; De Puy; MedtronicMedtronic; Stryker; Omega; OREF	F. A. Lipoarce is a consultant, paid lecturer, and educational presenter for Biomet, Synthes, De Puy, Medtronic, and Stryker. He has patents with and receives royalties from De Puy and Biomet. K. Egol receives research support from Synthes, Omega, and OREF. He is a consultant for and receives royalties from Exactech and owns stock in Johnson and Johnson. B. S. Shulman and J. H. Lee report no conflict of interest.	BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Cutler E C, 1926, Ann Surg, V84, P256, DOI 10.1097/00000658-192608000-00013; Duckworth AD, 2012, J HAND SURG-AM, V37A, P112, DOI 10.1016/j.jhsa.2011.09.034; Duckworth AD, 2011, J TRAUMA, V71, P643, DOI 10.1097/TA.0b013e3181f8fa5f; Egol K. A., 2010, HDB FRACTURES; Furey MJ, 2013, J SHOULDER ELB SURG, V22, P636, DOI 10.1016/j.jse.2013.01.019; Harding P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008130.pub2; Hausmann JT, 2009, J TRAUMA, V66, P457, DOI 10.1097/TA.0b013e31817fdedd; Herbertsson P, 2005, J SHOULDER ELB SURG, V14, P73, DOI 10.1016/j.jse.2004.07.001; HOLDSWORTH BJ, 1987, INJURY, V18, P44, DOI 10.1016/0020-1383(87)90385-8; Hotchkiss, 1997, J Am Acad Orthop Surg, V5, P1; Iannuzzi NP, 2012, CLIN ORTHOP RELAT R, V470, P1799, DOI 10.1007/s11999-012-2319-2; Kaas L, 2010, J SHOULDER ELB SURG, V19, P520, DOI 10.1016/j.jse.2009.10.015; Kovar FM, 2013, WORLD J ORTHOP, V4, P80, DOI 10.5312/wjo.v4.i2.80; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; Pappas N, 2010, CLIN ORTHOP RELAT R, V468, P914, DOI 10.1007/s11999-009-1183-1; Paschos NK, 2013, J ORTHOP TRAUMA, V27, P134, DOI 10.1097/BOT.0b013e31825cf765; Rineer CA, 2010, J SHOULDER ELB SURG, V19, P21, DOI 10.1016/j.jse.2009.05.015; Ruchelsman DE, 2013, J BONE JOINT SURG AM, V95A, P469, DOI 10.2106/JBJS.J.01989; Sheehan SE, 2013, RADIOGRAPHICS, V33, P869, DOI 10.1148/rg.333125176; UNSWORTHWHITE J, 1994, INJURY, V25, P165, DOI 10.1016/0020-1383(94)90154-6; Yoon A, 2012, J HAND SURG-AM, V37A, P2626, DOI 10.1016/j.jhsa.2012.10.001	23	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	FEB	2015	29	2					E31	E35					5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CA3TH	WOS:000348828500002	24978945				2022-02-06	
J	Yuan, Q; Wu, X; Du, ZY; Sun, YR; Yu, J; Li, ZQ; Wu, XH; Mao, Y; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Du, Zhuo-Ying; Sun, Yi-Rui; Yu, Jian; Li, Zhi-Qi; Wu, Xue-Hai; Mao, Ying; Zhou, Liang-Fu; Hu, Jin			Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Coagulopathy; Recombinant factor VIIa	ACTIVATED FACTOR-VII; FRESH-FROZEN PLASMA; COAGULATION DISORDERS; TRANSFUSION; HEMORRHAGE	Purpose: The purpose of this study was to investigate the role of low-dose recombinant factor VIIa (rFVIIa) (20 mu g/kg) in reversing coagulopathy in patients with isolated traumatic brain injury (TBI). Materials and methods: Patients with isolated TBI and coagulopathy at admission were enrolled prospectively from January 2010 to December 2011. The patients were divided into 2 groups: the rFVIIa and the no-rFVIIa groups. In the rFVIIa group, patients received a single dose of 20 mu g/kg rFVIIa intravenously to reverse their coagulopathy in addition to blood products. Patients in the no-rFVIIa group received only blood products to correct the coagulopathy. The clinical outcome variables evaluated included changes in coagulation parameters after administration for reversing coagulopathy, the occurrence of progressive hemorrhagic injury (PHI), intensive care unit length of stay, the incidence of thromboembolic complications, inhospital mortality, and 90-day Glasgow Outcome Scale. Results: Eighty-seven patients were ultimately included in this study. Of them, 49 patients were treated with blood products alone, whereas 38 patients also received rFVIIa to reverse their coagulopathy. The improvement in international normalized ratio was greater in the rFVIIa group (0.26 [0.18-0.39]) than in the no-rFVIIa group (0.06 [-0.11 to 0.30]) (P = .001). In addition, the improvement in lactate was also greater in the rFVIIa group (0.33 [-0.18 to 0.54]) than in the no-rFVIIa group (0.04 [-0.25 to 0.20]) (P = .029). During the period after we began to correct the coagulopathy, PHI occurred in 19 patients (38.8%) in the no-rFVIIa group, which was significantly higher than that in the rFVIIa group (7, 18.4%; P = .040). The rate of cerebral infarction was similar in both groups (10.2% vs 5.3%). There was a trend indicating that low-dose rFVIIa therapy was associated with a lower mortality, but the association was not statistically significant (P = .266). Conclusions: The use of low-dose rFVIIa (20 mu g/kg) is effective for correcting coagulopathy in patients with TBI without an increase in thromboembolic events. Moreover, it is more effective for preventing the occurrence of PHI. (C) 2014 Elsevier Inc. All right reserved.	[Yuan, Qiang; Wu, Xing; Du, Zhuo-Ying; Sun, Yi-Rui; Yu, Jian; Li, Zhi-Qi; Wu, Xue-Hai; Mao, Ying; Zhou, Liang-Fu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	yq123abc011@163.com		Mao, Ying/0000-0001-8055-115X	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, 08dj1400503]; National Basic Research ProgramNational Basic Research Program of China [2009CB941100, 2010CB945500, 2012CB966300]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This work is supported, in part, by funds from the National Natural Science Foundation of China (NSFC grants 30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, and 08dj1400503), the National Basic Research Program (2009CB941100, 2010CB945500, 2012CB966300), the Science and Technology Commission of Shanghai Municipality Project (10JC1402300), and the Shanghai Nature Science Foundation (08411952000).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Andersen ND, 2012, ANN THORAC SURG, V93, P1921, DOI 10.1016/j.athoracsur.2012.02.037; Bochicchio GV, 2008, WORLD J SURG, V32, P2185, DOI 10.1007/s00268-008-9655-0; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS55; Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI [10.1097/01.CCM.0000186745.53059.F0, 10.1097/01.CCM.0000151062.00501.60]; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; Eikelboom JW, 2003, BLOOD COAGUL FIBRIN, V14, P713, DOI 10.1097/00001721-200312000-00004; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; FARINGER PD, 1993, J TRAUMA, V34, P481, DOI 10.1097/00005373-199304000-00002; Geeraedts LMG, 2005, INJURY, V36, P495, DOI 10.1016/j.injury.2004.08.001; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hawryluk GWJ, 2006, J NEUROSURG, V105, P859, DOI 10.3171/jns.2006.105.6.859; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Howes Jeremy L, 2009, Am J Surg, V198, P895, DOI 10.1016/j.amjsurg.2009.05.026; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Khan AZ, 2005, AM J SURG, V189, P331, DOI 10.1016/j.amjsurg.2004.11.021; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Morey Allen F, 2005, J Urol, V174, P968, DOI 10.1097/01.ju.0000168117.11396.89; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; O'Connell NM, 2003, TRANSFUSION, V43, P1711, DOI 10.1046/j.0041-1132.2003.00577.x; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Schurr MJ, 2004, J TRAUMA, V57, P718; Simpson E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005011.pub4; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	41	14	20	2	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2015	30	1					116	120		10.1016/j.jcrc.2014.07.009			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW4GJ	WOS:000346238900020	25092615				2022-02-06	
J	Sharma, A; Sane, H; Kulkarni, P; Yadav, J; Gokulchandran, N; Biju, H; Badhe, P				Sharma, Alok; Sane, Hemangi; Kulkarni, Pooja; Yadav, Jayanti; Gokulchandran, Nandini; Biju, Hema; Badhe, Prerna			Cell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot study	SPRINGERPLUS			English	Article						Traumatic brain injury; Cellular therapy; Autologous; Bone marrow; Mononuclear cells; Intrathecal; PET CT scan	SPINAL-CORD-INJURY; MARROW STROMAL CELLS; STEM-CELLS; NEURAL CELLS; TRANSPLANTATION; DIFFERENTIATE; DEFICITS; CULTURE	Traumatic brain injury is an injury to the brain parenchyma resulting from external factors such as vehicular accidents, falls, or sports injuries. Its outcome involves primary insult followed by a cascade of secondary insult, resulting in diffuse axonal injury further causing white matter damage. Surgical intervention targets the primary damage, whereas only few treatment alternatives are available to treat the secondary damage. Cellular therapy could be one of the prospective therapeutic options, as it has the potential to arrest the degeneration and promote regeneration of new cells in the brain. We conducted a pilot study on 14 cases who were administered with autologous bone marrow mononuclear cells, intrathecally. The follow up was done at 1 week, 3 months and 6 months after the intervention. The Functional Independence Measure scale, the SF-8 Health Survey Scoring and the disability rating scale were used as outcome measures. These scales showed a positive shift in scores at the end of 6 months. Improvements were observed in various symptoms, along with activities of daily living. Improvement in PET CT scan performed before and 6 months after the intervention in 3 patients corresponded to the clinical and functional improvements observed in these patients. The results of this study suggest that cell therapy may promote functional recovery leading to an improved quality of life in chronic TBI. Although the results are positive, the improvements after cell therapy are not optimal. Hence, additional multicenter, controlled studies are required to establish cell therapy as a standard therapeutic approach.	[Sharma, Alok; Gokulchandran, Nandini; Badhe, Prerna] Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept Med Serv & Clin Res, Seawood W 400706, New Mumbai, India; [Sane, Hemangi; Kulkarni, Pooja] Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept Res & Dev, Seawood W 400706, New Mumbai, India; [Yadav, Jayanti; Biju, Hema] Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept NeuroRehabil, Seawood W 400706, New Mumbai, India		Kulkarni, P (corresponding author), Stem Asia Hosp & Res Ctr, NeuroGen Brain & Spine Inst, Dept Res & Dev, Sect 40,Plot 19,Palm Beach Rd, Seawood W 400706, New Mumbai, India.	poojakul28@gmail.com					Ahmed A, 2014, LANCET, V383, P18; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bunch J, 2000, TBI CHALLENGE, V4; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hsu Yi-Chao, 2013, Biomed J, V36, P98, DOI 10.4103/2319-4170.113226; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lawall H, 2010, THROMB HAEMOSTASIS, V103, P696, DOI 10.1160/TH09-10-0688; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Muotri Alysson Renato, 2010, Estud. av., V24, P71, DOI 10.1590/S0103-40142010000300005; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sharma A, 2012, J CLIN CASE REP, V2, P195; Sharma A, 2012, J STEM CELL RES THER, V2, P129; Sharma A, 2012, INDIAN J CLIN PRACTI, V23, P100; Sharma A, 2013, CASE REP NEUROL MED, V2013, DOI 10.1155/2013/141983; Sharma A, 2013, J NEURORESTORATOLOGY, V1, P13, DOI 10.2147/JN.S43712; Sharma A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/623875; Sharma A, 2012, CELL TRANSPLANT, V21, pS79, DOI 10.3727/096368912X633798; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Ul Hassan Ashfaq, 2009, Int J Health Sci (Qassim), V3, P227; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6	37	14	14	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JAN 17	2015	4								26	10.1186/s40064-015-0794-0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4PC	WOS:000359142000003	25628985	Green Published, gold			2022-02-06	
J	Lengenfelder, J; Arjunan, A; Chiaravalloti, N; Smith, A; DeLuca, J				Lengenfelder, Jeannie; Arjunan, Aparna; Chiaravalloti, Nancy; Smith, Angela; DeLuca, John			Assessing Frontal Behavioral Syndromes and Cognitive Functions in Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						traumatic brain injury; frontal behaviors; executive functions	POSITRON-EMISSION-TOMOGRAPHY; EXECUTIVE DYSFUNCTION; SELF-AWARENESS; SCALE FRSBE; DRUG-USE; DIFFERENTIAL IMPACT; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; VISUAL MEMORY; HEAD-INJURY	This study examined the relationship between individual and family ratings on a measure of frontal behaviors using the Frontal Systems Behavior Scale (FrSBe). Additionally, this study investigated whether self-reported symptoms of frontal-lobe dysfunction correspond to neuropsychological performance, particularly those tests measuring executive functions. Thirty-three individuals with moderate-to-severe traumatic brain injury (TBI) and 19 healthy individuals completed the FrSBe and neuropsychological measures. Results indicated that the self-ratings of individuals' apathy, disinhibition, and executive dysfunction significantly increased from before to after injury, as did the family members' ratings, with no significant difference between the patients' and family members' reports for any of the three FrSBe subscales. Although individuals with TBI demonstrated impairments in neuropsychological measures, including measures of executive functioning, few significant correlations were found between the patients' FrSBe ratings and measures of cognitive functioning. This suggests that information from the FrSBe may differ from information gathered during a cognitive evaluation and may enhance our understanding of the behavioral sequelae following TBI that may not be captured by neuropsychological assessment alone.	[Lengenfelder, Jeannie; Arjunan, Aparna; Chiaravalloti, Nancy; Smith, Angela; DeLuca, John] Kessler Fdn Res Ctr, W Orange, NJ 07052 USA; [Lengenfelder, Jeannie; Chiaravalloti, Nancy; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA		Lengenfelder, J (corresponding author), Kessler Fdn Res Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jlengenfelder@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K23HD042128-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD042128] Funding Source: NIH RePORTER	This research was supported in part by the National Institute of Health Grant #5K23HD042128-05 awarded to Dr. Lengenfelder.	Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Cahn-Weiner DA, 2002, NEUROPSY NEUROPSY BE, V15, P79, DOI 10.1097/01.WNN.0000012908.05122.F4; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Faul M, 2010, TRAUMATIC BRAIN INJU; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grace J, 2001, FRONTAL SYSTEM BEHAV; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim E, 2002, NEUROREHABILITATION, V17, P297; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1016/S0003-9993(00)90227-2; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marsh L, 2009, MOVEMENT DISORD, V24, P277, DOI 10.1002/mds.22307; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McKinlay W, 1999, COGNITIVE BEHAV EFFE; Mendez MF, 2008, INT J GERIATR PSYCH, V23, P1203, DOI 10.1002/gps.2019; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41; Pachalska M., 2002, MED SCI MONITOR, V8, P1; Perecman E., 1987, FRONTAL LOBES REVISI; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; RICKER JH, 1994, NEUROPSYCHOLOGIA, V32, P1287, DOI 10.1016/0028-3932(94)90110-4; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Spinella M, 2007, J GEN PSYCHOL, V134, P101, DOI 10.3200/GENP.134.1.101-111; Stout JC, 2003, AM J GERIAT PSYCHIAT, V11, P683; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Verdejo-Garcia A, 2008, PSYCHIAT RES, V158, P172, DOI 10.1016/j.psychres.2006.08.001; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Yoshizumi M, 2008, PSYCHIAT CLIN NEUROS, V62, P669, DOI 10.1111/j.1440-1819.2008.01866.x	55	14	15	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2015	22	1					7	15		10.1080/23279095.2013.816703			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CC5ZA	WOS:000350442800001	25529586				2022-02-06	
J	Alsalaheen, BA; Haines, J; Yorke, A; Stockdale, K; Broglio, SP				Alsalaheen, Bara A.; Haines, Jamie; Yorke, Amy; Stockdale, Kayla; Broglio, Steven P.			Reliability and concurrent validity of instrumented balance error scoring system using a portable force plate system	PHYSICIAN AND SPORTSMEDICINE			English	Article						Postural control; static balance; measurements; concussion	POSTURAL STABILITY; ANKLE INSTABILITY; CONCUSSION; SCHOOL; SPORT; REPRODUCIBILITY; ASSESSMENTS; PERFORMANCE; STATEMENT; SYMPTOMS	Objectives: The Balance Error Scoring System (BESS) is a commonly used test in adolescents and young adults. Affordability and portability of newer force plates has led to instrumentation of many clinical balance tests including the BESS. Despite the higher precision of force plate measures compared with clinical scoring, it is unclear if the instrumented BESS demonstrate concurrent validity and reliability when compared with the original BESS. The purpose of this study was to examine the reliability and concurrent validity of instrumented BESS testing using a commercially available force plate system. Methods: Thirty-six participants participated in the initial testing day (17 male/19 female, M = 15.9 years, SD = 1.5 years). The test-retest sample consisted of 26 participants who completed the same testing procedure after 1 week. For all testing sessions, participants performed the BESS while standing on a portable force plate system. Number of errors and sway velocity were obtained. Concurrent validity was established through correlation analysis examining the relationship between the original and the instrumented BESS scores. Reliability was established using Intraclass Correlation Coefficient (ICC3,1) computed for the instrumented and the original BESS. Results: A significant moderate relationship exists between the total scores of the original and the instrumented BESS (rs = 0.54, p = 0.001). Despite a range of reliability scores for the different conditions in the instrumented BESS (ICC3,1 = 0.19-0.61) and the clinically scored BESS (ICC3,1 = 0.13-0.71), the reliability score for the total test score was the same for the instrumented and the clinical test (ICC3,1 = 0.74). Conclusion: Although the instrumented BESS may appear to demonstrate concurrent validity against the original BESS, instrumentation did not improve its reliability. Future research should examine if the instrumented BESS demonstrates validity against laboratory level force plates and if it is able to overcome the ceiling effect reported for the clinical BESS test.	[Alsalaheen, Bara A.; Haines, Jamie; Yorke, Amy; Stockdale, Kayla] Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA; [Broglio, Steven P.] Univ Michigan, NeuroSport Res Lab, Ann Arbor, MI 48109 USA		Alsalaheen, BA (corresponding author), Univ Michigan, Phys Therapy Dept, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313	Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity (RCA) Award	This project was funded by Ben F. Bryer Foundation Medical Research Fund, and by the University of Michigan-Flint's Research and Creative Activity (RCA) Award. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Abujaber S, 2015, GAIT POSTURE, V41, P676, DOI 10.1016/j.gaitpost.2015.01.023; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Arnold BL, 2009, MED SCI SPORT EXER, V41, P1048, DOI 10.1249/MSS.0b013e318192d044; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davisson C, 2014, TEST RETEST RELIABIL; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, P595; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Walsh MS, 2006, J STRENGTH COND RES, V20, P730; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5	40	14	14	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2015	43	3					221	226		10.1080/00913847.2015.1040717			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	CR4TF	WOS:000361331100004	26109242				2022-02-06	
J	Behfar, MH; Bjorninen, T; Moradi, E; Sydanheimo, L; Ukkonen, L				Behfar, Mohammad H.; Bjorninen, Toni; Moradi, Elham; Sydanheimo, Lauri; Ukkonen, Leena			Biotelemetric Wireless Intracranial Pressure Monitoring: An In Vitro Study	INTERNATIONAL JOURNAL OF ANTENNAS AND PROPAGATION			English	Article							CHILDREN	Assessment of intracranial pressure (ICP) is of great importance in management of traumatic brain injuries (TBIs). The existing clinically established ICP measurement methods require catheter insertion in the cranial cavity. This increases the risk of infection and hemorrhage. Thus, noninvasive but accurate techniques are attractive. In this paper, we present two wireless, batteryless, and minimally invasive implantable sensors for continuous ICP monitoring. The implants comprise ultrathin (50 mu m) flexible spiral coils connected in parallel to a capacitive microelectromechanical systems (MEMS) pressure sensor. The implantable sensors are inductively coupled to an external on-body reader antenna. The ICP variation can be detected wirelessly through measuring the reader antenna's input impedance. This paper also proposes novel implant placement to improve the efficiency of the inductive link. In this study, the performance of the proposed telemetry system was evaluated in a hydrostatic pressure measurement setup. The impact of the human tissues on the inductive link was simulated using a 5mm layer of pig skin. The results from the in vitro measurement proved the capability of our developed sensors to detect ICP variations ranging from 0 to 70 mm Hg at 2.5 mm Hg intervals.	[Behfar, Mohammad H.; Bjorninen, Toni; Moradi, Elham; Sydanheimo, Lauri; Ukkonen, Leena] Tampere Univ Technol, Dept Elect & Commun Engn, Tampere 33720, Finland		Behfar, MH (corresponding author), Tampere Univ Technol, Dept Elect & Commun Engn, Tampere 33720, Finland.	mohammadhossein.behfar@tut.fi	Bjorninen, Toni/AAN-6987-2021; Sydanheimo, Lauri/AAL-8784-2021	Bjorninen, Toni/0000-0001-9335-7196; Sydanheimo, Lauri/0000-0003-3069-8887; Behfar, Mohammadhossein/0000-0002-9108-569X	Academy of FinlandAcademy of FinlandEuropean Commission [265768, 258460, 264947]; Jane and Aatos Erkko Foundation; Finnish Funding Agency for Technology and Innovation (TEKES)Finnish Funding Agency for Technology & Innovation (TEKES)	This work was supported by the Academy of Finland (Funding Decisions 265768, 258460, and 264947), Jane and Aatos Erkko Foundation, and the Finnish Funding Agency for Technology and Innovation (TEKES). The authors thank Nazanin Zanjanizadeh Ezazi for her contribution to the graphical illustration of the brain tissue.	Chen LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6028; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Ellison WJ, 1996, J MOL LIQ, V68, P171, DOI 10.1016/0167-7322(96)00926-9; Huixin Z., 2013, J SEMICONDUCTORS, V34; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Meng X, 2012, ELECTRON LETT, V48, P363, DOI 10.1049/el.2012.0281; Moradi E, 2014, 2014 IEEE RFID TECHNOLOGY AND APPLICATIONS CONFERENCE (RFID-TA), P145, DOI 10.1109/RFID-TA.2014.6934217; Moreira-Gonzalez A, 2006, PLAST RECONSTR SURG, V117, P1964, DOI 10.1097/01.prs.0000209933.78532.a7; O'Reilly MA, 2011, ULTRASOUND MED BIOL, V37, P1930, DOI 10.1016/j.ultrasmedbio.2011.08.001; Peyman A, 2009, PHYS MED BIOL, V54, P227, DOI 10.1088/0031-9155/54/2/004; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x	15	14	14	1	21	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-5869	1687-5877		INT J ANTENN PROPAG	Int. J. Antennas Propag.		2015	2015								918698	10.1155/2015/918698			10	Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Telecommunications	CZ6YM	WOS:000367247100001		gold, Green Submitted			2022-02-06	
J	Doig, E; Prescott, S; Fleming, J; Cornwell, P; Kuipers, P				Doig, Emmah; Prescott, Sarah; Fleming, Jennifer; Cornwell, Petrea; Kuipers, Pim			Development and construct validation of the Client-Centredness of Goal Setting (C-COGS) scale	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						rehabilitation; goal planning; brain injury	TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; REHABILITATION QUESTIONNAIRE; NEUROLOGICAL REHABILITATION; OCCUPATIONAL-THERAPY; PERSPECTIVES; ADULTS; HOME; RELIABILITY; OUTCOMES	Background: Client-centred philosophy is integral to occupational therapy practice and client-centred goal planning is considered fundamental to rehabilitation. Evaluation of whether goal-planning practices are client-centred requires an understanding of the client's perspective about goal-planning processes and practices. The Client-Centredness of Goal Setting (C-COGS) was developed for use by practitioners who seek to be more client-centred and who require a scale to guide and evaluate individually orientated practice, especially with adults with cognitive impairment related to acquired brain injury. Aims: To describe development of the C-COGS scale and examine its construct validity. Material and methods: The C-COGS was administered to 42 participants with acquired brain injury after multidisciplinary goal planning. C-COGS scores were correlated with the Canadian Occupational Performance Measure (COPM) importance scores, and measures of therapeutic alliance, motivation, and global functioning to establish construct validity. Results: The C-COGS scale has three subscales evaluating goal alignment, goal planning participation, and client-centredness of goals. The C-COGS subscale items demonstrated moderately significant correlations with scales measuring similar constructs. Conclusion: Findings provide preliminary evidence to support the construct validity of the C-COGS scale, which is intended to be used to evaluate and reflect on client-centred goal planning in clinical practice, and to highlight factors contributing to best practice rehabilitation.	[Doig, Emmah; Prescott, Sarah; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld 4102, Australia; [Fleming, Jennifer; Kuipers, Pim] Queensland Hlth, Metro South Hlth Dist, Ctr Functioning & Hlth Res, Buranda, Qld, Australia; [Cornwell, Petrea] Metro North Hosp, Herston, Qld, Australia; [Cornwell, Petrea] Queensland Hlth, Hlth Serv, Herston, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Sch Appl Psychol & Behav Basis Hlth, Griffith Hlth Inst, Nathan, Qld 4111, Australia; [Kuipers, Pim] Griffith Univ, GHI, CONROD, Nathan, Qld 4111, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia Campus, Brisbane, Qld, Australia.	e.doig@uq.edu.au	Cornwell, Petrea/AAE-5547-2019; Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286	Division of Rehabilitation at Princess Alexandra Hospital	This research was conducted with the assistance of a Community Rehabilitation Workforce Project Grant from the Division of Rehabilitation at Princess Alexandra Hospital.	Barnes M. D., 2000, TXB REHABILITATION M; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; *CAN ASS OCC THER, 1997, EN OCC OCC THER PERS; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Cott CA, 2006, DISABIL REHABIL, V28, P1387, DOI 10.1080/09638280600638398; Doig E., 2008, BRIT J OCCUP THER, V71, P360, DOI [10.1177/030802260807100902, DOI 10.1177/030802260807100902]; Doig E., 2014, REHABILITATION GOAL, P181, DOI DOI 10.1201/B17166; Doig E, 2014, AM J OCCUP THER, V68, P578, DOI 10.5014/ajot.2014.010785; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Fleming JM, 1996, BRAIN INJURY, V10, P1; Hale LA, 2010, EUR J PHYSIOTHER, V12, P142, DOI 10.3109/14038196.2010.486040; Hammell KRW, 2013, CAN J OCCUP THER, V80, P141, DOI 10.1177/0008417413497906; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Holliday RC, 2007, J NEUROL NEUROSUR PS, V78, P576, DOI 10.1136/jnnp.2006.102509; Law M, 1995, Can J Occup Ther, V62, P250; Law MJS, 1998, CLIENT CTR OCCUPATIO; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Luborsky L, 1996, J Psychother Pract Res, V5, P260; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mew MM, 1996, AUST OCCUP THER J, V43, P155; Palmadottir G., 2006, BR J OCCUP THER, V69, P394, DOI DOI 10.1177/030802260606900902; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pollock N, 1998, CANADIAN OCCUPATIONA; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M., 2014, HDB NEUROPSYCHOLOGY, P233, DOI [10.1007/978-1-4939-0784-7_12, DOI 10.1007/978-1-4939-0784-7_12]; Sumison T., 1999, CLIENT CTR PRACTICE; Townsend E., 2013, ENABLING OCCUPATION, V2nd ed., P87; Van De Weyer RC, 2010, DISABIL REHABIL, V32, P1419, DOI 10.3109/09638280903574345; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Wade DT, 1998, CLIN REHABIL, V12, P273, DOI 10.1191/026921598678166365; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	39	14	14	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2015	22	4			SI		302	310		10.3109/11038128.2015.1017530			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CR4RY	WOS:000361326800010	25699472				2022-02-06	
J	Karic, T; Sorteberg, A; Nordenmark, TH; Becker, F; Roe, C				Karic, Tanja; Sorteberg, Angelika; Nordenmark, Tonje Haug; Becker, Frank; Roe, Cecilie			Early rehabilitation in patients with acute aneurysmal subarachnoid hemorrhage	DISABILITY AND REHABILITATION			English	Article						Brain injury; early rehabilitation; intracranial aneurysm; mobilization; stroke; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; EARLY MOBILIZATION; PHASE-II; INTRACRANIAL-PRESSURE; STROKE; MANAGEMENT; VASOSPASM; MORTALITY; SAFETY; RETURN	Purpose: The aim of this study was to describe and quantify the content of early rehabilitation adapted to patients with acute aneurysmal subarachnoid hemorrhage (aSAH) and to assess its feasibility. Methods: This was a prospective, observational study including 37 aSAH patients. Early rehabilitation was applied according to a mobilization algorithm. Clinical parameters, the time that rehabilitation team used on early rehabilitation and progression in mobilization were recorded. The patients' clinical conditions were graded according to the World Federation of Neurological Surgeons scale (WFNS). Results: Poor-grade patients (WFNS 3, 4, 5) (n = 12) received more rehabilitation (median 412 min) than did good-grade patients (WFNS 1, 2) (median 240 min). Mobilization to 600 of head elevation in good-grade patients began on day one after securing the aneurysm. Out-of-bed mobilization was possible on day three. Poor-grade patients were mobilized to 60 after two days and were out of bed on day seven. At discharge, 67% of poor-grade patients were mobilized to walking versus 78% of good-grade patients. No serious adverse effects to early rehabilitation were observed. Conclusions: Early rehabilitation in aSAH patients is feasible from the first day after securing the aneurysm. The rehabilitation content varied according to the patient's clinical grade.	[Karic, Tanja; Nordenmark, Tonje Haug; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Karic, Tanja; Sorteberg, Angelika] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway; [Becker, Frank] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Becker, Frank; Roe, Cecilie] Univ Oslo, Inst Clin Med, Oslo, Norway		Karic, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.	tanja.karic@gmail.com		Becker, Frank/0000-0002-0857-0628			Albano C, 2005, CRIT CARE NURS Q, V28, P135, DOI 10.1097/00002727-200504000-00006; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2005, CLIN REHABIL, V19, P811, DOI 10.1191/0269215505cr923ed; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006187.pub2; Blissitt PA, 2006, AM J CRIT CARE, V15, P206; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Cumming TB, 2011, STROKE, V42, P153, DOI 10.1161/STROKEAHA.110.594598; Diserens K, 2006, CEREBROVASC DIS, V22, P183, DOI 10.1159/000093453; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; DRAKE CG, 1988, J NEUROSURG, V68, P985; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Haug T, 2007, NEUROSURGERY, V60, P649, DOI 10.1227/01.NEU.0000255414.70807.A0; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; HEROS RC, 1983, ANN NEUROL, V14, P599, DOI 10.1002/ana.410140602; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Jessup RL, 2007, AUST HEALTH REV, V31, P330, DOI 10.1071/AH070330; Koch SM, 1996, J CRIT CARE, V11, P176, DOI 10.1016/S0883-9441(96)90028-3; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; Langhorne P, 1996, Physiother Res Int, V1, P75; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lindekleiv HM, 2011, ACTA NEUROL SCAND, V123, P34, DOI 10.1111/j.1600-0404.2010.01336.x; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Olkowski BF, 2013, PHYS THER, V93, P208, DOI 10.2522/ptj.20110334; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Ryu CW, 2011, J KOREAN NEUROSURG S, V49, P112, DOI 10.3340/jkns.2011.49.2.112; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Sorteberg A, 2013, CURR PEDIATR REV, V9, P343, DOI 10.2174/221155281120100005; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Sveinsson OA, 2011, LAEKNABLADID, V97, P355, DOI 10.17992/lbl.2011.06.377; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; van Wijk R, 2012, NEUROREHAB NEURAL RE, V26, P20, DOI 10.1177/1545968311407779; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146	43	14	15	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	16-17					1446	1454		10.3109/09638288.2014.966162			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CN7RC	WOS:000358630700007	25264735				2022-02-06	
J	Lefebvre, G; Tremblay, S; Theoret, H				Lefebvre, Genevieve; Tremblay, Sara; Theoret, Hugo			Probing the effects of mild traumatic brain injury with transcranial magnetic stimulation of the primary motor cortex	BRAIN INJURY			English	Article						Concussion; cortical excitability; Inhibition; primary motor cortex	SPORT-RELATED CONCUSSION; INTRACORTICAL INHIBITION; CORTICAL EXCITABILITY; FOOTBALL PLAYERS; HEAD-INJURIES; LONG-TERM; GABA; PLASTICITY; GLUTAMATE; TMS	Primary objective: The present paper systematically reviews studies using transcranial magnetic stimulation (TMS) over the primary motor cortex (M1) to assess cortical excitability, intra-cortical inhibition/facilitation and synaptic plasticity following mild traumatic brain injury (mTBI). Methods: Articles using TMS over M1 in patients with mTBI or sport-related concussion indexed in PubMed and published between 1998 and September 2014 were included in the present review. Main outcomes and results: From the 17 articles that matched search criteria, results from various TMS paradigms were summarized and divided in three main areas of interest: motor cortical excitability/facilitation, motor cortical inhibition and cortical plasticity. Although studies suggest a trend of abnormal intra-cortical inhibition following mTBI, no clear and specific pattern emerges from the surveyed data. Conclusions: At this time and with the possible exception of intra-cortical inhibitory measures, TMS cannot reliably detect changes in M1 excitability in individuals with mTBI or a concussion at both the acute and chronic stages of injury. This may be explained by the small number of studies and large variety of stimulation parameters. Additional longitudinal and multimodal studies are needed to better understand the nature of the excitability changes that may occur within M1 following mTBI.	[Lefebvre, Genevieve; Tremblay, Sara; Theoret, Hugo] Univ Montreal, Psychol, Montreal, PQ H3C 3J7, Canada; [Lefebvre, Genevieve; Tremblay, Sara; Theoret, Hugo] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca	Tremblay, Sara/X-5471-2019	Theoret, Hugo/0000-0002-7458-8797	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Vanier Canada Graduate scholarship from the Canadian Institutes of Health Research	This work was supported by grants from the Canadian Institutes of Health Research and the Fonds de Recherche du Quebec-Sante. ST was supported by a Vanier Canada Graduate scholarship from the Canadian Institutes of Health Research. The authors report no conflicts of interest.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; BARKER AT, 1985, LANCET, V1, P1106; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Di Lazzaro V, 2007, CLIN NEUROPHYSIOL, V118, P2207, DOI 10.1016/j.clinph.2007.07.005; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Di Lazzaro V, 2003, J PHYSIOL-LONDON, V547, P485, DOI 10.1113/jphysiol.2002.030486; Di Lazzaro V, 2000, EXP BRAIN RES, V135, P455, DOI 10.1007/s002210000543; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Udupa K, 2009, EXP BRAIN RES, V199, P177, DOI 10.1007/s00221-009-1997-9; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	64	14	14	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1032	1043		10.3109/02699052.2015.1028447			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000003	25996466				2022-02-06	
J	Linton, KF				Linton, Kristen Faye			Interpersonal violence and traumatic brain injuries among Native Americans and women	BRAIN INJURY			English	Article						Brain injury; interpersonal violence; Native American; rural	OUTCOMES; HEALTH	Objectives: This study aimed to assess the odds of experiencing a traumatic brain injury (TBI) as a result of interpersonal violence (IPV) among Native Americans compared to other races controlling for gender, age, socioeconomic status, rurality and intoxication at the time of the injury. Methods: A secondary data analysis of the Arizona Trauma Database consisting of 18 944 cases of TBI between 2008-2010 throughout the state of Arizona was conducted. There were 312 patients who experienced injuries caused by IPV in the sample. Descriptive statistics, cross-tabulations, bivariate analyses and a logistic regression model were used for analyses. Results: The logistic regression model found that Native Americans (OR = 1.15), patients from the other race category (OR = 1.18), females (OR = 1.35) and those who were insured (OR = 1.26) had higher odds of experiencing a TBI as a result of IPV. Rurality and intoxication were mediators of the correlation between Native American race and TBI as a result of IPV. Conclusions: Native Americans are more likely than Whites and females are more likely than males to experience TBIs as a result of IPV.	[Linton, Kristen Faye] Univ Hawaii Manoa, Sch Social Work, Honolulu, HI 96822 USA		Linton, KF (corresponding author), Univ Nevada, Sch Social Work, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.	kristen.linton@unlv.edu					Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US R; Evans-Campbell T, 2006, AM J PUBLIC HEALTH, V96, P1416, DOI 10.2105/AJPH.2004.054213; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Jones L, 2008, J FAM VIOLENCE, V23, P113, DOI 10.1007/s10896-007-9132-9; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Malcoe LH, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-20; National Institute of Justice, 2002, IMP EV STOP GRANT PR; POLISSAR L, 1982, MED CARE, V20, P959, DOI 10.1097/00005650-198209000-00008; Saler Mihaela, 2011, Curr Treat Options Cardiovasc Med, V13, P215, DOI 10.1007/s11936-011-0124-y; Somers SA, 2010, COVERING LOW INCOME; U.S. Department of Health and Human Services, 2012, NAT AM TRAUM BRAIN I; Yuan NP, 2006, J INTERPERS VIOLENCE, V21, P1566, DOI 10.1177/0886260506294239	15	14	14	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					639	643		10.3109/02699052.2014.989406			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000014	25517042				2022-02-06	
J	Mao, X; Hao, SY; Zhu, ZD; Zhang, H; Wu, WC; Xu, FF; Liu, BY				Mao, Xiang; Hao, Shuyu; Zhu, Zhendan; Zhang, Hao; Wu, Weichuan; Xu, Feifan; Liu, Baiyun			Procyanidins protects against oxidative damage and cognitive deficits after traumatic brain injury	BRAIN INJURY			English	Article						Antioxidant; CREB; hippocampus; oxidative stress; procyanidins; TBI	LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; CAMP RESPONSE; CREB; ANTIOXIDANTS; ACTIVATION; EXPRESSION; PLASTICITY; PHOSPHORYLATION; HIPPOCAMPUS	Primary objective: Oxidative stress is the principal factor in traumatic brain injury (TBI) that initiates the events that result in protracted neuronal dysfunction and remodeling. Importantly, antioxidants can protect the brain against oxidative damage and modulate the capacity of the brain to cope with synaptic dysfunction and cognitive impairment. Research design: To date, however, no studies have investigated the effects of procyanidins (PC) on cognitive deficits after TBI. Methods and Procedures: In the present study, rats with controlled cortical impact (CCI) were used to investigate the protective effects of procyanidins. Main outcomes and results: The results showed that procyanidins reduced the level of malondialdehyde (MDA) and elevated the level of glutathione (GSH) and the activity of superoxide dismutase (SOD). In addition, treatment with procyanidins, which elevated the levels of brain-derived neurotropic factor (BDNF), phosphorylation-cAMP-response element binding protein (pCREB), total CREB, and cyclic AMP (cAMP), improved cognitive performance in the Morris water maze after TBI. Conclusions: These results suggest that procyanidins appear to counteract oxidative damage and behavioral dysfunction after TBI through antioxidant activity and the up-regulation of cAMP/CREB signaling.	[Mao, Xiang; Zhang, Hao] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China; [Hao, Shuyu; Xu, Feifan; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Mao, Xiang; Zhu, Zhendan; Zhang, Hao; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China; [Mao, Xiang; Liu, Baiyun] Armed Police Forces, Gen Hosp, Dept Neurotrauma, Beijing, Peoples R China; [Mao, Xiang; Hao, Shuyu; Zhu, Zhendan; Zhang, Hao; Xu, Feifan; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Mao, Xiang; Hao, Shuyu; Zhu, Zhendan; Zhang, Hao; Xu, Feifan; Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Zhu, Zhendan] Anhui Med Univ, Armed Police Forces Clin Coll, Gen Hosp, Hefei, Anhui, Peoples R China; [Wu, Weichuan] Guangdong Med Coll, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 6 Tiantan Xili, Beijing, Peoples R China.	liubaiyun1212@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144]; Beijing Nova programBeijing Municipal Science & Technology Commission [XX2012033]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]	The authors report no conflict of interests related to this study or the findings specified in this paper. This study was supported by National Natural Science Foundation of China (No. 81171144), Beijing Nova program (No. XX2012033) and National Key Technology Research and Development Program of the Ministry of Science and Technology of China(2013BAI09B03).	Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brightwell JJ, 2007, LEARN MEMORY, V14, P195, DOI 10.1101/lm.395407; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Koleckar V, 2008, MINI-REV MED CHEM, V8, P436, DOI 10.2174/138955708784223486; Li YF, 2009, NEUROPSYCHOPHARMACOL, V34, P2404, DOI 10.1038/npp.2009.66; [刘虓虓 Liu Xiaoxiao], 2013, [中国兽医学报, Chinese Journal of Veterinary Science], V33, P1426; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Rosenegger D, 2008, NEUROBIOL LEARN MEM, V90, P544, DOI 10.1016/j.nlm.2008.06.005; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; SCHNEIDER HH, 1984, BIOCHEM PHARMACOL, V33, P1690, DOI 10.1016/0006-2952(84)90295-8; Segal M, 1998, NEURAL PLAST, V6, P1, DOI 10.1155/NP.1998.1; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Xu JQ, 2010, J GERONTOL A-BIOL, V65, P236, DOI 10.1093/gerona/glp211; Yamashima T, 2012, PROG LIPID RES, V51, P221, DOI 10.1016/j.plipres.2012.02.001; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	36	14	17	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					86	92		10.3109/02699052.2014.968621			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000011	25279568				2022-02-06	
J	Max, JE; Lopez, A; Wilde, EA; Bigler, ED; Schachar, RJ; Saunders, A; Ewing-Cobbs, L; Chapman, SB; Yang, TT; Levin, HS				Max, Jeffrey E.; Lopez, Aholibama; Wilde, Elisabeth A.; Bigler, Erin D.; Schachar, Russell J.; Saunders, Ann; Ewing-Cobbs, Linda; Chapman, Sandra B.; Yang, Tony T.; Levin, Harvey S.			Anxiety disorders in children and adolescents in the second six months after traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Anxiety; traumatic brain injury; child and adolescent psychiatric disorders		The objective of this prospective longitudinal study was to assess the nature, rate, predictive variables, and neuroimaging characteristics of novel (new-onset) anxiety disorders (compared with no novel anxiety disorders) 6-12 months after pediatric traumatic brain injury (TBI). Psychiatric and psychosocial interviews were administered to children who sustained mild to severe TBI at baseline (soon after injury) and at the 12-month follow-up post-injury (n = 125). The psychiatric outcome of children 12-months post-injury revealed that novel anxiety disorders present in the second six months after TBI were heterogeneous and occurred in 13 (10.4%) participants. Novel anxiety disorder was significantly associated with concurrent novel depressive disorder and with novel personality change due to TBI. Novel anxiety disorder was marginally associated with younger age at injury and with pre-injury anxiety disorder in univariate analyses. Age at injury, pre-injury anxiety disorder, and personality change due to TBI were each significantly and independently related to novel anxiety disorder in a logistic regression analysis. There were no significant neuroimaging group differences. These findings suggest that the emergence of novel anxiety disorder after TBI might be related to a broader problem of affective dysregulation especially in younger children and those with a vulnerability even to pre-injury anxiety disorder.	[Max, Jeffrey E.; Lopez, Aholibama] Univ Calif San Diego, La Jolla, CA 92093 USA; [Max, Jeffrey E.] Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Provo, UT 84602 USA; [Schachar, Russell J.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Saunders, Ann; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Dallas, TX USA; [Yang, Tony T.] Univ Calif San Francisco, San Francisco, CA 94143 USA		Max, JE (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu			National institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800, R01MH085734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by National institute of Mental Health (NIMH) Grant K-08 MH01800 (Dr. Max) and National Institute of Neurological Disorders and Stroke (NINDS) Grant NS-21889 (Dr. Levin). Drs. Max and Bigler independently provide expert testimony in cases of traumatic brain injury on an ad hoc basis for plaintiffs and defendants on a more or less equal ratio. This activity constitutes approximately 5% of each of Dr. Max's and Dr. Bigler's professional activity. Dr. Schachar is a consultant for Eli Lily Corporation and Purdue Pharma (Canada). Other authors have no conflict of interest to declare.	American Psychiatric Association, 2000, DIAGNC STAT MAN MENT; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Ciccetti D., 1984, VINELAND ADAPTIVE BE; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Last CG, 1996, J AM ACAD CHILD PSY, V35, P1502, DOI 10.1097/00004583-199611000-00019; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Sciberras E, 2014, PEDIATRICS, V133, P801, DOI 10.1542/peds.2013-3686; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x	42	14	14	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					345	355		10.3233/PRM-150352			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LK	WOS:000448290900008	26684074				2022-02-06	
J	Padula, WV; Subramanian, P; Spurling, A; Jenness, J				Padula, William V.; Subramanian, Prem; Spurling, April; Jenness, Jonathan			Risk of fall (RoF) intervention by affecting visual egocenter through gait analysis and yoked prisms	NEUROREHABILITATION			English	Article						Visual midline shift syndrome; yoked prisms; balance; spatial visual process; visual egocenter	ADAPTATION; NEGLECT; VISION	BACKGROUND: Following a neurologic event such as traumatic brain injury (TBI), cerebrovascular accident (CVA), and chronic neurological conditions including Parkinson's disease, multiple sclerosis, and cerebral palsy a shift in the visual midline (egocenter) can directly affect posture, balance and spatial orientation. As a consequence, this increases the risk of fall (RoF) and injury that imposes a major financial burden on the public health system. OBJECTIVE: To determine if there is a statistically significant change in balance with the intervention of yoked prisms to reduce the risk of fall in subjects with neurological impairments. METHODS: Ambulation of thirty-six subjects was evaluated on a pressure sensitive mat before and after intervention with yoked prisms. Changes in gait and balance were analyzed in the anterior-posterior (AP) and medial-lateral (ML) axes during ambulation. RESULTS: T-tests for each measure comparing the difference-of-differences to a zero change at baseline returned statistically significant reductions in both AP (p < 0.0001; 95% CI: 1.368-2.976) and ML (p = 0.0002; 95% CI: 1.472-4.173) imbalances using specifically directed yoked prisms to correct the visual midline deviation. CONCLUSION: These findings demonstrate that yoked prisms have the potential to provide a cost-effective means to restore the visual midline thereby improving balance, reduce RoF and subsequent injury.	[Padula, William V.; Spurling, April; Jenness, Jonathan] Padula Inst Vis Rehabil, Guilford, CT 06437 USA; [Subramanian, Prem] Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO USA; [Padula, William V.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA		Padula, WV (corresponding author), Padula Inst Vis Rehabil, 37 Soundview Rd, Guilford, CT 06437 USA.	wpadula@padulainstitute.com					Adams G., 1963, LANCET, V282, P533; Benabib R, 1993, OCCUPATIONAL THERAPY, P57; *CDCP, 2004, WEB BAS INJ STAT QUE; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Eubank T., 2001, J AM OPTOMETRY ASS, V72, P217; FIFE D, 1985, ANN EMERG MED, V14, P244, DOI 10.1016/S0196-0644(85)80448-0; Himmelbach M., 2007, BMC NEUROSCI, V8, P1471; Johannsen L., 2006, BMC NEUROLOGY, V6, P1471; Milner A., 2003, PROGR BRAIN RES, P225; MOORE J, 1993, BRAIN ATLAS FUNCTION; NASHOLD BS, 1972, ARCH OPHTHALMOL-CHIC, V88, P245; National Hospital Ambulatory Medical Care Survey, 2015, AMB HLTH CAR DAT; Padula WV, 2009, BRAIN INJURY, V23, P566, DOI 10.1080/02699050902926283; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Padula WV, 2012, NEUROVISUAL PROCESSI; Perennou D, 2006, RESTOR NEUROL NEUROS, V24, P319; Rode G, 2006, NEUROPSYCHOLOGIA, V44, P2487, DOI 10.1016/j.neuropsychologia.2006.04.002; Rolfs M, 2011, J NEUROPHYSIOL, V105, P1, DOI 10.1152/jn.00862.2010; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Tilikete C, 2001, CURR BIOL, V11, P524, DOI 10.1016/S0960-9822(01)00151-8; TREVARTHEN CB, 1968, PSYCHOL FORSCH, V31, P299, DOI 10.1007/BF00422717; Tripathi B, 1997, WOLFFS ANATOMY EYE O; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	25	14	14	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	2					305	314		10.3233/NRE-151263			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV9HB	WOS:000364597200015	26484522	Bronze			2022-02-06	
J	Raggi, A; Leonardi, M; Covelli, V; Sattin, D; Scaratti, C; Schiavolin, S; Willems, M; Meucci, P				Raggi, A.; Leonardi, M.; Covelli, V.; Sattin, D.; Scaratti, C.; Schiavolin, S.; Willems, M.; Meucci, P.			The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions	NEUROREHABILITATION			English	Article						Disability; ICF classification; mental functions; mobility; barriers	DISEASE; BRAIN	INTRODUCTION: Neurological conditions are associated with high levels of disability. OBJECTIVES: The aim of this study was to describe, using the International Classification of Functioning, Disability and Health (ICF), the most relevant aspects of disability in patients with neurological conditions. We collated data from previous studies on myasthenia gravis, migraine, Parkinson's disease, multiple sclerosis, traumatic brain injury, stroke, epilepsy, vegetative state and minimally conscious state, and identified as relevant those ICF categories reported by at least 50% of patients in each condition. CONCLUSIONS: Records from 1310 patients were available. A total of 97 ICF categories were reported, and 21 were commonly addressed in more than five conditions. Approximately half of the categories in body functions were related to mental and movement-related functions and more than 25% of the activities-related categories involved activities that require the support from a caregiver. Environmental factors were mostly reported as facilitators. Our data indicate a residual mind-body dichotomy, the relevance of disability not only for the patients but also for their caregivers, and the difficulties in addressing barriers in the environment.	[Raggi, A.; Leonardi, M.; Covelli, V.; Sattin, D.; Scaratti, C.; Schiavolin, S.; Willems, M.; Meucci, P.] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, I-20133 Milan, Italy		Raggi, A (corresponding author), Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Via Celoria 11, I-20133 Milan, Italy.	araggi@istituto-besta.it	COVELLI, VENUSIA/AAG-9232-2020; Schiavolin, Silvia/K-6595-2016; Scaratti, Chiara/K-5196-2018; Raggi, Alberto/K-5787-2016; Sattin, Davide/K-5963-2016; leonardi, matilde/J-9997-2018	COVELLI, VENUSIA/0000-0002-5965-2658; Schiavolin, Silvia/0000-0002-5391-7539; Scaratti, Chiara/0000-0002-6664-4787; Raggi, Alberto/0000-0002-7433-7779; Sattin, Davide/0000-0001-7736-4337; leonardi, matilde/0000-0003-0552-8923			Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS22, DOI 10.1097/PHM.0b013e31823d4d6f; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Goljar N, 2010, DISABIL REHABIL, V32, pS50, DOI 10.3109/09638288.2010.517598; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Leonardi M, 2012, SCI WORLD J, P1, DOI 10.1100/2012/189097; Leonardi M, 2010, DISABIL REHABIL, V32, pS23, DOI 10.3109/09638288.2010.511687; Leonardi M, 2010, DISABIL REHABIL, V32, pS139, DOI 10.3109/09638288.2010.520807; Leonardi M, 2009, DISABIL REHABIL, V31, P2041, DOI 10.3109/09638280902893634; Raggi A, 2010, DISABIL REHABIL, V32, pS33, DOI 10.3109/09638288.2010.511688; Sattin D, 2014, EUR J PHYS REHAB MED, V50, P309; Svestkova O, 2010, DISABIL REHABIL, V32, pS59, DOI 10.3109/09638288.2010.511689; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2007, INT CLASS FUNCT DIS	15	14	14	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	1					17	22		10.3233/NRE-141186			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0OT	WOS:000349326700004	25547761				2022-02-06	
J	Raj, R; Brinck, T; Skrifvars, MB; Kivisaari, R; Siironen, J; Lefering, R; Handolin, L				Raj, Rahul; Brinck, Tuomas; Skrifvars, Markus B.; Kivisaari, Riku; Siironen, Jari; Lefering, Rolf; Handolin, Lauri			Validation of the revised injury severity classification score in patients with moderate-to-severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Prognostic model; External validation; Revised injury severity classification score; TR-DGU; TR-THEL; Trauma register	RETROSPECTIVE ANALYSIS; PREDICTION MODELS; PROGNOSTIC VALUE; MORTALITY; CARE; EPIDEMIOLOGY; PERFORMANCE	Introduction: By analysing risk-adjusted mortality ratios, weaknesses in the process of care might be identified. Traumatic brain injury (TBI) is the main cause of death in trauma, and thus it is crucial that trauma prediction models are valid for TBI patients. Accordingly, we assessed the validity of the RISC score in TBI patients by internal and external validation analyses. Methods: Patients with moderate-to-severe TBI admitted to the TraumaRegister DGU (R) (TR-DGU) and the trauma registry of Helsinki University Hospital (TR-THEL) in 2006-2011 were included in this retrospective open cohort study. Definition of moderate-to-severe TBI was head abbreviated injury scale of 3 or higher. Subgroup analysis for patients with isolated and polytrauma TBI was performed. The performance of the RISC score was evaluated by assessing its discrimination (area under the curve, AUC) and calibration (Hosmer-Lemeshow [H-L] test). Results: Among the 9106 and 809 patients with moderate-to-severe TBI admitted to TR-DGU and TR-THEL, unadjusted mortality was 26% and 23%, respectively. Internal and external validation of the RISC score showed good discrimination (TR-DGU AUC 0.89, 95% confidence interval [CI] 0.88-0.90 and TR-THEL AUC 0.84, 95% CI 0.81-0.87), but poor calibration (p < 0.001) in patients with moderate-to-severe TBI. Subgroup analysis found the discrimination only to be modest in isolated TBI (AUC 0.76) and calibration to be particularly poor in polytrauma TBI (TR-DGU H-L = 4356, p < 0.001; TR-THEL H-L 112, p < 0.001). Conclusion: The RISC score was found to be of limited predictive value in patients with moderate-to-severe TBI. A new general trauma scoring system that includes TBI specific prognostic factors is warranted. (C) 2014 Elsevier Ltd. All rights reserved.	[Raj, Rahul; Kivisaari, Riku; Siironen, Jari] Helsinki Univ Hosp, Dept Neurosurg, Toolo Hosp, FI-00029 Helsinki, Finland; [Brinck, Tuomas; Handolin, Lauri] Helsinki Univ Hosp, Toolo Hosp, Dept Orthoped & Traumatol, FI-00029 Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Meilahti Hosp, Dept Intens Care, FI-00029 Helsinki, Finland; [Lefering, Rolf] Univ Witten Herdecke, Fac Hlth, Inst Res Operat Med IFOM, Cologne Merheim Med Ctr, D-51109 Cologne, Germany		Raj, R (corresponding author), Topeliuksenkatu 5,PB-266, Helsinki 00029, Finland.	rahul.br.raj@icloud.com; tuomas.brinck@hus.fi; markus.skrifvars@hus.fi; riku.kivisaari@hus.fi; jari.siironen@hus.fi; rolf.lefering@uni-wh.de; lauri.handolin@hus.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	Helsinki University Hospital EVO grant [TYH2012142]	The authors have no personal conflict of interest to declare. This study was funded by a Helsinki University Hospital EVO grant (TYH2012142).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Bertolini G, 2000, J Epidemiol Biostat, V5, P251; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; David W., 2013, APPL LOGISTIC REGRES, V3rd Edition; Demetriades D, 1998, BRIT J SURG, V85, P379; Finazzi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016110; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hosmer DW, 1997, STAT MED, V16, P965; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maegele M, 2009, TRANSFUSION MED, V19, P117, DOI 10.1111/j.1365-3148.2009.00920.x; Moreno R, 1998, CRIT CARE MED, V26, P50, DOI 10.1097/00003246-199801000-00016; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nathens AB, 2008, J TRAUMA, V65, P628, DOI 10.1097/TA.0b013e3181837994; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wafaisade A, 2012, J TRAUMA ACUTE CARE, V72, P936, DOI 10.1097/TA.0b013e31823dca70; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	35	14	15	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					86	93		10.1016/j.injury.2014.08.026			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600017	25195181				2022-02-06	
J	Risen, SR; Barber, AD; Mostofsky, SH; Suskauer, SJ				Risen, S. R.; Barber, A. D.; Mostofsky, S. H.; Suskauer, S. J.			Altered functional connectivity in children with mild to moderate TBI relates to motor control	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						TBI; pediatric; resting-state networks; fMRI		PURPOSE: Functionally relevant alterations in resting state fMRI (rs-fMRI) connectivity have been identified in adults with traumatic brain injury (TBI). We evaluated rs-fMRI connectivity in children with TBI and explored the relationship between altered connectivity and measures of neurological function. METHODS: Rs-fMRI was obtained in 14 children after TBI and 14 controls matched for age, sex, and handedness. Whole-brain connectivity was evaluated separately for the default mode network (DMN) and dorsal attention network (DAN); Between-group contrasts identified regions with altered connectivity between TBI and control cohorts. In children with TBI, the relationships between regions of altered connectivity and performance on relevant functional measures were examined. RESULTS: Compared to controls, children with TBI showed significantly greater connectivity between DMN and right dorsal premotor cortex (RdPM) and between DAN and bilateral sensorimotor cortex (SM1). In children with TBI, greater DMN-RdPM connectivity was associated with worse motor performance whereas greater DAN-LSM1 connectivity was associated with better motor performance; furthermore, DMN-RdPM and DAN-LSM1 connectivity were negatively correlated. CONCLUSION: Rs-fMRI reveals significant altered connectivity in children with TBI compared to controls. After TBI in children, patterns of altered connectivity appear divergent, with increased DMN-motor network connectivity associated with worse motor control whereas increased DAN-motor network connectivity appears compensatory.	[Risen, S. R.; Barber, A. D.; Mostofsky, S. H.; Suskauer, S. J.] Kennedy Krieger Inst, Baltimore, MD USA; [Risen, S. R.; Barber, A. D.; Mostofsky, S. H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Risen, S. R.; Mostofsky, S. H.; Suskauer, S. J.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Suskauer, S. J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, Dept Phys Med & Rehabil, 707 N Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org	Barber, Anita D/P-7010-2016	Barber, Anita D/0000-0001-8766-3103	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD061611, R01MH078160, R01MH085328]; NIH/NCRR CTSA ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [UL1TR001079-01];  [RC2DA029475]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611, T32HD007414, U54HD079123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085328, R01MH078160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [RC2DA029475] Funding Source: NIH RePORTER	S.R. Risen received funding from NIH grant T32HD 007414-20. S.H. Mostofsky received funding from RC2DA029475 and remains funded by NIH R01MH078160 and R01MH085328. S.J. Suskauer was funded by NIH K23HD061611 and received research support from NIH/NCRR CTSA Program UL1TR001079-01.	Addamo PK, 2007, BRAIN RES REV, V54, P189, DOI 10.1016/j.brainresrev.2007.01.004; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barber AD, 2013, NEUROPSYCHOLOGIA, V51, P156, DOI 10.1016/j.neuropsychologia.2012.11.011; Barber AD, 2012, CEREB CORTEX, V22, P51, DOI 10.1093/cercor/bhr062; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borich M., 2014, J NEUROTRAUM; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Delis DC., 2001, DELIS KAPLAN EXECUTI; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Mahone EM, 2006, J INT NEUROPSYCH SOC, V12, P622, DOI 10.1017/S1355617706060814; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reich W, 1997, DIAGNOSTIC INTERVIEW; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Venkatesan UM, 2014, J NEUROTRAUMA; WATSON RT, 1978, ANN NEUROL, V3, P505, DOI 10.1002/ana.410030609; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	44	14	14	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					309	319		10.3233/PRM-150349			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LK	WOS:000448290900005	26684071	Green Accepted			2022-02-06	
J	Shang, HB; Cui, DR; Yang, DH; Liang, S; Zhang, WF; Zhao, WG				Shang, Hanbing; Cui, Derong; Yang, Dehua; Liang, Sheng; Zhang, Weifeng; Zhao, Weiguo			The Radical Scavenger Edaravone Improves Neurologic Function and Perihematomal Glucose Metabolism after Acute Intracerebral Hemorrhage	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Intracerebral hemorrhage; edaravonecerebral metabolism; apoptosis; positron emission tomography/computed; tomography	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ACUTE CEREBRAL INFARCTION; CELL-DEATH; WHOLE-BLOOD; RAT MODEL; ISCHEMIA; MICRODIALYSIS; EDEMA; PLASMA	Oxidative injury caused by reactive oxygen species plays an important role in the progression of intracerebral hemorrhage (ICH)-induced secondary brain injury. Previous studies have demonstrated that the free radical scavenger edaravone may prevent neuronal injury and brain edema after ICH. However, the influence of edaravone on cerebral metabolism in the early stages after ICH and the underlying mechanism have not been fully investigated. In the present study, we investigated the effect of edaravone on perihematomal glucose metabolism using F-18-fluorordeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). Additionally, the neurologic deficits, brain edemas, and cell death that followed ICH were quantitatively analyzed. After blood infusion, the rats treated with edaravone showed significant improvement in both forelimb placing and corner turn tests compared with those treated with vehicle. Moreover, the brain water content of the edaravone-treated group was significantly decreased compared with that of the vehicle group on day 3 after ICH. PET/CT images of ICH rats exhibited obvious decreases in FDG standardized uptake values in perihematomal region on day 3, and the lesion-to-normal ratio of the edaravone-treated ICH rats was significantly increased compared with that of the control rats. Calculation of the brain injury volumes from the PET/CT images revealed that the volumes of the blood-induced injuries were significantly smaller in the edaravone group compared with the vehicle group. Terminal Deoxynucleotidyl Transferasemediated dUTP Nick End Labeling assays performed 3 days after ICH revealed that the numbers of apoptotic cells in perihematomal region of edaravone-treated ICH rats were decreased relative to the vehicle group. Thus, the present study demonstrates that edaravone has scavenging properties that attenuate neurologic behavioral deficits and brain edema in the early period of ICH. Additionally, edaravone may improve cerebral metabolism around the hematoma by attenuating apoptotic cell death after ICH.	[Shang, Hanbing; Zhang, Weifeng; Zhao, Weiguo] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China; [Cui, Derong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Dept Anesthesiol, Shanghai 200025, Peoples R China; [Yang, Dehua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Yang, Dehua] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200025, Peoples R China; [Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Micro PET CT Res Ctr, Shanghai 200025, Peoples R China		Zhao, WG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	rjneurosurgery@gmail.com	Yang, Dehua/S-6156-2017; Yang, Dehua/M-5789-2019				ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Frykholm P, 2004, ACTA NEUROL SCAND, V109, P25, DOI 10.1034/j.1600-0404.2003.00174.x; Gaetani P, 1992, J Neurosurg Sci, V36, P1; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Hickenbottom SL, 1999, STROKE, V30, P2472, DOI 10.1161/01.STR.30.11.2472; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; HUTCHINS GD, 1984, J CEREBR BLOOD F MET, V4, P35, DOI 10.1038/jcbfm.1984.5; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kaynar MY, 2005, NEUROL RES, V27, P562, DOI 10.1179/016164105X17288; Krengli M, 2009, RADIAT ONCOL, V4, DOI [10.1186/1748-717X-4-9, 10.1186/1748-717X-5-10]; Lin XT, 2010, ACTA RADIOL, V51, P549, DOI 10.3109/02841851003660065; Liu H, 2004, BRAIN RES, V1025, P43, DOI 10.1016/j.brainres.2004.07.071; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Mizuno A, 1998, GEN PHARMACOL-VASC S, V30, P575, DOI 10.1016/S0306-3623(97)00311-X; Nakagomi Tadayoshi, 2003, J Stroke Cerebrovasc Dis, V12, P17, DOI 10.1053/jscd.2003.2; Nakamura T, 2005, BRAIN RES, V1039, P30, DOI 10.1016/j.brainres.2005.01.036; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Peeling J, 1998, BRAIN RES, V795, P63, DOI 10.1016/S0006-8993(98)00253-4; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Sorokin J, 2014, CLIN NUCL MED, V39, pE35, DOI 10.1097/RLU.0b013e318292aa81; Strong AJ, 2008, INTENS CARE MED, V34, P1169, DOI 10.1007/s00134-008-1045-4; Uno M, 2005, FREE RADICAL BIO MED, V39, P1109, DOI 10.1016/j.freeradbiomed.2005.06.001; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wagner KR, 2002, DEV NEUROSCI-BASEL, V24, P154, DOI 10.1159/000065703; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06; Zhou F, 2009, BRAIN INJURY, V23, P353, DOI 10.1080/02699050902788527	54	14	15	2	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					215	222		10.1016/j.jstrokecerebrovasdis.2014.08.021			8	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700045	25440340				2022-02-06	
J	Spritzer, SD; Kinney, CL; Condie, J; Wellik, KE; Hoffman-Snyder, CR; Wingerchuk, DM; Demaerschalk, BM				Spritzer, Scott D.; Kinney, Carolyn L.; Condie, John; Wellik, Kay E.; Hoffman-Snyder, Charlene R.; Wingerchuk, Dean M.; Demaerschalk, Bart M.			Amantadine for Patients With Severe Traumatic Brain Injury A Critically Appraised Topic	NEUROLOGIST			English	Article						amantadine; traumatic brain injury; therapy; evidence-based medicine	TRIAL; SCALE; COMA	Background: Research into traumatic brain injury (TBI) has increased significantly. Diagnostic testing and therapeutics for patients with severe TBI are 2 areas on which there is increasing focus. Amantadine hydrochloride is one treatment considered to have potential therapeutic value in this patient population. Objective: The objective was addressed through the development of a structured critically appraised topic. This included a clinical scenario, structured question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and content experts in the disciplines of neurocritical care and physical medicine and rehabilitation. Results: A multicenter, placebo-controlled, double-blind, randomized controlled trial was selected for review. The trial compared the rate of recovery, as determined by the overall Disability Rating Scale score, in a total of 184 patients with severe TBI. Patients were randomized to either receive amantadine (87) or visually identical placebo (97) over the 4-week study interval. The rate of recovery, as measured by the Disability Rating Scale, was found to be greater in the treatment arm as compared with the placebo arm (difference in slope -0.24 points/wk, P = 0.007) over the 4-week treatment interval. Conclusions: The results from this study demonstrated that amantadine hydrochloride accelerates recovery in patients with severe TBI.	[Spritzer, Scott D.; Hoffman-Snyder, Charlene R.; Wingerchuk, Dean M.; Demaerschalk, Bart M.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Kinney, Carolyn L.] Mayo Clin, Dept Phys Med & Rehabil, Phoenix, AZ 85054 USA; [Wellik, Kay E.] Mayo Clin, Dept Lib Serv, Div Educ Adm, Phoenix, AZ 85054 USA; [Condie, John] Phoenix Childrens Hosp, Dept Pediat Neurol, Phoenix, AZ USA		Demaerschalk, BM (corresponding author), Mayo Clin, Dept Neurol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	demaerschalk.bart@mayo.edu			Clinician Educator grants from the Mayo Clinic College of Medicine	B.M.D. and D.M.W., Co-Directors of Mayo Clinic Evidence Based Clinical Practice, Research, Informatics, and Training (MERIT) Center, were supported by Clinician Educator grants from the Mayo Clinic College of Medicine.	Faul M, 2002, TRAUMATIC BRAIN INJU; Forsyth RJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003984.pub2; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V20, P111; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schneider WN, 1999, BRAIN INJURY, V13, P863; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637	10	14	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	JAN	2015	19	2					61	64		10.1097/NRL.0000000000000001			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0FY	WOS:000348593500008	25607336				2022-02-06	
J	Yengo-Kahn, AM; Solomon, G				Yengo-Kahn, Aaron Michael; Solomon, Gary			Are psychotropic medications associated with differences in baseline neurocognitive assessment scores for young athletes? A pilot study	PHYSICIAN AND SPORTSMEDICINE			English	Article						Brain concussion; neuropsychological test; immediate post-concussion assessment and cognitive test; psychotropic drugs; depression	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; NEUROPSYCHOLOGICAL MEASURES; ONLINE VERSION; UNITED-STATES; IMPACT; SENSITIVITY; PERFORMANCE; DEPRESSION	Objectives. Baseline and post-concussive neurocognitive testing is useful in managing concussed athletes. The Concussion in Sport Group has postulated that the use of psychotropic medications is a modifying factor in the management of sport-related concussion. About 7% of US adolescents are prescribed psychotropics in a given year. Our aim was to investigate whether psychotropic medication use or psychiatric illness is associated with differences in baseline neurocognitive test scores. Methods. From 2007 to 2012, over 7000 athletes underwent pre-participation baseline neurocognitive testing using the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery. Following application of inclusion and exclusion criteria, athletes' self-reported medication lists were reviewed and: 1) classified as psychotropic or not and 2) subclassified. Group subclassification yielded: 1) use of any psychotropic medication, 2) psychostimulant use, 3) antidepressant use and 4) self-reported history of depression and/or anxiety without psychotropic use. Each group was matched, by sex, age, body mass index, education level and concussion history with athletes who were not reportedly prescribed psychotropic medications or did not report a depression/anxiety history, respectively. Each group's baseline ImPACT scores were compared to matched controls. Results. The use of prescribed psychotropic medications without regard to subclass had no effect on baseline ImPACT composite scores among athletes ages 13-25. However, athletes reportedly prescribed psychostimulants displayed significantly lower visual motor speed scores (32.8 vs 37.1, p = 0.030) and slower reaction times (0.65 vs 0.60, p = 0.044) than non-users. In contrast, antidepressant users displayed significantly faster reaction times (0.58 vs 0.61, p = 0.029). Those reporting a history of depression/anxiety, not treated with psychotropics, displayed significantly lower visual memory (70.4 vs 75.2, p = 0.010) and higher symptom scores (8.83 vs 4.72, p = 0.005). Conclusions. This pilot study suggests that self-reported psychotropic medications are associated with differences in baseline ImPACT test scores, which appear dependent on medication subclass. Our preliminary results support the inclusion of psychotropic medications, specifically psychostimulants and antidepressants, as well as history of depression/anxiety as potential concussion modifiers.	[Yengo-Kahn, Aaron Michael; Solomon, Gary] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Solomon, Gary] Vanderbilt Univ, Neurol Surg, Nashville, TN 37235 USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 1500 21st Ave S Suite 1506, Nashville, TN 37212 USA.	aaron.m.yengo-kahn@vanderbilt.edu	Yengo-Kahn, Aaron/AAV-7647-2020; Solomon, Gary/K-9011-2019; Meijer, Anna/K-5118-2016	Yengo-Kahn, Aaron/0000-0002-5989-3064; 	Nashville Predators; Tennessee Titans; ImPACTEuropean Commission	GS Solomon receives royalties from book sales. He receives consulting fees from the Nashville Predators, Tennessee Titans, ImPACT, and several university athletic programs. However, no funding was received for this study, and none of these institutions with which he is affiliated had any input into the design, execution, analysis, or decision to pursue or publish this study. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; AMADOBOCCARA I, 1995, NEUROSCI BIOBEHAV R, V19, P479, DOI 10.1016/0149-7634(94)00068-C; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Baune BT, 2014, PSYCHIAT RES, V219, P25, DOI 10.1016/j.psychres.2014.05.013; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Comer JS, 2010, J AM ACAD CHILD PSY, V49, P1001, DOI 10.1016/j.jaac.2010.07.007; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; GADDIS GM, 1990, ANN EMERG MED, V19, P1054, DOI 10.1016/S0196-0644(05)82571-5; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gevins A, 2011, J PSYCHOPHARMACOL, V25, P1062, DOI 10.1177/0269881110388334; Gevins A, 2011, CLIN NEUROPHYSIOL, V122, P114, DOI 10.1016/j.clinph.2010.06.010; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ilieva I, 2013, NEUROPHARMACOLOGY, V64, P496, DOI 10.1016/j.neuropharm.2012.07.021; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P1; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Merikangas KR, 2013, JAMA PEDIATR, V167, P141, DOI 10.1001/jamapediatrics.2013.431; Olfson M, 2013, J AM ACAD CHILD PSY, V52, P378, DOI 10.1016/j.jaac.2012.12.006; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	37	14	14	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2015	43	3					227	235		10.1080/00913847.2015.1071638			9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	CR4TF	WOS:000361331100005	26200262				2022-02-06	
J	Casaletto, KB; Doyle, KL; Weber, E; Woods, SP				Casaletto, Kaitlin Blackstone; Doyle, Katie L.; Weber, Erica; Woods, Steven Paul		HIV Neurobehav Res Program HNRP	Self-Predictions of Prospective Memory in HIV-Associated Neurocognitive Disorders: Evidence of a Metamemory Deficit	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functions; Metacognition; Everyday functioning	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; OLDER-ADULTS; INFECTION; AWARENESS; IMPAIRMENT; TIME; DISSOCIATIONS; RELIABILITY; PERFORMANCE	HIV-associated neurocognitive disorders (HAND) are associated with deficits in prospective memory (PM; "remembering to remember"), conferring risk of daily functioning declines. However, self-perceptions of PM functioning are not reliably associated with PM performance in HIV, suggesting a possible deficit in awareness of PM abilities (meta-PM). Our study examined meta-PM in HAND and its correlates using self-predictions of laboratory-based PM performance. Performance-based PM abilities, self-reported prediction of PM performance, and PM complaints in everyday life were assessed in 49 individuals with HAND, 93 HIV+ without HAND (HIV+ noHAND), and 121 seronegative adults (HIV-). After controlling for group-level differences, HAND was associated with a greater number of PM symptoms in everyday life and worse PM performance when compared with both HIV+ noHAND and HIV- samples. Although HAND individuals reported somewhat lower predictions regarding their laboratory PM performance relative to the other study groups, they nevertheless exhibited significantly greater inaccurate overconfidence in time-based PM abilities. Within the HAND group, overconfidence in time-based meta-PM was associated with executive dysfunction and antiretroviral (ARV) nonadherence. HAND individuals evidenced a moderate deficit in awareness of PM functioning characterized by overconfidence in time-based PM abilities. Overconfidence in PM may result in absence of compensatory strategy use, and lead to increased errors in daily functioning (e.g., ARV nonadherence).	[Casaletto, Kaitlin Blackstone; Doyle, Katie L.; Weber, Erica] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Woods, Steven Paul] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Woods, Steven Paul] Univ Houston, Dept Psychol, Houston, TX 77204 USA		Woods, SP (corresponding author), Univ Houston, Dept Psychol, 126 Heyne Bldg, Houston, TX 77204 USA.	spwoods@uh.edu		Woods, Steven Paul/0000-0003-0776-4233	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH073419, P30-MH62512, T32-DA31098, F31-DA035708, F31-DA034510]; Foundation for Rehabilitation Psychology; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073419, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [F31DA034510, T32DA031098, F31DA035708] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health grants R01-MH073419, P30-MH62512, T32-DA31098, F31-DA035708, and F31-DA034510. This study was also supported (in part) by a Foundation for Rehabilitation Psychology Dissertation Award.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Chiao S, 2013, AIDS RES HUM RETROV, V29, P949, DOI [10.1089/aid.2012.0229, 10.1089/AID.2012.0229]; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; Culbertson W, 2001, TOL DX TOWER LONDON; Delis D.C., 2001, CALIFORNIA VERBAL LE; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; Doyle KL, 2013, J CLIN EXP NEUROPSYC, V35, P359, DOI 10.1080/13803395.2013.776010; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Gupta S, 2010, J CLIN EXP NEUROPSYC, V32, P898, DOI 10.1080/13803391003596470; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hinkin CH, 1996, J CLIN EXP NEUROPSYC, V18, P431, DOI 10.1080/01688639608408999; Juengst S, 2012, DISABIL REHABIL, V34, P19, DOI 10.3109/09638288.2011.587088; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Loft S, 2014, J CLIN EXP NEUROPSYC, V36, P761, DOI 10.1080/13803395.2014.942255; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McNair D., 1981, MANUAL PROFILE MOOD; Morgan EE, 2012, J CLIN EXP NEUROPSYC, V34, P416, DOI 10.1080/13803395.2012.654764; Oksanen KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092123; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Pirogovsky E, 2012, J INT NEUROPSYCH SOC, V18, P986, DOI 10.1017/S1355617712000781; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Reitan R, 1985, HALSTEAD REITAN NEUR; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P757, DOI 10.1076/jcen.21.6.757.852; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith SJ, 2011, NEUROPSYCHOLOGY, V25, P734, DOI 10.1037/a0025475; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Woods S. P., 2014, J INT NEUROPSYCH SOC, V20, P1; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2006, COGN BEHAV NEUROL, V19, P217, DOI 10.1097/01.wnn.0000213916.10514.57; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; World Health Organization (WHO), 1998, COMP INT DIAGN INT C; Zogg JB, 2011, ARCH CLIN NEUROPSYCH, V26, P250, DOI 10.1093/arclin/acr020	46	14	14	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2014	29	8					818	827		10.1093/arclin/acu061			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AU9DD	WOS:000345890900009	25404005	Bronze, Green Published			2022-02-06	
J	Douglas, JM; Knox, L; De Maio, C; Bridge, H				Douglas, Jacinta M.; Knox, Lucy; De Maio, Carren; Bridge, Helen			Improving Communication-specific Coping after Traumatic Brain Injury: Evaluation of a New Treatment using Single-case Experimental Design	BRAIN IMPAIRMENT			English	Article						brain injury; rehabilitation; communication; coping; treatment; evaluation	SOCIAL INTEGRATION; FACIAL EXPRESSION; N-OF-1 TRIALS; RATING-SCALE; FOLLOW-UP; QUESTIONNAIRE; DISCOURSE; OUTCOMES; ABILITY; SKILLS	Background and aims: Impaired communication is a well-documented and enduring consequence of traumatic brain injury (TBI). As a result of this impairment, people with TBI frequently experience communication breakdown and associated stress. Typically, we use communication-specific coping strategies in situations characterised by communication breakdown. Productive strategies enhance message transfer; non-productive strategies do little to resolve problems and frequently result in negative social interaction. This research aimed to evaluate the effectiveness of a new treatment, Communication-specific Coping Intervention (CommCope-I), which specifically targets coping in the context of communication breakdown. Method: Single-case experimental design (A-B-A with follow-up using multiple probes) across two participants was used. Participants were Samantha, a 30-year-old woman who had sustained severe TBI 8 years previously, and Thomas, a 34-year-old man who had sustained severe TBI when he was 29 years old. CommCope-I is a 6-week programme which targets personally relevant productive coping strategies identified collaboratively with the client. Productive coping scripts are developed and practised through a series of graded scenarios that are evaluated with the aid of video recording. Results: Percentage of non-overlapping corrected data (PNCD) was used to analyse the results. PNCD involves a data-correction procedure to remove baseline trend from the data series prior to calculating the change produced as a result of intervention. A large treatment effect was demonstrated in both participants (PNCD: end of treatment Samantha = 100%, Thomas = 100%, 3-month follow-up Samantha = 100%, Thomas = 100%). These results are consistent with highly effective treatment. Conclusions: This study provides sound phase-1 evidence for the effectiveness of CommCope-I.	[Douglas, Jacinta M.; Knox, Lucy; De Maio, Carren; Bridge, Helen] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia; [Douglas, Jacinta M.] Summer Fdn, Melbourne, Vic, Australia; [De Maio, Carren] Scope, Box Hill, Vic, Australia; [Bridge, Helen] Beachside & South Eastern Suburbs Speech Pathol S, Melbourne, Vic, Australia		Douglas, JM (corresponding author), La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia.	J.Douglas@latrobe.edu.au	Knox, Lucy/E-8642-2013	Knox, Lucy/0000-0001-8331-6032; Douglas, Jacinta/0000-0003-0940-6624	Victoria Neurotrauma Initiative of the Transport Accident Commission, Victoria, Australia [D071]	This research was funded by the Victoria Neurotrauma Initiative of the Transport Accident Commission, Victoria, Australia (grant no. D071).	Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Crice P., 1975, STUDIES SYNTAX SEMAN, V3, P41; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DOUGLAS J, 2004, EVIDENCE BASED PRACT; Douglas J., 2012, BRAIN IMPAIR, V13, P170; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Friedman A., 2005, BRAIN INJURY S, V19, P50; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Manolov R, 2009, BEHAV RES METHODS, V41, P1262, DOI 10.3758/BRM.41.4.1262; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Mellick D., 2000, CRAIG HANDICAP ASSES; Mitchell C., 2011, BRAIN IMPAIRMENT S, V41; Muir A., 2007, BRAIN IMPAIR, V8, P83; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Scruggs TE, 1998, BEHAV MODIF, V22, P221, DOI 10.1177/01454455980223001; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P235; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	44	14	14	1	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2014	15	3					190	201		10.1017/BrImp.2014.25			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CC2NV	WOS:000350182800003					2022-02-06	
J	Kong, XD; Bai, S; Chen, X; Wei, HJ; Jin, WN; Li, MS; Yan, YP; Shi, FD				Kong, Xiao-Dong; Bai, Sheng; Chen, Xin; Wei, Hui-Jie; Jin, Wei-Na; Li, Min-Shu; Yan, Yaping; Shi, Fu-Dong			Alterations of natural killer cells in traumatic brain injury	NEUROSCIENCE BULLETIN			English	Article						natural killer cells; traumatic brain injury; central nervous system; immunity	ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEAD-INJURY; SYSTEM; CYTOTOXICITY; RECEPTORS; PROLACTIN; CORTISOL; FEATURES; MODERATE	To investigate the relationship between natural killer (NK) cells and traumatic brain injury (TBI), we tracked an established phenotype of circulating NK cells at several time points in patients with different grades of TBI. In serial peripheral blood samples, NK cells were prospectively measured by flow cytometry of CD3(-) CD56(+) lymphocytes. Compared to healthy controls, TBI patients had reductions in both the percentage and the absolute number of NK cells. Furthermore, the magnitude of NK cell reduction correlated with the degree of TBI severity at several time points. That is, NK cell population size was independently associated with lower Glasgow Coma Scale scores. In addition, at some time points, a positive correlation was found between the NK cell counts and Glasgow Outcome Scale scores. Our results indicate that TBI induces a reduction in the number of NK cells, and the magnitude of the reduction appears to parallel the severity of TBI.	[Kong, Xiao-Dong; Bai, Sheng; Chen, Xin; Wei, Hui-Jie; Jin, Wei-Na; Li, Min-Shu; Yan, Yaping; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin Neurol Inst,Minist Educ,Dept Neurol, Tianjin 300052, Peoples R China; [Kong, Xiao-Dong; Bai, Sheng; Chen, Xin; Wei, Hui-Jie; Jin, Wei-Na; Li, Min-Shu; Yan, Yaping; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin Neurol Inst,Minist Educ,Dept Neurosurg, Tianjin 300052, Peoples R China; [Kong, Xiao-Dong] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin Geriatr Inst, Tianjin 300052, Peoples R China; [Shi, Fu-Dong] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, Phoenix, AZ USA		Shi, FD (corresponding author), Tianjin Med Univ, Gen Hosp, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin Neurol Inst,Minist Educ,Dept Neurol, Tianjin 300052, Peoples R China.	fshi@tijmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370029, 81200907]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCQNJC6800]; National Key Clinical Specialty Construction Project of China [12ZCDZSY17400]; National Clinical Key subject Construction Project of the NHFPC Fund	We thank Drs. J. Hao, L Liu and F. Chen for helpful advice, and Ms. P. Minick for editorial assistance. This work was supported in part by the National Natural Science Foundation of China (81370029 and 81200907); the Tianjin Research Program of Application Foundation and Advanced Technology (12JCQNJC6800); a National Key Clinical Specialty Construction Project of China (12ZCDZSY17400); and a National Clinical Key subject Construction Project of the NHFPC Fund.	Annane D, 2008, EUR RESPIR J, V31, P1150, DOI 10.1183/09031936.00040908; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Forel JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050446; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hao JW, 2011, ANN NEUROL, V69, P721, DOI 10.1002/ana.22339; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hsueh CM, 2002, J NEUROIMMUNOL, V123, P102, DOI 10.1016/S0165-5728(01)00488-X; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jurkowski M, 2001, BRAIN BEHAV IMMUN, V15, P93, DOI 10.1006/brbi.2000.0602; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Liu RL, 2006, J IMMUNOL, V176, P5247, DOI 10.4049/jimmunol.176.9.5247; Lunemann A, 2008, J IMMUNOL, V181, P6170, DOI 10.4049/jimmunol.181.9.6170; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASERA R, 1989, IMMUNOPHARMACOLOGY, V18, P11, DOI 10.1016/0162-3109(89)90026-X; Mavoungou E, 2005, CLIN EXP IMMUNOL, V139, P287, DOI 10.1111/j.1365-2249.2004.02686.x; Mavoungou E, 2006, CLIN MED RES, V4, P33, DOI 10.3121/cmr.4.1.33; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shi FD, 2000, NAT IMMUNOL, V1, P245, DOI 10.1038/79792; Shi FD, 2001, TRENDS IMMUNOL, V22, P97, DOI 10.1016/S1471-4906(00)01821-4; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Shi FD, 2011, AUTOIMMUNITY, V44, P3, DOI 10.3109/08916931003782122; Shi FD, 2010, NATURAL KILLER CELLS: BASIC SCIENCE AND CLINICAL APPLICATION, P373, DOI 10.1016/B978-0-12-370454-2.00028-4; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Shi QG, 2012, NEUROSCI BULL, V28, P469, DOI 10.1007/s12264-012-1256-0; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; TEASDALE G, 1974, LANCET, V2, P81; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491	41	14	14	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	DEC	2014	30	6					903	912		10.1007/s12264-014-1481-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU6ZO	WOS:000345750500002	25446874	Green Published			2022-02-06	
J	Takeda, Y; Kawashima, T; Kiyota, K; Oda, S; Morimoto, N; Kobata, H; Isobe, H; Honda, M; Fujimi, S; Ondaj, J; Seishi, I; Sakamoto, T; Ishikawa, M; Nakano, H; Kishikawa, M; Sadamitsu, D; Kinoshita, K; Yokoyama, T; Harada, M; Kitaura, M; Ichihara, K; Hashimoto, H; Tsuji, H; Yorifuji, T; Nagano, O; Katayama, H; Ujike, Y; Morita, K				Takeda, Yoshimasa; Kawashima, Takahisa; Kiyota, Kazuya; Oda, Shigeto; Morimoto, Naoki; Kobata, Hitoshi; Isobe, Hisashi; Honda, Mitsuru; Fujimi, Satoshi; Ondaj, Jun; Seishi, I; Sakamoto, Tetsuya; Ishikawa, Masami; Nakano, Hiroshi; Kishikawa, Masanobu; Sadamitsu, Daikai; Kinoshita, Kosaku; Yokoyama, Tomoharu; Harada, Masahiro; Kitaura, Michio; Ichihara, Kiyoshi; Hashimoto, Hiroshi; Tsuji, Hidekazu; Yorifuji, Takashi; Nagano, Osamu; Katayama, Hiroshi; Ujike, Yoshihito; Morita, Kiyoshi			Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency room	RESUSCITATION			English	Article						Cardiac arrest; Brain ischaemia; Therapeutic hypothermia	BRAIN TEMPERATURE; HYPOTHERMIA	Aim: Cooling the pharynx and upper oesophagus would be more advantageous for rapid induction of therapeutic hypothermia since the carotid arteries run in their vicinity. The aim of this study was to determine the effects of pharyngeal cooling on brain temperature and the safety and feasibility for patients under resuscitation. Methods: Witnessed non-traumatic cardiac arrest patients (n = 108) were randomized to receive standard care with (n = 53) or without pharyngeal cooling (n = 55). In the emergency room, pharyngeal cooling was initiated before or shortly after return of spontaneous circulation by perfusing physiological saline (5 degrees C) into a pharyngeal cuff for 120 min. Results: There was a significant decrease in tympanic temperature at 40 min after arrival (P = 0.02) with a maximum difference between the groups at 120 min (32.9 +/- 1.2 degrees C, pharyngeal cooling group vs. 34.1 +/- 1.3 degrees C, control group; P < 0.001). The return of spontaneous circulation (70% vs. 65%, P = 0.63) and rearrest (38% vs. 47%, P = 0.45) rates were not significantly different based on the initiation of pharyngeal cooling. No post-treatment mechanical or cold-related injury was observed on the pharyngeal epithelium by macroscopic observation. The thrombocytopaenia incidence was lower in the pharyngeal cooling group (P = 0.001) during the 3-day period after arrival. The cumulative survival rate at 1 month was not significantly different between the two groups. Conclusions: Initiation of pharyngeal cooling before or immediately after the return of spontaneous circulation is safe and feasible. Pharyngeal cooling can rapidly decrease tympanic temperature without adverse effects on circulation or the pharyngeal epithelium. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.	[Takeda, Yoshimasa] Okayama Univ, Sch Med, Dept Anesthesiol, Kita Ku, Okayama 7008558, Japan; [Kawashima, Takahisa] Iseikai Hosp, Dept Emergency & Crit Care Med, Higashiyodogawa Ku, Osaka 5330022, Japan; [Kiyota, Kazuya] Saitama Red Cross Hosp, Tertiary Emergency Med Ctr, Chuo Ku, Saitama 3380001, Japan; [Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chuo Ku, Chiba 2600856, Japan; [Morimoto, Naoki] Osaka Mishima Emergency Crit Care Ctr, Okayama 7080841, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Osaka 5691124, Japan; [Isobe, Hisashi] Himeji Med Ctr, Dept Emergency Diag & Treatment, Himeji, Hyogo 6700012, Japan; [Honda, Mitsuru] Toho Univ, Fac Med, Emergency & Crit Care Ctr, Ota Ku, Tokyo 1430015, Japan; [Fujimi, Satoshi] Osaka Gen Med Ctr, Crit Care & Trauma Ctr, Sumiyoshi Ku, Osaka 5580056, Japan; [Ondaj, Jun] Kitakyushu Yugawa Hosp, Dept Neurosurg, Kokuraminami Ku, Fukuoka 8000251, Japan; [Seishi, I] Japanese Red Cross Kumamoto Hosp, Dept Emergency Med, Higashi Ku, Kumamoto 8618039, Japan; [Sakamoto, Tetsuya] Teikyo Univ, Trauma & Resuscitat Ctr, Sch Med, Itabashi Ku, Tokyo 1730003, Japan; [Ishikawa, Masami] Kure Kyosai Hosp, Emergency Dept, Hiroshima 7370811, Japan; [Nakano, Hiroshi] Okazaki City Hosp, Emergency Dept, Okazaki, Aichi 4440002, Japan; [Kishikawa, Masanobu] Osaka Med Ctr, Emergency & Crit Care Ctr, Chuo Ku, Osaka 5400006, Japan; [Sadamitsu, Daikai] Saiseikai Fukuoka Gen Hosp, Emergency & Crit Care Ctr, Chuo Ku, Fukuoka 8100001, Japan; [Kinoshita, Kosaku] Nihon Univ, Itabashi Hosp, Emergency & Crit Care Ctr, Itabashi Ku, Tokyo 1730032, Japan; [Yokoyama, Tomoharu] Tokyo Med Univ, Hachioji Med Ctr, Hachioji, Tokyo 1930944, Japan; [Harada, Masahiro] Kumamoto Med Ctr, Emergency & Crit Care Ctr, Chuo Ku, Kumamoto 8600008, Japan; [Kitaura, Michio] Kagawa Rosai Hosp, Dept Emergency & Crit Care Med, Kagawa 7630013, Japan; [Ichihara, Kiyoshi] Yamaguchi Univ, Grad Sch Med, Dept Clin Lab Sci, Yamaguchi 7550046, Japan; [Hashimoto, Hiroshi; Tsuji, Hidekazu] Daiken Med Co, Chuo Ku, Osaka 5410045, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Kita Ku, Okayama 7008558, Japan; [Nagano, Osamu] Kochi Univ, Sch Med, Dept Disaster & Emergency Med, Kochi 7838505, Japan; [Katayama, Hiroshi] Kawasaki Med Sch, Dept Anesthesiol & Intens Care Med, Kita Ku, Okayama 7000821, Japan; [Ujike, Yoshihito] Okayama Univ, Sch Med, Dept Emergency & Crit Care Med, Kita Ku, Okayama 7008558, Japan; [Morita, Kiyoshi] Okayama Univ, Kita Ku, Okayama 7000082, Japan		Takeda, Y (corresponding author), Okayama Univ, Sch Med, Dept Anesthesiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	yoshit@cc.okayama-u.ac.jp	Kiyota, Kazuya/AAB-5707-2022; Hashimoto, Hiroshi/AAD-3667-2020; Harada, Masahiro/S-8719-2018	Kiyota, Kazuya/0000-0003-4423-4434; Harada, Masahiro/0000-0002-0162-5390	Ministry of Health, Labour and Welfare of JapanMinistry of Health, Labour and Welfare, Japan [H19-trans-005]; Daiken Medical Co	The research was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (H19-trans-005) and by a grant from Daiken Medical Co. No sources of funding were involved in the study design; in the collection, analysis, and interpretation of the data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Endo K, 2007, AM J OTOLARYNG, V28, P126, DOI 10.1016/j.amjoto.2006.07.001; Hagioka S, 2003, CRIT CARE MED, V31, P2502, DOI 10.1097/01.CCM.0000084845.76762.F4; Holzer M, 2002, NEW ENGL J MED, V346, P549; Keller C, 1997, ANAESTHESIA, V52, P592; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; MCCAFFREY TV, 1975, J APPL PHYSIOL, V39, P114, DOI 10.1152/jappl.1975.39.1.114; Murphy JV, 2000, J TRAUMA, V48, P171, DOI 10.1097/00005373-200001000-00036; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; PATEL PM, 1994, BRAIN RES, V650, P205, DOI 10.1016/0006-8993(94)91783-3; Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Takata K, 2005, CRIT CARE MED, V33, P1340, DOI 10.1097/01.CCM.0000166351.19369.D3; Takeda Y, 2012, ANESTHESIOLOGY, V117, P117, DOI 10.1097/ALN.0b013e3182580536; Wadelek J, 2012, ANAESTH INTENSIVE TH, V44, P31; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	19	14	14	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	DEC	2014	85	12					1647	1653		10.1016/j.resuscitation.2014.09.014			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	AW9UQ	WOS:000346603700009	25263513	hybrid, Green Published			2022-02-06	
J	Thongrong, C; Kong, N; Govindarajan, B; Allen, D; Mendel, E; Bergese, SD				Thongrong, Cattleya; Kong, Nicolas; Govindarajan, Barani; Allen, Duane; Mendel, Ehud; Bergese, Sergio D.			Current Purpose and Practice of Hypertonic Saline in Neurosurgery: A Review of the Literature	WORLD NEUROSURGERY			English	Article						Anesthesia; Hyperosmolar agent; Hypertonic saline; Intracranial pressure; Mannitol; Neurosurgery	TRAUMATIC BRAIN-INJURY; ELEVATED INTRACRANIAL-PRESSURE; SPINAL-CORD-INJURY; SMALL-VOLUME RESUSCITATION; RANDOMIZED CLINICAL-TRIAL; HEMORRHAGIC-SHOCK; SODIUM-CHLORIDE; HEAD-INJURY; BLOOD-FLOW; 20-PERCENT MANNITOL	OBJECTIVE: To review and summarize controversies and current concepts regarding the use of hypertonic saline during the perioperative period in neurosurgery. METHODS: Relevant literature was searched on PubMed and Scopus electronic databases to identify all studies that have investigated the use of hypertonic saline in neurosurgery. RESULTS: Fluid management during the course of neurosurgical practice has been debated at length, especially strategies to control intracranial pressure and small volume resuscitation. The goal of fluid therapy includes minimizing cerebral edema, preserving intravascular volume, and maintaining cerebral perfusion pressure. Mannitol is widely recognized as the gold standard for treating intracranial hypertension but can result in systemic hypotension. Thus, hypertonic saline provides volume expansion and may improve cerebral and systemic hemodynamics. Recently published prospective data, however, regarding the use of osmotic agents fails to establish clear guidelines in neurosurgical patients. CONCLUSIONS: We suggest that hypertonic saline will emerge as an alternative to mannitol, especially for a long-term use or multiple doses are needed and lead to a great opportunity for collaborative research.	[Thongrong, Cattleya; Kong, Nicolas; Govindarajan, Barani; Allen, Duane; Bergese, Sergio D.] Ohio State Univ, Wexner Med Ctr, Dept Anesthesiol, Columbus, OH 43210 USA; [Mendel, Ehud; Bergese, Sergio D.] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA; Arthur G James Canc Hosp, Columbus, OH USA; Richard J Solove Res Inst, Columbus, OH USA; [Thongrong, Cattleya] Khon Kaen Univ, Fac Med, Srinagarind Hosp, Dept Anesthesiol, Khon Kaen, Thailand		Thongrong, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Anesthesiol, Columbus, OH 43210 USA.	jupiters66@gmail.com		Bergese, Sergio/0000-0001-5641-5908			ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BEDFORD RF, 1982, ANESTH ANALG, V61, P430; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Charalambous MP, 2008, SURG INFECT, V9, P67, DOI 10.1089/sur.2005.069; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Ciesla DJ, 2001, J TRAUMA, V50, P206, DOI 10.1097/00005373-200102000-00004; Ciesla DJ, 2001, SHOCK, V16, P285, DOI 10.1097/00024382-200116040-00009; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; De Vivo P, 2001, Minerva Anestesiol, V67, P603; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Fields JD, 2009, CRIT CARE MED, V37, P2306, DOI 10.1097/CCM.0b013e3181a9f18f; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Gemma M, 1997, J NEUROSURG ANESTH, V9, P329, DOI 10.1097/00008506-199710000-00007; HARIRI RJ, 1989, J TRAUMA, V29, P1203, DOI 10.1097/00005373-198909000-00003; Hartl R, 1997, ACT NEUR S, V70, P126; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; JOHNSON AL, 2004, CRIT CARE NURSE, V24, P40; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kolsen-Petersen JA, 2005, SCAND J CLIN LAB INV, V65, P13, DOI 10.1080/00365510410003138; Koura SS, 1998, ACT NEUR S, V71, P244; KRAUS GE, 1991, SURG NEUROL, V35, P20, DOI 10.1016/0090-3019(91)90197-H; KREIMEIER U, 1990, CIRC SHOCK, V32, P83; Kumar B, 2011, ANESTH ANALG, V112, P485, DOI 10.1213/ANE.0b013e318200cca4; Levene HB, 2011, J NEUROSURG-SPINE, V14, P131, DOI 10.3171/2010.9.SPINE08314; Luostarinen T, 2011, NEUROCRIT CARE, V14, P238, DOI 10.1007/s12028-010-9475-6; MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009; McDornagh DL, 2007, ANESTHESIOLOGY, V107, P689, DOI 10.1097/01.anes.0000286923.77106.63; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Nout YS, 2009, CRIT CARE MED, V37, P2160, DOI 10.1097/CCM.0b013e3181a05d41; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAMIRES JAF, 1992, CIRC SHOCK, V37, P220; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sapsford W, 2003, J R Army Med Corps, V149, P110; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schimetta W, 2002, WIEN KLIN WOCHENSCHR, V114, P89; Schroder ML, 1998, ACT NEUR S, V71, P127; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Spera PA, 2000, ACTA NEUROCHIR, V142, P811, DOI 10.1007/s007010070097; SPIERS JP, 1993, CIRC SHOCK, V40, P29; STEENBERGEN JM, 1993, AM J PHYSIOL, V265, pH323, DOI 10.1152/ajpheart.1993.265.1.H323; STERNS RH, 1986, NEW ENGL J MED, V314, P1535, DOI 10.1056/NEJM198606123142402; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Sumas ME, 2001, NEUROSURGERY, V48, P167; Thompson R, 2006, J R Army Med Corps, V152, P6; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; Tommasino C, 2007, BEST PRACT RES-CLIN, V21, P497, DOI 10.1016/j.bpa.2007.07.002; TRACHTMAN H, 1993, J AM SOC NEPHROL, V3, P1913; TRAVERSO LW, 1987, J TRAUMA, V27, P32, DOI 10.1097/00005373-198701000-00006; Tseng MY, 2007, J NEUROSURG, V107, P274, DOI 10.3171/JNS-07/08/0274; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Victorino GP, 2003, J SURG RES, V112, P79, DOI 10.1016/S0022-4804(03)00132-X; Boas WWV, 2011, REV BRAS ANESTESIOL, V61, P456, DOI 10.1016/S0034-7094(11)70053-8; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; WADE CE, 1989, CIRC SHOCK, V29, P193; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; Wu CT, 2010, ANESTH ANALG, V110, P903, DOI 10.1213/ANE.0b013e3181cb3f8b; YOUNG WF, 1994, J NEUROSURG ANESTH, V6, P122; Zhao L, 2009, RESUSCITATION, V80, P253, DOI 10.1016/j.resuscitation.2008.10.014	87	14	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2014	82	6								10.1016/j.wneu.2013.02.027			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AY5TZ	WOS:000347635900119	23402866				2022-02-06	
J	Westerhof-Evers, HJ; Visser-Keizer, AC; McDonald, S; Spikman, JM				Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.; McDonald, Skye; Spikman, Jacoba M.			Performance of healthy subjects on an ecologically valid test for social cognition: The short, Dutch Version of The Awareness of Social Inference Test (TASIT)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Brain injury; Social inferences; Assessment; Emotion recognition; Social cognition	TRAUMATIC BRAIN-INJURY; EMOTION RECOGNITION; FACIAL EXPRESSION; NEUROPSYCHOLOGICAL ASSESSMENT; HEAD-INJURY; FOLLOW-UP; PERCEPTION; MIND; DEFICITS; ABILITY	The present paper addresses the psychometric quality of the shortened Dutch version of The Awareness of Social Inference Test (TASIT), a social cognition task comprising dynamic social interactions. Because the original TASIT required a rather long administration time, two shortened parallel forms were developed. Results showed that TASIT-short was feasible and that the two alternate forms were reasonably comparable in a group of neurologically healthy individuals (N = 98). Also, the results confirmed the ecological validity of TASIT-short in this healthy group. The test appeared sensitive to brain injury as it differentiated between the healthy subjects and a group of patients with acquired brain injury (N = 16). On the basis of the present study we conclude that TASIT-short has added value to the assessment of social cognition in patients with acquired brain injury.	[Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands; [Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Haren, Netherlands; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9712 TS Groningen, Netherlands		Westerhof-Evers, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	h.j.evers@rug.nl	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [F2008-1-18]	This work was supported by the Dutch Brain Foundation [grant number F2008-1-18]	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Allain P, 2011, NEUROPSYCHOLOGY, V25, P741, DOI 10.1037/a0024408; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; Bate S, 2010, PERS INDIV DIFFER, V48, P239, DOI 10.1016/j.paid.2009.10.005; Beer JS, 2006, BRAIN RES, V1079, P1, DOI 10.1016/j.brainres.2006.02.001; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; BROTHERS L, 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; CUSTRINI RJ, 1989, J CLIN CHILD PSYCHOL, V18, P336, DOI 10.1207/s15374424jccp1804_7; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; EDWARDS R, 1984, EUR J SOC PSYCHOL, V14, P235, DOI 10.1002/ejsp.2420140212; Ekman P., 1976, PICTURES FACIAL AFFE; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Henderson HA, 2009, J CHILD PSYCHOL PSYC, V50, P853, DOI 10.1111/j.1469-7610.2008.02059.x; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mill A, 2009, EMOTION, V9, P619, DOI 10.1037/a0016562; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Nelson HE, 1991, REVISED NATL ADULT R; PHILIPPOT P, 1990, BRIT J SOC PSYCHOL, V29, P43, DOI 10.1111/j.2044-8309.1990.tb00885.x; Pijnenborg GHM, 2009, J INT NEUROPSYCH SOC, V15, P239, DOI 10.1017/S1355617709090341; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Schmand BL., 1992, NEDERLANDSE LEESLIJS NEDERLANDSE LEESTEST; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; van der Naalt J, 1994, Ned Tijdschr Geneeskd, V138, P2279; Verhage F, 1964, INTELLIGENTIE LEEFTI; VOSK BN, 1983, J BEHAV ASSESS, V5, P151, DOI 10.1007/BF01321447; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Young A., 2002, FACIAL EXPRESSIONS E	48	14	14	1	21	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 26	2014	36	10					1031	1041		10.1080/13803395.2014.966661			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AX3MB	WOS:000346842300003	25380130				2022-02-06	
J	Poole, D; Chieregato, A; Langer, M; Viaggi, B; Cingolani, E; Malacarne, P; Mengoli, F; Nardi, G; Nascimben, E; Riccioni, L; Turriziani, I; Volpi, A; Coniglio, C; Gordini, G				Poole, Daniele; Chieregato, Arturo; Langer, Martin; Viaggi, Bruno; Cingolani, Emiliano; Malacarne, Paolo; Mengoli, Francesca; Nardi, Giuseppe; Nascimben, Ennio; Riccioni, Luigi; Turriziani, Ilaria; Volpi, Annalisa; Coniglio, Carlo; Gordini, Giovanni		Trauma Update Working Grp	Systematic Review of the Literature and Evidence-Based Recommendations for Antibiotic Prophylaxis in Trauma: Results from an Italian Consensus of Experts	PLOS ONE			English	Article							PENETRATING ABDOMINAL-TRAUMA; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS MRSA; BASILAR SKULL FRACTURES; EARLY-ONSET PNEUMONIA; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-AEROGENES; COMATOSE PATIENTS; GUIDELINES; GRADE	Background: Antibiotic prophylaxis is frequently administered in severe trauma. However, the risk of selecting resistant bacteria, a major issue especially in critical care environments, has not been sufficiently investigated. The aim of the present study was to provide guidelines for antibiotic prophylaxis for four different trauma-related clinical conditions, taking into account the risks of antibiotic-resistant bacteria selection, thus innovating previous guidelines in the field. Methods: The MEDLINE database was searched for studies comparing antibiotic prophylaxis to controls (placebo or no antibiotic administration) in four clinical traumatic conditions that were selected on the basis of the traumatic event frequency and/or infection severity. The selected studies focused on the prevention of early ventilator associated pneumonia (VAP) in comatose patients with traumatic brain injury, of meningitis in severe basilar skull fractures, of wound infections in long-bone open fractures. Since no placebo-controlled study was available for deep surgical site-infections prevention in abdominal trauma with enteric contamination, we compared 24-hour and 5-day antibiotic prophylaxis policies. A separate specific research focused on the question of antibiotic-resistant bacteria selection caused by antibiotic prophylaxis, an issue not adequately investigated by the selected studies. Randomised trials, reviews, meta-analyses, observational studies were included. Data extraction was carried out by one author according to a predefined protocol, using an electronic form. The strength of evidence was stratified and recommendations were given according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Results: Uncertain evidence deserving further studies was found for two-dose antibiotic prophylaxis for early VAP prevention in comatose patients. In the other cases the risk of resistant-bacteria selection caused by antibiotic administration for 48 hours or more, outweighed potential benefits. Conclusions: When accounting for antibiotic-resistant bacteria selection we found no evidence in favour of antibiotic prophylaxis lasting two or more days in the studied clinical conditions.	[Poole, Daniele] Osped San Martino Genova, UO Anestesia & Rianimaz, Belluno, Italy; [Chieregato, Arturo; Viaggi, Bruno] AOU Careggi, SOD Anestesia & Area Intens CTO, Florence, Italy; [Langer, Martin] Fdn IRCCS Ist Nazl Tumori, Dipartimento Anestesia & Rianimaz, Milan, Italy; [Langer, Martin] Univ Milan, Milan, Italy; [Cingolani, Emiliano; Nardi, Giuseppe; Riccioni, Luigi] AO San Camillo Forlanini, UOC Shock & Trauma, Rome, Italy; [Malacarne, Paolo] Azienda Osped Univ Pisana, UO Anestesia & Rianimaz PS, Pisa, Italy; [Mengoli, Francesca; Turriziani, Ilaria; Coniglio, Carlo; Gordini, Giovanni] Osped Maggiore Bologna, UO Rianimaz 118, Bologna, Italy; [Nascimben, Ennio] Neurorianimaz Osped S Maria Ca Foncello, Treviso, Italy; [Volpi, Annalisa] Azienda Osped Univ Parma, I-43100 Parma, Italy		Poole, D (corresponding author), Osped San Martino Genova, UO Anestesia & Rianimaz, Belluno, Italy.	daniele.poole@alice.it	Viaggi, Bruno/X-5074-2018; Poole, Daniele/X-7210-2019; Gordini, Giovanni/AAB-8170-2022; Coniglio, Carlo/AAB-7128-2022	Viaggi, Bruno/0000-0001-5710-2479; Poole, Daniele/0000-0001-5279-9844; Gordini, Giovanni/0000-0003-4518-0204; Coniglio, Carlo/0000-0002-8207-0525			Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BERGMAN BR, 1982, ACTA ORTHOP SCAND, V53, P57, DOI 10.3109/17453678208992179; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; Bozorgzadeh A, 1999, AM J SURG, V177, P125, DOI 10.1016/S0002-9610(98)00317-1; Brand M, 2013, COCHRANE DB SYST REV, V11; Brand M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007370.pub2; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Braun R, 1987, J Orthop Trauma, V1, P12, DOI 10.1097/00005131-198701010-00002; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Cornwell EE, 1999, J GASTROINTEST SURG, V3, P648, DOI 10.1016/S1091-255X(99)80088-2; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; de Kraker MEA, 2011, J ANTIMICROB CHEMOTH, V66, P398, DOI 10.1093/jac/dkq412; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; DEMETRIADES D, 1992, INJURY, V23, P377, DOI 10.1016/0020-1383(92)90011-G; Dickey R L, 1989, J Orthop Trauma, V3, P6, DOI 10.1097/00005131-198903010-00002; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; FABIAN TC, 1992, SURGERY, V112, P788; FEINSTEIN AR, 1995, J CLIN EPIDEMIOL, V48, P71, DOI 10.1016/0895-4356(94)00110-C; Filius PMG, 2005, ANTIMICROB AGENTS CH, V49, P2879, DOI 10.1128/AAC.49.7.2879-2886.2005; FRAZEE RC, 1988, POSTGRAD MED, V83, P267, DOI 10.1080/00325481.1988.11700238; Gosselin R A, 1800, Cochrane Database Syst Rev, pCD003764, DOI 10.1002/14651858.CD003764.pub2; Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Hauser Carl J, 2006, Surg Infect (Larchmt), V7, P379; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFF JT, 1976, J NEUROSURG, V44, P649; Hoff WS, 2011, J TRAUMA, V70, P751, DOI 10.1097/TA.0b013e31820930e5; Hospenthal DR, 2011, J TRAUMA, V71, pS210, DOI 10.1097/TA.0b013e318227ac4b; Hurwitz B, 1999, BRIT MED J, V318, P661, DOI 10.1136/bmj.318.7184.661; IGNELZI RJ, 1975, J NEUROSURG, V43, P721, DOI 10.3171/jns.1975.43.6.0721; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; KERNODLE DS, 1988, ANTIMICROB AGENTS CH, V32, P202, DOI 10.1128/AAC.32.2.202; Kirton OC, 2000, J TRAUMA, V49, P822, DOI 10.1097/00005373-200011000-00006; Klastersky J, 1976, Surg Neurol, V6, P111; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Luchette FA, 2000, E PRACT MAN GUID WOR; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; PATZAKIS MJ, 1983, CLIN ORTHOP RELAT R, P31; PATZAKIS MJ, 1974, J BONE JOINT SURG AM, VA 56, P532, DOI 10.2106/00004623-197456030-00010; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PRICE D, 1970, J CLIN PATHOL, V23, P378, DOI 10.1136/jcp.23.4.378-c; PRICE DJE, 1972, J NEUROL NEUROSUR PS, V35, P903, DOI 10.1136/jnnp.35.6.903; PRICE DJE, 1970, LANCET, V2, P1213; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Rojczyk M, 1983, Hefte Unfallheilkd, V162, P33; Schentag JJ, 1998, CLIN INFECT DIS, V26, P1204, DOI 10.1086/520287; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Tacconelli E, 2009, ANTIMICROB AGENTS CH, V53, P4264, DOI 10.1128/AAC.00431-09; Tacconelli E, 2009, CURR OPIN INFECT DIS, V22, P352, DOI 10.1097/QCO.0b013e32832d52e0; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Zrebeet H A, 1986, Del Med J, V58, P741	72	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2014	9	11							e113676	10.1371/journal.pone.0113676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9ND	WOS:000345253000071	25412442	Green Published, gold, Green Submitted			2022-02-06	
J	Jones, E; Wessely, S				Jones, Edgar; Wessely, Simon			Legacy of the 1914-18 war 2 Battle for the mind: World War 1 and the birth of military psychiatry	LANCET			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SHELL-SHOCK; HIGH EXPLOSIVES; IRAQ; AFGHANISTAN; COMBAT; 20TH-CENTURY; NEUROTRAUMA; PSYCHOLOGY	The 100th anniversary of the outbreak of World War 1 could be viewed as a tempting opportunity to acknowledge the origins of military psychiatry and the start of a journey from psychological ignorance to enlightenment. However, the psychiatric legacy of the war is ambiguous. During World War 1, a new disorder (shellshock) and a new treatment (forward psychiatry) were introduced, but the former should not be thought of as the first recognition of what is now called post-traumatic stress disorder and the latter did not off er the solution to the management of psychiatric casualties, as was subsequently claimed. For this Series paper, we researched contemporary publications, classified military reports, and casualty returns to reassess the conventional narrative about the effect of shellshock on psychiatric practice. We conclude that the expression of distress by soldiers was culturally mediated and that patients with postcombat syndromes presented with symptom clusters and causal interpretations that engaged the attention of doctors but also resonated with popular health concerns. Likewise, claims for the efficacy of forward psychiatry were inflated. The vigorous debates that arose in response to controversy about the nature of psychiatric disorders and the discussions about how these disorders should be managed remain relevant to the trauma experienced by military personnel who have served in Iraq and Afghanistan. The psychiatric history of World War 1 should be thought of as an opportunity for commemoration and in terms of its contemporary relevance-not as an opportunity for self-congratulation.	[Jones, Edgar; Wessely, Simon] Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, London SE5 9RJ, England		Jones, E (corresponding author), Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, 10 Cutcombe Rd, London SE5 9RJ, England.	edgar.jones@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Jones, Edgar/0000-0002-4610-9584; Wessely, Simon Charles/0000-0002-6743-9929	UK charity	EJ is employed by the Institute of Psychiatry and is the programme leader for an MSc in war and psychiatry. SW is an honorary civilian consultant adviser in psychiatry to the British Army and a trustee of Combat Stress, a UK charity that provides service and support for veterans with mental health problems. We declare that we have no competing interests.	[Anonymous], 1939, BRIT MED J, V2, P1199; [Anonymous], 1917, ADM DISCH BOOK 4 STA; ARTISS KL, 1963, MIL MED, V128, P1011, DOI 10.1093/milmed/128.10.1011; Barker Pat, 1991, REGENERATION; Beebe GW, 1952, BATTLE CASUALTIES IN; Beebe GW, 1958, VARIATION PSYCHOL TO, P88; Brown W, 1918, LANCET, V2, P197; Cooper EL, 1942, MED J AUSTRALIA, V2, P73; GLASS A J, 1947, Bull U S Army Med Dep, V7, P1034; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holmes G, 1939, PIN15240215B, P12; JAMES GWB, 1945, LANCET, V249, P801; James GWB, 1955, TYPESCRIPT, V2, P98; Jones DWC, 1919, BRAIN, V42, P171, DOI 10.1093/brain/42.3.171; Jones E, 2006, J MILITARY HIST, V70, P439, DOI 10.1353/jmh.2006.0103; Jones E, 2003, J TRAUMA STRESS, V16, P411, DOI 10.1023/A:1024426321072; Jones E, 2003, BRIT J PSYCHIAT, V182, P158, DOI 10.1192/bjp.182.2.158; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Jones E, 2001, BRIT J PSYCHIAT, V178, P242, DOI 10.1192/bjp.178.3.242; Jones E, 2007, PSYCHOL MED, V37, P215, DOI 10.1017/S0033291706009329; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones E, 2007, MED HIST, V51, P357, DOI 10.1017/S0025727300001484; Jones E, 2007, J ANXIETY DISORD, V21, P164, DOI 10.1016/j.janxdis.2006.09.009; Jones E, 2014, WAR HIST, V21, P355, DOI 10.1177/0968344513510248; Jones E, 2010, J HIST MED ALL SCI, V65, P368, DOI 10.1093/jhmas/jrq006; Leri A., 1919, SHELL SHOCK COMMOTIO; LEVAV I, 1979, AM J PSYCHIAT, V136, P637; LUDWIG A O, 1947, Mil Surg, V100, P51; Mason E S, 1973, MED DEP US ARMY NEUR, P2; Ministry of Pensions, 1953, 28 MIN PENS; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1917, J MENT SCI, V63, P467; Mott F. W., 1919, WAR NEUROSES SHELL S; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1917, BRIT MED J, V1917, P39, DOI 10.1136/bmj.2.2950.39; Mott FW, 1918, LANCET, V1, P169; Myers Charles, 1940, SHELL SHOCK FRANCE 1; Myers CS, 1915, LANCET, V1, P316; Newman Bonnie J., 1992, Archives of Physical Medicine and Rehabilitation, V73, P955; Pear Thomas, 1917, SHELL SHOCK ITS LESS; Prost A, 2014, CAMBRIDGE HISTORY OF THE FIRST WORLD WAR, VOL III: CIVIL SOCIETY, P561; Raynor MW, 1918, STATE HOSP Q, V4, P301; Rhein John H. W., 1919, J ABNORM PSYCHOL, V14, P9; Rivers WHR, 1918, LANCET, V1, P173; Rivers WHR, 1917, LANCET, V2, P237; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Ross TA, 1941, LECT WAR NEROSES; Salmon T, 1929, MED DEP US ARMY, VX; Sheffield Gary, 2001, FORGOTTEN VICTORY 1; Shephard B, 1999, HIST PSYCHIATR, V10, P491, DOI 10.1177/0957154X9901004005; Shephard B, 2000, WAR NERVES SOLDIER P; Southborough Lord, 1922, REPORT WAR OFFICE CO; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Wessely S, 2006, J ROY SOC MED, V99, P440, DOI 10.1258/jrsm.99.9.440; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Winter J, 2014, CAMBRIDGE HISTORY OF THE FIRST WORLD WAR, VOL III: CIVIL SOCIETY, P310; Wolfsohn JM, 1918, LANCET, V1, P177; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	61	14	15	1	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1708	1714		10.1016/S0140-6736(14)61260-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	WOS:000345116200034	25441201				2022-02-06	
J	Nemeth, CL; Reddy, R; Bekhbat, M; Bailey, J; Neigh, GN				Nemeth, Christina L.; Reddy, Renuka; Bekhbat, Mandakh; Bailey, Jabari; Neigh, Gretchen N.			Microglial activation occurs in the absence of anxiety-like behavior following microembolic stroke in female, but not male, rats	JOURNAL OF NEUROINFLAMMATION			English	Article						Sex differences; Vascular ischemia; Animal model; Behavior; Microglia	TRAUMATIC BRAIN-INJURY; HYPOXIA-ISCHEMIA; SEX-DIFFERENCES; STRESS; GENDER; NEUROINFLAMMATION; RECOVERY; DISEASE; WOMEN; MODEL	Background: The incidence of depression and anxiety disorders is twice as high in women than men; however, females exhibit less neuronal damage following an equivalent ischemic event. Microembolic stroke increases anxiety- and depressive-like behaviors in male rats but the behavioral repercussions in females are unknown. Findings: Given the relative neuronal protection from stroke in ovary-intact females, female rats exposed to microembolic stroke may be behaviorally protected as compared to males. The data presented demonstrate that anxiety-like behavior is increased in males despite a comparable increase in microglial activation following microembolic stroke in both males and females. Conclusions: These data suggest that males may be more behaviorally susceptible to the effects of microembolic stroke and further illustrate a dissociation between neuroinflammation and behavior in females.	[Nemeth, Christina L.; Neigh, Gretchen N.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Nemeth, Christina L.; Reddy, Renuka; Bekhbat, Mandakh; Bailey, Jabari; Neigh, Gretchen N.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA		Neigh, GN (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gretchen.neigh@emory.edu	Bekhbat, Mandakh/AAS-2355-2021; Neigh, Gretchen/AAW-5691-2020	Bekhbat, Mandakh/0000-0003-1093-5160; Neigh, Gretchen/0000-0003-0955-9161	American Heart AssociationAmerican Heart Association; National Alliance for Research in Schizophrenia and Affective DisordersNARSAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008605] Funding Source: NIH RePORTER	American Heart Association, National Alliance for Research in Schizophrenia and Affective Disorders.	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Li J, 2011, J CEREBR BLOOD F MET, V31, P413, DOI 10.1038/jcbfm.2010.181; Manwani B, 2011, WOMENS HEALTH, V7, P319, DOI [10.2217/WHE.11.22, 10.2217/whe.11.22]; Moisse K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-29; Neigh GN, 2009, STROKE, V40, P3601, DOI 10.1161/STROKEAHA.109.564146; Nemeth CL, 2012, BEHAV BRAIN RES, V234, P259, DOI 10.1016/j.bbr.2012.06.014; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Pyter LM, 2013, BRAIN BEHAV IMMUN, V30, P88, DOI 10.1016/j.bbi.2013.01.075; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wendell CR, 2010, AM J GERIAT PSYCHIAT, V18, P940, DOI 10.1097/JGP.0b013e3181d57a2b; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Zhang LQ, 2004, J CLIN INVEST, V113, P85, DOI 10.1172/JCI200418336	17	14	14	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	NOV 6	2014	11								174	10.1186/s12974-014-0174-7			5	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AW1CG	WOS:000346027700001	25374157	gold, Green Published			2022-02-06	
J	Davis, A				Davis, Alice			Violence-Related Mild Traumatic Brain Injury in Women: Identifying a Triad of Postinjury Disorders	JOURNAL OF TRAUMA NURSING			English	Article						Depression; Interpersonal violence; Mild traumatic brain injury and violence in women; Postconcussion syndrome and posttraumatic stress disorder; Violence and women	INTIMATE PARTNER VIOLENCE; PHYSICAL HEALTH; DEPRESSION; ETIOLOGY; PHYSIOGENESIS; PSYCHOGENESIS; CONSEQUENCE; VICTIMS; HISTORY; STRESS	Violence against women whether from domestic partner abuse, sex trafficking injuries, or sexual assault is a pervasive health problem without racial or social boundaries. Regardless of cause, violence results in a complex triad of physical, emotional, and psychological injuries. There is clear evidence that female victims of violence or "battered women" experience brain injury. What is less certain is whether the constellations of events surrounding brain injury including postconcussion syndrome, depression, and posttraumatic stress disorder are acute symptoms after the brain injury, premorbid as a result of persistent abuse, or a synergistic triad of combined disorders as a result of the injuries. The purpose of this article is to examine the relationship between physical violence-associated mild traumatic brain injury (MTBI) and postinjury cognitive, emotional, and psychological disorders. The review of the literature addresses epidemiological factors associated with domestic partners and sexual violence, abuse and health outcomes in women, physical injury, and its consequences. Along with MTBI, a triad of disorders is hypothesized that includes postconcussion syndrome, depression, and posttraumatic stress disorder. Screening for MTBI and the triad of disorders is advocated, and assessment methods are offered.	[Davis, Alice] Univ Hawaii, Sch Nursing, Hilo, HI 96720 USA		Davis, A (corresponding author), 7923A Ululi Rd 673, Kekaha, HI 96720 USA.	aedavis@hawaii.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1989, US PREV SERV TASK FO; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Black M, 2005, AM J LIFESTYLE MED, V5, P428; Black M C., 2011, NATL INTIMATE PARTNE; Bogat GA, 2003, J INTERPERS VIOLENCE, V18, P1271, DOI 10.1177/0886260503256657; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Centers for Disease Control and Prevention, 2010, INT PARTN VIOL RISK; Ciechanowski P, 2012, UPTODATE; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kendler KS, 2000, AM J PSYCHIAT, V157, P1243, DOI 10.1176/appi.ajp.157.8.1243; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Loxton D, 2006, VIOLENCE AGAINST WOM, V12, P715, DOI 10.1177/1077801206291483; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Magnussen Lois, 2004, J Am Acad Nurse Pract, V16, P502, DOI 10.1111/j.1745-7599.2004.tb00430.x; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Oram S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001224; Paranjape A, 2006, J NATL MED ASSOC, V98, P1663; Picard M., 1991, HELPS TBI SCREENING; Remick RA, 2002, CAN MED ASSOC J, V167, P1253; Roberts A, 2007, J SOC SER RES, V32, P33; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; Sherin K M, 1998, Fam Med, V30, P508; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Sutherland CA, 2002, AM J COMMUN PSYCHOL, V30, P609, DOI 10.1023/A:1016317130710; Tam S, 2010, J OTOLARYNGOL-HEAD N, V39, P737, DOI 10.2310/7070.2010.090292; U.S. Preventive Services Task Force, 2013, SCREEN INT PARTN VIO; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Weiss Steve J, 2003, Violence Vict, V18, P131, DOI 10.1891/vivi.2003.18.2.131	40	14	14	1	30	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	NOV-DEC	2014	21	6					300	308		10.1097/JTN.0000000000000086			9	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	CB5DA	WOS:000349646500010	25397339				2022-02-06	
J	Lee, J; Costantini, TW; D'Mello, R; Eliceiri, BP; Coimbra, R; Bansal, V				Lee, Jisook; Costantini, Todd W.; D'Mello, Ryan; Eliceiri, Brian P.; Coimbra, Raul; Bansal, Vishal			Altering leukocyte recruitment following traumatic brain injury with ghrelin therapy	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Symposium of the National-Neurotrauma-Society	AUG 04-07, 2013	Nashville, TN	Natl Neurotrauma Soc		Traumatic brain injury (TBI); ghrelin; leukocyte; monocyte; mice	PROINFLAMMATORY CYTOKINE EXPRESSION; CELL TRAFFICKING; INNATE IMMUNITY; IN-VITRO; MICROGLIA; BARRIER; ACTIVATION; RESPONSES; PROTECTS; DAMAGE	BACKGROUND: Traumatic brain injury (TBI)-induced cerebral inflammation involves several mediators including activation of resident microglia, infiltration of leukocytes, and release of proinflammatory cytokines and chemokines at the site of injury. Invading leukocytes, mainly neutrophil and inflammatory monocytes, contribute to ongoing post-TBI cerebral edema and neuronal injury. Based on the beneficial effect of ghrelin hormone treatment following TBI, we hypothesized that ghrelin may alter the infiltrating inflammatory cell profile. METHODS: A weight drop model was used to create severe TBI. C57 mice were divided into three groups: sham, no TBI or ghrelin treatment; TBI, TBI only; TBI/ghrelin, animals were treated with ghrelin 20 mu g (intraperitoneally) immediately following TBI and again 1 hour later. Seven days after injury, brain sections were immunostained with Iba-1 and CD11b to assess the recruitment and activation of resident microglia and infiltrated leukocytes. Alternatively, brain dissociates were isolated, and flow cytometry was used to gate for microglia (CD11b(+), CD45(low) cells), monocytes (CD11b(+), CD45(high), F4/80(+) cells), and neutrophils (CD11b(+), CD45(high), F4/80 cells) to measure their recruitment to injury site. RESULTS: TBI resulted in a rapid invasion (16-fold) of inflammatory leukocytes to the site of injury, which persisted for at least 1 week. Ghrelin treatment significantly reduced infiltration of peripheral leukocytes (2.8-fold). In particular, recruitment of CD11b(+)CD45(high) inflammatory monocytes (2.4-fold) and CD11b(+)CD45(high)F4/80(-) neutrophils (1.7-fold) was reduced following ghrelin treatment. There were no observed ghrelin-mediated changes in either the number of CD11b(+)CD45(low) resident microglia or its activation state. CONCLUSION: Together, our data demonstrate that ghrelin attenuated leukocyte recruitment, which correlates with improved histologic outcome following TBI. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Lee, Jisook; Costantini, Todd W.; D'Mello, Ryan; Eliceiri, Brian P.; Coimbra, Raul; Bansal, Vishal] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA		Bansal, V (corresponding author), 200 W Arbor Dr,8896, San Diego, CA USA.	v3bansal@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916; Costantini, Todd/0000-0002-0215-5327			Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2009, BLOOD, V113, P5202, DOI 10.1182/blood-2008-09-181255; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kwidzinski E, 2003, J NEURAL TRANSM-SUPP, P29, DOI 10.1007/978-3-7091-0643-3_2; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Lopez NE, 2014, J SURG RES, V187, P230, DOI 10.1016/j.jss.2013.09.030; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Molfino A, 2014, CURR OPIN CLIN NUTR; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Smrcka M, 2007, BRATISL MED J, V108, P144; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	35	14	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2014	77	5					709	715		10.1097/TA.0000000000000445			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	AT1OB	WOS:000344702300012	25494422				2022-02-06	
J	Rosenbaum, BP; Kelly, ML; Kshettry, VR; Weil, RJ				Rosenbaum, Benjamin P.; Kelly, Michael L.; Kshettry, Varun R.; Weil, Robert J.			Neurologic disorders, in-hospital deaths, and years of potential life lost in the USA, 1988-2011	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Hospital mortality; Nationwide Inpatient Sample; Neurologic disease burden; Premature mortality; Public health; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNITED-STATES; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; INTRACEREBRAL HEMORRHAGE; GBD 2010; DISEASE; DISPARITIES; EXPECTANCY; MORTALITY	Premature mortality is a public health concern that can be quantified as years of potential life lost (YPLL). Studying premature mortality can help guide hospital initiatives and resource allocation. We investigated the categories of neurologic and neurosurgical conditions associated with in-hospital deaths that account for the highest YPLL and their trends over time. Using the Nationwide Inpatient Sample (NIS), we calculated YPLL for patients hospitalized in the USA from 1988 to 2011. Hospitalizations were categorized by related neurologic principal diagnoses. An estimated 2,355,673 in-hospital deaths accounted for an estimated 25,598,566 YPLL. The traumatic brain injury (TBI) category accounted for the highest annual mean YPLL at 361,748 (33.9% of total neurologic YPLL). Intracerebral hemorrhage, cerebral ischemia, subarachnoid hemorrhage, and anoxic brain damage completed the group of five diagnoses with the highest YPLL. TBI accounted for 12.1% of all inflation adjusted neurologic hospital charges and 22.4% of inflation adjusted charges among neurologic deaths. The in-hospital mortality rate has been stable or decreasing for all of these diagnoses except TBI, which rose from 5.1% in 1988 to 7.8% in 2011. Using YPLL, we provide a framework to compare the burden of premature in-hospital mortality on patients with neurologic disorders, which may prove useful for informing decisions related to allocation of health resources or research funding. Considering premature mortality alone, increased efforts should be focused on TBI, particularly in and related to the hospital setting. (C) 2014 Elsevier Ltd. All rights reserved.	[Rosenbaum, Benjamin P.; Kelly, Michael L.; Kshettry, Varun R.; Weil, Robert J.] Cleveland Clin, Neurol Inst, Dept Neurosurg, Cleveland, OH 44195 USA; [Rosenbaum, Benjamin P.] Oregon Hlth & Sci Univ, BICC, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Weil, Robert J.] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44195 USA; [Weil, Robert J.] Geisinger Hlth Syst, Dept Neurosurg, Danville, PA USA		Rosenbaum, BP (corresponding author), Cleveland Clin, Neurol Inst, Dept Neurosurg, S40,9500 Euclid Ave, Cleveland, OH 44195 USA.	rosenbb@ccf.org	Kshettry, Varun/ABD-4745-2021	Kshettry, Varun/0000-0003-3217-8279	Melvin Burkhardt Chair in Neurosurgical Oncology; Karen Colina Wilson Research Endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic	R.J.W. was supported in part by the Melvin Burkhardt Chair in Neurosurgical Oncology, and by the Karen Colina Wilson Research Endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic. The funders of this philanthropic support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Adeoye O, 2010, NEUROCRIT CARE, V13, P82, DOI 10.1007/s12028-010-9351-4; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; Borse NN, 2013, J SAFETY RES, V45, P127, DOI 10.1016/j.jsr.2013.02.001; Borse Nagesh N., 2012, Morbidity and Mortality Weekly Report, V61, P830; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Centers for Disease Control, 1986, MMWR S, V35, p1S; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Hoyert D, 2012, DEATHS PRELIMINARY D, P52; Institute of Medicine (IOM), 2013, US HLTH INT PERSP SH; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McDonnell S, 1998, PUBLIC HEALTH REP, V113, P55; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Meador KJ, 2011, NEUROLOGY, V77, P1305, DOI 10.1212/WNL.0b013e318230a18f; Moses H, 2013, JAMA-J AM MED ASSOC, V310, P1947, DOI 10.1001/jama.2013.281425; Murphy S, 2013, DEATHS FINAL DATA 20, P168; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Institutes of Health, 2013, EST FUND VAR RES CON; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Richmond TS, 2008, AM J PHYS MED REHAB, V87, P609, DOI 10.1097/PHM.0b013e31817fb496; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Shield KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051923; Shkolnikov VM, 2011, DEMOGRAPHY, V48, P211, DOI 10.1007/s13524-011-0015-6; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Statistics USBoL, 2012, INFL CALC BUR LAB ST; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Towfighi A, 2010, STROKE, V41, P499, DOI 10.1161/STROKEAHA.109.571828; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Young WB, 2012, NEUROLOGY, V78, P292, DOI 10.1212/WNL.0b013e3182475126	46	14	14	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2014	21	11					1874	1880		10.1016/j.jocn.2014.05.006			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AU4TK	WOS:000345604100006	25012487				2022-02-06	
J	Pastorek, RA; Cripps, MW; Bernstein, IH; Scott, WW; Madden, CJ; Rickert, KL; Wolf, SE; Phelan, HA				Pastorek, Rachel A.; Cripps, Michael W.; Bernstein, Ira H.; Scott, William W.; Madden, Christopher J.; Rickert, Kim L.; Wolf, Steven E.; Phelan, Herb A.			The Parkland Protocol's Modified Berne-Norwood Criteria Predict Two Tiers of Risk for Traumatic Brain Injury Progression	JOURNAL OF NEUROTRAUMA			English	Article						progression; TBI; validation; venous thromboembolism	VENOUS THROMBOEMBOLISM PROPHYLAXIS; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENA-CAVA FILTERS; INTRACRANIAL HEMORRHAGE; ENOXAPARIN PROPHYLAXIS; PULMONARY-EMBOLISM; SAFETY; THROMBOPROPHYLAXIS; ANTICOAGULATION	As a basis for venous thromboembolism (VTE) prophylaxis after traumatic brain injury (TBI), we have previously published an algorithm known as the Parkland Protocol. Patients are classified by risk for spontaneous progression of hemorrhage with chemoprophylaxis regimens tailored to each tier. We sought to validate this schema. In our algorithm, patients with any of the following are classified "low risk" for spontaneous progression: subdural hemorrhage <= 8 mm thick; epidural hemorrhage <= 8 mm thick; contusions <= 20 mm in diameter; a single contusion per lobe; any amount of subarachnoid hemorrhage; or any amount of intraventricular hemorrhage. Patients with any injury exceeding these are "moderate risk" for progression, and any patient receiving a monitor or craniotomy is "high risk." From February 2010 to November 2012, TBI patients were entered into a dedicated database tracking injury types and sizes, risk category at presentation, and progression on subsequent computed tomgraphies (CTs). The cohort (n = 414) was classified as low risk (n = 200), moderate risk (n = 75), or high risk (n = 139) after first CT. After repeat CT scan, radiographic progression was noted in 27% of low-risk, 53% of moderate-risk, and 58% of high-risk subjects. Omnibus analysis of variance test for differences in progression rates was highly significant (p < 0.0001). Tukey's post-hoc test showed the low-risk progression rate to be significantly different than both the moderate-and high-risk arms; no difference was noted between the moderate-and high-risk arms themselves. These criteria are a valid tool for classifying TBI patients into two categories of risk for spontaneous progression. This supports tailored chemoprophylaxis regimens for each arm.	[Pastorek, Rachel A.] Univ Texas SW Med Ctr Dallas, Dept Surg, Parkland Mem Hosp, Dallas, TX 75390 USA; [Cripps, Michael W.; Wolf, Steven E.; Phelan, Herb A.] Univ Texas SW Med Ctr Dallas, Div Burns Trauma Crit Care, Parkland Mem Hosp, Dept Surg, Dallas, TX 75390 USA; [Bernstein, Ira H.] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA; [Scott, William W.; Madden, Christopher J.; Rickert, Kim L.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Parkland Mem Hosp, Dallas, TX 75390 USA		Phelan, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Burns Trauma Crit Care, Parkland Mem Hosp, Dept Surg, 5323 Harry Hines Blvd,E5-508A, Dallas, TX 75390 USA.	herb.phelan@utsouthwestern.edu		Wolf, Steven/0000-0003-2972-3440; Cripps, Michael/0000-0002-1263-1876	UT Southwestern Clinical Translational Science Initiative - National Institutes of Health [1 KL2 RR024983-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024983] Funding Source: NIH RePORTER	This work was supported by a pilot grant awarded by the UT Southwestern Clinical Translational Science Initiative, which is itself funded by a National Institutes of Health grant (no. 1 KL2 RR024983-01) titled, "North and Central Texas Clinical and Translational Science Initiative" (Robert Toto, MD, principal investigator). This work was presented as a poster at the September 2013 Annual Meeting of the AAST in San Francisco, California.	AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Antevil JL, 2006, J TRAUMA, V60, P35, DOI 10.1097/01.ta.0000197607.23019.ab; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Brakenridge SC, 2013, J TRAUMA ACUTE CARE, V74, P1231, DOI 10.1097/TA.0b013e31828cc9a0; Cherry RA, 2008, J TRAUMA, V65, P544, DOI 10.1097/TA.0b013e31817f980f; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Depew AJ, 2008, AM SURGEON, V74, P906; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; McMurtry AL, 1999, J AM COLL SURGEONS, V189, P314, DOI 10.1016/S1072-7515(99)00137-4; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Phelan HA, 2013, SEMIN THROMB HEMOST, V39, P541, DOI 10.1055/s-0033-1343356; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027	27	14	14	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1737	1743		10.1089/neu.2014.3366			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200007	24945196	Green Published			2022-02-06	
J	Stinson, JD; Robbins, SB				Stinson, Jill Diane; Robbins, Sharon Bradford			Characteristics of People With Intellectual Disabilities in a Secure U.S. Forensic Hospital	JOURNAL OF MENTAL HEALTH RESEARCH IN INTELLECTUAL DISABILITIES			English	Article						forensic disability services; secure forensic services; offenders with disabilities; intellectual disabilities	PERSONALITY-DISORDERS; OFFENDERS; VARIABLES; SERVICES; NEEDS	Prior research examining persons with intellectual disabilities who have committed criminal offenses has focused primarily on correctional populations, or those who reside in secure forensic settings in the United Kingdom and Australia. This study describes 235 persons with intellectual, developmental, and cognitive disabilities who reside in a secure forensic psychiatric hospital in the Midwestern United States. Participants were further divided into groups of persons with pervasive developmental disorders (n = 35), fetal alcohol syndrome (n = 18), traumatic brain injuries (n = 52), or IQ scores falling within the range of moderate (n = 20) or mild (n = 55) mental retardation or borderline intellectual functioning (n = 55). These participants presented with significant histories of childhood maltreatment and adversity, serious psychiatric impairment, criminal histories marked by multiple arrests and serious violent behavior, and frequent histories of institutionalization and out-of-home placement. Their adaptive functioning within the community was characterized by limited histories of normative intimate relationships; sporadic, unskilled employment; and difficulties with maintaining residential and psychiatric stability. Important commonalities and future research needs are discussed. Important differences and similarities between groups are discussed and compared with other available literature.	[Stinson, Jill Diane] E Tennessee State Univ, Johnson City, TN 37614 USA; [Robbins, Sharon Bradford] Fulton State Hosp, Fulton, MO USA		Stinson, JD (corresponding author), E Tennessee State Univ, 420 Rogers Stout,Box 70649, Johnson City, TN 37614 USA.	dr.jill.stinson@hotmail.com		Stinson, Jill/0000-0003-4158-4850			Alexander RT, 2010, J INTELL DISABIL RES, V54, P650, DOI 10.1111/j.1365-2788.2010.01248.x; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beber E, 2012, ADV MENT HEALTH INTE, V6, P151, DOI 10.1108/20441281211227247; Brackenridge I, 2010, ADV MENT HEALTH INTE, V4, P49, DOI 10.5042/amhid.2010.0544; Charlot L, 2013, J MENT HEALTH RES IN, V6, P74, DOI 10.1080/19315864.2012.715724; Crocker AG, 2007, J INTELL DISABIL RES, V51, P786, DOI 10.1111/j.1365-2788.2007.00953.x; Glaser W, 2004, J INTELL DISABIL RES, V48, P591, DOI 10.1111/j.1365-2788.2004.00628.x; Gore N, 2009, BRIT J FORENSIC PRAC, V11, P8; Hogue TE, 2007, J INTELL DISABIL RES, V51, P778, DOI 10.1111/j.1365-2788.2006.00938.x; Hogue Todd, 2006, Crim Behav Ment Health, V16, P13, DOI 10.1002/cbm.52; Lindsay W.R., 2009, ADV MENTAL HLTH LEAR, V3, P19, DOI [10.1108/17530180200900035, DOI 10.1108/17530180200900035]; Lindsay WR, 2006, J FORENSIC PSYCHI PS, V17, P485, DOI 10.1080/14789940600821719; Lindsay WR, 2010, CRIM JUSTICE BEHAV, V37, P678, DOI 10.1177/0093854810363725; Lunsky Y, 2011, PSYCHOL CRIME LAW, V17, P9, DOI 10.1080/10683160903392277; Morrissey C, 2011, PSYCHOL CRIME LAW, V17, P133, DOI 10.1080/10683160903392442; Myers F., 2004, SOCIAL CARE ONLINE, P105; Raina P, 2010, RES DEV DISABIL, V31, P218, DOI 10.1016/j.ridd.2009.09.008; Reed S, 2004, BRIT J PSYCHIAT, V185, P499, DOI 10.1192/bjp.185.6.499; Yacoub E, 2008, PSYCHIATR BULL, V32, P205, DOI 10.1192/pb.bp.107.018523	19	14	14	1	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1931-5864	1931-5872		J MENT HEALTH RES IN	J. Ment. Health Res. Intellect. Disabil.	OCT 2	2014	7	4					337	358		10.1080/19315864.2014.930549			22	Education, Special; Psychiatry; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychiatry; Rehabilitation	AS3EB	WOS:000344158200004					2022-02-06	
J	Cruse, D; Norton, L; Gofton, T; Young, GB; Owen, AM				Cruse, Damian; Norton, Loretta; Gofton, Teneille; Young, G. Bryan; Owen, Adrian M.			Positive Prognostication from Median-Nerve Somatosensory Evoked Cortical Potentials	NEUROCRITICAL CARE			English	Article						Coma; Somatosensory evoked potentials; Prognosis	TRAUMATIC BRAIN-INJURY; POSTANOXIC COMA; PRACTICAL SCALE; CONSCIOUSNESS; PREDICTION; RESPONSES; LATENCY	The bilateral absence of the cortical N20 median-nerve somatosensory evoked potential (SSEP) is a strong predictor of poor outcome from coma. However, when N20s are present, accurate prognostication is challenging. Here, we investigated the potential for later SSEP components to help disambiguate outcome in these cases. In a retrospective review of data from two intensive care units, the amplitudes and latencies of the N20, P25, and N35 components of 28 patients in coma were quantified and related to outcome at discharge from primary care (average 1-month post-injury). Only patients who had survived primary care were included in order to avoid self-fulfilling prophecies, and to focus outcome prediction on those patients with relatively present SSEPs. The amplitudes of the N20 and N35 components (averaged across hemispheres) significantly predicted the range of outcomes beyond death. Abnormal amplitudes of the N20 and N35-as derived from a healthy control group-were significantly associated with poor outcome. The relative latencies of the cortical components were not related to outcome. While it is well documented that absent SSEPs are highly predictive of poor outcome, the current data indicate that the relative preservation (absolute amplitude) of "present" N20 and N35 SSEP components can also provide predictive value and thereby inform clinicians and families with decision-making in coma. Further prospective study will elucidate the relative contributions of etiology to the predictive power of these SSEP measures.	[Cruse, Damian; Norton, Loretta; Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON N6A 5B7, Canada; [Norton, Loretta; Gofton, Teneille; Young, G. Bryan] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 5B7, Canada		Cruse, D (corresponding author), Univ Western Ontario, Brain & Mind Inst, Nat Sci Ctr Room 237, London, ON N6A 5B7, Canada.	dcruse@uwo.ca	Cruse, Damian/ABA-6346-2021; Owen, Adrian M/B-4997-2015; Williams, Jackie/B-3495-2015	Cruse, Damian/0000-0003-4363-5981; Norton, Loretta/0000-0002-6651-1837	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canada Excellence Research Chair (CERC) programme	This research was conducted at Western University, London, ON, Canada. This research was funded by the Canadian Institutes of Health Research (CIHR)and the Canada Excellence Research Chair (CERC) programme.	ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; CHU NS, 1986, J NEUROL SCI, V76, P199, DOI 10.1016/0022-510X(86)90169-3; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; JENNETT B, 1975, LANCET, V1, P480; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Neurophysiology AC, 1994, J CLIN NEUROPHYSIOL, V11, P40; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; TEASDALE G, 1974, LANCET, V2, P81; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	16	14	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					238	244		10.1007/s12028-014-9982-y			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900010	24865267				2022-02-06	
J	Kurki, T; Himanen, L; Vuorinen, E; Myllyniemi, A; Saarenketo, AR; Kauko, T; Brandstack, N; Tenovuo, O				Kurki, Timo; Himanen, Leena; Vuorinen, Elina; Myllyniemi, Anna; Saarenketo, Anna-Riitta; Kauko, Tommi; Brandstack, Nina; Tenovuo, Olli			Diffusion tensor tractography-based analysis of the cingulum: clinical utility and findings in traumatic brain injury with chronic sequels	NEURORADIOLOGY			English	Article						Traumatic brain injury; Traumatic axonal injury; Diffusion tensor imaging; Diffusion tensor tractography	WHITE-MATTER INJURY; AXONAL INJURY; COGNITIVE IMPAIRMENT; WORKING-MEMORY; VOLUME CHANGES; CONNECTIVITY; CHILDREN; TRACTS; MRI; REPRODUCIBILITY	Introduction To evaluate the clinical utility of quantitative diffusion tensor tractography (DTT) and tractography-based core analysis (TBCA) of the cingulum by defining the reproducibility, normal values, and findings in traumatic brain injury (TBI). Methods Eighty patients with TBI and normal routine MRI and 78 controls underwent MRI at 3T. To determine reproducibility, 12 subjects were scanned twice. Superior (SC) and inferior (IC) cingulum were analyzed separately by DTT (fractional anisotropy (FA) thresholds 0.15 and 0.30). TBCA was performed from volumes defined by tractography with gradually changed FA thresholds. FA values were correlated with clinical and neuropsychological data. Results The lowest coefficient of variation was obtained at DTT threshold 0.30 (2.0 and 2.4 % for SC and IC, respectively), but in proportion to standard deviations of normal controls, the reproducibility of TBCA was better in SC and similar to that of DTT in IC. In patients with TBI, volume reduction with loss of peripheral fibers was relatively common; mean FA was mostly normal in these tractograms. The frequency of FA reductions (>2 SD) was in DTT smaller than in TBCA, in which FA decrease was present in 42 (13.1 %) of the 320 measurements. Central FA values in SC predicted visuoperceptual ability, and those in left IC predicted cognitive speed, language, and communication ability (p<0.05). Conclusion Tractography-based measurements have sufficient reproducibility for demonstration of severe abnormalities of the cingulum. TBCA is preferential for clinical FA analysis, because it measures corresponding areas in patients and controls without inaccuracies due to trauma-induced structural changes.	[Kurki, Timo; Brandstack, Nina] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland; [Kurki, Timo] Terveystalo Pulssi Med Ctr, MRI Unit, Turku, Finland; [Himanen, Leena; Vuorinen, Elina; Myllyniemi, Anna; Saarenketo, Anna-Riitta] NeuTera Neuropsychologist Ctr, Turku, Finland; [Kauko, Tommi] Univ Turku, Dept Biostat, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, FIN-20520 Turku, Finland; [Tenovuo, Olli] Univ Turku, Turku, Finland; [Brandstack, Nina] Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland		Kurki, T (corresponding author), Terveystalo Pulssi Med Ctr, MRI Unit, Turku, Finland.	kurti@suomi24.fi		Kurki, Timo/0000-0001-5532-3534; Himanen, Leena/0000-0001-7261-8027			Alegret M, 2012, J ALZHEIMERS DIS, V30, P109, DOI 10.3233/JAD-2012-111850; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Catani M., 2012, ATLAS HUMAN BRAIN CO; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Nandigam RNK, 2007, J NEUROIMAGING, V17, P74, DOI 10.1111/j.1552-6569.2006.00069.x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rudrauf D, 2008, CORTEX, V44, P1084, DOI 10.1016/j.cortex.2008.05.005; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; van Huijzen, 2008, HUMAN CENTRAL NERVOU; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang SM, 2005, ANN NY ACAD SCI, V1064, P61, DOI 10.1196/annals.1340.013; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	45	14	15	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2014	56	10					833	841		10.1007/s00234-014-1410-7			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS5ZZ	WOS:000344346100004	25080234				2022-02-06	
J	Maia, PD; Kutz, JN				Maia, Pedro D.; Kutz, J. Nathan			Compromised axonal functionality after neurodegeneration, concussion and/or traumatic brain injury	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Neurodegenerative diseases; Traumatic brain injury; Concussion; Alzheimer; Parkinson; Axonal Swellings; Axonal Computation; Spike train metrics	ACTION-POTENTIAL PROPAGATION; MILD; ABNORMALITIES; MECHANISMS; TRANSPORT; PATHOLOGY; BREAKAGE; DEMENTIA; DYNAMICS	Axonal swellings are almost universal in neurodegenerative diseases of the central nervous system, including Alzheimer's and Parkinson's disease. Concussions and traumatic brain injuries can also produce cognitive and behavioral deficits by compromising neuronal morphology. Using a spike metric analysis, we characterize computationally the effects of such axonal varicosities on spike train propagation by comparing Poisson spike train classes before and after propagation through a prototypical axonal enlargement, or focused axonal swelling. Misclassification of spike train classes and low-pass filtering of firing rate activity increases with more pronounced axonal injury. We show that confusion matrices and a calculation of the loss of transmitted information provide a very practical way to characterize how injured neurons compromise the signal processing and faithful conductance of spike trains. The method demonstrates that (i) neural codes encoded with low firing rates are more robust to injury than those encoded with high firing rates, (ii) classification depends upon the length of the spike train used to encode information, and (iii) axonal injuries reduce the variance of spike trains within a given stimulus class. The work introduces a novel theoretical and computational framework to quantify the interplay between electrophysiological dynamics with focused axonal swellings generated by injury or other neurodegenerative processes. It further suggests how pharmacology and plasticity may play a role in recovery of neural computation. Ultimately, the work bridges vast experimental observations of in vitro morphological pathologies with post-traumatic cognitive and behavioral dysfunction.	[Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA		Maia, PD (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	pmaia@u.washington.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257			Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Altenberger R, 2001, J NEUROSCI METH, V112, P101, DOI 10.1016/S0165-0270(01)00456-3; Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x; Aronov D., 2005, PHYS REV E, V69; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Chen W.R., 2002, J NEUROPHYSIOL, V88; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Dayan P, 2001, THEORETICAL NEUROSCI; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Ermentrout G., 2010, MATH FDN NEUROSCIENC; Ermentrout GB, 1996, SIAM J APPL MATH, V56, P1107, DOI 10.1137/S0036139994276793; Fainaru-Wada M., 2013, CROWN ARCHETYPE; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Gerstner W., 2002, SPIKING NEURON MODEL; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich E.M., 2007, DYNAMICAL SYSTEMS NE; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Khodorov B.I., 1975, Progress Biophys Molec Biol, V30, P145; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Kutz JN., 2013, DATA DRIVEN MODELING; Liberski PP, 1999, ACTA NEUROPATHOL, V97, P329, DOI 10.1007/s004010050995; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia P.D., 2014, J COMPUTATIONAL NEUR, V36, P55; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; PARNAS I, 1972, J NEUROPHYSIOL, V35, P903, DOI 10.1152/jn.1972.35.6.903; Parnas I., 1976, J NEUROPHYSIOLOGY, V39; Parnas I, 1979, NEUROSCIENCES, P499; RAMON F, 1975, FED PROC, V34, P1357; Rinzel J., 1990, ANN NEW YORK ACAD SC, V591; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; SCOTT A, 2002, NEUROSCIENCE MATH PR; Segev I, 1999, J PHYSIOLOGY-PARIS, V93, P263, DOI 10.1016/S0928-4257(00)80055-8; Shepherd G.M.G., 1998, J NEUROSCIENCE, V18; Smith DH, 1999, J NEUROSCI, V19, P4263; SMITH DO, 1980, J PHYSIOL-LONDON, V301, P243, DOI 10.1113/jphysiol.1980.sp013202; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Victor JD, 2005, CURR OPIN NEUROBIOL, V15, P585, DOI 10.1016/j.conb.2005.08.002; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; ZHOU Y, 1994, MATH BIOSCI, V119, P169, DOI 10.1016/0025-5564(94)90075-2	63	14	14	0	25	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	OCT	2014	37	2					317	332		10.1007/s10827-014-0504-x			16	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	AP4QG	WOS:000342062400010	24916135				2022-02-06	
J	Neuberger, EJ; Wahab, RA; Jayakumar, A; Pfister, BJ; Santhakumar, V				Neuberger, Eric J.; Wahab, Radia Abdul; Jayakumar, Archana; Pfister, Bryan J.; Santhakumar, Vijayalakshmi			Distinct Effect of Impact Rise Times on Immediate and Early Neuropathology After Brain Injury in Juvenile Rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; neuronal cell death; electrophysiology; dentate gyrus; neuroexcitation	FLUID PERCUSSION INJURY; WHITE-MATTER; BLAST INJURY; MOUSE MODEL; IN-VITRO; EPILEPSY; NEURONS; TISSUE; HYPEREXCITABILITY; MECHANISMS	Traumatic brain injury (TBI) can occur from physical trauma from a wide spectrum of insults ranging from explosions to falls. The biomechanics of the trauma can vary in key features, including the rate and magnitude of the insult. Although the effect of peak injury pressure on neurological outcome has been examined in the fluid percussion injury (FPI) model, it is unknown whether differences in rate of rise of the injury waveform modify cellular and physiological changes after TBI. Using a programmable FPI device, we examined juvenile rats subjected to a constant peak pressure at two rates of injury: a standard FPI rate of rise and a faster rate of rise to the same peak pressure. Immediate postinjury assessment identified fewer seizures and relatively brief loss of consciousness after fast-rise injuries than after standard-rise injuries at similar peak pressures. Compared with rats injured at standard rise, fewer silver-stained injured neuronal profiles and degenerating hilar neurons were observed 4-6 hr after fast-rise FPI. However, 1 week postinjury, both fast-and standard-rise FPI resulted in hilar cell loss and enhanced perforant path-evoked granule cell field excitability compared with sham controls. Notably, the extent of neuronal loss and increase in dentate excitability were not different between rats injured at fast and standard rates of rise to peak pressure. Our data indicate that reduced cellular damage and improved immediate neurological outcome after fast rising primary concussive injuries mask the severity of the subsequent cellular and neurophysiological pathology and may be unreliable as a predictor of prognosis. (C) 2014 Wiley Periodicals, Inc.	[Neuberger, Eric J.; Jayakumar, Archana; Santhakumar, Vijayalakshmi] Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Wahab, Radia Abdul; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Santhakumar, Vijayalakshmi] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA		Santhakumar, V (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, MSB H-512,185 S Orange Ave, Newark, NJ 07103 USA.	santhavi@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187	NJCBIR [CBIR11PJT003, 09.003-BIR1]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069861]; F.M, Kirby Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	Contract grant sponsor: NJCBIR, contract grant numbers: CBIR11PJT003; 09.003-BIR1; Contract grant sponsor: NIH/NINDS, contract grant number: NS069861; Contract grant sponsor: F.M, Kirby Foundation (to V.S.).	Abdul-Wahab R, 2011, NORTHEAST BIOENGIN C; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; [Anonymous], 2002, STROKE; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chauhan NB, 2014, RESTOR NEUR IN PRESS; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Engel J., 1998, EPILEPSY COMPREHENSI; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; MANEV H, 1989, MOL PHARMACOL, V36, P106; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Toth Z, 1997, J NEUROSCI, V17, P8106; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu JD, 2013, J NEUROPHYSIOL, V109, P1746, DOI 10.1152/jn.00891.2012; Zhang Jiangyue, 2006, Annu Proc Assoc Adv Automot Med, V50, P1; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang Jiangyue, 2009, Ann Adv Automot Med, V53, P249; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215	69	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2014	92	10					1350	1361		10.1002/jnr.23401			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN3QX	WOS:000340504500012	24799156	Green Accepted, hybrid			2022-02-06	
J	Styrke, J; Sojka, P; Bjornstig, U; Stalnacke, BM				Styrke, Johan; Sojka, Peter; Bjornstig, Ulf; Stalnacke, Britt-Marie			Symptoms, disabilities, and life satisfaction five years after whiplash injuries	SCANDINAVIAN JOURNAL OF PAIN			English	Article						Whiplash injuries; Post-Concussion Symptoms; Disability; Life satisfaction		Background: Chronic whiplash-associated disorders (WADs) are often associated with social functioning problems and decreased ability to perform previous activities. This may lead to decreased life satisfaction, which is insufficiently studied in the context of whiplash injuries. Symptoms included in chronic WAD are similar to symptoms frequently reported by persons who have sustained mild traumatic brain injury (MTBI)/concussion. In cases of MTBI, the severity and number of symptoms have been suggested to have a diagnostic value. The corresponding importance of symptoms in chronic WAD has not been documented. Most studies of whiplash injuries have focused on neck pain because this is the dominant complaint, while other symptoms are less studied. The frequency of long-term symptoms after whiplash injuries seems to vary. It is difficult to compare the long-term outcome since the follow-up after whiplash injury in most studies has been rather short. Therefore, the primary aim of this investigation was to study neck pain and other symptoms, disability, and life satisfaction five years after whiplash injury in a defined population and geographical area. Methods: The study was carried out at a public hospital in northern Sweden and was a cross-sectional survey of patients five years after the injury event in a cohort of whiplash-injured patients. Five years after the emergency department visit, 186 persons aged 18-64 answered questionnaires on symptoms (Rivermead Post-Concussion Symptoms Questionnaire, RPQ), disabilities (Rivermead Head Injury Follow Up Questionnaire, RHFUQ), and life satisfaction (LiSat-11). The answers were compared to those of a comparison cohort. Results: The most common symptoms five years after whiplash injury were fatigue (41%), poor memory (39%), and headache (37%). Inability to sustain previous workload (44%) and fatigue at work (43%) were frequently reported disabilities. Only 39% were satisfied with their somatic health and 60% with their psychological health. Compared with healthy controls, the whiplash injured exhibited more symptoms and had lower life satisfaction. Women reported significantly higher pain intensity than men. Few significant differences between women and men regarding the other parameters were found. Conclusions: This study shows that five years after a whiplash injury, patients reported symptoms that are typical of mild traumatic brain injury. Further, this study emphasizes the possibility of screening patients with chronic WAD for these symptoms as a complement to the assessment. (C) 2014 Scandinavian Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	[Styrke, Johan; Bjornstig, Ulf] Umea Univ, Dept Surg & Perioperat Sci, Div Surg, Umea, Sweden; [Sojka, Peter] Mid Sweden Univ, Dept Hlth Sci, Ostersund, Sweden; [Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil Rehabil Med, S-90185 Umea, Sweden		Stalnacke, BM (corresponding author), Umea Univ, Dept Community Med & Rehabil Rehabil Med, S-90185 Umea, Sweden.	brittmarie.stalnacke@rehabmed.umu.se	Styrke, Johan/AAE-1193-2021		The Swedish Association of Survivors of Traffic Accidents; Swedish Cancer and Traffic Injury Society Fund	We thank Per-Olov Bylund for his assistance in providing the data from the Umea University Hospitals' injury and trauma register. The Swedish Association of Survivors of Traffic Accidents and the Swedish Cancer and Traffic Injury Society Fund economically supported this study.	[Anonymous], 2008, Eur Spine J, V17 Suppl 3, P355, DOI 10.1007/s00586-008-0767-x; Antepohl W, 2003, NEUROREHABILITATION, V18, P307; BJORNSTIG U, 1990, SCAND J SOC MED, V18, P263, DOI 10.1177/140349489001800405; Borsbo B, 2008, J REHABIL MED, V40, P562, DOI 10.2340/16501977-0207; Buitenhuis J, 2009, SPINE, V34, P262, DOI 10.1097/BRS.0b013e3181913d07; Bunketorp L, 2002, EUR SPINE J, V11, P227, DOI 10.1007/s00586-002-0393-y; Carlesso LC, 2012, DISABIL REHABIL, V34, P1131, DOI 10.3109/09638288.2011.632467; Carlsson A, 2011, TRAFFIC INJ PREV, V12, P347, DOI 10.1080/15389588.2011.585408; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cote P, 2001, Spine (Phila Pa 1976), V26, pE445, DOI 10.1097/00007632-200110010-00020; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Crutebo S, 2010, J RHEUMATOL, V37, P1527, DOI 10.3899/jrheum.091321; Curatolo M, 2011, SPINE, V36, pS309, DOI 10.1097/BRS.0b013e318238842a; Duckworth MP, 2005, CLIN J PAIN, V21, P251, DOI 10.1097/00002508-200505000-00008; Eva-Maj M, 2013, EUR J APPL PHYSIOL, V113, P2487, DOI 10.1007/s00421-013-2683-y; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Guez M, 2002, ACTA ORTHOP SCAND, V73, P455, DOI 10.1080/00016470216329; Haldeman S, 2008, SPINE, V33, pS5; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; Kalawy H, 2013, SCAND J PAIN, V4, P173, DOI 10.1016/j.sjpain.2013.06.006; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; Krafft Maria, 2003, Traffic Inj Prev, V4, P136, DOI 10.1080/15389580309862; Kullgren A, 2013, IRCOBI C; Kyhlback M, 2002, INT J REHABIL RES, V25, P181, DOI 10.1097/00004356-200209000-00003; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Linnman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019182; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Mayou R, 1996, INJURY, V27, P617, DOI 10.1016/S0020-1383(96)00114-3; McLean SA, 2011, SPINE, V36, P5226; Ozegovic D, 2010, J REHABIL MED, V42, P66, DOI 10.2340/16501977-0466; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Peolsson M, 2007, J REHABIL MED, V39, P260, DOI 10.2340/16501977-0052; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Rebbeck T, 2006, INJURY PREV, V12, P93, DOI 10.1136/ip.2005.010421; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Siegmund GP, 2009, TRAFFIC INJ PREV, V10, P101, DOI 10.1080/15389580802593269; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2009, J REHABIL MED, V41, P353, DOI 10.2340/16501977-0349; Stemper Brian D, 2009, Biomed Sci Instrum, V45, P149; Sterling M, 2011, SPINE, V36, pS330, DOI 10.1097/BRS.0b013e3182388523; Sterling M, 2006, PAIN, V122, P102, DOI 10.1016/j.pain.2006.01.014; Sterner Y, 2004, J REHABIL MED, V36, P193, DOI 10.1080/16501970410030742; Sterner Y, 2003, J SPINAL DISORD TECH, V16, P195, DOI 10.1097/00024720-200304000-00013; STERNER Y, 2002, J WHIPLASH RELAT DIS, V1, P39; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Styrke J, 2012, PM&R, V4, P739, DOI 10.1016/j.pmrj.2012.05.010; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x; Versteegen G J, 1998, Eur Spine J, V7, P201, DOI 10.1007/s005860050056; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; WHO, 1992, INT STAT CLASS DIS R	59	14	14	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1877-8860	1877-8879		SCAND J PAIN	Scand. J. Pain	OCT	2014	5	4					229	236		10.1016/j.sjpain.2014.06.001			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V2U7A	WOS:000217927700004	29911576				2022-02-06	
J	Munyon, C; Eakin, KC; Sweet, JA; Miller, JP				Munyon, Charles; Eakin, Katharine C.; Sweet, Jennifer A.; Miller, Jonathan P.			Decreased bursting and novel object-specific cell firing in the hippocampus after mild traumatic brain injury	BRAIN RESEARCH			English	Article						Hippocampus; Bursting; Novel object recognition; Traumatic brain injury	SYNAPTIC PLASTICITY; ENTORHINAL CORTEX; TEMPORAL-LOBE; MEMORY; RAT; NEURONS; CANNABINOIDS; RECOGNITION; PROPAGATION; DEFICITS	Objective: mild traumatic brain injury (mTBI) can produce lasting memory deficits even in the absence of cell loss. We investigated changes in hippocampal firing patterns during exploration and during a novel object recognition (NOR) task. Methods: six male Sprague-Dawley rats were subjected to mTBI via fluid percussion injury and were compared with sham-operated rats. Microelectrodes were implanted into CA1 and CA3 and multiple units were recorded from the pyramidal cell layer. Spontaneous "burst" characteristics were analyzed and temporal firing patterns were correlated with object encounters to establish object-specific firing patterns. Results: mTBI was associated with significantly less hippocampal bursting (p < 0.05) with a trend toward longer bursts and lower interburst spike frequency. mTBI was also associated with no preference for a novel object at 12 h (p < 0.05). During the NOR task, a subset of pyramidal cells were identified which consistently demonstrated a transiently increased firing rate upon encounter of a specific object ("object-specific" cell). Across both groups, there was a significant (p < 0.05) correlation between preference for object novelty and the difference between the total number of novel object-specific cells and familiar object-specific cells. The proportion of object-specific cells that responded to the unexpected (novel) object compared to those responding to the familiar object was significantly smaller in rats that had been exposed to mTBI (p < 0.05). Conclusion: memory deficits after mTBI are associated with decreased intrinsic burst activity and impaired context-specific firing patterns in the hippocampus during object exploration. (C) 2014 Elsevier B.V. All rights reserved.	[Munyon, Charles; Eakin, Katharine C.; Sweet, Jennifer A.; Miller, Jonathan P.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA		Miller, JP (corresponding author), Case Western Reserve Univ, Dept Neurol Surg, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Jonathan.Miller@UHHospitals.org		Miller, Jonathan/0000-0001-5441-1751; Munyon, Charles/0000-0002-0093-5442			Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K.C., 2012, J NEUROTRAUM, V29, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Funahashi M, 2000, BRAIN RES, V884, P104, DOI 10.1016/S0006-8993(00)02854-7; Goonawardena AV, 2011, HIPPOCAMPUS, V21, P520, DOI 10.1002/hipo.20769; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hampson RE, 2003, HIPPOCAMPUS, V13, P543, DOI 10.1002/hipo.10081; Hampson RE, 2000, J NEUROSCI, V20, P8932; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Stewart M, 1999, BRAIN RES, V830, P274, DOI 10.1016/S0006-8993(99)01404-3; Viskontas IV, 2007, HIPPOCAMPUS, V17, P49, DOI 10.1002/hipo.20241; Watson HC, 2012, J NEUROSCI, V32, P4473, DOI 10.1523/JNEUROSCI.5751-11.2012; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	26	14	14	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 25	2014	1582						220	226		10.1016/j.brainres.2014.07.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR1PM	WOS:000343357100021	25086204				2022-02-06	
J	Ma, Y; Xia, X; Cheng, JM; Kuang, YQ; Yang, T; Yang, LB; Fan, K; Gu, JW				Ma, Yuan; Xia, Xun; Cheng, Jing-min; Kuang, Yong-qin; Yang, Tao; Yang, Li-bin; Fan, Kexia; Gu, Jian-wen			Emodin Inhibits Inducible Nitric Oxide Synthase in a Rat Model of Craniocerebral Explosive Injury	NEUROCHEMICAL RESEARCH			English	Article						Emodin; Nitric oxide; iNOS; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLAST; NEUROINFLAMMATION; MACROPHAGES; AGENTS	To investigate the effects of emodin on blast-induced traumatic brain injury (bTBI) in a rat model. Eighty rats were randomly divided into 2 groups (the control group and the emodin-treated group; N = 40 per group) and were used to establish the model of blast-induced traumatic brain injury. Ten minutes after the explosion, an isotonic saline solution (10 mg/kg) or emodin (10 mg/kg) were administered via an intraperitoneal injection to the control group and the emodin-treated group, respectively. At each time point (pre-explosion, 2, 6, 12, 24 h after explosion), 2 rats were used for the pathological assessment and 6 rats were used for the biochemical assessment. The concentration of nitric oxide (NO) and the expression and activity of inducible nitric oxide synthase (iNOS) were measured at each time point by spectrophotometry and western blot analysis. Light and electron microscopy showed that the brain damage in the emodin-treated group was less serious than that observed in the control group. The concentration of NO in the emodin-treated group was lower compared with the control group (p < 0.05). Western blot analysis showed that protein expression in the emodin-treated group was lower than the control group (p < 0.05). Emodin can alleviate brain damage after bTBI by inhibiting iNOS. These findings suggest that emodin has a protective effect against bTBI. One possible mechanism may occur by inhibiting the expression and activity of iNOS and consequently decreasing the concentration of NO.	[Ma, Yuan; Xia, Xun; Cheng, Jing-min; Kuang, Yong-qin; Yang, Tao; Yang, Li-bin; Fan, Kexia; Gu, Jian-wen] Peoples Liberat Army, Dept Neurosurg, Chengdu Mil Gen Hosp, Chengdu, Peoples R China; [Ma, Yuan; Xia, Xun; Cheng, Jing-min] Third Mil Med Univ, Grad Management Team, Chongqing, Peoples R China; [Gu, Jian-wen] PLA, Air Force Geneal Hosp, Beijing, Peoples R China		Gu, JW (corresponding author), PLA, Air Force Geneal Hosp, 30 Fucheng Rd, Beijing, Peoples R China.	676392000@qq.com					Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Basu S, 2005, PHYTOTHER RES, V19, P888, DOI 10.1002/ptr.1752; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; HUANG HC, 1991, EUR J PHARMACOL, V205, P289; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kuo YC, 2001, LIFE SCI, V68, P1271, DOI 10.1016/S0024-3205(00)01033-X; Li HL, 2005, INT J MOL MED, V16, P41; Lu Jian-Sheng, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1939; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Park MY, 2009, BIOSCI BIOTECH BIOCH, V73, P828, DOI 10.1271/bbb.80714; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Shuangsuo D, 2006, MED SCI MONITOR, V12, pR302; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	19	14	15	1	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2014	39	9					1809	1816		10.1007/s11064-014-1395-y			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AO9WV	WOS:000341711800021	25064046				2022-02-06	
J	Pang, L; Wang, HL; Wang, ZH; Wu, Y; Dong, N; Xu, DH; Wang, DW; Xu, H; Zhang, N				Pang, Li; Wang, He-Lei; Wang, Zhi-Hao; Wu, Yang; Dong, Ning; Xu, Da-Hai; Wang, Da-Wei; Xu, Hong; Zhang, Nan			Plasma copeptin as a predictor of intoxication severity and delayed neurological sequelae in acute carbon monoxide poisoning	PEPTIDES			English	Article						Biomarker; Carbon monoxide poisoning; Copeptin; Delayed neurological sequelae; Severity	TRAUMATIC BRAIN-INJURY; VASOPRESSIN PRECURSOR; PROGNOSTIC BIOMARKER; EMERGENCY-DEPARTMENT; STABLE PEPTIDE; S100B PROTEIN; MORTALITY; HEMORRHAGE; MARKER	The present study was designed to assess the usefulness of measuring plasma levels of copeptin (a peptide co-released with the hypothalamic stress hormone vasopressin) as a biomarker for the severity of carbon monoxide (CO) poisoning and for predicting delayed neurological sequelae (DNS). Seventy-two patients with CO poisoning and 72 sex and age matched healthy individuals were recruited. Plasma copeptin levels were measured on admission from CO poisoning patients and for healthy individuals at study entry by using a sandwich immunoassay. The CO poisoning patients were divided into two groups according to severity (unconscious and conscious) and occurrence of DNS. The mean plasma copeptin levels (52.5 +/- 18.5 pmol/L) in the unconscious group were significantly higher than in the conscious group (26.3 +/- 12.7 pmol/L) (P < 0.001). Plasma copeptin levels of more than 39.0 pmol/L detected CO poisoning with severe neurological symptoms e.g. unconsciousness (sensitivity 84.6% and specificity 81.4%). The plasma copeptin levels were higher in patients with DNS compared to patients without DNS (52.2 +/- 20.6 pmol/L vs. 27.9 +/- 14.8 pmol/L, P < 0.001). Plasma copeptin levels higher than 40.5 pmol/L predicted the development of DNS (sensitivity 77.8%, specificity 82.1%). Plasma copeptin levels were identified as an independent predictor for intoxication severity [odds ratio (OR) 1.261,95% confidence interval (CI) 1.112-1.638,P = 0.002] and DNS (OR 1.313,95% CI 1.106-1.859,P = 0.001). Thus, plasma copeptin levels independently related to intoxication severity and were identified as a novel biomarker for predicting DNS after acute CO poisoning. (C) 2014 Elsevier Inc. All rights reserved.	[Pang, Li; Wang, Zhi-Hao; Wu, Yang; Dong, Ning; Xu, Da-Hai; Wang, Da-Wei; Zhang, Nan] Jilin Univ, Hosp 1, Dept Emergency, Changchun 130021, Peoples R China; [Wang, He-Lei; Xu, Hong] Jilin Univ, Hosp 1, Dept Surg Gastroenterol, Changchun 130021, Peoples R China		Xu, H (corresponding author), Jilin Univ, Hosp 1, Dept Surg Gastroenterol, 71 Xinmin Rd, Changchun 130021, Peoples R China.	187211618@qq.com; 466634002@qq.com	wang, helei/AAF-2533-2020		Youth Development Foundation of the First Hospital of Jilin University	This study was supported by research grants from the Youth Development Foundation of the First Hospital of Jilin University. We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Deschamps D, 2003, OCCUP ENVIRON MED, V60, P212, DOI 10.1136/oem.60.3.212; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Hu HJ, 2011, AM J EMERG MED, V29, P261, DOI 10.1016/j.ajem.2009.09.030; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; Katan M, 2011, NEUROLOGY, V76, P563, DOI 10.1212/WNL.0b013e31820b75e6; Katan M, 2010, SWISS MED WKLY, V140, P11, DOI 10.4414/smw.2010.13101; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nickel CH, 2011, ACAD EMERG MED, V18, P851, DOI 10.1111/j.1553-2712.2011.01126.x; Pang L, 2013, J BIOCHEM MOL TOXIC, V27, P266, DOI 10.1002/jbt.21484; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.x; Raub JA, 2000, TOXICOLOGY, V145, P1, DOI 10.1016/S0300-483X(99)00217-6; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhang X, 2012, PEPTIDES, V33, P336, DOI 10.1016/j.peptides.2012.01.011; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575	24	14	18	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	SEP	2014	59						89	93		10.1016/j.peptides.2014.07.007			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AO5ZT	WOS:000341427300014	25038511				2022-02-06	
J	Vanderploeg, RD; Belanger, HG; Kaufmann, PM				Vanderploeg, Rodney D.; Belanger, Heather G.; Kaufmann, Paul M.			Nocebo Effects and Mild Traumatic Brain Injury: Legal Implications	PSYCHOLOGICAL INJURY & LAW			English	Article						Brain concussion; Head injury; Concussion; Forensic; Traumatic brain injury; Nocebo		Expectations may play a large role in health-related outcomes, but they may not be fully addressed or considered in medical-legal contexts. Contextual factors can influence a patient's expectations for recovery following a concussion, including explicit or implicit messages from the media, healthcare providers and systems of care, and the forensic arena. This article discusses these factors as nocebo effects, that is, various inherently "inert" factors may create negative expectancies for recovery and therefore impede a given patient's progress and recovery. It is argued that the negligence theory upon which the legal system is based tends to compound these nocebo effects. In accident-related concussions, both the accident itself and subsequent nocebo effects including potential healthcare and medical-legal provider negligence can create legal liability.	[Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, MHBS Psychol 116B,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychiat, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Kaufmann, Paul M.] Univ Arizona, Tucson, AZ USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, MHBS Psychol 116B,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov					Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J., 2004, J REHABILITATION M S, V43, P15, DOI DOI 10.1080/16501960410023688; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; GREENWALD AG, 1986, PSYCHOL REV, V93, P216, DOI 10.1037/0033-295X.93.2.216; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hauser W, 2012, CLIN J PAIN, V28, P437, DOI 10.1097/AJP.0b013e3182321ad8; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; KATZ I, 1965, J PERS SOC PSYCHOL, V2, P53, DOI 10.1037/h0022080; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Martindale DA, 2005, J CHILD CUSTODY, V2, P31, DOI 10.1300/J190v02n01_03; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKay PF, 2002, J APPL SOC PSYCHOL, V32, P767, DOI 10.1111/j.1559-1816.2002.tb00241.x; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Nickerson R. S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paniak C, 2000, BRAIN INJURY, V14, P219; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Peters KD, 2011, J ABNORM PSYCHOL, V120, P168, DOI 10.1037/a0021899; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Witthoft M, 2013, J PSYCHOSOM RES, V74, P206, DOI 10.1016/j.jpsychores.2012.12.002	62	14	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	SEP	2014	7	3					245	254		10.1007/s12207-014-9201-3			10	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB4JI	WOS:000415477900004					2022-02-06	
J	Li, XW; Liu, XY; Zhang, N; Wen, XJ				Li, Xiaowei; Liu, Xiaoyan; Zhang, Ning; Wen, Xuejun			Engineering In Situ Cross-Linkable and Neurocompatible Hydrogels	JOURNAL OF NEUROTRAUMA			English	Article						differentiation; hydrogel; morphology; neural stem cell; proliferation	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR-MATRIX; CELL THERAPY; SPINAL-CORD; STEM-CELLS; TISSUE; DIFFERENTIATION; GROWTH; VITRO; TRANSPLANTATION	Physical injuries of the central nervous system (CNS) are prevalent and very severe because the CNS has limited capacity to replace neuronal loss from the injury. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote CNS regeneration. Direct injection of neural stem cells (NSCs) to the lesion site, however, may not be an optimal therapeutic strategy because of poor viability and functionality of transplanted cells resulting from the local hostile tissue environment. The overall objective of this study is to engineer an injectable and biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted NSCs to survive, functionally differentiate, and integrate with host tissues for CNS regeneration. A highly biocompatible hydrogel, based on thiol functionalized hyaluronic acid and thiol functionalized gelatin (Gtn-SH), which can be cross-linked by poly(ethylene glycol) diacrylate (PEGDA), was used. By controlling the cross-linking density via varying the amount of cross-linker (PEGDA) and the concentration of the adhesive component gelatin, an optimal microenvironment for the survival, proliferation, and neuronal differentiation of NSCs was created in vitro. The soft hydrogel of less than 10 Pa with Gtn-SH content (50%) is one of the optimal conditions to support NSCs growth and neuronal differentiation in vitro. The optimized hydrogel holds great potential as a carrier of stem cells to treat CNS injuries and diseases in which cell therapies may be essential.	[Li, Xiaowei] Johns Hopkins Univ, Whitaker Biomed Engn Inst, Translat Tissue Engn Ctr, Baltimore, MD USA; [Liu, Xiaoyan; Zhang, Ning; Wen, Xuejun] Virginia Commonwealth Univ, Inst Engn & Med, Richmond, VA 23284 USA; [Wen, Xuejun] Tongji Univ, Tongji Med Sch, Inst Biomed Engn & Nano Sci iNANO, Shanghai 200092, Peoples R China		Zhang, N (corresponding author), Virginia Commonwealth Univ, 601 West Main St, Richmond, VA 23284 USA.	nzhang2@vcu.edu; xwen@vcu.edu	Li, Xiaowei/E-4973-2014		NSF CAREERNational Science Foundation (NSF)NSF - Office of the Director (OD) [1055922]; Department of Defense (CDMRP TBI Program); Center for Innovative Technology (Virginia) [MF13-004-LS]; American Heart AssociationAmerican Heart Association [10PRE4280017]; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1346387] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp SysNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1312970] Funding Source: National Science Foundation	This work was made possible by the NSF CAREER (1055922), Department of Defense (CDMRP TBI Program), Center for Innovative Technology (Virginia, MF13-004-LS), and American Heart Association (10PRE4280017).	Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049; Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lim TC, 2012, BIOMATERIALS, V33, P3446, DOI 10.1016/j.biomaterials.2012.01.037; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036; Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70; Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116; Pollok JM, 2001, TRANSPLANT P, V33, P1713, DOI 10.1016/S0041-1345(00)02654-3; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310141; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141; Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002	49	14	14	1	51	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1431	1438		10.1089/neu.2013.3215			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700006	24447305				2022-02-06	
J	Bigsby, K; Mangine, RE; Clark, JF; Rauch, JT; Bixenmann, B; Susaret, AW; Hasselfeld, KA; Colosimo, AJ				Bigsby, Kathryn; Mangine, Robert E.; Clark, Joseph F.; Rauch, Joseph T.; Bixenmann, Benjamin; Susaret, Antonia W.; Hasselfeld, Kimberly A.; Colosimo, Angelo J.			EFFECTS OF POSTURAL CONTROL MANIPULATION ON VISUOMOTOR TRAINING PERFORMANCE: COMPARATIVE DATA IN HEALTHY ATHLETES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Balance; postural control; vestibular; Dynavision (TM); concussion	REACTION-TIME; POSITION STATEMENT; HIGH-SCHOOL; CONCUSSION; INJURY; SPORTS; EPIDEMIOLOGY; DEFICITS; TASK	Purpose/Background: Visuomotor ability is an important parameter for neurologic function and effective sport performance. Adding a balance challenge during a structured eye-hand coordination task, such as hitting lights on a light board (Dynavision (TM)), has not been previously reported. Using Division I football players, the aim of this study was to determine normative data on a dual-task performance regimen combining a visuomotor light board task with a balance task. The intent is to use such normative data and baseline data as part of a concussion management program. Methods: Division I college football team members, n=105, were consented. Subjects first performed Dynavision T D2 (TM) Visuomotor Training Device (D2 (TM)) eye-hand coordination tasks, the A* and the RT; they then performed the same tasks with an added balance challenge, standing on a BOSU (R) ball. Results: Ninety-four athletes completed the full testing procedure on the D2 (TM) system. The mean score of the A* test was 93 +/- 11.0 hits per minute; and the mean on the A* test with the added BOSU (R) balance challenge was 83.7 +/- 9.2 hits per minute. The mean RT time was 0.33 +/- 0.036 seconds. Mean reaction time increased to 0.38 +/- 0.063 while the subject stood on the BOSU (R) ball. Performance on the D2 (TM) A* and RT were both statistically significantly different in the dual task condition (p <= 0.05). Conclusions: Results show an approximate 10% decline in D2 (TM) performance when healthy individuals stand on a BOSU (R) ball. From the data presented here, the authors determined that there is a 10% decrement in performance when one's balance is challenged on the BOSU (R) ball. A fall in performance of substantially greater than 10% may indicate abnormal vestibulocerebellar regulatory processing of balance and motion. Further research, using these normative data is needed to determine more specific parameters for definitions of impairment and return-to-play and if there is utility for such studies as part of a concussion management program.	[Bigsby, Kathryn; Mangine, Robert E.] Univ Cincinnati, Sports Phys Therapy Clin Residency, NovaCare Rehabil, Cincinnati, OH 45221 USA; [Mangine, Robert E.] Univ Cincinnati, Sports Med, Cincinnati, OH 45221 USA; [Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Rauch, Joseph T.] Univ Cincinnati, NovaCare Rehabil, Cincinnati, OH 45221 USA; [Bixenmann, Benjamin] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45221 USA; [Susaret, Antonia W.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Hasselfeld, Kimberly A.; Colosimo, Angelo J.] Univ Cincinnati, Coll Med, Dept Orthopaed & Sports Med, Cincinnati, OH 45221 USA		Clark, JF (corresponding author), Univ Cincinnati, Neurol & Rehabil Med, Med Sci Bldg 1055B,ML 0536, Cincinnati, OH 45267 USA.	Joseph.clark@uc.edu			Orthopaedic Research and Education Foundation, University of Cincinnati	This work was support in part by a grant awarded to Angelo Colosimo, MD from the Orthopaedic Research and Education Foundation, University of Cincinnati.	Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; American Academy of Orthopedic Surgeons, 2011, CONC MILD TRAUM BRAI; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Centers for Disease Control and Prevention, 2006, TRAUMATIC BRAIN INJU; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Deliagina TG, 2012, CURR OPIN NEUROBIOL, V22, P646, DOI 10.1016/j.conb.2012.03.002; Deveau J, 2014, VISION RES; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hauser S., 2010, HARRISONS NEUROLOGY; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS RELATED CONCU; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; McCormack WP, LEARNING EFFECT REPE; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; NCAA, 2012 2013 NCAA SPORT, P53; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4	33	14	14	2	5	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	AUG	2014	9	4					436	446					11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA1LW	WOS:000409670600005	25133072				2022-02-06	
J	Heverly-Fitt, S; Wimsatt, MA; Menzer, MM; Rubin, KH; Dennis, M; Taylor, HG; Stancin, T; Gerhardt, CA; Vannatta, K; Bigler, ED; Yeates, KO				Heverly-Fitt, Sara; Wimsatt, Maureen A.; Menzer, Melissa M.; Rubin, Kenneth H.; Dennis, Maureen; Taylor, H. Gerry; Stancin, Terry; Gerhardt, Cynthia A.; Vannatta, Kathryn; Bigler, Erin D.; Yeates, Keith Owen			Friendship Quality and Psychosocial Outcomes among Children with Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Pediatric; Behavior; Rejection; Head; Trauma; Social competence	1ST 6 MONTHS; PROBLEM BEHAVIORS; PEER REJECTION; ADOLESCENTS; CHILDHOOD; ADJUSTMENT; PREDICTION; WITHDRAWN; DISORDERS; SKILLS	This study examined differences in friendship quality between children with traumatic brain injury (TBI) and orthopedic injury (OI) and behavioral outcomes for children from both groups. Participants were 41 children with TBI and 43 children with OI (M age = 10.4). Data were collected using peer- and teacher-reported measures of participants' social adjustment and parent-reported measures of children's post-injury behaviors. Participants and their mutually nominated best friends also completed a measure of the quality of their friendships. Children with TBI reported significantly more support and satisfaction in their friendships than children with OI. Children with TBI and their mutual best friend were more similar in their reports of friendship quality compared to children with OI and their mutual best friends. Additionally, for children with TBI who were rejected by peers, friendship support buffered against maladaptive psychosocial outcomes, and predicted skills related to social competence. Friendship satisfaction was related to higher teacher ratings of social skills for the TBI group only. Positive and supportive friendships play an important role for children with TBI, especially for those not accepted by peers. Such friendships may protect children with TBI who are rejected against maladaptive psychosocial outcomes, and promote skills related to social competence.	[Heverly-Fitt, Sara; Wimsatt, Maureen A.; Menzer, Melissa M.; Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43210 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Dept Psychol, Provo, UT 84602 USA		Heverly-Fitt, S (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, 3304 Benjamin Bldg, College Pk, MD 20742 USA.	sfitt@umd.edu	Rubin, Kenneth H/M-5276-2018; Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007542] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058116] Funding Source: NIH RePORTER	This research was supported by grant R01HD048946 from the National Institute of Child Health and Human Development to Keith Owen Yeates. The authors have no conflicts of interest to declare.	Anderson V., 2012, DEV SOCIAL NEUROSCIE; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Demir M, 2004, J EXP CHILD PSYCHOL, V88, P68, DOI 10.1016/j.jecp.2004.02.006; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Denton K, 1996, CHILD DEV, V67, P1360, DOI 10.1111/j.1467-8624.1996.tb01801.x; FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037/0012-1649.21.6.1016; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; HIGHTOWER AD, 1986, SCHOOL PSYCHOL REV, V15, P393; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kendrick K, 2012, J ADOLESCENCE, V35, P1069, DOI 10.1016/j.adolescence.2012.02.014; Kerr DCR, 2007, J CHILD PSYCHOL PSYC, V48, P967, DOI 10.1111/j.1469-7610.2007.01776.x; Kingery JN, 2011, MERRILL PALMER QUART, V57, P215; Ladd GW, 2006, CHILD DEV, V77, P822, DOI 10.1111/j.1467-8624.2006.00905.x; Laursen B., 2009, HDB PEER INTERACTION; Malcolm KT, 2006, J SOC PERS RELAT, V23, P721, DOI 10.1177/0265407506068260; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McDonald KL, 2013, J EARLY ADOLESCENCE, V33, P897, DOI 10.1177/0272431612472259; McDonald KL, 2010, J YOUTH ADOLESCENCE, V39, P563, DOI 10.1007/s10964-010-9519-4; Menzer M.M., 2012, INT J DEV SCI, V6, P191, DOI [10.3233/dev-1211079, DOI 10.3233/DEV-1211079]; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Nangle DW, 2003, J CLIN CHILD ADOLESC, V32, P546, DOI 10.1207/S15374424JCCP3204_7; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; Peters E, 2011, CHILD DEV, V82, P1906, DOI 10.1111/j.1467-8624.2011.01647.x; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Rubin K.H., 2004, INT SOC STUDY BEHAV, V46, P5; Rubin K, 2008, SOC DEV, V17, P1085, DOI 10.1111/j.1467-9507.2007.00445.x; RUBIN KH, 1993, MERRILL PALMER QUART, V39, P518; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Teasdale G., 1974, BRAIN INJURY, V19, P511; Waldrip AM, 2008, SOC DEV, V17, P832, DOI 10.1111/j.1467-9507.2008.00476.x; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; West S. G., 1991, MULTIPLE REGRESSION; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	41	14	14	0	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2014	20	7					684	693		10.1017/S1355617714000393			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AN9QW	WOS:000340943800002	24840021	Green Accepted			2022-02-06	
J	Pesek, M; Kibler, K; Easley, RB; Mytar, J; Rhee, C; Andropoulos, D; Brady, K				Pesek, Matthew; Kibler, Kathleen; Easley, R. Blaine; Mytar, Jennifer; Rhee, Christopher; Andropoulos, Dean; Brady, Ken			The Upper Limit of Cerebral Blood Flow Autoregulation Is Decreased With Elevations in Intracranial Pressure	NEUROSURGERY			English	Article						Autoregulation; Hypertension; Hydrocephalus; Pediatric; Traumatic brain injury	PEDIATRIC HEAD-INJURY; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; ARTERIAL-HYPERTENSION; PERFUSION-PRESSURE; CHILDREN; HYPOXIA	BACKGROUND: The upper limit of cerebrovascular pressure autoregulation (ULA) is inadequately characterized. OBJECTIVE: To delineate the ULA in an infant swine model. METHODS: Neonatal piglets with sham surgery (n = 9), interventricular fluid infusion (INF) (n = 10), controlled cortical impact (CCI) (n = 10), or CCI+INF (n = 11) had intracranial pressure monitoring and bilateral cortical laser-Doppler flowmetry recordings during arterial hypertension to lethality using an aortic balloon catheter. An increase of red cell flux as a function of cerebral perfusion pressure was determined by piecewise linear regression, and static rates of autoregulation were determined above and below this inflection. The ULA was rendered as the first instance of an upward deflection of Doppler flux causing a static rate of autoregulation decrease greater than 0.5. RESULTS: ULA was identified in 55% of piglets after sham surgery, 70% after INF, 70% after CCI, and 91% after CCI with INF (P = .36). When identified, the median (interquartile range) ULA was as follows: sham group, 102 mm Hg (97-109 mm Hg); INF group, 75 mm Hg (52-84 mm Hg); CCI group, 81 mm Hg (69-101 mm Hg); and CCI+INF group, 61 mm Hg (52-57 mm Hg) (P = .01). In post hoc analysis, both groups with interventricular INF had significantly lower ULA than that observed in the sham group. CONCLUSION: Neonatal piglets without intracranial pathology tolerated acute hypertension with minimal perturbation of cerebral blood flow. Piglets with acutely increased intracranial pressure with or without trauma demonstrated loss of autoregulation when subjected to arterial hypertension.	[Pesek, Matthew; Easley, R. Blaine; Brady, Ken] Touro Univ, Div Pediat Crit Care, Dept Pediat, Vallejo, CA USA; [Kibler, Kathleen; Easley, R. Blaine; Andropoulos, Dean; Brady, Ken] Touro Univ, Div Pediat Anesthesiol, Dept Anesthesiol, Vallejo, CA USA; [Mytar, Jennifer] Touro Univ, Coll Osteopath Med, Vallejo, CA USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Rhee, Christopher] Texas Childrens Hosp, Baylor Coll Med, Div Neonatol, Dept Pediat, Houston, TX 77030 USA		Brady, K (corresponding author), Texas Childrens Hosp, 6621 Fannin,WT 17-417B, Houston, TX 77030 USA.	kbrady@texaschildrens.org					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Hauerberg J, 1998, J NEUROSURG ANESTH, V10, P106, DOI 10.1097/00008506-199804000-00007; KANTER RK, 1985, CLIN PEDIATR, V24, P320, DOI 10.1177/000992288502400603; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LASSEN NA, 1972, SCAND J CLIN LAB INV, V30, P113, DOI 10.3109/00365517209081099; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; STRANDGAARD S, 1974, CIRC RES, V34, P435, DOI 10.1161/01.RES.34.4.435; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	23	14	15	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2014	75	2					163	169		10.1227/NEU.0000000000000367			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AM8PE	WOS:000340138400032	24739364				2022-02-06	
J	Wong, D; Mckay, A; Stolwyk, R				Wong, Dana; Mckay, Adam; Stolwyk, Rene			Delivery of Psychological Interventions by Clinical Neuropsychologists: Current Practice in Australia and Implications for Training	AUSTRALIAN PSYCHOLOGIST			English	Article						interventions; neuropsychologist; placements; postgraduate; supervision; survey	TRAUMATIC BRAIN-INJURY; REHABILITATION; TRIAL	Clinical neuropsychologists are increasingly involved in delivering psychological interventions to people with neurological conditions. This is a key competency for accredited Australian postgraduate neuropsychology courses; however it is not clear how effective courses are in preparing neuropsychologists to deliver interventions. The study aims were to (a) determine the frequency and confidence with which particular types of interventions are delivered by Australian neuropsychologists, (b) examine the availability of opportunities to deliver interventions on clinical placements, (c) identify barriers to delivering interventions in current workplaces; and (d) determine which factors influence the frequency and confidence with which neuropsychologists deliver interventions. An online survey was completed by 114 participants who had graduated from a postgraduate neuropsychology program. Results indicated that respondents delivered different intervention types with varying frequency. They reported limited opportunities to practice these interventions on placements. The majority wanted to be doing more interventions, with lack of time, resources, and adequate training being the major barriers. There were several significant relationships between the frequency and confidence with which respondents delivered interventions and the perceived quality of their postgraduate training. These results highlight the need to consider appropriate postgraduate training options in delivery of interventions, including increasing opportunities to practice interventions on placements.	[Wong, Dana; Mckay, Adam; Stolwyk, Rene] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia		Wong, D (corresponding author), Monash Univ, Sch Psychol Sci, Wellington Rd, Clayton, Vic 3800, Australia.	dana.wong@monash.edu	Wong, Dana/AAD-3410-2020; McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929			Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Miller WR, 2004, J CONSULT CLIN PSYCH, V72, P1050, DOI 10.1037/0022-006X.72.6.1050; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	9	14	14	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	AUG	2014	49	4					209	222		10.1111/ap.12061			14	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AM7TA	WOS:000340070400003					2022-02-06	
J	Kartal, AG; Yilmaz, S; Yaka, E; Pekdemir, M; Sarisoy, HT; Cekmen, MB; Yuksel, M				Kartal, Asli Gulfer; Yilmaz, Serkan; Yaka, Elif; Pekdemir, Murat; Sarisoy, Hasan Tahsin; Cekmen, Mustafa Baki; Yuksel, Melih			Diagnostic Value of S100B Protein in the Differential Diagnosis of Acute Vertigo in the Emergency Department	ACADEMIC EMERGENCY MEDICINE			English	Article							NEURON-SPECIFIC ENOLASE; S-100 PROTEIN; BRAIN-DAMAGE; DIZZINESS; SERUM; MARKERS; STROKE	Objectives: Vertigo is a common presenting complaint resulting from central or peripheral etiologies. Because central causes may be life-threatening, ascertaining the nature of the vertigo is crucial in the emergency department (ED). With a broad range of potential etiologies, distinguishing central causes from benign peripheral causes is a diagnostic challenge. Cranial magnetic resonance imaging (MRI) is the recommended neuroimaging method when clinical findings are ambiguous. However, MRI scanning for every patient with an uncertain diagnosis may not be efficient or possible. Therefore, to improve ED resource utilization for patients with vertigo, there is a need to identify the subset most likely to have MRI abnormalities. It has previously been shown that S100B protein provides a useful serum marker of stroke, subarachnoid hemorrhage, and traumatic brain injury. This study evaluated whether S100B levels could predict central causes of vertigo as identified by cranial MRI in the ED. Methods: This prospective, observational study was conducted with adult patients with acute-onset vertigo (within 6 hours) in the ED of a teaching hospital in Kocaeli, Turkey. Patients with nausea or dizziness complaints without previously known vertigo or cranial pathology, and who agreed to participate in the study, were included. Patients with trauma or with neurologic findings that developed concurrent with their symptoms were excluded. Serum levels of S100B were measured with an electrochemiluminescence immunoassay kit. All subjects underwent cranial MRI. The predictors of positive MRI results were evaluated using logistic regression analysis. Sensitivity and specificity of S100B levels for identifying subjects with central causes of vertigo on MRI were calculated with receiver operating characteristic (ROC) curve. Results: Of the 82 subjects included in the study, 48 (58.5%) were female, and the mean (+/- SD) age was 51 (+/- 16) years. Thirty-one (37.8%) subjects had positive MRI results. Median (with interquartile range [IQR]) serum S100B levels were significantly different between MRI-negative and MRI-positive groups (median = 27.00 pg/mL, IQR = 10.00 to 44.60 vs. median = 60.94 pg/mL, IQR = 38.25 to 77.95, respectively; p = 0.04). In logistic regression analysis, subjective "he or she is spinning" (p = 0.030, odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.38 to 2.49), systolic blood pressure (sBP; p = 0.045, OR = 1.044, 95% CI = 1.021 to 1.080), and serum S100B level (p = 0.042, OR = 1.22, 95% CI = 1.018 to 1.445) were found to be independent predictors of MRI abnormalities. In the ROC analysis, S100B > 30 pg/mL predicted the clinical outcome with 83.9% sensitivity (95% CI = 66.3% to 94.5%) and 51.0% specificity (95% CI = 36.6% to 65.2%). The area under the ROC curve was 0.774 (95% CI = 0.666 to 0.881). Conclusions: To the best of our knowledge this is the first study assessing the utility of serum S100B levels for diagnosis of acute-onset vertigo. Serum S100B levels are associated with the presence of central causes of vertigo on cranial MRI. However, serum S100B levels are not sufficiently sensitive to exclude candidates from cranial MRI. (C) 2014 by the Society for Academic Emergency Medicine	[Kartal, Asli Gulfer; Yilmaz, Serkan; Yaka, Elif; Pekdemir, Murat; Yuksel, Melih] Kocaeli Univ, Fac Med, Dept Emergency Med, Kocaeli, Turkey; [Sarisoy, Hasan Tahsin] Kocaeli Univ, Fac Med, Dept Radiol, Kocaeli, Turkey; [Cekmen, Mustafa Baki] Kocaeli Univ, Fac Med, Dept Biochem, Kocaeli, Turkey		Yilmaz, S (corresponding author), Kocaeli Univ, Fac Med, Dept Emergency Med, Kocaeli, Turkey.	serkanyilmaz@kocaeli.edu.tr	Pekdemir, Murat/F-9741-2018; YILMAZ, Serkan/G-2746-2018; Yuksel, Melih/ABI-1074-2020; Sarisoy, Hasan Tahsin/Q-8399-2019; Yaka, Elif/F-8511-2018	Pekdemir, Murat/0000-0002-3917-0192; YILMAZ, Serkan/0000-0003-1496-6976; 			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; Akinci E, 2007, ADV THER, V24, P1068, DOI 10.1007/BF02877713; Bruzzone MG, 2004, NEUROL SCI, V1, P20; Cloutier JF, 2008, J OTOLARYNGOL-HEAD N, V37, P331, DOI 10.2310/7070.2008.0067; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Heath CL, 2013, EMERG RADIOL, V20, P45; Heinzmann CW, 2002, FRONT BIOSCI ZURICH, V7, P1356; Herr D, 1989, ANN EMERG MED, V18, P664; Kerber KA, 2008, ACAD EMERG MED, V15, P744, DOI 10.1111/j.1553-2712.2008.00189.x; Marzo SJ, 2000, SKULL BASE SURG, V10, P171, DOI 10.1055/s-2000-9334; Navi BB, 2012, MAYO CLIN PROC, V87, P1080, DOI 10.1016/j.mayocp.2012.05.023; Newman-Toker DE, 2008, MAYO CLIN PROC, V83, P765, DOI 10.4065/83.7.765; NORRVING B, 1995, ACTA NEUROL SCAND, V91, P43; Ozono Y, 2014, ACTA OTO-LARYNGOL, V134, P140, DOI 10.3109/00016489.2013.832377; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	19	14	15	1	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2014	21	7					736	741		10.1111/acem.12420			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AN5AA	WOS:000340600200003	25125270	Bronze			2022-02-06	
J	Kazemi, P; Villar, G; Flexman, AM				Kazemi, Pooya; Villar, Giselle; Flexman, Alana M.			Anesthetic Management of Neurosurgical Procedures During Pregnancy: A Case Series	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						pregnancy; neurosurgery; craniotomy; complications; outcomes; anesthesia	HEMORRHAGE; NEOPLASMS; WOMEN	Introduction: Neurosurgical disorders are rare during pregnancy and challenge the anesthesiologist with conflicting anesthetic considerations and little evidence to guide decision-making. Our objective was to review the anesthetic management of pregnant patients undergoing intracranial neurosurgery at our institution and to describe the perioperative complications and outcomes. Methods: We used our institutional Discharge Abstract Database to identify patients assigned both neurological and obstetrical International Classification of Disease 10-A codes between April 1, 2001 and March 1, 2012. Pregnant patients who underwent intracranial neurosurgical procedures underwent a detailed chart review to extract demographic data and details about their anesthetic management and outcome. Results: Nine patients underwent full chart review with a median age of 28 (range, 17 to 35) years and a gestational age of 23 (range, 7 to 30) weeks. Patients underwent a craniotomy for vascular lesions (4), neoplasms (3), and traumatic brain injuries (2). One patient was hyperventilated (PaCO2 28 mmHg), and mannitol and furosemide were used in 6 and 3 patients, respectively, without complication. Maternal neurological outcomes were good in 5 patients (Glasgow Outcome Scale of > 3), poor in 3 patients (Glasgow Outcome Scale 3), and 1 patient died. Fetal outcomes were good in 5 patients and poor in 4 patients (1 therapeutic abortion, 3 intrauterine fetal demises). All cases of fetal distress or demise were either remote or occurred before the anesthetic management. Conclusions: Pregnant patients undergoing neurosurgery experience a high rate of morbidity and mortality. There were no adverse outcomes directly attributed to the use of osmotic diuretics and hyperventilation in our series.	[Kazemi, Pooya; Villar, Giselle; Flexman, Alana M.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Villar, Giselle] British Columbias Womens Hosp, Dept Anesthesia, Vancouver, BC, Canada; [Flexman, Alana M.] Vancouver Gen Hosp, Dept Anesthesiol & Perioperat Care, Vancouver, BC V5Z 1M9, Canada		Flexman, AM (corresponding author), Vancouver Gen Hosp, Dept Anesthesiol & Perioperat Care, Room 2449,899 West 12th Ave, Vancouver, BC V5Z 1M9, Canada.	alana.flexman@vch.ca					Allen G, 2006, NEUROCRIT CARE, V4, P18, DOI 10.1385/NCC:4:1:018; [Anonymous], 2011, OBSTET GYNECOL, V117, P420, DOI 10.1097/AOG.0b013e31820eede9; Bader AP., 2009, OBSTET ANESTHESIA PR, V4th ed, P1053; Bateman BT, 2006, NEUROLOGY, V67, P424, DOI 10.1212/01.wnl.0000228277.84760.a2; Bateman BT, 2012, ANESTHESIOLOGY, V116, P324, DOI 10.1097/ALN.0b013e3182410b22; Bharti N, 2002, INT J OBSTET ANESTH, V11, P219, DOI 10.1054/ijoa.2001.0941; BRUNS PD, 1963, AM J OBSTET GYNECOL, V86, P160; Cohen-Gadol AA, 2009, J NEUROSURG, V111, P2009, DOI 10.3171/2009.3.JNS081160; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czeizel AE, 1999, CLIN DRUG INVEST, V18, P307, DOI 10.2165/00044011-199918040-00007; Elwatidy S, 2011, BRIT J NEUROSURG, V25, P478, DOI 10.3109/02688697.2010.550345; Flemming KD, 2003, SURG NEUROL, V60, P545, DOI 10.1016/S0090-3019(03)00251-9; Goldschlager Tony, 2009, J Trauma, V66, pE50, DOI 10.1097/TA.0b013e318031cc98; Gross BA, 2012, NEUROSURGERY, V71, P349, DOI 10.1227/NEU.0b013e318256c34b; HAAS JF, 1986, J NEUROL NEUROSUR PS, V49, P874, DOI 10.1136/jnnp.49.8.874; Hayasaka IU, 1984, CONGENIT ANOM, V24, P111; JENNETT B, 1975, LANCET, V1, P480; LOW JA, 1970, AM J OBSTET GYNECOL, V106, P1032, DOI 10.1016/S0002-9378(16)34089-3; LUMBERS ER, 1983, J PHYSIOL-LONDON, V343, P439, DOI 10.1113/jphysiol.1983.sp014902; Lynch JC, 2011, BRIT J NEUROSURG, V25, P225, DOI 10.3109/02688697.2010.508846; Muench MV, 2007, OBSTET GYN CLIN N AM, V34, P555, DOI 10.1016/j.ogc.2007.06.001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NAKATSUKA T, 1993, TERATOLOGY, V48, P139, DOI 10.1002/tera.1420480208; Ng J, 2008, J NEUROL NEUROSUR PS, V79, P745, DOI 10.1136/jnnp.2007.117002; Nossek E, 2011, ACTA NEUROCHIR, V153, P1727, DOI 10.1007/s00701-011-1061-y; PLISKOW S, 1995, J REPROD MED, V40, P154; Qaiser R, 2007, SEMIN NEUROL, V27, P476, DOI 10.1055/s-2007-991129; ROSS MG, 1986, PEDIATR PULM, V2, P40, DOI 10.1002/ppul.1950020111; Sharma JB, 2003, INT J GYNECOL OBSTET, V80, P321, DOI 10.1016/S0020-7292(02)00342-9; Terry AR, 2012, NEURO-ONCOLOGY, V14, P768, DOI 10.1093/neuonc/nos078; Tewari KS, 2000, AM J OBSTET GYNECOL, V182, P1215, DOI 10.1016/S0002-9378(00)70188-8; Tuncali Bahattin, 2006, J Anesth, V20, P40, DOI 10.1007/s00540-005-0359-4; Wang LP, 2008, ANESTH ANALG, V107, P193, DOI 10.1213/ane.0b013e31816c8888	33	14	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2014	26	3					234	240					7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	AJ0FN	WOS:000337325500008	24296540				2022-02-06	
J	Sobuwa, S; Hartzenberg, HB; Geduld, H; Uys, C				Sobuwa, S.; Hartzenberg, H. B.; Geduld, H.; Uys, C.			Predicting outcome in severe traumatic brain injury using a simple prognostic model	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							SURVIVAL	Background. Several studies have made it possible to predict outcome in severe traumatic brain injury (TBI) making it beneficial as an aid for clinical decision-making in the emergency setting. However, reliable predictive models are lacking for resource-limited prehospital settings such as those in developing countries like South Africa. Objective. To develop a simple predictive model for severe TBI using clinical variables in a South African prehospital setting. Methods. All consecutive patients admitted at two level-one centres in Cape Town, South Africa, for severe TBI were included. A binary logistic regression model was used, which included three predictor variables: oxygen saturation (SpO(2)), Glasgow Coma Scale (GCS) and pupil reactivity. The Glasgow Outcome Scale was used to assess outcome on hospital discharge. Results. A total of 74.4% of the outcomes were correctly predicted by the logistic regression model. The model demonstrated SpO(2) (p=0.019), GCS (p=0.001) and pupil reactivity (p=0.002) as independently significant predictors of outcome in severe TBI. Odds ratios of a good outcome were 3.148 (SpO(2) >= 90%), 5.108 (GCS 6 - 8) and 4.405 (pupils bilaterally reactive). Conclusion. This model is potentially useful for effective predictions of outcome in severe TBI.	[Sobuwa, S.] Cape Peninsula Univ Technol, Dept Emergency Med Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa; [Hartzenberg, H. B.] Univ Stellenbosch, Div Neurosurg, Parow, South Africa; [Geduld, H.] Univ Cape Town, Div Emergency Med, ZA-7700 Rondebosch, South Africa; [Uys, C.] Cape Peninsula Univ Technol, Ctr Postgrad Studies, Cape Town, South Africa		Sobuwa, S (corresponding author), Cape Peninsula Univ Technol, Dept Emergency Med Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa.	simpiwesobuwa@gmail.com		Uys, Corrie/0000-0002-0313-3875; Geduld, Heike/0000-0001-6512-1274			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sobuwa Simpiwe, 2013, S Afr Med J, V103, P644, DOI 10.7196/samj.7035	12	14	15	0	6	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	JUL	2014	104	7					492	494		10.7196/SAMJ.7720			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3OA	WOS:000341984400019	25214051	gold, Green Submitted			2022-02-06	
J	Solbakk, AK; Funderud, I; Lovstad, M; Endestad, T; Meling, T; Lindgren, M; Knight, RT; Kramer, UM				Solbakk, Anne-Kristin; Funderud, Ingrid; Lovstad, Marianne; Endestad, Tor; Meling, Torstein; Lindgren, Magnus; Knight, Robert T.; Kraemer, Ulrike M.			Impact of Orbitofrontal Lesions on Electrophysiological Signals in a Stop Signal Task	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; INFERIOR FRONTAL GYRUS; EVENT-RELATED POTENTIALS; GLASGOW OUTCOME SCALE; RESPONSE-INHIBITION; PREFRONTAL CORTEX; DECISION-MAKING; BRAIN POTENTIALS; EMOTIONAL STIMULI	Behavioral inhibition and performance monitoring are critical cognitive functions supported by distributed neural networks including the pFC. We examined neurophysiological correlates of motor response inhibition and action monitoring in patients with focal orbitofrontal (OFC) lesions (n = 12) after resection of a primary intracranial tumor or contusion because of traumatic brain injury. Healthy participants served as controls (n = 14). Participants performed a visual stop signal task. We analyzed behavioral performance as well as event-related brain potentials and oscillations. Inhibition difficulty was adjusted individually to yield an equal amount of successful inhibitions across participants. RTs of patients and controls did not differ significantly in go trials or in failed stop trials, and no differences were observed in estimated stop signal RT. However, electrophysiological response patterns during task performance distinguished the groups. Patients with OFC lesions had enhanced P3 amplitudes to congruent condition go signals and to stop signals. In stop trials, patients had attenuated N2 and error-related negativity, but enhanced error positivity. Patients also showed enhanced and prolonged post-error beta band increases for stop errors. This effect was particularly evident in patients whose lesion extended to the subgenual cingulate cortex. In summary, although response inhibition was not impaired, the diminished stop N2 and ERN support a critical role of the OFC in action monitoring. Moreover, the increased stop P3, error positivity, and post-error beta response indicate that OFC injury affected action outcome evaluation and support the notion that the OFC is relevant for the processing of abstract reinforcers such as performing correctly in the task.	[Solbakk, Anne-Kristin; Funderud, Ingrid; Meling, Torstein] Rigshosp, Oslo Univ Hosp, N-0424 Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesodden, Norway; [Endestad, Tor] Univ Oslo, N-0316 Oslo, Norway; [Lindgren, Magnus] Lund Univ, S-22100 Lund, Sweden; [Knight, Robert T.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kraemer, Ulrike M.] Univ Lubeck, Lubeck, Germany		Solbakk, AK (corresponding author), Rigshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway.	annesolbakk@gmail.com	Kramer, Ulrike M./A-8871-2019; Kramer, Ulrike/AAF-2966-2020; Meling, Torstein/Q-2568-2019	Kramer, Ulrike M./0000-0002-3841-1812; Meling, Torstein/0000-0001-6595-0873; Endestad, Tor/0000-0002-4403-6887; Funderud, Ingrid/0000-0002-4481-7237	Research Council of NorwayResearch Council of Norway [186504/V50]; South-Eastern Norway Regional Health Authority [2008047]; German Research FoundationGerman Research Foundation (DFG) [KR 3691/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS021135] Funding Source: NIH RePORTER	The study was supported by the Research Council of Norway (186504/V50 to A. K. S.), the South-Eastern Norway Regional Health Authority (2008047 to A. K. S.), and the German Research Foundation (KR 3691/1-1 to U. M. K.). We would like to thank Clay Campbell Clayworth and Hakon Engen for support in establishing routines for lesion reconstructions and Dr. Paulina Due-Tonnessen for evaluating the structural MRI scans.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Beyer F, 2012, NEUROPSYCHOLOGIA, V50, P3304, DOI 10.1016/j.neuropsychologia.2012.10.007; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brazdil M, 2002, EXP BRAIN RES, V146, P460, DOI 10.1007/s00221-002-1201-y; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Cohen MX, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.054.2009; Crawford JR, 2012, CORTEX, V48, P1009, DOI 10.1016/j.cortex.2011.06.021; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Elliott R, 2005, INT REV NEUROBIOL, V65, P89, DOI 10.1016/S0074-7742(04)65004-5; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2008, PSYCHOL SCI, V19, P103, DOI 10.1111/j.1467-9280.2008.02053.x; Hartikainen KA, 2001, BRAIN COGNITION, V47, P339; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Huynh H., 1976, J EDUC STAT, V1, P69, DOI [10.3102/10769986001001069, DOI 10.3102/10769986001001069, 10.2307/1164736]; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jung JL, 2011, INT J PSYCHOPHYSIOL, V79, P64, DOI 10.1016/j.ijpsycho.2010.09.014; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kramer UM, 2013, CORTEX, V49, P837, DOI 10.1016/j.cortex.2012.05.003; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Krikorian R, 2004, BRAIN COGNITION, V54, P257, DOI 10.1016/j.bandc.2004.02.038; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Marco-Pallares J, 2008, J COGNITIVE NEUROSCI, V20, P1595, DOI 10.1162/jocn.2008.20117; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Navarro-Cebrian A, 2013, J NEUROSCI, V33, P12375, DOI 10.1523/JNEUROSCI.0447-13.2013; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pearson JM, 2013, J EXP ANAL BEHAV, V99, P74, DOI 10.1002/jeab.5; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Ramautar JR, 2006, BIOL PSYCHOL, V72, P96, DOI 10.1016/j.biopsycho.2005.08.001; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; Rubia K, 1998, BEHAV BRAIN RES, V94, P25, DOI 10.1016/S0166-4328(97)00166-6; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Rushworth MFS, 2005, CURR BIOL, V15, pR54, DOI 10.1016/j.cub.2004.12.054; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Senderecka M, 2012, INT J PSYCHOPHYSIOL, V85, P93, DOI 10.1016/j.ijpsycho.2011.05.007; Shalgi S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00124; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2002, NEUROPSYCHOLOGY, V16, P548, DOI 10.1037//0894-4105.16.4.548; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P413, DOI 10.1037/0096-1523.34.2.413; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x	95	14	14	0	12	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0898-929X	1530-8898		J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	JUL	2014	26	7					1528	1545		10.1162/jocn_a_00561			18	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AI9CW	WOS:000337226700016	24392904	Green Accepted			2022-02-06	
J	Saunders, NR; Noor, NM; Dziegielewska, KM; Wheaton, BJ; Liddelow, SA; Steer, DL; Ek, CJ; Habgood, MD; Wakefield, MJ; Lindsay, H; Truettner, J; Miller, RD; Smith, AI; Dietrich, WD				Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Steer, David L.; Ek, C. Joakim; Habgood, Mark D.; Wakefield, Matthew J.; Lindsay, Helen; Truettner, Jessie; Miller, Robert D.; Smith, A. Ian; Dietrich, W. Dalton			Age-Dependent Transcriptome and Proteome Following Transection of Neonatal Spinal Cord of Monodelphis domestica (South American Grey Short-Tailed Opossum)	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; AXONAL REGENERATION; UBIQUITIN LIGASE; DIFFERENTIAL EXPRESSION; INFLAMMATORY RESPONSE; THERAPEUTIC HYPOTHERMIA; GALECTIN-1 EXPRESSION	This study describes a combined transcriptome and proteome analysis of Monodelphis domestica response to spinal cord injury at two different postnatal ages. Previously we showed that complete transection at postnatal day 7 (P7) is followed by profuse axon growth across the lesion with near-normal locomotion and swimming when adult. In contrast, at P28 there is no axon growth across the lesion, the animals exhibit weight-bearing locomotion, but cannot use hind limbs when swimming. Here we examined changes in gene and protein expression in the segment of spinal cord rostral to the lesion at 24 h after transection at P7 and at P28. Following injury at P7 only forty genes changed (all increased expression); most were immune/inflammatory genes. Following injury at P28 many more genes changed their expression and the magnitude of change for some genes was strikingly greater. Again many were associated with the immune/inflammation response. In functional groups known to be inhibitory to regeneration in adult cords the expression changes were generally muted, in some cases opposite to that required to account for neurite inhibition. For example myelin basic protein expression was reduced following injury at P28 both at the gene and protein levels. Only four genes from families with extracellular matrix functions thought to influence neurite outgrowth in adult injured cords showed substantial changes in expression following injury at P28: Olfactomedin 4 (Olfm4, 480 fold compared to controls), matrix metallopeptidase (Mmp1, 104 fold), papilin (Papln, 152 fold) and integrin alpha 4 (Itga4, 57 fold). These data provide a resource for investigation of a priori hypotheses in future studies of mechanisms of spinal cord regeneration in immature animals compared to lack of regeneration at more mature stages.	[Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Habgood, Mark D.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Steer, David L.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Ek, C. Joakim] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden; [Wakefield, Matthew J.; Lindsay, Helen] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wakefield, Matthew J.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Lindsay, Helen] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Truettner, Jessie; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Miller, Robert D.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA		Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia.	n.saunders@unimelb.edu.au	Liddelow, Shane/ABE-6456-2020; Wheaton, Ben/AAC-7037-2021; Wakefield, Matthew J/A-7795-2008; Wakefield, Matthew/X-7593-2019	Liddelow, Shane/0000-0002-0840-1437; Wakefield, Matthew J/0000-0001-6624-4698; Wakefield, Matthew/0000-0001-6624-4698; Wheaton, Benjamin/0000-0003-0619-4777; Saunders, Norman/0000-0001-6660-7639; Lindsay, Helen/0000-0001-8614-1661; Miller, Robert/0000-0002-8479-8819	Victoria Neurotrauma Initiative	This project was supported by the Victoria Neurotrauma Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akbik F, 2011, EXPT NEUROLOGY; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Anders A, 2011, HTSEQ ANAL HIGH THRO; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Biancheri R, 2013, EUR J HUM GENET, V21, P34, DOI 10.1038/ejhg.2012.93; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Chen KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072567; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Dulhunty A, 2009, J PHYSIOL-LONDON, V587, P3135, DOI 10.1113/jphysiol.2009.171959; Dziegielewska KM, 2000, J COMP NEUROL, V423, P373, DOI 10.1002/1096-9861(20000731)423:3<373::AID-CNE2>3.0.CO;2-D; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Eva R, 2012, INT REV NEUROBIOL, V106, P75, DOI 10.1016/B978-0-12-407178-0.00004-1; Farlow DN, 2000, J CELL BIOCHEM, V80, P171; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gris P, 2003, MOL CELL NEUROSCI, V24, P555, DOI 10.1016/S1044-7431(03)00211-2; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hollis ER, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00005; Hu WH, 2002, J NEUROCHEM, V81, P36, DOI 10.1046/j.1471-4159.2002.00788.x; Hurtado A, 2012, EXP NEUROL, V233, P606, DOI 10.1016/j.expneurol.2010.11.015; Iketani M, 2013, DEV NEUROBIOL, V73, P230, DOI 10.1002/dneu.22058; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; Kubota F, 2008, INT J DEV BIOL, V52, P397, DOI 10.1387/ijdb.072424fk; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Kurihara D, 2010, NEUROSCI RES, V66, P265, DOI 10.1016/j.neures.2009.11.008; Lane MA, 2007, EUR J NEUROSCI, V25, P1725, DOI 10.1111/j.1460-9568.2007.05439.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li C, 2011, NEUROSCIENCE, V197, P121, DOI 10.1016/j.neuroscience.2011.08.031; Lin AW, 2003, J NEUROBIOL, V56, P328, DOI 10.1002/neu.10239; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGraw J, 2005, EXP NEUROL, V195, P103, DOI 10.1016/j.expneurol.2005.04.004; McGraw J, 2004, NEUROSCIENCE, V128, P713, DOI 10.1016/j.neuroscience.2004.06.075; McKerracher L, 2012, INT REV NEUROBIOL, V105, P117, DOI 10.1016/B978-0-12-398309-1.00007-X; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller RD, 2010, SEMIN IMMUNOL, V22, P3, DOI 10.1016/j.smim.2009.11.005; Mladinic M, 2005, CELL MOL NEUROBIOL, V25, P407, DOI 10.1007/s10571-005-3150-z; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Noor NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027465; Parra ZE, 2009, J IMMUNOL, V182, P154, DOI 10.4049/jimmunol.182.1.154; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Ponyeam W, 2012, CELL SIGNAL, V24, P290, DOI 10.1016/j.cellsig.2011.08.020; Ramon y Cajal S., 1928, DEGENERATION REGENER; Reddy SJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E4; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; Seale SM, 2012, PHARMACOL BIOCHEM BE, V101, P77, DOI 10.1016/j.pbb.2011.12.006; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Sharp KG, 2012, EXP NEUROL, V233, P625, DOI 10.1016/j.expneurol.2010.12.020; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tello J.F., 1911, TRAB LAB INVEST BIOL, V9, P123; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; van den Berg R, 2012, ADV EXP MED BIOL, V970, P173, DOI 10.1007/978-3-7091-0932-8_8; Veeravalli KK, 2012, J NEUROTRAUM, V29, P2251, DOI 10.1089/neu.2012.2460; Veeravalli KK, 2009, NEUROBIOL DIS, V36, P200, DOI 10.1016/j.nbd.2009.07.012; Verhaagen Joost, 2012, Handb Clin Neurol, V109, P595, DOI 10.1016/B978-0-444-52137-8.00037-1; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045931; Wang XM, 1998, J COMP NEUROL, V398, P83; Wheaton BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071181; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; Xiao Lin, 2005, Shengli Xuebao, V57, P705; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yau TO, 2002, DEV BIOL, V252, P287, DOI 10.1006/dbio.2002.0849; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zhu H, 2012, EXP BIOL MED, V237, P143, DOI 10.1258/ebm.2011.011152	121	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99080	10.1371/journal.pone.0099080			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	WOS:000340947700059	24914927	Green Published, gold			2022-02-06	
J	Cavus, G; Altas, M; Aras, M; Ozgur, T; Serarslan, Y; Yilmaz, N; Sefil, F; Ulutas, KT				Cavus, G.; Altas, M.; Aras, M.; Ozgur, T.; Serarslan, Y.; Yilmaz, N.; Sefil, F.; Ulutas, K. T.			Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Medulla spinalis; Spinal trauma; Methylprednisolone; Montelukast; Superoxide dismutase; Malondialdehyde	TRAUMATIC BRAIN-INJURY; CYSTEINYL LEUKOTRIENE RECEPTOR-1; SUPEROXIDE-DISMUTASE; CEREBROSPINAL-FLUID; BB ISOENZYME; EXPRESSION; DAMAGE; SERUM; ASSAY; CSF	OBJECTIVE: The development of secondary brain injury after trauma is known to involve in many cellular mediators. The aim of the study was to evaluate and compare the effects of the use of both methylprednisolone and montelukast on serum and tissue concentrations of NO, malondialdehyde (MDA) levels, superoxide dismutase (SOD) activity, and tissue glutathione peroxidase (GSH-Px) activity in rats with spinal cord injury (SCI). MATERIALS AND METHODS: SCI was induced in Wistar albino rats by dropping a 10 g rod from a 5.0 cm height at T9-10. The 28 rats were randomly divided into four equal groups: montelukast, methylprednisolone, non-treatment and sham groups. Rats were neurologically tested at 24 hours after trauma and spinal cord tissue levels of MDA, SOD, GSH-PX, CAT levels and blood CK, CK-BB, LDH levels were measured. In addition, histopathological changes were also examined. RESULTS: There was a significant improvement in Tarlov scores in methylprednisolone and montelukast administered group compared to the trauma group (p = 0.001). When compared to trauma group, methylprednisolone and montelukast groups had significant differences in MDA (p < 0.05), SOD (p < 0.001), CK-BB (p < 0.001) and LDH (p < 0.05) levels. Histopathologically, no significant changes were observed. CONCLUSIONS: The present study shows effects of montelukast with biochemical and histopathological parameters and compares its effects with those of methylprednisolone for the first time. Our research has shown that montelukast and methylprednisolone have a neuroprotective effect on spinal cord injury.	[Cavus, G.] Aksaray State Hosp, Dept Neurosurg, Aksaray, Turkey; [Altas, M.; Aras, M.; Serarslan, Y.; Yilmaz, N.] Mustafa Kemal Univ, Tayfur Ata Sokmen Med Fac, Dept Neurosurg, Antakya, Turkey; [Ozgur, T.] Mustafa Kemal Univ, Tayfur Ata Sokmen Med Fac, Dept Pathol, Antakya, Turkey; [Sefil, F.] Mustafa Kemal Univ, Tayfur Ata Sokmen Med Fac, Dept Physiol, Antakya, Turkey; [Ulutas, K. T.] Kadirli State Hosp, Dept Clin Biochem, Osmaniye, Turkey		Cavus, G (corresponding author), Aksaray State Hosp, Dept Neurosurg, Aksaray, Turkey.	gokhanctf@yahoo.com	ULUTAS, KEMAL TURKER/I-3045-2019; CAVUS, GOKHAN/C-7096-2018; Sefil, Fatih/AAR-6907-2020; Aras, Mustafa/ABC-4734-2020; Sefil, Fatih/C-3094-2011; Ozgur, Tumay/AAA-1530-2020; Ulutas, Kemal Turker/N-8935-2013	ULUTAS, KEMAL TURKER/0000-0003-2852-0449; CAVUS, GOKHAN/0000-0001-7078-2501; Sefil, Fatih/0000-0001-5534-7448; Ulutas, Kemal Turker/0000-0003-2852-0449			Aebi H, 1974, METHODS ENZYMATIC AN, P673; Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Akpek EA, 1999, SPINE, V24, P128, DOI 10.1097/00007632-199901150-00006; Alaygut E., 2007, THESIS; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; APPLE FS, 1994, J CLIN IMMUNOASSAY, V17, P24; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; DEPRAETER C, 1991, PEDIATRICS, V88, P1204; DURAK I, 1993, CLIN CHIM ACTA, V214, P103, DOI 10.1016/0009-8981(93)90307-P; Ekmekci H, 2007, THESIS; Erol FS, 2008, J CLIN NEUROSCI, V15, P784, DOI 10.1016/j.jocn.2007.06.009; FERNANDEZ F, 1987, ACTA PAEDIATR SCAND, V76, P914, DOI 10.1111/j.1651-2227.1987.tb17263.x; Genovese T, 2008, BRIT J PHARMACOL, V153, P568, DOI 10.1038/sj.bjp.0707577; Hildebrand J, 1973, Acta Neurol Belg, V73, P229; Kanter M, 2006, HUM EXP TOXICOL, V25, P127, DOI 10.1191/0960327106ht608oa; Kurt G, 2009, SURG NEUROL, V71, P332, DOI 10.1016/j.surneu.2008.01.038; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALINOVSKY JM, 1991, ANESTHESIOLOGY, V75, P91, DOI 10.1097/00000542-199107000-00015; MITSUHASHI T, 1994, PARAPLEGIA, V32, P524, DOI 10.1038/sc.1994.84; NISHIBE M, 1989, Hokkaido Journal of Medical Science, V64, P301; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PFEIFFER FE, 1983, ARCH NEUROL-CHICAGO, V40, P169, DOI 10.1001/archneur.1983.04050030063012; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; Sala A, 2001, BIOCHEM BIOPH RES CO, V283, P1003, DOI 10.1006/bbrc.2001.4865; Sener G, 2007, J PHARM PHARMACOL, V59, P837, DOI 10.1211/jpp.59.6.0009; Serarslan Y, 2010, J CLIN NEUROSCI, V17, P349, DOI 10.1016/j.jocn.2009.03.036; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; SUN Y, 1988, CLIN CHEM, V34, P497; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; TARLOV IM, 1972, J NEUROSURG, V36, P10, DOI 10.3171/jns.1972.36.1.0010; TSUNG SH, 1976, CLIN CHEM, V22, P173; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yilmaz G., 2007, THESIS; Yu GL, 2005, PHARMACOLOGY, V73, P31, DOI 10.1159/000081072; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	36	14	16	0	5	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JUN	2014	18	12					1770	1777					8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AP3KV	WOS:000341975800018	24992621				2022-02-06	
J	Ozawa, T; Takeda, T; Ishigami, K; Narimatsu, K; Hasegawa, K; Nakajima, K; Noh, K				Ozawa, Takamitsu; Takeda, Tomotaka; Ishigami, Keiichi; Narimatsu, Keishiro; Hasegawa, Ken; Nakajima, Kazunori; Noh, Kwantae			Shock absorption ability of mouthguard against forceful, traumatic mandibular closure	DENTAL TRAUMATOLOGY			English	Article						mouthguard; shock absorption ability; traumatic mandibular closure; tooth; mandibular; strain	HIGH-SCHOOL FOOTBALL; OF-THE-LITERATURE; PROFESSIONAL FOOTBALL; DENTAL INJURIES; CONCUSSIONS; FRACTURES; PREVENTION; IMPACT; SAFE	BackgroundThe positive effects of wearing a mouthguard on shock absorption have been indicated in various papers. The ability of a mouthguard to protect against indirect injury, however, is not clear, and the thickness that a mouthguard would require to provide such protection remains to be determined. The primary aim of this study was to clarify the shock absorption potential of a mouthguard against forced, traumatic occlusion. The secondary objective was to compare the shock absorption ability of different thicknesses of mouthguard against this type of trauma. Materials and methodsAn artificial skull (ZA20; 3B Scientific International, Co. Ltd, Niigata, Japan) with two-axis strain gages applied to the right buccal aspect of the mandible and the mandibular and maxillary teeth was used to measure shock absorption ability. Three different thicknesses of EVA mouthguard (1, 2, and 3mm at the first molar) were tested. Results and conclusionsWithin the limitations of this laboratory study, the following results were obtained: the results showed that increasing the thickness of the mouthguard improved its shock absorption ability.	[Ozawa, Takamitsu; Takeda, Tomotaka; Ishigami, Keiichi; Narimatsu, Keishiro; Hasegawa, Ken; Nakajima, Kazunori] Kyung Hee Univ, Dept Sports Dent, Tokyo Dent Coll, Chiba 2618502, Japan; [Noh, Kwantae] Kyung Hee Univ, Dept Prosthodont, Sch Dent, Chiba 2618502, Japan		Takeda, T (corresponding author), Kyung Hee Univ, Dept Sports Dent, Tokyo Dent Coll, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	ttakeda@tdc.ac.jp	Noh, Kwantae/AAK-3492-2020	Noh, Kwantae/0000-0003-3480-7737			ADA, 2006, J AM DENT ASSOC, V137, P1712; Andreasen JO, 2007, TXB COLOR ATLAS TRAU; Andreasen JO AF, 1994, TXB COLOR ATLAS TRAU; Araki A, 2004, J SPORTS DENT, V7, P1; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Del Rossi G, 2007, DENT TRAUMATOL, V23, P149, DOI 10.1111/j.1600-9657.2006.00436.x; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hayakawa Masaya, 2006, Shikwa Gakuho, V106, P81; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Holan G, 1998, Int J Paediatr Dent, V8, P143; Iinuma M, 2003, J SPORTS DENT, V6, P16; Kawarai C, 2004, J SPORTS DENT, V7, P36; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Ou Meiqi, 1996, Bulletin of Tokyo Medical and Dental University, V43, P13; Padilla R, 1996, J Calif Dent Assoc, V24, P30; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ranalli DN, 2002, DENT TRAUMATOL, V18, P231, DOI 10.1034/j.1600-9657.2002.00122.x; Rayes MA, 2009, INT J SPORTS DENT, V2; Satoh T, 1990, J JPN SOC BIOMECHANI, V14, P68; Saura-Ingles A, 2005, BRIT DENT J, V199, P27, DOI 10.1038/sj.bdj.4812536; Shomura M., 2007, J MATSUMOTO DENT U S, V33, P255; Tajima T, 2003, J SPORTS DENT, V6, P1; Takahashi Mutsumi, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P465; Takamata T, 2008, J SPORTS DENT, V12, P38; Takeda T, 2006, DENT TRAUMATOL, V22, P77, DOI 10.1111/j.1600-9657.2006.00361.x; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Takeda T, 2004, DENT TRAUMATOL, V20, P150, DOI 10.1111/j.1600-4469.2004.00247.x; Takeda T, 2008, DENT TRAUMATOL, V24, P360, DOI 10.1111/j.1600-9657.2008.00576.x; Tejani Z, 2008, DENT TRAUMATOL, V24, P253, DOI 10.1111/j.1600-9657.2007.00537.x; Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Yamada J, 2003, J SPORTS DENT, V6, P42	41	14	15	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2014	30	3					204	210		10.1111/edt.12063			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AG5OT	WOS:000335469000007	23998278				2022-02-06	
J	Zelnick, LR; Morrison, LJ; Devlin, SM; Bulger, EM; Brasel, KJ; Sheehan, K; Minei, JP; Kerby, JD; Tisherman, SA; Rizoli, S; Karmy-Jones, R; van Heest, R; Newgard, CD				Zelnick, Leila R.; Morrison, Laurie J.; Devlin, Sean M.; Bulger, Eileen M.; Brasel, Karen J.; Sheehan, Kellie; Minei, Joseph P.; Kerby, Jeffrey D.; Tisherman, Samuel A.; Rizoli, Sandro; Karmy-Jones, Riyad; van Heest, Rardi; Newgard, Craig D.		Resuscitation Outcomes Consortium	Addressing the Challenges of Obtaining Functional Outcomes in Traumatic Brain Injury Research: Missing Data Patterns, Timing of Follow-Up, and Three Prognostic Models	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial design; functional outcomes; prognostic models; traumatic brain injury	SEVERE HEAD-INJURY; HYPERTONIC RESUSCITATION; CLINICAL-TRIALS; MULTICENTER; VALIDATION; REGRESSION; EFFICACY; SCALE	Traumatic brain injury (TBI) is common and debilitating. Randomized trials of interventions for TBI ideally assess effectiveness by using long-term functional neurological outcomes, but such outcomes are difficult to obtain and costly. If there is little change between functional status at hospital discharge versus 6 months, then shorter-term outcomes may be adequate for use in future clinical trials. Using data from a previously published multi-center, randomized, placebo-controlled TBI clinical trial, we evaluated patterns of missing outcome data, changes in functional status between hospital discharge and 6 months, and three prognostic models to predict long-term functional outcome from covariates available at hospital discharge (functional measures, demographics, and injury characteristics). The Resuscitation Outcomes Consortium Hypertonic Saline trial enrolled 1282 TBI patients, obtaining the primary outcome of 6-month Glasgow Outcome Score Extended (GOSE) for 85% of patients, but missing the primary outcome for the remaining 15%. Patients with missing outcomes had less-severe injuries, higher neurological function at discharge (GOSE), and shorter hospital stays than patients whose GOSE was obtained. Of 1066 (83%) patients whose GOSE was obtained both at hospital discharge and at 6-months, 71% of patients had the same dichotomized functional status (severe disability/death vs. moderate/no disability) after 6 months as at discharge, 28% had an improved functional status, and 1% had worsened. Performance was excellent (C-statistic between 0.88 and 0.91) for all three prognostic models and calibration adequate for two models (p values, 0.22 and 0.85). Our results suggest that multiple imputation of the standard 6-month GOSE may be reasonable in TBI research when the primary outcome cannot be obtained through other means.	[Zelnick, Leila R.; Sheehan, Kellie] Univ Washington, ROC Clin Trial Ctr, Dept Biostat, Seattle, WA 98105 USA; [Morrison, Laurie J.] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Devlin, Sean M.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Brasel, Karen J.] Med Coll Wisconsin, Div Trauma Crit Care, Milwaukee, WI 53226 USA; [Minei, Joseph P.] UT Southwestern Med Ctr, Dept Surg BTCC, Dallas, TX USA; [Kerby, Jeffrey D.] Univ Alabama Birmingham, Sch Med, Dept Surg, Birmingham, AL 35294 USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Surg, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Rizoli, Sandro] Univ Toronto, St Michaels Hosp, Dept Surg & Crit Care Med, Toronto, ON, Canada; [Karmy-Jones, Riyad] Southwest Washington Med Ctr, Div Trauma & Thorac, Vancouver, WA USA; [Karmy-Jones, Riyad] Southwest Washington Med Ctr, Div Vasc Surg, Vancouver, WA USA; [van Heest, Rardi] Royal Columbian Hosp, Dept Surg, New Westminster, BC, Canada; [Newgard, Craig D.] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA		Zelnick, LR (corresponding author), Univ Washington, ROC Clin Trial Ctr, Dept Biostat, 1107 NE 45th St,Suite 505, Seattle, WA 98105 USA.	lzelnick@u.washington.edu	morrison, laurie J/A-6325-2012; Tisherman, Samuel A./AAK-9377-2020	morrison, laurie J/0000-0001-8369-9774; Tisherman, Samuel A./0000-0003-3810-3729; Zelnick, Leila/0000-0002-8461-5111	University of Washington Data Coordinating Center from the National Heart, Lung and Blood Institute (NHLBI) [5U01 HL077863]; University of Iowa from the National Heart, Lung and Blood Institute (NHLBI) [HL077865]; Medical College of Wisconsin from the National Heart, Lung and Blood Institute (NHLBI) [HL077866]; University of Washington from the National Heart, Lung and Blood Institute (NHLBI) [HL077867]; University of Pittsburgh from the National Heart, Lung and Blood Institute (NHLBI) [HL077871]; St. Michael's Hospital from the National Heart, Lung and Blood Institute (NHLBI) [HL077872]; Oregon Health & Science University from the National Heart, Lung and Blood Institute (NHLBI) [HL077873]; University of Alabama at Birmingham from the National Heart, Lung and Blood Institute (NHLBI) [HL077881]; Ottawa Hospital Research Institute from the National Heart, Lung and Blood Institute (NHLBI) [HL077885]; University of Texas SW Medical Center Dallas from the National Heart, Lung and Blood Institute (NHLBI) [HL077887]; University of California San Diego from the National Heart, Lung and Blood Institute (NHLBI) [HL077908]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Institute of Circulatory and Respiratory Health; Defense Research and Development Canada; Heart, Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; American Heart AssociationAmerican Heart Association; ROC; NovoNordiskNovo Nordisk; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 CA09168]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009168] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077871, U01HL077887, U01HL077885, U01HL077865, U01HL077908, U01HL077866, U01HL077867, U01HL077872, U01HL077863, U01HL077881, U01HL077873] Funding Source: NIH RePORTER	The ROC is supported by a series of cooperative agreements to 10 regional clinical centers and one data coordinating center (5U01 HL077863-University of Washington Data Coordinating Center, HL077865-University of Iowa, HL077866-Medical College of Wisconsin, HL077867-University of Washington, HL077871-University of Pittsburgh, HL077872-St. Michael's Hospital, HL077873-Oregon Health & Science University, HL077881-University of Alabama at Birmingham, HL077885-Ottawa Hospital Research Institute, HL077887-University of Texas SW Medical Center Dallas, and HL077908-University of California San Diego) from the National Heart, Lung and Blood Institute (NHLBI) in partnership with the National Institute of Neurological Disorders and Stroke, U.S. Army Medical Research and Material Command, The Canadian Institutes of Health Research (CIHR), the Institute of Circulatory and Respiratory Health, Defense Research and Development Canada, the Heart, Stroke Foundation of Canada, and the American Heart Association. Laurie J. Morrison (Toronto Regional Coordinating Center [RCC]), Eileen M. Bulger (Data Coordinating Center, University of Washington, Seattle RCC), Karen J. Brasel (Milwaukee RCC), Kellie Sheehan (Data Coordinating Center, University of Washington), Joseph P. Minei (Dallas RCC), Jeffrey D. Kerby (Alabama RCC), and Samuel A. Tisherman (Pittsburgh RCC) all receive ROC funding. Sandro Rizoli receives ROC funding for the PROPPR study, plus honoraria from CSL Behring and KCI and, until recently, a CIHR new investigator award in partnership with NovoNordisk. Leila R. Zelnick receives salary support from the National Institutes of Health (NIH; grant no.: T32 CA09168). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI or the NIH.	BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Edwards P, 2005, LANCET, V365, P1957; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming TR, 2011, ANN INTERN MED, V154, P113, DOI 10.7326/0003-4819-154-2-201101180-00010; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; R Development Core Team, 2012, LANG ENV STAT COMP; Rubin D.B., 1987, MULTIPLE IMPUTATION; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	32	14	14	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1029	1038		10.1089/neu.2013.3122			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300005	24552494	Green Published			2022-02-06	
J	Cunningham, C; Chen, WC; Shorten, A; McClurkin, M; Choezom, T; Schmidt, CP; Chu, V; Bozik, A; Best, C; Chapman, M; Furman, M; Detyniecki, K; Giacino, JT; Blumenfeld, H				Cunningham, Courtney; Chen, William C.; Shorten, Andrew; McClurkin, Michael; Choezom, Tenzin; Schmidt, Christian P.; Chu, Victoria; Bozik, Anne; Best, Cameron; Chapman, Melissa; Furman, Moran; Detyniecki, Kamil; Giacino, Joseph T.; Blumenfeld, Hal			Impaired consciousness in partial seizures is bimodally distributed	NEUROLOGY			English	Article							TEMPORAL-LOBE EPILEPSY; COMA RECOVERY SCALE; ICTAL CONSCIOUSNESS; VEGETATIVE STATE; CLASSIFICATION; COMPLEX; RESPONSIVENESS; RES	Objective:To investigate whether impaired consciousness in partial seizures can usually be attributed to specific deficits in the content of consciousness or to a more general decrease in the overall level of consciousness.Methods:Prospective testing during partial seizures was performed in patients with epilepsy using the Responsiveness in Epilepsy Scale (n = 83 partial seizures, 30 patients). Results were compared with responsiveness scores in a cohort of patients with severe traumatic brain injury evaluated with the JFK Coma Recovery Scale-Revised (n = 552 test administrations, 184 patients).Results:Standardized testing during partial seizures reveals a bimodal scoring distribution, such that most patients were either fully impaired or relatively spared in their ability to respond on multiple cognitive tests. Seizures with impaired performance on initial test items remained consistently impaired on subsequent items, while other seizures showed spared performance throughout. In the comparison group, we found that scores of patients with brain injury were more evenly distributed across the full range in severity of impairment.Conclusions:Partial seizures can often be cleanly separated into those with vs without overall impaired responsiveness. Results from similar testing in a comparison group of patients with brain injury suggest that the bimodal nature of Responsiveness in Epilepsy Scale scores is not a result of scale bias but may be a finding unique to partial seizures. These findings support a model in which seizures either propagate or do not propagate to key structures that regulate overall arousal and thalamocortical function. Future investigations are needed to relate these behavioral findings to the physiology underlying impaired consciousness in partial seizures.	[Cunningham, Courtney; Chen, William C.; Shorten, Andrew; McClurkin, Michael; Choezom, Tenzin; Schmidt, Christian P.; Chu, Victoria; Bozik, Anne; Best, Cameron; Chapman, Melissa; Furman, Moran; Detyniecki, Kamil; Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA		Blumenfeld, H (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	hal.blumenfeld@yale.edu	Giacino, Joseph/AAF-1952-2021; Chapman, Melissa/AAA-8332-2021	Giacino, Joseph/0000-0002-7916-9698; Chapman, Melissa/0000-0002-1377-1539; Chen, William/0000-0001-8924-5853	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS055829]; Clinical and Translational Science Award (CTSA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR0249139]; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A031713]; Patrick and Catherine Weldon Donaghue Medical Research Foundation; Betsy and Jonathan Blattmachr Family; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055829] Funding Source: NIH RePORTER	Supported by NIH R01 NS055829, Clinical and Translational Science Award (CTSA) UL1 RR0249139, National Institute on Disability and Rehabilitation Research (NIDRR) H133A031713, the Patrick and Catherine Weldon Donaghue Medical Research Foundation, and by the Betsy and Jonathan Blattmachr Family.	Ali F, 2012, EPILEPSY BEHAV, V23, P98, DOI 10.1016/j.yebeh.2011.11.021; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Bauerschmidt A, 2013, EPILEPSY BEHAV, V26, P25, DOI 10.1016/j.yebeh.2012.10.022; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x; Blumenfeld H, 2004, NEUROLOGY, V63, P1015, DOI 10.1212/01.WNL.0000141086.91077.CD; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Blumenfeld H, 2013, EPILEPSIA, V54, P1125, DOI 10.1111/epi.12157; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; Blumenfeld H, 2011, NEUROL CLIN, V29, P801, DOI 10.1016/j.ncl.2011.07.014; Cavanna AE, 2008, EPILEPSY BEHAV, V13, P184, DOI 10.1016/j.yebeh.2008.01.009; Cavanna AE, 2011, EPILEPSY BEHAV, V22, P651, DOI 10.1016/j.yebeh.2011.10.003; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Englot DJ, 2010, BRAIN, V133, P3764, DOI 10.1093/brain/awq316; Englot DJ, 2009, J NEUROSCI, V29, P13006, DOI 10.1523/JNEUROSCI.3846-09.2009; ESCUETA AVD, 1982, ANN NEUROL, V11, P292, DOI 10.1002/ana.410110310; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Herskovitz M, 2012, J CLIN NEUROSCI, V19, P1605, DOI 10.1016/j.jocn.2012.04.004; Johanson M, 2011, BEHAV NEUROL, V24, P11, DOI [10.3233/BEN-2011-0316, 10.1155/2011/874295]; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Laff R, 2003, NEUROLOGY, V61, P1262, DOI 10.1212/01.WNL.0000090464.03392.9B; Lambert I, 2012, EPILEPSIA, V53, P2104, DOI 10.1111/j.1528-1167.2012.03690.x; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Laureys S, 2009, ANN NEW YORK ACAD SC; Lee KH, 2002, NEUROLOGY, V59, P841, DOI 10.1212/WNL.59.6.841; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; McPherson A, 2012, EPILEPSIA, V53, pe180, DOI 10.1111/j.1528-1167.2012.03657.x; Motelow JE, 2012, SOC NEUR ABS; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Yang L, 2012, EPILEPSIA, V53, P437, DOI 10.1111/j.1528-1167.2011.03341.x	37	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAY 13	2014	82	19					1736	1744		10.1212/WNL.0000000000000404			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH9XO	WOS:000336499000017	24727311	Green Published			2022-02-06	
J	Dhandapani, S; Sharma, A; Sharma, K; Das, L				Dhandapani, Sivashanmugam; Sharma, Anurag; Sharma, Karamchand; Das, Lakshman			Comparative evaluation of MRS and SPECT in prognostication of patients with mild to moderate head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Head injury; Hypoperfusion; MRS; NAA/Cr ratio; Outcome; SPECT	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; PHOTON EMISSION CT; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; DAMAGE; EPIDEMIOLOGY; PERFORMANCE	Magnetic resonance spectroscopy (MRS) and single-photon emission computed tomography (SPECT) have only been individually studied in patients with head injury. This study aimed to comparatively assess both in patients with mild to moderate head injury. Patients with a Glasgow Coma Scale (GCS) score of 9-14 who underwent MRS and/or SPECT were evaluated in relation to various clinical factors and neurological outcome at 3 months. There were 56 SPECT (Tc99m-ethylcysteinate dimer [ECD]) studies and 41 single voxel proton MRS performed in 53 patients, with 41 patients having both. Of the 41 who underwent MRS, 13 had a lower N-acetyl-aspartate/creatine (NAA/Cr) ratio, 14 had a higher choline (Cho)/Cr ratio, 19 were normal, and nine had bilateral MRS abnormalities. Of the 56 who underwent SPECT, 22 and 19 had severe and moderate hypoperfusion, respectively. Among those in Traumatic Coma Data Bank CT scan category 1 and 2, 50% had MRS abnormalities, whereas 64% had SPECT hypoperfusion, suggesting greater incremental validity of SPECT over MRS. In univariate analyses, GCS, moderate/severe hypoperfusion and bilateral SPECT changes were found to have significant association with unfavorable outcome (odds ratio 13.2, 15.9, and 4.4, and p values <0.01, 0.01, and 0.05, respectively). Patients with lower NAA/Cr ratio in MRS had more unfavorable outcomes, however this was not significant. In multivariate analysis employing binary logistic regression, GCS and severe hypoperfusion on SPECT were noted to have significant association with unfavorable outcome, independent of age, CT scan category, and MRS abnormalities (p values = 0.02 and 0.04, respectively). To conclude, ECD-SPECT seems to have greater sensitivity, incremental validity and prognostic value than single voxel proton MRS in select patients with head injury, with only severe hypoperfusion in SPECT significantly associated with unfavorable outcome independent of other confounding factors. (C) 2013 Elsevier Ltd. All rights reserved.	[Sharma, Anurag] Safdarjang Hosp, Dept Neurosurg, New Delhi, India; PGIMER, Chandigarh, India		Dhandapani, S (corresponding author), Safdarjang Hosp, Dept Neurosurg, New Delhi, India.	ssdhandapani.neurosurg@gmail.com	Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255			Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnold DL, 1996, MR SPECTROSCOPY CLIN, P139; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Devous Michael D Sr, 2005, NeuroRx, V2, P237, DOI 10.1007/BF03206669; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P107, DOI 10.1016/S0973-0508(10)80024-3; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P23, DOI 10.1016/S0973-0508(10)80007-3; Du YL, 2011, NEUROL INDIA, V59, P31, DOI 10.4103/0028-3886.86540; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; ICHISE M, 1994, J NUCL MED, V35, P217; Jacobs A, 1996, J NUCL MED, V37, P1605; JENNETT B, 1975, LANCET, V1, P480; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Marshall LF, 1991, J NEUROSURG S, V75, P14; Masdeu JC, 2008, SEMIN NEUROL, V28, P423, DOI 10.1055/s-0028-1083683; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Nayak P, 2011, J NEUROSCI RURAL PRA, V2, P12, DOI 10.4103/0976-3147.80079; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Son BC, 2000, ACT NEUR S, V76, P13; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427	35	14	14	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2014	21	5					745	750		10.1016/j.jocn.2013.07.038			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH0JP	WOS:000335805500007	24417798				2022-02-06	
J	Lipszyc, J; Levin, H; Hanten, G; Hunter, J; Dennis, M; Schachar, R				Lipszyc, Jonathan; Levin, Harvey; Hanten, Gerri; Hunter, Jill; Dennis, Maureen; Schachar, Russell			Frontal White Matter Damage Impairs Response Inhibition in Children Following Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Response inhibition; Impulsiveness; Brain lesions; White matter; Frontal lobe	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; STOP-SIGNAL TASK; DEFICIT HYPERACTIVITY DISORDER; BEHAVIOR RATING INVENTORY; EVENT-RELATED FMRI; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; HEAD-INJURY; ONGOING RESPONSES; PERFORMANCE	Inhibition, the ability to suppress inappropriate cognitions or behaviors, can be measured using computer tasks and questionnaires. Inhibition depends on the frontal cortex, but the role of the underlying white matter (WM) is unclear. We assessed the specific impact of frontal WM damage on inhibition in 29 children with moderate-to-severe traumatic brain injury (15 with and 14 without frontal WM damage), 21 children with orthopedic injury, and 29 population controls. We used the Stop Signal Task to measure response inhibition, the Behavior Rating Inventory of Executive Function to assess everyday inhibition, and T2 fluid-attenuated inversion recovery magnetic resonance imaging to identify lesions. Children with frontal WM damage had impaired response inhibition compared with all other groups and poorer everyday inhibition than the orthopedic injury group. Frontal WM lesions most often affected the superior frontal gyrus. These results provide evidence for the critical role of frontal WM in inhibition.	[Lipszyc, Jonathan; Schachar, Russell] Hosp Sick Children, Dept Psychiat Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Lipszyc, Jonathan; Schachar, Russell] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Levin, Harvey; Hanten, Gerri] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill] Texas Childrens Hosp, Dept Pediat Neuroradiol, Houston, TX 77030 USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada		Schachar, R (corresponding author), Hosp Sick Children, Dept Psychiat Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	russell.schachar@sickkids.ca		Schachar, Russell/0000-0002-2015-4395	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-64277, MOP-44070, MOP-74699]; Hospital for Sick ChildrenUniversity of Toronto; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-21889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by the Canadian Institutes of Health Research (Frederick Banting and Charles Best Canada Graduate Scholarship to J.L. and MOP-64277, MOP-44070, and MOP-74699 to R. S.); the Hospital for Sick Children (Restracomp Studentship to J.L.); and the National Institutes of Health (NS-21889 to H.L.).	Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bari A, 2011, J NEUROSCI, V31, P9254, DOI 10.1523/JNEUROSCI.1543-11.2011; Bunce D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013567; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Damasio H, 1995, HUMAN BRAIN ANATOMY; Damasio H., 1989, LESION ANAL NEUROPSY; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Easdon C, 2004, BRAIN COGNITION, V54, P136; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Logan GD, 1994, INHIBITORY PROCESSES, P189; Madsen KS, 2010, NEUROPSYCHOLOGIA, V48, P854, DOI 10.1016/j.neuropsychologia.2009.11.001; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muggleton NG, 2010, J COGNITIVE NEUROSCI, V22, P2804, DOI 10.1162/jocn.2010.21416; Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schutter DJ, 2009, METHODS SOCIAL NEURO, P233; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; TEASDALE G, 1974, LANCET, V2, P81; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Young SE, 2009, J ABNORM PSYCHOL, V118, P117, DOI 10.1037/a0014657	59	14	15	0	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2014	29	3					289	299		10.1093/arclin/acu004			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AG9WC	WOS:000335769700008	24618405	Bronze, Green Published			2022-02-06	
J	Murayama, H; Hitosugi, M; Motozawa, Y; Ogino, M; Koyama, K				Murayama, Haruo; Hitosugi, Masahito; Motozawa, Yasuki; Ogino, Masahiro; Koyama, Katsuhiro			Rotational Acceleration during Head Impact Resulting from Different Judo Throwing Techniques	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						head injury; judo; prevention; head acceleration; biomechanics	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; BIOMECHANICS; EPIDEMIOLOGY; SPORTS	Most severe head injuries in judo are reported as acute subdural hematoma. It is thus necessary to examine the rotational acceleration of the head to clarify the mechanism of head injuries. We determined the rotational acceleration of the head when the subject is thrown by judo techniques. One Japanese male judo expert threw an anthropomorphic test device using two throwing techniques, Osoto-gari and Ouchigari. Rotational and translational head accelerations were measured with and without an under-mat. For Osoto-gari, peak resultant rotational acceleration ranged from 4,284.2 rad/s(2) to 5,525.9 rad/s(2) and peak resultant translational acceleration ranged from 64.3 g to 87.2 g; for Ouchi-gari, the accelerations respectively ranged from 1,708.0 rad/s(2) to 2,104.1 rad/s(2) and from 120.2 g to 149.4 g. The resultant rotational acceleration did not decrease with installation of an under-mat for both Ouchi-gari and Osoto-gari. We found that head contact with the tatami could result in the peak values of translational and rotational accelerations, respectively. In general, because kinematics of the body strongly affects translational and rotational accelerations of the head, both accelerations should be measured to analyze the underlying mechanism of head injury. As a primary preventative measure, throwing techniques should be restricted to participants demonstrating ability in ukemi techniques to avoid head contact with the tatami.	[Murayama, Haruo] Dokkyo Med Univ, Dept Sports Sci, Sch Med, Shimotsuga, Tochigi 3210293, Japan; [Hitosugi, Masahito; Motozawa, Yasuki] Dokkyo Med Univ, Dept Legal Med, Sch Med, Shimotsuga, Tochigi 3210293, Japan; [Ogino, Masahiro] Dokkyo Med Univ, Dept Neurosurg, Sch Med, Shimotsuga, Tochigi 3210293, Japan; [Murayama, Haruo; Koyama, Katsuhiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Kofu, Yamanashi, Japan		Murayama, H (corresponding author), Dokkyo Med Univ, Dept Sports Sci, Sch Med, 880 Kita Kobayashi, Shimotsuga, Tochigi 3210293, Japan.	hmurayam@dokkyomed.ac.jp		Hitosugi, Masahito/0000-0001-5243-8766	Honda RD (Tochigi)	The authors gratefully acknowledge Honda R&D (Tochigi) for support of the experiment.	Akiyama A., 2001, ESV PAP, V463, P1; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Kerrigan JK, 2005, P 19 C ENH SAF VEH E; Kumar Sri, 2012, Biomed Sci Instrum, V48, P239; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Murayama H, 2013, NEUROL MED-CHIR, V53, P580; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmitt KU, 2010, TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION, P1, DOI 10.1007/978-3-642-03713-9; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	14	14	14	1	25	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2014	54	5					374	378		10.2176/nmc.oa.2013-0227			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AI5DA	WOS:000336884400004	24477065	Green Published, Bronze			2022-02-06	
J	Niemela, M; Kinnunen, L; Paananen, R; Hakko, H; Merikukka, M; Karttunen, V; Gissler, M; Rasanen, S				Niemela, Mika; Kinnunen, Lotta; Paananen, Reija; Hakko, Helina; Merikukka, Marko; Karttunen, Vesa; Gissler, Mika; Rasanen, Sami			Parents' traumatic brain injury increases their children's risk for use of psychiatric care: the 1987 Finnish Birth Cohort study	GENERAL HOSPITAL PSYCHIATRY			English	Article						Psychiatric care; Children; Parental TBI	INDIVIDUALS; SUPPORT	Objective: Traumatic brain injury (TBI) of a parent causes significant changes in their family life and parent-children relationships. However, the number of children affected by parental TBI and the long-term consequences for these children remain unknown. We estimated the prevalence of children affected by parental TBI and investigated whether these children had greater use of psychiatric services than their peers. Methods: This a retrospective population-based register study. All 60,069 children born in Finland in 1987 were followed up through national health and social registers from 1987 to 2008. Results: During the 21-year follow-up, 1532 (2.6%) children had a parent with TBI. Overall, 22.5% of those having a parent with TBI were treated in specialized psychiatric care. Use of psychiatric care was significantly increased among those cohort members with a parent with mild [odds ratio (OR) 1.80, 95% confidence interval (CI) 1.37-2.38] or severe (OR 1.49, 95% CI 1.12-1.98) TBI compared to their peers. Conclusions: Parental TBI is associated with increased use of specialized psychiatric services by children. Adult health care services must have appropriate systems in place to address the psychosocial needs and support the welfare and development of children of patients with TBI. (C) 2014 Elsevier Inc. All rights reserved.	[Niemela, Mika] Natl Inst Hlth & Welf, Child & Adolescent Mental Hlth Unit, Helsinki, Finland; [Kinnunen, Lotta; Hakko, Helina] Oulu Univ Hosp, Dept Psychiat, Oulu, Finland; [Paananen, Reija; Merikukka, Marko] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Karttunen, Vesa] Oulu Univ Hosp, Dept Neurol, Oulu, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Rasanen, Sami] Oulu Deaconess Inst, Oulu, Finland		Niemela, M (corresponding author), Natl Inst Hlth & Welf, Child & Adolescent Mental Hlth Unit, Helsinki, Finland.	mika.niemela@thl.fi		Gissler, Mika/0000-0001-8254-7525; Kinnunen, Lotta/0000-0001-5428-6938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006525/1] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K006525/1] Funding Source: UKRI		Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Chuang E, 2013, J SUBST ABUSE TREAT, V45, P118, DOI 10.1016/j.jsat.2013.01.007; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Fryers T., 2007, CHILDREN RISK CHILDH; Gissler M, 1998, SOC SCI MED, V46, P1543, DOI 10.1016/S0277-9536(98)00013-6; Gissler M, 2004, NORSK EPIDEMIOLOGI, V14, P113; Gissler M, 1999, STAKES RES REPORTS; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kobak R., 2006, DEV PSYCHOL, V2nd ed.), P333; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617713000428; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Niemela M, 2012, STRUCTURED CHILD CTR; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; Paananen R, 1987, INT J EPIDEMIOL, V2011, P1; Paananen R, 2013, EUR J PUBLIC HEALTH, V23, P372, DOI 10.1093/eurpub/cks147; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007	30	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	MAY-JUN	2014	36	3					337	341		10.1016/j.genhosppsych.2013.12.012			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AF2AS	WOS:000334515600017	24556261				2022-02-06	
J	Stergiannis, P; Katsoulas, T; Fildissis, G; Intas, G; Galanis, P; Kosta, N; Zidianakis, V; Baltopoulos, G				Stergiannis, Pantelis; Katsoulas, Theodoros; Fildissis, George; Intas, George; Galanis, Peter; Kosta, Natalia; Zidianakis, Vasilios; Baltopoulos, George			Health-Related Quality of Life and Rehabilitation Cost Following Intensive Care Unit Stay in Multiple Trauma Patients	JOURNAL OF TRAUMA NURSING			English	Article						Cost; Multiple trauma patients; Quality of life; Rehabilitation	WORK STATUS; INJURY; DETERMINANTS; SURVIVORS; MEMORIES; ICU	Objectives: The objective of this study was to assess changes in health-related quality of life (HRQOL) in multiple trauma patients due to motor vehicle crashes during a follow-up period of 2 years after discharge from an intensive care unit (ICU) and the effect of income and financial cost of rehabilitation in HRQOL. Methods: The study was a prospective observational study of multiple trauma patients from January 2009 to January 2011 who were hospitalized in a general, medical, and surgical ICU of a district hospital in Athens, Greece. Eighty-five patients with multiple traumas due to motor vehicle crashes and with an ICU stay of more than 24 hours were included in the study. HRQOL was assessed by a general questionnaire, the EuroQol 5D. Results: Increased monthly household income and absence of traumatic brain injuries were associated with an improved EQ-VAS score. The frequency of severe problems in mobility, self-care, usual activities, pain/discomfort, and anxiety/depression decreased over time. The financial cost of rehabilitation was initially high but decreased over time. Conclusions: Severely injured victims of motor vehicle crashes suffer from serious problems in terms of HRQOL which is gradually improved even 2 years after hospital discharge. In addition, HRQOL is significantly related to income. Resources used for rehabilitation decrease over time, but even at 24 months, the patients still use half of the amount as compared with the cost of the first 6 months after trauma.	[Stergiannis, Pantelis; Katsoulas, Theodoros; Fildissis, George; Kosta, Natalia; Zidianakis, Vasilios; Baltopoulos, George] Univ Athens, GONK Agioi Anargyroi Hosp, Intens Care Unit, Sch Nursing, Kalyftaki, N Kifisia, Greece; [Intas, George] Univ Athens, Sch Nursing, Athens 11528, Greece; [Galanis, Peter] Univ Athens, Sch Nursing, Ctr Hlth Serv Management & Evaluat, Athens 11528, Greece		Katsoulas, T (corresponding author), Agisilaou 70 Petroupoli, Athens 13231, Greece.	katsoula@otenet.gr	Stergiannis, Pantelis I./G-2283-2016; Katsoulas, Theodoros/AAD-8516-2019	Stergiannis, Pantelis I./0000-0001-8297-3460; Intas, George/0000-0001-7430-7724			Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Drummond M., 2005, METHODS EC EVALUATIO; Fildissis G, 2007, CROAT MED J, V48, P814, DOI 10.3325/cmj.2007.6.814; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Heyland DK, 1998, CRIT CARE MED, V26, P591, DOI 10.1097/00003246-199803000-00037; Hofhuis JGM, 2009, CURR OPIN CRIT CARE, V15, P425, DOI 10.1097/MCC.0b013e32833079e4; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kaarlola A, 2003, INTENS CARE MED, V29, P1294, DOI 10.1007/s00134-003-1849-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KONOPAD E, 1995, CRIT CARE MED, V23, P1653, DOI 10.1097/00003246-199510000-00008; Kosty JA, 2013, NEUROL RES, V35, P277, DOI 10.1179/1743132813Y.0000000168; Kvale Reidar, 2003, Health Qual Life Outcomes, V1, P2, DOI 10.1186/1477-7525-1-2; Lizana FG, 2003, INTENS CARE MED, V29, P1286, DOI 10.1007/s00134-003-1875-z; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Ringdal M, 2010, CRIT CARE MED, V38, P38, DOI 10.1097/CCM.0b013e3181b42909; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Szende A, 2007, INVENTORY COMP REV U; Timmers TK, 2011, ARCH SURG-CHICAGO, V146, P412, DOI 10.1001/archsurg.2010.279; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Ulvik A, 2008, ACTA ANAESTH SCAND, V52, P195, DOI 10.1111/j.1399-6576.2007.01533.x; WHO, 2004, WORLD REPORT ROAD TR; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yfantopoulos J., 2001, ARCH HELLENIC MED, V18, P180	29	14	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	MAY-JUN	2014	21	3					115	121		10.1097/JTN.0000000000000042			7	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	CB4ZS	WOS:000349637800007	24828773				2022-02-06	
J	Wessel, L; Balakrishnan-Renuka, A; Henkel, C; Meyer, HE; Meller, K; Brand-Saberi, B; Theiss, C				Wessel, Lisa; Balakrishnan-Renuka, Ajeesh; Henkel, Corinna; Meyer, Helmut E.; Meller, Karl; Brand-Saberi, Beate; Theiss, Carsten			Long-term incubation with mifepristone (MLTI) increases the spine density in developing Purkinje cells: new insights into progesterone receptor mechanisms	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Confocal laser scanning microscopy; Electron microscopy; Neuronal development; Microinjection; MALDI IMS; Organotypic slice cultures; PGRMC1; AG 205; Trilostane	TRAUMATIC BRAIN-INJURY; BINDING-PROTEIN 25-DX; SYNTHESIZED DE-NOVO; DENDRITIC GROWTH; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; POSTNATAL-DEVELOPMENT; REGULATED KINASE; RAT; EXPRESSION; BIOSYNTHESIS	Cerebellar Purkinje cells (PC) physiologically reveal an age-dependent expression of progesterone with high endogenous concentrations during the neonatal period. Even if progesterone has been previously shown to induce spinogenesis, dendritogenesis and synaptogenesis in immature PC, data about the effects of progesterone on mature PC are missing, even though they could be of significant therapeutic interest. The current study demonstrates for the first time a progesterone effect, depending on the developmental age of PC. Comparable with the physiological course of the progesterone concentration, experimental treatment with progesterone for 24 h achieves the highest effects on the dendritic tree during the early neonate, inducing an highly significant increase in dendritic length, spine number and spine area, while spine density in mature PC could not be further stimulated by progesterone incubation. Observed progesterone effects are certainly mediated by classical progesterone receptors, as spine area and number were comparable to controls when progesterone incubation was combined with mifepristone (incubation for 24 h), an antagonist of progesterone receptors A and B (PR-A/PR-B). In contrast, an increase in the spine number and area of both immature and mature PC was detected when slice cultures were incubated with mifepristone for more than 72 h (mifepristone long-time incubation, MLTI). By including time-lapse microscopy, electron microscopic techniques, PCR, western blot, and MALDI IMS receptor analysis, as well as specific antagonists like trilostane and AG 205, we were able to detect the underlying mechanism of this diverging mifepristone effect. Thus, our results provide new insights into the function and signaling mechanisms of the recently described progesterone receptor membrane component 1 (PGRMC1) in PC. It is highly suitable that progesterone does not just induce effects by the well-known genomic mechanisms of the classical progesterone receptors but also acts through PGRMC1 mediated non-genomic mechanisms. Thus, our results provide first proofs for a previously discussed progesterone-dependent induction of neurosteroidogenesis in PC by interaction with PGRMC1. But while genomic progesterone effects mediated through classical PR-A and PR-B seem to be restricted to the neonatal period of PC, PGRMC1 also transmits signals by non-genomic mechanisms like regulation of the neurosteroidogenesis in mature PC. Thus, PGRMC1 might be an interesting target for future clinical studies and therapeutic interventions.	[Wessel, Lisa; Balakrishnan-Renuka, Ajeesh; Brand-Saberi, Beate; Theiss, Carsten] Ruhr Univ Bochum, Inst Anat & Mol Embryol, D-44780 Bochum, Germany; [Henkel, Corinna; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; [Meller, Karl; Theiss, Carsten] Ruhr Univ Bochum, Inst Anat, Fac Med, Dept Cytol, D-44780 Bochum, Germany		Theiss, C (corresponding author), Ruhr Univ Bochum, Inst Anat, Fac Med, Dept Cytol, Univ Str 150, D-44780 Bochum, Germany.	carsten.theiss@rub.de			PURE (Protein-research Unit Ruhr within Europe)	The authors gratefully thank C. Grzelak, A. Lodwig, H.- T. Nguyen and J. Elm for excellent technical assistance, as well as A. Lenz for secretarial work. C. Henkel was supported by PURE (Protein-research Unit Ruhr within Europe).	AHIMA RS, 1992, P SOC EXP BIOL MED, V201, P244; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BERRY M, 1976, BRAIN RES, V112, P1, DOI 10.1016/0006-8993(76)90331-0; BERTAGNA X, 1984, J CLIN ENDOCR METAB, V59, P25, DOI 10.1210/jcem-59-1-25; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cadepond F, 1997, ANNU REV MED, V48, P129; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; COMPAGNONE NA, 1995, ENDOCRINOLOGY, V136, P5212, DOI 10.1210/en.136.11.5212; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Furukawa A, 1998, J NEUROCHEM, V71, P2231; GAILLARD RC, 1984, P NATL ACAD SCI-BIOL, V81, P3879, DOI 10.1073/pnas.81.12.3879; Ghoumari AM, 2003, P NATL ACAD SCI USA, V100, P7953, DOI 10.1073/pnas.1332667100; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Kimura I, 2008, J BIOL CHEM, V283, P4323, DOI 10.1074/jbc.M706679200; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; LAIRD SM, 1988, ACTA ENDOCRINOL-COP, V119, P420, DOI 10.1530/acta.0.1190420; LAWSON A, 1992, NEUROENDOCRINOLOGY, V55, P695, DOI 10.1159/000126189; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Maloney SE, 2011, BEHAV SCI-BASEL, V1, P4, DOI 10.3390/behavsci1010004; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meller K, 2005, DEV BRAIN RES, V160, P101, DOI 10.1016/j.devbrainres.2005.08.007; MELLER K, 1989, CELL TISSUE RES, V256, P283; MELLON SH, 1993, BRAIN RES, V629, P283, DOI 10.1016/0006-8993(93)91332-M; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; ROBEL P, 1985, NEUROCHEM INT, V7, P953, DOI 10.1016/0197-0186(85)90143-3; Runko E, 2002, J COMP NEUROL, V451, P289, DOI 10.1002/cne.10356; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Sakamoto H, 2003, NEUROSCI LETT, V343, P163, DOI 10.1016/S0304-9340(03)000362-8; Sakamoto H, 2002, NEUROSCI LETT, V322, P111, DOI 10.1016/S0304-3940(02)00077-0; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; Sakamoto H, 2008, CEREBELLUM, V7, P18, DOI 10.1007/s12311-008-0007-2; Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Theiss C, 2005, EUR J CELL BIOL, V84, P29, DOI 10.1016/j.ejcb.2004.09.001; Theiss C, 2010, MICROSCOPY SCI TECHN, P1091; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Tsutsui K, 2000, NEUROSCI RES, V36, P261, DOI 10.1016/S0168-0102(99)00132-7; Tsutsui K, 2006, CEREBELLUM, V5, P89, DOI 10.1080/14734220600697211; Ukena K, 1998, ENDOCRINOLOGY, V139, P137, DOI 10.1210/en.139.1.137; Ukena K, 1999, ENDOCRINOLOGY, V140, P805, DOI 10.1210/en.140.2.805; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	57	14	16	0	6	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	MAY	2014	71	9					1723	1740		10.1007/s00018-013-1448-4			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AF0RM	WOS:000334421700010	23982753				2022-02-06	
J	Miyauchi, T; Wei, EP; Povlishock, JT				Miyauchi, Takashi; Wei, Enoch P.; Povlishock, John T.			Evidence for the Therapeutic Efficacy of Either Mild Hypothermia or Oxygen Radical Scavengers after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						superoxide dismutase; hypothermia; rats; Tempol; cerebrovascular reactivity; axonal damage	CLOSED-HEAD INJURY; TEMPORAL WINDOW; AXONAL INJURY; INTRACRANIAL-PRESSURE; ANIMAL-MODEL; VULNERABILITY; CONCUSSION; DAMAGE; FK506; TEMPERATURE	Repetitive brain injury, particularly that occurring with sporting-related injuries, has recently garnered increased attention in both the clinical and public settings. In the laboratory, we have demonstrated the adverse axonal and vascular consequences of repetitive brain injury and have demonstrated that moderate hypothermia and/or FK506 exerted protective effects after repetitive mild traumatic brain injury (mTBI) when administered within a specific time frame, suggesting a range of therapeutic modalities to prevent a dramatic exacerbation. In this communication, we revisit the utility of targeted therapeutic intervention to seek the minimal level of hypothermia needed to achieve protection while probing the role of oxygen radicals and their therapeutic targeting. Male Sprague-Dawley rats were subjected to repetitive mTBI by impact acceleration injury. Mild hypothermia (35 degrees C, group 2), superoxide dismutase (group 3), and Tempol (group 4) were employed as therapeutic interventions administered 1 h after the repetitive mTBI. To assess vascular function, cerebral vascular reactivity to acetylcholine was evaluated 3 and 4 h after the repetitive mTBI, whereas to detect the burden of axonal damage, amyloid precursor protein (APP) density in the medullospinal junction was measured. Whereas complete impairment of vascular reactivity was observed in group 1 (without intervention), significant preservation of vascular reactivity was found in the other groups. Similarly, whereas remarkable increase in the APP-positive axon was observed in group 1, there were no significant increases in the other groups. Collectively, these findings indicate that even mild hypothermia or the blunting free radical damage, even when performed in a delayed period, is protective in repetitive mTBI.	[Miyauchi, Takashi; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Miyauchi, Takashi] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077657, NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077675, P30NS047463, R01NS077657] Funding Source: NIH RePORTER	The authors thank Ms. Lynn Davis and Mrs. Susan Walker for their technical assistance. This study was supported by National Institutes of Health grants NS077657 and NS047463.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Campbell K, 2013, BRAIN RES, V1502, P47, DOI 10.1016/j.brainres.2013.01.038; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035313; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Kawanishi Masahiko, 2008, J Stroke Cerebrovasc Dis, V17, P187, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.003; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Khan JN, 2010, EUROPACE, V12, P266, DOI 10.1093/europace/eup376; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Miyauchi T, 2013, J NEUROTRAUM, V30, P1664, DOI 10.1089/neu.2013.2995; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003	49	14	18	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					773	781		10.1089/neu.2013.3181			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200008	24341607	Green Published			2022-02-06	
J	Erenberk, U; Dundaroz, R; Gok, O; Uysal, O; Agus, S; Yuksel, A; Yilmaz, B; Kilic, U				Erenberk, Ufuk; Dundaroz, Rusen; Gok, Ozlem; Uysal, Omer; Agus, Sami; Yuksel, Adnan; Yilmaz, Bayram; Kilic, Ulkan			Melatonin attenuates phenytoin sodium-induced DNA damage	DRUG AND CHEMICAL TOXICOLOGY			English	Article						Antioxidants; DNA damage; melatonin; oxidative stress; phenytoin sodium; rat	CISPLATIN-INDUCED NEPHROTOXICITY; FOCAL CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; REACTIVE OXYGEN; IN-VITRO; PROTECTS; METABOLITE; CATALASE; REPAIR	Phenytoin sodium (PHT Na+) is a potent antiepileptic drug against epileptic seizures and is used as a prophylactic treatment in traumatic brain injury. PHT Na+ leads to the formation of reactive oxygen species (ROS), and DNA is a crucial molecular target of ROS-initiated toxicity. Melatonin and its metabolites possess free-radical-scavenging activity. We therefore designed this study to investigate the potential protective effect of melatonin against PHT Na+-induced DNA damage by using the comet assay in a rat model in vivo. Thirty-three 3-month-old male Wistar rats were divided into five groups of control treated with isotonic sodium chloride (a single injection of isotonic sodium chloride and 100 mL in drinking water for 10 days), ethanol treated (in drinking water for 10 days containing 100 mL of ethanol in each 300-mL drinking bottle), melatonin treated (4 mg/kg body weight [b.w.] intraperitoneally [i.p.] at the start, in drinking water for 10 days), PHT Na+ treated (a single i.p. injection of 50 mg/kg) and PHT Na+ (50 mg/kg b.w., single i.p.) and melatonin (4 mg/kg b.w. i.p. at the start and 4 mg/kg in drinking water for 10 days) cotreated. To determine the protective effects of melatonin, the comet assay was performed using lymphocytes isolated in different time intervals (0, 15, 30, 45 and 60 minutes) from each group of animals. On days 1, 3, 7 and 10, blood samples were taken and the comet assay technique was performed. Our present data suggest that melatonin reversed PHT Na+-induced DNA damage.	[Erenberk, Ufuk; Dundaroz, Rusen] Bezmialem Vakif Univ, Dept Pediat, Istanbul, Turkey; [Gok, Ozlem; Agus, Sami; Kilic, Ulkan] Bezmialem Vakif Univ, Dept Med Biol, Istanbul, Turkey; [Uysal, Omer] Bezmialem Vakif Univ, Fac Med, Dept Biostat, Istanbul, Turkey; [Yuksel, Adnan] Istanbul Univ, Fac Med, Dept Med Genet, Istanbul, Turkey; [Yilmaz, Bayram] Yeditepe Univ, Fac Med, Dept Physiol, Istanbul, Turkey		Kilic, U (corresponding author), Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Adnan Menderes Bulvari Vatan Caddesi, TR-34093 Fatih Istanbul, Turkey.	uckilic@yahoo.com	Uysal, Omer/AAR-4220-2020	Uysal, Omer/0000-0002-8833-697X; Yuksel, Adnan/0000-0002-7275-8254	Scientific and Technological Research Council of TurkeyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [TUBITAK/SBAG 11S418]	This work was supported partially by The Scientific and Technological Research Council of Turkey (TUBITAK/SBAG 11S418).	AMES BN, 1993, ENVIRON HEALTH PERSP, V101, P35, DOI 10.2307/3431840; Bhuller Y, 2006, TOXICOL SCI, V93, P156, DOI 10.1093/toxsci/kfl045; Bhuller Y, 2006, TOXICOL SCI, V93, P146, DOI 10.1093/toxsci/kfl022; Bittigau P, 2003, ANN NY ACAD SCI, V993, P103, DOI 10.1111/j.1749-6632.2003.tb07517.x; Cheung RTF, 2006, J PINEAL RES, V41, P337, DOI 10.1111/j.1600-079X.2006.00372.x; Collins A, 1997, ENVIRON MOL MUTAGEN, V30, P139, DOI 10.1002/(SICI)1098-2280(1997)30:2<139::AID-EM6>3.0.CO;2-I; Dziegiel P, 2002, J PINEAL RES, V33, P95, DOI 10.1034/j.1600-079X.2002.02902.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gitto E, 2001, PEDIATR RES, V50, P756, DOI 10.1203/00006450-200112000-00021; Gitto E, 2001, J PHARM PHARMACOL, V53, P1393, DOI 10.1211/0022357011777747; Hamed SA, 2004, J PHARMACOL SCI, V96, P465, DOI 10.1254/jphs.FPJ04032X; Hara M, 2001, J PINEAL RES, V30, P129, DOI 10.1034/j.1600-079X.2001.300301.x; Hardeland R, 2007, J PINEAL RES, V43, P382, DOI 10.1111/j.1600-079X.2007.00489.x; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Katz I, 2007, J PHARMACOL EXP THER, V322, P494, DOI 10.1124/jpet.107.123133; Kaul A, 2001, TERATOGEN CARCIN MUT, V21, P151, DOI 10.1002/1520-6866(2001)21:2<151::AID-TCM4>3.0.CO;2-E; Kilic E, 2004, J PINEAL RES, V37, P247, DOI 10.1111/j.1600-079X.2004.00162.x; Kilic U, 2005, J PINEAL RES, V38, P67, DOI 10.1111/j.1600-079X.2004.00178.x; Kilic U, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-7; Kilic U, 2012, J PINEAL RES, V52, P228, DOI 10.1111/j.1600-079X.2011.00932.x; Kim PM, 1997, J PHARMACOL EXP THER, V280, P200; Kopjar Nevenka, 2006, Arhiv za Higijenu Rada i Toksikologiju, V57, P155; Lialiaris T, 2008, MUTAGENESIS, V23, P347, DOI 10.1093/mutage/gen020; Lovell DP, 2008, MUTAGENESIS, V23, P171, DOI 10.1093/mutage/gen015; Lowenstein DH, 1998, HARRISONS PRINCIPLES, P2315; Mahle C, 1997, LIFE SCI, V61, P437, DOI 10.1016/S0024-3205(97)00401-3; Manda K, 2007, J PINEAL RES, V42, P386, DOI 10.1111/j.1600-079X.2007.00432.x; Mayo JC, 2003, FREE RADICAL RES, V37, P543, DOI 10.1080/1071576031000083206; Murray JC, 1996, J PEDIAT HEMATOL ONC, V18, P241, DOI 10.1097/00043426-199605000-00033; Nava M, 2000, AM J PHYSIOL-RENAL, V279, pF910, DOI 10.1152/ajprenal.2000.279.5.F910; Ortiz GG, 2008, CURR NEUROPHARMACOL, V6, P203, DOI 10.2174/157015908785777201; Pei Z, 2002, J PINEAL RES, V32, P168, DOI 10.1034/j.1600-079x.2002.1o847.x; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Reiter RJ, 2002, J PHARM PHARMACOL, V54, P1299, DOI 10.1211/002235702760345374; Reiter RJ, 2005, EXP BIOL MED, V230, P104; Reiter RJ, 2003, ADV EXP MED BIOL, V527, P539; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Reiter RJ, 2009, CRIT REV BIOCHEM MOL, V44, P175, DOI 10.1080/10409230903044914; Sandal S, 2008, MUTAT RES-GEN TOX EN, V654, P88, DOI 10.1016/j.mrgentox.2008.05.005; Sener G, 2002, J PINEAL RES, V32, P231, DOI 10.1034/j.1600-079X.2002.01858.x; Singh G, 2005, BRAIN, V128, P7, DOI 10.1093/brain/awh363; Sun FY, 2002, J PINEAL RES, V33, P48, DOI 10.1034/j.1600-079X.2002.01891.x; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Ustundag A, 2007, BIOL TRACE ELEM RES, V117, P53, DOI 10.1007/BF02698083; Urata Y, 1999, FREE RADICAL BIO MED, V27, P838, DOI 10.1016/S0891-5849(99)00131-8; Wells PG, 2010, BIRTH DEFECTS RES C, V90, P103, DOI 10.1002/bdrc.20177; Wells PG, 1997, COMPREHENSIVE TOXICO, P479; Winn LM, 2003, J PHARMACOL EXP THER, V306, P523, DOI 10.1124/jpet.103.052639; Winn LM, 1999, FREE RADICAL BIO MED, V26, P266, DOI 10.1016/S0891-5849(98)00193-2; WINN LM, 1995, MOL PHARMACOL, V48, P112	50	14	14	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0148-0545	1525-6014		DRUG CHEM TOXICOL	Drug Chem. Toxicol.	APR	2014	37	2					233	239		10.3109/01480545.2013.838777			7	Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy; Toxicology	AB8IZ	WOS:000332034900016	24171672				2022-02-06	
J	Sivaswamy, L				Sivaswamy, Lalitha			Approach to Acute Ataxia in Childhood: Diagnosis and Evaluation	PEDIATRIC ANNALS			English	Article							BENIGN PAROXYSMAL VERTIGO; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE CEREBELLAR-ATAXIA; ACUTE OTITIS-MEDIA; CHILDREN; COMPLICATIONS; FEATURES	Ataxia refers to motor incoordination that is usually most prominent during movement or when a child is attempting to maintain a sitting posture. The first part of the review focuses on the anatomic localization of ataxia - both within the nervous system and without - using a combination of historical features and physical findings. The remainder of the review discusses etiological considerations that vary depending on the age group under consideration. In infancy, certain specific diseases, such as opsoclonus myoclonus ataxia syndrome, must receive special mention because the underlying disease process may be amenable to surgical intervention. In the toddler- and school-age groups, certain conditions (such as stroke and acute cerebellitis) require immediate recognition and imaging, whereas others (such as post-infectious ataxia and concussion) require close follow-up. Finally, mention must be made of diseases outside of the central nervous system that can present with ataxia, such as Guillain-Barre syndrome.	[Sivaswamy, Lalitha] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Sivaswamy, Lalitha] Childrens Hosp Michigan, Headache Clin, Detroit, MI USA		Sivaswamy, L (corresponding author), Wayne State Univ, Sch Med, Childrens Hosp Michigan, Dept Neurol, 3901 Beaubien, Detroit, MI 48201 USA.	lsivaswamy@med.wayne.edu					Adams C, 2000, CAN J NEUROL SCI, V27, P316, DOI 10.1017/S0317167100001074; Banwell B, 2007, LANCET NEUROL, V6, P887, DOI 10.1016/S1474-4422(07)70242-9; BASSER LS, 1964, BRAIN, V87, P141, DOI 10.1093/brain/87.1.141; Bigi S, 2012, J CHILD NEUROL, V27, P1378, DOI 10.1177/0883073812452784; BRADSHAW DY, 1992, MUSCLE NERVE, V15, P500, DOI 10.1002/mus.880150415; Brazis PW, 2001, LOCALIZATION CLIN NE, P309; Cuvellier JC, 2010, PEDIATR NEUROL, V42, P1, DOI 10.1016/j.pediatrneurol.2009.07.001; Desai J, 2012, J CHILD NEUROL, V27, P1482, DOI 10.1177/0883073812450318; Edlow JA, 2008, LANCET NEUROL, V7, P951, DOI 10.1016/S1474-4422(08)70216-3; Fumeya Hiroshi, 1994, Neurologia Medico-Chirurgica, V34, P612, DOI 10.2176/nmc.34.612; Gayatri N, 2009, BRAIN DEV-JPN, V31, P618, DOI 10.1016/j.braindev.2008.09.011; GIERONKORTHALS MA, 1994, J CHILD NEUROL, V9, P381, DOI 10.1177/088307389400900408; Gohil JR, 2006, INDIAN PEDIATR, V43, P829; Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f; Hacohen Y, 2011, CLIN NEUROL NEUROSUR, V113, P928, DOI 10.1016/j.clineuro.2011.06.014; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; HEROS RC, 1992, STROKE, V23, P937, DOI 10.1161/01.STR.23.7.937; Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308; Kamate M, 2009, PEDIATR NEUROL, V41, P220, DOI 10.1016/j.pediatrneurol.2009.03.018; KING MD, 1982, HUM TOXICOL, V1, P281, DOI 10.1177/096032718200100311; Kitsko DJ, 2007, CURR ALLERGY ASTHM R, V7, P444, DOI 10.1007/s11882-007-0068-1; LANZI G, 1986, HEADACHE, V26, P494, DOI 10.1111/j.1526-4610.1986.hed2610494.x; Mackay MT, 2010, STROKE, V41, P2201, DOI 10.1161/STROKEAHA.110.583831; Manto Mario, 2012, Handb Clin Neurol, V103, P201, DOI 10.1016/B978-0-444-51892-7.00012-7; Marcelli V, 2006, BRAIN DEV-JPN, V28, P80, DOI 10.1016/j.braindev.2005.05.003; Nussinovitch M, 2003, CLIN PEDIATR, V42, P581, DOI 10.1177/000992280304200702; Pellegrini S, 2012, ACTA OTORRINOLAR ESP, V63, P21, DOI 10.1016/j.otorri.2011.06.007; Ryan MM, 2003, J CHILD NEUROL, V18, P309, DOI 10.1177/08830738030180050901; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; Winchester S, 2013, HAND CLINIC, V112, P1213, DOI 10.1016/B978-0-444-52910-7.00043-X; Yeoh HK, 2006, CHILD NERV SYST, V22, P310, DOI 10.1007/s00381-005-1154-0	31	14	16	0	6	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	APR	2014	43	4					153	159		10.3928/00904481-20140325-13			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AF2XE	WOS:000334575000013	24716559				2022-02-06	
J	Tado, M; Mori, T; Fukushima, M; Oshima, H; Maeda, T; Yoshino, A; Aizawa, S; Katayama, Y				Tado, Masahiro; Mori, Tatsuro; Fukushima, Masamichi; Oshima, Hideki; Maeda, Takeshi; Yoshino, Atsuo; Aizawa, Shin; Katayama, Yoichi			Increased Expression of Vascular Endothelial Growth Factor Attenuates Contusion Necrosis without Influencing Contusion Edema after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular permeability; cerebral contusion; bevacizumab; vascular endothelial growth factor (VEGF)	MIDDLE CEREBRAL-ARTERY; CORTICAL CONTUSION; TRANSIENT ISCHEMIA; VEGF; ANGIOGENESIS; BARRIER; PERMEABILITY; DEGENERATION; BEVACIZUMAB; RECEPTORS	To clarify the role of vascular endothelial growth factor (VEGF) in the formation of contusion edema and necrosis after traumatic brain injury, we examined the time course of changes in the VEGF expression (enzyme-linked immunosorbent assay), cerebrovascular permeability (extravasation of Evans blue), and water content (dry-wet weight method) of the contused brain tissue in a cortical impact injury model using rats. In addition, we tested the effects of administration of bevacizumab (VEGF monoclonal antibody) on changes in the cerebrovascular permeability and water content of the contused brain tissue, as well as the neurological deficits (rota rod test) and volume of contusion necrosis. Increased VEGF expression was maximal at 72 h after injury (p<0.003). Increases in cerebrovascular permeability and water content, however, became maximal within 24 h (p<0.001) after injury (p<0.01), respectively. Administration of bevacizumab did not influence these changes in cerebrovascular permeability and water content, but led to a significant rise in the neurological deficits at 72 h-14 days (p<0.05 or 0.01) and the volume of contusion necrosis at 21 days (p<0.001) after injury. These findings suggest that increased expression of VEGF after injury does not contribute to the formation of contusion edema, but attenuates the formation of contusion necrosis. This is probably because of an increased angiogenesis and improved microcirculation in the areas surrounding the core of contusion.	[Tado, Masahiro; Mori, Tatsuro; Fukushima, Masamichi; Oshima, Hideki; Maeda, Takeshi; Yoshino, Atsuo; Katayama, Yoichi] Nihon Univ, Sch Med, Dept Neurol Surg, Div Neurosurg, Kamimachi, Tokyo 1738610, Japan; [Aizawa, Shin] Nihon Univ, Sch Med, Dept Funct Morphol, Div Anat Sci, Kamimachi, Tokyo 1738610, Japan		Tado, M (corresponding author), Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, 30-1 Oyaguchi, Kamimachi, Tokyo 1738610, Japan.	tadochin1978@yahoo.co.jp					Acevedo LM, 2008, NAT MED, V14, P372, DOI 10.1038/nm0408-372; Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; Bauerle T, 2008, NEOPLASIA, V10, P511, DOI 10.1593/neo.08220; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hai J, 2003, NEUROSURGERY, V53, P963, DOI 10.1227/01.NEU.0000083594.10117.7A; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kawamata T, 1997, ACT NEUR S, V70, P191; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; MADSEN FF, 1990, ACTA NEUROCHIR, V105, P150, DOI 10.1007/BF01670000; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Moreira T, 2006, BEHAV BRAIN RES, V167, P9, DOI 10.1016/j.bbr.2005.06.048; ORTEGA N, 1999, FRONT BIOSCI, V4, P141; Salgaller ML, 2003, CURR OPIN MOL THER, V5, P657; SENGER DR, 1986, CANCER RES, V46, P5629; Shen FX, 2011, J CEREBR BLOOD F MET, V31, P2343, DOI 10.1038/jcbfm.2011.97; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; TODD NV, 1990, ACT NEUR S, V51, P296; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Wang T, 2004, INT J IMPOT RES, V16, P403, DOI 10.1038/sj.ijir.3901186; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	38	14	15	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					691	698		10.1089/neu.2013.2940			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000011	24294928				2022-02-06	
J	Zhu, HP; Gao, Q; Xia, X; Xiang, J; Yao, HL; Shao, JB				Zhu, Huiping; Gao, Qi; Xia, Xin; Xiang, Joe; Yao, Hongli; Shao, Jianbo			Clinically-Important Brain Injury and CT Findings in Pediatric Mild Traumatic Brain Injuries: A Prospective Study in a Chinese Reference Hospital	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						mild traumatic brain injury; children; emergency department; CT scan; clinically-important brain injury	HEAD-INJURY; COMPUTED-TOMOGRAPHY; UNITED-STATES; CHILDREN; POPULATION; EMERGENCY; OUTCOMES; TERM; EPIDEMIOLOGY; CONCUSSION	This study investigated injury patterns and the use of computed tomography (CT) among Chinese children with mild traumatic brain injury (MTBI). We enrolled children with MTBI who were treated within 24 hours of head trauma in the emergency department of Wuhan Medical Care Center for Women and Children in Wuhan, China. Characteristics of MTBIs were analyzed by age and gender. Results of cranial CT scan and clinically-important brain injury (ciTBI) for children were obtained. The definition of ciTBI was: death from TBI, intubation for more than 24 h for TBI, neurosurgery, or hospital admission of 2 nights or more. Of 455 eligible patients with MTBI, ciTBI occurred in two, and no one underwent neurosurgical intervention. CT scans were performed for 441 TBI patients (96.9%), and abnormal findings were reported for 147 patients (33.3%, 95% CI 29.0-37.8). Falls were the leading cause of MTBI (61.5%), followed by blows (18.9%) and traffic collisions (14.1%) for children in the 0-2 group and 10-14 group. For children aged between 3 and 9, the top three causes of TBI were falls, traffic collisions and blows. Leisure activity was the most reported activity when injuries occurred for all age groups. Sleeping/resting and walking ranked in the second and third place for children between 0 and 2 years of age, and walking and riding for the other two groups. The places where the majority injuries occurred were the home for the 0-2 and 3-9 years of age groups, and school for the 10-14 years of age group. There was no statistical difference between boys and girls with regard to the activity that caused the MTBI. This study highlights the important roles that parents and school administrators in the development of preventive measures to reduce the risk of traumatic brain injury in children. Also, identifying children who had a head trauma at very low risk of clinically important TBI for whom CT might be unnecessary is a priority area of research in China.	[Zhu, Huiping; Gao, Qi] Capital Med Univ, Sch Publ Hlth, Beijing 100069, Peoples R China; [Zhu, Huiping; Gao, Qi] Beijing Municipal Key Lab Clin Epidemiol, Beijing 100069, Peoples R China; [Xia, Xin] Hubei Prov Ctr Dis Control & Prevent, Wuhan 430079, Peoples R China; [Xiang, Joe] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yao, Hongli; Shao, Jianbo] Wuhan Childrens Hosp, Wuhan 430016, Peoples R China		Shao, JB (corresponding author), Capital Med Univ, Sch Publ Hlth, 10 Xitoutiao, Beijing 100069, Peoples R China.	zhuhuiping@ccmu.edu.cn; gaoqi@ccmu.edu.cn; xiaxin84@163.com; yxx125@case.edu; yhl778@sina.com; shaojb2002@sina.com	Gao, Qi/N-8721-2019	Gao, Qi/0000-0002-5370-5536			Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; [Anonymous], 2007, NEUR DIS PUBL HLTH C, P164; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Dorfman AL, 2011, ARCH PEDIAT ADOL MED, V165, P458, DOI 10.1001/archpediatrics.2010.270; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Kozlowski KF, 2007, NEUROREHABILITATION, V22, P191; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Murgio A, 2001, CHILD NERV SYST, V17, P257, DOI 10.1007/s003810000403; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Shang Y. Q., 2002, CHIN J RADIOL HLTH, V11, P232; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zhong H. P., 2010, MED INNOVATION CHINA, V7, P166	35	14	16	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2014	11	4					3493	3506		10.3390/ijerph110403493			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	AG9TM	WOS:000335762700002	24675642	Green Published, Green Submitted, gold			2022-02-06	
J	Amara, J; Iverson, KM; Krengel, M; Pogoda, TK; Hendricks, A				Amara, Jomana; Iverson, Katherine M.; Krengel, Maxine; Pogoda, Terri K.; Hendricks, Ann			Anticipating the Traumatic Brain Injury-Related Health Care Needs of Women Veterans After the Department of Defense Change in Combat Assignment Policy	WOMENS HEALTH ISSUES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; IRAQI FREEDOM; MILITARY	Background: Female service members' presence in combat zones during Operation Enduring Freedom and Operation Iraqi Freedom is unprecedented both in terms of the number of women deployed and the nature of their involvement. In light of changing Department of Defense policy governing the deployment of women in combat zones, this article intends to set the groundwork for estimating future combat-related injuries and subsequent Veterans Health Administration (VHA) utilization while focusing on traumatic brain injury (TBI). Methods: The article summarizes and presents the results of a study that examines veterans who present to VHA for TBI evaluation. For a national sample of veterans, a dataset including information on post-screening utilization, diagnoses, and location of care was constructed. The dataset included self-reported health symptoms and other information obtained from a standardized national VHA post-screening clinical evaluation, the comprehensive TBI evaluation (CTBIE). Findings: Both women and men utilize high levels of VHA health care after a CTBIE. However, there are gender differences in the volume and types of services used, with women utilizing different services than their male counterparts and incurring higher costs, including higher overall and outpatient costs. Conclusion: As women veterans seek more of their health care from the VHA, there will be a need for more coordinated care to identify and manage deployment-related TBI and common comorbidities such as posttraumatic stress disorder, depression, and chronic pain. Deployment-connected injuries are likely to rise because of the rescinding of the ban on women in combat. This in turn has critical implications for VHA strategic planning and budgeting. Published by Elsevier Inc.	[Amara, Jomana] Naval Postgrad Sch, DRMI, Monterey, CA 93943 USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Krengel, Maxine] VA Boston Healthcare Syst, Boston, MA USA; [Krengel, Maxine] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Hendricks, Ann] VA Boston Healthcare Syst, Hlth Care Financing & Econ Ctr, Boston, MA USA		Amara, J (corresponding author), Naval Postgrad Sch, DRMI Code 64, 699 Dyer Rd,Bldg 234, Monterey, CA 93943 USA.	jhamara@nps.edu	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780			Amara J., 2011, DETERMINANTS OF UTIL; Bass C. R., 2012, ANNALS OF BIOMEDICAL, V40, P1185; Beckett M. K., 2002, STATUS OF GENDER INT; Bumiller E., 2013, THE NEWYORK TIMES; Burrelli D. F., 2013, WOMEN IN COMBAT ISSU; Congressional Budget Office, 2010, POTENTIAL COSTS OF V; Department of Veterans Affairs, 2009, COMPREHENSIVE TBI EV; Department of Veterans Affairs, 2010, NATIONAL SURVEY OF V; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLINICAL PRAC; Fontana A, 2006, PSYCHIAT QUART, V77, P55, DOI 10.1007/s11126-006-7961-y; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Frayne SM, 2010, SOURCEBOOK WOMEN VET, V1; Frayne SM, 2012, SOURCEBOOK WOMEN VET, V2; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Harrell M. C., 2007, MONOGRAPH REPORTS; Harrell M. C., 2002, THE STATUS OF GENDER; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kaur S, 2007, J GEN INTERN MED, V22, P228, DOI 10.1007/s11606-006-0048-5; Kimerling R, 2011, WOMEN HEALTH ISS, V21, pS145, DOI 10.1016/j.whi.2011.04.007; Krengel M., 2011, VA HEALTH CARE UTILI; Lehavot K, 2012, AM J PREV MED, V42, P473, DOI 10.1016/j.amepre.2012.01.006; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Mengeling MA, 2011, WOMEN HEALTH ISS, V21, pS120, DOI 10.1016/j.whi.2011.04.021; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pellerin C., 2013, DEFENSE GOV NEWS ART; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vogt D., 2011, JOURNAL OF ABNORMAL, V120, P786; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Washington DL, 2007, MIL MED, V172, P812, DOI 10.7205/MILMED.172.8.812; Washington DL, 2013, J GEN INTERN MED, V28, pS571, DOI 10.1007/s11606-012-2323-y	37	14	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1049-3867	1878-4321		WOMEN HEALTH ISS	Womens Health Iss.	MAR-APR	2014	24	2					E171	E176		10.1016/j.whi.2013.12.004			6	Public, Environmental & Occupational Health; Women's Studies	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Women's Studies	AO1ZG	WOS:000341113500003	24630421				2022-02-06	
J	Kawoos, U; Meng, X; Huang, SM; Rosen, A; McCarron, RM; Chavko, M				Kawoos, Usmah; Meng, Xu; Huang, Shi-Min; Rosen, Arye; McCarron, Richard M.; Chavko, Mikulas			Telemetric Intracranial Pressure Monitoring in Blast-Induced Traumatic Brain Injury	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Blast injury; intracranial pressure (ICP); telemetric monitoring; traumatic brain injury (TBI)	HEAD-INJURY; ICP; INCREASE; MODEL	The long-term monitoring of intracranial pressure (ICP) is important for the management of acute and chronic neuropathological conditions which include head injury, traumatic brain injury, hydrocephalus, etc. In this study, we developed an implantable device for measuring ICP over long periods of time in an animal model of blast-induced brain injury. The performance of the device was first evaluated in vitro and subsequently utilized to measure ICP in rats exposed to blast overpressures. The effects of blast-induced brain injury on ICP were measured for six days. A significant difference was observed between the injured group and the nonexposed control group. ICP in injured animals showed a biphasic transient increase; an immediate increase within the first 1-3 h and a more gradual elevation occurring two days after the blast. The ability to monitor changes of ICP continuously over long periods after brain injury and during the course of treatment may improve the prognosis after injury and can also serve as a tool in determining the therapeutic effectiveness of new drugs.	[Kawoos, Usmah; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept NeuroTrauma, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA; [Meng, Xu; Rosen, Arye] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Huang, Shi-Min] Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA		Kawoos, U (corresponding author), Naval Med Res Ctr, Dept NeuroTrauma, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA.	usmahk@gmail.com; xm26@drexel.edu; sh592@drexel.edu; ar86@drexel.edu; richard.mccarron@med.navy.mil; mikulas.chavko@med.navy.mil	Huang, Shimin/X-6369-2019		CDMRP Research Unit [2780.00000.22.A0810]	This work was supported in part by CDMRP Research Unit #2780.00000.22.A0810. Asterisk indicates corresponding author.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Poca MA, 2007, J NEUROSURG, V106, P548, DOI 10.3171/jns.2007.106.4.548; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FRISEN L, 1982, J NEUROL NEUROSUR PS, V45, P13, DOI 10.1136/jnnp.45.1.13; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gregson BA, 2001, J NEUROL NEUROSUR PS, V70, P138; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Jamali S, 1998, BRAIN INJURY, V12, P525, DOI 10.1080/026990598122485; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kiefer Michael, 2012, Acta Neurochir Suppl, V114, P111, DOI 10.1007/978-3-7091-0956-4_20; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Meng X, 2012, ELECTRON LETT, V48, P363, DOI 10.1049/el.2012.0281; Meng XL, 2011, PHIL MAG LETT, V91, P344, DOI 10.1080/09500839.2011.559912; MOSS SM, 1991, EUR J PEDIATR SURG, V1, P25, DOI 10.1055/s-2008-1042533; Paxinos G, 2004, RAT BRAIN STEREOTAXI; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; REID A, 1990, British Journal of Audiology, V24, P123, DOI 10.3109/03005369009077853; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Salvador L, 2010, J NEUROSURG ANESTH, V22, P240, DOI 10.1097/ANA.0b013e3181dbe1cc; Shapiro S, 1996, SURG NEUROL, V45, P278, DOI 10.1016/0090-3019(95)00359-2; Silasi G, 2009, CURR NEUROVASC RES, V6, P62, DOI 10.2174/156720209787466046; Weerakkody Ruwan Alwis, 2012, Acta Neurochir Suppl, V114, P181, DOI 10.1007/978-3-7091-0956-4_35; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	28	14	15	0	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAR	2014	61	3					841	847		10.1109/TBME.2013.2291239			7	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AD5DX	WOS:000333273000023	24557686				2022-02-06	
J	King, PR; Wade, MJ; Beehler, GP				King, Paul R.; Wade, Michael J.; Beehler, Gregory P.			Health Service and Medication Use Among Veterans With Persistent Postconcussive Symptoms	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Chronic pain; health service utilization; persistent postconcussive symptoms; posttraumatic stress disorder; veterans	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; COMORBIDITY SURVEY REPLICATION; MILD HEAD-INJURY; LOW-BACK-PAIN; CARE UTILIZATION; UNITED-STATES; IRAQ WAR; DEPRESSION	Persistent postconcussive symptoms (PPCS) are noted when a series of cognitive, emotional, and somatosensory complaints persist for months after a concussion. Clinical management of PPCS can be challenging in the veteran population because of the nonspecific nature of symptoms and co-occurrence with affective disturbances such as posttraumatic stress disorder (PTSD) and chronic pain. In this study, we compared health service and medication use patterns in a sample of 421 veterans with PPCS with an age-matched cohort of case controls. The results suggest that the veterans with PPCS showed high rates of medical and mental health service utilization during a mean treatment period of 2 years. Although chronic pain commonly co-occurs with PPCS in veterans, service use and medication prescribing trends seem to have been influenced more by the presence of PTSD than chronic pain. Our findings reinforce the overlap among PPCS, PTSD, and chronic pain and demonstrate the complexity inherent in treating these conditions in veterans.	[King, Paul R.; Beehler, Gregory P.] VA Western New York Healthcare Syst, Ctr Integrated Healthcare, Buffalo, NY 14215 USA; [Wade, Michael J.] Syracuse VA Med Ctr, Ctr Integrated Healthcare, Syracuse, NY USA; [Beehler, Gregory P.] SUNY Buffalo, Buffalo, NY 14260 USA		King, PR (corresponding author), VA Western New York Healthcare Syst, Ctr Integrated Healthcare 116N, 3495 Bailey Ave, Buffalo, NY 14215 USA.	Paul.King2@va.gov			Department of Veterans Affairs Office of Academic AffiliationsUS Department of Veterans Affairs; Department of Veterans Affairs Center for Integrated Healthcare, VA Western New York Healthcare System at Buffalo	This study was supported by the Department of Veterans Affairs Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, and the Department of Veterans Affairs Center for Integrated Healthcare, VA Western New York Healthcare System at Buffalo.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arnow BA, 2009, PSYCHIAT SERV, V60, P344, DOI 10.1176/appi.ps.60.3.344; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Beehler GP, 2013, PAIN MED, V14, P1021, DOI 10.1111/pme.12126; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Department of Veterans Affairs/ Department of Defense ( VA/ DoD), 2009, VA DOD CLIN PRACT GU; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Engel CC, 1996, PAIN, V65, P197, DOI 10.1016/0304-3959(95)00164-6; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lund BC, 2013, PSYCHIAT SERV, V64, P21, DOI 10.1176/appi.ps.201100544; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Outcalt SD, PAIN MED; Parsons LS., 2001, SAS SUGI, V26, P214, DOI DOI 10.1016/J.MICINF.2011.07.011; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Ritzwoller DP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-72; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tamcan O, 2010, PAIN, V150, P451, DOI 10.1016/j.pain.2010.05.019; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VA/DoD, 2010, VA DOD CLIN PRACT GU; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; World Health Organization, 2004, ICD 10 INT STAT CLAS	49	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	MAR	2014	202	3					231	238		10.1097/NMD.0000000000000103			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	AD7OK	WOS:000333453300008	24566509				2022-02-06	
J	Ott, S; Schatz, P; Solomon, G; Ryan, JJ				Ott, Summer; Schatz, Philip; Solomon, Gary; Ryan, Joseph J.			Neurocognitive Performance and Symptom Profiles of Spanish-Speaking Hispanic Athletes on the ImPACT Test	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ImPACT; Baseline testing; Neurocognitive performance; Concussion; Spanish-speaking; Language	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TEST-RETEST RELIABILITY; AFRICAN-AMERICAN ACCULTURATION; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; COGNITIVE-ABILITIES; CONSENSUS STATEMENT; CONSTRUCT-VALIDITY; CLINICAL UTILITY; SEX-DIFFERENCES	This study documented baseline neurocognitive performance of 23,815 athletes on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test. Specifically, 9,733 Hispanic, Spanish-speaking athletes who completed the ImPACT test in English and 2,087 Hispanic, Spanish-speaking athletes who completed the test in Spanish were compared with 11,955 English-speaking athletes who completed the test in English. Athletes were assigned to age groups (13-15, 16-18). Results revealed a significant effect of language group (p < .001; partial eta(2) = 0.06) and age (p < .001; partialh eta(2) = 0.01) on test performance. Youngerathletes performed more poorly than older athletes, and Spanish-speaking athletes completing the test in Spanish scored more poorly than Spanish-speaking and English-speaking athletes completing the test in English, on all Composite scores and Total Symptom scores. Spanish-speaking athletes completing the test in English also performed more poorly than English-speaking athletes completing the test in English on three Composite scores. These differences in performance and reported symptoms highlight the need for caution in interpreting ImPACT test data for Hispanic Americans.	[Ott, Summer] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Solomon, Gary] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ryan, Joseph J.] Univ Cent Missouri, Warrensburg, MO USA		Ott, S (corresponding author), Univ Texas Houston, Sch Med, 6400 Fannin St,Suite 1620, Houston, TX 77030 USA.	summer.d.ott@uth.tmc.edu	Solomon, Gary/K-9011-2019				Alegret M, 2012, J CLIN EXP NEUROPSYC, V34, P209, DOI 10.1080/13803395.2011.630652; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Arnold B. R., 1993, ASSESSMENT, V1, P239; Aubry M., 2002, BRIT J SPORT MED, V36, P3; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT, 1989, MILD HEAD INJURY, P257; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bure-Reyes A, 2013, J CLIN EXP NEUROPSYC, V35, P404, DOI 10.1080/13803395.2013.778232; Cohen J., 2013, STAT POWER ANAL BEHA; Cosentino S, 2007, J INT NEUROPSYCH SOC, V13, P228, DOI 10.1017/S1355617707070257; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T., 2010, J NEUROL NEUROSUR PS, V8, P734; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gasquoine PG, 2007, ARCH CLIN NEUROPSYCH, V22, P991, DOI 10.1016/j.acn.2007.08.003; Gasquoine PG, 2012, ARCH CLIN NEUROPSYCH, V27, P268, DOI 10.1093/arclin/acs004; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harris J. G., 2003, CLIN INTERPRETATION; Heaton R. K., 2004, REVISED COMPREHENSIV; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Keith TZ, 2008, INTELLIGENCE, V36, P502, DOI 10.1016/j.intell.2007.11.001; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R., 2012, CLIN INTERPRETATION; Lynn R., 2006, RACE DIFFERENCES INT; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maitland SB, 2000, AGING NEUROPSYCHOL C, V7, P32, DOI 10.1076/anec.7.1.32.807; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; NCAA, 2010, RAC GEND MEMB I PERS; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P307, DOI 10.1093/arclin/acp027; Prifitera A., 2008, WISC 4 CLIN ASSESSME; Putukian M, 2011, PM&R, V3, pS425, DOI 10.1016/j.pmrj.2011.08.003; Quintana M, 2011, ARCH CLIN NEUROPSYCH, V26, P144, DOI 10.1093/arclin/acq098; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, PM&R, V3, pS433, DOI 10.1016/j.pmrj.2011.08.002; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Razani J, 2007, CLIN NEUROPSYCHOL, V21, P776, DOI 10.1080/13854040701437481; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Roivainen E, 2010, INTELLIGENCE, V38, P187, DOI 10.1016/j.intell.2009.10.001; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; US Census, 2010, CENS SUMM; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Weiss L. G., 2010, WAIS 4 CLIN INTERPRE; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zuckerman S., 2012, PEDIATRICS, V10, P1	78	14	14	0	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2014	29	2					152	163		10.1093/arclin/act091			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AB8FY	WOS:000332026800004	24389704	Bronze			2022-02-06	
J	Qiu, B; Li, XG; Sun, XY; Wang, Y; Jing, ZT; Zhang, X; Wang, YJ				Qiu, Bo; Li, Xinguo; Sun, Xiyang; Wang, Yong; Jing, Zhitao; Zhang, Xu; Wang, Yunjie			Overexpression of aquaporin-1 aggravates hippocampal damage in mouse traumatic brain injury models	MOLECULAR MEDICINE REPORTS			English	Article						secondary injury; vasogenic edema; cytotoxic edema; delayed cell death; BALB; c mice	CLOSED-HEAD-INJURY; SELECTIVE VULNERABILITY; CHOROID-PLEXUS; GLIAL-CELLS; IN-VITRO; EDEMA; RAT; PATHOPHYSIOLOGY; ASTROCYTES; EXPRESSION	Secondary insult' following primary traumatic brain injury (TBI), including ischemia and edema, may aggravate brain impairments and affect the outcomes. The hippocampus is particularly sensitive to ischemia or edema due to its selective vulnerability, as neural cells of the hippocampus may be more prone to abnormal function or cell death in response to ischemia and edema. Aquaporin-1 (AQP-1) was reported to be associated with cerebral edema; however, the expression and role of AQP-1 in hippocampal edema following TBI have seldom been investigated. In the current study, BALB/c mouse closed craniocerebral injury models were established and the changes of AQP-1 expression in hippocampi of mouse models following TBI were investigated. Neurological function and edema formation of the models were evaluated and the apoptotic hippocampal cells were then stained in situ and detected, followed by determination of AQP-1 expression in the hippocampus using immunohistochemistry and western blot analysis. As a result, the majority of mice in the TBI group were severely injured and hippocampal edema was confirmed. The apoptotic cells increased significantly in the hippocampi of mice in the TBI group compared with those in the sham group (P<0.01) and the apoptotic rate increased gradually in a time-dependent manner. The expression levels of AQP-1 in the hippocampi of mice were markedly higher in the TBI group than in the sham group (P<0.05) at various time points and AQP-1 expression levels peaked one day following TBI. These results indicate that upregulation of AQP-1 may participate in edema formation and delayed cell death of the hippocampus following TBI and may also be a novel therapeutic target to protect the hippocampus from secondary injury following TBI.	[Qiu, Bo; Li, Xinguo; Wang, Yong; Jing, Zhitao; Wang, Yunjie] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Liaoning, Peoples R China; [Sun, Xiyang] Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China; [Zhang, Xu] Liaoning Ctr Dis Control & Prevent, Shenyang 110005, Liaoning, Peoples R China		Qiu, B (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	bo_qiu@msn.com	Wang, Yonghuai/AAJ-6778-2021	Qiu, Bo/0000-0003-2109-140X	Chinese National Natural Science Foundation of Youth Science Foundation [81000565, 81101917]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2012M520831]; Liaoning Provincial Natural Science Foundation [201102095, 2013021075]	This study was supported by grants from the Chinese National Natural Science Foundation of Youth Science Foundation (grant nos. 81000565 and 81101917), the China Postdoctoral Science Foundation (grant no. 2012M520831) and the Liaoning Provincial Natural Science Foundation (grant nos. 201102095 and 2013021075).	Adeva MM, 2012, NEUROCHEM INT, V61, P166, DOI 10.1016/j.neuint.2012.05.007; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Ameli PA, 2012, ACTA NEUROCHIR SUPPL, V113, P59, DOI 10.1007/978-3-7091-0923-6_13; Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Deng P, 2011, J NEUROTRAUM, V28, P1173, DOI 10.1089/neu.2010.1683; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Kawamata T, 2003, ACTA NEUROCHIR SUPPL, V86, P545; Kim JE, 2009, NEUROSCIENCE, V163, P781, DOI 10.1016/j.neuroscience.2009.07.028; Kim J, 2012, J NEUROSCI RES, V90, P1437, DOI 10.1002/jnr.23017; Kim J, 2011, ANAT CELL BIOL, V44, P295, DOI 10.5115/acb.2011.44.4.295; Kobayashi H, 2001, NEUROSCI LETT, V297, P163, DOI 10.1016/S0304-3940(00)01705-5; Marmarou A., 2007, NEUROSURG FOCUS, V22, P1; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Padayachy LC, 2012, CHILD NERV SYST, V28, P1911, DOI 10.1007/s00381-012-1837-2; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Qiu B, 2012, INT J MOL SCI, V13, P9142, DOI 10.3390/ijms13079142; Ringel F, 1997, ACT NEUR S, V70, P144; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Staub F, 1996, ACT NEUR S, V66, P56; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang Q, 2012, INT J LEGAL MED, V126, P875, DOI 10.1007/s00414-012-0758-7; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022	45	14	14	1	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAR	2014	9	3					916	922		10.3892/mmr.2014.1899			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AC7HO	WOS:000332699000023	24430824	Bronze			2022-02-06	
J	Sandhi, J; Singh, JP; Kaur, T; Ghuman, SS; Singh, AP				Sandhi, Jasmine; Singh, Jaswinder Pal; Kaur, Tajpreet; Ghuman, Sarvpreet Singh; Singh, Amrit Pal			Involvement of progesterone receptors in ascorbic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Ascorbic acid; Progesterone; Ischemia-reperfusion; Acute kidney injury; Oxidative stress	ACUTE-RENAL-FAILURE; TRAUMATIC BRAIN-INJURY; VITAMIN-C; MALE RATS; FUNCTIONAL DEFICITS; GONADAL-STEROIDS; PLASMA-LEVEL; MODULATION; ALLOPREGNANOLONE; EXPRESSION	Background: Ascorbic acid (AA) is an established antioxidant and has been used for treatment of various disorders. Recent reports suggest that administration of AA increases the level of steroids such as progesterone in the body. The present study investigated the protective role of progesterone against ischemia-reperfusion-induced acute kidney injury (AKI) and possible involvement of progesterone receptors in AA-mediated renoprotection in rats. Materials and methods: The male rats were subjected to bilateral renal ischemia for 40 min followed by reperfusion for 24 h to induce AKI. The rats were treated with progesterone (5 and 10 mg/kg, intraperitoneally) and AA (500 mg/kg, intraperitoneally for 1, 2, and 5 d) before AKI. In separate groups, mifepristone, the progesterone receptor antagonist was administered to rats before progesterone (10 mg/kg) and AA treatment (5 d). Various parameters including creatinine clearance, serum urea, uric acid, potassium level, fractional excretion of sodium, lactate dehydrogenase, and microproteinuria were used to assess kidney injury. Moreover, renal tissues were subjected to quantification of oxidative stress and evaluation of histopathologic changes. Results: The exogenous administration of progesterone afforded protection against AKI in a dose-dependent manner that was abolished by mifepristone. The administration of AA for 1, 2, and 5 d induced significant increase in serum progesterone levels and afforded protection against AKI. The antioxidant and renoprotective effect of AA was abolished by prior treatment with mifepristone. Conclusions: It is concluded that exogenous administration of progesterone exerts significant antioxidant and renoprotective effect. Moreover, the progesterone receptors find their explicit involvement in AA-mediated renoprotection against ischemia-reperfusion einduced AKI in rats. (C) 2014 Elsevier Inc. All rights reserved.	[Sandhi, Jasmine; Singh, Jaswinder Pal; Singh, Amrit Pal] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143005, Punjab, India; [Kaur, Tajpreet] Khalsa Coll Pharm, Dept Pharmacol, Amritsar, Punjab, India; [Ghuman, Sarvpreet Singh] Guru Angad Dev Vet & Anim Sci Univ, Coll Vet Sci, Dept Vet Gynaecol & Obstet, Ludhiana, Punjab, India		Singh, AP (corresponding author), Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143005, Punjab, India.	apsingh82@gmail.com	Kaur, Tajpreet/AAA-2282-2021; Singh, Amrit Pal/ABI-8109-2020	Kaur, Tajpreet/0000-0002-3987-4069; Singh, Amrit Pal/0000-0002-7658-241X			AEBI H, 1974, EUR J BIOCHEM, V48, P137, DOI 10.1111/j.1432-1033.1974.tb03751.x; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Andersen ML, 2005, HORM BEHAV, V47, P477, DOI 10.1016/j.yhbeh.2004.12.005; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brann DW, 2005, NEUROENDOCRINOLOGY, V81, P120, DOI 10.1159/000086405; Brown AA, 2001, AM J CLIN NUTR, V73, P673; Buttros JB, 2009, PHARMACOLOGY, V84, P29, DOI 10.1159/000222245; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Clayden E.C., 1971, PRACTICAL SECTION CU; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Deicher R, 2005, J AM SOC NEPHROL, V16, P1811, DOI 10.1681/ASN.2004100850; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Duffy SJ, 2001, AM J PHYSIOL-HEART C, V280, pH528, DOI 10.1152/ajpheart.2001.280.2.H528; Gemzell-Danielsson K, 2004, HUM REPROD UPDATE, V10, P341, DOI 10.1093/humupd/dmh027; Gonzalez-Ramirez M, 2010, PHARMACOL BIOCHEM BE, V97, P267, DOI 10.1016/j.pbb.2010.08.009; Haliloglu S, 2008, REPROD DOMEST ANIM, V43, P573, DOI 10.1111/j.1439-0531.2007.00954.x; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Higa OH, 2007, CLINICS, V62, P315, DOI 10.1590/S1807-59322007000300017; Honparkhe M, 2008, INDIAN VET J, V85, P906; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P387; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jaroenporn S, 2008, BIOL PHARM BULL, V31, P1205, DOI 10.1248/bpb.31.1205; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Kapper S, 2002, TRANSPLANTATION, V74, P253, DOI 10.1097/00007890-200207270-00017; Kelly RW, 1997, BIOCHEM BIOPH RES CO, V239, P557, DOI 10.1006/bbrc.1997.7502; Korkmaz A, 2009, RENAL FAILURE, V31, P36, DOI 10.1080/08860220802546271; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lemale J, 2008, BBA-MOL CELL RES, V1783, P2234, DOI 10.1016/j.bbamcr.2008.07.023; Lu Na, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P2026; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Nakamura M, 1997, TRANSPL INT, V10, P89, DOI 10.1007/s001470050018; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Nissenson AR, 1998, KIDNEY INT, V53, pS7; Parikh CR, 2004, AM J KIDNEY DIS, V43, P405, DOI 10.1053/j.ajkd.2003.10.040; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; Quinkler M, 2004, HORM METAB RES, V36, P381, DOI 10.1055/s-2004-814572; Rana T, 2010, HUM EXP TOXICOL, V29, P965, DOI 10.1177/0960327110364641; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Robert R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-14; Roscetti G, 1998, J NEUROCHEM, V71, P1108; Sanchez-Criado JE, 1999, J ENDOCRINOL, V160, P197, DOI 10.1677/joe.0.1600197; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Sebrel WH, 1967, VITAMINS CHEM PHYSL; Sekhon CS, 2003, J NEPHROL, V16, P63; Singh R, 2011, FREE RADICAL BIO MED, V50, P363, DOI 10.1016/j.freeradbiomed.2010.11.020; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; SUBRAMANIAN M, 1993, NEUROSCI LETT, V155, P151, DOI 10.1016/0304-3940(93)90695-H; Takahashi N, 2011, NEPHROL DIAL TRANSPL, V26, P1252, DOI 10.1093/ndt/gfq547; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weinberg JM, 2000, AM J PHYSIOL-RENAL, V279, pF927, DOI 10.1152/ajprenal.2000.279.5.F927; Wilson JX, 2002, FEBS LETT, V527, P5, DOI 10.1016/S0014-5793(02)03167-8	56	14	14	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2014	187	1					278	288		10.1016/j.jss.2013.10.025			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AB2FB	WOS:000331607500040	24246438				2022-02-06	
J	Wang, YH; Wang, CL; Yang, LK; Cai, S; Cai, XJ; Dong, JR; Zhang, JD; Zhu, J				Wang, Yuhai; Wang, Chunli; Yang, Likun; Cai, Sang; Cai, Xuejian; Dong, Jirong; Zhang, Jiandong; Zhu, Jun			Controlled Decompression for the Treatment of Severe Head Injury: A Preliminary Study	TURKISH NEUROSURGERY			English	Article						Brain swelling; Decompressive craniectomy; Severe; Head injury; Traumatic intracranial hematoma	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; CONTRALATERAL EXTRADURAL HEMATOMA; EPIDURAL HEMATOMA; CRANIECTOMY; EVACUATION; SURGERY	AIM: Fast direct decompression surgery for treatment of severe head injury often results in intraoperative and postoperative complications. Controlled decompression may help prevent these complications. This preliminary study aims to compare the effects of controlled and conventional decompression in patients with severe head injury. MATERIAL and METHODS: A total of 128 patients with severe head injury were included. Patients were allocated to receive either controlled decompression surgery (n = 64) or conventional decompressive craniectomy (n = 64). Controlled decompression comprised controlled ventricular drainage and controlled hematoma evacuation. The occurrence of delayed hematoma, acute brain swelling, and postoperative cerebral infarction were recorded. RESULTS: Significantly lower proportion of patients in the controlled decompression group had intraoperative acute brain swelling compared to patients in the decompressive craniectomy group (9.4% vs 26.6%, P = 0.011). Intraoperative acute encephalocele occurred in 3 of 13 patients (23.1%) who had delayed hematoma in the controlled decompression group compared with 11 of 18 patients (61.1%) in the decompressive craniectomy group. There was no significant between group difference in the incidence of delayed hematoma or postoperative cerebral infarction. CONCLUSION: Controlled decompression may reduce or delay intraoperative acute brain swelling by delaying hematoma formation in patients with severe head injury.	[Wang, Yuhai; Wang, Chunli; Yang, Likun; Cai, Sang; Cai, Xuejian; Dong, Jirong; Zhang, Jiandong; Zhu, Jun] Chinese Peoples Liberat Army, Hosp 101, Dept Neurosurg, Wu Xi, Jiangsu, Peoples R China		Wang, YH (corresponding author), Chinese Peoples Liberat Army, Hosp 101, Dept Neurosurg, XingYuan North Rd, Wu Xi, Jiangsu, Peoples R China.	dryuhaiwang@yeah.net			Nanjing Military Region	This work was supported by Nanjing Military Region.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Dong JR, 1999, CHIN J NEUROSURG, V15, P4; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; FUKAMACHI A, 1985, J TRAUMA, V25, P145, DOI 10.1097/00005373-198502000-00010; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Huang X, 2010, INT J MED SCI, V7, P385; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Saito T, 2003, ACTA NEUROCHIR SUPPL, V86, P351; Sawauchi S, 2008, ACTA NEUROCHIR, V150, P531, DOI 10.1007/s00701-007-1497-2; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9	17	14	19	0	13	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2014	24	2					214	220		10.5137/1019-5149.JTN.8135-13.1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AF2RX	WOS:000334560800011	24831363	Bronze			2022-02-06	
J	Whitaker-Azmitia, PM; Lobel, M; Moyer, A				Whitaker-Azmitia, Patricia M.; Lobel, Marci; Moyer, Anne			Low maternal progesterone may contribute to both obstetrical complications and autism	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; PERINATAL RISK-FACTORS; SPECTRUM DISORDERS; INFANTILE-AUTISM; NEONATAL FACTORS; GENE-EXPRESSION; NEURODEVELOPMENTAL DISORDERS; SOCIOECONOMIC-STATUS; SYNAPTIC PLASTICITY; RECEPTOR EXPRESSION	Studies show increased autism risk among children born to mothers experiencing obstetrical complications. Although this is usually interpreted as suggesting that the obstetrical complications could be causing autism, it is possible that a single factor could be responsible for both complications and autism. We hypothesized that low levels of the hormone progesterone is responsible since it is supplied to the fetus maternally and does not only support pregnancy but also promotes brain development. Following a review of the literature, we report findings from a survey of mothers of autistic children (n = 86) compared to mothers of typically-developing children (n = 88) regarding obstetrical histories, including five obstetrical risk factors indicative of low progesterone. Using this analysis, the ASD group had significantly more risk factors than controls (1.21 +/- 0.09 vs. 0.76 +/- 0.08, p <.0001), suggesting low progesterone. Thus, results suggest that low progesterone may be responsible for both obstetrical complications and brain changes associated with autism and that progesterone levels should be routinely monitored in at-risk pregnancies. Our hypothesis also suggests that ensuring adequate levels of progesterone may decrease the likelihood of autism. (C) 2014 Elsevier Ltd. All rights reserved.	[Whitaker-Azmitia, Patricia M.; Lobel, Marci; Moyer, Anne] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA		Whitaker-Azmitia, PM (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	patricia.whitaker@stonybrook.edu			Center for Survey Research at Stony Brook University	This research was supported through a seed Grant from the Center for Survey Research at Stony Brook University. The authors are grateful for the assistance of the Center's Director, Dr. Leonie Huddy.	Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Azmitia EC, 2011, NEUROPHARMACOLOGY, V60, P1347, DOI 10.1016/j.neuropharm.2011.02.002; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Bauman MD, 2013, BIOL PSYCHIAT; Bethea CL, 2011, NEUROSCIENCE, V192, P675, DOI 10.1016/j.neuroscience.2011.06.003; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Bilder D, 2009, PEDIATRICS, V123, P1293, DOI 10.1542/peds.2008-0927; Bohm H.V., 2013, MED HYPOTHESES; Bolton PF, 1997, J AM ACAD CHILD PSY, V36, P272, DOI 10.1097/00004583-199702000-00018; Breton AB, 2012, REPROD FERT DEVELOP, V24, P916, DOI 10.1071/RD12006; Brimacombe M, 2007, MATERN CHILD HLTH J, V11, P73, DOI 10.1007/s10995-006-0142-7; Brun CC, 2009, HUM BRAIN MAPP, V30, P3887, DOI 10.1002/hbm.20814; Brunton PJ, 2010, BRAIN RES, V1364, P198, DOI 10.1016/j.brainres.2010.09.062; Burd L, 1999, J PERINAT MED, V27, P441, DOI 10.1515/JPM.1999.059; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Cardwell MS, 2013, OBSTET GYNECOL SURV, V68, P119, DOI 10.1097/OGX.0b013e31827f2481; Carmichael SL, 2005, ARCH PEDIAT ADOL MED, V159, P957, DOI 10.1001/archpedi.159.10.957; Carmody DP, 2010, DEV PSYCHOBIOL, V52, P755, DOI 10.1002/dev.20471; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Chamak B, 2010, M S-MED SCI, V26, P659, DOI 10.1051/medsci/2010266-7659; Chugani DC, 2004, MENT RETARD DEV D R, V10, P112, DOI 10.1002/mrdd.20021; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; DeSoto MC, 2010, ACTA NEUROBIOL EXP, V70, P165; DEYKIN EY, 1980, AM J DIS CHILD, V134, P860, DOI 10.1001/archpedi.1980.02130210044012; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; Druckmann R, 2005, J STEROID BIOCHEM, V97, P389, DOI 10.1016/j.jsbmb.2005.08.010; ELLISON PT, 1990, AM ANTHROPOL, V92, P933, DOI 10.1525/aa.1990.92.4.02a00050; Essa MM, 2013, NEUROTOX RES, V23, P393, DOI 10.1007/s12640-012-9354-3; FINEGAN JA, 1979, J CHILD PSYCHOL PSYC, V20, P119, DOI 10.1111/j.1469-7610.1979.tb00492.x; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; Gil M, 2013, PSYCHONEUROENDOCRINO, V38, P1688, DOI 10.1016/j.psyneuen.2013.02.002; GILLBERG C, 1983, J AUTISM DEV DISORD, V13, P153, DOI 10.1007/BF01531816; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gronborg TK, 2013, JAMA PEDIATR, V167, P947, DOI 10.1001/jamapediatrics.2013.2259; Haas DM, 2008, COCHRANE DB SYST REV, V2; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Hall NR, 2011, OBSTET GYN CLIN N AM, V38, P235, DOI 10.1016/j.ogc.2011.02.014; Halpert J, 2012, ENVIRON HEALTH PERSP, V120, pA390, DOI 10.1289/ehp.120-a390; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hill M, 2011, PHYSIOL RES, V60, P225, DOI 10.33549/physiolres.932077; Hill M, 2010, PHYSIOL RES, V59, P211, DOI 10.33549/physiolres.931807; Hughes GC, 2013, J LEUKOCYTE BIOL, V93, P369, DOI 10.1189/jlb.1012491; Hvidtjorn D, 2009, ARCH PEDIAT ADOL MED, V163, P72, DOI 10.1001/archpediatrics.2008.507; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jahagirdar V, 2010, CEREB CORTEX, V20, P1046, DOI 10.1093/cercor/bhp165; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Juul-Dam N, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e63; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Konno T, 2010, ENDOCRINOLOGY, V151, P4537, DOI 10.1210/en.2010-0440; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lagiou P, 2006, EUR J CANCER PREV, V15, P20, DOI 10.1097/01.cej.0000186639.12249.c7; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; LAUDER JM, 1990, ANN NY ACAD SCI, V600, P297, DOI 10.1111/j.1749-6632.1990.tb16891.x; Lee JH, 2011, J IMMUNOL, V187, P1778, DOI 10.4049/jimmunol.1003919; Lima FB, 2010, MOL PSYCHIATR, V15, P657, DOI 10.1038/mp.2009.97; Lockwood CJ, 2010, J CLIN ENDOCR METAB, V95, P2271, DOI 10.1210/jc.2009-2136; Maimburg RD, 2006, ACTA PSYCHIAT SCAND, V114, P257, DOI 10.1111/j.1600-0447.2006.00805.x; MASONBROTHERS A, 1987, J AM ACAD CHILD PSY, V26, P39, DOI 10.1097/00004583-198701000-00008; Matsunaga H, 2010, J NEUROCHEM, V114, P1333, DOI 10.1111/j.1471-4159.2010.06847.x; Mazer C, 1997, BRAIN RES, V760, P68, DOI 10.1016/S0006-8993(97)00297-7; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Rivera HM, 2013, SYNAPSE, V67, P897, DOI 10.1002/syn.21702; Rivera R, 1999, AM J OBSTET GYNECOL, V181, P1263, DOI 10.1016/S0002-9378(99)70120-1; Romeo RD, 2004, NEURON GLIA BIOL, V1, P219, DOI 10.1017/S1740925X05000086; Sa SI, 2009, NEUROSCIENCE, V162, P307, DOI 10.1016/j.neuroscience.2009.04.066; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; Sanchez AM, 2011, J NEUROENDOCRINOL, V24, P195; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Steinman G, 2013, MED HYPOTHESES, V81, P21, DOI 10.1016/j.mehy.2013.03.034; Su MT, 2011, J ASSIST REPROD GEN, V28, P239, DOI 10.1007/s10815-010-9510-8; Szekeres-Bartho J, 2008, HUM REPROD UPDATE, V14, P27, DOI 10.1093/humupd/dmm035; SZEKERESBARTHO J, 1989, J REPROD IMMUNOL, V16, P239, DOI 10.1016/0165-0378(89)90053-3; Theoharides TC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-168; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wagner CK, 2008, ENDOCRINOLOGY, V149, P2743, DOI 10.1210/en.2008-0049; Wagner CK, 1998, ENDOCRINOLOGY, V139, P3658, DOI 10.1210/en.139.8.3658; Walker CK, 2013, BIOL PSYCHIAT; Wang JP, 2011, MOL MED REP, V4, P319, DOI 10.3892/mmr.2011.418; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wiebe ER, 2009, CONTRACEPTION, V79, P178, DOI 10.1016/j.contraception.2008.10.004; Wilkerson DS, 2002, INT J NEUROSCI, V112, P1085, DOI 10.1080/00207450290026076; Willing J, 2013, DEV NEUROBIOL; Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yawno T, 2009, NEUROSCIENCE, V163, P838, DOI 10.1016/j.neuroscience.2009.07.009; Young SL, 2010, SEMIN REPROD MED, V28, P5, DOI 10.1055/s-0029-1242988; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	102	14	17	0	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAR	2014	82	3					313	318		10.1016/j.mehy.2013.12.018			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AD8CM	WOS:000333494100014	24485701				2022-02-06	
J	Turnley, AM; Basrai, HS; Christie, KJ				Turnley, Ann M.; Basrai, Harleen S.; Christie, Kimberly J.			Is integration and survival of newborn neurons the bottleneck for effective neural repair by endogenous neural precursor cells?	FRONTIERS IN NEUROSCIENCE			English	Article						adult neurogenesis; neural stem cells; neural repair; SVZ; SGZ; hippocampus; olfactory bulb; neurite outgrowth	ADULT HIPPOCAMPAL NEUROGENESIS; TRAUMATIC BRAIN-INJURY; ERYTHROPOIETIN ENHANCES NEUROGENESIS; IMPROVES FUNCTIONAL RECOVERY; NEWLY GENERATED NEURONS; SPINAL-CORD-INJURY; OLFACTORY-BULB; DENTATE GYRUS; BORN NEURONS; STEM-CELLS	After two decades of research the existence of adult neural precursor cells and the phenomenon of adult neurogenesis is well established. However, there has been little or no effective harnessing of these endogenous cells to promote functional neuronal replacement following neural injury or disease. Neural precursor cells can respond to neural damage by proliferating, migrating to the site of injury, and differentiating into neuronal or glial lineages. However, after a month or so, very few or no newborn neurons can be detected, suggesting that even though neuroblasts are generated, they generally fail to survive as mature neurons and contribute to the local circuitry. Is this lack of survival and integration one of the major bottlenecks that inhibits effective neuronal replacement and subsequent repair of the nervous system following injury or disease? In this perspective article the possibility that this bottleneck can be targeted to enhance the integration and subsequent survival of newborn neurons will be explored and will suggest some possible mechanisms that may need to be modulated for this to occur.	[Turnley, Ann M.; Basrai, Harleen S.; Christie, Kimberly J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia		Turnley, AM (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Dept Anat & Neurosci, 30 Royal Parade, Parkville, Vic 3010, Australia.	turnley@unimelb.edu.au			NHMRC of AustraliaNational Health and Medical Research Council of Australia [1045125, 628344]	This work is supported by an NHMRC of Australia grant (#1045125) and Fellowship (#628344) to Ann M. Turnley. We apologize to the authors of many papers we could not cite due to word limits.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Basrai H. S., 2013, TRENDS CELL SIGNALIN; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bergami M, 2013, J NEUROSCI, V33, P11464, DOI 10.1523/JNEUROSCI.4812-12.2013; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Cancino GI, 2013, J NEUROSCI, V33, P12569, DOI 10.1523/JNEUROSCI.1251-13.2013; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Chancey JH, 2013, J NEUROSCI, V33, P6614, DOI 10.1523/JNEUROSCI.0781-13.2013; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Christie KJ, 2013, ADV EXP MED BIOL, V786, P129, DOI 10.1007/978-94-007-6621-1_8; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doeppner TR, 2011, ACTA NEUROPATHOL, V122, P429, DOI 10.1007/s00401-011-0856-5; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gascon E, 2006, J NEUROSCI, V26, P12956, DOI 10.1523/JNEUROSCI.4508-06.2006; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Lemmens R, 2013, HUM MOL GENET, V22, P2214, DOI 10.1093/hmg/ddt073; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miwa N, 2005, J NEUROSCI, V25, P5404, DOI 10.1523/JNEUROSCI.1039-05.2005; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Murai K, 2010, STEM CELLS, V28, P1581, DOI 10.1002/stem.474; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; Petreanu L, 2002, J NEUROSCI, V22, P6106; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rodriguez-Perez AI, 2013, NEUROBIOL DIS, V58, P209, DOI 10.1016/j.nbd.2013.06.004; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Spanevello MD, 2013, J NEUROTRAUM, V30, P1023, DOI 10.1089/neu.2012.2729; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Vadodaria Krishna C, 2013, Front Synaptic Neurosci, V5, P4, DOI 10.3389/fnsyn.2013.00004; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang SZ, 2012, P NATL ACAD SCI USA, V109, P18589, DOI 10.1073/pnas.1210479109; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015	74	14	16	0	4	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 20	2014	8								29	10.3389/fnins.2014.00029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW7DT	WOS:000346425500001	24600341	gold, Green Published			2022-02-06	
J	Castel-Lacanal, E; Tarri, M; Loubinoux, I; Gasq, D; de Boissezon, X; Marque, P; Simonetta-Moreau, M				Castel-Lacanal, E.; Tarri, M.; Loubinoux, I.; Gasq, D.; de Boissezon, X. .; Marque, P.; Simonetta-Moreau, M.			Transcranial magnetic stimulation in brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			English	Article						Stroke; Traumatic brain injury; Transcranial magnetic stimulation	MOTOR-EVOKED-POTENTIALS; THETA-BURST STIMULATION; TRANSCALLOSAL INHIBITION; UNAFFECTED HEMISPHERE; CORTEX EXCITABILITY; FOLLOW-UP; STROKE; RECOVERY; RTMS; REORGANIZATION	Objectives. - Transcranial magnetic stimulations (TMS) have been used for many years as a diagnostic tool to explore changes in cortical excitability, and more recently as a tool for therapeutic neuromodulation. We are interested in their applications following brain injury: stroke, traumatic and anoxic brain injury. Data synthesis. - Following brain injury, there is decreased cortical excitability and changes in interhemispheric interactions depending on the type, the severity, and the time-lapse between the injury and the treatment implemented. rTMS (repetitive TMS) is a therapeutic neuromodulation tool which restores the interhemispheric interactions following stroke by inhibiting the healthy cortex with frequencies <= 1 Hz, or by exciting the lesioned cortex with frequencies between 3 and 50 Hz. Results in motor recovery are promising and those in improving aphasia or visuospatial neglect are also encouraging. Finally, the use of TMS is mainly limited by the risk of seizure, and is therefore contraindicated for many patients. Conclusion. - TMS is a useful non-invasive brain stimulation tool to diagnose the effects of brain injury, to study the mechanisms of recovery and a non-invasive neuromodulation promising tool to influence the post-lesional recovery. (C) 2013 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Castel-Lacanal, E.; Gasq, D.; de Boissezon, X. .; Marque, P.] CHU Rangueil, Serv Med Phys & Readaptat, F-31059 Toulouse 9, France; [Castel-Lacanal, E.; Tarri, M.; Loubinoux, I.; Gasq, D.; de Boissezon, X. .; Marque, P.; Simonetta-Moreau, M.] CHU Purpan, INSERM U 825, F-31024 Toulouse 3, France; [Simonetta-Moreau, M.] CHU Purpan, Serv Neurol, F-31024 Toulouse 3, France		Castel-Lacanal, E (corresponding author), CHU Rangueil, Serv Med Phys & Readaptat, 1 Ave Jean Poulhes,TSA 50032, F-31059 Toulouse 9, France.	castel-lacanal.e@chu-toulouse.fr	MARQUE, Philippe/AAC-4798-2019; Loubinoux, Isabelle/E-5537-2016	Loubinoux, Isabelle/0000-0003-4461-0890; GASQ, David/0000-0002-1339-370X			Adeyemo Bamidele O, 2012, Front Psychiatry, V3, P88, DOI 10.3389/fpsyt.2012.00088; Baeumer T, 2006, J PHYSIOL-LONDON, V572, P857, DOI 10.1113/jphysiol.2006.104901; Bagnato S, 2012, CLIN NEUROPHYSIOL, V123, P1937, DOI 10.1016/j.clinph.2012.03.014; Barba C, 2006, NEUROCASE, V12, P232, DOI 10.1080/13554790600878879; BARKER AT, 1985, LANCET, V1, P1106; Barwood CHS, 2011, EUR J NEUROL, V18, P935, DOI 10.1111/j.1468-1331.2010.03284.x; Barwood CHS, 2011, NEUROREHABILITATION, V28, P113, DOI 10.3233/NRE-2011-0640; Bembenek JP, 2012, FUNCT NEUROL, V27, P79; BERARDELLI A, 1990, NEUROSCI LETT, V112, P54, DOI 10.1016/0304-3940(90)90321-Y; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Centonze D, 2005, J PSYCHIATR NEUROSCI, V30, P127; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fitzgerald PB, 2002, CLIN NEUROPHYSIOL, V113, P1136, DOI 10.1016/S1388-2457(02)00145-1; Fujiki M, 2006, NEUROSCI LETT, V405, P226, DOI 10.1016/j.neulet.2006.07.005; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanajima R, 2001, J PHYSIOL-LONDON, V531, P849, DOI 10.1111/j.1469-7793.2001.0849h.x; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lefaucheur JP, 2011, NEUROPHYSIOL CLIN, V41, P221, DOI 10.1016/j.neucli.2011.10.062; Leo RJ, 2007, J PAIN, V8, P453, DOI 10.1016/j.jpain.2007.01.009; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Lim JY, 2010, J REHABIL MED, V42, P447, DOI 10.2340/16501977-0553; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Martin Paula I., 2004, Seminars in Speech and Language, V25, P181; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Modugno N, 2001, EXP BRAIN RES, V140, P453, DOI 10.1007/s002210100843; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Nyffeler T, 2009, STROKE, V40, P2791, DOI 10.1161/STROKEAHA.109.552323; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Song WQ, 2009, J REHABIL MED, V41, P162, DOI 10.2340/16501977-0302; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Szaflarski JP, 2011, MED SCI MONITOR, V17, pCR132, DOI 10.12659/MSM.881446; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Traversa R, 1998, BRAIN RES, V803, P1, DOI 10.1016/S0006-8993(98)00505-8; Traversa R, 2000, CLIN NEUROPHYSIOL, V111, P1695, DOI 10.1016/S1388-2457(00)00373-4; Wang RY, 2012, NEUROREHAB NEURAL RE, V26, P222, DOI 10.1177/1545968311423265; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502	57	14	15	0	30	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2014	33	2					83	87		10.1016/j.annfar.2013.11.006			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AD8IS	WOS:000333510300004	24378049				2022-02-06	
J	Wolf, H; Machold, W; Frantal, S; Kecht, M; Pajenda, G; Leitgeb, J; Widhalm, H; Hajdu, S; Sarahrudi, K				Wolf, Harald; Machold, Wolfgang; Frantal, Sophie; Kecht, Mathias; Pajenda, Gholam; Leitgeb, Johannes; Widhalm, Harald; Hajdu, Stefan; Sarahrudi, Kambiz			Risk factors indicating the need for cranial CT scans in elderly patients with head trauma: an Austrian trial and comparison with the Canadian CT Head Rule Clinical article	JOURNAL OF NEUROSURGERY			English	Article						head rule; cranial CT; minor head injury; skull radiography; traumatic brain injury	NEW-ORLEANS CRITERIA; NEURON-SPECIFIC ENOLASE; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MILD; ANTICOAGULATION; CONCUSSION; PREDICTION; RADIATION; PROTEIN	Object. This study presents newly defined risk factors for detecting clinically important brain injury requiring neurosurgical intervention and intensive care, and compares it with the Canadian CT Head Rule (CCHR). Methods. This prospective cohort study was conducted in a single Austrian Level-I trauma center and enrolled a consecutive sample of mildly head-injured adults who presented to the emergency department with witnessed loss of consciousness, disorientation, or amnesia, and a Glasgow Coma Scale (GCS) score of 13-15. The studied population consisted of a large number of elderly patients living in Vienna. The aim of the study was to investigate risk factors that help to predict the need for immediate cranial CT in patients with mild head trauma. Results. Among the 12,786 enrolled patients, 1307 received a cranial CT scan. Four hundred eighty-nine patients (37.4%) with a mean age of 63.9 +/- 22.8 years had evidence of an acute traumatic intracranial lesion on CT. Three patients (< 0.1%) were admitted to the intensive care unit for neurological observation and received oropharyngeal intubation. Seventeen patients (0.1%) underwent neurosurgical intervention. In 818 patients (62.6%), no evidence of an acute trauma-related lesion was found on CT. Data analysis showed that the presence of at least 1 of the following factors can predict the necessity of cranial CT: amnesia, GCS score, age > 65 years, loss of consciousness, nausea or vomiting, hypocoagulation, dementia or a history of ischemic stroke, anisocoria, skull fracture, and development of a focal neurological deficit. Patients requiring neurosurgical intervention were detected with a sensitivity of 90% and a specificity of 67% by using the authors' analysis. In contrast, the use of the CCHR in these patients detected the need for neurosurgical intervention with a sensitivity of only 80% and a specificity of 72%. Conclusions. The use of the suggested parameters proved to be superior in the detection of high-risk patients who sustained a mild head trauma compared with the CCHR rules. Further validation of these results in a multicenter setting is needed. Clinical trial registration no.: NCT00451789 (ClinicalTrials.gov.)	[Wolf, Harald; Machold, Wolfgang; Kecht, Mathias; Pajenda, Gholam; Leitgeb, Johannes; Widhalm, Harald; Hajdu, Stefan; Sarahrudi, Kambiz] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Frantal, Sophie] Med Univ Vienna, Dept Med Stat, Vienna, Austria		Wolf, H (corresponding author), Vienna Gen Hosp, Dept Trauma Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	harald.wolf@meduniwien.ac.at	Widhalm, Harald/ABE-8863-2020	Widhalm, Harald/0000-0001-9739-6176			Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Karni A, 2001, AM SURGEON, V67, P1098; Ledic D, 2012, MED HYPOTHESES, V78, P23, DOI 10.1016/j.mehy.2011.09.032; Leidel BA, 2012, UNFALLCHIRURG, V115, P903, DOI 10.1007/s00113-010-1946-x; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Martin DR, 2006, LANCET, V367, P1712, DOI 10.1016/S0140-6736(06)68748-5; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Saadat S, 2009, J NEUROSURG, V111, P688, DOI 10.3171/2009.2.JNS08909; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vogel T, 2008, UNFALLCHIRURG, V111, P898, DOI 10.1007/s00113-008-1502-0; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	29	14	14	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2014	120	2					447	452		10.3171/2013.10.JNS13726			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	301UA	WOS:000330556400028	24313609				2022-02-06	
J	Yu, HR; Watt, H; Mohan, S				Yu, Hongrun; Watt, Heather; Mohan, Subburaman			The negative impact of traumatic brain injury (TBI) on bone in a mouse model	BRAIN INJURY			English	Article						Bone density; bone formation; mice; traumatic brain injury; weight drop model	HYPOTHALAMIC-PITUITARY DYSFUNCTION; HETEROTOPIC OSSIFICATION; CALCIUM-METABOLISM; MINERAL DENSITY; HEAD-INJURY; LONG-TERM; MICE; GROWTH; SERUM; ADOLESCENTS	Introduction: While it is well established that the brain produces hypothalamic hormones and neuropeptides that influence skeletal metabolism, the impact of traumatic brain injury (TBI) on bone is unknown. Based on the recognition from clinical studies that there is an association between TBI and long-term hypothalamic pituitary dysfunction, it was hypothesized that TBI exerts a negative impact on skeletal growth and maintenance. Methods: To test the hypothesis, this study employed a repetitive weight drop model for TBI. Four impacts were applied for four consecutive days on 5-week old female C57BL/6 J mice. Bone measurements were taken 2 weeks after the first impact. Results: Bone mineral content (BMC), bone area (B area) and bone mineral density (BMD) in the total body were reduced by 14.5%, 9.8% and 5.2%, respectively, in the impacted vs. control mice. There was a 17.1% reduction in total volumetric BMD (vBMD) and a 4.0% reduction in material vBMD in cortical bone. In trabecular bone, there was a 44.0% reduction in BV/TV. Although there was no change in the cross-sectional bone size, the tibial growth plate and the tibia itself were shortened. Conclusion: The repetitive animal TBI model produced an immediate, strong negative impact on bone mass acquisition in young mice.	[Yu, Hongrun; Watt, Heather; Mohan, Subburaman] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Yu, Hongrun; Mohan, Subburaman] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA		Mohan, S (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, 11201 Benton St 151, Loma Linda, CA 92357 USA.	subburaman.mohan@va.gov			Rehabilitation Research and Development Merit Review Program of the Department of Veterans AffairsUS Department of Veterans Affairs	This work was funded through the Rehabilitation Research and Development Merit Review Program of the Department of Veterans Affairs, and was performed at research facilities provided by the VA Loma Linda HealthCare System. The authors thank Catrina Alarcon, Sheila Pourteymoor and Joe Rung-Aroon for their technical assistance. They also thank James DeKeyser for making the apparatus used in the study, and Charles Rundle for assistance in taking photographs of the mouse brains.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Affairs DoV, 2011, UND TRAUM BRAIN INJ; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Bruno-Petrina A, POSTTRAUMATIC HETERO; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kesavan C, 2010, J MUSCULOSKEL NEURON, V10, P274; Kesikburun S, 2011, BRAIN INJURY, V25, P127, DOI 10.3109/02699052.2010.536198; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Linares GR, 2011, AM J PHYSIOL-ENDOC M, V301, pE40, DOI 10.1152/ajpendo.00065.2011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Mohan S, 2005, J ENDOCRINOL, V185, P415, DOI 10.1677/joe.1.06141; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; MYSIW WJ, 1993, AM J PHYS MED REHAB, V72, P184, DOI 10.1097/00002060-199308000-00002; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Sato Y, 2000, ARCH PHYS MED REHAB, V81, P117, DOI 10.1053/apmr.2000.0810117; Sato Y, 2000, J NEUROL SCI, V175, P135, DOI 10.1016/S0022-510X(00)00298-7; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Wergedal JE, 2002, BONE, V31, P670, DOI 10.1016/S8756-3282(02)00908-0; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908; Yu HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042684; Yu HR, 2012, CALCIFIED TISSUE INT, V91, P81, DOI 10.1007/s00223-012-9613-6; Zaben M, 2013, DISABIL REHABIL, V35, P522, DOI 10.3109/09638288.2012.697252	49	14	15	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					244	251		10.3109/02699052.2013.859735			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900014	24295038				2022-02-06	
J	Zhang, H; Tang, B; Yin, CG; Chen, Y; Meng, QL; Jiang, L; Wang, WP; Niu, GZ				Zhang, Hao; Tang, Bo; Yin, Cong-Guo; Chen, Yan; Meng, Qing-Lian; Jiang, Lin; Wang, Wei-Ping; Niu, Guo-Zhong			Plasma adrenomedullin levels are associated with long-term outcomes of acute ischemic stroke	PEPTIDES			English	Article						Ischemic stroke; Outcome; Adrenomedullin	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; CAROTID ATHEROSCLEROSIS; NEUROLOGICAL DEFICITS; PEPTIDE; PHEOCHROMOCYTOMA; CHILDREN	Plasma adrenomedullin concentration has been found to be enhanced in ischemic stroke. Up to now, little is known about the association of plasma adrenomedullin concentration with clinical outcomes of ischemic stroke. This study recruited 138 patients with ischemic stroke and 138 healthy volunteers. Unfavorable outcome was defined as modified Rankin Scale score >2 at 3 months. Plasma adrenomedullin concentrations were determined by enzyme-linked immunosorbent assay. Plasma adrenomedullin concentrations were statistically significantly higher in patients than in healthy individuals (79.9 +/- 27.3 pg/mL vs. 36.8 +/- 10.4 pg/mL; 13< 0.001). 3-Month mortality was 20.3% (281138) and sixty-six patients (47.8%) had unfavorable outcome in 3 months. A logistic regression analysis identified plasma adrenomedullin concentration as an independent predictor of 3-month mortality (odds ratio, 1.211; 95% confidence interval, 1.101-1.582; P=0.004) and unfavorable outcome (odds ratio, 1.193; 95% confidence interval, 1.082-1.447; 13= 0.006). Receiver operating characteristic curve analysis showed that plasma adrenomedullin concentration predicted 3-month mortality (area under curve, 0.806; 95% confidence interval, 0.730-0.868) and unfavorable outcome (area under curve, 0.816; 95% confidence interval, 0.742-0.877) with the high predictive value. Its predictive performance was similar to that of National Institutes of Health Stroke Scale score (P=0.694 or 0.206). Its combined use with National Institutes of Health Stroke Scale score did not improve the predictive value (13= 0.236 or 0.590). Thus, adrenomedullin may aid to predict long-term clinical outcomes of patients with ischemic stroke. (C) 2013 Elsevier Inc. All rights reserved.	[Zhang, Hao; Tang, Bo; Yin, Cong-Guo; Chen, Yan; Meng, Qing-Lian; Jiang, Lin; Wang, Wei-Ping; Niu, Guo-Zhong] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurol, Hangzhou 310006, Zhejiang, Peoples R China		Niu, GZ (corresponding author), Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurol, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	guozhongniu@126.com					BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827, DOI 10.1038/jcbfm.1995.103; Charung WW, 2011, MOL MED, V17, P1075; Demir H, 2013, PEPTIDES, V43, P27, DOI 10.1016/j.peptides.2013.02.018; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Hamada H, 2010, MOD RHEUMATOL, V20, P389, DOI 10.1007/s10165-010-0295-5; Hosomi N, 2004, J HYPERTENS, V22, P1945, DOI 10.1097/00004872-200410000-00017; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Kondoh T, 2011, BRAIN RES BULL, V84, P69, DOI 10.1016/j.brainresbull.2010.11.005; Kubo Y, 2008, CEREBROVASC DIS, V25, P164, DOI 10.1159/000113734; Kubo Y, 2013, NEUROL RES, V35, P713, DOI 10.1179/1743132813Y.0000000222; Lang MG, 1997, STROKE, V28, P181, DOI 10.1161/01.STR.28.1.181; Liu J, 2014, INT J NEUROSCI, V124, P271, DOI 10.3109/00207454.2013.837462; Nicholls MG, 2004, BRAZ J MED BIOL RES, V37, P1247, DOI 10.1590/S0100-879X2004000800016; Peckova M, 2012, J INT MED RES, V40, P1552, DOI 10.1177/147323001204000435; Robertson CL, 2000, ACT NEUR S, V76, P419; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; SATOH F, 1995, J CLIN ENDOCR METAB, V80, P1750, DOI 10.1210/jc.80.5.1750; Shinomiya K, 2001, PEPTIDES, V22, P1873, DOI 10.1016/S0196-9781(01)00507-1; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480; Wong Hoi Kin, 2012, JRSM Cardiovasc Dis, V1, DOI 10.1258/cvd.2012.012003	23	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	FEB	2014	52						44	48		10.1016/j.peptides.2013.11.025			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AD5EU	WOS:000333275400007	24333654				2022-02-06	
J	Lange, RT; Shewchuk, JR; Heran, MKS; Rauscher, A; Jarrett, M; Brubacher, JR; Iverson, GL				Lange, Rael T.; Shewchuk, Jason R.; Heran, Manraj K. S.; Rauscher, Alexander; Jarrett, Michael; Brubacher, Jeffrey R.; Iverson, Grant L.			To Exclude or Not To Exclude: Further Examination of the Influence of White Matter Hyperintensities in Diffusion Tensor Imaging Research	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; magnetic resonance imaging; neuroimaging; neurotrauma; traumatic brain injury; white matter hyperintensities	TRAUMATIC BRAIN-INJURY; LOW SCORES; MILD; PREVALENCE; ROBUST; REGISTRATION; ABNORMALITIES; OPTIMIZATION; DYSFUNCTION; ANISOTROPY	White matter hyperintensities (WMHIs) visible on magnetic resonance imaging (MRI) are common in both healthy adults and in those with medical or psychiatric problems. A practical methodological issue for diffusion tensor imaging (DTI) researchers is whether to include, or exclude, participants from a control group who have WMHIs. The aim of this study was to compare the influence of WMHIs on whole-brain DTI in trauma control subjects. Participants were 48 patients (no-WMHIs, n=36; 2+WMHIs, n=12) prospectively recruited from the Emergency Department of Vancouver General Hospital (British Columbia, Canada). Participants completed an MRI brain scan at 6-8 weeks postinjury (mean, 47.3 days; standard deviation [SD], 6.2; range, 39-66). DTI was used to examine the integrity of white matter (WM) in 50 regions of the brain using measures of fractional anisotropy (FA), and mean (MD), radial (RD), and axial (AD) diffusivity. FA values that were >2 SDs below the mean, and MD, RD, and AD values that were >2 SDs above the mean, were classified as abnormal scores indicative of reduced WM integrity. In the entire sample, the 2+WMHI group had a greater number of abnormal FA, MD, and RD scores, compared to the no-WMHI group (p<0.015 and Cohen's d >0.82, indicating large to very large effect sizes, for all comparisons). When controlling for the effects of age using a matched-groups design, the 2+WMHI group still had a significantly greater number of abnormal FA, MD, and RD scores, compared to the no-WMHI group (all p<0.012, all d >0.89, large to very large effect sizes). Researchers should be aware that the inclusion or exclusion of subjects with incidental WMHIs will influence the results of DTI studies.	[Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD 20889 USA; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Shewchuk, Jason R.; Heran, Manraj K. S.; Rauscher, Alexander; Jarrett, Michael] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Rauscher, Alexander; Jarrett, Michael] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Rauscher, Alexander] Univ British Columbia, UBC Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Brubacher, Jeffrey R.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Vancouver Gen Hosp, Dept Emergency Med, Vancouver, BC, Canada		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	rlange@dvbic.org		Rauscher, Alexander/0000-0002-1961-8252; Jarrett, Michael/0000-0002-3702-2014; Iverson, Grant/0000-0001-7348-9570; Brubacher, Jeffrey/0000-0002-4866-4231	Alcohol Beverage Medical Research Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; CIHR New Investigator Award ProgramCanadian Institutes of Health Research (CIHR); National Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)	This study was partly supported by competitive research funding from the Alcohol Beverage Medical Research Foundation and the Canadian Institutes of Health Research (CIHR).; J.B.'s research program is supported by a scholar award from the Michael Smith Foundation for Health Research. A.R.'s research is supported by the CIHR New Investigator Award Program and by the National Sciences and Engineering Research Council of Canada.	Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ayling E, 2012, CURR PSYCHIAT REP, V14, P197, DOI 10.1007/s11920-012-0273-z; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Dimou S, 2013, NEUROSURG REV, V36, P205, DOI 10.1007/s10143-012-0436-8; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jang SH, 2010, NEUROREHABILITATION, V27, P367, DOI 10.3233/NRE-2010-0621; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; National Institute on Alcoholism and Alcohol Abuse, 2005, HELP PAT WHO DRINK T; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.3.CO;2-J; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soderlund H, 2003, CORTEX, V39, P1093, DOI 10.1016/S0010-9452(08)70879-7; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Van Zijl, 2004, MRI ATLAS HUMAN WHIT; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	60	14	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2014	31	2					198	205		10.1089/neu.2013.2866			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	291ZE	WOS:000329870600006	23952763				2022-02-06	
S	Bormann, JE; Weinrich, S; Allard, CB; Beck, D; Johnson, BD; Holt, LC		Kelley, PW		Bormann, Jill E.; Weinrich, Sally; Allard, Carolyn B.; Beck, Danielle; Johnson, Brian D.; Holt, Lindsay Cosco			Mantram Repetition An Evidence-Based Complementary Practice for Military Personnel and Veterans in the 21st Century	ANNUAL REVIEW OF NURSING RESEARCH, VOL 32: MILITARY AND VETERAN INNOVATIONS OF CARE	Annual Review of Nursing Research-Series		English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; CRITICAL INCIDENT; FOCUSED ATTENTION; INTERVENTION; MEDITATION; HIV; MINDFULNESS; RESPONSES; PTSD; SPIRITUALITY	Today in the digital age, with our advances in modern technology and communication, there are additional stressors for our military personnel and Veterans. Constant dangers exist both on and off the battlefield, unlike prior wars that had clearly-defined war zones. In addition, medical advances have assisted in saving the lives of many more gravely injured troops than ever previously possible. As the wars in Iraq and Afghanistan come to an end, large numbers of service men and women are returning home with multiple injuries. This group of Veterans has significantly higher rates of posttraumatic stress disorder (PTSD) and traumatic brain injury than ever before reported. Although existing PTSD therapies have been found to be highly effective for many Veterans, there is a substantial minority unsatisfactorily treated. Mantram repetition, an innovative, complementary, evidence-based treatment, is proving to be successful for these new Veterans. When used regularly it helps with "road rage, impatience, anger, frustration, and being out of control." A mantram is a brief, sacred word or phrase that embodies divine power or the greatest positive energy one can imagine (Easwaran, 2008a). Mantram repetition is a simple, quick, personal, portable, and private complementary practice that may be used as an adjunct to current treatments for PTSD. Growing research evidence supports mantram repetition's value for dissemination and adoption in the 21st century. This chapter summarizes Mantram Program research conducted from 2003 to 2014. It describes the health-related benefits of the Mantram Program in various populations. The current research focuses on benefits for managing psychological distress and promoting quality of life in Veterans. Future areas for research are suggested.	[Bormann, Jill E.; Allard, Carolyn B.; Beck, Danielle] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; [Weinrich, Sally; Johnson, Brian D.; Holt, Lindsay Cosco] Univ San Diego, San Diego, CA 92110 USA		Bormann, JE (corresponding author), Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA.		Allard, Carolyn B./B-3521-2013	Allard, Carolyn B./0000-0002-7803-2243	NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R21 AT01159] Funding Source: Medline		Balshem H., 2011, 05225 VAESP DEP VET; Benson H, 1993, MIND BODY MED USE YO, P233; Benson H, 1996, TIMELESS HEALING; Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Blake DD, 1990, CLINICIAN ADM PTSD S; Bormann J. E., MED CARE SP IN PRESS; Bormann JE, 2006, J ADV NURS, V53, P502, DOI 10.1111/j.1365-2648.2006.03752.x; Bormann JE, 2010, CONTEMPLATIVE PRACTI, P78; Bormann J, 2009, FAM COMMUNITY HEALTH, V32, P345, DOI 10.1097/FCH.0b013e3181b91fd6; Bormann JE, 2006, J BEHAV MED, V29, P359, DOI 10.1007/s10865-006-9063-6; Bormann JE, 2005, J HOLIST NURS, V23, P395, DOI 10.1177/0898010105278929; Bormann JE, 2013, J REHABIL RES DEV, V50, P769, DOI 10.1682/JRRD.2012.06.0118; Bormann JE, 2012, INT J BEHAV MED, V19, P496, DOI 10.1007/s12529-011-9186-1; Bormann JE, 2013, PSYCHOL TRAUMA-US, V5, P259, DOI 10.1037/a0027522; Bormann Jill E, 2007, J Healthc Qual, V29, P45; Bormann JE, 2008, J HOLIST NURS, V26, P109, DOI 10.1177/0898010107311276; Bormann JE, 2009, INT J BEHAV MED, V16, P74, DOI 10.1007/s12529-008-9007-3; Bormann Jill E, 2006, J Contin Educ Nurs, V37, P218; Bormann JE, 2009, J PSYCHOSOM RES, V66, P161, DOI 10.1016/j.jpsychores.2008.09.017; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Cahn BR, 2013, SOC COGN AFFECT NEUR, V8, P100, DOI 10.1093/scan/nss060; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chan Roxane Raffin, 2014, Medsurg Nurs, V23, P84; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Easwaran E, 2008, MANTRAM HDB PRACTICA; Easwaran E., 2008, PASSAGE MEDITATION B; Easwaran E., 2005, STRENGTH STORM TRANS; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; Foa E. B., 2010, EFFECTIVE TREATMENTS; Fontana A, 2004, J NERV MENT DIS, V192, P579, DOI 10.1097/01.nmd.0000138224.17375.55; Frost ND, 2014, J TRAUMA STRESS, V27, P1, DOI 10.1002/jts.21881; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hunter L, 2011, APPL NURS RES, V24, P138, DOI 10.1016/j.apnr.2009.06.002; Kemeny ME, 2012, EMOTION, V12, P338, DOI 10.1037/a0026118; Kemppainen J., 2012, SIGM THET TAU INT NU; Kemppainen J, 2012, J ALTERN COMPLEM MED, V18, P76, DOI 10.1089/acm.2009.0489; Khusid M, 2013, PSYCHIAT ANN, V43, P340, DOI 10.3928/00485713-20130703-11; Koenig H. G., 2012, HDB RELIG HLTH, V2nd; Lang AJ, 2012, BEHAV MODIF, V36, P759, DOI 10.1177/0145445512441200; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Leary S., 2013, W I NURS 46 ANN COMM; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Oman D., 2013, 34 ANN M SOC BEH MED; Oman D., 2003, J PSYCHOL CHRISTIANI, V22, P5; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Plumb DN, 2014, INT RES C INT MED HL; Polit DF., 2012, NURSING RES GENERATI, V9th ed.; Richards TA, 2006, NURS SCI QUART, V19, P231, DOI 10.1177/0894318406289490; Schaefer FC, 2008, INT J PSYCHIAT MED, V38, P507, DOI 10.2190/PM.38.4.i; Shaw A, 2005, MENT HEALTH RELIG CU, V8, P1, DOI 10.1080/1367467032000157981; Thorp S, 2009, 2009 ANX DIS ASS AM; Travis F, 2010, CONSCIOUS COGN, V19, P1110, DOI 10.1016/j.concog.2010.01.007; Tsai J, 2012, MIL MED, V177, P27, DOI 10.7205/MILMED-D-11-00128; VA Office of Inspector General, 2012, 1100334115 VA OFF IN, P1; Vujanovic AA, 2011, PROF PSYCHOL-RES PR, V42, P24, DOI 10.1037/a0022272; Wachholtz A. B., 2013, APA HDB PSYCHOL RELI, V1, P311, DOI DOI 10.1037/14045-017; Ware JE, 2002, USERS MANUAL SF 12V2; Weathers FW, 1993, P 9 ANN C INT SOC TR; Weinrich S P, 1998, J Cancer Educ, V13, P213; WEINRICH SP, 1993, GERONTOLOGIST, V33, P491, DOI 10.1093/geront/33.4.491; Wolf DB, 2003, RES SOCIAL WORK PRAC, V13, P27, DOI 10.1177/104973102237471; Yong J, 2011, J CONTIN EDUC NURS, V42, P280, DOI 10.3928/00220124-20101201-04	65	14	14	0	10	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2809-6; 978-0-8261-2807-2	ANNU REV NURS RES-SE			2014	32						79	108		10.1891/0739-6686.32.79			30	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YJ	WOS:000412974700006	25222539				2022-02-06	
J	Brown, AW; Leibson, CL; Mandrekar, J; Ransom, JE; Malec, JF				Brown, Allen W.; Leibson, Cynthia L.; Mandrekar, Jay; Ransom, Jeanine E.; Malec, James F.			Long-Term Survival After Traumatic Brain Injury: A Population-Based Analysis Controlled for Nonhead Trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epidemiology; risk; mortality; rehabilitation	MORTALITY TRENDS; HEAD TRAUMA; SPECTRUM; DISEASE; CARE; REHABILITATION; RESIDUALS; SEVERITY; COHORT; MODEL	Objective: To examine the contribution of cooccurring nonhead injuries to hazard of death after traumatic brain injury (TBI). Participants: A random sample of Olmsted County, Minnesota, residents with confirmed TBI from 1987 through 1999 was identified. Design: Each case was assigned an age- and sex-matched, non-TBI "regular control" from the population. For "special cases" with accompanying nonhead injuries, 2 matched "special controls" with nonhead injuries of similar severity were assigned. Measures: Vital status was followed from baseline (ie, injury date for cases, comparable dates for controls) through 2008. Cases were compared first with regular controls and second with regular or special controls, depending on case type. Results: In total, 1257 cases were identified (including 221 special cases). For both cases versus regular controls and cases versus regular or special controls, the hazard ratio was increased from baseline to 6 months (10.82 [2.86-40.89] and 7.13 [3.10-16.39], respectively) and from baseline through study end (2.92 [1.74-4.91] and 1.48 [1.09-2.02], respectively). Among 6-month survivors, the hazard ratio was increased for cases versus regular controls (1.43 [1.06-2.15]) but not for cases versus regular or special controls (1.05 [0.80-1.38]). Conclusions: Among 6-month survivors, accounting for nonhead injuries resulted in a nonsignificant effect of TBI on long-term mortality.	[Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Leibson, Cynthia L.] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA; [Mandrekar, Jay; Ransom, Jeanine E.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Mandrekar, Jay] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Malec, James F.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA		Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research [H133A020507, H133A070013]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD-07447]; Rochester Epidemiology Project (from the National Institute on Aging) [R01 AG034676]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007447] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R56HD007447, R01HD007447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034676] Funding Source: NIH RePORTER	This work was supported by TBI Model System grants to Mayo Clinic from the National Institute on Disability and Rehabilitation Research (H133A020507, H133A070013) and a National Research Service Award from the National Institute of Health (Training Grant HD-07447). The study was made possible by the Rochester Epidemiology Project (grant no. R01 AG034676 from the National Institute on Aging).	ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bergen G, 2008, INJURY US 2007 CHART, P27; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.2307/2335876; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ., 1995, GUIDELINES SURVEILLA; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	32	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					E1	E8		10.1097/HTR.0b013e318280d3e6			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400002		Green Accepted, Green Published			2022-02-06	
J	Carlsson, A; Chang, F; Lemmen, P; Kullgren, A; Schmitt, KU; Linder, A; Svensson, MY				Carlsson, Anna; Chang, Fred; Lemmen, Paul; Kullgren, Anders; Schmitt, Kai-Uwe; Linder, Astrid; Svensson, Mats Y.			Anthropometric Specifications, Development, and Evaluation of EvaRID-A 50th Percentile Female Rear Impact Finite Element Dummy Model	TRAFFIC INJURY PREVENTION			English	Article						rear impact; whiplash; crash dummies; finite elements; females; neck injury; impact responses	TOTAL HEAD EXCURSION; GENDER-DIFFERENCES; CERVICAL STRENGTH; MALE-VOLUNTEERS; NECK INJURY; WHIPLASH; DRIVERS; MOTION; FREQUENCY; RESPONSES	Objectives: Whiplash-associated disorders (WADs), or whiplash injuries, due to low-severity vehicle crashes are of great concern in motorized countries and it is well established that the risk of such injuries is higher for females than for males, even in similar crash conditions. Recent protective systems have been shown to be more beneficial for males than for females. Hence, there is a need for improved tools to address female WAD prevention when developing and evaluating the performance of whiplash protection systems. The objective of this study is to develop and evaluate a finite element model of a 50th percentile female rear impact crash test dummy. Methods: The anthropometry of the 50th percentile female was specified based on literature data. The model, called EvaRID (female rear impact dummy), was based on the same design concept as the existing 50th percentile male rear impact dummy, the BioRID II. A scaling approach was developed and the first version, EvaRID V1.0, was implemented. Its dynamic response was compared to female volunteer data from rear impact sled tests. Results: The EvaRID V1.0 model and the volunteer tests compared well until similar to 250 ms of the head and T1 forward accelerations and rearward linear displacements and of the head rearward angular displacement. Markedly less T1 rearward angular displacement was found for the EvaRID model compared to the female volunteers. Similar results were received for the BioRID II model when comparing simulated responses with experimental data under volunteer loading conditions. The results indicate that the biofidelity of the EvaRID V1.0 and BioRID II FE models have limitations, predominantly in the T1 rearward angular displacement, at low velocity changes (7 km/h). The BioRID II model was validated against dummy test results in a loading range close to consumer test conditions (EuroNCAP) and lower severity levels of volunteer testing were not considered. Conclusions: The EvaRID dummy model demonstrated the potential of becoming a valuable tool when evaluating and developing seats and whiplash protection systems. However, updates of the joint stiffness will be required to provide better correlation at lower load levels. Moreover, the seated posture, curvature of the spine, and head position of 50th percentile female occupants needs to be established and implemented in future models.	[Carlsson, Anna; Kullgren, Anders; Svensson, Mats Y.] Chalmers Univ Technol, SE-40278 Gothenburg, Sweden; [Chang, Fred; Lemmen, Paul] Humanet Innovat Solut, Plymouth, MI USA; [Kullgren, Anders] Folksam, Stockholm, Sweden; [Schmitt, Kai-Uwe] AGU Zurich, Zurich, Switzerland; [Linder, Astrid] Swedish Natl Rd & Transport Res Inst VTI, Gothenburg, Sweden		Carlsson, A (corresponding author), Chalmers Univ Technol, Dept Appl Mech, Div Vehicle Safety, SE-40278 Gothenburg, Sweden.	anna.carlsson@chalmers.se	Svensson, Mats Yngve/A-6014-2013	Svensson, Mats Yngve/0000-0002-8304-1398; Schmitt, Kai-Uwe/0000-0003-3439-9323; Carlsson, Anna/0000-0002-3216-8145	European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Swedish Transport Agency	This study is part of the ADSEAT (Adaptive Seat to Reduce Neck Injuries for Female and Male Occupants) project funded by the European Commission within the 7th Framework Programme. Additional funding has been received from the Swedish Transport Agency.	Abraham S, 1979, VITAL HLTH STAT SERI, V11; [Anonymous], 2012, 725022012 SIS CEN IS; BUCK C A, 1959, Arch Phys Med Rehabil, V40, P390; Carlsson A, 2012, TRAFFIC INJ PREV, V13, P378, DOI 10.1080/15389588.2012.659362; Carlsson A, 2011, TRAFFIC INJ PREV, V12, P347, DOI 10.1080/15389588.2011.585408; Carstensen TBW, 2012, EUR J PAIN, V16, P49, DOI 10.1016/j.ejpain.2011.06.002; Chapline JF, 2000, ACCIDENT ANAL PREV, V32, P287, DOI 10.1016/S0001-4575(99)00126-8; Cheng H, 1994, ALCFTR19940051 HUM E; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Croft AC, 2002, IRCOBI C SEPT 18 20; Desantis Klinich Kathleen, 2004, Stapp Car Crash J, V48, P301; Diffrient N., 1974, HUMANSCALE 1 2 3 POR HUMANSCALE 1 2 3 POR; Dolinis J, 1997, INJURY, V28, P173, DOI 10.1016/S0020-1383(96)00186-6; Eichberger A, 1996, IRCOBI C SEPT 11 13; Farmer CM, 1999, ACCIDENT ANAL PREV, V31, P719, DOI 10.1016/S0001-4575(99)00035-4; FOUST DR, 1973, 17 STAPP CAR CRASH C; Galasko CSB, 1996, 15 ESV C MAY 13 17 1; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Hanson L, 2009, APPL ERGON, V40, P797, DOI 10.1016/j.apergo.2008.08.007; HANTEN WP, 1991, ARCH PHYS MED REHAB, V72, P877, DOI 10.1016/0003-9993(91)90003-2; Hanten WP, 2000, ARCH PHYS MED REHAB, V81, P62, DOI 10.1053/apmr.2000.0810062; Hell W, 1999, IRCOBI C SEPT 23 24; Jakobsson L, 2000, ACCIDENT ANAL PREV, V32, P307, DOI 10.1016/S0001-4575(99)00107-4; Jakobsson Lotta, 2004, Traffic Inj Prev, V5, P156, DOI 10.1080/15389580490435989; Jonsson Bertil, 2007, Traffic Inj Prev, V8, P87, DOI 10.1080/15389580600911010; Jonsson B, 2008, ERGONOMICS, V51, P232, DOI 10.1080/00140130701561793; Kihlberg JK, 1969, 13 AAAM C OCT 16 17; Krafft Maria, 2003, Traffic Inj Prev, V4, P136, DOI 10.1080/15389580309862; Kullgren A, 2010, IRCOBI C SEPT 15 16; Kullgren A., 2003, 18 ESV C MAY 19 22 2; Kullgren A, 2007, 20 ESV C JUN 18 21 2; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; Lemmen P, 2013, 23 ESV C MAY 27 30 2; Linder A, 2008, TRAFFIC INJ PREV, V9, P592, DOI 10.1080/15389580802384669; Maag U, 1990, IRCOBIO C SEPT 12 14; McConville J. T., 1980, AMRLTR80119; Mordaka J., 2003, ACTA POLITECHNICA, V43, P47; MORRIS A, 1996, 40 STAPP CAR CRASH C; Moss S, 2000, 220012202 SAE; Narragon EA, 1965, VJ1823R15 CAL CORN U; National Highway Traffic Safety Administration, 2004, FED REGISTER, V69, P74848; Nygren A, 1984, AKTA OTO LARYNG S395; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; Ono K, 2006, IRCOBI C SEPT 20 22; Osakabe T, 2001, ANN CLIN BIOCHEM, V38, P527, DOI 10.1258/0004563011901118; OTREMSKI I, 1989, INJURY, V20, P349, DOI 10.1016/0020-1383(89)90011-9; Peolsson A, 2001, Physiother Res Int, V6, P15, DOI 10.1002/pri.210; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Robbins D.H., 1983, UMTRI83532; ROBBINS DH, 1983, UMTRI83533; Schick S, 2008, 2 TUV SUD C WHIPL NE; Schneider L.W., 1983, UMTRI83531; Seacrist T, 2009, 21 ESV C JUN 15 18 2; SEIDL A, 1997, 970088 SAE; Siegmund G. P., 1997, 41 STAPP CAR CRASH C; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Stahlschmidt S, 2006, 5 GERM LS DYNA FOR O; States JD, 1972, 16 STAPP CAR CRASH C; Stemper BD, 2007, IRCOBI C SEPT 19 21; Stemper BD, 2008, SPINE, V33, pE44, DOI 10.1097/BRS.0b013e318160462a; Storvik Steven G, 2009, Biomed Sci Instrum, V45, P244; Svensson MY, 1993, SAESP93963; Szabo TJ, 1994, 38 STAPP CAR CRASH C; Temming J, 1998, IRCOBI C SEPT 16 18; The Whiplash Commission, 2005, WHIPL COMM FIN REP; Thomas C, 1982, IRCOBI C SEPT 8 10 1; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Viano David C, 2003, Traffic Inj Prev, V4, P228, DOI 10.1080/15389580309880; Watanabe Y, 2000, ACCIDENT ANAL PREV, V32, P243, DOI 10.1016/S0001-4575(99)00082-2; Welcher JB, 2001, ACCIDENT ANAL PREV, V33, P289, DOI 10.1016/S0001-4575(00)00043-9; Welsh R, 2001, 45 AAAM C SEPT 24 26; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Young J. W., 1983, ANTHROPOMETRIC MASS	74	14	15	3	23	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2014	15	8					855	865		10.1080/15389588.2014.885647			11	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	AM8PD	WOS:000340138300011	24484526				2022-02-06	
J	Dowdy, J; Pait, TG				Dowdy, Justin; Pait, T. Glenn			The influence of war on the development of neurosurgery	JOURNAL OF NEUROSURGERY			English	Article						history; medicine; neurosurgery; war trephination; head injury	PENETRATING HEAD-INJURIES; DECOMPRESSIVE CRANIECTOMY; NEUROLOGICAL SURGERY; TRAUMATIC ANEURYSMS; BONE FRAGMENTS; MISSILE WOUNDS; FOLLOW-UP; BRAIN; WARTIME; MANAGEMENT	The treatment of craniospinal war wounds proved to be a significant driving force in the early growth of neurosurgery as a specialty. This publication explores the historical relationship between the evolution of combat methodology from antiquity through modern conflicts as it dovetails with and drives corresponding advancements in the field of neurosurgery. Whether it's the basic management principles for intracranial projectile wounds derived from World War I experiences, the drastic improvement in the outcomes and management of spinal cord injuries observed in World War II, or the fact that both of these wars played a crucial role in the development of a training system that is the origin of modern residency programs, the influence of wartime experiences is pervasive.	[Dowdy, Justin; Pait, T. Glenn] Univ Arkansas Med Sci, Dept Neurosurg, Little Rock, AR 72205 USA		Dowdy, J (corresponding author), Univ Arkansas Med Sci, Dept Neurosurg, 4301 W Markham St,Slot 507, Little Rock, AR 72205 USA.	jtdowdy@uams.edu					AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Agarwalla PK, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1038; Albutt TC, 1905, HIST RELATIONS MED S, P92; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Ascroft PB, 1944, ARCH NEUROL PSYCHIAT, V21, P295; BEDBROOK GM, 1987, PARAPLEGIA, V25, P172, DOI 10.1038/sc.1987.31; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Benini A, 1996, SPINE, V21, P1388, DOI 10.1097/00007632-199606010-00024; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BREASTED JH, 1930, E SMITH SURG PAPYRUS, V1; CAIRNS H, 1947, Br J Surg, V55, P9; Cairns H, 1944, Proc R Soc Med, V37, P371; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; Carey ME, 2011, J NEUROSURG, V114, P1495, DOI 10.3171/2011.1.JNS101259; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Coates JB, 1958, SURG WORLD WAR 2 NEU, V2, p[8, 25, 261]; Coates JB, 1965, NEUROLOGICAL SURG TR, p[17, 103]; Cushing H, 1908, SURG GYNECOL OBSTET, V6, P227; Cushing H, 1918, BRIT J SURG, V5, P558; Cushing H, 1918, Br Med J, V1, P221; Cushing H, 1905, B JOHNS HOPKINS HOSP, V16, P77; Cushing H., 1927, MED DEP UNITED STATE, VXI, P749; Cushing H, 1916, MIL SURG, V38, P601; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; Finger S, 2001, NEUROSURGERY, V48, P911, DOI 10.1097/00006123-200104000-00045; Goetz CG, 2003, ANN NEUROL, V53, pS2, DOI 10.1002/ana.8888; Gray HMW, 1916, BRIT MED J, V1916, P261, DOI 10.1136/bmj.1.2877.261; GUTTMANN L, 1979, PARAPLEGIA, V17, P6, DOI 10.1038/sc.1979.5; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; Hanigan WC, 2003, NEUROSURGERY, V53, P713, DOI 10.1227/01.NEU.0000079626.37622.6A; HANIGAN WC, 1988, NEUROSURGERY, V23, P283, DOI 10.1227/00006123-198809000-00001; Hanigan W, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS103; Hanigan William C, 2004, Neurosurg Focus, V16, pE4; KAUFMAN HH, 1993, J NEUROSURG, V78, P838, DOI 10.3171/jns.1993.78.5.0838; Lanska DJ, 2009, ANN NEUROL, V66, P444, DOI 10.1002/ana.21822; Lifshutz Jason, 2004, Neurosurg Focus, V16, pE5; Lister Joseph, 1867, LANCET, V2, P353, DOI DOI 10.1016/S0140-6736(02)51827-4; MacLeod GHB, 1862, NOTES SURG WAR CRIME, p[373, 760]; Marketos SG, 1999, SPINE, V24, P2358, DOI 10.1097/00007632-199911150-00012; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MEIROWSKY AM, 1953, ANN SURG, V138, P178, DOI 10.1097/00000658-195308000-00003; MEIROWSKY AM, 1953, J NEUROSURG, V10, P373, DOI 10.3171/jns.1953.10.4.0373; Moodie RL, 1929, ANN MED HIST, V11, P698; Naderi Sait, 2004, Neurosurg Focus, V16, pE15; Otis GA, 1870, MED SURG HIST WAR RE, VII, p[35, 309]; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rahimi Scott Y, 2007, Neurosurg Focus, V23, pE14; ROWE SN, 1945, J NEUROSURG, V2, P391, DOI 10.3171/jns.1945.2.5.0391; Rusk HA, 1972, WORLD CARE AUTOBIOGR, P97; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Sargent P, 1915, BRIT MED J, V1915, P537, DOI 10.1136/bmj.1.2830.537; Sargent P, 1915, BRIT J SURG, V3, P475; Schurr PH, 2005, J ROY SOC MED, V98, P423, DOI 10.1258/jrsm.98.9.423; Silver JR, 2003, HIST TREATMENT SPINA, P85; SPURLING R G, 1960, Arch Surg, V80, P406; STONE JL, 1985, NEUROSURGERY, V17, P997, DOI 10.1227/00006123-198512000-00024; WILKINS RH, 1964, J NEUROSURG, V21, P240, DOI 10.3171/jns.1964.21.3.0240	62	14	14	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2014	120	1					237	243		10.3171/2013.8.JNS122369			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	281GL	WOS:000329087900034	24116730				2022-02-06	
J	George, DR; Whitehouse, PJ				George, Daniel R.; Whitehouse, Peter J.			The War (on Terror) on Alzheimer's	DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE			English	Article						Alzheimer's disease; metaphor; traumatic brain injury; public health	TRAUMATIC BRAIN-INJURY; COGNITIVE DECLINE; DISEASE; DEMENTIA; SELF	In the decade following the tragedies of 9/11, a US-led "War on Terror'' has coincided with a US-led "War on Alzheimer's disease''. Not only has the rhetoric from these two wars overlapped and produced similar practical and conceptual problems, the campaigns have also become interwoven through the emerging public health issue of war-related head injuries, as well as a shared neglect for environmental contributions to human suffering. This article first explores similarities in the framing and prosecution of both wars, and then considers the long-term consequences of traumatic brain injuries (TBI) and traumatic environmental injuries (TEI) in the context of a society facing the increased prevalence of dementia. Ultimately, it is argued that addressing the challenges of cognitive aging and preventing violent social conflict both require a vernacular of higher ideals and values - as well as new language patterns rising out of the ecological movement - to trump the more expedient war rhetoric that has disproportionately marked public discourse around terrorism and Alzheimer's disease during the past decade.	[George, Daniel R.] Penn State Hershey Coll Med, Dept Humanities, Hershey, PA 17033 USA; [Whitehouse, Peter J.] Case Western Reserve Univ, Cleveland, OH 44106 USA		George, DR (corresponding author), Penn State Hershey Coll Med, Dept Humanities, 500 Univ Dr, Hershey, PA 17033 USA.	drg21@psu.edu					Alzheimer's Association, 2011, GEN ALZH DEF DIS BAB; Alzheimer's Disease International, 2010, WORLD ALZHEIMER REPO; ANNAS GJ, 1995, NEW ENGL J MED, V332, P744; Ballenger Jesse, 2006, SELF SENILITY ALZHEI; Behuniak SM, 2011, AGEING SOC, V31, P70, DOI 10.1017/S0144686X10000693; Brayne C., 2010, BRIT MED J, V341, P865; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Bush G. W., 2001, ADDR JOINT SESS C FO; Butler Robert N., 2008, LONGEVITY REVOLUTION; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; CNN.com, 2005, CNN             0620; CORKIN S, 1989, J NEUROSCI, V9, P3876; D'Alton S, 2011, J ALZHEIMERS DIS, V25, P571, DOI 10.3233/JAD-2011-110089; Dimond PF, 2010, GENET ENG BIOTECHN N, V30, P51; Ehrenreich B, 2009, BRIGHTSIDED RELENTLE; Ehrenreich Barbara, 2001, HARPERS MAGAZINE, P43; FOX P, 1989, MILBANK Q, V67, P58, DOI 10.2307/3350070; GAINES AD, 1992, SOC SCI MED, V35, P3, DOI 10.1016/0277-9536(92)90115-7; George DR, 2010, LANCET, V376, P586, DOI 10.1016/S0140-6736(10)61286-X; Gingrich N., 2009, MINNEAPOLIS STA 0921; Gubrium, 1986, OLDTIMERS ALZHEIMERS; Hachinski V, 2008, JAMA-J AM MED ASSOC, V300, P2172, DOI 10.1001/jama.2008.525; HERSKOVITS E, 1995, MED ANTHROPOL Q, V9, P146, DOI 10.1525/maq.1995.9.2.02a00030; Holstein M, 1997, J AGING STUD, V11, P1, DOI 10.1016/S0890-4065(97)90008-6; Jobst K. A., 2000, J ALTERN COMPLEM MED, V6, P125, DOI DOI 10.1089/ACM.2000.6.125; Kennedy J. F., 1963, ADDRESS 18 GEN ASSEM; Kleinman A., 1988, ILLNESS NARRATIVES; Korcyzn A. D., 2012, J ALZHEIMERS DIS, V30, P1; Lakoff G, 2008, METAPHORS WE LIVE; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martin E, 2007, BIPOLAR EXPEDITION: MANIA AND DEPRESSION IN AMERICAN CULTURE, P1; Martin E., 1987, WOMAN BODY CULTURAL; Martin Emily, 1994, FLEXIBLE BODIES TRAC; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Nietzsche F., DAWN DAY, P379; O'Connor S. D., 2010, AGE ALZHEIMERS; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pagel M, 2012, WIRED CULTURE ORIGIN; Pascrell Bill, 2007, FUNDING SIGNATURE IN; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sontag Susan, 1978, ILLNESS METAPHOR; Sontag Susan, 1989, AIDS ITS METAPHORS; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Turner Victor W., 1969, RITUAL PROCESS; Whitehouse P. J., 2008, MYTH ALZHEIMERS WHAT; Whitehouse PJ, 2011, J ALZHEIMERS DIS, V24, P11, DOI 10.3233/JAD-2010-101639; Yaffe K., 2011, INT C ALZH DIS; [No title captured]	55	14	15	2	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1471-3012	1741-2684		DEMENTIA-LONDON	Dement.-Int. J. soc. Res. Pract.	JAN	2014	13	1					120	130		10.1177/1471301212451382			11	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	AR7MF	WOS:000343763100009	24381043				2022-02-06	
J	Kang, HJ; Dang, ABC; Joshi, SK; Halloran, B; Nissenson, R; Zhang, X; Li, JA; Kim, HT; Liu, XH				Kang, Heejae; Dang, Alexis B. C.; Joshi, Sunil K.; Halloran, Bernard; Nissenson, Robert; Zhang, Xia; Li, Jianan; Kim, Hubert T.; Liu, Xuhui			Novel mouse model of spinal cord injury-induced heterotopic ossification	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						bone morphogenetic protein-2; heterotopic ossification; injury; microcomputed tomography; mouse model; muscle; rehabilitation; spinal cord injury; trauma; Veterans	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; PREVALENCE; SYSTEM; BONE	Heterotopic ossification (HO) develops in about 20% to 30% of patients with spinal cord injury (SCI) and significantly impairs their rehabilitation. There is no effective prevention or treatment for this condition at this time. Our current understanding of its etiology and pathophysiology is limited partially due to the lack of clinically relevant animal models. In this study, we report a novel mouse model of SCI-induced HO by administering a subthreshold dose of bone morphogenetic protein (BMP)-2 to muscles in mice after SCI. Microcomputed tomography scanning showed that an intramuscular injection of 0.25 micrograms of BMP-2 causes significant HO in mice with SCI but not in control (sham surgery) mice. Our analysis of gene expression showed significantly increased BMP signaling in quadriceps following SCI, suggesting that BMP signaling may play a role in SCI-induced HO. Administering 0.25 micrograms of BMP-2 to the front arms of the mice with SCI also results in the development of significant HO but not in control mice. This suggests that SCI causes a systematic osteogenic effect, which is not limited to paralyzed limbs. This novel mouse model will serve as a powerful tool in exploring the molecular mechanisms of SCI-induced HO, which may lead to novel treatment for this disease.	[Kang, Heejae; Dang, Alexis B. C.; Joshi, Sunil K.; Halloran, Bernard; Nissenson, Robert; Kim, Hubert T.; Liu, Xuhui] San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Dang, Alexis B. C.; Joshi, Sunil K.; Kim, Hubert T.; Liu, Xuhui] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Halloran, Bernard; Nissenson, Robert] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Zhang, Xia; Li, Jianan] Nanjing Med Univ, Affiliate Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China		Liu, XH (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,Bldg 2,Room 639, San Francisco, CA 94121 USA.	Liux@orthosurg.ucsf.edu		Joshi, Sunil/0000-0003-2798-5762	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0189]; Department of Veterans Affairs (VA) Rehabilitation Research and Development Merit ReviewUS Department of Veterans Affairs [RX000195]; Northern California Institute for Research and Education; Veterans AffairsUS Department of Veterans Affairs [IP1BX001599, I01BX001496] Funding Source: NIH RePORTER	This material was based on work supported by the Department of Defense (grant W81XWH-11-2-0189), Department of Veterans Affairs (VA) Rehabilitation Research and Development Merit Review (grant RX000195), and the Northern California Institute for Research and Education. We thank Drs. Olla Larm and Lars Adolfsson (ExThera AB; Stockholm, Sweden) for their kind gift of heparin-chitosan hydrogel.	Baldwin K, 2011, J HAND SURG-AM, V36A, P798, DOI 10.1016/j.jhsa.2011.01.015; Biering-Sorensen F, 2012, SPINAL CORD, V50, P797, DOI 10.1038/sc.2012.102; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Engstrand T, 2008, PLAST RECONSTR SURG, V121, P1920, DOI 10.1097/PRS.0b013e31817151b0; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Liu XH, 2014, J ORTHOP RES, V32, P183, DOI 10.1002/jor.22500; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152	20	14	15	0	2	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1109	1117		10.1682/JRRD.2014.01.0019			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AU8JB	WOS:000345841300010	25436890	Bronze			2022-02-06	
S	Lee, RR; Huang, MX		Niranjan, A; Lunsford, LD		Lee, Roland R.; Huang, Mingxiong			Magnetoencephalography in the Diagnosis of Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; DELTA WAVES; IMAGING APPROACH; HEAD TRAUMA; MEG; MILD; DOMINANCE; BLAST; EEG	Magnetoencephalography (MEG) is a biomedical technique which measures the magnetic fields emitted by the brain, generated by neuronal activity. Commercial whole-head MEG units have been available for about 15 years, but currently there are only about 20 such units operating in the USA. Here, we review the basic concepts of MEG and list some of the usual clinical indications: noninvasive localization of epileptic spikes and presurgical mapping of eloquent cortex. We then discuss using MEG to diagnose mild traumatic brain injury (mTBI; concussions). Injured brain tissues in TBI patients generate abnormal low-frequency magnetic activity (delta-waves: 1-4 Hz) that can be measured and localized by MEG. These abnormal delta-waves originate from neurons that experience deafferentation from axonal injury to the associated white matter fiber tracts, also manifested on diffusion tensor imaging as reduced fractional anisotropy. Magnetoencephalographic evaluation of abnormal delta-waves (1-4 Hz) is probably the most sensitive objective test to diagnose concussions. An automated MEG low-frequency (slow wave) source imaging method, frequency-domain vector-based spatiotemporal analysis using a L1-minimum norm (VESTAL), achieved a positive finding rate of 87% for diagnosing concussions (blast-induced plus nonblast), 100% for moderate TBI, and no false-positive diagnoses in normal controls. There were also significant correlations between the number of cortical regions generating abnormal slow waves and the total postconcussive symptom scores in TBI patients. (C) 2014 S. Karger AG, Basel	VA San Diego Healthcare Syst, Dept Radiol, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92161 USA		Lee, RR (corresponding author), Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Radiol, 3350 La Jolla Village Dr,MC 114, San Diego, CA 92161 USA.	rrlee@ucsd.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alberstone CD, 2000, J NEUROSURG, V92, P79, DOI 10.3171/jns.2000.92.1.0079; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Medical Association, 2003, CURR PROC TECHN CPT; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Canive JM, 1996, PSYCHOPHARMACOL BULL, V32, P741; Castillo EM, 2004, NEUROIMAGE, V21, P973, DOI 10.1016/j.neuroimage.2003.10.020; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; CUFFIN BN, 1977, IEEE T BIO-MED ENG, V24, P372, DOI 10.1109/TBME.1977.326145; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; FERGUSON AS, 1994, IEEE T BIO-MED ENG, V41, P455, DOI 10.1109/10.293220; Fernandez A, 2002, BIOL PSYCHIAT, V52, P764, DOI 10.1016/S0006-3223(02)01366-5; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hirata M, 2004, NEUROIMAGE, V23, P46, DOI 10.1016/j.neuroimage.2004.05.009; Huang M, 1998, EVOKED POTENTIAL, V108, P32, DOI 10.1016/S0168-5597(97)00091-9; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2006, NEUROIMAGE, V31, P1025, DOI 10.1016/j.neuroimage.2006.01.029; Knowlton RC, 2008, ANN NEUROL, V64, P25, DOI 10.1002/ana.21389; Knowlton RC, 2008, ANN NEUROL, V64, P35, DOI 10.1002/ana.21419; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MEIJS JWH, 1987, ELECTROEN CLIN NEURO, V66, P286, DOI 10.1016/0013-4694(87)90078-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Papanicolaou AC, 2004, J NEUROSURG, V100, P867, DOI 10.3171/jns.2004.100.5.0867; Roberts T P, 2000, Brain Tumor Pathol, V17, P57, DOI 10.1007/BF02482736; Rockstroh BS, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-44; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; SCHLITT HA, 1995, IEEE T BIO-MED ENG, V42, P52, DOI 10.1109/10.362919; Simos PG, 2000, J CLIN NEUROPHYSIOL, V17, P143, DOI 10.1097/00004691-200003000-00004; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Ulmer JL, 2004, NEUROSURGERY, V55, P569, DOI 10.1227/01.NEU.0000134384.94749.B2; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Wienbruch C, 2003, CLIN NEUROPHYSIOL, V114, P2052, DOI 10.1016/S1388-2457(03)00210-4; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; [No title captured]	47	14	14	0	4	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						94	111		10.1159/000358768	10.1159/isbn.978-3-318-02649-8		18	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000010	24923396				2022-02-06	
J	Lequerica, A; Chiaravalloti, N; Cantor, J; Dijkers, M; Wright, J; Kolakowsky-Hayner, SA; Bushnick, T; Hammond, F; Bell, K				Lequerica, Anthony; Chiaravalloti, Nancy; Cantor, Joshua; Dijkers, Marcel; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.; Bushnick, Tamara; Hammond, Flora; Bell, Kathleen			The factor structure of the Pittsburgh Sleep Quality Index in persons with traumatic brain injury. A NIDRR TBI model systems module study	NEUROREHABILITATION			English	Article						Brain injury; sleep; measurement	PSYCHOMETRIC EVALUATION; DAYTIME SLEEPINESS; HEAD-INJURY; OF-LIFE; DISTURBANCES; REHABILITATION; PREVALENCE; ADULTS; WAKE; ORIENTATION	BACKGROUND: Sleep disturbances are common following traumatic brain injury (TBI). The Pittsburgh Sleep Quality Index (PSQI) is a widely used measure of sleep quality that has been used in numerous populations. Although this measure has been used in TBI research, there are few studies examining the psychometric properties in this population. OBJECTIVE: The current study examined the factor structure of the PSQI in a sample of persons with TBI and tested the one, two, and three factor models derived from previous studies in other populations. METHODS: A telephone interview was conducted with 243 individuals who had sustained a TBI. All participants were approximately one year post-injury. Factor analyses were conducted (exploratory and confirmatory) to examine the factor structure of the PSQI. RESULTS: Results confirm the fit of models previously tested in the literature but also reveal an alternative conceptualization of sleep containing both qualitative and quantitative factors. CONCLUSIONS: While the 3-factor model best fits the data in this TBI sample, the use of a 2-factor model is acceptable and may be more clinically relevant due to the grouping of time-related variables that could provide important information with regard to circadian rhythm disorders.	[Lequerica, Anthony; Chiaravalloti, Nancy] Kessler Fdn Res Ctr, W Orange, NJ 07052 USA; [Lequerica, Anthony; Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, W Orange, NJ 07052 USA; [Cantor, Joshua; Dijkers, Marcel] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Wright, Jerry; Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Resarch Ctr, San Jose, CA 95128 USA; [Bushnick, Tamara] NYU Sch Med, New York, NY USA; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Bell, Kathleen] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Lequerica, A (corresponding author), Kessler Fdn Res Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	alequerica@kesslerfoundation.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Bell, Kathleen/0000-0002-0928-2046; Chiaravalloti, Nancy/0000-0003-2943-7567			Afonso P, 2011, INT J PSYCHIAT CLIN, V15, P311, DOI 10.3109/13651501.2011.605954; Afsar B, 2013, GEN HOSP PSYCHIAT, V35, P625, DOI 10.1016/j.genhosppsych.2013.05.001; Afsar B, 2013, HIGH BLOOD PRESS CAR, V20, P19, DOI 10.1007/s40292-013-0002-7; Cavalcanti PRA, 2013, NEUROREHABILITATION, V32, P337, DOI 10.3233/NRE-130853; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Beck SL, 2004, J PAIN SYMPTOM MANAG, V27, P140, DOI 10.1016/j.jpainsymman.2003.12.002; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Burkhalter H, 2011, PROG TRANSPLANT, V21, P27, DOI 10.7182/prtr.21.1.d15486415621357w; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Cole JC, 2006, SLEEP, V29, P112, DOI 10.1093/sleep/29.1.112; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Engstrom M, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-12; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gentili A, 1997, AGING-CLIN EXP RES, V9, P207, DOI 10.1007/BF03340151; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; GUILLEMINAULT C, 1983, NEUROLOGY, V33, P1584, DOI 10.1212/WNL.33.12.1584; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Karkare K, 2013, ACTA NEUROL SCAND, V127, P116, DOI 10.1111/j.1600-0404.2012.01688.x; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Knutson KL, 2006, SLEEP, V29, P1503, DOI 10.1093/sleep/29.11.1503; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Magee CA, 2008, SLEEP BIOL RHYTHMS, V6, P222, DOI 10.1111/j.1479-8425.2008.00371.x; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mariman A, 2012, ACTA CLIN BELG, V67, P19, DOI 10.2143/ACB.67.1.2062621; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Soler X, 2013, COPD, V10, P156, DOI 10.3109/15412555.2012.729622; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th	36	14	14	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	3					485	492		10.3233/NRE-141141			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AS8UO	WOS:000344523600015	25260230				2022-02-06	
J	Li, PC; Yang, CH				Li, Pengcheng; Yang, Chaohua			Moderate hypothermia treatment in adult patients with severe traumatic brain injury: A meta-analysis	BRAIN INJURY			English	Article						Meta-analysis; Moderate hypothermia; severe traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; CEREBRAL HYPOTHERMIA; MANAGEMENT	Objectives: To evaluate the effect of moderate hypothermia treatment (MHT) in severe traumatic brain injury (sTBI) compared to normothermia management. Methods: PubMed, Medline, Springer, Elsevier Science Direct, Cochrane Library and Google scholar were searched up to December 2012. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) for the mortality and clinical neurological outcome of the adult patients with sTBI were collected and calculated in a fixed-effects model or a random-effects model. Summary effect estimates were stratified by study design and ethnicity. Egger's regression asymmetry tests were utilized for detecting the publication bias. Results: The overall estimates showed that MHT could reduce the mortality (hypothermia vs. normothermia, RR = 0.86, 95% CI = 0.73-1.01, p = 0.06) and unfavourable clinical neurological outcomes (RR = 1.21, 95% CI = 0.95-1.53, p = 0.12) for traumatic brain injured patients without statistical significance. Moreover, the further stratification sub-group analysis indicated that MHT presented a significant reduction (RR = 0.60, 95% CI = 0.44-0.83, p = 0.002) of mortality compared to the normothermia management in an Asian population. Surprisingly, American patients treated with moderate hypothermia showed an increasing mortality (RR = 1.07, 95% CI = 0.83-1.39, p = 0.61). Conclusions: MHT may be effective in reducing death and unfavourable clinical neurological outcomes, but this finding is not statistically significant, except for decreasing the mortality in Asian patients.	[Li, Pengcheng; Yang, Chaohua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Peoples R China		Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China.	yangchaohuua@hotmail.com					Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERING EA, 1961, AM J PHYSIOL, V200, P417; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Deeks J.J., 2008, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926.CH15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Franschman G, 2013, INJURY, V44, P1232, DOI 10.1016/j.injury.2013.06.002; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Le Roux P., 2013, CURRENT NEUROLOGY NE, V13, P1; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Mantel N, 2004, CHALLENGE EPIDEMIOLO, V1, P533; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2004, CURR PHARM DESIGN, V10, P2193, DOI 10.2174/1381612043384051; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zygun DA, 2003, CAN J NEUROL SCI, V30, P307, DOI 10.1017/S0317167100003000	37	14	14	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1036	1041		10.3109/02699052.2014.910609			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200003	24892219				2022-02-06	
J	Loher, S; Fatzer, ST; Roebers, CM				Loher, Sarah; Fatzer, Simone T.; Roebers, Claudia M.			Executive Functions After Pediatric Mild Traumatic Brain Injury: A Prospective Short-Term Longitudinal Study	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						children; executive functions; inhibition; mild traumatic brain injury; prospective longitudinal study; switching; working memory	WORKING-MEMORY; POSTCONCUSSIVE SYMPTOMS; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; HEAD-INJURY; CHILDREN; INHIBITION; IDENTIFICATION; ADOLESCENTS; PERFORMANCE	Traumatic brain injuries (TBIs) occur frequently in childhood and entail broad cognitive deficits, particularly in the domain of executive functions (EF). Concerning mild TBI (mTBI), only little empirical evidence is available on acute and postacute performance in EF. Given that EF are linked to school adaptation and achievement, even subtle deficits in performance may affect children's academic careers. The present study assessed performance in the EF components of inhibition, working memory (WM), and switching in children after mTBI. Regarding both acute and postacute consequences, performance trajectories were measured in 13 patients aged between 5 and 10 years and 13 controls who were closely matched in terms of sex, age, and education. Performance in the EF components of inhibition, switching, and WM was assessed in a short-term longitudinal design at 2, 6, and 12 weeks after the mTBI. Results indicate subtle deficits after mTBI, which became apparent in the longitudinal trajectory in the EF components of switching and WM. Compared with controls, children who sustained mTBI displayed an inferior performance enhancement across testing sessions in the first 6 weeks after the injury in switching and WM, resulting in a delayed deficit in the EF component of WM 12 weeks after the injury. Results are interpreted as mTBI-related deficits that become evident in terms of an inability to profit from previous learning opportunities, a finding that is potentially important for children's mastery of their daily lives.	[Loher, Sarah; Fatzer, Simone T.; Roebers, Claudia M.] Univ Bern, Dept Dev Psychobiol, CH-3000 Bern 9, Switzerland		Loher, S (corresponding author), Univ Bern, Dept Dev Psychobiol, Muesmattstr 45, CH-3000 Bern 9, Switzerland.	sarah.loher@psy.unibe.ch					Altermatt S., 2002, PAEDIATRICA, V13, P41; Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2000, BRAIN INJURY, V14, P679; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cragg L, 2012, Q J EXP PSYCHOL, V65, P209, DOI 10.1080/17470210903204618; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Diamond A, 2006, LIFESPAN COGNITION M, P70; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fatzer ST, 2012, J COGN DEV, V13, P454, DOI 10.1080/15248372.2011.608322; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; KAIL R, 1991, DEV PSYCHOL, V27, P259, DOI 10.1037/0012-1649.27.2.259; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; Menascu S., 2007, HEAD INJURY CHILDREN, P41; Michel E, 2008, SWISS J PSYCHOL, V67, P249, DOI 10.1024/1421-0185.67.4.249; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Roebers CM, 2011, EUR J DEV PSYCHOL, V8, P526, DOI 10.1080/17405629.2011.571841; Roebers CM, 2010, J GENET PSYCHOL, V171, P1, DOI 10.1080/00221320903300361; Roebers CM, 2009, DEVELOPMENTAL SCI, V12, P175, DOI 10.1111/j.1467-7687.2008.00755.x; Rose SA, 2011, DEVELOPMENTAL SCI, V14, P1161, DOI 10.1111/j.1467-7687.2011.01068.x; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Schmid C, 2008, Z ENTWICKL PADAGOGIS, V40, P2, DOI 10.1026/0049-8637.40.1.2; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zelazo P. D., 2008, HDB DEV COGNITIVE NE, P553, DOI 10.7551/mitpress/7437.001.0001; Zelazo P. D., 2002, HDB CHILDHOOD COGNIT, P445, DOI DOI 10.1002/9780470996652.CH20; Zelazo P. D., NATL I HLTH IN PRESS; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x; [No title captured]	55	14	14	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2014	3	2					103	114		10.1080/21622965.2012.716752			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AF8DR	WOS:000334946200003	24716869				2022-02-06	
J	Milne, G; Deck, C; Bourdet, N; Carreira, RP; Allinne, Q; Gallego, A; Willinger, R				Milne, G.; Deck, C.; Bourdet, N.; Carreira, R. P.; Allinne, Q.; Gallego, A.; Willinger, R.			Bicycle helmet modelling and validation under linear and tangential impacts	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						bicycle helmet; helmet modelling; validation; standard impacts; oblique impacts	HEAD; INJURY	In the context of head protection against traumatic brain injuries, this work attempts to understand the degree of protection offered by a commercial bicycle helmet under both linear and oblique impact conditions. In accordance with EN 1078 standard, an experimental program has been carried out on an existing helmet by performing 90 normative impacts. In parallel, a finite element model (FEM) of this helmet has been developed and implemented under the LS-DYNA (R) crash code to numerically reproduce the 90 experimental standard impact tests. Experimental oblique impacts on this commercial helmet have also been performed in order to validate it and to be able to assess its protection capability in case of tangential impact. Finally, the bicycle helmet FEM has been coupled to a Hybrid III dummy head FEM and oblique impacts have been reproduced numerically leading to a realistic behaviour of the helmet model in terms of rotational accelerations.	[Milne, G.; Deck, C.; Bourdet, N.; Willinger, R.] Univ Strasbourg, Fluid & Solid Mech Inst, Strasbourg, France; [Carreira, R. P.; Allinne, Q.; Gallego, A.] Oxylane Res, Villeneuve Dascq, France		Deck, C (corresponding author), Univ Strasbourg, Fluid & Solid Mech Inst, Strasbourg, France.	caroline.deck@unistra.fr		DECK, Caroline/0000-0003-2289-1222	French Department of Transport	The authors wish to thank the French Department of Transport for its support in the framework of the PREDIT-BICYTETE project.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aldman B., 1978, P IRCOBI C LYON; [Anonymous], 1995, 960 EN; [Anonymous], 2002, 6487 ISO; [Anonymous], 1999, INT J; [Anonymous], 1997, 1078 NF EN, pS72; Asiminei A.G., 2009, P IRCOBI C YORK; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; *BS, 1985, 6658 BS; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; COLLINS BA, 1993, NEW ZEAL MED J, V106, P514; Deck C, 2006, INT J CRASHWORTHINES, V11, P561, DOI 10.1533/ijcr.2006.0149; Deck C., 2007, P IRCOBI C MAASTR; EilertPetersson E, 1997, ACCIDENT ANAL PREV, V29, P363, DOI 10.1016/S0001-4575(97)00002-X; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Harrison T.I., 1996, P IRCOBI C DUBL; Larsen L.B., 1991, P IRCOBI C BERL; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh A, 1995, P 39 STAPP CAR CRASH; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Mills NJ, 1996, INT J CRASHWORTHINES, V2, P7; *NIS, 2000, MOB 1998 1999; OSTROM M, 1993, INT J EPIDEMIOL, V22, P483, DOI 10.1093/ije/22.3.483; Otte D., 1999, CONTRIBUTION FINAL R; Otte D., 1985, P 33 STAPP CAR CRASH; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Takhounts E.G., 2011, 22 ESV C WASH DC; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Tinard V, 2012, INT J CRASHWORTHINES, V17, P209, DOI 10.1080/13588265.2011.648465; Untaroiu CD, 2013, INT J AUTO TECH-KOR, V14, P395, DOI 10.1007/s12239-013-0043-x; Willinger R., 1998, P IRCOBI C GOTH	35	14	15	0	25	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2014	19	4					323	333		10.1080/13588265.2013.859470			11	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AJ3JR	WOS:000337562900001					2022-02-06	
J	Palermo, S; Leotta, D; Bongioanni, MR; Amanzio, M				Palermo, S.; Leotta, D.; Bongioanni, M. R.; Amanzio, M.			Unawareness of deficits in ischemic injury: Role of the cingulate cortex	NEUROCASE			English	Article						Anterior cingulate cortex; Unawareness of deficits; Executive function assessment; Behavioral assessment of the dysexecutive syndrome; Case study	TRAUMATIC BRAIN-INJURY; UNDERSTANDING AWARENESS DEFICITS; MINI-MENTAL-STATE; SELF-AWARENESS; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; CORTICOBASAL DEGENERATION; DAMAGED PATIENTS; RATING-SCALE; ANOSOGNOSIA	Reduced awareness of illness is a well-known phenomenon that has been studied in patients with vascular disease, but the precise nature of their executive dysfunction is an intriguing question that still has to be resolved. It would be particularly interesting to study patients with reduced awareness of disease possibly related to vascular lesions of the prefrontal cortex. Due to the clinical importance of the case, here we present a patient with a selective right anterior cingulate ischemic injury and impaired awareness of deficits. We suggest that the cingulo-frontal area dysfunction may represent one of the corresponding neurobiological substrates of his persistent unawareness, which has not yet been evaluated in the literature on patients with acquired brain injury (ABI).	[Palermo, S.] Univ Turin, Dept Psychol, I-10123 Turin, Italy; [Palermo, S.; Leotta, D.; Bongioanni, M. R.] Martini Hosp, Neurol Unit, I-10100 Turin, Italy; [Amanzio, M.] Dept Psychol, I-10123 Turin, Italy; [Amanzio, M.] NIT, I-10123 Turin, Italy; [Amanzio, M.] Natl Inst Neurosci, Turin, Italy		Palermo, S (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	sara.palermo@unito.it	Amanzio, Martina/A-9085-2010; Palermo, Sara/M-7102-2013	Amanzio, Martina/0000-0002-2504-032X; Palermo, Sara/0000-0002-1451-3793			Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Amanzio M, 2008, BRAIN LANG, V107, P1, DOI 10.1016/j.bandl.2007.08.003; Amanzio M, 2013, J INT NEUROPSYCH SOC, V19, P63, DOI 10.1017/S1355617712000896; Amanzio M, 2011, BRAIN, V134, P1061, DOI 10.1093/brain/awr020; Amanzio M, 2010, BRAIN COGNITION, V72, P337, DOI 10.1016/j.bandc.2009.10.011; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BECH P, 1978, NEUROPHARMACOLOGY, V17, P430, DOI 10.1016/0028-3908(78)90022-9; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Bisiach E., 1991, AWARENESS DEFICITS B; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOGOUSSLAVSKY J, 1994, EUR NEUROL, V34, P306, DOI 10.1159/000117068; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Colombo L, 2002, GIORNALE ITALIANO PS, DOI DOI 10.1421/1249; Conde-Sala JL, 2013, J GERIATR PSYCH NEUR, V26, P86, DOI 10.1177/0891988713481266; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Devinsky Orrin, 2008, Rev Neurol Dis, V5, P97; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Dieci, 2002, NUOVA RIV NEUROLOGIA, V12, P111; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAINOTTI G, 1977, CORTEX, V13, P109, DOI 10.1016/S0010-9452(77)80002-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KUMRAL E, 1995, STROKE, V26, P964, DOI 10.1161/01.STR.26.6.964; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Liebson E, 2000, J NEUROL NEUROSUR PS, V68, P107, DOI 10.1136/jnnp.68.1.107; Litvan I, 1997, NEUROLOGY, V48, P119, DOI 10.1212/WNL.48.1.119; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; MIGLIORELLI R, 1995, J NEUROPSYCH CLIN N, V7, P338; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; MORRIS RG, 2004, COGNITIVE NEUROPSYCH; Nelson H.E., 1982, NATL ADULT READING T; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Perez DL, 2012, J NEUROPSYCH CLIN N, V24, P141, DOI 10.1176/appi.neuropsych.11050110; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Posner MI., 1994, IMAGES MIND; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Ryan JJ, 2006, J CLIN PSYCHOL, V62, P1319, DOI 10.1002/jclp.20307; Saj A, 2009, JAMA-J AM MED ASSOC, V302, P2552, DOI 10.1001/jama.2009.1834; Sartori G., 1995, PROFESSIONE PSICOLOG, V4, P1; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sinanovic O, 2010, PSYCHIAT DANUB, V22, P278; Spinnler H., 1987, ITAL J NEUROL SCI S8, V6, P25; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; Starkstein SE, 1996, STROKE, V27, P408, DOI 10.1161/01.STR.27.3.408; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Starkstein Sergio E, 2004, Cogn Behav Neurol, V17, P139, DOI 10.1097/01.wnn.0000119241.65522.90; Stuss D. T., 2001, PRINCIPLES FRONTAL L; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Wechsler D., 1945, WECHSLER MEMORY SCAL; ZAIDEL E, 1987, DUALITY UNITY BRAIN	94	14	14	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2014	20	5					540	555		10.1080/13554794.2013.826686			16	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AJ8NU	WOS:000337963200007	23962086				2022-02-06	
J	Umerani, MS; Abbas, A; Sharif, S				Umerani, Muhammad Sohail; Abbas, Asad; Sharif, Salman			Traumatic Brain Injuries: Experience from a Tertiary Care Center in Pakistan	TURKISH NEUROSURGERY			English	Article						Accident; Contusion; CT scan brain; Head trauma; Traumatic brain injury (TBI)	MINOR HEAD-INJURY; NEW-ORLEANS CRITERIA; MOTOR-VEHICLE; CT; MILD; HEMORRHAGE; RULE; ASSOCIATION; TOMOGRAPHY; MANAGEMENT	AIM: Traumatic Brain Injury (TBI) is one of the leading causes for morbidity, mortality and economic loss. The impact is much worse in developing countries like Pakistan. The objective of our study was to highlight the etiological pattern and distribution of TBI in Pakistan. MATERIAL and METHODS: From July 2009 to June 2011, 1378 patients presenting to our Accident and Emergency Department with head injury were included in the study. Patients underwent detailed clinical and radiological evaluation as per trauma protocol. RESULTS: The most commonly affected age group was 21 to 30 years (34.1%) with male to female ratio of 3.3:1. Injuries were predominantly caused by road traffic accident (62.6%), followed by fall (31.7%) and assault (5.5%). Amongst those with RTA less than 1% of the patients were wearing proper safety equipment. The most common CT scan finding was brain contusion (14.1%); others included traumatic sub-arachnoid hemorrhage (7.1%), subdural hematoma (7.6%), extra-dural hematoma (5.8%) and depressed skull fracture (4.6%). CONCLUSION: Motorbike accidents are a major cause of severe traumatic brain injury. Although this can be minimized by wearing proper helmets, its use is limited. Moreover, there is an imperative need to implement proper referral system amongst hospitals citywide in order to minimize the consequences of secondary brain injury.	[Umerani, Muhammad Sohail; Abbas, Asad; Sharif, Salman] Liaquat Natl Hosp, Dept Neurosurg, Karachi, Pakistan; [Abbas, Asad] Ziauddin Univ Hosp, Karachi, Pakistan		Umerani, MS (corresponding author), Liaquat Natl Hosp, Dept Neurosurg, Karachi, Pakistan.	drumerani@yahoo.com	Umerani, Muhammad Sohail/Y-9707-2019	Umerani, Muhammad Sohail/0000-0001-7598-6650			[Anonymous], 2001, J TRAUMA, V51, P516; Bainbridge J, 2012, BRIT J RADIOL, V85, P183, DOI 10.1259/bjr/56169980; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bakshi R, 2000, NEUROLOGY, V55, P1595, DOI 10.1212/WNL.55.10.1595; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Faul M, 2010, TRAUMATIC BRAIN UNJU; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Glauser J, 2004, CLEV CLIN J MED, V71, P353, DOI 10.3949/ccjm.71.4.353; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; Harr ME, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-25; Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038; Hyder A A, 2000, Inj Prev, V6, P199, DOI 10.1136/ip.6.3.199; Jinnah Postgraduate Medical Centre, 2011, HALF YEARL REP JAN J; Jooma R, 2005, J PAK MED ASSOC, V55, P630; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee Bruce, 2005, NeuroRx, V2, P372; Lee YB, 2009, J KOREAN NEUROSURG S, V46, P451, DOI 10.3340/jkns.2009.46.5.451; Leong LB, 2012, EUR J EMERG MED; Marion DW, 2006, NEUROSURGERY, V58, P655; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Medscape, 2011, TRAUM BRAIN INJ TBI; Nasir S, 2011, CHIN J TRAUMATOL, V14, P297, DOI 10.3760/cma.j.issn.1008-1275.2011.05.008; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; O'Neill B, 2002, BRIT MED J, V324, P1142, DOI 10.1136/bmj.324.7346.1142; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Puder DR, 1999, AM J PUBLIC HEALTH, V89, P1736, DOI 10.2105/AJPH.89.11.1736; Raja IA, 2001, WORLD J SURG, V25, P1230; Rivara F P, 1999, Inj Prev, V5, P194; Samandouras G., 2010, NEUROSURGEONS HDB, P207; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Siddiqui FM, 2011, NEUROTHERAPEUTICS, V8, P28, DOI 10.1007/s13311-010-0009-x; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Stevens JA, 2002, INJ PREV, V8, P272, DOI 10.1136/ip.8.4.272; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Swanson JO, 2012, PEDIATR RADIOL, V42, P974, DOI 10.1007/s00247-012-2372-8; Thurman DJ, 2001, HEAD TRAUMA, P327; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60	51	14	15	0	6	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JAN	2014	24	1					19	24		10.5137/1019-5149.JTN.7080-12.1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AB3AI	WOS:000331663300006	24535786				2022-02-06	
J	Zonfrillo, MR; Durbin, DR; Winston, FK; Zhang, XM; Stineman, MG				Zonfrillo, Mark R.; Durbin, Dennis R.; Winston, Flaura K.; Zhang, Xuemei; Stineman, Margaret G.			Residual Cognitive Disability after Completion of Inpatient Rehabilitation among Injured Children	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; UNIFORM DATA SYSTEM; PHYSICAL-DISABILITY; PROGRAMS; RECOVERY; VALIDITY; OUTCOMES; TBI	Objective To determine the prevalence and nature of residual cognitive disability after inpatient rehabilitation for children aged 7-18 years with traumatic injuries. Study design This retrospective cohort study included children aged 7-18 years in the Uniform Data System for Medical Rehabilitation who underwent inpatient rehabilitation for traumatic injuries in 523 facilities from 2002-2011. Traumatic injuries were identified by standardized Medicare Inpatient Rehabilitation Facility-Patient Assessment Instrument codes. Cognitive outcomes were measured by the Functional Independence Measure instrument. A validated, categorical staging system derived from responses to the items in the cognitive domain of the functional independence measure was used and consisted of clinically relevant levels of cognitive achievement from stage 1 (total cognitive disability) to stage 7 (completely independent cognitive function). Results There were 13 798 injured children who completed inpatient rehabilitation during the 10-year period. On admission to inpatient rehabilitation, patients with traumatic brain injury (TBI) had more cognitive disability (median stage 2) than those with spinal cord injury or other injuries (median stage 5). Cognitive functioning improved for all patients, but children with TBI still tended to have significant residual cognitive disability (median stage on discharge, 4). Conclusions Injured children gained cognitive functionality throughout inpatient rehabilitation. Those with TBI had more severe cognitive disability on admission and more residual disability on discharge. This is important not only for patient and family expectation setting but also for resource and service planning, as discharge from inpatient rehabilitation is a critical milestone for reintegration into society for children with serious injury.	[Zonfrillo, Mark R.; Durbin, Dennis R.; Winston, Flaura K.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Durbin, Dennis R.; Winston, Flaura K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Durbin, Dennis R.; Stineman, Margaret G.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Winston, Flaura K.; Stineman, Margaret G.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Zhang, Xuemei] Childrens Hosp Philadelphia, Biostat & Data Management Core, Philadelphia, PA 19104 USA; [Stineman, Margaret G.] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA		Zonfrillo, MR (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Zonfrillo@email.chop.edu	Durbin, Dennis/AAD-7829-2022; Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K08HD073241-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241] Funding Source: NIH RePORTER	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K08HD073241-01 to M.Z.). The views presented are those of the authors and not necessarily the views of the National Institutes of Health. The authors declare no conflicts of interest.	Aitken ME, 1999, ARCH PHYS MED REHAB, V80, P889, DOI 10.1016/S0003-9993(99)90079-5; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bkin SH, 2008, DEV MED CHILD NEUROL, V50, P89, DOI [10.1111/j.1469-8749-2007.02021.x, 10.1111/j.1469-8749.2007.02021.x]; Burd RS, 2009, ACAD EMERG MED, V16, P639, DOI 10.1111/j.1553-2712.2009.00446.x; Centers for Disease Control and Prevention, 10 LEAD CAUS DEATH I; Centers for Medicare & Medicaid Services (CMS), INP REH FAC IRF PAT; Glang A, 2008, NEUROREHABILITATION, V23, P477; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Jaffe KM, 2008, J TRAUMA, V64, P819, DOI 10.1097/TA.0b013e318165f177; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Keith R A, 1987, Adv Clin Rehabil, V1, P6; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P38, DOI 10.1053/apmr.2003.50060; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P29, DOI 10.1053/apmr.2003.50061; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	26	14	15	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JAN	2014	164	1					130	135		10.1016/j.jpeds.2013.09.022			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	276FU	WOS:000328734700030	24268846	Green Accepted			2022-02-06	
J	Freppel, S; Bisdorff, A; Colnat-Coulbois, S; Ceyte, H; Cian, C; Gauchard, G; Auque, J; Perrin, P				Freppel, S.; Bisdorff, A.; Colnat-Coulbois, S.; Ceyte, H.; Cian, C.; Gauchard, G.; Auque, J.; Perrin, P.			VISUO-PROPRIOCEPTIVE INTERACTIONS IN DEGENERATIVE CERVICAL SPINE DISEASES REQUIRING SURGERY	NEUROSCIENCE			English	Article						cervical proprioception; degenerative cervical spine diseases; surgical treatment; static postural control; postural sensorimotor strategies	NECK MUSCLE VIBRATION; CERVICOCEPHALIC KINESTHETIC SENSIBILITY; EVOKED POSTURAL RESPONSES; PAIN; HEAD; POSITION; SPONDYLOSIS; VERTIGO; MOTION; RANGE	Cervical proprioception plays a key role in postural control, but its specific contribution is controversial. Postural impairment was shown in whiplash injuries without demonstrating the sole involvement of the cervical spine. The consequences of degenerative cervical spine diseases are underreported in posture-related scientific literature in spite of their high prevalence. No report has focused on the two different mechanisms underlying cervicobrachial pain: herniated discs and spondylosis. This study aimed to evaluate postural control of two groups of patients with degenerative cervical spine diseases with or without optokinetic stimulation before and after surgical treatment. Seventeen patients with radiculopathy were recruited and divided into two groups according to the spondylotic or discal origin of the nerve compression. All patients and a control population of 31 healthy individuals underwent a static posturographic test with 12 recordings; the first four recordings with the head in 0 degrees position: eyes closed, eyes open without optokinetic stimulation, with clockwise and counter clockwise optokinetic stimulations. These four sensorial situations were repeated with the head rotated 30 degrees to the left and to the right. Patients repeated these 12 recordings 6 weeks postoperatively. None of the patients reported vertigo or balance disorders before or after surgery. Prior to surgery, in the eyes closed condition, the herniated disc group was more stable than the spondylosis group. After surgery, the contribution of visual input to postural control in a dynamic visual environment was reduced in both cervical spine diseases whereas in a stable visual environment visual contribution was reduced only in the spondylosis group. The relative importance of visual and proprioceptive inputs to postural control varies according to the type of pathology and surgery tends to reduce visual contribution mostly in the spondylosis group. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Freppel, S.; Bisdorff, A.; Colnat-Coulbois, S.; Ceyte, H.; Gauchard, G.; Perrin, P.] Univ Lorraine, EA DevAH Dev Adapt & Disadvantage 3450, Fac Med, Nancy, France; [Freppel, S.; Bisdorff, A.; Colnat-Coulbois, S.; Ceyte, H.; Gauchard, G.; Perrin, P.] Univ Lorraine, UFR STAPS, Nancy, France; [Freppel, S.] Univ Hosp, Grp Hosp Sud Reunion, Dept Neurosurg, St Pierre, Reunion, France; [Bisdorff, A.] Ctr Hosp Emile Mayrisch, Dept Neurol, Luxembourg, Luxembourg; [Colnat-Coulbois, S.; Auque, J.] Univ Hosp Nancy, Dept Neurosurg, Nancy, France; [Ceyte, H.; Cian, C.] Inst Rech Biomed Armees, La Tronche, France; [Perrin, P.] Univ Hosp, Dept Otorhinolaryngol, Vandoeuvre Les Nancy, France		Perrin, P (corresponding author), Univ Lorraine, EA DevAH Dev Adapt & Handicap 3450, UFR STAPS Nancy, 30 Rue Jardin Bot, F-54600 Villers Les Nancy, France.	philippe.perrin@univ-lorraine.fr		Ceyte, Hadrien/0000-0003-1746-5026			Bell KM, 2011, SPINE, V36, P263, DOI 10.1097/BRS.0b013e3181ccc552; Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; BIGUER B, 1988, BRAIN, V111, P1405, DOI 10.1093/brain/111.6.1405; Bove M, 2002, J NEUROPHYSIOL, V88, P2232, DOI 10.1152/jn.00198.2002; Bove M, 2001, J APPL PHYSIOL, V91, P581, DOI 10.1152/jappl.2001.91.2.581; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; Cevik R, 2010, CLIN RHEUMATOL, V29, P541, DOI 10.1007/s10067-010-1385-7; Ceyte H, 2006, EXP BRAIN RES, V170, P136, DOI 10.1007/s00221-006-0389-7; CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602; Dumas G, 2013, J VESTIBUL RES-EQUIL, V23, P41, DOI 10.3233/VES-130468; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Gangloff P, 2002, NEUROSCI LETT, V330, P179, DOI 10.1016/S0304-3940(02)00779-6; KARLBERG M, 1995, ACTA OTO-LARYNGOL, P440; Kristjansson E, 2003, CLIN REHABIL, V17, P768, DOI 10.1191/0269215503cr676oa; Lee HJ, 2005, SPINE, V30, pE60, DOI 10.1097/01.brs.0000152160.28052.a2; Machaly SA, 2011, CLIN RHEUMATOL, V30, P1527, DOI 10.1007/s10067-011-1770-x; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCormack BM, 1996, WESTERN J MED, V165, P43; Persson L, 1996, J VESTIBUL RES-EQUIL, V6, P439; Pinsault N, 2008, ARCH PHYS MED REHAB, V89, P2375, DOI 10.1016/j.apmr.2008.06.009; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Rix GD, 2001, ARCH PHYS MED REHAB, V82, P911, DOI 10.1053/apmr.2001.23300; ROLL JP, 1988, INT CONGR SER, V812, P155; RYAN GMS, 1955, LANCET, V2, P1355; TAYLOR JL, 1991, BRAIN, V114, P755, DOI 10.1093/brain/114.2.755; Thurrell AEI, 2002, EXP BRAIN RES, V147, P558, DOI 10.1007/s00221-002-1296-1; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Vitte E, 1992, POSTURE GAIT CONTROL, V2, P176; Wolsley CJ, 1996, EXP BRAIN RES, V111, P283	30	14	15	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 26	2013	255						226	232		10.1016/j.neuroscience.2013.09.060			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	302GR	WOS:000330591500020	24120556	Green Submitted			2022-02-06	
J	Binenbaum, G; Christian, CW; Ichord, RN; Ying, GS; Simon, MA; Romero, K; Pollock, AN; Forbes, BJ				Binenbaum, Gil; Christian, Cindy W.; Ichord, Rebecca N.; Ying, Gui-shaung; Simon, Melissa A.; Romero, Kathleen; Pollock, Avrum N.; Forbes, Brian J.			Retinal hemorrhage and brain injury patterns on diffusion-weighted magnetic resonance imaging in children with head trauma	JOURNAL OF AAPOS			English	Article							SHAKEN-BABY SYNDROME; HYPOXIC-ISCHEMIC INJURY; MENTAL-RETARDATION; YOUNG-CHILDREN; SHAKING; DAMAGE; INFANTS	PURPOSE To evaluate associations between retinal hemorrhage severity and hypoxic-ischemic brain injury (HIT) patterns by diffusion-weighted magnetic resonance imaging (DIV-MRI) in young children with head trauma. METHODS DW-MRI images of a consecutive cohort study of children under age 3 years with inflicted or accidental head trauma who had eye examinations were analyzed by two independent masked examiners for type, severity, and location of primary lesions attributable to trauma, HIT secondary to trauma, and mixed injury patterns. Retinal hemorrhage was graded retrospectively on a scale from 1 (none) to 5 (severe). RESULTS Retinal hemorrhage score was 3-5 in 6 of 7 patients with predominantly post-traumatic HII pattern and 4 of 32 who had traumatic injury without HIT (P < 0.001) on DW-MRI imaging. Severe retinal hemorrhage was observed in absence of HIT but only in inflicted injury. Retinal hemorrhage severity was correlated with HIT severity (rho = 0.53, P < 0.001) but not traumatic injury severity (rho = -0.10, P = 0.50). HII severity was associated with retinal hemorrhage score 3-5 (P = 0.01), but traumatic injury severity was not (P = 0.37). CONCLUSIONS During inflicted head injury, a distinct type of trauma occurs causing more global brain injury with HIT and more severe retinal hemorrhages. HIT is not a necessary factor for severe retinal hemorrhage to develop from inflicted trauma.	[Binenbaum, Gil; Forbes, Brian J.] Childrens Hosp Philadelphia, Div Ophthalmol, Philadelphia, PA 19104 USA; [Christian, Cindy W.; Ichord, Rebecca N.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Binenbaum, Gil; Ying, Gui-shaung; Forbes, Brian J.] Childrens Hosp Philadelphia, Dept Neuroradiol, Philadelphia, PA 19104 USA; [Binenbaum, Gil; Ying, Gui-shaung; Forbes, Brian J.] Perelman Sch Med, Dept Ophthalmol, Philadelphia, PA USA; [Christian, Cindy W.] Perelman Sch Med, Dept Pediat, Philadelphia, PA USA; [Ichord, Rebecca N.] Perelman Sch Med, Dept Neurol, Philadelphia, PA USA; [Pollock, Avrum N.] Perelman Sch Med, Dept Radiol, Philadelphia, PA USA; [Pollock, Avrum N.] Univ Penn, Philadelphia, PA 19104 USA; [Simon, Melissa A.] Univ Med & Dent New Jersey, Dept Ophthalmol, Newark, NJ 07103 USA; [Romero, Kathleen] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA		Binenbaum, G (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd,9 MAIN, Philadelphia, PA 19104 USA.	binenbaum@email.chop.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 EY015398, P30 EY01583-26, R01NS39679]; Loan Repayment ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY001583, K12EY015398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER	Supported by the National Institutes of Health grants K12 EY015398, P30 EY01583-26, R01NS39679, and Loan Repayment Program.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Agrawal S, 2012, PEDIATRICS, V129, pE1388, DOI 10.1542/peds.2011-2772; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J ROENTGENOL, V114, P217; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; Phillips MD, 1999, NEUROIMAG CLIN N AM, V9, P41	17	14	14	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1091-8531	1528-3933		J AAPOS	J. AAPOS	DEC	2013	17	6					603	608		10.1016/j.jaapos.2013.09.002			6	Ophthalmology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology; Pediatrics	277DU	WOS:000328799900009	24215807	Green Accepted			2022-02-06	
J	Covassin, T; Crutcher, B; Wallace, J				Covassin, Tracey; Crutcher, Bryan; Wallace, Jessica			Does a 20 minute cognitive task increase concussion symptoms in concussed athletes?	BRAIN INJURY			English	Article						Cognitive rest; concussion; neurocognitive testing; post-concussion symptoms scale	HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; AGREEMENT STATEMENT; FOOTBALL PLAYERS; IMPACT; SPORT; RECOVERY; SENSITIVITY; MANAGEMENT; VALIDITY	Objective: The purpose of the present study was to examine if concussion symptoms worsened immediately (i.e. 20 minutes) following performance on a scomputerized neurocognitive test. Research design: Cross-sectional study; Level of evidence, 2. Methods and procedures: A total of 165 athletes with a concussion participated in the study. Participants completed the Immediate Post-concussion Assessment and Cognitive Test (ImPACT) and Post-concussion Symptom Scale (PCSS) at baseline, 3 and 10 days post-concussion. Participants completed a second PCSS following the ImPACT test at 3 and 10 days post-injury. Main outcomes and results: Athletes with a concussion exhibited greater symptoms post-neurocognitive test 3 days post-concussion on headache (p = 0.01), nausea (p = 0.03), dizziness (p = 0.03), sadness (p = 0.005), mentally foggy (p = 0.002) and visual problems (p = 0.007). Athletes with a concussion demonstrated increased symptoms on sadness (p = 0.00) and difficulty remembering (p = 0.03) at 10 days post-injury. Athletes also demonstrated neurocognitive impairments in verbal memory (p = 0.009) and slower reaction time (p = 0.01) 10 days post-concussion and visual memory (p = 0.000) and motor processing speed (p = 0.000) impairments at 3 days post-injury. Conclusion: The current study suggests that there may be an increase in concussion symptoms following a 20-minute cognitive task. Thus, it illustrates the need for clinicians to make sure they are symptom free with both physical and cognitive testing.	[Covassin, Tracey; Crutcher, Bryan; Wallace, Jessica] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 105 IM Sport Circle, E Lansing, MI 48824 USA.	covassin@msu.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P287; Lovell MR, 2001, IMMEDIATE POSTCONCUS; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Valentine V, 2012, AM FAM PHYSICIAN, V85, P100; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213	31	14	14	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1589	1594		10.3109/02699052.2013.823656			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400013	24143995				2022-02-06	
J	Lukersmith, S; Radbron, L; Hopman, K				Lukersmith, Sue; Radbron, Lesley; Hopman, Katherine			Development of clinical guidelines for the prescription of a seated wheelchair or mobility scooter for people with traumatic brain injury or spinal cord injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						functioning; guidelines; occupational therapist; scooter; wheelchair	COMPLEX INTERVENTIONS; USER	Background/aimProviding a wheelchair or scooter is a complex therapy intervention aimed at enhancing the person's functioning. The research and experience has shown that a wheelchair which is poorly matched to the individual, adversely affects potential activities and participation, lifestyle goals, health status and can be costly. The development of an evidence-based clinical guideline will provide a synthesis of the evidence and recommendations for best practice. MethodsThe guidelines were developed using a rigorous methodology of systematic search for primary studies, critical appraisal and synthesis of the evidence using an adaptation of the National Health and Medical Research Council recommendation grades in conjunction with a multidisciplinary working party. ResultsSeventy-six recommendations were developed from 44 clinical questions related to goals, assessment and review, capacity and performance, upper limb capacity and injury risk, wheelchair features, propulsion, training, transport and maintenance. Resources were developed to support the use of the guidelines. Only examples of recommendations are provided here. The complete guidelines and technical report should be downloaded from http://www.lifetimecare.nsw.gov.au/Brain_Injury.aspx. ConclusionThe guidelines provide appraisal and synthesis of the literature and recommendations for best practice on the prescription of a wheelchair or scooter for adults with spinal cord injury and/or traumatic brain injury. The guidelines are intended to reduce the potential for poor wheelchair prescription, inform and guide practice to enhance outcomes. Through judicious application of the available research, these guidelines provide best practice recommendations for prescribing the most appropriate wheelchair for a person with a traumatic brain injury/spinal cord injury.	[Lukersmith, Sue; Radbron, Lesley] Lifetime Care & Support Author, Serv Dev & Review, Sydney, NSW 2000, Australia; [Lukersmith, Sue] Lukersmith & Associates, Woodford, NSW, Australia; [Hopman, Katherine] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Lukersmith, S (corresponding author), Lifetime Care & Support Author, Serv Dev & Review, Level 24,580 George St, Sydney, NSW 2000, Australia.	sue@lukersmith.com.au		Lukersmith, Sue/0000-0001-8202-3828	Lifetime Care & Support Authority (LTCSA); EnableNSW	The Lifetime Care & Support Authority (LTCSA) and EnableNSW initiated and provided funding for the development of the guidelines. The guidelines were written by S. Lukersmith and revised following feedback from the reviewers and stakeholders.	Brubaker C E, 1986, J Rehabil Res Dev, V23, P19; Consortium for Spinal Cord Medicine, 2000, PRESS ULC PREV TREAT; ConsortiumforSpinalCordMedicine, 2005, PRES UPP LIMB FUNCT; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Di Marco A., 2005, THESIS U S AUSTR ADE; Di Marco A, 2003, AUST OCCUP THER J, V50, P30, DOI DOI 10.1046/J.1440-1630.2003.00316.X; Edwards K, 2010, DISABIL REHABIL-ASSI, V5, P411, DOI 10.3109/17483101003793412; EnableNSW and Lifetime Care & Support Authority, 2011, GUID PRESCR SEAT WHE; Fayed N, 2011, DISABIL REHABIL, V33, P1941, DOI 10.3109/09638288.2011.553704; Hoffman T., 2010, EVIDENCE BASED PRACT; Kittel A, 2002, DISABIL REHABIL, V24, P106, DOI 10.1080/09638280110066785; Letts L., 2007, CRITICAL REV FORM QU; Medical Research Council, 2000, FRAM DEV EV RCTS COM; Mortenson W Ben, 2008, Can J Occup Ther, V75, P167; National Health and Medical Research Council(NHMRC) in Australia, 2009, ADD LEV EV GRAD REC; NHMRC, 1999, REV EV SYST ID REV S; Papadimitriou C, 2008, DISABIL SOC, V23, P691, DOI 10.1080/09687590802469420; Petticrew M, 2011, EUR J PUBLIC HEALTH, V21, P397, DOI 10.1093/eurpub/ckr084; Physiotherapy Evidence Database, 1999, PEDRO SCAL; Samuelsson K, 2008, DISABIL REHABIL, V30, P551, DOI 10.1080/09638280701355777; SCIRE, 2010, SPIN CORD INJ REH EV; Straus SE., 2005, EVIDENCE BASED MED P, V3rd; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; The AGREE Research Trust, 2009, APPR GUID RES EV 2; Transport Accident Commission & Victorian WorkCover Authority, 2009, CLIN FRAM DEL HLTH S; United Nations Office of the High Commissioner for Human Rights, 2006, CONV RIGHTS PERS DIS; Walach H., 2006, BMC MED RES METHODOL, V6, P9; World Health Organization, 2007, INT CLASS FUNCT DIS; Ziviani J, 2003, AUST OCCUP THER J, V50, P13, DOI DOI 10.1046/J.1440-1630.2003.00341.X	29	14	14	2	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	DEC	2013	60	6					378	386		10.1111/1440-1630.12077			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	260GZ	WOS:000327584300002	24299477				2022-02-06	
J	Mountney, A; Shear, DA; Potter, B; Marcsisin, SR; Sousa, J; Melendez, V; Tortella, FC; Lu, XCM				Mountney, Andrea; Shear, Deborah A.; Potter, Brittney; Marcsisin, Sean R.; Sousa, Jason; Melendez, Victor; Tortella, Frank C.; Lu, Xi-Chun M.			Ethosuximide and Phenytoin Dose-Dependently Attenuate Acute Nonconvulsive Seizures after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						EEG; ETX; NCS; PBBI; PHT; Rats; TBI	SPONTANEOUSLY EPILEPTIC RAT; ANTIEPILEPTIC DRUGS; MODEL; ANTICONVULSANTS; LEVETIRACETAM; HEMORRHAGE; ISCHEMIA	Acute seizures frequently occur following severe traumatic brain injury (TBI) and have been associated with poor patient prognosis. Silent or nonconvulsive seizures (NCS) manifest in the absence of motor convulsion, can only be detected via continuous electroencephalographic (EEG) recordings, and are often unidentified and untreated. Identification of effective anti-epileptic drugs (AED) against post-traumatic NCS remains crucial to improve neurological outcome. Here, we assessed the anti-seizure profile of ethosuximide (ETX, 12.5-187.5 mg/kg) and phenytoin (PHT, 5-30 mg/kg) in a spontaneously occurring NCS model associated with penetrating ballistic-like brain injury (PBBI). Rats were divided between two drug cohorts, PHT or ETX, and randomly assigned to one of four doses or vehicle within each cohort. Following PBBI, NCS were detected by continuous EEG monitoring for 72 h post-injury. Drug efficacy was evaluated on NCS parameters of incidence, frequency, episode duration, total duration, and onset latency. Both PHT and ETX attenuated NCS in a dose-dependent manner. In vehicle-treated animals, 69-73% experienced NCS (averaging 9-10 episodes/rat) with average onset of NCS occurring at 30 h post-injury. Compared with control treatment, the two highest PHT and ETX doses significantly reduced NCS incidence to 13-40%, reduced NCS frequency (1.8-6.2 episodes/rat), and delayed seizure onset: <20% of treated animals exhibited NCS within the first 48 h. NCS durations were also dose-dependently mitigated. For the first time, we demonstrate that ETX and PHT are effective against spontaneously occurring NCS following PBBI, and suggest that these AEDs may be effective at treating post-traumatic NCS.	[Mountney, Andrea; Shear, Deborah A.; Tortella, Frank C.; Lu, Xi-Chun M.] Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Potter, Brittney; Marcsisin, Sean R.; Sousa, Jason; Melendez, Victor] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA		Mountney, A (corresponding author), US Army, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	andrea.mountney.mil@mail.mil	Sousa, Jason/A-9177-2011		U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Combat Casualty Care Research ProgramUnited States Department of Defense; Defence Medical Research and Development Program [DIO_1_AR_J6_414]; Walter Reed Army Institute of Research	This work was supported by core funding provided by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program and Defence Medical Research and Development Program, Grant DIO_1_AR_J6_414. The work was performed while the first author held a National Research Council Research Associateship Award at Walter Reed Army Institute of Research.	Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; ALBERTSON TE, 1980, NEUROPHARMACOLOGY, V19, P1141, DOI 10.1016/0028-3908(80)90115-X; Bailer M, 2004, EPILEPSY BEHAV, V5, P866, DOI 10.1016/j.yebeh.2004.08.021; Brunton L., 2011, GOODMAN GILMANS PHAR; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; CONSROE P, 1977, J PHARMACOL EXP THER, V201, P26; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Edmonds HL, 1996, LIFE SCI, V59, pPL127, DOI 10.1016/0024-3205(96)00379-7; Goren MZ, 2007, CNS DRUG REV, V13, P224, DOI 10.1111/j.1527-3458.2007.00009.x; Ji-qun C, 2005, EPILEPSIA, V46, P1362, DOI 10.1111/j.1528-1167.2005.29604.x; Khan AA, 2010, INT J EMERG MED, V3, P187, DOI 10.1007/s12245-010-0180-1; KILPATRICK CJ, 1992, ARCH NEUROL-CHICAGO, V49, P509, DOI 10.1001/archneur.1992.00530290097017; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Loscher W, 1998, EPILEPSY RES, V30, P69, DOI 10.1016/S0920-1211(97)00098-3; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Manning JPA, 2003, TRENDS PHARMACOL SCI, V24, P542, DOI 10.1016/j.tips.2003.08.006; SASA M, 1988, EPILEPSIA, V29, P505, DOI 10.1111/j.1528-1157.1988.tb03754.x; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SCHMUTZ M, 1988, J NEURAL TRANSM, V72, P245, DOI 10.1007/BF01243423; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; SWINYARD EA, 1952, J PHARMACOL EXP THER, V106, P319; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; van Rijn CM, 2004, EPILEPSY RES, V59, P181, DOI 10.1016/j.eplepsyres.2004.04.003; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Walker MC, 1996, EPILEPSIA, V37, P421, DOI 10.1111/j.1528-1157.1996.tb00586.x; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	39	14	14	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1973	1982		10.1089/neu.2013.3001			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400006	23822888	Green Published			2022-02-06	
J	Schmidt, AT; Hanten, G; Li, XQ; Wilde, EA; Ibarra, AP; Chu, ZD; Helbling, AR; Shah, S; Levin, HS				Schmidt, Adam T.; Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Ibarra, Alyssa P.; Chu, Zili D.; Helbling, Antonia R.; Shah, Sanjeev; Levin, Harvey S.			Emotional prosody and diffusion tensor imaging in children after traumatic brain injury	BRAIN INJURY			English	Article						Brain imaging; DTI; emotional prosody; paediatric; traumatic brain injury	PERCEPTION DEFICITS; SOCIAL OUTCOMES; RECOGNITION; LANGUAGE; DISCONNECTION; MODERATE; AMYGDALA	Primary objective: Brain structures and their white matter connections that may contribute to emotion processing and may be vulnerable to disruption by a traumatic brain injury (TBI) occurring in childhood have not been thoroughly explored. Research design and methods: The current investigation examines the relationship between diffusion tensor imaging (DTI) metrics, including fractional anisotropy (FA) and apparent diffusion coefficient (ADC), and 3-month post-injury performance on a task of emotion prosody recognition and a control task of phonological discrimination in a group of 91 children who sustained either a moderate-to-severe TBI (n = 45) or orthopaedic injury (OI) (n = 46). Main outcomes and results: Brain-behaviour findings within OI participants confirmed relationships between several significant white matter tracts in emotional prosody performance (i.e. the cingulum bundle, genu of the corpus callosum, inferior longitudinal fasciculus (ILF) and the inferior fronto-occipital fasciculus (IFOF). The cingulum and genu were also related to phonological discrimination performance. The TBI group demonstrated few strong brain behaviour relationships, with significant findings emerging only in the cingulum bundle for Emotional Prosody and the genu for Phonological Processing. Conclusion: The lack of clear relationships in the TBI group is discussed in terms of the likely disruption to cortical networks secondary to significant brain injuries.	[Schmidt, Adam T.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77340 USA; [Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Ibarra, Alyssa P.; Helbling, Antonia R.; Shah, Sanjeev; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA		Schmidt, AT (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ats013@shsu.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This research was supported by Grant Number R01NS021889 from the National Institute of Neurological Disorders and Stroke to H.S. Levin.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Gaffan D, 2008, CORTEX, V44, P928, DOI 10.1016/j.cortex.2008.03.005; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hoekert M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-93; Koch K, 2010, NEUROSCIENCE, V168, P190, DOI 10.1016/j.neuroscience.2010.03.026; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Leitman DI, 2010, FRONT HUM NEUROSCI, V4, P4; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Moos RH, 1994, LISRES A LIFE STRESS; Mori S, 1999, ANAT REC, V257, P102; Netsch T, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P718, DOI 10.1109/ICCV.2001.937595; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Rota G, 2011, BRAIN LANG, V117, P123, DOI 10.1016/j.bandl.2010.07.008; Schmidt AT, 2010, BRAIN INJURY, V24, P1550, DOI 10.3109/02699052.2010.523047; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; TEASDALE G, 1974, LANCET, V2, P81; Wiethoff S, 2009, NEUROREPORT, V20, P1356, DOI 10.1097/WNR.0b013e328330eb83; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	39	14	15	1	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1528	1535		10.3109/02699052.2013.828851			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400006	24266795				2022-02-06	
J	Chen, B; Mutschler, M; Yuan, YJ; Neugebauer, E; Huang, QB; Maegele, M				Chen, Bo; Mutschler, Manuel; Yuan, Yongjun; Neugebauer, Edmund; Huang, Qiaobing; Maegele, Marc			Superimposed traumatic brain injury modulates vasomotor responses in third-order vessels after hemorrhagic shock	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Hemorrhagic shock; Lateral fluid percussion; Brain injury; Spinotrapezius muscle; Third order vessels; Vasomotor response; Microcirculation	TUMOR-NECROSIS-FACTOR; SKELETAL-MUSCLE; EXPERIMENTAL-MODELS; FACTOR-ALPHA; PENTOBARBITAL-ANESTHESIA; CARDIAC-OUTPUT; RAT; MICROCIRCULATION; ISCHEMIA; VASODILATATION	Background: Traumatic brain injury (TBI) and hemorrhagic shock (HS) are the leading causes of death in trauma. Recent studies suggest that TBI may influence physiological responses to acute blood loss. This study was designed to assess to what extent superimposed TBI may modulate physiologic vasomotor responses in third-order blood vessels in the context of HS. Methods: We have combined two established experimental models of pressure-controlled hemorrhagic shock (HS; MAP 50 mmHg/60 min) and TBI (lateral fluid percussion (LFP)) to assess vasomotor responses and microcirculatory changes in third-order vessels by intravital microscopy in a spinotrapezius muscle preparation. 23 male Sprague-Dawley rats (260-320 g) were randomly assigned to experimental groups: i) Sham, ii) HS, iii) TBI + HS, subjected to impact or sham operation, and assessed. Results: HS led to a significant decrease in arteriolar diameters by 20% to baseline (p < 0.01). In TBI + HS this vasoconstriction was less pronounced (5%, non-significant). At completed and at 60 minutes of resuscitation arteriolar diameters had recovered to pre-injury baseline values. Assessment of venular diameters revealed similar results. Arteriolar and venular RBC velocity and blood flow decreased sharply to < 20% of baseline in HS and TBI + HS (p < 0.01). Immediately after and at 60 minutes of resuscitation, an overshoot in arterial RBC velocity (140% of baseline) and blood flow (134.2%) was observed in TBI + HS. Conclusion: Superimposed TBI modulated arteriolar and venular responses to HS in third-order vessels in a spinotrapezius muscle preparation. Further research is necessary to precisely define the role of TBI on the microcirculation in tissues vulnerable to HS.	[Chen, Bo; Yuan, Yongjun; Huang, Qiaobing] SMU, Key Lab Shock & Microcirculat Res, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China; [Mutschler, Manuel; Neugebauer, Edmund; Maegele, Marc] Private Univ Witten Herdecke, CMMC, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Mutschler, Manuel; Maegele, Marc] Private Univ Witten Herdecke, CMMC, Dept Traumatol Orthoped Surg & Sportsmed, D-51109 Cologne, Germany		Huang, QB (corresponding author), SMU, Key Lab Shock & Microcirculat Res, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China.	bing@smu.edu.cn; Marc.Maegele@t-online.de			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30971201, 81170297]; International Bureau of the BMBF/GermanyFederal Ministry of Education & Research (BMBF) [01DO12025]	This study was supported by the General Program from the Natural Science Foundation of China (30971201, 81170297) and the International Bureau of the BMBF/Germany (01DO12025). The authors have no other financial interest to disclose.	Adanali G, 2001, ANN PLAS SURG, V47, P652, DOI 10.1097/00000637-200112000-00013; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; Backstrom T, 2004, SHOCK, V21, P572, DOI 10.1097/01.shk.0000127069.65490.65; BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; Boerma EC, 2009, CURR OPIN CRIT CARE, V15, P261, DOI 10.1097/MCC.0b013e32832b0ff4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; den Uil CA, 2008, PROG CARDIOVASC DIS, V51, P161, DOI 10.1016/j.pcad.2008.07.002; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Douzinas EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032968; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Gao C, 2009, AUTON NEUROSCI-BASIC, V147, P70, DOI 10.1016/j.autneu.2009.01.010; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; GRAY SD, 1973, MICROVASC RES, V5, P395, DOI 10.1016/0026-2862(73)90055-1; Guo J, 2008, SHOCK, V29, P205, DOI 10.1097/SHK.0b013e318070c61a; Han JY, 2001, AM J PHYSIOL-GASTR L, V280, pG939, DOI 10.1152/ajpgi.2001.280.5.G939; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Joyner MJ, 2003, ACTA PHYSIOL SCAND, V177, P329, DOI 10.1046/j.1365-201X.2003.01090.x; KAWAUE Y, 1984, JPN J PHYSIOL, V34, P283, DOI 10.2170/jjphysiol.34.283; Kerger H, 1999, AM J PHYSIOL-HEART C, V276, pH2035, DOI 10.1152/ajpheart.1999.276.6.H2035; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; LUNDVALL J, 1978, ACTA PHYSIOL SCAND, V102, P450, DOI 10.1111/j.1748-1716.1978.tb06093.x; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; MANDERS WT, 1976, CIRC RES, V39, P512, DOI 10.1161/01.RES.39.4.512; MARSHALL JM, 1982, J PHYSIOL-LONDON, V332, P169, DOI 10.1113/jphysiol.1982.sp014408; Matsukawa K, 1997, J PHYSIOL-LONDON, V500, P213, DOI 10.1113/jphysiol.1997.sp022011; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntyre A, EVIDENCE BASED REV M; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Minghini A, 1998, SHOCK, V9, P210, DOI 10.1097/00024382-199803000-00009; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NAGAI M, 1981, J AUTONOM NERV SYST, V4, P365, DOI 10.1016/0165-1838(81)90039-4; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Russell J, 2003, AM J PHYSIOL-GASTR L, V284, pG123, DOI 10.1152/ajpgi.00303.2002; Sakai H, 1999, AM J PHYSIOL-HEART C, V276, pH563, DOI 10.1152/ajpheart.1999.276.2.H563; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VATNER SF, 1978, ENVIRON HEALTH PERSP, V26, P193, DOI 10.2307/3428842; Venkatesh B, 1999, CRIT CARE MED, V27, P1175, DOI 10.1097/00003246-199906000-00047; VICAUT E, 1991, J CLIN INVEST, V87, P1537, DOI 10.1172/JCI115165; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141; Yuan XQ, 1991, J NEUROTRAUM, V8, P219, DOI 10.1089/neu.1991.8.219; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; ZHAO KS, 1985, MICROVASC RES, V30, P143, DOI 10.1016/0026-2862(85)90046-9; Zhao KS, 2000, CLIN HEMORHEOL MICRO, V23, P259; Zhao O, 2007, SHOCK, V28, P717, DOI 10.1097/shk.0b013e318050c914	63	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 21	2013	21								77	10.1186/1757-7241-21-77			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	266SB	WOS:000328042900001	24257108	gold, Green Published			2022-02-06	
J	Rados, A; Tiruta, C; Xiao, ZW; Kortbeek, JB; Tourigny, P; Ball, CG; Kirkpatrick, AW				Rados, Alma; Tiruta, Corina; Xiao, Zhengwen; Kortbeek, John B.; Tourigny, Paul; Ball, Chad G.; Kirkpatrick, Andrew W.			Does trauma team activation associate with the time to CT scan for those suspected of serious head injuries?	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Trauma triage; Trauma activation; Trauma human factors; Traumatic brain injury; Diagnostic imaging	MULTISLICE COMPUTED-TOMOGRAPHY; MAJOR TRAUMA; MANAGEMENT; PROTOCOL; IMPACT; ROOM	Background: Traumatic brain injury (TBI) constitutes the leading cause of posttraumatic mortality. Practically, the major interventions required to treat TBI predicate expedited transfer to CT after excluding other immediately life-threatening conditions. At our center, trauma responses variably consist of either full trauma activation (FTA) including an attending trauma surgeon or a non-trauma team response (NTTR). We sought to explore whether FTAs expedited the time to CT head (TTCTH). Methods: Retrospective review of augmented demographics of 88 serious head injuries identified from a Regional Trauma Registry within one year at a level I trauma center. The inclusion criteria consisted of a diagnosis of head injury recorded as intubated or GCS < 13; and CT-head scanning after arriving the emergency department. Data was analyzed using STATA. Results: There were 58 FTAs and 30 NTTRs; 86% of FTAs and 17% of NTTRs were intubated prehospital out of 101 charts reviewed in detail; 13 were excluded due to missing data. Although FTAs were more seriously injured (median ISS 29, MAIS head 19, GCS score at scene 6.0), NTTRs were also severely injured (median ISS 25, MAIS head 21, GCS at scene 10) and older (median 54 vs. 26 years). Median TTCTH was double without dedicated FTA (median 50 vs. 26 minutes, p < 0.001), despite similar justifiable delays (53% NTTR, 52% FTA). Without FTA, most delays (69%) were for emergency intubation. TTCTH after securing the airway was longer for NTTR group (median 38 vs. 26 minutes, p =0.0013). Even with no requirements for ED interventions, TTCTH for FTA was less than half versus NTTR (25 vs. 61 minutes, p =0.0013). Multivariate regression analysis indicated age and FTA with an attending surgeon as significant predictors of TTCTH, although the majority of variability in TTCTH was not explained by these two variables (R-2 = 0.33). Conclusion: Full trauma activations involving attending trauma surgeons were quicker at transferring serious head injury patients to CT. Patients with FTA were younger and more seriously injured. Discerning the reasons for delays to CT should be used to refine protocols aimed at minimizing unnecessary delays and enhancing workforce efficiency and clinical outcome.	[Rados, Alma; Tiruta, Corina; Xiao, Zhengwen; Kortbeek, John B.; Ball, Chad G.; Kirkpatrick, Andrew W.] Univ Calgary, Foothills Med Ctr, Reg Trauma Serv, Calgary, AB 1403, Canada; [Kortbeek, John B.; Ball, Chad G.; Kirkpatrick, Andrew W.] Univ Calgary, Foothills Med Ctr, Dept Surg, Calgary, AB 1403, Canada; [Kortbeek, John B.; Tourigny, Paul; Kirkpatrick, Andrew W.] Univ Calgary, Foothills Med Ctr, Calgary, AB 1403, Canada		Kirkpatrick, AW (corresponding author), Univ Calgary, Foothills Med Ctr, Reg Trauma Serv, 29 St, Calgary, AB 1403, Canada.	Andrew.kirkpatrick@albertahealthservices.ca	Kortbeek, John B/AAO-5298-2020				Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Chen EH, 2006, ACAD EMERG MED, V13, P349, DOI 10.1197/j.aem.2005.10.011; Cherry RA, 2007, J TRAUMA, V63, P326, DOI 10.1097/TA.0b013e31811eaad1; *COMM TRAUM AM COL, 2006, RES OPT CAR INJ; Committee on Trauma American College of Surgeons, 2012, ADV TRAUM LIF SUPP C; Cook CH, 2001, ARCH SURG-CHICAGO, V136, P752, DOI 10.1001/archsurg.136.7.752; Davis T, 2010, INJURY, V41, P470, DOI 10.1016/j.injury.2010.01.003; Esposito TJ, 2006, J TRAUMA, V60, P8, DOI 10.1097/01.ta.0000197425.87092.d5; Grossman MD, 2009, J AM COLL SURGEONS, V208, P503, DOI 10.1016/j.jamcollsurg.2009.01.013; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Jin PHPFK, 2009, EUR J RADIOL, V72, P134, DOI 10.1016/j.ejrad.2008.06.022; Jin PHPFK, 2008, J TRAUMA, V64, P1320, DOI 10.1097/TA.0b013e318059b9ae; Jurkovich GJ, 2005, J TRAUMA, V58, P614, DOI 10.1097/01.TA0000159347.03278.E1; Kouzminova N, 2009, J TRAUMA, V67, P829, DOI 10.1097/TA.0b013e3181b57b6d; Lehmann RK, 2007, AM J SURG, V193, P630, DOI 10.1016/j.amjsurg.2007.01.017; Marion DW, 2006, NEUROSURGERY, V58, P655; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; *REG AHSC, 2010, TRAUM SERV ANN REP; Rieger M, 2009, J TRAUMA, V66, P648, DOI 10.1097/TA.0b013e31816275f3; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Salim A, 2006, ARCH SURG-CHICAGO, V141, P73, DOI DOI 10.1001/ARCHSURG.141.5.468; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; Shackford S, 2006, J TRAUMA, V60, P1, DOI 10.1097/01.ta.0000197144.19182.c4; Tillou A, 2009, J TRAUMA, V67, P779, DOI 10.1097/TA.0b013e3181b5f2eb; Tinkoff GH, 2002, J TRAUMA, V52, P1153, DOI 10.1097/00005373-200206000-00022; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Willmann JK, 2002, AM J ROENTGENOL, V179, P437, DOI 10.2214/ajr.179.2.1790437; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4	30	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	NOV 18	2013	8								48	10.1186/1749-7922-8-48			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	262GI	WOS:000327721900001	24245486	Green Published, gold			2022-02-06	
J	Armstead, WM; Bohman, LE; Riley, J; Yarovoi, S; Higazi, A; Cines, DB				Armstead, William M.; Bohman, Leif-Erik; Riley, John; Yarovoi, Serge; Higazi, Abd Al-Roof; Cines, Douglas B.			tPA-S(481)A Prevents Impairment of Cerebrovascular Autoregulation by Endogenous tPA after Traumatic Brain Injury by Upregulating p38 MAPK and Inhibiting ET-1	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; cerebral blood flow; excitatory amino acids; newborn; plasminogen activators; traumatic brain injury	TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-BLOOD-FLOW; NMDA CEREBROVASODILATION; MEK/ERK PATHWAY; CHILDREN; RECEPTOR; HEMODYNAMICS; PERMEABILITY; METABOLISM; POTASSIUM	Traumatic brain injury (TBI) is associated with loss of cerebrovascular autoregulation, which leads to cerebral hypoperfusion. Mitogen activated protein kinase (MAPK) isoforms ERK, p38, and JNK and endothelin-1 (ET-1) are mediators of impaired cerebral hemodynamics after TBI. Excessive tissue plasminogen activator (tPA) released after TBI may cause loss of cerebrovascular autoregulation either by over-activating N-methyl-D-aspartate receptors (NMDA-Rs) or by predisposing to intracranial hemorrhage. Our recent work shows that a catalytically inactive tPA variant (tPA-S(481)A) that competes with endogenous wild type (wt) tPA for binding to NMDA-R through its receptor docking site but that cannot activate it, prevents activation of ERK by wt tPA and impairment of autoregulation when administered 30min after fluid percussion injury (FPI). We investigated the ability of variants that lack proteolytic activity but bind/block activation of NMDA-Rs by wt tPA (tPA-S(481)A), do not bind/block activation of NMDA-Rs but are proteolytic (tPA-A(296-299)), or neither bind/block NMDA-Rs nor are proteolytic (tPA-A(296-299)S(481)A) to prevent impairment of autoregulation after TBI and the role of MAPK and ET-1 in such effects. Results show that tPA-S(481)A given 3h post-TBI, but not tPA-A(296-299) or tPA-A(296-299)S(481)A prevents impaired autoregulation by upregulating p38 and inhibiting ET-1, suggesting that tPA-S(481)A has a realistic therapeutic window and focuses intervention on NMDA-Rs to improve outcome.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Bohman, Leif-Erik] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Yarovoi, Serge; Higazi, Abd Al-Roof; Cines, Douglas B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Clin Biochem, IL-91010 Jerusalem, Israel		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935; Bohman, Leif-Erik/0000-0002-3889-9328; Cines, Douglas/0000-0001-5986-504X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD57355, HL77760, HL82545, HL76406, CA83121, HL76206, HL07971, HL81864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083121, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL077760, P01HL076406, T32HL007971, R01HL076206, R21HL081864] Funding Source: NIH RePORTER	Sources of financial support: This research was supported by grants from the National Institutes of Health, HD57355 (WMA), HL77760 and HL82545 (AARH), HL76406, CA83121, HL76206, HL07971, and HL81864 (DBC).	Abu Fanne R, 2010, NEUROPHARMACOLOGY, V58, P972, DOI 10.1016/j.neuropharm.2009.12.017; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 2008, BRAIN RES, V1231, P121, DOI 10.1016/j.brainres.2008.06.115; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Leffler CW, 1993, REGULATION CEREBRAL, P297; Maddahi A, 2011, J CEREBR BLOOD F MET, V31, P144, DOI 10.1038/jcbfm.2010.62; Merchant RE, 1999, ANN NY ACAD SCI, V890, P42, DOI 10.1111/j.1749-6632.1999.tb07979.x; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nassar T, 2011, AM J RESP CELL MOL, V45, P1015, DOI 10.1165/rcmb.2010-0302OC; Nassar T, 2011, AM J PHYSIOL-LUNG C, V301, pL307, DOI 10.1152/ajplung.00429.2010; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Sandhu H, 2010, EUR J PHARMACOL, V644, P128, DOI 10.1016/j.ejphar.2010.06.053; Thomas S, 2000, ACT NEUR S, V76, P397; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	42	14	15	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2013	30	22					1898	1907		10.1089/neu.2013.2962			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	243PH	WOS:000326328400008	23731391	Green Published			2022-02-06	
J	Machamer, J; Temkin, N; Dikmen, S				Machamer, Joan; Temkin, Nancy; Dikmen, Sureyya			Health-Related Quality of Life in Traumatic Brain Injury: Is a Proxy Report Necessary?	JOURNAL OF NEUROTRAUMA			English	Article						awareness; brain injuries; quality of life	IMPAIRED SELF-AWARENESS; HEAD-INJURY; RANDOMIZED-TRIAL; PRACTICAL SCALE; FOLLOW-UP; SATISFACTION; MODERATE; REHABILITATION; INDIVIDUALS; EMPLOYMENT	Despite its importance to care, clinicians and researchers often discount patient-reported outcomes in favor of proxy reports, in persons with traumatic brain injury (TBI). The rationale relates to concerns about lack of awareness of patients regarding their functioning. However, although lack of awareness occurs in some patients with severe TBI, or in TBI involving certain lesion locations, or very soon after injury, this conclusion has been overgeneralized. The objective of this study is to determine the validity of patient-reported health-related quality of life by evaluating its relationship to injury severity and more objective indices of outcome, in a representative series of adults with TBI. A consecutive sample of 374 persons with TBI at least 14 years old, and having a post-resuscitation Glasgow Coma Scale score 12, an acute seizure, or a CT scan showing TBI- related findings. Seventy-six percent (374/491) of the eligible survivors were assessed at 6 months post-injury on the Life Satisfaction Survey. The greatest decrease in satisfaction was in the ability to think and remember, work, receive adequate income, and participate in leisure and recreational activities. Dissatisfaction significantly related to the functional limitation in that area as judged by the patients themselves (p<0.001) or by someone who knew them well (p0.001). The most severely injured group reported the most dissatisfaction for 13 out of 17 areas assessed. Patients with TBI, in general, do not need a proxy to report on their behalf regarding their functional limitations or health-related quality of life.	[Machamer, Joan; Temkin, Nancy; Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Temkin, Nancy; Dikmen, Sureyya] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA		Machamer, J (corresponding author), Univ Washington, Dept Rehabil Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	machamer@u.washington.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS19643]; Department of Defense (DoD)United States Department of Defense [W81XWH-08-2-159]; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A070032]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER	This study was supported by grants R01NS19643 from National Institute of Neurological Disorders and Stroke (NINDS), W81XWH-08-2-159 from Department of Defense (DoD), and H133A070032 from National Institute on Disability and Rehabilitation Research (NIDRR). No funding organization or sponsor was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Emery Marie-Pierre, 2005, Health Qual Life Outcomes, V3, P12, DOI 10.1186/1477-7525-3-12; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; JENNETT B, 1975, LANCET, V1, P480; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	41	14	14	2	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2013	30	22					1845	1851		10.1089/neu.2013.2920			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	243PH	WOS:000326328400002	23731370	Green Published			2022-02-06	
J	Ownsworth, T; Fleming, J; Tate, R; Shum, DHK; Griffin, J; Schmidt, J; Lane-Brown, A; Kendall, M; Chevignard, M				Ownsworth, Tamara; Fleming, Jennifer; Tate, Robyn; Shum, David H. K.; Griffin, Janelle; Schmidt, Julia; Lane-Brown, Amanda; Kendall, Melissa; Chevignard, Mathilde			Comparison of error-based and errorless learning for people with severe traumatic brain injury: study protocol for a randomized control trial	TRIALS			English	Article						Brain injury; Metacognition; Self-awareness; Rehabilitation; Functional activities; Randomized controlled trial	ASSESSING SUPPORT NEEDS; METACOGNITIVE SKILLS; TREATMENT FIDELITY; SELF-AWARENESS; COOKING TASK; SCALE; INDIVIDUALS; CARE; INTERVENTIONS; VALIDITY	Background: Poor skills generalization poses a major barrier to successful outcomes of rehabilitation after traumatic brain injury (TBI). Error-based learning (EBL) is a relatively new intervention approach that aims to promote skills generalization by teaching people internal self-regulation skills, or how to anticipate, monitor and correct their own errors. This paper describes the protocol of a study that aims to compare the efficacy of EBL and errorless learning (ELL) for improving error self-regulation, behavioral competency, awareness of deficits and long-term outcomes after TBI. Methods/Design: This randomized, controlled trial (RCT) has two arms (EBL and ELL); each arm entails 8 x 2 h training sessions conducted within the participants' homes. The first four sessions involve a meal preparation activity, and the final four sessions incorporate a multitasking errand activity. Based on a sample size estimate, 135 participants with severe TBI will be randomized into either the EBL or ELL condition. The primary outcome measure assesses error self-regulation skills on a task related to but distinct from training. Secondary outcomes include measures of self-monitoring and self-regulation, behavioral competency, awareness of deficits, role participation and supportive care needs. Assessments will be conducted at pre-intervention, post-intervention, and at 6-months post-intervention. Discussion: This study seeks to determine the efficacy and long-term impact of EBL for training internal self-regulation strategies following severe TBI. In doing so, the study will advance theoretical understanding of the role of errors in task learning and skills generalization. EBL has the potential to reduce the length and costs of rehabilitation and lifestyle support because the techniques could enhance generalization success and lifelong application of strategies after TBI.	[Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Fleming, Jennifer; Griffin, Janelle] Princess Alexandra Hosp, Woolloongabba, Australia; [Tate, Robyn; Lane-Brown, Amanda] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Tate, Robyn] Royal Rehabil Ctr, Brain Injury Unit,Royal, Sydney, NSW, Australia; [Schmidt, Julia] Australian Catholic Univ Sydney, Brisbane, Qld, Australia; [Lane-Brown, Amanda] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Chevignard, Mathilde] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Kendall, Melissa] Acquired Brain Injury Outreach Serv, Brisbane, Qld, Australia; [Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury INR A, St Maurice, France; [Chevignard, Mathilde] Univ Paris 06, ER6, Paris, France		Ownsworth, T (corresponding author), Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David/A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David/0000-0002-4810-9262; Schmidt, Julia/0000-0003-2004-4871	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1043677]; NHMRC ProjectNational Health and Medical Research Council of Australia [APP1043677]	The project outlined in this study protocol is funded by the National Health and Medical Research Council (NHMRC; project grant APP1043677). The authors would like to acknowledge Dr Elizabeth Beadle who contributed to the preparation of this manuscript in her position as Project Coordinator funded the NHMRC Project Grant (APP1043677).	Access Economics, 2008, EC COST SPIN CORD IN; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Borrelli B, 2011, J PUBLIC HEALTH DENT, V71, pS52, DOI 10.1111/j.1752-7325.2011.00233.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Domholdt E, 2005, REHABILITATION RES P; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Kolakowsky-Hayner S, PATIENT COMPETENCY R; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; OWNSWORTH T, 2004, BRAIN IMPAIR, V5, P53, DOI DOI 10.1375/BRIM.5.1.53.35407; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J.P., 2011, COGNITION OCCUPATION, P116; [No title captured]	42	14	14	2	27	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	NOV 5	2013	14								369	10.1186/1745-6215-14-369			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	276KX	WOS:000328750300002	24192067	Green Published, gold			2022-02-06	
J	Choy, DKS; Nga, VDW; Lim, J; Lu, J; Chou, N; Yeo, TT; Teoh, SH				Choy, David Kim Seng; Nga, Vincent Diong Weng; Lim, Jing; Lu, Jia; Chou, Ning; Yeo, Tseng Tsai; Teoh, Swee-Hin			Brain Tissue Interaction with Three-Dimensional, Honeycomb Polycaprolactone-Based Scaffolds Designed for Cranial Reconstruction Following Traumatic Brain Injury	TISSUE ENGINEERING PART A			English	Article							TRICALCIUM PHOSPHATE SCAFFOLDS; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; PCL-TCP SCAFFOLDS; IN-VIVO; DRUG-DELIVERY; GROWTH-FACTOR; COMBINATION; DIFFERENTIATION; TRANSPLANTATION	Following traumatic brain injury (TBI), resultant voids are unable to support injections of suspension treatments, leading to ineffective healing. Moreover, without a structure to support the large defect, the defect site suffers from mechanical instability, which may impair the healing process. Therefore, having a delivery vehicle that can temporarily fill and provide mechanical support to the defect site may alleviate the healing process. In this work, we reported for the first time, the inflammatory response of brain tissue with polycaprolactone (PCL) and PCL-tricalcium phosphate (TCP) scaffolds designed and fabricated for cranial reconstruction. After cranial defects were created in Sprague-Dawley rats, PCL and PCL-TCP scaffolds were implanted for a period of 1 week and 1 month. Following histology and immunofluorescence staining with the ionized calcium binding adaptor molecule-1 (IBA-1), glial fibrillary acidic protein (GFAP), nestin, and neuronal nuclei (NeuN), results indicated that IBA-1-positive activated microglia were observed across all groups, and declined significantly by 1 month (p<0.05). Interestingly, IBA-1-positive microglia were significantly fewer in the PCL-TCP group (p<0.05), suggesting a relatively milder inflammatory response. A decrease in the number of GFAP-positive cells among all groups over time (>29%) was also observed. Initially, astrocyte hypertrophy was observed proximal to the TBI site (55% in PCL and PCL-TCP groups, 75% in control groups), but it subsided by 1 month. Proximal to the TBI site, nestin immunoreactivity was intense during week 1, and which reduced by 1 month across all groups. NeuN-positive neurons were shrunken proximal to the TBI site (<0.9mm), 32% smaller in the PCL-TCP group and 27% smaller in the PCL group. Based on above data indicating the comparatively milder, initial inflammatory response of brain tissue to PCL-TCP scaffolds, it is suggested that PCL-TCP scaffolds have notable clinical advantages as compared to PCL scaffolds.	[Choy, David Kim Seng; Nga, Vincent Diong Weng; Chou, Ning; Yeo, Tseng Tsai] Natl Univ Singapore Hosp, Div Neurosurg, Singapore, Singapore; [Lim, Jing; Teoh, Swee-Hin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore; [Lu, Jia] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Lu, Jia] Def Med & Environm Res Inst, DSO Natl Labs DMERI DSO, Singapore, Singapore		Teoh, SH (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, 70 Nanyang Dr,N1-3, Singapore 637457, Singapore.	teohsh@ntu.edu.sg	Yeo, Tseng Tsai/U-8864-2017; Nga, Vincent Diong Weng/U-3308-2017; Chou, Ning/B-5314-2011	Nga, Vincent Diong Weng/0000-0001-5256-5669; 	National University Health System Clinician's Research Grant	This work was funded by the National University Health System Clinician's Research Grant. The authors would like to express their gratitude toward Mary Kan for her contribution to histopathology, Kian Chye for his involvement as a perfusionist, Dr. Enoka for her help in the IACUC application, and Dr. Yang Ming for helping out in the procedure.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Johann V, 2007, EXP BRAIN RES, V177, P458, DOI 10.1007/s00221-006-0689-y; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lim HC, 2011, J BONE JOINT SURG BR, V93B, P120, DOI 10.1302/0301-620X.93B1.24767; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379; Ng K, 2001, BALLET REV, V29, P13; O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]; Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052; Rai B, 2007, J ORAL MAXIL SURG, V65, P2195, DOI 10.1016/j.joms.2006.11.026; Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142; Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Teo EY, 2011, BIOMATERIALS, V32, P279, DOI 10.1016/j.biomaterials.2010.08.089; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Yeo A, 2008, J BIOMED MATER RES A, V84A, P208, DOI 10.1002/jbm.a.31454; Yeo A, 2010, J BIOMED MATER RES A, V92A, P311, DOI 10.1002/jbm.a.32366; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078	34	14	14	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	NOV 1	2013	19	21-22					2382	2389		10.1089/ten.tea.2012.0733			8	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	239PN	WOS:000326038000009	23691928	Green Published			2022-02-06	
J	Dias, MS; Sussman, JS; Durham, S; Iantosca, MR				Dias, Mark S.; Sussman, Jeffrey S.; Durham, Susan; Iantosca, Mark R.			Perceived benefits and barriers to a career in pediatric neurosurgery: a survey of neurosurgical residents Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric neurosurgery; medical education; residency; postgraduate training; workforce; career choice	UNITED-STATES; BRAIN-TUMORS; WORKFORCE; STUDENTS; SURGERY; CHOICE	Object. Research suggests that there may be a growing disparity between the supply of and demand for both pediatric specialists and neurosurgeons. Whether pediatric neurosurgeons are facing such a disparity is disputable, but interest in pediatric neurosurgery (PNS) has waxed and waned as evidenced by the number of applicants for PNS fellowships. The authors undertook a survey to analyze current neurosurgical residents' perceptions of both benefits and deterrents to a pediatric neurosurgical career. Methods. All residents and PNS fellows in the United States and Canada during the academic year 2008-2009 were invited to complete a Web-based survey that assessed 1) demographic and educational information about residents and their residency training, particularly as it related to training in PNS; 2) residents' exposure to mentoring opportunities from pediatric neurosurgical faculty and their plans for the future; and 3) residents' perceptions about how likely 40 various factors were to influence their decision about whether to pursue a PNS career. Results. Four hundred ninety-six responses were obtained: 89% of the respondents were male, 63% were married, 75% were in at least their 3rd year of postgraduate training, 61% trained in a children's hospital and 29% in a children's "hospital within a hospital," and 72% were in programs having one or more dedicated PNS faculty members. The residencies of 56% of respondents offered 6-11 months of PNS training and nearly three-quarters of respondents had completed 2 months of PNS training. During medical school, 92% had been exposed to neurosurgery and 45% to PNS during a clinical rotation, but only 7% identified a PNS mentor. Nearly half (43%) are considering a PNS career, and of these, 61% are definitely or probably considering post-residency fellowship. On the other hand, 68% would prefer an enfolded fellowship during residency. Perceived strengths of PNS included working with children, developing lasting relationships, wider variety of operations, fast healing and lack of comorbidities, and altruism. Perceived significant deterrents included shunts, lower reimbursement, cross-coverage issues, higher malpractice premiums and greater legal exposure, and working with parents and pediatric health professionals. The intrinsic nature of PNS was listed as the most significant deterrent (46%) followed by financial concerns (25%), additional training (12%), longer work hours (12%), and medicolegal issues (4%). The majority felt that fellowship training and PNS certification should be recommended for surgeons treating of all but traumatic brain injuries and Chiari I malformations and performing simple shunt-related procedures, although they felt that these credentials should be required only for treating complex craniosynostosis. Conclusions. The nature of PNS is the most significant bather to attracting residents, although reimbursement, cross-coverage, and legal issues are also important to residents. The authors provide several recommendations that might enhance resident perceptions of PNS and attract trainees to the specialty.	[Dias, Mark S.; Iantosca, Mark R.] Penn State Univ, Coll Med, Dept Neurosurg, Hershey, PA USA; [Dias, Mark S.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Sussman, Jeffrey S.] Brandeis Univ, Heller Sch Publ Policy & Management, Waltham, MA USA; [Durham, Susan] Dartmouth Coll, Sch Med, Lebanon, NH USA		Dias, MS (corresponding author), Penn State Hershey Med Ctr, Dept Surg, EC 2750,30 Hope Dr, Hershey, PA 17033 USA.	mdias@hmc.psu.edu			Joint Section on Pediatric Neurological Surgery of the American Association of Neurological Surgeons; Congress of Neurological Surgeons	This study was funded in part by the Joint Section on Pediatric Neurological Surgery of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.	Albright AL, 2000, NEUROSURGERY, V47, P879, DOI 10.1097/00006123-200010000-00018; Althouse LA, 1999, ADV HEALTH SCI EDUC, V4, P111, DOI 10.1023/A:1009768526142; Benzil DL, 2006, AANS B, V15, P7; Boop FA, 2007, AANS B, V16, P7; Chen H, 2001, J SURG RES, V97, P172, DOI 10.1006/jsre.2001.6135; Dohn H, 1996, MED EDUC, V30, P157; Durham SR, 2008, J NEUROSURG-PEDIATR, V1, P429, DOI 10.3171/PED/2008/1/6/429; Durham SR, 2009, J NEUROSURG-PEDIATR, V3, P1, DOI 10.3171/2008.10.PEDS08255; ELAM C, 1994, J CAREER DEV, V21, P37, DOI 10.1177/089484539402100104; Ernst R L, 1984, Med Care Rev, V41, P1, DOI 10.1177/107755878404100101; Flannery AM, 1998, PEDIATR NEUROSURG, V29, P114, DOI 10.1159/000028703; Gottfried ON, 2005, J NEUROSURG, V102, P202, DOI 10.3171/jns.2005.102.2.0202; KAUFMAN BA, 1994, PEDIATR NEUROSURG, V21, P36, DOI 10.1159/000120812; Kozar RA, 2003, J SURG RES, V111, P166, DOI 10.1016/S0022-4804(03)00104-5; Mayer ML, 2006, PEDIATRICS, V118, P2313, DOI 10.1542/peds.2006-1570; MITCHELL WD, 1975, SOC SCI MED, V9, P641, DOI 10.1016/0037-7856(75)90178-X; Musunuru S, 2007, J AM COLL SURGEONS, V204, P164, DOI 10.1016/j.jamcollsurg.2006.08.029; O'Herrin JK, 2004, J SURG RES, V119, P124, DOI 10.1016/j.jss.2004.03.009; O'Herrin JK, 2003, AM J SURG, V186, P125, DOI 10.1016/S0002-9610(03)00188-0; O'Neill J A Jr, 1996, Bull Am Coll Surg, V81, P34; O'Neill JA, 2000, ANN SURG, V232, P442, DOI 10.1097/00000658-200009000-00016; Osipow S.H., 1996, THEORIES CAREER DEV, V4th; Smith ER, 2004, NEUROSURGERY, V54, P553, DOI 10.1227/01.NEU.0000108421.69822.67; Stoddard JJ, 2000, PEDIATRICS, V106, P1325, DOI 10.1542/peds.106.6.1325	24	14	14	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2013	12	5					422	433		10.3171/2013.7.PEDS12597			12	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	238OD	WOS:000325956400003	23992238				2022-02-06	
J	Doyle, ST; Perrin, PB; Sosa, DMD; Jove, IGE; Lee, GK; Arango-Lasprilla, JC				Doyle, Sarah T.; Perrin, Paul B.; Diaz Sosa, Dulce Maria; Espinosa Jove, Irma Guadalupe; Lee, Gloria K.; Carlos Arango-Lasprilla, Juan			Connecting family needs and TBI caregiver mental health in Mexico City, Mexico	BRAIN INJURY			English	Article						Caregiver and cultural; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PUERTO-RICAN; DEPRESSION; QUESTIONNAIRE; INTEGRATION; ADJUSTMENT; ATTENTION; AMERICAN; BURDEN; IMPACT	Purpose: This study examined relationships between caregiver mental health and the extent to which needs were met in families of individuals with traumatic brain injury (TBI) in Mexico City, Mexico. Method: Sixty-eight TBI caregivers completed Spanish versions of instruments assessing their own mental health and whether specific family needs were met. Results: Twenty-seven per cent of caregivers reported clinically significant depression levels, 40% reported below-average life satisfaction and 49% reported mild-to-severe burden. Several of the most frequently met family needs were in the emotional support domain, whereas the majority of unmet needs were in the health information domain. Family needs and caregiver mental health were significantly and highly related. When family needs were met, caregiver mental health was better. The strongest pattern of connections in multivariate analyses was between family instrumental support (assistance in the completion of daily life tasks) and caregiver burden, such that caregivers with less instrumental support had greater burden. Additional results suggested that instrumental support uniquely predicted caregiver satisfaction with life, burden and depression. Conclusions: Interventions for TBI caregivers, especially in Latin America, should help family members determine how best to meet their health information and instrumental needs, with the former being likely to improve caregiver mental health.	[Doyle, Sarah T.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Diaz Sosa, Dulce Maria] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Espinosa Jove, Irma Guadalupe] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Lee, Gloria K.] SUNY Buffalo, Buffalo, NY 14260 USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbao 48007, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, IKERBASQUE, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; Cohen J., 1998, STAT POWER ANAL BEHA, V2, P567; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fischer L, 1994, FAMILY CAREGIVING LI, P287; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Gulin S, FAMILIES SY IN PRESS; Hinojosa MS, 2009, ETHNIC HEALTH, V14, P591, DOI 10.1080/13557850903165403; Kim Y, 2006, PSYCHO-ONCOLOGY, V15, P795, DOI 10.1002/pon.1013; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J, 1989, FAMILY NEEDS QUESTIO; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Marin G, 1991, RES HISPANIC POPULAT, P130; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Martin M., 1996, REV GERONTOLOGIA, V6, P338; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Moules S, 1999, BRAIN INJURY, V13, P983; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Triandis HC, 1995, INDIVIDUALISM COLLEC, P280; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	51	14	14	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1441	1449		10.3109/02699052.2013.826505			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500016	23957747				2022-02-06	
J	Wagner, AK; Brayer, SW; Hurwitz, M; Niyonkuru, C; Zou, HC; Failla, M; Arenth, P; Manole, MD; Skidmore, E; Thiels, E				Wagner, Amy K.; Brayer, Samuel W.; Hurwitz, Max; Niyonkuru, Christian; Zou, Huichao; Failla, Michelle; Arenth, Patricia; Manole, Mioara D.; Skidmore, Elizabeth; Thiels, Edda			Non-spatial pre-training in the water maze as a clinically relevant model for evaluating learning and memory in experimental TBI	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Traumatic brain injury; Controlled cortical impact; Implicit memory; Water maze; Spatial memory; Thigmotaxis	TRAUMATIC BRAIN-INJURY; COGNITIVE DEFICITS; EXPLICIT MEMORY; SPATIAL NAVIGATION; HIDDEN PLATFORM; SEX-DIFFERENCES; IMPLICIT; LESIONS; PLACE; RATS	Explicit and implicit learning and memory networks exist where each network can facilitate or inhibit cognition. Clinical evidence suggests that implicit networks are relatively preserved after traumatic brain injury (TBI). Non-spatial pre-training (NSPT) in the Morris Water Maze (MWM) provides the necessary behavioral components to complete the task, while limiting the formation of spatial maps. Our study utilized NSPT in the MWM to assess implicit and explicit learning and memory system deficits in the controlled cortical impact (CCI) model of TBI. 76 adult male Sprague-Dawley rats were divided: CCI vs. sham surgery, NSPT vs. No-NSPT, and cued vs. non-cued groups. NSPT occurred for 4d prior to surgery (dynamic hidden platform location, extra-maze cues covered, static pool entry point). Acquisition (d14-18), Probe/Visible Platform (d19), and Reversal (d20-21) trials were conducted with or without extra-maze cues. Novel time allocation and search strategy selection metrics were utilized. Results indicated implicit and explicit learning/memory networks are distinguishable in the MWM. In the cued condition, NSPT reduced thigmotaxis, improved place learning, and largely eliminated the apparent injury-induced deficits typically observed between untrained CCI and sham rats. However, among NSPT groups, incorporation of cues into search strategy selection for CCI rats was relatively impaired compared to shams. Noncued condition performance showed sham/NSPT and CCl/NSPT rats perform similarly, suggesting implicit memory networks are largely intact 2 weeks after CCI. Place learning differences between CCl/NSPT and sham/NSPT rats more accurately reflect spatial deficits in our CCI model compared to untrained controls. These data suggest NSPT as a clinically relevant construct for evaluating potential neurorestorative and neuroprotective therapies. These findings also support development of non-spatial cognitive training paradigms for evaluating rehabilitation relevant combination therapies. (C) 2013 Elsevier Inc. All rights reserved.	[Wagner, Amy K.; Brayer, Samuel W.; Hurwitz, Max; Niyonkuru, Christian; Zou, Huichao; Failla, Michelle; Arenth, Patricia] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, Amy K.; Brayer, Samuel W.; Zou, Huichao; Manole, Mioara D.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Manole, Mioara D.] Childrens Hosp Pittsburgh UPMC, Div Pediat Emergency Med, Pittsburgh, PA 15224 USA; [Skidmore, Elizabeth] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA 15260 USA; [Thiels, Edda] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD071728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD071728] Funding Source: NIH RePORTER	Work associated with this study was supported, in part, by the National Institutes of Health (1R21HD071728). The authors would like to acknowledge Christopher Henderson, Jay Fuletra, Krishma Kumar and Scott Ketchman for their assistance in data collection.	BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Brooks SP, 2007, BRAIN RES, V1185, P179, DOI 10.1016/j.brainres.2007.09.017; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Carrasco C, 2006, BEHAV PHARMACOL, V17, P441, DOI 10.1097/00008877-200609000-00010; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen SHA, 1997, BRAIN INJURY, V11, P197; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Da Cunha C, 2007, NEUROBIOL LEARN MEM, V87, P451, DOI 10.1016/j.nlm.2006.12.004; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Dobkin BH, 2007, DEV NEUROBIOL, V67, P1133, DOI 10.1002/dneu.20514; Dyer K, 2007, BEHAV BRAIN RES, V181, P85, DOI 10.1016/j.bbr.2007.03.029; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0; Hamilton DA, 2008, J EXP PSYCHOL ANIM B, V34, P31, DOI 10.1037/0097-7403.34.1.31; Hamilton DA, 2007, J EXP PSYCHOL-ANIM B, V33, P100, DOI 10.1037/0097-7403.33.2.100; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hoh TE, 1997, BEHAV NEUROSCI, V111, P1285, DOI 10.1037/0735-7044.111.6.1285; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Lukoyanov NV, 2005, BEHAV BRAIN RES, V158, P175, DOI 10.1016/j.bbr.2004.08.023; Mair RG, 2003, BEHAV NEUROSCI, V117, P596, DOI 10.1037/0735-7044.117.3.596; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MOSER E, 1993, J NEUROSCI, V13, P3916; Mouton PR, 2011, UNBIASED STEREOLOGY, V1st; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; PerrotSinal TS, 1996, BEHAV NEUROSCI, V110, P1309, DOI 10.1037/0735-7044.110.6.1309; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ramos JMJ, 2010, NEUROBIOL LEARN MEM, V93, P506, DOI 10.1016/j.nlm.2010.01.008; Rothi LJG, 2009, J INT NEUROPSYCH SOC, V15, P311, DOI 10.1017/S1355617709090201; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Steenbergen B, 2010, DISABIL REHABIL, V32, P1509, DOI 10.3109/09638288.2010.497035; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wolff M, 2008, NEUROBIOL LEARN MEM, V90, P71, DOI 10.1016/j.nlm.2008.01.007; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618	63	14	14	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	NOV	2013	106						71	86		10.1016/j.nlm.2013.07.006			16	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	273FO	WOS:000328520800010	23871745	Green Accepted			2022-02-06	
J	Beynon, C; Scherer, M; Jakobs, M; Jung, C; Sakowitz, OW; Unterberg, AW				Beynon, Christopher; Scherer, Moritz; Jakobs, Martin; Jung, Carla; Sakowitz, Oliver W.; Unterberg, Andreas W.			Initial experiences with Multiplate (R) for rapid assessment of antiplatelet agent activity in neurosurgical emergencies	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Antiplatelet therapy; Aspirin; Clopidogrel; Intracerebral haemorrhage; Point-of-care	TRAUMATIC BRAIN-INJURY; WHOLE-BLOOD AGGREGOMETRY; ELECTRODE AGGREGOMETRY; PLATELET TRANSFUSION; CORONARY SYNDROMES; ASPIRIN; THERAPY; RISK	Objective: As the population ages, physicians encounter a growing number of patients who are treated with antiplatelet agents and present with severe conditions requiring urgent neurosurgical therapy. Standard laboratory investigations are insufficient to evaluate platelet activity and furthermore, it is difficult to evaluate effects of haemostatic measures on platelet function. In this article we report our initial experiences with the point-of-care device Multiplate (R) for assessment of platelet activity in neurosurgical emergencies on patients with a reported intake of antiplatelet medication. Methods: Multiplate (R) assessment of antiplatelet activity was carried out in 21 non-consecutive patients with a reported intake of antiplatelet medication (aspirin: n = 21, clopidogrel: n = 3, ticragrelor: n = 1) and urgent admission to our hospital because of conditions such as intracranial haemorrhage requiring urgent neurosurgical therapy. Analysis was repeated in order to evaluate the effectiveness of haemostatic drugs and platelet concentrate transfusion on platelet activity in six patients. Results: No technical difficulties occurred and in all cases, results were obtained within 15 min. On admission, patients' arachidonic acid induced platelet activity was reduced by 44.4 +/- 33.5% (range: -79.7% to +44.3%) compared to the lower reference limit. Two patients had a normal platelet activity despite a reported intake of aspirin. Haemostatic measures significantly increased arachidonic acid induced platelet activity by 100 +/- 66% (p < 0.005). Conclusion: The Multiplate device allowed rapid assessment of antiplatelet agent activity and evaluation of haemostatic measures on platelet activity. Further studies with larger patient numbers are needed, but this device may represent a valuable tool to improve treatment modalities in patients treated with antiplatelet medication and conditions requiring urgent neurosurgical therapy. (C) 2013 Elsevier B.V. All rights reserved.	[Beynon, Christopher; Scherer, Moritz; Jakobs, Martin; Jung, Carla; Sakowitz, Oliver W.; Unterberg, Andreas W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany		Beynon, C (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	christopher.beynon@med.uni-heidelberg.de	Jakobs, Martin/AAA-1132-2022	Sakowitz, Oliver/0000-0003-3248-6335			Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11816; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Beynon C, 2013, J CLIN NEUR IN PRESS, DOI DOI 10.1016/JJ0CN.2013.02.022; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Hazarbasanov D, 2012, J THROMB THROMBOLYS, V34, P85, DOI 10.1007/s11239-012-0684-z; Hussein HM, 2013, AM J NEURORADIOL, V34, P700, DOI 10.3174/ajnr.A2963; Jambor C, 2011, ANESTH ANALG, V113, P31, DOI 10.1213/ANE.0b013e31821acddc; Lopes RD, 2011, J THROMB THROMBOLYS, V31, P306, DOI 10.1007/s11239-011-0558-9; Norfolk DR, 1998, BRIT J HAEMATOL, V101, P609; Ozal E, 2002, J THORAC CARDIOV SUR, V123, P539, DOI 10.1067/mtc.2002.117281; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Paniccia R, 2009, AM J CLIN PATHOL, V131, P834, DOI 10.1309/AJCPTE3K1SGAPOIZ; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Ranucci M, 2011, ANN THORAC SURG, V91, P123, DOI 10.1016/j.athoracsur.2010.09.022; Roden DM, 2011, CIRC RES, V109, P807, DOI 10.1161/CIRCRESAHA.110.230995; Roos YB, 2003, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schulz C, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-13; Stead LG, 2010, CLIN NEUROL NEUROSUR, V112, P275, DOI 10.1016/j.clineuro.2009.12.002; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Ulehlova J, 2011, INT J LAB HEMATOL, V33, P305, DOI 10.1111/j.1751-553X.2010.01286.x; Weber CF, 2011, EUR J ANAESTH, V28, P57, DOI 10.1097/EJA.0b013e32834050ab	27	14	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2003	2008		10.1016/j.clineuro.2013.06.002			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200013	23830497				2022-02-06	
J	Salvador, E; Neuhaus, W; Foerster, C				Salvador, Ellaine; Neuhaus, Winfried; Foerster, Carola			Stretch in Brain Microvascular Endothelial Cells (cEND) as an In Vitro Traumatic Brain Injury Model of the Blood Brain Barrier	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 80; stretch injury; traumatic brain injury; blood-brain barrier; brain microvascular endothelial cells (cEND)	PERMEABILITY; BREAKDOWN; CULTURE; HYPOXIA; TARGET	Due to the high mortality incident brought about by traumatic brain injury (TBI), methods that would enable one to better understand the underlying mechanisms involved in it are useful for treatment. There are both in vivo and in vitro methods available for this purpose. In vivo models can mimic actual head injury as it occurs during TBI. However, in vivo techniques may not be exploited for studies at the cell physiology level. Hence, in vitro methods are more advantageous for this purpose since they provide easier access to the cells and the extracellular environment for manipulation. Our protocol presents an in vitro model of TBI using stretch injury in brain microvascular endothelial cells. It utilizes pressure applied to the cells cultured in flexible-bottomed wells. The pressure applied may easily be controlled and can produce injury that ranges from low to severe. The murine brain microvascular endothelial cells (cEND) generated in our laboratory is a well-suited model for the blood brain barrier (BBB) thus providing an advantage to other systems that employ a similar technique. In addition, due to the simplicity of the method, experimental set-ups are easily duplicated. Thus, this model can be used in studying the cellular and molecular mechanisms involved in TBI at the BBB.	[Salvador, Ellaine; Neuhaus, Winfried; Foerster, Carola] Univ Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, Wurzburg, Germany; [Neuhaus, Winfried] Univ Vienna, Fac Life Sci, Dept Med Chem, A-1010 Vienna, Austria		Foerster, C (corresponding author), Univ Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, Wurzburg, Germany.	Foerster_C@klinik.uni-wuerzburg.de		Neuhaus, Winfried/0000-0002-6552-7183	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [FO 315/4-]; European UnionEuropean Commission [HEALTH-F2-2009- 241778]	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under grant number FO 315/4- and the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement No. HEALTH-F2-2009- 241778 to CF.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; Burek M, 2012, JOVE-J VIS EXP, DOI 10.3791/4022; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Geddes-Klein D., 2006, J NEUROTRAUM, V23, P93; Gidday JM, 1999, J NEUROTRAUM, V16, P27, DOI 10.1089/neu.1999.16.27; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; RAYCHAUDHURY A, 1994, J CELL SCI, V107, P39; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thal S. C., 2013, CRIT CARE M IN PRESS; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	25	14	14	0	9	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	OCT	2013		80							e50928	10.3791/50928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36RP	WOS:000209228800050	24193450	Green Published, Green Submitted, Bronze			2022-02-06	
J	Stamataki, E; Stathopoulos, A; Garini, E; Kokkoris, S; Glynos, C; Psachoulia, C; Pantziou, H; Nanas, S; Routsi, C				Stamataki, Elisavet; Stathopoulos, Anastasios; Garini, Eleanna; Kokkoris, Stelios; Glynos, Constantinos; Psachoulia, Christina; Pantziou, Harikleia; Nanas, Serafeim; Routsi, Christina			SERUM S100B PROTEIN IS INCREASED AND CORRELATES WITH INTERLEUKIN 6, HYPOPERFUSION INDICES, AND OUTCOME IN PATIENTS ADMITTED FOR SURGICAL CONTROL OF HEMORRHAGE	SHOCK			English	Article						Hemorrhagic shock; inflammation; S100B protein; interleukin 6; lactate; brain damage; control of bleeding	NEURON-SPECIFIC ENOLASE; CARDIAC-SURGERY; TRAUMA PATIENTS; BRAIN-INJURY; CYTOKINE; SHOCK; BLOOD; RESUSCITATION; ISCHEMIA; PATTERNS	S100B protein, an acknowledged biomarker of brain injury, has been reported to be increased in hemorrhagic shock. Also, acute hemorrhage is associated with inflammatory response. The aim of this study was to investigate the concentrations of serum S100B and the potential relationships with interleukin 6 (IL-6), severity of tissue hypoperfusion, and prognosis in patients admitted for surgical control of severe hemorrhage. Patients undergoing elective abdominal aortic aneurysm surgery participated as control subjects. Serum samples were drawn before, at the end of surgery, and after 6 and 24 h. Sixty-four patients with severe hemorrhage (23 trauma and 41 nontrauma) and 17 control subjects were included. Increased preoperative concentrations of S100B protein (1.70 +/- 2.13 and 0.81 +/- 1.23 mu g/L) and IL-6 (241 +/- 291 and 226 +/- 238 pg/mL) were found in patients with traumatic and nontraumatic reason, respectively, and remained elevated throughout 24 h. Compared with nontrauma, trauma patients exhibited higher preoperative S100B levels (P < 0.05). Overall mortality was 47%. In control subjects, preoperative S100B and IL-6 levels were within normal limits and increased at the end of surgery (P < 0.001 and P < 0.01, respectively). Preoperative S100B correlated with IL-6 (r = 0.78, P < 0.01), arterial lactate (r = 0.50, P < 0.01), pH (r = -0.45, P < 0.01), and bicarbonate (r = -0.40, P < 0.01). Multiple analysis revealed that preoperative S100B in trauma and lactate in nontrauma patients were independently associated with outcome. In predicting death, preoperative S100B yielded receiver operator characteristics curve areas of 0.75 for all patients and 0.86 for those with trauma. These results indicate that severe hemorrhage in patients without brain injury is associated with increased serum levels of S100B, which correlates with IL-6 and tissue hypoperfusion. Moreover, the predictive ability of S100B for mortality, suggests that it could be a marker of potential clinical value in identifying, among patients with severe hemorrhage, those at greater risk for adverse outcome.	[Stamataki, Elisavet; Stathopoulos, Anastasios; Garini, Eleanna] Univ Athens, Sch Med, Dept Anesthesiol, Athens 10676, Greece; [Stathopoulos, Anastasios; Kokkoris, Stelios; Glynos, Constantinos; Nanas, Serafeim; Routsi, Christina] Univ Athens, Sch Med, Dept Crit Care 1, Athens 10676, Greece; [Psachoulia, Christina; Pantziou, Harikleia] Evangelismos Med Ctr, Biochem Lab, Athens, Greece		Routsi, C (corresponding author), Univ Athens, Sch Med, Evangelismos Hosp, Crit Care Dept, 45-47 Ipsilantou Str, Athens 10676, Greece.	chroutsi@hotmail.com		Nanas, Serafim/0000-0003-4666-4550			Anderson RE, 2003, J CARDIOTHOR VASC AN, V17, P598, DOI 10.1016/S1053-0770(03)00203-9; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Ashraf S, 1999, EUR J CARDIO-THORAC, V16, P32, DOI 10.1016/S1010-7940(99)00136-0; Beer C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-71; Brin T, 2011, SHOCK, V36, P356, DOI 10.1097/SHK.0b013e31822bd07d; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; CHEN RYZ, 1984, STROKE, V15, P343, DOI 10.1161/01.STR.15.2.343; CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; Herrmann M, 2001, NEUROSURGERY, V49, P1272, DOI 10.1097/00006123-200111000-00058; Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88; Johnsson P, 2003, ANN THORAC SURG, V75, P162, DOI 10.1016/S0003-4975(02)04318-7; Lee CC, 2007, ANN EMERG MED, V49, P37, DOI 10.1016/j.annemergmed.2006.05.031; Li YK, 2000, J NEUROCHEM, V74, P143; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; Meybohm P, 2008, RESUSCITATION, V76, P449, DOI 10.1016/j.resuscitation.2007.09.002; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Molina PE, 2001, NEUROIMMUNOMODULAT, V9, P125, DOI 10.1159/000049016; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Rasmussen LS, 2000, BRIT J ANAESTH, V84, P242, DOI 10.1093/oxfordjournals.bja.a013410; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Welborn MB, 2000, CRIT CARE MED, V28, P3191, DOI 10.1097/00003246-200009000-00013; Zhao PC, 2012, CLIN LAB, V58, P1051, DOI 10.7754/Clin.Lab.2011.111004	35	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	OCT	2013	40	4					274	280		10.1097/SHK.0b013e3182a35de5			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	297HK	WOS:000330246300004	23856918				2022-02-06	
J	Bendinelli, C; Bivard, A; Nebauer, S; Parsons, MW; Balogh, ZJ				Bendinelli, Cino; Bivard, Andrew; Nebauer, Shane; Parsons, Mark W.; Balogh, Zsolt J.			Brain CT perfusion provides additional useful information in severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain CT perfusion (CTP); Severe traumatic brain injury (STBI); Post-traumatic stroke	SEVERE HEAD TRAUMA; BLOOD-FLOW	Background: The role of brain CT perfusion (CTP) imaging in severe traumatic brain injury (STBI) is unclear. We hypothesised that in STBI early CTP may provide additional information beyond the non contrast CT (NCCT). Methods: Subset analysis of an ongoing prospective observational study on trauma patients with STBI who did not require craniectomy and deteriorated or failed to improve neurologically during the first 48 h from trauma. Subsequently to follow-up NCCT, a CTP was obtained. Additional findings were defined as an area of altered perfusion on CTP larger than the abnormal area detected by the simultaneous NCCT. Patients who had additional finding (A-CTP) were compared with patients who did not have additional findings (NA-CTP). Results: Study population was 30 patients [male: 90%, mean age: 38.6 (SD 16.9), blunt trauma: 100%; prehospital intubation: 6 (20%); lowest GCS before intubation: 5.1 (SD 2.0); mean ISS: 30.5 (SD 8.3); mean head and neck AIS: 4.4 (SD 0.8). Days in ICU: 10.2 (SD 6.3). Intracranial pressure (ICP) monitored in 12 (40%). Mean highest ICP in mmHg: 30.1 (SD14.1). There were five (17%) deaths. Findings of NCCT: primarily diffuse axonal injury (DAI) pattern in seven (23%), primarily haematoma in ten (33%), and primarily intracerebral contusion in nine (30%). CTP was performed 24.9 (SD 13) hours from trauma. There were 18 (60%) patients in the A-CTP group and 12 (40.0%) in NA-CTP. The A-CTP group was older (41.7 (SD16.9) vs 27.7 (SD 12.8): P < 0.02) and showed on admission NCCT presence of cerebral contusion and absence of DAI. The degree of hypoperfusion was found to be severe enough to be in the ischaemic range in eight patients (27%). CTP altered clinical management in three patients (10%), who were diagnosed with massive and unsurvivable strokes despite minimal changes on NCCT. Conclusion: When compared to NCCT, CTP provided additional diagnostic information in 60% of patients with STBI. CTP altered clinical management in 10% of patients. (C) 2013 Elsevier Ltd. All rights reserved.	[Bendinelli, Cino; Balogh, Zsolt J.] Dept Traumatol, Newcastle, NSW, Australia; [Bivard, Andrew; Parsons, Mark W.] Dept Neurol, Newcastle, NSW, Australia; [Bendinelli, Cino; Bivard, Andrew; Parsons, Mark W.; Balogh, Zsolt J.] John Hunter Hosp, Newcastle, NSW 2300, Australia; [Nebauer, Shane; Parsons, Mark W.; Balogh, Zsolt J.] Univ Newcastle, Newcastle, NSW 2300, Australia		Balogh, ZJ (corresponding author), John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2300, Australia.	Cino.bendinelli@hnehealth.nsw.gov.au; Andrew.bivard@unimelb.edu.au; Shane.nebauer@uon.edu.au; Mark.parson@hnehealth.nsw.gov.au; zsolt.balogh@hnehealth.nsw.gov.au	Balogh, Zsolt J/A-2002-2010; Parsons, Mark W./G-3750-2014	Balogh, Zsolt J/0000-0002-0277-4822; 			[Anonymous], 2012, GRAPHPAD ONL SOFTW; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Horn P, 2001, AM J NEURORADIOL, V22, P1543; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Parsons MW, 2007, NEUROLOGY, V68, P730, DOI 10.1212/01.wnl.0000256366.86353.ff; Parsons MW, 2008, INT J STROKE, V3, P41, DOI 10.1111/j.1747-4949.2008.00175.x; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; von Oettingen G, 2000, NEURORADIOLOGY, V42, P168, DOI 10.1007/s002340050039; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824	18	14	16	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1208	1212		10.1016/j.injury.2013.03.039			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600013	23642628				2022-02-06	
J	Erez, N; Weiss, PL; Kizony, R; Rand, D				Erez, Neta; Weiss, Patrice L.; Kizony, Rachel; Rand, Debbie			Comparing Performance Within a Virtual Supermarket of Children With Traumatic Brain Injury to Typically Developing Children: A Pilot Study	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						virtual reality; executive function; traumatic brain injury	EXECUTIVE FUNCTION; REALITY; REHABILITATION; ENVIRONMENT; CHILDHOOD; VALIDITY; IMPACT; SKILLS; TASK	The purpose of this study was to determine the usability of a virtual reality environment for pediatric traumatic brain injury (TBI) by assessing the performance of a simple virtual shopping task and comparing their results to typically developing peers. Twenty children with TBI and 20 typically developing children, matched in age and sex, "shopped" for four items in a virtual supermarket (VMall). A short feedback questionnaire, Borg's scale of perceived exertion, and the Zoo Map subtest from the Behavioral Assessment of the Dysexecutive Syndrome for Children were also administered. All of the children were able to complete a four-item test within the VMall. Overall, good usability was obtained. A significant difference in shopping performance was found between the two groups; the mean shopping time and number of mistakes was higher for the children with TBL The use of a short shopping test within a functional virtual environment enabled detection of poorer performance of children with TBI that may be due to executive function deficits. Because the task was enjoyable and motivating, the VMall may also be used to enhance participation in instrumental activities of daily living and play for children with TBI.	[Erez, Neta] Safra Childrens Hosp, Sheba Med Ctr, Dept Occupat Therapy, Tel Hashomer, Israel; [Erez, Neta] Univ Haifa, Dept Occupat Therapy, Masters program, IL-31999 Haifa, Israel; [Weiss, Patrice L.; Kizony, Rachel] Univ Haifa, Dept Occupat Therapy, IL-31999 Haifa, Israel; [Kizony, Rachel] Sheba Med Ctr, Tel Hashomer, Israel; [Rand, Debbie] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, IL-69978 Tel Aviv, Israel		Rand, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, IL-69978 Tel Aviv, Israel.	drand@post.tau.ac.il					Bart O, 2008, OTJR-OCCUP PART HEAL, V28, P89, DOI 10.3928/15394492-20080301-01; Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Emslie H., 2003, BEHAV ASSESSMENT DYS; Engel-Yeger B, 2009, NEUROPSYCHOL REHABIL, V19, P662, DOI 10.1080/09602010802622730; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gitlin-Weiner K., 2000, PLAY DIAGNOSIS ASSES; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Josman N, 2008, INT J DISABIL HUM DE, V7, P49; Josman N, 2010, AM J OCCUP THER, V64, P47, DOI 10.5014/ajot.64.1.47; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Kizony R., 2006, P 11 ANN CYB C VIRT; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Mortenson Patricia A, 2006, Phys Occup Ther Pediatr, V26, P181, DOI 10.1300/J006v26n01_11; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Parsons TD, 2009, DEV NEUROREHABIL, V12, P224, DOI 10.1080/17518420902991719; Piaget J., 1962, PLAY DREAMS IMITATIO; Rand D, 2005, ANN REV CYBERTHERAPY, V3, P193; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Rizzo AA, 1997, ST HEAL T, V44, P123; Rocke K, 2008, AM J OCCUP THER, V62, P528, DOI 10.5014/ajot.62.5.528; Sandlund M, 2009, DEV MED CHILD NEUROL, V51, P173, DOI 10.1111/j.1469-8749.2008.03184.x; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shimoni M, 2012, RES DEV DISABIL, V33, P858, DOI 10.1016/j.ridd.2011.12.014; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Weiss, 2011, J PHYS THER ED, V25, P59, DOI [10.1097/00001416-201110000-00011, DOI 10.1097/00001416-201110000-00011]; Weiss P, 2006, TXB NEURAL REPAIR RE, p182 197, DOI [10.1017/CBO9780511545078.015, DOI 10.1017/CBO9780511545078.015, DOI 10.1017/CB09780511545078.015]; Weiss P L, 1998, Work, V11, P277, DOI 10.3233/WOR-1998-11305; Weiss Patrice L, 2004, J Neuroeng Rehabil, V1, P12, DOI 10.1186/1743-0003-1-12; Weiss PL, 2009, PHYS THER REV, V14, P307, DOI 10.1179/108331909X12488667117339; Weiss PL, 2003, CYBERPSYCHOL BEHAV, V6, P335, DOI 10.1089/109493103322011650; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P37, DOI 10.1097/00008483-199701000-00005; White SJ, 2009, AUTISM RES, V2, P138, DOI 10.1002/aur.78; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	54	14	14	1	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	FAL	2013	33	4					218	227		10.3928/15394492-20130912-04			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	234WX	WOS:000325676100006	24652030				2022-02-06	
J	Nobs, L; Nestel, S; Kulik, A; Nitsch, C; Atanasoski, S				Nobs, Lionel; Nestel, Sigrun; Kulik, Akos; Nitsch, Cordula; Atanasoski, Suzana			Cyclin D1 is required for proliferation of olig2-expressing progenitor cells in the injured cerebral cortex	GLIA			English	Article						glial progenitor cells; cell cycle; proliferation; brain injuries	TRAUMATIC BRAIN-INJURY; ADULT NEUROGENESIS; SCHWANN-CELLS; IBOTENIC ACID; SPINAL-CORD; CNS INJURY; EXPRESSION; ACTIVATION; NEURONS; MICE	Little is known about the molecular mechanisms driving proliferation of glial cells after an insult to the central nervous system (CNS). To test the hypothesis that the G1 regulator cyclin D1 is critical for injury-induced cell division of glial cells, we applied an injury model that causes brain damage within a well-defined region. For this, we injected the neurotoxin ibotenic acid into the prefrontal cortex of adult mice, which leads to a local nerve cell loss but does not affect the survival of glial cells. Here, we show that cyclin D1 immunoreativity increases drastically after neurotoxin injection. We find that the cyclin D1-immunopositive (cyclin D1+) cell population within the lesioned area consists to a large extent of Olig2+ oligodendrocyte progenitor cells. Analysis of cyclin D1-deficient mice demonstrates that the proliferation rate of Olig2+ cells diminishes upon loss of cyclin D1. Further, we show that cyclin-dependent kinase (cdk) 4, but not cdk6 or cdk2, is essential for driving cell division of Olig2-expressing cells in our injury model. These data suggest that distinct cell cycle proteins regulate proliferation of Olig2+ progenitor cells following a CNS insult.	[Nobs, Lionel; Atanasoski, Suzana] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland; [Nestel, Sigrun; Atanasoski, Suzana] Univ Freiburg, Inst Anat & Cell Biol, D-79106 Freiburg, Germany; [Kulik, Akos] Univ Freiburg, Inst Physiol, Freiburg, Germany; [Kulik, Akos] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Nitsch, Cordula] Univ Basel, Inst Anat, Dept Biomed, CH-4056 Basel, Switzerland		Atanasoski, S (corresponding author), Univ Basel, Inst Physiol, Dept Biomed, Pestalozzistr 20, CH-4056 Basel, Switzerland.	suzana.atanasoski@unibas.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Swiss Life; Botnar Foundation; Freiwillige Akademische Gesellschaft (FAG), Basel	Grant sponsors: the Swiss National Science Foundation; Swiss Life; the Botnar Foundation; Freiwillige Akademische Gesellschaft (FAG), Basel.	Atanasoski S, 2006, GLIA, V53, P147, DOI 10.1002/glia.20263; Atanasoski S, 2002, J NEUROSCI RES, V67, P443, DOI 10.1002/jnr.10133; Atanasoski S, 2001, MOL CELL NEUROSCI, V18, P581, DOI 10.1006/mcne.2001.1055; Atanasoski S, 2008, MOL CELL NEUROSCI, V37, P519, DOI 10.1016/j.mcn.2007.11.005; Beukelaers P, 2011, STEM CELLS, V29, P713, DOI 10.1002/stem.616; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen Z, 2005, J NEUROCHEM, V92, P1281, DOI 10.1111/j.1471-4159.2004.02934.x; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Glickstein SB, 2007, CEREB CORTEX, V17, P632, DOI 10.1093/cercor/bhk008; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Inglis WL, 1997, BRAIN RES, V755, P17, DOI 10.1016/S0006-8993(97)00101-7; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Koeller HB, 2008, NEUROBIOL DIS, V31, P230, DOI 10.1016/j.nbd.2008.04.010; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Sakurai M, 2000, STROKE, V31, P200, DOI 10.1161/01.STR.31.1.200; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Small DL, 2001, BRAIN RES, V900, P26, DOI 10.1016/S0006-8993(01)02102-3; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004	36	14	14	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491			GLIA	Glia	SEP	2013	61	9					1443	1455		10.1002/glia.22533			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190ID	WOS:000322331700005	23839966				2022-02-06	
J	Rubiano, AM; Sanchez, AI; Estebanez, G; Peitzman, A; Sperry, J; Puyana, JC				Rubiano, Andres M.; Sanchez, Alvaro I.; Estebanez, Glyn; Peitzman, Andrew; Sperry, Jason; Puyana, Juan Carlos			The effect of admission spontaneous hypothermia on patients with severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Outcome; Severe head injury; Hypothermia; Traumatic brain injury; Mortality	MODERATE HYPOTHERMIA; INTRACRANIAL-PRESSURE; ENZYME-ACTIVITY; THERAPY; TEMPERATURE; COAGULATION; MANAGEMENT	Introduction: Recent information has emerged regarding the harmful effects of spontaneous hypothermia at time of admission in trauma patients. However the volume of evidence regarding the role of spontaneous hypothermia in TBI patients is inadequate. Methods: We performed secondary data analysis of 10 years of the Pennsylvania trauma outcome study (PTOS) database. Unadjusted comparisons of the association of admission spontaneous hypothermia with mortality were performed. In addition, full assessment of the association of hypothermia with mortality was conducted using multivariable logistic regressions reporting the odds ratios (OR) with the 95% confidence intervals (CI) and P-values. Results: There were 11,033 patients identified from the PTOS with severe TBI. There were 4839 deaths (43.9%). The proportion of deaths in hypothermic patients was higher than the proportion of deaths in normothermic patients (53.9% vs. 37.4% respectively; P value < 0.001). In a multivariable logistic regression model adjusted for demographics, injury characteristics, and information at admission to the trauma centre, the odds of death among patients with hypothermia were 1.70 times the odds of death among patients with normothermia (OR 1.70, 95% CI 1.50-1.93), indicating that the probability of death was significantly higher when patients arrived hypothermic at the trauma centre. Conclusion: The presence of spontaneous hypothermia at hospital admission is associated with a significant increase in the risk of mortality in patients with severe TBI. The benefit of maintaining normothermia in severe TBI patients, the impact of prolonged re-warming in patients with established hypothermia and the introduction of prophylactic measures to complications of hypothermia are key points that require further investigation. (C) 2012 Elsevier Ltd. All rights reserved.	[Rubiano, Andres M.] South Colombian Univ, Neiva Univ Hosp, Neiva, Colombia; [Sanchez, Alvaro I.] Univ Pittsburgh, Med Ctr, Div Trauma, Pittsburgh, PA USA; [Estebanez, Glyn] Whiston Hosp, Dept Surg, Warrington, Cheshire, England; [Peitzman, Andrew; Sperry, Jason; Puyana, Juan Carlos] Univ Pittsburgh, Med Ctr, Dept Gen Surg, Div Trauma, Pittsburgh, PA USA		Rubiano, AM (corresponding author), South Colombian Univ, Neiva Univ Hosp, Neiva, Colombia.	andresrubiano@aol.com; sanchezortiza@upmc.edu; glynestebanez@hotmail.com; peitzmanab@upmc.edu; sperryjl@upmc.edu; puyanajc@upmc.edu	RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254	FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43 TW007560] Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007560] Funding Source: NIH RePORTER		Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Clark DE, 2009, ICDPIC STATA MODULE, VS457028; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; De Deyne CS, 2010, CURR OPIN ANESTHESIO, V23, P258, DOI 10.1097/ACO.0b013e328336ea44; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Jurkovich GJ, 2007, SURG CLIN N AM, V87, P247, DOI 10.1016/j.suc.2006.10.003; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Krause KR, 2000, AM SURGEON, V66, P348; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; REED RL, 1990, CIRC SHOCK, V32, P141; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; World Health Organization, 1977, INT CLASS DIS	37	14	14	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1219	1225		10.1016/j.injury.2012.11.026			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600015	23273319	Green Accepted			2022-02-06	
J	Sinha, S; Gunawat, P; Nehra, A; Sharma, BS				Sinha, Sumit; Gunawat, Prashant; Nehra, Ashima; Sharma, Bhawani S.			Cognitive, functional, and psychosocial outcome after severe traumatic brain injury: A cross-sectional study at a tertiary care trauma center	NEUROLOGY INDIA			English	Article						Cognitive outcome; functional outcome; glasgow outcome score; psychosocial outcome; traumatic brain injury	CLOSED-HEAD-INJURY; REHABILITATION; PLASTICITY; MORTALITY; RECOVERY; TESTS	Background: Traumatic brain injury (TBI) constitutes a significant public health problem. Objectives: To assess cognitive, functional, and psychosocial outcome in patients with severe TBI (STBI). Materials and Methods: A total of 77 survivors of STBI treated at our center were prospectively assessed in the outpatient department 1 year after the injury. These patients were assessed for cognitive, functional, and psychosocial outcome using cognitive outcome tests, dysfunctional analysis questionnaire, and personality trait inventory, respectively. Cognitive and functional outcome was graded as average and above average recovery (good recovery) or below average recovery (poor recovery). Psychosocial outcome was assessed as average recovery (good recovery) or mild impairment and severe impairment (poor to very poor recovery). Statistical analysis was done using Chi-square and Fisher's exact tests. Results: The ability to learn new things was most affected aspect of cognitive function and only 1% of patients had good recovery in this domain. However, 44% had good outcome for simple memory. A total of 61% showed good recovery in several aspects of functional status. At the end of 1 year, 62.5% patients still remained unemployed. 45.4% patients had good recovery, while 37% had severe impairment for various personality traits and 40% of patients had impaired emotional stability, while 57% patients showed impaired recovery in depressive tendency. Conclusion: In this study 61% patients with STBI had good recovery in functional outcome and 45.4% in psychosocial outcome at 1 year follow-up. However, improvement in cognitive outcome was not so optimistic with the ability to learn new things being most affected.	[Sinha, Sumit; Gunawat, Prashant; Sharma, Bhawani S.] All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi 110029, India; [Nehra, Ashima] All India Inst Med Sci, Ctr Neurosci, Dept Clin Neuropsychol, New Delhi 110029, India		Sinha, S (corresponding author), All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, Room 713,7th Floor, New Delhi 110029, India.	sumitaiims@yahoo.com					Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brooks D N, 1979, Int Rehabil Med, V1, P166; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Furlonger A J, 2000, Crit Care Resusc, V2, P246; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; HAMMELL KRW, 1994, INT J REHABIL RES, V17, P319; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kaufman AS, ASSESSING ADOLESCENT, V006, P7; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lu J, 2005, ACT NEUR S, V95, P281; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MAHAJAN A, 1990, J PERSONALITY CLIN S, V6, P134; Mahapatra AK, 2005, TXB HEAD INJURY, P197; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mammi P, 2006, Eura Medicophys, V42, P17; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pershad D, 1976, Neurol India, V24, P86; PERSHAD D, 1985, MEASUREMENT DYSFUNCT; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; RUBIN H, 1948, J CONSULT PSYCHOL, V12, P251, DOI 10.1037/h0055299; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sousa J, 2002, NEUROL INDIA, V50, P430; TEASDALE G, 1974, LANCET, V2, P81; Turner G. R., 2008, NEUROPSYCHOL REHABIL, V18, P372; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	40	14	15	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2013	61	5					501	506		10.4103/0028-3886.121920			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	277KA	WOS:000328816300010	24262453				2022-02-06	
J	Majidi, S; Siddiq, F; Qureshi, AI				Majidi, Shahram; Siddiq, Farhan; Qureshi, Adnan I.			Prehospital neurologic deterioration is independent predictor of outcome in traumatic brain injury: analysis from National Trauma Data Bank	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							SEVERE HEAD-INJURY; GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; CONTROLLED-TRIAL; EMERGENCY CARE; PROGNOSIS; IMPACT; CENTERS; DEXTRAN; SCORES	Background: The prevalence and impact of prehospital neurologic deterioration (PhND) in patients with traumatic brain injury (TBI) have not been investigated. We aimed to determine the prevalence of PhND during emergency medical service (EMS) transportation among patients with TBI and its impact on patient's outcome. Methods: We used the National Trauma Data Bank, using data files from 2009 to 2010 to identify patients with TBI through International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. The initial Glasgow Coma Scale (GCS) score ascertained at the scene by EMS was compared with the subsequent GCS score evaluation in the emergency department (ED) to identify neurologic deterioration (defined as a decrease in GCS of >= 2 points). Patients' demographics, initial injury severity score (ISS), admission GCS score, and hospital outcome were compared between patients with PhND and patients without neurologic deterioration. Results: A total of 257 127 patients with TBI were identified. Among patients with TBI, 22 254 patients had PhND, which comprised 9% of all patients with TBI. The mean of GCS score decrease during EMS transport was 5 points (+/- 3). Patients without PhND tended to have higher GCS recorded by EMS (median, 15 vs 12; P < .0001). Patients with TBI who had PhND had significantly higher hospital length of stay and intensive care unit days after adjusting for baseline characteristics and EMS GCS score, EMS transport time, type of injury, presence of intracranial hemorrhages, and ED ISS (P < .0001). These patients had higher rate of in-hospital mortality after adjusting for the same variables (odds ratio, 2.30; 95% confidence interval, 2.18-2.41). Conclusion: Prehospital neurologic deterioration occurs in 9% of patients with TBI. It is more prevalent in men and associated with lower EMS GCS level and higher ED ISS. Prehospital neurologic deterioration is an independent predictor of worse hospital outcome and higher resource use in patients with TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Majidi, Shahram; Siddiq, Farhan; Qureshi, Adnan I.] Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA; [Siddiq, Farhan; Qureshi, Adnan I.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA		Majidi, S (corresponding author), Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA.	drsmajidi@gmail.com		Qureshi, Adnan/0000-0003-4962-540X	National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS062091-01A2]; American Heart AssociationAmerican Heart Association [0840053N]	Dr Adnan I. Qureshi is supported by the National Institute of Neurological Diseases and Stroke (principal investigator: Antihypertensive Treatment in Acute Cerebral Hemorrhage II), 1R01NS062091-01A2 (medication provided by Cornerstone Therapeutics Inc.), and American Heart Association Established Investigator Award 0840053N, Innovative Strategies for Treating Cerebral Hemorrhage.	Alkhoury F, 2011, AM SURGEON, V77, P277; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Defazio MV, 2013, WORLD NEUROSURGERY; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; Inhospital Severe TBI Guidelines, 2007, INHOSPITAL SEVERE TB; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lane PL, 2000, CAN J SURG, V43, P442; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Moon JS, 2008, CRIT CARE MED, V36, P172, DOI 10.1097/01.CCM.0000297876.62464.6B; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Salazar AM, 2002, J NEUROL NEUROSUR PS, V73, P239, DOI 10.1136/jnnp.73.3.239; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Souayah N, 2012, J NEUROTRAUMA; Traumatic Brain Injury In The United States, 2010, TRAUMATIC BRAIN INJU; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; WINKLER J V, 1984, Journal of Emergency Medicine, V2, P1, DOI 10.1016/0736-4679(84)90038-6	37	14	16	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	AUG	2013	31	8					1215	1219		10.1016/j.ajem.2013.05.026			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	201SN	WOS:000323163400011	23809095				2022-02-06	
J	Rienstra, A; Twennaar, MK; Schmand, B				Rienstra, Anne; Twennaar, Michelle Klein; Schmand, Ben			Neuropsychological Characterization of Patients with the WMT Dementia Profile	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity; Effort testing; Word Memory Test; Cognitive impairment; Classification accuracy	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; TEST-PERFORMANCE; HIGH SPECIFICITY; TESTS; VETERANS	The "dementia profile" is used to reduce false positives on the Word Memory Test (WMT). Provided that this profile reflects genuine memory impairment, corresponding cognitive deficits should be found in neuropsychological testing. We examined whether a WMT dementia profile is a significant indicator of cognitive impairment and/or decline. In addition, we evaluated the classification accuracy for the clinical diagnosis of dementia. Elderly patients (n = 167) with cognitive complaints were given an extensive neuropsychological test battery, including the WMT. This was repeated 2 years later. The results demonstrate that patients with the dementia profile have a higher chance of showing real cognitive impairment at baseline, and even more so 2 years later. They showed a faster cognitive decline than patients who passed the WMT effort subtasks. Sensitivity of the profile was a moderate 60%. However, the positive predictive value was high, viz. 81% at baseline and 93% at follow-up.	[Rienstra, Anne; Twennaar, Michelle Klein; Schmand, Ben] Univ Amsterdam, Dept Brain & Cognit, NL-1018 XA Amsterdam, Netherlands; [Rienstra, Anne; Twennaar, Michelle Klein; Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands		Rienstra, A (corresponding author), Univ Amsterdam, Dept Brain & Cognit, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	a.rienstra@uva.nl			Psychology Research Institute of the University of Amsterdam; Department of Neurology of the Academic Medical Center of the University of Amsterdam; Department of Radiology of the Academic Medical Center of the University of Amsterdam; Graduate School of Neurosciences Amsterdam-Rotterdam	This study was financed by the Psychology Research Institute of the University of Amsterdam, the Departments of Neurology and Radiology of the Academic Medical Center of the University of Amsterdam, and the Graduate School of Neurosciences Amsterdam-Rotterdam.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; BICKART WT, 1991, AM J FORENSIC PSYCHO, V0009, P00003; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 1996, WORD MEMORY TEST USE; Green P., 2009, ADV INTERPRETATION P; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Hamster K., 1983, MULTILINGUAL APHASIA; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Jolles J., 1995, MAASTRICHT AGING STU; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Lim WS, 2007, CLIN MED RES, V5, P61, DOI 10.3121/cmr.2007.693; Lindeboom J, 2003, VISUAL ASS TEST; Luteijn F, 2004, GRONINGEN INTELLIGEN; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Miller L, 2001, NEUROREHABILITATION, V16, P109; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Schmand B, 2012, NORMEN PSYCHOL TESTS; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	45	14	15	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2013	28	5					463	475		10.1093/arclin/act026			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	186CN	WOS:000322019600008	23644672	Bronze			2022-02-06	
J	Zhou, HH; Ongodia, D; Liu, Q; Yang, RT; Li, ZB				Zhou, Hai-Hua; Ongodia, David; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing			Dental trauma in patients with maxillofacial fractures	DENTAL TRAUMATOLOGY			English	Article						dental trauma; maxillofacial fractures; prevalence	CONDYLE FRACTURES; MOUTHGUARD USE; INJURIES; ASSOCIATION; TURKEY	Purpose: The purpose of this study was to analyze and evaluate the correlation between dental injuries and the pattern of maxillofacial fractures. The correlation with age, gender, trauma mechanism and type of maxillofacial fracture was also investigated. Materials and methods: From January 2000 to December 2009, 1131 patients with facial fractures were registered. Of these, 473 presented with associated dental trauma. The information and data collected and analyzed included: age, gender, mechanism of injury, type of facial fracture, type of dental injury, and the relationship between dental injury and facial fracture. Results: Dental injury was sustained by 473 patients (41.8%), with a total of 2215 injured teeth. Of the 2215 injured teeth, 1191 (53.8%) were in the maxilla and 1024 (46.2%) in the mandible. Fall from a height had the highest risk of dental injuries (OR = 4.145, P = 0.002). The central incisor was the most injured tooth for both the maxilla (388, 36.2%) and mandible (284, 27.7%). The most common type of dental injury was avulsion (1070, 47.4%). More anterior teeth in the maxilla were of crown fracture, avulsion, and intrusion than that in the mandible, whereas more anterior teeth in the mandible were of subluxation and concussion than that in the maxilla. Dental injuries were more prone to occur in patients who sustained only symphysis fractures (OR = 2.817, P < 0.001), only 0.236-fold risk in patients who sustained only mandible angle fracture (P < 0.001). Conclusions: The occurrence of dental trauma is significantly related to the pattern and position of the maxillofacial fractures.	[Zhou, Hai-Hua; Ongodia, David; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Ongodia, David; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430079, Hubei, Peoples R China; [Zhou, Hai-Hua; Liu, Qi; Yang, Rong-Tao; Li, Zu-Bing] Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430079, Hubei, Peoples R China		Li, ZB (corresponding author), Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	lizubing0827@163.com	zhou, haihua/F-5179-2012	zhou, haihua/0000-0002-6838-0113			Andreasen J O, 1970, Scand J Dent Res, V78, P329; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Burden DJ, 1995, EUR J ORTHODONT, V17, P513, DOI 10.1093/ejo/17.6.513; da Silva AC, 2004, DENT TRAUMATOL, V20, P6, DOI 10.1111/j.1600-4469.2004.00212.x; Eyuboglu O, 2009, DENT TRAUMATOL, V25, P110, DOI 10.1111/j.1600-9657.2008.00668.x; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Gassner R, 1999, ORAL SURG ORAL MED O, V87, P27, DOI 10.1016/S1079-2104(99)70290-8; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Gutmann J L, 1995, Dent Clin North Am, V39, P1; IGNATIUS ET, 1992, ENDOD DENT TRAUMATOL, V8, P235; Kececi AD, 2005, DENT TRAUMATOL, V21, P76, DOI 10.1111/j.1600-9657.2004.00302.x; Lam R, 2008, DENT TRAUMATOL, V24, P663, DOI 10.1111/j.1600-9657.2008.00689.x; Levin L, 2003, DENT TRAUMATOL, V19, P237, DOI 10.1034/j.1600-9657.2003.00196.x; Lieger O, 2009, J ORAL MAXIL SURG, V67, P1680, DOI 10.1016/j.joms.2009.03.052; Ma WL, 2008, DENT TRAUMATOL, V24, P430, DOI 10.1111/j.1600-9657.2008.00586.x; OIKARINEN K, 1987, ENDOD DENT TRAUMATOL, V3, P220; SILVENNOINEN U, 1993, ENDOD DENT TRAUMATOL, V9, P254; Thoren H, 2010, INT J ORAL MAX SURG, V39, P774, DOI 10.1016/j.ijom.2010.03.024; Yamada T, 1998, ENDOD DENT TRAUMATOL, V14, P84	19	14	14	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	AUG	2013	29	4					285	290		10.1111/j.1600-9657.2012.01169.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	178GO	WOS:000321433900005	22783913				2022-02-06	
J	Fraisier, C; Camoin, L; Lim, S; Bakli, M; Belghazi, M; Fourquet, P; Granjeaud, S; Osterhaus, ADME; Koraka, P; Martina, B; Almeras, L				Fraisier, Christophe; Camoin, Luc; Lim, Stephanie; Bakli, Mahfoud; Belghazi, Maya; Fourquet, Patrick; Granjeaud, Samuel; Osterhaus, Ab D. M. E.; Koraka, Penelope; Martina, Byron; Almeras, Lionel			Altered Protein Networks and Cellular Pathways in Severe West Nile Disease in Mice	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TRAUMATIC BRAIN-INJURY; JAPANESE ENCEPHALITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; RNA PROFILING REVEALS; PLASMODIUM-FALCIPARUM; CEREBROSPINAL-FLUID; ARP2/3 COMPLEX; DENGUE-VIRUS; IN-VIVO	Background: The recent West Nile virus (WNV) outbreaks in developed countries, including Europe and the United States, have been associated with significantly higher neuropathology incidence and mortality rate than previously documented. The changing epidemiology, the constant risk of (re-)emergence of more virulent WNV strains, and the lack of effective human antiviral therapy or vaccines makes understanding the pathogenesis of severe disease a priority. Thus, to gain insight into the pathophysiological processes in severe WNV infection, a kinetic analysis of protein expression profiles in the brain of WNV-infected mice was conducted using samples prior to and after the onset of clinical symptoms. Methodology/Principal Findings: To this end, 2D-DIGE and gel-free iTRAQ labeling approaches were combined, followed by protein identification by mass spectrometry. Using these quantitative proteomic approaches, a set of 148 proteins with modified abundance was identified. The bioinformatics analysis (Ingenuity Pathway Analysis) of each protein dataset originating from the different time-point comparisons revealed that four major functions were altered during the course of WNV-infection in mouse brain tissue: i) modification of cytoskeleton maintenance associated with virus circulation; ii) deregulation of the protein ubiquitination pathway; iii) modulation of the inflammatory response; and iv) alteration of neurological development and neuronal cell death. The differential regulation of selected host protein candidates as being representative of these biological processes were validated by western blotting using an original fluorescence-based method. Conclusion/Significance: This study provides novel insights into the in vivo kinetic host reactions against WNV infection and the pathophysiologic processes involved, according to clinical symptoms. This work offers useful clues for anti-viral research and further evaluation of early biomarkers for the diagnosis and prevention of severe neurological disease caused by WNV.	[Fraisier, Christophe; Bakli, Mahfoud; Almeras, Lionel] IRBA, Armed Forces Biomed Res Inst, Inst Rech Biomed Armees, Unite Parasitol,URMITE UM 63, Marseille, France; [Camoin, Luc; Fourquet, Patrick; Granjeaud, Samuel] Aix Marseille Univ, Inserm,CNRS,CRCM, U1068,UMR7258, UM 105, Marseille, France; [Camoin, Luc; Fourquet, Patrick; Granjeaud, Samuel] Inst J Paoli I Calmettes, Marseille Prote, F-13009 Marseille, France; [Lim, Stephanie; Osterhaus, Ab D. M. E.; Koraka, Penelope; Martina, Byron] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Belghazi, Maya] Aix Marseille Univ, CNRS, UMR 7286, Marseille, France; [Almeras, Lionel] Aix Marseille Univ, Fac Med, WHO Collaborat Ctr Rickettsioses & Other Arthropo, URMITE,UM 63,CNRS 7278,IRD 198,Inserm 1095, Marseille, France		Almeras, L (corresponding author), IRBA, Armed Forces Biomed Res Inst, Inst Rech Biomed Armees, Unite Parasitol,URMITE UM 63, Marseille, France.	almeras.lionel@gmail.com	Camoin, Luc/AAB-3856-2019	Camoin, Luc/0000-0002-1230-4787; BAKLI, Mahfoud/0000-0002-1427-2985; Granjeaud, Samuel/0000-0001-9245-1535; ALMERAS, Lionel/0000-0003-0490-5774; Martina, Byron/0000-0003-4980-4619	European CommunityEuropean Commission [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the project "VECTORIE", EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060; Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Almeras L, 2004, PROTEOMICS, V4, P2184, DOI 10.1002/pmic.200300732; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Beasley DWC, 2001, ANN NY ACAD SCI, V951, P332; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Bin H, 2001, ANN NY ACAD SCI, V951, P127; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Bourgeois MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024371; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Cepeda V, 2011, CELL MICROBIOL, V13, P846, DOI 10.1111/j.1462-5822.2011.01583.x; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Del Giudice P, 2004, EMERG INFECT DIS, V10, P1885, DOI 10.3201/eid1010.031021; Dhingra V, 2005, J BIOMED BIOTECHNOL, P271, DOI 10.1155/JBB.2005.271; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Feart C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029480; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Gnanapavan S, 2010, J NEUROIMMUNOL, V225, P118, DOI 10.1016/j.jneuroim.2010.04.020; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Grummer B, 2004, J VET MED B, V51, P427, DOI 10.1111/j.1439-0450.2004.00798.x; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; He XL, 2010, INT J CLIN EXP PATHO, V3, P156; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hoe HS, 2012, CNS NEUROSCI THER, V18, P47, DOI 10.1111/j.1755-5949.2010.00221.x; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49; Kobayashi S, 2012, NEUROPATHOLOGY, V32, P398, DOI 10.1111/j.1440-1789.2011.01275.x; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kong KF, 2008, VIRAL IMMUNOL, V21, P78, DOI 10.1089/vim.2007.0072; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; LANFORD RE, 1994, VIROLOGY, V202, P606, DOI 10.1006/viro.1994.1381; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Li S, 2010, BBA-PROTEINS PROTEOM, V1804, P1882, DOI 10.1016/j.bbapap.2010.05.011; Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811; Lin RJ, 2004, J VIROL, V78, P9285, DOI 10.1128/JVI.78.17.9285-9294.2004; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06; McCarthy Derrick P, 2012, Methods Mol Biol, V900, P381, DOI 10.1007/978-1-60761-720-4_19; McGinnis KM, 1998, J BIOL CHEM, V273, P19993, DOI 10.1074/jbc.273.32.19993; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Okuma Y, 2012, ANN NEUROL; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Papa A, 2010, EURO SURVEILL, V15; Parquet MD, 2001, FEBS LETT, V500, P17, DOI 10.1016/S0014-5793(01)02573-X; Passali D, 2012, ACTA OTORHINOLARYNGO, V32, P46; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006; Rossman JS, 2012, J VIROL, V86, P10950, DOI 10.1128/JVI.05992-11; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Smithburn K.C., 1940, AM J TROP MED HYG, V1, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tian Zuo-jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P250; Togashi H, 2009, CELL ADHES MIGR, V3, P29, DOI 10.4161/cam.3.1.6773; Torrentino-Madamet M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-4; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Tseng YF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-20; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang W, 2012, NEUROCHEM RES, V37, P819, DOI 10.1007/s11064-011-0677-x; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Whitaker JN, 1998, MULT SCLER J, V4, P16, DOI 10.1191/135245898678909123; Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224; Zakharov VV, 2001, NEUROSCI RES, V39, P447, DOI 10.1016/S0168-0102(01)00201-2; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zheng J, 2011, ANAL CHIM ACTA, V702, P149, DOI 10.1016/j.aca.2011.06.045	130	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68318	10.1371/journal.pone.0068318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	WOS:000321765300041	23874584	Green Submitted, Green Published, gold			2022-02-06	
J	Brandner, S; Thaler, C; Buchfelder, M; Kleindienst, A				Brandner, Sebastian; Thaler, Christian; Buchfelder, Michael; Kleindienst, Andrea			Brain-Derived Protein Concentrations in the Cerebrospinal Fluid: Contribution of Trauma Resulting from Ventricular Drain Insertion	JOURNAL OF NEUROTRAUMA			English	Article						Beta-Trace; biomarker; neuroproteins; neurotrauma; NSE; S100B; ventricular drain	NEURON-SPECIFIC ENOLASE; BETA-TRACE PROTEIN; S-100 PROTEIN; SUBARACHNOID HEMORRHAGE; POTENTIAL MARKER; S100B; SERUM; DYNAMICS; DAMAGE	In recent years, the measurement of biomarkers following neurotrauma assisted in improving outcome prediction and guiding therapy. The use of neuroproteins as diagnostic parameters requires a detailed knowledge of their dynamics in biological fluids for an appropriate interpretation. S100B is the most widely studied neuromarker, and its concentration in serum and cerebrospinal fluid (CSF) reflects the extent of brain damage. Neuron-specific enolase (NSE) is considered reflecting neuronal damage, while Beta-Trace is a lepto-meningeal protein used to diagnose CSF leakage. In five patients treated with an external ventricular drain (EVD) because of aneurysmal subarachnoid hemorrhage (SAH, n = 3) or postinfectious hydrocephalus (n = 2), an EVD exchange was performed 8 to 12 days after initial insertion. S100B and NSE were measured with the Cobas e411 (R) electrochemiluminescence assay (Roche Diagnostics, Mannheim, Germany) and Beta-Trace with the BN Pro Spec (R) nephelometer (Dade Behring/Siemens, Germany) 1 h before EVD exchange, upon the insertion of the new drain, and 1, 3, 6, 12, 18, 24 and 48 h after EVD exchange. Before EVD exchange, S100B CSF concentrations were within the normal range in all patients (1.48 +/- 0.37 mu g/L), while NSE CSF concentrations were normal in four of five patients (6.51 +/- 2.98 mu g/L). Following EVD exchange, S100B and NSE CSF levels peaked significantly at 3 h after insertion of the new drain (S100B 39.02 +/- 9.17 mu g/L; NSE 54.80 +/- 43.34 mu g/L). S100B serum levels were slightly increased 6 to 24 h after EVD exchange. Beta-Trace concentrations in the CSF were not altered by EVD insertion. Our data demonstrate that EVD insertion results in a distinct increase of S100B and NSE concentrations in the CSF. Thus, the tampering of brain-derived protein concentrations in the CSF by diagnostic or therapeutic procedures has to be considered in the interpretation of neuromarker levels.	[Brandner, Sebastian; Thaler, Christian; Buchfelder, Michael; Kleindienst, Andrea] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany		Kleindienst, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, D-91054 Erlangen, Germany.	andrea.kleindienst@uk-erlangen.de	Brandner, Sebastian/AAU-2615-2021; Kleindienst, Andrea/F-1674-2014; Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-8635-7195; Kleindienst, Andrea/0000-0003-4758-0324; Brandner, Sebastian/0000-0002-9821-0342	Kuratorium ZNS-Hannelore Kohl Stiftung	This work was partially supported by the Kuratorium ZNS-Hannelore Kohl Stiftung.	[Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brandner S, 2012, Acta Neurochir Suppl, V114, P217, DOI 10.1007/978-3-7091-0956-4_42; HARDEMARK HG, 1989, ACTA NEUROCHIR, V99, P135, DOI 10.1007/BF01402322; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; JACOBI C, 1988, CLIN CHIM ACTA, V177, P49, DOI 10.1016/0009-8981(88)90306-3; Kirchhoff C, 2008, EUR J MED RES, V13, P511; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1997, CLIN CHEM, V43, P541; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; Reiber H, 2003, ACTA NEUROL SCAND, V108, P359, DOI 10.1034/j.1600-0404.2003.00173.x; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Woertgen C, 2004, NEUROSURG REV, V27, P178, DOI 10.1007/s10143-004-0341-x	26	14	16	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1205	1210		10.1089/neu.2012.2621			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400012	23390981				2022-02-06	
J	Harris, NG; Chen, SF; Pickard, JD				Harris, Neil G.; Chen, Szu-Fu; Pickard, John D.			Cortical Reorganization after Experimental Traumatic Brain Injury: A Functional Autoradiography Study	JOURNAL OF NEUROTRAUMA			English	Article						autoradiography; blood flow; cortical contusion injury; plasticity	CEREBRAL-BLOOD-FLOW; FORELIMB SENSORIMOTOR CORTEX; PRIMARY SOMATOSENSORY CORTEX; MOTOR CORTEX; BEHAVIORAL RECOVERY; NEOCORTICAL DAMAGE; EVOKED-POTENTIALS; AXONAL INJURY; ADULT-RATS; STROKE	Cortical sensorimotor (SM) maps are a useful readout for providing a global view of the underlying status of evoked brain function, as well as a gross overview of ongoing mechanisms of plasticity. Recent evidence in the rat controlled cortical impact (CCI) injury model shows that the ipsilesional (injured) hemisphere is temporarily permissive for axon sprouting. This would predict that size and spatial alterations in cortical maps may occur much earlier than previously tested and that they might be useful as potential markers of the postinjury plasticity period as well as indicators of outcome. We investigated the evolution of changes in brain activation evoked by affected hindlimb electrical stimulation at 4, 7, and 30 days following CCI or sham injury over the hindlimb cortical region of adult rats. [C-14]-iodoantipyrine autoradiography was used to quantitatively examine the local cerebral blood flow changes in response to hindlimb stimulation as a marker for neuronal activity. The results show that although ipsilesional hindlimb SM activity was persistently depressed from 4 days, additional novel regions of ipsilesional activity appeared concurrently within SM barrel and S2 regions as well as posterior auditory cortex. Simultaneously with this was the appearance of evoked activity within the intact, contralesional cortex that was maximal at 4 and 7 days, compared to stimulated sham-injured rats, where activation was solely unilateral. By 30 days, however, contralesional activation had greatly subsided and existing ipsilesional activity was enhanced within the same novel cortical regions that were identified acutely. These data indicate that significant reorganization of the cortical SM maps occurs after injury that evolves with a particular postinjury time course. We discuss these data in terms of the known mechanisms of plasticity that are likely to underlie these map changes, with particular reference to the differences and similarities that exist between rodent models of stroke and traumatic brain injury.	[Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Pickard, John D.] Univ Cambridge, Cambridge Ctr Brain Repair, Neurosurg Unit, Cambridge, England; [Pickard, John D.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England		Harris, NG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA.	ngharris@mednet.ucla.edu		Harris, Neil/0000-0002-1965-6750	National Institutes of Health/National Institute of Neurological Disorders and Stroke award [NS055910]; UCLA Brain Injury Research Center; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G9439390, G0001237, G0001354, G1000183B, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055910] Funding Source: NIH RePORTER	This work was supported by a National Institutes of Health/National Institute of Neurological Disorders and Stroke award (#NS055910) and the UCLA Brain Injury Research Center.	Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Cho YR, 2007, MAGN RESON MED, V58, P901, DOI 10.1002/mrm.21408; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; Emery DL, 2000, J COMP NEUROL, V424, P521; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Harris N., 2010, J NEUROTRAUM, V27, P1; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harris N.G., 2011, 25 INT S CER BLOOD F; Harris N, 2009, J NEUROTRAUM, V26, pA37; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hillier SL, 1997, BRAIN INJURY, V11, P661; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Luke LM, 2004, SYNAPSE, V54, P187, DOI 10.1002/syn.20080; Maggiolini E, 2008, EUR J NEUROSCI, V27, P2733, DOI 10.1111/j.1460-9568.2008.06248.x; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nordin M, 1995, J PHYSIOL-LONDON, V489, P885, DOI 10.1113/jphysiol.1995.sp021101; OHTA M, 1989, COMP BIOCHEM PHYS A, V94, P99, DOI 10.1016/0300-9629(89)90791-3; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924, DOI 10.1152/ajpheart.2000.279.3.H924; Rasband W. S, 2008, IMAGEJ; Rema V, 2003, J NEUROSCI, V23, P10378; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Roy C S, 1890, J Physiol, V11, P85; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; SHAW NA, 1986, J NEUROL SCI, V74, P257, DOI 10.1016/0022-510X(86)90111-5; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Verley D., 2011, J NEUROTRAUM, V28, p[A, P220]; Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502	64	14	14	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1137	1146		10.1089/neu.2012.2785			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400005	23305562	Green Published			2022-02-06	
J	Heath, CJ; Callahan, JL				Heath, Christopher J.; Callahan, Jennifer L.			Self-Reported Concussion Symptoms and Training Routines in Mixed Martial Arts Athletes	RESEARCH IN SPORTS MEDICINE			English	Article						athletic injuries; brain injury; concussion	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; AMATEUR; PERFORMANCE; COHORT; SCHOOL; RISK	Mixed martial arts (MMA) is a full-contact, fighting sport that has risen in popularity over recent years, resulting in an increase in both training facilities and sport participants. To date, little research has examined the complications and vulnerability to head trauma, or concussive symptomatology, in MMA athletes. In this study, we assessed relationships between training routines and concussive symptoms, as well as medical care, in MMA athletes. A sample (N=119) of MMA athletes reported concussive symptoms, training routines, and medical histories through an online survey. Nearly 15% of the MMA athletes reported history of a knockout, and nearly one-third reported a technical knockout. Subjective ratings of concussive symptoms were high for these athletes, with many of them waiting only a brief time after such incidents to return to competition. These findings have important implications for informing the medical treatment and safety decision for returning to participation for these athletes.	[Heath, Christopher J.; Callahan, Jennifer L.] Univ N Texas, Dept Psychol, Denton, TX 76203 USA		Heath, CJ (corresponding author), Univ N Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	christopher-heath@my.unt.edu		Callahan, Jennifer/0000-0001-9190-3886			Amtmann J. A., 2008, J STRENGTH COND RES, V18, P194; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2009, J INT NEUROPSYCH SOC, V15, P509, DOI 10.1017/S1355617709090936; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Loosemore M, 2008, BRIT J SPORT MED, V42, P864, DOI 10.1136/bmj.39342.690220.55; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Nevada Department of Business and Industry Nevada State Athletic Commission, 2011, 467427 NAC NEV DEP B; Nevada Department of Business and Industry Nevada State Athletic Commission, 2011, 4674748 NAC NEV DEP; New Jersey State Athletic Control Board, 2011, TYP BOUT RES; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924	23	14	14	0	33	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	JUL 1	2013	21	3					195	203		10.1080/15438627.2013.792082			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	166PT	WOS:000320570300001	23777375				2022-02-06	
J	Soliman, ML; Ohm, JE; Rosenberger, TA				Soliman, Mahmoud L.; Ohm, Joyce E.; Rosenberger, Thad A.			Acetate Reduces PGE(2) Release and Modulates Phospholipase and Cyclooxygenase Levels in Neuroglia Stimulated with Lipopolysaccharide	LIPIDS			English	Article						Phospholipase; Cyclooxygenase; Eicosanoid; Acetate; Histone acetylation	HISTONE DEACETYLASE INHIBITORS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; RAT MODEL; MOUSE MODEL; NUCLEOSOMAL DNA; A(2); ACETYLATION	Acetate supplementation attenuates neuroglial activation, increases histone and non-histone protein acetylation, reduces pro-inflammatory cytokine expression, and increases IL-4 transcription in rat models of neuroinflammation and Lyme's neuroborreliosis. Because eicosanoid signaling is involved in neuroinflammation, we measured the effect acetate treatment had on phospholipase, cyclooxygenase, and prostaglandin E-2 (PGE(2)) levels in BV-2 microglia and primary astrocytes stimulated with lipopolysaccharide (LPS). In BV-2 microglia, we found that LPS increased the phosphorylation-state of cytosolic phospholipase A(2) (cPLA(2)), reduced the levels of phospholipase C (PLC) beta 1, and increased the levels of cyclooxygenase (Cox)-1 and -2. Acetate treatment returned PLC beta 1 and Cox-1 levels to normal, attenuated the increase in Cox-2, but had no effect on cPLA(2) phosphorylation. In primary astrocytes, LPS increased the phosphorylation of cPLA(2) and increased the levels of Cox-1 and Cox-2. Acetate treatment in these cells reduced secretory PLA(2) IIA and PLC beta 1 levels as compared to LPS-treatment groups, reversed the increase in cPLA(2) phosphorylation, and returned Cox-1 levels to normal. Acetate treatment reduced PGE(2) release in astrocytes stimulated with LPS to control levels, but did not alter PGE(2) levels in BV-2 microglia. The amount of acetylated H3K9 bound to the promoter regions of Cox-1, Cox-2, IL-1 beta and NF-kappa B p65 genes, but not IL-4 in were increased in BV-2 microglia treated with acetate. These data suggest that acetate treatment can disrupt eicosanoid signaling in neuroglia that may, in part, be the result of altering gene expression due chromatin remodeling as a result of increasing H3K9 acetylation.	[Soliman, Mahmoud L.; Rosenberger, Thad A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Ohm, Joyce E.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58203 USA		Rosenberger, TA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, 501 North Columbia Rd,Room 3742, Grand Forks, ND 58203 USA.	thad.rosenberger@med.und.edu		Rosenberger, Thad/0000-0001-6360-4977	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P20RR17699, P30GM103329]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES022030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103329] Funding Source: NIH RePORTER	This work was funded by grants from the National Institutes of Health (2P20RR17699 and P30GM103329). We would like to thank Kendra L. Puig and Dr. Colin K. Combs (University of North Dakota School of Medicine and Health Sciences) for providing primary astrocytes and BV-2 microglia.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Adibhatla RM, 2007, BRAIN RES, V1134, P199, DOI 10.1016/j.brainres.2006.11.080; Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Anthonsen MW, 2001, J BIOL CHEM, V276, P30527, DOI 10.1074/jbc.M008481200; Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Balboa MA, 2002, FEBS LETT, V531, P12, DOI 10.1016/S0014-5793(02)03481-6; Bhatt DP, 2013, NEUROCHEM INT, V62, P296, DOI 10.1016/j.neuint.2013.01.004; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Brissette CA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-249; Casolini P, 2002, J NEUROSCI RES, V68, P337, DOI 10.1002/jnr.10192; da Silva PF, 2012, NEUROSCIENCE, V200, P42, DOI 10.1016/j.neuroscience.2011.10.038; Lima IVD, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/946813; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Farooqui AA, 2005, REPROD NUTR DEV, V45, P613, DOI 10.1051/rnd:2005049; Farooqui AA, 1997, J NEUROCHEM, V69, P889; FUJIMORI Y, 1992, J BIOCHEM-TOKYO, V111, P54, DOI 10.1093/oxfordjournals.jbchem.a123718; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Grinberg S, 2009, AM J PATHOL, V175, P2439, DOI 10.2353/ajpath.2009.090290; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Hiller G, 1999, CELL SIGNAL, V11, P863, DOI 10.1016/S0898-6568(99)00058-3; Jupp OJ, 2003, BIOCHEM J, V374, P453, DOI 10.1042/BJ20030705; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; LAURITZEN I, 1994, BRAIN RES, V651, P353, DOI 10.1016/0006-8993(94)90719-6; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Mu Changjun, 2007, Mol Biol (Mosk), V41, P395; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Reisenauer CJ, 2011, J NEUROCHEM, V117, P264, DOI 10.1111/j.1471-4159.2011.07198.x; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soliman ML, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-51; Soliman ML, 2013, J NEUROIMMUNE PHARM, V8, P287, DOI 10.1007/s11481-012-9426-4; Soliman ML, 2012, J NEUROCHEM, V123, P555, DOI 10.1111/j.1471-4159.2012.07955.x; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Yermakova A, 2000, CURR PHARM DESIGN, V6, P1755, DOI 10.2174/1381612003398672; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	58	14	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4201	1558-9307		LIPIDS	Lipids	JUL	2013	48	7					651	662		10.1007/s11745-013-3799-x			12	Biochemistry & Molecular Biology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Nutrition & Dietetics	170OD	WOS:000320861600001	23709104	Green Accepted			2022-02-06	
J	Abrahamson, EE; Foley, LM; DeKosky, ST; Hitchens, TK; Ho, C; Kochanek, PM; Ikonomovic, MD				Abrahamson, Eric E.; Foley, Lesley M.; DeKosky, Steven T.; Hitchens, T. Kevin; Ho, Chien; Kochanek, Patrick M.; Ikonomovic, Milos D.			Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Alzheimer's disease; amyloid; arterial spin-labeling MRI; blood flow; brain injury; statin	TRAUMA-INDUCED INCREASES; NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; FUNCTIONAL HYPEREMIA; REDUCTASE INHIBITORS; OXIDATIVE STRESS; SIMVASTATIN; ACTIVATION	Traumatic brain injury (TBI) is an environmental risk factor for Alzheimer's disease (AD). Increased brain concentrations of amyloid-beta (A beta) peptides and impaired cerebral blood flow (CBF) are shared pathologic features of TBI and AD and promising therapeutic targets. We used arterial spin-labeling magnetic resonance imaging to examine if CBF changes after TBI are influenced by human A beta and amenable to simvastatin therapy. CBF was measured 3 days and 3 weeks after controlled cortical impact (CCI) injury in transgenic human A beta-expressing APP(NLh/NLh) mice compared to murine A beta-expressing C57Bl/6J wild types. Compared to uninjured littermates, CBF was reduced in the cortex of the injured hemisphere in both A beta transgenics and wild types; deficits were more pronounced in the transgenic group, which exhibited injury-induced increased concentrations of human A beta. In the hemisphere contralateral to CCI, CBF levels were stable in A beta transgenic mice but increased in wild-type mice, both relative to uninjured littermates. Post-injury treatment of A beta transgenic mice with simvastatin lowered brain A beta concentrations, attenuated deficits in CBF ipsilateral to injury, restored hyperemia contralateral to injury, and reduced brain tissue loss. Future studies examining long-term effects of simvastatin therapy on CBF and chronic neurodegenerative changes after TBI are warranted.	[Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Foley, Lesley M.; Hitchens, T. Kevin; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, VA Pittsburgh Healthcare Syst, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [DeKosky, Steven T.] Univ Virginia, Sch Med, Off Dean, Charlottesville, VA 22908 USA; [DeKosky, Steven T.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA		Ikonomovic, MD (corresponding author), Univ Pittsburgh, Dept Neurol, BSTWR S-521,200 Lothrop St, Pittsburgh, PA 15213 USA.	ikonomovicmd@upmc.edu	Ho, Chien/O-6112-2016; Kochanek, Patrick M/D-2371-2015	Ho, Chien/0000-0002-4094-9232; Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 NS30318]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41-EB001977]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB001977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER	Supported by NIH P50 NS30318. The Pittsburgh NMR Center for Biomedical Research is supported by a grant from the National Institutes of Health (P41-EB001977). We acknowledge expert technical assistance provided by Mr. William Paljug, Mr. John Melick, and Ms. Lan Shao.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dietrich HH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-15; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iadecola C, 2003, CELL MOL NEUROBIOL, V23, P681, DOI 10.1023/A:1025092617651; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Laufs U, 2000, TRENDS CARDIOVAS MED, V10, P143, DOI 10.1016/S1050-1738(00)00044-X; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Nagaoka T, 2007, INVEST OPHTH VIS SCI, V48, P825, DOI 10.1167/iovs.06-0856; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Reaume AG, 1996, J BIOL CHEM, V271, P23380, DOI 10.1074/jbc.271.38.23380; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Suo ZM, 1998, NEUROSCI LETT, V257, P77, DOI 10.1016/S0304-3940(98)00814-3; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tong XK, 2009, NEUROBIOL DIS, V35, P406, DOI 10.1016/j.nbd.2009.06.003; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9	37	14	16	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2013	33	6					826	833		10.1038/jcbfm.2013.24			8	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	156KP	WOS:000319821100005	23443172	Green Published, Bronze			2022-02-06	
J	Law, AS; Trawley, SL; Brown, LA; Stephens, AN; Logie, RH				Law, Anna S.; Trawley, Steven L.; Brown, Louise A.; Stephens, Amanda N.; Logie, Robert H.			The impact of working memory load on task execution and online plan adjustment during multitasking in a virtual environment	QUARTERLY JOURNAL OF EXPERIMENTAL PSYCHOLOGY			English	Article						Multitasking; Planning; Working memory; Dual task; Executive function	TRAUMATIC BRAIN-INJURY; STRATEGY APPLICATION DISORDER; MULTIPLE ERRANDS TEST; ECOLOGICAL VALIDITY; SIMPLIFIED VERSION; INNER SPEECH; LONDON TASK; CAPACITY; PERFORMANCE; GENERATION	Three experiments investigated the impact of working memory load on online plan adjustment during a test of multitasking in young, nonexpert, adult participants. Multitasking was assessed using the Edinburgh Virtual Errands Test (EVET). Participants were asked to memorize either good or poor plans for performing multiple errands and were assessed both on task completion and on the extent to which they modified their plans during EVET performance. EVET was performed twice, with and without a secondary task loading a component of working memory. In Experiment 1, articulatory suppression was used to load the phonological loop. In Experiment 2, oral random generation was used to load executive functions. In Experiment 3, spatial working memory was loaded with an auditory spatial localization task. EVET performance for both good- and poor-planning groups was disrupted by random generation and sound localization, but not by articulatory suppression. Additionally, people given a poor plan were able to overcome this initial disadvantage by modifying their plans online. It was concluded that, in addition to executive functions, multiple errands performance draws heavily on spatial, but not verbal, working memory resources but can be successfully completed on the basis of modifying plans online, despite a secondary task load.	[Law, Anna S.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Trawley, Steven L.] Natl Univ Ireland Univ Coll Cork, Sch Med, Ctr Gerontol & Rehabil, Cork, Ireland; [Brown, Louise A.] Nottingham Trent Univ, Div Psychol, Nottingham, England; [Stephens, Amanda N.] Natl Univ Ireland Univ Coll Cork, Sch Appl Psychol, Cork, Ireland; [Logie, Robert H.] Univ Edinburgh, Edinburgh, Midlothian, Scotland		Law, AS (corresponding author), Liverpool John Moores Univ, Tom Reilly Bldg,Byrom St, Liverpool L3 3AF, Merseyside, England.	a.law@ljmu.ac.uk	Logie, Robert H/C-6965-2009; Trawley, Steven/C-3261-2018; Stephens, Amanda/C-4857-2018	Trawley, Steven/0000-0002-0917-730X; Stephens, Amanda/0000-0002-4118-4972; Law, Anna/0000-0002-0926-1309; Brown Nicholls, Louise A./0000-0003-3520-6175; Logie, Robert/0000-0003-4532-9312	Leverhulme TrustLeverhulme Trust [F/00 158/W]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K026992/1] Funding Source: researchfish	We are grateful to Matthew Logie for undertaking the programming to create the Edinburgh Virtual Errands Test (EVET) environment. We acknowledge Leverhulme Trust Research Grant F/00 158/W, which supported the research that we report here.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; BADDELEY A, 1984, Q J EXP PSYCHOL-A, V36, P233, DOI 10.1080/14640748408402157; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Baumann O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019707; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Cowan N., 2005, WORKING MEMORY CAPAC; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; Crepeau F, 1996, BRAIN COGNITION, V32, P266; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Deyzac E, 2006, BRIT J PSYCHOL, V97, P217, DOI 10.1348/000712605X67484; Emerson MJ, 2003, J MEM LANG, V48, P148, DOI 10.1016/S0749-596X(02)00511-9; EVANS FJ, 1978, B PSYCHONOMIC SOC, V12, P35; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Garden S, 2002, APPL COGNITIVE PSYCH, V16, P35, DOI 10.1002/acp.746; Garden SE, 2001, NEUROPSYCHOLOGY, V15, P472, DOI 10.1037//0894-4105.15.4.472; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; Hambrick DZ, 2010, APPL COGNITIVE PSYCH, V24, P1149, DOI 10.1002/acp.1624; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Law A. S., 2004, THESIS U ABERDEEN AB; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; Law AS, 2004, ACTA PSYCHOL, V116, P285, DOI 10.1016/j.actpsy.2004.04.003; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Logie R. H., 1995, VISUOSPATIAL WORKING; Logie R. H., 2012, MENTAL IMAGERY SPATI, P77; Logie RH, 2011, CURR DIR PSYCHOL SCI, V20, P240, DOI 10.1177/0963721411415340; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Logie RH, 2010, PSYCHOL BELG, V50, P309, DOI 10.5334/pb-50-3-4-309; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; Miyake A, 2004, ACTA PSYCHOL, V115, P123, DOI 10.1016/j.actpsy.2003.12.004; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MURRAY DJ, 1965, Q J EXP PSYCHOL, V17, P47, DOI 10.1080/17470216508416407; Phillips LH, 2001, Q J EXP PSYCHOL-A, V54, P579, DOI 10.1080/02724980042000237; Phillips LH, 1999, MEMORY, V7, P209, DOI 10.1080/741944066; Rajendran G, 2011, J AUTISM DEV DISORD, V41, P1445, DOI 10.1007/s10803-010-1151-3; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Saito S, 2008, J MEM LANG, V59, P1, DOI 10.1016/j.jml.2008.01.004; Shah, 1999, MODELS WORKING MEMOR, DOI DOI 10.1017/CBO9781139174909.005; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Towse JN, 1998, BEHAV RES METH INS C, V30, P583, DOI 10.3758/BF03209475; Trawley SL, 2011, Q J EXP PSYCHOL, V64, P2181, DOI 10.1080/17470218.2011.584976; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104	45	14	16	0	31	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1747-0218	1747-0226		Q J EXP PSYCHOL	Q. J. Exp. Psychol.	JUN 1	2013	66	6					1241	1258		10.1080/17470218.2012.748813			18	Psychology, Biological; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Physiology	152SW	WOS:000319552400014	23234420	Green Submitted			2022-02-06	
J	Li, XJ; Han, H; Hou, RL; Wei, LY; Wang, GH; Li, CK; Li, DL				Li, Xinjuan; Han, Hua; Hou, Ruanling; Wei, Linyu; Wang, Guohong; Li, Chaokun; Li, Dongliang			Progesterone treatment before experimental hypoxia-ischemia enhances the expression of glucose transporter proteins GLUT1 and GLUT3 in neonatal rats	NEUROSCIENCE BULLETIN			English	Article						hypoxic-ischemic injury; progesterone; GLUT1; GLUT3; stroke	INDUCED DIABETIC-RATS; BLOOD-BRAIN-BARRIER; 17 BETA-ESTRADIOL; GLUCOSE-TRANSPORTER-1 EXPRESSION; CEREBRAL-CORTEX; GROWTH-FACTOR; INSULIN; STROKE; NEURONS; INJURY	Progesterone is an efficient candidate for treating stroke and traumatic brain damage. The current study was designed to investigate the effects of progesterone on glucose transporter proteins (GLUT1 and GLUT3) during hypoxic-ischemic injury in a neonatal rat model. We demonstrated strong staining for GLUT1 in the walls of blood vessels and GLUT3 immunoreactivity in hippocampal neurons after hypoxiaischemia. Hypoxia-ischemia elevated GLUT1 and GLUT3 at both the mRNA and protein levels in the hippocampus, and pre-treatment with progesterone (8 mg/kg) further enhanced their accumulation until 24 h after hypoxic-ischemic injury. These results showed that progesterone treatment induced the accumulation of both GLUT1 and GLUT3 transporters, and an energy-compensation mechanism may be involved in the neuroprotective effect of progesterone during hypoxic-ischemic injury after cerebral ischemic attacks.	[Li, Xinjuan; Han, Hua; Hou, Ruanling; Wei, Linyu; Wang, Guohong; Li, Chaokun; Li, Dongliang] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang 453003, Peoples R China; [Li, Dongliang] Henan Key Lab Biol Psychiat, Xinxiang 453002, Peoples R China; [Han, Hua] Cent Hosp Xinxiang City, Dept Ultrason Diag, Xinxiang 453000, Peoples R China		Li, CK (corresponding author), Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang 453003, Peoples R China.	lichaokun@hotmail.com; xyldl8@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100912]; Science Foundation of Xinxiang Medical University, China [2009-63]; Science and Technology Project of Henan Province, China [092102310098]	This work was supported by the National Natural Science Foundation of China (81100912), the Science Foundation of Xinxiang Medical University, China (CL and ZD 2009-63) and the Science and Technology Project of Henan Province, China (092102310098).	Abdul Muneer P M, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P48; Balietti M, 2010, AGEING RES REV, V9, P273, DOI 10.1016/j.arr.2010.02.003; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Chavez JC, 2002, J NEUROSCI, V22, P8922; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duarte AI, 2005, FREE RADICAL BIO MED, V39, P876, DOI 10.1016/j.freeradbiomed.2005.05.002; Espinoza-Rojo Monica, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P317; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Iwabuchi S, 2011, NEUROCHEM INT, V59, P319, DOI 10.1016/j.neuint.2011.06.006; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Lawrence MS, 1996, J CEREBR BLOOD F MET, V16, P181, DOI 10.1097/00004647-199603000-00001; Li SY, 2010, FREE RADICAL BIO MED, V48, P597, DOI 10.1016/j.freeradbiomed.2009.12.004; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Ordonez P, 2007, EXP PHYSIOL, V92, P241, DOI 10.1113/expphysiol.2006.035006; Shi J, 1997, AM J PHYSIOL-ENDOC M, V272, pE1016, DOI 10.1152/ajpendo.1997.272.6.E1016; Shi J, 1997, EXP BRAIN RES, V117, P200, DOI 10.1007/s002210050216; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Urabe T, 1996, J NEUROCHEM, V67, P265; VARGADEFTERDAROVIC L, 1992, INT J PEPT PROT RES, V39, P12; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	28	14	16	1	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067			NEUROSCI BULL	Neurosci. Bull.	JUN	2013	29	3					287	294		10.1007/s12264-013-1298-y			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149ZG	WOS:000319359400004	23307114	Green Published			2022-02-06	
J	Ozturk, G; Cengiz, N; Erdogan, E; Him, A; Oguz, EK; Yenidunya, E; Aysit, N				Ozturk, G.; Cengiz, N.; Erdogan, E.; Him, A.; Oguz, E. K.; Yenidunya, E.; Aysit, N.			Two distinct types of dying back axonal degeneration in vitro	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						axotomy; caspase; degeneration; dying back; laser; neurone death	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; NEURITE TRANSECTION; SCHWANN-CELLS; II-SPECTRIN; CROSS-TALK; ADULT-RAT; CALPAIN; NEURONS; CALCIUM	G. ozturk, N. Cengiz, E. Erdoan, A. Him, E. K. Ouz, E. Yenidunya and N. Ayit (2013) Neuropathology and Applied Neurobiology39, 362376 Two distinct types of dying back axonal degeneration in vitro Aims: In many neurodegenerative diseases and following traumas, dying back degeneration is a common phenomenon that aggravates the pathology and may eventually lead to death of the affected neurone. We aimed to investigate the mechanism of dying back degeneration with an in vitro axonal injury model. Methods: We cultured adult mouse dorsal root ganglion neurones and with a precise laser beam, cut the axons they extended. Preparations were imaged continuously and images were analysed to describe and quantify ensuing events. Potential contributions of calpains and caspases to the degeneration were explored using specific inhibitors and immunohistochemistry. In vivo implications of the results were sought in nerve sections after sciatic nerve cut. Results: The proximal part of the transected axons went under basically two types of dying back degeneration, fragmentation and retraction. In fragmentation the cytoplasm became condensed and with concomitant axial collapse the axon disintegrated into small pieces. In retraction, the severed axon was pulled back to the soma in an organized manner. We demonstrated that fragmentation was associated with a high risk of cell death, while survival rate with retraction was as high as those of uninjured neurones. Regeneration of transected axon was more likely after retraction than following fragmentation. Activities of caspase-3 and calpains but not of caspase-6 were found linked with retraction and regeneration but not with the fragmentation. Conclusions: This study describes two quite distinct types of dying back degeneration that lead an injured neurone to quite different fates.	[Ozturk, G.; Aysit, N.] Istanbul Medipol Univ, Sch Med, Dept Physiol, TR-34083 Istanbul, Turkey; [Cengiz, N.] Yuzuncu Yil Univ, Sch Med, Dept Histol & Embryol, Van, Turkey; [Erdogan, E.] Selcuk Univ, Sch Med, Dept Histol & Embryol, Konya, Turkey; [Him, A.] Ondokuz Mayis Univ, Sch Med, Dept Biophys, Samsun, Turkey; [Oguz, E. K.] Yuzuncu Yil Univ, Fac Educ, Dept Sci Educ, Van, Turkey; [Yenidunya, E.] Yuzuncu Yil Univ, Fac Sci, Dept Biol, Van, Turkey		Ozturk, G (corresponding author), Istanbul Medipol Univ, Ataturk Bulv 27, TR-34083 Istanbul, Turkey.	gozturk@medipol.edu.tr	Him, Aydin/B-4728-2018; Cengiz, Nureddin/A-4949-2018; Ozturk, Gurkan/AAE-1401-2019; Ozturk, Gurkan/C-7035-2018	Cengiz, Nureddin/0000-0002-2486-5901; Ozturk, Gurkan/0000-0003-0352-1947; KAVAL OGUZ, Elif/0000-0003-0196-2693	Yuzuncu Yil University Directorate of Scientific Research ProjectsYuzuncu Yil University [TF073]	This study was supported by Yuzuncu Yil University Directorate of Scientific Research Projects with the grant TF073.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Andre S, 2003, NEUROREPORT, V14, P147, DOI 10.1097/01.wnr.0000051545.96524.bb; BARRON KD, 1988, J NEUROPATH EXP NEUR, V47, P62, DOI 10.1097/00005072-198801000-00008; Barron KD., 1989, NEURAL REGENERATION, P79; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BOULDIN TW, 1979, AM J PATHOL, V94, P241; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cajal R., 1928, DEGENERATION REGENER; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CAVANAGH JB, 1979, ARCH PATHOL LAB MED, V103, P659; Cengiz N, 2012, J NEUROTRAUM, V29, P2465, DOI 10.1089/neu.2009.0947; Chen QX, 1997, J NEUROSCI, V17, P4032; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Court FA, 2011, GLIA, V59, P1529, DOI 10.1002/glia.21196; DALE SM, 1995, EXP NEUROL, V135, P67, DOI 10.1006/exnr.1995.1066; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fishman PS, 1998, BRAIN RES, V779, P231, DOI 10.1016/S0006-8993(97)01125-6; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; GOSHGARIAN HG, 1983, J COMP NEUROL, V214, P251, DOI 10.1002/cne.902140303; GROSS GW, 1983, J NEUROSCI, V3, P1979; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Houle JD, 2001, EXP NEUROL, V169, P208, DOI 10.1006/exnr.2001.7645; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim KA, 2007, INT J PARASITOL, V37, P1209, DOI 10.1016/j.ijpara.2007.03.011; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; LASEK RJ, 1974, P NATL ACAD SCI USA, V71, P1188, DOI 10.1073/pnas.71.4.1188; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; LUCAS JH, 1987, BRAIN RES, V425, P384, DOI 10.1016/0006-8993(87)90526-9; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NICOTERA P, 1992, ANN NY ACAD SCI, V648, P17, DOI 10.1111/j.1749-6632.1992.tb24520.x; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; OLNEY JW, 1994, J NEURAL TRANSM-SUPP, P47; Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x; Ozturk G, 2004, MICROSC RES TECHNIQ, V64, P228, DOI 10.1002/jemt.20075; Pan YA, 2003, J NEUROSCI, V23, P11479; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Samsam M, 2003, J NEUROSCI, V23, P2833; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; SCHLAEPFER WW, 1973, J CELL BIOL, V59, P456, DOI 10.1083/jcb.59.2.456; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sun M, 2008, CELL MOL NEUROBIOL, V28, P71, DOI 10.1007/s10571-007-9250-1; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Vaisid T, 2005, BBA-MOL CELL RES, V1743, P223, DOI 10.1016/j.bbamcr.2005.01.001; Vaisid T, 2009, INT J BIOCHEM CELL B, V41, P2450, DOI 10.1016/j.biocel.2009.07.010; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Vickers JC, 1996, EXP NEUROL, V141, P1, DOI 10.1006/exnr.1996.0133; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; von Meyenburg J, 1998, EXP NEUROL, V154, P583, DOI 10.1006/exnr.1998.6912; Waller A, 1850, PHIL T R SOC LOND BI, V140, P432; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Wood DE, 1999, J BIOL CHEM, V274, P8309, DOI 10.1074/jbc.274.12.8309; XIE XY, 1991, J NEUROSCI, V11, P3257; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878	72	14	14	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	JUN	2013	39	4					362	376		10.1111/j.1365-2990.2012.01295.x			15	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	137HI	WOS:000318425900004	22845867				2022-02-06	
J	Selvan, V; Ganpule, S; Kleinschmit, N; Chandra, N				Selvan, Veera; Ganpule, Shailesh; Kleinschmit, Nick; Chandra, Namas			Blast Wave Loading Pathways in Heterogeneous Material Systems-Experimental and Numerical Approaches	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						blast wave; pressure; transmission; deflection; impedance; shell thickness	TRAUMATIC BRAIN-INJURY; SHOCK-WAVES; RAT; PROPAGATION; MECHANISM; IMPACT; MODEL	Blast waves generated in the field explosions impinge on the head-brain complex and induce mechanical pressure pulses in the brain resulting in traumatic brain injury. Severity of the brain injury (mild to moderate to severe) is dependent upon the magnitude and duration of the pressure pulse, which in turn depends on the intensity and duration of the oncoming blast wave. A fluid-filled cylinder is idealized to represent the head-brain complex in its simplest form; the cylinder is experimentally subjected to an air blast of Friedlander type, and the temporal variations of cylinder surface pressures and strains and fluid pressures are measured. Based on these measured data and results from computational simulations, the mechanical loading pathways from the external blast to the pressure field in the fluid are identified; it is hypothesized that the net loading at a given material point in the fluid comprises direct transmissive loads and deflection-induced indirect loads. Parametric studies show that the acoustic impedance mismatches between the cylinder and the contained fluid as well as the flexural rigidity of the cylinder determine the shape/intensity of pressure pulses in the fluid.	[Selvan, Veera; Ganpule, Shailesh; Kleinschmit, Nick; Chandra, Namas] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA			veera_1431@yahoo.co.in; shailesh@huskers.unl.edu; n_kleinschmit@yahoo.com; nchandra2@unl.edu			US Army Research Office for the project on 'Army-UNL Center for Trauma Mechanics' [W911NF-08-1-0483]	The authors acknowledge the financial support provided by the US Army Research Office for the project on 'Army-UNL Center for Trauma Mechanics', Contract No. W911NF-08-1-0483 (Project manager: Larry Russell, PI: Namas Chandra). The authors thank Ruqiang Feng for his valuable suggestions during discussions.	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Anderson J. D., 2001, J NEUROL NEUROSUR PS; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bir C., 2011, MEASURING BLAST RELA; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Carlucci P., 2010, SIMULIA CUST C; Cernak I, 1997, WORLD J SURG, V21, P240, DOI 10.1007/s002689900223; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2009, INT J IMPACT ENG, V36, P1269, DOI 10.1016/j.ijimpeng.2009.03.007; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen X, 2004, INT J SOLIDS STRUCT, V41, P4635, DOI 10.1016/j.ijsolstr.2004.02.064; Chen X, 2004, COMPOS SCI TECHNOL, V64, P1477, DOI 10.1016/j.compscitech.2003.10.024; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; CLEMEDSON CJ, 1953, AM J PHYSIOL, V174, P316, DOI 10.1152/ajplegacy.1953.174.2.316; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; Cullis I G, 2001, J R Army Med Corps, V147, P16; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ganpule S., 2012, BIOMECH MODEL MECHAN; Ganpule S., 2013, INTRACRANIA IN PRESS; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Honma H, 2003, SHOCK WAVES, V13, P179, DOI 10.1007/s00193-003-0206-1; King AI, 2001, ANNU REV BIOMED ENG, V3, P27, DOI 10.1146/annurev.bioeng.3.1.27; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Krohn P., 1941, REPORT HO, V195, P249; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LUDWIG GD, 1950, J ACOUST SOC AM, V22, P862, DOI 10.1121/1.1906706; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mowatt S, 2011, SHOCK WAVES, V21, P467, DOI 10.1007/s00193-011-0322-2; Narayan Yoganandan P. D., 1998, FRONTIERS HEAD NECK; Ofengeim DK, 1997, SHOCK WAVES, V7, P305, DOI 10.1007/s001930050085; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rahman, 2005, P INT C MECH ENG 200; Romba J. J., 1961, TM1761 HUM ENG LAB A; Skotak M., 2013, J NEUROTRAU IN PRESS; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Stewart OW, 1941, LANCET, V1, P172; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; TEASDALE G, 1974, LANCET, V2, P81; Varas J. M., 2011, FRONTIERS NEUROLOGY, V2; YOUNG MW, 1945, WAR MED, V8, P73; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	52	14	15	0	14	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUN	2013	135	6							061002	10.1115/1.4024132			14	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	240GO	WOS:000326083300002	23699714				2022-02-06	
J	Zhou, TE; Jiang, J; Zhang, M; Fu, Y; Yang, ZF; Jiang, LY				Zhou, Tianen; Jiang, Jun; Zhang, Meng; Fu, Yue; Yang, Zhengfei; Jiang, Longyuan			Protective effect of mild hypothermia on oxygen-glucose deprivation injury in rat hippocampal neurons after hypoxia	MOLECULAR MEDICINE REPORTS			English	Article						neuron; oxygen-glucose deprivation; mild hypothermia; lactic acid dehydrogenase; release rate; MTT; caspase-3	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; THERAPEUTIC HYPOTHERMIA; CORTICAL CULTURES; FLUID-PERCUSSION; ISCHEMIA; MODEL; NEUROPROTECTION; EXCITOTOXICITY; REOXYGENATION	The present study aimed to establish an oxygen-glucose deprivation (OGD) model of ischemic and hypoxic cerebral neurons to investigate the protective effect of mild hypothermia on neuronal OGD and its mechanisms. OGD injury was significantly mitigated in cells with 24 h of mild hypothermia compared with cells without mild hypothermia; cell morphology improved, the lactic acid dehydrogenase (LDH) release rate was decreased, cytoactivity was increased and the neuronal apoptotic rate was decreased. By contrast, no significant improvement in injury was observed after 6 h of mild hypothermia. This suggests that mild hypothermia treatment following OGD is effective only when implemented for 24 h. Additionally, the caspase-3 activity of neurons increased following OGD, which was positively associated with the neuronal apoptotic rate. However, the caspase-3 activity after 24 h of mild hypothermia was reduced. Simultaneously, the neuronal apoptotic rate was decreased, suggesting that mild hypothermia may inhibit neuronal apoptosis by reducing caspase-3 activity. Therefore, reducing caspase-3 activity potentially constitutes one of the protective mechanisms of mild hypothermia in neuronal OGD.	[Zhou, Tianen; Zhang, Meng; Yang, Zhengfei; Jiang, Longyuan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency, Guangzhou 510120, Guangdong, Peoples R China; [Jiang, Jun; Fu, Yue] Sun Yat Sen Univ, Affiliated Foshan Hosp, Dept Emergency, Foshan 528000, Guangdong, Peoples R China		Jiang, LY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency, 107 Yanjiangxi Rd,Yuexiu, Guangzhou 510120, Guangdong, Peoples R China.	longyuanjiang@yeah.net					Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Bai Y, 2009, NEUROSCIENCE, V160, P371, DOI 10.1016/j.neuroscience.2009.01.076; Baltan S, 2011, J NEUROSCI, V31, P3990, DOI 10.1523/JNEUROSCI.5379-10.2011; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Cheah SO, 2010, ANN ACAD MED SINGAP, V39, P542; Dalen ML, 2009, BRAIN RES, V1259, P80, DOI 10.1016/j.brainres.2008.12.055; Diestel A, 2011, CRYOBIOLOGY, V62, P53, DOI 10.1016/j.cryobiol.2010.12.003; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Fritz HG, 2004, J NEUROSURG ANESTH, V16, P43, DOI 10.1097/00008506-200401000-00009; Gwak MS, 2011, ENVIRON TOXICOL PHAR, V31, P262, DOI 10.1016/j.etap.2010.10.009; Inamasu J, 2003, J NEUROL SCI, V209, P55, DOI 10.1016/S0022-510X(02)00463-X; Iwamoto S, 2010, J TRAUMA, V68, P669, DOI 10.1097/TA.0b013e3181a0fbb3; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kunimatsu T, 2011, J CLIN NEUROSCI, V18, P545, DOI 10.1016/j.jocn.2010.07.140; Kunimatsu Teruhito, 2009, J Oral Sci, V51, P615; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Labrande C, 2006, NEUROSCIENCE, V137, P231, DOI 10.1016/j.neuroscience.2005.08.080; Lei ZG, 2006, NEUROSCI LETT, V407, P224, DOI 10.1016/j.neulet.2006.06.019; Li H, 2011, BRAIN RES, V1368, P59, DOI 10.1016/j.brainres.2010.10.073; Lin CH, 2010, AM J MED SCI, V339, P258, DOI 10.1097/MAJ.0b013e3181ce507f; Liu Cui-Qing, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P690; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; National Research Council of the National Academies, 2011, GUIDE CARE USE LAB A, V8, P199; Noguchi K, 2011, RESUSCITATION, V82, P481, DOI 10.1016/j.resuscitation.2010.09.477; Okauchi M, 2002, J NEUROTRAUM, V19, P741, DOI 10.1089/08977150260139110; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Savoia Claudia, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P57; Scorziello A, 2001, J NEUROSCI RES, V63, P20, DOI 10.1002/1097-4547(20010101)63:1<20::AID-JNR3>3.0.CO;2-N; Shibuta S, 2010, BRIT J ANAESTH, V104, P52, DOI 10.1093/bja/aep320; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wang ZF, 2007, FEBS LETT, V581, P596, DOI 10.1016/j.febslet.2007.01.016; Wang ZC, 2010, PLATELETS, V21, P229, DOI 10.3109/09537100903443949; Yokoyama H, 2011, CIRC J, V75, P1063, DOI 10.1253/circj.CJ-11-0137; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	41	14	14	0	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUN	2013	7	6					1859	1864		10.3892/mmr.2013.1410			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	179AH	WOS:000321488300024	23563479	Bronze			2022-02-06	
J	Scivoletto, G; Farchi, S; Laurenza, L; Tamburella, F; Molinari, M				Scivoletto, Giorgio; Farchi, Sara; Laurenza, Letizia; Tamburella, Federica; Molinari, Marco			Impact of multiple injuries on functional and neurological outcomes of patients with spinal cord injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Spinal cord injury; Multiple injuries; Outcomes	REHABILITATION; POLYTRAUMA; RECOVERY; INDEX	Background: The effects of multiple injuries on the neurological and functional outcomes of patients with traumatic spinal cord injury (SCI) are debated-some groups have shown that subjects with multiple injuries have the same neurological and functional outcomes of those without them, whereas others have found that SCI patients with associated traumatic brain injury have worse functional status at admission and discharge and longer rehabilitation stays than patients without brain injury. Thus, the aim of this study was to compare the outcomes of SCI subjects with or without multiple injuries. Methods: A total of 245 patients with a traumatic SCI during the first rehabilitation stay after the development of the lesion (202 males and 43 females; age 39.8 +/- 17 years; lesion to admission time 51.1 +/- 58 days) were examined on a referral basis. Patients were assessed using the following measures: American Spinal Injury Association standards, Barthel Index, Rivermead Mobility Index, and Walking Index for Spinal Cord Injury. The statistical analysis comprised Poisson regression models with relative risks and 95% confidence intervals, adjusted for the following confounders: age, sex, lesion level, and ASIA impairment scale (AIS) grade. Student's T test was used to compare the outcomes of patients divided by AIS impairment and lesion level. Results: SCI patients with and without multiple injuries differed significantly with regard to the level and completeness of the lesion. Overall, patients with multiple injuries had worse functional status at admission and discharge than monotraumatic subjects. However, when adjusted for neurological features, the populations had comparable functional and neurological status at admission and discharge and similar rates of complications and discharge destinations. The separate analysis per each level of lesion/AIS grade showed that in some groups, patients with multiple injuries had a significant longer length of stay or worse functional status at rehabilitation admission (but not at discharge) than their monotraumatic counterparts. Conclusions: Multiple injuries do not affect the neurological or rehabilitative prognosis of spinal cord injuries. At discharge, patients with spinal cord injuries with and without multiple injuries achieved similar results with regard to neurological and functional improvement. Some groups of patients with multiple injuries had a longer length of stay.	[Scivoletto, Giorgio; Laurenza, Letizia; Tamburella, Federica; Molinari, Marco] IRCCS S Lucia Fdn, Spinal Cord Unit, Rome, Italy; [Scivoletto, Giorgio; Tamburella, Federica] IRCCS S Lucia Fdn, Clin & Res Movement Anal CaRMA Lab, Rome, Italy; [Farchi, Sara] Publ Hlth Agcy Lazio Reg, Rome, Italy		Scivoletto, G (corresponding author), IRCCS S Lucia Fdn, Spinal Cord Unit, Rome, Italy.	g.scivoletto@hsantalucia.it	Tamburella, Federica/J-9917-2016; Molinari, Marco/A-9624-2010; Scivoletto, Giorgio/J-3030-2018	Tamburella, Federica/0000-0001-9920-1010; Molinari, Marco/0000-0001-9808-9688; Scivoletto, Giorgio/0000-0001-5766-6952	Italian Ministry of HealthMinistry of Health, Italy [RC12G]; International Foundation for Research in Paraplegie [P133]	The authors declare no conflict of interest; supported in part by grant RC12G of the Italian Ministry of Health and grant P133 of the International Foundation for Research in Paraplegie to GS.	American Spinal Injury Association, 2000, INT STAND NEUR CLASS; Boerger TO, 2000, J BONE JOINT SURG BR, V82B, P629, DOI 10.1302/0301-620X.82B5.11321; Calancie B, 2005, J SPINAL CORD MED, V28, P92, DOI 10.1080/10790268.2005.11753804; Chafetz RS, 2007, J SPINAL CORD MED, V30, pS178, DOI 10.1080/10790268.2007.11754598; *CO SP CO CL PR GU, 1999, OUTC FOLL TRAUM SPIN, P1999; Collen F M, 1991, Int Disabil Stud, V13, P50; Ditunno JF, 1999, ARCH PHYS MED REHAB, V80, P361, DOI 10.1016/S0003-9993(99)90270-8; Ditunno PL, 2001, SPINAL CORD, V39, P654, DOI 10.1038/sj.sc.3101223; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Lieutaud T, 2010, J NEUROTRAUM, V27, P1101, DOI 10.1089/neu.2009.1197; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Madersbacher H, 1999, INCONTINENCE, P775; MAHONEY F I, 1965, Md State Med J, V14, P61; Pagliacci MC, 2003, SPINAL CORD, V41, P620, DOI 10.1038/sj.sc.3101521; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Putz C, 2011, SPINAL CORD, V49, P721, DOI 10.1038/sc.2010.181; Putz C, 2011, J TRAUMA, V70, P1078, DOI 10.1097/TA.0b013e3181e73fa0; Rahimi-Movaghar V, 2005, J SPINAL CORD MED, V28, P415, DOI 10.1080/10790268.2005.11753841; Reynard JM, 2003, SPINAL CORD, V41, P1, DOI 10.1038/sj.sc.3101378; Scivoletto G, 2011, SPINAL CORD, V49, P391, DOI 10.1038/sc.2010.85; Scivoletto G, 2003, SPINAL CORD, V41, P457, DOI 10.1038/sj.sc.3101489; Shenot PJ, 1998, NEUROUROL URODYNAM, V17, P25, DOI 10.1002/(SICI)1520-6777(1998)17:1<25::AID-NAU5>3.0.CO;2-F; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Sumida M, 2001, ARCH PHYS MED REHAB, V82, P391, DOI 10.1053/apmr.2001.19780	25	14	15	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAY 30	2013	21								42	10.1186/1757-7241-21-42			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	160NB	WOS:000320125300001	23718823	gold, Green Published			2022-02-06	
J	Batty, RA; Rossell, SL; Francis, AJP; Ponsford, J				Batty, Rachel A.; Rossell, Susan L.; Francis, Andrew J. P.; Ponsford, Jennie			Psychosis Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; psychosis; schizophrenia; review	RISK MENTAL STATE; II PSYCHIATRIC-DISORDERS; HEAD-INJURY; SUBSTANCE USE; NONAFFECTIVE PSYCHOSIS; CHRONIC-SCHIZOPHRENIA; LIFETIME PREVALENCE; CELL-DEATH; AXIS-I; SYMPTOMS	Psychosis following traumatic brain injury (PFTBI) has received modest empirical investigation, and is subsequently poorly understood, identified and treated. The current article reports on consistencies in PFTBI phenomenology according to the existing peer-reviewed literature. The potential for psychotic symptoms post TBI, aetiological propositions, prevalence, significance of onset latency and injury severity, clinical and cognitive neuropsychological presentation and injury localisation/neuroimaging data are reviewed. Substantial methodological limitations associated with the majority of publications informing this work are also discussed. Despite controversies in the literature, psychosis following TBI appears to be three times more prevalent than psychotic disorders in the general population, and comparable in presentation to other idiopathic psychotic spectrum disorders, including schizophrenia.	[Batty, Rachel A.; Rossell, Susan L.] Swinburne Univ Technol, Fac Life & Social Sci, Brain & Psychol Sci Res Ctr BPsyC, Melbourne, Vic 3122, Australia; [Batty, Rachel A.; Rossell, Susan L.] Alfred Hosp, Monash Alfred Psychiat Res Ctr MAPrc, Cognit Neuropsychiat Lab, Melbourne, Vic 3004, Australia; [Batty, Rachel A.; Rossell, Susan L.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Batty, Rachel A.; Francis, Andrew J. P.] RMIT Univ, Sch Hlth Sci Psychol & Disabil, Bundoora, Vic 3083, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic 3121, Australia		Batty, RA (corresponding author), Brain & Psychol Sci Res Ctr, Neuroimaging Facil, POB 218, Hawthorn, Vic 3122, Australia.	rachel.ann.batty@gmail.com		Batty, Rachel A/0000-0001-6413-5332; Rossell, Susan/0000-0002-7415-8252			AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Ahlskog J. E., 1991, CLIN EXAMINATIONS NE; Albert N, 2011, SCHIZOPHR RES, V125, P257, DOI 10.1016/j.schres.2010.10.013; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bachus SE, 1996, J CLIN PSYCHIAT, V57, P72; Badcock JC, 2006, PERS INDIV DIFFER, V40, P77, DOI 10.1016/j.paid.2005.06.015; BAMRAH JS, 1991, BRIT J PSYCHIAT, V158, P117, DOI 10.1192/bjp.158.1.117; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Belina S, 2011, COLLEGIUM ANTROPOL, V35, P1197; Bell V, 2006, TRENDS COGN SCI, V10, P219, DOI 10.1016/j.tics.2006.03.004; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Bourque F, 2012, CURR PHARM DESIGN, V18, P518, DOI 10.2174/138161212799316028; Broome MR, 2010, PSYCHOL MED, V40, P1987, DOI 10.1017/S0033291710000280; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; Corcoran C, 2007, CURR PSYCHIATRY REV, V3, P25, DOI 10.2174/157340007779815646; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davison K, 1969, CURRENT PROBLEMS NEU, P113; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Egan MF, 2001, AM J PSYCHIAT, V158, P1827, DOI 10.1176/appi.ajp.158.11.1827; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Feinberg TE, 1999, CORTEX, V35, P373, DOI 10.1016/S0010-9452(08)70806-2; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; FRISTON KJ, 1992, BRAIN, V115, P367, DOI 10.1093/brain/115.2.367; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; Fusar-Poli P, 2012, EUR PSYCHIAT, V27, P181, DOI 10.1016/j.eurpsy.2011.06.006; Gard DE, 2009, SCHIZOPHR RES, V115, P74, DOI 10.1016/j.schres.2009.08.015; Gareishizadeh MA, 2012, IRAN J PUBLIC HEALTH, V41, P116; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gilleen J, 2005, PSYCHOL MED, V35, P5, DOI 10.1017/S0033291704003976; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Hartley S, 2012, BEHAV RES THER, V50, P65, DOI 10.1016/j.brat.2011.10.007; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horn H, 2010, PSYCHIAT RES-NEUROIM, V182, P183, DOI 10.1016/j.pscychresns.2010.01.016; Hughes ME, 2012, BIOL PSYCHOL, V89, P220, DOI 10.1016/j.biopsycho.2011.10.013; JABLENSKY A, 1992, PSYCHOL MED, P1; Jessen F, 2003, AM J PSYCHIAT, V160, P1305, DOI 10.1176/appi.ajp.160.7.1305; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joshua N, 2009, SCHIZOPHR RES, V112, P99, DOI 10.1016/j.schres.2009.03.033; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kulhara P, 2001, PSYCHIAT CLIN N AM, V24, P449, DOI 10.1016/S0193-953X(05)70240-9; Kumar CTS, 2010, SCHIZOPHR RES, V124, P152, DOI 10.1016/j.schres.2010.07.006; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; Max JE, 1997, BRAIN INJURY, V11, P699; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; Medalia A, 2010, SCHIZOPHRENIA BULL, V36, P912, DOI 10.1093/schbul/sbq073; Murrey GJ, 2004, REHABIL PSYCHOL, V49, P259, DOI 10.1037/0090-5550.49.3.259; Must Anita, 2011, Neuropsychopharmacol Hung, V13, P211; Myers NL, 2011, CURR PSYCHIAT REP, V13, P305, DOI 10.1007/s11920-011-0208-0; Myin-Germeys I, 2003, CURR OPIN PSYCHIATR, V16, P443, DOI 10.1097/01.yco.0000079208.36371.cd; Nakagami E, 2010, SCHIZOPHRENIA BULL, V36, P935, DOI 10.1093/schbul/sbq043; Newburn G, 1998, CNS DRUGS, V9, P441, DOI 10.2165/00023210-199809060-00003; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; OCALLAGHAN E, 1988, BRIT J PSYCHIAT, V153, P394, DOI 10.1192/bjp.153.3.394; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J., 2012, TRAUMATIC BRAIN INJU, P226; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pridmore S, 2011, MALAYS J MED SCI, V18, P6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao V, 2003, INT REV PSYCHIATR, V15, P299, DOI 10.1080/09540260310001606674; Reitan R, 1985, HALSTEAD REITAN NEUR; RINK A, 1995, AM J PATHOL, V147, P1575; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rossler W, 2012, ADDICTION, V107, P1174, DOI 10.1111/j.1360-0443.2011.03760.x; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Rossell SL, 2006, SCHIZOPHR RES, V82, P121, DOI 10.1016/j.schres.2005.11.001; Rossell SL, 2010, EUR ARCH PSY CLIN N, V260, P571, DOI 10.1007/s00406-010-0101-6; RUTHERFORD WH, 1977, LANCET, V1, P1; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Senathi-Raja D. R., 2010, J REHABILITATION MED, V41, P666; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smieskova R, 2012, CURR PHARM DESIGN, V18, P416, DOI 10.2174/138161212799316046; Snow P, 2012, TRAUMATIC BRAIN INJU, P34; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stewart B, 2005, J NEUROPSYCH CLIN N, V17, P243, DOI 10.1176/appi.neuropsych.17.2.243; Sutterland AL, 2013, SOC PSYCH PSYCH EPID, V48, P1357, DOI 10.1007/s00127-013-0651-9; Switaj P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-193; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Westermeyer J, 2006, AM J ADDICTION, V15, P345, DOI 10.1080/10550490600860114; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Wisdom JP, 2011, PSYCHIAT SERV, V62, P1007, DOI 10.1176/appi.ps.62.9.1007; Zierhut K, 2010, PSYCHIAT RES-NEUROIM, V183, P187, DOI 10.1016/j.pscychresns.2010.03.007; Zierhut KC, 2013, BRAIN, V136, P804, DOI 10.1093/brain/aws335; [No title captured]	131	14	15	2	22	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2013	14	1			SI		21	41		10.1017/BrImp.2013.10			21	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	189EY	WOS:000322251300004					2022-02-06	
J	Chan, M; Al-Buali, W; Stewart, TC; Singh, RN; Kornecki, A; Seabrook, JA; Fraser, DD				Chan, M.; Al-Buali, W.; Stewart, T. Charyk; Singh, R. N.; Kornecki, A.; Seabrook, J. A.; Fraser, D. D.			Cervical spine injuries and collar complications in severely injured paediatric trauma patients	SPINAL CORD			English	Article						children; severe trauma; cervical spine; injury; clearance; collar complications	PRESSURE	Study design: A retrospective registry review. Objectives: To determine the incidence of cervical spine (CS) injuries and collar complications in severely injured paediatric trauma patients. Setting: Regional Trauma Centre, Children's Hospital. Methods: A retrospective review of 365 paediatric severe trauma patients (0-17 years), defined as an Injury Severity Score (ISS)>= 12, admitted to the paediatric intensive care unit (PICU). Results: Clinically significant CS injuries occurred in 5% (n=18/365) of trauma patients, in 9% (n=13/149) of traumatic brain injury (TBI) patients and in 11% (n=6/56) of in-hospital trauma deaths. CS injuries were suspected before imaging in 33% (n=6/18) of patients based on either motor/sensory impairment or shock. CS injuries were deemed unstable in 61% (n=11/18) of patients. Patients with CS injuries had higher ISS, and longer PICU and hospital stays (P<0.05). CS collar complications occurred in 10% of patients, mainly identified by day 6 and consisting of either erythema or ulcers. Patients with CS collar complications were older and more likely to have TBI, lower Glasgow Coma Scale (GCS) scores, longer PICU and hospital stays, and increased days to CS clearance (P<0.05). Three CS X-rays, together with flexion/extension views, were used most frequently for CS clearance. Conclusion: CS injuries were prevalent in severely injured paediatric trauma patients, particularly in those with TBI and in nonsurvivors. CS collar complications were associated with a lower GCS and longer CS clearance times. Attention to CS collar management protocols and earlier CS clearance with computed tomography/magnetic resonance imaging in obtunded patients might reduce CS collar complications.	[Chan, M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Al-Buali, W.] King Faisal Univ, Khobar, Saudi Arabia; [Stewart, T. Charyk; Singh, R. N.; Kornecki, A.; Seabrook, J. A.; Fraser, D. D.] Univ Western Ontario, London, ON, Canada; [Singh, R. N.; Kornecki, A.; Seabrook, J. A.; Fraser, D. D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, D. D.] Ctr Crit Illness Res, London, ON, Canada		Fraser, DD (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Paediat Crit Care Med Off, Room C2-C82,800 Commissioners Rd East, London, ON N6C 2V5, Canada.	douglas.fraser@lhsc.on.ca					Browne Gary J, 2003, Emerg Med (Fremantle), V15, P133, DOI 10.1046/j.1442-2026.2003.00345.x; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Duhem R, 2008, CHILD NERV SYST, V24, P343, DOI 10.1007/s00381-007-0497-0; Frank JB, 2002, SPINE, V27, P1176, DOI 10.1097/00007632-200206010-00008; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Hofbauer M, 2012, J TRAUMA ACUTE CARE, V73, P156, DOI 10.1097/TA.0b013e31824e32b5; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Lustrin ES, 2003, RADIOGRAPHICS, V23, P539, DOI 10.1148/rg.233025121; Mohseni S, 2011, J PEDIATR SURG, V46, P1771, DOI 10.1016/j.jpedsurg.2011.03.007; Molano Alvarez Esteban, 2004, Enferm Intensiva, V15, P112; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; Pizzutillo Peter D, 2006, Instr Course Lect, V55, P633; PLAISIER B, 1994, J TRAUMA, V37, P714, DOI 10.1097/00005373-199411000-00004; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Polk-Williams A, 2008, J PEDIATR SURG, V43, P1718, DOI 10.1016/j.jpedsurg.2008.06.002; Powers J, 1997, J NURS CARE QUAL, V12, P46, DOI 10.1097/00001786-199710000-00008; Powers Jan, 2006, J Trauma Nurs, V13, P198; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20	20	14	15	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAY	2013	51	5					360	364		10.1038/sc.2013.6			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	139NR	WOS:000318590200004	23459123	Bronze			2022-02-06	
J	Gadegone, WM; Lokhande, V; Salphale, Y; Ramteke, A				Gadegone, W. M.; Lokhande, Vijayanand; Salphale, Yogesh; Ramteke, Alankar			Long proximal femoral nail in ipsilateral fractures proximal femur and shaft of femur	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Fracture shaft femur; intracapsular neck fracture; ipsilateral fracture hip and shaft femur; long proximal femoral nail; pertrochanteric fracture	CONCOMITANT FRACTURES; RECONSTRUCTION NAIL; NECK; HIP; FIXATION	Background: Ipsilateral fractures of the proximal femur and femoral shaft are extremely uncommon injuries which occur in young adults who sustain a high energy trauma. A variety of management modalities have been tried to treat this complex fracture pattern ranging from conservative approach to recently introduced reconstruction nails. All these approaches have their own difficulties. We studied the outcome of long proximal femoral nail (LPFN) in the management of concomitant ipsilateral fracture of the proximal femur and femoral shaft. Materials and Methods: We analysed the prospective data of 36 consecutive patients who had sustained a high energy trauma (30 closed fractures and 6 open shaft fractures) who had concomitant ipsilateral fractures of the femoral shaft associated with proximal femur fractures treated with LPFN between December 2005 and December 2011. The mean age was 39 years (range 28-64 years). Twenty nine males and seven females were enrolled for this study. Results: The patients were followed up at three, six, twelve, and eighteen months. The mean healing time for the neck fractures was 4.8 months and for the shaft fractures was 6.2 months. The greater trochanter was splintered and widened in two cases which eventually consolidated. Two patients had superficial infection, two patients had lateral migration of the screws with coxa vara which was due to severe osteoporosis detected during the followup. We had two cases of nonunion of shaft fracture and one case of nonunion of neck fracture. Two cases of avascular necrosis of femoral head were detected after 2 years of followup. No cases of implant failure were noted. Limb shortening of less than 2 cms was noted in four of our patients. The functional assessment system of Friedman and Wyman was used for evaluating the results. In our series 59.9% (n = 23) were rated as good, 30.6% (n = 11) as fair, and 5.5% (n = 2) as poor. Conclusion: Long PFN is a reliable option for concomitant ipsilateral diaphyseal and proximal femur fractures.	[Gadegone, W. M.; Lokhande, Vijayanand; Salphale, Yogesh] Chandrapur Multispecial Hosp, Vivek Nagar Chandrapur, India; [Ramteke, Alankar] Chandrapur Multispecial Hosp, Dept Orthopaed & Traumatol, Vivek Nagar Chandrapur, India		Gadegone, WM (corresponding author), Mul Rd, Chandrapur 442401, India.	gadegone123@yahoo.co.in	Salphale, Yogesh/J-9765-2019; RAMTEKE, ALANKAR/AAH-8781-2019	Salphale, Yogesh/0000-0001-6893-7922; Ramteke, Alankar/0000-0003-4023-4074			Abalo A, 2008, J Orthop Surg (Hong Kong), V16, P35; Alho A, 1996, J TRAUMA, V40, P10, DOI 10.1097/00005373-199601000-00003; Alho A, 1997, ANN CHIR GYNAECOL FE, V86, P326; BARQUET A, 1985, ACTA ORTHOP SCAND, V56, P36, DOI 10.3109/17453678508992976; BENNETT FS, 1993, CLIN ORTHOP RELAT R, P168; BOSE WJ, 1992, J TRAUMA, V32, P71, DOI 10.1097/00005373-199201000-00015; BUCHOLZ RW, 1985, ORTHOPEDICS, V8, P1402; CASEY MJ, 1979, J BONE JOINT SURG AM, V61, P503, DOI 10.2106/00004623-197961040-00003; CHATURVEDI S, 1993, INJURY, V24, P243, DOI 10.1016/0020-1383(93)90178-9; Chen C H, 2001, Kaohsiung J Med Sci, V17, P207; Dousa P, 2002, Acta Chir Orthop Traumatol Cech, V69, P22; Dousa P, 2010, ACTA CHIR ORTHOP TR, V77, P378; Friedman RJ, 1986, CLIN ORTHOP RELAT R, V208, P1880; Gadegone WM, 2007, INT ORTHOP, V31, P403, DOI 10.1007/s00264-006-0170-3; Huny SH, 2004, INJURY, V35, P165, DOI 10.1016/S0020-1383(03)00278-X; Oh CW, 2006, ARCH ORTHOP TRAUM SU, V126, P448, DOI 10.1007/s00402-006-0161-2; Pavleka T, 2005, ZENTRALBL CHIR, V130, P148; RAMSER JR, 1993, CLIN ORTHOP RELAT R, P189; RUSSEL T, 1992, CAMPBELLS OPERATIVE, V2, P896; Russell TA, 1986, CLIN ORTHOP RELAT R, V208, P188; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P260, DOI 10.2106/00004623-198466020-00013; Windolf J, 2005, LANGENBECK ARCH SURG, V390, P59, DOI 10.1007/s00423-004-0466-y; Winquist, 1993, J Am Acad Orthop Surg, V1, P95; Wiss D A, 1992, J Orthop Trauma, V6, P159, DOI 10.1097/00005131-199206000-00005; WU CC, 1991, ACTA ORTHOP SCAND, V62, P346, DOI 10.3109/17453679108994467; ZETTAS JP, 1981, CLIN ORTHOP RELAT R, P63	26	14	17	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	MAY-JUN	2013	47	3					272	277		10.4103/0019-5413.109441			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	207QS	WOS:000323618600009	23798758	Green Published			2022-02-06	
J	Kolakowsky-Hayner, SA; Wright, J; Englander, J; Duong, T; Ladley-O'Brien, S				Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Englander, Jeffrey; Duong, Thao; Ladley-O'Brien, Susan			Impact of late post-traumatic seizures on physical health and functioning for individuals with brain injury within the community	BRAIN INJURY			English	Article						Post-traumatic seizures; epilepsy; traumatic brain injury; health; function; community integration	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; RISK-FACTORS; RATING-SCALE; EPILEPSY; MODERATE; PEOPLE; ADULTS; REHABILITATION; PARTICIPATION	Primary objective: To better characterize, describe and highlight issues that individuals with TBI and active LPTS may face in their daily lives. Design: Prospective multi-centre mixed method qualitative and quantitative interview. Participants: Twenty-five individuals, 5-13 years post-injury, who had reported having LPTS and TBI. Measures: Disability Rating Scale (DRS); Supervision Rating Scale (SRS); Glasgow Outcome Scale-Extended (GOS-E); Perceived Stress Scale (PSS); Craig Handicap Assessment Reporting Technique-Short Form (CHART-SF) sub-scales: Physical Independence, Cognitive Independence, Mobility, Occupation, Social Integration; and Craig Hospital Inventory of Environmental Factors (CHIEF); and qualitative interview questions pertaining to management of the seizure disorder and its effect on the individual's health, function, community integration and participation. Results: Data are presented regarding seizure activity and management; return to driving post-seizure; coping and participation; and standardized outcome measures. Conclusions: Individuals with TBI and LPTS are at a double-barrelled disadvantage regarding ongoing physical, cognitive, psychosocial and reintegration issues following brain injury and epilepsy. Clearer clinical guidelines and treatment strategies need to be developed to help ameliorate these ongoing issues. Additional research is needed to identify what the rehabilitation community can do to continue to facilitate people living safely and independently.	[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Englander, Jeffrey; Duong, Thao] Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA; [Ladley-O'Brien, Susan] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Denver Hlth Med Ctr, Denver, CO USA		Kolakowsky-Hayner, SA (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	stephanie.hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	Santa Clara Valley Medical Center; Denver Health Medical Center; NIDRR; NIDRR [H133A070038]	The authors wish to thank all of the data collectors and project staff at Santa Clara Valley Medical Center and Denver Health Medical Center and NIDRR for the continued support and funding.; The authors report no conflicts of interest. This study was partially supported by NIDRR Grant # H133A070038.	Achterberg TJ, 2009, J OCCUP REHABIL, V19, P129, DOI 10.1007/s10926-009-9169-0; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arida RM, 2008, SPORTS MED, V38, P607, DOI 10.2165/00007256-200838070-00006; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Drazkowski JF, 2011, NEUROLOGY, V76, pS44, DOI 10.1212/WNL.0b013e31820c360c; Dunne JW, 2011, NEUROL ASIA, V16, P45; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Gilliam F, 1997, EPILEPSIA, V38, P233, DOI 10.1111/j.1528-1157.1997.tb01102.x; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hartshorn J C, 1994, J Neurosci Nurs, V26, P288; Holland P, 2009, EPILEPSIA, V50, P1030, DOI 10.1111/j.1528-1167.2008.01819.x; Hoofien D, 2011, BRAIN INJURY M, V15, P189; Hup CK, 2010, MALAYS J MED SCI, V17, P36; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jehi L, 2011, EPILEPSY BEHAV, V22, P723, DOI 10.1016/j.yebeh.2011.08.039; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Khan N, 2011, GOMAL J MED SCI, V9, P42; Leidy NK, 1999, EPILEPSIA, V40, P97, DOI 10.1111/j.1528-1157.1999.tb01995.x; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Misra UK, 2011, ANN INDIAN ACAD NEUR, V14, P2, DOI 10.4103/0972-2327.78041; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALINSKY MC, 1992, EPILEPSIA, V33, P469, DOI 10.1111/j.1528-1157.1992.tb01693.x; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; The Traumatic Brain Injury Model Systems National Data and Statistical Center (TBINDSC), 2011, TBI MOD SYST PRES; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Wilson JT, 2001, J NEUROL NEUROSUR PS, V70, P267; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	58	14	14	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2013	27	5					578	586		10.3109/02699052.2013.765595			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000008	23472705				2022-02-06	
J	Ma, QY; Chen, S; Klebe, D; Zhang, JH; Tang, JP				Ma, Qingyi; Chen, Sheng; Klebe, Damon; Zhang, John H.; Tang, Jiping			Adhesion Molecules in CNS Disorders: Biomarker and Therapeutic Targets	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Adhesion molecule; CNS disorders; leukocyte adhesion cascade; vascular adhesion protein-1	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL CELL-INTERACTIONS; VASCULAR ADHESION; E-SELECTIN; MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION; P-SELECTIN; SUBARACHNOID HEMORRHAGE	Mounting evidence has been provided regarding the crucial role of leukocyte extravasation and subsequent inflammatory response in several central nervous system (CNS) disorders. The infiltrated leukocytes release pro-inflammatory mediators and activate resident cells, leading to tissue injury. Leukocyte-endothelia interaction is critical for leukocyte extravasation and migration from the intravascular space into the tissue during inflammation. The basic physiology of leukocyte-endothelia interaction has been investigated extensively. Traditionally, three kinds of adhesion molecules, selectin, integrin, and immunoglobulin families, are responsible for this multiple-step interaction. Furthermore, blocking adhesion molecule function by genetic knockout, antagonizing antibodies, or inhibitory pharmacological drugs provides neuroprotection, which is associated with a reduction in leukocyte accumulation within the tissue. Detection of the soluble form of adhesion molecules has also been proven to predict outcomes in CNS disorders. Lately, vascular adhesion protein-1, a novel adhesion molecule and endothelial cell surface enzyme, has been implicated as a brake in the rolling step of the adhesion cascade, and also a regulator of leukocyte transmigration step. In this review, we summarize the functions of traditional adhesion molecules as well as vascular adhesion protein-1 in the leukocyte adhesion cascade. We also discuss the diagnostic and therapeutic potential of adhesion molecules in CNS disorders.	[Ma, Qingyi; Chen, Sheng; Klebe, Damon; Zhang, John H.; Tang, Jiping] Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA; [Chen, Sheng] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, John H.] Loma Linda Med Ctr, Dept Anesthesiol, Loma Linda, CA USA; [Zhang, John H.] Loma Linda Med Ctr, Dept Neurosurg, Loma Linda, CA USA		Tang, JP (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA.	jtang@llu.edu	Ma, Qingyi/AAC-9203-2022	Ma, Qingyi/0000-0002-3499-0992; Zhang, John H./0000-0002-4319-4285; chen, sheng/0000-0002-8374-136X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS060936, R01 NS053407]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053407, R01NS060936] Funding Source: NIH RePORTER	This study was supported by NIH R01 NS060936 to Jiping Tang and NIH R01 NS053407 to John H. Zhang	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Airas L, 2008, NEUROPATH APPL NEURO, V34, P394, DOI 10.1111/j.1365-2990.2007.00911.x; Airas L, 2006, J NEUROIMMUNOL, V177, P132, DOI 10.1016/j.jneuroim.2006.05.014; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.me.38.020187.001135; Arumugam TV, 2004, AM J PHYSIOL-HEART C, V287, pH2555, DOI 10.1152/ajpheart.00588.2004; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Bavbek M, 1998, STROKE, V29, P1930, DOI 10.1161/01.STR.29.9.1930; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Becker Kyra J, 2002, Curr Med Res Opin, V18 Suppl 2, ps18, DOI 10.1185/030079902125000688; Bednar MM, 1996, NEUROL RES, V18, P171; Bill R, 2011, J NEUROIMMUNOL, V232, P207, DOI 10.1016/j.jneuroim.2010.10.008; Blann A, 1999, BLOOD COAGUL FIBRIN, V10, P277, DOI 10.1097/00001721-199907000-00009; Blum A, 2006, EUR CYTOKINE NETW, V17, P295; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; BOWES MP, 1995, NEUROLOGY, V45, P815, DOI 10.1212/WNL.45.4.815; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CARLOS TM, 1990, BLOOD, V76, P965; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Casoli T, 2010, BIOGERONTOLOGY, V11, P627, DOI 10.1007/s10522-010-9281-8; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chang CZ, 2010, ACTA NEUROCHIR, V152, P861, DOI 10.1007/s00701-010-0602-0; CHEN H, 1994, ANN NEUROL, V35, P458, DOI 10.1002/ana.410350414; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Clatterbuck RE, 2002, J NEUROSURG, V97, P676, DOI 10.3171/jns.2002.97.3.0676; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P178, DOI 10.1038/nrd3676; DeGraba TJ, 1998, NEUROLOGY, V51, pS62, DOI 10.1212/WNL.51.3_Suppl_3.S62; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doerck S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015478; Doring A, 2007, J IMMUNOL, V179, P8470, DOI 10.4049/jimmunol.179.12.8470; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; EIKELENBOOM P, 1994, VIRCHOWS ARCH, V424, P421, DOI 10.1007/BF00190565; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Ewers M, 2010, EXP GERONTOL, V45, P75, DOI 10.1016/j.exger.2009.09.005; FUJIMOTO T, 1993, BLOOD, V82, P1758; GAMBLE JR, 1990, SCIENCE, V249, P414; Gan Y, 2012, J NEUROIMMUNOL, V247, P9, DOI 10.1016/j.jneuroim.2012.03.011; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hammond MD, 2012, TRANSL STROKE RES, V3, pS125, DOI 10.1007/s12975-012-0174-9; HANDA Y, 1995, ACTA NEUROCHIR, V132, P92, DOI 10.1007/BF01404854; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hernandez-Guillamon M, 2012, CEREBROVASC DIS, V33, P55, DOI 10.1159/000333370; Hernandez-Guillamon M, 2010, STROKE, V41, P1528, DOI 10.1161/STROKEAHA.110.584623; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Huang J, 2000, STROKE, V31, P3047, DOI 10.1161/01.STR.31.12.3047; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Irjala H, 2001, J IMMUNOL, V166, P6937, DOI 10.4049/jimmunol.166.11.6937; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674; Janner G, 1978, Occup Health (Lond), V30, P110; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Jha Mithilesh Kumar, 2012, Immune Netw, V12, P41, DOI 10.4110/in.2012.12.2.41; Jiang N, 1995, ANN NEUROL, V38, P935, DOI 10.1002/ana.410380615; Johnston B, 1996, AM J PHYSIOL-HEART C, V271, pH614, DOI 10.1152/ajpheart.1996.271.2.H614; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kanemoto Y, 2002, NEUROSURGERY, V51, P1034, DOI 10.1097/00006123-200210000-00033; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P1336, DOI 10.1097/00004647-199812000-00008; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Knorr R, 1997, J EXP MED, V186, P719, DOI 10.1084/jem.186.5.719; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kozubski W, 2002, ALZ DIS ASSOC DIS, V16, P52, DOI 10.1097/00002093-200201000-00009; Kramer AH, 2008, NEUROSURGERY, V62, P422, DOI 10.1227/01.neu.0000316009.19012.e3; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; Lalor PF, 2007, HEPATOLOGY, V45, P465, DOI 10.1002/hep.21497; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Licastro F, 2011, J ALZHEIMERS DIS, V23, P421, DOI 10.3233/JAD-2010-090871; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; Lin ZX, 2011, CLIN CHIM ACTA, V412, P1678, DOI 10.1016/j.cca.2011.05.031; Lively S, 2012, TRANSL STROKE RES, V3, pS132, DOI 10.1007/s12975-012-0151-3; Ma QY, 2011, J CEREBR BLOOD F MET, V31, P881, DOI 10.1038/jcbfm.2010.167; MA XL, 1993, CIRCULATION, V88, P649, DOI 10.1161/01.CIR.88.2.649; Maiuri F, 1987, J Neurosurg Sci, V31, P45; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Martelius T, 2004, AM J PATHOL, V165, P1993, DOI 10.1016/S0002-9440(10)63250-6; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; NEILDWYER G, 1974, BRAIN, V97, P79, DOI 10.1093/brain/97.1.79; Nielsen HM, 2007, NEUROBIOL DIS, V26, P27, DOI 10.1016/j.nbd.2006.11.011; Nissen JJ, 2000, ACT NEUR S, V76, P55; Nissen JJ, 2001, J NEUROL NEUROSUR PS, V71, P329, DOI 10.1136/jnnp.71.3.329; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Offner H, 2012, TRANSL STROKE RES, V3, P324, DOI 10.1007/s12975-012-0187-4; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Oshiro EM, 1997, STROKE, V28, P2031, DOI 10.1161/01.STR.28.10.2031; Osmers I, 2005, J NEUROIMMUNOL, V166, P193, DOI 10.1016/j.jneuroim.2005.06.001; Penberthy TW, 1997, CRIT REV ORAL BIOL M, V8, P380, DOI 10.1177/10454411970080040201; Piraino PS, 2002, J NEUROIMMUNOL, V131, P147, DOI 10.1016/S0165-5728(02)00273-4; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Rentzos A, 2004, J GERIATR PSYCH NEUR, V17, P225, DOI 10.1177/0891988704269822; Rentzos M, 2005, J NEUROL SCI, V228, P129, DOI 10.1016/j.jns.2004.11.001; Rivera-Nieves J, 2008, INFLAMM BOWEL DIS, V14, P1715, DOI 10.1002/ibd.20501; Ruehl ML, 2002, NEUROL RES, V24, P226, DOI 10.1179/016164102101199738; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; SCHMIDSCHONBEIN GW, 1994, STROKE, V25, P875; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Selakovic V, 2009, DIS MARKERS, V26, P65, DOI [10.1155/2009/490867, 10.3233/DMA-2009-0608]; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Shyu KG, 1997, J NEUROL, V244, P90, DOI 10.1007/s004150050055; Sills AK, 1997, NEUROSURGERY, V41, P453, DOI 10.1097/00006123-199708000-00025; Simard J.M., 2012, TRANSL STROKE RES S1, V3, P155; SIMON RH, 1986, J CLIN INVEST, V78, P1375, DOI 10.1172/JCI112724; Simundic AM, 2004, CLIN INVEST MED, V27, P86; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; SOBEL RA, 1990, AM J PATHOL, V136, P1309; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Sughrue ME, 2004, INFLAMM RES, V53, P497, DOI 10.1007/s00011-004-1282-0; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Titova E, 2008, J NEUROSCI RES, V86, P3240, DOI 10.1002/jnr.21762; Tohka S, 2001, FASEB J, V15, P373, DOI 10.1096/fj.00-0240com; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Vemuganti R, 2004, STROKE, V35, P179, DOI 10.1161/01.STR.0000106479.53235.3E; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Vuorte J, 1999, J IMMUNOL, V162, P2353; WALCHECK B, 1992, EUR J IMMUNOL, V22, P469, DOI 10.1002/eji.1830220227; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WANG XK, 1995, J NEUROTRAUM, V12, P825, DOI 10.1089/neu.1995.12.825; WASHINGTON R, 1994, ANN NEUROL, V35, P89, DOI 10.1002/ana.410350114; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wraith DC, 2012, J CLIN INVEST, V122, P1172, DOI 10.1172/JCI58648; Xu HL, 2006, J PHARMACOL EXP THER, V317, P19, DOI 10.1124/jpet.105.096958; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yenari MA, 1998, EXP NEUROL, V153, P223, DOI 10.1006/exnr.1998.6876; Yilmaz G, 2008, NEUROL RES, V30, P783, DOI 10.1179/174313208X341085; Yoong KF, 1998, J IMMUNOL, V160, P3978; Yu PH, 1997, DIABETOLOGIA, V40, P1243, DOI 10.1007/s001250050816; Zhang RL, 1996, J CEREBR BLOOD F MET, V16, P1126, DOI 10.1097/00004647-199611000-00006; Zhang RL, 1998, BRAIN RES, V785, P207, DOI 10.1016/S0006-8993(97)01343-7; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8; Zuliani G, 2008, J NEUROL SCI, V272, P164, DOI 10.1016/j.jns.2008.05.020	177	14	14	0	9	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	MAY	2013	12	3					392	404		10.2174/1871527311312030012			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	145CE	WOS:000318990800012	23469854	Green Accepted			2022-02-06	
J	Rizzo, JA; Burgess, P; Cartie, RJ; Prasad, BM				Rizzo, Julie A.; Burgess, Pamela; Cartie, Richard J.; Prasad, Balakrishna M.			Moderate systemic hypothermia decreases burn depth progression	BURNS			English	Article						Therapeutic hypothermia; Burn progression; Matrix metalloprotease; Inflammation; Microarray	THERAPEUTIC HYPOTHERMIA; THERMAL-INJURY; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; PROFOUND HYPOTHERMIA; CEREBRAL-ISCHEMIA; LETHAL HEMORRHAGE; MILD HYPOTHERMIA; UP-REGULATION; BRAIN-INJURY	Background: Therapeutic hypothermia has been proposed to be beneficial in an array of human pathologies including cardiac arrest, stroke, traumatic brain and spinal cord injury, and hemorrhagic shock. Burn depth progression is multifactorial but inflammation plays a large role. Because hypothermia is known to reduce inflammation, we hypothesized that moderate hypothermia will decrease burn depth progression. Methods: We used a second-degree 15% total body surface area thermal injury model in rats. Burn depth was assessed by histology of biopsy sections. Moderate hypothermia in the range of 31-33 degrees C was applied for 4 h immediately after burn and in a delayed fashion, starting 2 h after burn. In order to gain insight into the beneficial effects of hypothermia, we analyzed global gene expression in the burned skin. Results: Immediate hypothermia decreased burn depth progression at 6 h post injury, and this protective effect was sustained for at least 24 h. Burn depth was 18% lower in rats subjected to immediate hypothermia compared to control rats at both 6 and 24 h post injury. Rats in the delayed hypothermia group did not show any significant decrease in burn depth at 6 h, but had 23% lower burn depth than controls at 24 h. Increased expression of several skin-protective genes such as CCL4, CCL6 and CXCL13 and decreased expression of tissue remodeling genes such as matrix metalloprotease-9 were discovered in the skin biopsy samples of rats subjected to immediate hypothermia. Conclusions: Systemic hypothermia decreases burn depth progression in a rodent model and up-regulation of skin-protective genes and down-regulation of detrimental tissue remodeling genes by hypothermia may contribute to its beneficial effects. Published by Elsevier Ltd and ISBI	[Rizzo, Julie A.; Burgess, Pamela; Cartie, Richard J.; Prasad, Balakrishna M.] Dwight D Eisenhower Army Med Ctr, Ft Gordon, GA USA		Rizzo, JA (corresponding author), MCHF SCL GSS, Ft Gordon, GA 30905 USA.	julie.rizzo@us.army.mil; pamela.burgess@us.army.mil; rcartie@hotmail.com; balakrishna.prasad@us.army.mil					Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; BOYKIN JV, 1981, J SURG RES, V31, P111, DOI 10.1016/0022-4804(81)90038-X; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHOI MY, 1993, AM J PATHOL, V142, P519; COURTICE FC, 1946, J PHYSIOL-LONDON, V104, P321, DOI 10.1113/jphysiol.1946.sp004125; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; DEMLING RH, 1979, J TRAUMA, V19, P56, DOI 10.1097/00005373-197901000-00011; Hamann GF, 2004, STROKE, V35, P764, DOI 10.1161/01.STR.0000116866.60794.21; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Han YP, 2001, J CELL SCI, V114, P131; Iwasaki K, 1997, BRIT J DERMATOL, V137, P647, DOI 10.1111/j.1365-2133.1997.tb03805.x; Jackson DM, 1953, BRIT J SURG, V40, P388; Jonsson A, 1998, J BURN CARE REHABIL, V19, P50; Klein RD, 2000, J BURN CARE REHABIL, V21, P345, DOI 10.1097/00004630-200021040-00010; Kochanek PM, 2009, J NEUROTRAUM, V26, P417, DOI 10.1089/neu.2008.0612; Li Y, 2009, ARCH DERMATOL RES, V301, P205, DOI 10.1007/s00403-008-0881-y; Maier CM, 2001, J NEUROSURG, V94, P90, DOI 10.3171/jns.2001.94.1.0090; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; Morita-Fujimura Y, 2000, J CEREBR BLOOD F MET, V20, P130, DOI 10.1097/00004647-200001000-00017; Nisanci M, 2010, BURNS, V36, P397, DOI 10.1016/j.burns.2009.06.208; Oda J, 2009, J TRAUMA, V66, P1525, DOI 10.1097/TA.0b013e3181a51f35; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Pham TN, 2007, TOTAL BURN CARE, P119; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; POOL JL, 1958, J NEUROSURG, V15, P52, DOI 10.3171/jns.1958.15.1.0052; REGAS FC, 1992, J TRAUMA, V32, P557, DOI 10.1097/00005373-199205000-00004; Reiss MJ, 2009, WOUND REPAIR REGEN, V17, P418, DOI 10.1111/j.1524-475X.2009.00476.x; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Roth N, 2011, ALLERGY, V66, P1477, DOI 10.1111/j.1398-9995.2011.02694.x; Sawada Y, 1997, BURNS, V23, P55, DOI 10.1016/S0305-4179(96)00080-0; Shupp JW, 2010, J BURN CARE RES, V31, P849, DOI 10.1097/BCR.0b013e3181f93571; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; Tang CH, 2008, CARCINOGENESIS, V29, P35, DOI 10.1093/carcin/bgm220; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; ULEVITCH RJ, 1990, J TRAUMA, V30, pS189; Weckroth M, 1996, J INVEST DERMATOL, V106, P1119, DOI 10.1111/1523-1747.ep12340167; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Yoshizaki T, 2009, CLIN EXP IMMUNOL, V157, P71, DOI 10.1111/j.1365-2249.2009.03945.x; YOUNG PK, 1994, J INVEST DERMATOL, V103, P660, DOI 10.1111/1523-1747.ep12398424	43	14	15	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179			BURNS	Burns	MAY	2013	39	3					436	444		10.1016/j.burns.2012.07.022			9	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	118KX	WOS:000317025500009	23149435				2022-02-06	
J	Sun, KJ; Zhu, L; Wang, HD; Ji, XJ; Pan, H; Chen, M; Lu, TJ; Fan, YW; Cheng, HL; Hang, CH; Shi, JX				Sun, Kang-jian; Zhu, Lin; Wang, Han-dong; Ji, Xiang-jun; Pan, Hao; Chen, Min; Lu, Tin -jia; Fan, You-wu; Cheng, Hui-lin; Hang, Chun-hua; Shi, Ji-xin			Zinc as mediator of ubiquitin conjugation following traumatic brain injury	BRAIN RESEARCH			English	Article						Neuron; Traumatic brain injury; Ubiquitin; Zinc	HIPPOCAMPAL-NEURONS; IN-VITRO; EXPRESSION; PATHWAY; DEATH; DEUBIQUITINATION; AUTOFLUORESCENCE; NEUROTOXICITY; DEGRADATION; NEDD4-1	Previous studies have shown that pathological zinc accumulation and deposition of ubiquitinated protein aggregates are commonly detected in many acute neural injuries, such as trauma, epilepsy and ischemia. However, the underlying mechanisms are poorly understood. Here we assessed the effect of zinc on ubiquitin conjugation and subsequent neurodegeration following traumatic brain injury (TBI). First, we found that scavenging endogenous Zn2+ reduced trauma-induced ubiquitin conjugation and protected neurons from TBI insults in rat hippocampus. Second, we detected both zinc accumulation and increased ubiquitin conjugated protein following brain trauma in human cortical neurons. Our previous study has shown that zinc can induce ubiquitin conjugation in cultured hippocampal neurons. All these findings indicate that alterations in Zn2+ homeostasis may impair the protein degradation pathway and ultimately cause neuronal injury following traumatic brain injury. (C) 2013 Elsevier B.V. All rights reserved.	[Sun, Kang-jian; Zhu, Lin; Wang, Han-dong; Ji, Xiang-jun; Pan, Hao; Fan, You-wu; Cheng, Hui-lin; Hang, Chun-hua; Shi, Ji-xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Min; Lu, Tin -jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurosci, Inst Neurosci State, Shanghai, Peoples R China		Zhu, L (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	linzhu75@163.com	Chen, Min/A-1134-2014		Jinling Hospital of Nanjing [10MA097]; Chines Postdoctoral Science FoundationChina Postdoctoral Science Foundation [201150M1572]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271377/H0910]	The authors gratefully acknowledge Professor Zhang-You Wang (Department of Cell Engineering, China Medical University, Shenyang) for providing us with silver lactate and Professor Zhi-Qi Xiong (Institute of Neuroscience State, Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) for technical assistance. This work was financially supported by the Jinling Hospital of Nanjing (Grant No 10MA097), the Chines Postdoctoral Science Foundation (Grant No 201150M1572) and the National Natural Science Foundation of China ( Grant 81271377/H0910).	BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Chen M, 2009, J NEUROCHEM, V111, P1094, DOI 10.1111/j.1471-4159.2009.06401.x; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Elleder M, 2001, HISTOCHEM J, V33, P273, DOI 10.1023/A:1017925023408; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Figueiredo-Pereira ME, 1999, MOL BIOL REP, V26, P65, DOI 10.1023/A:1006909918866; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Gil MLG, 2001, J NEUROL SCI, V192, P27, DOI 10.1016/S0022-510X(01)00587-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; He CZ, 2004, J NEUROL SCI, V217, P47, DOI 10.1016/j.jns.2003.08.016; Ide T, 1999, J CEREBR BLOOD F MET, V19, P750, DOI 10.1097/00004647-199907000-00004; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Majetschak M, 2008, J TRAUMA, V64, P586, DOI 10.1097/TA.0b013e3181641bc5; Mizukami K, 2002, ACTA NEUROPATHOL, V103, P453, DOI 10.1007/s00401-001-0489-1; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Watanabe T, 2010, J NEUROL SCI, V298, P52, DOI 10.1016/j.jns.2010.08.026; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhu L, 2012, BRAIN RES, V1438, P1, DOI 10.1016/j.brainres.2011.12.031; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	31	14	14	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 19	2013	1506						132	141		10.1016/j.brainres.2013.02.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134KJ	WOS:000318208800012	23419896				2022-02-06	
J	Baranyi, A; Rothenhausler, HB				Baranyi, Andreas; Rothenhaeusler, Hans-Bernd			The impact of S100b and persistent high levels of neuron-specific enolase on cognitive performance in elderly patients after cardio-pulmonary bypass	BRAIN INJURY			English	Article						Neuron-specific enolase; S100 calcium-binding protein B; cognitive performance; cardiopulmonary bypass; intensive care unit	CORONARY-ARTERY-BYPASS; TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; FOLLOW-UP; NEUROCOGNITIVE FUNCTION; BIOCHEMICAL MARKERS; VALVE-REPLACEMENT; S-100 PROTEIN; DAMAGE; ASSOCIATION	Primary objectives: The primary aim was to investigate the impact of neuron-specific enolase (NSE) and S100 calcium-binding protein B (S100b) on cognitive functioning after cardiopulmonary bypass (CPB). Research design: Prospective exploratory study. Setting: Psychiatric Consultation-Liaison Service, Ludwig-Maximilians-University Medical School, Munich, Germany. Participants: Thirty-four patients who underwent elective CPB. Measurements: Before the CPB and on the day before discharge neurocognitive tests based on the Syndrom Kurztest (SKT) were carried out. During the ICU stay and shortly after discharge from the ICU, the delirious state was evaluated daily using the Delirium-Rating-Scale. NSE and S100b levels were assayed before CPB, 24 hours and 48 hours post-operatively and on the day before discharge. Results: After the CPB, 1 day before discharge, six (17.6%) participants had sub-threshold cognitive deficits and seven (20.6%) had clinically significant cognitive deficits. A trend toward persistently high NSE levels at discharge indicates greater cognitive impairment at the time of discharge. After surgical intervention S100b is elevated in all patients, independent of cognitive status. Conclusions: Persistently high levels of NSE might be a useful biomarker to identify patients with cognitive performance impairments, while no significant correlation between levels of S100b and impaired cognitive function were found.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd] Univ Med Graz, Dept Psychiat, A-8036 Graz, Austria; [Rothenhaeusler, Hans-Bernd] Univ Munich, Dept Psychiat, D-80539 Munich, Germany		Baranyi, A (corresponding author), Univ Med Graz, Dept Psychiat, Auenbruggerpl 31, A-8036 Graz, Austria.	andreas.baranyi@klinikum-graz.at		Baranyi, Andreas/0000-0003-2389-1945			Anastasiadis K, 2011, HEART, V97, P1082, DOI 10.1136/hrt.2010.218610; Bankier B, 2002, PSYCHOTHER PSYCHOSOM, V71, P133, DOI 10.1159/000056280; Basile AM, 2001, EUR NEUROL, V45, P151, DOI 10.1159/000052114; Chiappini B, 2003, CARDIOVASC SURG, V11, P359, DOI 10.1016/S0967-2109(03)00104-2; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; Feil D, 2003, AM J GERIAT PSYCHIAT, V11, P551, DOI 10.1176/appi.ajgp.11.5.551; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Gerriets T, 2010, AM J CARDIOL, V105, P1095, DOI 10.1016/j.amjcard.2009.12.009; Herrmann M, 1999, EUR J CARDIO-THORAC, V16, P513, DOI 10.1016/S1010-7940(99)00245-6; Kendel F, 2011, PSYCHOSOM MED, V73, P280, DOI 10.1097/PSY.0b013e3182114d35; KIMBALL CP, 1973, PSYCHOTHER PSYCHOSOM, V22, P310, DOI 10.1159/000286536; Kneebone AC, 2005, J NEUROL NEUROSUR PS, V76, P1121, DOI 10.1136/jnnp.2004.047456; Lehfeld H, 1997, Int Psychogeriatr, V9 Suppl 1, P115; MATTLAR CE, 1991, PSYCHOTHER PSYCHOSOM, V55, P145, DOI 10.1159/000288422; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4; McKhann GM, 1997, ANN THORAC SURG, V63, P510; MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Peterson JC, 2002, AM J GERIAT PSYCHIAT, V10, P192, DOI 10.1176/appi.ajgp.10.2.192; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; Prohl J, 2009, J INT NEUROPSYCH SOC, V15, P344, DOI 10.1017/S1355617709090493; Ramlawi B, 2006, ANN SURG, V244, P593, DOI 10.1097/01.sla.0000239087.00826.b4; Rasmussen LS, 1999, ACTA ANAESTH SCAND, V43, P495, DOI 10.1034/j.1399-6576.1999.430502.x; Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718; Rothenhausler HB, 2005, GEN HOSP PSYCHIAT, V27, P18, DOI 10.1016/j.genhosppsych.2004.09.001; SHAW PJ, 1985, BRIT MED J, V291, P1384, DOI 10.1136/bmj.291.6506.1384; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stroobant N, 2009, HEART, V95, P1820, DOI 10.1136/hrt.2009.168237; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; van Dijk D, 2004, HEART, V90, P431, DOI 10.1136/hrt.2003.010173; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399	34	14	22	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2013	27	4					417	424		10.3109/02699052.2012.750751			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300006	23473361				2022-02-06	
J	Porter, CK; Thura, N; Riddle, MS				Porter, Chad K.; Thura, Nadia; Riddle, Mark S.			Quantifying the Incidence and Burden of Postinfectious Enteric Sequelae	MILITARY MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; FUNCTIONAL GASTROINTESTINAL DISORDERS; SALMONELLA REACTIVE ARTHRITIS; SYNDROME FOLLOWING INFECTION; BACTERIAL GASTROENTERITIS; CAMPYLOBACTER-JEJUNI; FOLLOW-UP	Background: Evidence continues to reveal that travelers' diarrhea (TD) may be associated with several chronic conditions. We quantified the burden of these TD sequelae (TDS) and compared it to post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI), both well-appreciated long-term health outcomes (LTHO) of deployment. Methods: A systematic review of outcome-specific incidence and disability was conducted to estimate years lived with disability (YLDs) allowing for comparisons of disease burden across outcomes. Results: Estimates varied within outcomes across publication year, study design, and data source. YLD estimates showed that although PTSD results in the highest overall disability (1,225 per 100,000), the impact of TDS is similarly elevated with the greatest burden associated with irritable bowel syndrome (627 per 100,000) followed by reactive arthritis (139). Conclusion: Given the significant impact of the acute effects of TD on troop readiness and the growing appreciation for its LTHO, the need for improved primary prevention strategies are evident. Additional study of the pathogen-specific risk of these sequelae and duration and level of disability are needed to further refine our understanding of morbidity and inform evidence-based decisions on policy toward disease mitigation among those put in harm's way.	[Porter, Chad K.; Thura, Nadia; Riddle, Mark S.] Naval Med Res Ctr, Infect Dis Res Directorate, Enter Dis Dept, Silver Spring, MD 20910 USA		Porter, CK (corresponding author), Naval Med Res Ctr, Infect Dis Res Directorate, Enter Dis Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.		Riddle, Mark/R-8788-2019	Riddle, Mark/0000-0002-0607-7880; Saif, Nadia/0000-0001-5024-0676	Military Infectious Disease Research Program	This study was conducted under support of the Military Infectious Disease Research Program.	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; [Anonymous], 2006, Clin Privil White Pap, P1; [Anonymous], 2008, 9780833044549 RAND C; Bernsen RAJAM, 2002, J NEUROL SCI, V201, P13, DOI 10.1016/S0022-510X(02)00158-2; Bevan Gwyn, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P469, DOI 10.1586/14737167.3.4.469; Borgaonkar MR, 2006, DIGEST DIS SCI, V51, P1026, DOI 10.1007/s10620-006-9348-1; BREMELL T, 1991, ANN RHEUM DIS, V50, P934, DOI 10.1136/ard.50.12.934; Cumberland P, 2003, EPIDEMIOL INFECT, V130, P453, DOI 10.1017/S0950268803008410; Curry JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-266; DeFraites RF, 2011, MIL MED, V176, P17, DOI 10.7205/MILMED-D-11-00115; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Dworkin MS, 2001, CLIN INFECT DIS, V33, P1010, DOI 10.1086/322644; EASTMOND CJ, 1983, J RHEUMATOL, V10, P107; Garg AX, 2008, RHEUMATOLOGY, V47, P200, DOI 10.1093/rheumatology/kem339; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gaylord KM, 2008, J TRAUMA, V64, pS5; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Gray GC, 1996, NEW ENGL J MED, V335, P1505, DOI 10.1056/NEJM199611143352007; Gwee KA, 1996, LANCET, V347, P150, DOI 10.1016/S0140-6736(96)90341-4; Haagsma JA, 2008, INJURY PREV, V14, P5, DOI 10.1136/ip.2007.017178; Haagsma JA, 2006, 3303310012009 RIVM I; Haagsma JA, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-10; Haagsma Juanita A, 2008, Popul Health Metr, V6, P7, DOI 10.1186/1478-7954-6-7; HAKANSSON U, 1976, SCAND J INFECT DIS, V8, P245, DOI 10.3109/inf.1976.8.issue-4.05; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Hanevik K, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-27; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Hannu T, 2005, ANN RHEUM DIS, V64, P594, DOI 10.1136/ard.2004.027524; Hannu T, 2002, ANN RHEUM DIS, V61, P264, DOI 10.1136/ard.61.3.264; Hannu T, 2011, BEST PRACT RES CL RH, V25, P347, DOI 10.1016/j.berh.2011.01.018; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hermann BA, 2012, MIL MED, V177, P1; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ilnyckyj A, 2003, AM J GASTROENTEROL, V98, P596, DOI [10.1016/S0002-9270(02)06019-7, 10.1111/j.1572-0241.2003.07297.x]; INMAN RD, 1988, ARTHRITIS RHEUM, V31, P1377, DOI 10.1002/art.1780311106; Institute of Medicine, 2008, GULF WAR HLTH, V7; Institute of Medicine (IOM), 2008, TREATM POSTTR STRESS, P21; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; Kim Hee Sun, 2006, Korean J Gastroenterol, V47, P300; KOSUNEN TU, 1980, LANCET, V1, P1312; LAUHIO A, 1988, ARTHRITIS RHEUM, V31, P1190, DOI 10.1002/art.1780310917; Locht H, 2002, J RHEUMATOL, V29, P767; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Mathers C., 1999, BURDEN DIS INJURY AU; Mattila L, 1998, J INFECTION, V36, P289, DOI 10.1016/S0163-4453(98)94243-8; McCarthy N, 1999, EPIDEMIOL INFECT, V122, P15, DOI 10.1017/S0950268898001861; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; McColl GJ, 2000, AUST NZ J MED, V30, P28, DOI 10.1111/j.1445-5994.2000.tb01050.x; MCKENDRICK MW, 1994, J INFECTION, V29, P1, DOI 10.1016/S0163-4453(94)94871-2; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1053/j.gastro.2005.04.012; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Neal KR, 1997, BRIT MED J, V314, P779, DOI 10.1136/bmj.314.7083.779; Nelson Laura, 2009, BMC Res Notes, V2, P171, DOI 10.1186/1756-0500-2-171; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Parry SD, 2003, AM J GASTROENTEROL, V98, P1970, DOI 10.1016/S0002-9270(03)00627-0; Piche T, 2007, CAN J GASTROENTEROL, V21, P727, DOI 10.1155/2007/262478; Pitzurra R, 2011, J TRAVEL MED, V18, P250, DOI 10.1111/j.1708-8305.2011.00529.x; Pope JE, 2007, SEMIN ARTHRITIS RHEU, V37, P48, DOI 10.1016/j.semarthrit.2006.12.006; Porter CK, 2008, GASTROENTEROLOGY, V135, P781, DOI 10.1053/j.gastro.2008.05.081; Porter CK, 2011, DIGEST DIS SCI, V56, P3262, DOI 10.1007/s10620-011-1762-3; Porter CK, 2011, AM J GASTROENTEROL, V106, P130, DOI 10.1038/ajg.2010.371; Rees JR, 2004, CLIN INFECT DIS, V38, pS311, DOI 10.1086/381601; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Rodriguez LAG, 1999, BRIT MED J, V318, P565, DOI 10.1136/bmj.318.7183.565; Rohekar S, 2008, J RHEUMATOL, V35, P1599; Ruigomez A, 2007, CLIN GASTROENTEROL H, V5, P465, DOI 10.1016/j.cgh.2007.02.008; Sanderson K, 2001, AUST NZ J PSYCHIAT, V35, P668, DOI 10.1046/j.1440-1614.2001.00931.x; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schiellerup P, 2008, J RHEUMATOL, V35, P480; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sostek MB, 1996, AM J GASTROENTEROL, V91, P2494; Soyturk M, 2007, AM J GASTROENTEROL, V102, P1064, DOI 10.1111/j.1572-0241.2007.01084.x; Stermer E, 2006, CLIN INFECT DIS, V43, P898, DOI 10.1086/507540; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Ternhag A, 2008, EMERG INFECT DIS, V14, P143, DOI 10.3201/eid1401.070524; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; THOMSON GTD, 1995, AM J MED, V98, P13, DOI 10.1016/S0002-9343(99)80076-X; THOMSON GTD, 1992, CLIN IMMUNOL IMMUNOP, V64, P227, DOI 10.1016/0090-1229(92)90204-2; Townes JM, 2010, CLIN INFECT DIS, V50, P247, DOI 10.1086/649540; Uotila T, 2011, SCAND J RHEUMATOL, V40, P358, DOI 10.3109/03009742.2011.562533; Wang LH, 2004, GUT, V53, P1390, DOI 10.1136/gut.2003.021154corr1; World Health Organization, NAT BURD DIS SUPPL F	92	14	14	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2013	178	4					452	469		10.7205/MILMED-D-12-00510			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7TY	WOS:000340805100019	23707833	Bronze			2022-02-06	
J	Dapul, HR; Park, J; Zhang, J; Lee, C; DanEshmand, A; Lok, J; Ayata, C; Gray, T; Scalzo, A; Qiu, JH; Lo, EH; Whalen, MJ				Dapul, Heda R.; Park, Juyeon; Zhang, Jimmy; Lee, Christopher; DanEshmand, Ali; Lok, Josephine; Ayata, Cenk; Gray, Tory; Scalzo, Allison; Qiu, Jianhua; Lo, Eng H.; Whalen, Michael J.			Concussive Injury before or after Controlled Cortical Impact Exacerbates Histopathology and Functional Outcome in a Mixed Traumatic Brain Injury Model in Mice	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cognition; concussion; controlled cortical impact; mice; models	DIFFUSE AXONAL INJURY; MICROGLIAL ACTIVATION; SEIZURE SUSCEPTIBILITY; CEREBRAL CONCUSSION; COGNITIVE DEFICITS; CELL-DEATH; RATS; NEURODEGENERATION; PATHOPHYSIOLOGY; INCREASES	Traumatic brain injury (TBI) may involve diverse injury mechanisms (e. g., focal impact vs. diffuse impact loading). Putative therapies developed in TBI models featuring a single injury mechanism may fail in clinical trials if the model does not fully replicate multiple injury subtypes, which may occur concomitantly in a given patient. We report development and characterization of a mixed contusion/concussion TBI model in mice using controlled cortical impact (CCI; 0.6mm depth, 6 m/sec) and a closed head injury (CHI) model at one of two levels of injury (53 vs. 83 g weight drop from 66 in). Compared with CCI or CHI alone, sequential CCI-CHI produced additive effects on loss of consciousness (p < 0.001), acute cell death (p < 0.05), and 12-day lesion size (p < 0.05) but not brain edema or 48-h contusion volume. Additive effects of CHI and CCI on post-injury motor (p < 0.05) and cognitive (p < 0.005) impairment were observed with sequential CCI-CHI (83 g). The data suggest that concussive forces, which in isolation do not induce histopathological damage, exacerbate histopathology and functional outcome after cerebral contusion. Sequential CHI-CCI may model complex injury mechanisms that occur in some patients with TBI and may prove useful for testing putative therapies.	[Dapul, Heda R.; Park, Juyeon; Zhang, Jimmy; Lee, Christopher; DanEshmand, Ali; Lok, Josephine; Ayata, Cenk; Qiu, Jianhua; Lo, Eng H.; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA USA; [Dapul, Heda R.; Park, Juyeon; Zhang, Jimmy; Lee, Christopher; Lok, Josephine; Gray, Tory; Qiu, Jianhua; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA USA; [DanEshmand, Ali; Ayata, Cenk; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA; [Ayata, Cenk; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Scalzo, Allison] Penn State Univ, University Pk, PA 16802 USA		Whalen, MJ (corresponding author), Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA 02129 USA.	mwhalen@partners.org		Dapul, Heda/0000-0002-7209-1285	 [1R21NS075226];  [RO1NS047447];  [RO1NS064545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447, R01NS064545, R21NS075226, K08NS057339] Funding Source: NIH RePORTER	This work was supported by 1R21NS075226, RO1NS047447 and RO1NS064545 (MJW).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; JENKINS A, 1986, LANCET, V2, P445; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Mirzayan MJ, 2012, EXP TOXICOL PATHOL, V64, P133, DOI 10.1016/j.etp.2010.07.007; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Wang XJ, 2011, FREE RADICAL BIO MED, V50, P1094, DOI 10.1016/j.freeradbiomed.2011.01.032; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhou Y, 2005, MOL CELL PROTEOMICS, V4, P1471, DOI 10.1074/mcp.M500114-MCP200	43	14	16	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	5					382	391		10.1089/neu.2012.2536			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	103CI	WOS:000315891600008	23153355	Green Published			2022-02-06	
J	Li, W; Liu, HD; You, WC; Zhou, ML; Ling, HP; Shen, W; Zhu, L; Hang, CH				Li, Wei; Liu, Huan-Dong; You, Wan-Chun; Zhou, Meng-Liang; Ling, Hai-Ping; Shen, Wei; Zhu, Lin; Hang, Chun-Hua			Enhanced cortical expression of myeloid differentiation primary response protein 88 (Myd88) in patients with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Myd88; TBI; Human; Inflammatory response; NF-kappa B	FACTOR-KAPPA-B; SIGNALING PATHWAY; CEREBRAL-CORTEX; CONTUSION; RATS; INVOLVEMENT; ACTIVATION; REPERFUSION; CYTOKINES; ISCHEMIA	Background: Inflammatory response has been proven to play a crucial role in the pathophysilogical process after traumatic brain injury (TBI). Myeloid differentiation primary response protein 88 (Myd88) is considered as a vital factor for inflammation and immunity. Therefore, it is essential to know the detailed expression of Myd88 after TBI. However, the expression patterns of Myd88 in patients with TBI remain obscure. Hence, the aim of present study was to investigate the cortical expression of Myd88 in human contused brain. Methods: Nineteen contused brain tissue biopsies were obtained from 19 patients undergoing surgery for brain contusions 3 h-17 d after trauma, and samples of control group were from three patients in the pathway during surgical removal of deep benign tumors. The expression of Myd88 was assessed by quantitative real-time polymerase chain reaction, Western blotting, immunohistochemistry and double immunofluorescent staining, and the messenger RNA (mRNA) levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin 1beta (IL-1 beta) were measured by quantitative real-time polymerase chain reaction. Results: The progressively elevated mRNA and protein levels of Myd88 were detected after trauma, with the maximum after 72 h post-injury, and the distribution of Myd88 was found in neurons, astrocytes, and microglia. TNF-alpha and IL-1 beta mRNA levels ascended significantly within 12 h, and then descended gradually until after 72 h post-injury. Interestingly, there was a positive relationship between the expression of Myd88 and the proinflammatory cytokine TNF-alpha. Conclusions: These findings indicated that Myd88 might play an important role in the inflammatory response after human TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Li, Wei; You, Wan-Chun; Zhou, Meng-Liang; Zhu, Lin; Hang, Chun-Hua] Jinling Hosp, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Liu, Huan-Dong; Zhou, Meng-Liang; Ling, Hai-Ping; Shen, Wei; Zhu, Lin; Hang, Chun-Hua] So Med Univ Guangzhou, Dept Neurosurg, Sch Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China		Hang, CH (corresponding author), Jinling Hosp, Dept Neurosurg, Jinling Hosp, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021	Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170, 8100053, 81271377]; Nature Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	The authors acknowledge support for this study by grants from National Natural Science Foundation, China (no. 81171170 to C.-H. H., no. 8100053 to M.-L. Z., and no. 81271377 to L. Z.) and Nature Science Foundation of Jiangsu Province, China (BK2010459).	Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Gao Y, 2009, BIOMED PHARMACOTHER, V63, P442, DOI 10.1016/j.biopha.2008.06.028; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hua F, 2009, BIOCHEM BIOPH RES CO, V390, P678, DOI 10.1016/j.bbrc.2009.10.027; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li W, 2012, NEUROL SCI; Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Sette Claudio, 2007, J Leukoc Biol, V82, P811; Victoni T, 2010, MED MICROBIOL IMMUN, V199, P35, DOI 10.1007/s00430-009-0134-5; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	25	14	16	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2013	180	1					133	139		10.1016/j.jss.2012.10.928			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	089LQ	WOS:000314912400028	23186691				2022-02-06	
J	Valiyaveettil, M; Alamneh, Y; Wang, Y; Arun, P; Oguntayo, S; Wei, YL; Long, JB; Nambiar, MP				Valiyaveettil, Manojkumar; Alamneh, Yonas; Wang, Ying; Arun, Peethambaran; Oguntayo, Samuel; Wei, Yanling; Long, Joseph B.; Nambiar, Madhusoodana P.			Contribution of systemic factors in the pathophysiology of repeated blast-induced neurotrauma	NEUROSCIENCE LETTERS			English	Article						Repeated blast exposure; Platelets; Leukocytes; Systemic factors; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; LYSOPHOSPHATIDIC ACID; SUICIDAL-BEHAVIOR; INTRACRANIAL-PRESSURE; NERVOUS-SYSTEM; SEROTONIN; MYELOPEROXIDASE; PLATELETS; MODEL; OVERPRESSURE	Blast-induced traumatic brain injury is complex and involves multiple factors including systemic pathphysiological factors in addition to direct brain injuries. We hypothesize that systemic activation of platelets/leukocytes plays a major role in the development and exacerbation of brain injury after blast exposure. A mouse model of repeated blast exposure that results in significant neuropathology, neurobehavioral changes and regional specific alterations in various biomolecules in the brain was used for the proposed study. Activation of platelets was evaluated by flow cytometry and serotonin content was analyzed by ELISA. Expression of myeloperoxidase was analyzed by Western blotting. Histopathology of the brain was used to assess blast-induced cerebral vasoconstriction. The data showed an increase in the activation of platelets at 4 h after repeated blast exposures, indicating changes in platelet phenotype in blast neurotrauma. Platelet serotonin concentration showed a significant decrease at 4 h after blast with a concurrent increase in the plasma serotonin levels, confirming the early onset of platelet activation after repeated blast exposures. Blood, plasma and brain myeloperoxidase enzyme activity and expression was increased in repeated blast exposed mice at multiple time points. Histopathological analysis of the brains of blast exposed mice showed constriction of blood vessels compared to the respective controls, a phenomenon similar to the reported cerebral vasoconstriction in blast affected victims. These results suggest that repeated blast exposure leads to acute activation of platelets/leukocytes which can augment the pathological effects of brain injury. Platelet/leukocyte targeted therapies can be evaluated as potential acute treatment strategies to mitigate blast-induced neurotrauma. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Valiyaveettil, Manojkumar; Alamneh, Yonas; Wang, Ying; Arun, Peethambaran; Oguntayo, Samuel; Wei, Yanling; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	m.valiyaveettil@us.army.mil; madhunambiar1@gmail.com					Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Frisca F, 2012, INT REV CEL MOL BIO, V296, P273, DOI 10.1016/B978-0-12-394307-1.00005-9; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; GARCIA JH, 1994, AM J PATHOL, V144, P188; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Gorbunov NV, 2005, INT J IMMUNOPATH PH, V18, P547, DOI 10.1177/039463200501800315; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovacic Z, 2008, PROG NEURO-PSYCHOPH, V32, P544, DOI 10.1016/j.pnpbp.2007.10.014; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Noguchi N, 2000, J BIOCHEM-TOKYO, V127, P971, DOI 10.1093/oxfordjournals.jbchem.a022713; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ryding E, 2008, PROG BRAIN RES, V172, P307, DOI 10.1016/S0079-6123(08)00915-1; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; VITOLO E, 1962, BRIT HEART J, V24, P422; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; WHITE JG, 1969, BLOOD-J HEMATOL, V33, P598, DOI 10.1182/blood.V33.4.598.598; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	31	14	15	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 28	2013	539						1	6		10.1016/j.neulet.2013.01.028			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120FJ	WOS:000317155900001	23370286				2022-02-06	
J	Hawkins, BE; Cowart, JC; Parsley, MA; Capra, BA; Eidson, KA; Hellmich, HL; DeWitt, DS; Prough, DS				Hawkins, Bridget E.; Cowart, Jeremy C.; Parsley, Margaret A.; Capra, Bridget A.; Eidson, Kristine A.; Hellmich, Helen L.; DeWitt, Douglas S.; Prough, Donald S.			Effects of trauma, hemorrhage and resuscitation in aged rats	BRAIN RESEARCH			English	Article						Age; Cerebral blood flow; Hemorrhage; Neuron cell death; Traumatic brain injury; Fluid percussion injury	CEREBRAL-BLOOD-FLOW; PERCUSSION BRAIN-INJURY; HEAD-INJURY; AUTO-REGULATION; CEREBROVASCULAR RESPONSES; FLUORO-JADE; ISCHEMIA; HYPOTENSION; HYPERTENSION; PRESSURE	Traumatic brain injury (TBI) is a leading cause of death in the elderly and the incidence of mortality and morbidity increases with age. This study tested the hypothesis that, after TBI followed by hemorrhagic hypotension (HH) and resuscitation, cerebral blood flow (CBF) would decrease more in aged compared with young rats. Young adult (4-6 months) and aged (20-24 months) male Sprague-Dawley rats were anesthetized with isoflurane, prepared for parasagittal fluid percussion injury (FPI) and randomly assigned to receive either moderate FPI (2.0 atm) only, moderate FPI+severe HH (40 mm Hg for 45 min) followed by return of shed blood, or sham FPI. Intracranial pressure (ICP), CBF, and mean arterial pressure (MAP) were measured and, after twenty-four hours survival, the rats were euthanized and their brains were sectioned and stained with Fluoro-Jade (FJ), a dye that stains injured neurons. After moderate FPI, severe HH and reinfusion of shed blood, MAP and CBF were significantly reduced in the aged group, compared to the young group. Both FPI and FPI+HH groups significantly increased the numbers of FJ-positive neurons in hippocampal cell layers CA1, CA2 and CA3 (p<0.05 vs Sham) in young and aged rats. Despite differences in post-resuscitation MAP and CBF, there were no differences in the numbers of FJ-positive neurons in aged compared to young rats after FPI, HH and blood resuscitation. Although cerebral hypoperfusion in the aged rats was not associated with increased hippocampal cell injury, the trauma-induced reductions in CBF and post-resuscitation blood pressure may have resulted in damage to brain regions that were not examined or neurological or behavioral impairments that were not assessed in this study. Therefore, the maintenance of normal blood pressure and cerebral perfusion would be advisable in the treatment of elderly patients after TBI. (c) 2013 Elsevier B.V. All rights reserved.	[Hawkins, Bridget E.; Cowart, Jeremy C.; Parsley, Margaret A.; Capra, Bridget A.; Eidson, Kristine A.; Hellmich, Helen L.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA		Hawkins, BE (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	behawkin@utmb.edu; jccowart@live.com; maparsle@utmb.edu; bacapra@utmb.edu; kristyeidson@yahoo.com; hhellmic@utmb.edu; ddewitt@utmb.edu; dsprough@utmb.edu	Hawkins, Bridget/H-4933-2015; Prough, Donald S/G-5793-2013	Hawkins, Bridget/0000-0002-1887-3657; Prough, Donald S/0000-0001-7994-532X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS19355]; UTMB Sealy Center on Aging; Moody Center for Traumatic Brain and Spinal Cord Injury Research/Mission Connect; NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [5T32ES007254-17]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER	This study was supported in part by grants from the National Institutes of Health (NS19355 to DSD), UTMB Sealy Center on Aging (DSP) and Moody Center for Traumatic Brain and Spinal Cord Injury Research/Mission Connect (to DSD). Bridget E. Hawkins' work was supported by a predoctoral fellowship under NIEHS Grant no. 5T32ES007254-17 ("Molecular Mechanisms for Environmental Injury," Dr. Mary Moslen, PI). We thank Tatsuo Uchida for his help performing the post-hoc power analysis.	Armstead WM, 2002, J NEUROTRAUM, V19, P1193, DOI 10.1089/08977150260337994; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Castillo-Ruiz MM, 2007, EXP GERONTOL, V42, P343, DOI 10.1016/j.exger.2006.10.008; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; GOZES I, 1981, J NEUROCHEM, V36, P1311, DOI 10.1111/j.1471-4159.1981.tb01738.x; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hawkins BE, 2012, BRAIN RES, V1432, P28, DOI 10.1016/j.brainres.2011.11.009; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; HOFFMAN WE, 1981, BRAIN RES, V214, P196, DOI 10.1016/0006-8993(81)90454-6; HONGO K, 1988, STROKE, V19, P892, DOI 10.1161/01.STR.19.7.892; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Ley EJ, 2012, J SURG RES, V177, P326, DOI 10.1016/j.jss.2012.05.019; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1138, DOI 10.1152/ajpheart.1990.258.4.H1138; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; SMEDA JS, 1992, CAN J PHYSIOL PHARM, V70, P552, DOI 10.1139/y92-070; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wasserman JK, 2008, EUR J NEUROSCI, V28, P1316, DOI 10.1111/j.1460-9568.2008.06442.x; ZHU CZ, 1995, J CEREBR BLOOD F MET, V15, P980, DOI 10.1038/jcbfm.1995.124	44	14	14	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 16	2013	1496						28	35		10.1016/j.brainres.2012.12.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	090WN	WOS:000315010800003	23274538	Green Accepted			2022-02-06	
J	Dagher, JH; Richard-Denis, A; Lamoureux, J; de Guise, E; Feyz, M				Dagher, Jehane H.; Richard-Denis, Andreane; Lamoureux, Julie; de Guise, Elaine; Feyz, Mitra			Acute global outcome in patients with mild uncomplicated and complicated traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; acute care; outcome	GLASGOW COMA SCALE; HEAD-INJURY; PREDICTION; ALCOHOL; INTOXICATION; PROGNOSIS; RECOVERY; TIME	Primary objective: This study assesses the influence of socio-demographic, psychosocial, clinical and radiological variables on the outcome of patients with mild traumatic brain injury (MTBI) in an acute care inpatient setting. Research design: Retrospective cohort study. Methods and procedure: A total of 2127 inpatients with MTBI were included. Outcomes measured were Extended Glasgow Outcome Scale (GOS-E), the FIM (R) instrument, length of stay (LOS) and discharge destination. Main outcomes and results: Fifty-four per cent of patients with MTBI with a median GOS-E of 2 were discharged home with no need for further follow-up. Age, LOS, lower Glasgow score (GCS) at admission, insurance coverage and positive CT scans were associated with rehabilitation referrals on discharge. Age, LOS, alcohol and drug abuse, motor vehicle collision and lower GCS at admission were associated with greater physical disabilities and functional impairment at discharge. FIM (R) cognitive functional scores were higher in women, younger patients and patients without psychiatric disorders. Brain lesions were correlated with longer LOS. CT scan findings in patients with MTBI may help clinicians predict the final outcome and resources required for patient care during their hospitalization and on discharge. Conclusion: This study can help healthcare professionals in treating and planning future care of patients with MTBI.	[Dagher, Jehane H.] McGill Univ, Ctr Hlth, Phys Med & Rehabil Dept, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane H.; Richard-Denis, Andreane] Inst Readaptat Lindsay Gingras Montreal, Phys Med & Rehabil Dept, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [de Guise, Elaine; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada		Dagher, JH (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.			Lamoureux, Julie/0000-0002-4986-2504			Agence de la sante et des services sociaux de Montreal, 2011, PROJ ORG SERV INT MO, P23; Alban RF, 2010, AM SURGEON, V76, P1108; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Caplain S., 2008, J REHABILITATION M S, V22, P528; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; *CDCP, 2007, HEADS FACTS PHYS MIL; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	37	14	14	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					189	199		10.3109/02699052.2012.729288			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500007	23384216				2022-02-06	
J	Wang, KW; Chen, HJ; Lu, K; Liliang, PC; Huang, CK; Tang, PL; Tsai, YD; Wang, HK; Liang, CL				Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Huang, Chun-Kai; Tang, Pi-Lien; Tsai, Yu-Duan; Wang, Hao-Kuang; Liang, Cheng-Loong			Pneumonia in patients with severe head injury: incidence, risk factors, and outcomes	JOURNAL OF NEUROSURGERY			English	Article						severe head injury; pneumonia incidence; risk factor; traumatic brain injury	INTENSIVE-CARE; PULMONARY COMPLICATIONS; NOSOCOMIAL PNEUMONIA; TRACT-INFECTION; SEVERE TRAUMA; STROKE; DYSPHAGIA; FAILURE; VICTIMS; TRIAL	Object. The reported incidence of hospital-acquired bacterial pneumonia in critically ill trauma patients varies from as low as 4% to as high as 87%, with fatality rates varying from 6% to 59%. Clinical studies have identified the risk factors for pneumonia. The authors undertook this retrospective study to evaluate the incidence, risk factors, and outcomes of hospital-acquired bacterial pneumonia in a group of patients with severe head injuries. Methods. This was a retrospective review of consecutive adult patients admitted to the neurosurgical ICU in the authors' hospital because of severe head injury (Glasgow Coma Scale scores <= 8) between January 2008 and December 2010. Results. During the study period, 290 patients were admitted to the neurosurgical ICU. Multivariate Cox regression analysis showed that age (HR 1.01, 95% CI 1.001-1.02), nasogastric tube insertion (BR 4.56, 95% CI 1.11-18.64), and hemiplegia or hemiparesis (BR 3.79, 95% CI 2.01-7.17) were significantly associated with the development of pneumonia. Conclusions. The authors identified 3 risk factors (age, nasogastric tube insertion, and hemiplegia or hemiparesis) associated with the development of pneumonia in patients with severe head injury. This finding constituted the basis for developing a simple screening tool that can be used to assess the risk of occurrence of pneumonia in such patients. (http://thejns.org/doi/abs/10.3171/2012.10.JNS127)	[Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Tsai, Yu-Duan; Wang, Hao-Kuang; Liang, Cheng-Loong] I Shou Univ, Dept Neurosurg, E Da Hosp, Kaohsiung 824, Taiwan; [Huang, Chun-Kai] I Shou Univ, Dept Infect, E Da Hosp, Kaohsiung 824, Taiwan; [Tang, Pi-Lien] Fooyin Univ Hosp, Dept Nursing, Kaohsiung, Taiwan		Liang, CL (corresponding author), I Shou Univ, Dept Neurosurg, E Da Hosp, 1 E Da Rd, Kaohsiung 824, Taiwan.	ed100183@edah.org.tw		Wang, Hao-Kuang/0000-0002-1928-7502			Andermahr J, 2002, INFLAMM RES, V51, P265, DOI 10.1007/PL00000303; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRAUN SR, 1986, CRIT CARE MED, V14, P198, DOI 10.1097/00003246-198603000-00006; CRAIG CP, 1984, AM J INFECT CONTROL, V12, P233, DOI 10.1016/0196-6553(84)90114-7; CROSS AS, 1981, AM J MED, V70, P681, DOI 10.1016/0002-9343(81)90596-9; ESPERSEN F, 1981, J INFECT DIS, V144, P19, DOI 10.1093/infdis/144.1.19; FAIST E, 1992, SURGERY, V112, P562; FINK MP, 1990, CHEST, V97, P132, DOI 10.1378/chest.97.1.132; FULTON RL, 1975, SURG GYNECOL OBSTET, V140, P179; HALEY RW, 1981, AM J MED, V70, P51, DOI 10.1016/0002-9343(81)90411-3; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kostadima E, 2005, EUR RESPIR J, V26, P106, DOI 10.1183/09031936.05.00096104; LAFORCE FM, 1981, AM J MED, V70, P664, DOI 10.1016/0002-9343(81)90593-3; LANGER M, 1989, AM REV RESPIR DIS, V140, P302, DOI 10.1164/ajrccm/140.2.302; LANGER M, 1987, INTENS CARE MED, V13, P342; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; MILLER EH, 1984, SURG GYNECOL OBSTET, V159, P153; Richards Guy, 2011, J Intensive Care Med, V26, P34, DOI 10.1177/0885066610383949; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; SCHIMPFF SC, 1974, ANN SURG, V179, P352, DOI 10.1097/00000658-197403000-00017; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Walker WE, 1985, ANN SURG, V201, P705; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; Wong WP, 2000, PHYS THER, V80, P662, DOI 10.1093/ptj/80.7.662	32	14	17	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	2013	118	2					358	363		10.3171/2012.10.JNS127			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	076DY	WOS:000313937900020	23157183				2022-02-06	
J	Krawczyk, DC; de la Plata, CM; Schauer, GF; Vas, AK; Keebler, M; Tuthill, S; Gardner, C; Jantz, T; Yu, WK; Chapman, SB				Krawczyk, Daniel C.; de la Plata, Carlos Marquez; Schauer, Guido F.; Vas, Asha K.; Keebler, Molly; Tuthill, Stephanie; Gardner, Claire; Jantz, Tiffani; Yu, Weikei; Chapman, Sandra B.			Evaluating the effectiveness of reasoning training in military and civilian chronic traumatic brain injury patients: study protocol	TRIALS			English	Article						Cognitive rehabilitation; Traumatic brain injury; Neuroimaging; Neuropsychology; Reasoning; Memory; Attention	WORKING-MEMORY; CORTEX; MILD; AREA	Background: Individuals who sustain traumatic brain injuries (TBIs) often continue to experience significant impairment of cognitive functions mediated by the prefrontal cortex well into chronic stages of recovery. Traditional brain training programs that focus on improving specific skills fall short of addressing integrative functions that draw upon multiple higher-order processes critical for social and vocational integration. In the current study, we compare the effects of two short-term, intensive, group-based cognitive rehabilitation programs for individuals with chronic TBI. One program emphasizes learning about brain functions and influences on cognition, while the other program adopts a top-down approach to improve abstract reasoning abilities that are largely reliant on the prefrontal cortex. These treatment programs are evaluated in civilian and military veteran TBI populations. Methods/design: One hundred individuals are being enrolled in this double-blinded clinical trial (all measures and data analyses will be conducted by blinded raters and analysts). Each individual is randomly assigned to one of two treatment conditions, with each condition run in groups of five to seven individuals. The primary anticipated outcomes are improvement in abstract reasoning and everyday life functioning, measured through behavioral tasks and questionnaires, and attention modulation, as measured by functional neuroimaging. Secondary expected outcomes include improvements in the cognitive processes of working memory, attention, and inhibitory control. Discussion: Results of this trial will determine whether cognitive rehabilitation aimed at teaching TBI-relevant information about the brain and cognition versus training in TBI-affected thinking abilities (e.g., memory, attention, and executive functioning) can improve outcomes in chronic military and civilian TBI patient populations. It should shed light on the nature of improvements and the characteristics of patients most likely to benefit. This trial will also provide information about the sustainability of treatment-related improvements 3 months post-training.	[Krawczyk, Daniel C.; de la Plata, Carlos Marquez; Schauer, Guido F.; Vas, Asha K.; Keebler, Molly; Tuthill, Stephanie; Gardner, Claire; Jantz, Tiffani; Yu, Weikei; Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75235 USA; [Krawczyk, Daniel C.; de la Plata, Carlos Marquez] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA		Krawczyk, DC (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 Mockingbird Lane, Dallas, TX 75235 USA.	daniel.krawczyk@utdallas.edu			US Department of Defense (DOD) through the program in Psychological Health/Traumatic Brain Injury (PH/TBI) of the Congressionally Directed Medical Research Programs (CDMRP) Cognitive Rehabilitation for TBI Clinical Trial Award [W81XWH-11-2-0194, W81XWH-11-2-01945]	This study is funded by the US Department of Defense (DOD) through the program in Psychological Health/Traumatic Brain Injury (PH/TBI) of the Congressionally Directed Medical Research Programs (CDMRP) Cognitive Rehabilitation for TBI Clinical Trial Award (Award W81XWH-11-2-0194 to DCK) and (Award W81XWH-11-2-01945 to SBC). The funding agency has not had a direct role in the design, data collection, analysis, or interpretation of the data for this study, nor have they had a direct role in the preparation of this manuscript or the decision to submit it. We would like to acknowledge Dr. John Hart for helpful input on various aspects of the design and implementation of the study and to thank Bruce Jones and Sarah Sprinkle for contributions to the administration of the study.	Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Alderman N, 2003, J INT NEUROPSYCH SOC, V12, P194; Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Binder DTG, 2008, BRAIN HEALTHW ROTM R; Burgess P.W., 1997, HAYLING BRIXTON TEST; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delis D. C., 2001, D KEFS EXECUTIVE FUN; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Faul M, 2010, TRAUMATIC BRAIN INJU; Gamino JF, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00188; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Humeniuk VD, 2008, TECHNICAL REPORT PHA; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Krawczyk DC, 2008, NEUROPSYCHOLOGIA, V46, P2020, DOI 10.1016/j.neuropsychologia.2008.02.001; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Sherer M., 2004, AWARENESS QUESTIONAI; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Weathers FLB, 1993, SAN ANT ANN M INT SO; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER MEMORY SCAL; WechslerD, 2001, WECHSLER TEST ADULT; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, BRAIN INJURY, V11, P403	40	14	14	1	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JAN 30	2013	14								29	10.1186/1745-6215-14-29			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	083WS	WOS:000314496700001	23363480	gold, Green Published			2022-02-06	
J	Gonzalez, MMC; Blaya, MO; Alonso, OF; Bramlett, HM; Hentall, ID				Gonzalez, Melissa M. Carballosa; Blaya, Meghan O.; Alonso, Ofelia F.; Bramlett, Helen M.; Hentall, Ian D.			Midbrain Raphe Stimulation Improves Behavioral and Anatomical Recovery from Fluid-Percussion Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cAMP; deep brain stimulation; forebrain trauma; forelimb reaching; neuroanatomical volume; water maze	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; PHA-L ANALYSIS; ELECTRICAL-STIMULATION; HIPPOCAMPAL-THETA; SEROTONIN RELEASE; MEDULLARY RAPHE; RAT; NUCLEUS; PROJECTIONS	The midbrain median raphe (MR) and dorsal raphe (DR) nuclei were tested for their capacity to regulate recovery from traumatic brain injury (TBI). An implanted, wireless self-powered stimulator delivered intermittent 8-Hz pulse trains for 7 days to the rat's MR or DR, beginning 4-6 h after a moderate parasagittal (right) fluid-percussion injury. MR stimulation was also examined with a higher frequency (24 Hz) or a delayed start (7 days after injury). Controls had sham injuries, inactive stimulators, or both. The stimulation caused no apparent acute responses or adverse long-term changes. In water-maze trials conducted 5 weeks post-injury, early 8-Hz MR and DR stimulation restored the rate of acquisition of reference memory for a hidden platform of fixed location. Short-term spatial working memory, for a variably located hidden platform, was restored only by early 8-Hz MR stimulation. All stimulation protocols reversed injury-induced asymmetry of spontaneous forelimb reaching movements tested 6 weeks post-injury. Post-mortem histological measurement at 8 weeks post-injury revealed volume losses in parietal-occipital cortex and decussating white matter (corpus callosum plus external capsule), but not hippocampus. The cortical losses were significantly reversed by early 8-Hz MR and DR stimulation, the white matter losses by all forms of MR stimulation. The generally most effective protocol, 8-Hz MR stimulation, was tested 3 days post-injury for its acute effect on forebrain cyclic adenosine monophosphate (cAMP), a key trophic signaling molecule. This procedure reversed injury-induced declines of cAMP levels in both cortex and hippocampus. In conclusion, midbrain raphe nuclei can enduringly enhance recovery from early disseminated TBI, possibly in part through increased signaling by cAMP in efferent targets. A neurosurgical treatment for TBI using interim electrical stimulation in raphe repair centers is suggested.	[Gonzalez, Melissa M. Carballosa; Blaya, Meghan O.; Alonso, Ofelia F.; Bramlett, Helen M.; Hentall, Ian D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33101 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA		Hentall, ID (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, R-48,POB 016960, Miami, FL 33101 USA.	ihentall@med.miami.edu		Hentall, Ian/0000-0002-9937-2546	Department of Defense (CDMPRP) [W81XWH-08-1-0288]; State of Florida	The work described in this article was supported by the Department of Defense (CDMPRP grant W81XWH-08-1-0288) and State of Florida funding. We thank Jessie S. Truettner, William J. Moreno, Scott S. Burns, Allison Irvine, Clayton Jackson, and Lizbeth Manoah for technical assistance.	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P405, DOI 10.1038/jcbfm.1986.73; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hentall ID, 2006, NEUROSCIENCE, V142, P893, DOI 10.1016/j.neuroscience.2006.06.038; Hentall ID, 2012, NEUROREHAB NEURAL RE, V26, P374, DOI 10.1177/1545968311425178; Hentall ID, 2009, J REHABIL RES DEV, V46, P109, DOI 10.1682/JRRD.2008.04.0054; HENTALL ID, 1984, J NEUROPHYSIOL, V51, P968, DOI 10.1152/jn.1984.51.5.968; Hobson SA, 2010, EXPERIENTIA SUPPL, V102, P25, DOI 10.1007/978-3-0346-0228-0_3; Hokfelt T, 1998, ANN NY ACAD SCI, V863, P252, DOI 10.1111/j.1749-6632.1998.tb10700.x; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Jackson J, 2008, J NEUROPHYSIOL, V99, P3009, DOI 10.1152/jn.00065.2008; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kanjhan R, 1999, J COMP NEUROL, V407, P11; Kitson SL, 2007, CURR PHARM DESIGN, V13, P2621, DOI 10.2174/138161207781663000; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Langhans W, 2007, P NUTR SOC, V66, P321, DOI 10.1017/S0029665107005587; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meyer-Bernstein EL, 1999, NEUROSCIENCE, V92, P267, DOI 10.1016/S0306-4522(98)00733-7; Mokler DJ, 2009, BRAIN RES BULL, V78, P132, DOI 10.1016/j.brainresbull.2008.09.017; MOLLIVER ME, 1987, J CLIN PSYCHOPHARM, V7, pS3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakamura K, 2001, NEUROSCIENCE, V103, P763, DOI 10.1016/S0306-4522(01)00027-6; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924, DOI 10.1152/ajpheart.2000.279.3.H924; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Garcia AS, 2011, J INVEST ALLERG CLIN, V21, P1; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Shannon R V, 1997, IEEE Trans Rehabil Eng, V5, P70, DOI 10.1109/86.559351; Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x; SUTHERLAND RJ, 1989, BEHAV NEURAL BIOL, V52, P331, DOI 10.1016/S0163-1047(89)90457-3; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Turlejski K, 1996, ACTA NEUROBIOL EXP, V56, P619; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; Vazey EM, 2006, EXP NEUROL, V199, P384, DOI 10.1016/j.expneurol.2006.01.034; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; VERTES RP, 1994, J COMP NEUROL, V340, P11, DOI 10.1002/cne.903400103; Wagner AK, 2012, PATHOPHYSIOLOGY; WHISHAW IQ, 1984, BEHAV BRAIN RES, V11, P123, DOI 10.1016/0166-4328(84)90135-9; Williams JM, 2003, HIPPOCAMPUS, V13, P109, DOI 10.1002/hipo.10082; Xiong Y, 2010, DISCOV MED, V10, P434; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	61	14	14	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	2					119	130		10.1089/neu.2012.2499			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	069NT	WOS:000313444000007	22963112	Green Published			2022-02-06	
J	Kalpinski, RJ; Williamson, MLC; Elliott, TR; Berry, JW; Underhill, AT; Fine, PR				Kalpinski, Ryan J.; Williamson, Meredith L. C.; Elliott, Timothy R.; Berry, Jack W.; Underhill, Andrea T.; Fine, Philip R.			Modeling the Prospective Relationships of Impairment, Injury Severity, and Participation to Quality of Life Following Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							INTERNATIONAL CLASSIFICATION; HEALTH; REHABILITATION; SATISFACTION; DISABILITY; PERFORMANCE; VALIDATION; PREDICTION; HAPPINESS; OUTCOMES	Identifying reliable predictors of positive adjustment following traumatic brain injury (TBI) remains an important area of inquiry. Unfortunately, much of available research examines direct relationships between predictor variables and outcomes without attending to the contextual relationships that can exist between predictor variables. Relying on theoretical models of well-being, we examined a theoretical model of adjustment in which the capacity to engage in intentional activities would be prospectively associated with greater participation, which in turn would predict subsequent life satisfaction and perceived health assessed at a later time. Structural equation modeling of data collected from 312 individuals (226 men, 86 women) with TBI revealed that two elements of participation-mobility and occupational activities-mediated the prospective influence of functional independence and injury severity to optimal adjustment 60 months following medical discharge for TBI. The model accounted for 21% of the variance in life satisfaction and 23% of the variance in self-rated health. Results indicate that the effects of functional independence and injury severity to optimal adjustment over time may be best understood in the context of participation in meaningful, productive activities. Implications for theoretical models of well-being and for clinical interventions that promote adjustment after TBI are discussed.	[Kalpinski, Ryan J.; Williamson, Meredith L. C.; Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA; [Berry, Jack W.] Samford Univ, Birmingham, AL 35229 USA; [Underhill, Andrea T.; Fine, Philip R.] Univ Alabama Birmingham, Injury Control Res Ctr, Birmingham, AL 35294 USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, 4225 TAMU, College Stn, TX 77845 USA.	telliott@tamu.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Bond T, 2001, APPL RASCH MODEL FUN; BRASURE M, 2012, AHRQ PUBLICATION, V12; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Doninger NA, 2003, REHABIL PSYCHOL, V48, P67, DOI 10.1037/0090-5550.48.2.67; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Dunn D. S., 2013, OXFORD HDB POSITIVE, P427; Dunn D.S., 2009, OXFORD HDB POSITIVE, P650, DOI [DOI 10.1093/OXFORDHB/9780195187243.013.0062, 10.1093/oxfordhb/9780195187243.013.0062]; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; EROSA NA, BRIT J HLTH PSYCHOL; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hoyt WT, 2008, REHABIL PSYCHOL, V53, P321, DOI 10.1037/a0013021; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kline R., 2011, PRINCIPLES PRACTICES; KOK B, 2008, POSITIVE PSYCHOL EXP, P1; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACHAMER J, J NEUROTRAU IN PRESS; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mausbach BT, 2011, CLIN PSYCHOL REV, V31, P900, DOI 10.1016/j.cpr.2011.04.004; McDowell I, 2006, MEASURING HLTH GUIDE; Muthen L. K., 1998, MPLUS USERS GUIDE, V7th; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; Seligman, 2002, USING NEW POSITIVE P; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SPEAKE DL, 1989, RES NURS HEALTH, V12, P93, DOI 10.1002/nur.4770120206; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Thompson B., 2006, FDN BEHAV STAT INSIG; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van Leeuwen CM, 2012, ARCH PHYS MED REHAB, V93, P82, DOI 10.1016/j.apmr.2011.07.203; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2007, INT CLASS FUNCT DIS; Yu C.Y., 2002, EVALUATION MODEL FIT; [No title captured]	50	14	14	0	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								102570	10.1155/2013/102570			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	233PA	WOS:000325580000001	24199186	Green Published, gold, Green Submitted			2022-02-06	
J	Kholod, H; Jamil, A; Katz-Leurer, M				Kholod, Hajuj; Jamil, Andrawes; Katz-Leurer, Michal			The associations between motor ability, walking activity and heart rate and heart rate variability parameters among children with cerebral palsy and typically developed controls	NEUROREHABILITATION			English	Article						Cerebral palsy; heart rate variability; motor performance; walking	TRAUMATIC BRAIN-INJURY; RELIABILITY; PREDICTION; SYSTEM	AIMS: To measure heart rate (HR) and heart rate variability (HRV) at rest, during and after walking among children with cerebral palsy (CP) as compared to age matched typically developed (TD) controls. The second aim was to describe the association between HRV and motor performance in children with CP. METHODS: Twenty six children with CP (age 8-14 years) and sixteen TD children matched for age assessed during rest, walking and after walking. HR and HRV parameters include: time domain parameters: standard deviation of the R-R interval (SDNN), square root of the mean squared differences of successive R-R differences (RMSSD). RESULTS: Children with CP demonstrated higher mean HR values at rest; 98.4 +/- 13.9 bpm vs 83.0 +/- 11.5 bpm in controls, (p < 0.05) and significantly lower time domain measures of HRV; RMSSD was 52.0 +/- 19.1 ms and 87.0 +/- 39.8 ms respectively (p < 0.05). Significant interaction effects were noted for HR and time domain HRV parameters. HR increased and SDNN and RMSSD decreased when children change their activity level from rest to walking and HR decreased and SDNN and RMSSD increased again after walking for TD children but not for children with CP (p < 0.05). No association was noted between HRV and motor performance in children with CP. INTERPRETATION: The findings of this study suggest that among children with CP, the cardiac autonomic mechanism is less efficient at rest and less adaptive to exercise and activity as compared to TD children.	[Kholod, Hajuj; Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Jamil, Andrawes] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Child Dev Ctr, San Vincent Hosp Nazareth,Pediat Dept, IL-32000 Haifa, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Bjelakovic B, 2010, EARLY HUM DEV, V86, P77, DOI 10.1016/j.earlhumdev.2010.01.022; Camm AJ, 1996, CIRCULATION, V93, P1043; DoussardRoosevelt JA, 1997, CHILD DEV, V68, P173, DOI 10.1111/j.1467-8624.1997.tb01934.x; El-Sayed HL, 2007, ACTA NEUROL SCAND, V115, P377, DOI 10.1111/j.1600-0404.2006.00792.x; Ferreira MC, 2011, J ORAL PATHOL MED, V40, P576, DOI 10.1111/j.1600-0714.2011.01008.x; FOX NA, 1985, CHILD DEV, V56, P28, DOI 10.2307/1130170; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Hadley DM, 2008, MED SCI SPORT EXER, V40, P1072, DOI 10.1249/MSS.0b013e318167665a; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Korpelainen JT, 1999, CLIN AUTON RES, V9, P325, DOI 10.1007/BF02318379; Maestri R, 2010, CLIN SCI, V118, P195, DOI 10.1042/CS20090183; Maher CA, 2008, INT J REHABIL RES, V31, P185, DOI 10.1097/MRR.0b013e32830150f9; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Park ES, 2002, YONSEI MED J, V43, P65, DOI 10.3349/ymj.2002.43.1.65; Pastore CA, 2011, J ELECTROCARDIOL, V44, P138, DOI 10.1016/j.jelectrocard.2011.01.002; Russell DJ, 2000, PHYS THER, V80, P873, DOI 10.1093/ptj/80.9.873; Schreiber Joe, 2004, Pediatr Phys Ther, V16, P173, DOI 10.1097/01.PEP.0000136007.39269.17; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Vos-Vromans DCW, 2005, DISABIL REHABIL, V27, P1245, DOI 10.1080/09638280500076178; Yang TF, 2002, AM J PHYS MED REHAB, V81, P350, DOI 10.1097/00002060-200205000-00005; Zamuner AR, 2011, RES DEV DISABIL, V32, P217, DOI 10.1016/j.ridd.2010.09.020	26	14	14	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	1					113	119		10.3233/NRE-130934			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216DA	WOS:000324260400014	23949027				2022-02-06	
J	Lagbas, C; Bazargan-Hejazi, S; Shaheen, M; Kermah, D; Pan, DY				Lagbas, Clint; Bazargan-Hejazi, Shahrzad; Shaheen, Magda; Kermah, Dulcie; Pan, Deyu			Traumatic Brain Injury Related Hospitalization and Mortality in California	BIOMED RESEARCH INTERNATIONAL			English	Article							UNITED-STATES; OLDER-ADULTS; TRENDS; POPULATION; MODERATE; OUTCOMES; CHILDREN; FALL	Objective. The aim of this study is to describe the traumatic brain injury (TBI) population and causes and identify factors associated with TBI hospitalizations and mortality in California. Methods. This is a cross-sectional study of 61,188 patients with TBI from the California Hospital Discharge Data 2001 to 2009. We used descriptive, bivariate, and multivariate analyses in SAS version 9.3. Results. TBI-related hospitalizations decreased by 14% and mortality increased by 19% from 2001 to 2009. The highest percentages of TBI hospitalizations were due to other causes (38.4%), falls (31.2%), being of age > 75 years old (37.2%), being a males (58.9%), and being of Medicare patients (44%). TBIs due to falls were found in those age <= 4 years old (53.5%), >= 75 years old (44.0%), and females (37.2%). TBIs due to assaults were more frequent in Blacks (29.0%). TBIs due to motor vehicle accidents were more frequent in 15-19 and 20-24 age groups (48.7% and 48.6%, resp.) and among Hispanics (27.8%). Higher odds of mortality were found among motor vehicle accident category (adjusted odds ratio (AOR): 1.27, 95% CI: 1.14-1.41); males (AOR: 1.36, 95% CI: 1.27-1.46); and the >= 75-year-old group (AOR: 6.4, 95% CI: 4.9-8.4). Conclusions. Our findings suggest a decrease in TBI-related hospitalizations but an increase in TBI-related mortality during the study period. The majority of TBI-related hospitalizations was due to other causes and falls and was more frequent in the older, male, and Medicare populations. The higher likelihood of TBI-related mortalities was found among elderly male >= 75 years old who had motor vehicle accidents. Our data can inform practitioners, prevention planners, educators, service sectors, and policy makers who aim to reduce the burden of TBI in the community. Implications for interventions are discussed.	[Lagbas, Clint] Univ Calif Los Angeles, Charles R Drew Univ Med & Sci, David Geffen Sch Med, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, Shahrzad] Charles R Drew Univ Med, Coll Med, Dept Psychiat, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Shaheen, Magda] Charles R Drew Univ Med & Sci, Coll Med, Los Angeles, CA 90059 USA; [Kermah, Dulcie; Pan, Deyu] Charles R Drew Univ Med & Sci, Dept Res, Los Angeles, CA 90059 USA		Bazargan-Hejazi, S (corresponding author), Charles R Drew Univ Med, Coll Med, Dept Psychiat, 1731 East 120th St, Los Angeles, CA 90059 USA.	shahrzadbazargan@cdrewu.edu			Accelerating Excellence in Translational Science AXIS Grant [U54MD007598]; NIH/NCRRN/NCATS UCLA CTSI Grant [UL1TR000124];  [S21MD000103]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007598, S21MD000103] Funding Source: NIH RePORTER	This study was supported in part by the Endowment Grant S21MD000103 and by the Accelerating Excellence in Translational Science AXIS Grant (U54MD007598) and NIH/NCRRN/NCATS UCLA CTSI Grant UL1TR000124.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Beiki O., 2013, J INJURY VIOLENCE RE; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P276; Clark ED, ICDPIC VERSION 3 0 I; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Ellis AA, 2001, J GERONTOL A-BIOL, V56, pM686, DOI 10.1093/gerona/56.11.M686; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; Gujral IB, 2006, BRAIN INJURY, V20, P283, DOI 10.1080/02699050500488058; Kalaiselvan Ganapathy, 2011, J Inj Violence Res, V3, P62, DOI 10.5249/jivr.v3i2.74; Langlois J. A., 2004, US DEP HLTH HUMAN SE; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Li Shaohua, 2013, J Inj Violence Res, V5, P89, DOI 10.5249/jivr.v5i2.304; Lyman S, 2002, INJ PREV, V8, P116, DOI 10.1136/ip.8.2.116; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Robertson B. D., 2013, J INJURY VIOLENCE RE, V5; Rosen Tony, 2013, J Inj Violence Res, V5, P61, DOI 10.5249/jivr.v5i1.177; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	33	14	14	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								143092	10.1155/2013/143092			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	256VI	WOS:000327341700001		gold, Green Published			2022-02-06	
J	Ling, HP; Li, W; Zhou, ML; Tang, Y; Chen, ZR; Hang, CH				Ling, Hai-Ping; Li, Wei; Zhou, Meng-Liang; Tang, Yong; Chen, Zhen-Rui; Hang, Chun-Hua			Expression of intestinal myeloid differentiation primary response protein 88 (Myd88) following experimental traumatic brain injury in a mouse model	JOURNAL OF SURGICAL RESEARCH			English	Article						TBI; Myd88; Intestinal inflammation; NF-kappa B; Pro-inflammatory cytokines	NF-KAPPA-B; TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; TNF-ALPHA; INFLAMMATION; GUT; ISCHEMIA; RATS; ISCHEMIA/REPERFUSION; REPERFUSION	Background: Traumatic brain injury (TBI) can cause gastrointestinal dysfunction and increase intestinal permeability. Nuclear factor kappa B (NF-kappa B) has been shown to be associated with these intestinal events, but it is not well known how NF-kappa B is activated in the intestine after TBI. Based on previous studies, we hypothesize that myeloid differentiation primary response protein 88 (Myd88) may have an important role in NF-kappa B activation in the intestine, which mediates the inflammation and ultimately results in acute intestinal mucosal injury. Methods: We randomly divided adult male C57BL/6 mice into control groups and TBI groups at different time points. We induced a closed head injury model by weight drop (a 333-g metal rod dropping from a 2.5-cm height). We detected Myd88 protein level and NF-kappa B binding activity in ileum tissue by Western blot and electrophoretic mobility shift assay, respectively. Meanwhile, we detected the mRNA levels of Myd88, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and intercellular adhesion molecule-1 by real-time polymerase chain reaction. Results: The Myd88 protein and mRNA levels, as well as NF-kappa B binding activity in the ileum tissue, significantly increased at 6 h after TBI, peaked at 3 d, and remained elevated by 5 d post-injury. The levels of TNF-alpha, IL-1 beta, and intercellular adhesion molecule-1 also remarkably increased after TBI. There was a positive relationship between the expression of Myd88 and that of NF-kappa B, TNF-alpha, and IL-1 beta. Conclusions: Traumatic brain injury induced a rapid and persistent up-regulation of Myd88, NF-kappa B, and proinflammatory cytokines in the intestine. This up-regulation which might have an important role in the pathogenesis of acute intestinal mucosal injury. (C) 2013 Elsevier Inc. All rights reserved.	[Ling, Hai-Ping; Zhou, Meng-Liang; Chen, Zhen-Rui; Hang, Chun-Hua] So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Li, Wei; Zhou, Meng-Liang; Tang, Yong; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Hang, CH (corresponding author), So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021	Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171170, 8100053]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	The authors appreciate the excellent technical assistance of Dr. Gen-bao Feng. This work was supported by grants from the National Natural Science Foundation of China (No. 81171170 for C. H. Hang and No. 8100053 for M. L. Zhou) and the Natural Science Foundation of Jiangsu Province, China (No. BK2010459).	Akhtar Suhail, 2011, Recent Pat Antiinfect Drug Discov, V6, P206; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Buchholz BM, 2010, AM J PHYSIOL-GASTR L, V299, pG531, DOI 10.1152/ajpgi.00060.2010; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kessel A, 2008, CLIN EXP IMMUNOL, V151, P341, DOI 10.1111/j.1365-2249.2007.03571.x; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Matharu KS, 2009, GASTROENTEROLOGY, V137, P1380, DOI 10.1053/j.gastro.2009.07.004; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Moses T, 2009, J LEUKOCYTE BIOL, V86, P971, DOI 10.1189/jlb.0708396; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Suzuki T, 2008, J SURG RES, V149, P69, DOI 10.1016/j.jss.2008.01.020; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Victoni T, 2010, MED MICROBIOL IMMUN, V199, P35, DOI 10.1007/s00430-009-0134-5; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	35	14	17	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2013	179	1					E227	E234		10.1016/j.jss.2012.03.030			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	051LW	WOS:000312129700029	22498027				2022-02-06	
J	Moore, TL; Pessina, MA; Finklestein, SP; Kramer, BC; Killiany, RJ; Rosene, DL				Moore, Tara L.; Pessina, Monica A.; Finklestein, Seth P.; Kramer, Brian C.; Killiany, Ronald J.; Rosene, Douglas L.			Recovery of fine motor performance after ischemic damage to motor cortex is facilitated by cell therapy in the rhesus monkey	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Monkey; stroke	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; GROWTH-ASSOCIATED GENE; INTRACEREBRAL HEMORRHAGE; MOLECULAR-MECHANISMS; NEURAL REPAIR; STEM-CELLS; STROKE; BLOOD; EXPRESSION	We investigated the efficacy on recovery of function following controlled cortical ischemia in the monkey of the investigational cell drug product, CNTO 0007. This drug contains a cellular component, human umbilical tissue-derived cells, in a proprietary thaw and inject formulation. Results demonstrate significantly better recovery of motor function in the treatment group with no difference between groups in the volume or surface area of ischemic damage, suggesting that the cells stimulated plasticity.	[Moore, Tara L.; Pessina, Monica A.; Killiany, Ronald J.; Rosene, Douglas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Moore, Tara L.; Killiany, Ronald J.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Finklestein, Seth P.] Biotrofix Inc, Waltham, MA USA; [Kramer, Brian C.] Janssen Serv LLC, Horsham, PA USA; [Rosene, Douglas L.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA		Moore, TL (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 700 Albany St, Boston, MA 02118 USA.	tlmoore@bu.edu	Rosene, Douglas L/G-1973-2015; Killiany, Ronald/Y-7251-2019	Killiany, Ronald/0000-0003-4740-2181; Rosene, Douglas/0000-0001-8719-1441; Moore, Tara/0000-0003-3869-3837	Advanced Technologies and Regenerative Medicine, LLC (ATRM), RR [101115-PR]	This study was supported by a contract from Advanced Technologies and Regenerative Medicine, LLC (ATRM), RR# 101115-PR, who funded the study and provided CNTO 0007 and a vehicle control.	Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhasin A, 2011, CEREBROVASC DIS EXTR, V1, P93, DOI 10.1159/000333381; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Broxmeyer H E, 1996, Cancer Treat Res, V84, P139; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2008, ACTA NEUROCHIR SUPPL, V105, P79; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GRABOWSKI M, 1993, ANN NEUROL, V34, P362, DOI 10.1002/ana.410340310; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Hess DC, 2002, TRENDS MOL MED, V8, P452, DOI 10.1016/S1471-4914(02)02404-8; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kluver H, 1935, J PSYCHOL, V1, P1; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li HY, 2013, J CELL BIOCHEM, V114, P650, DOI 10.1002/jcb.24407; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lin SZ, 2010, CELL TRANSPLANT, V19, P1451, DOI 10.3727/096368910X514198; Liu HA, 2010, J CLIN BIOCHEM NUTR, V47, P174, DOI 10.3164/jcbn.10-47; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Moore TL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.005; Moore TL, 2010, SOMATOSENS MOT RES, V27, P121, DOI 10.3109/08990220.2010.485963; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Nieda M, 1997, BRIT J HAEMATOL, V98, P775, DOI 10.1046/j.1365-2141.1997.2583074.x; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Qu ZB, 2007, ONKOLOGIE, V30, P256, DOI 10.1159/000101010; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; ROSENE DL, 1986, J HISTOCHEM CYTOCHEM, V34, P1301, DOI 10.1177/34.10.3745909; Rosenkranz K, 2011, ANN ANAT, V193, P371, DOI 10.1016/j.aanat.2011.03.005; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Savitz SI, 2002, ANN NEUROL, V52, P266, DOI 10.1002/ana.60000; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Seyfried DM, 2010, J NEUROSURG, V112, P329, DOI 10.3171/2009.2.JNS08907; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Sng J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/521343; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Yang DM, 2012, BRAIN RES, V1444, P1, DOI 10.1016/j.brainres.2012.01.024; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	67	14	15	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0899-0220	1369-1651		SOMATOSENS MOT RES	Somatosens. Mot. Res.		2013	30	4					185	196		10.3109/08990220.2013.790806			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	255OJ	WOS:000327249400004	23758412	Green Accepted			2022-02-06	
J	Olson, K; Jacobson, KK; Van Oot, P				Olson, Katie; Jacobson, Kristin K.; Van Oot, Peter			Ecological Validity of Pediatric Neuropsychological Measures: Current State and Future Directions	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						child/clinical/pediatric; memory; rural/urban; teaching; tests	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; MEMORY QUESTIONNAIRE; EVERYDAY MEMORY; REAL-WORLD; TESTS; PREDICT; ATTENTION; CHILDREN; SKILLS	Neuropsychologists are increasingly requested to identify specific deficits in cognitive abilities and determine the ways in which these deficits will affect a client's everyday functioning. The demand for prescriptive diagnostic endeavors that provide recommendations for rehabilitation has drawn attention to the necessity of considering the ecological validity of instruments. Most of the current knowledge regarding the ecological validity of neuropsychological measures is the result of studies examining adult and older adult populations. The relationship of test performance and everyday functioning in children has been less examined and is, therefore, less understood. The purpose of this article is to provide a brief history of ecological validity in neuropsychology, discuss why this is an important consideration when working with child populations, and provide suggestions for continued research in this field.	[Olson, Katie; Jacobson, Kristin K.; Van Oot, Peter] John F Kennedy Univ, Coll Grad & Profess Studies, Pleasant Hill, CA 94523 USA		Olson, K (corresponding author), John F Kennedy Univ, Coll Grad & Profess Studies, 100 Ellinwood Way, Pleasant Hill, CA 94523 USA.	kolson2@jfku.edu					BENNETTLEVY J, 1980, BRIT J SOC CLIN PSYC, V19, P177, DOI 10.1111/j.2044-8260.1980.tb00946.x; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Drysdale K, 2004, CHILD NEUROPSYCHOL, V10, P67, DOI 10.1080/09297040490911087; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; FAUST D, 1991, Neuropsychology Review, V2, P205, DOI 10.1007/BF01109045; Franzen M. D., 1996, ECOLOGICAL VALIDITY, P75; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia D, 2009, QUAL HEALTH RES, V19, P1495, DOI 10.1177/1049732309348500; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; HARTLAGE LC, 1996, ECOLOGICAL VALIDITY, P301; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Kingstone A, 2003, CURR DIR PSYCHOL SCI, V12, P176, DOI 10.1111/1467-8721.01255; Kingstone Alan, 2005, MEASURING MIND SPEED, P341; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Poletti M, 2010, NEUROPSYCHOLOGICAL T, V7, P7; Price KJ, 2003, CLIN NEUROPSYCHOL, V17, P170, DOI 10.1076/clin.17.2.170.16506; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; SBORDONE RJ, 1996, ECOLOGICAL VALIDITY, P91; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; STROOP JR, 1935, J EXP PSYCHOL, V18, P642; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Williams JM, 1996, ECOLOGICAL VALIDITY, P129; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1991, RIVERMEAD BEHAV MEMO	37	14	14	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2013	2	1					17	23		10.1080/21622965.2012.686330			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AD0SV	WOS:000332945300004	23427773				2022-02-06	
J	Ortolano, S; Spuch, C				Ortolano, Saida; Spuch, Carlos			tPA in the Central Nervous System: Relations Between tPA and Cell Surface LRPs	RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY			English	Article						BBB; brain diseases; CNS; LRP; neurodegenerative diseases; plasmin; plasminogen; tPA	TISSUE-PLASMINOGEN ACTIVATOR; BLOOD-BRAIN-BARRIER; A-BETA DEGRADATION; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; NEUROVASCULAR MECHANISMS; MICROGLIAL ACTIVATION; NEURONAL DEGENERATION; LIPOPROTEIN RECEPTORS; MOLECULAR-MECHANISMS	A growing body of evidence has implicated the plasminogen activating system in various aspects of neurophysiology and pathophysiology. In ischemic stroke, blood-brain barrier (BBB) regulations, typically involving matrix metalloproteinases (MMPs), inhibitors tissue inhibitors of metalloproteinases (TIMPs) and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRPs) as mediators became interesting since tissue plasminogen activator (tPA)-related BBB breakdown with risk of secondary hemorrhage was considered to involve these mediators too. The mechanism by which tPA implements its actions within the central nervous system (CNS) has been the topic of much controversy. Binding of plasminogen to surfaces is of crucial importance in regulating the function of this system. tPA can modulate permeability of the neurovascular unit in physiological conditions and pathological events exacerbating injury in ischemic stroke, vascular dementia, traumatic brain injury or neurotoxic events. The plasminogen activating enzyme system is widely appreciated for its role in fibrinolysis and thrombolysis and in other areas related to remodelling of the extracellular matrix. However, this enzyme system also has a major impact in the central nervous system under pathological circumstances. The aim of this review is to revise the last patents and news to understand the mechanism by which t-PA modulates BBB permeability.	[Ortolano, Saida; Spuch, Carlos] Univ Hosp Vigo, Dept Pathol & Neuropathol, Vigo, Spain		Spuch, C (corresponding author), Univ Hosp Vigo CHUVI, Dept Pathol & Neuropathol, Hosp Meixoeiro, Meixoeiro S-N, Vigo 36125, Spain.	carlos.spuch@gmail.com	spuch, carlos/A-4563-2012; Spuch, Carlos/G-9235-2019	spuch, carlos/0000-0002-9161-0124; Spuch, Carlos/0000-0002-9161-0124; ortolano, saida/0000-0002-1098-3376	Xunta de GaliciaXunta de GaliciaEuropean Commission [09CSA051905PR]; Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [PI11/00842]; "Isidro Parga Pondal" programme	This work was supported by grants from Xunta de Galicia (INCITE2009, 09CSA051905PR), Ministerio de Ciencia e Innovacion (PI11/00842) and "Isidro Parga Pondal" programme.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvira-Botero X, 2010, MOL CELL NEUROSCI, V45, P306, DOI 10.1016/j.mcn.2010.07.005; An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; Anderberg J, 2012, Patent No. [US2012231472, 2012231472]; Andersen OM, 2006, TRENDS NEUROSCI, V29, P687, DOI 10.1016/j.tins.2006.09.002; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Barker R, 2012, J CELL MOL MED, V16, P865, DOI 10.1111/j.1582-4934.2011.01394.x; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Beliveau R, 2012, Patent No. [EP2497485, 2497485]; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Benchenane K, 2005, STROKE, V36, P1059, DOI 10.1161/01.STR.0000163050.39122.4f; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Correa F, 2011, J EXP MED, V208, P1229, DOI 10.1084/jem.20101880; Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008; Docagne F, 1999, FASEB J, V13, P1315, DOI 10.1096/fasebj.13.11.1315; Eugen-Olsen J, 2012, Patent No. [EP2500730, 2500730, EP2500730A1]; Fester L, 2009, HIPPOCAMPUS, V19, P692, DOI 10.1002/hipo.20548; Frey U, 1996, J NEUROSCI, V16, P2057; FRIEDMAN GC, 1994, DEV BRAIN RES, V81, P41, DOI 10.1016/0165-3806(94)90066-3; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Gravanis I, 2008, EXPERT OPIN THER TAR, V12, P159, DOI [10.1517/14728222.12.2.159, 10.1517/14728222.12.2.159 ]; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hu KB, 2008, J AM SOC NEPHROL, V19, P503, DOI 10.1681/ASN.2007030300; Indyk JA, 2003, NEUROSCIENCE, V116, P359, DOI 10.1016/S0306-4522(02)00704-2; Jianning L, 2007, Patent No. [CN101886066, 101886066]; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; Lawrence D. A, 2008, Patent No. [US20087375076, 20087375076]; Lawrence D. A, 2005, Patent No. [US20050019329, 20050019329]; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Ledesma MD, 2000, EMBO REP, V1, P530; Lee HY, 2007, J NEUROCHEM, V101, P1236, DOI 10.1111/j.1471-4159.2007.04417.x; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Liot G, 2006, J NEUROCHEM, V98, P1458, DOI 10.1111/j.1471-4159.2006.03982.x; Lukic-Panin V, 2010, CURR NEUROVASC RES, V7, P319, DOI 10.2174/156720210793180747; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.0.CO;2-L; Masos T, 1997, MOL BRAIN RES, V47, P157, DOI 10.1016/S0169-328X(97)00040-5; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Melchor JP, 2003, J NEUROSCI, V23, P8867; Michalski D, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-2; Mishiro K, 2012, NEUROSCIENCE, V205, P39, DOI 10.1016/j.neuroscience.2011.12.042; Morgan EH, 2002, DEV NEUROSCI-BASEL, V24, P106, DOI 10.1159/000065699; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Petersen K, 2011, Patent No. [WO2011023249, 2011023249]; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodriguez-Gonzalez R, 2011, THROMB HAEMOSTASIS, V105, P421, DOI 10.1160/TH10-09-0621; Rogove AD, 1999, J CELL SCI, V112, P4007; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sakharov DV, 1999, THROMB HAEMOSTASIS, V81, P233; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; SEEDS NW, 1992, ANN NY ACAD SCI, V667, P32; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Seeds NW, 2003, J NEUROSCI, V23, P7368; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Siao CJ, 2002, J NEUROSCI, V22, P3352; Skrzypczak-Jankun E, 2010, INT J MOL MED, V26, P45; Skrzypiec AE, 2008, J PHYSIOL PHARMACOL, V59, P135; Sohngen M, 2012, Patent No. [NZ584640, 584640]; Spuch C, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/469679; Spuch C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00269; Spuch C, 2012, RECENT PATENTS ENDOC, V6, P99, DOI 10.2174/187221412800604617; Spuch C, 2010, RECENT PATENTS ENDOC, V4, P190, DOI 10.2174/1872214811004030190; Spuch Carlos, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P249; Strickland S, 2001, THROMB HAEMOSTASIS, V86, P138; Sutton ET, 1997, EXP CELL RES, V230, P368, DOI 10.1006/excr.1996.3440; SUTTON R, 1994, BLOOD COAGUL FIBRIN, V5, P167, DOI 10.1097/00001721-199404000-00002; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070, DOI 10.1093/jnen/59.12.1070; Teesalu T, 2004, THROMB HAEMOSTASIS, V92, P358; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1997, J NEUROSCI, V17, P543; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Vivien D, 2012, Patent No. [EP2473185, 2473185]; Vivien D, 2012, NAT REV NEUROL, V8, P538, DOI 10.1038/nrneurol.2012.192; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wnendt S, 1997, THROMB RES, V85, P217, DOI 10.1016/S0049-3848(97)00006-6; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2000, BLOOD, V96, P569; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	114	14	16	0	6	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1872-2148	2212-3334		RECENT PATENTS ENDOC	Recent Patents Endocr. Metab. Immune Drug Discov.		2013	7	1					65	76		10.2174/187221413804660962			12	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	VG3XJ	WOS:000446637700005	23231415				2022-02-06	
J	Slattery, M; Dugger, MT; Lamb, TA; Williams, L				Slattery, Michelle; Dugger, Mallory Tascha; Lamb, Theodore A.; Williams, Laura			Catch, Treat, and Release: Veteran Treatment Courts Address the Challenges of Returning Home	SUBSTANCE USE & MISUSE			English	Article						Veteran Treatment Court; substance use; PTSD; TBI; employment; housing; US military; OEF/OIF; justice; SAMHSA	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; SUBSTANCE USE; AFGHANISTAN; IRAQ	After a decade of war, there is a great need for treatment and alternatives to incarceration for justice-involved veterans. U. S. military service members are returning from combat with substantial mental health challenges, which increase the potential for justice involvement. Veteran Treatment Courts are starting across the nation to meet this need for therapeutic justice. These problem solving courts provide access to treatment and motivation for engagement. Preliminary evidence from a Substance Abuse and Mental Health Services Administration-funded evaluation suggests that significant improvements in posttraumatic stress disorder and substance use are just a few of the positive outcomes that these courts may help veterans achieve.	[Slattery, Michelle; Dugger, Mallory Tascha] UCCS, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80918 USA; [Slattery, Michelle; Lamb, Theodore A.] Peak Res LLC, Colorado Springs, CO USA; [Williams, Laura] Colorado Dept Human Serv, Off Behav Hlth, Denver, CO USA		Slattery, M (corresponding author), UCCS, Trauma Hlth & Hazards Ctr, 1420 Austin Bluffs Pkwy, Colorado Springs, CO 80918 USA.	peakresearch@usa.net			Substance Abuse and Mental Health Services AdministrationUnited States Department of Health & Human Services [SM58806]	Funding support for the study was provided by the Jail Diversion and Trauma Recovery-Priority to Veterans Grant awarded to the Colorado Department of Human Services, Division of Behavioral Health from the Substance Abuse and Mental Health Services Administration, Grant #SM58806.	American Psychiatric Association, 1980, DIAGN STAT MAN MENT; [Anonymous], 2011, BUR LAB STAT REP EMP; [Anonymous], 2010, ARMY TIMES; [Anonymous], 2012, ARMY GOLD BOOK; *ARM SUIC PREV TAS, 2010, ARM HLTH PROM RISK R; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Drug Policy Alliance, 2009, HEAL BROK SYST VET B; Erickson SK, 2008, PSYCHIAT SERV, V59, P178, DOI 10.1176/ps.2008.59.2.178; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Foa E. B., 1995, POSTTRAUMATIC STRESS; Friedman MJ, 2004, NEW ENGL J MED, V351, P75, DOI 10.1056/NEJMe048129; GAO, 2008, GAO08276; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook J. G., 2011, 1125 WID LAW SCH; Idiculla T., 2005, BASIS 24 COMP GROUP; Institute of Medicine, 2012, SUBST US IDS US ARM; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; MSMR, 2010, MED SURVEILLANCE MON, V17, P2; Mumola C. J., 2000, 178888 NCJ; National Association of Drug Court Professionals (NADCP), 2010, VET TREATM COURTS SE; National Association of Drug Court Professionals (NADCP), 2012, VET TREATM COURT STU; National Center for PTSD, 2010, RET WAR ZON GUID MIL; Noonan M. E., 2004, VETERANS STATE FEDER; Ouimette PC, 1998, ADDICT BEHAV, V23, P785, DOI 10.1016/S0306-4603(98)00064-1; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Reynolds M, 2005, DRUG ALCOHOL DEPEN, V77, P251, DOI 10.1016/j.drugalcdep.2004.08.017; Russell R. T., 2009, N E J CRIM CIV CONF, V35, P357; Russell Robert T., 2009, VETERANS TREATMENT C; Saxon AJ, 2001, PSYCHIATR SERV, V52, P959, DOI 10.1176/appi.ps.52.7.959; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Substance Abuse and Mental Health Service Administration (SAMHSA), 2008, JAIL DIV TRAUM REC P; Substance Abuse and Mental Health Services Administration, 2013, HHS PUBL; Substance Abuse and Mental Health Services Administration (SAMHSA), 2012, BRIEF, V7; Tanielian T., 2008, INVISIBLE WOUNDS WAR; United States Census Bureau, 2010, HIST VET QUEST INSTR; United States Department of Veterans Affairs National Center for PTSD, FACT SHEET EP FACTS; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilson JP., 1983, BEHAV SCI LAW, V1, P69, DOI [DOI 10.1002/BSL.2370010308, 10.1002/bsl.2370010308]	48	14	14	0	22	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2013	48	10					922	932		10.3109/10826084.2013.797468			11	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	186ES	WOS:000322025400011	23869463				2022-02-06	
J	Sullivan, KA; Edmed, SL; Cunningham, LC				Sullivan, Karen A.; Edmed, Shannon L.; Cunningham, Lauren C.			A comparison of new and existing mild traumatic brain injury vignettes: Recommendations for research into post-concussion syndrome	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion syndrome; expectation-as-aetiology; illness expectations; neuropsychology	MINOR HEAD-INJURY; SYMPTOM EXPECTATION; KNOWLEDGE; ATTRIBUTIONS; CANADA	Objective: To review and compare the mild traumatic brain injury (mTBI) vignettes used in postconcussion syndrome (PCS) research, and to develop 3 new vignettes. Method: The new vignettes were devised using World Health Organization (WHO) mTBI diagnostic criteria [1]. Each vignette depicted a very mild (VM), mild (M), or severe (S) brain injury. Expert review (N=27) and readability analysis was used to validate the new vignettes and compare them to 5 existing vignettes. Results: The response rate was 44%. The M vignette and existing vignettes were rated as depicting a mTBI; however, the fit-to-criteria of these vignettes differed significantly. The fit-to-criteria of the M vignette was as good as that of 3 existing vignettes and significantly better than 2 other vignettes. As expected, the VM and S vignettes were a poor fit-to-criteria. Conclusions: These new vignettes will assist PCS researchers to test the limits of important etiology factors by varying the severity of depicted injuries.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. We have no relevant financial or other conflicts of interests to declare in relation to this work.	Agoritsas T, 2011, J CLIN EPIDEMIOL, V64, P107, DOI 10.1016/j.jclinepi.2010.02.007; Arzy S, 2009, J EVAL CLIN PRACT, V15, P804, DOI 10.1111/j.1365-2753.2008.01098.x; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KLARE GR, 1974, READ RES QUART, V10, P62, DOI 10.2307/747086; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, J HEAD TRAUMA REHAB, V26, P392, DOI 10.1097/HTR.0b013e3181f8fd34; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Schoenberg N. E., 2000, INT J SOC RES METHOD, V3, P63, DOI DOI 10.1080/136455700294932; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P691, DOI 10.1016/S0887-6177(01)00171-8; Sullivan KA, J HEAD TRAUMA REHABI; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	21	14	14	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2013	27	1					19	30		10.3109/02699052.2012.698360			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300003	23252435	Green Submitted			2022-02-06	
J	Thaut, MH				Thaut, Michael H.			Entrainment and the Motor System	MUSIC THERAPY PERSPECTIVES			English	Article								Entrainment is a universal phenomenon that can be observed in physical (e.g., pendulum clocks) and biological systems (e.g., fire flies) when one system's motion or signal frequency entrains the frequency of another system. The use of entrainment for therapeutic purposes was established for the first time in the early 1990s by Thaut and colleagues in several research studies, showing that the periodicity of auditory rhythmic patterns could entrain movement patterns in patients with movement disorders (Thaut, Kenyon, Schauer, & McIntosh, 1999). Physiological, kinematic and behavioral movement analysis showed very quickly that entrainment cues not only changed the timing of movement but also improved spatial and force parameters. We know now that anticipatory rhythmic templates are critical coordinative constraints in the brain for optimal motor planning and execution. Rhythmic entrainment is one of the most important underlying mechanisms for the successful application of rhythmic-musical stimuli in motor rehabilitation for movement disorders associated with stroke, Parkinson's disease, traumatic brain injury, cerebral palsy etc. Most importantly, temporal rhythmic entrainment has been successfully extended into applications in cognitive rehabilitation and speech and language rehabilitation, and thus become one of the major neurological mechanisms linking music and rhythm to brain rehabilitation. Multiple treatment techniques in Neurologic Music Therapy utilize entrainment concepts in sensorimotor, cognitive, and speech/language training.	[Thaut, Michael H.] Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA		Thaut, MH (corresponding author), Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA.						Felix RA, 2011, J NEUROSCI, V31, P12566, DOI 10.1523/JNEUROSCI.2450-11.2011; Ford MP, 2007, GAIT POSTURE, V26, P150, DOI 10.1016/j.gaitpost.2006.08.007; Homberg V, 2005, ACTA NEUROCHIR SUPPL, V93, P3; Konoike N, 2012, NEUROIMAGE, V63, P328, DOI 10.1016/j.neuroimage.2012.07.002; Kugler P.N., 1987, INFORM NATURAL LAW S; Large EW, 2002, PSYCHOL RES-PSYCH FO, V66, P3, DOI 10.1007/s004260100069; Malcolm MP, 2009, TOP STROKE REHABIL, V16, P69, DOI 10.1310/tsr1601-69; Massie C, 2009, ARCH PHYS MED REHAB, V90, P571, DOI 10.1016/j.apmr.2008.09.574; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; McIntosh GC, 1998, MOVEMENT DISORD, V13, P212; Miller RA, 1996, ELECTROMYOGR MOTOR C, V101, P1, DOI 10.1016/0013-4694(95)00209-X; Moore B.C.J., 2003, PSYCHOL HEARING; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; PALTSEV YI, 1967, BIOPHYS-USSR, V12, P1219; Pantaleone J, 2002, AM J PHYS, V70, P992, DOI 10.1119/1.1501118; Peng YC, 2011, GAIT POSTURE, V33, P274, DOI 10.1016/j.gaitpost.2010.11.020; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Roerdink M, 2011, GAIT POSTURE, V33, P690, DOI 10.1016/j.gaitpost.2011.03.001; ROSSIGNOL S, 1976, ELECTROEN CLIN NEURO, V41, P83, DOI 10.1016/0013-4694(76)90217-0; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Shelton J., 2010, NEUROSCI MED, V1, P30, DOI [DOI 10.4236/NM.2010.11004, 10.4236/nm.2010.11004]; Stahl B, 2011, BRAIN, V134, P3083, DOI 10.1093/brain/awr240; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; THAUT M, 1991, J MUSIC THER, V28, P64, DOI 10.1093/jmt/28.2.64; Thaut M. H., 1992, J NEUROL REHABIL, V6, P185; Thaut MH, 1997, J NEUROL SCI, V151, P207, DOI 10.1016/S0022-510X(97)00146-9; Thaut MH, 1998, HUM MOVEMENT SCI, V17, P839, DOI 10.1016/S0167-9457(98)00031-1; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 2003, HUM MOVEMENT SCI, V22, P321, DOI 10.1016/S0167-9457(03)00048-4; Thaut MH, 1998, BIOL CYBERN, V79, P241, DOI 10.1007/s004220050474; Thaut MH, 2002, NEUROPSYCHOLOGIA, V40, P1073, DOI 10.1016/S0028-3932(01)00141-5; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Thaut MH, 1993, J NEUROL REHABIL, V7, P9, DOI DOI 10.1177/136140969300700103; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390	35	14	15	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0734-6875	2053-7387		MUSIC THER PERSPECT	Music Ther. Perspect.		2013	31	1			SI		31	34		10.1093/mtp/31.1.31			4	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VG1KC	WOS:000445374900006					2022-02-06	
J	Tomaszewski, W; Manko, G; Ziolkowski, A; Pachalska, M				Tomaszewski, Wieslaw; Manko, Grzegorz; Ziolkowski, Artur; Pachalska, Maria			An evaluation of health-related quality of life of patients aroused from prolonged coma when treated by physiotherapists with or without training in the 'Academy of Life' programme	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						social isolation; aphasia; dysarthria; memory; paresis; akinetic mutism	TRAUMATIC BRAIN-INJURY; REHABILITATION; EPIDEMIOLOGY	Objective: To evaluate the health-related quality of life (HRQOL) in patients aroused from prolonged coma after a severe traumatic brain injury (TBI) treated by physiotherapists trained in the 'Academy of Life' programme. It was assumed that physiotherapists who acquired this knowledge and experience would create a better therapeutic milieu, and would be more effective than physiotherapists who had not received this training. Material and methods: 40 patients who had suffered a severe TBI in a motor vehicle accident and had been aroused from prolonged coma were examined. All the patients underwent long-term rehabilitation according to a standard, phased programme. They were divided into two numerically even groups: an experimental group, treated by therapists trained in the 'Academy of Life' programme, and a control group, treated by physiotherapists who were not trained in this programme. The research instruments included an analysis of documentation, a structured clinical interview, and the Quality of Life Scale. Results: As hypothesized, the experimental group showed significant improvement in HRQOL, whereas in the control group improvement was statistically non-significant. Conclusions: The patients from the experimental group, treated by physiotherapists trained in the 'Academy of Life', obtained a significantly greater improvement in physical and social functioning, and thus in HRQOL, than patients from the control group.	[Tomaszewski, Wieslaw] Coll Physiotherapy, Wroclaw, Poland; [Manko, Grzegorz] Jagiellonian Univ, Dept Ergon & Exert Physiol, Inst Physiotherapy, Fac Allied Hlth Sci,Coll Med, Krakow, Poland; [Ziolkowski, Artur] Acad Phys Educ & Sport Gdansk, Gdansk, Poland; [Pachalska, Maria] Andrzej Frycz Modrzewski Univ, Chair Neuropsychol, Krakow, Poland		Tomaszewski, W (corresponding author), Jagiellonska 3-20, PL-03721 Warsaw, Poland.						Atrice M, 1995, NEUROLOGICAL REHABIL, P484; Baranowski P, 2000, Ortop Traumatol Rehabil, V2, P31; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Di Mauro S, 1998, STROKE REHABILITATIO, P508; Marvasti Jamshid A, 2011, Conn Med, V75, P133; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Meinzer M, 2011, APHASIOLOGY, V25, P271, DOI 10.1080/02687038.2010.530672; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Pachalska M, 1998, SKALA OCENY JAKOSCI; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2012, MED SCI MONITOR, V18, pCR432; Pachalska M, 2010, MED SCI MONITOR, V16, pCS157; Pachalski Adam, 2004, Ortop Traumatol Rehabil, V6, P643; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Talar J, 2002, URAZY PNIA MOZGU KOM, P207; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Tomaszewski W, 2011, MED SCI MONITOR, V17, P35; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Worthington AD, 2003, HDB CLIN NEUROPSYCHO, P322	25	14	14	0	6	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2013	20	2					361	365					5	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	172SN	WOS:000321025300029	23772592				2022-02-06	
J	Tsushima, WT; Shirakawa, N; Geling, O				Tsushima, William T.; Shirakawa, Nicole; Geling, Olga			Neurocognitive Functioning and Symptom Reporting of High School Athletes Following a Single Concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						concussion; high school athletes; ImPACT; neurocognitive functioning; symptom reporting	SPORTS-RELATED CONCUSSION; COLLEGIATE; RECOVERY; MANAGEMENT; IMPACT	The aim of this research was to evaluate the neurocognitive functioning and symptom reporting of high school athletes with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery after sustaining a single sports-related concussion. The ImPACT battery was administered to 26 athletes at an average of 6.8 days after their head injury. ImPACT composite scores, including neurocognitive measures of Verbal Memory, Visual Memory, Processing Speed, and Reaction Time, as well as a Total Symptom Score, were also obtained from an equivalent group of 25 nonconcussed football players. The composite scores of the concussed athletes were lower but not statistically different than the nonconcussed athletes. The findings were consistent with previous ImPACT research that reported no differences between concussed and nonconcussed athletes 7 days after a concussion. The symptom scores of the concussed athletes, on the other hand, were significantly higher than those who had no concussion. The similarities and differences in ImPACT test performances of the present sample of concussed high school athletes as compared with previous studies of concussed high school athletes are discussed. This study raises awareness that with high school athletes, symptom complaints may persist, even after cognitive functioning has returned to preinjury levels.	[Tsushima, William T.] Straub Clin & Hosp, Honolulu, HI 96813 USA; [Shirakawa, Nicole] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Geling, Olga] Univ Hawaii, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			Hawaii Pacific Health Conference Service's Summer Student Research Program	This research was supported in part by the Hawaii Pacific Health Conference Service's Summer Student Research Program. The study was approved by the institutional review board of the Hawaii Pacific Health Research Institute.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304	20	14	14	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2013	2	1					13	16		10.1080/09084282.2011.643967			4	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AD0SV	WOS:000332945300003	23427772				2022-02-06	
J	Yu, WY; Hwang, HF; Hu, MH; Chen, CY; Lin, MR				Yu, Wen-Yu; Hwang, Hei-Fen; Hu, Ming-Hsia; Chen, Chih-Yi; Lin, Mau-Roung			Effects of fall injury type and discharge placement on mortality, hospitalization, falls, and ADL changes among older people in Taiwan	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Falls; Older people; Fracture; Discharge placement; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HIP FRACTURE; RISK-FACTORS; DISTAL FOREARM; CARE; EMERGENCY; OUTCOMES; EPIDEMIOLOGY; ADULTS; OPPORTUNITIES	A longitudinal study was conducted to investigate the effects of injury type and discharge placement on mortality, falls, hospital admissions, and changes in activities of daily living (ADLs) over a 12-month period among older fallers. Of 762 community-dwelling people aged 65 years or older who visited an emergency department (ED) of a general hospital in Taiwan due to a fall, 273 sustained a hip fracture, 157 had a vertebral fracture, 47 had a distal forearm fracture, 102 had a traumatic brain injury, and 183 had soft-tissue injuries. Results showed that, compared to patients with a soft-tissue injury, those with TBI had significantly higher risks of dying (rate ratio (RR) = 3.59) and hospital admissions (RR = 3.23) and better improvement in ADLs (1.93 points) at 6 months post-injury, and those who sustained a hip fracture (4.26 and 4.41 points), a vertebral fracture (3.81 and 3.83 points), or a distal-forearm fracture (2.80 and 2.80 points) had significantly better improvement in ADLs at 6 and 12 months post-injury. Patients discharged to a nursing home had a significantly increased risk of death (RR = 2.08) and hospital admission (RR = 2.05) than those returning to their usual residence during the first year post-injury. No significant differences in the occurrence of falls during the first post-injury year were found among patients with different injury types or between those with different discharge placements. In conclusion, among the five major fall injury types in older people, TBIs result in the highest risk of death and hospital admissions, while hip and vertebral fractures exhibited the largest improvement during the first year after injury. Additionally, nursing home care may be associated with increased risks of death and hospital admissions than home care. In addition to primary prevention of falls, further research to investigate mechanisms leading to TBIs during a fall is needed to facilitate effective secondary fall-prevention programs for older people. (C) 2012 Elsevier Ltd. All rights reserved.	[Yu, Wen-Yu] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hwang, Hei-Fen] Natl Taipei Coll Nursing, Dept Nursing, Taipei, Taiwan; [Hu, Ming-Hsia] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Hu, Ming-Hsia] Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei, Taiwan; [Chen, Chih-Yi; Lin, Mau-Roung] Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, Taipei 110, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	mrlin@tmu.edu.tw		HU, MING-HSIA/0000-0003-0904-255X			Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Baron JA, 1996, EPIDEMIOLOGY, V7, P612, DOI 10.1097/00001648-199611000-00008; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Boockvar KS, 2003, J AM GERIATR SOC, V51, P399, DOI 10.1046/j.1532-5415.2003.51115.x; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; Carpenter CR, 2009, ACAD EMERG MED, V16, P211, DOI 10.1111/j.1553-2712.2009.00351.x; Castle NG, 2001, MED CARE RES REV, V58, P291, DOI 10.1177/107755870105800302; Chen C.F., 2006, THESIS NATL CHUNG CH; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COX DR, 1972, J R STAT SOC B, V34, P187; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Department of Health, 2010, STAT YB REP CHIN ROC; Edwards BJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3324; ETTINGER B, 1992, J BONE MINER RES, V7, P449; Faul M, 2010, TRAUMATIC BRAIN INJU; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Frost ML, 2000, OSTEOPOROSIS INT, V11, P321, DOI 10.1007/s001980070121; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Grimmer K, 2004, INT J QUAL HEALTH C, V16, P465, DOI 10.1093/intqhc/mzh071; Gruneir A, 2010, J AM GERIATR SOC, V58, P510, DOI 10.1111/j.1532-5415.2010.02736.x; Herala M, 2000, J EPIDEMIOL COMMUN H, V54, P557, DOI 10.1136/jech.54.7.557; Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Keegan THM, 2004, AM J EPIDEMIOL, V159, P192, DOI 10.1093/aje/kwh026; KELSEY JL, 1992, AM J EPIDEMIOL, V135, P477, DOI 10.1093/oxfordjournals.aje.a116314; KOVAL KJ, 1995, CLIN ORTHOP RELAT R, P150; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lim HJ, 2007, J TRAUMA, V63, P902, DOI 10.1097/01.ta.0000240110.14909.71; Magaziner J, 2003, AM J EPIDEMIOL, V157, P1023, DOI 10.1093/aje/kwg081; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ministry of the Interior, 2009, SURV ELD PEOPL LIV C; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI [10.1359/JBMR.041003, 10.1359/jbmr.2005.20.1.131]; Paniagua MA, 2006, AM J EMERG MED, V24, P413, DOI 10.1016/j.ajem.2005.12.005; Peel NM, 2002, INJ PREV, V8, P280, DOI 10.1136/ip.8.4.280; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Sanders AB, 2001, J AM GERIATR SOC, V49, P1390, DOI 10.1046/j.1532-5415.2001.49272.x; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Sheikh JA, 1986, CLIN GERONTOLOGY GUI; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; The International Association for the Study of Obesity and the International Obesity Task Force, 2000, AS PAC PERSP RED OB; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tsuboi M, 2007, J BONE JOINT SURG BR, V89B, P461, DOI 10.1302/0301-620X.89B4; United Nations, 2005, LIV ARR OLD PERS WOR	52	14	14	1	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2013	50						887	894		10.1016/j.aap.2012.07.015			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	079SD	WOS:000314191600102	22878142				2022-02-06	
J	Athiviraham, A; Bartsch, A; Mageswaran, P; Benzel, EC; Perse, B; Jones, MH; Schickendantz, M				Athiviraham, Aravind; Bartsch, Adam; Mageswaran, Prasath; Benzel, Edward C.; Perse, Brian; Jones, Morgan H.; Schickendantz, Mark			Analysis of Baseball-to-Helmet Impacts in Major League Baseball	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; beanball; helmet impact; baseball pitch; head injury	HIGH-SCHOOL; FOOTBALL PLAYERS; CONCUSSION; IDENTIFICATION; MANAGEMENT; STATEMENT; INJURIES; CATCHERS; SPORT	Background: In Major League Baseball (MLB), helmet hit-by-pitch (H-HBP) incidents are a leading cause of concussion. However, not all H-HBPs result in diagnosed concussion. Purpose: This study was designed to (1) quantify batter concussion risk as a function of H-HBP pitch velocity, time duration batter spent on the ground post-H-HBP, first responder assessment time duration, and number of days missed post-H-HBP and (2) estimate H-HBP impact locations on the helmet with respect to current National Operating Committee on Standards for Athletic Equipment (NOCSAE) helmet test standards and correlate impact locations with concussion diagnosis. Study Design: Case-control study; Level of evidence, 3. Methods: A retrospective case-control study of 18 MLB players with H-HBP incidents in the 2009 and 2010 seasons was undertaken. A database was compiled via quantitative and qualitative analysis using video coverage obtained from MLB. Quantitative factors included batter concussion diagnosis, pitch velocity, number of days missed post-H-HBP, time duration batter spent on the ground post-H-HBP, and first responder assessment time duration. The H-HBP impact location was among several qualitative factors developed via video analysis of each H-HBP from 4 raters. Results: In our study, 9 players (50%) were diagnosed with concussion. Concussion diagnoses were more frequent for posterior versus anterior impacts. The majority of H-HBP impact locations were different from those in the current NOCSAE standard tests. First responders took an average of approximately 65 seconds (time to reach batter plus assessment time) to decide on batter removal/return to play. The 25% logistic regression concussion risk threshold for pitch velocity and days missed was 86.2 mph and 1.3 days, respectively. The number of days missed after H-HBP showed a significant correlation (P = .02) among concussed and nonconcussed batters. Conclusion: In professional baseball H-HBP incidents, first responders should (1) be aware of pitch velocity in excess of 86 mph and (2) be provided ample time when assessing batters' removal/return to play.	[Athiviraham, Aravind; Bartsch, Adam; Mageswaran, Prasath; Benzel, Edward C.; Perse, Brian; Jones, Morgan H.; Schickendantz, Mark] Cleveland Clin, Cleveland, OH 44106 USA		Athiviraham, A (corresponding author), Baylor Coll Med, Dept Orthoped Surg, 6620 Main 11A-35, Houston, TX 77030 USA.	aravindathi@yahoo.com	Athiviraham, Aravind/AAQ-9512-2020; Jones, Morgan H/ABG-3503-2021	Athiviraham, Aravind/0000-0003-1121-2634; Jones, Morgan H/0000-0002-5466-0624			[Anonymous], 1920, NY TIMES, P6; Batting season finder, 2012, BATTING SEASON FINDE; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Campanelli J, 2010, PLAIN DEALER    0406, V6; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cummings D, 2009, FINDINGDULCINEA 0815; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; GOLDSMITH W, 1982, AM J SPORT MED, V10, P31, DOI 10.1177/036354658201000108; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; James Bill Handbook., 2011, B JAMES HDB; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; NOCSAE, STAND PERF SPEC NEWL; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; PELLMAN EJ, 2004, NEUROSURGERY, V55, P1303; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Sowell M., 1991, PITCH KILLED	21	14	14	0	28	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	DEC	2012	40	12					2808	2814		10.1177/0363546512461754			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	045KC	WOS:000311693700017	23104607				2022-02-06	
J	Homnick, A; Sifri, Z; Yonclas, P; Mohr, A; Livingston, D				Homnick, Adena; Sifri, Ziad; Yonclas, Peter; Mohr, Alicia; Livingston, David			The temporal course of intracranial haemorrhage progression: How long is observation necessary?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury (TBI); Mild traumatic brain injury (MTBI); Intracranial haemorrhage (ICH); Temporal course of TBI; Timing of ICH progression; Non-operative management of TBI; Minimal head injury (MHI)	TRAUMATIC BRAIN-INJURY; MINIMAL HEAD-INJURY; COMPUTED-TOMOGRAPHY; FOLLOW-UP; CT; UTILITY	Introduction: Patients with mild traumatic brain injury (MTBI) and intracranial haemorrhage (ICH) are hospitalized and monitored for progression of injury. The timeframe for ICH progression is unknown, and so the optimal duration and location of observation are generally discretionary. The goal of this study was to examine the temporal course of injury progression and establish a timeframe for when haemorrhage ceases. Methods: We performed a retrospective review of all adult patients (age >= 18) with MTBI (GCS >= 13) and ICH admitted to a level 1 trauma centre over a consecutive 36 month period, who underwent a minimum of 2 cranial CT scans (HCT) within 48 h from ED presentation prior to any neurosurgical intervention (NSI). Patients with a history of NSI or nontraumatic cerebral lesions were excluded. Data collected include demographics and the number, timing and findings of serial HCT scans. Results: A total of 341 patients met inclusion criteria. The timing for cessation of bleeding could not be confirmed in 37 patients (11 had NSI after 2nd HCT, 1 died of coagulopathy prior to NSI and 25 had no repeat HCT that could confirm the cessation of bleeding). Of the remaining 304 ICH, 96% stopped progressing by 24 h and 99% by 48 h. The remaining 1% stopped by 72 h. Of all 341 ICH, 236 (69%) showed no progression after initial HCT, indicating that haemorrhage had stopped by that time (1.2 h (SD +/- 1.1 h) from admission). None required a NSI. Conclusion: Almost all ICH in MTBI stop progressing within the first 24 h post injury, supporting a 24-h observational period. In fact, over 3/4 s of ICH has stopped by the time of the initial HCT (< 2 h from arrival). This suggests that early repeat HCT may identify those ICH no longer progressing, and possibly avoid unnecessary admission and prolonged observation in those patients not requiring admission for post-TBI symptom management. Prospective data are needed to evaluate this proposed paradigm change in the management of MTBI. (c) 2012 Elsevier Ltd. All rights reserved.	[Homnick, Adena] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma, Newark, NJ 07103 USA		Homnick, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma, 150 Bergen St, Newark, NJ 07103 USA.	homnicat@umdnj.edu	Mohr, Alicia M/E-3016-2015	Mohr, Alicia/0000-0003-1732-1313			Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	19	14	15	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2122	2125		10.1016/j.injury.2012.04.013			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600027	22658418				2022-02-06	
J	Mulcahey, MJ; Calhoun, CL; Tian, F; Ni, P; Vogel, LC; Haley, SM				Mulcahey, M. J.; Calhoun, C. L.; Tian, F.; Ni, P.; Vogel, L. C.; Haley, S. M.			Evaluation of newly developed item banks for child-reported outcomes of participation following spinal cord injury	SPINAL CORD			English	Article						item response theory; computer adaptive testing; spinal cord injury; participation outcomes	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; DISABILITIES; HANDICAP; HEALTH	Study design: Multi-center, prospective calibration study. Objectives: To examine the psychometric properties of item banks designed for a computer adaptive test (CAT) of participation. Setting: Three pediatric specialty care hospitals in North America. Methods: Newly developed item banks containing questions about participation were administered to 381 children, 8-21 years. Unidimensionality was evaluated using categorical confirmatory factor analysis (CFA). CFA model fit was assessed by the comparative fit index (CFI), Tucker-Lewis index (TLI), root mean square error of approximation (RMSEA) and residual correlations. Pearson's correlations were calculated between simulated CATs and the full-item banks. Results: CFI = 0.905, TLI = 0.951 and RMSEA = 0.089 for the self-participation item bank; CFI - 0.924, TLI = 0.963 and RMSEA = 0.083 friend-participation item bank. The 15-(r = 0.96 self; r = 0.95 friend), 10-(r = 0.93 self; r = 0.92 friend) and 5-(r = 0.85 self; r = 0.85 friend) item simulated CATs and full-item banks were highly correlated. Conclusion: The newly developed self and friend-participation item banks met the required assumptions for CAT. Simulated CATs yielded scores comparable to full-item banks. The results of the study support the use of the item banks for a CAT of participation in children following spinal cord injury. Sponsorship: The study was funded by the Shriners Hospitals for Children Research Advisory Board (RAB #9146). Spinal Cord (2012) 50, 915-919; doi:10.1038/sc.2012.80; published online 21 August 2012	[Mulcahey, M. J.; Calhoun, C. L.] Shriners Hosp Children, Dept Clin Res, Philadelphia, PA 19140 USA; [Tian, F.; Ni, P.; Haley, S. M.] Boston Univ, Hlth & Disabil Res Inst, Sch Publ Hlth, Boston, MA USA; [Vogel, L. C.] Shriners Hosp Children, Dept Clin Res, Chicago, IL USA		Mulcahey, MJ (corresponding author), Shriners Hosp Children, Dept Clin Res, 3551 N Broad St, Philadelphia, PA 19140 USA.	mmulcahey@shrinenet.org		mulcahey, MJ/0000-0002-0837-714X	Shriners Hospitals for Children Research Advisory Board [9146]	Craig McDonald, MD, Mr Jason Kwanda and Ms Leah Bent are acknowledged for their assistance with the study. Dr Anita Bagley, Dr John Gaughan and Mr George Gorton are acknowledged for their critical review of the paper. Mr Brian O'Doherty is acknowledged for the figure production. The study was funded by the Shriners Hospitals for Children Research Advisory Board Grant 9146 (Mulcahey, PI).	Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Bollen K.A., 1989, STRUCTURAL EQUATIONS, VXIV; Calhoun C, 2009, INT J PEDIAT, P854; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; DeVivo MJ, 2004, J SPINAL CORD MED, V27, pS4, DOI 10.1080/10790268.2004.11753778; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; King GA, 2007, CHILD CARE HLTH DEV, V33, P28, DOI 10.1111/j.1365-2214.2006.00613.x; Linacre J, 1999, USERS GUIDE WINSTERS; Magasi S, 2010, ARCH PHYS MED REHAB, V91, pS17, DOI 10.1016/j.apmr.2010.07.011; Mulcahey MJ, 2009, DEV NEUROREHABIL, V12, P191, DOI 10.1080/17518420902998177; MUTHEN LK, 2007, MPLUS STAT ANAL LATE; Noonan VK, 2009, SPINAL CORD, V47, P435, DOI 10.1038/sc.2008.171; Noreau L, 2007, DEV MED CHILD NEUROL, V49, P666, DOI 10.1111/j.1469-8749.2007.00666.x; Oladeji Oluwabunmi, 2007, Pediatr Phys Ther, V19, P296, DOI 10.1097/PEP.0b013e31815a12ef; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Van Brakel WH, 2006, DISABIL REHABIL, V28, P193, DOI 10.1080/09638280500192785; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	20	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	DEC	2012	50	12					915	919		10.1038/sc.2012.80			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	052MA	WOS:000312200700014	22907639	Bronze			2022-02-06	
J	Smith, B; Harms, WD; Burres, S; Korda, H; Rosen, H; Davis, J				Smith, Brad; Harms, William D.; Burres, Stephanie; Korda, Holly; Rosen, Howard; Davis, Jamie			Enhancing behavioral health treatment and crisis management through mobile ecological momentary assessment and SMS messaging	HEALTH INFORMATICS JOURNAL			English	Article						Mental health; mHealth; SMS messaging; pilot study	POSTTRAUMATIC-STRESS-DISORDER; MEMORY; INTERVENTION; VETERANS; DEFICITS; RELAPSE; PHONE	Many veterans returning from service in Afghanistan or Iraq suffer from post-traumatic stress disorder or mild traumatic brain injury. Treating these conditions can be challenging because of high rates of relapse and associated memory impairments. We report on a pilot study that assessed the utility of mobile health (mHealth) technologies, including personal digital assistant-based ecological momentary assessment and two-way interactive text (SMS) messaging, for providing treatment feedback to clinicians, encouraging and motivating veterans throughout treatment, and monitoring participants for relapse after treatment discharge. The results of the pilot suggest that mHealth technologies are feasible adjuncts to traditional mental treatment in the veteran population. Additional work is needed to establish the degree of clinical and economic value.	[Smith, Brad] Altarum Inst, San Antonio, TX 78216 USA; [Harms, William D.] Life WIRE Grp, Washington, DC USA; [Burres, Stephanie] Altarum Inst, Washington, DC USA; [Korda, Holly] Altarum Inst, Portland, ME USA; [Rosen, Howard] Life WIRE Grp, Toronto, ON, Canada; [Davis, Jamie] VA Maryland Hlth Care Syst, Baltimore, MD USA		Smith, B (corresponding author), Altarum Inst, 10001 Reunion Pl,Suite 200, San Antonio, TX 78216 USA.	brad.smith@altarum.org					Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; Daly R, 2009, PSYCHIAT NEWS; Davidson J, 2001, AM J PSYCHIAT, V158, P1974, DOI 10.1176/appi.ajp.158.12.1974; Department of Veterans Affairs, 2010, WHIT HOUS SEEKS 125; Franklin VL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.962; Gerber BS, 2009, HEALTH INFORM J, V15, P17, DOI 10.1177/1460458208099865; Hareva DH, 2009, ACTA MED OKAYAMA, V63, P113; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Lockwood A, 2009, ANN PHARMACOTHER, V43, P1227, DOI 10.1345/aph.1M017; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Mirza Farhaan, 2008, Health Informatics J, V14, P309, DOI 10.1177/1460458208096559; National Council on Disability, 2009, INV WOUNDS SERV SERV; Norris AC, 2009, HEALTH INFORM J, V15, P244, DOI 10.1177/1460458209337445; NORRIS T, 2008, J INFORM TECHNOLOGY, V6, P326; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Rosen CS, 2000, ASSESSMENT, V7, P103, DOI 10.1177/107319110000700201; Shiffman S, 2002, J ABNORM PSYCHOL, V111, P531, DOI 10.1037/0021-843X.111.4.531; SKULIMOWSKI AMJ, 2004, 81 IPTS, P3; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Stockdale R, 2008, 19 AUSTR C INF SYST; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; Velez Olivia, 2011, DESIGN USABILITY TES; Waller Annalu, 2006, Health Informatics J, V12, P304, DOI 10.1177/1460458206070023; Wegner KE, 2002, INT J EAT DISORDER, V32, P352, DOI 10.1002/eat.10086	28	14	14	0	35	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1460-4582	1741-2811		HEALTH INFORM J	Health Inform. J.	DEC	2012	18	4					294	308		10.1177/1460458212445349			15	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	057HU	WOS:000312554600005	23257059				2022-02-06	
J	Vargas, BB; Channer, DD; Dodick, DW; Demaerschalk, BM				Vargas, Bert B.; Channer, Dwight D.; Dodick, David W.; Demaerschalk, Bart M.			Teleconcussion: An Innovative Approach to Screening, Diagnosis, and Management of Mild Traumatic Brain Injury	TELEMEDICINE AND E-HEALTH			English	Article						teleconcussion; concussion; traumatic brain injury; e-health; telemedicine		Concussion awareness and management in sports have gained a great deal of attention in light of research illustrating the potentially devastating consequences of repeated traumatic brain injuries. In order to address this public health crisis, numerous states have passed legislation that mandates medical clearance before being eligible to return to play of concussed athletes by a qualified healthcare provider. As the number of qualified healthcare providers with expertise in the diagnosis and management of concussions remains very small, patient safety and the ability to fulfill these legislative return-to-play requirements present unique problems to rural communities without easy access to subspecialty care. Telemedicine is a possible means by which to address the needs of the rural student-athlete.	[Vargas, Bert B.; Channer, Dwight D.; Dodick, David W.; Demaerschalk, Bart M.] Mayo Clin, Dept Neurol, Phoenix, AZ USA		Vargas, BB (corresponding author), Mayo Clin Hosp, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	vargas.bert@mayo.edu					Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Demaerschalk BM, 2010, STROKE, V41, P1251, DOI 10.1161/STROKEAHA.109.574509; Doarn CR, 2010, TELEMED J E-HEALTH, V16, P378; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Latifi R, 2011, TELEMEDICINE FOR TRAUMA, EMERGENCIES AND DISASTER MANAGEMENT, P225; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer BC, 2008, LANCET NEUROL, V7, P787, DOI 10.1016/S1474-4422(08)70171-6; Miley ML, 2009, TELEMED J E-HEALTH, V15, P691, DOI 10.1089/tmj.2009.0018; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74	12	14	14	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	DEC	2012	18	10					803	806		10.1089/tmj.2012.0118			4	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	055TN	WOS:000312440600015	23101482				2022-02-06	
J	Brenner, LA; Braden, CA; Bates, M; Chase, T; Hancock, C; Harrison-Felix, C; Hawley, L; Morey, C; Newman, J; Pretz, C; Staniszewski, K				Brenner, Lisa A.; Braden, Cynthia A.; Bates, Mike; Chase, Terry; Hancock, Celeste; Harrison-Felix, Cynthia; Hawley, Lenore; Morey, Clare; Newman, Jody; Pretz, Christopher; Staniszewski, Kristi			A Health and Wellness Intervention for Those With Moderate to Severe Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health and wellness; traumatic brain injury; Veterans; intervention	QUALITY-OF-LIFE; COMMUNITY INTEGRATION; PARTICIPATION ASSESSMENT; BEHAVIOR-CHANGE; LIVING WELL; PROMOTION; DISABILITIES; OUTCOMES; PROGRAM; ADULTS	Objectives: To assess the efficacy of a standardized 12-week health and wellness group intervention for those with moderate to severe traumatic brain injury (TBI). Study Design: Randomized controlled trial. Participants: Seventy-four individuals with moderate to severe TBI recruited from the outpatient program at a rehabilitation hospital, a Veterans Affairs Medical Center, and the community. Method: Eligible participants were randomized to treatment (health and wellness therapy group) or wait-list control (treatment, n = 37; wait-list, n = 37). The primary outcome was the Health Promoting Lifestyle Profile-II. Results: The results of the mixed-model repeated-measures analysis indicated no differences between treatment and control groups engaging in activities to increase their health and well-being. Conclusions: Findings did not support the efficacy of the intervention. Results may have been impacted by the wide variability of individualized health and wellness goals selected by group members, the structure and/or content of the group, and/or the outcome measures selected.	[Brenner, Lisa A.] VISN 19 Mental Illness Res Educ & Clin Ctr MIRECC, Denver, CO USA; [Brenner, Lisa A.; Braden, Cynthia A.; Bates, Mike; Chase, Terry; Hancock, Celeste; Harrison-Felix, Cynthia; Hawley, Lenore; Morey, Clare; Newman, Jody; Pretz, Christopher; Staniszewski, Kristi] Craig Hosp, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.; Harrison-Felix, Cynthia] Univ Colorado Denver, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA		Brenner, LA (corresponding author), VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		US Department of Education, Office of Special Education and Rehabilitation Services, National Institute on Disability and Rehabilitation Research [H133A070022]; Veterans Integrated Service Network (VISN) 19 Mental Illness Research Education and Clinical Center (MIRECC)	This research was supported by an award from the US Department of Education, Office of Special Education and Rehabilitation Services, National Institute on Disability and Rehabilitation Research to the Rocky Mountain Regional Brain Injury System (H133A070022). Additional support was provided by the Veterans Integrated Service Network (VISN) 19 Mental Illness Research Education and Clinical Center (MIRECC). The views expressed in this article are those of the authors and do not necessarily represent the official policy or position of the Department of Education, the National Institute on Disability and Rehabilitation Research, the Department of Veterans Affairs, or the US Government. The authors thank Craig Ravensloot, Jeff Cuthbert, Lisa Betthauser, and Melissa Sendroy-Terrill for their contributions to this project.	Abdullah N, 2006, NW PUBLIC HLTH, V23, P8; Adams T, 1997, AM J HEALTH PROMOT, V11, P208, DOI 10.4278/0890-1171-11.3.208; Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 2007, REH RES TRAIN CTR HL; BANDURA A, 1990, EVAL PROGRAM PLANN, V13, P9, DOI 10.1016/0149-7189(90)90004-G; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1995, SELF EFFICACY CHANGI; Bandura A., 1997, SELF EFFICACY EXERCI; Becker H, 1991, Am J Health Promot, V5, P449; Becker H., 1993, HLTH VALUES J HLTH B, V17, P42; BERK RA, 1988, J QUANTITATIVE CRIMI, V0004; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Hagen C, 1972, RANCHO LOS AMIGOS SC; Harrison T, 2006, FAM COMMUNITY HEALTH, V29, p12S, DOI 10.1097/00003727-200601001-00004; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; Hawley L., 2008, GROUP INTERACTIVE ST; Hawley L, 2006, SOCIAL SKILLS TRAUMA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LANIG IS, 1996, PRACTICAL GUIDE HLTH; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Mann J, 2006, AM J MENT RETARD, V111, P62, DOI 10.1352/0895-8017(2006)111[62:HBCOAW]2.0.CO;2; McCullagh S, 2005, TXB TRAUMATIC BRAIN, P321; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Nieuwenhuijsen ER, 2006, DISABIL REHABIL, V28, P245, DOI 10.1080/09638280500197743; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pavot W, 1993, J PSYCHOL ASSESS, V5, P164; Ravesloot C, 2005, REHABIL PSYCHOL, V50, P239, DOI 10.1037/0090-5550.50.3.239; Ravesloot CH, 2007, HEALTH EDUC RES, V22, P522, DOI 10.1093/her/cyl114; Rimmer JH, 2001, AM J HEALTH PROMOT, V16, P34, DOI 10.4278/0890-1171-16.1.34; Rimmer JH., 2001, CTR HLTH PROMOTION R; Roller S, 1991, STAY WELL POLIO NETW; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; *STAT U NEW YORK, 1993, GUID UN DAT SET MED; Stuifbergen A K, 1995, Sch Inq Nurs Pract, V9, P31; Stuifbergen AK, 2000, NURS RES, V49, P122, DOI 10.1097/00006199-200005000-00002; STUIFBERGEN AK, 1994, RES NURS HEALTH, V17, P3, DOI 10.1002/nur.4770170103; Stuifbergen AK, 1995, SCHOLARLY INQUIRY NU, V9, P51; Stuifbergen AK, 2002, PROMOTING WELLNESS W; Stuifbergen Alexa K, 2003, J Neurosci Nurs, V35, P94; Stuifbergen Alexa K, 2004, J Holist Nurs, V22, P12; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; US Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Walker S. N., 1996, P 1996 SCI SESS AM N; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Watt D, 1998, CAN MED ASSOC J, V158, P224; Weinert C, 1987, West J Nurs Res, V9, P589; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P957, DOI 10.1097/01.PHM.0000098504.78524.E2	71	14	14	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E57	E68		10.1097/HTR.0b013e318273414c			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200006	23131971				2022-02-06	
J	Cohen-Adad, J; Buchbinder, B; Oaklander, AL				Cohen-Adad, Julien; Buchbinder, Bradley; Oaklander, Anne Louise			Cervical spinal cord injection of epidural corticosteroids: Comprehensive longitudinal study including multiparametric magnetic resonance imaging	PAIN			English	Article						Adverse event; Spinal cord injury; Wallerian degeneration; Diffusion tensor imaging; Magnetization transfer; Central motor conduction time	MULTIPLE-SCLEROSIS; WALLERIAN DEGENERATION; WHITE-MATTER; AXONAL INJURY; CLINICAL-APPLICATIONS; STEROID INJECTIONS; MOUSE MODEL; BRAIN; MYELIN; NERVE	Despite widespread use, the efficacy of epidural corticosteroid injections (ESI) for osteoarthritis-associated neck or radicular pain remains uncertain, so even rare serious complications enter into discussions about use. However, various factors impede investigation and publication of serious adverse events. To that end, we developed new magnetic resonance imaging (MRI) techniques for spinal cord white matter quantification and used the best available physiological tests to characterize a cervical spinal cord lesion caused by inadvertent intramedullary injection of Depo-Medrol. A 29-year-old woman with mild cervical osteoarthritis had 2 years of headache and neck pain (concussion and whiplash) after 2 minor motor vehicle accidents. During C5-6 ESI, she developed new left-sided motor and sensory symptoms, and MRI demonstrated a new left dorsal spinal cord cavity. Mild left-sided motor and sensory symptoms have persisted for more than 2.5 years, during which time we performed serial neurological examinations, standard electrodiagnostics, somatosensory evoked potentials, and transcranial measurement of cortico-spinal central motor conduction time (CMCT). We used 3-Tesla MRI with a 32-channel coil developed for high-resolution cervical spinal cord structural imaging, diffusion tensor imaging (DTI), and magnetization transfer (MT). T-2(*)-weighted signal and DTI and MT metrics showed delayed spread of the lesion across 4 vertebral levels rostrally, consistent with Wallerian degeneration within the ascending left dorsal columns. However, only CMCT metrics detected objective correlates of her left hemiparesis and bilateral hyperreflexia. DTI and MT metrics may better distinguish between post-traumatic demyelination and axonal degeneration than conventional MRI. These tests should be considered to better characterize similar spinal cord injuries. (C) 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	[Cohen-Adad, Julien] Ecole Polytech, Dept Elect Engn, Montreal, PQ H3T 1J4, Canada; [Cohen-Adad, Julien] Massachusetts Gen Hosp, Dept Radiol, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Cohen-Adad, Julien; Buchbinder, Bradley; Oaklander, Anne Louise] Harvard Univ, Sch Med, Boston, MA USA; [Buchbinder, Bradley] Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA 02114 USA; [Oaklander, Anne Louise] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Oaklander, Anne Louise] Massachusetts Gen Hosp, Dept Neuropathol, Boston, MA 02114 USA		Cohen-Adad, J (corresponding author), Ecole Polytech, Dept Elect Engn, 2900 Edouard Montpetit Bld, Montreal, PQ H3T 1J4, Canada.	jcohen@polymtl.ca			Public Health ServiceUnited States Department of Health & Human ServicesUnited States Public Health Service; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [FG 1892A1/1];  [NIH-P41RR14075];  [NIH-K24NS59892];  [NIH-1S10OD010364];  [NIH-U01MH093765]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH093765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K24NS059892] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD010364] Funding Source: NIH RePORTER	Funded in part by the Public Health Service; NIH-P41RR14075, NIH-K24NS59892, NIH-1S10OD010364, NIH-U01MH093765 National Multiple Sclerosis Society (FG 1892A1/1). Presented in abstract form at the 2011 meeting of the International Society for Magnetic Resonance in Medicine. We thank Dr. Lawrence Wald for helping with MRI acquisition.	Abbasi A, 2007, SPINE, V32, P2144, DOI 10.1097/BRS.0b013e318145a360; Benzon HT, 2007, ANESTHESIOLOGY, V106, P331, DOI 10.1097/00000542-200702000-00022; BENZON HT, 1987, ANESTH ANALG, V66, P553; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Cohen-Adad J, 2011, MAGN RESON MED, V66, P1198, DOI 10.1002/mrm.22906; Cohen-Adad J, 2011, NEUROIMAGE, V57, P1068, DOI 10.1016/j.neuroimage.2011.04.068; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cohen-Adad J, 2010, NEUROIMAGE, V50, P1074, DOI 10.1016/j.neuroimage.2009.12.122; Cohen-Adad J, NEUROLOGY IN PRESS; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Derby Richard, 2004, Pain Physician, V7, P445; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; DVORAK J, 1990, SPINE, V15, P1013, DOI 10.1097/00007632-199015100-00006; FEASBY TE, 1983, NEW ENGL J MED, V308, P966; Goel A, 2006, SPINE, V31, P1576, DOI 10.1097/01.brs.0000222020.45794.ac; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; HAHN AF, 1983, NEUROLOGY, V33, P1032, DOI 10.1212/WNL.33.8.1032; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hodges SD, 1998, SPINE, V23, P2137, DOI 10.1097/00007632-199810010-00020; Hodges SD, 1998, SPINE, V23, P2141; Huang RC, 2004, SPINE, V29, pE7, DOI 10.1097/01.BRS.0000106764.40001.84; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kashani H, 2010, J COMPUT ASSIST TOMO, V34, P251, DOI 10.1097/RCT.0b013e3181c34626; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Lee JH, 2008, REGION ANESTH PAIN M, V33, P377, DOI 10.1016/j.rapm.2007.12.006; Lo YL, 2004, SPINE, V29, P1137, DOI 10.1097/00007632-200405150-00017; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MACKINNON SE, 1982, PLAST RECONSTR SURG, V69, P482, DOI 10.1097/00006534-198203000-00014; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Neema M, 2007, NEUROTHERAPEUTICS, V4, P602, DOI 10.1016/j.nurt.2007.08.001; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pike GB, 2000, RADIOLOGY, V215, P824, DOI 10.1148/radiology.215.3.r00jn02824; Reich DS, 2007, NEUROIMAGE, V38, P271, DOI 10.1016/j.neuroimage.2007.07.049; Reitman CA, 2002, SPINE, V27, pE174, DOI 10.1097/00007632-200203150-00022; Rijsdijk M, 2012, ANESTHESIOLOGY, V116, P170, DOI 10.1097/ALN.0b013e31823cf035; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Smith SA, 2005, MAGN RESON MED, V54, P201, DOI 10.1002/mrm.20553; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Trentman TL, 2009, PAIN PRACT, V9, P59, DOI 10.1111/j.1533-2500.2008.00242.x; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; WALDMAN SD, 1989, REGION ANESTH, V14, P149; WALDMAN SD, 1991, ANESTH ANALG, V72, P717; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	55	14	16	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959			PAIN	Pain	NOV	2012	153	11					2292	2299		10.1016/j.pain.2012.07.028			8	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	033CZ	WOS:000310772400021	22964435	Green Published, Green Accepted			2022-02-06	
J	Li, J; Gu, L; Feng, DF; Ding, F; Zhu, GY; Rong, JD				Li, Jia; Gu, Lei; Feng, Dong-Fu; Ding, Fang; Zhu, Guangyao; Rong, Jiandong			Exploring Temporospatial Changes in Glucose Metabolic Disorder, Learning, and Memory Dysfunction in a Rat Model of Diffuse Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; hippocampus; hypometabolism; learning and memory dysfunction; rat	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; FLUID-PERCUSSION INJURY; REGIONAL CEREBRAL METABOLISM; STATISTICAL IMAGE-ANALYSIS; CORTICAL IMPACT INJURY; WATER MAZE PERFORMANCE; HEAD-INJURY; CELL-DEATH; FDG-PET	Diffuse axonal injury (DAI) is the predominant effect of severe traumatic brain injury and contributes significantly to cognitive deficits. The mechanisms underlying these cognitive deficits are often associated with complex metabolic alterations. However, the relationships between temporospatial alterations in cerebral glucose metabolism and the pathophysiology of DAI-related learning and memory dysfunction are not yet completely understood. We used a small animal positron emission tomography (PET) scanner with 2-[F-18]-fluoro-2-deoxy-D-glucose (F-18-FDG) as a molecular probe to evaluate temporospatial glucose metabolism in vulnerable areas of rats with DAI. The Morris water maze (MWM) was used to evaluate the development and progression of learning and memory dysfunction. Compared to the sham-treated group, PET-MRI fusion images showed that glucose metabolism was reduced in animals with DAI. In addition, the standardized uptake value (SUV) of F-18-FDG was significantly decreased in the sensorimotor cortex, hippocampus, corpus callosum, caudate putamen, brain stem, and cerebellum at days 1, 3, and 7 after injury. SUV returned to baseline levels by 30 days after injury. The escape latency of the injured group was significantly increased, and the percentages of distance travelled and time spent in the target quadrant were significantly decreased 1 month after injury. These effects persisted for 3 months. SUVs in the hippocampus at the acute stage were significantly correlated with MWM performance during the recovery stage of DAI. These results demonstrate that microstructural injury-induced hypometabolism in the hippocampus at the acute stage are all significantly correlated with learning and memory dysfunctions during the recovery stage of DAI.	[Li, Jia; Gu, Lei; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Neurosurg, Shanghai 200030, Peoples R China; [Li, Jia; Ding, Fang; Zhu, Guangyao; Rong, Jiandong] Ningbo Univ, Sch Med, Lihuili Hosp, Ningbo Med Ctr,Dept Neurosurg, Ningbo, Peoples R China; [Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai 200030, Peoples R China		Feng, DF (corresponding author), 280 Mo He Rd, Shanghai 201900, Peoples R China.	feng_df@yahoo.com			Shanghai Committee of Science and TechnologyShanghai Science & Technology Committee [114119a8300]; Baosan Science and Technology Development Fund [11-E-1]; Medicine-Engineering Combination Project of Shanghai Jiao Tong Universtiy [YG08PETMS19]	This study was supported by grants from the Shanghai Committee of Science and Technology (No. 114119a8300), Baosan Science and Technology Development Fund (No. 11-E-1) and the Medicine-Engineering Combination Project of Shanghai Jiao Tong Universtiy (No. YG08PETMS19).	Alavi A, 1997, J NUCL MED, V38, P1717; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Baron J C, 1981, Trans Am Neurol Assoc, V105, P459; Beresford MJ, 2006, J MAGN RESON IMAGING, V24, P1316, DOI 10.1002/jmri.20768; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Brauck K, 2008, RADIOLOGY, V246, P910, DOI 10.1148/radiol.2463062017; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Coello C, 2011, J NEUROSCI METH, V199, P166, DOI 10.1016/j.jneumeth.2011.04.026; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; COLLE LM, 1986, BRAIN RES, V397, P27, DOI 10.1016/0006-8993(86)91366-1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Doot RK, 2007, J NUCL MED, V48, P920, DOI 10.2967/jnumed.106.037382; Dunnwald LK, 2011, CLIN CANCER RES, V17, P2400, DOI 10.1158/1078-0432.CCR-10-2649; Frumberg DB, 2007, BRAIN RES, V1144, P209, DOI 10.1016/j.brainres.2007.01.134; Gao F, 2009, NEUROBIOL DIS, V34, P477, DOI 10.1016/j.nbd.2009.03.001; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Goffin K, 2009, EXP NEUROL, V217, P205, DOI 10.1016/j.expneurol.2009.02.008; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Guo Y, 2009, NEUROSCIENCE, V162, P972, DOI 10.1016/j.neuroscience.2009.05.041; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hattori N, 2004, J NUCL MED, V45, P775; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Huang SC, 2000, NUCL MED BIOL, V27, P643; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; KEYES JW, 1995, J NUCL MED, V36, P1836; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; KUSHNER M, 1984, ANN NEUROL, V15, P425, DOI 10.1002/ana.410150505; Lagali PS, 2010, CLIN GENET, V78, P321, DOI 10.1111/j.1399-0004.2010.01503.x; Lebesgue D, 2006, J NEUROTRAUM, V23, P1814, DOI 10.1089/neu.2006.23.1814; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Loeffelbein DJ, 2012, J ORAL MAXIL SURG, V70, P473, DOI 10.1016/j.joms.2011.02.120; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; Mankoff David A, 2003, Mol Imaging Biol, V5, P281, DOI 10.1016/j.mibio.2003.09.002; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Muller MJ, 2006, AM J NEURORADIOL, V27, P440; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Pichler Bernd J., 2008, V185, P109, DOI 10.1007/978-3-540-72718-7_6; Prieto E, 2011, EUR J NUCL MED MOL I, V38, P2228, DOI 10.1007/s00259-011-1905-y; Prins ML, 2012, EPILEPSY RES, V100, P218, DOI 10.1016/j.eplepsyres.2011.09.027; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Raylman RR, 2006, PHYS MED BIOL, V51, P6371, DOI 10.1088/0031-9155/51/24/006; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shih YYI, 2008, NEUROSCIENCE, V155, P1221, DOI 10.1016/j.neuroscience.2008.07.013; Shimoji K, 2004, J NUCL MED, V45, P665; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Szutowicz A, 2006, METAB BRAIN DIS, V21, P149, DOI 10.1007/s11011-006-9007-4; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; WORLEY G, 1995, DEV MED CHILD NEUROL, V37, P213; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8; Yamaki T, 1996, J NUCL MED, V37, P1166; Yamamoto S, 2010, ANN NUCL MED, V24, P89, DOI 10.1007/s12149-009-0333-6; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	76	14	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2635	2646		10.1089/neu.2012.2411			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400005	22880625	Green Published			2022-02-06	
J	Schnell, E; Bensen, AL; Washburn, EK; Westbrook, GL				Schnell, Eric; Bensen, AeSoon L.; Washburn, Eric K.; Westbrook, Gary L.			Neuroligin-1 Overexpression in Newborn Granule Cells In Vivo	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; TRAUMATIC BRAIN-INJURY; INHIBITORY SYNAPSE FORMATION; DENTATE GYRUS; PARKINSONS-DISEASE; EXCITATORY SYNAPSES; ADULT HIPPOCAMPUS; ADHESION MOLECULE; NEUROGENESIS; PLASTICITY	Adult-born dentate granule cells integrate into the hippocampal network, extend neurites and form synapses in otherwise mature tissue. Excitatory and inhibitory inputs innervate these new granule cells in a stereotyped, temporally segregated manner, which presents a unique opportunity to study synapse development in the adult brain. To examine the role of neuroligins as synapse-inducing molecules in vivo, we infected dividing neural precursors in adult mice with a retroviral construct that increased neuroligin-1 levels during granule cell differentiation. By 21 days post-mitosis, exogenous neuroligin-1 was expressed at the tips of dendritic spines and increased the number of dendritic spines. Neuroligin-1-overexpressing cells showed a selective increase in functional excitatory synapses and connection multiplicity by single afferent fibers, as well as an increase in the synaptic AMPA/NMDA receptor ratio. In contrast to its synapse-inducing ability in vitro, neuroligin-1 overexpression did not induce precocious synapse formation in adult-born neurons. However, the dendrites of neuroligin-1-overexpressing cells did have more thin protrusions during an early period of dendritic outgrowth, suggesting enhanced filopodium formation or stabilization. Our results indicate that neuroligin-1 expression selectively increases the degree, but not the onset, of excitatory synapse formation in adult-born neurons.	[Schnell, Eric] Portland VA Med Ctr, Portland, OR USA; [Schnell, Eric] OHSU Dept Anesthesiol & Perioperat Med, Portland, OR USA; [Bensen, AeSoon L.; Washburn, Eric K.; Westbrook, Gary L.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA		Schnell, E (corresponding author), Portland VA Med Ctr, Portland, OR USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Oregon Medical Research Foundation; Department of Veteran's Affairs Career Development Award; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH46613]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS06180]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS061800] Funding Source: NIH RePORTER	This work was supported by the Oregon Medical Research Foundation (ES), a Department of Veteran's Affairs Career Development Award (ES), the National Institute of Mental Health (R01MH46613; GLW), and the Jungers Center Light Microscopy Image Core that is supported in part by NIH P30 NS06180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstikaitis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016998; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; El-Hussein AE, 2000, SCIENCE, V290, P1364; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gorecki DC, 1999, MOL CELL NEUROSCI, V13, P218, DOI 10.1006/mcne.1999.0740; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hagell P, 2005, BRAIN RES BULL, V68, P4, DOI 10.1016/j.brainresbull.2004.10.013; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kernie SG, 2009, NEUROBIOL DIS; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Liu JL, 1998, J NEUROSCI, V18, P7768; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	79	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e48045	10.1371/journal.pone.0048045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	WOS:000310193400031	23110172	Green Submitted, gold, Green Published			2022-02-06	
J	Kim, JY; Choi, SY; Moon, Y; Kim, HJ; Chin, JH; Kim, H; Sun, W				Kim, J. Y.; Choi, S. Y.; Moon, Y.; Kim, H. J.; Chin, J. H.; Kim, H.; Sun, W.			DIFFERENT EXPRESSION PATTERNS OF PHACTR FAMILY MEMBERS IN NORMAL AND INJURED MOUSE BRAIN	NEUROSCIENCE			English	Article						Phactrs; neural stem/progenitor cell; traumatic brain injury; in situ hybridization	PROTEIN PHOSPHATASE 1; PROGRAMMED CELL-DEATH; NITRIC-OXIDE SYNTHASE; NEURAL STEM-CELLS; REACTIVE ASTROCYTES; HIPPOCAMPAL CONTINUATION; INDUSIUM GRISEUM; ADULT BRAIN; GLIOSIS; RAT	Phosphatase and actin regulators (Phactrs) are a novel family of proteins expressed in the brain, and they exhibit both strong modulatory activity of protein phosphatase 1 and actin-binding activity. Phactrs are comprised of four family members (Phactr1-4), but their detailed expression patterns during embryonic and postnatal development are not well understood. We found that these family members exhibit different spatiotemporal mRNA expression patterns. Phactr4 mRNA was found in neural stem cells in the developing and adult brains, whereas Phactr1 and 3 appeared to be expressed in post-mitotic neurons. Following traumatic brain injury which promotes neurogenesis in the neurogenic region and gliogenesis in the injury penumbra, the mRNA expression of phactr2 and 4 was progressively increased in the injury penumbra, and phactr4 mRNA and protein induction was observed in reactive astrocytes. These differential expression patterns of phactrs imply specific functions for each protein during development, and the importance of Phactr4 in the reactive gliosis following brain injury. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kim, J. Y.; Choi, S. Y.; Kim, H. J.; Chin, J. H.; Kim, H.; Sun, W.] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Moon, Y.] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Brain & Neuroendocrine Lab, Seoul 151742, South Korea		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Choi, So Yoen/AAV-1947-2020	sun, woong/0000-0003-1792-4894; Moon, Younghye/0000-0002-3737-0043; Kim, Hyun/0000-0002-7210-5798	Korean Ministry of Education, Science, and Technology by Brain Research Center of the twenty-first century Frontier Program in Neuroscience [2011K000262, 2011K000288]; National Research Foundation of KoreaNational Research Foundation of Korea [20110019409]	This work is supported by Grants from the Korean Ministry of Education, Science, and Technology by Brain Research Center of the twenty-first century Frontier Program in Neuroscience (2011K000262; 2011K000288) and the National Research Foundation of Korea (20110019409).	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Brown AM, 2008, J BIOL CHEM, V283, P14286, DOI 10.1074/jbc.M801377200; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Farghaian H, 2011, J BIOL CHEM, V286, P19724, DOI 10.1074/jbc.M110.205781; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; Horiguchi T, 2002, NEUROSCI LETT, V325, P115, DOI 10.1016/S0304-3940(02)00244-6; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kim WR, 2012, NEUROSCI LETT, V513, P155, DOI 10.1016/j.neulet.2012.02.023; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Kunzle H, 2004, ANAT EMBRYOL, V208, P183, DOI 10.1007/s00429-004-0384-3; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Pahan K, 1998, J BIOL CHEM, V273, P12219, DOI 10.1074/jbc.273.20.12219; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Runden E, 1998, J NEUROSCI, V18, P7296; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Saha RN, 2006, NEUROCHEM INT, V49, P154, DOI 10.1016/j.neuint.2006.04.007; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Wider C, 2009, NEUROSCI LETT, V453, P9, DOI 10.1016/j.neulet.2009.02.009; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; WYSS JM, 1983, J COMP NEUROL, V219, P251, DOI 10.1002/cne.902190302; Yi KD, 2005, J NEUROSCI, V25, P7191, DOI 10.1523/JNEUROSCI.1328-05.2005; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	40	14	14	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	SEP 27	2012	221						37	46		10.1016/j.neuroscience.2012.06.059			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	003RD	WOS:000308628100005	22766235				2022-02-06	
J	Booth-Kewley, S; Highfill-McRoy, RM; Larson, GE; Garland, CF; Gaskin, TA				Booth-Kewley, Stephanie; Highfill-McRoy, Robyn M.; Larson, Gerald E.; Garland, Cedric F.; Gaskin, Thomas A.			Anxiety and Depression in Marines Sent to War in Iraq and Afghanistan	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Anxiety; depression; psychiatric disorders; military populations; Marines; Iraq/Afghanistan wars; veterans; combat; deployment stressors	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; TRAUMATIC BRAIN-INJURY; GULF-WAR; PSYCHIATRIC DIAGNOSES; DEPLOYMENT STRESSORS; COMBAT DEPLOYMENT; ZONE STRESSORS; SOCIAL SUPPORT; RISK-FACTORS	Although the effects of combat deployment on posttraumatic stress disorder have been extensively studied, little is known about the effects of combat deployment on depression and anxiety. This study examined the factors associated with anxiety and depression in a sample of 1560 US Marines who were deployed to Iraq and Afghanistan. Eleven demographic and psychosocial factors were studied in relation to depression and anxiety. Five factors emerged as significant in relation to depression: deployment-related stressors, combat exposure, attitudes toward leadership, mild traumatic brain injury symptoms, and marital status. The same factors, with the exception of marital status, emerged as significant in relation to anxiety. Deployment-related stressors had a stronger association with both depression and anxiety than any other variable, including combat exposure. This finding is important because deployment-related stressors are potentially modifiable by the military.	[Booth-Kewley, Stephanie] Naval Hlth Res Ctr, Behav Sci & Epidemiol Dept, San Diego, CA 92106 USA; [Garland, Cedric F.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Garland, Cedric F.] Univ Calif San Diego, Moores UCSD Canc Ctr, San Diego, CA 92103 USA; [Gaskin, Thomas A.] US Marine Corps, Combat Operat Stress Control, Quantico, VA USA		Booth-Kewley, S (corresponding author), Naval Hlth Res Ctr, Behav Sci & Epidemiol Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	stephanie.kewley@med.navy.mil			Headquarters, Marine Corps (Combat Operational Stress Control), Work Unit [60518]	This research was supported by Headquarters, Marine Corps (Combat Operational Stress Control), Work Unit 60518. The authors declare no conflict of interest.	Adler AB, 1996, MIL PSYCHOL, V8, P1, DOI 10.1207/s15327876mp0801_1; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Bartone PT, 1998, MIL MED, V163, P587, DOI 10.1093/milmed/163.9.587; Booth-Kewley S, 2010, J TRAUMA STRESS, V23, P69, DOI 10.1002/jts.20485; Bray RM, 2006, RTI7841106FR; Britt TW, 2004, MIL MED, V169, P541, DOI 10.7205/MILMED.169.7.541; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Brown WJ, 2005, AM J PREV MED, V29, P265, DOI 10.1016/j.amepre.2005.06.009; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Castro CA, 2007, TRAUMATOLOGY, V13, P6, DOI [DOI 10.1177/1534765607309950, 10.1177/1534765607309950]; DELONGIS A, 1988, J PERS SOC PSYCHOL, V54, P486, DOI 10.1037/0022-3514.54.3.486; Dohrenwend BP, 2007, J TRAUMA STRESS, V20, P449, DOI 10.1002/jts.20296; DUBOIS DL, 1992, CHILD DEV, V63, P542, DOI 10.1111/j.1467-8624.1992.tb01645.x; Engelhard IM, 2007, CAN J PSYCHIAT, V52, P505, DOI 10.1177/070674370705200808; Fiedler N, 2006, BRIT J PSYCHIAT, V188, P453, DOI 10.1192/bjp.188.5.453; Fikretoglu D, 2006, CAN J PSYCHIAT, V51, P755, DOI 10.1177/070674370605101205; FISHER CD, 1985, J MANAGE, V11, P39, DOI 10.1177/014920638501100304; Fontana A, 1999, J TRAUMA STRESS, V12, P111, DOI 10.1023/A:1024750417154; GRIFFITH J, 1988, BASIC APPL SOC PSYCH, V9, P149, DOI 10.1207/s15324834basp0902_6; Griffith J, 2010, MIL PSYCHOL, V22, P176, DOI 10.1080/08995601003638967; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen A, 2005, BRIT J PSYCHIAT, V186, P480, DOI 10.1192/bjp.186.6.480; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; KARASEK RA, 1982, J OCCUP BEHAV, V3, P181, DOI 10.1002/job.4030030205; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; Koenen KC, 2003, J CONSULT CLIN PSYCH, V71, P980, DOI 10.1037/0022-006X.71.6.980; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Litz BT, 1997, J CONSULT CLIN PSYCH, V65, P1001, DOI 10.1037/0022-006X.65.6.1001; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; Mental Health Advisory Team, 2008, MENT HLTH ADV TEAM M; Mental Health Advisory Team VI, 2009, MENT HLTH ADV TEAM M; Miller MW, 2008, J TRAUMA STRESS, V21, P58, DOI 10.1002/jts.20303; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renshaw KD, 2009, ANXIETY STRESS COPIN, V22, P101, DOI 10.1080/10615800802354000; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simon RW, 2002, AM J SOCIOL, V107, P1065, DOI 10.1086/339225; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; SOUTHWICK SM, 1995, AM J PSYCHIAT, V152, P1150; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Vogt DS, 2008, J TRAUMA STRESS, V21, P66, DOI 10.1002/jts.20306; Vogt DS, 2005, J TRAUMA STRESS, V18, P115, DOI 10.1002/jts.20018; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; WOLFE J, 1993, J SOC ISSUES, V49, P15, DOI 10.1111/j.1540-4560.1993.tb01179.x; Yi MS, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00643.x; Zauszniewski JA, 2009, WESTERN J NURS RES, V31, P219, DOI 10.1177/0193945908326065	55	14	14	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	SEP	2012	200	9					749	757		10.1097/NMD.0b013e318266b7e7			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	003KX	WOS:000308611500004	22922233				2022-02-06	
J	Wall, L; O'Donnell, JC; Schoenecker, PL; Keeler, KA; Dobbs, MB; Luhmann, SJ; Gordon, JE				Wall, Lindley; O'Donnell, June C.; Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric			Titanium elastic nailing radius and ulna fractures in adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						adolescent; forearm; fracture; internal fixation; intramedullary; nail; pediatric; radius; titanium elastic nail; trauma; ulna; upper extremity	UNSTABLE FOREARM FRACTURES; COMPRESSION-PLATE FIXATION; INTRAMEDULLARY FIXATION; OPEN REDUCTION; INTERNAL-FIXATION; OPERATIVE MANAGEMENT; DIAPHYSEAL FRACTURES; PEDIATRIC FRACTURES; SHAFT FRACTURES; CHILDREN	Over the last 40 years, anatomic reduction with plate stabilization has become the standard in adult patients with diaphyseal fractures of the radius and ulna. When operative fixation has been indicated in skeletally immature patients with these fractures, a variety of techniques have been reported, with intramedullary fixation becoming increasingly accepted. There is currently significant variability in the treatment of adolescents with forearm fractures. The purpose of this study was to investigate the clinical and radiographic outcomes in the adolescent population after intramedullary fixation of both bone forearm fractures. A retrospective review identified 32 patients 12-18 years of age who had undergone intramedullary fixation of both forearm bones in the past 20 years at our institution. Galeazzi, Monteggia, radial head, and distal metaphyseal fractures were excluded. Radiographic evaluation was performed to determine union and postoperative radial bow. Clinical follow-up was carried out for postoperative complications and range of motion of the wrist, forearm, and elbow. The mean age of the patients was 14.1 years. A total of 19 fractures were closed injuries, nine were grade 1, three were grade 2, and one fracture was a grade 3b. Of the patients, 15.6% had limited postoperative range of motion. All patients in the older age group, 15-18 years of age, had a normal range of motion. A decrease in radial bow was not associated with limitation in motion. There was a 98% union rate, and all unions occurred by 7.5 months. Only three major complications occurred, two refractures and one ulnar hardware migration, and subsequent radius nonunion occurred in the one grade 3b injury. Flexible intramedullary nailing of both bone forearm fractures provides reliable bony union and excellent postoperative clinical results in adolescents. Level of evidence, IV. J Pediatr Orthop B 21:482-488 (c) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric] St Louis Childrens Hosp, St Louis, MO 63110 USA; [Wall, Lindley; O'Donnell, June C.; Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric] St Louis Shriners Hosp, St Louis, MO USA		Gordon, JE (corresponding author), St Louis Childrens Hosp, 4S-60,1 Childrens Pl, St Louis, MO 63110 USA.	Gordone@wustl.edu		Wall, Lindley/0000-0003-0818-8995			ANDERSON LD, 1975, J BONE JOINT SURG AM, VA 57, P287, DOI 10.2106/00004623-197557030-00001; Ballal MS, 2009, J PEDIATR ORTHOP B, V18, P261, DOI 10.1097/BPB.0b013e32832f0648; CHAPMAN MW, 1989, J BONE JOINT SURG AM, V71A, P159, DOI 10.2106/00004623-198971020-00001; Chitgopkar SD, 2008, J PEDIATR ORTHOP B, V17, P251, DOI 10.1097/BPB.0b013e328306898d; Cullen MC, 1998, J PEDIATR ORTHOPED, V18, P14, DOI 10.1097/00004694-199801000-00004; Dell'Oca AAF, 2001, CLIN ORTHOP RELAT R, P196; Dennison DG, 2007, J HAND SURG-AM, V32A, P801, DOI 10.1016/j.jhsa.2007.03.010; Fernandez FF, 2005, INJURY, V36, P1210, DOI 10.1016/j.injury.2005.03.004; Firl M, 2004, J BONE JOINT SURG BR, V86B, P1047, DOI 10.1302/0301-620X.86B7.14294; Flynn JM, 2010, J PEDIATR ORTHOPED, V30, P313, DOI 10.1097/BPO.0b013e3181d98f2c; Flynn John M, 2002, Instr Course Lect, V51, P355; Hong G, 2006, CLIN ORTHOP RELAT R, P186, DOI 10.1097/01.blo.0000214444.87645.75; Garg NK, 2008, J TRAUMA, V65, P109, DOI 10.1097/TA.0b013e3181623309; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Gustilo RB., 1982, MANAGEMENT OPEN FRAC; Hanel DP, 2006, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000205885.58458.f9; Huber RI, 1996, J PEDIATR ORTHOPED, V16, P602, DOI 10.1097/01241398-199609000-00011; Kang SN, 2011, J BONE JOINT SURG BR, V93B, P262, DOI 10.1302/0301-620X.93B2.24882; Kose O, 2008, J Orthop Surg (Hong Kong), V16, P165; Krzykawski Ryszard, 2008, Ortop Traumatol Rehabil, V10, P35; LASCOMBES P, 1990, J PEDIATR ORTHOPED, V10, P167; Lascombes P, 2006, J PEDIATR ORTHOPED, V26, P827, DOI 10.1097/01.bpo.0000235397.64783.d6; Lee S, 2002, CLIN ORTHOP RELAT R, P245; LIGIER JN, 1985, Z KINDERCHIR, V40, P209; Luhmann SJ, 1998, J PEDIATR ORTHOPED, V18, P451, DOI 10.1097/00004694-199807000-00009; Majed A, 2007, J PEDIATR ORTHOP B, V16, P129, DOI 10.1097/01.bpb.0000210597.66146.2a; MANN DC, 1990, J PEDIATR ORTHOPED, V10, P713, DOI 10.1097/01241398-199011000-00002; MOED BR, 1986, J BONE JOINT SURG AM, V68A, P1008, DOI 10.2106/00004623-198668070-00007; Noonan K J, 1998, J Am Acad Orthop Surg, V6, P146; ONO M, 1989, CLIN ORTHOP RELAT R, P236; Ortega R, 1996, J PEDIATR ORTHOPED, V16, P651, DOI 10.1097/01241398-199609000-00019; Reinhardt KR, 2008, J PEDIATR ORTHOPED, V28, P403, DOI 10.1097/BPO.0b013e31816d71f2; Richter D, 1998, J PEDIATR ORTHOPED, V18, P457, DOI 10.1097/00004694-199807000-00010; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000156480.76450.04; ROY DR, 1990, ORTHOP CLIN N AM, V21, P245; SAGE FP, 1959, J BONE JOINT SURG AM, V41, P1489, DOI 10.2106/00004623-195941080-00010; Schmittenbecher PP, 2005, INJURY, V36, pA25, DOI 10.1016/j.injury.2004.12.010; Shah AS, 2010, J ORTHOP TRAUMA, V24, P440, DOI 10.1097/BOT.0b013e3181ca343b; Smith VA, 2005, J PEDIATR ORTHOPED, V25, P309, DOI 10.1097/01.bpo.0000153943.45396.22; STREET DM, 1986, CLIN ORTHOP RELAT R, P219; Van der Reis WL, 1998, J PEDIATR ORTHOPED, V18, P9, DOI 10.1097/00004694-199801000-00003; Visna P, 2008, ACTA CHIR BELG, V108, P333, DOI 10.1080/00015458.2008.11680232; Wal A, 1997, AUST NZ J SURG, V67, P622, DOI 10.1111/j.1445-2197.1997.tb04610.x; Wyrsch B, 1996, J PEDIATR ORTHOPED, V16, P644, DOI 10.1097/01241398-199609000-00018; Yuan PS, 2004, J PEDIATR ORTHOPED, V24, P370, DOI 10.1097/01241398-200407000-00005	45	14	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2012	21	5					482	488		10.1097/BPB.0b013e3283528db5			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	983NE	WOS:000307125200021	22415404				2022-02-06	
J	Walz, NC; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Walz, Nicolay Chertkoff; Yeates, Keith Owen; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			Emerging narrative discourse skills 18 months after traumatic brain injury in early childhood	JOURNAL OF NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; BEHAVIOR RATING INVENTORY; EXECUTIVE FUNCTION; WORKING-MEMORY; YOUNG-CHILDREN; COMPREHENSION; ADOLESCENCE; RELIABILITY; PREDICTORS; RECOVERY	This study examined the longer term effect of traumatic brain injury (TBI), approximately 18 months post-injury, on emerging narrative discourse skills of 85 children with orthopaedic injury (OI), 43 children with moderate TBI, and 19 children with severe TBI who were between 3 years and 6 years 11 months at injury. Children with TBI performed worse than children with OI on most discourse indices. Children with severe TBI were less proficient than children with moderate TBI at identifying unimportant story information. Age and pragmatic skills were predictors of discourse performance.	[Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH 45229 USA; [Walz, Nicolay Chertkoff; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus Childrens Hosp, Div Pediat Psychol, Columbus, OH 43210 USA; [Yeates, Keith Owen] Childrens Res Inst, Columbus, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Pediat Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil, Cincinnati, OH USA		Walz, NC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, MLC 10006,2800 Winslow Ave, Cincinnati, OH 45229 USA.	nicolay.walz@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	CCHMC GCRC CReFF award, Institutional Clinical and Translational Science Award; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1Ul1RR026314, K23 HD046690, R01 HD42729]; State of Ohio Emergency Medical Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD046690] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	Supported by a CCHMC GCRC CReFF award (as part of an Institutional Clinical and Translational Science Award, NIH/NCRR 1Ul1RR026314) and grant K23 HD046690 to Dr. Walz, grant R01 HD42729 to Dr. Wade, and by Trauma Research grants from the State of Ohio Emergency Medical Services to Dr. Taylor. The authors wish to acknowledge the contributions of Christine Abraham, Andrea Beebe, Lori Bernard, Anne Birnbaum, Beth Bishop, Tammy Matecun, Karen Oberjohn, Elizabeth Roth, Elizabeth Shaver, and Maegan Swartwout in data collection and Abby Burkhardt in coding and data management. The Cincinnati Children's Medical Center Trauma Registry, Rainbow Pediatric Trauma Center, Rainbow Babies & Children's Hospital, Columbus Children's Hospital Trauma Program, and MetroHealth Center Department of Pediatrics and Trauma Registry provided assistance with recruitment. We would also like to thank Sandy Chapman and Lori Cook for assistance with the discourse measure throughout the project.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T.M., 2001, MANUAL ASEBA PRESCHO; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4; Carrow-Woolfolk E, 2000, COMPREHENSIVE ASSESS; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2000, TRAUM BRAIN INJ US A; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Ladd GW, 1999, ANNU REV PSYCHOL, V50, P333, DOI 10.1146/annurev.psych.50.1.333; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MALONE LD, 1992, EXCEPT CHILDREN, V58, P270, DOI 10.1177/001440299105800309; Merrell K. W., 2002, PRESCHOOL KINDERGART; Merrell KM., 2002, HOME COMMUNITY SOCIA; Merrell KW, 2001, PSYCHOL SCHOOLS, V38, P313, DOI 10.1002/pits.1021; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; Peterson C, 1999, J CHILD LANG, V26, P49, DOI 10.1017/S0305000998003651; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TAYLOR HG, 2008, J INT NEUROPSYCH SOC, V14, P1; TEASDALE G, 1974, LANCET, V2, P81; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Walz NC, 2009, DEV NEUROPSYCHOL, V34, P507, DOI 10.1080/87565640902964490; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	51	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	SEP	2012	6		2				143	160		10.1111/j.1748-6653.2011.02020.x			18	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	000ZN	WOS:000308429700001	22257728	Green Accepted			2022-02-06	
J	Roehl, AB; Zoremba, N; Kipp, M; Schiefer, J; Goetzenich, A; Bleilevens, C; Kuehn-Velten, N; Tolba, R; Rossaint, R; Hein, M				Roehl, Anna B.; Zoremba, Norbert; Kipp, Markus; Schiefer, Johannes; Goetzenich, Andreas; Bleilevens, Christian; Kuehn-Velten, Nikolaus; Tolba, Rene; Rossaint, Rolf; Hein, Marc			The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia	BMC NEUROLOGY			English	Article						Levosimendan; Cerebral ischaemia; Hypoxia; Microdialysis	SENSITIVE POTASSIUM CHANNELS; FOCAL CEREBRAL-ISCHEMIA; INFARCT SIZE; DIFFUSION PARAMETERS; REPERFUSION INJURY; GLUTAMATE RELEASE; NITRIC-OXIDE; SPINAL-CORD; IN-VITRO; MODEL	Backround: Neuroprotective strategies after cardiopulmonary resuscitation are currently the focus of experimental and clinical research. Levosimendan has been proposed as a promising drug candidate because of its cardioprotective properties, improved haemodynamic effects in vivo and reduced traumatic brain injury in vitro. The effects of levosimendan on brain metabolism during and after ischaemia/hypoxia are unknown. Methods: Transient cerebral ischaemia/hypoxia was induced in 30 male Wistar rats by bilateral common carotid artery clamping for 15 min and concomitant ventilation with 6% O-2 during general anaesthesia with urethane. After 10 min of global ischaemia/hypoxia, the rats were treated with an i.v. bolus of 24 mu g kg(-1) levosimendan followed by a continuous infusion of 0.2 mu g kg(-1) min(-1). The changes in the energy-related metabolites lactate, the lactate/pyruvate ratio, glucose and glutamate were monitored by microdialysis. In addition, the effects on global haemodynamics, cerebral perfusion and autoregulation, oedema and expression of proinflammatory genes in the neocortex were assessed. Results: Levosimendan reduced blood pressure during initial reperfusion (72 +/- 14 vs. 109 +/- 2 mmHg, p = 0.03) and delayed flow maximum by 5 minutes (p = 0.002). Whereas no effects on time course of lactate, glucose, pyruvate and glutamate concentrations in the dialysate could be observed, the lactate/pyruvate ratio during initial reperfusion (144 +/- 31 vs. 77 +/- 8, p = 0.017) and the glutamate release during 90 minutes of reperfusion (75 +/- 19 vs. 24 +/- 28 mu mol.L-1) were higher in the levosimendan group. The increased expression of IL-6, IL-1 beta TNFa and ICAM-1, extend of cerebral edema and cerebral autoregulation was not influenced by levosimendan. Conclusion: Although levosimendan has neuroprotective actions in vitro and on the spinal cord in vivo and has been shown to cross the blood-brain barrier, the present results showed that levosimendan did not reduce the initial neuronal injury after transient ischaemia/hypoxia.	[Roehl, Anna B.; Zoremba, Norbert; Goetzenich, Andreas; Bleilevens, Christian; Rossaint, Rolf; Hein, Marc] RWTH Aachen Univ Hosp, Dept Anesthesiol, D-52074 Aachen, Germany; [Kipp, Markus] Rhein Westfal TH Aachen, Dept Neuroanat, D-52072 Aachen, Germany; [Schiefer, Johannes] RWTH Aachen Univ Hosp, Dept Neurol, D-52074 Aachen, Germany; [Kuehn-Velten, Nikolaus] Med Lab Bremen, MLHB, D-28357 Bremen, Germany; [Tolba, Rene] RWTH Aachen Univ Hosp, Dept Expt Anim Sci, D-52074 Aachen, Germany		Roehl, AB (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Pauwelstr 30, D-52074 Aachen, Germany.	aroehl@ukaachen.de	Bleilevens, Christian/AAG-8034-2020; Kipp, Markus/K-2694-2015	Bleilevens, Christian/0000-0002-2104-1843; 	Medical Faculty RWTH Aachen (START) [10/2010]	This work was supported by the Medical Faculty RWTH Aachen (START grant number 10/2010). We would like to specifically thank Renate Nadenau and Christian Beckers (Department of Anaesthesiology) for their help in our laboratory and Dr. Hartmut Kirchherr (MLHB) for the HPLC-MS/MS analyses.	Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; [Anonymous], 2011, GUIDE CARE USE LAB A; Antila S, 1999, EUR J PHARM SCI, V9, P85, DOI 10.1016/S0928-0987(99)00048-2; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Bernard S, 2009, CRIT CARE MED, V37, pS227, DOI 10.1097/CCM.0b013e3181aa5d0c; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Cengiz SL, 2010, BRAIN INJURY, V24, P877, DOI 10.3109/02699051003789260; Choi SK, 2011, J KOREAN NEUROSURG S, V49, P1, DOI 10.3340/jkns.2011.49.1.1; Das B, 2007, VASC PHARMACOL, V47, P248, DOI 10.1016/j.vph.2007.06.008; Bravo MD, 2011, NEONATOLOGY, V99, P217, DOI 10.1159/000314955; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Dethloff TJ, 2008, J CEREBR BLOOD F MET, V28, P916, DOI 10.1038/sj.jcbfm.9600589; Domoki F, 1999, STROKE, V30, P2713; Fukuda S, 2007, BRIT J ANAESTH, V99, P10, DOI 10.1093/bja/aem140; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; GROVER GJ, 1991, J PHARMACOL EXP THER, V257, P156; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Hein M, 2009, ACTA ANAESTH SCAND, V53, P941, DOI 10.1111/j.1399-6576.2009.01994.x; Honisch A, 2010, BASIC RES CARDIOL, V105, P155, DOI 10.1007/s00395-009-0064-9; Iqbal S, 2002, BRAIN RES, V946, P162, DOI 10.1016/S0006-8993(02)02871-8; Kang SW, 2011, BRAIN RES, V1371, P121, DOI 10.1016/j.brainres.2010.11.057; Katircioglu SF, 2008, J CARDIAC SURG, V23, P44, DOI 10.1111/j.1540-8191.2007.00486.x; Kersten JR, 2000, ANESTH ANALG, V90, P5, DOI 10.1097/00000539-200001000-00003; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Kopustinskiene DM, 2001, EUR J PHARMACOL, V428, P311, DOI 10.1016/S0014-2999(01)01350-4; Kulik A, 2000, J NEUROPHYSIOL, V83, P2905, DOI 10.1152/jn.2000.83.5.2905; Kunimatsu T, 1999, BRAIN RES, V831, P273, DOI 10.1016/S0006-8993(99)01481-X; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Lasarzik I, 2011, NEUROCRIT CARE, V15, P577, DOI 10.1007/s12028-011-9562-3; Lenzser G, 2005, BRAIN RES, V1051, P72, DOI 10.1016/j.brainres.2005.05.064; Mayanagi K, 2007, BRAIN RES, V1168, P106, DOI 10.1016/j.brainres.2007.06.071; Munakata H, 2010, PERFUSION-UK, V25, P159, DOI 10.1177/0267659110370068; Nakayama R, 2002, ANESTHESIOLOGY, V96, P705, DOI 10.1097/00000542-200203000-00029; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zhao ZQ, 2006, CARDIOVASC RES, V70, P200, DOI 10.1016/j.cardiores.2006.01.024; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zhu HL, 2008, NEUROSCIENCE, V157, P884, DOI 10.1016/j.neuroscience.2008.09.033; Zoremba N, 2008, J CEREBR BLOOD F MET, V28, P1665, DOI 10.1038/jcbfm.2008.58; Zoremba N, 2007, EXP NEUROL, V203, P34, DOI 10.1016/j.expneurol.2006.07.017	45	14	19	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	AUG 24	2012	12								81	10.1186/1471-2377-12-81			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	035AN	WOS:000310914100001	22920500	Green Published, gold			2022-02-06	
J	Firsching, R; Piek, J; Skalej, M; Rohde, V; Schmidt, U; Striggow, F				Firsching, Raimund; Piek, Juergen; Skalej, Martin; Rohde, Veit; Schmidt, Uwe; Striggow, Frank		KN38-7271 Study Grp	Early Survival of Comatose Patients after Severe Traumatic Brain Injury with the Dual Cannabinoid CB1/CB2 Receptor Agonist KN38-7271: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						traumatic brain injury; severe head trauma; cannabinoids; cannabinoid receptor agonist	FOCAL CEREBRAL-ISCHEMIA; SEVERE HEAD-INJURY; ENDOCANNABINOID SYSTEM; DEXANABINOL HU-211; PREDICTIVE-VALUE; CLINICAL-TRIAL; STEM LESIONS; BAY 38-7271; CLASSIFICATION; EFFICACY	Background and Study Object Despite many drug trials, no substance has yet been identified that improves the outcome of severe head injury. The dual cannabinoid CB1/CB2 receptor agonist KN38-7271 mediates potent neuroprotection in animal models. We describe here the first randomized, double-blind, prospective, placebo-controlled clinical phase IIa proof-of-concept trial to investigate the safety, pharmacokinetics, and potential efficacy of a cannabinoid receptor agonist in humans. Patients and Methods Out of the 439, 97 comatose patients at 14 European neurosurgical centers met the inclusion criteria. KN38-7271 was administered within 4.5 hours of the injury, and the patients received 1000, 500 mu g, or placebo. The primary analysis was pharmacokinetic; efficacy was measured by survival and by neurological improvement or deterioration 7 and 14 days and 1, 3, and 6 months after the injury. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) were analyzed from start of treatment to end of day 7. Results Survival rates within 1 month of the injury were significantly better in the treatment groups than in the placebo group (high-dose, Kaplan-Meier difference on day 30 + 0.12 with p = 0.043; low-dose, difference +0.15 with p = 0.011) but this effect was not seen after 6 months. Critical ICP and CPP were less extreme and less frequent in the treatment group. There were no severe and no serious adverse effects that could be attributed to KN38-7271. Conclusions KN38-7271 appeared beneficial in the acute early phase of the comatose patient after a head injury. Its use was safe and well tolerated by patients. These results may provide the basis for further phase II/III trials in larger study populations.	[Firsching, Raimund] Univ Magdeburg, Univ Klinikum, Klin Neurochirurg, D-39120 Magdeburg, Germany; [Piek, Juergen] Chirurg Univ Klin Rostock, Abt Neurochirurg, Rostock, Germany; [Skalej, Martin] Univ Magdeburg, Univ Klinikum, Inst Neuroradiol, Zentrum Radiol, D-39120 Magdeburg, Germany; [Rohde, Veit] Univ Gottingen, Klin & Poliklin Neurochirurg, D-37073 Gottingen, Germany; [Schmidt, Uwe] StatConsult Gesell Klin & Versorgungsforsch mbH, Biometrie, Magdeburg, Germany; [Striggow, Frank] KeyNeurotek Pharmaceut Ag, Magdeburg, Germany; [Striggow, Frank] DZNE, Arbeitsgrp Neurodegenerat & Intervent Strategien, Magdeburg, Germany		Firsching, R (corresponding author), Univ Magdeburg, Univ Klinikum, Klin Neurochirurg, Leipziger Str 44, D-39120 Magdeburg, Germany.	raimund.firsching@med.ovgu.de	Skalej, Martin/G-2122-2013	Skalej, Martin/0000-0001-9506-619X	KeyNeurotek Pharmaceuticals AG, Magdeburg, Germany	This study was sponsored by KeyNeurotek Pharmaceuticals AG, Magdeburg, Germany. The authors would like to thank all patients and their involved relatives for their agreement to participate in this study. We greatly acknowledge the contribution and commitment of our colleagues in the KN38-7271 study group, and of H. Riethmuller-Winzen, O. Mielke, K. Barnitzke, M. Hartleb, H. Koppitz, H. Kurzidim, and A. Platz. Special thanks go to Prof. G. Murray for advising us on the optimization of study endpoint criteria and Prof. H. E. von der Leyen, who provided consultation as Medical Expert in the study.	[Anonymous], 2007, DTSCH GES NEUR LEITL; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bedell EA, 2002, CRIT CARE MED, V30, P710, DOI 10.1097/00003246-200203000-00041; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; Brewster ME, 1997, INT J CLIN PHARM TH, V35, P361; BRIHAYE J, 1978, ACTA NEUROCHIR, V40, P181, DOI 10.1007/BF01773126; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2008, ACTA NEUROCHIR SUPPL, V102, P237, DOI 10.1007/978-3-211-85578-2_45; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mauler F, 2003, CNS DRUG REV, V9, P343; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; MECHOULAM R, 1988, EXPERIENTIA, V44, P762, DOI 10.1007/BF01959156; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagayama T, 1999, J NEUROSCI, V19, P2987; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Wolf SA, 2008, CURR PHARM DESIGN, V14, P2266, DOI 10.2174/138161208785740090; [No title captured]	35	14	15	1	6	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	AUG	2012	73	4					204	216		10.1055/s-0032-1304815			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	175UV	WOS:000321260000003	22696266				2022-02-06	
J	Holly, LT; Blaskiewicz, D; Wu, AG; Feng, C; Ying, Z; Gomez-Pinilla, F				Holly, Langston T.; Blaskiewicz, Donald; Wu, Aiguo; Feng, Cameron; Ying, Zhe; Gomez-Pinilla, Fernando			Dietary therapy to promote neuroprotection in chronic spinal cord injury Laboratory investigation	JOURNAL OF NEUROSURGERY-SPINE			English	Article						myelopathy; docosahexaenoic acid; curcumin; membrane; spinal cord injury; rat	TRAUMATIC BRAIN-INJURY; DOCOSAHEXAENOIC ACID; MECHANICAL COMPRESSION; SYNAPTIC PLASTICITY; CURCUMIN; COUNTERACTS; HOMEOSTASIS; MYELOPATHY; COGNITION; NEURONS	Object. The pathogenesis of cervical spondylotic myelopathy (CSM) is related to both primary mechanical and secondary biological injury. The authors of this study explored a novel, noninvasive method of promoting neuroprotection in myelopathy by using curcumin to minimize oxidative cellular injury and the capacity of omega-3 fatty acids to support membrane structure and improve neurotransmission. Methods. An animal model of CSM was created using a nonresorbable expandable polymer placed in the thoracic epidural space, which induced delayed myelopathy. Animals that underwent placement of the expandable polymer were exposed to either a diet rich in docosahexaenoic acid and curcumin (DHA-Cur) or a standard Western diet (WD). Twenty-seven animals underwent serial gait testing, and spinal cord molecular assessments were performed after the 6-week study period. Results. At the conclusion of the study period, gait analysis revealed significantly worse function in the WD group than in the DHA-Cur group. Levels of brain-derived neurotrophic factor (BDNF), syntaxin-3, and 4-hydroxynonenal (4-HNE) were measured in the thoracic region affected by compression and lumbar enlargement. Results showed that BDNF levels in the DHA-Cur group were not significantly different from those in the intact animals but were significantly greater than in the WD group. Significantly higher lumbar enlargement syntaxin-3 in the DHA-Cur animals combined with a reduction in lipid peroxidation (4-HNE) indicated a possible healing effect on the plasma membrane. Conclusions. Data in this study demonstrated that DHA-Cur can promote spinal cord neuroprotection and neutralize the clinical and biochemical effects of myelopathy. (http://thejns.org/doi/abs/10.3171/2012.5.SPINE1216)	[Holly, Langston T.; Blaskiewicz, Donald; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Wu, Aiguo; Feng, Cameron; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA		Holly, LT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Ctr Hlth Sci, Box 956901, Los Angeles, CA 90095 USA.	lholly@mednet.ucla.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS056413]; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	This work was supported by NIH Grant No. RO1 NS056413 and the Craig H. Neilsen Foundation.	Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Henderson FC, 2005, NEUROSURGERY, V56, P1101, DOI 10.1227/01.NEU.0000157929.85251.7C; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Jyoti A, 2009, EPILEPSY BEHAV, V14, P300, DOI 10.1016/j.yebeh.2008.11.011; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kasahara K, 2006, SPINE, V31, P2059, DOI 10.1097/01.brs.0000231893.21964.f2; Kim David H, 2003, Spine J, V3, P510, DOI 10.1016/S1529-9430(03)00117-7; Kim P, 2004, ANN NEUROL, V55, P503, DOI 10.1002/ana.20018; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Lapchak PA, 2011, EXPERT OPIN INV DRUG, V20, P13, DOI 10.1517/13543784.2011.542410; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Wakade C, 2009, ANTIOXID REDOX SIGN, V11, P35, DOI 10.1089/ars.2008.2056; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Xu K, 2006, SPINE, V31, P1867, DOI 10.1097/01.brs.0000228772.53598.cc; Yamaura I, 2002, SPINE, V27, P21, DOI 10.1097/00007632-200201010-00008	27	14	16	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654			J NEUROSURG-SPINE	J. Neurosurg.-Spine	AUG	2012	17	2					134	140		10.3171/2012.5.SPINE1216			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	978SU	WOS:000306766900011	22735048	Green Accepted			2022-02-06	
J	Marks, JA; Li, SH; Gong, WF; Sanati, P; Eisenstadt, R; Sims, C; Smith, DH; Reilly, PM; Pascual, JL				Marks, Joshua A.; Li, Shenghui; Gong, Wanfeng; Sanati, Paymon; Eisenstadt, Rachel; Sims, Carrie; Smith, Douglas H.; Reilly, Patrick M.; Pascual, Jose L.			Similar effects of hypertonic saline and mannitol on the inflammation of the blood-brain barrier microcirculation after brain injury in a mouse model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Intravital microscopy; pial cranial window; neutrophil; endothelium; traumatic brain injury	HEMORRHAGIC-SHOCK; INTRACRANIAL HYPERTENSION; CEREBRAL MICROCIRCULATION; NEUTROPHIL; RESUSCITATION; INTERLEUKIN-1-BETA; ENDOTHELIUM; INCREASES; PERMEABILITY	BACKGROUND: There has been substantial debate regarding the efficacy of hypertonic saline (HTS) versus mannitol (MTL) in treating moderate and severe traumatic brain injury (TBI). HTS blunts polymorphonuclear neutrophil (PMN) and endothelial cell (EC) activation and reduces tissue edema after resuscitated shock in systemic microvascular beds. MTL also modulates PMN activation markers. It remains unknown if either of these osmotherapies exert similar anti-inflammatory effects along the blood-brain barrier (BBB). We hypothesized that HTS, as compared with MTL, would more greatly reduce PMN-EC interactions, thereby reducing BBB permeability and tissue edema after simulated TBI. METHODS: CD1 male mice (25-30 g) underwent craniotomy and window placement for observation of in vivo PMN-EC interactions in pial venules using intravital video microscopy. TBI was simulated through local suffusion of the brain surface with interleukin 1 beta (100 ng/0.1 mL). Animals were randomized to receive a single, equiosmolar, intravenous dose of 20% MTL or 5% HTS after injury. Live microcirculatory footage was obtained every 15 minutes for 2 hours, after which fluorescent-labeled albumin was administered to assess microvascular permeability. PMN rolling and adhesion and macromolecular leakage were analyzed offline by a blinded observer and postmortem brain and lung edema assessed by wet-to-dry ratios. Student's t test and Mann-Whitney U test determined significance (p <= 0.05). RESULTS: Neither osmotherapy resulted in significant differences in PMN rolling or adhesion; however, both trended higher in HTS. Similarly, vessel permeability did not differ between groups but also trended higher with HTS. In contrast, brain and lung edema was greater in MTL than HTS as compared with controls (p = 0.05). CONCLUSION: MTL and HTS have indistinguishable effects on PMN-EC interactions in the brain after simulated TBI. Additional studies are needed to determine if either osmotherapy has more subtle effects on BBB PMN-EC interactions after injury exerting a potential clinical advantage. (J Trauma Acute Care Surg. 2012; 73: 351-357. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Pascual, Jose L.] Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Trauma Ctr Penn, Perelman Sch Med,Dept Surg, Philadelphia, PA 19104 USA; [Marks, Joshua A.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Trauma Ctr Penn, Perelman Sch Med,Dept Surg, 3400 Spruce St,Maloney Bldg,5th Floor, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912; Sanati-Mehrizy, Paymon/0000-0002-1134-6125			Ahmed N, 1996, SHOCK, V6, pS39, DOI 10.1097/00024382-199610001-00008; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Barone M, 1997, ACT NEUR S, V70, P267; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Chen LW, 2004, CRIT CARE MED, V32, P2476, DOI 10.1097/01.CCM.0000147831.07329.32; Chen LW, 2004, SHOCK, V22, P472, DOI 10.1097/01.shk.0000140304.71215.f7; Coiombra R, 2003, J TRAUMA, V54, P130; Gaber MW, 2004, BRAIN RES PROTOC, V13, P1, DOI 10.1016/j.brainresprot.2003.11.005; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gao XP, 1997, AM J PHYSIOL-REG I, V272, pR294, DOI 10.1152/ajpregu.1997.272.1.R294; Gong WF, 2011, J TRAUMA, V71, P275, DOI 10.1097/TA.0b013e318226eb51; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; LINTHORST ACE, 1994, ENDOCRINOLOGY, V135, P520, DOI 10.1210/en.135.2.520; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; NOLTE D, 1992, AM J PHYSIOL, V263, pH1411, DOI 10.1152/ajpheart.1992.263.5.H1411; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Papia G, 2008, SURGERY, V144, P814, DOI 10.1016/j.surg.2008.07.008; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH815, DOI 10.1152/ajpheart.1986.250.5.H815; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Shapiro ML, 2011, J TRAUMA, V71, P281; Shields CJ, 2003, ANN SURG, V238, P249, DOI 10.1097/01.sla.0000080827.77985.fc; Staudenmayer KL, 2005, SHOCK, V23, P459, DOI 10.1097/01.shk.0000160523.37106.33; Turina M, 2008, INFLAMMATION, V31, P74, DOI 10.1007/s10753-007-9051-1; Vachharajani V, 2007, MICROCIRCULATION, V14, P223, DOI 10.1080/10739680601139153; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2005, COCHRANE DB SYST REV, V3; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Woiciechowsky C, 1999, NEUROBIOL DIS, V6, P200, DOI 10.1006/nbdi.1999.0242; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684, DOI 10.1177/153537020422900713; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017	40	14	20	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73	2					351	357		10.1097/TA.0b013e3182592f76			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	992VG	WOS:000307807400013	22846939				2022-02-06	
J	Bay, EH; Blow, AJ; Yan, X				Bay, Esther H.; Blow, Adrian J.; Yan, Xie (Emily)			Interpersonal Relatedness and Psychological Functioning following Traumatic Brain Injury: Implications for Marital and Family Therapists	JOURNAL OF MARITAL AND FAMILY THERAPY			English	Article							COMPETENCE RATING-SCALE; IMPAIRED SELF-AWARENESS; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; CHRONIC STRESS; HEAD-INJURY; MILD HEAD; CONFLICT; SENSE; PREDICTORS	Recovery from a mild-to-moderate traumatic brain injury (TBI) is a challenging process for injured persons and their families. Guided by attachment theory, we investigated whether relationship conflict, social support, or sense of belonging were associated with psychological functioning. Community-dwelling persons with TBI (N = 75) and their relatives/significant others (N = 74) were surveyed on relationship variables, functional status, and TBI symptom severity. Results from this cross-sectional study revealed that only sense of belonging was a significant predictor of postinjury psychological functioning, although interpersonal conflict approached significance. No relevant preinjury or injury-related variables impacted these relationships, except marital status. Our findings suggest that interventions targeting strengthening the injured persons sense of belonging and lowering interpersonal conflict may benefit those living with TBI.	[Bay, Esther H.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Blow, Adrian J.] Michigan State Univ, Couple & Family Therapy Program, Dept Human Dev & Family Studies, E Lansing, MI 48824 USA; [Yan, Xie (Emily)] Michigan State Univ, CSTAT, Dept Stat, E Lansing, MI 48824 USA		Bay, EH (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy,Suite 300, Ann Arbor, MI 48108 USA.	pdq@med.umich.edu	Blow, Adrian/U-1647-2019		NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD007422] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER		AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E., 2005, J NEUROSCIENCE NURSI, V36, P55; Bay E., 2007, J NEUROSCIENCE NURSI, V39, P33; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2007, ARCH PSYCHIAT NURS, V21, P2, DOI 10.1016/j.apnu.2006.07.005; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Center for Outcome Measurement in Brain Injury, 2008, OUTCOME MEASUREMENT; Centers for Disease Control and Prevention, 2011, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2010, WHAT ARE POTENTIAL L; Clark PC, 2004, NURS RES, V53, P406, DOI 10.1097/00006199-200411000-00009; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN NJ, 1993, J CHILD PSYCHOL PSYC, V34, P545, DOI 10.1111/j.1469-7610.1993.tb01035.x; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Florian V, 1991, Int Disabil Stud, V13, P150; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Frohlich KL, 1997, PSYCHOL REP, V80, P883, DOI 10.2466/pr0.1997.80.3.883; Hagerty B M, 1993, Image J Nurs Sch, V25, P291; Hagerty B M, 1992, Arch Psychiatr Nurs, V6, P172, DOI 10.1016/0883-9417(92)90028-H; Hagerty BM, 1999, NURS RES, V48, P215, DOI 10.1097/00006199-199907000-00004; Hagerty BM, 1996, ARCH PSYCHIAT NURS, V10, P235, DOI 10.1016/S0883-9417(96)80029-X; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Johnson SM, 2002, GUIL FAM TH, P3; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kupfer D. J., 1974, K D S MODERN MENTAL, V1; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; SAS Software, 2002, SAS SOFTWARE SAS SYS; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Tilden V P, 1994, J Nurs Meas, V2, P63; TILDEN VP, 1990, NURS RES, V39, P337; Turner HA, 2003, J YOUTH ADOLESCENCE, V32, P89, DOI 10.1023/A:1021853600645; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Whiffen VE, 2005, TRAUMA VIOLENCE ABUS, V6, P24, DOI 10.1177/1524838004272543; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Young E A, 1997, Depress Anxiety, V5, P66, DOI 10.1002/(SICI)1520-6394(1997)5:2<66::AID-DA2>3.0.CO;2-3	61	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0194-472X	1752-0606		J MARITAL FAM THER	J. Marital Fam. Ther.	JUL	2012	38	3					556	567		10.1111/j.1752-0606.2011.00231.x			12	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	973ZO	WOS:000306399600010	22804472	Green Accepted, Green Submitted			2022-02-06	
J	Fries, R; Schrohe, K; Lotz, F; Arndt, G				Fries, R.; Schrohe, K.; Lotz, F.; Arndt, G.			Application of captive bolt to cattle stunning - a survey of stunner placement under practical conditions	ANIMAL			English	Article						stunning; cattle; shot precision; captive bolt; animal welfare	SLAUGHTER PLANTS; CONCUSSION	In two cattle head deboning plants, a total of 8879 cattle skulls were investigated for number and precision of shots. Deviation from the ideal position on the forehead and the direction of the shot were measured, results were then attributed to three classes of precision. In all, 64.7% of the skulls in plant 1 and 65.3% in plant 2 were shot from the ideal position and in the ideal direction. A medium precision was observed in 31.3% and 31.5% of cases, 4.0% and 3.1%, respectively, of the skulls indicated a poor precision. In both plants, skulls with more than one shot hole were observed. Shot holes may indicate the precision of a shot, and thus the risk of suffering during the sensitive time of stunning. In addition to observations at the time of stunning, the observation of shot holes on skulls at random or in total after a day's slaughter can reflect the shooting precision.	[Fries, R.; Schrohe, K.] Free Univ Berlin, Fac Vet Med, Inst Meat Hyg & Technol, D-14195 Berlin, Germany; [Lotz, F.; Arndt, G.] Free Univ Berlin, Fac Vet Med, Inst Biometr & Data Proc, D-14163 Berlin, Germany		Fries, R (corresponding author), Free Univ Berlin, Fac Vet Med, Inst Meat Hyg & Technol, Brummerstr 10, D-14195 Berlin, Germany.	fries.reinhard@vetmed.fu-berlin.de					EFSA Panel on Animal Health and Welfare (AHAW), 2004, EFSA J, V45, P1; EU, 2004, AHAW04027 EU EFSA; FAO, 2004, GOOD PRACT MEAT IND, p[9, 14]; FINNIE JW, 1995, NEW ZEAL VET J, V43, P183, DOI 10.1080/00480169.1995.35886; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Grandin T, 1998, J AM VET MED ASSOC, V212, P36; Grandin T, 2002, J AM VET MED ASSOC, V221, P1258, DOI 10.2460/javma.2002.221.1258; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Hagen U, 2002, P ARB ARB LEB DVG GA, P109; Ilgert H, 1985, THESIS MED VET BERLI; Kaegi B, 1988, THESIS MED VET ZURIC; PALMER AC, 1982, VET REC, V111, P575; Schrohe K, THESIS MED VET BERLI	13	14	14	0	21	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1751-7311			ANIMAL	Animal	JUL	2012	6	7					1124	1128		10.1017/S1751731111002667			5	Agriculture, Dairy & Animal Science; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Veterinary Sciences	949VA	WOS:000304602900012	23031473	hybrid			2022-02-06	
J	Hall, A; Grohn, B; Nalder, E; Worrall, L; Fleming, J				Hall, Alexandra; Grohn, Brooke; Nalder, Emily; Worrall, Linda; Fleming, Jennifer			A Mixed Methods Study of the Experience of Transition to the Community of Working-Aged People with Non-Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Aneurysm; stroke; psychosocial integration; qualitative	QUALITY-OF-LIFE; STROKE SURVIVORS; FAMILY CAREGIVERS; HOME; RECOVERY; REHABILITATION; SUPPORT; NEEDS	Background and aims: The 'transition' phase from hospital to home following brain injury is well established as a critical period of adjustment for individuals and their families. There is, however, a lack of knowledge about the experience of transition following nontraumatic brain injury (e.g., stroke, aneurysm) for individuals of working age. The purpose of this study was to explore the transition experiences of individuals with nontraumatic brain injury using mixed methods approach. Methods: Six individuals with nontraumatic brain injury were recruited from a larger study using maximum variation sampling criteria. Individuals participated in semistructured interviews at 6-months postdischarge and completed quantitative measures of psychosocial outcomes predischarge and at 6-months postdischarge. Results: Qualitative content analysis of interviews identified three themes: (1) changes in role performance, (2) support and services and (3) coping with life after brain injury. The transition experience was characterised by loss of valued roles including driving and work, identified as major barriers to regaining independence postdischarge. Informal support provided by family and friends were relied on, while formal supports were accessed infrequently. Life post-injury presented a number of challenges including adjusting to changes in physical and cognitive abilities and a fear of reinjury. Qualitative data were supported by an overall trend of improved functioning on the quantitative measures over the 6 months. Conclusions: Key life circumstances of working age adults with nontraumatic brain injury influence the transition experience. Clinically, the findings support the need for individualised, structured transition services pre- and postdischarge for this group.	[Worrall, Linda] Univ Queensland, NHMRC CCRE Aphasia Rehabil, St Lucia, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Brisbane, Qld, Australia; [Fleming, Jennifer] Ctr Functioning & Hlth Res, Brisbane, Qld, Australia		Worrall, L (corresponding author), Univ Queensland, NHMRC CCRE Aphasia Rehabil, St Lucia, Qld 4072, Australia.	l.worrall@uq.edu.au	Worrall, Linda/D-2579-2010	Worrall, Linda/0000-0002-3283-7038; Ryan, Brooke/0000-0002-6053-7614	National Stroke Foundation; ARCAustralian Research Council [LP0776294]	The authors would like to thank the staff, patients and their families in the brain injury rehabilitation unit and acute neurosciences unit and our partner organisations, Department of Communities (Disability Services) and the Acquired Brain Injury Outreach Service for the larger research project. This study was supported by a National Stroke Foundation Honours Grant awarded to A. Hall and an ARC Linkage Grant (LP0776294) awarded to J. Fleming and L. Worall.	*AUSTR I HLTH WELF, 2006, AUSTR HLTH 2006; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Burton CR, 2000, J ADV NURS, V32, P301, DOI 10.1046/j.1365-2648.2000.01477.x; Cameron JI, 2008, PATIENT EDUC COUNS, V70, P305, DOI 10.1016/j.pec.2007.10.020; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Dolan P, 2002, MED CARE, V40, P442, DOI 10.1097/00005650-200205000-00009; Ellis-Hill C, 2009, DISABIL REHABIL, V31, P61, DOI 10.1080/09638280701775289; GLASS TA, 1992, SOC SCI MED, V34, P1249, DOI 10.1016/0277-9536(92)90317-J; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kirkevold M, 2002, DISABIL REHABIL, V24, P887, DOI 10.1080/09638280210142239; Kvigne Kari, 2004, Health Care Women Int, V25, P370, DOI 10.1080/07399330490278376; Kwok T, 2006, ARCH PHYS MED REHAB, V87, P1177, DOI 10.1016/j.apmr.2006.05.015; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Lawrence Maggie, 2010, Br J Nurs, V19, P241; LEWINTER M, 1995, DISABIL REHABIL, V17, P3, DOI 10.3109/09638289509166621; Lister R, 1999, BRIT J OCCUPATIONAL, V62, P514; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Malec J. F., 2003, MANUAL MAYO PORTLAND; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Michels N, 1988, Home Health Care Serv Q, V9, P29, DOI 10.1300/J027v09n01_03; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Nalder E., BRAIN INJUR IN PRESS; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; National Stroke Foundation, 2010, FACTS FIG STAT; National Stroke Foundation, 2007, WALK OUR SHOES STROK; National Stroke Foundation, 2010, CLIN GUID STROK MAN; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; O'Connell B, 2001, J Qual Clin Pract, V21, P120, DOI 10.1046/j.1440-1762.2001.00426.x; Olofsson A, 2005, CLIN REHABIL, V19, P433, DOI 10.1191/0269215505cr788oa; Patomella AH, 2009, DISABIL REHABIL, V31, P726, DOI 10.1080/09638280802306539; Pound P, 1998, CLIN REHABIL, V12, P338, DOI 10.1191/026921598677661555; POUND P, 1995, BMJ-BRIT MED J, V311, P18, DOI 10.1136/bmj.311.6996.18; Rittman M, 2004, J REHABIL RES DEV, V41, P259, DOI 10.1682/JRRD.2003.06.0099; Rittman M, 2007, TOP STROKE REHABIL, V14, P21, DOI 10.1310/tsr1402-21; Roding J, 2003, DISABIL REHABIL, V25, P867, DOI 10.1080/0963828031000122276; Schlossberg N., 1984, COUNSELING ADULTS TR; Smith LN, 2004, J ADV NURS, V46, P235, DOI 10.1111/j.1365-2648.2004.02983.x; Stone SD, 2005, DISABIL REHABIL, V27, P293, DOI 10.1080/09638280400008990; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Townend W, 2001, J NEUROL NEUROSUR PS, V70, P267; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Wiles R, 2002, DISABIL REHABIL, V24, P841, DOI 10.1080/09638280210142158; Wissel J., J STROKE CE IN PRESS; [No title captured]	46	14	14	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646			BRAIN IMPAIR	Brain Impair.	JUL	2012	13	1			SI		85	98		10.1017/BrImp.2012.7			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	964VQ	WOS:000305725200008					2022-02-06	
J	Martins, AT; Faisca, LM; Esteves, F; Muresan, A; Reis, A				Martins, Ana T.; Faisca, Luis M.; Esteves, Francisco; Muresan, Angelica; Reis, Alexandra			Atypical moral judgment following traumatic brain injury	JUDGMENT AND DECISION MAKING			English	Article						moral judgment; social emotion recognition; frontal TBI	EMOTION RECOGNITION; SOCIAL EMOTIONS; PERCEPTION; DEFICITS; DAMAGE; BASES	Previous research has shown an association between emotions, particularly social emotions, and moral judgments. Some studies suggested an association between blunted emotion and the utilitarian moral judgments observed in patients with prefrontal lesions. In order to investigate how prefrontal brain damage affects moral judgment, we asked a sample of 29 TBI patients (12 females and 17 males) and 41 healthy participants (16 females and 25 males) to judge 22 hypothetical dilemmas split into three different categories (non-moral, impersonal and personal moral). The TBI group presented a higher proportion of affirmative (utilitarian) responses for personal moral dilemmas when compared to controls, suggesting an atypical pattern of utilitarian judgements. We also found a negative association between the performance on recognition of social emotions and the proportion of affirmative responses on personal moral dilemmas. These results suggested that the preference for utilitarian responses in this type of dilemmas is accompanied by difficulties in social emotion recognition. Overall, our findings suggest that deontological moral judgments are associated with normal social emotion processing and that frontal lobe plays an important role in both emotion and moral judgment.	[Martins, Ana T.; Faisca, Luis M.; Reis, Alexandra] Univ Algarve, Inst Biotechnol & Bioengn CBME, Fac Humanities & Social Sci, Cognit Neurosci Res Grp,Dept Psychol & Educ Sci, Faro, Portugal; [Esteves, Francisco] Inst Univ Lisboa, ISCTE, Ctr Invest & Intervencao Social, Lisbon, Portugal; [Muresan, Angelica] Ctr Med & Reabilitacao S, Sao Bras De Alportel, Portugal		Martins, AT (corresponding author), Univ Algarve, Inst Biotechnol & Bioengn CBME, Fac Humanities & Social Sci, Cognit Neurosci Res Grp,Dept Psychol & Educ Sci, Faro, Portugal.	atmartins@ualg.pt	GNC, GNC/B-5716-2013; Faisca, Luis/A-4633-2013; Esteves, Francisco/I-1206-2012; Martins, Ana Teresa/A-8885-2013; Reis, Alexandra A I/A-3888-2013	Faisca, Luis/0000-0003-4859-8817; Esteves, Francisco/0000-0002-5403-0091; Martins, Ana Teresa/0000-0002-3304-6051; Reis, Alexandra A I/0000-0001-5598-0999			Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Baron J, 2012, SYNTHESE, V189, P693, DOI 10.1007/s11229-012-0121-z; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Choe SY, 2011, JUDGM DECIS MAK, V6, P580; Ciaramelli E., 2007, SOCIAL COGNITIVE AFF, V17, P344; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Gazzaniga M.S., 2009, COGNITIVE NEUROSCIEN, V3; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Kahane G, 2010, MIND LANG, V25, P561, DOI 10.1111/j.1468-0017.2010.01401.x; Keltner D., 2006, SOCIAL JUSTICE RES, V19, P208, DOI [DOI 10.1007/S11211-006-0006-8, 10.1007/s11211-006-0006-8]; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1981, ESSAYS MORAL DEV, VI; Martins A., 2007, PROVAS APTIDAO PEDAG; Mendez Mario F, 2009, Cogn Neuropsychiatry, V14, P165, DOI 10.1080/13546800902924122; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28; Paxton JM, 2010, TOP COGN SCI, V2, P511, DOI 10.1111/j.1756-8765.2010.01096.x; Piaget Jean, 1965, MORAL JUDGMENT CHILD; Prehn K, 2008, SOC COGN AFFECT NEUR, V3, P33, DOI 10.1093/scan/nsm037; Raven J, 1998, MANUAL RAVENS PROGR; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Slovackova B, 2007, NURS ETHICS, V14, P320, DOI 10.1177/0969733007075867; Tamietto M, 2007, NEUROPSYCHOLOGIA, V45, P836, DOI 10.1016/j.neuropsychologia.2006.08.012; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Young L, 2006, J COGN CULT, V6, P291, DOI 10.1163/156853706776931312	39	14	15	4	28	SOC JUDGMENT & DECISION MAKING	TALLAHASSEE	FLORIDA STATE UNIV, TALLAHASSEE, FL 32306-1110 USA	1930-2975			JUDGM DECIS MAK	Judgm. Decis. Mak.	JUL	2012	7	4					478	487					10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	982UW	WOS:000307071900011					2022-02-06	
J	Sharma, D; Brown, MJ; Curry, P; Noda, S; Chesnut, RM; Vavilala, MS				Sharma, Deepak; Brown, Michelle J.; Curry, Parichat; Noda, Sakura; Chesnut, Randall M.; Vavilala, Monica S.			Prevalence and Risk Factors for Intraoperative Hypotension During Craniotomy for Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intraoperative hypotension; traumatic brain injury; craniotomy	VENTRICULAR DIASTOLIC FUNCTION; BLOOD-PRESSURE; PROPOFOL; SEVOFLURANE; ANESTHESIA; HYPOTHERMIA; ISOFLURANE; HEMATOMA; CHILDREN; HUMANS	Background: Hypotension after traumatic brain injury (TBI) is associated with poor outcomes. However, data on intraoperative hypotension (IH) are scarce and the effect of anesthetic agents on IH is unknown. We examined the prevalence and risk factors for IH, including the effect of anesthetic agents during emergent craniotomy for isolated TBI. Methods: This is a retrospective cohort study of patients 18 years and above, who underwent emergent craniotomy for TBI at Harborview Medical Center (level 1 trauma center) between October 2007 and January 2010. Demographic, clinical, and radiographic characteristics and hemodynamic and anesthetic data were abstracted from medical and electronic anesthesia records. Hypotension was defined as systolic blood pressure <90 mm Hg. Univariate analyses were performed to compare the clinical characteristics of patients with and without IH, and multiple logistic regression analysis was used to determine independent risk factors for IH. Results: Data abstracted from 113 eligible patients aged 48 +/- 19 years were analyzed. IH was common (n = 73, 65%) but not affected by the choice of anesthetic agent. Independent risk factors for IH were multiple computed tomographic (CT) lesions [adjusted odds ratios (AOR) 19.1; 95% confidence interval (CI), 2.08-175.99; P = 0.009], subdural hematoma (AOR 17.9; 95% CI, 2.97-108.10; P = 0.002), maximum CT lesion thickness (AOR 1.1; 95% CI, 1.01-1.13; P = 0.016), and anesthesia duration (AOR 1.1; 95% CI, 1.01-1.30; P = 0.009). Conclusions: IH was common in adult patients with isolated TBI undergoing emergent craniotomy. The presence of multiple CT lesions, subdural hematoma, maximum thickness of CT lesion, and longer duration of anesthesia increase the risk for IH.	[Sharma, Deepak; Brown, Michelle J.; Curry, Parichat; Noda, Sakura; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Sharma, Deepak; Chesnut, Randall M.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98104 USA		Sharma, D (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Box 359724,325 9th Ave, Seattle, WA 98104 USA.	dsharma@uw.edu		Chesnut, Randall/0000-0001-6377-3666; Noda, Sakura/0000-0002-8341-5740	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308, R01 NS072308-02] Funding Source: Medline		Bhagat H, 2009, ANN CARD ANAESTH, V12, P149, DOI 10.4103/0971-9784.53446; Bolliger D, 2010, BRIT J ANAESTH, V104, P547, DOI 10.1093/bja/aeq066; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Conti A, 2006, BRIT J ANAESTH, V97, P333, DOI 10.1093/bja/ael169; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Faul M, 2010, TRAUMATIC BRAIN INJU; Filipovic M, 2005, BRIT J ANAESTH, V94, P186, DOI 10.1093/bja/aei028; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kadoi Y, 2009, ANAESTH INTENS CARE, V37, P598, DOI 10.1177/0310057X0903700412; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kawano Y, 2004, J NEUROSURG ANESTH, V16, P6, DOI 10.1097/00008506-200401000-00002; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; MARTIN C, 1994, ACTA ANAESTH SCAND, V38, P223, DOI 10.1111/j.1399-6576.1994.tb03878.x; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Pecha T, 2011, ANESTH ANALG, V30, P1; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Uchida M, 1982, CRIT CARE MED, V19, P5; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	25	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2012	24	3					178	184		10.1097/ANA.0b013e318254fb70			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	958WT	WOS:000305272400002	22504924	Green Accepted			2022-02-06	
J	Hong, MY; Gao, JL; Cui, JZ; Wang, KJ; Tian, YX; Li, R; Wang, HT; Wang, H				Hong Ming-yan; Gao Jun-ling; Cui Jian-zhong; Wang Kai-jie; Tian Yan-xia; Li Ran; Wang Hai-tao; Wang Huan			Effect of c-Jun NH2-terminal kinase-mediated p53 expression on neuron autophagy following traumatic brain injury in rats	CHINESE MEDICAL JOURNAL			English	Article						brain injuries; autophagy; c-Jun NH2-terminal kinase; p53; damage-regulated autophagy modulator	CEREBRAL-ISCHEMIA; HIPPOCAMPAL CA1; DEATH; ACTIVATION; APOPTOSIS; PATHWAYS; JNK; PHOSPHORYLATION; MECHANISMS; INHIBITOR	Background Activation of c-Jun NH2-terminal kinase (JNK) has been implicated in neuron apoptosis as well as autophagy in response to various stressors after traumatic brain injury (TBI). However, the underlying molecular pathway remains unclear. Our study assessed whether JNK-mediated p53 phosphorylation might be an important mechanism for enhancing neuron autophagy in response to TBI. Methods A total of 186 male Sprague-Dawley (SD) rats (300-350 g) were used in this study. By randomized block method rats were randomly divided into four groups: sham-operated (n=46), TBI (n=60), TBI + dimethyl sulfoxide (DMSO) (n=40), and TBI + SP600125 (n=40). JNK was treated with SP600125, a specific JNK inhibitor. JNK, p-P53, Beclin-1, damage-regulated autophagy modulator (DRAM) and p-bcl-2 were evaluated by Western blotting analysis. The cellular localization and expression of Beclin-1 and DRAM was observed by immunofluorescence and immunohistochemistry, and the expression of Beclin-1-Bcl-2/Bcl-xL complexes was evaluated by immunoprecipitation. Multiple-group comparisons were conducted using analysis of variance (ANOVA). P values of less than 0.05 were considered statistically significant. Results It was observed that the expression of JNK, p-P53, Beclin-1, DRAM and p-bcl-2 was increasing after TBI, and the expression of Beclin-1 and DRAM was mainly located in the cytoplasm of neurons. But these were significantly inhibited in SP600125 group compared with sham group and TBI+SP600125 group (P <0.05). The expression of Beclin-1-Bcl-2/Bcl-xL complexes was reduced after TBI. Conclusion JNK-mediated p53 phosphorylation might be an important mechanism for enhancing neuron autophagy in response to TBI. Chin Med J 2012;125(11):2019-2024	[Hong Ming-yan; Cui Jian-zhong] Hebei Med Univ, Dept Surg, Shijiazhuang 050017, Hebei, Peoples R China; [Gao Jun-ling; Tian Yan-xia; Li Ran; Wang Hai-tao; Wang Huan] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China; [Wang Kai-jie] Workers Hosp, Tangshan 063000, Hebei, Peoples R China		Cui, JZ (corresponding author), Hebei Med Univ, Dept Surg, Shijiazhuang 050017, Hebei, Peoples R China.	jzhcui01@hotmail.com			Hebei Province Natural Science FoundationNatural Science Foundation of Hebei Province [C2009001247]	This work was supported by a grant from Hebei Province Natural Science Foundation (No. C2009001247).	Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Fan SM, 2012, FREE RADICAL RES, V46, P310, DOI 10.3109/10715762.2012.655244; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Guan QH, 2005, BRAIN RES, V1035, P51, DOI 10.1016/j.brainres.2004.11.050; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Malik SA, 2011, AUTOPHAGY, V7, P914, DOI 10.4161/auto.7.8.15785; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NEELY N, 1974, BIOCHEM BIOPH RES CO, V59, P680, DOI 10.1016/S0006-291X(74)80033-1; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang QG, 2005, J NEUROCHEM, V95, P784, DOI 10.1111/j.1471-4159.2005.03435.x	28	14	16	0	10	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUN 5	2012	125	11					2019	2024		10.3760/cma.j.issn.0366-6999.2012.11.032			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958RZ	WOS:000305259700033	22884071				2022-02-06	
J	Bobinski, L; Olivecrona, M; Koskinen, LOD				Bobinski, Lukas; Olivecrona, Magnus; Koskinen, Lars-Owe D.			Dynamics of brain tissue changes induced by traumatic brain injury assessed with the Marshall, Morris-Marshall, and the Rotterdam classifications and its impact on outcome in a prostacyclin placebo-controlled study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Traumatic subarachnoid hemorrhage; Marshall; Morris-Marshall; Rotterdam classification	COMPUTERIZED-TOMOGRAPHY SCAN; LOW-DOSE PROSTACYCLIN; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; PROGNOSTIC VALUE; PROGRESSION; LESION; MICRODIALYSIS; THERAPY	The present study evaluates the types and dynamics of intracranial pathological changes in patients with severe traumatic brain injury (sTBI) who participated in a prospective, randomized, double-blinded study of add-on treatment with prostacyclin. Further, the changes of brain CT scan and their correlation to Glasgow Coma Scale score (GCS), maximal intracranial pressure (ICPmax), minimal cerebral perfusion pressure (CPPmin), and Glasgow Outcome Score (GOS) at 3, 6, and 12 months were studied. Forty-eight subjects with severe traumatic brain injury were treated according to an ICP-targeted therapy protocol based on the Lund concept with the addition of prostacyclin or placebo. The first available CT scans (CTi) and follow-up scans nearest to 24 h (CT24) were evaluated using the Marshall, Rotterdam, and Morris-Marshall classifications. There was a significant correlation of the initial Marshall, Rotterdam, Morris-Marshall classifications and GOS at 3 and 12 months. The CT24 Marshall classification did not significantly correlate to GOS while the Rotterdam and the Morris-Marshall classification did. The CTi Rotterdam classification predicted outcome evaluated as GOS at 3 and 12 months. Prostacyclin treatment did not influence the dynamic of tissue changes. The Rotterdam classification seems to be appropriate for describing the evolution of the injuries on the CT scans and contributes in predicting of outcome in patients treated with an ICP-targeted therapy. The Morris-Marshall classification can also be used for prognostication of outcome but it describes only the impact of traumatic subarachnoid hemorrhage (tSAH).	[Bobinski, Lukas; Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden		Bobinski, L (corresponding author), Umea Univ, Div Neurosurg, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden.	lukasbobinski@yahoo.com; magnus.olivecrona@neuro.umu.se; lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Olivecrona, Magnus/0000-0001-8457-4711	Foundation for Clinical Neuroscience at Umea University; collecting Foundation at Umea University; Kempe Foundation; Carnegie Research Foundation; Capio Research Foundation	This study was financially supported by grants from the Foundation for Clinical Neuroscience at Umea University, collecting Foundation at Umea University, Kempe Foundation, Carnegie Research Foundation, and Capio Research Foundation, which is gratefully acknowledged.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 2000, J NEUROTRAUM, V17, P71; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Grande PO, 2002, INTENS CARE MED, V28, P529, DOI 10.1007/s00134-002-1236-3; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Lubillo S, 1999, J NEUROSURG, V91, P581, DOI 10.3171/jns.1999.91.4.0581; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Morris GF, 1997, ACTA NEUROCHIR S, V71, P382; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Procaccio F, 2000, J Neurosurg Sci, V44, P11; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	41	14	15	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2012	154	6					1069	1079		10.1007/s00701-012-1345-x			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	943II	WOS:000304113800017	22538327				2022-02-06	
J	Caracuel, A; Verdejo-Garcia, A; Fernandez-Serrano, MJ; Moreno-Lopez, L; Santago-Ramajo, S; Salinas-Sanchez, I; Perez-Garcia, M				Caracuel, Alfonso; Verdejo-Garcia, Antonio; Jose Fernandez-Serrano, Maria; Moreno-Lopez, Laura; Santago-Ramajo, Sandra; Salinas-Sanchez, Ignacio; Perez-Garcia, Miguel			Preliminary validation of the Spanish version of the Frontal Systems Behavior Scale (FrSBe) using Rasch analysis	BRAIN INJURY			English	Article						FrSBe; Rasch analysis; prefrontal cortex systems; apathy; disinhibition; executive dysfunction; frontal behaviours; traumatic brain injury; stroke	EXECUTIVE DYSFUNCTION; SELF-AWARENESS; BRAIN-INJURY; DRUG-USE; SUBCORTICAL CIRCUITS; EMOTIONAL SYMPTOMS; MEASUREMENT MODEL; RATING-SCALES; NEUROPSYCHOLOGY; CONSEQUENCES	Primary objective: To explore the construct validity of the Spanish version of the Frontal Systems Behavioral Scale (FrSBe) using Rasch modelling. Methods: Item responses of 245 Spanish subjects were analysed using Rasch analysis: self-rating of 65 participants with TBI or stroke (sample A), family-rating of the same 65 participants (sample B) and self-rating of 115 healthy individuals (sample C). Results: After removing or grouping several problematic items, the Apathy and the Executive Dysfunction sub-scales were found to be valid measures for samples A and B and the Disinhibition sub-scale was valid for samples B and C. Person Separation Index of reliability of sub-scales was greater than 0.83 for sample B and similar to 0.72 for A and C. All items showed disordered threshold categories in samples A and B and five items were ordered in sample C. Conclusions: With a few modifications, the sub-scales of the FrSBe-Spanish version are adequate measures for the assessment of the behavioural syndromes derived from frontal systems dysfunction in persons with brain injury. The family-rating form is preferable to the self-rating form. Only the Disinhibition scale is a valid measure for the behavioural assessment of the normal population. A reduction of response categories is suggested.	[Caracuel, Alfonso] Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, E-18071 Granada, Spain; [Caracuel, Alfonso; Verdejo-Garcia, Antonio; Perez-Garcia, Miguel] Univ Granada, Inst Neurosci F Oloriz, E-18071 Granada, Spain; [Salinas-Sanchez, Ignacio] Virgen de las Nieves Hosp, Granada, Spain		Caracuel, A (corresponding author), Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, Campus Cartuja, E-18071 Granada, Spain.	acaracuel@ugr.es	Verdejo-Garcia, Antonio/AAV-1147-2021; Caracuel, Alfonso/V-3695-2019; Santiago-Ramajo, Sandra/H-6801-2015; Moreno-Lopez, Laura/K-9568-2015; Garcia, Miguel Perez/F-9630-2010; Serrano, M Josefa Fernandez/V-3124-2019	Verdejo-Garcia, Antonio/0000-0001-8874-9339; Caracuel, Alfonso/0000-0002-9738-8456; Santiago-Ramajo, Sandra/0000-0002-6358-6155; Moreno-Lopez, Laura/0000-0003-3687-7237; Garcia, Miguel Perez/0000-0003-4775-7556; Serrano, M Josefa Fernandez/0000-0002-6158-237X			Andrich D., 2003, RUMM2020; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P920, DOI 10.1080/13803390801888733; Batistuzzo MC, 2009, NEUROCASE, V15, P157, DOI 10.1080/13554790802709047; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Caracuel A, 2008, ARCH CLIN NEUROPSYCH, V23, P447, DOI 10.1016/j.acn.2008.03.004; Caracuel A, J HEAD TRAUMA REHABI; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Decruynaere C, 2007, EUR J PAIN, V11, P469, DOI 10.1016/j.ejpain.2006.07.001; Denheyer M, 2009, NEUROPSYCHOLOGIA, V47, P3203, DOI 10.1016/j.neuropsychologia.2009.07.022; Fox CM, 1998, J COUNS PSYCHOL, V45, P30; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Kawada R, 2009, PROG NEURO-PSYCHOPH, V33, P1255, DOI 10.1016/j.pnpbp.2009.07.014; Kersten P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-26; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lawton G, 2006, SPINAL CORD, V44, P746, DOI 10.1038/sj.sc.3101895; LINACRE JM, 2000, RASCH MEASUREMENT T, V14, P768; Linacre John M, 2002, J Appl Meas, V3, P85; Lyvers M, 2010, PERS INDIV DIFFER, V48, P332, DOI 10.1016/j.paid.2009.10.030; Lyvers M, 2009, ADDICT RES THEORY, V17, P668, DOI 10.3109/16066350802404158; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Malloy P, 2007, ALZHEIMERS DEMENT, V3, P200, DOI 10.1016/j.jalz.2007.04.374; Marsh L, 2009, MOVEMENT DISORD, V24, P277, DOI 10.1002/mds.22307; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Rasch Georg, 1980, PROBABILISTIC MODELS; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Ross SR, 2007, J PERS DISORD, V21, P384, DOI 10.1521/pedi.2007.21.4.384; Spinella M, 2005, BIOL PSYCHOL, V70, P175, DOI 10.1016/j.biopsycho.2004.01.005; Spinella M, 2004, INT J NEUROSCI, V114, P1323, DOI 10.1080/00207450490476011; Spinella M, 2004, INT J NEUROSCI, V114, P83, DOI 10.1080/00207450490249356; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Spinella M., 2008, J SOCIO-ECON, V37, P1785; Spinella M, 2007, J GEN PSYCHOL, V134, P101, DOI 10.3200/GENP.134.1.101-111; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tesio L, 2007, Eura Medicophys, V43, P515; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Verdejo-Garcia A, 2008, PSYCHIAT RES, V158, P172, DOI 10.1016/j.psychres.2006.08.001; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003; Wilson M., 2005, CONSTRUCTING MEASURE; Yoshizumi M, 2008, PSYCHIAT CLIN NEUROS, V62, P669, DOI 10.1111/j.1440-1819.2008.01866.x	54	14	15	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2012	26	6					844	852		10.3109/02699052.2012.655365			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500006	22583175				2022-02-06	
J	Chabok, SY; Kapourchali, SR; Leili, EK; Saberi, A; Mohtasham-Amiri, Z				Chabok, Shahrokh Yousefzadeh; Kapourchali, Sara Ramezani; Leili, Ehsan Kazemnezhad; Saberi, Alia; Mohtasham-Amiri, Zahra			Effective factors on linguistic disorder during acute phase following traumatic brain injury in adults	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Post-traumatic language disorder; Post-traumatic cognitive deficit; Acute phase	EXECUTIVE DYSFUNCTION; WORKING-MEMORY; DEFICITS; DISCOURSE; APHASIA	Traumatic brain injury (TBI) has been known to be the leading cause of breakdown and long-term disability in people under 45 years of age. This study highlights the effective factors on post-traumatic (PT) linguistic disorder and relations between linguistic and cognitive function after trauma in adults with acute TBI. A cross-sectional design was employed to study 60 post-TBI hospitalized adults aged 18-65 years. Post-traumatic (PT) linguistic disorder and cognitive deficit after TBI were respectively diagnosed using the Persian Aphasia Test (PAT) and Persian version of Mini-Mental State Examination (MMSE) at discharge. Primary post-resuscitation consciousness level was determined using the Glasgow Coma Scale (GCS). Paracilinical data was obtained by CT scan technique. Multiple logistic regression analysis illustrated that brain injury severity was the first powerful significant predictor of PT linguistic disorder after TBI and frontotemporal lesion was the second. It was also revealed that cognitive function score was significantly correlated with score of each language skill except repetition. Subsequences of TBI are more commonly language dysfunctions that demand cognitive flexibility. Moderate, severe and frontotemporal lesion can increase the risk of processing deficit in linguistic macrostructure production and comprehension. The dissociation risk of cortical and subcortical pathways related to cognitive-linguistic processing due to intracranial lesions can augment possibility of lexical-semantic processing deficit in acute phase which probably contributes to later cognitive-communication disorder. (C) 2012 Elsevier Ltd. All rights reserved.	[Kapourchali, Sara Ramezani; Saberi, Alia] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Dept Neurol, Rasht 4193713194, Guilan Province, Iran; [Mohtasham-Amiri, Zahra] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Dept Social Med, Rasht 4193713194, Guilan Province, Iran		Kapourchali, SR (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Dept Neurol, Rasht 4193713194, Guilan Province, Iran.	s.ramezanislp@gmail.com	Ramezani, Sara/E-6926-2012; Mohtasham-Amiri, Zahra/C-4469-2012; Saberi, Alia/X-4857-2018	Ramezani, Sara/0000-0001-6096-7975; Mohtasham-Amiri, Zahra/0000-0002-4896-6248; Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015	Road Trauma Research Center, Guilan University of Medical Sciences	We offer our special thanks to Road Trauma Research Center, Guilan University of Medical Sciences for supporting us, the staff of Neurosurgery Ward in Poorsina Teaching Hospital, who helped us in sampling procedure and Ms. Fatemeh Javadi for editing the manuscript.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Baldo JV, 2010, BRAIN LANG, V113, P59, DOI 10.1016/j.bandl.2010.01.004; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bear M.F., 2007, NEUROSCIENCE EXPLORI; Bhatnagar S. C., 2002, NEUROSCIENCE STUDY C; Bourgeois M. S., 2009, DEMENTIA DIAGNOSIS M; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chapey R., 2008, LANGUAGE INTERVENTIO, P33; Chua S. E., 2005, HONG KONG J PSYCHIAT, V15, P77; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Cohen N. J., 2003, NEUROPSYCHOLOGY NEUR, P322; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Foroughan M, 2008, ADV COGNITIVE SCI, V10, P29; Hanlon RE, 1999, J NEUROL NEUROSUR PS, V66, P365, DOI 10.1136/jnnp.66.3.365; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Helm-Estabrooks N, 2002, J COMMUN DISORD, V35, P171, DOI 10.1016/S0021-9924(02)00063-1; Hemmati H., 2009, Acta Medica Iranica, V47, P403; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; HJELMQUIST EKE, 1989, SCAND J PSYCHOL, V30, P243, DOI 10.1111/j.1467-9450.1989.tb01087.x; Jonides J., 1995, INVITATION COGNITIVE, V3, P215; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Martin N., 2004, BRAIN LANG, V89, P243; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mitrushina M. N., 2000, HDB NORMATIVE DATA N; Nilipour R, 1993, PERSIAN APHASIA TEST; Paradis M., 1989, BILINGUAL APHASIA TE; Rengachary S. S., 2005, PRINCIPLE NEUROSURGE; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Saygin AP, 2004, NEUROPSYCHOLOGIA, V42, P1788, DOI 10.1016/j.neuropsychologia.2004.04.016; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Spreen O., 2003, ASSESSMENT APHASIA; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P691, DOI 10.1076/jcen.25.5.691.14573; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thothathiri M, 2010, BRAIN LANG, V113, P28, DOI 10.1016/j.bandl.2010.01.002; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vukovic M, 1998, TRAUMATIC APHASIA; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wong GKC, 2010, J NEUROL SCI, V299, P5, DOI 10.1016/j.jns.2010.08.059; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; Yousefzadeh Ch. Sh., 2007, J GUILAN U MED SCI, V16, P112; Yousefzadeh Ch. Sh., 2010, NEUROSURG QUART, V20, P65	59	14	17	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUN	2012	50	7					1444	1450		10.1016/j.neuropsychologia.2012.02.029			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	966RQ	WOS:000305855500023	22410412				2022-02-06	
J	Goodman, MJ; Durkin, M; Forlenza, J; Ye, XY; Brixner, DI				Goodman, Michael J.; Durkin, Michael; Forlenza, Jamie; Ye, Xiangyang; Brixner, Diana I.			Assessing adherence-based quality measures in epilepsy	INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE			English	Article						quality management; quality indicators; measurement of quality; epilepsy; quality of care	ANTIEPILEPTIC DRUGS; NONADHERENCE; SEIZURES; RISK	To examine the relationship of three alternative measures of adherence with seven negative outcomes associated with epilepsy for development of a quality measure in epilepsy. Retrospective cohort analysis. PharMetrics national claims database. Patients in the PharMetrics database for the years 200408 taking antiepileptic drugs. None. For each definition of adherence, the odds ratios (ORs) comparing non-adherent with adherent groups were assessed for consistency and direction for the number of hospital admissions, emergency room (ER) visits, head injuries including traumatic brain injuries, falls, motor vehicle accidents (MVAs), fractures and a oseizure' outcome defined as hospital admissions or ER visits with a primary diagnosis of epilepsy or convulsions. The inclusion criteria were met by 31 635 individuals. In the multivariate analysis, the adherent group had lower odds of hospital admissions with ORs for the eight specifications ranging from 0.729 to 0.872 and ER visits where ORs for the eight specifications ranged from 0.750 to 0.893. The eight ORs for head injuries ranged from 0.647 to 0.888. For fractures, the ORs ranged from 0.407 to 0.841. Our proxy for seizure was inconsistently associated with adherence status. All the adherence measures defined non-adherent groups that were associated with negative outcomes in epilepsy.	[Goodman, Michael J.; Ye, Xiangyang; Brixner, Diana I.] Univ Utah, Outcomes Res Ctr, Dept Pharmacotherapy, Salt Lake City, UT 84108 USA; [Durkin, Michael; Forlenza, Jamie] Ortho McNeil Janssen Pharmaceut Inc, Raritan, NJ USA		Goodman, MJ (corresponding author), Univ Utah, Outcomes Res Ctr, Dept Pharmacotherapy, 421 Wakara Way,Suite 208, Salt Lake City, UT 84108 USA.	michael.goodman@pharm.utah.edu		Ye, Xiangyang/0000-0003-2722-3653	Ortho-McNeil Janssen Pharmaceuticals Inc.	This research was funded by Ortho-McNeil Janssen Pharmaceuticals Inc.	Cramer JA, 2002, EPILEPSY BEHAV, V3, P338, DOI 10.1016/S1525-5050(02)00037-9; Davis KL, 2008, EPILEPSIA, V49, P446, DOI 10.1111/j.1528-1167.2007.01414.x; Davis KL, 2007, AC MAN CAR PHARM 19; Ettinger AB, 2009, EPILEPSY BEHAV, V14, P324, DOI 10.1016/j.yebeh.2008.10.021; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jones RM, 2006, SEIZURE-EUR J EPILEP, V15, P504, DOI 10.1016/j.seizure.2006.06.003; Karve S, 2008, MED CARE, V46, P1125, DOI 10.1097/MLR.0b013e31817924d2; Manjunath R, 2009, EPILEPSY BEHAV, V14, P372, DOI 10.1016/j.yebeh.2008.12.006; Martin BC, 2009, ANN PHARMACOTHER, V43, P36, DOI 10.1345/aph.1K671; National Epilepsy Foundation, EP SEIZ STAT; Pharmacy Quality Alliance, 2010, PQA APPR MEAS; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; Vanderpoel DR, 2004, CLIN THER, V26, P2066, DOI 10.1016/j.clinthera.2004.12.018; Vink NM, 2009, PHARMACOEPIDEM DR S, V18, P159, DOI 10.1002/pds.1698; Weiden PJ, 2004, PSYCHIAT SERV, V55, P886, DOI 10.1176/appi.ps.55.8.886	18	14	14	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1353-4505			INT J QUAL HEALTH C	Int. J. Qual. Health Care	JUN	2012	24	3					293	300		10.1093/intqhc/mzs017			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	944KA	WOS:000304198700013	22507847	Bronze			2022-02-06	
J	Gurkoff, GG; Shahlaie, K; Lyeth, BG				Gurkoff, Gene G.; Shahlaie, Kiarash; Lyeth, Bruce G.			In vitro mechanical strain trauma alters neuronal calcium responses: Implications for posttraumatic epilepsy	EPILEPSIA			English	Article						Traumatic brain injury; Calcium; Cell culture; Glutamate; Excitability	FLUID PERCUSSION INJURY; LONG-TERM POTENTIATION; BRAIN-INJURY; CORTICAL-NEURONS; HEAD TRAUMA; SEIZURES; ASTROCYTES; MODEL; RAT; SUSCEPTIBILITY	Traumatic brain injury (TBI) is known to initiate a series of chemical cascades resulting in neuronal dysfunction and death. Epidemiology studies have found that a prior incidence of TBI is the most important cause of remote symptomatic epilepsy in young adults and children. TBI-induced changes in neuronal sensitivity to stimulation may contribute to acute seizures and the eventual generation of epilepsy. This study examined TBI-induced changes in neuronal sensitivity to stimulation by measuring intracellular calcium ([Ca++]i) responses in neurons during glutamate application in vitro. Initial experiments examined neuronal and glial cell death and determined that a 31% mechanical strain trauma to mixed neuronal-astrocyte rat cortical cultures produced a trend, but no significant cell death at 48 h after injury. Subsequent experiments utilized this magnitude of trauma to examine the sensitivity of cortical neurons to changes in [Ca++]i in response to 100-mu m glutamate at five time points postinjury (1, 6, 24, 48, and 72 h). Traumatically strain-injured neurons responded with a dynamic change in the accumulation of [Ca++]i, with a significant increase at 48 h and a significant decrease at 72 h as compared to uninjured cultures. These data highlight that TBI leads to abnormal responsiveness to stimulation, an indicator of neuronal dysfunction in surviving cells. Such changes in sensitivity to stimulation may also be associated with changes in excitability in the first hours to days after TBI, and may play a role in early posttraumatic seizures observed in patients with TBI. In addition, this study provides an in vitro paradigm for testing the function of surviving cells following treatment interventions targeted at reducing cell death and dysfunction.	[Gurkoff, Gene G.; Shahlaie, Kiarash; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Shahlaie, Kiarash] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA		Gurkoff, GG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS29995]; Center for Biophotonics Science and Technology, NSF Science and Technology Center [PHY 0120999]; Bronte Epilepsy Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH NINDS) NS29995, the Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center, managed by the University of California, Davis, under Cooperative Agreement number PHY 0120999, and the Bronte Epilepsy Research Program. Expert technical assistance was provided by Paul Mello and Vanessa Atkinson. We want to thank H. Jurgen Wenzel for the many years of friendship, collegial interactions, and insightful discussions of neuroanatomy and neuropathology. Jurgen has been an inspiration that has enriched our science and a trustworthy friend that has enriched our lives.	Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Beller JA, 2011, RESTOR NEUROL NEUROS, V29, P331, DOI 10.3233/RNN-2011-603; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DAWSON RE, 1951, J NEUROSURG, V8, P613, DOI 10.3171/jns.1951.8.6.0613; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Segatore M, 1993, Axone, V15, P34; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	37	14	15	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580			EPILEPSIA	Epilepsia	JUN	2012	53			1	SI		53	60		10.1111/j.1528-1167.2012.03475.x			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	945FH	WOS:000304257700008	22612809				2022-02-06	
J	Yang, Y; Li, L; Wang, YG; Fei, Z; Zhong, J; Wei, LZ; Long, QF; Liu, WP				Yang, Yang; Li, Ling; Wang, Yan-Gang; Fei, Zhou; Zhong, Jun; Wei, Li-Zhou; Long, Qian-Fa; Liu, Wei-Ping			Acute neuroprotective effects of extremely low-frequency electromagnetic fields after traumatic brain injury in rats	NEUROSCIENCE LETTERS			English	Article						TBI; ELFEF; Secondary insults	NEURONAL DAMAGE; VULNERABILITY; ISCHEMIA; PROTECTS; EXPOSURE; SEIZURE	Traumatic brain injury commonly has a result of a short window of opportunity between the period of initial brain injury and secondary brain injury, which provides protective strategies and can reduce damages of brain due to secondary brain injury. Previous studies have reported neuroprotective effects of extremely low-frequency electromagnetic fields. However, the effects of extremely low-frequency electromagnetic fields on neural damage after traumatic brain injury have not been reported yet. The present study aims to investigate effects of extremely low-frequency electromagnetic fields on neuroprotection after traumatic brain injury. Male Sprague-Dawley rats were used for the model of lateral fluid percussion injury, which were placed in non-electromagnetic fields and 15 Hz (Hertz) electromagnetic fields with intensities of 1 G (Gauss), 3 G and 5 G. At various time points (ranging from 0.5 to 30 h) after lateral fluid percussion injury, rats were treated with kainic acid (administered by intraperitoneal injection) to induce apoptosis in hippocampal cells. The results were as follows: (1) the expression of hypoxia-inducible factor-1 alpha was dramatically decreased during the neuroprotective time window. (2) The kainic acid-induced apoptosis in the hippocampus was significantly decreased in rats exposed to electromagnetic fields. (3) Electromagnetic fields exposure shortened the escape time in water maze test. (4) Electromagnetic fields exposure accelerated the recovery of the blood-brain barrier after brain injury. These findings revealed that extremely low-frequency electromagnetic fields significantly prolong the window of opportunity for brain protection and enhance the intensity of neuroprotection after traumatic brain injury. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yang, Yang; Wang, Yan-Gang; Fei, Zhou; Zhong, Jun; Wei, Li-Zhou; Long, Qian-Fa; Liu, Wei-Ping] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Li, Ling] Fourth Mil Med Univ, Dept Neurol, Xijing Hosp, Xian 710032, Peoples R China		Liu, WP (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 17 W Changle Rd, Xian 710032, Peoples R China.	yangyang19800627@163.com; liuwp008@163.com	Long, Qianfa/F-6461-2017	Long, Qianfa/0000-0001-8848-9688			Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Burda J, 2009, CELL MOL NEUROBIOL, V29, P821, DOI 10.1007/s10571-009-9363-9; Chang AY, 2005, EXP NEUROL, V195, P40, DOI 10.1016/j.expneurol.2004.09.014; Chen W, 2009, EXP NEUROL, V216, P7, DOI 10.1016/j.expneurol.2008.10.016; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Feeney D M, 1987, Brain Inj, V1, P27, DOI 10.3109/02699058709034441; Franzellitti S, 2010, MUTAT RES-FUND MOL M, V683, P35, DOI 10.1016/j.mrfmmm.2009.10.004; Grafstrom G, 2008, BRAIN RES BULL, V77, P257, DOI 10.1016/j.brainresbull.2008.08.004; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Gustavsson M, 2005, PEDIATR RES, V57, P305, DOI 10.1203/01.PDR.0000151122.58665.70; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Juutilainen J, 2005, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.20125; KATO H, 1992, BRAIN RES BULL, V29, P395, DOI 10.1016/0361-9230(92)90074-8; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Li F., 2007, J MED COLL PLA, V22, P106; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo E, 2007, BIOELECTROMAGNETICS, V28, P608, DOI 10.1002/bem.20342; Najm IM, 1998, BRAIN RES, V810, P72, DOI 10.1016/S0006-8993(98)00886-5; Nakasono S, 2008, MUTAT RES-GEN TOX EN, V649, P187, DOI 10.1016/j.mrgentox.2007.09.003; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Strasak L, 2002, BIOELECTROCHEMISTRY, V55, P161, DOI 10.1016/S1567-5394(01)00152-9; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	28	14	18	1	23	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 10	2012	516	1					15	20		10.1016/j.neulet.2012.03.022			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	941LG	WOS:000303964100004	22484017				2022-02-06	
J	Conidi, FX				Conidi, Francis X.			Sports-Related Concussion: The Role of the Headache Specialist	HEADACHE			English	Article						headache; sports; concussion	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; MILD; MECHANISM; FOOTBALL; RETURN; BLAST; PLAY; PREVENTION; MANAGEMENT	Over the past few years, sports-related concussion has received significant media attention making it one of the most, if not highest profile neurological disorder. Thirty-one states now have passed sports concussion laws, with 14 states pending legislation. Most concussions are managed by primary care physicians, ie, family practice trained sports medicine physicians and pediatricians. Symptoms are usually short lived and do not require treatment. The one exception is headache, which is usually present from onset and is often the last symptom to resolve. Headache is the most common reason for referral to a specialist, and therefore it is imperative that the headache specialist have at least a basic understanding of all aspects of sports concussion as they are likely going to be called upon to evaluate these athletes, especially the more refractory cases.	Florida Ctr Headache & Sports Neurol Neurol, Port St Lucie, FL 34952 USA		Conidi, FX (corresponding author), Florida Ctr Headache & Sports Neurol Neurol, 10377 S US Highway 1 Suite 104, Port St Lucie, FL 34952 USA.	fxneuro@bellsouth.net					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Charles A, 2007, J HEADACHE PAIN, V8, P248, DOI 10.1007/s10194-007-0406-7; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Keightley M, 2011, J VIS EXP, V306, P79; Kelly JP, 1997, NEUROLOGY, V48, P581; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zafonte R, 2011, JAMA-J AM MED ASSOC, V306, P79, DOI 10.1001/jama.2011.819	34	14	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAY	2012	52			1	SI		15	21		10.1111/j.1526-4610.2012.02138.x			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932WH	WOS:000303320700006	22540200				2022-02-06	
J	Gioia, GA				Gioia, Gerard A.			Pediatric Assessment and Management of Concussions	PEDIATRIC ANNALS			English	Article							SPORT		[Gioia, Gerard A.] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Safe Concuss Outcome Recovery & Educ SCORE Progra, Washington, DC USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Dept Pediat, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Dept Psychiat & Behav Sci, Washington, DC 20052 USA		Gioia, GA (corresponding author), Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA.	ggioia@childrensnational.org					Centers for Disease Control and Prevention, 2007, NAT CTR INJ PREV CON; Gioia GA, 2006, HEADS BRAIN INJURY Y; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008	7	14	14	0	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481			PEDIATR ANN	Pediatr. Annu.	MAY	2012	41	5					198	203		10.3928/00904481-20120426-10			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	965FH	WOS:000305752000014	22587503				2022-02-06	
J	Kramer, AH; Jette, N; Pillay, NL; Federico, P; Zygun, DA				Kramer, Andreas H.; Jette, Nathalie; Pillay, Neelan; Federico, Paolo; Zygun, David A.			Epileptiform Activity in Neurocritical Care Patients	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEURON-SPECIFIC ENOLASE; PERIODIC EEG PATTERNS; INTRACEREBRAL HEMORRHAGE; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; BACTERIAL-MENINGITIS; PROGNOSTIC-FACTORS	Background: Non-convulsive seizures have been reported to be common in neurocritical care patients. Many jurisdictions do not have sufficient resources to enable routine continuous electroencephaloaraphy (cEEG) and instead use primarily intermittent EEG, for which the diagnostic yield remains uncertain. Determining risk factors for epileptiform activity and seizures could help identify patients who might particularly benefit from EEG monitoring. Methods: We performed a cohort study involving neurocritical care patients with admission Glascow Coma Scale (GCS) scores <= 12, who underwent >= 1 EEG. EEGs were reviewed for presence of interictal discharges, periodic epileptiform discharges (PEDs), and seizures. Multivariate analysis was used to identify predictors of these findings and to describe their prognostic implications. Results: 393 patients met inclusion criteria. 34 underwent cEEG, usually because epileptiform activity was first detected on a routine EEG. The prevalence of PEDs or electrographic seizures was 13%, and was highest with anoxic encephalopathy and central nervous system infections. Other independent predictors for epileptiforrn activity included a history of convulsive seizure(s), increasing age, deeper coma, and female gender. Although patients with epileptiform activity had higher mortality, this association disappeared after adjustment for confounders. Conclusion: Approximately 7-8 neurocritical care patients must undergo intermittent EEG monitoring in order to diagnose one with PEDs or seizures. The predictors we identified could potentially help guide use of resources. Repeated intermittent studies, or cEEG, should be considered in patients with multiple risk factors, or when interictal discharges are identified on an initial EEG. It remains unclear whether aggressive prevention and treatment of electrographic seizures improves neurologic outcomes.	[Kramer, Andreas H.] Univ Calgary, Dept Crit Care Med, Foothills Med Ctr, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kramer, Andreas H.] Univ Calgary, Dept Clin Neurosci, Foothills Med Ctr, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jette, Nathalie; Zygun, David A.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada		Kramer, AH (corresponding author), Univ Calgary, Dept Crit Care Med, Foothills Med Ctr, Hotchkiss Brain Inst, Calgary, AB, Canada.						Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; [Anonymous], 1988, J NEUROSURGERY, V68, P985; [Anonymous], 1991, CLIN EXAMINATION NEU, P354; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Badawy RAB, 2011, CLIN NEUROPHYSIOL, V122, P1086, DOI 10.1016/j.clinph.2010.10.048; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BERGER AR, 1988, NEUROLOGY, V38, P1363, DOI 10.1212/WNL.38.9.1363; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Correale J, 1998, NEUROLOGY, V50, P1388, DOI 10.1212/WNL.50.5.1388; DeGiorgio CM, 1999, NEUROLOGY, V52, P746, DOI 10.1212/WNL.52.4.746; Fraser DD, 2009, CRIT CARE MED, V37, P3181, DOI 10.1097/CCM.0b013e3181bdd98a; Frye CA, 2010, EPILEPSIA, V51, P135, DOI 10.1111/j.1528-1167.2010.02628.x; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Ronner HE, 2009, SEIZURE-EUR J EPILEP, V18, P257, DOI 10.1016/j.seizure.2008.10.010; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Rossetti AO, 2007, NEUROLOGY, V69, P255, DOI 10.1212/01.wnl.0000265819.36639.e0; Steiner T, 1997, STROKE, V28, P711, DOI 10.1161/01.STR.28.4.711; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Varelas PN, 2004, CLIN EEG NEUROSCI, V35, P173, DOI 10.1177/155005940403500406; Veliskova J, 2010, EPILEPSIA, V51, P141, DOI 10.1111/j.1528-1167.2010.02629.x; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wigginton JG, 2010, CRIT CARE MED, V38, pS620, DOI 10.1097/CCM.0b013e3181f243a9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao G, 2008, CRIT CARE, V12, P1; Young GB, 2005, NEUROCRIT CARE, V2, P5, DOI 10.1385/NCC:2:1:005; Young GB, 1997, CAN J NEUROL SCI, V24, P320, DOI 10.1017/S0317167100032996; Young GB, 1996, NEUROLOGY, V47, P83; Young JD, 2001, BRIT J ANAESTH, V87, P543, DOI 10.1093/bja/87.4.543; Zoons E, 2008, NEUROLOGY, V70, P2109, DOI 10.1212/01.wnl.0000288178.91614.5d; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	50	14	14	0	1	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2012	39	3					328	337		10.1017/S0317167100013469			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	946VR	WOS:000304386100012	22547513	Bronze			2022-02-06	
J	Mei-Dan, O; Carmont, MR; Monasterio, E				Mei-Dan, Omer; Carmont, Michael R.; Monasterio, Erik			The Epidemiology of Severe and Catastrophic Injuries in BASE Jumping	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						epidemiology; injury; BASE jumping; parachuting	PROFESSIONAL RUGBY UNION; EVENTS	Objective: To report the demographic characteristics, injury rate, severity, and morbidity in BASE jumping. Design: Cross-sectional survey. Setting: BASE jumping group meetings from 2006 to 2010. Participants: Heterogenic group of 102 International BASE jumpers. Assessment of Risk Factors: Injuries reported as function of jumps made, jumping days, age, experience, and sex. Main Outcome Measures: Incidence, severity, and type of injuries. Results: Responses from 68 subjects were available for analysis. The median number of jumps was estimated at 286 per respondent. The median time respondents had participated in BASE jumping was 5.8 years. There were 39 reported severe injuries sustained by 29 different jumpers. Nineteen thousand four hundred ninety-seven jumps were reported, resulting in 2 severe injuries per 1000 jumps (0.2% severe injury rate) or 2.6 severe injuries per 1000 jumping days. Forty-nine respondents (72%) had witnessed the death or serious injury of other participants in the sport. Twenty-four accidents (61%) involved the lower limbs, 8 (20%) the back/spine, 7 (18%) the chest wall, and 5 (13%) were a head injury. The mean Abbreviated Injury Score was 3.2 (range, 2-5). Fifteen (52%) of the 29 injured jumpers required 20 acute surgical interventions, which were mostly orthopedic related. There was a significant correlation between number of jumps made and injuries sustained (P < 0.05). Conclusions: BASE jumpers have an average of I severe injury for every 500 jumps. Most active BASE jumpers have witnessed death or severe injury of a participant and have experienced a "close call" incident.	[Mei-Dan, Omer] Univ Colorado, Sch Med, Dept Orthopaed, Div Sports Med, Aurora, CO 80045 USA; [Carmont, Michael R.] Princess Royal Hosp, Telford TF6 6TF, Shrops, England; [Monasterio, Erik] Hillmorton Hosp, Forens Psychiat Serv, Christchurch, New Zealand		Mei-Dan, O (corresponding author), Univ Colorado, Sch Med, Dept Orthopaed, Div Sports Med, Aurora, CO 80045 USA.	omer@extremegate.com					Agel J, 2010, CAN J SURG, V53, P319; Barrows TH, 2005, J EMERG MED, V28, P63, DOI 10.1016/j.jemermed.2004.07.008; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Di Giovanni N, WORLD BASE FATALITY; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Emery CA, 2010, JAMA-J AM MED ASSOC, V9, P2265; Fiore DC, 2001, BRIT J SPORT MED, V35, P235, DOI 10.1136/bjsm.35.4.235; International Parachuting Commission FAI Technical and Safety Committee, 2006 SAF REP; International Parachuting Commission FAI Technical and Safety Committee, 2009 SAF REP; Joint Committee on Injury Scaling, 1980, ABBR INJ SCAL AIS 19; Kim PTW, 2006, J TRAUMA, V60, P312, DOI 10.1097/01.ta.0000202714.31780.5f; Maland S, 2004, NORSK ANTROPOLOGISK, V1, P80; Monasterio E, 2008, NZ MED J, V4, P70; Monasterio M Erik, 2005, N Z Med J, V118, pU1249; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; Nickel C, 2004, AM J SPORT MED, V32, P921, DOI 10.1177/0363546503262162; Paul S, 2009, USPA PARACHUTIST MAG, V50, P30; Soreide K, 2007, J TRAUMA, V62, P1113, DOI 10.1097/01.ta.0000239815.73858.88; Torjussen J, 2006, BRIT J SPORT MED, V40, P230, DOI 10.1136/bjsm.2005.021329; Westman A, 2008, BRIT J SPORT MED, V42, P431, DOI 10.1136/bjsm.2008.046565; Westman A, 2005, ACCIDENT ANAL PREV, V37, P1040, DOI 10.1016/j.aap.2005.06.002; Westman A, 2007, BRIT J SPORT MED, V41, P356, DOI 10.1136/bjsm.2006.031682	23	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2012	22	3					262	267		10.1097/JSM.0b013e31824bd53a			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	945OC	WOS:000304284900010	22450590				2022-02-06	
J	Newsome, MR; Scheibel, RS; Chu, ZL; Hunter, JV; Li, XQ; Wilde, EA; Lu, HZ; Wang, ZYJ; Lin, XD; Steinberg, JL; Vasquez, AC; Cook, L; Levin, HS				Newsome, Mary R.; Scheibel, Randall S.; Chu, Zili; Hunter, Jill V.; Li, Xiaoqi; Wilde, Elisabeth A.; Lu, Hanzhang; Wang, Zhiyue J.; Lin, Xiaodi; Steinberg, Joel L.; Vasquez, Ana C.; Cook, Lori; Levin, Harvey S.			The relationship of resting cerebral blood flow and brain activation during a social cognition task in adolescents with chronic moderate to severe traumatic brain injury: a preliminary investigation	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Cerebral blood flow; fMRI; Social cognition; Adolescents	PROBLEM-SOLVING SKILLS; CLOSED-HEAD-INJURY; EMOTION RECOGNITION; FMRI SIGNAL; 3.0 TESLA; CHILDREN; CHILDHOOD; PERFUSION; SELF; TERM	`Alterations in cerebrovascular function are evident acutely in moderate to severe traumatic brain injury (TBI), although less is known about their chronic effects. Adolescent and adult patients with moderate to severe TBI have been reported to demonstrate diffuse activation throughout the brain during functional magnetic resonance imaging (fMRI). Because fMRI is a measure related to blood flow, it is possible that any deficits in blood flow may alter activation. An arterial spin labeling (ASL) perfusion sequence was performed on seven adolescents with chronic moderate to severe TBI and seven typically developing (TD) adolescents during the same session in which they had performed a social cognition task during fMRI. In the TD group, prefrontal CBF was positively related to prefrontal activation and negatively related to non-prefrontal, posterior, brain activation. This relationship was not seen in the TBI group, who demonstrated a greater positive relationship between prefrontal CBF and non-prefrontal activation than the TD group. An analysis of CBF data independent of fMRI showed reduced CBF in the right non-prefrontal region (p < .055) in the TBI group. To understand any role reduced CBF may play in diffuse extra-activation, we then related the right non-prefrontal CBF to activation. CBF in the right non-prefrontal region in the TD group was positively associated with prefrontal activation, suggesting an interactive role of non-prefrontal and prefrontal blood flow throughout the right hemisphere in healthy brains. However, the TBI group demonstrated a positive association with activation constrained to the right non-prefrontal region. These data suggest a relationship between impaired non-prefrontal CBF and the presence of non-prefrontal extra-activation, where the region with more limited blood flow is associated with activation limited to that region. In a secondary analysis, pathology associated with hyperintensities on T2-weighted FLAIR imaging over the whole brain was related to whole brain activation, revealing a negative relationship between lesion volume and frontal activation, and a positive relationship between lesion volume and posterior activation. These preliminary data, albeit collected with small sample sizes, suggest that reduced non-prefrontal CBF, and possibly pathological tissue associated with T2-hyperintensities, may provide contributions to the diffuse, primarily posterior extra-activation observed in adolescents following moderate to severe TBI. Published by Elsevier Ltd on behalf of ISDN.	[Newsome, Mary R.] Univ Texas Houston Med Sch, Baylor Coll Med, Cognit Neurosci Lab, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Newsome, Mary R.; Scheibel, Randall S.; Li, Xiaoqi; Wilde, Elisabeth A.; Lin, Xiaodi; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Traumat Brain Injury Ctr Excellence, Houston, TX USA; [Chu, Zili; Hunter, Jill V.; Wilde, Elisabeth A.; Wang, Zhiyue J.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Chu, Zili; Hunter, Jill V.; Wang, Zhiyue J.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lu, Hanzhang] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX USA; [Steinberg, Joel L.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat, Houston, TX USA; [Cook, Lori] Univ Texas Dallas, Ctr Brain Hlth, Richardson, TX 75083 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Newsome, MR (corresponding author), Univ Texas Houston Med Sch, Baylor Coll Med, Cognit Neurosci Lab, Phys Med & Rehabil Alliance, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mnewsome@bcm.edu	Wang, Zhiyue J/L-3851-2014	Wang, Zhiyue J/0000-0002-5649-2900	National Institute Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889, R01NS067015] Funding Source: NIH RePORTER	This work was supported by the National Institute Neurological Disorders and Stroke grant R01-NS21889 ("Neurobehavioral outcome of head injury in children," Harvey S. Levin, PI, R01 MH084021Normalized functional MRI in human brain disorders and R01 NS067015Modulation of brain activity by control of the inspired air, Hanzhang Lu, PI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We are grateful to the adolescents and their families for taking part in the research, to two anonymous reviewers for valuable comments to Jason Crowther, Ragini Yallampalli Sanyal, Zahra Kadivar, Joshua Cooper, and Vanessa Abadia for assistance in the preparation of the manuscript, and to the Michael E. DeBakey VA Medical Center and the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) for providing facilities that allowed the analyses of the fMRI data.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brett M, 2002, NEUROIMAGE, V16; BRETT M, 2002, MNI BRAIN TALAIRACH; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Golay X, 1999, JMRI-J MAGN RESON IM, V9, P454, DOI 10.1002/(SICI)1522-2586(199903)9:3<454::AID-JMRI14>3.0.CO;2-B; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hendrikse J, 2003, MAGNET RESON MED, V50, P429, DOI 10.1002/mrm.10525; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lindauer U., 2010, FRONT NEUROENERGETIC, V2; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lu HZ, 2005, J MAGN RESON IMAGING, V22, P13, DOI 10.1002/jmri.20356; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; Magri C., 2011, MAGN RESON IMAGING; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; Mayer A.R., 2011, HUM BRAIN MAPP; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmer HS, 2010, J NEUROTRAUM, V27, P853, DOI 10.1089/neu.2009.1225; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D., 2011, WECHSLER ABBREVIATED; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937; [No title captured]	75	14	14	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2012	30	3			SI		255	266		10.1016/j.ijdevneu.2011.10.008			12	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	936XH	WOS:000303622800012	22120754	Green Accepted			2022-02-06	
J	Yin, C; Zhou, S; Jiang, L; Sun, XC				Yin, Cheng; Zhou, Shuai; Jiang, Li; Sun, Xiaochuan			Mechanical injured neurons stimulate astrocytes to express apolipoprotein E through ERK pathway	NEUROSCIENCE LETTERS			English	Article						Neuron; Astrocyte; Mechanical injury; Apolipoprotein E; ERK pathway	TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAY; LIPOPROTEINS; PROTEIN; MODEL; MICE; APOE	To explore the possible cellular source and mechanism of apolipoprotein E(apoE) expression in mechanical injured neuronal cultures. Primary cultured mouse cortical neurons were subjected into mechanical injury by needle scratching. The conditioned medium of wild type (WT) primary mouse astrocytes was collected and added into cultured injured apoE knockout (KO) neurons. Separately, the conditioned medium of injured apoE KO neurons was collected and added into cultured WT astrocytes. We used a specific inhibitor of extracellular signal-regulated kinase (ERK) to block the possible apoE-associated pathway between injured neurons and astrocytes. The apoE expression levels of the cells and secreted into medium were measured by Western blot, respectively. The apoE expression was increased in neurons after mechanically injury, and the injured neurons uptook the astrocyte-secreted apoE, as well. Furthermore, the injured neurons stimulated astrocytes to express more apoE through the ERK signaling pathway. Mechanical injury triggered the neurons to increasingly synthesized apoE and uptook exogenous apoE, while stimulators released from injured neurons elevated astrocytes in apoE expression and secretion. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yin, Cheng; Zhou, Shuai; Jiang, Li; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1st Youyi Rd, Chongqing 400016, Peoples R China.	sunxch1445@gmail.com		sun, xiao chuan/0000-0001-6992-332X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973087]	This research was supported by the National Natural Science Foundation of China (No. 30973087).	Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Champagne D, 2005, EXP NEUROL, V194, P31, DOI 10.1016/j.expneurol.2005.01.016; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189, DOI 10.1097/01.wcb.0000037991.07114.4e; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; LaDu MJ, 2001, NEUROCHEM INT, V39, P427, DOI 10.1016/S0197-0186(01)00050-X; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Matsuo M., 2010, BIOCHIM BIOPHYS ACTA, V1811, P31; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Oh JY, 2010, J NEUROCHEM, V114, P685, DOI 10.1111/j.1471-4159.2010.06773.x; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Osada N, 2009, NEUROCHEM INT, V54, P403, DOI 10.1016/j.neuint.2009.01.010; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006	23	14	19	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 25	2012	515	1					77	81		10.1016/j.neulet.2012.03.023			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932LW	WOS:000303293600015	22450050				2022-02-06	
J	Fischer, CM; Burkhardt, JK; Sarnthein, J; Bernays, RL; Bozinov, O				Fischer, Claudia M.; Burkhardt, Jan-Karl; Sarnthein, Johannes; Bernays, Rene Ludwig; Bozinov, Oliver			Aesthetic outcome in patients after polymethyl-methacrylate (PMMA) cranioplasty - a questionnaire-based single-centre study	NEUROLOGICAL RESEARCH			English	Article						Bone deformity; Cranioplasty; Polymethyl-methacrylate; PMMA; Aesthetic outcome; Questionnaire	TRAUMATIC BRAIN-INJURY; LARGE SKULL DEFECTS; POLYMETHYLMETHACRYLATE; RECONSTRUCTION; PROSTHESES; INFECTION; DESIGN; RATES	Objectives: Acquired skull deformities are common and most likely treated surgically by cranioplasty. Since data on patient aesthetic outcome after cranioplasty are rare in literature, we aimed to assess patient satisfaction after polymethyl-methacrylate (PMMA) cranioplasty in this study using a questionnaire. Methods: A patient questionnaire was developed to evaluate the grade of satisfaction after surgery. After approval by the institutional ethical review board, we were allowed to send to all 115 patients, who received a cranioplasty from 2001 to 2008 at the University Hospital of Zurich, our questionnaire once to retrospectively analyze the patient response together with the patient hospital records. Results: Out of 115 patients, 36 patients were lost to follow-up and our questionnaire was sent out once to 79 patients. Sixty-three of 79 patients replied to the questionnaire (79.7%) and 16 did not reply. Seventeen declined to participate in this study and out of the remaining 46 patients (58.2%, 18 women, mean age 54 years, range 20-83 years), who agreed to participate in this study, 22 (47.8%) judged their cranioplasty to be aesthetically 'excellent', 16 (34.8%) 'favorable' and 4 (8.7%) 'poor'. Another four patients (8.7%) were not satisfied, asking for a surgical revision. Patient age and gender was not related to the assessment of the aesthetic result. A higher satisfaction grade was found in patients with primary PMMA cranioplasty compared to PMMA cranioplasty implanted during a second surgery (Fisher's exact test, P=0.031). A dent was strongly associated with absence of satisfaction (P < 0.01, Fisher's exact test). Conclusion: Our questionnaire was suitable to assess patient satisfaction after cranioplasty. Localization of cranioplasty showed to be an important factor of aesthetic outcome, especially in the fronto-temporal region where a carefully planned reconstruction should be performed to guarantee an excellent grade of satisfaction after surgery.	[Fischer, Claudia M.; Burkhardt, Jan-Karl; Sarnthein, Johannes; Bernays, Rene Ludwig; Bozinov, Oliver] Univ Zurich, Univ Hosp, Dept Neurosurg, CH-8006 Zurich, Switzerland; [Burkhardt, Jan-Karl] Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA		Burkhardt, JK (corresponding author), Univ Zurich Hosp, Dept Neurosurg, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	JanKarl.Burkhardt@gmail.com	Sarnthein, Johannes/E-7959-2010	Sarnthein, Johannes/0000-0001-9141-381X; Bozinov, Oliver/0000-0002-4620-3992; Kuzan-Fischer, Claudia Miranda/0000-0003-2226-0682			Balossier A, 2011, NEUROCHIRURGIE, V57, P21, DOI 10.1016/j.neuchi.2010.08.003; Baumeister S, 2008, PLAST RECONSTR SURG, V122, p195E, DOI 10.1097/PRS.0b013e3181858eee; Bhargava D, 2010, ACTA NEUROCHIR, V152, P173, DOI 10.1007/s00701-009-0394-2; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowles AP, 1999, SURG NEUROL, V52, P524, DOI 10.1016/S0090-3019(99)00112-3; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Fathi AR, 2008, J CRANIOFAC SURG, V19, P777, DOI 10.1097/SCS.0b013e31816b1b2a; GLADSTONE HB, 1995, OTOLARYNG CLIN N AM, V28, P381; Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236; Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088; Kelly BJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-65; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Kriegel RJ, 2007, ZBL NEUROCHIR, V68, P182, DOI 10.1055/s-2007-985857; LEE C, 1995, J CRANIO MAXILL SURG, V23, P133, DOI 10.1016/S1010-5182(05)80001-0; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Luparello D, 1998, Minerva Chir, V53, P575; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Oblu N, 1969, Rev Med Chir Soc Med Nat Iasi, V73, P911; Raza SM, 2008, NEUROSURGERY, V63, P262, DOI [10.1227/01.NEU.0000297011.27846.62, 10.1227/01.neu.0000317402.46583.c7]; Reichenberger MA, 2007, AESTHET PLAST SURG, V31, P397, DOI 10.1007/s00266-007-0009-3; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Trelle S, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-15; 홍기선, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P96	28	14	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2012	34	3					281	285		10.1179/1743132812Y.0000000007			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	922XR	WOS:000302582500009	22449405				2022-02-06	
J	Liu, CF; Bryson, CL; Burgess, JF; Sharp, N; Perkins, M; Maciejewski, ML				Liu, Chuan-Fen; Bryson, Chris L.; Burgess, James F., Jr.; Sharp, Nancy; Perkins, Mark; Maciejewski, Matthew L.			Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients	BMC HEALTH SERVICES RESEARCH			English	Article						Outpatient; Utilization; Primary care; Veterans; Medicare	TRAUMATIC BRAIN-INJURY; RISK ADJUSTMENT; HEALTH-CARE; SERVICES; AFFAIRS; BENEFICIARIES; IRAQ; WAR; PERFORMANCE; POPULATION	Background: More than half of veterans who use Veterans Health Administration (VA) care are also eligible for Medicare via disability or age, but no prior studies have examined variation in use of outpatient services by Medicare-eligible veterans across health system, type of care or time. Objectives: To examine differences in use of VA and Medicare outpatient services by disability-eligible or age-eligible veterans among veterans who used VA primary care services and were also eligible for Medicare. Methods: A retrospective cohort study of 4,704 disability-and 10,816 age-eligible veterans who used VA primary care services in fiscal year (FY) 2000. We tracked their outpatient utilization from FY2001 to FY2004 using VA administrative and Medicare claims data. We examined utilization differences for primary care, specialty care, and mental health outpatient visits using generalized estimating equations. Results: Among Medicare-eligible veterans who used VA primary care, disability-eligible veterans had more VA primary care visits (p < 0.001) and more VA specialty care visits (p < 0.001) than age-eligible veterans. They were more likely to have mental health visits in VA (p < 0.01) and Medicare-reimbursed visits (p < 0.01). Disability-eligible veterans also had more total (VA+Medicare) visits for primary care (p < 0.01) and specialty care (p < 0.01), controlling for patient characteristics. Conclusions: Greater use of primary care and specialty care visits by disability-eligible veterans is most likely related to greater health needs not captured by the patient characteristics we employed and eligibility for VA care at no cost. Outpatient care patterns of disability-eligible veterans may foreshadow care patterns of veterans returning from Afghanistan and Iraq wars, who are entering the system in growing numbers. This study provides an important baseline for future research assessing utilizations among returning veterans who use both VA and Medicare systems. Establishing effective care coordination protocols between VA and Medicare providers can help ensure efficient use of taxpayer resources and high quality care for disabled veterans.	[Liu, Chuan-Fen; Bryson, Chris L.; Sharp, Nancy; Perkins, Mark] VA Puget Sound Hlth Care Syst, NW Ctr Outcomes Res Older Adults, Seattle, WA 98101 USA; [Liu, Chuan-Fen; Sharp, Nancy] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Bryson, Chris L.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA; [Burgess, James F., Jr.] VA Boston Healthcare Syst, Ctr Org Leadership & Management Res, Boston, MA USA; [Burgess, James F., Jr.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Maciejewski, Matthew L.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Maciejewski, Matthew L.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA		Liu, CF (corresponding author), VA Puget Sound Hlth Care Syst, NW Ctr Outcomes Res Older Adults, 1100 Olive Way,Suite 1400, Seattle, WA 98101 USA.	Chuan-Fen.Liu@va.gov		Burgess, James/0000-0002-6646-7071	Office of Research and Development, Health Services Research and Development Service, Department of Veterans AffairsUS Department of Veterans Affairs [IIR 04- 292]	This work was supported by the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs, project number IIR 04- 292. Drs. Liu, Bryson, Sharp, and Perkins are at the Northwest Center for Outcomes Research in Older Adults at the VA Puget Sound Health Care System, Seattle Division. Dr. Burgess is at the Center for Organization, Leadership and Management Research at the VA Boston Healthcare System. Dr. Maciejewski is at Center for Health Services Research in Primary Care at the Durham VA Medical Center and a VA Research Career Scientist. The views expressed herein are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs, the University of Washington, Boston University, or Duke University.	Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Atherly A, 2005, HEALTH CARE FINANC R, V26, P93; Bean-Mayberry Bevanne, 2004, J Am Med Womens Assoc (1972), V59, P192; Briesacher B, 2002, MEDICARES DISABLED B; Burgess JF, 2011, HEALTH ECON, V20, P239, DOI 10.1002/hec.1588; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; Cubanski J., 2005, MEDICARE CHARTBOOK; Cubanski J, 2010, HEALTH AFFAIR, V29, P1725, DOI 10.1377/hlthaff.2009.0962; Davis MH, 1996, HEALTH CARE FINANC R, V17, P179; Fan VS, 2006, HEALTH SERV OUTCOME, V6, P21, DOI 10.1007/s10742-006-0004-1; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gleberg L, 2000, HEALTH SERV RES, V34, P30; Grabowski DC, 2009, HEALTH AFFAIR, V28, P136, DOI 10.1377/hlthaff.28.1.136; Hanson KW, 2003, HLTH AFF MILLWOOD S; Hoff RA, 2000, J BEHAV HEALTH SER R, V27, P98, DOI 10.1007/BF02287807; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hwang K., 2009, J DISABIL POLICY STU, V20, P28, DOI [DOI 10.1177/1044207308315564, 10.1177/1044207308315564]; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Iezzoni LI, 2008, J HEALTH SERV RES PO, V13, P129, DOI 10.1258/jhsrp.2008.008034; Jha A, 2002, ARCH PHYS MED REHAB, V83, P1335, DOI 10.1053/apmr.2002.33986; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Kennedy Jae, 2007, J Health Hum Serv Adm, V30, P268; Kizer KW, 2000, MED CARE, V38, pS7; Liu CF, 2003, HEALTH SERV RES, V38, P1319, DOI 10.1111/1475-6773.00179; Liu Chuan-Fen, 2005, Health Res Policy Syst, V3, P5, DOI 10.1186/1478-4505-3-5; Liu CF, 2010, HEALTH SERV RES, V45, P1268, DOI 10.1111/j.1475-6773.2010.01123.x; Maciejewski ML, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-56; Maciejewski ML, 2005, HEALTH SERV RES, V40, P887, DOI 10.1111/j.1475-6773.2005.00390.x; Moon S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-88; Morgan RO, 2009, AM J MANAG CARE, V15, pE1; O'Leary JE, 2007, HEALTH CARE FINANC R, V28, P57; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perry M., 2003, ROLE HLTH COVERAGE P; Petersen LA, 1999, J GEN INTERN MED, V14, P318, DOI 10.1046/j.1525-1497.1999.00343.x; PETERSEN LA, 2010, HEALTH SERV RES, V45, P29; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Pope GC, 2000, HEALTH CARE FINANC R, V21, P93; Richardson T, 2003, REDISTRIBUTION EFFEC, P243; Riley GF, 2003, INQUIRY-J HEALTH CAR, V40, P71, DOI 10.5034/inquiryjrnl_40.1.71; Rosenbach M L, 1995, Health Care Financ Rev, V17, P29; Sales AE, 2003, MED CARE, V41, P753, DOI 10.1097/00005650-200306000-00008; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; StataCorp, 2009, STATA REF MAN REL 11, Patent No. College Station, TX; Veterans' Disability Benefits Commission, 2007, HON CALL DUT VAT DIS; Weeks WB, 2005, J RURAL HEALTH, V21, P167, DOI 10.1111/j.1748-0361.2005.tb00077.x; Weeks WB, 2005, J HEALTHC MANAG, V50, P95, DOI 10.1097/00115514-200503000-00006; Weeks WB, 2009, J RURAL HEALTH, V25, P62, DOI 10.1111/j.1748-0361.2009.00200.x; Wright SM, 1997, HEALTH SERV RES, V31, P739; Wright SM, 1999, MED CARE, V37, P529, DOI 10.1097/00005650-199906000-00002	55	14	14	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	MAR 5	2012	12								51	10.1186/1472-6963-12-51			13	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	947DV	WOS:000304407900001	22390389	Green Published, gold			2022-02-06	
J	Nout, YS; Beattie, MS; Bresnahan, JC				Nout, Yvette S.; Beattie, Michael S.; Bresnahan, Jacqueline C.			Severity of Locomotor and Cardiovascular Derangements after Experimental High-Thoracic Spinal Cord Injury Is Anesthesia Dependent in Rats	JOURNAL OF NEUROTRAUMA			English	Article						animal model; arterial blood pressure; chronic telemetry; critical care; hemodynamics; HR; hypotension; isofluorane; MAP; neurology; pentobarbital; recovery of function	ARTERIAL-BLOOD-PRESSURE; POST-TRAUMATIC ISCHEMIA; PENTOBARBITAL-ANESTHESIA; CONSCIOUS RATS; CRITICAL-CARE; BRAIN-INJURY; FLOW; TRANSECTION; RECOVERY; HEART	Anesthetics affect outcomes from central nervous system (CNS) injuries differently. This is the first study to show how two commonly used anesthetics affect continuously recorded hemodynamic parameters and locomotor recovery during a 2-week period after two levels of contusion spinal cord injury (SCI) in rats. We hypothesized that the level of cardiovascular depression and recovery of locomotor function would be dependent upon the anesthetic used during SCI. Thirty-two adult female rats were subjected to a sham, 25-mm or 50-mm SCI at T3-4 under pentobarbital or isoflurane anesthesia. Mean arterial pressure (MAP) and heart rate (HR) were telemetrically recorded before, during, and after SCI. Locomotor function recovered best in the 25-mm-injured isoflurane-anesthetized animals. There was no significant difference in locomotor recovery between the 25-mm-injured pentobarbital-anesthetized animals and the 50-mm-injured isoflurane-anesthetized animals. White matter sparing and extent of intermediolateral cell column loss appeared larger in animals anesthetized with pentobarbital, but this was not significant. There were no differential effects of anesthetics on HR and MAP before SCI, but recovery from anesthesia was significantly slower in pentobarbital-anesthetized animals. At the time of SCI, MAP was acutely elevated in the pentobarbital-anesthetized animals, whereas MAP decreased in the isoflurane-anesthetized animals. Hypotension occurred in the pentobarbital-anesthetized groups and in the 50-mm-injured isoflurane-anesthetized group. In pentobarbital-anesthetized animals, SCI resulted in acute elevation of HR, although HR remained low. Return of HR to baseline was much slower in the pentobarbital-anesthetized animals. Severe SCI at T3 produced significant chronic tachycardia that was injury severity dependent. Although some laboratories monitor blood pressure, HR, and other physiological variables during surgery for SCI, inherently few have monitored cardiovascular function during recovery. This study shows that anesthetics affect hemodynamic parameters differently, which in turn can affect functional outcome measures. This supports the need for a careful evaluation of cardiovascular and other physiological measures in experimental models of SCI. Choice of anesthetic should be an important consideration in experimental designs and data analyses.	[Nout, Yvette S.; Beattie, Michael S.; Bresnahan, Jacqueline C.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA		Nout, YS (corresponding author), Calif State Polytech Univ Pomona, Coll Agr, 3801 W Temple Ave, Pomona, CA 91768 USA.	yvette.nout@ucsf.edu			Craig H. Neilsen Foundation [124585]; Roman Reed Spinal Cord Injury Research Fund of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038079] Funding Source: NIH RePORTER	This study was supported by the Craig H. Neilsen Foundation (124585) and Roman Reed Spinal Cord Injury Research Fund of California.	Baldridge BR, 2002, AM J PHYSIOL-REG I, V283, pR748, DOI 10.1152/ajpregu.00003.2002; Ball PA, 2001, SPINE, V26, pS27, DOI 10.1097/00007632-200112151-00006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BONICA JJ, 1968, ANESTHESIOLOGY, V29, P793, DOI 10.1097/00000542-196807000-00023; Bravo G, 2002, NEUROSCI LETT, V319, P95, DOI 10.1016/S0304-3940(01)02557-5; Bravo G, 2001, LIFE SCI, V68, P1527, DOI 10.1016/S0024-3205(01)00952-3; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; COCHRANE KL, 1988, J AUTONOM NERV SYST, V22, P181, DOI 10.1016/0165-1838(88)90105-1; Fee JPH, 1997, DRUG SAFETY, V16, P157, DOI 10.2165/00002018-199716030-00002; Filho MBL, 2005, NEUROSCI LETT, V373, P165, DOI 10.1016/j.neulet.2004.10.019; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; GRISSOM TE, 1994, ANESTH ANALG, V79, P66; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Guizar-Sahagun G, 2004, J NEUROTRAUM, V21, P1614, DOI 10.1089/0897715042441765; Ho SM, 2002, EXP NEUROL, V177, P494, DOI 10.1006/exnr.2002.8013; Iltis I, 2005, J MAGN RESON IMAGING, V22, P242, DOI 10.1002/jmri.20352; Kiyatkin EA, 2005, PHYSIOL BEHAV, V84, P563, DOI 10.1016/j.physbeh.2005.02.002; KOBRINE AI, 1976, J NEUROSURG, V44, P12, DOI 10.3171/jns.1976.44.1.0012; Kube S, 2003, J AM ANIM HOSP ASSOC, V39, P513, DOI 10.5326/0390513; Laird AS, 2006, J PHYSIOL-LONDON, V577, P539, DOI 10.1113/jphysiol.2006.116301; Leal P. R., 2007, Autonomic & Autacoid Pharmacology, V27, P167, DOI 10.1111/j.1474-8673.2007.00408.x; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; LEVINE S, 1960, AM J PATHOL, V36, P1; Maiorov DN, 1998, J NEUROTRAUM, V15, P365, DOI 10.1089/neu.1998.15.365; Mathias C.J., 1992, SPINAL CORD TRAUMA H, P435; Mayorov DN, 2001, J NEUROTRAUM, V18, P727, DOI 10.1089/089771501750357663; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; National Spinal Cord Injury Statistical Center, 2010, FACTS FIG GLANC; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; OSBORN JW, 1989, AM J PHYSIOL, V256, pR666, DOI 10.1152/ajpregu.1989.256.3.R666; OSSENBERG FW, 1975, J PHARMACOL EXP THER, V194, P111; Rodenbaugh DW, 2003, BRAIN RES, V980, P242, DOI 10.1016/S0006-8993(03)02982-2; SALZMAN SK, 1990, BRAIN RES, V521, P33, DOI 10.1016/0006-8993(90)91521-H; Savci V, 1998, NEUROCHEM RES, V23, P733, DOI 10.1023/A:1022407409727; SEGEL LD, 1986, J CARDIOVASC PHARM, V8, P392, DOI 10.1097/00005344-198603000-00024; SENTER HJ, 1979, J NEUROSURG, V50, P198, DOI 10.3171/jns.1979.50.2.0198; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; STAUFFER JL, 1988, AM J VET RES, V49, P1143; Szczesny G, 2004, LAB ANIM-UK, V38, P64, DOI 10.1258/00236770460734416; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Tei R, 2005, NEUROL RES, V27, P403, DOI 10.1179/016164105X25180; Torbati D, 1999, CRIT CARE MED, V27, P1878, DOI 10.1097/00003246-199909000-00028; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; VALEN G, 1993, J MOL CELL CARDIOL, V25, P31, DOI 10.1006/jmcc.1993.1005; Waibl H., 1973, TOPOGRAPHIE MEDULLA; WALKER LA, 1986, J PHARMACOL EXP THER, V236, P721; Wallis D, 1996, MICROSC RES TECHNIQ, V35, P69; WEBBER CL, 1979, RESP PHYSIOL, V38, P37, DOI 10.1016/0034-5687(79)90005-7; Weightman W., 2004, ANZCA SCI M PERTH AU; YAMADA KA, 1983, J PHARMACOL EXP THER, V226, P349; Yanagawa Y, 2001, J NEUROTRAUM, V18, P635, DOI 10.1089/089771501750291873; YOUNG W, 1982, J NEUROSURG, V56, P706, DOI 10.3171/jns.1982.56.5.0706; YOUNG W, 1993, RES P ARNMD, V71, P191	55	14	16	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					990	999		10.1089/neu.2011.1845			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900025	21545262	Green Published			2022-02-06	
J	Xing, GQ; Ren, M; O'Neill, JT; Verma, A; Watson, WD				Xing, Guoqiang; Ren, Ming; O'Neill, J. Timothy; Verma, Ajay; Watson, William D.			Controlled cortical impact injury and craniotomy result in divergent alterations of pyruvate metabolizing enzymes in rat brain	EXPERIMENTAL NEUROLOGY			English	Article						Head injury; Pyruvate dehydrogenase; Kinase; Phosphatase; mRNA; Protein; In situ hybridization; Real-time PCR; Western blotting; Rat	CEREBRAL GLUCOSE-UTILIZATION; DEHYDROGENASE KINASE; DECOMPRESSIVE HEMICRANIECTOMY; FUNCTIONAL CONNECTIVITY; SPREADING DEPRESSION; MICRODIALYSIS; EXPRESSION; PHOSPHATASE; RECOVERY; COMPLEX	Dysregulated glucose metabolism and energy deficit is a characteristic of severe traumatic brain injury (TBI) but its mechanism remains to be fully elucidated. Phosphorylation of pyruvate dehydrogenase (PDH) is the rate-limiting mitochondria enzyme reaction coupling glycolysis to the tricarboxylic acid cycle. Phosphorylation of PDHE1 alpha 1 subunit catalyzed by PDH kinase (PDK) inhibits PDH activity, effectively decoupling aerobic glycolysis whereas dephosphorylation of phosphorylated PDHE1 alpha 1 by PDH phosphatase (PDP) restores PDH activity. We recently reported altered expression and phosphorylation of pyruvate dehydrogenase (PDH) following TBI. However, little is known about PDK and PDP involvement. We determined PDK (PDK1-4) and PDP isoenzyme (PDP1-2) mRNA and protein expression in rat brain using immunohistochemistry and in situ hybridization techniques. We also quantified PDK and PDP mRNA and protein levels in rat brain following TBI using quantitative real-time PCR and Western blot, respectively. Controlled cortical impact-induced TB! (CCI-TBI) and craniotomy significantly enhanced PDK1-2 isoenzyme mRNA expression level but significantly suppressed PDP1 and PDK4 mRNA expression after the injury (4 h to 7 days). CCI-TBI and craniotomy also significantly increased PDK1-4 isoenzyme protein expression but suppressed PDP1-2 protein expression in rat brain. In summary, the divergent changes between PDK and PDP expression indicate imbalance between PDK and PDP activities that would favor increased PDHE1 alpha 1 phosphorylation and enzyme inhibition contributing to impaired oxidative glucose metabolism in TBI as well as craniotomy. (C) 2011 Elsevier Inc. All rights reserved.	[Xing, Guoqiang; Ren, Ming; Verma, Ajay; Watson, William D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Xing, Guoqiang] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [O'Neill, J. Timothy] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Xing, Guoqiang] Friends Res Inst, Baltimore, MD 21201 USA		Xing, GQ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	gxing99@yahoo.com	Xing, Guoqiang/ABA-8450-2020		GEMI; Henry Jackson Foundation TRP	This work was supported, in part, by GEMI Fund and Henry Jackson Foundation TRP grant.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13442, DOI 10.1021/bi0494875; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Chowdhury GMI, 2003, NEUROSCI RES, V45, P149, DOI 10.1016/S0168-0102(02)00207-9; Cole J.T., 2010, ANN M SOC NEUR SAN D; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Hattori N, 2003, J NUCL MED, V44, P1709; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 2008, CRIT CARE MED, V36, P2952, DOI 10.1097/CCM.0b013e3181872178; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lim Y, 2007, BRAIN RES REV, V53, P17, DOI 10.1016/j.brainresrev.2006.06.004; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Mitelman SA, 2006, BRAIN RES, V1114, P125, DOI 10.1016/j.brainres.2006.07.043; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Schaller B, 2004, BRAIN RES PROTOC, V12, P125, DOI 10.1016/j.brainresprot.2003.09.003; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sokoloff L, 2008, COGN NEURODYNAMICS, V2, P1, DOI 10.1007/s11571-007-9033-x; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xing GQ, 1997, MOL BRAIN RES, V47, P251, DOI 10.1016/S0169-328X(97)00056-9; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	43	14	14	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAR	2012	234	1					31	38		10.1016/j.expneurol.2011.12.007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	910DN	WOS:000301617500005	22193111				2022-02-06	
J	Cicerone, KD				Cicerone, Keith D.			Facts, Theories, Values: Shaping the Course of Neurorehabilitation. The 60th John Stanley Coulter Memorial Lecture	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Evidence-based practice; Plasticity; Rehabilitation; Research	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; COGNITIVE REHABILITATION; NEUROSCIENCE; OUTPATIENTS; DEFICITS; NETWORK	Cicerone KD. Facts, theories, values: shaping the course of neurorehabilitation. The 60th John Stanley Coulter memorial lecture. Arch Phys Med Rehabil 2012;93: 188-91. We have seen an increase in efforts to establish evidence-based parameters for the practice of rehabilitation. This effort has been placed in a broader context involving the role of theory in advancing rehabilitation science, particularly in relation to specifying the active ingredients and mechanisms of action of interventions. One approach to cognitive rehabilitation is through direct training of cognitive functions such as working memory, which purportedly relies on mechanisms of neuroplasticity. However, this approach is also shown to be dependent on qualities of active attention and learning, feedback, effort, and motivation. Changes in functional and structural connectivity after cognitive rehabilitation suggest that the dynamic adjustment of task-related and resting activity in areas connected to the site of injury is the most likely mechanism underlying recovery of function. Behavioral interventions that address this process have emphasized the role of metacognitive and emotional regulation, as well as an appreciation of the role of subjective experience and beliefs, as central to the rehabilitation process. Our understanding of these processes occurs in the context of scientific values that influence judgments about how much evidence is sufficient to support the evaluation and acceptance of scientific results, including judgments about the effectiveness of rehabilitation. Evidence and theory are necessary to understanding rehabilitation, but we also need to acknowledge the values that directly and indirectly guide our research and practice.	JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08820 USA		Cicerone, KD (corresponding author), JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, 2048 Oak Tree Rd, Edison, NJ 08820 USA.	kcicerone@jfkhealth.org					Bach-y-Rita P, 2003, ARCH PHYS MED REHAB, V84, P1100, DOI 10.1016/S0003-9993(03)00312-5; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corbetta M., 2008, COGNITIVE NEUROREHAB, VSecond, P162; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Diller, 2011, HDB HOLISTIC NEUROPS; Diller L, 2005, ARCH PHYS MED REHAB, V86, P1075, DOI 10.1016/j.apmr.2004.11.009; Douglas Heather., 2009, SCI POLICY VALUE FRE; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Evans JJ, 2009, J INT NEUROPSYCH SOC, V15, P112, DOI 10.1017/S1355617708090152; Fine, 2006, MIND ITS OWN YOUR BR; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Halstead LS, 2001, ARCH PHYS MED REHAB, V82, P149, DOI 10.1053/apmr.2001.22207; Institute of Medicine, 2011, COGN REH THER TRAUM; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Lasagna L., HIPPOCRATIC OATH MOD; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Luria AR, 1963, RESTORATION FUNCTION; Mahoney M. J., 1977, COGNITIVE THER RES, V1, P161, DOI DOI 10.1007/BF01173636; Mangels JA, 2006, SOC COGN AFFECT NEUR, V1, P75, DOI 10.1093/scan/nsl013; Mercier H, 2011, BEHAV BRAIN SCI, V34, P57, DOI 10.1017/S0140525X10000968; Miller G.A., 1960, PLANS STRUCTURE BEHA; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; SHALLICE T, 1981, BRIT MED BULL, V37, P187, DOI 10.1093/oxfordjournals.bmb.a071699; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Teuber H.-L., 1964, FRONTAL GRANULAR COR; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P203, DOI 10.1016/j.apmr.2007.11.026	42	14	14	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2012	93	2					188	191		10.1016/j.apmr.2011.12.003			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	893ER	WOS:000300338900002	22289226				2022-02-06	
J	Morgan, M; Lockwood, A; Steinke, D; Schleenbaker, R; Botts, S				Morgan, Meghan; Lockwood, Anna; Steinke, Doug; Schleenbaker, Randal; Botts, Sheila			Pharmacotherapy Regimens Among Patients With Posttraumatic Stress Disorder and Mild Traumatic Brain Injury	PSYCHIATRIC SERVICES			English	Article							ADHERENCE	Objective: The purpose of this study was to determine if veterans with posttraumatic stress disorder (PTSD) and mild traumatic brain injury (TBI) are treated differently pharmacologically than patients with PTSD alone. Methods: A retrospective evaluation of PTSD pharmacotherapy of Operation Enduring Freedom/Operation Iraqi Freedom veterans with PTSD (N=707) was conducted between April 1, 2007, and March 31, 2009. A total of 45 veterans had suffered a mild TBI. Results: Compared with the patients with PTSD alone, the patients with PTSD and TBI were more likely to be prescribed an antidepressant (p<.001), a sedative-hypnotic (p<.001), or an antipsychotic (p=.024). The patients with TBI were also significantly more likely to receive psychotropic polypharmacy (p=.001) and to receive higher doses of psychiatric medications (p=.03). Conclusions: The differences in drug therapy found in this study may indicate that patients with TBI and PTSD respond differently to treatment than patients with PTSD alone.	[Morgan, Meghan] US Dept Vet Affairs VA Gulf Coast Vet Healthcare, Dept Pharm, Biloxi, MS 39531 USA; [Lockwood, Anna; Steinke, Doug; Botts, Sheila] Lexington VA Med Ctr, Dept Pharm, Lexington, KY USA; [Morgan, Meghan; Steinke, Doug; Botts, Sheila] Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA; [Schleenbaker, Randal] Lexington VA Med Ctr, Dept Med, Lexington, KY USA; [Schleenbaker, Randal] Univ Kentucky, Coll Med, Lexington, KY 40506 USA		Morgan, M (corresponding author), US Dept Vet Affairs VA Gulf Coast Vet Healthcare, Dept Pharm, 400 Vet Ave, Biloxi, MS 39531 USA.	meghan.mor-gan@va.gov					[Anonymous], 2009, EV BAS SYNTH PROGR A; [Anonymous], 1995, J NEUROLOGY NEUROSUR, V58, P753; [Anonymous], 2011, EV VAS TRAUM BRAIN I; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Hertz RP, 2005, CLIN THER, V27, P1064, DOI 10.1016/j.clinthera.2005.07.009; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Lew HL, 2009, J REHABILITATION RES, V45, pxi; Management of Concussion-Mild Traumatic Brain Injury, 2009, MAN CONC MILD TRAUM; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spoont M, 2005, J NERV MENT DIS, V193, P515, DOI 10.1097/01.nmd.0000172474.86877.2b; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Who Collaborating Centre for Drug Statistics Methodology, 2011, ATC DDD IND 2011	13	14	17	0	5	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	FEB	2012	63	2					182	185		10.1176/appi.ps.201000531			4	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	255WD	WOS:000327269900017	22302339				2022-02-06	
J	Sun, M; Yuan, W; Hertzler, DA; Cancelliere, A; Altaye, M; Mangano, FT				Sun, M.; Yuan, W.; Hertzler, D. A.; Cancelliere, A.; Altaye, M.; Mangano, F. T.			Diffusion tensor imaging findings in young children with benign external hydrocephalus differ from the normal population	CHILDS NERVOUS SYSTEM			English	Article						Benign external hydrocephalus; Benign extra axial fluid of infancy; Diffusion tensor imaging; Fractional anisotropy; Mean diffusivity; Pediatric hydrocephalus	TRAUMATIC BRAIN-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; WHITE-MATTER MATURATION; CLINICAL ARTICLE; EARLY-CHILDHOOD; INFANTS; PREDICTORS	Purpose To compare a pediatric population diagnosed with benign external hydrocephalus (BEH) to normal age-matched controls using diffusion tensor imaging (DTI) techniques. Methods We retrospectively identified 17 BEH patients by specific clinical and neuroimaging criteria. Fractional anisotropy (FA) and mean diffusivity (MD) values obtained from DTI scans were compared to a population of age-matched controls and group differences were examined by mixed model analysis. A longitudinal comparison was completed on a subset that underwent multiple scans (n=8). Results In the genu of the corpus callosum (gCC), six of 15 BEH children had an FA value above the upper limit of 95% prediction interval, nine of 15 BEH children had MD values below the lower limit of 95% prediction interval. A similar trend applied to the other regions of interest (ROIs): splenium of the corpus callosum (sCC), ALIC, and PLIC. Statistical analysis demonstrated significant differences in FA within the gCC, sCC, and PLIC and in MD within the sCC between BEH patients and controls given (P=0.05). No statistical differences were identified at any ROIs at the later scans. Conclusions We found a significant increase in FA and decrease in MD in children with BEH compared with normal children in specific white matter (WM) ROIs, notably in the gCC and sCC; furthermore, in longitudinal comparison, DTI parameters normalized over time. The current study further demonstrates the ability of DTI to distinguish between subtle diffusion changes in periventricular white matter and establishes preliminary objective radiographic parameters for watchful observation of patients with BEH.	[Sun, M.; Hertzler, D. A.; Cancelliere, A.; Mangano, F. T.] Dept Neurosurg, Div Pediat Neurosurg, Cincinnati, OH 44529 USA; [Yuan, W.] Pediat Neuroimaging Res Consortium, Cincinnati, OH 44529 USA; [Altaye, M.] Univ Cincinnati, Div Biostat & Epidemiol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 44529 USA		Mangano, FT (corresponding author), Dept Neurosurg, Div Pediat Neurosurg, MLC 2016,3333 Burnet Ave, Cincinnati, OH 44529 USA.	francesco.mangano@cchmc.org	Altaye, Mekibib/N-5274-2015		Cincinnati Children's Hospital Medical Center	This study was supported in part by the Robert L. McLaurin MD Faculty Development Scholarship at Cincinnati Children's Hospital Medical Center.	Air EL, 2010, J NEUROSURG-PEDIATR, V5, P385, DOI 10.3171/2009.11.PEDS09343; ALVAREZ LA, 1986, PEDIATRICS, V77, P901; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boujraf S, 2002, MAGN RESON IMAGING, V20, P327, DOI 10.1016/S0730-725X(02)00501-5; Bradley WG, 2006, J MAGN RESON IMAGING, V24, P747, DOI 10.1002/jmri.20684; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Girard NJ, 2001, CHILD NERV SYST, V17, P239, DOI 10.1007/PL00013727; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kumar R, 2006, CHILD NERV SYST, V22, P1237, DOI 10.1007/s00381-006-0047-1; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leliefeld PH, 2010, J NEUROSURG-PEDIATR, V5, P562, DOI 10.3171/2010.2.PEDS09309; Leliefeld PH, 2009, J NEUROSURG-PEDIATR, V4, P56, DOI 10.3171/2009.3.PEDS08337; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Nevo Y, 2002, PEDIATR NEUROL, V27, P363, DOI 10.1016/S0887-8994(02)00454-X; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Olney Ann Haskins, 2007, Semin Pediatr Neurol, V14, P128, DOI 10.1016/j.spen.2007.07.004; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Pena A, 2006, BRIT J RADIOL, V79, P101, DOI 10.1259/bjr/24908512; PETTIT RE, 1980, ARCH NEUROL-CHICAGO, V37, P518, DOI 10.1001/archneur.1980.00500570066011; Provenzale JM, 2007, AM J ROENTGENOL, V189, P476, DOI 10.2214/AJR.07.2132; Saksena S, 2008, CEREBELLUM, V7, P392, DOI 10.1007/s12311-008-0041-0; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Smith R, 1998, PEDIATR RADIOL, V28, P143, DOI 10.1007/s002470050315; Suara RO, 2001, J NATL MED ASSOC, V93, P70; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tarnaris A, 2009, J NEUROSURG, V110, P837, DOI 10.3171/2007.9.17572; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yuan W, 2008, J NEUROSURG-PEDIATR, V1, P263, DOI 10.3171/PED/2008/1/4/263	40	14	16	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	2012	28	2					199	208		10.1007/s00381-011-1651-2			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	897PU	WOS:000300666300004	22167268				2022-02-06	
J	Wessels, KK; Broglio, SP; Sosnoff, JJ				Wessels, Karla K.; Broglio, Steven P.; Sosnoff, Jacob J.			Concussions in Wheelchair Basketball	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Disabilities; Rehabilitation; Sports medicine	INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; PARALYMPIC GAMES; SPORT	Wessels KK, Broglio SP, Sosnoff B. Concussions in wheelchair basketball. Arch Phys Med Rehabil 2012; 93:275-8. Objective: To estimate the incidence rate of concussions in wheelchair basketball. Design: Survey. Setting: Wheelchair basketball tournaments during the 2009 to 2010 season. Participants: Wheelchair basketball players (N=263) ranging in age from 18 to 60 years. Intervention: Not applicable. Main Outcome Measures: Participants completed a survey on their concussion history including how many concussions they have sustained, how many days they refrained from physical activity because of injury, to whom they reported their injury, and reasons for not reporting an injury if they did not. Participants also provided demographic information about their disability, age, sex, and length of wheelchair use and sports participation. Results: Within the sample of 263 wheelchair basketball players, 6.1% reported experiencing a concussion in the current season. Of those experiencing concussions during the current season, 44% did not report their concussion. Of those not reporting the incident, 67% did not because they did not want to be removed from physical activity. Analysis by sex indicated that 5.82% of the male athletes sustained a concussion during the current season, and 14.36% had sustained an injury during their athletic career. Female athletes, however, sustained concussions at a higher rate, with 6.67% having concussions during the current season and 30.6% during their athletic careers. Women were also 2.5 times more likely to sustain a concussion than men. Athletes were most likely to report their concussion to their coach (60% of concussed athletes). Conclusions: The current investigation was consistent with previous research in that women were more likely to sustain a concussion than men, and injury rates were similar to those in able-bodied basketball. Further work is needed in concussion assessment in persons with disability, as well as greater education concerning concussion in disability sports.	[Wessels, Karla K.; Sosnoff, Jacob J.] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA; [Broglio, Steven P.] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA		Wessels, KK (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, 1207 S Oak, Champaign, IL 61820 USA.	karlawessels1@gmail.com	Sosnoff, Jacob/P-3397-2019	Sosnoff, Jacob/0000-0002-0286-9207			Agel J, 2007, J ATHL TRAINING, V42, P202; Agel J, 2007, J ATHL TRAINING, V42, P249; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P194; FERRARA MS, 1990, PARAPLEGIA, V28, P335, DOI 10.1038/sc.1990.44; Gold JR, 2007, J R SOC PROMO HEALTH, V127, P133, DOI 10.1177/1466424007077348; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marshall SW, 2007, J ATHL TRAINING, V42, P234; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Nyland J, 2000, ARCH PHYS MED REHAB, V81, P368, DOI 10.1053/apmr.2000.0810368; REYNOLDS J, 1994, BRIT J SPORT MED, V28, P14, DOI 10.1136/bjsm.28.1.14; TAYLOR D, 1995, PARAPLEGIA, V33, P296, DOI 10.1038/sc.1995.67; Webborn N, 2006, MED SCI SPORT EXER, V38, P811, DOI 10.1249/01.mss.0000218120.05244.da	16	14	14	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2012	93	2					275	278		10.1016/j.apmr.2011.09.009			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	893ER	WOS:000300338900014	22289237				2022-02-06	
J	Ayer, RE; Jafarian, N; Chen, WQ; Applegate, RL; Colohan, ART; Zhang, JH				Ayer, Robert E.; Jafarian, Nazanin; Chen, Wanqiu; Applegate, Richard L., II; Colohan, Austin R. T.; Zhang, John H.			Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						surgical brain injury; mucosal tolerance; neuroprotection; traumatic brain injury; mouse	MYELIN BASIC-PROTEIN; GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FOCAL CEREBRAL-ISCHEMIA; PPAR-GAMMA AGONIST; ORAL TOLERANCE; IN-VIVO; IMMUNOLOGICAL-TOLERANCE; MULTIPLE-SCLEROSIS; T-CELLS	Object. Intracranial surgery causes cortical injury from incisions, hemorrhage, retraction, and electrocautery. The term "surgical brain injury" (SBI) has been developed to categorize this injury inherent to the procedure. Neuroinflammation plays a significant role in SBI. Traditional antiinflammatory therapies are often limited by their immunosuppressive side effects and poor CNS penetration. This study uses mucosal tolerance to develop an immune system that is tolerant to brain myelin basic protein (MBP) so that inflammation can be suppressed in a timely and site-specific manner following surgical disruption of the blood-brain barrier. Methods. A standard SBI model using CD57 mice was used. Nasopharyngeal mucosa was exposed to vehicle, ovalbumin, or MBP to develop mucosal tolerance to these antigens. Immunological tolerance to MBP was confirmed in vivo through hypersensitivity testing. Neurological scores, cerebral edema, and interleukin (IL)-1 beta and transforming growth factor (TGF)-beta 1 cytokine levels were measured 48 hours postoperatively. Results. Hypersensitivity testing confirmed the development of immune tolerance to MBP. Myelin basic protein-tolerant mice demonstrated reduced neurological injury, less cerebral edema, decreased levels of IL-1 beta, and increased levels of TGF beta 1 following SBI. Conclusions. Developing preoperative immunological tolerance to brain antigens through mucosal tolerance provides neuroprotection, reduces brain edema, and modulates neuroinflammation following SBI. (DOI: 10.3171/2011.8.JNS11883)	[Ayer, Robert E.; Colohan, Austin R. T.; Zhang, John H.] Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA 92354 USA; [Jafarian, Nazanin; Applegate, Richard L., II; Zhang, John H.] Loma Linda Univ, Med Ctr, Dept Anesthesiol, Loma Linda, CA 92354 USA; [Chen, Wanqiu; Zhang, John H.] Loma Linda Univ, Med Ctr, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA		Zhang, JH (corresponding author), Loma Linda Univ, Med Ctr, Dept Neurosurg, 11234 Anderson St,Room 2562B, Loma Linda, CA 92354 USA.	johnzhang3910@yahoo.com	Applegate, Richard/Y-1249-2019	Applegate, Richard/0000-0002-1454-4549	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS053407]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053407] Funding Source: NIH RePORTER	This study was supported by a grant (No. NS053407) awarded by NIH to Dr. Zhang.	Allahtavakoli M, 2009, BRAIN RES, V1271, P121, DOI 10.1016/j.brainres.2009.03.040; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Becker KJ, 2005, J CEREBR BLOOD F MET, V25, P1634, DOI 10.1038/sj.jcbfm.9600160; Becker KJ, 1997, P NATL ACAD SCI USA, V94, P10873, DOI 10.1073/pnas.94.20.10873; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YH, 1996, P NATL ACAD SCI USA, V93, P388, DOI 10.1073/pnas.93.1.388; Clark SR, 2008, J CEREBR BLOOD F MET, V28, P387, DOI 10.1038/sj.jcbfm.9600537; Esiri MM, 2007, J NEUROIMMUNOL, V184, P4, DOI 10.1016/j.jneuroim.2006.11.013; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Gee JM, 2008, STROKE, V39, P1575, DOI 10.1161/STROKEAHA.107.501486; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Jadhav V, 2007, J NEUROSURG, V106, P680, DOI 10.3171/jns.2007.106.4.680; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; KHOURY SJ, 1990, CELL IMMUNOL, V131, P302, DOI 10.1016/0008-8749(90)90256-Q; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li Khan W, 2005, Neurosurg Focus, V19, pE1; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maciunas Robert J, 2006, Clin Neurosurg, V53, P267; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Tharin S, 2007, NEUROSURGERY, V60, P185, DOI 10.1227/01.0000255386.95464.52; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yong VW, 2010, NEUROLOGY, V74, pS9, DOI 10.1212/WNL.0b013e3181c97d04; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	49	14	18	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JAN	2012	116	1					246	253		10.3171/2011.8.JNS11883			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	869XJ	WOS:000298632500039	22017304	Green Accepted			2022-02-06	
J	Bottari, C; Lamothe, MP; Gosselin, N; Gelinas, I; Ptito, A				Bottari, Carolina; Lamothe, Marie-Pierre; Gosselin, Nadia; Gelinas, Isabelle; Ptito, Alain			Driving Difficulties and Adaptive Strategies: The Perception of Individuals Having Sustained a Mild Traumatic Brain Injury	REHABILITATION RESEARCH AND PRACTICE			English	Article							SELF-AWARENESS; CONCUSSION; RETURN; REHABILITATION; SYMPTOMS; SPORTS; SCALE; PLAY	Introduction. After a mild traumatic brain injury (mTBI), individuals quickly resume driving. However, relatively little is known about the impact of mTBI on driving ability and, notably, on the perceived influence of postconcussive symptoms on driving. Hence, the objective of this study was to document the perception of driving abilities in individuals with mTBI. Method. Twenty-seven drivers with mTBI were interviewed to document their perception regarding their driving abilities. Both driving-related difficulties and compensatory strategies used to increase driving safety were documented. A mixed quantitative and qualitative analysis of the data was completed. Results. 93% of participants reported at least one difficulty perceived as having an impact on everyday activities. Most frequently named problems affecting driving were fatigue and reduced concentration. In addition, 74% of participants had adapted their driving or developed strategies to compensate for driving difficulties. Discussion/Conclusion. Postconcussive symptoms have repercussions on driving ability. However, people with mTBI tend to be aware of their difficulties and develop, over time, adaptive strategies. Preventive measures are thus warranted to increase health care professionals' awareness of the potential consequences of mTBI on driving ability and to promote guidelines for the safe resumption of driving after injury.	[Bottari, Carolina; Lamothe, Marie-Pierre] Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ H3C 3J7, Canada; [Bottari, Carolina; Gelinas, Isabelle; Ptito, Alain] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ H2H 2N8, Canada; [Gosselin, Nadia; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Gosselin, Nadia; Ptito, Alain] Montreal Neurol Hosp & Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada; [Gelinas, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G IY5, Canada; [Ptito, Alain] McGill Univ Hlth Ctr, Dept Psychol, Montreal, PQ H3A IA1, Canada		Bottari, C (corresponding author), Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ H3C 3J7, Canada.	carolina.bottari@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This study was supported by the Canadian Institutes of Health Research (postdoctoral fellowships to C. Bottari and N. Gosselin). The authors are grateful to Dr. Diane Diorio, Mitra Feyz, Dr. Simon Tinawi, Elaine De Guise, Isabel Roy, Dr. Gilles Lavigne, and Kristina Martinu for their help to recruit subjects.	Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Beck A. T., 1993, BECK DEPRESSION INVE; Beck AT, 1993, BECK ANXIETY INVENTO; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; De Raedt R, 2000, AGE AGEING, V29, P517, DOI 10.1093/ageing/29.6.517; Duquette J, 2010, AM J OCCUP THER, V64, P279, DOI 10.5014/ajot.64.2.279; Dutil E, 2005, ADL PROFILE DESCRIPT; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lovel M. R., 2010, NEUROPSYCHOLOGY EVER, P331; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; Michon J. A., 1979, DEALING WITH DANGER; Milleville-Pennel I, 2010, BRAIN INJURY, V24, P678, DOI 10.3109/02699051003692159; Piche J., 1997, ETUDE FIDELITE INTER; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rizzo M., 2010, NEUROPSYCHOLOGY EVER, P168; Rousseau J., 1994, CANADIAN J OCCUPATIO, V61, P149, DOI DOI 10.1177/000841749406100304; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Stutts J.C., 2001, ROLE DRIVER DISTRACT; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343	33	14	14	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2867	2090-2875		REHABIL RES PRACT	Rehabil. Res. Pract.		2012	2012								837301	10.1155/2012/837301			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V18NK	WOS:000214757900039	22448334	Green Published, gold			2022-02-06	
J	Capo-Aponte, JE; Tarbett, AK; Urosevich, TG; Temme, LA; Sanghera, NK; Kalich, ME				Capo-Aponte, Jose E.; Tarbett, Aaron K.; Urosevich, Thomas G.; Temme, Leonard A.; Sanghera, Navjit K.; Kalich, Melvyn E.			Effectiveness of computerized oculomotor vision screening in a military population: Pilot study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; binocular vision; computerized oculomotor vision screening; mTBI; oculomotor function; TBI; traumatic brain injury; vergence; version; vision	TRAUMATIC BRAIN-INJURY; RANDOMIZED CLINICAL-TRIAL; POLYTRAUMA NETWORK SITE; DUAL SENSORY IMPAIRMENT; CONVERGENCE INSUFFICIENCY; VISUAL FUNCTION; REHABILITATION; RECOVERY; DYSFUNCTION; REDUCTION	The prevalence of oculomotor dysfunctions associated with blast-induced mild traumatic brain injury (mTBI) in warfighters has increased as a consequence of recent conflicts. This study evaluated the effectiveness of computerized oculomotor vision screening (COVS) in a military population. Oculomotor functions were assessed with COVS and by conventional methods in 20 U.S. military personnel with and 20 without mTBI. The validity of COVS was determined by Pearson correlation and Bland-Altman method or the kappa coefficient. The repeatability of the COVS was assessed with the coefficient of repeatability or the kappa coefficient. The results showed that COVS had high sensitivity and specificity for screening near oculomotor functions. Overall, the COVS showed excellent validity and repeatability for assessing near lateral and vertical phorias, Worth 4 Dot, and fixation, as well as pursuit and saccadic eye movements. Despite the strong Pearson correlation, the Bland-Altman analysis identified minor to moderate discrepancies for both positive and negative fusional vergence and their associated recovery as well as for the monocular accommodative facility measurements. This study demonstrated that non-eye-care professionals may be able to use the COVS as a tool to efficiently screen oculomotor functions in a military population with or without mTBI.	[Capo-Aponte, Jose E.; Urosevich, Thomas G.; Temme, Leonard A.; Kalich, Melvyn E.] USA, Visual Sci Branch, Aeromed Res Lab, Ft Rucker, AL 36362 USA; [Tarbett, Aaron K.] Walter Reed Natl Mil Med Ctr, Optometry Serv, Bethesda, MD USA; [Sanghera, Navjit K.] Illinois Coll Optometry, Clin Serv, Chicago, IL USA		Capo-Aponte, JE (corresponding author), USA, Visual Sci Branch, Aeromed Res Lab, Ft Rucker, AL 36362 USA.	jose.capoaponte@us.army.mil			USAARL	This material is based on work supported with resources and funding from the USAARL.	ARMITAGE P, 1971, STAT METHODS MED RES; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOMAN DK, 1985, AM J OPTOM PHYS OPT, V62, P222; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Carlson NB, 2004, CLIN PROCEDURES OCUL, P28; Chan Y H, 2003, Singapore Med J, V44, P614; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda KJ, 2007, JBO, V18, P72; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; COOPER J, 1983, AM J OPTOM PHYS OPT, V60, P982; COOPER J, 1988, AM J OPTOM PHYS OPT, V65, P455; COOPER J, 1978, AM J OPTOM PHYS OPT, V55, P599; COOPER J, 1987, AM J OPTOM PHYS OPT, V64, P430; COOPER J, 1980, American Journal of Optometry and Physiological Optics, V57, P205; Cooper J., 1998, PRACT OPTOM, P6; Cooper J, 2009, OPTOMETRY, V80, P481, DOI 10.1016/j.optm.2009.05.007; DAUM KM, 1984, AM J OPTOM PHYS OPT, V61, P184; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; FELDMAN J, 1980, J AM OPTOM ASSOC, V51, P767; FELDMAN JM, 1989, OPTOMETRY VISION SCI, V66, P375, DOI 10.1097/00006324-198906000-00007; Feldman JM., 1993, BINOC VIS EYE MUSCLE, V8, P23; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goss DA, 1991, CLIN PROCEDURES OPTO, P716; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Maples W C, 1988, J Am Optom Assoc, V59, P549; McAllister T., 2005, TXB TRAUMATIC BRAIN, P279; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman M, 2002, OPTOMETRY VISION SCI, V79, P151, DOI 10.1097/00006324-200203000-00009; Serna A, 2011, J AAPOS, V15, P140, DOI 10.1016/j.jaapos.2010.11.023; Sheedy JE, 1983, VERGENCE EYE MOVEMEN; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff IB, 2000, PHYS MED REHABILITAT; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; Zasler ND, 2000, REHABILITATION INJUR, P207	50	14	14	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	9					1377	1398		10.1682/JRRD.2011.07.0128			22	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FB	WOS:000319303300009	23408219	Bronze			2022-02-06	
J	Dikranian, K; Kim, J; Stewart, FR; Levy, MA; Holtzman, DM				Dikranian, Krikor; Kim, Jungsu; Stewart, Floy R.; Levy, Marilyn A.; Holtzman, David M.			Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Alzheimer's disease; electron microscopy; amyloid precursor protein; presenilin 1; ApoE	AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MOUSE MODELS; TRAUMATIC AXONAL INJURY; FIBRILLAR PLAQUE-FORMATION; APOLIPOPROTEIN-E GENE; SYNAPTIC PATHOLOGY; A-BETA; MUTANT PRESENILIN-1; MICROGLIAL CELLS; TAU	Alzheimer's disease is characterized in part by extracellular aggregation of the amyloid-beta peptide in the form of diffuse and fibrillar plaques in the brain. Electron microscopy (EM) has made an important contribution in understanding of the structure of amyloid plaques in humans. Classical EM studies have revealed the architecture of the fibrillar core, characterized the progression of neuritic changes, and have identified the neurofibrillary tangles formed by paired helical filaments (PHF) in degenerating neurons. Clinical data has strongly correlated cognitive impairment in AD with the substantial synapse loss observed in these early ultrastructural studies. Animal models of AD-type brain amyloidosis have provided excellent opportunities to study amyloid and neuritic pathology in detail and establish the role of neurons and glia in plaque formation. Transgenic mice overexpressing mutant amyloid precursor protein (APP) alone with or without mutant presenilin 1 (PS1), have shown that brain amyloid plaque development and structure grossly recapitulate classical findings in humans. Transgenic APP/PS1 mice expressing human apolioprotein E isoforms also develop amyloid plaque deposition. However no ultrastructural data has been reported for these animals. Here we show results from detailed EM analysis of amyloid plaques in APP/PS1 mice expressing human isoforms of ApoE and compare these findings with EM data in other transgenic models and in human AD. Our results show that similar to other transgenic animals, APP/PS1 mice expressing human ApoE isoforms share all major cellular and subcellular degenerative features and highlight the identity of the cellular elements involved in A beta deposition and neuronal degeneration.	[Dikranian, Krikor] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA; [Kim, Jungsu; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO USA; [Levy, Marilyn A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA; [Kim, Jungsu; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO USA; [Kim, Jungsu; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Knight Alzheimers Dis Res Ctr, St Louis, MO USA		Dikranian, K (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660S Euclid Ave, St Louis, MO 63130 USA.	kdikrani@pcg.wustl.edu	Kim, Jungsu/F-2457-2012	Kim, Jungsu/0000-0002-6931-8581	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG13956]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG013956, R01AG013956] Funding Source: NIH RePORTER	Supported by NIH grant AG13956 (DMH).	Bertram L, 2007, NAT GENET       0527, V39, P7; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260; Boutajangout A, 2004, NEUROBIOL DIS, V15, P47, DOI 10.1016/j.nbd.2003.09.007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Crews L, 2010, BRAIN STRUCT FUNCT, V214, P111, DOI 10.1007/s00429-009-0232-6; Cruts M, 1998, ANN MED, V30, P560, DOI 10.3109/07853899809002605; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; GALLOWAY PG, 1987, BRAIN RES, V403, P337, DOI 10.1016/0006-8993(87)90071-0; GOLDMAN JE, 1983, J NEUROPATH EXP NEUR, V42, P146, DOI 10.1097/00005072-198303000-00004; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.3.CO;2-#; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; IKEDA K, 1990, J NEUROL, V237, P88, DOI 10.1007/BF00314668; Janus C, 2000, BBA-MOL BASIS DIS, V1502, P63, DOI 10.1016/S0925-4439(00)00033-8; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Kurt MA, 1999, EXP NEUROL, V158, P221, DOI 10.1006/exnr.1999.7096; Kurt MA, 2001, EXP NEUROL, V171, P59, DOI 10.1006/exnr.2001.7717; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lin WL, 2005, J NEUROCYTOL, V34, P397, DOI 10.1007/s11068-006-8726-0; Lin WL, 2003, J NEUROCYTOL, V32, P1091, DOI 10.1023/B:NEUR.0000021904.61387.95; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; Masliah E, 1996, J NEUROSCI, V16, P5795; Masliah E, 2001, J NEUROPATH EXP NEUR, V60, P357, DOI 10.1093/jnen/60.4.357; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pastor Pau, 2004, Curr Psychiatry Rep, V6, P125, DOI 10.1007/s11920-004-0052-6; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Phinney AL, 1999, J NEUROSCI, V19, P8552; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; Samura E, 2006, BRAIN RES, V1094, P192, DOI 10.1016/j.brainres.2005.12.134; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; TERRY RD, 1964, AM J PATHOL, V44, P269; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; TSUKITA S, 1980, J CELL BIOL, V84, P513, DOI 10.1083/jcb.84.3.513; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Wegiel J, 2004, BRAIN RES, V1022, P19, DOI 10.1016/j.brainres.2004.06.058; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; Wirths O, 2006, ACTA NEUROPATHOL, V111, P312, DOI 10.1007/s00401-006-0041-4; Wisniewski H, 1973, PROGR NEUROPATHOLOGY, V2, P26; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; Yamaguchi H, 1989, Prog Clin Biol Res, V317, P467; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176	79	14	17	0	7	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2012	5	6					482	495					14	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	000BF	WOS:000308360800001	22949930				2022-02-06	
J	Gomez, D; Haas, B; Al-Ali, K; Monneuse, O; Nathens, AB; Ahmed, N				Gomez, David; Haas, Barbara; Al-Ali, Kaes; Monneuse, Olivier; Nathens, Avery B.; Ahmed, Najma			Controversies in the management of splenic trauma	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Splenic trauma; Non-operative management	NONOPERATIVE MANAGEMENT; ASSOCIATION; ULTRASOUND; INJURIES; ADULTS	Background: The technologic innovations of the last three decades, coupled with a deeper understanding of the immunologic role of the spleen, have significantly shifted the management of splenic injuries towards non-operative approaches. However, there continuous to be a wide range of practice patterns related to the non-operative management of splenic injuries, from which the authors infer a gap between the best available evidence and its translation into practice. We sought to explore ongoing areas of controversy in the non-operative management of splenic trauma with the aim of further elucidating why these controversies continue to exist. Methods: We explored areas of ongoing controversy in the management of splenic injury though a series of iterative surveys. We invited 70 experts in trauma care from ten countries around the world to participate. Areas of controversy explored included: indications and frequency for in-hospital and follow-up imaging, definitions of failure of non-operative management, indications for angioembolisation and non-operative management in special populations (i.e. elderly, concomitant traumatic brain injury, penetrating trauma). Results: A 49% response rate was obtained. Even though a wide range of practice patterns were identified, no controversies were identified in areas that do not involve the adoption of new technologies. In areas where practice pattern variation was observed, the strong influence of the local environment was constantly identified as an impediment to changes in practice. Conclusions: We have identified that barriers present within local practice environments are the major driving forces behind controversies in the non-operative management of splenic injuries. (C) 2010 Elsevier Ltd. All rights reserved.	[Gomez, David; Haas, Barbara; Al-Ali, Kaes; Nathens, Avery B.; Ahmed, Najma] Univ Toronto, St Michaels Hosp, Dept Surg, Div Trauma, Toronto, ON M5S 1A1, Canada; [Gomez, David; Haas, Barbara; Al-Ali, Kaes; Nathens, Avery B.; Ahmed, Najma] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5S 1A1, Canada; [Monneuse, Olivier] Hosp Civils, Hop Edouard Herriot, Lyon, France		Gomez, D (corresponding author), 30 Bond St,Queen Wing 3-076, Toronto, ON M5B 1W8, Canada.	GomezJaramiD@smh.ca		Gomez, David/0000-0002-0926-2547			AGREE Collaboration, 2001, MONOGRAPH INTERNET; Alonso MBC, 2003, E ASS SURG TRAUMA; [Anonymous], 2005, J GASTROINTEST SURG, V9, P453, DOI 10.1016/j.gassur.2004.05.003; Archer LP, 1996, ARCH SURG-CHICAGO, V131, P309; Branney SW, 1997, J TRAUMA, V42, P1086, DOI 10.1097/00005373-199706000-00017; BRANNEY SW, 1995, J TRAUMA, V39, P375, DOI 10.1097/00005373-199508000-00032; COBURN MC, 1995, ARCH SURG-CHICAGO, V130, P332; COGBILL TH, 1989, J TRAUMA, V29, P1312, DOI 10.1097/00005373-198910000-00002; Fata P, 2005, J TRAUMA, V59, P836, DOI 10.1097/01.ta.0000187652.55405.73; FEDERLE MP, 1981, RADIOLOGY, V138, P637, DOI 10.1148/radiology.138.3.6450962; Fishman EK, 1996, RADIOGRAPHICS, V16, P943, DOI 10.1148/radiographics.16.4.8835983; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Graham ID, 2002, JOGNN-J OBST GYN NEO, V31, P599, DOI 10.1111/j.1552-6909.2002.tb00086.x; Grol R, 2001, MED CARE, V39, pII46; KOURY HI, 1991, INJURY, V22, P349, DOI 10.1016/0020-1383(91)90091-R; MILLIKAN JS, 1982, AM J SURG, V144, P711, DOI 10.1016/0002-9610(82)90556-6; Moore FA, 2008, J TRAUMA, V65, P1007, DOI 10.1097/TA.0b013e31818a93bf; O'Neill P, 2005, J TRAUMA, V59, P841; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; SCLAFANI SJA, 1995, J TRAUMA, V39, P818, DOI 10.1097/00005373-199511000-00004; SHACKFORD SR, 1981, J TRAUMA, V21, P538, DOI 10.1097/00005373-198107000-00006	22	14	15	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2012	43	1					55	61		10.1016/j.injury.2010.09.007			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	879BZ	WOS:000299306000011	20970799				2022-02-06	
B	Howe, LLS		Reynolds, CR; Horton, AM		Howe, Laura L. S.			Distinguishing Genuine from Malingered Posttraumatic Stress Disorder in Head Injury Litigation	DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION			English	Article; Book Chapter							FAKE-BAD SCALE; MMPI-2 VALIDITY SCALES; TRAUMATIC BRAIN-INJURY; MILLER-FORENSIC ASSESSMENT; PERSONALITY-ASSESSMENT INVENTORY; COMPENSATION SEEKING STATUS; COMBAT VETERANS; RESPONSE BIAS; SYMPTOM INVENTORY; MENTAL-DISORDERS		VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA		Howe, LLS (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	lauralshowe@yahoo.com					Alwes YR, 2008, J CLIN EXP NEUROPSYC, V30, P133, DOI 10.1080/13803390701260363; *AM PSYCH ASS, 1992, DIAGN STAT MAN MENT; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2006, LOY L REV, V52, P525; Arbisi P. A., 2006, SYMBOL DIGITS MODALI, V3, P249; Arbisi PA, 2004, ARCH CLIN NEUROPSYCH, V19, P341, DOI 10.1016/j.acn.2003.12.003; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Bagby, 1994, Assessment, V1, P31, DOI 10.1177/1073191194001001005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Berry D. T. R., 2007, ASSESSMENT MALINGERE, P226; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard E. B., 1997, CRASH ASSESSMENT TRE; Blanchard EB, 2003, BEHAV RES THER, V41, P79, DOI 10.1016/S0005-7967(01)00131-0; Blanchard EB, 2001, CURR OPIN PSYCHIATR, V14, P143, DOI 10.1097/00001504-200103000-00008; BOWEN C, 2006, INT J FORENSIC PSYCH, V1, P22, DOI DOI 10.1207/S15327752JPA7103_3; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Braverman M., 1978, ANN NY ACAD SCI, V444, P502; Breed A., 2009, POW CLAIMANTS EXCEED; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Breslau N., 1991, ARCH GEN PSYCHIAT, V156, P908; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Briere J., 1995, TRAUMA SYMPTOM INVEN; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher JN, 2008, PSYCHOL INJ LAW, V1, P191, DOI 10.1007/s12207-007-9002-z; Butcher JN, 2003, ARCH CLIN NEUROPSYCH, V18, P473, DOI 10.1016/S0887-6177(02)00142-7; Calhoun PS, 2000, J PERS ASSESS, V75, P338, DOI 10.1207/S15327752JPA7502_11; Carmody DP, 2005, J FORENSIC PSYCHI PS, V16, P477, DOI 10.1080/14789940500034462; Carone D. A., 2008, APPL NEUROPSYCHOL, V16, P309; CHARNEY DS, 1998, CNS SPECTRUMS S2, V3, P7; Crawford EF, 2006, J PERS ASSESS, V86, P217, DOI 10.1207/s15327752jpa8602_11; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; DALTON JE, 1989, PSYCHOL ASSESSMENT, V1, P56, DOI DOI 10.1037/1040-3590.1.1.56; Davidson HA, 1950, B MENNINGER CLIN, V14, P157; Davidson J., 1993, AM PSYCHIAT PRESS RE; deCarteret J C, 1994, AAOHN J, V42, P494; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Eakin D. E., 2004, THESIS AUBURN U AUBU; Eakin DE, 2006, J PSYCHOPATHOL BEHAV, V28, P145, DOI 10.1007/s10862-005-9006-5; Edens JF, 1998, J PERS ASSESS, V71, P379, DOI 10.1207/s15327752jpa7103_7; Efendov AA, 2008, PSYCHOL ASSESSMENT, V20, P317, DOI 10.1037/a0013870; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Elhai J, 2005, ASSESSMENT, V12, P210, DOI 10.1177/1073191105275456; Elhai JD, 2000, J PERS ASSESS, V75, P449, DOI 10.1207/S15327752JPA7503_06; Elhai JD, 2004, ASSESSMENT, V11, P139, DOI 10.1177/1073191104264965; Elhai JD, 2003, J CLIN PSYCHOL, V59, P385, DOI 10.1002/jclp.10135; Elhai JD, 2002, J PERS ASSESS, V79, P531, DOI 10.1207/S15327752JPA7903_08; Elhai JD, 2001, ASSESSMENT, V8, P221, DOI 10.1177/107319110100800210; Elhai JD, 2000, J NERV MENT DIS, V188, P708, DOI 10.1097/00005053-200010000-00010; Elhai JD, 2007, J PERS ASSESS, V88, P328, DOI 10.1080/00223890701332136; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Faust D, 1998, CRIT ISS NE, P1; Fecteau G., 1999, BEHAV COGN PSYCHOTHE, V27, P201; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; Foa E., 1995, POSTTRAUMATIC DIAGNO; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 1996, J TRAUMA STRESS, V9, P427, DOI 10.1007/BF02103656; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Garner B.A., 2005, BLACKS LAW DICT; Geraerts E., 2006, J FORENSIC PSYCHIATR, V20, P278; Geraerts E, 2006, LAW HUMAN BEHAV, V30, P621, DOI 10.1007/s10979-006-9043-y; GERARDI RJ, 1989, BEHAV THER, V20, P229, DOI 10.1016/S0005-7894(89)80071-1; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gold PB, 1999, J NERV MENT DIS, V187, P680, DOI 10.1097/00005053-199911000-00005; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Green B. L., 2003, POSTTRAUMATIC STRESS, P19; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Green P, 1995, MANUAL ORAL WORD MEM; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P337, DOI 10.1016/j.acn.2003.12.005; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guriel J., 2004, J FORENSIC PSYCHOL P, V4, P37, DOI DOI 10.1300/J158V04N02_02; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Guriel-Tennant J, 2006, J FORENSIC PSYCHI PS, V17, P577, DOI 10.1080/14789940600895838; Guy LS, 2006, BEHAV SCI LAW, V24, P687, DOI 10.1002/bsl.706; Guy LS, 2004, CRIM JUSTICE BEHAV, V31, P695, DOI 10.1177/0093854804268754; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; Hathaway S. R., 1951, MMPI MANUAL; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hertzberg M A, 2000, Ann Clin Psychiatry, V12, P101, DOI 10.3109/10401230009147096; Hickling E. J., 1999, INT HDB ROAD TRAFFIC, P305; HICKLING EJ, 2002, J FORENSIC PSYCHOL P, V0002, P00033, DOI [DOI 10.1300/J158v02n01_02, DOI 10.1300/J158V02N01_]; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Howe LLS, 2010, CLIN NEUROPSYCHOL, V24, P518, DOI 10.1080/13854041003775347; HYER L, 1987, J CLIN PSYCHOL, V43, P79, DOI 10.1002/1097-4679(198701)43:1<79::AID-JCLP2270430110>3.0.CO;2-P; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Iverson G. L., 1996, J COGNITIVE REHABILI, P10; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Jackson RL, 2005, LAW HUMAN BEHAV, V29, P199, DOI 10.1007/s10979-005-2193-5; Johnson DR, 1996, AM J PSYCHIAT, V153, P771; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; KEANE TM, 1984, J CONSULT CLIN PSYCH, V52, P888, DOI 10.1037/0022-006X.52.5.888; KEANE TM, 1995, POSTTRAUMATIC STRESS, P99; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kremen WS, 2007, ARCH GEN PSYCHIAT, V64, P361, DOI 10.1001/archpsyc.64.3.361; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lees-Haley PR, 2004, ARCH CLIN NEUROPSYCH, V19, P333, DOI 10.1016/j.acn.2003.12.004; Lees-Haley PR., 1986, TRIAL DIPLOMACY J, V9, P17; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; LEESHALEY PR, 2001, J FORENSIC NEUROPSYC, V2, P45, DOI DOI 10.1300/J151V02N02_04; Lewis JL, 2002, PSYCHOL ASSESSMENT, V14, P170, DOI 10.1037//1040-3590.14.2.170; Liljequist L, 1998, J PERS ASSESS, V71, P322, DOI 10.1207/s15327752jpa7103_3; LYONS JA, 1994, J TRAUMA STRESS, V7, P1; Marino SE, 2009, EPILEPSY BEHAV, V14, P459, DOI 10.1016/j.yebeh.2008.12.007; Marshall MB, 2006, ASSESSMENT, V13, P417, DOI 10.1177/1073191106290842; McCaffrey RJ, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P287, DOI 10.1007/978-1-4614-0442-2_10; McCrea M., 2008, MILD TRAUMATIC BRAIN; McNally RJ, 2006, ANN NY ACAD SCI, V1071, P267, DOI 10.1196/annals.1364.021; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Merten Th, 2006, Versicherungsmedizin, V58, P19; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Messer JM, 2007, J FORENSIC PSYCHOL P, V7, P33, DOI 10.1300/J158v07n03_02; Miller H.A., 2001, M FAST MILLER FORENS; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore SA, 2009, CURR OPIN PSYCHIATR, V22, P19, DOI 10.1097/YCO.0b013e328314e3bb; Morel K. R., 2008, GERMAN J PSYCHIAT, V11, P128; Morel K. R., 1995, ANXIETY DISORDERS PR, V2, P55; Morel KR, 2008, J FORENSIC PSYCHI PS, V19, P52, DOI 10.1080/14789940701594645; Morel KR, 1998, J PERS ASSESS, V70, P299, DOI 10.1207/s15327752jpa7002_8; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2004, COMPREHENSIVE HDB PS, V2, P15; Moyer D. M., 2002, AMER J FOREN PSYCHOL, V20, P81; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; O'Bryant SE, 2007, J PSYCHOPATHOL BEHAV, V29, P111, DOI 10.1007/s10862-006-9034-9; Olsen W. K, 1991, LITIGATION EXPLOSION; ORR SP, 1993, BIOL PSYCHIAT, V33, P127, DOI 10.1016/0006-3223(93)90312-2; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Peterson DI, 1998, NEUROLOGIST, V4, P131, DOI 10.1097/00127893-199805000-00004; Poythress NG, 2001, LAW HUMAN BEHAV, V25, P567, DOI 10.1023/A:1012702223004; Price K. P., 1994, DEF LAW J, V43, P113; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Resnick P, 2008, CLIN ASSESSMENT MALI, P109; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; ROGERS R, 1992, J CLIN PSYCHOL, V48, P643; Rogers R., 1992, STRUCTURED INTERVIEW; Rogers R., 2008, CLIN ASSESSMENT MALI, P14; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rogers R, 2009, J PERS ASSESS, V91, P429, DOI 10.1080/00223890903087745; Rogers R, 2009, LAW HUMAN BEHAV, V33, P213, DOI 10.1007/s10979-008-9145-9; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Rosen G. M., 2004, POSTTRAUMATIC STRESS, P85, DOI 10.1002/9780470713570.ch5.; Rosen GM, 2007, J ANXIETY DISORD, V21, P201, DOI 10.1016/j.janxdis.2006.09.011; Rosen GM, 2006, J ANXIETY DISORD, V20, P530, DOI 10.1016/j.janxdis.2005.03.004; Rosen GM, 2006, J PERS ASSESS, V86, P329, DOI 10.1207/s15327752jpa8603_08; Rosen GM, 2004, PERS INDIV DIFFER, V36, P1291, DOI 10.1016/S0191-8869(03)00216-2; Rosen GM, 1996, B AM ACAD PSYCH LAW, V24, P267; ROSEN GM, 1995, PROF PSYCHOL-RES PR, V26, P82, DOI 10.1037/0735-7028.26.1.82; Rosen GM, 2004, POSTTRAUMATIC STRESS, P15, DOI [10.1002/9780470713570.ch2, DOI 10.1002/9780470713570]; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Sachinvala N, 2000, J NERV MENT DIS, V188, P818, DOI 10.1097/00005053-200012000-00005; Samuel R.Z., 2005, PRIMARY PSYCHIAT, V12, P60; Sayer NA, 2008, J TRAUMA STRESS, V21, P40, DOI 10.1002/jts.20309; Scheibe S, 2001, PSYCHOL ASSESSMENT, V13, P369, DOI 10.1037/1040-3590.13.3.369; Scragg P, 2000, CLIN PSYCHOL PSYCHOT, V7, P155, DOI 10.1002/(SICI)1099-0879(200005)7:2<155::AID-CPP237>3.0.CO;2-Z; Sellers S, 2006, PSYCHIAT PSYCHOL LAW, V13, P91; Shapinsky A, 2005, ASSESSMENT, V12, P220, DOI 10.1177/1073191104273130; Skodol AE, 1996, BRIT J PSYCHIAT, V169, P717, DOI 10.1192/bjp.169.6.717; SLOVENKO R, 1994, PSYCHIAT CLIN N AM, V17, P439; Smith G. P., 2008, CLIN ASSESSMENT MALI, P323; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Stone A A, 1993, Bull Am Acad Psychiatry Law, V21, P23; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wetter, 1994, Assessment, V1, P199, DOI 10.1177/1073191194001002010; WETTER MW, 1993, PSYCHOL ASSESSMENT, V5, P317, DOI DOI 10.1037/1040-3590.5.3.317; Whitley, 1998, STOLEN VALOR VIETNAM; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Widows M. R., 2005, STRUCTURED INVENTORY; Williams CL, 2009, PSYCHOL INJ LAW, V2, P182, DOI 10.1007/s12207-009-9046-3; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Yanez YT, 2006, ARCH CLIN NEUROPSYCH, V21, P161, DOI 10.1016/j.acn.2005.07.009; [No title captured]; [No title captured]	212	14	14	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4614-0441-5				2012							301	331		10.1007/978-1-4614-0442-2_11	10.1007/978-1-4614-0442-2		31	Psychology, Clinical; Neurosciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology	BAD69	WOS:000303852000011					2022-02-06	
J	Malakouti, A; Sookplung, P; Siriussawakul, A; Philip, S; Bailey, N; Brown, M; Farver, K; Zimmerman, JJ; Bell, MJ; Vavilala, MS				Malakouti, Amin; Sookplung, Pimwan; Siriussawakul, Arunotai; Philip, Shaji; Bailey, Natalia; Brown, Marcia; Farver, Katie; Zimmerman, Jerry J.; Bell, Michael J.; Vavilala, Monica S.			Nutrition support and deficiencies in children with severe traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						nutrition; head injury; children; outcome; delivery; risk factor	MEASURED ENERGY-EXPENDITURE; ENTERAL NUTRITION; GUIDELINES	Objective: Adequate nutrition support is considered important to recovery after pediatric traumatic brain injury. The 2003 Pediatric Guidelines recommend initiation of nutrition within 72 hrs after traumatic brain injury. We examined our local experience with nutritional support in severe pediatric traumatic brain injury patients (cases) and non-traumatic brain injury patients (controls). Design: A retrospective review of pediatric patients with severe traumatic brain injury over an 11-yr period (1997-2009) and without traumatic brain injury over a 3-yr period (2007-2009). Setting: Level I pediatric trauma center pediatric intensive care unit. Patients: Patients with severe pediatric traumatic brain injury (age <15 yrs, Glasgow Coma Scale score of <9) and admitted to the pediatric intensive care unit for >7 days and patients without traumatic brain injury (age <15 yrs, head Abbreviated Injury Scale score of 0) and admitted to pediatric intensive care unit. Interventions: None. Measurements and Main Results: Data from 101 severe traumatic brain injury and 92 non-traumatic brain injury patients were analyzed. Traumatic brain injury patients: All received enteral nutrition while 13 (12%) also received parenteral nutrition. Nutrition was started 53 +/- 20 hrs (range 12-162) after pediatric intensive care unit admission. Fifty patients (52%) received nutrition within the first 48 hrs, and 83 (82%) received nutrition support within the first 72 hrs. Caloric and protein intakes were 47% and 40% of the goals on pediatric intensive care unit day 7 and 76% and 70% of the goals on pediatric intensive care unit day 14. Caloric and protein goals were met in 26% +/- 16% and 18% +/- 19% of pediatric intensive care unit stay, respectively. Patients whose intake met nutritional goals on pediatric intensive care unit day 7 had earlier initiation of nutrition support at admission than patients who never met the goals (calorie goal met vs. unmet by day 7, 44 +/- 23 hrs vs. 67 +/- 31 hrs; p < .001; protein goal met vs. unmet by day 7, 43 +/- 17 hrs vs. 65 +/- 29 hrs; p = .001). Patients gained 0.6% +/- 11% weight by pediatric intensive care unit day 7 and lost 7% +/- 11% weight by pediatric intensive care unit day 14. Non-traumatic brain injury patients: The time to start of nutrition for the non-traumatic brain injury group was earlier only for patients with isolated orthopedic injuries (24 +/- 6 hrs; p = .02). The average caloric and protein intakes were less for the traumatic brain injury (n = 20) group (caloric 52% +/- 16% of goal and protein 42% +/- 18% of goal) than for the non-traumatic brain injury (n = 23) group (65% +/- 11% of goal and protein 51% +/- 20% of goal; both p < .01) for pediatric intensive care unit days 0-7. For pediatric intensive care unit days 8-14, there was no difference in average caloric (82% +/- 22% vs. 79% +/- 18% of goal) or protein (77% +/- 6% vs. 79% +/- 7% of goal) between the traumatic brain injury (n = 12) and non-traumatic brain injury (n = 10) groups. Addition of a nutritionist was associated with earlier time to nutrition start (p = .02). Conclusions: Nutritional support was initiated in most patients within 72 hrs of pediatric intensive care unit admission. Although daily caloric and protein goals were not achieved in the first 2 wks of pediatric intensive care unit stay and nutritional deficiencies were common, earlier start of nutritional support was associated with involvement of a nutritionist and with meeting both caloric and protein goals by pediatric intensive care unit day 7. (Pediatr Crit Care Med 2012; 13:e18-e24)	[Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Malakouti, Amin; Sookplung, Pimwan; Siriussawakul, Arunotai; Brown, Marcia] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Bailey, Natalia; Farver, Katie] Univ Washington, Dept Nutr Sci, Seattle, WA 98195 USA; [Philip, Shaji] Columbia Univ, Dept Internal Med, New York, NY USA; [Zimmerman, Jerry J.] Seattle Childrens Hosp, Div Pediat Crit Care Med, Seattle, WA USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA		Vavilala, MS (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	vavilala@u.washington.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J Parenter Enteral Nutr, V26, p1SA; Braga JM, 2006, J AM DIET ASSOC, V106, P281, DOI 10.1016/j.jada.2005.10.039; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; Darbar A, 2001, NUTRITION, V17, P71, DOI 10.1016/S0899-9007(00)00476-7; de Lucas C, 2000, J PEDIATR GASTR NUTR, V30, P175, DOI 10.1097/00005176-200002000-00015; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Havalad Suresh, 2006, Nutr Clin Pract, V21, P175, DOI 10.1177/0115426506021002175; Kleinman R., 1998, PEDIAT NUTR HDB, V4th; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Loan T, 1999, NUTRITION, V15, P809; MATTHEWS DSF, 1995, ARCH DIS CHILD, V72, P507, DOI 10.1136/adc.72.6.507; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Meert KL, 2004, CHEST, V126, P872, DOI 10.1378/chest.126.3.872; Mehta NM, 2009, JPEN-PARENTER ENTER, V33, P260, DOI 10.1177/0148607109333114; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; *NAT AC SCI, 1989, REC DIET ALL; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rogers EJ, 2003, NUTRITION, V19, P865, DOI 10.1016/S0899-9007(03)00170-9	24	14	17	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1					E18	E24		10.1097/PCC.0b013e31820aba1f			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	875YT	WOS:000299073000004	21317678				2022-02-06	
J	Martelli, MF; Zasler, ND; Tiernan, P				Martelli, Michael F.; Zasler, Nathan D.; Tiernan, Patricia			Community based rehabilitation: Special issues	NEUROREHABILITATION			English	Article						Post-acute rehabilitation; community care; brain injury; biopsychosocial; community based rehabilitation; community reintegration	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; INDUCED MOVEMENT THERAPY; VOCATIONAL-REHABILITATION; MENTORING PROGRAM; VANISHING CUES; MEMORY; PSYCHOTHERAPY; INDIVIDUALS; EXERCISE	The primary goal in the developing field of community based rehabilitation (CBR) for individuals with TBI/ABI is community participation and integration. At present, CBR is less than clearly defined and is represented by a set of interventions with varied types, degrees of clinical support and models of intervention that are conducted for a diverse and complex set of individuals, situations, deficits and settings. Nonetheless, holistic neurorehabilitation programs should be considered both evidence based and a practice standard. This paper attempts to address some of the significant issues relevant to optimizing long term adaptation for persons receiving CBR. The article also addresses the current need for definitions, models, program classifications and comparisons, as well as programmatic methodologies by attempting to integrate some of the best scientifically supported methodologies within an eclectic holistic rehabilitation model that is easily understood and teachable to persons with TBI, families and rehabilitation professionals. This model and associated methodologies are intended to inform best practices while offering a framework for hypothesis generation, clinical decision-making, evaluation of treatment outcomes and direction of future research.	[Martelli, Michael F.; Zasler, Nathan D.; Tiernan, Patricia] Tree Life Serv Inc, Richmond, VA USA; [Martelli, Michael F.; Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA		Zasler, ND (corresponding author), 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA.	nzasler@cccv-ltd.com					AGEL J, 1971, RADICAL THERAPIST RA; Andrews S.S., 2004, TRAUMATIC BRAIN INJU; [Anonymous], 1999, TRAUMATIC BRAIN INJU; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P1, DOI 10.1201/9781439849828; Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Ben-Yishay Y, 2000, INT HDB NEUROPSYCHOL, P127, DOI DOI 10.1007/978-1-4757-5569-5_8; Bender MC, 2003, WILL TRAUM BRAIN INJ; Bergin AE, 1994, HDB PSYCHOTHERAPY BE; Broach E, 2000, FACILITATION TECHNIQ; Buffington ALH, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199710000-00002; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Condeluci A., 1996, DIFFERENCE; Condeluci A., 2004, ADVOCACY CHANGE MANU; Condeluci A., 2008, ESSENCE INTERDEPENDE; Dahlberg C.A., 2005, HEAD TRAUMA REHABIL, V20, P62; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; Division of Acute Care Rehabilitation Research and DisabiIlity Prevention. National Center for Injury Prevention and Control Centers for Disease Control and Prevention. U.S. Department of Health and Human Services, 1999, TRAUM BRAIN INJ US R; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Englander J., 2007, BRAIN INJURY MED PRI; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feeney T.J., 2010, J HEAD TRAUMA REHAB, V25, P1; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Fenech A.M., BRAIN INJURY MED PRI; Finkenflugel H, 2005, INT J REHABIL RES, V28, P187, DOI 10.1097/00004356-200509000-00001; Finkenflugel H, 2008, DISABIL REHABIL, V30, P348, DOI 10.1080/09638280701257288; Frank J., 1993, PERSUASION HEALING C; FRANK JD, 1974, J NERV MENT DIS, V159, P325, DOI 10.1097/00005053-197411000-00003; FRANK JD, 1983, BEHAV BRAIN SCI, V6, P291, DOI 10.1017/S0140525X00015958; FRANK JD, 1982, PSYCHOTHERAPY RES BE, P9; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; Goldstein, 1939, ORGANISM HOLISTIC AP; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Greenwood R, 2001, BRIT MED J, V323, P1082, DOI 10.1136/bmj.323.7321.1082; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hanson S., 2004, TRAUMATIC BRAIN INJU; Hanson S.L., 2000, HDB REHABILITATION P; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; Helander Einar, 1989, TRAINING COMMUNITY P; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hubble MA, 1999, HEART SOUL CHANGE WH; Hutchinson SL, 2003, LEISURE SCI, V25, P143, DOI 10.1080/01490400306566; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; JONASSEN DH, 1999, TASK ANAL METHODS IN; Judd T, 2009, NEUROPSYCHOL REHABIL, V19, P841, DOI 10.1080/09602010903024943; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kern RS, 2002, AM J PSYCHIAT, V159, P1921, DOI 10.1176/appi.ajp.159.11.1921; Kern RS, 2005, AM J PSYCHIAT, V162, P513, DOI 10.1176/appi.ajp.162.3.513; Kern RS, 2003, PSYCHOL MED, V33, P433, DOI 10.1017/S0033291702007298; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kiser L, 2009, NEUROREHABILITATION, V25, P219, DOI 10.3233/NRE-2009-0518; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Klonoff P., 2003, COMMUNITY REHABILITA, P213; Klonoff PS, 2000, INT HDB NEUROPSYCHOL, P195; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; LENG NRC, 1991, BEHAV PSYCHOTHER, V19, P173, DOI 10.1017/S0141347300012209; Mackelprang RW, 2009, J SOC WORK DISABIL R, V8, P205, DOI 10.1080/15367100903202771; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Martelli M.F., 1999, ARCH CLIN NEUROPSYCH, V14; Martelli M. F., 2007, BRAIN INJURY MED PRI; Martelli MF, 2005, BRAIN INJURY PROFESS, V2, P10; MARTELLI MF, 2002, 21 ANN S BRAIN INJ A; MARTELLI MF, 2003, ANN M COAL CLIN PRAC; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; Martins S, 2006, NEUROPSYCHOLOGIA, V44, P2792, DOI 10.1016/j.neuropsychologia.2006.05.022; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masters J. C., 1987, BEHAV THERAPY TECHNI; Masters RSW, 2004, REHABIL PSYCHOL, V49, P79, DOI 10.1037/0090-5550.49.1.79; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NORDAL KC, 2009, MONITOR PSYCHOL, V40, P43; Ormrod J.E., 1999, HUMAN LEARNING; PATTERSON CH, 1989, PSYCHOTHERAPY, V26, P427, DOI 10.1037/h0085461; Pitel AL, 2006, BRAIN INJURY, V20, P1099, DOI 10.1080/02699050600909961; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; RIM DC, 1979, BEHAV THERAPY TECHNI; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander A.M., 2006, CONT FOR BRAIN INJ C; Sander A.M., 2007, BRAIN INJURY MED PRI; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sbordone R.J., 1990, PSYCHOTHERAPY PRIVAT, V8, P129; SCHACTER DL, 1996, SEARCHING MEMORY; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schutz LE, 2007, BRAIN INJURY, V21, P545, DOI 10.1080/02699050701426923; SELIGMAN MEP, 2000, ENCY STRESS; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; SPIEGLER MD, 2003, CONT BEHAV THERAPY; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; The Cornell Institute for Translational Research on Aging (CITRA), 2007, SOC IS STRAT CONN EN; Todd D.D., 1999, COGNIPHOBIA SCALE C; TRIESCHMANN RB, 1984, REHABIL LIT, V45, P345; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; VERFAELLIE M, 1990, BRAIN COGNITION, V13, P178, DOI 10.1016/0278-2626(90)90049-T; Wampold, 2001, GREAT PSYCHOTHERAPY; WEHMAN P, 1993, COMMUNITY BASED EMPL; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201; Weintraub A., 2004, TRAUMATIC BRAIN INJU; Wheeler SD, 2007, OTJR-OCCUP PART HEAL, V27, P13, DOI 10.1177/153944920702700103; Whiteneck G.G., 2007, ARCH PHYS MED REHAB, V88, P1561; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638; Zasler N. D., 2012, BRAIN INJURY MED PRI; Zasler ND, 2010, CHALLENGE, V3, P1825; ZASLER ND, 2005, TXB TRAUMATIC BRAIN, P419; [No title captured]	121	14	14	1	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					3	18		10.3233/NRE-2012-0770			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900002	22523014				2022-02-06	
S	Morris, DC; Zhang, ZG; Zhang, J; Xiong, Y; Zhang, L; Chopp, M		Goldstein, AL; Garaci, E		Morris, Daniel C.; Zhang, Zheng G.; Zhang, Jing; Xiong, Ye; Zhang, Li; Chopp, Michael			Treatment of neurological injury with thymosin beta 4	THYMOSINS IN HEALTH AND DISEASE I	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	3rd International Symposium on Thymosins in Health and Disease	MAR 14-16, 2012	Washington, DC	George Washington Univ, Ist Superiore Sanita (ISS), Univ Rome Tor Vergata		thymosin beta 4; stroke; multiple sclerosis; traumatic brain injury; rat	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; RAT MODEL; STROKE; REMYELINATION; NEUROGENESIS; PRECURSORS; ISCHEMIA; RECOVERY	Neurorestorative therapy targets multiple types of parenchymal cells in the intact tissue of injured brain tissue to increase neurogenesis, angiogenesis, oligodendrogenesis, and axonal remodeling during recovery from neurological injury. In our laboratory, we tested thymosin beta 4 (T beta 4) as a neurorestorative agent to treat models of neurological injury. This review discusses our results demonstrating that T beta 4 improves neurological functional outcome in a rat model of embolic stroke, a mouse model of multiple sclerosis, and a rat model of traumatic brain injury. T beta 4 is a pleiotropic peptide exhibiting many actions in several different types of tissues. One mechanism associated with improvement of neurological improvement from T beta 4 treatment is oligodendrogenesis involving the differentiation of oligodendrocyte progenitor cells to mature myelin-secreting oligodendrocytes. Moreover, our preclinical data provide a basis for movement of T beta 4 into clinical trials for treatment of these devastating neurological diseases and injuries.	[Morris, Daniel C.] Henry Ford Hlth Sci Ctr, Dept Emergency Med, Detroit, MI USA; [Zhang, Zheng G.; Zhang, Jing; Zhang, Li; Chopp, Michael] Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI USA; [Xiong, Ye] Henry Ford Hlth Sci Ctr, Dept Neurosurg, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Morris, DC (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 W Grand Blvd,CFP 2, Detroit, MI 48202 USA.	Dmorris4@hfhs.org		Xiong, Ye/0000-0001-9770-6031	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [PO1 NS23393, RO1 NS062832, R01 NS075156, R01 AG038648]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS023393, R01NS075156, R01NS062832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG038648] Funding Source: NIH RePORTER	This research was supported in part by NINDS and NIA Grants PO1 NS23393, RO1 NS062832, R01 NS075156, and R01 AG038648. T beta 4 was supplied by RegeneRx Biopharmaceuticals Inc. under a Material Transfer Agreement. A U.S. Provisional Patent 61/163,556 has been filed for use of T beta 4 in neurological disease.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuchs VR, 2008, NEW ENGL J MED, V359, P1749, DOI 10.1056/NEJMp0807432; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; Sharma JC, 1999, CEREBROVASC DIS, V9, P2, DOI 10.1159/000015889; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	27	14	17	0	9	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923		978-1-57331-871-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2012	1269						110	116		10.1111/j.1749-6632.2012.06651.x			7	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Multidisciplinary Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Science & Technology - Other Topics	BDB67	WOS:000312491500016	23045978	Green Accepted			2022-02-06	
S	Starkstein, SE; Tranel, D		Schlaepfer, TE; Nemeroff, CB		Starkstein, Sergio E.; Tranel, Daniel			Neurological and psychiatric aspects of emotion	NEUROBIOLOGY OF PSYCHIATRIC DISORDERS	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PROVISIONAL DIAGNOSTIC-CRITERIA; POSTSTROKE DEPRESSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SELF-AWARENESS; NEUROPSYCHIATRIC-SYMPTOMS; FUNCTIONAL RECOVERY; MAJOR DEPRESSION; DOUBLE-BLIND		[Starkstein, Sergio E.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Tranel, Daniel] Univ Iowa, Coll Med, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA; [Tranel, Daniel] Univ Iowa, Dept Psychol, Coll Med, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA		Starkstein, SE (corresponding author), Fremantle Hosp T 7, Fremantle, WA 6959, Australia.	ses@meddent.-uwa.edu.au		Tranel, Daniel/0000-0002-1338-1389	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA022549] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA022549] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS19632] Funding Source: Medline		Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Aalten P, 2005, INT J GERIATR PSYCH, V20, P523, DOI 10.1002/gps.1316; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2004, PRINCIPLES PRACTICE, P457; Aggleton J., 2000, AMYGDALA FUNCTIONAL; Aggleton JP., 1992, AMYGDALA NEUROBIOLOG, V1; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMARAL D G, 1992, P1; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Babinski J., 1918, REV NEUROL, V31, P365; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bennet M., 2003, PHILOS FDN NEUROSCIE; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOLLAWILSON K, 1989, AM J PSYCHIAT, V146, P627; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Borod JC, 1997, NEUROPSYCHOL REV, V7, P41, DOI 10.1007/BF02876972; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bowers D., 1993, NEUROPSYCHOLOGY, V7, P433, DOI [10.1037/0894-4105.7.4.433, DOI 10.1037/0894-4105.7.4.433]; Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173; BROTHERS L, 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Buchanan T. W., 2009, HUMAN AMYGDALA; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; BURNS A, 1990, BRIT J PSYCHIAT, V157, P81, DOI 10.1192/bjp.157.1.81; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P320, DOI 10.1192/bjp.166.3.320; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CANCELLIERE AEB, 1990, BRAIN COGNITION, V13, P133, DOI 10.1016/0278-2626(90)90046-Q; Canli T, 1999, NEUROSCIENTIST, V5, P201, DOI 10.1177/107385849900500409; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chemerinski E, 2001, J NERV MENT DIS, V189, P421, DOI 10.1097/00005053-200107000-00002; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Chung J. C. C., 2002, COCHRANE DATABASE SY, V4, P1, DOI DOI 10.1002/14651858; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P177, DOI 10.1348/014466504323088042; Cohen CI, 2003, AM J PSYCHIAT, V160, P2012, DOI 10.1176/appi.ajp.160.11.2012; Cummings JL, 2001, J GERIATR PSYCH NEUR, V14, P101, DOI 10.1177/089198870101400211; CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443; CUTTING J, 1978, J NEUROL NEUROSUR PS, V41, P548, DOI 10.1136/jnnp.41.6.548; Czernecki V, 2008, MOVEMENT DISORD, V23, P964, DOI 10.1002/mds.21949; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio A., 1999, FEELING WHAT HAPPENS; Damasio A. R., 2011, CLIN NEUROPSYCHOLOGY, P417; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davidson Richard J., 1992, BRAIN COGNITION, V6, P245; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Dobkin Roseanne DeFronzo, 2008, Expert Rev Neurother, V8, P27, DOI 10.1586/14737175.8.1.27; DOWNHILL JE, 1994, J NERV MENT DIS, V182, P425, DOI 10.1097/00005053-199408000-00001; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Dujardin K, 2007, MOVEMENT DISORD, V22, P778, DOI 10.1002/mds.21316; Fall PA, 1999, J NEURAL TRANSM, V106, P737, DOI 10.1007/s007020050194; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Feinberg TE, 2000, J NEUROL NEUROSUR PS, V68, P511, DOI 10.1136/jnnp.68.4.511; Figiel G, 2008, CURR MED RES OPIN, V24, P157, DOI 10.1185/030079908X260961; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gainotti G, 1997, J CLIN EXP NEUROPSYC, V19, P340, DOI 10.1080/01688639708403863; GAINOTTI G, 2000, NEUROPSYCHOLOGY EMOT; Gallegos DR, 2005, BRAIN LANG, V93, P338, DOI 10.1016/j.bandl.2004.11.001; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallo JJ, 1997, J AM GERIATR SOC, V45, P570, DOI 10.1111/j.1532-5415.1997.tb03089.x; Galynker I, 1997, J NERV MENT DIS, V185, P616, DOI 10.1097/00005053-199710000-00004; Garre-Olmo J, 2003, ALZ DIS ASSOC DIS, V17, P77, DOI 10.1097/00002093-200304000-00005; Gazzaniga M., 2000, NEW COGNITIVE NEUROS, P1047; Gialanella B, 2005, STROKE, V36, P2687, DOI 10.1161/01.STR.0000189627.27562.c0; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hackett ML, 2004, COCHRANE DB SYST REV, V4; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hare R.D., 1970, PSYCHOPATHY THEORY R; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Heilman K., 2003, CLIN NEUROPSYCHOLOGY, V4e, P447; Herrmann N, 2005, AM J GERIAT PSYCHIAT, V13, P527, DOI 10.1176/appi.ajgp.13.6.527; Herrmann N, 2008, J CLIN PSYCHOPHARM, V28, P296, DOI 10.1097/JCP.0b013e318172b479; Holmes C, 2006, INT PSYCHOGERIATR, V18, P623, DOI 10.1017/S1041610206003887; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; JACOBS DH, 1995, NEUROLOGY, V45, P1217, DOI 10.1212/WNL.45.6.1217; Jansari A, 2000, COGNITION EMOTION, V14, P341, DOI 10.1080/026999300378860; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kimura M, 2000, STROKE, V31, P1482, DOI 10.1161/01.STR.31.7.1482; Koscik T, 2010, NEUROPSYCHOPHARMACOL, V35, P340, DOI 10.1038/npp.2009.122; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Landes AM, 2005, J NEUROPSYCH CLIN N, V17, P342, DOI 10.1176/appi.neuropsych.17.3.342; Lane-Brown A, 2009, COCHRANE DB SYST REV, V2; LeDoux J.E., 1996, EMOTIONAL BRAIN; Lee HCB, 2003, BIOL PSYCHIAT, V54, P353, DOI 10.1016/S0006-3223(03)00543-2; Leentjens AFG, 2003, INT J GERIATR PSYCH, V18, P552, DOI 10.1002/gps.865; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; LIPSEY JR, 1986, AM J PSYCHIAT, V143, P527; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lyketsos CG, 2002, BIOL PSYCHIAT, V52, P243, DOI 10.1016/S0006-3223(02)01348-3; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P1686, DOI 10.1176/appi.ajp.157.10.1686; Magai C, 2000, AM J GERIAT PSYCHIAT, V8, P66, DOI 10.1097/00019442-200002000-00009; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh L, 2006, MOVEMENT DISORD, V21, P148, DOI 10.1002/mds.20723; Menza M, 2009, NEUROLOGY, V72, P886, DOI 10.1212/01.wnl.0000336340.89821.b3; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P129, DOI 10.1176/appi.ajgp.10.2.129; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Palhagen SE, 2008, ACTA NEUROL SCAND, V117, P295, DOI 10.1111/j.1600-0404.2007.00986.x; Panksepp, 1998, AFFECTIVE NEUROSCIEN; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Pedersen KF, 2010, J NEUROL, V257, P217, DOI 10.1007/s00415-009-5297-x; Pedersen KF, 2009, PARKINSONISM RELAT D, V15, P295, DOI 10.1016/j.parkreldis.2008.07.006; Piccinelli M, 1999, J PSYCHOSOM RES, V46, P455, DOI 10.1016/S0022-3999(98)00126-3; Pohjasvaara T, 2001, EUR J NEUROL, V8, P315, DOI 10.1046/j.1468-1331.2001.00182.x; Prigatano, 2010, STUDY ANOSOGNOSIA, P229; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Robert PH, 2006, CLIN NEUROL NEUROSUR, V108, P733, DOI 10.1016/j.clineuro.2006.02.003; ROBERTS RC, 1988, PHILOS REV, V97, P183, DOI 10.2307/2185261; ROBINSON RG, 1987, STROKE, V18, P837, DOI 10.1161/01.STR.18.5.837; Robinson RG, 2006, CLIN NEUROPSYCHIATRY; Robinson RG, 2008, J NEUROL NEUROSUR PS, V21, P144; Robinson RG, 2008, JAMA-J AM MED ASSOC, V299, P2391, DOI 10.1001/jama.299.20.2391; Rolls ET, 1999, NEUROCASE, V5, P301, DOI 10.1093/neucas/5.4.301; Royet JP, 2000, J NEUROSCI, V20, P7752; Santa N, 2008, INT J REHABIL RES, V31, P321, DOI 10.1097/MRR.0b013e3282fc0f0e; Santangelo G, 2009, J NEUROL, V256, P632, DOI 10.1007/s00415-009-0146-5; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1997, P ROY SOC B-BIOL SCI, V264, P1767, DOI 10.1098/rspb.1997.0245; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; Starkstein SE, 2007, EUR J NEUROL, V14, P455, DOI 10.1111/j.1468-1331.2007.01745.x; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; STARKSTEIN SE, 1988, ARCH GEN PSYCHIAT, V45, P247; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; STARKSTEIN SE, 1995, ARCH NEUROL-CHICAGO, V52, P415, DOI 10.1001/archneur.1995.00540280105024; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Starkstein SE, 2005, AM J PSYCHIAT, V162, P2086, DOI 10.1176/appi.ajp.162.11.2086; Starkstein SE, 2005, AM J GERIAT PSYCHIAT, V13, P802, DOI 10.1176/appi.ajgp.13.9.802; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Starkstein SE, 1998, MOVEMENT DISORD, V13, P29, DOI 10.1002/mds.870130109; STARKSTEIN SE, 1990, J NERV MENT DIS, V178, P27, DOI 10.1097/00005053-199001000-00005; STARKSTEIN SE, 1991, EUR NEUROL, V31, P352, DOI 10.1159/000116692; STARKSTEIN SE, 1992, J NEUROL NEUROSUR PS, V55, P377, DOI 10.1136/jnnp.55.5.377; Starkstein SE, 1997, BRIT J PSYCHIAT, V171, P47, DOI 10.1192/bjp.171.1.47; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Starkstein SE, 1992, NEUROPSY NEUROPSY BE, V5, P114; Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Starkstein SE, 2010, J NEUROPSYCH CLIN N, V22, P378, DOI 10.1176/appi.neuropsych.22.4.378; Starkstein SE, 2009, MOVEMENT DISORD, V24, P1211, DOI 10.1002/mds.22577; Steinberg M, 2004, INT J GERIATR PSYCH, V19, P144, DOI 10.1002/gps.1048; Strauss ME, 2002, NEUROPSY NEUROPSY BE, V15, P176, DOI 10.1097/01.WNN.0000020010.79870.C3; Tatsch MF, 2006, AM J GERIAT PSYCHIAT, V14, P438, DOI 10.1097/01.JGP.0000218218.47279.db; Teng E, 2008, AM J GERIAT PSYCHIAT, V16, P469, DOI 10.1097/JGP.0b013e318165dbae; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Thompson S, 2007, CAN J PSYCHIAT, V52, P248, DOI 10.1177/070674370705200407; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; TRANEL D, 1990, ARCH NEUROL-CHICAGO, V47, P349, DOI 10.1001/archneur.1990.00530030131029; Tranel D, 2009, NEUROCASE, V15, P217, DOI 10.1080/13554790902775492; Tranel Daniel, 2000, AMYGDALA FUNCTIONAL, P587; Turro-Garriga O, 2009, REV NEUROLOGIA, V48, P7, DOI 10.33588/rn.4801.2008565; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; VANLANCKER D, 1992, J SPEECH HEAR RES, V35, P963, DOI 10.1044/jshr.3505.963; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Vilalta-Franch J, 2006, AM J GERIAT PSYCHIAT, V14, P589, DOI 10.1097/01.JGP.0000209396.15788.9d; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whyte EM, 2008, CEREBROVASC DIS, V26, P317, DOI 10.1159/000149580; Williams LS, 2007, STROKE, V38, P998, DOI 10.1161/01.STR.0000257319.14023.61; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zawacki TM, 2002, J NEUROPSYCH CLIN N, V14, P296, DOI 10.1176/appi.neuropsych.14.3.296	218	14	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-453500-9; 978-0-44-452002-9	HAND CLINIC			2012	106						53	74					22	Clinical Neurology; Neurosciences; Psychiatry	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychiatry	BCQ82	WOS:000311042100006	22608615				2022-02-06	
J	Stiers, W; Carlozzi, N; Cernich, A; Velozo, C; Pape, T; Hart, T; Gulliver, S; Rogers, M; Villarreal, E; Gordon, S; Gordon, W; Whiteneck, G				Stiers, William; Carlozzi, Noelle; Cernich, Alison; Velozo, Craig; Pape, Theresa; Hart, Tessa; Gulliver, Suzy; Rogers, Margaret; Villarreal, Edgar; Gordon, Shalanda; Gordon, Wayne; Whiteneck, Gale			Measurement of social participation outcomes in rehabilitation of veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						clinical practice; measurement; outcomes; participation; rehabilitation; research; social participation; traumatic brain injury; VA; veterans	COMMUNITY INTEGRATION QUESTIONNAIRE; PORTLAND ADAPTABILITY INVENTORY; QUALITY-OF-LIFE; POSTCONCUSSION SYNDROME; PSYCHOMETRIC EVALUATION; SOCIETAL PARTICIPATION; SYMPTOMS; DISABILITY; INDIVIDUALS; AWARENESS	Traumatic brain injury (TBI) is a significant concern in the veteran population, and the Department of Veteran Affairs (VA) has devoted substantial healthcare resources to the rehabilitation of veterans with TBI. Evaluating the outcomes of these rehabilitation activities requires measuring whether they meaningfully improve veterans' lives, especially with regard to community and vocational participation, which are strongly linked to perceived quality of life. In January 2010, the VA Rehabilitation Research and Development Service convened an invitational conference focused on outcome measurement in rehabilitation with a specific focus on veterans' community and vocational participation. This article reports on the working group, addressing the issues of conceptualizing and operationalizing such participation outcome measures for veterans with TBI; we discuss conceptual models of participation, review participation subdomains and their instruments of measurement, and identify current research issues and needs. Two avenues are identified for advancing participation measurement in veterans with TBI. First, we describe suggestions to facilitate the immediate implementation of participation measurement into TBI clinical practice and rehabilitation (cont) research within the VA healthcare system. Second, we describe recommendations for future VA research funding initiatives specific to improving the measurement of participatiOn in veterans with TBI.	[Stiers, William] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21239 USA; [Carlozzi, Noelle] Kessler Fdn, Res Ctr, W Orange, NJ USA; [Carlozzi, Noelle] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Cernich, Alison] Dept Vet Affairs VA Maryland Hlth Care Syst, Baltimore, MD USA; [Cernich, Alison] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Cernich, Alison] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Velozo, Craig] North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA; [Velozo, Craig] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Pape, Theresa] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Pape, Theresa] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Hart, Tessa] Einstein Healthcare Network, Dept Psychiat, Einstein Med Ctr, Philadelphia, PA USA; [Gulliver, Suzy] Cent Texas Vet Hlth Care Syst, Waco VA Med Ctr, Ctr Excellence Res Returning War Vet, Waco, TX USA; [Gulliver, Suzy] Texas A&M Hlth Sci Ctr, Coll Med, Bryan, TX USA; [Rogers, Margaret] Amer Speech Language Hearing Assoc, Rockville, MD USA; [Villarreal, Edgar] VA Eastern Colorado Hlth Care Syst, Denver, CO USA; [Gordon, Shalanda] Cent Texas Vet Hlth Care Syst, Austin Outpatient Clin, Austin, TX USA; [Gordon, Shalanda] St Phillips Coll, San Antonio, TX USA; [Gordon, Wayne] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Whiteneck, Gale] Craig Hosp, Englewood, CO USA		Stiers, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, 5601 Loch Raven Blvd,Suite 406, Baltimore, MD 21239 USA.	wstiers1@jhmi.edu	Gulliver, Suzy/X-9776-2019	Bender Pape, Theresa/0000-0001-7738-5963; Gulliver, Suzy Bird/0000-0002-6476-9447; Stiers, William/0000-0002-1826-8350	State of the Art Conference on Outcome Measures in Rehabilitation; VA Office of Research and Development	This material was based on work supported by the State of the Art Conference on Outcome Measures in Rehabilitation, VA Office of Research and Development.	[Anonymous], 1980, INT CLASS IMP DIS HA; Bode RK, 2010, ARCH PHYS MED REHAB, V91, pS60, DOI 10.1016/j.apmr.2009.10.035; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Bond T. G., 2001, APPL RASCH MODEL; Brandt EN, 1997, ENABLING AM ASSESSIN; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Campbell A.-Ph. E. Converse-W. L., 1976, QUALITY AM LIFE PERC; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D F, 1995, Oncology (Williston Park), V9, P47; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; *DOD, 2009, DOD WORLDW NUMB TRAU; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Faul M, 2010, TRAUMATIC BRAIN INJU; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gandek B, 2007, AM J PHYS MED REHAB, V86, P57, DOI 10.1097/01.PHM.0000233200.43822.21; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; *INST MED, 2009, GULF WAR HLTH, V7; International Classification of Functioning, 2001, INT CLASS FUNCT DIS; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JAFFEE M, 2010, P 8 WORLD C BRAIN IN; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC27; Kahneman D., 1999, WELL BEING FDN HEDON; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MALEC J, 2005, MAYOPORTLAND ADAPTAB; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; *NAT CTR INJ PREV, TRAUM BRAIN INJ; Park N, 2009, CYBERPSYCHOL BEHAV, V12, P729, DOI 10.1089/cpb.2009.0003; PATRICK DL, 1988, TGO-TIJDSCHR THER GE, V13, P152; Pope AM, 1991, DISABILITY AM NATL A; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; SCHWARTZ S, 1996, ANSWERING QUESTIONS; Seekins T, 2007, REHABIL PSYCHOL, V52, P319, DOI 10.1037/0090-5550.52.3.319; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; *US DEP EDUC, 2007, NIDRR LONG RANG PLAN; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 1997, ICIDH 2 INT CLASS IM; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002; 2010, SYLL DET; 2009, DOD WORLDW NUMB TRAU	76	14	15	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	1					139	153		10.1682/JRRD.2010.07.0131			15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149ES	WOS:000319302400013	22492344	Bronze			2022-02-06	
J	Zeilig, G; Weingarden, H; Shemesh, Y; Herman, A; Heim, M; Zeweker, M; Dudkiewicz, I				Zeilig, Gabi; Weingarden, Harold; Shemesh, Yeheskel; Herman, Amir; Heim, Michael; Zeweker, Manual; Dudkiewicz, Israel			Functional and environmental factors affecting work status in individuals with longstanding poliomyelitis	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Employment status; Disability; Poliomyelitis; Post-polio syndrome; Activities of daily living; Mobility; Orthotics	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; POSTPOLIO SYNDROME; POLIO SURVIVORS; RETURN; DISABILITY; HEALTH; WALKING	Introduction: Remunerative employment is a major concern of individuals with chronic disabilities, among them, those with longstanding poliomyelitis (LSP). Although LSP is not rare there are almost no data related to work participation. Purpose: The aims of the current study were to determine the effects of a number of social and functional variables as barriers or facilitators to work participation in persons with LSP. Patients and methods: Charts of 123 LSP patients of working age that were seen in the post-polio outpatient clinic, between the years 2000 and 2005 were reviewed for the study. Data on age, gender, family status, level of function in activities of daily living, basic, and extended (B-ADL and E-ADL), and mobility were then analyzed for correlation to the vocational status. Results: Seventy-two people (58.5%) were employed at the time of the survey. Gender and marital status were not found to significantly differ as regard to employment. Using assistive devices for mobility or being dependent for basic ADL were associated with lower levels of employment. Driving was positively associated with the employment status of the LSP individuals. Conclusion: Persons with LSP encounter important barriers to work participation, particularly on the International Classification of Functioning, Disability, and Health (ICF) components of activity and environment.	[Dudkiewicz, Israel] Tel Aviv Sourasky Med Ctr, Dept Rehabil, IL-64239 Tel Aviv, Israel; [Zeilig, Gabi; Weingarden, Harold; Shemesh, Yeheskel; Zeweker, Manual] Chaim Sheba Med Ctr, Dept Neurol Rehabil, IL-52621 Tel Hashomer, Israel; [Zeilig, Gabi; Weingarden, Harold; Shemesh, Yeheskel; Heim, Michael; Zeweker, Manual; Dudkiewicz, Israel] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Herman, Amir] Chaim Sheba Med Ctr, Dept Orthoped Surg, IL-52621 Tel Hashomer, Israel; [Herman, Amir] Univ Haifa, Dept Stat, IL-31999 Haifa, Israel; [Heim, Michael] Chaim Sheba Med Ctr, Dept Orthoped Rehabil, IL-52621 Tel Hashomer, Israel		Dudkiewicz, I (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Rehabil, IL-64239 Tel Aviv, Israel.	Israel.dudkiewicz@gmail.com	Herman, Amir/AAD-3632-2022				Anderson CJ, 2003, SPINAL CORD, V41, P684, DOI 10.1038/sj.sc.3101533; Brehm MA, 2007, J REHABIL MED, V39, P651, DOI 10.2340/16501977-0110; Burger H, 2007, DISABIL REHABIL, V29, P1323, DOI 10.1080/09638280701320797; Elrod Lisa M, 2005, Work, V25, P155; Farbu E, 1997, ACTA NEUROL SCAND, V96, P353; Farbu E, 2001, J NEUROL, V248, P500, DOI 10.1007/s004150170160; Farbu E, 2010, THER CLIN RISK MANAG, V6, P307; Genet F., 2010, Annals of Physical and Rehabilitation Medicine, V53, P51, DOI 10.1016/j.rehab.2009.11.005; Gonzalez H, 2010, LANCET NEUROL, V9, P634, DOI 10.1016/S1474-4422(10)70095-8; GRIMBY G, 1994, PHYS THER, V74, P415, DOI 10.1093/ptj/74.5.415; Hachisuka K, 2007, J REHABIL MED, V39, P646, DOI 10.2340/16501977-0105; Halbritter T, 2001, J Am Acad Nurse Pract, V13, P555; Halstead LS, 2011, ARCH PHYS MED REHAB, V92, P1344, DOI 10.1016/j.apmr.2011.03.002; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Jacob T, 2010, J REHABIL MED, V42, P377, DOI 10.2340/16501977-0515; Jang Y, 2005, ARCH PHYS MED REHAB, V86, P681, DOI 10.1016/j.apmr.2004.10.025; Johnson KL, 2010, PHYS MED REH CLIN N, V21, P267, DOI 10.1016/j.pmr.2009.12.004; Karmarkar A, 2008, ARCH PHYS MED REHAB, V89, P1191, DOI 10.1016/j.apmr.2007.10.029; Kelley C, 2007, J PROSTHET ORTHOT, V19, P109; Krause JS, 2006, ARCH PHYS MED REHAB, V87, P1318, DOI 10.1016/j.apmr.2006.07.254; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LaBan MM, 2010, ARCH PHYS MED REHAB, V91, P966, DOI 10.1016/j.apmr.2010.03.019; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Marini I, 2008, J VOCAT REHABIL, V28, P1; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P995, DOI 10.1016/S0003-9993(96)90058-1; R Development Core Team, 2008, R LANG ENV STAT COMP; Rekand T, 2003, J EPIDEMIOL COMMUN H, V57, P368, DOI 10.1136/jech.57.5.368; ROBERTSON T, 1981, ANN STAT, V9, P1248, DOI 10.1214/aos/1176345641; Stanghelle JK, 1997, SPINAL CORD, V35, P503, DOI 10.1038/sj.sc.3100425; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Sweetland J, 2007, MULT SCLER J, V13, P1183, DOI 10.1177/1352458507078414; Tomassen PCD, 2000, SPINAL CORD, V38, P51, DOI 10.1038/sj.sc.3100948; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wekre LL, 1998, SPINAL CORD, V36, P280, DOI 10.1038/sj.sc.3100557; Yasuda S, 2002, NEUROREHABILITATION, V17, P177	36	14	14	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JAN	2012	35	1					22	27		10.1179/2045772311Y.0000000048			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	879PX	WOS:000299345200004	22330187	Green Published			2022-02-06	
J	Kimbler, DE; Murphy, M; Dhandapani, KM				Kimbler, Donald E.; Murphy, Marguerite; Dhandapani, Krishnan M.			Concussion and the Adolescent Athlete	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; NCAA CONCUSSION; MANAGEMENT; RECOVERY	Traumatic brain injury (TBI) is a complex and debilitating neurological injury that places a significant financial and emotional burden on both families and medical providers. Accumulating evidence suggests that mild TBI or concussion remains grossly underdiagnosed, as compared with more severe TBI, due to a poor understanding of the clinical signs and symptoms involved with a head injury. Notably, pediatric head injury may be associated with the subsequent development of serious, long-term neurological consequences, emphasizing the need for improved diagnosis and acute medical intervention. The purpose of this minireview is to summarize the association between participation in youth athletics and the occurrence of concussions, a primary source of mild TBI in the adolescent population, with the goal of increasing awareness within the nursing profession for this clinically important yet underdiagnosed form of brain injury.	[Kimbler, Donald E.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Murphy, Marguerite] Georgia Hlth Sci Univ, Sch Nursing, Augusta, GA USA		Kimbler, DE (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA.	dkimbler@georgiahealth.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS065172]; Uniformed Services University of the Health Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065172] Funding Source: NIH RePORTER	This project is sponsored, in part, by grants from the National Institutes of Health (R01NS065172) and from the TriService Nursing Research Program, Uniformed Services University of the Health Sciences. The information, content, and conclusions do not necessarily represent the official position or policy of, nor should any official endorsement be inferred by the TriService Nursing Research Program, the Uniformed Services University of the Health Sciences, the Department of Defense, or the U. S. Government.	BINDER S, 2005, REHABILITATION, V20, pY195; BRADSHAW BD, 2008, REPORT SURGEON GEN T; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; KUSINSKI P, 2011, MED EXAMINER; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Management of Concussion/mTBI Working Group, 2009, J REHABILITATION RES, V46; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Schwarz A, 2010, NY TIMES; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; STREETER J, 2011, INNOVATING DIAGNOSTI; Tanielian T., 2008, INVISIBLE WOUNDS WAR; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR, P1; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599; 2011, NEUROLOGY, V48	32	14	14	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2011	43	6					286	290		10.1097/JNN.0b013e31823858a6			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	850PL	WOS:000297207700002	22045196	Green Accepted			2022-02-06	
J	Willis, PF; Farrer, TJ; Bigler, ED				Willis, Pamelia F.; Farrer, Thomas J.; Bigler, Erin D.			Are Effort Measures Sensitive to Cognitive Impairment?	MILITARY MEDICINE			English	Article							WORD MEMORY TEST; TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; CARD SORTING TEST; NEUROPSYCHOLOGICAL ASSESSMENT; AMERICAN-ACADEMY; TEST-PERFORMANCE; RETENTION TRIAL; SCORES; DAMAGE	The basic premise of symptom validity tests (SVTs) is that appropriate effort can be assessed because the designs of SVT measures are thought to be insensitive to all but the most extreme forms of impairment of memory. In patients with mild traumatic brain injury in particular, it is thought that failure on effort measures consistently reflects poor effort or even conscious exaggeration of symptoms. This study examines the issue of SVT failure as a reflection of cognitive impairment and/or neuropsychiatric impairment by presenting cases of three patients who were given full neuropsychological batteries but in each case failed the Word Memory Test (WMT), a verbal recognition SVT measure. One patient who failed the WMT was probably in the early stages of dementia. The WMT fit the "Genuine Memory Impaired Profile". Two mild traumatic brain injury patients failed the WMT but their patterns of performance suggested that cognitive deficits influenced WMT performance. In determining the validity of neuropsychological test data in the individual case, it is recommended that the examiner consider whether cognitive impairment could affect performance on effort measures and the recommended cut score. Also, it is recommended that examiners use multiple indicators of effort.	[Willis, Pamelia F.] Brooke Army Med Ctr, Dept Behav Med, ATTN MCHE BM, Ft Sam Houston, TX 78234 USA; [Farrer, Thomas J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA		Willis, PF (corresponding author), Brooke Army Med Ctr, Dept Behav Med, ATTN MCHE BM, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.			Farrer, Thomas J./0000-0001-8092-6214			Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Booksh RL, 2007, ARCH CLIN NEUROPSYCH, V22, P87, DOI 10.1016/j.acn.2006.11.002; Conners C.K., 2004, CONNERS CONTINUOUS P; DEFILIPUS N, 2005, CATEGORY TEST COMPUT; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; Dwyer CA, 1996, PSYCHOL ASSESSMENT, V8, P360, DOI 10.1037/1040-3590.8.4.360; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; GREEN P, 2003, MANUAL WORLD MEMORY; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; HEATON RK, 2005, WISCONSIN CARD SORTI; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wolfson, 1993, HALSTEAD REITAN NEUR	31	14	14	0	11	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	DEC	2011	176	12					1426	1431		10.7205/MILMED-D-11-00168			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861OK	WOS:000298028900014	22338360	Bronze			2022-02-06	
J	Carlstrom, LP; Hines, JH; Henle, SJ; Henley, JR				Carlstrom, Lucas P.; Hines, Jacob H.; Henle, Steven J.; Henley, John R.			Bidirectional remodeling of beta 1-integrin adhesions during chemotropic regulation of nerve growth	BMC BIOLOGY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCANS; XENOPUS SPINAL NEURONS; NEURITE OUTGROWTH; FOCAL ADHESION; AXONAL REGENERATION; INTEGRIN ACTIVATION; CELL-ADHESION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION	Background: Chemotropic factors in the extracellular microenvironment guide nerve growth by acting on the growth cone located at the tip of extending axons. Growth cone extension requires the coordination of cytoskeleton-dependent membrane protrusion and dynamic adhesion to the extracellular matrix, yet how chemotropic factors regulate these events remains an outstanding question. We demonstrated previously that the inhibitory factor myelin-associated glycoprotein (MAG) triggers endocytic removal of the adhesion receptor beta 1-integrin from the growth cone surface membrane to negatively remodel substrate adhesions during chemorepulsion. Here, we tested how a neurotrophin might affect integrin adhesions. Results: We report that brain-derived neurotropic factor (BDNF) positively regulates the formation of substrate adhesions in axonal growth cones during stimulated outgrowth and prevents removal of beta 1-integrin adhesions by MAG. Treatment of Xenopus spinal neurons with BDNF rapidly triggered beta 1-integrin clustering and induced the dynamic formation of nascent vinculin-containing adhesion complexes in the growth cone periphery. Both the formation of nascent beta 1-integrin adhesions and the stimulation of axon extension by BDNF required cytoplasmic calcium ion signaling and integrin activation at the cell surface. Exposure to MAG decreased the number of beta 1-integrin adhesions in the growth cone during inhibition of axon extension. In contrast, the BDNF-induced adhesions were resistant to negative remodeling by MAG, correlating with the ability of BDNF pretreatment to counteract MAG-inhibition of axon extension. Pre-exposure to MAG prevented the BDNF-induced formation of beta 1-integrin adhesions and blocked the stimulation of axon extension by BDNF. Conclusions: Altogether, these findings demonstrate the neurotrophin-dependent formation of integrin-based adhesions in the growth cone and reveal how a positive regulator of substrate adhesions can block the negative remodeling and growth inhibitory effects of MAG. Such bidirectional remodeling may allow the growth cone to rapidly adjust adhesiveness to the extracellular matrix as a general mechanism for governing axon extension. Techniques for manipulating integrin internalization and activation state may be important for overcoming local inhibitory factors after traumatic injury or neurodegenerative disease to enhance regenerative nerve growth.	[Hines, Jacob H.; Henle, Steven J.; Henley, John R.] Mayo Clin, Dept Neurol Surg, Coll Med, Rochester, MN 55905 USA; [Carlstrom, Lucas P.] Mayo Clin, Med Scientist Training Program, Mayo Grad Sch, Coll Med, Rochester, MN 55905 USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN 55905 USA; [Hines, Jacob H.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA		Henley, JR (corresponding author), Mayo Clin, Dept Neurol Surg, Coll Med, Rochester, MN 55905 USA.	Henley.John@mayo.edu		Henley, John/0000-0003-1846-5941; Henle, Steven/0000-0002-8007-1030; Hines, Jacob/0000-0003-1557-3795	Mayo Clinic; Craig Neilsen Foundation; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Robert D. and Patricia E. Kern Predoctoral Fellowship; Langan MD/PhD Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067311] Funding Source: NIH RePORTER	We thank David Marks and the late Dick Pagano (Mayo Clinic) for insightful discussions and for the lipid probes; Jim Tarara, Zheyan Chen and Jarred Nesbitt for technical assistance; and members of the Henley lab for critical comments. We would also like to thank Ken Yamada (US National Institutes of Health) and Doug DeSimone (University of Virginia) for their generous gifts of antibodies to beta 1-integrin and alpha 5-integrin, respectively. This work was supported by a John M. Nasseff, Sr. Career Development Award in Neurologic Surgery Research from the Mayo Clinic (JRH), career development funds from the Craig Neilsen Foundation (JRH), and the US National Institutes of Health (JRH). A Robert D. and Patricia E. Kern Predoctoral Fellowship award supported JHH. A Langan MD/PhD Predoctoral Fellowship award supported LPC.	Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Blackmore M, 2006, J NEUROBIOL, V66, P1564, DOI 10.1002/neu.20311; BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DUBAND JL, 1991, J CELL SCI, V98, P517; Eastwood SL, 2003, MOL PSYCHIATR, V8, P148, DOI 10.1038/sj.mp.4001233; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Frame M, 2008, NAT CELL BIOL, V10, P1017, DOI 10.1038/ncb0908-1017; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gomez TM, 2003, METHOD CELL BIOL, V71, P129, DOI 10.1016/S0091-679X(03)01008-2; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Grabham PW, 1997, J NEUROSCI, V17, P5455; Grabham PW, 2000, J CELL SCI, V113, P3003; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; HINKLE PM, 1987, J BIOL CHEM, V262, P16333; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Isenberg G, 1998, INT REV CYTOL, V178, P73; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LINDSAY RM, 1985, J CELL SCI, P115; Liu Y, 1999, J NEUROSCI, V19, P4370; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 1997, J NEUROSCI, V17, P7860; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Niederost B, 2002, J NEUROSCI, V22, P10368; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Ramon y Cajal, 1928, DEGENERATION REGENER; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Santiago-Medina M., 2011, DEV NEUROBIOL; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Sydor AM, 1996, J CELL BIOL, V134, P1197, DOI 10.1083/jcb.134.5.1197; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Urbaniak G, 2013, RES RANDOMIZER; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Woo S, 2009, J NEUROSCI, V29, P13981, DOI 10.1523/JNEUROSCI.4028-09.2009; ZHENG MZ, 1993, J BIOL CHEM, V268, P2217; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	84	14	14	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7007			BMC BIOL	BMC Biol.	NOV 30	2011	9								82	10.1186/1741-7007-9-82			15	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	895QY	WOS:000300512600001	22126462	Green Published, gold			2022-02-06	
J	Jiang, L; Yin, XH; Yin, C; Zhou, SA; Dan, W; Sun, XC				Jiang, Li; Yin, Xiaohong; Yin, Cheng; Zhou, Shuai; Dan, Wei; Sun, Xiaochuan			Different quantitative EEG alterations induced by TBI among patients with different APOE genotypes	NEUROSCIENCE LETTERS			English	Article						TBI; QEEG; APOE polymorphism; Brain electrical activity	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; EARLY-STAGE; ASSOCIATION; PROMOTER	Although several studies have revealed the EEG alterations in AD and TBI patients, the influence of APOE (apolipoprotein E) genotype in EEG at the early stage of TBI has not been reported yet. We have previously studied EEG alterations caused by TBI among different APOE genotype carriers. In this study, we firstly investigated the relationship between APOE polymorphisms and quantitative EEG (QEEG) changes after TBI. A total of 118 consecutive TBI patients with a Glasgow Coma Scale (GCS) of 9 or higher were recruited, and 40 normal adults were also included as a control group. APOE genotype was determined by PCR-RFLP for each subject, and QEEG recordings were performed in rest, relaxed, awake and with eyes closed in normal subjects and TBI patients during 1-3 days after TBI. In the normal control group, both APOE epsilon 4 carriers and non-carriers had normal EEG, and no significant difference of QEEG data was found between APOE epsilon 4 carriers and non-carriers. But in the TBI group, APOE epsilon 4 carriers had more focal or global irregular slow wave activities than APOE epsilon 4 non-carriers. APOE gene did not influence brain electrical activity under normal conditions, but TBI can induce different alterations among different APOE gene carriers, and APOE epsilon 4 allele enhances the EEG abnormalities at the early stage of TBI. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Jiang, Li; Yin, Cheng; Zhou, Shuai; Dan, Wei; Sun, Xiaochuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Yin, Xiaohong] N Sichuan Med Coll, Affiliated Hosp, Dept Neurosurg, Chengtu, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1st Youyi Rd, Chongqing 400016, Peoples R China.	sunxch1445@gmail.com		Jiang, Li/0000-0002-2407-3672; sun, xiao chuan/0000-0001-6992-332X	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973087]	The study was supported by National Science Foundation of China (approval number: 30973087).	Babiloni C, 2006, ANN NEUROL, V59, P323, DOI 10.1002/ana.20724; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; COURJON J, 1972, TRAUMATIC DISORDERS, V14, P1; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Jelic V, 1997, J NEUROL NEUROSUR PS, V63, P59, DOI 10.1136/jnnp.63.1.59; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Lehtovirta M, 1996, NEUROBIOL AGING, V17, P523; Lin B, 2011, ACTA NEUROCHIR SUPPL, V110, P39, DOI 10.1007/978-3-7091-0353-1_7; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; PONOMAREVA NV, 2008, NEUROBIOLOGY, V81, P9; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HT, 2010, BRAIN RES, V1362, P112, DOI 10.1016/j.brainres.2010.09.013	17	14	19	1	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 14	2011	505	2					160	164		10.1016/j.neulet.2011.10.011			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	856CO	WOS:000297614600021	22015765				2022-02-06	
J	Gross, T; Amsler, F				Gross, Thomas; Amsler, Felix			Prevalence and incidence of longer term pain in survivors of polytrauma	SURGERY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; MULTIPLE INJURIES; HEALTH-STATUS; MAJOR TRAUMA; RECOMMENDATIONS; DISABILITY; DETERMINANTS; POPULATION; INSTRUMENT	Background. Little is known about the longer term status of pain or the factors associated with pain-related outcome in patients after polytrauma. The current study evaluated the prevalence and severity of pain at least 2 years after injury compared with preinjury status using several pain scores in a Swiss cohort of survivors of blunt poly trauma. Methods. Pearson correlation testing was used for the comparison of different measures of pain. Uni and multivariate analyses of patient, trauma, and treatment characteristics, as well as parameters. of self-reported, health-related quality of life and functional outcome, were undertaken to determine associations with pain after polytrauma. Results. Depending on the measure used, 46% to 85% of polytrauma survivors indicated the presence of pain. at longer term follow-up. Both the prevalence and the severity of pain were increased compared with the preinjury status (P < .001) and varied importantly depending on scoring. The Trauma Outcome Profile was the most sensitive pain measure and showed the greatest correlation with objective, longer term outcomes (R = .5). Pain measured by the SF-36 was found to have the best internal criterion validity among the scores investigated (R = .6-.8). Patients' longer term pain status had greater associations with health-related quality-of-life scores (R = .6-.8) than with capacity to work or income (R = .4-.5). Conclusion. Our study shows a high rate of longer term pain in survivors of polytrauma and important differences in the type and sensitivity of the standard pain measures investigated. Given the potential impact of these findings, international guidelines for the assessment of pain in polytraumatized patients are needed. (Surgery 2011;150:985-95.)	[Gross, Thomas; Amsler, Felix] Univ Basel Hosp, Dept Comp Assisted Radiol & Suigely Switzerland C, CH-4031 Basel, Switzerland; [Amsler, Felix] Amsler Consulting, Basel, Switzerland		Gross, T (corresponding author), Kantonsspital Aarau, Dept Traumatol, Tellstr, CH-5003 Aarau, Switzerland.	Thomas.Gross@ksa.ch		Amsler, Felix/0000-0003-4259-7004	Scientific Foundation of the Swiss Accident Insurance Fund (SUVA); Voluntary Academic Society (FAG) Basel; Swiss Intervention; Swiss National Information Center For Accident Prevention (BFU)	Supported by the Scientific Foundation of the Swiss Accident Insurance Fund (SUVA), the Voluntary Academic Society (FAG) Basel, Swiss Intervention, and the Swiss National Information Center For Accident Prevention (BFU).	Attenberger C, 2011, INJURY; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouamra O, 2006, J TRAUMA, V38, P185; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Bouillon B, 1998, LANGENBECK ARCH SURG, V383, P228, DOI 10.1007/s004230050123; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Carstensen TBW, 2008, PAIN, V139, P248, DOI 10.1016/j.pain.2008.04.008; Casey CY, 2008, PAIN, V134, P69, DOI 10.1016/j.pain.2007.03.032; Castillo RC, 2006, PAIN, V124, P321, DOI 10.1016/j.pain.2006.04.020; Chien LC, 2007, J TRAUMA, V62, P928, DOI 10.1097/01.ta.0000215411.92950.72; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Committee on Trauma American College of Surgeons, 1997, ADV TRAUM LIF SUPP P; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Eastman AB, 2008, ARCH SURG-CHICAGO, V143, P288, DOI 10.1001/archsurg.2007.63; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Engelberg R, 1996, J ORTHOPAED RES, V14, P182, DOI 10.1002/jor.1100140204; FALCONE RE, 1993, WORLD J SURG, V17, P575, DOI 10.1007/BF01659111; Fuglistaler-Montali I, 2009, WORLD J SURG, V33, P2477, DOI 10.1007/s00268-009-0193-1; Gennarelli T, 1990, ASS ADVANCEMENT AUTO; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gross T, 2010, J AM COLL SURGEONS, V211, P81, DOI 10.1016/j.jamcollsurg.2010.02.042; Harris I, 2008, J TRAUMA, V64, P696; HETHERINGTON H, 1995, INJURY, V26, P97, DOI 10.1016/0020-1383(95)92185-D; Hinrichs-Rocker A, 2009, EUR J PAIN, V13, P719, DOI 10.1016/j.ejpain.2008.07.015; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; JENNETT B, 1975, LANCET, V1, P480; Kappesser J, 2010, PAIN, V148, P184, DOI 10.1016/j.pain.2009.10.007; Konig HH, 2005, GESUNDHEITSWESEN, V67, P173, DOI 10.1055/s-2005-857991; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Martin DP, 1996, J ORTHOP RES, V14, P173, DOI 10.1002/jor.1100140203; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Neugebauer E, 2006, EUR J TRAUMA, V32, P44, DOI 10.1007/s00068-006-0150-8; Nijboer JMM, 2007, J TRAUMA, V63, P670, DOI 10.1097/01.ta.0000228890.65522.53; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rivara FP, 2008, ARCH SURG-CHICAGO, V143, P282, DOI 10.1001/archsurg.2007.61; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; SALOVEY P, 1993, APS J, V2, P184, DOI 10.1016/S1058-9139(05)80087-7; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; SMITH WB, 1993, PAIN, V55, P355, DOI 10.1016/0304-3959(93)90011-D; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Spertus IL, 1999, PAIN, V82, P97, DOI 10.1016/S0304-3959(99)00040-8; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Szende A, 2004, EUROQOL GROUPS INT T; TEASDALE G, 1974, LANCET, V2, P81; THIAGARAJAN J, 1994, ANAESTHESIA, V49, P211; Turchin DC, 1999, J ORTHOP TRAUMA, V13, P1, DOI 10.1097/00005131-199901000-00001; Ulvik A, 2008, ACTA ANAESTH SCAND, V52, P195, DOI 10.1111/j.1399-6576.2007.01533.x; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Vranceanu AM, 2009, J BONE JOINT SURG AM, V91A, P2014, DOI 10.2106/JBJS.H.01512; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	59	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2011	150	5					985	995		10.1016/j.surg.2011.04.003			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	845NC	WOS:000296828600014	21676423				2022-02-06	
J	Kwaan, HC				Kwaan, Hau C.			Microvascular Thrombosis: A Serious and Deadly Pathologic Process in Multiple Diseases	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						Thrombosis; disseminated intravascular coagulation; inflammation; hypercoagulable state; sepsis	TRAUMATIC BRAIN-INJURY; SICKLE-CELL-DISEASE; HEMOLYTIC-UREMIC SYNDROME; DISSEMINATED INTRAVASCULAR COAGULATION; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-C; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; ANEURYSMAL SUBARACHNOID HEMORRHAGE; POSTVARICELLA-PURPURA-FULMINANS; TISSUE FACTOR EXPRESSION	Much of our understanding of the pathogenesis of thrombosis has long been based on observations made on large blood vessels. Nevertheless, there has been a recent shift in our attention to the microvasculature and to how microcirculatory occlusion affects function of various organs in diseases. This article provides an overview of microthrombosis in small blood vessels, with discussion of the progressive stages of its development. The initial event is triggered by a variety of diseases, followed by a second phase when multiple contributory factors amplify the process with the final phase of microvascular occlusion and microvascular thrombosis. The outcome is either recovery or injury to the affected organ. If the process is generalized, it is often associated with catastrophic or fatal outcomes. Our current knowledge of the major role of contributory factors leads to a new paradigm. A therapeutic approach limited to a single target of the underlying pathogenic factor, such as the use of anticoagulants, is insufficient and too often unsuccessful. Simultaneous management of all the contributory factors should therefore be considered.	Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA		Kwaan, HC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 710 Fairbanks Court,Room 8258, Chicago, IL 60611 USA.	h-kwaan@northwestern.edu					Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Asherson RA, 1998, MEDICINE, V77, P195, DOI 10.1097/00005792-199805000-00005; Asherson RA, 2001, MEDICINE, V80, P355, DOI 10.1097/00005792-200111000-00002; Ashjian P, 2007, ANN PLAS SURG, V59, P36, DOI 10.1097/01.sap.0000264837.15110.2f; ASTEDT B, 1974, EXPERIENTIA, V30, P1466; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Azizzadeh Babak, 2003, Arch Facial Plast Surg, V5, P31; Bajzar L, 2004, CRIT CARE MED, V32, pS320, DOI 10.1097/01.CCM.0000126361.00450.B1; Barie Philip S, 2007, Surg Infect (Larchmt), V8, P491, DOI 10.1089/sur.2007.9980; Barie Philip S, 2008, Curr Infect Dis Rep, V10, P368, DOI 10.1007/s11908-008-0060-5; Baronzio G, 2003, SEMIN THROMB HEMOST, V29, P489; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Beek AM, 2010, INT J CARDIOVAS IMAG, V26, P49, DOI 10.1007/s10554-009-9499-1; Bekkers SCAM, 2010, J AM COLL CARDIOL, V55, P1649, DOI 10.1016/j.jacc.2009.12.037; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1993, THROMB HAEMOSTASIS, V70, P152; Bhavsar J, 2010, CLIN HEMORHEOL MICRO, V44, P193, DOI 10.3233/CH-2010-1274; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Blum W, 2007, SEMIN THROMB HEMOST, V33, P350, DOI 10.1055/s-2007-976170; Brands MT, 2010, INT J ORAL MAX SURG, V39, P101, DOI 10.1016/j.ijom.2009.11.020; BRANDTZAEG P, 1989, THROMB RES, V55, P459, DOI 10.1016/0049-3848(89)90054-6; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Bucciarelli S, 2009, CLIN REV ALLERG IMMU, V36, P80, DOI 10.1007/s12016-008-8107-9; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Busuttil DP, 2000, BRIT J HAEMATOL, V110, P1012, DOI 10.1046/j.1365-2141.2000.02270-9.x; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Cervera R, 2009, ANN RHEUM DIS, V68, P1428, DOI 10.1136/ard.2008.093179; Cervera R, 2006, PATHOPHYSIOL HAEMO T, V35, P181, DOI 10.1159/000093565; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Chinen K, 2010, PATHOL RES PRACT, V206, P682, DOI 10.1016/j.prp.2010.05.002; Chwajol M, 2008, NEUROCRIT CARE, V8, P418, DOI 10.1007/s12028-008-9088-5; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Costa Vania, 2007, BMC Anesthesiol, V7, P5, DOI 10.1186/1471-2253-7-5; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; CREUTZIG U, 1987, CANCER-AM CANCER SOC, V60, P3071, DOI 10.1002/1097-0142(19871215)60:12<3071::AID-CNCR2820601235>3.0.CO;2-Y; CROMPTON MR, 1964, BRAIN, V87, P491, DOI 10.1093/brain/87.3.491; CUTTNER J, 1980, AM J MED, V69, P555, DOI 10.1016/0002-9343(80)90467-2; DAHLBACK B, 1995, THROMB HAEMOSTASIS, V74, P139; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Dhainaut JF, 2001, CRIT CARE MED, V29, pS42, DOI 10.1097/00003246-200107001-00016; DIETRICH WD, 1994, ANN NY ACAD SCI, V723, P15, DOI 10.1111/j.1749-6632.1994.tb36713.x; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dragon-Durey MA, 2010, J AM SOC NEPHROL, V21, P2180, DOI 10.1681/ASN.2010030315; Dropcho EJ, 2010, NEUROL CLIN, V28, P217, DOI 10.1016/j.ncl.2009.09.008; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Elliott MA, 2010, EUR J HAEMATOL, V85, P43, DOI 10.1111/j.1600-0609.2010.01448.x; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Esmon CT, 1999, HAEMATOLOGICA, V84, P254; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Espinosa G, 2010, NAT REV RHEUMATOL, V6, P296, DOI 10.1038/nrrheum.2010.47; Fluri S, 2010, PEDIATR EMERG CARE, V26, P932, DOI 10.1097/PEC.0b013e3181fe91cd; FRANCIS RB, 1991, BLOOD COAGUL FIBRIN, V2, P341, DOI 10.1097/00001721-199104000-00018; FRANCIS RB, 1990, SEMIN THROMB HEMOST, V16, P310, DOI 10.1055/s-2007-1002684; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Galindo M, 2009, RHEUMATOLOGY, V48, P1003, DOI 10.1093/rheumatology/kep152; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Garcia F, 1999, J INFECT DIS, V179, P475, DOI 10.1086/314598; Giller CA, 1998, NEUROSURGERY, V42, P490, DOI 10.1097/00006123-199803000-00010; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2007, HAEMATOLOGICA, V93, P1, DOI 10.3324/haematol.12318; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Gordeuk VR, 2009, BLOOD, V114, P4639, DOI 10.1182/blood-2009-04-218040; Gordon LI, 1997, SEMIN HEMATOL, V34, P140; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Hallahan D, 1995, BIOCHEM BIOPH RES CO, V217, P784, DOI 10.1006/bbrc.1995.2841; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; ISHII H, 1986, BLOOD, V67, P362; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jahroudi N, 1996, BLOOD, V88, P3801, DOI 10.1182/blood.V88.10.3801.bloodjournal88103801; Josephson C, 2001, PEDIATR RES, V50, P345, DOI 10.1203/00006450-200109000-00009; Karpman D, 2010, SEMIN THROMB HEMOST, V36, P575, DOI 10.1055/s-0030-1262879; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Kelton JG, 2008, BLOOD, V112, P2607, DOI 10.1182/blood-2008-02-078014; Key NS, 2010, SEMIN THROMB HEMOST, V36, P805, DOI 10.1055/s-0030-1267033; Key NS, 1998, BLOOD, V91, P4216, DOI 10.1182/blood.V91.11.4216.411k15_4216_4223; KHOURI RK, 1992, CLIN PLAST SURG, V19, P757; KIEHL R, 1987, THROMB RES, V45, P191, DOI 10.1016/0049-3848(87)90173-3; Klintman D, 2004, CLIN DIAGN LAB IMMUN, V11, P56, DOI 10.1128/CDLI.11.1.56-62.2004; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Kojima M, 1983, Bibl Haematol, P95; KURANTSINMILLS J, 1992, BRIT J HAEMATOL, V81, P539, DOI 10.1111/j.1365-2141.1992.tb02989.x; KURANTSINMILLS J, 1994, BRIT J HAEMATOL, V87, P580, DOI 10.1111/j.1365-2141.1994.tb08316.x; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kwaan HC, 2010, SEMIN THROMB HEMOST, V36, P917, DOI 10.1055/s-0030-1267045; Kwaan HC, 2010, SEMIN THROMB HEMOST, V36, P286, DOI 10.1055/s-0030-1253451; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P23; Kwaan HC, 2005, SEMIN THROMB HEMOST, V31, P615, DOI 10.1055/s-2005-925467; Kwaan HC, 2005, SEMIN THROMB HEMOST, V31, P673, DOI 10.1055/s-2005-925473; Kwaan HC, 2003, SEMIN THROMB HEMOST, V29, P451; KWAAN HC, 1987, SEMIN HEMATOL, V24, P141; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P199, DOI 10.1055/s-2007-994921; Kwaan HC, 2001, ACTA HAEMATOL-BASEL, V106, P52, DOI 10.1159/000046589; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Laurence J, 1997, SEMIN HEMATOL, V34, P98; Le Quintrec M, 2010, SEMIN THROMB HEMOST, V36, P641, DOI 10.1055/s-0030-1262886; Lecoq JP, 2006, ACTA CHIR BELG, V106, P158; Lee CC, 2001, ANN EMERG MED, V38, P170, DOI 10.1067/mem.2001.114313; Leitner JM, 2006, CLIN PHARMACOL THER, V79, P23, DOI 10.1016/j.clpt.2005.10.003; Leung LLK, 2008, ADV EXP MED BIOL, V632, P61, DOI 10.1007/978-0-387-78952-1_5; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2010, HAMOSTASEOLOGIE, V30, P10; Levi M, 2007, AM J RESP CRIT CARE, V176, P483, DOI 10.1164/rccm.200612-1803OC; Levi M, 2010, SEMIN THROMB HEMOST, V36, P550, DOI 10.1055/s-0030-1255449; Levi M, 2010, SEMIN THROMB HEMOST, V36, P367, DOI 10.1055/s-0030-1254046; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P378, DOI 10.1055/s-0030-1254047; Lippi G, 2009, SEMIN THROMB HEMOST, V35, P597, DOI 10.1055/s-0029-1242713; Lippi G, 2008, SEMIN THROMB HEMOST, V34, P747, DOI 10.1055/s-0029-1145257; LOUISE CB, 1994, MICROVASC RES, V47, P377, DOI 10.1006/mvre.1994.1030; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Lyons A, 2008, BRIT J ORAL MAX SURG, V46, P653, DOI 10.1016/j.bjoms.2008.04.006; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Madrid C, 2010, ORAL ONCOL, V46, P471, DOI 10.1016/j.oraloncology.2010.03.017; Maeda T, 1997, ACT NEUR S, V70, P102; MancoJohnson MJ, 1996, J PEDIATR-US, V128, P319, DOI 10.1016/S0022-3476(96)70274-3; MCEVER RP, 1991, J CELL BIOCHEM, V45, P156, DOI 10.1002/jcb.240450206; MCGEHEE WG, 1984, ANN INTERN MED, V101, P59, DOI 10.7326/0003-4819-101-1-59; Mehdi Ali A, 2011, Semin Thromb Hemost, V37, P49, DOI 10.1055/s-0030-1270071; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Milner DA, 2010, CURR OPIN INFECT DIS, V23, P456, DOI 10.1097/QCO.0b013e32833c3dbe; Mitra D, 1997, BLOOD, V89, P1224, DOI 10.1182/blood.V89.4.1224; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; MYHREJENSEN O, 1972, ACTA PATH MICRO IM A, VA 80, P403; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Newton CRJC, 1996, PEDIATR NEUROL, V15, P41, DOI 10.1016/0887-8994(96)00115-4; Nsiri B, 1996, HEMATOL CELL THER, V38, P279, DOI 10.1007/s00282-996-0279-2; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; Ott I, 2000, ARTERIOSCL THROM VAS, V20, P874, DOI 10.1161/01.ATV.20.3.874; PABINGER I, 1986, BLUT, V52, P365, DOI 10.1007/BF00320783; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Patel B, 2010, PHARMACOL THERAPEUT, V127, P131, DOI 10.1016/j.pharmthera.2010.04.014; PETERS M, 1994, THROMB HAEMOSTASIS, V71, P169; Porcu P, 1997, BRIT J HAEMATOL, V98, P433, DOI 10.1046/j.1365-2141.1997.1943011.x; Pries A. R., 2006, V176, P1; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Romano JG, 2002, NEUROSURGERY, V50, P1026, DOI 10.1097/00006123-200205000-00016; Roos Y, 2000, NEUROLOGY, V54, P77, DOI 10.1212/WNL.54.1.77; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; ROSE VL, 1986, AM J CLIN PATHOL, V86, P653, DOI 10.1093/ajcp/86.5.653; ROSE VL, 1985, AM J HEMATOL, V19, P419, DOI 10.1002/ajh.2830190413; RUBIN DB, 1991, INT J RADIAT BIOL, V60, P29, DOI 10.1080/09553009114551461; Ruch J, 2009, AM J HEMATOL, V84, P120, DOI 10.1002/ajh.21330; Sallah S, 1998, HAEMOSTASIS, V28, P25; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; SCOTT CS, 1988, BRIT J HAEMATOL, V69, P247, DOI 10.1111/j.1365-2141.1988.tb07629.x; Sharma V K, 2010, J Indian Med Assoc, V108, P529; Shih HM, 2011, AM J EMERG MED, V29, DOI 10.1016/j.ajem.2010.03.004; SHIMAMURA K, 1983, ARCH PATHOL LAB MED, V107, P543; Soriano AO, 2005, CRIT CARE MED, V33, P2540, DOI 10.1097/01.CCM.0000186414.86162.03; Starke RM, 2008, STROKE, V39, P2617, DOI 10.1161/STROKEAHA.107.506097; Stegmayr BG, 2001, THER APHER, V5, P123, DOI 10.1046/j.1526-0968.2001.005002123.x; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; Stucki A, 2001, BLOOD, V97, P2121, DOI 10.1182/blood.V97.7.2121; Tehrani M, 2008, BRAIN PATHOL, V18, P164, DOI 10.1111/j.1750-3639.2007.00108.x; ten Cate H, 1999, THROMB HAEMOSTASIS, V82, P713; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; VANDERPOLL T, 1991, J EXP MED, V174, P729, DOI 10.1084/jem.174.3.729; VAUGHAN WP, 1981, CANCER TREAT REP, V65, P1007; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; VERHEIJ M, 1995, THROMB HAEMOSTASIS, V73, P894; Virchow R, 1856, GESAMMELTE ABHANDLUN, P458; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Wang J, 2001, BRIT J HAEMATOL, V115, P382, DOI 10.1046/j.1365-2141.2001.03095.x; Ward PA, 2008, J LEUKOCYTE BIOL, V83, P467, DOI 10.1189/jlb.0607376; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Welty-Wolf KE, 2002, THROMB HAEMOSTASIS, V88, P17; Wurm G, 2004, CLIN NEUROL NEUROSUR, V106, P97, DOI 10.1016/j.clineuro.2004.01.006; Zakarija Anaadriana, 2009, V148, P115, DOI 10.1007/978-0-387-79962-9_8; Zipfel PF, 2010, CURR OPIN NEPHROL HY, V19, P372, DOI 10.1097/MNH.0b013e32833aff4a	195	14	16	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	NOV	2011	37	8					960	976		10.1055/s-0031-1297375			17	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	866TS	WOS:000298407500013	22198861				2022-02-06	
J	Xu, DW; Cui, SY; Sun, YY; Bao, GF; Li, WD; Liu, W; Zhu, XH; Fan, JB; Wang, YH; Cui, ZM				Xu, Dawei; Cui, Shengyu; Sun, Yuyu; Bao, Guofeng; Li, Weidong; Liu, Wei; Zhu, Xinhui; Fan, Jianbo; Wang, Youhua; Cui, Zhiming			Overexpression of glucose-regulated protein 94 after spinal cord injury in rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Glucose-regulated protein 94; Spinal cord injury; Apoptosis; Rat	ENDOPLASMIC-RETICULUM STRESS; NEURONAL CELL-DEATH; C-JUN; SIGNALING PATHWAY; EPITHELIAL-CELLS; TRAUMATIC BRAIN; APOPTOSIS; GRP94; ACTIVATION; INDUCTION	Glucose-regulated protein (GRP) 94 is a member of the stress protein family, which is localized in the endoplasmic reticulum (ER). Spinal cord injury (SCI) induced ER stress that results in apoptosis. However, the role of GRP94 in injury of the central nervous system remains unknown. In this study, we performed SCI in adult rats and investigated acutely the protein expression and cellular localization of GRP94 in the spinal cord. Western blot analysis revealed that GRP94 was low in normal spinal cord. It rose at 6 h after SCI, peaked at 1 day, remained for another 3 days, then declined to basal levels at 5 days after injury. lmmunohistochemistry further confirmed that GRP94 immunoactivity was expressed at low levels in gray matter and white matter in normal condition and increased after SCI. Double immunofluorescence staining showed that GRP94 was co-expressed with NeuN (neuronal marker), and GFAP (astroglial marker). In addition, caspase-12, caspase-3 and phospho-c-Jun NH2-kinase (p-JNK) levels increased at 6 h, peaked at 1 day, and then gradually reduced to normal levels for 2 weeks after SCI by western blot analysis. Co-localization of GRP94/caspase-12 and GRP94/p-JNK was detected in neurons and glial cells. Taken together, these data suggest GRP94 involvement in the injury response of the adult spinal cord of the rats. (C) 2011 Published by Elsevier B.V.	[Xu, Dawei; Cui, Shengyu; Sun, Yuyu; Bao, Guofeng; Li, Weidong; Liu, Wei; Zhu, Xinhui; Fan, Jianbo; Wang, Youhua; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China		Xu, DW (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China.	xdw_nt@163.com; david290@sohu.com			Health Department of Jiangsu Province [kf200953]; Social Development Project of Nantong [S2008042, S2009014, S2010005]	This work was supported by the Open Project of Health Department of Jiangsu Province (no. kf200953) and Social Development Project of Nantong (no. S2008042, S2009014, S2010005).	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Bando Y, 2004, APOPTOSIS, V9, P501, DOI 10.1023/B:APPT.0000031446.95532.ad; Bando Y, 2003, EUR J NEUROSCI, V18, P829, DOI 10.1046/j.1460-9568.2003.02818.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAIRHOLM D, 1970, Surgical Forum (Chicago), V21, P453; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; HALL ED, 1993, RES P ARNMD, V71, P81; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Ishiguro S, 2002, EMBO J, V21, P898, DOI 10.1093/emboj/21.5.898; JACOBS TP, 1987, STROKE, V18, P741, DOI 10.1161/01.STR.18.4.741; Katoh K, 1996, NEUROSCI LETT, V216, P9; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Li W, 2007, PEPTIDES, V28, P1252, DOI 10.1016/j.peptides.2007.03.021; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Lu Qing, 2005, Keio Journal of Medicine, V54, P184, DOI 10.2302/kjm.54.184; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Nicchitta CV, 2000, ESSAYS BIOCHEM, V36, P15, DOI 10.1042/bse0360015; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; Nishisho T, 1996, NEUROSURGERY, V39, P950, DOI 10.1097/00006123-199611000-00014; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yin KJ, 2005, NEUROBIOL DIS, V20, P881, DOI 10.1016/j.nbd.2005.05.026; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	46	14	16	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	OCT 15	2011	309	1-2					141	147		10.1016/j.jns.2011.06.024			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825SV	WOS:000295303300029	21807380				2022-02-06	
J	Engstrom, A; Soderberg, S				Engstrom, Asa; Soderberg, Siv			Transition as Experienced by Close Relatives of People With Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article							CHRONIC ILLNESS; CONSEQUENCES; ADJUSTMENT; DIGNITY	When someone is afflicted by a traumatic brain injury (TBI), it entails a sudden change in the lives of their close relatives. Relatives provide the primary support system for the person with TBI, and new living patterns have to be developed by the family to achieve balance in the new situation. There is an absence of studies focusing on the process of transition for people living close to a person with TBI, especially in a long-term relationship. The aim of this study, therefore, was to describe such transitions experienced by the close relatives of people with TBI. Five close relatives, all women, who lived with or close to a person with TBI in the northern part of Sweden, were interviewed. The data were analyzed in accordance with the qualitative interpretive method and performed in a series of steps to arrive at a description of the transition. The findings of the analysis are presented in 4 categories: the starting point of the transitions, transitions in pattern of daily life, transitions in relationship, and transitions in social life. The transitions of daily life for close relatives began suddenly as the person with TBI was injured unexpectedly. The relatives could feel lonely as former friends were gone or avoided them. How the person with TBI was met by other people strongly affected how the close relatives felt. Although they struggled to lessen the dependence of the person with TBI on them, they also felt anxious about how things would be if close relatives were no longer there for that person. The findings are discussed with reference to works by the philosophers Buber, Levinas, and Logstrup and theories of transition.	[Engstrom, Asa; Soderberg, Siv] Lulea Univ Technol, Dept Hlth Sci, Div Nursing, S-95187 Lulea, Sweden		Engstrom, A (corresponding author), Lulea Univ Technol, Dept Hlth Sci, Div Nursing, S-95187 Lulea, Sweden.	asa.engstrom@ltu.se					Bond A Elaine, 2003, Crit Care Nurse, V23, P63; BUBER M, 1957, PSYCHIATR, V20, P97; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Chick N., 1986, NURSING RES METHODOL, P237; DeMarle DJ, 2001, J LOSS TRAUMA, V6, P29, DOI 10.1080/108114401753197459; DONOGHUE PJ, 1992, SICK TIRED FEELING S; Engstrom A, 2008, THESIS LULEA U TECHN; Engstrom Asa, 2004, Intensive Crit Care Nurs, V20, P299; Fumiyo I, 2009, J NEUROSCI NURS, V41, P277, DOI 10.1097/JNN.0b013e3181b2c73c; Gallagher A, 2004, NURS ETHICS, V11, P587, DOI 10.1191/0969733004ne744oa; Hammer K, 2009, SCAND J CARING SCI, V23, P549, DOI 10.1111/j.1471-6712.2008.00635.x; Johnson L H, 1996, J Neurosci Nurs, V28, P259; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kralik D, 2002, J ADV NURS, V39, P146, DOI 10.1046/j.1365-2648.2000.02254.x; Kuyper MB, 1998, QUAL HEALTH RES, V8, P237, DOI 10.1177/104973239800800207; Kvale S., 2009, KVALITATIVA FORSKNIN; Levinas E., 1990, ETIK OANDLIGHET SAMT; Levinas E., 2003, HUMANISM OTHER; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Logstrup K.E., 1994, ETISKA KRAVET; LUSKIN BD, 2009, CHRONIC ILLNESS IMPA, P85; Meleis AI, 2000, ADV NURS SCI, V23, P12, DOI 10.1097/00012272-200009000-00006; MELEIS AI, 1994, NURS OUTLOOK, V42, P255, DOI 10.1016/0029-6554(94)90045-0; Meleis AI., 1991, THEORETICAL NURSING; Minnes P, 2000, BRAIN INJURY, V14, P737; Morse JM., 1991, QUALITATIVE NURSING; Ohman M, 2004, QUAL HEALTH RES, V14, P396, DOI 10.1177/1049732303261692; POLIT DF, 2008, NURSING RES GENER AT; Schumacher K L, 1994, Image J Nurs Sch, V26, P119; Shotton L, 1998, NURS ETHICS, V5, P246, DOI 10.1177/096973309800500308; Soderberg S, 2001, Health Care Women Int, V22, P617, DOI 10.1080/07399330127169; Soderberg S, 2003, J ADV NURS, V42, P143, DOI 10.1046/j.1365-2648.2003.02597.x; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne S., 2008, INTERPRETIVE DESCRIP; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020	38	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2011	43	5					253	260		10.1097/JNN.0b013e318227ef9b			8	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	821SR	WOS:000294995200005	21926520				2022-02-06	
J	Imaizumi, T; Miyata, K; Inamura, S; Kohama, I; Nyon, KS; Nomura, T				Imaizumi, Toshio; Miyata, Kei; Inamura, Shigeru; Kohama, Ikuhide; Nyon, Kim Sang; Nomura, Tatsufumi			The Difference in Location between Traumatic Cerebral Microbleeds and Microangiopathic Microbleeds Associated with Stroke	JOURNAL OF NEUROIMAGING			English	Article						Microbleed; diffuse axonal injury; concussion; head trauma	DIFFUSE AXONAL INJURY; AMYLOID ANGIOPATHY; INTRACEREBRAL HEMORRHAGE; HEMOSIDERIN SPOTS; BRAIN-INJURY; CORPUS-CALLOSUM; HEAD-INJURY; CT FINDINGS; MR; ECHO	BACKGROUND AND PURPOSE Microbleeds (MBs) are low-intensity spots on gradient echo T2*-weighted MRI frequently associated with cerebral microangiopathies resulting in stroke. MBs can also be caused by cerebral axonal injuries. We compared the location of MBs associated with cerebral microangiopathies with those associated with trauma. METHODS T2*-weighted MRI identified traumatic MBs (t-MBs) in 23 (6 females; 38.7 +/- 25.8 years old) of the 312 patients with head trauma consecutively admitted to our hospital between March 2003 and March 2009. We prospectively examined for the presence of microangiopathic MBs (m-MBs) in the 131 patients (59 females; 65.2 +/- 9.2 years old) admitted consecutively for stroke (May -December 2004) as controls. RESULTS We identified a total of 145 t-MBs and 504 m-MBs. t-MBs were frequently located in the mid portion of the subcortical area of the cerebrum, above the corpus callosum in axial slices, and were absent from the basal ganglia. In contrast, m-MBs were frequently located within the basal ganglia or thalamus. CONCLUSION There are substantial differences in locations of MB development in trauma patients in comparison to stroke patients.	[Imaizumi, Toshio; Miyata, Kei; Inamura, Shigeru; Kohama, Ikuhide; Nyon, Kim Sang; Nomura, Tatsufumi] Kushiro City Gen Hosp, Dept Neurosurg, Kushiro, Hokkaido 0850822, Japan		Imaizumi, T (corresponding author), Kushiro City Gen Hosp, Dept Neurosurg, 1-12 Shunkodai, Kushiro, Hokkaido 0850822, Japan.	timaizum@d9.dion.ne.jp					Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Gadda D, 2004, NEURORADIOLOGY, V46, P812, DOI 10.1007/s00234-004-1250-y; Gennarelli TA, 1993, HEAD INJURY, P137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; GODERSKY JC, 1990, ACT NEUR S, V51, P311; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Good CD, 1998, NEURORADIOLOGY, V40, P308, DOI 10.1007/s002340050590; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, P281; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 1999, NEUROLOGY, V53, P1135, DOI 10.1212/WNL.53.5.1135; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Horita Y, 2003, NEUROL SURG TOKYO, V31, P263; Imaizumi T, 2005, J NEUROIMAGING, V15, P157, DOI 10.1177/1051228404274307; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Imaizumi T, 2003, J NEUROIMAGING, V13, P155, DOI 10.1177/1051228403251250; Imaizumi Toshio, 2008, J Stroke Cerebrovasc Dis, V17, P30, DOI 10.1016/j.jstrokecerebrovasdis.2007.11.001; Kidwell CS, 2002, STROKE, V33, P95, DOI 10.1161/hs0102.101792; Kinoshita T, 2000, STROKE, V31, P1646, DOI 10.1161/01.STR.31.7.1646; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; McCarron MO, 1999, STROKE, V30, P1643, DOI 10.1161/01.STR.30.8.1643; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nighoghossian N, 2002, STROKE, V33, P735, DOI 10.1161/hs0302.104615; Roob G, 2000, STROKE, V31, P2665, DOI 10.1161/01.STR.31.11.2665; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006	35	14	14	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1051-2284			J NEUROIMAGING	J. Neuroimaging	OCT	2011	21	4					359	364		10.1111/j.1552-6569.2011.00593.x			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	834OF	WOS:000295970700011	21447027				2022-02-06	
J	Krasnokutsky, MV				Krasnokutsky, Michael V.			Cerebral Venous Thrombosis: A Potential Mimic of Primary Traumatic Brain Injury in Infants	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						abusive head injury; cerebral venous thrombosis; hemorrhage; subdural hematoma; trauma	DURAL SINUS THROMBOSIS; CLOSED-HEAD-INJURY; FULL-TERM NEONATE; INTRAVENTRICULAR HEMORRHAGE; SINOVENOUS THROMBOSIS; CHILDREN	OBJECTIVE. Hyperdense venous thrombi on unenhanced head CT may be misinterpreted as different types of extraaxial hemorrhages, and hemorrhagic venous infarctions may be interpreted as parenchymal contusion, leading to an incorrect diagnosis of trauma as the cause of the blood products. The purpose of this article is to show the various appearances of cerebral venous thrombosis (CVT) that mimic different types of hemorrhages and to show hemorrhagic venous infarctions that mimic parenchymal contusions. CONCLUSION. CVT, as an entity, must be kept in the differential diagnosis when patients present with extraaxial hyperdensities on unenhanced head CT so appropriate management can be initiated to minimize potentially devastating consequences.	Madigan Army Med Ctr, Dept Radiol, Tacoma, WA 98431 USA		Krasnokutsky, MV (corresponding author), Madigan Army Med Ctr, Dept Radiol, 9040 Fitzsimmons Dr, Tacoma, WA 98431 USA.	michael.krasnokutsky@us.army.mil					Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Berfelo FJ, 2010, STROKE, V41, P1382, DOI 10.1161/STROKEAHA.110.583542; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; GOVAERT P, 1992, PEDIATR RADIOL, V22, P123, DOI 10.1007/BF02011312; Heineking B, 2003, PEDIATR INT, V45, P93, DOI 10.1046/j.1442-200X.2003.01658.x; Heller C, 2003, CIRCULATION, V108, P1362, DOI 10.1161/01.CIR.0000087598.05977.45; JANG JY, 2010, PEDIATRICS, V126, pE693; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; Sebire G, 2005, BRAIN, V128, P477, DOI 10.1093/brain/awh412; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Tamimi A, 2005, PEDIATR NEUROSURG, V41, P237, DOI 10.1159/000087480; VOUTSINAS L, 1991, CLIN IMAG, V15, P273, DOI 10.1016/0899-7071(91)90117-E; Wu YW, 2003, ANN NEUROL, V54, P123, DOI 10.1002/ana.10619; Yuen HW, 2005, ANN ACAD MED SINGAP, V34, P639	17	14	14	0	6	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	SEP	2011	197	3					W503	W507		10.2214/AJR.10.5977			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	810YD	WOS:000294165600019	21862779				2022-02-06	
J	Petkovic, S; Maletin, M; Durendic-Brenesel, M				Petkovic, Stojan; Maletin, Miljen; Durendic-Brenesel, Maja			Complex Suicide: An Unusual Case with Six Methods Applied	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; complex suicide; screwdriver; traumatic brain injury; insecticide; hypothermia		Complex suicides (CSs) are committed by using more than one method. They account for 1.5-5% of all suicides. We present a case of CSs of a 44-year-old man, found dead in the vicinity of his car, in a deserted frozen field. Police investigation excluded homicide, and no medical data confirmed mental illnesses. Autopsy revealed wrist cuts, neck cuts, acid burns in the GI tract, multiple stab wounds to the head by a screwdriver, and several uncertain signs of hypothermia. Toxicology analysis (gas chromatography-mass spectrometry) confirmed ingestion of insecticide. We concluded that stab wounds to the head were the cause of death, while external hemorrhage and hypothermia were contributing factors. This is the first case of CSs reviewed in the literature where six suicide methods were applied. This particular case is interesting because the victim used a screwdriver as a tool for inflicting stab wounds to the head, which is a rare suicidal method.	[Petkovic, Stojan; Maletin, Miljen; Durendic-Brenesel, Maja] Clin Ctr Vojvodina, Inst Forens Med, Novi Sad 21000, Serbia		Petkovic, S (corresponding author), Clin Ctr Vojvodina, Inst Forens Med, Hajduk Veljkova 5-7, Novi Sad 21000, Serbia.	pstojan@eunet.rs			Ministry of Science and Technological Development, Republic of SerbiaMinistry of Education, Science & Technological Development, Serbia [III41012]	The Ministry of Science and Technological Development, Republic of Serbia (grant number III41012) supported this work.	Altun G, 2006, FORENSIC SCI INT, V157, P83, DOI 10.1016/j.forsciint.2005.04.039; Arevalo-Silva C, 2006, LARYNGOSCOPE, V116, P1422, DOI 10.1097/01.mlg.0000225376.83670.4d; Bohnert M, 2003, FORENSIC SCI INT, V131, P197, DOI 10.1016/S0379-0738(02)00449-8; Bohnert M, 2004, FOREN PATHOL REV, V2, P127; Bohnert Michael, 2004, Archiv fuer Kriminologie, V213, P138; Bozzeto-Ambrosi P, 2008, ARQ NEURO-PSIQUIAT, V66, P93, DOI 10.1590/S0004-282X2008000100024; Cingolani M, 2000, AM J FOREN MED PATH, V21, P255, DOI 10.1097/00000433-200009000-00015; Demirci S, 2009, AM J FOREN MED PATH, V30, P152, DOI 10.1097/PAF.0b013e318187deb7; HARRINGTON T, 2000, HEAD INJURY, P349; MADEA B, 1989, Z RECHTSMED, V102, P59; MARCINKOWSKI T, 1974, FORENSIC SCI, V3, P95, DOI 10.1016/0300-9432(74)90013-2; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Racette S, 2007, J FORENSIC SCI, V52, P449, DOI 10.1111/j.1556-4029.2007.00387.x; Smrkolj V, 1995, FORENSIC SCI INT, V76, P211, DOI 10.1016/0379-0738(95)01824-7; Toero K, 2009, FORENSIC SCI INT, V184, P6, DOI 10.1016/j.forsciint.2008.10.020; Turk EE, 2004, FORENSIC SCI INT, V139, P35, DOI 10.1016/j.forsciint.2003.09.013; Viel G, 2009, FORENSIC SCI INT, V187, pE7, DOI 10.1016/j.forsciint.2009.01.022; VILLIERS JCD, 1975, BRIT J OPHTHALMOL, V59, P52, DOI 10.1136/bjo.59.1.52	18	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2011	56	5					1368	1372		10.1111/j.1556-4029.2011.01821.x			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	816OT	WOS:000294612600048	21644993				2022-02-06	
J	Sabin, MJ; Van Boxtel, BA; Nohren, MW; Broglio, SP				Sabin, Matthew J.; Van Boxtel, Bridget A.; Nohren, Matthew W.; Broglio, Steven P.			Presence of Headache Does Not Influence Sideline Neurostatus or Balance in High School Football Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; postural control	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; POSTURAL STABILITY; NCAA CONCUSSION; PLAYERS; EPIDEMIOLOGY; COLLEGIATE; MANAGEMENT; SYMPTOMS; PERFORMANCE	Objective: Headache is the primary self-reported symptom used to indicate concussion. Thus, we examined the relationship between reports of nonconcussion-induced headache after contact sport participation and scores on common concussion assessment measures. Design: Two-group repeated measures. Setting: Secondary school. Participants: One hundred five athletes from 3 area football teams completed a baseline evaluation. Sixteen athletes reported headaches after a practice/game and were compared with 16 gender-matched, age-matched, height-matched, weight-matched, and position-matched controls. Independent Variable: Self-report headache. Main Outcome Measures: Symptom severity and endorsement reported on the Graded Symptoms Checklist (GSC), neurostatus measured using the Standard Assessment of Concussion (SAC), and postural control evaluated with the Balance Error Scoring System (BESS). Results: Total symptom severity significantly increased (P < 0.01; 8.06 +/- 2.22 to 16.06 +/- 3.82) in the headache group and significantly decreased in the nonheadache group (P = 0.01; 6.81 +/- 1.85 to 3.00 +/- 1.08). Symptom endorsement increased in the headache group (P = 0.06; 3.25 +/- 0.80 to 5.25 +/- 1.08) and significantly decreased in the nonheadache group (P = 0.01; 3.19 +/- 0.78 to 1.69 +/- 0.58). Both groups showed nonsignificant (P > 0.05) changes in SAC scores (headache, 24.75 +/- 0.73 to 24.81 +/- 0.75; nonheadache, 24.50 +/- 0.73 to 24.87 +/- 1.20). Errors of the BESS significantly increased in both the groups at postgame/postpractice evaluation (headache, P = 0.01; 14.94 +/- 1.86 to 20.31 +/- 2.23; nonheadache, P < 0.01; 13.31 +/- 1.68 to 18.13 +/- 1.69). The presence of headache was significantly correlated with symptom reports (P > 0.05) but not SAC or BESS performance. Conclusions: These findings indicate that the use of headache, exclusively or in combination with other concussion-related symptoms, does not indicate performance on common concussion tools. This supports previous works, suggesting that clinicians must adopt a multifaceted approach to concussion assessment.	[Sabin, Matthew J.] Eastern Kentucky Univ, Dept Exercise & Sport Sci, Richmond, KY 40475 USA; [Van Boxtel, Bridget A.] Steadman Clin, Vail, CO USA; [Nohren, Matthew W.] ATI Phys Therapy, Chicago, IL USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Neurotrauma Res Lab, Ann Arbor, MI 48109 USA		Sabin, MJ (corresponding author), Eastern Kentucky Univ, Dept Exercise & Sport Sci, Moberly Bldg,Room 231,521 Lancaster Ave, Richmond, KY 40475 USA.	mnmsabin@yahoo.com					Blau JN, 2004, HEADACHE, V44, P79, DOI 10.1111/j.1526-4610.2004.04014.x; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Crystal SC, 2010, CURR PAIN HEADACHE R, V14, P449, DOI 10.1007/s11916-010-0146-2; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Klenck Chris A, 2007, Curr Sports Med Rep, V6, P25, DOI 10.1007/s11932-007-0008-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Patel AV, 2007, J ATHL TRAINING, V42, P66; Ramadan Nabih M, 2004, Curr Pain Headache Rep, V8, P301, DOI 10.1007/s11916-004-0012-1; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	33	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2011	21	5					411	415		10.1097/JSM.0b013e318223f3a4			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	814VJ	WOS:000294485000005	21860349				2022-02-06	
J	Wang, ZP; Chen, HS; Wang, FX				Wang, Zhi-ping; Chen, Hong-sheng; Wang, Feng-xiang			Influence of Plasma and Cerebrospinal Fluid Levels of Endothelin-1 and No in Reducing Cerebral Vasospasm after Subarachnoid Hemorrhage During Treatment with Mild Hypothermia, in a Dog Model	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Mild hypothermia; Subarachnoid hemorrhage; Cerebral vasospasm; Endothelin-1	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; RESUSCITATIVE HYPOTHERMIA; PROLONGED VASOSPASM; NITRIC-OXIDE; FEASIBILITY; KINASE; INTERVENTION; INHIBITORS; MECHANISM	Using vascular heat-exchange controller implemented mild hypothermia treatment, the authors established the cerebral vasospasm model in which blood was injected twice into dog's foramen magnum; and it was discussed the influence of the concentration of endothelin-1 and NO in blood plasma and cerebrospinal fluid through continuing treatment of mild hypothermia at different times in secondary brain vasospasm model after subarachnoid hemorrhage. Thirty healthy mongrel dogs were randomly divided into five groups; artificial cerebrospinal fluid group (group A), normal temperature control group (group C), mild hypothermia 8 h group (group H1), mild hypothermia 16 h group (group H2), and mild hypothermia 32 h group (group H3). The authors injected the artificial CSF into dog's foramen magnum in group A while the other four groups were injected with autologous arterial blood. The normal group's temperature maintained 38.5A degrees C. The authors set the temperature at 33.5A degrees C in mild hypothermia groups and this was maintained for 8, 16, and 32 h, respectively. ET-1 and NO levels in the cerebrospinal fluid and plasma were assayed in each group on days 0, 7, 14, and 21. Then the changes of the diameter of blood vessels of cerebral basilar artery and overall performance categories score in each group through application of CT angiography were recorded. In the cerebral vasospasm model which was constructed by injecting the blood to dog twice, mild hypothermia treatment, through the application of vascular heat-exchange controller, could reduce cerebral vasospasm. It was observed that the duration of the mild hypothermia is directly proportional to the longer duration of the relieving of cerebral vasospasm. The reciprocal changes observed in the levels of ET-1 and NO in cerebrospinal fluid and plasma revealed that it might be possible to reduce the cerebral vasospasm by regulating the rising amplitude of ET-1 and the decrease in NO in CSF and plasma.	[Wang, Zhi-ping] Nanjing Med Univ, Dept Anesthesiol, Wuxi Peoples Hosp, Affiliated Hosp, Wuxi 241023, Jiangsu, Peoples R China; [Chen, Hong-sheng; Wang, Feng-xiang] Hosp Xuzhou Med Coll, Jiangsu Prov Inst Anesthesiol, Dept Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China		Wang, ZP (corresponding author), Nanjing Med Univ, Dept Anesthesiol, Wuxi Peoples Hosp, Affiliated Hosp, Wuxi 241023, Jiangsu, Peoples R China.	zhpsqxt@163.com					Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alabadi JA, 1997, NEUROSURGERY, V41, P245, DOI 10.1097/00006123-199707000-00039; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Doufas AG, 2002, ANESTH ANALG, V95, P1752, DOI 10.1097/00000539-200212000-00052; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; Juvela S, 2000, J NEUROSURG, V92, P390, DOI 10.3171/jns.2000.92.3.0390; Kandzari DE, 2004, AM J CARDIOL, V93, P636, DOI 10.1016/j.amjcard.2003.11.038; Kastner S, 2005, ACTA NEUROCHIR, V147, P1271, DOI 10.1007/s00701-005-0633-0; Koide M, 2002, NEUROSURGERY, V51, P1468, DOI 10.1227/01.NEU.0000036389.57399.DS; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Levati A, 1998, J Neurosurg Sci, V42, P27; Liu Zhen, 2007, Shengli Xuebao, V59, P285; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mascia L, 2001, STROKE, V32, P1185, DOI 10.1161/01.STR.32.5.1185; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; Mizuno Y, 2008, VASC PHARMACOL, V48, P21, DOI 10.1016/j.vph.2007.11.002; Neuschmelting V, 2009, ACTA NEUROCHIR, V151, P795, DOI 10.1007/s00701-009-0350-1; Nishizawa S, 2000, ACTA NEUROCHIR, V142, P1409, DOI 10.1007/s007010070013; Nishizawa S, 2003, J VASC RES, V40, P169, DOI 10.1159/000070714; OHLSTEIN EH, 1992, J NEUROSURG, V77, P274, DOI 10.3171/jns.1992.77.2.0274; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; POOL JL, 1958, J NEUROSURG, V15, P52, DOI 10.3171/jns.1958.15.1.0052; Popovic R, 2000, ANESTHESIOLOGY, V92, P1343, DOI 10.1097/00000542-200005000-00024; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; WEBB WR, 1962, SURGERY, V52, P643; Yanagawa Y, 1998, RESUSCITATION, V39, P61, DOI 10.1016/S0300-9572(98)00118-X; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86	32	14	15	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	SEP	2011	61	1					137	143		10.1007/s12013-011-9170-z			7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	805UA	WOS:000293753300015	21347657				2022-02-06	
J	McGregor, SJ; Armstrong, WJ; Yaggie, JA; Bollt, EM; Parshad, R; Bailey, JJ; Johnson, SM; Goin, AM; Kelly, SR				McGregor, Stephen J.; Armstrong, W. Jeffrey; Yaggie, James A.; Bollt, Erik M.; Parshad, Rana; Bailey, Jerry J.; Johnson, Sean M.; Goin, Aleta M.; Kelly, Samuel R.			Lower extremity fatigue increases complexity of postural control during a single-legged stance	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article							APPROXIMATE ENTROPY; TRUNK ACCELEROMETRY; CEREBRAL CONCUSSION; BALANCE	Background: Non-linear approaches to assessment of postural control can provide insight that compliment linear approaches. Control entropy (CE) is a recently developed statistical tool from non-linear dynamical systems used to assess the complexity of non-stationary signals. We have previously used CE of high resolution accelerometry in running to show decreased complexity with exhaustive exercise. The purpose of this study was to determine if complexity of postural control decreases following fatiguing exercise using CE. Methods: Ten subjects (5 M/5 F; 25 +/- 3 yr; 169.4 +/- 11.7 cm; 79.0 +/- 16.9 kg) consented to participation approved by Western Oregon University IRB and completed two trials separated by 2-7 days. Trials consisted of two single-legged balance tests separated by two Wingate anaerobic tests (WAnT; PreFat/PostFat), or rest period (PreRest/PostRest). Balance tests consisted of a series of five single-legged stances, separated by 30 s rest, performed while standing on the dominant leg for 15-s with the participant crossing the arms over the chest and flexing the non-dominant knee to 90 degrees. High resolution accelerometers (HRA) were fixed superficial to L3/L4 at the approximate center of mass (COM). Triaxial signals from the HRA were streamed in real time at 625 Hz. COM accelerations were recorded in g's for vertical (VT), medial/lateral (ML), and anterior/posterior (AP) axes. A newly developed statistic (R-test) was applied to group response shapes generated by Karhunen Loeve (KL) transform modes resulting from Control Entropy (CE) analysis. Results: R-tests showed a significant mean vector difference (p < .05) within conditions, between axes in all cases, except PostFat, indicating the shape of the complexity response was different in these cases. R-test between conditions, within axis, differences were only present in PostFat for AP vs. PreFat (p < .05). T-tests showed a significantly higher overall CE PostFat in VT and ML compared to PreFat and PostRest (p < .0001). PostFat CE was also higher than PostRest in AP (p < .0001). Conclusions: These data indicate that fatiguing exercise eliminates the differential complexity response between axes, but increases complexity in all axes compared to the non-fatigued condition. This has implications with regard to the effects of fatigue on strategies of the control system to maintain postural control.	[McGregor, Stephen J.] Eastern Michigan Univ, Sch HPHP, Ypsilanti, MI 48197 USA; [Armstrong, W. Jeffrey; Bailey, Jerry J.; Johnson, Sean M.; Goin, Aleta M.; Kelly, Samuel R.] Western Oregon Univ, Div HPF, Monmouth, OR USA; [Yaggie, James A.] Univ Findlay, Coll Hlth Profess, Findlay, OH USA; [Bollt, Erik M.; Parshad, Rana] Clarkson Univ, Dept Math & Comp Sci, Potsdam, NY USA		McGregor, SJ (corresponding author), Eastern Michigan Univ, Sch HPHP, Ypsilanti, MI 48197 USA.	smcgregor@emich.edu					Adlerton Anna-Karin, 2003, Physiother Res Int, V8, P187, DOI 10.1002/pri.289; ARMSTRONG WJ, J ELECTROMYOGR KINES, V20, P726; Bollt EM, 2009, MATH BIOSCI ENG, V6, P1, DOI 10.3934/mbe.2009.6.1; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Mardia K., 1979, MULTIVARIATE ANAL; McGregor SJ, 2009, CHAOS, V19, DOI 10.1063/1.3147423; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; PARSHAD R, 2011, MATH BIOSCIENCES ENG; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Schreiber, 2004, NONLINEAR TIME SERIE; TDE MV, 2009, J ELECTROMYOGR KINES, V19, pE513; Thomas M., 2006, ELEMENTS INFORM THEO, V2nd ed.; Yaggie J, 2004, J SPORT REHABIL, V13, P312, DOI 10.1123/jsr.13.4.312; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	20	14	14	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	AUG 4	2011	8								43	10.1186/1743-0003-8-43			10	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	819JO	WOS:000294821400001	21816084	Green Published, gold			2022-02-06	
J	Lee, HJ; Goudarzi, K; Baldwin, B; Rosenfield, D; Telch, MJ				Lee, Han-Joo; Goudarzi, Katy; Baldwin, Brian; Rosenfield, David; Telch, Michael J.			The Combat Experience Log: A web-based system for the in theater assessment of war zone stress	JOURNAL OF ANXIETY DISORDERS			English	Article						Assessment; PTSD; Combat experiences; Iraq; Army soldiers; War zone stress; Military	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC-STRESS; RESILIENCE INVENTORY; DEPLOYMENT RISK; PTSD CHECKLIST; VIETNAM VETERANS; NATIONAL SAMPLE; DISORDER; IRAQ	This article presents preliminary data on the Combat Experience Log (CEL) - a web-based prospective data collection system for the in theater assessment of war zone stressors and stress reactions. 177 U.S. Army soldiers deployed to Iraq took part in the study. The overall response rate was 90.1% and the majority of CEL responders perceived the CEL system to be quite easy and convenient to use, and relevant to their war-zone experiences. Preliminary data on stress reactions, CEL utilization and soldier satisfaction are encouraging and suggest that the CEL assessment system offers a potentially useful assessment tool for enhancing our understanding of war-zone stress experiences and their contribution to PTSD and other combat stress disorders. (C) 2011 Elsevier Ltd. All rights reserved.	[Goudarzi, Katy; Telch, Michael J.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Lee, Han-Joo] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Baldwin, Brian] Univ Texas Austin, Inst Adv Technol, Austin, TX 78712 USA; [Rosenfield, David] So Methodist Univ, Dallas, TX 75275 USA		Telch, MJ (corresponding author), Univ Texas Austin, Dept Psychol, 1 Univ Stn,A8000, Austin, TX 78712 USA.	telch@austin.utexas.edu	Telch, Michael J/E-7027-2010	Telch, Michael/0000-0003-3444-8500			ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; BEEVERS CG, AM J PSYCHI IN PRESS; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BURKE A, 1992, MEM COGNITION, V20, P277, DOI 10.3758/BF03199665; Carlson EB, 1997, TRAUMA ASSESSMENT CL; Connor KM, 2001, INT CLIN PSYCHOPHARM, V16, P279, DOI 10.1097/00004850-200109000-00005; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Fikretoglu D, 2006, CAN J PSYCHIAT, V51, P755, DOI 10.1177/070674370605101205; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; LOFTUS EF, 1982, MEM COGNITION, V10, P318, DOI 10.3758/BF03202423; McNally RJ, 2007, J ANXIETY DISORD, V21, P192, DOI 10.1016/j.janxdis.2006.09.005; Metts S, 1991, STUDYING INTERPERSON, P162; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shen YC, 2009, MIL MED, V174, P217, DOI 10.7205/MILMED-D-03-4307; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TELCH MJ, 2011, SOLDIERS EMOTI UNPUB; Vaishnavi S, 2006, DEPRESS ANXIETY, V23, P437, DOI 10.1002/da.20202; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Watkins PC, 1996, J ABNORM PSYCHOL, V105, P34, DOI 10.1037/0021-843X.105.1.34; Weathers F.W., 1993, ANN CONV INT SOC TRA	40	14	15	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6185	1873-7897		J ANXIETY DISORD	J. Anxiety Disord.	AUG	2011	25	6					794	800		10.1016/j.janxdis.2011.03.018			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	779HF	WOS:000291768000006	21550204				2022-02-06	
J	Cook, A; Osler, T; Gaudet, M; Berne, J; Norwood, S				Cook, Alan; Osler, Turner; Gaudet, Matthew; Berne, John; Norwood, Scott			Blunt Cerebrovascular Injury Is Poorly Predicted by Modeling With Other Injuries: Analysis of NTDB Data	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Blunt cerebrovascular injury; Carotid artery injury; Vertebral artery injury; Prediction	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; VASCULAR NECK INJURIES; CAROTID-ARTERY; EARLY-DIAGNOSIS; TRAUMA; SEVERITY; IMPROVES; OUTCOMES	Background: Traumatic blunt cerebrovascular injury (BCVI) may portend catastrophic complications if untreated. Who should be screened for BCVI is controversial. The purpose of this study was to develop and validate a prediction score (pBCVI) to identify those at sufficient risk to warrant dedicated screening. Methods: We conducted a cohort study using data for years 2002-2007 from the National Trauma Data Bank. Blunt trauma patients aged 16 years and older were randomly divided into two groups for score creation and validation. Final prediction model included age, sex, Trauma Mortality Prediction Model p(death), traumatic intracranial hemorrhage, cerebellar/brain stem injury, malar/maxillary fracture, mandible fracture, cervical spine fracture, cervical spinal cord injury, thoracic spinal cord injury, and chest Abbreviated Injury Scale >= 3. pBCVI was evaluated using receiver operating characteristic curve area and the Hosmer-Lemeshow statistic. The Youden Index estimated an optimal cut-point (J) of the pBCVI. Results: The cohort numbered 1,398,310 patients, including 2,125 with BCVI. The overall incidence of BCVI was 0.15%. Cervical spine fracture had the strongest association with BCVI (odds ratio 4.82, p < 0.001). The receiver operating characteristic curve for pBCVI was 0.93 and the Hosmer-Lemeshow statistic was 206.3, p < 0.01. The optimal cut-point (J) of pBCVI was 0.0013 (sensitivity 0.91, specificity 0.82) and would miss 186 (8.8%) injuries in our cohort. To identify all BCVI using this model, an unrealistic 96% of the cohort would require screening. Conclusions: A model based on a pattern of other injuries cannot be used as a stand-alone instrument to determine screening for BCVI. "Optimal" model cut-points are not ideal for all injuries. Clinical suspicion that integrates energy of mechanism and associated injuries remains essential to effectively screen for BCVI and minimize patient risk for a catastrophic missed injury.	[Cook, Alan] Baylor Univ, Med Ctr, Div Trauma, Dallas, TX 75246 USA; [Osler, Turner] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA; [Gaudet, Matthew] Ochsner Clin Fdn, Dept Surg, New Orleans, LA USA; [Norwood, Scott] Reg Med Ctr Bayonet Point, Trauma Serv, Hudson, FL USA; [Berne, John] E Texas Med Ctr, Div Trauma Crit Care, Tyler, TX USA		Cook, A (corresponding author), Baylor Univ, Med Ctr, Div Trauma, 3409 Worth St,Suite 640, Dallas, TX 75246 USA.	adcookmd@gmail.com					Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Berne JD, 2010, J VASC SURG, V51, P57, DOI 10.1016/j.jvs.2009.08.071; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2002, J TRAUMA, V53, P850, DOI 10.1097/00005373-200211000-00008; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Brown LH, 2009, PREHOSP EMERG CARE, V13, P516, DOI 10.1080/10903120903144809; Carrillo EH, 1999, J TRAUMA, V46, P1120, DOI 10.1097/00005373-199906000-00030; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cothren CC, 2005, AM J SURG, V190, P845, DOI 10.1016/j.amsurg.2005.08.007; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Giacobetti FB, 1997, SPINE, V22, P188, DOI 10.1097/00007632-199701150-00011; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Goodwin RB, 2009, J TRAUMA, V67, P1046, DOI 10.1097/TA.0b013e3181b83b63; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; MARTIN RF, 1991, J VASC SURG, V14, P789, DOI 10.1067/mva.1991.32076; McKevitt EC, 2002, J TRAUMA, V53, P472, DOI 10.1097/00005373-200209000-00013; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Mulholland SA, 2005, INJURY, V36, P1298, DOI 10.1016/j.injury.2005.07.010; Mulholland SA, 2008, J TRAUMA, V64, P754, DOI 10.1097/01.ta.0000244384.85267.c5; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Parikh AA, 1997, J AM COLL SURGEONS, V185, P80, DOI 10.1016/S1072-7515(97)00002-1; Richter M, 2001, J TRAUMA, V51, P10, DOI 10.1097/00005373-200107000-00002; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Schneidereit NP, 2006, J TRAUMA, V60, P209, DOI 10.1097/01.ta.0000195651.60080.2c; Sliker CW, 2007, EUR J RADIOL, V64, P3, DOI 10.1016/j.ejrad.2007.02.015; Spain DA, 2006, J TRAUMA, V60, P929; Spain DA, 2006, J TRAUMA, V60, P751; Vaca FE, 2009, WEST J EMERG MED, V10, P62; VERNEUIL M, 1872, B ACAD NAT MED PARIS, V1, P46; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	38	14	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					114	119		10.1097/TA.0b013e31821c350f			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	790RR	WOS:000292607400030	21818020				2022-02-06	
J	Mogensen, J				Mogensen, Jesper			Almost Unlimited Potentials of a Limited Neural Plasticity Levels of Plasticity in Development and Reorganization of the Injured Brain	JOURNAL OF CONSCIOUSNESS STUDIES			English	Article							FORNIX AND/OR ABLATION; LONG-TERM POTENTIATION; SPATIAL DELAYED ALTERNATION; GENE-EXPRESSION; CORTICAL REPRESENTATION; FUNCTIONAL RECOVERY; STRIATE CORTEX; VISUAL-FIELD; COGNITIVE REHABILITATION; SOMATOSENSORY CORTEX	Neuroplasticity is a core feature of the brain throughout the entire life of the individual. And when injury to the adult brain destroys part of the circuitry mediating behaviour and/or conscious experience, neuroplasticity is required to bring about the highest possible degree of post-traumatic functional recovery. But is the brain able to recreate the lost circuitry? Scrutiny of the impressive plasticity seen during development and in the adult brain reveals many similarities but also some crucial differences. And studies of the mechanisms of functional recovery demonstrate that even an apparently full recovery' of the surface phenomena of behaviour and/or conscious representations is accomplished without a recreation of the lost circuitry. Instead, the post-traumatic process utilizes mechanisms, which have evolved to mediate problem solving in the intact brain. The newly developed REF (Reorganization of Elementary Functions) model suggests how such dynamic reorganizations occur in the intact and injured brain.	Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, DK-1353 Copenhagen K, Denmark		Mogensen, J (corresponding author), Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	jesper.mogensen@psy.ku.dk		Mogensen, Jesper/0000-0003-1959-581X			Albrecht T, 2010, CONSCIOUS COGN, V19, P656, DOI 10.1016/j.concog.2009.12.002; Antonini A, 1999, J NEUROSCI, V19, P4388; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Bao JX, 1998, J NEUROSCI, V18, P458; Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Bechtel W, 1999, PHILOS SCI, V66, P175, DOI 10.1086/392683; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/j.neuron.2004.12.008; Berry M, 1982, Bibl Anat, P1; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLOCK NJ, 1972, PHILOS REV, V81, P159, DOI 10.2307/2183991; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRIDGEMAN B, 1982, VISION RES, V22, P1199, DOI 10.1016/0042-6989(82)90085-2; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Choi JY, 2007, J NUCL MED, V48, P194; Chokron S, 2008, RESTOR NEUROL NEUROS, V26, P305; CRAGG BG, 1975, J COMP NEUROL, V160, P147, DOI 10.1002/cne.901600202; Del Rio JA, 2007, CURR PHARM DESIGN, V13, P2485; DELFS JM, 1995, J NEUROSCI, V15, P6562; DERRICK BE, 1994, P NATL ACAD SCI USA, V91, P10290, DOI 10.1073/pnas.91.22.10290; DINEEN J, 1981, EXP BRAIN RES, V41, P338; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fodor J., 2000, MIND DOESNT WORK WAY; Fodor J.A., 1983, MODULARITY MIND; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friston KJ, 2003, TRENDS COGN SCI, V7, P151, DOI 10.1016/S1364-6613(03)00054-8; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Hamburger V, 1934, J EXP ZOOL, V68, P449, DOI 10.1002/jez.1400680305; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Henriksson L, 2007, J NEUROL NEUROSUR PS, V78, P74, DOI 10.1136/jnnp.2006.099374; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; HUMPHREY NK, 1974, PERCEPTION, V3, P241, DOI 10.1068/p030241; Irvine DRF, 2007, HEARING RES, V229, P158, DOI 10.1016/j.heares.2007.01.006; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; KELSO SR, 1986, SCIENCE, V232, P85; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Krechevsky I, 1933, J COMP PSYCHOL, V16, P99, DOI 10.1037/h0072223; Krechevsky I, 1932, PSYCHOL REV, V39, P516, DOI 10.1037/h0073500; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Levi-Montallini R, 1942, Archives de Biologie Liege, V53, P537; LEVIMONTALCINI R, 1982, ANNU REV NEUROSCI, V5, P341, DOI 10.1146/annurev.ne.05.030182.002013; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; Mala H, 2007, J NEUROTRAUM, V24, P1647, DOI 10.1089/neu.2007.0292; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McClelland J. L, 1986, PARALLEL DISTRIBUTED, V2; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; McLeod P., 1998, INTRO CONNECTIONIST; Merzenich M M, 1993, J Hand Ther, V6, P89; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MOGENSEN J, 1982, BEHAV BRAIN RES, V5, P375, DOI 10.1016/0166-4328(82)90041-9; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; MOGENSEN J, 1987, PHARMACOL BIOCHEM BE, V26, P89, DOI 10.1016/0091-3057(87)90539-9; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V75, P381, DOI 10.1016/S0091-3057(03)00107-2; MOGENSEN J, 1994, PHARMACOL BIOCHEM BE, V47, P647, DOI 10.1016/0091-3057(94)90170-8; Mogensen J, 2002, NEUROBIOL LEARN MEM, V78, P139, DOI 10.1006/nlme.2001.4055; MOGENSEN J, 1991, BEHAV BRAIN RES, V42, P135, DOI 10.1016/S0166-4328(05)80004-X; Mogensen J., NEUROREHABI IN PRESS; Mogensen J., 2011, HDB LAB ANIMAL SCI, VII, P47; Mogensen J., 2003, HDB LAB ANIMAL SCI, VII, P95; Mogensen J, 2008, BEHAV BRAIN RES, V186, P215, DOI 10.1016/j.bbr.2007.08.009; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Mogensen J, 2009, SCAND J PSYCHOL, V50, P561, DOI 10.1111/j.1467-9450.2009.00781.x; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V4, P4; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Overgaard M., 2011, FRONT PSYCHOL, V2, P1; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Peter ME, 1997, CELL DEATH DIFFER, V4, P523, DOI 10.1038/sj.cdd.4400285; PINES J, 1992, Current Opinion in Cell Biology, V4, P144, DOI 10.1016/0955-0674(92)90024-7; Pinker S., 1999, MIND WORKS; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Raninen A, 2007, J NEUROL NEUROSUR PS, V78, P66, DOI 10.1136/jnnp.2006.099366; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rosenzweig M.R., 1987, ENRICHED IMPOVERISHE; ROSENZWEIG MR, 1984, AM PSYCHOL, V39, P365, DOI 10.1037/0003-066X.39.4.365; ROSENZWEIG MR, 1971, BIOPSYCHOLOGY DEV, P303; ROSENZWEIG MR, 1961, CURRENT TRENDS PSYCH, P87; Rumelhart DE., 1986, PARALLEL DISTRIBUTED, P318, DOI 10.7551/mitpress/5236.001.0001; Sahraie A, 2006, P NATL ACAD SCI USA, V103, P14971, DOI 10.1073/pnas.0607073103; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Schafer R, 2008, NEUROSCI LETT, V439, P61, DOI 10.1016/j.neulet.2008.04.098; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Scheich H, 1991, Curr Opin Neurobiol, V1, P236, DOI 10.1016/0959-4388(91)90084-K; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; Schwiedrzik CM, 2009, J VISION, V9, DOI 10.1167/9.10.18; Shapiro L., 2004, THE MIND INCARNATE; Shapiro LA, 2008, PHILOS SCI, V75, P514, DOI 10.1086/594503; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sterr A, 1998, J NEUROSCI, V18, P4417; Sterr A, 1998, NATURE, V391, P134, DOI 10.1038/34322; Stoerig P, 2006, PROG BRAIN RES, V155, P217, DOI 10.1016/S0079-6123(06)55012-5; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Thai-Van H, 2007, HEARING RES, V233, P14, DOI 10.1016/j.heares.2007.06.003; Weiss T, 2000, EXP BRAIN RES, V134, P199, DOI 10.1007/s002210000456; Werbos P. J., 1994, ROOTS BACKPROPAGATIO; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008; Xerri C, 1996, J PHYSIOLOGY-PARIS, V90, P277, DOI 10.1016/S0928-4257(97)81438-6; YANG TT, 1994, NEUROREPORT, V5, P701, DOI 10.1097/00001756-199402000-00010; ZIHL J, 1980, NEUROPSYCHOLOGIA, V18, P71, DOI 10.1016/0028-3932(80)90085-8; ZIHL J, 1984, NEUROPSYCHOLOGIA, V22, P13, DOI 10.1016/0028-3932(84)90003-4; [No title captured]	159	14	14	0	6	IMPRINT ACADEMIC	EXETER	PO BOX 200, EXETER EX5 5YX, DEVON, ENGLAND	1355-8250			J CONSCIOUSNESS STUD	J. Conscious. Stud.	JUL-AUG	2011	18	7-8			SI		13	45					33	Philosophy; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Philosophy; Social Sciences - Other Topics	802DO	WOS:000293489700002					2022-02-06	
J	Shim, DJ; Yang, L; Reed, JG; Noebels, JL; Chiao, PJ; Zheng, H				Shim, David J.; Yang, Li; Reed, J. Graham; Noebels, Jeffrey L.; Chiao, Paul J.; Zheng, Hui			Disruption of the NF-kappa B/I kappa B alpha Autoinhibitory Loop Improves Cognitive Performance and Promotes Hyperexcitability of Hippocampal Neurons	MOLECULAR NEURODEGENERATION			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; GLIAL TNF-ALPHA; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; MEMORY FORMATION; C-REL; ACTIVATION	Background: Though originally discovered in the immune system as an important mediator of inflammation, NF-kappa B has recently been shown to play key roles in the central nervous system, such as synaptogenesis, synaptic plasticity, and cognition. NF-kappa B activity is normally tightly regulated by its primary inhibitor, I kappa B alpha, through a unique autoinhibitory loop. In this study, we tested the hypothesis that the I kappa B alpha autoinhibitory loop ensures optimal levels of NF-kappa B activity to promote proper brain development and function. To do so, we utilized knock-in mice which possess mutations in the I kappa B alpha promoter to disrupt the autoinhibitory loop (I kappa B alpha(M/M) KI mice). Results: Here, we show that these mutations delay I kappa B alpha resynthesis and enhance NF-kappa B activation in neurons following acute activating stimuli. This leads to improved cognitive ability on tests of hippocampal-dependent learning and memory but no change in hippocampal synaptic plasticity. Instead, hippocampal neurons from I kappa B alpha(M/M) KI mice form more excitatory and less inhibitory synapses in dissociated cultures and are hyperexcitable. This leads to increased burst firing of action potentials and the development of abnormal hypersynchronous discharges in vivo. Conclusions: These results demonstrate that the I kappa B alpha autoinhibitory loop is critical for titrating appropriate levels of endogenous NF-kappa B activity to maintain proper neuronal function.	[Shim, David J.; Yang, Li; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Shim, David J.; Noebels, Jeffrey L.; Zheng, Hui] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shim, David J.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Noebels, Jeffrey L.; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Reed, J. Graham; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Chiao, Paul J.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol Res, Houston, TX 77030 USA		Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	huiz@bcm.edu		Noebels, Jeffrey/0000-0002-2887-0839	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG20670, AG32051, AG33467, NS614283]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA097159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS061428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033467, R01AG032051, R01AG020670] Funding Source: NIH RePORTER	We are grateful to N. Aithmitti and X. Chen for expert technical support, Z. Wang and B. Peng for assistance with initial breeding and characterization of the mice, and N. Justice and members of the Zheng laboratory for constructive discussions and help with the manuscript. We thank C. Spencer and the Baylor College of Medicine IDDRC Administrative, Mouse Neurobehavior, and Mouse Physiology cores (HD24064) for their assistance. This work was supported by grants from NIH (AG20670, AG32051, and AG33467 to HZ; NS614283 to DS).	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Albensi BC, 2000, SYNAPSE, V35, P151; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Barkmeier DT, 2009, CLIN EEG NEUROSCI, V40, P234, DOI 10.1177/155005940904000405; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Begni S, 2003, BIOL PSYCHIAT, V53, P617, DOI 10.1016/S0006-3223(02)01783-3; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kassed CA, 2002, EXP NEUROL, V176, P277, DOI 10.1006/exnr.2002.7967; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; O'Sullivan NC, 2010, BRAIN RES BULL, V81, P385, DOI 10.1016/j.brainresbull.2009.11.001; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Wang J, 2010, J NEUROSCI, V30, P11104, DOI 10.1523/JNEUROSCI.2118-10.2010; Yu ZF, 2002, NEUROBIOL DIS, V11, P199, DOI 10.1006/nbdi.2002.0530; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	56	14	14	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	JUN 10	2011	6								42	10.1186/1750-1326-6-42			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	795HQ	WOS:000292965700001	21663635	Green Published, gold			2022-02-06	
J	Agostini, V; Chiaramello, E; Bredariol, C; Cavallini, C; Knaflitz, M				Agostini, Valentina; Chiaramello, Emma; Bredariol, Carla; Cavallini, Chanda; Knaflitz, Marco			Postural control after traumatic brain injury in patients with neuro-ophthalmic deficits	GAIT & POSTURE			English	Article						Traumatic brain injury; Balance; Neuro-ophthalmic deficits; Static posturography; Quiet standing	HEAD TRAUMA; BODY SWAY; STABILITY; BALANCE; ADULTS; MANIFESTATIONS; POSTUROGRAPHY; INSTABILITY; MODERATE; YOUNG	Postural instability is a common and devastating consequence of traumatic brain injury (TBI). The majority of TBI patients also suffer from neuro-ophthalmic deficits that can be an important contributing element to their sensation of vertigo and dizziness. Static posturography aims at the objective evaluation of patient balance impairment, but is usually affected by large inter- and intra-subject variability. Here we propose a protocol based on 10 randomized trials stimulating in different ways the visual and vestibular systems. Due to its completeness, our protocol highlights the specific residual difficulties of each patient in the various conditions. In this way, it was possible to evidence significant balance abnormalities in TBI patients with respect to controls. Moreover, by means of a multivariate analysis we were able to discriminate different levels of residual neuro-ophthalmic impairment. (C) 2011 Elsevier B.V. All rights reserved.	[Agostini, Valentina; Chiaramello, Emma; Knaflitz, Marco] Politecn Torino, Dipartimento Elettron, I-10129 Turin, Italy; [Bredariol, Carla; Cavallini, Chanda] Osped Oftalm Torino, Clin C Sperino, Turin, Italy		Agostini, V (corresponding author), Politecn Torino, Dipartimento Elettron, Corso Duca degli Abruzzi 24, I-10129 Turin, Italy.	valentina.agostini@polito.it; emma.chiaramello@polito.it; neuroftalmologia.to@gmail.com; marco.knaflitz@polito.it	Agostini, Valentina/A-9570-2009; Chiaramello, Emma/AAY-8463-2020	Agostini, Valentina/0000-0001-5887-1499; Chiaramello, Emma/0000-0003-2503-4779			[Anonymous], 1995, GAIT POSTURE; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Krzanowski W.J., 1988, PRINCIPLES MULTIVARI; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mardia K., 1979, MULTIVARIATE ANAL; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rocchi L, 2004, MED BIOL ENG COMPUT, V42, P71, DOI 10.1007/BF02351013; SAMSON M, 1996, GAIT POSTURE, V4, P252; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tarantola J, 1997, NEUROSCI LETT, V228, P75, DOI 10.1016/S0304-3940(97)00370-4; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wichern D.W., 2002, APPL MULTIVARIATE ST	29	14	14	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362			GAIT POSTURE	Gait Posture	JUN	2011	34	2					248	253		10.1016/j.gaitpost.2011.05.008			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	801HS	WOS:000293429800020	21646021				2022-02-06	
J	Chan, YM; Williams, S; Davidson, LE; Drummond, BK				Chan, Yin Man; Williams, Sheila; Davidson, Lesley E.; Drummond, Bernadette K.			Orofacial and dental trauma of young children in Dunedin, New Zealand	DENTAL TRAUMATOLOGY			English	Article							OF-THE-LITERATURE; FACIAL FRACTURES; INJURIES; DENTISTRY; SCHOOLCHILDREN; EPIDEMIOLOGY; SCHOOL; TEETH	Aim: The aims were to identify the predominant causes and types of orofacial injury in young children attending clinics at a University Dental School in Dunedin, New Zealand. Material and methods: A retrospective analysis of data from the records of all children aged 0-10 years who had been seen for orofacial trauma in 1999 and 2000 was undertaken. Results and conclusions: Three hundred traumatic incidents in 288 children were analysed; 86.6% had causes noted. In very young children, most injuries were because of falls, while collisions, falling and sports were responsible for more injuries in school-aged children. Playground equipment and ride-on vehicles played a role particularly in the older children. There were no incidents of trauma as a result of road traffic accidents. Ten injuries were caused by animals, mainly dogs. Location was recorded for two-thirds of accidents: the predominant place was at home, followed by school. No seasonal variation was apparent. There were 228 non-dental injuries, of which the majority were to the lips. The predominant dental injuries in both dentitions were concussions and subluxations with a significantly higher occurrence of both in the primary dentition (P < 0.001). Upper central incisors were most often involved. The age distribution for boys and girls was similar. In conclusion, the causes and types of orofacial trauma in this group of young New Zealand school children attending a university dental school were similar to other studies, except for the high proportion of concussions recorded in both dentitions. While the injuries were well described, not all records noted the cause or location. This has resulted in changes to the standard recording form to provide consistency in data capture. Information from this study will also be used to support child injury prevention strategies in New Zealand.	[Drummond, Bernadette K.] Univ Otago, Sch Dent, Dept Oral Sci, Fac Dent, Dunedin, New Zealand		Drummond, BK (corresponding author), Univ Otago, Sch Dent, Dept Oral Sci, Fac Dent, POB 647, Dunedin, New Zealand.	bernadette.drummond@dent.otago.ac.nz	Williams, Sheila/L-4028-2019		New Zealand Child Injury Prevention Foundation	This study was supported by The New Zealand Child Injury Prevention Foundation.	Al-Jundi SH, 2002, DENT TRAUMATOL, V18, P181, DOI 10.1034/j.1600-9657.2002.02081.x; Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; Andreasen JO, 1970, SCAND J DENT RES, V78, P339; ATLAY N, 2001, DENT TRAUMATOL, V17, P201; BAGHDADY VS, 1981, COMMUNITY DENT ORAL, V9, P91, DOI 10.1111/j.1600-0528.1981.tb01036.x; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Borum M K, 2001, Int J Paediatr Dent, V11, P249; Caldas AD, 2001, DENT TRAUMATOL, V17, P250; CALVALCANTI AL, 2009, DENT TRAUMATOL, V25, P198; Chadwick BL, 2006, BRIT DENT J, V200, P379, DOI 10.1038/sj.bdj.4813424; Cunha RF, 2001, DENT TRAUMATOL, V17, P210; Fried Irwin, 1996, Pediatric Dentistry, V18, P145; Gabris K, 2001, DENT TRAUMATOL, V17, P103, DOI 10.1034/j.1600-9657.2001.017003103.x; GARCIA-GODOY F, 1987, Endodontics and Dental Traumatology, V3, P126; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; HAMMOND K L, 1991, New Zealand Dental Journal, V87, P5; Kieser J, 2002, INT J ORAL MAX SURG, V31, P206, DOI 10.1054/ijom.2002.0208; KOOREY AJ, 1992, INT J ORAL MAX SURG, V21, P77, DOI 10.1016/S0901-5027(05)80535-1; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-9657.2003.00203.x; Love Robert M., 1998, New Zealand Dental Journal, V94, P146; Love RM, 2008, DENT TRAUMATOL, V24, P170, DOI 10.1111/j.1600-9657.2007.00520.x; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; RAVN JJ, 1974, COMMUNITY DENT ORAL, V2, P231, DOI 10.1111/j.1600-0528.1974.tb01658.x; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Skaare AB, 2003, DENT TRAUMATOL, V19, P67, DOI 10.1034/j.1600-9657.2003.00133.x; Ferreira JMS, 2009, DENT TRAUMATOL, V25, P219, DOI 10.1111/j.1600-9657.2008.00754.x; *STAT NZ TE TAR NO, 1998, NZ NOW CHILDR; StataCorp, 2007, STAT STAT SOFTW REL; Wright G, 2007, DENT TRAUMATOL, V23, P226, DOI 10.1111/j.1600-9657.2006.00430.x; York A H, 1978, N Z Dent J, V74, P218; Zaragoza AA, 1998, J DENT CHILD, V65, P492	31	14	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2011	27	3					199	202		10.1111/j.1600-9657.2011.00989.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	763FS	WOS:000290541400008	21457187				2022-02-06	
J	Liu, ZQ; Wang, DL; Shao, B; Wu, XH; Xu, J; Lu, QH; Wang, YD; Li, CM; Shen, AG; Wu, QY				Liu, Zhiqiang; Wang, Donglin; Shao, Bai; Wu, Xiaohong; Xu, Jian; Lu, Qiuhui; Wang, Yidan; Li, Chunmiao; Shen, Aiguo; Wu, Qiyun			Increased expression of transcription initiation factor IIB after rat traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						General transcription initiation factor; Traumatic brain injury; Western blot; Rat	RNA-POLYMERASE-II; FACTOR-TFIIB; FUNCTIONAL DOMAINS; TBP; DROSOPHILA; PROTEIN; NEURODEGENERATION; PROLIFERATION; SPECIFICITY; MECHANISMS	The protein TFIIB is a general transcription initiation factor that plays a pivotal role in the preinitiation complex (PIC) and selects the transcription initiation site. However, its distribution and function in the central nervous system (CNS) remains unclear. In the present study, we mainly investigated the expression and cellular localization of TFIIB during traumatic brain injury (TBI). Western blot analysis revealed that TFIIB was present in normal rat brain cortex. It gradually increased, reached a peak at the 5th day after TBI, and then decreased. Importantly, more TFIIB was colocalized with astrocytes and microglia, which are largely proliferated. In addition, Western blot detection showed that the 5th day post injury was also the proliferation peak indicated by the elevated expression of PCNA. Importantly, injury-induced expression of TFIIB was colabelled by proliferating cell nuclear antigen (proliferating cells marker). These data suggested that TFIIB may be implicated in the proliferation of astrocytes and microglia and the recovery of neurological outcomes. But the inherent mechanisms remained unknown. Further studies are needed to confirm the exact role of TFIIB after brain injury.	[Liu, Zhiqiang; Wang, Donglin; Shen, Aiguo; Wu, Qiyun] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Liu, Zhiqiang; Wang, Donglin; Shao, Bai; Wu, Xiaohong; Xu, Jian; Lu, Qiuhui; Wang, Yidan; Li, Chunmiao] Nantong Univ, Dept Pathol, Coll Med, Nantong 226001, Peoples R China		Shen, AG (corresponding author), Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China.	shen_aiguo@yahoo.com; qiyunwu@163.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81070275]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161, BK2010169]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723 and No. 81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157, No. BK2009161 and No. BK2010169); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Felzien LK, 1999, MOL CELL BIOL, V19, P4241; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HISATAKE K, 1991, NUCLEIC ACIDS RES, V19, P6639, DOI 10.1093/nar/19.23.6639; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LOGAN A, 1992, J NEUROSCI, V12, P3828; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; TSUBOI A, 1992, NUCLEIC ACIDS RES, V20, P3250, DOI 10.1093/nar/20.12.3250; WAMPLER SL, 1992, GENE DEV, V6, P1542, DOI 10.1101/gad.6.8.1542; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; YAMASHITA S, 1992, P NATL ACAD SCI USA, V89, P2839, DOI 10.1073/pnas.89.7.2839	37	14	14	0	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2011	42	3					265	271		10.1007/s10735-011-9330-x			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	793QP	WOS:000292838500007	21544596				2022-02-06	
J	Vetreno, RP; Klintsova, A; Savage, LM				Vetreno, Ryan P.; Klintsova, Anna; Savage, Lisa M.			Stage-dependent alterations of progenitor cell proliferation and neurogenesis in an animal model of Wernicke-Korsakoff syndrome	BRAIN RESEARCH			English	Article						Neurogenesis; Cell proliferation; BrdU; Pyrithiamine; Wernicke-Korsakoff syndrome	INDUCED THIAMINE-DEFICIENCY; TRAUMATIC BRAIN-INJURY; IMPAIRED HIPPOCAMPAL NEUROGENESIS; SEIZURE-INDUCED NEUROGENESIS; NEWLY GENERATED CELLS; ADULT NEUROGENESIS; DENTATE GYRUS; NEUROTROPHIC FACTOR; DIENCEPHALIC AMNESIA; VOLUNTARY EXERCISE	Alcohol-induced Wernicke-Korsakoff syndrome (WKS) culminates in bilateral diencephalic lesion and severe amnesia. Using the pyrithiamine-induced thiamine deficiency (PTD) animal paradigm of WKS, our laboratory has demonstrated hippocampal dysfunction in the absence of gross anatomical pathology. Extensive literature has revealed reduced hippocampal neurogenesis following a neuropathological insult, which might contribute to hippocampus-based learning and memory impairments. Thus, the current investigation was conducted to determine whether PTD treatment altered hippocampal neurogenesis in a stage-dependent fashion. Male Sprague-Dawley rats were assigned to one of 4 stages of thiamine deficiency based on behavioral symptoms: pre-symptomatic stage, ataxic stage, early post-opisthotonus stage, or the late post-opisthotonus stage. The S-phase mitotic marker 5'-bromo-2'-deoxyuridine (BrdU) was administered at the conclusion of each stage following thiamine restoration and subjects were perfused 24 hours or 28 days after BrdU to assess cellular proliferation or neurogenesis and survival, respectively. Dorsal hippocampal sections were immunostained for BrdU (proliferating cell marker), NeuN (neurons), GFAP (astrocytes), Iba-1 (microglia), and O4 (oligodendrocytes). The PTD treatment increased progenitor cell proliferation and survival during the early post-opisthotonus stage. However, levels of neurogenesis were reduced during this stage as well as the late post-opisthotonus stage where there was also an increase in astrocytogenesis. The diminished numbers of newly generated neurons (BrdU/NeuN co-localization) was paralleled by increased BrdU cells that did not co-localize with any of the phenotypic markers during these later stages. These data demonstrate that long-term alterations in neurogenesis and gliogenesis might contribute to the observed hippocampal dysfunction in the PTD model and human WKS. Published by Elsevier B.V.	[Vetreno, Ryan P.; Klintsova, Anna; Savage, Lisa M.] SUNY Binghamton, Dept Psychol, Vestal, NY 13902 USA		Vetreno, RP (corresponding author), SUNY Binghamton, Dept Psychol, Vestal, NY 13902 USA.	rvetren1@binghamton.edu		Klintsova, Anna/0000-0003-0626-8385	 [NINDS 054272]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054272] Funding Source: NIH RePORTER	This work was supported by a research grant NINDS 054272 to LMS.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Anzalone S, 2010, EUR J NEUROSCI, V32, P847, DOI 10.1111/j.1460-9568.2010.07358.x; ARENDT T, 1983, ACTA NEUROPATHOL, V61, P101, DOI 10.1007/BF00697388; Bauer S, 2005, J CELL BIOL, V171, P641, DOI 10.1083/jcb.200505072; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Berchtold NC, 2002, J NEUROSCI RES, V68, P511, DOI 10.1002/jnr.10256; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Butters N, 1981, Curr Alcohol, V8, P205; BUTTERWORTH RF, 1989, J NEUROCHEM, V52, P1079, DOI 10.1111/j.1471-4159.1989.tb01850.x; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Caulo M, 2005, BRAIN, V128, P1584, DOI 10.1093/brain/awh496; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Conner JM, 2009, J NEUROSCI, V29, P10883, DOI 10.1523/JNEUROSCI.2594-09.2009; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fama R, 2004, J INT NEUROPSYCH SOC, V10, P427, DOI 10.1017/S135561770410310X; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; GIBSON GE, 1984, NEUROCHEM RES, V9, P803, DOI 10.1007/BF00965667; GILBEA FJ, 2010, HIPPOCAMPUS, DOI DOI 10.1002/HIPO.0812; Gold JJ, 2006, LEARN MEMORY, V13, P699, DOI 10.1101/lm.357406; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; HARPER CG, 1990, ALCOHOL ALCOHOLISM, V25, P207, DOI 10.1093/oxfordjournals.alcalc.a044994; Hattiangady B, 2010, HIPPOCAMPUS, V20, P97, DOI 10.1002/hipo.20594; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; He J, 2009, ALCOHOL CLIN EXP RES, V33, P129, DOI 10.1111/j.1530-0277.2008.00823.x; Helfer JL, 2009, BRAIN RES, V1294, P1, DOI 10.1016/j.brainres.2009.07.090; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007; Karuppagounder Saravanan, 2009, P235, DOI 10.1007/978-0-387-79112-8_12; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kotani S, 2008, CHEM-BIOL INTERACT, V175, P227, DOI 10.1016/j.cbi.2008.04.004; Kril JJ, 1996, METAB BRAIN DIS, V11, P9, DOI 10.1007/BF02080928; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Langlais PJ, 1996, METAB BRAIN DIS, V11, P19, DOI 10.1007/BF02080929; Langlais PJ, 1997, ALCOHOL CLIN EXP RES, V21, P434; LANGLAIS PJ, 1992, BEHAV BRAIN RES, V48, P177, DOI 10.1016/S0166-4328(05)80155-X; LANGLAIS PJ, 1995, BEHAV BRAIN RES, V68, P75, DOI 10.1016/0166-4328(94)00162-9; LANGLAIS PJ, 1990, J NEUROSCI, V10, P1664; LAPCHAK PA, 1993, NEUROSCIENCE, V52, P575, DOI 10.1016/0306-4522(93)90407-7; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leong DK, 1996, METAB BRAIN DIS, V11, P71, DOI 10.1007/BF02080932; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mair R G, 1994, Rev Neurosci, V5, P105; MARKOWITSCH HJ, 1988, BRAIN RES REV, V13, P351, DOI 10.1016/0165-0173(88)90012-4; Massey KA, 2006, MOL CELL NEUROSCI, V33, P381, DOI 10.1016/j.mcn.2006.08.011; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Zhao N, 2008, NEUROBIOL DIS, V29, P176, DOI 10.1016/j.nbd.2007.08.014; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ngwenya LB, 2008, HIPPOCAMPUS, V18, P210, DOI 10.1002/hipo.20384; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nonner D, 1996, J NEUROSCI, V16, P6665; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Pfefferbaum A, 2007, NEUROPSYCHOPHARMACOL, V32, P1159, DOI 10.1038/sj.npp.1301107; Pires RGW, 2005, BEHAV BRAIN RES, V162, P11, DOI 10.1016/j.bbr.2005.02.032; Pires RGW, 2001, PHARMACOL BIOCHEM BE, V70, P227, DOI 10.1016/S0091-3057(01)00593-7; Pitkin SR, 2004, BEHAV BRAIN RES, V148, P93, DOI 10.1016/S0166-4328(03)00208-0; Pitkin SR, 2001, BEHAV BRAIN RES, V119, P167, DOI 10.1016/S0166-4328(00)00350-8; Redila VA, 2006, HIPPOCAMPUS, V16, P305, DOI 10.1002/hipo.20164; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; ROBINSON JK, 1992, BEHAV NEUROSCI, V106, P623; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Roland JJ, 2009, NEUROSCIENCE, V160, P32, DOI 10.1016/j.neuroscience.2009.02.044; Roland JJ, 2007, NEUROBIOL LEARN MEM, V87, P123, DOI 10.1016/j.nlm.2006.07.007; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Savage LM, 2003, LEARN MEMORY, V10, P242, DOI 10.1101/lm.60003; Shetty AK, 2011, HIPPOCAMPUS, V21, P631, DOI 10.1002/hipo.20776; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sullivan EV, 2009, ALCOHOL ALCOHOLISM, V44, P155, DOI 10.1093/alcalc/agn103; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; TRONCOSO JC, 1981, ARCH NEUROL-CHICAGO, V38, P350, DOI 10.1001/archneur.1981.00510060052007; Van der Borght K, 2005, BRAIN RES BULL, V67, P117, DOI 10.1016/j.brainresbull.2005.06.018; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; VETRENO RP, NEUROBIOL L IN PRESS; Vetreno RP, 2008, NEUROBIOL LEARN MEM, V90, P237, DOI 10.1016/j.nlm.2008.04.001; Victor M., 1971, WERNICKE KORSAKOFF S; VICTOR M, 1989, WEMICKE KORSAKOFF SY; Voloboueva LA, 2010, J NEUROSCI, V30, P12242, DOI 10.1523/JNEUROSCI.1752-10.2010; VORHEES CV, 1977, J NUTR, V107, P1902, DOI 10.1093/jn/107.10.1902; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; WITT ED, 1985, ALCOHOL ALCOHOLISM, V20, P201; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582; ZHANG SX, 1995, J NEUROPATH EXP NEUR, V54, P255, DOI 10.1097/00005072-199503000-00012; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao YL, 2009, J NEUROCHEM, V111, P537, DOI 10.1111/j.1471-4159.2009.06341.x	127	14	14	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 19	2011	1391						132	146		10.1016/j.brainres.2011.03.048			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	773EU	WOS:000291290600014	21440532	Green Accepted			2022-02-06	
J	Mao, YT; Hua, TM; Pallas, SL				Mao, Yu-Ting; Hua, Tian-Miao; Pallas, Sarah L.			Competition and convergence between auditory and cross-modal visual inputs to primary auditory cortical areas	JOURNAL OF NEUROPHYSIOLOGY			English	Article						cross-modal plasticity; sensory substitution; cortical development; traumatic brain injury; stroke	INFERIOR COLLICULUS LESION; FERRET MUSTELA-PUTORIUS; RETINAL PROJECTIONS; OCULAR DOMINANCE; WORD DEAFNESS; MULTISENSORY INTEGRATION; COCHLEAR IMPLANTS; EVOKED POTENTIALS; RECEPTIVE-FIELDS; THALAMIC LESION	Mao YT, Hua TM, Pallas SL. Competition and convergence between auditory and cross-modal visual inputs to primary auditory cortical areas. J Neurophysiol 105: 1558-1573, 2011. First published January 27, 2011; doi: 10.1152/jn.00407.2010.-Sensory neocortex is capable of considerable plasticity after sensory deprivation or damage to input pathways, especially early in development. Although plasticity can often be restorative, sometimes novel, ectopic inputs invade the affected cortical area. Invading inputs from other sensory modalities may compromise the original function or even take over, imposing a new function and preventing recovery. Using ferrets whose retinal axons were rerouted into auditory thalamus at birth, we were able to examine the effect of varying the degree of ectopic, cross-modal input on reorganization of developing auditory cortex. In particular, we assayed whether the invading visual inputs and the existing auditory inputs competed for or shared postsynaptic targets and whether the convergence of input modalities would induce multisensory processing. We demonstrate that although the cross-modal inputs create new visual neurons in auditory cortex, some auditory processing remains. The degree of damage to auditory input to the medial geniculate nucleus was directly related to the proportion of visual neurons in auditory cortex, suggesting that the visual and residual auditory inputs compete for cortical territory. Visual neurons were not segregated from auditory neurons but shared target space even on individual target cells, substantially increasing the proportion of multisensory neurons. Thus spatial convergence of visual and auditory input modalities may be sufficient to expand multisensory representations. Together these findings argue that early, patterned visual activity does not drive segregation of visual and auditory afferents and suggest that auditory function might be compromised by converging visual inputs. These results indicate possible ways in which multisensory cortical areas may form during development and evolution. They also suggest that rehabilitative strategies designed to promote recovery of function after sensory deprivation or damage need to take into account that sensory cortex may become substantially more multisensory after alteration of its input during development.	[Pallas, Sarah L.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30302 USA; [Mao, Yu-Ting; Hua, Tian-Miao; Pallas, Sarah L.] Georgia State Univ, Dept Biol, Atlanta, GA USA		Pallas, SL (corresponding author), Georgia State Univ, Inst Neurosci, POB 5030, Atlanta, GA 30302 USA.	spallas@gsu.edu	Pallas, Sarah L/W-1860-2019; Mao, Yu-Ting/M-8586-2017	Pallas, Sarah L/0000-0002-1760-7437; Mao, Yu-Ting/0000-0001-8438-079X	National Science Foundation (NSF)National Science Foundation (NSF) [IBN-0451018]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY/MH12696]; Georgia State University (GSU) Research Foundation; GSU; NSF Science and Technology Centers [IBN-9876754]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012696] Funding Source: NIH RePORTER	This work was funded by National Science Foundation (NSF) Grant IBN-0451018, National Institutes of Health Grant EY/MH12696, and a Georgia State University (GSU) Research Foundation grant to S. L. Pallas, by a GSU Brains and Behavior scholarship to Y.-T. Mao, and by the NSF Science and Technology Centers Program Grant IBN-9876754.	Allman BL, 2009, P NATL ACAD SCI USA, V106, P5925, DOI 10.1073/pnas.0809483106; Angelucci A, 1998, J COMP NEUROL, V400, P417, DOI 10.1002/(SICI)1096-9861(19981026)400:3<417::AID-CNE10>3.0.CO;2-O; Angelucci A, 1997, J NEUROSCI, V17, P2040; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beauchamp MS, 2008, J NEUROSCI, V28, P13696, DOI 10.1523/JNEUROSCI.3872-08.2008; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; BOGNAR L, 1994, ACTA NEUROCHIR, V127, P161, DOI 10.1007/BF01808760; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; de la Mothe LA, 2006, J COMP NEUROL, V496, P72, DOI 10.1002/cne.20924; Fallon JB, 2009, HEARING RES, V257, P93, DOI 10.1016/j.heares.2009.08.006; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; FOX JG, 1998, BIOL DIS FERRET; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hoistad DL, 2003, AUDIOL NEURO-OTOL, V8, P111, DOI 10.1159/000068999; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; KELLY JB, 1986, HEARING RES, V24, P111, DOI 10.1016/0378-5955(86)90054-7; Kimiskidis VK, 2004, OTOL NEUROTOL, V25, P178, DOI 10.1097/00129492-200403000-00017; Kingsbury MA, 2000, J COMP NEUROL, V424, P165, DOI 10.1002/1096-9861(20000814)424:1<165::AID-CNE12>3.0.CO;2-U; Kingsbury MA, 2002, DEV BRAIN RES, V138, P35, DOI 10.1016/S0165-3806(02)00456-X; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee SS, 2009, J COMPUT ASSIST TOMO, V33, P305, DOI 10.1097/RCT.0b013e31817e6f58; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; MAO Y, FRONT NEUR C 2010 S, DOI DOI 10.3389/CONF.FNINS.2010.04.00013; MAO YT, 2007, SOC NEUR ABSTR, V36, P2; Masuda S, 2000, ANN OTO RHINOL LARYN, V109, P1107, DOI 10.1177/000348940010901204; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Meyer B, 1996, J NEUROL NEUROSUR PS, V61, P423, DOI 10.1136/jnnp.61.4.423; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229, DOI 10.1152/jn.1998.80.5.2229; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Musiek FE, 2004, J AM ACAD AUDIOL, V15, P172; Musiek Frank E, 2004, J Am Acad Audiol, V15, P133, DOI 10.3766/jaaa.15.2.4; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Nishimura H, 2000, NEUROREPORT, V11, P811, DOI 10.1097/00001756-200003200-00031; PALLAS SL, 1990, J COMP NEUROL, V298, P50, DOI 10.1002/cne.902980105; Pallas SL, 1999, P NATL ACAD SCI USA, V96, P8751, DOI 10.1073/pnas.96.15.8751; PALLAS SL, 1993, J COMP NEUROL, V337, P317, DOI 10.1002/cne.903370212; PHILLIPS DP, 1988, BRAIN RES, V443, P281, DOI 10.1016/0006-8993(88)91622-8; REH TA, 1985, J NEUROSCI, V5, P1132; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Ro T, 2007, ANN NEUROL, V62, P433, DOI 10.1002/ana.21219; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1993, J COMP NEUROL, V334, P263, DOI 10.1002/cne.903340208; ROE AW, 1992, J NEUROSCI, V12, P3651; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; SHESKIN D, 2004, HDB PARAMETRIC NONPA, pR33; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; Sterr A, 2003, BIOL PSYCHOL, V63, P117, DOI 10.1016/S0301-0511(03)00051-6; Stryker M P, 1982, Neurosci Res Program Bull, V20, P540; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Yaka R, 2000, EXP BRAIN RES, V131, P144, DOI 10.1007/s002219900295	73	14	16	0	15	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	APR	2011	105	4					1558	1573		10.1152/jn.00407.2010			16	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	751LW	WOS:000289620500012	21273321	Green Published			2022-02-06	
J	Clausen, F; Hillered, L; Gustafsson, J				Clausen, Fredrik; Hillered, Lars; Gustafsson, Jan			Cerebral glucose metabolism after traumatic brain injury in the rat studied by C-13-glucose and microdialysis	ACTA NEUROCHIRURGICA			English	Article						Microdialysis; Traumatic brain injury; Metabolism; In vivo studies	MEMBRANE PHOSPHOLIPID DEGRADATION; COMPRESSION CONTUSION TRAUMA; INTERSTITIAL GLYCEROL; ENERGY-METABOLISM; ISOFLURANE; OXYGEN; ANESTHESIA; ISCHEMIA; MARKER; DAMAGE	Following traumatic brain injury (TBI), a disturbed cerebral glucose metabolism contributes to secondary brain damage. To study local cerebral glucose metabolism after TBI, we delivered C-13-labeled glucose into brain tissue by microdialysis (MD). MD probes were inserted bilaterally into the parietal cortex of rat brain, one probe in the shear stress zone of the injury and the other at the corresponding contralateral coordinates. A moderately severe controlled cortical contusion was used to model TBI. Dialysate concentrations of glucose, pyruvate, lactate, and glycerol were measured, and following derivatization, C-13 enrichments of the compounds were determined by gas chromatography-mass spectrometry. We found that C-13-labeled glucose was rapidly converted into C-13-lactate and C-13-glycerol. In the hours following TBI, concentrations and C-13 enrichments of lactate and glycerol increased. The findings confirm the occurrence of anaerobic local glucose metabolism early after TBI. Only a small fraction of the glycerol was newly synthesized, suggesting that the hypothesis that most of the released glycerol after TBI comes from degradation of membrane phospholipids still holds. We conclude that the combination of microdialysis and stable isotope technique is a useful tool for investigating local glucose metabolism following brain injury.	[Clausen, Fredrik; Hillered, Lars] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden; [Gustafsson, Jan] Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden		Clausen, F (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, Entrance 85,2nd Floor, S-75185 Uppsala, Sweden.	fredrik.clausen@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417; Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Uppsala University Hospital; Selander Foundation; Gillberg Foundation; Ahlen Foundation	The authors would like to thank Elisabet Soderberg and Inger Stahl-Myllyaho for skillful technical assistance. This study was supported by the Swedish Research Council, the Swedish Brain Foundation, Uppsala University Hospital, the Selander Foundation, The Gillberg Foundation, and the Ahlen Foundation.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; ARCHER DP, 1990, J CEREBR BLOOD F MET, V10, P624, DOI 10.1038/jcbfm.1990.114; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Gustafsson J, 2007, SCAND J CLIN LAB INV, V67, P155, DOI 10.1080/00365510600995259; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Nguyen NHT, 2007, J NEUROCHEM, V101, P1694, DOI 10.1111/j.1471-4159.2006.04433.x; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; ORI C, 1986, ANESTHESIOLOGY, V65, P152, DOI 10.1097/00000542-198608000-00004; Pfeuffer J, 1999, MAGNET RESON MED, V41, P1077, DOI 10.1002/(SICI)1522-2594(199906)41:6<1077::AID-MRM1>3.0.CO;2-#; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	27	14	15	0	9	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2011	153	3					653	658		10.1007/s00701-010-0871-7			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	723HN	WOS:000287497500033	21103896				2022-02-06	
J	Mao, L; Wang, HD; Pan, H; Qiao, LA				Mao, Lei; Wang, Han-Dong; Pan, Hao; Qiao, Liang			Sulphoraphane enhances aquaporin-4 expression and decreases spinal cord oedema following spinal cord injury	BRAIN INJURY			English	Article						Spinal cord injury; sulphoraphane; Nrf2; Aquaporin-4; vasogenic oedema	TRAUMATIC BRAIN-INJURY; COMPRESSION INJURY; ISCHEMIC-INJURY; NULL MICE; SULFORAPHANE; RATS; CHEMOPREVENTION; RECOVERY; MOUSE; MODEL	Background: Aquaporin-4 (AQP4) is a water channel protein and it is an important determinant of outcome after brain injury. Sulphoraphane (SFN) increases AQP4 levels with reduction of brain oedema at 3 days post-traumatic brain injury. However, little is known about the effect of SFN on AQP4 expression and oedema after spinal cord injury (SCI). Methods and procedures: The present study used a murine SCI model induced by compression injury. AQP4 protein level and mRNA level were detected by Western blot and by RT-PCR at 48 hours after SCI, respectively. In addition, immunohistochemical study was used to show AQP4 expression in the spinal cord segments and water content of the spinal cord segments were measured by wet : dry weight ratio. Main outcomes and results: This study shows that AQP4 level was decreased in the injured spinal cord segments at 48 hours following SCI. Post-injury administration of SFN increased AQP4 levels, which was accompanied by a significant reduction in spinal cord segment oedema at 48 hours post-injury. Conclusion: These findings suggest that the reduction of spinal cord oedema in response to SFN administration could be due, in part, to water clearance by AQP4 from the injured spinal cord segments.	[Mao, Lei; Wang, Han-Dong; Pan, Hao; Qiao, Liang] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing 210002, Jiangsu Prov, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	hdwang_nj@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Jiangsu Provincial Key Subject [X4200722]; Jinling Hospital of Nanjing, China [2009Q016]	This work was supported by grants from National Natural Science Foundation of China (No. 81070974), the Jiangsu Provincial Key Subject (X4200722), and Jinling Hospital of Nanjing, China (2009Q016). The authors alone are responsible for the content and writing of the paper.	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Li S, 1999, SPINAL CORD, V37, P820, DOI 10.1038/sj.sc.3100941; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marques SA, 2009, J NEUROSCI METH, V177, P183, DOI 10.1016/j.jneumeth.2008.10.015; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9612(03)00497-6; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; vonEuler M, 1997, EXP NEUROL, V145, P502, DOI 10.1006/exnr.1997.6481; Wang YF, 2009, NEUROREPORT, V20, P145, DOI 10.1097/WNR.0b013e32831c6c44; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Xu WB, 2008, BRAIN RES, V1246, P11, DOI 10.1016/j.brainres.2008.09.087; Yan W, 2008, BRAIN INJURY, V22, P802, DOI 10.1080/02699050802372174; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	30	14	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2011	25	3					300	306		10.3109/02699052.2010.542432			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	734UP	WOS:000288365400006	21280976				2022-02-06	
J	Rubovitch, V; Shachar, A; Werner, H; Pick, CG				Rubovitch, Vardit; Shachar, Adi; Werner, Haim; Pick, Chaim G.			Does IGF-1 administration after a mild traumatic brain injury in mice activate the adaptive arm of ER stress?	NEUROCHEMISTRY INTERNATIONAL			English	Article						Brain-trauma; Cell death mechanisms; Cognitive impairments; Neuroprotection	UNFOLDED PROTEIN RESPONSE; DEATH; ATF6	Mild traumatic brain injury (mTBI) induces along with cognitive impairments, both cell death and survival pathways. Previously, IGF-1 (Insulin like growth factor 1) administration prevented TBI-induced damage. This study was aimed at testing the effect of mTBI on ER (endoplasmic reticulum) stress activation and looking for a possible interaction between IGF-1 and ER stress pathways. Mice were subjected to a weight drop closed head injury. Western blot analysis revealed that mTBI induced activation of ATF6 (activating transcription factor 6), but not of CHOP or grp78. IGF-1 administration following mTBI did not change ATF6 or grp78 levels, but significantly elevated CHOP. These results suggest that IGF-1 may exert its neuroprotection via PERK/CHOP, the adaptive arm of the unfolded protein response. (C) 2011 Elsevier Ltd. All rights reserved.	[Rubovitch, Vardit; Shachar, Adi; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Werner, Haim] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Rubovitch, V (corresponding author), Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	rubovitc@post.tau.ac.il					Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Benjamin IJ, 2006, CIRC RES, V98, P1120, DOI 10.1161/01.RES.0000223522.47948.16; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160	15	14	16	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186			NEUROCHEM INT	Neurochem. Int.	MAR	2011	58	4					443	446		10.1016/j.neuint.2011.01.009			4	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	740EQ	WOS:000288774800001	21219958				2022-02-06	
J	Salvatore, AP; Fjordbak, BS				Salvatore, Anthony P.; Fjordbak, Bess Sirmon			Concussion Management: The Speech-Language Pathologist's Role	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; HEAD-INJURY; SPORTS; EPIDEMIOLOGY; PREDICTORS; STATEMENT; RECOVERY; IMPACT	This article outlines the areas of concern in the evaluation and treatment of sports-related concussion and the role of speech-language pathologists (SLPs) in the management of this diagnosis. The specific diagnostic criteria for concussion are an area of ongoing controversy relative to differentiation from mild traumatic brain injury (mTBI). Assessment has evolved from simple paper and pencil tasks and ad hoc sideline examinations to computer-based assessment in the office and on the sideline. Treatment protocols are evolving, showing a clear change from traditional models of service delivery in mTBI to one in which the individual with a concussion is asked to limit both physical and cognitive stimulation. This period of reduced stimulation varies, depending on the severity of the injury and the rate of recovery. SLPs can play an important role in the prevention and management of concussion.	[Salvatore, Anthony P.; Fjordbak, Bess Sirmon] Univ Texas El Paso, Dept Rehabil Sci, Speech Language Pathol Program, El Paso, TX USA		Salvatore, AP (corresponding author), Coll Hlth Sci 401, 1101 N Campbell St, El Paso, TX 79902 USA.						Allen EA, 2007, TRAUMA, V9, P181, DOI 10.1177/1460408607087717; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2007, SCOP PRACT SPEECH LA; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Caridge N. E. F., 1981, HEAD INJURY; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cekic M, 2010, FUTUR NEUROL, V5, P37, DOI 10.2217/FNL.09.72; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kontos AP, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P315, DOI 10.1007/0-387-32565-4_14; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee M., 2009, MANAGEMENT RECOMMEND; Lovell MR, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P111, DOI 10.1007/0-387-32565-4_6; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meythaler J. M., 2006, BRAIN INJURY MED PRI, P1023; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Salvatore A. P., 2008, NEW DEV SPORTS REL C; Salvatore A. P., 2008, TEX SOC ALL HLTH PRO; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Springhouse Group, 2009, HDB SIGNS SYMPT; TEASDALE G, 1974, LANCET, V2, P81; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Tommasone BA, 2006, J ATHL TRAINING, V41, P470	44	14	14	0	9	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2011	19	1					1	12					12	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	V34SR	WOS:000209106500002					2022-02-06	
J	de Andrade, AF; Paiva, WS; de Amorim, RLO; Figueiredo, EG; de Almeida, AN; Brock, RS; Bor-Seng-Shu, E; Teixeira, MJ				de Andrade, Almir Ferreira; Paiva, Wellingson Silva; Oliveira de Amorim, Robson Luis; Figueiredo, Eberval Gadelha; de Almeida, Antonio Nogueira; Brock, Roger Schmidt; Bor-Seng-Shu, Edson; Teixeira, Manoel Jacobsen			Continuous ventricular cerebrospinal fluid drainage with intracranial pressure monitoring for management of posttraumatic diffuse brain swelling	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						decompressive craniectomy; intracranial pressure monitoring; head injury; brain swelling	INJURY; INFECTION; EDEMA; RISK; EXPERIENCE; RESOLUTION; DURATION	Background: Ventricular drainage has played an important role in the management of traumatic brain-injured patients. The aim of the present study was describe outcomes in a series of 57 patients with diffuse brain swelling underwent to intracranial pressure (ICP) monitoring. Method: Fifty-eight patients with diffuse posttraumatic brain swelling, were evaluated prospectively. The Glasgow Coma Scale (GCS) scores of patients varied from 4 to 12. Patients groups divided according to GCS and age. Patient neurological assessment was classified as favorable, unfavorable, and death. Results: Mechanisms of injury were vehicle accidents in 72.4% and falls in 15.6%. 54% of patients had GCS scores between 6 and 8. There were no statistical differences, regarding outcome, between groups separated by age. In the adults group (n=47), 44.7% evolved favorably. Conclusion: Our results indicate a poor prognosis in patients with brain swelling. We believe that continuous ventricular CSF drainage with ICP monitoring is a simple method as an adjunct in the management of these patients.	[de Andrade, Almir Ferreira; Paiva, Wellingson Silva; Oliveira de Amorim, Robson Luis; Figueiredo, Eberval Gadelha; de Almeida, Antonio Nogueira; Brock, Roger Schmidt; Bor-Seng-Shu, Edson; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Fac Med, Clin Hosp, Dept Neurol & Neurosurg, Sao Paulo, Brazil		Paiva, WS (corresponding author), Rua Teodoro Sampaio 498-66, BR-05406000 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Figueiredo, Eberval G/E-2071-2016; Figueiredo, Eberval Gadelha/H-3488-2012; Almeida, Antonio/O-5506-2019; Teixeira, Manoel J/E-3110-2012; Amorim, Robson/AAK-1368-2021; BOR-SENG-SHU, EDSON/AAC-9762-2019; Paiva, Wellingson S/G-5517-2013; BOR-SENG-SHU, EDSON/H-7784-2013; de Almeida, Antonio Nogueira/A-2957-2016	Almeida, Antonio/0000-0002-0796-7025; Amorim, Robson/0000-0003-2391-7519; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Paiva, Wellingson S/0000-0002-5165-7040; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; de Almeida, Antonio Nogueira/0000-0002-0796-7025			*AM COLL SURG, 2007, ATLS STUD MAN; ANDRADE AF, 2000, J NEUROTRAUM, V19, P1381; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; CAO MH, 1984, J NEUROSURG, V61, P707, DOI 10.3171/jns.1984.61.4.0707; Caruselli G, 1992, J Neurosurg Sci, V36, P219; CHESNUT RM, 1993, HEAD INJURY, P225; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; de Andrade AF, 2001, WORLD J SURG, V25, P1186; FELDMAN Z, 1993, HEAD INJURY, P247; Flibotte JJ, 2004, NEUROCRIT CARE, V1, P61, DOI 10.1385/NCC:1:1:61; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Kanter M J, 1991, Neurosurg Clin N Am, V2, P257; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; LUERSSEN TG, 1991, INTRACRANIAL PRESSUR, V8, P42; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; REULEN HJ, 1978, J NEUROSURG, V48, P754, DOI 10.3171/jns.1978.48.5.0754; Shore PM, 2004, J NEUROTRAUM, V21, P1113; SHU EBS, 2006, J NEUROSURG, V104, P93; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; WINFIELD JA, 1993, NEUROSURGERY, V33, P424	33	14	21	0	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	FEB	2011	69	1					79	84		10.1590/S0004-282X2011000100016			6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	727OB	WOS:000287809600016	21359428	gold, Green Published, Green Submitted			2022-02-06	
J	Gasparetto, EL; Lopes, FCR; Domingues, RC; Domingues, RC				Gasparetto, Emerson L.; Rueda Lopes, Fernanda C.; Domingues, Roberto C.; Domingues, Romeu C.			Diffusion Imaging in Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Diffusion imaging; Traumatic brain injury; Magnetic resonance imaging; Computed tomography	WHITE-MATTER INJURY; CLOSED-HEAD INJURY; AXONAL INJURY; PROFESSIONAL BOXERS; TENSOR TRACTOGRAPHY; OUTCOME PREDICTION; CORPUS-CALLOSUM; ANISOTROPY; MODERATE; DAMAGE	Traumatic brain injury is a common cause of death worldwide, affecting mostly young people. The most feasible examination to be performed in the emergency room is computed tomography. Magnetic resonance (MR) imaging is becoming a significant tool in the evaluation of severe brain trauma. Diffusion-weighted imaging is an advanced MR imaging sequence that has been used to detect areas of ischemia and tumor malignancy. This article describes the recent advances in trauma based on diffusion-weighted MR imaging findings and in brain injury from head trauma based on diffusion-weighted MR imaging and diffusion tensor MR imaging findings. Current and potential clinical applications are discussed.	[Gasparetto, Emerson L.; Rueda Lopes, Fernanda C.; Domingues, Roberto C.; Domingues, Romeu C.] CDPI Clin Diagnost Por Imagem, Rio De Janeiro, Brazil; [Gasparetto, Emerson L.; Rueda Lopes, Fernanda C.] Univ Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Domingues, Roberto C.; Domingues, Romeu C.] Clin Multiimagem, Rio De Janeiro, Brazil		Gasparetto, EL (corresponding author), Estrada Da Barra Da Tijuca 1006 Ap 1106, BR-22641003 Rio De Janeiro, Brazil.	egasparetto@gmail.com					Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; DUCKWORTH JL, 2010, CURR OPIN CRIT CARE; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schaefer PW, 2001, J NEUROL SCI, V186, pS25, DOI 10.1016/S0022-510X(01)00488-9; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	41	14	15	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2011	21	1					115	+		10.1016/j.nic.2011.02.003			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	757ZJ	WOS:000290128200007	21477754				2022-02-06	
J	Amantini, A; Carrai, R; Fossi, S; Pinto, F; Grippo, A				Amantini, Aldo; Carrai, Riccardo; Fossi, Selvaggia; Pinto, Francesco; Grippo, Antonello			The role of early electroclinical assessment in improving the evaluation of patients with disorders of consciousness	FUNCTIONAL NEUROLOGY			English	Article						coma; EEG; ERP; minimally conscious state; SEP; vegetative state	SOMATOSENSORY-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; ANOXIC-ISCHEMIC COMA; VEGETATIVE STATE; CARDIAC-ARREST; PROGNOSTIC VALUE; CARDIOPULMONARY-RESUSCITATION; MISMATCH NEGATIVITY; PREDICTS RECOVERY	We all share the need to optimise the evaluation of patients with disorders of consciousness (DOC), given the high rate of misdiagnosis of vegetative state based on clinical examination. We believe that one way to do this is to optimise assessment from the early stages, in order to reduce discontinuity between the hospital and rehabilitation phases. While clinical observation remains the "gold standard" for the diagnostic assessment of patients with DOC, neurophysiological investigations (electroencephalography, short latency evoked potentials and event-related potentials) could help to further understanding of the pathophysiology underlying the state of unresponsiveness, differentiate coma from other apparently similar conditions (i.e., locked-in and locked-in-like syndromes), and potentially integrate prognostic evaluation with monitoring of the evolution of the clinical state. Moreover, these techniques have the considerable advantage of being available at the bedside. Discontinuity between the hospital and rehabilitation phases is rightly considered to be one of the critical points in the assessment of patients with DOC. In our view, a continuum of expert neurological assessment that begins with monitoring of the acute phase (focusing on evolution of primary brain damage and secondary complications) and follows through to the patient's discharge from the intensive care unit (focusing on the pathophysiology of brain damage and prognostication based on clinical, neuroimaging and neurophysiological tests) could help to: i) optimise the rehabilitation programme according to the expectations of recovery; ii) provide a basis for comparison with subsequent periodic re-evaluations; iii) ensure uniformity of assessment regardless of the heterogeneity of care facilities; and iv) characterise a subset of patients who, showing discrepancies between neurophysiological tests and clinical status, are more likely to undergo unexpected recovery.	[Amantini, Aldo; Carrai, Riccardo; Fossi, Selvaggia; Pinto, Francesco; Grippo, Antonello] Careggi Univ Hosp, Dept Neurosci, Florence, Italy; [Carrai, Riccardo; Grippo, Antonello] IRCCS Don Carlo Gnocchi Fdn, UOF Neurol, Florence, Italy		Amantini, A (corresponding author), AOUC Careggi, Dip Sci Neurol, Largo Brambilla 3, I-50134 Florence, Italy.	amantini@unifi.it	grippo, antonello/AAP-6926-2020	Grippo, Antonello/0000-0002-9997-8564			Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Attia J, 1998, CRIT CARE CLIN, V14, P497, DOI 10.1016/S0749-0704(05)70013-0; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Bouwes A, 2009, NEUROLOGY, V73, P1457, DOI 10.1212/WNL.0b013e3181bf98f4; Carrai R, 2009, NEUROPHYSIOL CLIN, V39, P95, DOI 10.1016/j.neucli.2008.11.003; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Fins JJ, 2007, CURR OPIN NEUROL, V20, P650, DOI 10.1097/WCO.0b013e3282f11f6d; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Geocadin RG, 2008, CURR OPIN CRIT CARE, V14, P261, DOI 10.1097/MCC.0b013e3282fd68ea; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giugni E, 2010, FUNCT NEUROL, V25, P189; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; GUERIT JM, 2008, INTRAOPERATIVE MONIT, V8, P829; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kottenberg-Assenmacher E, 2003, ANESTHESIOLOGY, V98, P1112, DOI 10.1097/00000542-200305000-00013; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Lee YC, 2010, NEUROLOGY, V74, P572, DOI 10.1212/WNL.0b013e3181cff761; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Owen AM, 2007, CURR OPIN NEUROL, V20, P632, DOI 10.1097/WCO.0b013e3282f15669; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Tiainen M, 2005, CRIT CARE MED, V33, P1736, DOI 10.1097/01.CCM.0000171536.63641.D9; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	52	14	16	0	5	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264			FUNCT NEUROL	Funct. Neurol.	JAN-MAR	2011	26	1					7	14					8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	789OJ	WOS:000292524900002	21693083				2022-02-06	
J	Jacob, AT; Heuer, GG; Grant, R; Georgoff, P; Danish, SF; Storm, PB; Stein, SC				Jacob, Arun T.; Heuer, Gregory G.; Grant, Ryan; Georgoff, Patrick; Danish, Shabbar F.; Storm, Phillip B.; Stein, Sherman C.			Decompressive Hemicraniectomy for Pediatric Traumatic Brain Injury: Long-Term Outcome Based on Quality of Life	PEDIATRIC NEUROSURGERY			English	Article						Pediatric traumatic brain injury; Hemicraniectomy, outcome; Quality of life	SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL EDEMA; CRANIECTOMY; CHILDREN; CRANIOTOMY; MANAGEMENT; PRESSURE; EXPERIENCE; SCALE	Aims: The impact of decompressive hemicraniectomy (DCH) on the overall outcome of pediatric brain injury patients has not been fully determined. In this paper, the authors performed a systematic review of patient outcome based on quality of life following DCH in a pediatric population. Methods: We describe our experience with decompressive craniectomy in pediatric patients and perform a literature review and pooled outcomes analysis to supplement these findings. A total of 13 children underwent DCH for intractable intracranial pressure in our institution from 2000 to 2008. Follow-up was available in 11 patients with 1 death (9%) and 7 survivors (70%) obtaining a favorable outcome (Glasgow Outcome Scale, GOS, scores = 4-5). Results: A literature review to determine the usefulness of DCH identified 17 articles that, when combined with our series, resulted in 186 pediatric DCH cases. Pooled outcomes found 42 deaths and 112 patients who had favorable outcomes at 6 months. The average 6-month mortality was 21.1%, and the pooled mean quality of life among survivors 0.75 (0.68-0.82), midway between moderate disability and good outcome. Conclusions: Based on our findings, DCH results in a majority of pediatric patients having a good outcome based on the GOS score. Copyright (C) 2011 S. Karger AG, Basel	[Jacob, Arun T.; Heuer, Gregory G.; Grant, Ryan; Georgoff, Patrick; Storm, Phillip B.; Stein, Sherman C.] Univ Penn Hlth Syst, Dept Neurosurg, Philadelphia, PA 19104 USA; [Heuer, Gregory G.; Storm, Phillip B.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Danish, Shabbar F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Neurosurg, New Brunswick, NJ USA		Jacob, AT (corresponding author), Univ Penn Hlth Syst, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	arun.jacob@uphs.upenn.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Brain Trauma Foundation, 2003, MAN PROGN SEV TRAUM; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P305, DOI 10.1111/j.1749-6632.1997.tb48441.x; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Gold M., 1996, COST EFFECTIVENESS H; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Maas AIR, 2004, ACT NEUR S, V89, P113; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Mukherjee KK, 2006, SURG NEUROL, V66, P305, DOI 10.1016/j.surneu.2005.12.035; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Simma B, 2002, INTENS CARE MED, V28, P1000, DOI 10.1007/s00134-002-1333-3; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410	34	14	14	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2011	47	2					81	86		10.1159/000329624			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	842BP	WOS:000296561900001	21934271				2022-02-06	
J	Kreitschmann-Andermahr, I; Hartmann, Y; Poll, E; Schneider, HJ; Buchfelder, M; Stalla, GK				Kreitschmann-Andermahr, I.; Hartmann, Y.; Poll, E.; Schneider, H. J.; Buchfelder, M.; Stalla, G. K.		Investigator Board	The German Database on Hypopituitarism after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage - Description, Objectives and Design	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						traumatic brain injury; subarachnoid hemorrhage; hypopituitarism; growth hormone deficiency; database		Within the last years, a number of clinical studies have addressed the topic of hypothalamo-pituitary dysfunction following traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH). Clinical studies oftentimes reflect the investigation of highly selective patient groups, very standardized test procedures and may be influenced by a publication bias. Epidemiological data on the prevalence and incidence of hypopituitarism after TBI and SAH in the general population still do not exist. Moreover, very little is known about risk factors and clinical characteristics of pituitary impairment after brain damage. Epidemiologic surveys which aggregate information of many different treatment centers become an increasingly important means of bridging the gap between standardized study situations and clinical practice. Therefore, a multi-center, structured data assessment to create a national registry of TB! and SAH patients has been established in 2005. The Structured Data Assessment of Hypopituitarism after TBI and SAH is coordinated by the Department of Endocrinology, Max-Planck-Institute in Munich with participation of at present 13 neurosurgical, rehabilitation and endocrinological centers in Germany and one Austrian center. Within this database, a large scope of very detailed, clinical, endocrine and outcome information is collected. It also offers the possibility of long-term follow up of the recorded patients. This is the first report of the registry describing goals, organization, methodology, funding and the descriptive data of the first 1 242 patients entered until November 20(th), 2008.	[Kreitschmann-Andermahr, I.; Hartmann, Y.; Poll, E.] Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany; [Buchfelder, M.] Univ Erlangen Nurnberg, Dept Neurosurg, D-8520 Erlangen, Germany; [Stalla, G. K.] Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, D-80804 Munich, Germany; [Schneider, H. J.] Univ Munich, Med Klin Innenstadt, D-80804 Munich, Germany		Kreitschmann-Andermahr, I (corresponding author), Univ Technol RWTH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	ikreitschmann-andermahr@ukaachen.de			PfizerPfizer; Novo NordiskNovo Nordisk; NovartisNovartis; LillyEli Lilly	IKA received research grants from Pfizer and Novo Nordisk and travel grants from Pfizer, Novo Nordisk and Novartis. HJS received research grants from Pfizer, speaker fees and travel grants from Pfizer and Novo Nordisk, and travel grants from Lilly and Novartis. MB received research grants, speaker fees, and travel grants from Pfizer, Novo Nordisk and Novartis. GKS received research grants, speaker fees, and travel grants from Pfizer, Novo Nordisk and Novartis.	FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hutter BO, 1999, ACT NEUR S, V72, P157; JENNETT B, 1975, LANCET, V1, P480; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tamargo R J, 1997, New Horiz, V5, P364; TEASDALE G, 1974, LANCET, V2, P81; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6	11	14	17	0	1	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	JAN	2011	119	1					15	20		10.1055/s-0030-1253414			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	734TN	WOS:000288361900003	20533178				2022-02-06	
J	Linden, A; Lexell, J; Lund, ML				Linden, Anita; Lexell, Jan; Lund, Maria Larsson			Improvements of task performance in daily life after acquired brain injury using commonly available everyday technology	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Activities of daily living; assistive technology; brain injury; occupational therapy; rehabilitation		Purpose. To investigate how individualised occupation-based interventions with commonly available everyday technology (ET) can compensate for perceived difficulties with daily life tasks after an aquired brain injury (ABI) and improve satisfaction with occupational performance. Method. This intervention study was designed as a multiple case study according to Yin. Ten men and women with an ABI (traumatic or non-traumatic) participated. Data were collected through interviews, observations and field notes before and after the intervention and at follow-up (on average 11 weeks afterwards). The interventions focused on enabling each participant's prioritised goals related to task performance in daily life. Results. All participants achieved all their goals by learning to use both new functions in their own familiar ET and new ET. The participant's perceived difficulties in occupational performance decreased and their satisfaction with occupational performance increased with the use of ET. Conclusions. An individualised intervention process, involving the use of own familiar ET or ET off-the-shelf, has the potential to compensate for perceived difficulties following an ABI and improve satisfaction with occupational performance in daily life.	[Linden, Anita; Lexell, Jan] Skane Univ Hosp, Dept Rehabil Med, Lund, Sweden; [Lexell, Jan] Lund Univ, Dept Clin Sci, Div Rehabil Med, Lund, Sweden; [Lund, Maria Larsson] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden; [Lund, Maria Larsson] Umea Univ, Dept Community Med & Rehabil Occupat Therapy, Umea, Sweden		Lund, ML (corresponding author), Lulea Univ Technol, Dept Hlth Sci Occupat Therapy, Lulea, Sweden.	maria.larsson-lund@ltu.se		Lexell, Jan/0000-0001-5294-3332; Larsson-Lund, Maria/0000-0002-0341-6197	Swedish Inheritance Fund; Norrbacka-Eugenia Foundation; Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)	This study was part of the Cognition and Technology (CogniTech) project, conducted within the Swedish Institute of Assistive Technology and supported financially by the Swedish Inheritance Fund and the Norrbacka-Eugenia Foundation. Dr. Maria Larsson Lund is supported by a post-doc grant from the Swedish Council for Working Life and Social Research. Dr. Jan Lexell completed the study within the context of the Centre for Ageing and Supportive Environments (CASE) at Lund University, funded by the Swedish Council for Working Life and Social Research.	Angelo J, 1997, AM J OCCUP THER, V51, P916, DOI 10.5014/ajot.51.10.916; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Engstrom ALL, 2010, SCAND J OCCUP THER, V17, P233, DOI [10.1080/11038120903191806, 10.3109/11038120903191806]; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fisher AG, 2001, ASSESSMENT MOTOR PRO, VI; Fisher AG, 2009, MODEL PLANNING IMPLE; Fisher I, 2004, AUST OCCUP THER J, V51, P185, DOI DOI 10.1111/J.1440-1630.2004.00446.X; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Hocking C., 1999, TECHNOLOGY DISABILIT, V11, P3, DOI DOI 10.3233/TAD-1999-111-202; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Lange ML, 2002, AM J OCCUP THER, V56, P107, DOI 10.5014/ajot.56.1.107; Larsson Lund M, 2010, RESPONSES DIFF UNPUB; Law M., 2006, CANADIAN OCCUPATIONA; Linden A, SCAND J OCC IN PRESS; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nygard L, 2007, AGING MENT HEALTH, V11, P144, DOI 10.1080/13607860600844168; Phillips B, 1993, Assist Technol, V5, P36; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Salminen A.L., 2006, AUST OCCUP THER J, V53, DOI [10.1111/j.1440-1630.2006.00540.x, DOI 10.1111/J.1440-1630.2006.00540.X, https://doi.org/10.1111/j.1440-1630.2006.00540.x]; Scherer MJ, 2005, DISABIL REHABIL, V27, P731, DOI 10.1080/09638280400014816; Scherer MJ, 2002, DISABIL REHABIL, V24, P1, DOI 10.1080/09638280110066262; Scherer MJ, 1997, DISABIL REHABIL, V19, P528, DOI 10.3109/09638289709166046; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilson BA, 2002, J HEAD TRAUMA REHAB, V17, P542, DOI 10.1097/00001199-200212000-00006; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wilson BA, 2008, APPL NEUROPSYCHOL, V15, P229, DOI 10.1080/09084280802325017; Wressle E., 1999, SCAND J OCCUP THER, V6, P84, DOI [DOI 10.1080/110381299443771, 10.1080/110381299443771]; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Yin R., 2003, CASE STUDY RES	41	14	14	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2011	6	3					214	224		10.3109/17483107.2010.528142			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V06PR	WOS:000213952600003	20977393	Green Submitted			2022-02-06	
J	Liu, M; Wei, WL; Fergenbaum, J; Comper, P; Colantonio, A				Liu, Margaret; Wei, Wenli; Fergenbaum, Jennifer; Comper, Paul; Colantonio, Angela			Work-related mild-moderate traumatic brain injury and the construction industry	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Person-Environment-Occupation model; occupation; prevention; workplace safety	ACCIDENTS; DEATHS	Background: Consequences of traumatic brain injury underscore the need to study high-risk groups. Few studies have investigated work-related traumatic brain injuries (WrTBIs) in the construction industry. Objective: To examine WrTBIs in Ontario for the construction industry compared to other industries. Methods: A retrospective study of individuals who sustained a WrTBI and had a clinical assessment as an outpatient at a hospital-based referral centre. Data were collected for a number of factors including demographic, injury and occupation and were analyzed according to the Person-Environment-Occupation (PEO) model. Participants: 435 individuals who sustained a WrTBI. Results: There were 19.1% in the construction industry, 80.9% in other industries. Compared to other industries, individuals in the construction industry were more likely to be male, to not have attained post-secondary education, and experience multiple traumas. WrTBIs in the construction industry were commonly due to elevated work. The construction occupations involved included skilled workers and general labourers, and compared to other industries, WrTBIs occurred most often for those employed for a short duration in the construction industry. Conclusions: Construction industry workers experience serious WrTBIs that are amenable to prevention. Use of the PEO model increased our understanding of WrTBIs in the construction industry.	[Colantonio, Angela] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Fergenbaum, Jennifer; Comper, Paul; Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Rehabil Sci Bldg,500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765; Salerno, Jennifer/0000-0001-7282-5579			Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; COLEMAN VP, 1986, J OCCUP ACCID, V8, P161, DOI 10.1016/0376-6349(86)90002-7; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Haslam RA, 2005, APPL ERGON, V36, P401, DOI 10.1016/j.apergo.2004.12.002; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Hsiao H, 2001, ERGONOMICS, V44, P537, DOI 10.1080/00140130110034480; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kim H, 2006, NEUROREHABILITATION, V21, P269; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; Lipscomb HJ, 2006, APPL ERGON, V37, P267, DOI 10.1016/j.apergo.2005.07.008; McCann M, 2003, J SAFETY RES, V34, P507, DOI 10.1016/j.jsr.2003.07.001; Neitzel R L, 2001, Appl Occup Environ Hyg, V16, P1106; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schaller Bernhard J, 2008, J Trauma, V64, pE29, DOI 10.1097/01.ta.0000197145.19876.38; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Workplace Safety and Insurance Board, 2008, STAT SUPPL 2007 ANN	17	14	14	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2011	39	3					283	290		10.3233/WOR-2011-1176			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	806TL	WOS:000293835300009	21709364				2022-02-06	
J	McDonald, S; Saad, A; James, C				McDonald, Skye; Saad, Abdul; James, Charlotte			Social dysdecorum following severe traumatic brain injury: Loss of implicit social knowledge or loss of control?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Implicit cognition; Explicit cognition; Executive functioning; Implicit association test	ASSOCIATION TEST; EMOTION PERCEPTION; HUMAN AMYGDALA; HEAD-INJURY; COGNITION; BEHAVIOR; DEFICITS; DAMAGE; RELIABILITY; NEUROBIOLOGY	The purpose of the present study was to investigate two theoretical frameworks for understanding acquired deficits in social behavior in individuals with severe traumatic brain injury (TBI). Recent research has found that brain injury can lead to impairments in implicit processes including social cognition. Impairments in implicit social cognition have been recently advanced as an explanation for acquired social deficits, as implicit social cognition is hypothesized to mediate the processing and understanding of often subtle, nonverbal cues in social interactions. In contrast, the executive dysfunction account posits that deficits in higher order cognitive functions, such as attention, planning ability, and mental flexibility, are the locus for acquired deficits in social cognition and behavior. To test these two theories, 22 participants with severe TBI and 25 matched controls were administered a measure of implicit social cognition (Implicit Association Test, IAT), as well as two measure of explicit social attitudes and a range of executive functioning measures. The TBI participants were found to perform normally on the IAT and explicit measures of gender stereotyping but demonstrated executive deficits. Performance on the IAT and executive functions were correlated. Performance in general did not fit well with the implicit social cognition explanation for social dysdecorum following TBI. More evidence was found to support the executive account.	[McDonald, Skye; Saad, Abdul; James, Charlotte] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	S.McDonald@psy.unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094	Australian Research CouncilAustralian Research Council	This research was funded by the Australian Research Council. We would also like to extend many thanks to the research participants with traumatic brain injuries as well as our control participants who gave so freely of their time and showed genuine interest in the project. We wish to thank clinicians from the Royal Rehabilitation Centre Brain Injury Unit and the Liverpool Brain Injury Unit who assisted with recruitment.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; [Anonymous], 2003, INQ 2 0 COMP SOFTW; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Barker LA, 2006, NEUROPSYCHOLOGIA, V44, P1413, DOI 10.1016/j.neuropsychologia.2005.12.005; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beldarrain MG, 1999, NEUROLOGY, V52, P1853, DOI 10.1212/WNL.52.9.1853; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blanton H, 2006, J EXP SOC PSYCHOL, V42, P192, DOI 10.1016/j.jesp.2005.07.003; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Burgess P.W., 1997, HAYLING BRIXTON TEST; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Codispoti M, 2009, PSYCHOPHYSIOLOGY, V46, P731, DOI 10.1111/j.1469-8986.2009.00804.x; Conrey FR, 2005, J PERS SOC PSYCHOL, V89, P469, DOI 10.1037/0022-3514.89.4.469; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAUGHERTY CG, 1986, EDUC PSYCHOL MEAS, V46, P449, DOI 10.1177/001316448604600221; De Houwer J, 2006, LEARN MOTIV, V37, P176, DOI 10.1016/j.lmot.2005.12.002; de Sousa A., CORTEX IN PRESS; Eslinger PJ, 2008, NEUROPSYCHOLOGICAL RESEARCH: A REVIEW, P379; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Glick P., 1996, J PERS SOC PSYCHOL, V69, P1013; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hummert ML, 2002, PSYCHOL AGING, V17, P482, DOI 10.1037//0882-7974.17.3.482; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Klauer KC, 2007, J PERS SOC PSYCHOL, V93, P353, DOI 10.1037/0022-3514.93.3.353; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McFarland SG, 2002, SOC COGNITION, V20, P483, DOI 10.1521/soco.20.6.483.22977; Messner C, 2010, J MARKETING RES, V47, P374, DOI 10.1509/jmkr.47.2.374; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reitan RM, 1992, TRAIL MAKING TEST; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spence J. T., 1972, JSAS CATALOG SELECTE, V2, P66; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; von Stulpnagel R, 2010, Z PSYCHOL, V218, P51, DOI 10.1027/0044-3409/a000008; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Whalen PJ, 1998, J NEUROSCI, V18, P411; YODER JD, 1982, SEX ROLES, V8, P651, DOI 10.1007/BF00289898	74	14	15	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	6					619	630		10.1080/13803395.2011.553586			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882GA	WOS:000299550100002	21480024				2022-02-06	
J	O'Connor, MK; Mueller, L; Van Ormer, A; Drake, R; Penk, W; Rosenheck, R; Semiatin, A; Drebing, CE				O'Connor, Maureen K.; Mueller, Lisa; Van Ormer, Alice; Drake, Robert; Penk, Walter; Rosenheck, Robert; Semiatin, Alicia; Drebing, Charles E.			Cognitive impairment as barrier to engagement in vocational services among veterans with severe mental illness	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cognitive functioning; cognitive impairment; integrated services; pathways-to-care; return to work; severe mental illness; supported employment; treatment entry; vocational disability; vocational services	RANDOMIZED CONTROLLED-TRIAL; EUTHYMIC BIPOLAR PATIENTS; TRAUMATIC BRAIN-INJURY; SUPPORTED EMPLOYMENT; NEUROPSYCHOLOGICAL PERFORMANCE; SELF-AWARENESS; VISUAL-SEARCH; PART-B; SCHIZOPHRENIA; REHABILITATION	Vocational services (VS), particularly supported employment models, have clear advantages for assisting adults with severe mental illness (SMI) in returning to the workplace, but a majority of eligible individuals with SMI do not receive any type of VS. The reasons for nonparticipation in VS remain poorly understood, and the potential contribution of cognitive impairment as a barrier to entry has not been explored. The present study uses a pathways-to-care design to examine the specific contribution of cognitive functioning to entry into VS among veterans with SMI. We examined 179 veterans with both SMI and un- or underemployment who completed a work history, the Pathways To Care Inventory, and the Trail-Making Test, Part B. Analysis revealed that veterans with SMI and moderate to severe cognitive impairment took significantly longer to progress through pathways-to-care than those with SMI and mild or no cognitive impairment. These results suggest that identifying veterans with SMI and cognitive impairment early and providing them with integrated and adjunct services may help them navigate VS.	[O'Connor, Maureen K.; Mueller, Lisa; Van Ormer, Alice; Penk, Walter; Semiatin, Alicia; Drebing, Charles E.] Bedford Dept Vet Affairs VA Med Ctr, Bedford, MA USA; [O'Connor, Maureen K.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Drake, Robert] Dartmouth Med Sch, Hanover, NH USA; [Rosenheck, Robert] VA Connecticut Healthcare Syst, West Haven, CT USA; [Rosenheck, Robert] Yale Univ, Sch Med, New Haven, CT USA		O'Connor, MK (corresponding author), Bedford VAMC, Dept Psychol, 200 Springs Rd, Bedford, MA 01730 USA.	maureen.oconnor@va.gov	Drake, Robert/AAS-3310-2020	O'Connor, Maureen/0000-0002-2466-0367	VHA Office of Rehabilitation Research and Development [F3436R]	This material was based on work supported by the VHA Office of Rehabilitation Research and Development (grant F3436R).	Addington J, 2002, ACTA PSYCHIAT SCAND, V106, P358, DOI 10.1034/j.1600-0447.2002.02004.x; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bell M, 2003, ACTA PSYCHIAT SCAND, V108, P101, DOI 10.1034/j.1600-0447.2003.00090.x; Bell M, 2007, J REHABIL RES DEV, V44, P761, DOI 10.1682/JRRD.2007.02.0032; BLACK BJ, 1988, WORK MENTAL ILLNESS; Blankertz L, 1996, PSYCHIATR SERV, V47, P1216; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Bond GR, 1991, J VOCATIONAL REHABIL, V1, P9; Bryson G, 1998, J NERV MENT DIS, V186, P610, DOI 10.1097/00005053-199810000-00004; Burns T, 2009, SCHIZOPHRENIA BULL, V35, P949, DOI 10.1093/schbul/sbn024; Casper ES, 2006, PSYCHIAT SERV, V57, P1430, DOI 10.1176/appi.ps.57.10.1430; Cook J A, 1992, J Ment Health Adm, V19, P158, DOI 10.1007/BF02521316; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Crowther R. E., 2001, J MENTAL HLTH, V10, P373, DOI DOI 10.1080/09638230120041137; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Drebing CE, 2003, REHABIL COUNS BULL, V47, P15, DOI 10.1177/00343552030470010301; DREBING CE, 2000, P ANN CONV AM PSYCH; Drebing Charles, 2004, Am J Alzheimers Dis Other Demen, V19, P187, DOI 10.1177/153331750401900306; Drebing CE, 1994, NEUROPSYCHOLOGY, V8, P31, DOI 10.1037/0894-4105.8.1.31; Dunn EC, 2008, PSYCHIATR REHABIL J, V32, P59, DOI 10.2975/32.1.2008.59.62; EHRENSTEIN WH, 1982, ARCH PSYCHIAT NERVEN, V231, P333, DOI 10.1007/BF00345589; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FABIAN E, 1989, PSYCHOSOC REHABIL, V2, P53, DOI DOI 10.1037/H0099503; Field A., 2017, DISCOVERING STAT USI, V5th; First M. B., 1996, USERS GUIDE STRUCTUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Galderisi S, 2009, SCHIZOPHR RES, V115, P104, DOI 10.1016/j.schres.2009.09.022; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Gervey R., 1994, PSYCHOL ASSESSMENT T, P139; Goldberg DP., 1980, MENTAL ILLNESS COMMU; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Jablensky A, 1999, PEOPLE LIVING PSYCHO; KEEFE R, 2008, BEST PRACT MENT HLTH, V4, P123; Keefe RSE, 2007, SCHIZOPHRENIA BULL, V33, P912, DOI 10.1093/schbul/sbm046; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Krabbendam L, 2005, SCHIZOPHR RES, V80, P137, DOI 10.1016/j.schres.2005.08.004; Kurtz MM, 2004, SCHIZOPHR RES, V68, P95, DOI 10.1016/S0920-9964(03)00179-8; Larsen TK, 1998, BRIT J PSYCHIAT, V172, P45, DOI 10.1192/S0007125000297651; Lindenmayer JP, 2008, PSYCHIAT SERV, V59, P241, DOI 10.1176/appi.ps.59.3.241; MacDonald-Wilson K. L., 1991, J VOCATIONAL REHABIL, V1, P30; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Martinez-Aran A, 2002, NEUROPSYCHOBIOLOGY, V46, P16, DOI 10.1159/000068016; Marwaha S, 2004, SOC PSYCH PSYCH EPID, V39, P337, DOI 10.1007/s00127-004-0762-4; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; McGurk SR, 2000, SCHIZOPHR RES, V45, P175, DOI 10.1016/S0920-9964(99)00198-X; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; McGurk SR, 2004, SCHIZOPHR RES, V70, P147, DOI 10.1016/j.schres.2004.01.009; McGurk SR, 2008, PSYCHIATR REHABIL J, V31, P350, DOI 10.2975/31.4.2008.350.359; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; MOWBRAY CT, 1994, COMMUNITY MENT HLT J, V30, P347, DOI 10.1007/BF02207488; Mueser KT, 2001, SCHIZOPHRENIA BULL, V27, P281, DOI 10.1093/oxfordjournals.schbul.a006874; Osuji IJ, 2005, PSYCHIAT CLIN N AM, V28, P427, DOI 10.1016/j.psc.2005.02.005; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resnick SG, 2009, PSYCHIAT SERV, V60, P682, DOI 10.1176/appi.ps.60.5.682; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; STRAUSS ME, 1993, SCHIZOPHRENIA BULL, V19, P215, DOI 10.1093/schbul/19.2.215; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tsang H, 2000, INT J SOC PSYCHIATR, V46, P306, DOI 10.1177/002076400004600407; van Gorp WG, 1998, ARCH GEN PSYCHIAT, V55, P41, DOI 10.1001/archpsyc.55.1.41; vandenBosch RJ, 1997, COMPR PSYCHIAT, V38, P341, DOI 10.1016/S0010-440X(97)90930-5; VOLGRATH M, 1994, J CLIN PSYCHOL, V50, P727; Wexler BE, 2005, SCHIZOPHRENIA BULL, V31, P931, DOI 10.1093/schbul/sbi038; Wilder-Willis KE, 2002, SCHIZOPHR RES, V55, P259, DOI 10.1016/S0920-9964(01)00211-0; Woodruff G. R., 1995, ARCH CLIN NEUROPSYCH, V10, P408	71	14	14	0	13	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	5					597	607		10.1682/JRRD.2010.06.0117			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	783GJ	WOS:000292069200014	21674409	Bronze			2022-02-06	
J	Pistarini, C; Aiachini, B; Coenen, M; Pisoni, C				Pistarini, Caterina; Aiachini, Beatrice; Coenen, Michaela; Pisoni, Camilla		Italian Network	Functioning and disability in traumatic brain injury: the Italian patient perspective in developing ICF Core Sets	DISABILITY AND REHABILITATION			English	Article						International Classification of Functioning; Disability and Health; ICF; traumatic brain injury (MeSH); qualitative research (MeSH); focus groups (MeSH); patient perspective	QUALITY-OF-LIFE; PERSISTENT VEGETATIVE STATE; FOCUS GROUPS; INTERNATIONAL CLASSIFICATION; HEALTH-CARE; REHABILITATION; SATISFACTION; RETURN; MODEL; SCALE	Objective. The purpose of the study was to explore the aspects of functioning and health relevant to patients with traumatic brain injury (TBI) and to the caregivers of TBI patients explicitly involved in the preliminary study for the Development of the ICF Core Set for TBI using a qualitative research method. Method. The sampling of patients followed the maximum variation strategy. To respect this strategy, we involved patients with different degrees of impairment and so, for some people it was not possible to join the group because of their severe cognitive impairment, in this case we interviewed their caregivers. The focus groups were digitally recorded and transcribed verbatim. The meaning condensation procedure was used for the data analysis. After qualitative data analyses, the resulting concepts were linked to ICF categories according to established linking rules. Results. Eighteen focus groups and five single interviews were performed. Forty-one patients participated in 10 focus groups. Thirty-three caregivers participated in eight focus group and six caregivers underwent a single interview. Saturation at 10% cutoff was reached. Based on 10 patient focus groups, we linked the concepts to 144 2nd level ICF different categories. In the eight focus group with caregiver we linked the concepts to 129 2nd level categories. In the single interviews, we could link the concepts only to Environmental factors and we linked to 25 ICF different categories. Conclusion. A broad range of aspects of functioning and health as well as several Environmental factors important to patients with TBI were explored and included in the preparatory phase of the development of ICF Core Sets for TBI. Whereas patients focused on problems in mobility, employment and recreation and leisure the caregivers highlighted several issues related to self-care as being important for the patients.	[Pistarini, Caterina; Aiachini, Beatrice; Pisoni, Camilla] Coordinator Ctr IRCCS S Maugeri Fdn, Neurorehabil Unit, Sci Inst Pavia, Pavia, Italy; [Coenen, Michaela] Univ Munich, IHRS, Res Unit Biopsychosocial Hlth, Munich, Germany; [Coenen, Michaela] DIMDI, ICF Res Branch, WHO Collaborating Ctr Family Int Classificat Germ, Munich, Germany		Aiachini, B (corresponding author), Coordinator Ctr IRCCS S Maugeri Fdn, Neurorehabil Unit, Sci Inst Pavia, Pavia, Italy.	beatrice.aiachini@fsm.it	Casanova, Emanuela/AAD-3643-2022; aiachini, beatrice/AAC-1992-2020; Pistarini, CATERINA/K-5234-2018; Pisoni, Camilla/P-8491-2019	Casanova, Emanuela/0000-0002-5727-3769; Pistarini, CATERINA/0000-0001-8925-0484; Pisoni, Camilla/0000-0001-9292-9682; Coenen, Michaela/0000-0001-7492-7907; aiello, alessia/0000-0002-1616-3096			Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; BARNES MP, 2005, OXFORD HDB REHABILIT; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Carey A., 1994, CRITICAL ISSUES QUAL, P225; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; COENEN M, QUAL LIFE RES; Coenen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1956; Curtis S, 2000, SOC SCI MED, V50, P1001, DOI 10.1016/S0277-9536(99)00350-0; Denzin Norman K, 1978, RES ACT THEORETICAL; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Grill E, 2005, DISABIL REHABIL, V27, P459, DOI 10.1080/09638280400014063; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hagen C., 1972, LEVELS COGNITIVE FUN; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; JENNETT B, 1972, LANCET, V1, P734; Karlsson G, 1995, PSYCHOL QUALITATIVE; Kirchberger I, 2010, SPINAL CORD, V48, P603, DOI 10.1038/sc.2009.184; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Knodel J., 1993, SUCCESSFUL FOCUS GRO, V1, P35, DOI DOI 10.4135/9781483349008; Krueger R. A., 2000, FOCUS GROUPS PRACTIC, V3rd; KRUEGER RA, 1995, QUAL HEALTH RES, V5, P524, DOI 10.1177/104973239500500412; KVALE S, 1996, INTERVIEWSAN INTRO Q; Leonardi M, 2009, DISABIL REHABIL, V31, pS128, DOI 10.3109/09638280903317765; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Morgan D.L., 1997, FOCUS GROUPS QUALITA, V2nd ed.; Morgan DL, 1993, SUCCESSFUL FOCUS GRO, P3, DOI DOI 10.4135/9781483349008; Morse J.M., 1994, CRITICAL ISSUES QUAL; Murphy E., 1998, HLTH TECHNOL ASSESS, V2, P1, DOI DOI 10.3310/HTA2160; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patton M.Q., 1990, QUALITATIVE EVALUATI; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Powell RA, 1996, INT J SOC PSYCHIATR, V42, P193, DOI 10.1177/002076409604200303; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Varjacic M, 2010, COLLEGIUM ANTROPOL, V34, P157; Vaughn S, 1996, FOCUS GROUP INTERVIE; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; World Health Organization, 2007, INT CLASS FUNCT DIS; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	55	14	15	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	23-24					2333	2345		10.3109/09638288.2011.570414			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	841GB	WOS:000296499500021	21501040				2022-02-06	
J	Neil, S; Padgham, C; Martin, CJ				Neil, S.; Padgham, C.; Martin, C. J.			A study of the relationship between peak skin dose and cumulative air kerma in interventional neuroradiology and cardiology	JOURNAL OF RADIOLOGICAL PROTECTION			English	Article							FLUOROSCOPICALLY GUIDED PROCEDURES; KODAK EDR2 FILM; AREA PRODUCT; INJURIES; RADIOLOGY	A study of peak skin doses (PSDs) during neuroradiology and cardiology interventional procedures has been carried out using Gafchromic XR-RV2 film. Use of mosaics made from squares held in cling film has allowed doses to the head to be mapped successfully. The displayed cumulative air kerma (CAK) has been calibrated in terms of cumulative entrance surface dose (CESD) and results indicate that this can provide a reliable indicator of the PSD in neuroradiology. Results linking PSD to CESD for interventional cardiology were variable, but CAK is still considered to provide the best option for use as an indicator of potential radiation-induced effects. A CESD exceeding 3 Gy is considered a suitable action level for triggering follow-up of patients in neuroradiology and cardiology for possible skin effects. Application of dose action levels defined in this way would affect 8% of neurological embolisation procedures and 5% of cardiology ablation and multiple stent procedures at the hospitals where the investigations were carried out. A close relationship was observed between CESD and dose-area product (DAP) for particular types of procedure, and DAPs of 200-300 Gy cm(2) could be used as trigger levels where CAK readings were not available. The DAP value would depend on the mean field size and would need to be determined for each application.	[Neil, S.; Padgham, C.; Martin, C. J.] Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland		Neil, S (corresponding author), Ninewells Hosp, Dept Med Phys, Dundee DD1 9SY, Scotland.						Baiter S, 2008, MED PHYS, V35, P673, DOI 10.1118/1.2829868; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Bogaert E, 2009, BRIT J RADIOL, V82, P303, DOI 10.1259/bjr/29449648; Butson MJ, 2006, MED PHYS, V33, P2923, DOI 10.1118/1.2219330; Chida K, 2006, AM J ROENTGENOL, V186, P774, DOI 10.2214/AJR.04.1653; Chida K, 2007, AM J ROENTGENOL, V189, pW224, DOI 10.2214/AJR.07.2422; Chu RYL, 2006, HEALTH PHYS, V91, P41, DOI 10.1097/01.HP.0000198784.94210.1f; D'Ercole L, 2007, AM J NEURORADIOL, V28, P503; Domienik J, 2008, RADIAT PROT DOSIM, V132, P18, DOI 10.1093/rpd/ncn247; Faulkner K, 2005, RADIAT PROT DOSIM, V117, P166, DOI 10.1093/rpd/nci737; Ferreira BC, 2009, PHYS MED BIOL, V54, P1073, DOI 10.1088/0031-9155/54/4/017; Giles ER, 2002, HEALTH PHYS, V82, P875, DOI 10.1097/00004032-200206000-00017; Imanishi Y, 2005, EUR RADIOL, V15, P41, DOI 10.1007/s00330-004-2459-1; International Commission on Radiological Protection (ICRP), 2000, ICRP PUBL, V85; International Electrotechnical Commission (IEC), 2000, 60601243 IEC; Karambatsakidou A, 2005, BRIT J RADIOL, V78, P803, DOI 10.1259/bjr/14000648; Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003; Koenig TR, 2001, AM J ROENTGENOL, V177, P13, DOI 10.2214/ajr.177.1.1770013; Mooney RB, 2000, BRIT J RADIOL, V73, P745, DOI 10.1259/bjr.73.871.11089467; Morrell RE, 2006, BRIT J RADIOL, V79, P756, DOI 10.1259/bjr/57359387; Morrell RE, 2006, BRIT J RADIOL, V79, P603, DOI 10.1259/bjr/78359708; Morrell RE, 2004, PHYS MED BIOL, V49, P5559, DOI 10.1088/0031-9155/49/24/011; Padovani R, 2005, RADIAT PROT DOSIM, V117, P247, DOI 10.1093/rpd/nci757; Rampado O, 2006, PHYS MED BIOL, V51, pN403, DOI 10.1088/0031-9155/51/23/N01; Rampado O, 2005, RADIAT PROT DOSIM, V117, P256, DOI 10.1093/rpd/nci759; Shope TB, 1996, RADIOGRAPHICS, V16, P1195, DOI 10.1148/radiographics.16.5.8888398; Struelens L, 2005, RADIAT PROT DOSIM, V114, P143, DOI 10.1093/rpd/nch537; Taylor JB, 2009, HEALTH PHYS, V96, P138, DOI 10.1097/01.HP.0000327665.46577.af; van de Putte S, 2000, BRIT J RADIOL, V73, P504, DOI 10.1259/bjr.73.869.10884747; Vano E, 2005, RADIAT PROT DOSIM, V117, P190, DOI 10.1093/rpd/nci714; Vano E, 2001, BRIT J RADIOL, V74, P48, DOI 10.1259/bjr.74.877.740048; Zontar D, 2010, RADIAT PROT DOSIM, V139, P262, DOI 10.1093/rpd/ncq013	32	14	14	0	9	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0952-4746	1361-6498		J RADIOL PROT	J. Radiol. Prot.	DEC	2010	30	4					659	672		10.1088/0952-4746/30/4/002			14	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	691PK	WOS:000285093100003	21149930				2022-02-06	
J	Weiss, H; Agimi, Y; Steiner, C				Weiss, Harold; Agimi, Yll; Steiner, Claudia			Youth Motorcycle-Related Hospitalizations and Traumatic Brain Injuries in the United States in 2006	PEDIATRICS			English	Article						hospitalizations; motorcycle; scooters; traffic accidents; nontraffic accidents; adolescents; injury; traumatic brain injury; costs; injury severity		OBJECTIVES: The objectives were to provide national injury and health care cost estimates for youth motorcycle injuries in traffic and non-traffic settings and to focus on the burden of serious motorcycle-related traumatic brain injuries (TBIs) in children and young adults. METHODS: The 2006 Kids' Inpatient Database is a sample of inpatient discharges for US patients <21 years of age from 38 states. This cross-sectional analysis of the 2006 Kids' Inpatient Database included comparisons of TBI versus non-TBI and traffic versus nontraffic motorcycle-related crashes for ages 12 to 20, with national estimates of hospital charges and costs, length of stay, severity, and long-term disability rates. RESULTS: Motorcycle-related crashes accounted for 5662 discharges (95% confidence interval: 5201-6122 discharges), which amounts to 3% of injury hospitalizations among youths and 5% of TBI diagnoses; two-thirds of cases were traffic-related, and one-third of patients sustained a TBI (1793 patients [95% confidence interval: 1631-1955 patients]). Among patients with TBIs, the overall probability of long-term disability was 24%. Patients with TBIs were 3.6 times more likely to be discharged to a rehabilitation facility and >10 times more likely to die in the hospital than were patients without TBIs. CONCLUSIONS: Motorcycle injuries are a substantial cause of youth injury hospitalizations. The large proportion, costs, and morbidity of TBI diagnoses in youth motorcycle crashes emphasize the need for effective crash prevention and head protection. Pediatrics 2010;126:1141-1148	[Weiss, Harold] Univ Pittsburgh, Ctr Injury Res & Control, Pittsburgh, PA USA; [Agimi, Yll] Assoc Sch Publ Hlth, Washington, DC USA; [Steiner, Claudia] Ctr Delivery Org & Markets Agcy Healthcare Res &, Rockville, MD USA		Weiss, H (corresponding author), POB 56, Dunedin 9054, New Zealand.	hw@injurycontrol.com	AGIMI, YLL/AAL-9337-2021		National Highway Traffic Safety Administration [DTNH22-04-H-05087]	This work was performed under a cooperative agreement with the National Highway Traffic Safety Administration (grant DTNH22-04-H-05087).	Agency for Healthcare Research and Quality, 2008, INTR HCUP KIDS INP D; Agency for Healthcare Research and Quality, CLIN CLASS SOFTW CCS; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; BUTLER JA, 2001, CENTRAL NERVOUS SYST; *CDCP, WISQARS INJ MORT REP; Centers for Disease Control and Prevention, BRIDG RAC POP EST; Clark DE, 2008, 8 WORLD C INJ PREV S; Coben JH, 2007, ACCIDENT ANAL PREV, V39, P190, DOI 10.1016/j.aap.2006.06.018; *NAT CTR HLTH STAT, BAR INJ DIAGN MATR F; National Center for Injury Prevention and Control, WISQARS NONF INJ REP; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568	13	14	14	1	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	DEC	2010	126	6					1141	1148		10.1542/peds.2010-0271			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	688EF	WOS:000284831900040	21078737				2022-02-06	
J	Yoshihara, E; Takahashi, T; Otsuka, N; Isayama, T; Tomiyama, T; Hiraga, A; Wada, S				Yoshihara, E.; Takahashi, T.; Otsuka, N.; Isayama, T.; Tomiyama, T.; Hiraga, A.; Wada, S.			Heel movement in horses: comparison between glued and nailed horse shoes at different speeds	EQUINE VETERINARY JOURNAL			English	Article						horse; hoof mechanism; shoeing; heel movement; glued shoe	REACTION FORCE PATTERNS; HOOF FUNCTION; EQUINE; WALK	P>Reasons for performing study: It has been suggested that the heel of the horse's hoof expands in the stance phase and this reduces the concussion at impact and helps pump blood into the hoof. Therefore, farriers usually leave a gap in the heel region when using the traditional nailed shoe. Recently glued shoes which are attached firmly to the heel have been developed and these could restrict heel movement. Objective: To compare the degree of mediolateral heel movement between glued and nailed shoes. Methods: Seven Thoroughbreds were used. Either their fore- or hind hooves were shod with plain aluminium shoes, attached first with glue and later with nails. Measurements were collected continuously with a displacement sensor fixed between the medial and lateral hoof walls at the heel. The horses ran on a treadmill at a walk (1.8 m/s), trot (3.5 m/s), canter (8 m/s) and gallop (12 m/s). The mediolateral heel movement in a nonweightbearing position was set at zero for each hoof and thus positive and negative numbers represented expansion and contraction, respectively. Average values of 10 consecutive strides at each speed were compared between the 2 shoeing methods by paired t test. Results: At all running speeds, the heels expanded in the first 70-80% of the stance phase and contracted at breakover. The total heel movement calculated as the sum of the maximum expansion and contraction value was less with glued shoeing than with nailed shoeing for walking (all limbs), trotting (all limbs), cantering (leading forelimb and both hindlimbs) and galloping (both hindlimbs). Conclusions: Glueing restricted heel movement, suggesting possible interference with shock absorption and blood pumping in the hoof. Further study is needed to evaluate the influence of glued shoeing on hoof mechanics.	[Yoshihara, E.; Takahashi, T.; Isayama, T.; Hiraga, A.; Wada, S.] Japan Racing Assoc, Equine Res Inst, Utsunomiya, Tochigi, Japan; [Otsuka, N.] Japan Racing Assoc, Ritto Training Ctr, Shiga, Japan; [Tomiyama, T.] Japan Farriers Assoc, Educ Ctr, Utsunomiya, Tochigi, Japan		Yoshihara, E (corresponding author), Japan Racing Assoc, Equine Res Inst, Tokami Cho, Utsunomiya, Tochigi, Japan.	eirurich@gmail.com					Back W., 2001, Equine locomotion, P135; Barrey E, 1990, Equine Vet J Suppl, P35; Bowker RM, 1998, AM J VET RES, V59, P961; Cheramie HS, 2003, VET CLIN N AM-EQUINE, V19, P519, DOI 10.1016/S0749-0739(03)00021-X; COLLES CM, 1989, EQUINE VET J, V21, P17, DOI 10.1111/j.2042-3306.1989.tb02083.x; CURTIS S, 2006, CORRECTIVE FARRIERY, V2, P495; DAVIES HM, 1997, EQUINE VET J S, V23, P13; Dejardin LM, 2001, AM J VET RES, V62, P467, DOI 10.2460/ajvr.2001.62.467; Douglas JE, 1998, J EXP BIOL, V201, P2287; DYHREPOULSEN P, 1994, EQUINE VET J, V26, P362, DOI 10.1111/j.2042-3306.1994.tb04404.x; Kai M, 2000, AM J VET RES, V61, P979, DOI 10.2460/ajvr.2000.61.979; MERKENS HW, 1993, EQUINE VET J, V25, P134, DOI 10.1111/j.2042-3306.1993.tb02923.x; MERKENS HW, 1986, EQUINE VET J, V18, P207, DOI 10.1111/j.2042-3306.1986.tb03600.x; MERKENS HW, 1993, AM J VET RES, V54, P670; NIKI Y, 1982, B EQUINE RES INST, P1; NIKI Y, 1984, B EQUINE RES I, V21, P8; O'Grady SE, 2003, VET CLIN N AM-EQUINE, V19, pXI, DOI 10.1016/S0749-0739(03)00024-5; RATZLAFF MH, 1985, AM J VET RES, V46, P1545; ROEPSTORFF L, 2001, SUPPL, V33, P54; Stashak TS, 2002, ADAMS LAMENESS HORSE, P1081; THOMASON JJ, 1998, EQUINE VET J S, V26, P86	21	14	14	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0425-1644	2042-3306		EQUINE VET J	Equine Vet. J.	NOV 10	2010	42			38			431	435		10.1111/j.2042-3306.2010.00243.x			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	678KG	WOS:000284071900068	21059041				2022-02-06	
J	Bechir, M; Meierhans, R; Brandi, G; Sommerfeld, J; Fasshauer, M; Cottini, SR; Stocker, R; Stover, JF				Bechir, M.; Meierhans, R.; Brandi, G.; Sommerfeld, J.; Fasshauer, M.; Cottini, S. R.; Stocker, R.; Stover, J. F.			Insulin differentially influences brain glucose and lactate in traumatic brain injured patients	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; Glucose; Lactates; Critical care; Pharmacology	CEREBRAL ENERGY-METABOLISM; NERVOUS-SYSTEM; INTENSIVE-CARE; GLUT4; HYPERGLYCEMIA; MICRODIALYSIS; TRANSPORTERS; THERAPY; HYPOGLYCEMIA; EXPRESSION	Background. Hypo- and hyperglycemia must be avoided to prevent additional brain damage following traumatic brain injury (TBI). However, the optimal blood glucose range requiring insulin remains unknown. Cerebral microdialysis is helpful in unmasking signs of metabolic impairment, thereby identifying deleterious blood glucose levels. Methods. A retrospective analysis of prospectively collected cerebral microdialysis samples obtained from 20 non-diabetic patients with severe TBI treated at the trauma surgical intensive care unit at the University Hospital Zurich, Switzerland. Results. The impact of different arterial blood glucose values and concomitant insulin administration on cerebral interstitial glucose and lactate levels was investigated. In addition, energetic impairment was determined by calculating lactate-to-glucose ratios. Insulin administration was associated with significantly reduced cerebral glucose concentrations and significantly increased lactate-to-glucose ratios with arterial blood glucose levels <5 mM. At arterial blood glucose levels >7 mM, insulin administration was associated with significantly increased interstitial glucose values, significantly decreased lactate concentrations, and markedly diminished lactate-to-glucose ratios. Conclusion. Insulin exerts differential effects that depend strongly on the underlying arterial blood glucose concentrations. To avoid energetic impairment, insulin should not be administered at arterial blood glucose levels <5 mM. However, at arterial blood glucose levels >7-8 mM, insulin administration appears to be encouraged to increase extra-cellular glucose concentrations and decrease energetic impairment reflected by reduced interstitial brain lactate and decreased lactate-to-glucose ratios. Nevertheless, frequent analysis is required to minimize the risk of inducing impaired brain metabolism. (Minerva Anestesiol 2010;76:896-904)	[Bechir, M.; Meierhans, R.; Brandi, G.; Sommerfeld, J.; Fasshauer, M.; Cottini, S. R.; Stocker, R.; Stover, J. F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Brandi, G.] Osped Maggiore, Neurosurg Intens Care Unit, Dept Anesthesia & Crit Care Med, Policlin IRCCS Fdn, Milan, Italy		Stover, JF (corresponding author), Univ Zurich Hosp, CH-8091 Zurich, Switzerland.	john.stover@access.unizh.ch			Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF); SUVA Fonds	The help of:the nursing staff in collecting and analyzing cerebral microdialysis samples is gratefully acknowledged. The study was supported by grants from the Swiss National Science Foundation (SNF) and the SUVA Fonds to JFS and RS.	Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Leloup C, 1996, MOL BRAIN RES, V38, P45, DOI 10.1016/0169-328X(95)00306-D; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nehlig A, 1997, DIABETES METAB, V23, P18; Ngarmukos C, 2001, BRAIN RES, V900, P1, DOI 10.1016/S0006-8993(01)02184-9; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sonnewald U, 1996, DEV NEUROSCI-BASEL, V18, P443, DOI 10.1159/000111439; Sperry JL, 2007, J TRAUMA, V63, P487, DOI 10.1097/TA.0b013e31812e51fc; Stocchetti N, 2008, MINERVA ANESTESIOL, V74, P199; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Uehara Y, 1997, AM J PHYSIOL-ENDOC M, V272, pE716, DOI 10.1152/ajpendo.1997.272.4.E716; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	33	14	16	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	NOV	2010	76	11					896	904					9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	691XN	WOS:000285114200005	20634790				2022-02-06	
J	Huebinger, RM; Rivera-Chavez, F; Chang, LY; Liu, MM; Minei, JP; Purdue, GF; Hunt, JL; Arnoldo, BD; Barber, RC				Huebinger, Ryan M.; Rivera-Chavez, Fernando; Chang, Ling-Yu; Liu, Ming-Mei; Minei, Joseph P.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Barber, Robert C.			IL-10 Polymorphism Associated with Decreased Risk for Mortality After Burn Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						interleukin-10; genetic association; burn injury; mortality	SEVERE SEPSIS; INTERLEUKIN-10; EXPRESSION; GENE	Objective. Evaluation of single nucleotide polymorphisms (SNPs) in the interleukin-10 promoter (-592 and -819) on risk for death after burn injury. Methods. Association between the IL-10 SNPs and outcome after burn injury was evaluated in a cohort of 265 patients from Parkland Hospital, Dallas, TX with >= 15% TBSA burns without non-burn trauma (ISS <= 16), traumatic or anoxic brain injury or spinal cord injury, who survived > 48 h under an IRB-approved protocol. Clinical data were collected prospectively and genotyping was conducted by TaqMan assay. Whole blood from 31 healthy volunteers was stimulated with LPS (100 ng/mL) to determine the level of IL-10 expression for each allele by enzyme-linked immunosorbent assay (ELISA). Results. After adjustment for percent total body surface area (TBSA) burned, inhalation injury, age, gender, and race/ethnicity, carriage of -592A and/or -819T was significantly associated (P = 0.014) with a decreased risk for death (adjusted odds ratio: 0.404; 95% CI: 0.197-0.829). As the candidate SNPs were in complete linkage disequilibrium, it was not possible to distinguish which allele was associated with decreased mortality risk. Age, inhalation injury, and full-thickness burn size were significantly associated with increased risk for death. In the LPS stimulated blood of healthy controls, carriage of the -592A and/or -819T allele demonstrated a trend for decreased levels of IL-10 (P = 0.079). Conclusion. Carriage of the -592A and/or -819T allele in the IL-10 promoter appears to reduce the risk for death after burn injury. (C) 2010 Elsevier Inc. All rights reserved.	[Barber, Robert C.] Univ N Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Huebinger, Ryan M.; Rivera-Chavez, Fernando; Chang, Ling-Yu; Liu, Ming-Mei; Minei, Joseph P.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA		Barber, RC (corresponding author), Univ N Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3500 Camp Bowie Rd, Ft Worth, TX 76107 USA.	robert.barber@UNTHSC.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P50 GM21681-42, 5T32 GM008593-13]; NIH/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32 GM008593-13, 5P50 GM21681-43, 5K08GM071646-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM071646, T32GM008593, P50GM021681] Funding Source: NIH RePORTER	This study was supported by NIH grants 5P50 GM21681-42 and 5T32 GM008593-13.; SS SSupported by NIH/NIGMS 5P50 GM21681-43, 5T32 GM008593-13, 5K08GM071646-5.	Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bagnoli S, 2007, NEUROSCI LETT, V418, P262, DOI 10.1016/j.neulet.2007.03.030; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Csontos C, 2010, BURNS, V36, P483, DOI 10.1016/j.burns.2009.10.009; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Hee Chee Seng, 2007, Mod Rheumatol, V17, P429, DOI 10.1007/s10165-007-0612-9; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; MERRELL SW, 1989, J TRAUMA, V29, P1362, DOI 10.1097/00005373-198910000-00012; Miller SF, 2006, J BURN CARE RES, V27, P411, DOI 10.1097/01.BCR.0000226260.17523.22; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Yao JG, 2008, CLIN CHIM ACTA, V388, P84, DOI 10.1016/j.cca.2007.10.012	17	14	15	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2010	164	1					E141	E145		10.1016/j.jss.2010.07.021			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	700MR	WOS:000285747600020	20863526	Green Accepted			2022-02-06	
J	Degeneffe, CE; Lee, GK				Degeneffe, Charles Edmund; Lee, Gloria K.			Quality of Life After Traumatic Brain Injury: Perspectives of Adult Siblings	JOURNAL OF REHABILITATION			English	Article							REHABILITATION; DEPRESSION; SERVICES; SF-36	This study examined sibling perceptions on the quality of life of their brothers and sisters with traumatic brain injury (TBI). The authors examined how a national sample of 279 adult siblings of persons with TBI felt about the quality of life of their injured brothers and sisters. Using a constant comparative approach to text analysis, the authors analyzed responses to the question, "What is your feeling regarding your sibling's quality of life?" Participants expressed views that the life quality for their injured siblings was overall more negative than positive. Participants believed that the quality of life for their injured siblings was negative when they found difficulties in meeting expected life roles, when they were unable to psychologically adjust to their injuries, and when they received poor professional care. Alternatively, quality of life was rated positively when their injured siblings psychologically adjusted to their post-injury lives, when they experienced recovery from their post-injury functional impairments, and when they received positive support from family and professionals.	[Degeneffe, Charles Edmund] San Diego State Univ, Interwork Inst, Rehabil Counseling Program, San Diego, CA USA; [Lee, Gloria K.] SUNY Buffalo, Buffalo, NY 14260 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Interwork Inst, Rehabil Counseling Program, 3590 Camino Rio N, San Diego, CA USA.	cdegenef@mail.sdsu.edu					Basu M., 2006, ATLANTA J CONSTITUTI; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; BILLINGTON R, 1999, WHOQOL ANNOTATED BIB; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Bogdan R.C., 1998, QUALITATIVE RES ED I, V3rd; *BRAIN INJ ASS AM, 2004, TBI INC COMP TRAUM B; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chandra Ashish, 2005, Hosp Top, V83, P33, DOI 10.3200/HTPS.83.2.33-37; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CROW N, 2005, PERCEPTIONS REALITY; Cunningham J.M., 1999, CASE MANAGEMENT REHA, P91; Degeneffe C. E., 2008, REHABILITATION ED, V22, P101; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; DEPUIS PR, 1994, HYPERRESEARCH VERSIO; Dillman DA, 1978, MAIL TELEPHONE SURVE, V19; Elliott TE, 2003, PAIN MED, V4, P331, DOI 10.1111/j.1526-4637.2003.03040.x; FRANKSTROMBERG M, 1988, INSTRUMENTS CLIN NUR; Gephart R, 1997, J ORGAN BEHAV, V18, P583, DOI 10.1002/(SICI)1099-1379(199711)18:1+<583::AID-JOB908>3.0.CO;2-T; Gilbride D, 2003, REHABIL COUNS BULL, V46, P130, DOI 10.1177/00343552030460030101; HAGNER DC, 1994, REHABIL COUNS BULL, V37, P290; KINCAID CA, 1998, DISS ABSTR INT, V59, P93; Livneh HF, 1997, PSYCHOSOCIAL ADAPTAT; *NIH, 1999, REP NIH CONS DEV C R; OCAMPO S, 1997, OCCUPATIONAL THERAPY, V4, P163; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; REDMOND G, 1988, DISSERT ABSTR, V49, P3608; Rontondi A. J., 2005, J HEAD TRAUMA REHAB, V20, P173; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; SPRIGGS VT, 1998, PROMOTING CULTURAL C, P149; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Tian Y, 2006, CORP COMMUN, V11, P13, DOI 10.1108/13563280610643516; Vaughn SL, 2001, J HEAD TRAUMA REHAB, V16, P20, DOI 10.1097/00001199-200102000-00005; Vickrey Barbara G., 1993, P623; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; [No title captured]	40	14	14	0	1	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	2010	76	4					27	36					10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	674NY	WOS:000283755100004					2022-02-06	
J	Gordon, KE; Dooley, JM; Fitzpatrick, EA; Wren, P; Wood, EP				Gordon, Kevin E.; Dooley, Joseph M.; Fitzpatrick, Eleanor A.; Wren, Patty; Wood, Ellen P.			Concussion or Mild Traumatic Brain Injury: Parents Appreciate the Nuances of Nosology	PEDIATRIC NEUROLOGY			English	Article							STATEMENT; SPORT	We explored whether parents of our pediatric patients valued the diagnostic terms "concussion," "minor traumatic brain injury," and "mild traumatic brain injury" as equivalent or nonequivalent. 1734 of 2304 parents attending a regional pediatric emergency department completed a brief questionnaire assessing the equivalence or nonequivalence of the diagnostic terms "concussion," "minor traumatic brain injury," and "mild traumatic brain injury" in a pairwise fashion. Many parents viewed these diagnostic terms as equivalent, when assessed side by side. For those who considered these diagnostic terms nonequivalent, concussion was regarded as considerably "better" (or less "worse") than minor traumatic brain injury (P < 0.001, chi(2) test) or mild traumatic brain injury (P < 0.001, chi(2) test). A moderate degree of variability was evident in parent/guardian responses. As a group, parents reported that concussion or mild/minor traumatic brain injuries are valued equivalently. However, many parents considered them different, with concussion reflecting a "better" (or less "worse") outcome. (C) 2010 by Elsevier Inc. All rights reserved.	[Gordon, Kevin E.; Dooley, Joseph M.; Wood, Ellen P.] IWK Hlth Ctr, Dept Pediat, Div Pediat Neurol, Halifax, NS B3K 6R8, Canada; [Fitzpatrick, Eleanor A.; Wren, Patty] IWK Hlth Ctr, Dept Emergency Med, Halifax, NS B3K 6R8, Canada; [Gordon, Kevin E.; Dooley, Joseph M.; Wood, Ellen P.] Dalhousie Univ, Dept Pediat, Div Pediat Neurol, Halifax, NS, Canada		Gordon, KE (corresponding author), IWK Hlth Ctr, Dept Pediat, Div Pediat Neurol, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	kegor@dal.ca					Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; FIENBERG SE, 1989, SCIENCE, V243, P1017, DOI 10.1126/science.243.4894.1017; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Lauritsen J, 2000, EPIDATA DATA ENTRY D; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Rutherford W. H., 1989, MILD HEAD INJURY, P217; *SSPS INC, 1997, SYSTAT VERS 9 0; Statistics Canada, 2006, CAN COMM HLTH SURV C; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004	14	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	OCT	2010	43	4					253	257		10.1016/j.pediatrneurol.2010.05.012			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	676KC	WOS:000283908800005	20837303				2022-02-06	
J	Howell, CA; Nelson, NG; McKenzie, LB				Howell, Candace A.; Nelson, Nicolas G.; McKenzie, Lara B.			Pediatric and Adolescent Sledding-Related Injuries Treated in US Emergency Departments in 1997-2007	PEDIATRICS			English	Article						National Electronic Injury Surveillance System; injury; sledding; emergency department; traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNITED-STATES; CHILDREN	OBJECTIVES: The objectives were to examine comprehensively the patterns and to estimate the rates of sledding-related injuries among children and adolescents treated in US emergency departments between 1997 and 2007. METHODS: Through the use of the National Electronic Injury Surveillance System database, cases of sledding-related injuries were selected by using diagnosis codes for sleds. Sample weights were used to calculate national estimates. US Census Bureau data were used to calculate injury rates per 100 000 individuals <= 19 years of age. Computation of odds ratios with 95% confidence intervals was performed. RESULTS: From 1997 through 2007 an estimated 229 023 patients <= 19 years of age were treated for sledding-related injuries in US emergency departments, with an average of 20 820 cases per year. Children 10 to 14 years of age sustained 42.5% of sledding-related injuries, and boys represented 59.8% of all cases. The most frequent injury diagnoses were fractures (26.3%), followed by contusions and abrasions (25.0%). The head was the most commonly injured body part (34.1%), and injuries to the head were twice as likely to occur during collisions as through other mechanisms. Traumatic brain injuries were more likely to occur with snow tubes than with other sled types. A total of 4.1% of all cases required hospitalization. CONCLUSIONS: More research on the prevention of sledding-related injuries is warranted, particularly regarding the impact of helmets in reducing injury rates. The use of sledding products that may reduce visibility (such as snow tubes) should be discouraged. Pediatrics 2010; 126: 517-524	[Howell, Candace A.; Nelson, Nicolas G.; McKenzie, Lara B.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	lara.mckenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			Barton BK, 2007, J PEDIATR PSYCHOL, V32, P517, DOI 10.1093/jpepsy/jsm014; Bernardo L M, 1998, J Trauma Nurs, V5, P34; *CONS PROD SAF COM, 2007, NAT EL INJ SURV SYST; *CONS PROD SAF COM, 1999, SKI HELM EV POT RED; Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; DERSHEWITZ R, 1990, AM J DIS CHILD, V144, P1071; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; Landsman I S, 1987, Pediatr Emerg Care, V3, P277, DOI 10.1097/00006565-198712000-00015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee F, 1999, Inj Prev, V5, P198; LEWIS LM, 1994, SOUTHERN MED J, V87, P174, DOI 10.1097/00007611-199402000-00004; Major CP, 1999, SOUTHERN MED J, V92, P193, DOI 10.1097/00007611-199902000-00006; MANARY MJ, 1993, PEDIATR EMERG CARE, V9, P155, DOI 10.1097/00006565-199306000-00011; Noffsinger Dana, 2008, J Trauma Nurs, V15, P58, DOI 10.1097/01.JTN.0000327328.60405.f9; OBRIEN K, 2009, BOSTON GLOBE    0309; Ortega HW, 2005, PEDIATR EMERG CARE, V21, P839, DOI 10.1097/01.pec.0000190233.27857.6a; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schroeder T., 2001, NEISS SAMPLE DESIGN; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; SHUGERMAN RP, 1992, PEDIATR EMERG CARE, V8, P283, DOI 10.1097/00006565-199210000-00009; Skarbek-Borowska S, 2006, ACAD EMERG MED, V13, P181, DOI 10.1111/j.1553-2712.2006.tb01669.x; *SLEDS COM, HIST SLEDS TOB; *US BUR CENS, INT EST US POP AG SE; *US BUR CENS, NAT POP EST 2000S; Voaklander DC, 2001, ACAD EMERG MED, V8, P629, DOI 10.1111/j.1553-2712.2001.tb00176.x; Wagner Christopher, 2005, Air Med J, V24, P10, DOI 10.1016/j.amj.2004.10.007; Whitebread D, 2000, BRIT J EDUC PSYCHOL, V70, P539, DOI 10.1348/000709900158290; WYNNE AD, 1994, J TRAUMA, V37, P820, DOI 10.1097/00005373-199411000-00019; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	29	14	14	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2010	126	3					517	524		10.1542/peds.2009-1499			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	646JK	WOS:000281535700014	20732939				2022-02-06	
J	Hurley, M; Dineen, R; Padfield, CJH; Wilson, S; Stephenson, T; Vyas, H; Mcconachie, N; Jaspan, T				Hurley, M.; Dineen, R.; Padfield, C. J. H.; Wilson, S.; Stephenson, T.; Vyas, H.; Mcconachie, N.; Jaspan, T.			Is there a causal relationship between the hypoxia-ischaemia associated with cardiorespiratory arrest and subdural haematomas? An observational study	BRITISH JOURNAL OF RADIOLOGY			English	Article							INTRACRANIAL HEMORRHAGE; MR; ENCEPHALOPATHY; PREVALENCE; INJURY; BRAIN	The aim of this study was to determine the frequency of subdural haematomas (SDHs) occurring in infants presenting following atraumatic cardiorespiratory collapse. This study was a review of retrospective case notes, brain imaging and post-mortem examinations carried out in the paediatric intensive care unit (PICU) and emergency department (ED) in a tertiary paediatric centre in the UK. The study included infants and children less than 4 years old dying in the ED or admitted to the PICU after atraumatic cardiorespiratory arrest. We identified macroscopic SDHs on brain imaging or post-mortem examination. Of those children who experienced a cardiorespiratory arrest from a non-traumatic cause and met inclusion criteria, 33 presented and died in the ED and 17 were admitted to the PICU. These children had a post-mortem examination, brain imaging or both. None of these infants had a significant SDH. One child had a small clot adherent to the dura found on post-mortem and two had microscopic intradural haemorrhage, but it is unclear in each case whether this was artefact, as each had otherwise normal brains. Subdural haematoma arising in infants or young children in the context of catastrophic cardiorespiratory compromise from a non-traumatic cause was not observed.	[Hurley, M.; Stephenson, T.; Vyas, H.; Mcconachie, N.; Jaspan, T.] Univ Nottingham, Nottingham NG7 2RD, England; [Hurley, M.; Dineen, R.; Padfield, C. J. H.; Wilson, S.; Vyas, H.] Queens Med Ctr, Nottingham NG7 2UH, England		Jaspan, T (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.	tim.jaspan@nuh.nhs.uk	Dineen, Robert/S-7192-2019	Hurley, Matthew/0000-0002-2439-8522; Stephenson, Terence/0000-0001-8871-7847; Dineen, Robert/0000-0002-9523-2546			Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; BARKOVICH AJ, PEDIAT NEUROIMAGING, P226; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Christophe C, 2002, AM J NEURORADIOL, V23, P716; Cohen MC, 2009, PEDIATR DEVEL PATHOL, V12, P169, DOI 10.2350/08-08-0509.1; Geddes J F, 2004, Pediatr Rehabil, V7, P261, DOI 10.1080/13638490412331280435; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Levene M., 2009, FETAL NEONATAL NEURO, P395; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Rao P, 1999, CLIN RADIOL, V54, P495, DOI 10.1016/S0009-9260(99)90845-0; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Rutty GN, 2005, NEUROPATH APPL NEURO, V31, P247, DOI 10.1111/j.1365-2990.2004.00633.x; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; VOLPE JJ, 2008, HYPOXICISCHEMIC ENCE, P408; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9	18	14	14	0	4	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285			BRIT J RADIOL	Br. J. Radiol.	SEP	2010	83	993					736	743		10.1259/bjr/36871113			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	642WX	WOS:000281252800008	20647510	Green Published			2022-02-06	
J	Koeberle, PD; Schlichter, LC				Koeberle, Paulo D.; Schlichter, Lyanne C.			Targeting K-V channels rescues retinal ganglion cells in vivo directly and by reducing inflammation	CHANNELS			English	Article						neurotrauma; axotomy; optic nerve transection; microglial activation; apoptosis; K(V)1.1; K(V)1.3; siRNA in vivo; agitoxin-2; margatoxin	GROWTH-FACTOR-BETA; OPTIC-NERVE; SURVIVAL; DEATH; APOPTOSIS; PHOSPHORYLATION; INTERLEUKIN-1; DEGENERATION; TRANSECTION; ACTIVATION	Retinal ganglion cell (RGC) degeneration is an important cause of visual impairment, and results in part from microglia-mediated inflammation. Numerous experimental studies have focused on identifying drug targets to rescue these neurons. We recently showed that K(V)1.1 and K(V)1.3 channels are expressed in adult rat RGCs and that siRNA-mediated knockdown of either channel reduces RGC death after optic nerve transection. Earlier we found that K(V)1.3 channels also contribute to microglial activation and neurotoxicity; raising the possibility that these channels contribute to neurodegeneration through direct roles in RGCs and through inflammatory mechanisms. Here, RGC survival was increased by combined siRNA-mediated knockdown of K(V)1.1 and K(V)1.3 in RGCs, but survival was much greater when knockdown of either channel was combined with intraocular injection of a K(V)1.3 channel blocker (agitoxin-2 or margatoxin). After axotomy, increased expression of several inflammation-related molecules preceded RGC loss and, consistent with a dual mechanism, their expression was differentially affected when channel knockdown in RGCs was combined with K(V)1.3 blocker injection. K(V)1.3 blockers reduced activation of retinal microglia and their tight apposition along RGC axon fascicles after axotomy, but did not prevent their migration from the inner plexiform to the damaged ganglion cell layer. Expression of several growth factors increased after axotomy; and again, there were differences following blocker injection compared with RGC-selective channel knockdown. These results provide evidence that K(V)1.3 channels play important roles in apoptotic degeneration of adult RGCs through cell-autonomous mechanisms mediated by channels in the neurons, and non-autonomous mechanisms mediated by microglia and inflammation.	[Koeberle, Paulo D.; Schlichter, Lyanne C.] Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Koeberle, Paulo D.; Schlichter, Lyanne C.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Koeberle, Paulo D.] Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada		Schlichter, LC (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	schlicht@uhnres.utoronto.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [MT-13657]; Heart and Stroke Foundation, Ontario chapter HSFOHeart & Stroke Foundation of Canada [T5546]; Krembil Scientific Development Seed Fund; HSF Canada	We are grateful to Drs. Yimin Wang and Xiaoping Zhu for performing real-time RT-PCR analysis. This work was supported by operating grants to Lyanne C. Schlichter from the Canadian Institutes for Health Research (MT-13657), the Heart and Stroke Foundation, Ontario chapter (HSFO T5546) and the Krembil Scientific Development Seed Fund. Paulo D. Koeberle was supported by a postdoctoral fellowship from HSF Canada.	Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Beier M, 2006, NEUROSCI RES, V56, P193, DOI 10.1016/j.neures.2006.07.002; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Diem R, 2001, J NEUROSCI, V21, P2058, DOI 10.1523/JNEUROSCI.21-06-02058.2001; Emch GS, 2001, AM J PHYSIOL-REG I, V281, pR1394, DOI 10.1152/ajpregu.2001.281.5.R1394; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Garcia-Valenzuela E, 2005, MOL VIS, V11, P225; Germain F, 2003, EUR J NEUROSCI, V18, P1103, DOI 10.1046/j.1460-9568.2003.02842.x; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Koeberle PD, 2010, CELL DEATH DIFFER, V17, P134, DOI 10.1038/cdd.2009.113; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Koeberle PD, 1999, EXP NEUROL, V158, P366, DOI 10.1006/exnr.1999.7113; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Levin LA, 1999, EUR J OPHTHALMOL, V9, pS12, DOI 10.1177/112067219900901S08; Missel PJ, 2002, ANN BIOMED ENG, V30, P1128, DOI 10.1114/1.1521417; Schuetz E, 2004, CURR DRUG TARGETS, V5, P619, DOI 10.2174/1389450043345164; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Watanabe M, 1997, CLIN NEUROSCI, V4, P233; Weishaupt JH, 2001, RESTOR NEUROL NEUROS, V19, P19; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yang JJ, 2000, CURR EYE RES, V21, P981, DOI 10.1076/ceyr.21.6.981.6991; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zhang X, 2004, EXP EYE RES, V78, P849, DOI 10.1016/j.exer.2003.10.018	31	14	14	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6950	1933-6969		CHANNELS	Channels	SEP-OCT	2010	4	5					337	346		10.4161/chan.4.5.12790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	663GB	WOS:000282870100002	20699649	Green Published, gold			2022-02-06	
J	Ley, EJ; Berry, C; Mirocha, J; Salim, A				Ley, Eric J.; Berry, Cherisse; Mirocha, James; Salim, Ali			Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	5th Annual Academic-Surgical Congress	JAN-FEB -, 2010	San Antonio, TX			traumatic brain injury; heart rate; beta-blockers; outcome; mortality	BETA-BLOCKER EXPOSURE; NONCARDIAC SURGERY; CEREBRAL PERFUSION; PROPRANOLOL; METAANALYSIS; SURVIVAL	Background. Increasing data indicate treatment with beta blockers might improve survival after traumatic brain injury (TBI); the optimal heart rate (HR) range for these patients is unknown. To guide treatment, admission HR in moderate to severe TBI patients was analyzed to determine if a specific range is associated with decreased mortality. Methods. The Los Angeles County Trauma System Database, consisting of five Level I and 8 Level II trauma centers, was queried for all injured patients admitted between 1998 and 2005 (n = 147,788). Isolated moderate to severe TBI patients (head abbreviated injury score >= 3) were then identified. Demographics and outcomes were compared at various admission HR subgroups ( < 50, 50-59, 60-69, 70-79, 80-89, 90-99, 100-109, >= 110). Logistic regression was then performed to determine predictors of mortality. Results. After exclusions, a total of 11,977 isolated moderate to severe isolated TBI patients were analyzed, overall mortality was 11.5% with a trend toward lowest mortality at HR 80 to 89 (7.3%). Each HR subgroup had a significantly increased unadjusted odds ratio for mortality compared with HR 80 to 89, except HR 90 to 99 (OR 1.2, CI 1.0-1.5) and HR 100 to 109 (OR 1.2, CI 1.0-1.5). In multivariable logistic regression analysis, HR < 50, 50-59, 60-69, and >= 110 were independent predictors for increased mortality compared with HR 80-89. Conclusion. After isolated moderate to severe TBI, HR <50, 50-59, 60-69, and >= 110 were independent predictors of increased mortality. HR outside the range 70-109 could serve as a marker for aggressive resuscitation. As mortality increased significantly with HR: <50 (AOR 4.70), 50-59 (AOR 2.21), and 60-69 (AOR 1.63), our findings recommend avoiding HR < 70 in patients with moderate to severe TBI. (C) 2010 Elsevier Inc. All rights reserved.	[Ley, Eric J.; Berry, Cherisse; Mirocha, James; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269, DOI 10.1152/ajpheart.1990.259.2.H269; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fleisher LA, 2006, CIRCULATION, V113, P2662, DOI 10.1161/CIRCULATIONAHA.106.176009; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; HERNDON DN, 1988, ANN SURG, V208, P484, DOI 10.1097/00000658-198810000-00010; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kaafarani HMA, 2008, ARCH SURG-CHICAGO, V143, P940, DOI 10.1001/archsurg.143.10.940; KAUFMAN TM, 1993, J SURG RES, V55, P516, DOI 10.1006/jsre.1993.1177; KRAUS J, 1985, J NEUROSURG, V63, P537, DOI 10.3171/jns.1985.63.4.0537; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Talati R, 2009, ANN PHARMACOTHER, V43, P1181, DOI 10.1345/aph.1L706; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	24	14	14	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2010	163	1					142	145		10.1016/j.jss.2010.04.046			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	640TT	WOS:000281076300023	20599219				2022-02-06	
J	Dong, XQ; Huang, M; Hu, YY; Yu, WH; Zhang, ZY				Dong, Xiao-Qiao; Huang, Man; Hu, Yue-Yu; Yu, Wen-Hua; Zhang, Zu-Yong			Time Course of Plasma Leptin Concentrations After Acute Spontaneous Basal Ganglia Hemorrhage	WORLD NEUROSURGERY			English	Article						Biomarker; Inflammatory reaction; Intracerebral hemorrhage; Leptin; Outcome; Stroke	TRAUMATIC BRAIN-INJURY; ADIPOKINE GENE-EXPRESSION; INTRACEREBRAL HEMORRHAGE; AUTOIMMUNE ENCEPHALOMYELITIS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; PITUITARY-GLAND; POTENTIAL ROLE; FOOD-INTAKE; INFLAMMATION	BACKGROUND: Brain cortex leptin messenger riboneucleic acid (mRNA) expression and serum leptin level are up-regulated in ischemic mouse brain, as well as in rat brain with traumatic brain injury. Elevated leptin plasma levels predict cerebral hemorrhagic stroke independently of traditional risk factors. The goal of this study was to investigate change in plasma leptin level after intracerebral hemorrhage (ICH) and to evaluate its relation with disease outcome. METHODS: Eighty-six patients admitted within 6 hrs after ICH and 30 healthy controls were included. Plasma samples were obtained on admission and at days 1, 2, 3, 5, and 7 after ICH. Its concentration was measured by enzyme-linked immunosorbent assay (ELISA). RESULTS: After ICH, plasma leptin level in patients increased during the 6-hour period immediately, peaked in 24 hours, decreased gradually thereafter, and was substantially higher than that in healthy controls during the 7-day period. Plasma leptin levels were highly associated with initial Glasgow coma scores, ICH volumes, presences of intraventricular hemorrhage, and survival rates (all P < 0.05). A multivariate analysis selected plasma leptin level related to plasma C-reactive protein level (standardized coefficient, 0.293; P = 0.003). A multivariate analysis showed baseline plasma leptin level as a good predictor for 1-week mortality (odds ratio, 1.228; 95% confidence interval, 1.070-1.409; P = 0.003). A receiver operating characteristic curve identified that a baseline plasma leptin level greater than 34.1 ng/mL predicted 1-week mortality of patients with 75.0% sensitivity and 85.2% specificity (P < 0.001). Area under curve of GCS score was statistically significantly larger than that of plasma leptin level (P = 0.035), but ICH volume's area under curve not (P = 0.078). CONCLUSIONS: Increased plasma leptin level is found after ICH and may contribute to inflammatory process of ICH, in association with a poor clinical outcome.	[Dong, Xiao-Qiao; Yu, Wen-Hua; Zhang, Zu-Yong] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Huang, Man; Hu, Yue-Yu] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Intens Care Unit, Hangzhou 310003, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	dxqhyy@163.com					Ahima RS, 2006, PROG BRAIN RES, V153, P155, DOI 10.1016/S0079-6123(06)53009-2; Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Brown R, 2005, MOL BRAIN RES, V139, P357, DOI 10.1016/j.molbrainres.2005.05.009; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Butcher K, 2003, J CLIN NEUROSCI, V10, P158, DOI 10.1016/S0967-5868(02)00324-7; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; De Rosa S, 2009, J VASC RES, V46, P609, DOI 10.1159/000226229; DeClercq Vanessa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P228, DOI 10.2174/187152908785849080; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Malendowicz LK, 2007, INT REV CYTOL, V263, P63, DOI 10.1016/S0074-7696(07)63002-2; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Sarraf P, 1997, J EXP MED, V185, P171, DOI 10.1084/jem.185.1.171; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Wilkinson M, 2007, NEUROENDOCRINOLOGY, V86, P191, DOI 10.1159/000108635; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang XJ, 2006, NEUROL INDIA, V54, P402	42	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG-SEP	2010	74	2-3					286	293		10.1016/j.wneu.2010.02.019			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	792WM	WOS:000292781100031	21492562				2022-02-06	
J	Hill, J; Zhao, J; Dash, PK				Hill, Julia; Zhao, Jing; Dash, Pramod K.			High Blood Glucose Does Not Adversely Affect Outcome in Moderately Brain-Injured Rodents	JOURNAL OF NEUROTRAUMA			English	Article						cerebral edema; diabetes; hyperglycemia; metabolic distress; secondary brain injury	CLOSED-HEAD-INJURY; INTENSIVE INSULIN THERAPY; HYPERGLYCEMIC RATS; COGNITIVE DEFICITS; CEREBRAL-ISCHEMIA; CONTUSION VOLUME; MOTOR DEFICITS; DIABETIC RATS; IMMATURE RAT; METABOLISM	In a number of clinical studies researchers have reported that acute hyperglycemia is associated with increased mortality and worsened neurological outcome in patients with traumatic brain injury (TBI). In contrast, it has been demonstrated that intensive insulin therapy to lower blood glucose can lead to an increased frequency of hypoglycemic episodes and poor outcome. Consistent with this, experimental and clinical studies have shown that TBI causes a "metabolic crisis'' in the injured brain, suggesting that a reduction in glucose availability may exacerbate brain damage. We therefore examined the consequences of hyperglycemia on cognitive and pathological measures. Using a rodent model of TBI, we find that when acute hyperglycemia is induced in animals prior to injury, there is little to no change in motor and cognitive performance, contusion volume, or cerebral edema. To examine the consequences of persistent hyperglycemia (as seen in diabetic patients), animals were treated with streptozotocin (STZ) to induce type 1 diabetes. We find that the presence of persistent STZ-induced hyperglycemia results in a reduction of brain edema. Insulin therapy to reduce blood glucose reverses this beneficial effect of hyperglycemia. Taken together, our results indicate that an acute increase in blood glucose levels may not be harmful, and that intervention with insulin therapy to lower blood glucose levels in TBI patients may increase secondary brain damage.	[Hill, Julia; Zhao, Jing; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Dept Neurosurg, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Dept Neurosurg, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Hill, Julia/0000-0003-4744-0532; Dash, Pramod/0000-0001-6746-1002	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The authors would like to thank Anthony Moore and Sara Orsi for their technical assistance and critical reading of the manuscript. This work was supported by grants from the NIH.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Griesdale DE, 2009, NEUROCRIT CARE; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; KADOWAKI T, 1984, J BIOL CHEM, V259, P4208; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MCNEILL JH, 1999, STREPTOZOTOCIN INDUC; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PLASCHKE K, 1993, INT J DEV NEUROSCI, V11, P477, DOI 10.1016/0736-5748(93)90021-5; PULSINELLI WA, 1982, ANN NEUROL, V11, P499, DOI 10.1002/ana.410110510; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Shram NF, 1997, NEUROREPORT, V8, P1109, DOI 10.1097/00001756-199703240-00009; SIEMKOWICZ E, 1978, ACTA NEUROL SCAND, V58, P1; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; XU Y, 2009, J CEREB BLOOD FLOW M, V30, P883, DOI DOI 10.1038/JCBFM.2009.263; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P332, DOI 10.1016/S0891-5849(97)00267-0	50	14	15	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2010	27	8					1439	1448		10.1089/neu.2010.1328			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	639OU	WOS:000280984900008	20504157	Green Published			2022-02-06	
J	Schutte, C; Hanks, R				Schutte, Christian; Hanks, Robin			Impact of the Presence of Alcohol at the Time of Injury on Acute and One-Year Cognitive and Functional Recovery After Traumatic Brain Injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						alcohol; cognitive recovery; functional recovery; traumatic brain injury	HEAD-INJURY; GALVESTON ORIENTATION; SUBSTANCE-ABUSE; PRACTICAL SCALE; AMNESIA TEST; OUTCOMES; LEVEL; PREVALENCE; COMA	The presence of alcohol is clearly a risk factor for sustaining a traumatic brain injury (TBI); however, the impact of alcohol on injury severity, and functional or cognitive outcome is unclear, as there is mixed evidence in the literature. This study examined 482 participants in a large urban medical center with documented mild-complicated to severe TBI and blood alcohol testing for functional and cognitive outcome. Functional outcomes were measured by the Functional Independence Measure (FIM) and cognitive outcomes were measured using neuropsychological tests known to be sensitive to the sequelae of TBI. Consistent with the hypotheses, there was a statistically significant negative impact of alcohol intoxication at the time of injury on Glasgow Coma Scale (GCS); however intoxication only lowered GCS by an average of 1.9 points. There was a statistically significant relationship between blood alcohol levels (BAL) and FIM at the time of admission to inpatient rehabilitation, but BAL accounted for only 3% of the variance in FIM total score. There was no relationship between BAL and FIM at discharge from rehabilitation or at 1-year follow-up. There was no statistically significant relationship between BAL at the time of injury and cognitive functioning at 1-year follow-up; however, contrary to the hypotheses GCS failed to show a strong relationship with cognitive outcome.	[Schutte, Christian] John D Dingell VAMC, Mental Hlth Serv, Detroit, MI 48201 USA; [Hanks, Robin] Rehabil Inst Michgian, Dept Neuropsychol, Detroit, MI USA		Schutte, C (corresponding author), John D Dingell VAMC, Mental Hlth Serv, 4646 John R,11MH, Detroit, MI 48201 USA.	christian.schutte@va.gov			National Institute on Disability and Rehabilitation Research [H133A020515]	This research was supported by the National Institute on Disability and Rehabilitation Research (Grant #H133A020515).	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Christensen M A, 2001, J Neurosci Nurs, V33, P184; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Heaton R., 2000, WISCONSIN CARD SORTI; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Reitan R.M., 1993, HALSTEADREITAN NEURO; Russell E., 1993, H RUSSELL NEUROPSYCH; Schmidt M., 1996, REY AUDITORY VERBAL; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Tate PS, 1999, BRAIN INJURY, V13, P767; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; TEASDALE G, 1974, LANCET, V2, P81; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604	23	14	14	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	AUG	2010	120	8					551	556		10.3109/00207454.2010.494789			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	639XT	WOS:000281011100005	20615059				2022-02-06	
J	Zlotnik, A; Klin, Y; Kotz, R; Dubilet, M; Boyko, M; Ohayon, S; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Klin, Yael; Kotz, Ruslan; Dubilet, Michael; Boyko, Mathew; Ohayon, Sharon; Shapira, Yoram; Teichberg, Vivian I.			Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism	EXPERIMENTAL NEUROLOGY			English	Article						Adrenaline; Isoproterenol; beta-Adrenoreceptor; Blood; Brain; CRF; L-Glutamate; Stress	CLOSED-HEAD-INJURY; CORTICOTROPIN-RELEASING-FACTOR; EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; ISCHEMIC-STROKE; INFARCT SIZE; RAT; NEUROPROTECTION	Isoflurane-anesthetized rats submitted to a closed head injury (CHI) display a significant decrease of their blood glutamate levels. Having demonstrated that a decrease of blood L-glutamate (glutamate) causes an increase of the driving force for a spontaneous brain-to-blood glutamate efflux, and consequently affords brain neuroprotection, we investigated here the possible mechanisms which can affect blood glutamate levels. Reasoning that the spontaneous decrease of blood glutamate levels post CHI could be part of a stress response, we observed that the stress involved in tail artery catheterization under isoflurane anesthesia does not affect blood glutamate levels. Investigating in naive rats the stress effectors, we found that corticotropin-releasing factor (CRF) significantly decreased blood glutamate levels. Pretreatment with antalarmine (a selective type-1 CRF receptor antagonist) occludes the CRF-mediated decrease in blood glutamate levels. In contrast, the adrenocorticotrophic hormone (ACTH) did not affect blood glutamate levels. Investigating the effectors of the sympathetic/adrenomedullary system, we observed that in naive rats, adrenaline but not noradrenaline decreased blood glutamate levels. Confirming the role of adrenaline, propranolol pretreatment (a non-selective beta-antagonist) prevented the spontaneous decrease of blood glutamate observed post CHI. On the strength of these results, we further observed that isoproterenol (a beta(1/2)-selective adrenoreceptor agonist) produced a marked sustained decrease in blood glutamate levels. These results suggest that stress induces a decrease of blood glutamate levels partly via the activation of peripheral CRF receptors and the activation of the beta-adrenoreceptors. We propose that this newly identified component of the stress response could be a peripherally mediated defense mechanism of the injured brain against the deleterious effects of excess glutamate. (C) 2010 Elsevier Inc. All rights reserved.	[Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Zlotnik, Alexander; Kotz, Ruslan; Dubilet, Michael; Boyko, Mathew; Ohayon, Sharon; Shapira, Yoram] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Zlotnik, Alexander; Kotz, Ruslan; Dubilet, Michael; Boyko, Mathew; Ohayon, Sharon; Shapira, Yoram] Soraka Med Ctr, Div Anesthesiol, Beer Sheva, Israel		Teichberg, VI (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Vivian.teichberg@weizmann.ac.il		Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases, Braintact Ltd.; Irwin Green Alzheimer's Research Fund; Carl and Micaela Einhorn-Dominic Institute for Brain Research	The authors thank Dorit Reymond for superb technical assistance. This work was supported in part by grants to V.I.T. from the Nella and Leon Benoziyo Center for Neurological Diseases, Braintact Ltd., the Irwin Green Alzheimer's Research Fund, and the Carl and Micaela Einhorn-Dominic Institute for Brain Research. The data obtained were part of A.Z.'s PhD thesis. V.I.T. is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	Adelson DW, 2007, J NEUROPHYSIOL, V97, P3004, DOI 10.1152/jn.01143.2006; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; BROWN MR, 1982, ENDOCRINOLOGY, V111, P928, DOI 10.1210/endo-111-3-928; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Han JL, 2008, NEUROSCI LETT, V432, P167, DOI 10.1016/j.neulet.2007.07.056; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477, DOI 10.1152/ajprenal.1999.277.4.F477; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; SUTTON RE, 1982, NATURE, V297, P331, DOI 10.1038/297331a0; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; WILSON KM, 1985, J APPL PHYSIOL, V58, P534, DOI 10.1152/jappl.1985.58.2.534; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; YASUDA N, 1977, EXPERIENTIA, V33, P683, DOI 10.1007/BF01946575; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b; Zorrilla EP, 2002, BRAIN RES, V952, P188, DOI 10.1016/S0006-8993(02)03189-X	39	14	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2010	224	2					465	471		10.1016/j.expneurol.2010.05.009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	631II	WOS:000280339600017	20493841				2022-02-06	
J	Kim, YW; Shin, JC; An, YS				Kim, Yong Wook; Shin, Ji-Cheol; An, Young-sil			Changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy: a preliminary study	ANNALS OF NUCLEAR MEDICINE			English	Article						Cerebral metabolism; Posttraumatic cognitive impairment; Memantine	TRAUMATIC BRAIN-INJURY; NMDA RECEPTOR; GLUTAMATE; PHARMACOLOGY; ANTAGONIST; DEMENTIA; DISEASE; TRIAL; PET	Objective To investigate the changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy. Methods We performed serial F-18 fluorodeoxyglucose positron emission tomography studies before and after memantine therapy (20 mg per day) on 17 patients with posttraumatic cognitive impairment using statistical parametric mapping analysis. In addition, covariance analysis was performed to identify regions, where changes in regional cerebral glucose metabolism correlated significantly with increased Mini-Mental Status Examination scores. Results Statistical parametric mapping analysis demonstrated that, compared with baseline, significantly increased cerebral glucose metabolism occurred in both inferior, middle and superior frontal gyri, both angular gyri, both precuneus, the right middle cingulum, the left inferior parietal lobule, the left fusiform gyrus, the left precentral gyrus, the left paracentral lobule, and the left lingual gyrus after memantine therapy (P-uncorrected < 0.005). In contrast, cerebral glucose metabolism was significantly decreased in both cerebellum, the left thalamus, the left olfactory, the right middle temporal gyrus, the right amygdala, and the right insula (P-uncorrected < 0.005). In the correlation analysis, improvements in Mini-Mental Status Examination scores after memantine therapy were significantly associated with increased cerebral glucose metabolism in the inferior and middle frontal gyri and the inferior parietal lobule of the left hemisphere (P-corrected < 0.0001). Conclusions Our findings indicate that the prefrontal and the parietal association cortices may be the relevant structures for the pharmacological response to memantine therapy in patients with posttraumatic cognitive impairment.	[Kim, Yong Wook; Shin, Ji-Cheol] Yonsei Univ, Coll Med, Dept Rehabil Med, Seoul 120752, South Korea; [Kim, Yong Wook; Shin, Ji-Cheol] Yonsei Univ, Coll Med, Res Inst Rehabil Med, Seoul 120752, South Korea; [An, Young-sil] Ajou Univ, Sch Med, Dept Nucl Med, Suwon 441749, South Korea		Kim, YW (corresponding author), Yonsei Univ, Coll Med, Dept Rehabil Med, 250 Seongsanno, Seoul 120752, South Korea.	ywkim1@yuhs.ac		KIM, YONGWOOK/0000-0002-5234-2454; Shin, Ji Cheol/0000-0002-1133-1361; An, Young-Sil/0000-0003-0777-6226			Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; AREOSA SA, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003154.pub4; Ben Smail D, 2006, BRAIN INJURY, V20, P111, DOI 10.1080/02699050500309700; Berthier ML, 2009, ANN NEUROL, V65, P577, DOI 10.1002/ana.21597; Cerullo MA, 2007, SCHIZOPHR RES, V97, P294, DOI 10.1016/j.schres.2007.07.034; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Liu CH, 2009, BRAIN RES, V1282, P173, DOI 10.1016/j.brainres.2009.05.071; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Mukhin A, 1996, J NEUROSCI, V16, P6012; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Pomara N, 2007, ALZ DIS ASSOC DIS, V21, P60, DOI 10.1097/WAD.0b013e318032cf29; Preuss UW, 2001, EUR NEUROL, V45, P57, DOI 10.1159/000052094; Rao VLR, 2001, BRAIN RES, V911, P96; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Riepe MW, 2007, DEMENT GERIATR COGN, V23, P301, DOI 10.1159/000100875; Rogers M, 2009, AM J HOSP PALLIAT ME, V26, P57, DOI 10.1177/1049909108330025; Sencer A, 2008, NEUROL RES, V30, P497, DOI 10.1179/016164107X251664; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	29	14	14	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	JUN	2010	24	5					363	369		10.1007/s12149-010-0360-3			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	621HE	WOS:000279565800004	20237871				2022-02-06	
J	Patel, DR; Reddy, V				Patel, Dilip R.; Reddy, Vinay			Sport-related Concussion in Adolescents	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Concussion; Neuropsychological testing; Balance Error Scoring System; Sport Concussion Assessment Tool	TRAUMATIC BRAIN-INJURY; COMPUTERIZED COGNITIVE ASSESSMENT; COLLEGIATE FOOTBALL PLAYERS; TEST-RETEST RELIABILITY; HIGH-SCHOOL; HEAD-INJURY; STANDARDIZED ASSESSMENT; MONITORING RESOLUTION; CEREBRAL CONCUSSION; POSTURAL CONTROL	Sport-related concussion is a common problem encountered by pediatricians and other primary care physicians Assessment of concussion is based on clinical evaluation The Zurich consensus statement provides a basic framework to guide concussion management decisions and recommends an individualized approach and the exercising of clinical judgment in return-to-play decisions. This article reviews practice aspects of concussion for the adolescent athletes who present in the primary care office or clinic setting.	[Patel, Dilip R.; Reddy, Vinay] Michigan State Univ, Coll Human Med, Kalamazoo Ctr Med Studies, Dept Pediat & Human Dev, Kalamazoo, MI 49008 USA		Patel, DR (corresponding author), Michigan State Univ, Coll Human Med, Kalamazoo Ctr Med Studies, Dept Pediat & Human Dev, 1000 Oakland Dr, Kalamazoo, MI 49008 USA.		Patel, Dilip/AAV-7575-2020				Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; *AM AC PED AM COLL, 2005, PREP PHYS EV MON; [Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; BICKLEY LS, 2006, BATES GUIDES PHYS EX; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bruce JM, 2004, NEUROLOGY, V63, P1516; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; CANTU RC, 2002, AM J SPORTS MED, V4, P152; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Dyson R, 2006, BRIT J SPORT MED, V40, P346, DOI 10.1136/bjsm.2005.023077; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson G, 2007, CLIN J SPORT MED, V17, P31; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Landry GL, 2002, PEDIATR CLIN N AM, V49, P723, DOI 10.1016/S0031-3955(02)00024-X; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory Paul, 2002, Curr Sports Med Rep, V1, P28; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; MCRORY P, 2005, CLIN J SPORT MED, V15, P48; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; PATEL DR, 2006, CONT PEDIAT, V23, P62; PATEL DR, 2001, CONT PEDIAT, V18, P45; PATEL DR, 2009, PEDIAT PRACTICE SPOR, P110; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	113	14	15	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	JUN	2010	57	3					649	670		10.1016/j.pcl.2010.03.006			22	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	621NH	WOS:000279585100003	20538149				2022-02-06	
J	Ceranoglu, TA				Ceranoglu, Tolga Atilla			Star Wars in Psychotherapy: Video Games in the Office	ACADEMIC PSYCHIATRY			English	Article							DISTRACTION; CHILDREN; CANCER; MEDIA	Objective: Video games are used in medical practice during psycho-education in chronic disease management, physical therapy, rehabilitation following traumatic brain injury, and as an adjunct in pain management during medical procedures or cancer chemotherapy. In psychiatric practice, video games aid in social skills training of children with developmental delays and in cognitive behavioral therapy (CBT). This most popular children's toy may prove a useful tool in dynamic psychotherapy of youth. Methods: The author provides a framework for using video games in psychotherapy by considering the characteristics of video games and describes the ways their use has facilitated various stages of therapeutic process. Results: Just as other play techniques build a relationship and encourage sharing of emotional themes, sitting together in front of a console and screen facilitates a relationship and allows a safe path for the patient's conflict to emerge. Conclusion: During video game play, the therapist may observe thought processes, impulsivity, temperament, decision-making, and sharing, among other aspects of a child's clinical presentation. Several features inherent to video games require a thoughtful approach as resistance and transference in therapy may be elaborated differently in comparison to more traditional toys. Familiarity with the video game content and its dynamics benefits child mental health clinicians in their efforts to help children and their families.	Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA		Ceranoglu, TA (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St, Boston, MA 02114 USA.	aceranoglu@partners.org					Brezinka V, 2008, STUD HEALTH TECHNOL, V136, P71; Das Debashish A, 2005, BMC Pediatr, V5, P1, DOI 10.1186/1471-2431-5-1; *ENT SOFTW RAT BOA, 2005, GAM RAT DESCR GUID; FREUD S, 1908, JOKES THEIR RELATION; Gold JI, 2006, CYBERPSYCHOL BEHAV, V9, P207, DOI 10.1089/cpb.2006.9.207; Jannink MJA, 2008, CYBERPSYCHOL BEHAV, V11, P27, DOI 10.1089/cpb.2007.0014; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; Klein M, 1955, WRITINGS M KLEIN, V3, P122; Koch-Mohr R, 1998, PRAX KINDERPSYCHOL K, V47, P416; Kutner LA, 2008, J ADOLESCENT RES, V23, P76, DOI 10.1177/0743558407310721; Lionhead Studios, 2004, FABL; Mineo BA, 2009, J AUTISM DEV DISORD, V39, P172, DOI 10.1007/s10803-008-0616-0; Olson CK, 2004, ACAD PSYCHIATR, V28, P144, DOI 10.1176/appi.ap.28.2.144; REDD WH, 1987, J CONSULT CLIN PSYCH, V55, P391, DOI 10.1037/0022-006X.55.3.391; *SON, 2001, IC; *TRAV TAL, 2000, LEG STAR WARS 2 LUC; Vitak J., 2008, TEENS VIDEO GAMES CI; Winnicott D., 2005, PLAYING REALITY, V2nd edn; Yoon Saunjoo L, 2007, Pediatr Nurs, V33, P60; Zelnick L., 2005, J INFANT CHILD ADOLE, V4, P209	20	14	14	2	24	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1042-9670			ACAD PSYCHIATR	Acad. Psych.	MAY-JUN	2010	34	3					233	236					4	Education & Educational Research; Psychiatry	Social Science Citation Index (SSCI)	Education & Educational Research; Psychiatry	589UP	WOS:000277180000014	20431107				2022-02-06	
J	McNett, M; Doheny, M; Sedlak, CA; Ludwick, R				McNett, Molly; Doheny, Margaret; Sedlak, Carol A.; Ludwick, Ruth			JUDGMENTS OF CRITICAL CARE NURSES ABOUT RISK FOR SECONDARY BRAIN INJURY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; INTRA-CRANICAL PRESSURE; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; DECISION-MAKING; OUTCOME PREDICTION; ADULTS; HYPERTENSION; AGE	Background Interdisciplinary care for patients with traumatic brain injury focuses on treating the primary brain injury and limiting further brain damage from secondary injury. Intensive care unit nurses have an integral role in preventing secondary brain injury; however, little is known about factors that influence nurses' judgments about risk for secondary brain injury. Objective To investigate which physiological and situational variables influence judgments of intensive care unit nurses about patients' risk for secondary brain injury, management solely with nursing interventions, and management by consulting another member of the health care team. Methods A multiple segment factorial survey design was used. Vignettes reflecting the complexity of real-life scenarios were randomly generated by using different values of each independent variable. Surveys containing the vignettes were sent to nurses at 2 level I trauma centers. Multiple regression was used to determine which variables influenced judgments about secondary brain injury. Results Judgments about risk for secondary brain injury were influenced by a patient's oxygen saturation, intracranial pressure, cerebral perfusion pressure, mechanism of injury, and primary diagnosis, as well as by nursing shift. Judgments about interventions were influenced by a patient's oxygen saturation, intracranial pressure, and cerebral perfusion pressure and by nursing shift. The initial judgments made by nurses were the most significant variable predictive of follow-up judgments. Conclusions Nurses need standardized, evidence-based content for management of secondary brain injury in critically ill patients with traumatic brain injury. (American Journal of Critical Care. 2010;19:250-260)	[McNett, Molly] Metrohlth Med Ctr, Nursing Business Off, Dept Nursing Res, Cleveland, OH 44109 USA; [Doheny, Margaret] Kent State Univ, Coll Nursing, Grad Nursing Adult Program, Kent, OH 44242 USA; [Sedlak, Carol A.; Ludwick, Ruth] Kent State Univ, Coll Nursing, Off Int Initiat, Kent, OH 44242 USA		McNett, M (corresponding author), Metrohlth Med Ctr, Nursing Business Off, Dept Nursing Res, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	mmcnett@metrohealth.org	Ludwick, Ruth/K-8066-2019	Ludwick, Ruth/0000-0002-2384-2599			*AM ASS NEUR SURG, JOINT SECT NEUR CRIT; *AM HEART ASS, HDB EM CARD CAR 2005; American Association of Critical-Care Nurses, STAND CAR AC CRIT CA; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bakalis N, 2003, INT J NURS STUD, V40, P749, DOI 10.1016/S0020-7489(03)00014-2; Bardt TF, 1998, ACT NEUR S, V71, P153; Bekar A, 1998, NEUROSURG REV, V21, P98, DOI 10.1007/BF02389312; BENNER P, 1999, CLIN WISDOM INTERVEN; BROWN RL, 1992, MED CARE, V30, P1083, DOI 10.1097/00005650-199212000-00002; Brown RL, 1997, J GEN INTERN MED, V12, P44; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; Bucknall TK, 2000, J CLIN NURS, V9, P25, DOI 10.1046/j.1365-2702.2000.00333.x; *CDCP DIV INJ DIS, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention Division of Injury and Disability Outcomes and Progress, 2004, TRAUM BRAIN INJ US E; Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cooksey, 1996, THINK REASONING, V2, P141, DOI DOI 10.1080/135467896394483; Corcoran-Perry S A, 1999, Nurs Health Sci, V1, P49, DOI 10.1046/j.1442-2018.1999.00008.x; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Crosby L J, 1992, J Neurosci Nurs, V24, P40; Currey J, 2006, J CLIN NURS, V15, P1081, DOI 10.1111/j.1365-2702.2006.01392.x; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; FONTEYN ME, 1994, NURSING INFORMATICS: AN INTERNATIONAL OVERVIEW FOR NURSING IN A TECHNOLOGICAL ERA, P481; Ganong LH, 2006, J MARRIAGE FAM, V68, P455, DOI 10.1111/j.1741-3737.2006.00264.x; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hickey J, 2003, CLIN PRACTICE NEUROL; HOLMES MM, 1989, MED CARE, V27, P59, DOI 10.1097/00005650-198901000-00006; Hugo M, 1987, Intensive Care Nurs, V3, P78, DOI 10.1016/0266-612X(87)90029-0; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KENNER G, 2000, THESIS U WASHINGTON; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Lai FC., 2007, THESIS KENT STATE U; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lauri S, 1998, HEART LUNG, V27, P133, DOI 10.1016/S0147-9563(98)90021-8; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; Ludwick R, 2004, ADV NURS SCI, V27, P224, DOI 10.1097/00012272-200407000-00007; Ludwick R, 2001, NURS RES, V50, P129, DOI 10.1097/00006199-200103000-00009; LUDWICK R, 1999, J CLIN GEROPSYCHOLOG, V5, P177, DOI DOI 10.1023/A:1022947615257; March K, 1990, J Neurosci Nurs, V22, P375; March K, 2004, AANN CORE CURRICULUM, P277; McNair ND, 1999, NURS CLIN N AM, V34, P637; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Minick P, 1995, Sch Inq Nurs Pract, V9, P303; MITCHELL PH, 1981, NURS RES, V30, P212; MITCHELL PH, 1978, NURS RES, V27, P4; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; PARSONS LC, 1984, HEART LUNG, V13, P372; Pasquale MD, 2005, CRIT CARE MED, V33, pA40, DOI 10.1097/00003246-200512002-00148; Peden-McAlpine Cynthia, 2002, Dimens Crit Care Nurs, V21, P144, DOI 10.1097/00003465-200207000-00006; Rising C J, 1993, J Neurosci Nurs, V25, P302; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; RUDY EB, 1991, HEART LUNG, V20, P667; Scheetz LJ, 2005, RES NURS HEALTH, V28, P198, DOI 10.1002/nur.20075; SNYDER M, 1983, J ADV NURS, V8, P273; Tanner CA, 2006, J NURS EDUC, V45, P204, DOI 10.3928/01484834-20060601-04; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P151; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Villanueva N E, 1999, J Neurosci Nurs, V31, P216	75	14	15	0	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	MAY 1	2010	19	3					250	260		10.4037/ajcc2009293			11	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	590DX	WOS:000277205300005	19542058				2022-02-06	
J	Portugal-Cohen, M; Numa, R; Yaka, R; Kohen, R				Portugal-Cohen, Meital; Numa, Ran; Yaka, Rami; Kohen, Ron			Cocaine induces oxidative damage to skin via xanthine oxidase and nitric oxide synthase	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Cocaine; Skin; Oxidative stress; Xanthine oxidase; Inducible nitric oxide synthase	TOTAL ANTIOXIDANT CAPACITY; MOLECULAR-WEIGHT ANTIOXIDANTS; RADICAL ABSORBENCY CAPACITY; CLOSED-HEAD INJURY; IN-VIVO; POSSIBLE MECHANISM; N-DEMETHYLATION; ASCORBIC-ACID; EXPRESSION; STRESS	Background: Heavy cocaine abusers are known to develop adverse skin manifestations, however, a possible mechanism for such damages has not yet been proposed. Objective: The present study was designed to investigate whether a systemic cocaine administration affects skin characteristics by elucidating modifications of reactive oxygen species (ROS) production, antioxidant defense and iNOS and XO activity. Methods: Two models were used: an in vivo rat model (male Sabra), in which skin specimens were taken 20 days after i.p. cocaine injection (15 mg/kg) and an in vitro model based on HaCaT cells representing human keratinocytes. Results: Our findings clearly showed that cocaine promoted skin oxidation via the involvement of the enzymes inducible nitric oxide synthase (iNOS) and xanthine oxidase (XO). Cocaine administration significantly increased iNOS expression in rats' skin. It also decreased total scavenging capacity (TSC), as well as reduced glutathione (GSH) and ascorbic acid (AA). HaCaT cells treatment with a cocaine concentration of 2 mM for 2411 (as was chosen by dose-response experiments) markedly enhanced superoxide radicals and peroxides formation. It also decreased TSC and GSH levels. Addition of iNOS and XO inhibitors completely abolished these findings. This study indicates for the first time that systemic cocaine administration affects skin condition, even after a long period of withdrawal. Conclusion: Our study therefore, suggests additional metabolic outcomes of cocaine due to its ability to enhance oxidative stress in skin. (c) 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Portugal-Cohen, Meital; Numa, Ran; Yaka, Rami; Kohen, Ron] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel		Kohen, R (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, POB 12065, IL-91120 Jerusalem, Israel.	meitalp@ekmd.huji.ac.il; ronk@ekmd.huji.ac.il	Kohen, Ron/ABC-2281-2021	Kohen, Ron/0000-0001-7268-9845	Ydidut Foundation (Mexico); Israel Science FoundationIsrael Science Foundation [292/05]	This study is supported by the Ydidut Foundation (Mexico) and by the Israel Science Foundation (Grant No.: 292/05 R.Y.). R.K. and R.Y. are affiliated with the David R. Bloom Center of Pharmacy. R.K. is the incumbent of the Richard and Jean Zarbin Chair in Medical Studies at the Hebrew University of Jerusalem.; We would like to thank Prof. Yoram Milner and Dr. Yoram Soroka (Department of Biological Chemistry, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem) for their valuable assistance.	Abd-El-Aleem SA, 2000, J PATHOL, V191, P434, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO;2-S; ABIDIN MR, 1990, ANN PLAS SURG, V24, P268, DOI 10.1097/00000637-199003000-00012; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Aoki K, 1997, EUR J PHARMACOL, V336, P43, DOI 10.1016/S0014-2999(97)01230-2; Ashton T, 1999, J APPL PHYSIOL, V87, P2032, DOI 10.1152/jappl.1999.87.6.2032; Bagetta G, 2004, NEUROSCI LETT, V356, P183, DOI 10.1016/j.neulet.2003.11.065; Bashkatova V, 2005, NEUROREPORT, V16, P1217, DOI 10.1097/00001756-200508010-00017; Bashkatova V, 2006, ANN NY ACAD SCI, V1074, P632, DOI 10.1196/annals.1369.061; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhargava HN, 1997, PHARMACOLOGY, V55, P292, DOI 10.1159/000139541; BOELSTERLI UA, 1991, ARCH TOXICOL, V65, P351, DOI 10.1007/BF02284256; Brewer JD, 2008, J AM ACAD DERMATOL, V59, P483, DOI 10.1016/j.jaad.2008.03.040; CAO G, 1995, CLIN CHEM, V41, P1738; CHEVALIER X, 1995, CLIN NEPHROL, V43, P348; CONLEE RK, 1991, J APPL PHYSIOL, V70, P1323, DOI 10.1152/jappl.1991.70.3.1323; Devi BG, 1996, J PHARMACOL EXP THER, V279, P359; Diez-Fernandez C, 1999, BIOCHEM PHARMACOL, V58, P797, DOI 10.1016/S0006-2952(99)00168-9; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Elliott JC, 2003, INT IMMUNOPHARMACOL, V3, P1011, DOI 10.1016/S1567-5769(03)00099-7; ENGERSON TD, 1987, J CLIN INVEST, V79, P1564, DOI 10.1172/JCI112990; Fan L, 2009, J PHARMACOL EXP THER, V328, P99, DOI 10.1124/jpet.108.145201; Ferdinandy P, 2006, BRIT J PHARMACOL, V148, P1, DOI 10.1038/sj.bjp.0706693; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hofbauer GFL, 1999, BRIT J DERMATOL, V141, P600; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Imam SZ, 2005, ANN NY ACAD SCI, V1053, P482, DOI 10.1196/annals.1344.042; Isabelle M, 2007, J MOL CELL CARDIOL, V42, P326, DOI 10.1016/j.yjmcc.2006.11.011; Itzhak Y, 1997, J PHARMACOL EXP THER, V282, P521; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; KLOSS MW, 1984, BIOCHEM PHARMACOL, V33, P169, DOI 10.1016/0006-2952(84)90471-4; KLOSS MW, 1983, MOL PHARMACOL, V23, P482; Kohen R, 2000, TOXICOLOGY, V148, P149, DOI 10.1016/S0300-483X(00)00206-7; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; Koren E, 2008, BIOMED PHARMACOTHER, V62, P179, DOI 10.1016/j.biopha.2007.12.012; LEDUC BW, 1993, PHARMACOLOGY, V46, P294, DOI 10.1159/000139058; MACGOWAN SW, 1995, ANN THORAC SURG, V60, P1289, DOI 10.1016/0003-4975(95)00616-S; MARLETTA MA, 1993, ADV EXP MED BIOL, V338, P281; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MEISTER A, 1994, CANCER RES, V54, pS1969; MENDELSON JH, 1992, J PHARMACOL EXP THER, V263, P505; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Moritz F, 2003, J CARDIOVASC PHARM, V42, P642, DOI 10.1097/00005344-200311000-00010; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Numa R, 2008, NEUROSCIENCE, V155, P649, DOI 10.1016/j.neuroscience.2008.05.058; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oliveira MT, 2002, ANN NY ACAD SCI, V965, P487; Ornoy A, 1999, TERATOLOGY, V60, P376, DOI 10.1002/(SICI)1096-9926(199912)60:6<376::AID-TERA10>3.3.CO;2-H; Pacifici R, 2003, INT IMMUNOPHARMACOL, V3, P581, DOI 10.1016/S1567-5769(03)00050-X; Park KK, 2001, PHYSIOL BEHAV, V74, P441, DOI 10.1016/S0031-9384(01)00588-1; PELLINEN P, 1994, EUR J PHARM-ENVIRON, V270, P35, DOI 10.1016/0926-6917(94)90078-7; Portugal Meital, 2008, P19, DOI 10.1007/978-1-4020-8399-0_2; PORTUGALCOHEN M, 2009, J DERMATOL SCI; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Richeson CE, 1998, J AM CHEM SOC, V120, P7211, DOI 10.1021/ja980871x; ROBERTS SM, 1991, DRUG METAB DISPOS, V19, P1046; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shilo S, 2003, BIOCHEM J, V370, P283, DOI 10.1042/BJ20021022; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SHUSTER L, 1983, BIOCHEM PHARMACOL, V32, P3045, DOI 10.1016/0006-2952(83)90247-2; Sies H, 2007, J NUTR, V137, P1493, DOI 10.1093/jn/137.6.1493; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Toda N, 2008, J ANESTH, V22, P155, DOI 10.1007/s00540-007-0590-2; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; ZAMORAQUEZADA JC, 1988, ANN INTERN MED, V108, P564, DOI 10.7326/0003-4819-108-4-564; Zaragoza A, 2000, BBA-MOL CELL RES, V1496, P183, DOI 10.1016/S0167-4889(00)00036-7	76	14	17	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2010	58	2					105	112		10.1016/j.jdermsci.2010.03.010			8	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	594MZ	WOS:000277543100004	20399619				2022-02-06	
J	Zweifel, C; Czosnyka, M; Lavinio, A; Castellani, G; Kim, DJ; Carrera, E; Pickard, JD; Kirkpatrick, PJ; Smielewski, P				Zweifel, Christian; Czosnyka, Marek; Lavinio, Andrea; Castellani, Gianluca; Kim, Dong-Joo; Carrera, Emmanuel; Pickard, John D.; Kirkpatrick, Peter J.; Smielewski, Peter			A comparison study of cerebral autoregulation assessed with transcranial Doppler and cortical laser Doppler flowmetry	NEUROLOGICAL RESEARCH			English	Article						Autoregulation; laser Doppler flowmetry; transcranial Doppler	HEAD-INJURED PATIENTS; BLOOD-FLOW; INTRACRANIAL-PRESSURE; CEREBROVASCULAR AUTOREGULATION; SPONTANEOUS FLUCTUATIONS; DYNAMIC AUTOREGULATION; MICROCIRCULATION; VALIDATION; RESPONSES; PERFUSION	Objectives: We compared autoregulation monitored with cortical laser Doppler flowmetry (LDF) and autoregulation monitored with transcranial Doppler (TCD) in the middle cerebral artery (MCA) to verify the hypothesis that, following brain trauma, cortical vessel autoregulation to intracranial hypertension is different than assessed in the MCA. Methods: Data collected from 29 head injured patients were analysed retrospectively. Arterial blood pressure (ABP), intracranial pressure (ICP), flow velocity (FV) of the MCA and cortical flux (LDF) were monitored. Indices of cortical autoregulation (Lx) and autoregulation of cerebral blood flow in the MCA (Mx) were calculated as a moving correlation coefficient between slow waves of LDF and cerebral perfusion pressure (CPP) (Lx) or FV and CPP (Mx), respectively. Intact autoregulation was indicated by negative values for Lx and Mx; disturbed autoregulation was reflected by positive values. Results: FV and LDF showed a high coherence in the slow wave spectrum of 1-4 cycles/min (mean: 0.79 +/- 0.12), indicating that similar information regarding autoregulation is carried by both signals. Mx and Lx correlated in all patients (R=0.43, p=0.02). On average, Lx was significantly higher than Mx; the mean difference was 0.13 +/- 0.38 (p=0.032), potentially due to severe intracranial hypertension above 40 mmHg, driving CPP values below 60 mmHg. Conclusion: After traumatic brain injury, cortical autoregulation appears to be worse than autoregulation assessed in the MCA during rising ICP and falling CPP. When CPP is above 60 mmHg, cortical assessed autoregulation is similar to autoregulation assessed in the MCA.	[Zweifel, Christian; Czosnyka, Marek; Lavinio, Andrea; Castellani, Gianluca; Kim, Dong-Joo; Carrera, Emmanuel; Pickard, John D.; Kirkpatrick, Peter J.; Smielewski, Peter] Univ Cambridge, Sch Clin, Acad Neurosurg Unit, Cambridge, England		Zweifel, C (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Acad Neurosurg Unit, Level 4,A Block, Cambridge CB2 2QQ, England.	zweifelch@gmx.ch	Lavinio, Andrea/M-1778-2016	Smielewski, Peter/0000-0001-5096-3938; Carrera, Emmanuel/0000-0003-0045-5382	Swiss National Science Foundation, Bern, SwitzerlandSwiss National Science Foundation (SNSF) [PBBSP3-125550, PBLAB-119620, PASSMP3-124262]; SICPA Foundation, Lausanne, Switzerland; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This work was supported by the Swiss National Science Foundation (PBBSP3-125550 to C. Zweifel; PBLAB-119620 and PASSMP3-124262 to E. Carrera), Bern, Switzerland and the SICPA Foundation, Lausanne, Switzerland, to E. Carrera. M. Czosnyka is on leave from Warsaw University of Technology, Poland. The software for brain monitoring ICM+ (http://www.neurosurg.cam.ac.uk/icmplus) is licensed by the University of Cambridge (Cambridge Enterprise). P. Smielewski and M. Czosnyka have a financial interest in a part of the licensing fee.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1382, DOI 10.1136/jnnp.57.11.1382; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lewis PM, 2007, ACTA NEUROCHIR, V149, P549, DOI 10.1007/s00701-007-1160-y; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 2005, ACT NEUR S, V95, P43; Soehle M, 2004, ANESTH ANALG, V98, P1133, DOI 10.1213/01.ANE.0000111101.41190.99; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; STERN MD, 1975, NATURE, V254, P56, DOI 10.1038/254056a0; ZABOLOTNY W, 1994, INTRACRANIAL PRESSUR, V9, P439	25	14	16	0	4	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAY	2010	32	4					425	428		10.1179/174313209X459165			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	593IJ	WOS:000277446600016	19703359				2022-02-06	
J	Waybright, T; Avellino, AM; Ellenbogen, RG; Hollinger, BJ; Veenstra, TD; Morrison, RS				Waybright, Timothy; Avellino, Anthony M.; Ellenbogen, Richard G.; Hollinger, Bradley J.; Veenstra, Timothy D.; Morrison, Richard S.			Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients	JOURNAL OF PROTEOMICS			English	Article; Proceedings Paper	3rd EuPA Congress	JUN 14-17, 2009	Stockholm, SWEDEN			Cerebrospinal fluid; Mass spectrometry; Proteomics; Fractionation; Ventricular CSF; Lumbar CSF	TANDEM MASS-SPECTROMETRY; MULTIDIMENSIONAL CHROMATOGRAPHY; BIOMARKERS; PROTEINS; CHILDREN; DISEASE; BRAIN	The continuing expansion of proteomic technology has been fueled by the potential for discovering novel biomarkers that may be used for the early detection of disease. It has been proposed that human cerebrospinal fluid (CSF), which surrounds and protects the brain and spinal cord from traumatic injury, may be a valuable target for the diagnosis of a variety of conditions such as Alzheimer's disease, traumatic brain injury, amyotrophic lateral sclerosis and Parkinson's disease. The immense complexity of biofluids, however, still requires that considerable development be made in the analytical techniques used so that comprehensive coverage of the proteins present in such samples is achieved. Using a simple separation strategy the protein complement of human ventricular cerebrospinal fluid obtained from patients with hydrocephalus was evaluated. The study resulted in the identification of over 1500 unique proteins that were found within all nine CSF samples that were analyzed. Comparison with the HUPO serum proteome database demonstrated that human ventricular CSF contains a large array of proteins that may be unique to CSF. This analysis greatly increases our knowledge of the protein content of this clinically important biofluid. (C) 2010 Elsevier B.V. All rights reserved.	[Waybright, Timothy; Hollinger, Bradley J.; Veenstra, Timothy D.] NCI, SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick, MD 21702 USA; [Avellino, Anthony M.; Ellenbogen, Richard G.] Seattle Childrens Hosp, Dept Neurol Surg, Seattle, WA 98105 USA; [Avellino, Anthony M.; Ellenbogen, Richard G.; Morrison, Richard S.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Veenstra, TD (corresponding author), NCI, SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, POB B,Bldg 469,Rm 160, Frederick, MD 21702 USA.	veenstra@ncifcrf.gov; yael@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035533] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N01-CO-12400] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35533] Funding Source: Medline		Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Chi JH, 2005, J NEUROSURG, V103, P113, DOI 10.3171/ped.2005.103.2.0113; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; FISHMAN RA, 1992, CEREBROSPINAL FLUID, P183; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Johnson MD, 2005, AM J PHARMACOGENOMIC, V5, P259, DOI 10.2165/00129785-200505040-00006; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Lacy M, 2008, PEDIATR NEUROSURG, V44, P376, DOI 10.1159/000149904; Lee BPL, 2008, NAT IMMUNOL, V9, P117, DOI 10.1038/ni0208-117; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petrik V, 2006, BRIT J NEUROSURG, V20, P275, DOI 10.1080/02688690600999620; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Provencio JJ, 2005, J NEUROIMMUNOL, V163, P179, DOI 10.1016/j.jneuroim.2005.03.003; Rekate HL, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-2; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	21	14	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3919	1876-7737		J PROTEOMICS	J. Proteomics	APR 18	2010	73	6			SI		1156	1162		10.1016/j.jprot.2010.02.004			7	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	597ND	WOS:000277763800013	20176152				2022-02-06	
J	Carlile, M; Nicewander, D; Yablon, SA; Brown, A; Brunner, R; Burke, D; Chae, H; Englander, J; Flanagan, S; Hammond, F; Khademi, A; Lombard, LA; Meythaler, JM; Mysiw, WJ; Zafonte, R; Diaz-Arrastia, R				Carlile, Mary; Nicewander, David; Yablon, Stuart A.; Brown, Allen; Brunner, Robert; Burke, David; Chae, Heechin; Englander, Jeffrey; Flanagan, Steve; Hammond, Flora; Khademi, Allen; Lombard, Lisa A.; Meythaler, Jay M.; Mysiw, W. Jerry; Zafonte, Ross; Diaz-Arrastia, Ramon			Prophylaxis for Venous Thromboembolism During Rehabilitation for Traumatic Brain Injury: A Multicenter Observational Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Venous thromboembolism; Prophylactic anticoagulation; Traumatic brain injury	MOLECULAR-WEIGHT HEPARIN; PROPENSITY SCORE METHODS; DEEP-VEIN THROMBOSIS; ENOXAPARIN; PREVENTION; RISK; MANAGEMENT; SAFETY; POWER; HEAD	Background: Deep venous thrombosis (DVT) is a major cause of mortality and morbidity after traumatic brain injury (TBI). There is no consensus regarding appropriate screening, prophylaxis, or treatment during acute rehabilitation. Methods: This prospective observational study evaluated prophylactic anticoagulation during rehabilitation in patients with TBI aged 16 years or older admitted to 12 TBI Model Systems rehabilitation centers (July 2004 December 2007). After propensity score stratification within center, the odds ratio associated with incidence of symptomatic DVT or pulmonary embolism (PE) for patients who did and did not receive prophylactic anticoagulation was estimated using conditional logistic regression in patients who were not screened for DVT on rehabilitation admission or who screened negative; the analysis was repeated in these two subgroups. Results: Patients with identified DVTs at rehabilitation admission (n = 266) were excluded, leaving 1,897 patients: 1,002 screened negative, 895 un-screened; 932 received prophylactic anticoagulation, and 965 did not. Symptomatic DVT/PE was detected in 32 patients (15 of 932 [1.6%] with prophylaxis, 17 of 965 [1.8%] without). After propensity score adjustment, the odds ratio (95% confidence interval) for symptomatic DVT/PE with prophylaxis versus no prophylaxis was 0.80 (0.33-1.94) in the full analytic population and 0.46 (0.12-1.84) in the screened-negative subgroup. The only probable venous thromboembolism-related death occurred in the prophylactic anticoagulation group. Fewer new/expanded intracranial hemorrhages occurred among patients who received prophylactic anticoagulation. Conclusions: Prophylactic anticoagulation during rehabilitation seemed safe for TBI patients whose physicians deemed it appropriate, but did not conclusively reduce venous thromboembolism. Given the number of DVTs present before rehabilitation, screening and prophylaxis during acute care may be more important.	[Carlile, Mary] Baylor Inst Rehabil, N Texas Traumat Brain Injury Model Syst, Dallas, TX 75246 USA; [Nicewander, David] Inst Hlth Care Res & Improvement, Baylor Hlth Care Syst, Dallas, TX USA; [Yablon, Stuart A.] Methodist Rehabil Ctr, Traumat Brain Injury Model Syst Mississippi, Jackson, MS USA; [Brown, Allen] Mayo Clin, Coll Med, Mayo Clin Traumat Brain Injury Model Syst, Rochester, MN USA; [Brunner, Robert; Meythaler, Jay M.] Birmingham TBI Injury Care Ctr, Univ Alabama, Univ Alabama Birmingham Traumat Brain Injury Mode, Birmingham, AL USA; [Meythaler, Jay M.] Rehabil Inst Michigan, So Michigan Traumat Brain Injury Model Syst, Detroit, MI USA; [Burke, David; Chae, Heechin] Harvard Univ, Sch Med, Spaulding Rehabil Hosp Network, Spaulding Partners Traumat Brain Injury Model Sys, Boston, MA USA; [Englander, Jeffrey] Santa Clara Med Ctr, Rehabil Res Ctr, No Calif Traumat Brain Injury Model Syst, Santa Clara, CA USA; [Flanagan, Steve] Mt Sinai Sch Med, New York Traumat Brain Injury Model Syst, New York, NY USA; [Hammond, Flora] Carolinas Hlth Care Syst, Carolinas Rehabil Traumat Brain Injury Model Syst, Charlotte, NC USA; [Khademi, Allen] JFK Johnson Rehabil Inst, JFK Johnson Rehabil Inst TBI Model Syst, Edison, NJ USA; [Lombard, Lisa A.; Zafonte, Ross] Univ Pittsburgh, Med Ctr, Univ Pittsburgh Med Ctr TBI Model Syst, Pittsburgh, PA USA; [Mysiw, W. Jerry] Ohio Valley Ctr Brain Injury Prevent & Rehabil, Ohio Reg TBI Model Syst, Columbus, OH USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, N Texas Traumat Brain Injury Model Syst, Dallas, TX 75390 USA		Carlile, M (corresponding author), Baylor Inst Rehabil, N Texas Traumat Brain Injury Model Syst, 909 N,Washington Ave, Dallas, TX 75246 USA.	marycar@baylorhealth.edu	Mysiw, Walter/E-3724-2011	Brown, Allen W./0000-0001-7228-3351; Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020526]	Supported by National Institute on Disability and Rehabilitation Research, US Department of Education Grant H133A020526.	Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Brandt MM, 2007, AM J SURG, V193, P383; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Elliott B, 2006, DISABIL REHABIL, V28, P333, DOI 10.1080/09638280500190722; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Klar, 2000, DESIGN ANAL CLUSTER; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Lai JM, 1997, BRAIN INJURY, V11, P331, DOI 10.1080/026990597123485; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Raabe A, 2001, ACTA NEUROCHIR, V143, P1, DOI 10.1007/s007010170131; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SHOJANIA K, 2001, 43 AG HEALTHC RES QU; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; Yablon SA, 2004, NEUROLOGY, V63, P485, DOI 10.1212/01.WNL.0000133009.24727.9F	35	14	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2010	68	4					916	923		10.1097/TA.0b013e3181b16d2d			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	583GY	WOS:000276663100032	19996796				2022-02-06	
J	Jagersberg, M; Schaller, C; Bostrom, J; Schatlo, B; Kotowski, M; Thees, C				Jaegersberg, M.; Schaller, C.; Bostroem, J.; Schatlo, B.; Kotowski, M.; Thees, C.			Simultaneous Bedside Assessment of Global Cerebral Blood Flow and Effective Cerebral Perfusion Pressure in Patients with Intracranial Hypertension	NEUROCRITICAL CARE			English	Article						Transcerebral double-indicator dilution technique; Global cerebral blood flow; Effective cerebral perfusion pressure; Critical closing pressure; Intracranial hypertension; Mannitol; Hypertonic saline	HEAD-INJURED PATIENTS; CRITICAL CLOSING PRESSURE; HYPERTONIC SALINE; BRAIN EDEMA; HYPERVENTILATION; MANNITOL; PATHOPHYSIOLOGY; HEMODYNAMICS; MODERATE; TONE	We examined a bedside technique transcerebral double-indicator dilution (TCID) for global cerebral blood flow (CBF) as well as the concept of effective cerebral perfusion pressure (CPPeff) during different treatment options for intracranial hypertension, and compared global CBF and CPPeff with simultaneously obtained conventional parameters. Twenty-six patients developing intracranial hypertension in the course of traumatic brain injury or subarachnoid hemorrhage were prospectively analyzed using a combined assessment during elevated ventilation (n = 15) or osmotherapy (hypertonic saline or mannitol). For calculation of global CBF, injections of ice-cold indocyanine green boluses were performed and temperature and dye concentration changes were monitored in the thoracic aorta and the jugular bulb. CBF was then calculated according to the mean transit time principle. Estimation of CCP, the arterial pressure at which cerebral blood flow becomes zero, was performed by synchronized registration of corresponding values of blood flow velocity in the middle cerebral artery and arterial pressure and extrapolation to zero-flow velocity. CPPeff was calculated as mean arterial pressure minus critical closing pressure (CPPeff = MAP(c) - CCP). Elevated ventilation causes a decrease in both ICP (P < 0.001) and CBF (P < 0.001). While CPPconv increased (P < 0.001), CPPeff decreased during this observation (P = 0.002). Administration of osmotherapeutic agents resulted in a decrease of ICP (P < 0.001) and a temporary increase of CBF (P = 0.052). CPPconv and CPPeff showed no striking difference under osmotherapy. TCID allows repeated measurements of global CBF at the bedside. Elevated ventilation lowered and osmotherapy temporarily raised global CBF. In situations of increased vasotonus, CPPeff is a better indicator of blood flow changes than conventional CPP.	[Jaegersberg, M.; Schaller, C.; Schatlo, B.; Kotowski, M.] Univ Geneva, Med Ctr, Dept Neurosurg, CH-1211 Geneva, Switzerland; [Jaegersberg, M.; Schaller, C.; Bostroem, J.; Schatlo, B.; Kotowski, M.] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany; [Thees, C.] Univ Bonn, Med Ctr, Dept Anaesthesiol, D-5300 Bonn, Germany		Jagersberg, M (corresponding author), Univ Geneva, Med Ctr, Dept Neurosurg, CH-1211 Geneva, Switzerland.	max.jaegersberg@bluewin.ch	SCHATLO, Bawarjan/F-4285-2010				Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Baethmann A, 1997, ZBL NEUROCHIR, V58, P20; Baethmann A, 1997, ZBL NEUROCHIR, V58, P29; BARZO P, 1993, NEUROSURGERY, V32, P611; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BURTON AC, 1951, AM J PHYSIOL, V164, P319, DOI 10.1152/ajplegacy.1951.164.2.319; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Coplin WM, 1997, NEUROSURGERY, V41, P101, DOI 10.1097/00006123-199707000-00022; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; DRAKE CG, 1988, J NEUROSURG, V68, P985; EARLY CB, 1974, J NEUROSURG, V41, P590, DOI 10.3171/jns.1974.41.5.0590; Ertel W, 1998, UNFALLCHIRURG, V101, P520, DOI 10.1007/s001130050304; FEGLER G, 1954, Q J EXP PHYSIOL CMS, V39, P153, DOI 10.1113/expphysiol.1954.sp001067; FOX IJ, 1957, P STAFF M MAYO CLIN, V32, P478; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Keller E, 2000, CRIT CARE MED, V28, P511, DOI 10.1097/00003246-200002000-00037; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KISCH H, 1995, CRIT CARE MED, V23, P885, DOI 10.1097/00003246-199505000-00017; Lassen N. A., 1979, TRACER KINETIC METHO; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marmarou A, 1997, ACT NEUR S, V70, P68; Marshall LF, 1991, J NEUROSURG S, V75, P14; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Mielck F, 2004, EUR J ANAESTH, V21, P289, DOI 10.1017/S0265021504004077; Mielck F, 2001, EUR J ANAESTH, V18, P653, DOI 10.1046/j.1365-2346.2001.00994.x; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PERMUTT S, 1963, J APPL PHYSIOL, V18, P924, DOI 10.1152/jappl.1963.18.5.924; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Wietasch GJK, 2000, ANESTHESIOLOGY, V92, P367, DOI 10.1097/00000542-200002000-00017; ZIERLER KL, 1962, CIRC RES, V10, P393, DOI 10.1161/01.RES.10.3.393; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	39	14	14	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2010	12	2					225	233		10.1007/s12028-009-9300-2			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	573IL	WOS:000275905800013	20182922	Green Submitted			2022-02-06	
J	Maguen, S; Cohen, G; Cohen, BE; Lawhon, GD; Marmar, CR; Seal, KH				Maguen, Shira; Cohen, Greg; Cohen, Beth E.; Lawhon, G. Dawn; Marmar, Charles R.; Seal, Karen H.			The Role of Psychologists in the Care of Iraq and Afghanistan Veterans in Primary Care Settings	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						integrated care; veterans; mental health; post-traumatic stress disorder; health care	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH-SERVICES; STEPPED COLLABORATIVE CARE; TRAUMATIC BRAIN-INJURY; AFFAIRS PRIMARY-CARE; UNITED-STATES; DEPRESSION; OUTCOMES; MANAGEMENT	Although military personnel serving in Iraq and Afghanistan are at high risk of developing mental health problems, many report significant barriers to care and few seek help. Integrated primary care is a comprehensive model of health care that aims to improve access to care and provides a framework to assess and meet the complex psychiatric needs of newly returning veterans by embedding mental health specialists within primary care. We describe the role of psychologists in a Department of Veterans Affairs (VA) integrated primary care clinic that serves veterans of Iraq and Afghanistan. Psychologists based in primary care can assist veterans with reintegration to civilian life by providing rapid mental health assessment, normalizing readjustment concerns, planning for veterans safety, implementing brief interventions within primary care. facilitating transition to additional mental health care, and informing veterans of other available psychosocial services. A case example demonstrating the psychologist's role highlights the benefits of an integrated care model. Implications of employing this model include reduction of symptoms and impairment by reducing stigma and barriers to seeking mental health care, increased motivation to engage ill treatment, and implementation of early interventions. This model may also be beneficial in the civilian health care sector with groups that are at high risk for mental health problems, yet experience barriers to care. particularly stigma.	[Maguen, Shira; Cohen, Greg; Cohen, Beth E.; Lawhon, G. Dawn; Marmar, Charles R.; Seal, Karen H.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Marmar, Charles R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA		Maguen, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA.	shira.maguen@va.gov	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607			Babor TF, 2001, AUDIT ALCOHOL USE DI; Bartels SJ, 2004, AM J PSYCHIAT, V161, P1455, DOI 10.1176/appi.ajp.161.8.1455; Blount A., 2003, FAMILIES SYSTEMS HEA, V21, P121, DOI [DOI 10.1037/1091-7527.21.2.121, 10.1037/1091-7527.21.2.121]; Blount A, 2007, PROF PSYCHOL-RES PR, V38, P290, DOI 10.1037/0735-7028.38.3.290; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Dobscha SK, 2006, ANN INTERN MED, V145, P477, DOI 10.7326/0003-4819-145-7-200610030-00005; Engel CC, 2008, MIL MED, V173, P935, DOI 10.7205/MILMED.173.10.935; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Felker Bradford L, 2006, Prim Care Companion J Clin Psychiatry, V8, P12; Galovski TE, 2009, J TRAUMA STRESS, V22, P197, DOI 10.1002/jts.20418; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Hedrick SC, 2003, J GEN INTERN MED, V18, P9, DOI 10.1046/j.1525-1497.2003.11109.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KATON W, 1994, PSYCHOSOMATICS, V35, P268, DOI 10.1016/S0033-3182(94)71775-8; Katon W, 2001, GEN HOSP PSYCHIAT, V23, P138, DOI 10.1016/S0163-8343(01)00136-0; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; Katon WJ, 2008, J OCCUP ENVIRON MED, V50, P459, DOI 10.1097/JOM.0b013e318168efb7; Kilbourne AM, 2006, ADM POLICY MENT HLTH, V33, P208, DOI 10.1007/s10488-006-0034-6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; MAGUEN S, J TRAUMATIC IN PRESS; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Robinson P.J., 2007, BEHAV CONSULTATION P; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SEAL KH, VA MENTAL H IN PRESS; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zeiss AM, 2008, J CLIN PSYCHOL MED S, V15, P73, DOI 10.1007/s10880-008-9100-4	37	14	14	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	APR	2010	41	2					135	142		10.1037/a0018835			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	586EY	WOS:000276886800007					2022-02-06	
J	Ghorbanian, MT; Tiraihi, T; Mesbah-Namin, SA; Fathollahi, Y				Ghorbanian, Mohammad Taghi; Tiraihi, Taki; Mesbah-Namin, Seyed A.; Fathollahi, Yaghoub			Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype	NEUROLOGICAL RESEARCH			English	Article						Selegiline; marrow stromal cells; differentiation; neuronal phenotype	IN-VITRO DIFFERENTIATION; BUTYLATED HYDROXYANISOLE BHA; SISTER-CHROMATID EXCHANGES; MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURAL-TUBE DEFECTS; RETINOIC ACID; VALPROIC ACID; ANTIEPILEPTIC DRUGS; GENE-EXPRESSION	Objective: Bone marrow stromal cells (BMSCs) were documented as a feasible candidate for cell therapy. Several protocols with one or more steps, using different chemicals, were used for inducing BMSCs differentiation into neuronal phenotype. Many of these chemicals were reported to be of mutagenic, teratogenic or carcinogenic properties. The purpose of this work was to evaluate the neuronal inductivity of selegiline to BMSCs. Methods: Selegiline was used to induce BMSCs following pre-induction with beta-mercaptoethanol and retinoic acid. The neuronal phenotype was evaluated using antineurofilament 200, neurofilament 68, anti-Map-2 and synapsin I antibodies. In addition, reverse transcription polymerase chain reaction was used for the expression of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 (NT-3), neuroligin 1 and post-synaptic density protein 95 (PSD-95). Results: The result of the work showed that the induced BMSCs were immunoreactive for neurofilaments 200 and 68. Moreover, anti-Map-2 and synapsin I antibodies showed a structure morphologically consistent with synapses. Reverse transcription polymerase chain reaction showed that the induced BMSCs could express BDNF, NGF, NT-3, neuroligin 1 and PSD-95. The time course used was 1, 3, 6, 12, 24, 36 and 48 hours, and the percentages of neurofilament 200 immunoreactive cells were analysed using the logistic growth curve. Discussion: The results showed that selegiline was efficient and a potent inducer for BMSCs into neuronal phenotype, which can be used in the cell therapy in neurodegeneration and traumatic nervous tissue injuries.	[Ghorbanian, Mohammad Taghi; Tiraihi, Taki] Tarbiat Modares Univ, Dept Anat Sci, Tehran, Iran; [Mesbah-Namin, Seyed A.] Tarbiat Modares Univ, Dept Clin Biochem, Tehran, Iran; [Fathollahi, Yaghoub] Tarbiat Modares Univ, Sch Med Sci, Dept Physiol, Tehran, Iran		Tiraihi, T (corresponding author), Tarbiat Modares Univ, Dept Anat Sci, Jalal Al Ahmed Express Way,POB 14155-4838, Tehran, Iran.	takialtr@modares.ac.ir	fathollahi, yaghoub/C-1670-2010	fathollahi, yghoub/0000-0002-3695-4805			Ali BH, 2001, VET HUM TOXICOL, V43, P228; BANTLE JA, 1990, DRUG CHEM TOXICOL, V13, P267, DOI 10.3109/01480549009032286; Barnes GL, 1996, TERATOLOGY, V54, P93, DOI 10.1002/(SICI)1096-9926(199606)54:2<93::AID-TERA5>3.0.CO;2-5; Bertani N, 2005, J CELL SCI, V118, P3925, DOI 10.1242/jcs.02511; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BRENNAN SM, 1991, TERATOLOGY, V43, P341, DOI 10.1002/tera.1420430409; CHIUEH CC, 1994, ANN NY ACAD SCI, V738, P25; Delgado A, 2005, J MICROBIOL METH, V62, P121, DOI 10.1016/j.mimet.2005.01.006; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Ebadi M, 2002, J NEUROSCI RES, V67, P285, DOI 10.1002/jnr.10148; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Esmaeili F, 2006, REJUV RES, V9, P475, DOI 10.1089/rej.2006.9.475; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; GRESSENS P, 1992, J NEUROPATH EXP NEUR, V51, P206, DOI 10.1097/00005072-199203000-00010; GU XF, 1993, EUR J PHARMACOL, V235, P51, DOI 10.1016/0014-2999(93)90819-4; Hagell P, 1998, MOVEMENT DISORD, V13, P34, DOI 10.1002/mds.870130110; Hansen DK, 2001, REPROD TOXICOL, V15, P31; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Henchcliffe Claire, 2005, Expert Rev Neurother, V5, P811, DOI 10.1586/14737175.5.6.811; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann Andreas, 2006, Expert Opin Biol Ther, V6, P653, DOI 10.1517/14712598.6.7.653; Hobbenaghi R, 2003, CLIN NEUROPHARMACOL, V26, P263, DOI 10.1097/00002826-200309000-00011; HSIAO WLW, 1985, MOL CELL BIOL, V5, P1800, DOI 10.1128/MCB.5.7.1800; HU LJ, 1990, MUTAT RES, V243, P63, DOI 10.1016/0165-7992(90)90124-3; Huang FJ, 2005, FERTIL STERIL, V83, P238, DOI 10.1016/j.fertnstert.2004.07.955; Huang FJ, 2003, HUM REPROD, V18, P130, DOI 10.1093/humrep/deg018; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; IVERSON F, 1995, CANCER LETT, V93, P49, DOI 10.1016/0304-3835(95)03787-W; Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Kini U, 2006, ARCH DIS CHILD-FETAL, V91, pF90, DOI 10.1136/adc.2004.067421; KITCHIN KT, 1984, TOXICOLOGY, V30, P45, DOI 10.1016/0300-483X(84)90061-1; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; KOCHHAR DM, 1993, PROG CLIN BIOL RES, V383, P815; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kramer BC, 2006, BIOCHEM BIOPH RES CO, V343, P1045, DOI 10.1016/j.bbrc.2006.02.191; KURISHITA A, 1989, TERATOLOGY, V39, P163, DOI 10.1002/tera.1420390208; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li TY, 2004, CELL BIOL INT, V28, P801, DOI 10.1016/j.cellbi.2004.07.010; LINDHOUT D, 1992, EPILEPSIA, V33, pS41; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Magaki T, 2005, NEUROSCI LETT, V384, P282, DOI 10.1016/j.neulet.2005.05.025; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Miescher K, 1938, BIOCHEM J, V32, P725, DOI 10.1042/bj0320725; Mis K, 2005, CHEM-BIOL INTERACT, V157, P29, DOI 10.1016/j.cbi.2005.10.003; MIYAKAWA Y, 1991, CARCINOGENESIS, V12, P1169, DOI 10.1093/carcin/12.7.1169; MONTERO D, 1990, LIFE SCI, V46, P1619; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nakaso K, 2006, BIOCHEM BIOPH RES CO, V339, P915, DOI 10.1016/j.bbrc.2005.11.095; NAU H, 1991, PHARMACOL TOXICOL, V69, P310, DOI 10.1111/j.1600-0773.1991.tb01303.x; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; OBEREMM A, 1992, TERATOGEN CARCIN MUT, V12, P251, DOI 10.1002/tcm.1770120603; Ornoy A, 2006, REPROD TOXICOL, V22, P214, DOI 10.1016/j.reprotox.2006.03.014; Panahi M, 2002, CLIN NEUROPHARMACOL, V25, P75, DOI 10.1097/00002826-200203000-00003; Paterson IA, 1997, NEUROSCI BIOBEHAV R, V21, P181, DOI 10.1016/S0149-7634(96)00008-5; Pennati R, 2001, TERATOGEN CARCIN MUT, V21, P121, DOI 10.1002/1520-6866(2001)21:2<121::AID-TCM2>3.0.CO;2-N; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; PHILLIPS BJ, 1989, MUTAT RES, V214, P105, DOI 10.1016/0027-5107(89)90203-0; Raedt R, 2007, EXP NEUROL, V203, P542, DOI 10.1016/j.expneurol.2006.09.016; Rismanchi N, 2003, BRAIN RES, V991, P46, DOI 10.1016/j.brainres.2003.07.004; Rutledge JC, 1997, MUTAT RES-FUND MOL M, V396, P113, DOI 10.1016/S0027-5107(97)00178-4; Saito M, 2003, ANTICANCER RES, V23, P4693; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SATO H, 1987, CARCINOGENESIS, V8, P1231, DOI 10.1093/carcin/8.9.1231; SCHAUMANN BA, 1989, EPILEPSY RES, V3, P182, DOI 10.1016/0920-1211(89)90048-X; Scintu F, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-14; SPEIT G, 1980, MUTAT RES, V78, P267, DOI 10.1016/0165-1218(80)90108-1; SULIK KK, 1995, TERATOLOGY, V51, P398, DOI 10.1002/tera.1420510605; Suon S, 2006, BRAIN RES, V1106, P46, DOI 10.1016/j.brainres.2006.05.109; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Tzeng SF, 2004, NEUROSCI LETT, V367, P23, DOI 10.1016/j.neulet.2004.05.117; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; Wang N, 2004, ACTA PHARMACOL SIN, V25, P442; Wang N, 2006, BIOORG MED CHEM LETT, V16, P4780, DOI 10.1016/j.bmcl.2006.06.080; WEST RW, 1993, CARCINOGENESIS, V14, P285, DOI 10.1093/carcin/14.2.285; WHITAKERAZMITIA PM, 1994, NEUROPSYCHOPHARMACOL, V11, P125, DOI 10.1038/npp.1994.42; Whitsel AI, 2002, TERATOLOGY, V66, P153, DOI 10.1002/tera.10093; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Williams SS, 2004, PHYSIOL GENOMICS, V19, P184, DOI 10.1152/physiolgenomics.00136.2004; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yu JK, 2003, PEDIATR SURG INT, V19, P355, DOI 10.1007/s00383-003-1010-9; Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025	88	14	15	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2010	32	2					185	193		10.1179/174313209X409016			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558XJ	WOS:000274781900013	19422735				2022-02-06	
J	Saito, S; Kobayashi, T; Osawa, T; Kato, S				Saito, Shinnosuke; Kobayashi, Toshiyuki; Osawa, Takuro; Kato, Satoshi			Effectiveness of Japanese herbal medicine yokukansan for alleviating psychiatric symptoms after traumatic brain injury	PSYCHOGERIATRICS			English	Article						traumatic brain injury; yokukansan (Yi-Gan San)	YI-GAN-SAN; PSYCHOLOGICAL SYMPTOMS; LEWY BODIES; DEMENTIA	The Japanese herbal medicine, yokukansan, has been reported to improve behavioral and psychological symptoms of dementia and activities of daily living in patients with dementia. In the present case report, the authors report the effectiveness of yokukansan in treating psychiatric symptoms after traumatic brain injury. An 85-year-old man, who underwent surgery for hepatic portal cholangiocarcinoma, sustained traumatic brain injury after falling from bed as the result of postoperative delirium. He subsequently presented with psychiatric symptoms, showing markedly impulsive and aggressive behavior. Neuroleptics did not alleviate the symptoms. Ultimately, we succeeded in controlling the symptoms, without adverse effects, by giving the patient yokukansan. Yokukansan shows the potential for reducing aggressive and impulsive behavior in dementia as well as in other psychiatric diseases.	[Saito, Shinnosuke; Kobayashi, Toshiyuki; Osawa, Takuro; Kato, Satoshi] Jichi Med Univ, Dept Psychiat, Shimotsuke, Tochigi 3290498, Japan		Saito, S (corresponding author), Jichi Med Univ, Dept Psychiat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	saitoshinnosuke@gmail.com		Kobayashi, Toshiyuki/0000-0002-0237-3623			Egashira N, 2008, PROG NEURO-PSYCHOPH, V32, P1516, DOI 10.1016/j.pnpbp.2008.05.010; Igarashi Y., 2008, GERIAT MED, V46, P255; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P1612, DOI 10.4088/JCP.v66n1219a; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P150, DOI 10.1016/j.pnpbp.2007.07.026; MIZUKAMI K, 2009, NT J NEUROPSYCHOPHAR, V12, P191; Monji A, 2009, PROG NEURO-PSYCHOPH, V33, P308, DOI 10.1016/j.pnpbp.2008.12.008; MUKAI N, 2008, HOKKAIDO GERKA ZASSH, V53, P90; RAO V, 2008, PSYCHIAT ASPECTS NEU, P84; Sekiguchi K, 2009, PHYTOTHER RES, V23, P1175, DOI 10.1002/ptr.2777; Shinno H, 2008, PROG NEURO-PSYCHOPH, V32, P881, DOI 10.1016/j.pnpbp.2007.12.027; Shinno H, 2007, PROG NEURO-PSYCHOPH, V31, P1543, DOI 10.1016/j.pnpbp.2007.07.002; SUDARSANAN BS, 2006, MED J ARMED FORCES I, V62, P259; Tateno M, 2008, PROG NEURO-PSYCHOPH, V32, P1704, DOI 10.1016/j.pnpbp.2008.07.006	15	14	14	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1346-3500			PSYCHOGERIATRICS	Psychogeriatrics	MAR	2010	10	1					45	48		10.1111/j.1479-8301.2010.00313.x			4	Geriatrics & Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Psychiatry	615XJ	WOS:000279171600008	20594286	Bronze			2022-02-06	
J	Xue, T; Mao, Z; Lin, L; Hou, Y; Wei, X; Fu, X; Zhang, J; Yu, C				Xue, T.; Mao, Z.; Lin, L.; Hou, Y.; Wei, X.; Fu, X.; Zhang, J.; Yu, C.			Non-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats	GENE THERAPY			English	Article						siRNA; Runx2; Smad4; non-virus; heterotopic ossification	TOTAL HIP-ARTHROPLASTY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE MORPHOGENETIC PROTEIN-2; TRAUMATIC BRAIN-INJURY; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; ECTOPIC OSSIFICATION; ENHANCED OSTEOGENESIS; GENE-EXPRESSION; RISK-FACTORS	Heterotopic ossification of muscles, tendons and ligaments are a common problem affecting patient with trauma or received elective surgery. But the existing preventive or therapeutic methods all have disadvantages. Runt-related protein 2 (Runx2) and Smad4 are two regulators that have important roles in the differentiation of osteoblast. In this study, we attempted to examine the effect of Runx2 and Smad4 on the development of heterotopic ossification in vitro. We constructed non-virus-containing small interference RNAs (siRNAs) against Runx2 and Smad4 and tested it with reverse transcriptase-PCR and western blot. We then analyzed the independent effect of Runx2- and Smad4-specific siRNAs and their cooperative effect on the formation of heterotopic ossification induced by trauma in rats. The effects were measured with computed tomography scanning, hematoxylin and eosin staining and immunohistochemistry. We found that the Runx2 and Smad4-specific siRNAs inhibited the expression of Runx2 and Smad4 at the level of messenger RNA and protein. Runx2 and Smad4 independently inhibited the formation of heterotopic ossification. Moreover, their co-expression significantly enhanced the inhibition of heterotopic ossification compared with the independent effect. We suggest that gene therapy to inhibit Runx2 and Smad4 by RNAi could be a powerful approach to prevent or treat heterotopic ossification. Gene Therapy (2010) 17, 370-379; doi:10.1038/gt.2009.154; published online 26 November 2009	[Xue, T.; Lin, L.; Hou, Y.; Fu, X.; Zhang, J.; Yu, C.] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China; [Mao, Z.] Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Wei, X.] Tianjin Hosp, Dept Orthoped Surg, Tianjin, Peoples R China		Yu, C (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, 49 N Garden Rd, Beijing 100191, Peoples R China.	YCL123@vip.sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [ZR09-1-01]	This research was supported by the program of Gene Therapy on Sports Injury sponsored by National Natural Science Foundation of China (Grant Number: ZR09-1-01).	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; ALTMAN RD, 1995, J ORTHOP TRAUMA, V9, P392, DOI 10.1097/00005131-199505000-00006; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BONARIGO BC, 1967, RADIOLOGY, V88, P889, DOI 10.1148/88.5.889; BRADY LW, 1979, SKELETAL RADIOL, V4, P72, DOI 10.1007/BF00349330; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; BRUMBACK RJ, 1990, J BONE JOINT SURG AM, V72A, P1067, DOI 10.2106/00004623-199072070-00017; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; Crawford C M, 1986, J Burn Care Rehabil, V7, P323, DOI 10.1097/00004630-198607000-00005; DELEE J, 1976, CLIN ORTHOP RELAT R, P53; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dimar JR, 1996, SPINE, V21, P1870, DOI 10.1097/00007632-199608150-00006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FAHRER H, 1988, BRIT J RHEUMATOL, V27, P187; GREEN DP, 1979, J BONE JOINT SURG AM, V61, P1092, DOI 10.2106/00004623-197961070-00021; Haque S, 1996, ARCH PATHOL LAB MED, V120, P666; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Igarashi M, 2004, J MOL HISTOL, V35, P3, DOI 10.1023/B:HIJO.0000020883.33256.fe; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lin L, 2006, BIOCHEM BIOPH RES CO, V349, P564, DOI 10.1016/j.bbrc.2006.08.089; LOVELOCK JE, 1990, SKELETAL RADIOL, V19, P31; MCCLURE J, 1983, J PATHOL, V139, P419, DOI 10.1002/path.1711390403; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naraghi FF, 1996, ORTHOPEDICS, V19, P145; ORZEL JA, 1985, J NUCL MED, V26, P125; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269; QUINLAN JG, 1995, MUSCLE NERVE, V18, P201, DOI 10.1002/mus.880180209; Richards AM, 1997, BURNS, V23, P64, DOI 10.1016/S0305-4179(96)00074-5; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; SHAMBERGER R, 1985, RECENT RESULTS CANC, V98, P17; SOBALLE K, 1988, CLIN ORTHOP RELAT R, P57; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Viola RW, 2000, CLIN ORTHOP RELAT R, P65; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	47	14	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	MAR	2010	17	3					370	379		10.1038/gt.2009.154			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	566SE	WOS:000275392600008	19940863	Bronze			2022-02-06	
J	Bauss, O; Schafer, W; Sadat-Khonsari, R; Knosel, M				Bauss, Oskar; Schaefer, Winfried; Sadat-Khonsari, Reza; Knoesel, Michael			Influence of Orthodontic Extrusion on Pulpal Vitality of Traumatized Maxillary Incisors	JOURNAL OF ENDODONTICS			English	Article						Dental trauma; orthodontic treatment; pulp necrosis	EXPERIMENTAL TOOTH INTRUSION; PERMANENT INCISORS; BLOOD-FLOW; ROOT RESORPTION; DENTAL-PULP; REPLANTED TEETH; ANTERIOR TEETH; MOVEMENT; FORCE; INJURIES	Introduction: The aim of this retrospective study was to examine the effect of orthodontic extrusion on the pulpal vitality of maxillary incisors with a history of trauma. Methods: Pulpal condition was examined clinically (rating of crown color and sensitivity testing with a cryogenic spray) and radiologically (periapical and panoramic radiographs) after orthodontic extrusion of previously traumatized (Orthodontics/Trauma group, n = 77) and nontraumatized teeth (Orthodontics group, n = 400) and after previous dental trauma without subsequent orthodontic treatment (Trauma group, n = 193). Dental traumata were divided into hard tissue injuries (fracture of enamel and enamel chipping, fracture of enamel-dentin without pulpal involvement, fracture of enamel-dentin with pulpal involvement, root fracture, crown-root fracture) and periodontal injuries (concussion, subluxation, intrusion, extrusion, lateral luxation, and avulsion). Results: Teeth in the Orthodontics/Trauma group showed a significantly higher frequency of pulp necrosis than teeth in the Orthodontics group (P <.001) or teeth in the Trauma group (P <.009). In addition, teeth in the Orthodontics/Trauma group with periodontal injuries showed a significantly higher rate of pulp necrosis than teeth in the Orthodontics group (P <.001) or the corresponding teeth in the Trauma group (P =.004). No significant differences were observed between teeth in the Orthodontics/Trauma group with previous hard tissue injuries and teeth in the Orthodontics group or the corresponding teeth in the Trauma group. In addition, no statistically significant differences were determined between central and lateral incisors. Conclusions: The results indicated that maxillary incisors with a history of severe periodontal injury have a higher susceptibility to pulp necrosis during orthodontic extrusion than nontraumatized teeth. (J Endod 2010;36:203-207)	[Bauss, Oskar] Hannover Med Sch, D-3000 Hannover, Germany; [Sadat-Khonsari, Reza; Knoesel, Michael] Univ Gottingen, Dept Orthodont, Gottingen, Germany		Bauss, O (corresponding author), Luisenstr 10-11, D-30159 Hannover, Germany.	o.bauss@praxisbauss.de					ANDREASEN FM, 1989, ENDOD DENT TRAUMATOL, V5, P111; Andreasen FM., 2007, TXB ATLAS TRAUMATIC, V4th, P255; Andreasen JO, 1981, TRAUMATIC INJURIES T, P19; Barwick PJ, 1996, AM J ORTHOD DENTOFAC, V110, P273, DOI 10.1016/S0889-5406(96)80011-4; Bauss O, 2004, DENT TRAUMATOL, V20, P61, DOI 10.1111/j.1600-4469.2004.00230.x; Bauss O, 2008, AM J ORTHOD DENTOFAC, V134, P12, DOI 10.1016/j.ajodo.2006.07.033; Bauss O, 2008, J ENDODONT, V34, P417, DOI 10.1016/j.joen.2008.01.006; Bauss O, 2008, J OROFAC ORTHOP, V69, P402, DOI 10.1007/s00056-008-8805-1; Bauss O, 2009, ANGLE ORTHOD, V79, P166, DOI 10.2319/010708-7.1; BRIN I, 1991, European Journal of Orthodontics, V13, P372; BURNSIDE RR, 1974, ANGLE ORTHOD, V44, P213; Cohenca N, 2003, DENT TRAUMATOL, V19, P289, DOI 10.1034/j.1600-9657.2003.t01-1-00191.x; Cvek M., 2007, TXB COLOR ATLAS TRAU, P598; Cwyk F, 1984, J DENT RES, V63; de Souza RS, 2006, J ENDODONT, V32, P115, DOI 10.1016/j.joen.2005.10.025; DELLINGE.EL, 1967, AMER J ORTHODONTICS, V53, P325, DOI 10.1016/0002-9416(67)90100-5; Derringer KA, 1996, J DENT RES, V75, P1761, DOI 10.1177/00220345960750100901; Esteves T, 2007, J ENDODONT, V33, P119, DOI 10.1016/j.joen.2006.09.007; GORDON NS, 1972, AMER J ORTHODONTICS, V62, P544, DOI 10.1016/0002-9416(72)90036-X; GRAUPPER JG, 1972, AMER J ORTHODONTICS, V62, P544, DOI 10.1016/0002-9416(72)90037-1; GUEVARA MJ, 1980, ANGLE ORTHOD, V50, P129; HINES FB, 1979, AM J ORTHOD DENTOFAC, V75, P1, DOI 10.1016/0002-9416(79)90135-0; JACOBSEN I, 1977, SCAND J DENT RES, V85, P588; JARVINEN S, 1979, ACTA ODONTOL SCAND, V37, P335, DOI 10.3109/00016357909004705; KVINNSLAND S, 1989, EUR J ORTHODONT, V11, P200, DOI 10.1093/oxfordjournals.ejo.a035986; LINGE BO, 1983, EUR J ORTHODONT, V5, P173, DOI 10.1093/ejo/5.3.173; MALMGREN O, 1982, AM J ORTHOD DENTOFAC, V82, P487, DOI 10.1016/0002-9416(82)90317-7; MCDONALD F, 1994, EUR J ORTHODONT, V16, P1; MOSTAFA YA, 1991, AM J ORTHOD DENTOFAC, V99, P30, DOI 10.1016/S0889-5406(05)81677-4; NIXON CE, 1993, J ENDODONT, V19, P13, DOI 10.1016/S0099-2399(06)81034-4; Petersson K, 1999, ENDOD DENT TRAUMATOL, V15, P127; Phillips JR, 1955, ANGLE ORTHOD, V25, P1; POPP TW, 1992, AM J ORTHOD DENTOFAC, V101, P228, DOI 10.1016/0889-5406(92)70091-N; Raiden G, 1998, Acta Odontol Latinoam, V11, P49; REITAN K, 1967, AMER J ORTHODONTICS, V53, P721, DOI 10.1016/0002-9416(67)90118-2; RICKETTS RM, 1976, AM J ORTHOD DENTOFAC, V70, P241, DOI 10.1016/0002-9416(76)90332-8; Robertson A, 1996, J ENDODONT, V22, P557, DOI 10.1016/S0099-2399(96)80018-5; Ronnerman A, 1973, Sven Tandlak Tidskr, V66, P527; Sano Y, 2002, EUR J ORTHODONT, V24, P159, DOI 10.1093/ejo/24.2.159; Spector J K, 1974, N Y State Dent J, V40, P30; STENVIK A, 1971, ORAL SURG ORAL MED O, V32, P639, DOI 10.1016/0030-4220(71)90331-8; STENVIK A, 1970, AMER J ORTHODONTICS, V57, P370, DOI 10.1016/S0002-9416(70)90219-8; VANDEVSKARADUNOVIC V, 1994, EUR J ORTHODONT, V16, P361, DOI 10.1093/ejo/16.5.361	43	14	16	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399			J ENDODONT	J. Endod.	FEB	2010	36	2					203	207		10.1016/j.joen.2009.10.025			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	617KK	WOS:000279279400003	20113775				2022-02-06	
J	Breshears, RE; Brenner, LA; Harwood, JEF; Gutierrez, PM				Breshears, Ryan E.; Brenner, Lisa A.; Harwood, Jeri E. F.; Gutierrez, Peter M.			Predicting Suicidal Behavior in Veterans With Traumatic Brain Injury: The Utility of the Personality Assessment Inventory	JOURNAL OF PERSONALITY ASSESSMENT			English	Article							PSYCHIATRIC-PATIENTS; MMPI-2 PROFILES; HEAD-INJURY; POPULATION; IRAQ; TBI; AFGHANISTAN; DEPRESSION; RISK	In this study, we investigated the Personality Assessment Inventory's (PAI; Morey, 1991, 2007) Suicide Potential Index (SPI) and Suicide Ideation scale (SUI) as predictors of suicidal behavior (SB) in military Veterans with traumatic brain injury (TBI; N = 154). We analyzed electronic medical records were searched for SB in the 2 years post-PAI administration and data via logistic regressions. We obtained statistical support for the SPI and SUI as predictors of SB. Analyses we performed using receiver operating characteristics suggested an optimal SPI cutoff of epsilon 15 for this sample. Findings suggest that SPI and SUI scores may assist in assessing suicide risk in those with TBI, particularly when population-based cutoffs are considered.	[Breshears, Ryan E.; Brenner, Lisa A.; Harwood, Jeri E. F.; Gutierrez, Peter M.] Denver VA Med Ctr, VA VISN MIRECC 19, Denver, CO USA; [Brenner, Lisa A.; Gutierrez, Peter M.] Univ Colorado, Denver Sch Med, Dept Psychiat, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Denver Sch Med, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Brenner, Lisa A.] Univ Colorado, Denver Sch Med, Dept Neurol, Boulder, CO 80309 USA; [Harwood, Jeri E. F.] Univ Colorado, Denver Sch Med, Dept Pediat, Boulder, CO 80309 USA		Breshears, RE (corresponding author), WellStar Hlth Syst, 2000 S Pk Pl, Atlanta, GA 30339 USA.	ryan.breshears@wellstar.org	Brenner, Lisa A./AAG-2442-2019; Gutierrez, Peter/K-8905-2019	Gutierrez, Peter/0000-0001-8981-8404			ANTSEY KJ, 2004, J CLIN EPIDEMIOL, V57, P1202; Arbisi PA, 1999, NEUROREHABILITATION, V13, P117; Belter RW, 2001, J CLIN PSYCHOL, V57, P717, DOI 10.1002/jclp.1044; BRENNER LA, 2010, 2010 DOD VA SUIC PRE; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; Butcher J. N., 2001, MINNESOTA MULTIPHASI; *CDCP, 2009, WISQAR WEBS FAT INJ; *CDCP, 2006, TRAUM BRAIN INJ US R; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; *DEP VET AFF, 2004, VETEESA138 SP; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Fleischmann A, 2005, AM J ORTHOPSYCHIAT, V75, P676, DOI 10.1037/0002-9432.75.4.676; Foley J, 2006, INT J NEUROSCI, V116, P1377, DOI 10.1080/00207450500514334; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Martin J., 2009, J MENTAL HEALTH COUN, V31, P101, DOI DOI 10.17744/MEHC.31.2.A6338384R2770383; MILLER MC, 1999, HARVARD MED SCH GUID, P463; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Morey L. C., 1996, INTERPRETIVE GUIDE P; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Rudd MD, 1996, J ABNORM PSYCHOL, V105, P541, DOI 10.1037/0021-843X.105.4.541; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; STANLEY B, 2008, SAFETY PLAN TR UNPUB; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wicklund AH, 2008, CLIN NEUROPSYCHOL, V22, P98, DOI 10.1080/13825580601025924; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	43	14	14	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0022-3891			J PERS ASSESS	J. Pers. Assess.		2010	92	4					349	355	PII 923051207	10.1080/00223891.2010.482011			7	Psychology, Clinical; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	611EL	WOS:000278794000007	20552509				2022-02-06	
J	De Monte, VE; Geffen, GM; May, CR; McFarland, K				De Monte, Veronica Eileen; Geffen, Gina Malke; May, Christopher Randall; McFarland, Ken			Improved sensitivity of the rapid screen of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Acute effects; Neuropsychology; Sensitivity; Severity	NEUROPSYCHOLOGICAL TESTING USEFUL; SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; MINOR HEAD-INJURY; FOOTBALL PLAYERS; STANDARDIZED ASSESSMENT; ATTENTION DEFICITS; WORD REPETITION; CT-SCAN; RECOVERY	This study aimed to investigate the acute effects of mild traumatic brain injury (mTBI) in an emergency department sample. A total of 246 (186 male, 60 female) cases of mTBI and 102 (65 male and 37 female) cases of orthopedic injuries were tested within 24 hours of injury. Mild TBI patients performed more poorly on all subtests of the Rapid Screen of Concussion (RSC) and completed fewer symbols on Digit Symbol than did orthopedic controls. RSC scores predicted group membership better than chance, and Digit Symbol scores contributed significantly to predicting group membership over and above the contribution of the RSC, resulting in 70.4% sensitivity and 74% specificity for the extended protocol. The results of this study indicate that learning and memory, orientation, and speed of information processing are impaired immediately following mTBI. Furthermore, a brief battery of tests that include word recall, orientation, and the Digit Symbol Substitution Test could assess the severity of dysfunction following mTBI, and assist in clinical decision making regarding discharge, return to routine activities, and management of the effects of injury.	[Geffen, Gina Malke] Univ Queensland, Sch Psychol, Cognit Psychophysiol Lab, Brisbane, Qld 4072, Australia; [May, Christopher Randall] Royal Brisbane Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia		Geffen, GM (corresponding author), Univ Queensland, Sch Psychol, Cognit Psychophysiol Lab, Brisbane, Qld 4072, Australia.	geffen@psy.uq.edu.au					Baddeley A., 1992, SPEED CAPACITY LANGU; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barrow IM, 2006, J TRAUMA, V61, P1142, DOI 10.1097/01.ta.0000241238.70269.c1; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Barth JT, 1989, MILD HEAD INJURY, P257; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P624, DOI 10.1080/13803390490918589; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; De Monte VE., 2005, BRAIN IMPAIR, V6, P109, DOI [10.1375/brim.2005.6.2.109, DOI 10.1375/BRIM.2005.6.2.109]; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; *HEADM INC, 1999, CONC RES IND COMP PR; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; KWAPIL KJ, 2003, BRAIN IMPAIR, V4, P155; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lemeshow S, 2000, APPL LOGISTIC REGRES; LOVELL MR, 1998, IMPACT IMMEDIATE POS; Macciocchi SN, 2005, J ATHL TRAINING, V40, P152; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McHugh T, 2006, BRAIN COGNITION, V60, P209; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Randolph C, 2005, J ATHL TRAINING, V40, P139; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Wechsler, 1997, WECHSLER ADULT INTEL; YOUNGJOHN JR, 1992, CLIN NEUROPSYCHOL, V6, P276, DOI DOI 10.1080/13854049208404129	55	14	14	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	1					28	37		10.1080/13803390902806519			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	550YJ	WOS:000274170400003	19418329				2022-02-06	
S	Difede, J; Barchas, JD		Barchas, JD; Difede, J		Difede, JoAnn; Barchas, Jack D.			Psychiatric and neurologic aspects of war: an overview and perspective	PSYCHIATRIC AND NEUROLOGIC ASPECTS OF WAR	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	89th Annual Conference of the Association for Research in Nervous and Mental Disease	DEC 16, 2009	Rockefeller Univ, New York, NY		Rockefeller Univ	posttraumatic stress disorder; traumatic brain injury; veterans; technology; methodology; virtual reality; valor; terrorist behavior; genocide prevention; mass violence	MENTAL-HEALTH DIAGNOSES; AFGHANISTAN VETERANS; EXPOSURE THERAPY; IRAQ; DISORDERS; SERVICES	The growing number of soldiers returning home with psychiatric and neurologic disorders, notably posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI), underscores the need for an interdisciplinary framework for understanding the emergent consequences of combat. Among the challenges facing the scientific community is the development of effective treatment strategies for TBI from blast and other injuries, given the confounding effects of comorbid psychological symptoms on accurate diagnoses. At the individual level, emerging technologies including virtual reality, the use of genetic biomarkers to inform treatment response, and new brain imaging methodology are playing an important role in the development of differential therapeutics to best address a soldier's particular clinical needs. At the macro level, new approaches toward understanding the political, cultural, and ideological contexts of mass conflict, the decision to join in violence, and ways of preventing genocide are discussed.	[Difede, JoAnn; Barchas, Jack D.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA		Difede, J (corresponding author), Weill Cornell Med Coll, Dept Psychiat, 525 E 68th St,Box 200, New York, NY 10065 USA.	jdifede@med.cornell.edu					Andreasen NC, 2006, INTRO TXB PSYCHIAT; [Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Arendt H., 2006, EICHMANN JERUSALEM R; Barry, 2004, GREAT INFLUENZA EPIC; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Bogdanos M., 2006, THIEVES BAGHDAD; Bremner JD, 1998, PROG PSYCH, pXIII; Cahill SP, 2006, J TRAUMA STRESS, V19, P597, DOI 10.1002/jts.20173; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gombrich EH, 2008, LITTLE HIST WORLD; Hamburg D. A., 2004, LEARNING LIVE TOGETH; Hamburg David A., 2008, PREVENTING GENOCIDE; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder Board on Population Health and Public Health Practice, 2008, TREATM POSTTR STRESS; IOM (Institute of Medicine), 2006, POSTTR STRESS DIS DI; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Nestler E. J., 2008, MOL NEUROPHARMACOLOG; Post JM, 2008, MIND TERRORIST PSYCH; Rees CS, 2005, PROF PSYCHOL-RES PR, V36, P649, DOI 10.1037/0735-7028.36.6.649; Rowland LPP, 2009, MERRITTS NEUROLOGY; Sadock BJ, 2009, KAPLAN SADOCKS COMPR, VII; Schatzberg AF, 2009, AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 4TH EDITION, P1; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shay J., 2002, ODYSSEUS AM COMBAT T; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TASMAN A, 2008, PSYCHIATRY, V2; Tasman A., 2008, PSYCHIATRY, V1; Thase ME, 2008, ANNU REV CLIN PSYCHO, V4, P53, DOI 10.1146/annurev.clinpsy.2.022305.095301; *US CENS BUR, 2003, VET 2000 CENS BRIEF; *US CENS BUR, 1990, 1990 VET POP 1990 CE; WRAY BT, 2003, AUSTR ASS COGN BEH T	35	14	14	1	18	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-804-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1208						1	9		10.1111/j.1749-6632.2010.05795.x			9	Neurosciences; Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	BSK28	WOS:000284742000001	20955319				2022-02-06	
J	Goldstein, G; Allen, DN; Caponigro, JM				Goldstein, Gerald; Allen, Daniel N.; Caponigro, Janelle M.			A retrospective study of heterogeneity in neurocognitive profiles associated with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; assessment; cluster analysis; intelligence	VERBAL-LEARNING TEST; PATTERNS; SUBTYPES; PERFORMANCE	Research design: The study was retrospective, applying cluster analyses and associated statistical tests to an established database. Methods and procedures: Neuropsychological data from veterans with brain trauma were cluster analysed using the WAIS-R and Halstead-Reitan Battery (HRB). External validity of the cluster solutions was evaluated. Experimental interventions: The study was based upon use of an established database that contained cognitive test data and information regarding diagnosis and clinical history. Main outcomes and results: The WAIS-R clusters described sub-groups with near normal function, preserved verbal but impaired problem-solving abilities or global impairment. The HRB clusters differed in level of performance with Near Normal, Moderately Impaired and Globally Impaired clusters. Cluster membership was associated with age and employment status, but not with neurological findings. Conclusion: The outcome of traumatic brain injury is heterogeneous and mainly associated with demographic considerations.	[Goldstein, Gerald; Caponigro, Janelle M.] VA Pittsburgh Healthcare Syst, MIRECC, Pittsburgh, PA 15206 USA; [Allen, Daniel N.] Univ Nevada Las Vegas, Dept Psychol, Las Vegas, NV USA		Goldstein, G (corresponding author), VA Pittsburgh Healthcare Syst, MIRECC, 7180 Highland Dr 151R, Pittsburgh, PA 15206 USA.	ggold@nb.net		Allen, Daniel/0000-0003-4868-2242	DVA VISN IV Mental Illness Research, Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA; Medical Research Service, Department of Veterans AffairsUS Department of Veterans Affairs	This research was supported by the DVA VISN IV Mental Illness Research, Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA and the Medical Research Service, Department of Veterans Affairs.	ALLEN DN, 2006, M AM PSYCH ASS NEW O; Blashfield R.K., 1984, CLUSTER ANAL; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Heaton R. K., 2004, REVISED COMPREHENSIV; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; *PSYCH ASS AM, 1952, DIAGN STAT MAN MENT; Reitan R.M., 1993, HALSTEADREITAN NEURO; REITAN RM, 2000, MILD HEAD INJURY INT; Russell E. W., 1970, ASSESSMENT BRAIN DAM; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TEILER A, 1998, J CONSULT CLIN PSYCH, V58, P531; Teuber H.-L., 1964, FRONTAL GRANULAR COR; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	23	14	14	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	4					625	635		10.3109/02699051003670882			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	570ML	WOS:000275682300007	20235765				2022-02-06	
J	Kelts, EA				Kelts, Eric A.			Traumatic brain injury and visual dysfunction: A limited overview	NEUROREHABILITATION			English	Article									[Kelts, Eric A.] Porter Adventist Hosp, Denver, CO USA		Kelts, EA (corresponding author), 7400 E Arapahoe Rd,Suite 100, Centennial, CO 80112 USA.	ekeltsmd@yahoo.com					Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; KEANE JR, 1982, NEUROLOGY, V32, pA146; PADULA WV, BRAIN INJURY MED PRI, V207, P511; TROBE JD, 2001, NEUROLOGY VISION, P32; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012	6	14	16	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	27	3					223	229		10.3233/NRE-2010-0601			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	684FM	WOS:000284535800004	21098990				2022-02-06	
J	Lange, RT; Iverson, GL; Brubacher, JR; Franzen, MD				Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.; Franzen, Michael D.			Effect of blood alcohol level on Glasgow Coma Scale scores following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; alcohol; Glasgow Coma Scale score	HEAD-INJURY; INTOXICATION; TOLERANCE; SEVERITY; ABUSE	Objective: It is a common clinical perception that alcohol intoxication systematically lowers Glasgow Coma Scale (GCS) scores when evaluating traumatic brain injury (TBI). However, the research findings in this area do not uniformly support this notion. The purpose of this study is to examine the effects of blood alcohol level (BAL) on GCS scores following TBI. Method: Participants were 475 patients (64% male) who presented to a Level 1 trauma centre following a TBI. Patients were selected if they were injured in a motor vehicle accident and had an available day-of-injury GCS, BAL and Computed Tomography (CT) brain scan. Results: Overall, acute alcohol intoxication did not significantly affect GCS scores, even in patients with BALs of 200 mg dl(-1) or higher. When controlling for the effects of injury severity, acute alcohol intoxication affected GCS scores only in those patients with BALs greater than 200 mg dl(-1) who also had intracranial abnormalities detected on CT scan. Conclusions: These findings suggest that GCS scores can be interpreted at face value in the vast majority of patients who are intoxicated. However, GCS scores will likely over-estimate the severity of brain injury in patients with abnormal head CT scans and BALs greater than 200 mg dl(-1).	[Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Lange, Rael T.; Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Franzen, Michael D.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA		Lange, RT (corresponding author), Mental Hlth & Addict Serv, PHSA Res & Networks, Suite 201,601 W Broadway St, Vancouver, BC V5Z 4C2, Canada.	rael.lange@gmail.com		Brubacher, Jeffrey/0000-0002-4866-4231; Iverson, Grant/0000-0001-7348-9570			Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Christensen M A, 2001, J Neurosci Nurs, V33, P184; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Hall D, 2005, SCOT MED J, V50, P24, DOI 10.1177/003693300505000110; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Lieber C S, 1991, Drug Alcohol Rev, V10, P175, DOI 10.1080/09595239100185231; MCCUSKER CG, 1990, J STUD ALCOHOL, V51, P494, DOI 10.15288/jsa.1990.51.494; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; NEWLIN DB, 1991, ALCOHOL CLIN EXP RES, V15, P399, DOI 10.1111/j.1530-0277.1991.tb00537.x; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; SDAOJARVIE K, 1992, J STUD ALCOHOL, V53, P533, DOI 10.15288/jsa.1992.53.533; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Smith-Seemiller L, 1996, Appl Neuropsychol, V3, P41, DOI 10.1207/s15324826an0301_6; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TEASDALE G, 1974, LANCET, V2, P81	25	14	15	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					919	927		10.3109/02699052.2010.489794			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000001	20545447				2022-02-06	
J	McAuliffe, MJ; Carpenter, S; Moran, C				McAuliffe, Megan J.; Carpenter, Sonja; Moran, Catherine			Speech intelligibility and perceptions of communication effectiveness by speakers with dysarthria following traumatic brain injury and their communication partners	BRAIN INJURY			English	Article						Dysarthria; communicative effectiveness; traumatic brain injury; intelligibility; speech	FUNCTIONAL COMMUNICATION; SOCIAL COMMUNICATION; EFFECTIVENESS INDEX; IMPAIRMENT; APHASIA; INDIVIDUALS; PERFORMANCE; VALIDITY; ABILITY; SKILLS	Primary objective: This study examined differences in perceived communicative effectiveness between a group of eight participants with chronic dysarthria following TBI and their nominated communication partners (TBIP). The relationship between communicative effectiveness and listener ratings of speech intelligibility was also examined. Research design: Group comparison design. Methods and procedures: The Communicative Effectiveness Survey was completed by the participants with TBI and their communication partner. Speech intelligibility of the eight adults with dysarthria was rated by nine naive listeners using direct magnitude estimation. Main outcomes and results: The participants with TBI tended to rate their communicative effectiveness higher than their TBIP; however, this trend was not significant. No significant differences were noted between the TBI and TBIP groups in ratings of communicative effectiveness in various communication settings. No significant relationship was found between conversation level intelligibility and perceptions of communicative effectiveness, as rated by individuals with TBI and TBIP. Conclusions: The findings of this study highlight the need for collaborative participation in the therapeutic process by all stakeholders. The lack of correlation between speech intelligibility and perceived communicative effectiveness highlights the need for careful examination of activity and participation during assessment and goal-setting.	[McAuliffe, Megan J.; Carpenter, Sonja; Moran, Catherine] Univ Canterbury, Dept Commun Disorders, Christchurch 1, New Zealand		McAuliffe, MJ (corresponding author), Univ Canterbury, Dept Commun Disorders, Christchurch 1, New Zealand.	megan.mcauliffe@canterbury.ac.nz		McAuliffe, Megan/0000-0003-3827-2215	New Zealand Neurological Foundation [0533-SPG]	The authors wish to thank the participants and their communication partners for taking part in this study. The financial support of the New Zealand Neurological Foundation Small Project Grant 0533-SPG is gratefully acknowledged.	ANGLEM J, 2007, COMMUNICATION; Bakheit AMO, 2005, DISABIL REHABIL, V27, P287, DOI 10.1080/09638280400009006; Ball LJ, 2004, J COMMUN DISORD, V37, P197, DOI 10.1016/j.jcomdis.2003.09.002; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Donovan NJ, 2008, AM J SPEECH-LANG PAT, V17, P335, DOI 10.1044/1058-0360(2008/07-0010); Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Duffy, 2005, MOTOR SPEECH DISORDE; HUSTAD KC, 1999, MANAGEMENT MOTOR SPE; Irwin WH, 2002, APHASIOLOGY, V16, P823, DOI 10.1080/02687030244000086; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Jones HN, 2006, J MED SPEECH-LANG PA, V14, P207; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schiavetti N., 1992, INTELLIGIBILITY SPEE, P11; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sullivan M, 2002, HEAD NECK-J SCI SPEC, V24, P530, DOI 10.1002/hed.10095; Sullivan M. D., 1993, J MED SPEECH-LANG PA, V1, P73; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, P27; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Weismer G, 2002, J SPEECH LANG HEAR R, V45, P421, DOI 10.1044/1092-4388(2002/033); World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Yorkston K. M., 1996, AM J SPEECH-LANG PAT, V5, P55, DOI [10.1044/1058-0360.0501.55, DOI 10.1044/1058-0360.0501.55]; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173	32	14	14	0	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1408	1415		10.3109/02699052.2010.511590			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800004	20858025				2022-02-06	
J	Noggle, CA; Pierson, EE				Noggle, Chad A.; Pierson, Eric E.			Psychosocial and Behavioral Functioning Following Pediatric TBI: Presentation, Assessment, and Intervention	APPLIED NEUROPSYCHOLOGY			English	Article						behavioral functioning; pediatric TBI; psychosocial functioning; TBI residuals	TRAUMATIC BRAIN-INJURY; OBSESSIVE-COMPULSIVE DISORDER; HEAD-INJURY; NEUROBEHAVIORAL SYMPTOMS; SOCIAL COMPETENCE; ANXIETY DISORDERS; YOUNG-CHILDREN; ADOLESCENTS; CHILDHOOD; MILD	This article reviews the current literature surrounding the emotional and behavioral consequences as a result of traumatic brain injury (TBI) for children and adolescents. The use of a treatment planning model incorporating developmental theory, recovery, and family needs is advocated. The article reviews the current literature for treatment of primary emotional and psychiatric problems associated with TBI. Additional research into the treatment and intervention of psychiatric, emotional, and behavioral problems in children with TBI remains necessary.	[Noggle, Chad A.] So Illinois Univ, Sch Med, Dept Psychiat, Springfield, IL 62794 USA; [Pierson, Eric E.] Ball State Univ, Dept Educ Psychol, Muncie, IN 47306 USA		Noggle, CA (corresponding author), So Illinois Univ, Sch Med, Dept Psychiat, 901 W Jefferson,POB 19642, Springfield, IL 62794 USA.	cnoggle@siumed.edu					Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bayliss DM, 2000, DEV NEUROPSYCHOL, V17, P161, DOI 10.1207/S15326942DN1702_02; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Bond M. R., 1990, REHABILITATION ADULT, P179; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; JANUSZ JA, 2000, J INT NEUROPSYCH SOC, V6, P226; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Konrad KN, 2000, BRAIN INJURY, V14, P859; Levinson M M, 1987, J Card Surg, V2, P3, DOI 10.1111/j.1540-8191.1987.tb00168.x; Livingston RB, 1996, CHILD NEUROPSYCHOL, V2, P48, DOI 10.1080/09297049608401350; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; Nybo T, 1999, BRAIN INJURY, V13, P759; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Roberts MA, 1996, BRAIN INJURY, V10, P739, DOI 10.1080/026990596124007; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; Slifer KJ, 1997, BRAIN INJURY, V11, P877; Stebbins P, 2001, REHABIL PSYCHOL, V46, P178, DOI 10.1037/0090-5550.46.2.178; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; [No title captured]	54	14	14	1	12	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					110	115	PII 922182262	10.1080/09084281003708977			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800006	20467951				2022-02-06	
J	Schmidt, AT; Orsten, KD; Hanten, GR; Li, XQ; Levin, HS				Schmidt, Adam T.; Orsten, Kimberley D.; Hanten, Gerri R.; Li, Xiaoqi; Levin, Harvey S.			Family environment influences emotion recognition following paediatric traumatic brain injury	BRAIN INJURY			English	Article						Children; traumatic brain injury; family functioning; emotional prosody; face emotion; social cognition	LONG-TERM OUTCOMES; FACIAL EXPRESSION; SOCIAL COGNITION; CHILDREN; PREDICTORS; TEMPERAMENT; PERCEPTION; BEHAVIOR; BURDEN; IDENTIFICATION	Objective: This study investigated the relationship between family functioning and performance on two tasks of emotion recognition (emotional prosody and face emotion recognition) and a cognitive control procedure (the Flanker task) following paediatric traumatic brain injury (TBI) or orthopaedic injury (OI). Methods: A total of 142 children (75 TBI, 67 OI) were assessed on three occasions: baseline, 3 months and 1 year post-injury on the two emotion recognition tasks and the Flanker task. Caregivers also completed the Life Stressors and Resources Scale (LISRES) on each occasion. Growth curve analysis was used to analyse the data. Results: Results indicated that family functioning influenced performance on the emotional prosody and Flanker tasks but not on the face emotion recognition task. Findings on both the emotional prosody and Flanker tasks were generally similar across groups. However, financial resources emerged as significantly related to emotional prosody performance in the TBI group only (p = 0.0123). Conclusions: Findings suggest family functioning variables-especially financial resources-can influence performance on an emotional processing task following TBI in children.	[Schmidt, Adam T.; Orsten, Kimberley D.; Hanten, Gerri R.; Li, Xiaoqi; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Schmidt, AT (corresponding author), 1709 Dryden Rd,12th Floor, Houston, TX 77030 USA.	ats1978@gmail.com			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by NINDS grant # NS21889 to HSL and by a NICHD T32 Fellowship to ATS.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bradley RH, 2001, CHILD DEV, V72, P1844, DOI 10.1111/1467-8624.t01-1-00382; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Cornell AH, 2007, J CLIN CHILD ADOLESC, V36, P305, DOI 10.1080/15374410701444181; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DUROCHER TD, 2004, SOCIAL DEV, V13, P171; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Frick PJ, 2004, J CLIN CHILD ADOLESC, V33, P54, DOI 10.1207/S15374424JCCP3301_6; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.1111/j.1467-8624.1993.tb02913.x; KOCHANSKA G, 1995, CHILD DEV, V66, P597, DOI 10.1111/j.1467-8624.1995.tb00892.x; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Levin HS, 2006, ARCH PHYS MED REHAB, V87, pS1, DOI 10.1016/j.apmr.2006.09.010; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; Moos RH, 1994, LISRES A LIFE STRESS; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Osberg JS, 1997, BRAIN INJURY, V11, P11; Rudolph KD, 1999, CHILD DEV, V70, P660, DOI 10.1111/1467-8624.00048; SCHMIDT AT, NEUROPSYCHO IN PRESS; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511	63	14	14	0	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	13-14					1550	1560		10.3109/02699052.2010.523047			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800004	21058900	Green Accepted			2022-02-06	
J	Williams, G; Pallant, J; Greenwood, K				Williams, Gavin; Pallant, Julie; Greenwood, Ken			Further development of the High-level Mobility Assessment Tool (HiMAT)	BRAIN INJURY			English	Article						Brain injuries; rehabilitation; gait disorders; neurologic; outcome assessment	TRAUMATIC BRAIN-INJURY; RASCH MEASUREMENT MODEL; STROKE PATIENTS; SCALE; VALIDITY; BALANCE; INDEX	Primary objectives: The high-level mobility assessment tool (HiMAT) was developed to measure high-level mobility limitations following traumatic brain injury (TBI). Rasch analysis was used in the development to ensure cognitive deficits would have a minimal impact on performance. The main aim of this study was to investigate the dimensionality of the HiMAT using recently developed advanced testing procedures. Research design: Results from the original sample of 103 adults with TBI used to develop the HiMAT were re-analysed using the RUMM2020 program. Revised minimal detectable change (MDC95) scores were also calculated. Main outcomes and results: Rasch analysis of all 13 HiMAT items suggested that the scale was multidimensional, showing a clear separation between the stair and non-stair items. The nine non-stair items of the HiMAT showed good overall fit, excellent internal consistency, with no disordered thresholds or misfitting items, however removal of one item was required to ensure a unidimensional scale. The final 8-item solution showed good model fit (p = 0.93), excellent internal consistency (PSI = 0.96), no disordered thresholds, no misfitting items and no differential item functioning for age or sex. The revised HiMAT total score is 32 points and the MDC95 was calculated to be +/-2 points. Conclusion: The results of this study demonstrate that the revised HiMAT is unidimensional and valid to use in rehabilitation and community settings where there is no access to stairs.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic 3010, Australia; [Pallant, Julie] Univ Melbourne, Sch Rural Hlth, Melbourne, Vic 3010, Australia; [Greenwood, Ken] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Greenwood, Kenneth M/J-8993-2015	Greenwood, Kenneth M/0000-0002-8420-6588; Williams, Gavin/0000-0003-2758-7473			Andrich D., 2003, RUMM2020; Antonucci G, 2002, ARCH PHYS MED REHAB, V83, P1442, DOI 10.1053/apmr.2002.34618; BELVEDERE S, J CLIN EPID IN PRESS; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Caty GD, 2008, ARCH PHYS MED REHAB, V89, P284, DOI 10.1016/j.apmr.2007.08.155; Collen F M, 1991, Int Disabil Stud, V13, P50; DUNCAN P, 1995, MOTOR CONTROL THEORY, P319; Granger CV, 1983, GUIDE USE UNIFORM DA; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Lincoln N, 1979, Physiotherapy, V65, P48; MacKnight C, 2000, J CLIN EPIDEMIOL, V53, P1242, DOI 10.1016/S0895-4356(00)00255-9; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wu M.L., 1998, ACER CONQUEST GEN IT	21	14	14	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					1027	1031		10.3109/02699052.2010.490517			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000013	20545456				2022-02-06	
J	Howard, AW; Macarthur, C; Rothman, L; Willan, A; Macpherson, AK				Howard, Andrew W.; Macarthur, Colin; Rothman, Linda; Willan, Andrew; Macpherson, Alison K.			School Playground Surfacing and Arm Fractures in Children: A Cluster Randomized Trial Comparing Sand to Wood Chip Surfaces	PLOS MEDICINE			English	Article							SURVEILLANCE SYSTEM; PLAY EQUIPMENT; INJURY RATES; RISK-FACTORS; FALLS; SAFETY; LIMB	Background: The risk of playground injuries, especially fractures, is prevalent in children, and can result in emergency room treatment and hospital admissions. Fall height and surface area are major determinants of playground fall injury risk. The primary objective was to determine if there was a difference in playground upper extremity fracture rates in school playgrounds with wood fibre surfacing versus granite sand surfacing. Secondary objectives were to determine if there were differences in overall playground injury rates or in head injury rates in school playgrounds with wood fibre surfacing compared to school playgrounds with granite sand surfacing. Methods and Findings: The cluster randomized trial comprised 37 elementary schools in the Toronto District School Board in Toronto, Canada with a total of 15,074 students. Each school received qualified funding for installation of new playground equipment and surfacing. The risk of arm fracture from playground falls onto granitic sand versus onto engineered wood fibre surfaces was compared, with an outcome measure of estimated arm fracture rate per 100,000 student-months. Schools were randomly assigned by computer generated list to receive either a granitic sand or an engineered wood fibre playground surface (Fibar), and were not blinded. Schools were visited to ascertain details of the playground and surface actually installed and to observe the exposure to play and to periodically monitor the depth of the surfacing material. Injury data, including details of circumstance and diagnosis, were collected at each school by a prospective surveillance system with confirmation of injury details through a validated telephone interview with parents and also through collection (with consent) of medical reports regarding treated injuries. All schools were recruited together at the beginning of the trial, which is now closed after 2.5 years of injury data collection. Compliant schools included 12 schools randomized to Fibar that installed Fibar and seven schools randomized to sand that installed sand. Noncompliant schools were added to the analysis to complete a cohort type analysis by treatment received (two schools that were randomized to Fibar but installed sand and seven schools that were randomized to sand but installed Fibar). Among compliant schools, an arm fracture rate of 1.9 (95% confidence interval [CI] 0.04-6.9) per 100,000 student-months was observed for falls into sand, compared with an arm fracture rate of 9.4 (95% CI 3.7-21.4) for falls onto Fibar surfaces (p <= 0.04905). Among all schools, the arm fracture rate was 4.5 (95% CI 0.26-15.9) per 100,000 student-months for falls into sand compared with 12.9 (95% CI 5.1-30.1) for falls onto Fibar surfaces. No serious head injuries and no fatalities were observed in either group. Conclusions: Granitic sand playground surfaces reduce the risk of arm fractures from playground falls when compared with engineered wood fibre surfaces. Upgrading playground surfacing standards to reflect this information will prevent arm fractures.	[Howard, Andrew W.] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Macarthur, Colin] Bloorview Kids Rehab, Toronto, ON, Canada; [Macpherson, Alison K.] York Univ, Dept Kinesiol, Toronto, ON M3J 2R7, Canada		Howard, AW (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca	Howard, Andrew/C-7163-2009	Howard, Andrew/0000-0001-7226-6471	Canadian Institutes for Health Research MCTCanadian Institutes of Health Research (CIHR) [70318]	The trial was funded by the Canadian Institutes for Health Research MCT 70318. The funders had no input into the collection, analysis or interpretation of data nor into the decision to publish or preparation of the manuscript. Playground installations were paid for by the Toronto District School board.	*ASTM, 2003, F148701E1 ASTM; *BRIT STAND, 1998, 71881998 BS; *CAN STAND ASS, 1998, GUID CHILDR PLAYSP E; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Chesney D A, 1996, IEEE Trans Rehabil Eng, V4, P182, DOI 10.1109/86.536773; Fiissel D, 2005, INJURY PREV, V11, P337, DOI 10.1136/ip.2005.009167; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Howard AW, 2005, CAN MED ASSOC J, V172, P1443, DOI 10.1503/cmaj.1041096; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Macarthur C, 1999, AM J EPIDEMIOL, V149, P586; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; Macarthur C, 1999, Inj Prev, V5, P214; Macarthur C, 1997, AM J EPIDEMIOL, V145, P834; Mitchell Rebecca, 2007, Health Promot J Austr, V18, P98; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Mowat D L, 1998, Inj Prev, V4, P39; Norton C, 2004, ARCH DIS CHILD, V89, P152, DOI 10.1136/adc.2002.024364; Rubie-Davies CM, 2007, J SCHOOL HEALTH, V77, P36, DOI 10.1111/j.1746-1561.2007.00160.x; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker Shauna, 2005, Int J Inj Contr Saf Promot, V12, P63, DOI 10.1080/17457300512331339184; SOSIN DM, 1993, AM J PUBLIC HEALTH, V83, P733, DOI 10.2105/AJPH.83.5.733; *STAND ASS AUSTR, 1981, AUSTR STAND PLAYGR E; *STAND ASS NZ, 1986, NZ STAND SPEC PLAYGR; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898; YAMAMOTO L G, 1991, Pediatric Emergency Care, V7, P267, DOI 10.1097/00006565-199110000-00002	26	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1549-1277			PLOS MED	PLos Med.	DEC	2009	6	12							e1000195	10.1371/journal.pmed.1000195			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536RD	WOS:000273060600010	20016688	gold, Green Published			2022-02-06	
J	Sloan, S; Callaway, L; Winkler, D; McKinley, K; Ziino, C; Anson, K				Sloan, Sue; Callaway, Libby; Winkler, Dianne; McKinley, Kirsten; Ziino, Carlo; Anson, Katie			The Community Approach to Participation: Outcomes Following Acquired Brain Injury Intervention	BRAIN IMPAIRMENT			English	Article						community rehabilitation; occupational therapy; outcome measurement	CLOSED HEAD-INJURY; INTEGRATION QUESTIONNAIRE; LIFE SATISFACTION; SOCIAL SUPPORT; REHABILITATION; QUALITY; PEOPLE; MODEL; POSTDISCHARGE; INDIVIDUALS	Objective: To investigate the participation outcomes of individuals with severe acquired brain injury (ABI) who were provided with up to 12 months of intervention based on the Community Approach to Participation (CAP). Method: A case series study design was undertaken with a total of 85 participants from two private practices specialising in community-based, CAP rehabilitation for people with severe ABI. Inclusion criteria were the person had sustained an acquired brain injury, was aged over 18 years and had received up to 12 consecutive months of CAP input from one of the two practices within a three-year period between January 2004 and January 2007 Twenty-six of the 85 participants were an average of 343 days post injury (Early group) and 59 of the participants were an average of 10.2 years post injury (Late group). They were living in a range of community environments and residential facilities. Initial participants were identified for the study in January 2005. Data were gathered using the Functional Independence Measure (FIM (TM)), Community Integration Questionnaire (CIQ), and Role Checklist (RC Part 1) at two time points: prior to intervention (baseline), and after a 12-month period or at discharge (TI). Within the intervention period, all participants received a customised community occupational therapy (OT) rehabilitation program based on the key principles of the CAP. Intervention focused on participation goals of the individual, and development of the associated skills that underpinned valued role performance. Results: Participants each received an average of 51.01 hours of CAP OT during the 12-month period of intervention. Considerable improvement was seen in functional independence, community integration, and role participation after intervention in both the Early and Late groups. A statistically significant increase in FIM (TM) and CIQ total scores was found for all participants from Baseline to T1. The number of roles in which participants engaged increased on average by almost one role per participant following intervention, from a mean of 3.06 to 3.99. Increased participation in volunteer, home maintainer, participant in organisations and hobbyist roles were most common. Conclusion: Increased functional independence, community integration, and participation in both the Early and Late groups over a 12 month period demonstrates the potential for improved participation outcomes for people with complex needs following ABI, even many years post injury.	[Sloan, Sue; McKinley, Kirsten; Ziino, Carlo; Anson, Katie] Osborn Sloan & Associates Pty Ltd, Melbourne, Vic, Australia; [Callaway, Libby] Monash Univ, Dept Occupat Therapy, Clayton, Vic 3800, Australia; [Winkler, Dianne] Summer Fdn Ltd, Melbourne, Vic, Australia		Sloan, S (corresponding author), Osborn Sloan & Associates Pty Ltd, 97 Princess St, Kew, Vic 3101, Australia.	sue@osbornsloan.com.au		Winkler, Di/0000-0003-3899-6248			Aron E., 1994, STAT PSYCHOL; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Beckley MN, 2007, AUST OCCUP THER J, V54, P215, DOI 10.1111/j.1440-1630.2007.00643.x; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; JACOBS HE, 1990, J HEAD TRAUMA REHAB, V5, P1; Jennett B, 1981, MANAGEMENT HEAD INJU; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; PONSFORD J, 2003, 26 ANN BRAIN IMP C S; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Refinetti R, 1996, TEACH PSYCHOL, V23, P51, DOI 10.1207/s15328023top2301_14; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; UDS Data Management Service, 1990, GUID US UN DAT SET M; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; [No title captured]	52	14	14	0	11	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2009	10	3					282	294		10.1375/brim.10.3.282			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	548OG	WOS:000273972400002					2022-02-06	
J	Aydin, S; Yilmazlar, S; Aker, S; Korfali, E				Aydin, Selcuk; Yilmazlar, Selcuk; Aker, Sibel; Korfali, Ender			Anatomy of the Floor of the Third Ventricle in Relation to Endoscopic Ventriculostomy	CLINICAL ANATOMY			English	Article						anatomy; cadaveric study; endoscopic third ventriculostomy; hypothalamus; complication; third ventricular floor	TRAUMATIC BASILAR ANEURYSM; 3-DIMENSIONAL CONSTRUCTIVE INTERFERENCE; 3RD VENTRICULOSTOMY; LILIEQUISTS MEMBRANE; COMPLICATIONS; HYDROCEPHALUS; SERIES	Neuroanatomical structures that form the floor of the third ventricle (FTV) and neighboring tissues are important in the context of third ventriculostomy (TV) procedures. Thorough knowledge of the anatomical and histological organization of the region would be useful in understanding and preventing surgical complications. Taking the third ventricle region as a model, we aimed to simulate TV and make measurements of 23 cadaver brains, as well as perform histological examinations of the third ventricular floor on five cadaver brains. During the endoscopic TV, we examined the degree to which the structures surrounding the FTV were affected by surgical simulation. To make a clinical comparison, the distance between the center of the FTV and the basilar apex was measured on cranial magnetic resonance images (MRIs) of 15 subjects with normal ventricular systems and 15 subjects with moderately enlarged ventricles. Histological examination revealed that the ependynnal cells and arachnoid membrane formed the inner and outer surfaces of the third ventricle floor, respectively, whereas the stroma was made up of glial cells exclusively. This region was gliotic and avascular. When cadaver brains with normal and hydrocephalic ventricles were compared, there were significant differences in the distance between the center of the floor and the basilar apex (P < 0.001). On the basis of our study, the optimal site for TV fenestration and balloon inflation is just anterior to the mamillary bodies to avoid injury to neighboring structures. Clin. Anat. 22:916-924, 2009. (C) 2009 Wiley-Liss, Inc.	[Aydin, Selcuk; Yilmazlar, Selcuk; Korfali, Ender] Uludag Univ, Sch Med, Dept Neurosurg, TR-16059 Bursa, Turkey; [Aker, Sibel] Uludag Univ, Sch Med, Dept Pathol, TR-16059 Bursa, Turkey		Yilmazlar, S (corresponding author), Uludag Univ, Sch Med, Dept Neurosurg, Gorukle Kampus, TR-16059 Bursa, Turkey.	selsus@uludag.edu.tr	, selcuk/AAH-5070-2021	, selcuk/0000-0003-3633-7919			Abtin K, 1998, PEDIATR NEUROSURG, V28, P35, DOI 10.1159/000028616; Amini MM, 2005, J SOL-GEL SCI TECHN, V36, P19, DOI 10.1007/s10971-005-4790-7; Baykan N, 2005, J NEUROSURG ANESTH, V17, P33; Bonanni R, 2004, EUR NEUROL, V51, P118, DOI 10.1159/000076793; Brockmeyer D, 1998, PEDIATR NEUROSURG, V28, P236, DOI 10.1159/000028657; Buxton N, 1998, CLIN ANAT, V11, P187, DOI 10.1002/(SICI)1098-2353(1998)11:3<187::AID-CA6>3.0.CO;2-Q; Buxton N, 2000, NEUROSURGERY, V46, P999; Di Roio C, 1999, ANN FR ANESTH, V18, P776, DOI 10.1016/S0750-7658(00)88456-7; Dusick JR, 2008, SURG NEUROL, V69, P5, DOI 10.1016/j.surneu.2007.08.024; El-Dawlatly AA, 2000, ANESTH ANALG, V91, P1142, DOI 10.1097/00000539-200011000-00019; Froelich SC, 2008, NEUROSURGERY, V63, P1, DOI 10.1227/01.neu.0000335004.22628.ee; Fukuhara T, 2000, NEUROSURGERY, V46, P1100, DOI 10.1097/00006123-200005000-00015; Fushimi Y, 2003, RADIOLOGY, V229, P360, DOI 10.1148/radiol.2292021507; Fushimi Yasutaka, 2006, Radiat Med, V24, P85, DOI 10.1007/BF02493273; Gangemi M, 2004, NEUROSURGERY, V55, P129, DOI 10.1227/01.NEU.0000126938.12817.DC; Grant JA, 1997, SURG NEUROL, V47, P210, DOI 10.1016/S0090-3019(96)00457-0; Gray H., 1918, ANATOMY HUMAN BODY; HANDLER MH, 1994, NEUROSURGERY, V35, P525, DOI 10.1227/00006123-199409000-00025; Hellwig D, 2005, NEUROSURG REV, V28, P1, DOI 10.1007/s10143-004-036-2; Hopf NJ, 1999, NEUROSURGERY, V44, P795, DOI 10.1097/00006123-199904000-00062; Iaccarino C, 2009, J NEUROSURG, V110, P852, DOI 10.3171/2008.4.17539; Jenkinson MD, 2009, J NEUROSURG, V110, P861, DOI 10.3171/2008.10.JNS17667; Kim LJ, 2005, ACTA NEUROCHIR, V147, P219, DOI 10.1007/s00701-004-0401-6; Kunz M, 2008, J NEUROSURG, V109, P931, DOI 10.3171/JNS/2008/109/11/0931; Lu J, 2005, J NEUROSURG, V103, P337, DOI 10.3171/jns.2005.103.2.0337; MARINKOVIC SV, 1993, NEUROSURGERY, V33, P80, DOI 10.1227/00006123-199307000-00012; McLaughlin MR, 1997, NEUROSURGERY, V41, P1400, DOI 10.1097/00006123-199712000-00034; Nakahara Y, 2004, NEUROL MED-CHIR, V44, P408, DOI 10.2176/nmc.44.408; Navarro R, 2006, CHILD NERV SYST, V22, P506, DOI 10.1007/s00381-005-0031-1; Rezende MTS, 2008, NEURORADIOLOGY, V50, P443, DOI 10.1007/s00234-007-0357-3; Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F; Rovira A, 1999, AM J NEURORADIOL, V20, P1647; Santamarta D, 2005, ACTA NEUROCHIR, V147, P377, DOI 10.1007/s00701-005-0484-8; Schroeder HWS, 1999, J NEUROSURG, V90, P153, DOI 10.3171/jns.1999.90.1.0153; Schroeder HWS, 2002, J NEUROSURG, V96, P1032, DOI 10.3171/jns.2002.96.6.1032; Vandertop PW, 1998, NEUROSURGERY, V43, P647, DOI 10.1097/00006123-199809000-00157	36	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	NOV	2009	22	8					916	924		10.1002/ca.20867			9	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	515DG	WOS:000271446200011	19806669				2022-02-06	
J	Oria, RB; Costa, CMC; Lima, AAM; Patrick, PD; Guerrant, RL				Oria, Reinaldo B.; Costa, Carlos Mauricio C.; Lima, Aldo A. M.; Patrick, Peter D.; Guerrant, Richard L.			Semantic fluency: A sensitive marker for cognitive impairment in children with heavy diarrhea burdens?	MEDICAL HYPOTHESES			English	Article							EARLY-CHILDHOOD DIARRHEA; TRICHURIS-TRICHIURA INFECTION; ISCHEMIC VASCULAR DEMENTIA; JAMAICAN SCHOOL-CHILDREN; TRAUMATIC BRAIN-INJURY; FOCAL FRONTAL LESIONS; ALZHEIMERS-DISEASE; VERBAL FLUENCY; EXECUTIVE CONTROL; TAU HYPERPHOSPHORYLATION	One of the most affected cognitive impairments in children who experienced heavy burdens of diarrhea is semantic fluency, the same impairment that is most affected in Alzheimer's dementia. These findings are leading us into provocative genetic studies that may elucidate the evolution of such genetic polymorphisms as the APOE alleles. Alternatively, diarrhea could launch the cognitive deficits that might later progress in neurodegenerative diseases. In addition, they suggest that semantic fluency could provide a simple mean to assess cognitive impairment in impoverished settings so as to determine preventive measures. (C) 2009 Elsevier Ltd. All rights reserved.	[Oria, Reinaldo B.; Costa, Carlos Mauricio C.] Univ Fed Ceara, Inst Biomed Semiarid, Fortaleza, Ceara, Brazil; [Oria, Reinaldo B.] Univ Fed Ceara, Dept Morphol, Fortaleza, Ceara, Brazil; [Costa, Carlos Mauricio C.] Univ Fed Ceara, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Oria, Reinaldo B.; Lima, Aldo A. M.; Guerrant, Richard L.] Univ Virginia, Sch Med, Ctr Global Hlth, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA; [Patrick, Peter D.] Univ Virginia, Dept Pediat, Kluge Childrens Rehabil Ctr, Div Neuropsychol, Charlottesville, VA 22908 USA		Oria, RB (corresponding author), Univ Fed Ceara, Inst Biomed Semiarid, Fortaleza, Ceara, Brazil.	rbo5u@virginia.edu	Lima, Aldo AM/D-8251-2018; Oria, Reinaldo B/D-6440-2014	Lima, Aldo AM/0000-0002-0299-1747; Oria, Reinaldo/0000-0002-6914-5481	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R21TW03-007, 5R01HD053131]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH Office of Dietary Supplements (ODS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053131] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW006713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U01AI026512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK067629] Funding Source: NIH RePORTER	This project was supported by NIH Research Grants #5R21TW03-007 and 5R01HD053131 funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the NIH Office of Dietary Supplements (ODS).	Abbott RD, 1998, PEDIATRICS, V102, P602, DOI 10.1542/peds.102.3.602; Barr A, 1996, J CLIN EXP NEUROPSYC, V18, P810, DOI 10.1080/01688639608408304; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Booth JR, 2003, NEUROIMAGE, V20, P737, DOI 10.1016/S1053-8119(03)00404-X; Bronzino JD, 1997, EXP NEUROL, V148, P317, DOI 10.1006/exnr.1997.6653; Chan AS, 1997, NEUROPSYCHOLOGIA, V35, P241, DOI 10.1016/S0028-3932(96)00067-X; CHANDLER AMK, 1995, J NUTR, V125, P894; Ciaroni S, 2002, NEUROSCI RES, V44, P369, DOI 10.1016/S0168-0102(02)00157-8; Dillingham R, 2004, LANCET, V363, P94, DOI 10.1016/S0140-6736(03)15307-X; DO JV, 1998, NEUROPSYCHOLOGY, V12, P259; Duke LM, 2000, NEUROPSYCHOL REV, V10, P75, DOI 10.1023/A:1009096603879; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Fama R, 2000, NEUROPSYCHOLOGY, V14, P29, DOI 10.1037/0894-4105.14.1.29; Fukuda MTH, 2002, BEHAV BRAIN RES, V133, P271, DOI 10.1016/S0166-4328(02)00010-4; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gardner JM, 1996, ANN TROP MED PARASIT, V90, P55, DOI 10.1080/00034983.1996.11813026; Gleissner U, 2001, CORTEX, V37, P55, DOI 10.1016/S0010-9452(08)70557-4; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2002, ARCH MED RES, V33, P351, DOI 10.1016/S0188-4409(02)00379-X; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kim MJ, 2001, NEUROSCI LETT, V302, P109, DOI 10.1016/S0304-3940(01)01684-6; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608; Laatu S, 2003, ACTA NEUROL SCAND, V108, P82, DOI 10.1034/j.1600-0404.2003.00097.x; Lafosse JM, 1997, NEUROPSYCHOLOGY, V11, P514, DOI 10.1037/0894-4105.11.4.514; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVITSKY DA, 1995, J NUTR, V125, pS2212, DOI 10.1093/jn/125.suppl_8.2212S; Lima AAM, 2000, J INFECT DIS, V181, P1643, DOI 10.1086/315423; Lukoyanov NV, 2000, BEHAV BRAIN RES, V112, P85, DOI 10.1016/S0166-4328(00)00164-9; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Moore SR, 2001, INT J EPIDEMIOL, V30, P1457, DOI 10.1093/ije/30.6.1457; Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590; NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Ralph MAL, 2001, J NEUROL NEUROSUR PS, V70, P149, DOI 10.1136/jnnp.70.2.149; Ribaut-Barassin C, 2003, NEUROSCIENCE, V120, P405, DOI 10.1016/S0306-4522(03)00332-4; Ricci PT, 1999, NEUROIMAGE, V9, P88, DOI 10.1006/nimg.1998.0386; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Rohrer D, 1999, NEUROPSYCHOLOGY, V13, P381, DOI 10.1037/0894-4105.13.3.381; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; SIMEON DT, 1995, PARASITOLOGY, V110, P457, DOI 10.1017/S0031182000064799; Simeon DT, 1998, AM J CLIN NUTR, V67, p790S, DOI 10.1093/ajcn/67.4.790S; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Tierney MC, 2001, ARCH NEUROL-CHICAGO, V58, P1654, DOI 10.1001/archneur.58.10.1654; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Watson JM, 2001, NEUROPSYCHOLOGY, V15, P254, DOI 10.1037//0894-4105.15.2.254; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5	56	14	15	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2009	73	5					682	686		10.1016/j.mehy.2009.05.013			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	516QS	WOS:000271558000012	19520520	Green Accepted			2022-02-06	
J	Peterson, E; Chesnut, RM				Peterson, Eric; Chesnut, Randall M.			Static Autoregulation is Intact in Majority of Patients With Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	67th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Meeting of the Association-for-Acute-Medicine	SEP 24-27, 2008	Maui, HI	Amer Assoc Surg Trauma, Assoc Acute Med		Traumatic brain injury; Autoregulation; CTP; Static autoregulation	DYNAMIC CEREBRAL AUTOREGULATION; HEAD-INJURY; BLOOD-FLOW; REACTIVITY; PRESSURE	Background: The management of severe traumatic brain injury (sTBI) patients with and without intact cerebral pressure autoregulation (CPA) varies markedly. Recent studies analyzing beat-to-beat interactions between intracranial pressure (ICP) and systolic blood pressure, or transcranial Doppler velocity changes during a rapid drop in cerebral perfusion pressure (CPP), suggest that CPA is disrupted after sTBI. We use computed tomography perfusion (CTP) to guide blood pressure manipulation in sTBI and have found CPA results that differ with this literature. We present these results here and suggest modifying Our basic concepts of CPA disruption. Methods: We tested CPA in 24 consecutive sTBI patients using CTP. ICP was monitored intraparenchymally and blood pressure with an arterial line. After a CTP study at baseline, a phenylephrine infusion was used to raise the CPP by 20 mm Hg, and a second CTP was performed immediately thereafter. Quantitative analysis of cerebral blood flow (CBF) was done offline. CPA was considered intact if CBF was unchanged despite the increase in CPP and disrupted if CBF rose after CPP manipulation. Results: CPA was intact in 25 of 33 patients (75.7%) and disrupted in 8 of 33 patients (24.3%). The mean age was significantly different for the 2 groups; 52 years for the disrupted group, 29 years for the intact group (p < 0.0003). The mean ICP change was also statistically different; 3.8 for the disrupted group and 1.5 for the intact group (p < 0.006). Injury Severity Score (ISS), Glasgow Coma Scale, and CPP were not statistically different between the two groups. Conclusion: By using direct measurement of CBF in response to a CPP challenge, we found CPA disruption to be much less common than reported in similar groups of sTBI patients. This difference reflects potentially important separate aspects of CPA. We suggest that CPA measurement using beat-to-beat interactions and transcranial Doppler measurements reflect dynamic CPA processes (dynamic autoregulation), whereas Our method reflects steady-state conditions (static autoregulation). If the major disruption of CPA after sTBI involves dynamic vascular responsiveness, perhaps we need more focus on this aspect and less on static-CPP manipulation in terms of pathophysiology and treatment.	[Peterson, Eric; Chesnut, Randall M.] Univ Washington, Med Ctr, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA		Peterson, E (corresponding author), Univ Washington, Med Ctr, Harborview Med Ctr, Dept Neurol Surg, 325 9th Ave, Seattle, WA 98104 USA.	ericpete@u.washington.edu		Chesnut, Randall/0000-0001-6377-3666			BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Carey BJ, 2000, STROKE, V31, P2895, DOI 10.1161/01.STR.31.12.2895; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; INGVAR DAVID H., 1964, ACTA ANAETH SCAND SUPPL, V15, P43; Kastrup A, 1998, STROKE, V29, P1311, DOI 10.1161/01.STR.29.7.1311; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; MARMAROU A, 1993, ACTA NEUROCHIR, P18; REICH T, 1989, STROKE, V20, P453, DOI 10.1161/01.STR.20.4.453; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	15	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2009	67	5					944	949		10.1097/TA.0b013e3181ae6e6d			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	518XO	WOS:000271729500008	19901652				2022-02-06	
J	Strote, J; Roth, R; Cone, DC; Wang, HE				Strote, Jared; Roth, Ronald; Cone, David C.; Wang, Henry E.			Prehospital endotracheal intubation: the controversy continues (Conference Proceedings)	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; NEUROMUSCULAR BLOCKING-AGENTS; EMERGENCY MEDICAL TECHNICIANS; SEVERE HEAD-INJURY; TRACHEAL INTUBATION; INAPPROPRIATE CARE; PREVENTABLE DEATH; SERVICES SYSTEM; RURAL STATE		[Strote, Jared] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA; [Roth, Ronald] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Cone, David C.] Yale Univ, Sch Med, Sect Emergency Med, New Haven, CT 06519 USA; [Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, AL 35249 USA		Strote, J (corresponding author), Univ Washington, Div Emergency Med, Box 356123, Seattle, WA 98195 USA.	strote@u.washington.edu		Cone, David/0000-0002-7437-959X			Abo BN, 2007, RESUSCITATION, V72, P234, DOI 10.1016/j.resuscitation.2006.06.028; *ACCR COUNC GRAD M, EM MED GUID PROC RES; Baker CC, 2005, J TRAUMA, V58, P723; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bozeman WP, 2006, PREHOSP EMERG CARE, V10, P8, DOI 10.1080/10903120500366854; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bulger EM, 2002, J EMERG MED, V23, P183, DOI 10.1016/S0736-4679(02)00490-0; Bushby Nathan, 2005, Emerg Med Australas, V17, P443, DOI 10.1111/j.1742-6723.2005.00775.x; Bushra JS, 2004, ACAD EMERG MED, V11, P66, DOI 10.1197/S1069-6563(03)00586-4; Charuluxananan Somrat, 2001, Journal of the Medical Association of Thailand, V84, pS251; Christensen EF, 2003, BRIT MED J, V327, P533, DOI 10.1136/bmj.327.7414.533; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; *COUNC ACCR NURS A, 2004, STAND ACCR NURS AN E; CUMMINS RO, 1986, ANN EMERG MED, V15, P1187, DOI 10.1016/S0196-0644(86)80863-0; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DELEO BC, 1977, HEART LUNG, V6, P851; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; ELLING R, 1983, ANN EMERG MED, V12, P765, DOI 10.1016/S0196-0644(83)80254-6; Esposito TJ, 2003, J TRAUMA, V54, P663, DOI 10.1097/01.TA.0000058124.78958.6B; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Gabrielli Andrea, 2002, Curr Opin Crit Care, V8, P199, DOI 10.1097/00075198-200206000-00002; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; GUSS DA, 1984, AM J EMERG MED, V2, P399, DOI 10.1016/0735-6757(84)90041-X; Hagberg C, 2006, ANESTH ANALG, V102, P621, DOI 10.1213/01.ane.0000189101.26403.06; Hall RE, 2005, ACAD EMERG MED, V12, P850, DOI 10.1197/j.aem.2005.04.007; HESS D, 1985, AM J EMERG MED, V3, P292, DOI 10.1016/0735-6757(85)90049-X; JACOBS LM, 1983, JAMA-J AM MED ASSOC, V250, P2175, DOI 10.1001/jama.250.16.2175; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Johnston BD, 2006, ACAD EMERG MED, V13, P1051, DOI 10.1197/j.aem.2006.06.031; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Konrad C, 1998, ANESTH ANALG, V86, P635; LEVITAN RM, 2004, AIRWAY CAM GUIDE INT; Lockey D, 2001, BRIT MED J, V323, P141, DOI 10.1136/bmj.323.7305.141; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; National Highway Traffic Safety Administration, EM MED TECHN PAR NAT; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Ochs M, 2000, Prehosp Emerg Care, V4, P333, DOI 10.1080/10903120090941065; Rinker CF, 2003, J TRAUMA, V54, P669; Shy Bradley D, 2004, Prehosp Emerg Care, V8, P394, DOI 10.1016/j.prehos.2004.06.013; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Suominen P, 2000, Eur J Emerg Med, V7, P3; Tiamfook-Morgan TO, 2006, PREHOSP EMERG CARE, V10, P363, DOI 10.1080/10903120600725835; Tracy S, 2006, J TRAUMA, V61, P1162, DOI 10.1097/01.ta.0000243887.90697.06; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717; Wang Henry E, 2005, Prehosp Emerg Care, V9, P145; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	67	14	14	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2009	27	9					1142	1147		10.1016/j.ajem.2008.08.011			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	527XB	WOS:000272403400019	19931764				2022-02-06	
J	Zhang, SR; Carroll, LJ; Cassidy, JD; Paniak, C				Zhang, Sharon; Carroll, Linda J.; Cassidy, J. David; Paniak, Chris			FACTORS INFLUENCING SELF-RATED HEALTH IN TRAFFIC-RELATED MILD TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; self-rated health; health-related quality of life	QUALITY-OF-LIFE; HEAD-INJURY; GENERAL-POPULATION; RATING-SCALES; NECK PAIN; SYMPTOMS; COMPENSATION; INDIVIDUALS; DEPRESSION; COMMUNITY	Objective: To report self-rated health and factors influencing health after traffic-related mild traumatic brain injury. Design: Population-based, cross-sectional study of traffic-related mild traumatic brain injury occurring between 1 December 1997 and 31 November 1999 in Saskatchewan, Canada. Subjects: Subjects were 929 adults making a personal injury claim after a traffic collision. Inclusion criteria were a head blow with certain or possible loss of consciousness or post-traumatic amnesia, or a possible head blow with certain loss of consciousness/post-traumatic amnesia. Excluded were those with loss of consciousness >30 min and those hospitalized longer than 2 days. Methods: Data were self-reported through insurance application forms completed within 6 weeks of the injury. Multi-variable multinomial logistic regression was applied to identity, factors associated with self-reported general health. Results. In contrast to the 74.5%, of subjects reporting excellent or very good health prior to injury, 70.8% reported having poor/fair health after the injury. Post-crash depressive symptoms, sleep problems, greater neck/low back pain and low expectations for recovery were associated with poorer post-injury health. Conclusion: Those with traffic-related mild traumatic brain injury reported a decline in self-perceived general health. We identified potentially modifiable factors associated with poor post-injury health and suggested that these factors should be considered during early clinical intervention.	[Zhang, Sharon] Alberta Childrens Prov Gen Hosp, Decis Support Res Team, Alberta Hlth Serv, Calgary, AB T3B 6A8, Canada; [Zhang, Sharon] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Carroll, Linda J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2M7, Canada; [Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cassidy, J. David] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada		Zhang, SR (corresponding author), Alberta Childrens Prov Gen Hosp, Decis Support Res Team, Alberta Hlth Serv, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	sharon.zhang@albertahealthservices.ca		Carroll, Linda/0000-0003-0876-2336			Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Breivik EK, 2000, CLIN J PAIN, V16, P22, DOI 10.1097/00002508-200003000-00005; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2003, J CLIN EPIDEMIOL, V56, P651, DOI 10.1016/S0895-4356(03)00118-5; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Cote P, 2000, SPINE, V25, P1109; Cote P, 2000, ACCIDENT ANAL PREV, V32, P151, DOI 10.1016/S0001-4575(99)00117-7; *DEP HIGHW TRANSP, 2002, SASK HIGHW TRANSP OP; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eriksson I, 2001, INT J EPIDEMIOL, V30, P326, DOI 10.1093/ije/30.2.326; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; JAROSZYNSKI G, 1996, DEV VALIDATION COMOR; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MacKenzie E J, 1989, Md Med J, V38, P725; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mercado AC, 2000, HEALTH PSYCHOL, V19, P333, DOI 10.1037/0278-6133.19.4.333; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; REVICKI DA, 1989, J FAM PRACTICE, V29, P377; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Rothman K. J., 1998, MODERN EPIDEMIOLOGY, P120; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Ware J.E., 1993, SF 36 HLTH SURVEY MA	35	14	16	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2009	41	13					1062	1067		10.2340/16501977-0462			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	527VZ	WOS:000272399000008	19894002	gold			2022-02-06	
J	Ampo, KI; Suzuki, A; Konishi, H; Kiyama, H				Ampo, Kei-Ichi; Suzuki, Akinobu; Konishi, Hiroyuki; Kiyama, Hiroshi			Induction of Pancreatitis-Associated Protein (PAP) Family Members in Neurons after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						inflammation; rat; Reg-2; Reg-III gamma; weight drop brain injury	INFLAMMATORY-BOWEL-DISEASE; NEUROTROPHIC FACTOR; NERVE INJURY; REG-2 EXPRESSION; GENE-EXPRESSION; MOTOR-NEURONS; HEAD-INJURY; CELL-DEATH; RAT-BRAIN; REGENERATION	The pancreatitis-associated protein (PAP) family is a group of 16-kDa secretory proteins initially identified in the pancreas in rats with acute pancreatitis. Although induction of PAP family genes was reported in peripheral nerve injury models, the expression in the central nervous system after traumatic injury has not been examined. In the present study, we examined the expression of PAP family members (PAP-I, PAP-II, and PAP-III) in the rat brain following traumatic brain injury (TBI) induced by weight drop. There was a significant upregulation of PAPI and PAP-III mRNA in the injured cortex beginning at 1 day after TBI. Immunohistochemical double-staining indicated that PAP-I and PAP-III staining was localized in a subpopulation of neurons in the peri-injured region. Expression of both PAP-I and PAP-III mRNA was observed following a transient increase in inflammatory cytokines, including TNF-alpha, IL-6, and IL-1 beta mRNA. The results of the present study suggest that expression of PAP family members in response to traumatic and inflammatory stimuli are not restricted to the pancreas, intestine, and peripheral nervous system, and are likely a more general cellular response, including the central nervous system in the rat. Thus, PAP family members may have an anti-inflammatory role, and this may contribute to the protection of injured neurons.	[Ampo, Kei-Ichi; Suzuki, Akinobu; Konishi, Hiroyuki; Kiyama, Hiroshi] Osaka City Univ, Dept Anat & Neurobiol, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan		Kiyama, H (corresponding author), Osaka City Univ, Dept Anat & Neurobiol, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kiyama@med.osaka-cu.ac.jp	Kiyama, Hiroshi/M-8867-2014; KONISHI, Hiroyuki/M-8871-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	Ministry of Education, Culture, Sports, and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry of Health, Labor, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan	We are grateful to C. Kadono for excellent technical assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, and Technology (MEXT), and the Ministry of Health, Labor, and Welfare of Japan.	Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Averill S, 2008, NEUROSCIENCE, V155, P1227, DOI 10.1016/j.neuroscience.2008.06.049; Averill S, 2002, J NEUROSCI, V22, P7493; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Closa D, 2007, WORLD J GASTROENTERO, V13, P170, DOI 10.3748/wjg.v13.i2.170; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; DUSETTI NJ, 1995, J BIOL CHEM, V270, P22417, DOI 10.1074/jbc.270.38.22417; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fiedler F, 1998, CRIT CARE MED, V26, P887, DOI 10.1097/00003246-199805000-00024; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; FRIGERIO JM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P329, DOI 10.1016/0167-4781(93)90167-C; FRIGERIO JM, 1993, BIOCHEMISTRY-US, V32, P9236, DOI 10.1021/bi00086a032; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Graf R, 2002, J SURG RES, V105, P136, DOI 10.1006/jsre.2002.6387; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Heller A, 1999, ANESTHESIOLOGY, V91, P1408, DOI 10.1097/00000542-199911000-00034; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Honma M, 2002, J NEUROCHEM, V82, P961, DOI 10.1046/j.1471-4159.2002.01043.x; IOVANNA JL, 1993, AM J PHYSIOL, V265, pG611, DOI 10.1152/ajpgi.1993.265.4.G611; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; MASCIOTRA L, 1995, DIGEST DIS SCI, V40, P519, DOI 10.1007/BF02064359; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Okamotoa T, 2004, MOL BRAIN RES, V131, P119, DOI 10.1016/j.molbrainres.2004.08.015; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Takahara Y, 2008, J UROLOGY, V179, P1603, DOI 10.1016/j.juro.2007.11.034; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhang H, 2004, SCAND J GASTROENTERO, V39, P870, DOI 10.1080/00365520410006477	48	14	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2009	26	10					1683	1693		10.1089/neu.2008.0847			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	507CT	WOS:000270829200007	19351265				2022-02-06	
J	Hutchings, L; Atijosan, O; Burgess, C; Willett, K				Hutchings, Lynn; Atijosan, Oluwarantimi; Burgess, Chris; Willett, Keith			Developing a Spinal Clearance Protocol for Unconscious Pediatric Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Pediatric; Spinal injury; Obtunded; Unconscious; Trauma; Clearance	CERVICAL-SPINE; INJURIES; CHILDREN	Background: Spinal injury in pediatric trauma is associated with significant morbidity and mortality, but no current consensus exists on the safest and most effective method of clearance in the high-risk pediatric trauma patient. Methods: A retrospective analysis was performed on the records of 115 pediatric patients who had suffered major trauma and required admission to the pediatric intensive care unit of a United Kingdom level 1 trauma centre during a 7-year period from January 2000 to December 2006. The spinal imaging performed, and methods of clearance for each spinal region were obtained from analysis of written and electronic medical documentation. Results: In the cohort of 115 patients, there was a male predominance (63%) with motor vehicle accidents as the major mechanism of injury (63.5%). Ten patients (8.7%) were identified with spinal injuries, all of whom had sustained closed head injuries. Two of these patients had spinal cord injuries; one subsequently died. Spinal injury resulted in longer intubation times and intensive care stays, but no difference in new injury severity score or outcome. Clearance methods ranged from clinical examination to imaging with radiographs, computed tomography (CT), and dynamic screening. Magnetic resonance imaging was used as a secondary modality in two cases only, and in neither case was it used for clearance. CT demonstrated 100% specificity and sensitivity with positive and negative predictive values of I for all spinal regions. There were no cases of Spinal Cord Injury WithOut Radiologic Abnormality and no evidence of missed injuries. Conclusions: There is a need for an evidence-based protocol for the clearance of the spine in the obtunded and high-risk pediatric trauma patient. High-resolution CT with sagittal and coronal reconstructions should be the basis for cervical spinal clearance, in combination with the interpretation of films by an expert radiologist. All spinal regions should be imaged, and clearance should be formally documented. The role of magnetic resonance imaging in routine clearance remains controversial. Multicenter prospective studies are needed to develop consensus for an evidenced-based protocol for clearance in this high-risk group.	[Hutchings, Lynn; Atijosan, Oluwarantimi; Burgess, Chris] John Radcliffe Hosp, Kadoorie Ctr Crit Care Res, Oxford OX3 9DU, England; [Willett, Keith] John Radcliffe Hosp, Dept Trauma, Oxford OX3 9DU, England		Hutchings, L (corresponding author), John Radcliffe Hosp, Kadoorie Ctr Crit Care Res, Oxford OX3 9DU, England.	lynnhutchings@doctors.org.uk					Brooks RA, 2001, J TRAUMA, V50, P862; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; Flynn JM, 2002, J PEDIATR ORTHOPED, V22, P573, DOI 10.1097/00004694-200209000-00002; Frank JB, 2002, SPINE, V27, P1176, DOI 10.1097/00007632-200206010-00008; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Khanna G, 2007, SKELETAL RADIOL, V36, P477, DOI 10.1007/s00256-006-0223-0; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Martin BW, 2004, ARCH DIS CHILD, V89, P860, DOI 10.1136/adc.2003.029223; Mower WR, 2002, J TRAUMA, V53, P1198, DOI 10.1097/00005373-200212000-00039; *NAT HLTH SERV NAT, HEAD INJ GUID CG56; ORENSTEIN JB, 1994, PEDIATR EMERG CARE, V10, P132, DOI 10.1097/00006565-199406000-00003; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Powers Jan, 2006, J Trauma Nurs, V13, P198; Proctor MR, 2002, CRIT CARE MED, V30, pS489, DOI 10.1097/00003246-200211001-00014; Roche C, 2001, PEDIATR RADIOL, V31, P677, DOI 10.1007/s002470100532; Shaw M, 1999, CLIN RADIOL, V54, P377, DOI 10.1053/crad.1999.0192; Slack SE, 2004, EMERG MED J, V21, P189, DOI 10.1136/emj.2003.012310; Spiteri V, 2006, J TRAUMA, V61, P1171, DOI 10.1097/01.ta.0000236000.95954.9a; Tomycz ND, 2008, J TRAUMA, V64, P1258, DOI 10.1097/TA.0b013e318166d2bd; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20	26	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2009	67	4					681	686		10.1097/TA.0b013e3181a5f0ed			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	506BE	WOS:000270747000001	19820570				2022-02-06	
J	Piebes, SK; Gourley, M; McLeod, TCV				Piebes, Sarah K.; Gourley, Meganne; McLeod, Tamara C. Valovich			Caring for Student-Athletes Following a Concussion	JOURNAL OF SCHOOL NURSING			English	Article						athlete health; injuries; safety; injury prevention; school nurse	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; POSTTRAUMATIC HEADACHE; TEST-PERFORMANCE; UNITED-STATES; MANAGEMENT; COLLEGIATE; CHILDREN; RECOVERY; INJURY	The school nurse plays a dynamic role in the care and treatment of a concussed athlete. Concussions in the adolescent populations are of special concern due to their potential impact on mental development and cognitive function, as well as an increased risk of serious complications including second impact syndrome. The complexity of a concussion requires collaboration between of a variety of health care and school personnel to create an optimal situation for the student-athlete and their family. As the primary health care provider for students during the school day, school nurses can help ensure all necessary steps are taken to aid the recovery of an injured student-athlete. It is important that school nurses are up-to-date on current concussion information to allow for optimal care following injury and during the recovery process.	[Piebes, Sarah K.] Univ Vermont, Dept Athlet Med, Burlington, VT 05405 USA; [Gourley, Meganne] Desert Ridge High Sch, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ USA		Piebes, SK (corresponding author), Univ Vermont, Dept Athlet Med, Burlington, VT 05405 USA.		Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Callaghan M, 2001, DEV MED CHILD NEUROL, V43, P819, DOI 10.1017/S0012162201001487; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CICCONE C, 2002, NONSTEROIDAL ANTIINF, P206; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; DEBETTENCOURT LU, 2002, TEACHING EXCEPTIONAL, V34, P16; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grazzi L, 2004, NEUROL SCI, V25, pS111, DOI 10.1007/s10072-004-0265-9; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; HOSSLER P, 2006, GETTING HEAD CONCUSS; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lake AE, 1999, J HEAD TRAUMA REHAB, V14, P70, DOI 10.1097/00001199-199902000-00008; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; MCCRORY P, 2004, PRAGUE BRIT J SPORTS, V39, P196; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Athletic Trainers' Association, 2009, ATHL TRAIN FILL NEC; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; U.S. Department of Education, 2000, GUID IND ED PROGR; *US DEP ED, 2007, FREE APPR PUBL ED ST; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	41	14	15	0	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	AUG	2009	25	4					270	281		10.1177/1059840509339782			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	483TH	WOS:000268990600005	19535497				2022-02-06	
J	Ciccia, AH; Meulenbroek, P; Turkstra, LS				Ciccia, Angela Hein; Meulenbroek, Peter; Turkstra, Lyn S.			Adolescent Brain and Cognitive Developments Implications for Clinical Assessment in Traumatic Brain Injury	TOPICS IN LANGUAGE DISORDERS			English	Article						adolescence; brain-behavior relationships; cognitive development	CLOSED-HEAD INJURY; WHITE-MATTER; WORKING-MEMORY; EXECUTIVE FUNCTIONS; CORPUS-CALLOSUM; FUNCTIONAL MRI; CHILDHOOD; CHILDREN; LANGUAGE; MATURATION	Adolescence is a time of significant physical, social, and emotional developments, accompanied by changes in cognitive and language skills. Underlying these are significant developments in brain structures and functions including changes in cortical and subcortical gray matter and white matter tracts. Among the brain regions that develop during adolescence are areas that are commonly damaged as a result of a traumatic brain injury (TBI). This paper summarizes major brain changes during adolescence and evidence linking maturation of these cognitive and language functions to brain development, placing consideration of both areas of development in the context of rehabilitation for adolescents with TBI.	[Meulenbroek, Peter; Turkstra, Lyn S.] Univ Wisconsin, Dept Communicat Disorders, Madison, WI 53706 USA; [Ciccia, Angela Hein] Case Western Reserve Univ, Dept Commun Sci, Cleveland, OH 44106 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Communicat Disorders, 1975 Goodnight Hall, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021; Ciccia, Angela/J-5967-2019	Turkstra, Lyn/0000-0002-6948-6921; Meulenbroek, Peter/0000-0003-4233-9910	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K23 DC000163] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K23DC000163] Funding Source: NIH RePORTER		Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anokhin AP, 2000, DEV PSYCHOBIOL, V36, P9, DOI 10.1002/(SICI)1098-2302(200001)36:1<9::AID-DEV2>3.0.CO;2-5; ARNETT JJ, 1994, J YOUTH ADOLESCENCE, V23, P517, DOI 10.1007/BF01537734; Asato MR, 2006, NEUROPSYCHOLOGIA, V44, P2259, DOI 10.1016/j.neuropsychologia.2006.05.010; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bhatnagar S. C., 2008, NEUROSCIENCE STUDY C; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Bosacki SL, 2003, J YOUTH ADOLESCENCE, V32, P141, DOI 10.1023/A:1021861902463; Bosacki SL, 2000, J EDUC PSYCHOL, V92, P709, DOI 10.1037//0022-0663.92.4.709; BROTHERS L, 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; BROWN BB, 1993, CHILD DEV, V64, P467, DOI 10.1111/j.1467-8624.1993.tb02922.x; Cameron JL, 2001, DEV COGN NEUROSCI, P59; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Ciccia Angel H., 2002, ADV SPEECH LANGUAGE, V4, P1, DOI DOI 10.1080/14417040210001669181; Crone EA, 2008, COGN AFFECT BEHAV NE, V8, P165, DOI 10.3758/CABN.8.2.165; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Donders J, 1997, Pediatr Rehabil, V1, P179; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; EYRE JA, 1991, J PHYSIOL-LONDON, V434, P441, DOI 10.1113/jphysiol.1991.sp018479; Felser Claudia, 2003, LANG ACQUIS, V11, P127, DOI DOI 10.1207/s15327817la1103_1; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Grumbach MM, 2002, HORM RES, V57, P2, DOI 10.1159/000058094; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kail RV, 2007, CHILD DEV, V78, P1760, DOI 10.1111/j.1467-8624.2007.01088.x; KAMHI H, 2007, CLIN DECISION MAKING; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; KLAHR D, 2001, TIME MATTERS COGNITI; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; Matthews PM, 2004, RESTOR NEUROL NEUROS, V22, P245; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; Moran CA, 2006, BRAIN INJURY, V20, P417, DOI 10.1080/02699050500488223; Muneoka KT, 2002, BRAIN RES, V956, P332, DOI 10.1016/S0006-8993(02)03567-9; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Nippold M., 1988, LATER LANGUAGE DEV A; Nippold M., 1998, LATER LANGUAGE DEV S; Nippold MA, 2000, TOP LANG DISORD, V20, P15, DOI 10.1097/00011363-200020020-00004; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Peters M, 1998, BRAIN COGNITION, V37, P254, DOI 10.1006/brcg.1998.0983; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Proctor A, 2000, BRAIN INJURY, V14, P633; RABINOWICZ T, 1979, HUMAN GROWTH, V3, P97; Raymer AM, 2008, J SPEECH LANG HEAR R, V51, pS259, DOI 10.1044/1092-4388(2008/020); RICKER J, 2007, BRAIN INJURY MED PRI, P149; SCHULKIN, 2000, ROOTS SOCIAL SENSIBI; Scott CherylM., 1988, LATER LANGUAGE DEV A, P49; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Singh PP, 2007, AM J TROP MED HYG, V77, P98; Snow PC, 2000, BRAIN INJURY, V14, P397; Sohlberg M., 2001, COGNITIVE REHABILITA; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005; STEINBERG L, 1999, ADOLESCENCE; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Williams SE, 2005, BRAIN INJURY, V19, P549, DOI 10.1080/02699050400013576; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; [No title captured]; [No title captured]	96	14	14	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2009	29	3					249	265		10.1097/TLD.0b013e3181b53211			17	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	488HT	WOS:000269340700006	30220763	Green Accepted			2022-02-06	
J	Olson, DM; Thoyre, SM; Bennett, SN; Stoner, JB; Graffagnino, C				Olson, DaiWai M.; Thoyre, Suzanne M.; Bennett, Stacey N.; Stoner, Joanna B.; Graffagnino, Carmelo			EFFECT OF MECHANICAL CHEST PERCUSSION ON INTRACRANIAL PRESSURE: A PILOT STUDY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; PREVENTION; MANAGEMENT	Background Treatment of brain injury is often focused on minimizing intracranial pressure, which, when elevated, can lead to secondary brain injury. Chest percussion is a common practice used to treat and prevent pneumonia. Conflicting and limited anecdotal evidence indicates that physical stimulation increases intracranial pressure and should be avoided in patients at risk of intracranial hypertension. Objectives To explore the safety of performing chest percussion for patients at high risk for intracranial hypertension. Methods A total of 28 patients with at least 1 documented episode of intracranial hypertension who were having intracranial pressure monitored were studied in a prospective randomized control trial. Patients were randomly assigned to either the control group (no chest percussion) or the intervention group (10 minutes of chest percussion at noon). Intracranial pressure was recorded once a minute before, during, and after the intervention. Results Mean intracranial pressures for the control group before, during, and after the study period (14.4, 15.0, and 15.9 mm Hg, respectively) did not differ significantly from pressures in the intervention group (13.6, 13.7, and 14.2 mm Hg, respectively). Conclusions Mechanical chest percussion may be a safe intervention for nurses to use on neurologically injured patients who are at risk for intracranial hypertension. (American Journal of Critical Care. 2009; 18: 330-335)	[Olson, DaiWai M.; Bennett, Stacey N.; Stoner, Joanna B.; Graffagnino, Carmelo] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Thoyre, Suzanne M.] Univ N Carolina, Chapel Hill, NC USA		Olson, DM (corresponding author), Duke Univ, Med Ctr, Box 2900,Bryan Res Bldg, Durham, NC 27710 USA.	Olson006@mc.duke.edu		Olson, DaiWai/0000-0002-9280-078X	Interventions to Prevent and Manage Chronic Illness [T32 NR07091]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007091] Funding Source: NIH RePORTER	This research was supported by T32 NR07091 Interventions to Prevent and Manage Chronic Illness.	Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Arbour R, 1998, Crit Care Nurse, V18, P30; Bader M K, 2000, Crit Care Nurs Clin North Am, V12, P413; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Brain Injury Association of America, BRAIN INJ; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; Cody R. P., 2006, APPL STAT SAS PROGRA; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Grap Mary Jo, 2004, Crit Care Nurs Clin North Am, V16, P349, DOI 10.1016/j.ccell.2004.03.005; Greenberg MS, 2001, HDB NEUROSURGERY; HAMMON WE, 1993, CHEST, V103, P1409, DOI 10.1378/chest.103.5.1409; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; MAHANES D, 2004, CRIT CARE NURS CLIN, V16, pR9; Mahanes Dea, 2004, Crit Care Nurs Clin North Am, V16, P387, DOI 10.1016/j.ccell.2004.03.007; March K, 2000, Crit Care Nurs Clin North Am, V12, P429; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marik PE, 2002, CRIT CARE MED, V30, P2146, DOI 10.1097/00003246-200209000-00035; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Munro BH, 2005, STAT METHODS HLTH CA, V5th; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; Olson DM, 2007, NEUROCRIT CARE, V6, P100, DOI 10.1007/s12028-007-0015-y; Quenot JP, 2007, CRIT CARE MED, V35, P2031, DOI 10.1097/01.ccm.0000282733.83089.4d; Wijdicks EFM, 1998, NEUROLOGY, V50, P11, DOI 10.1212/WNL.50.1.11; Wong F W, 2000, Crit Care Nurse, V20, P18; Yanko J R, 2001, Crit Care Nurs Q, V23, P1; Yilmazlar S, 2005, NEUROL RES, V27, P653, DOI 10.1179/016164105X35657; 2007, J NEUROTRAUMA S1, V24, pS45	31	14	17	0	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	JUL 1	2009	18	4					330	335		10.4037/ajcc2009523			6	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	465UW	WOS:000267614900006	19304565				2022-02-06	
J	Pothos, EM; Wood, RL				Pothos, Emmanuel M.; Wood, Rodger L.			Separate influences in learning: Evidence from artificial grammar learning with traumatic brain injury patients	BRAIN RESEARCH			English	Article						Learning; Categorization; COVIS; AGL; Traumatic brain injury	PREFRONTAL CORTEX; SIMILARITY; IMPLICIT; INTERFERENCE; SYSTEMS; ACQUISITION; FMRI	Artificial grammar learning (AGL) is one of the most extensively employed paradigms for the study of learning, Grammaticality is one of the most common ways to index performance in AGL. However, there is still extensive debate on whether there is a distinct psychological process which can lead to grammaticality knowledge. An application of the COVIS model of categorization in AGL suggests that grammaticality might arise from a hypothesis-testing system (when grammaticality is appropriately balanced with other knowledge influences), so that prefrontal cortex damage should be associated with impaired grammaticality and intact chunk strength performance. This prediction was confirmed in a study of traumatic brain injury (TBI) patients and matched controls. The TBI patient cohort had diffuse prefrontal cortex damage as evidenced by the history of their injury, CT scans, and severe executive functioning problems. Our results allow a novel interpretation of grammaticality and AGL in general. (C) 2009 Elsevier B.V. All rights reserved.	[Pothos, Emmanuel M.; Wood, Rodger L.] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales		Pothos, EM (corresponding author), Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.	e.m.pothos@swansea.ac.uk; R.L.Wood@Swansea.ac.uk			ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [R000222655]; ECEuropean CommissionEuropean Commission Joint Research Centre [516542]	This research was partly supported by ESRC grant R000222655 and EC Framework 6 grant contract 516542 (NEST) to EMP. We would like to thank Louise Cleobury for collecting the data and Clare Williams for her helpful advice regarding the patient assessment.	Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; BADDELEY AD, 2002, PRINCIPLES FRONTAL L; Bailey TM, 2008, BEHAV RES METHODS, V40, P164, DOI 10.3758/BRM.40.1.164; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; BANICH MT, CURRENT DIR IN PRESS; Berry D.C., 1993, IMPLICIT LEARNING TH; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Chang GY, 2004, J EXP PSYCHOL LEARN, V30, P714, DOI 10.1037/0278-7393.30.3.714; Conway CM, 2006, PSYCHOL SCI, V17, P905, DOI 10.1111/j.1467-9280.2006.01801.x; Dienes Z, 1999, BEHAV BRAIN SCI, V22, P735, DOI 10.1017/S0140525X99002186; DULANY DE, 1984, J EXP PSYCHOL GEN, V113, P541, DOI 10.1037/0096-3445.113.4.541; Fletcher P, 1999, CEREB CORTEX, V9, P168, DOI 10.1093/cercor/9.2.168; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Johnstone T, 1999, J EXP PSYCHOL LEARN, V25, P524, DOI 10.1037/0278-7393.25.2.524; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Knowlton BJ, 1996, J EXP PSYCHOL LEARN, V22, P169, DOI 10.1037/0278-7393.22.1.169; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; MATHEWS RC, 1989, J EXP PSYCHOL LEARN, V15, P1083, DOI 10.1037/0278-7393.15.6.1083; Minda JP, 2008, J EXP PSYCHOL LEARN, V34, P1518, DOI 10.1037/a0013355; Nosofsky RM, 2002, PSYCHON B REV, V9, P169, DOI 10.3758/BF03196274; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2004, J NEUROSCI, V24, P8436, DOI 10.1523/JNEUROSCI.2220-04.2004; Pothos EM, 2005, BEHAV BRAIN SCI, V28, P1, DOI 10.1017/S0140525X05000014; Pothos EM, 2000, J EXP PSYCHOL LEARN, V26, P847, DOI 10.1037//0278-7393.26.4.847; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Pothos EM, 2006, AM J PSYCHOL, V119, P275, DOI 10.2307/20445339; Reber A. S., 1993, IMPLICIT LEARNING TA; REBER AS, 1978, COGNITION, V6, P189, DOI 10.1016/0010-0277(78)90013-6; Redington M, 1996, J EXP PSYCHOL GEN, V125, P123, DOI 10.1037/0096-3445.125.2.123; Skosnik PD, 2002, NEUROIMAGE, V17, P1306, DOI 10.1006/nimg.2002.1291; Sloman SA, 1998, COGNITION, V65, P87, DOI 10.1016/S0010-0277(97)00048-6; Smith JG, 2006, BRAIN RES, V1067, P216, DOI 10.1016/j.brainres.2005.10.025; Smith JG, 2006, NEUROPSYCHOLOGIA, V44, P275, DOI 10.1016/j.neuropsychologia.2005.05.001; Stanton RD, 2007, MEM COGNITION, V35, P1747, DOI 10.3758/BF03193507; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tunney RJ, 2003, MEM COGNITION, V31, P1060, DOI 10.3758/BF03196127; Tunney RJ, 2001, J EXP PSYCHOL LEARN, V27, P614, DOI 10.1037//0278-7393.27.3.614; Wechsler D., 1998, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; Zeithamova D, 2006, MEM COGNITION, V34, P387, DOI 10.3758/BF03193416	46	14	14	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 12	2009	1275						67	72		10.1016/j.brainres.2009.04.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	462RY	WOS:000267374900007	19389386	Green Accepted			2022-02-06	
J	Kim, HW; Cho, KJ; Park, SC; Kim, HJ; Kim, GW				Kim, Hyun-Woo; Cho, Kyoung-Joo; Park, Soo-Chul; Kim, Hyun-Jeong; Kim, Gyung W.			The adenoviral vector-mediated increase in apurinic/apyrimidinic endonuclease inhibits the induction of neuronal cell death after transient ischemic stroke in mice	BRAIN RESEARCH			English	Article						DNA repair; DNA fragmentation; Cerebral ischemia; Adenoviral vector	FOCAL CEREBRAL-ISCHEMIA; SUPEROXIDE-DISMUTASE DEFICIENCY; SUBSEQUENT DNA FRAGMENTATION; EXCISION-REPAIR PATHWAY; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; EARLY DECREASE; STRAND BREAKS; MOUSE-BRAIN; RAT-BRAIN	Despite the correlation between changes in the levels of apurinic/apyrimidinic endonuclease and ischemic neuronal damage, no studies have addressed the question of whether increased APE/Ref-1 can prevent ischemic neuronal cell death in vivo. Using an adenoviral vector, we investigated whether increased APE/Ref-1 can inhibit the loss of APE/Ref-1 and thereby prevent oxidative DNA damage after transient focal cerebral ischemia. Mice were subjected to intraluminal suture occlusion of the middle cerebral artery for 1 h, followed by reperfusion. Pre-ischemic treatment of the adenoviral vector was introduced intra cerebrally. An adenoviral vector harboring the entire APE/Ref-1 gene sequence or a control virus without the APE/Ref-1 sequence was introduced 3 days before ischemia/reperfusion (I/R). The reduction of APE/Ref-1 occurred before DNA fragmentation, which was shown by temporal and spatial analysis, Increased APE/Ref-1 significantly decreased DNA damage and infarct volume after I/R. In conclusion, increased APE/Ref-1 enhanced DNA repair and inhibited the induction of ischemic oxidative DNA damage and cerebral infarction after I/R. (C) 2009 Elsevier B.V. All rights reserved.	[Kim, Gyung W.] Yonsei Univ, Dept Neurol, Coll Med, Seoul 120752, South Korea; Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul 120752, South Korea		Kim, GW (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, 134 Sinchon Dong, Seoul 120752, South Korea.	gyungkim@yuhs.ac		Kim, Gyung Whan/0000-0001-7053-4372	Korea Science and Engineering FoundationKorea Science and Engineering Foundation [KOSEF-2-0709-0008]	This work was supported by a grant from the Korea Science and Engineering Foundation (KOSEF-2-0709-0008).	Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chang YY, 1999, NEUROSCI LETT, V277, P61, DOI 10.1016/S0304-3940(99)00799-5; Chen J, 1997, J NEUROCHEM, V69, P232; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; Fujimura M, 1999, J CEREBR BLOOD F MET, V19, P495, DOI 10.1097/00004647-199905000-00003; Fujimura M, 1999, J NEUROSCI, V19, P3414; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gillardon F, 1997, MOL BRAIN RES, V52, P194, DOI 10.1016/S0169-328X(97)00237-4; Grosch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125; Grosch S, 1998, CANCER RES, V58, P4410; Hanna M, 2004, DNA REPAIR, V3, P51, DOI 10.1016/j.dnarep.2003.09.005; Huang DY, 2000, FASEB J, V14, P407, DOI 10.1096/fasebj.14.2.407; Kawase M, 1999, STROKE, V30, P441, DOI 10.1161/01.STR.30.2.441; Kim CS, 2006, CARDIOVASC RES, V69, P520, DOI 10.1016/j.cardiores.2005.10.014; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P1690, DOI 10.1097/00004647-200012000-00008; Kim GW, 2003, J NEUROSCI, V23, P8733; Kim GW, 2001, STROKE, V32, P1401, DOI 10.1161/01.STR.32.6.1401; Kumura E, 1996, AM J PHYSIOL-CELL PH, V270, pC748, DOI 10.1152/ajpcell.1996.270.3.C748; Lan J, 2003, J CEREBR BLOOD F MET, V23, P1324, DOI 10.1097/01.WCB.0000091540.60196.F2; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Li WJ, 2006, J CEREBR BLOOD F MET, V26, P181, DOI 10.1038/sj.jcbfm.9600180; Lin LH, 2000, J NEUROCHEM, V74, P1098; Liu PK, 1996, J NEUROSCI, V16, P6795; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Murakami K, 1998, J NEUROSCI, V18, P205; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Song YJ, 2008, BIOCHEM BIOPH RES CO, V368, P68, DOI 10.1016/j.bbrc.2008.01.037; Sugawara T, 2001, STROKE, V32, P2388, DOI 10.1161/hs1001.097109; Sweder K., 2002, Journal of Biomedicine & Biotechnology, V2, P94, DOI 10.1155/S1110724302205033; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506; Tsuchiya D, 2003, BRAIN RES, V970, P131, DOI 10.1016/S0006-8993(03)02300-X; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Walton M, 1997, MOL BRAIN RES, V44, P167, DOI 10.1016/S0169-328X(96)00291-4; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yan MD, 2000, ACTA BIOCH BIOPH SIN, V32, P63; Yenari MA, 2001, NEUROL RES, V23, P543, DOI 10.1179/016164101101198802; ZHAO B, 1992, NUCLEIC ACIDS RES, V20, P4097, DOI 10.1093/nar/20.15.4097; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	14	16	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 5	2009	1274						1	10		10.1016/j.brainres.2009.04.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457BB	WOS:000266898700001	19374886				2022-02-06	
J	Colak, A; Kaya, M; Karaoglan, A; Sagmanligil, A; Akdemir, O; Sahan, E; Celik, O				Colak, A.; Kaya, M.; Karaoglan, A.; Sagmanligil, A.; Akdemir, O.; Sahan, E.; Celik, Oe			Calpain inhibitor AK 295 inhibits calpain-induced apoptosis and improves neurologic function after traumatic spinal cord injury in rats	NEUROCIRUGIA			English	Article						AK 295; Apoptosis; Calpain inhibitor; Secondary damage; Spinal cord trauma	ACTIVATED NEUTRAL PROTEINASE; CRYSTAL-STRUCTURE; DOWN-REGULATION; CALCIUM; BRAIN; CALPASTATIN; EXPRESSION; NEUROPROTECTION; DEGRADATION; MECHANISM	Background. An increase in the level of intracellular calcium activates the calcium-dependent neutral protease calpain, which in turn leads to cellular dysfunction and cell death after an insult to the central nervous system. fit this study, we evaluated the effect of a calpain inhibitor, AK 295, on spinal cord structure, neurologic function, and apoptosis after spinal cord injury (SCI) in a murine model. Methods. Thirty albino Wistar rats were divided into 3 groups of 10 each: the sham-operated control group (group 1), the spinal cord trauma group (group 2), and the spinal cord trauma plus AK 295 treatment group (group 3). After having received a combination of ketamine 60 mg/kg and xylazine 9 mg/kg to induce anesthesia, the rats in groups 2 and 3 were subjected to thoracic trauma by the weight drop technique (40 g-cm). One hour after having been subjected to that trauma, the rats in groups 2 and 3 were treated with an intraperitoneal injection of either dimethyl sulfoxide 2 mg/kg or AK 295 2 mg/kg. The effects of the injury and the efficacy of AK 295 were determined by an assessment of the TUNEL technique and the results of examination with a light microscope. The neurologic performance of 5 rats from group 2 and 5 from group 3 was assessed by means of the inclined plane technique and the modified Tarlov's motor grading scale 1, 3, and 5 days after spinal cord trauma. Findings. Light-microscopic examination of spinal cord specimens from group 2 revealed hemorrhage, edema, necrosis, and vascular thrombi 24 : hours after trauma. Similar (but less prominent) features were seen in specimens obtained from group 3 rats. Twenty-four hours after injury, the mean apoptotie cell numbers in groups I and 2 were zero and 4.57 +/- 0.37 cells, respectively. In group 3, the mean apoptotic cell number was 2.30 +/- 0.34 cells, a value significantly lower than that in group 2 (P < .05). Five days after trauma, the injured rats in group 2 demonstrated significant motor dysfunction (P < .05). In comparison, the motor scores exhibited by group 3 rats were markedly better (P < .05). Conclusions. AK 295 inhibited apoptosis via calpain-dependent pathway's and provided neuroprotection and improved neurologic function in a rat model of SCI. To our knowledge, this is the first study to evaluate the use of AK 295, a calpain inhibitor, after SCI. Our data suggest that AK 295 might be a novel therapeutic compound for the neuroprotection of tissue and the recovery of function in patients with a SCI.	[Colak, A.; Karaoglan, A.] Maltepe Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Kaya, M.; Sagmanligil, A.; Akdemir, O.] Taksim Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Sahan, E.] Taksim Educ & Res Hosp, Dept Pathol, Istanbul, Turkey; [Celik, Oe] Istanbul Kultur Univ, Fac Sci & Letters, Dept Mol Biol & Genet, Istanbul, Turkey		Colak, A (corresponding author), Terakki Caddesi 47-7, Istanbul, Turkey.		Celik, Ozge/AAG-4778-2019				Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Banik NL, 1997, BRAIN RES, V748, P205, DOI 10.1016/S0006-8993(96)01302-9; Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; BANIK NL, 1986, J NEUROL SCI, V73, P245, DOI 10.1016/0022-510X(86)90149-8; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Bresnahan J. C., 1996, Society for Neuroscience Abstracts, V22, P1185; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Crowe MJ, 1997, NAT MED, V3, P240; Du S, 1999, EXP NEUROL, V157, P96, DOI 10.1006/exnr.1999.7041; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; GUROFF G, 1964, J BIOL CHEM, V239, P149; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Katoh K, 1996, NEUROSCI LETT, V216, P9; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; MOHAN PS, 1995, J NEUROCHEM, V64, P859; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ray GE, 1999, SOC DEV, V8, P380, DOI 10.1111/1467-9507.00102; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; Ray SK, 1999, ANN NY ACAD SCI, V890, P261, DOI 10.1111/j.1749-6632.1999.tb08001.x; RAY SK, 2002, WILEY ENCY MOL MED, V5, P435; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saido TC, 1997, NEUROSCI LETT, V227, P75, DOI 10.1016/S0304-3940(97)00309-1; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shields DC, 2000, J NEUROSCI RES, V61, P146; Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; TARLOV IM, 1957, SPINAL CORD COMPRESS, P147; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Villa PG, 1998, J CELL SCI, V111, P713; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1	51	14	19	0	4	SOC ESPANOLA NEUROCIRUGIA	MURCIA	C/O  DR POZA, GRAN VIA SALZILLO 42, 30005 MURCIA, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	JUN	2009	20	3					245	254					10	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	479TY	WOS:000268685000002	19575128				2022-02-06	
J	Chen, YF; Tzeng, IH; Li, YH; Lo, YC; Lin, WC; Chiang, HJ; Chen, RF; Shen, WC				Chen, Yung-Fang; Tzeng, Iuan-Hong; Li, Ying-Hsuan; Lo, Yu-Chien; Lin, Wei-Ching; Chiang, Hsein-Jar; Chen, Ruey-Fen; Shen, Wu-Chung			Transcatheter Arterial Embolization in the Treatment of Maxillofacial Trauma Induced Life-Threatening Hemorrhages	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Maxillofacial trauma; Hemorrhage; Transcatheter arterial embolization; Facial fractures; Le Fort fractures	THERAPEUTIC EMBOLIZATION; INTRACTABLE EPISTAXIS	Background: Life-threatening hemorrhages with hemodynamic instability are uncommon in patients with sustained maxillofacial trauma, but when they occur, require immediate surgical intervention if conservative treatment fails. This study assessed the effects of transcatheter arterial embolization (TAE) in the treatment of maxillofacial trauma-induced life-threatening hemorrhages. Methods: From January 2004 to January 2007, eight ambulatory patients admitted for maxillofacial injuries with life-threatening hemorrhaging and hemodynamic instability (systolic blood pressure <= 90 mm Hg) caused primarily by intractable oronasal bleeding who subsequently underwent TAE were included in this study. Results: Maxillofacial trauma was caused by motorcycle traffic injuries (6 cases), motor vehicle injury (1 case), and fall injury (1 case). All patients exhibited documented Le Fort III fractures. The average Glasgow Coma Scale score was 4.7. TAE was successfully performed and hemorrhaging arrested in all patients. Three deaths occurred (38%) from severe traumatic brain injury. The other five patients (62%) survived without development of systemic or neurologic complications post-TAE. Conclusions: Conservative treatment consisting of packing of the nares, compression, and blood transfusion should always precede TAE as the primary protocol. When conservative treatment fails, as shown either by the need for continued blood product replacement exceeding 1,500 mL and a systolic blood pressure <= 90 mm Hg, TAE intervention should immediately be considered as an alternative recourse before other surgical interventions.	[Chen, Yung-Fang; Tzeng, Iuan-Hong; Li, Ying-Hsuan; Lo, Yu-Chien; Lin, Wei-Ching; Chen, Ruey-Fen; Shen, Wu-Chung] China Med Univ Hosp, Dept Radiol, Taichung 40447, Taiwan; [Chiang, Hsein-Jar] Nantou Christian Hosp, Dept Radiol, Nantou, Taiwan		Chen, YF (corresponding author), China Med Univ Hosp, Dept Radiol, Yue Deh Rd 2, Taichung 40447, Taiwan.	cyfmagic@yahoo.com.tw					Bynoe RP, 2003, J TRAUMA, V55, P74, DOI 10.1097/01.TA.0000026494.22774.A0; ELAHI MM, 1995, ARCH OTOLARYNGOL, V121, P65; Hagiwara A, 2004, J TRAUMA, V57, P271, DOI 10.1097/01.TA.0000131198.79153.3C; KENDALL B, 1977, J NEUROL NEUROSUR PS, V40, P937, DOI 10.1136/jnnp.40.10.937; Komiyama M, 1998, J TRAUMA, V44, P330, DOI 10.1097/00005373-199802000-00017; Smith TP, 2006, J VASC INTERV RADIOL, V17, P1897, DOI 10.1097/01.RVI.0000247301.64269.27; SOKOLOFF J, 1974, RADIOLOGY, V111, P285, DOI 10.1148/111.2.285; STRUTZ J, 1990, ARCH OTOLARYNGOL, V116, P697	8	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2009	66	5					1425	1430		10.1097/TA.0b013e3181842046			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	445AJ	WOS:000266021700030	19430249				2022-02-06	
J	Sahuquillo, J; Perez-Barcena, J; Biestro, A; Zavala, E; Merino, MA; Vilalta, A; Poca, MA; Garnacho, A; Adalia, R; Homar, J; LLompart-Pou, JA				Sahuquillo, Juan; Perez-Barcena, Jon; Biestro, Alberto; Zavala, Elizabeth; Merino, Mari-Angels; Vilalta, Anna; Antonia Poca, Maria; Garnacho, Angel; Adalia, Ramon; Homar, Javier; Antonio LLompart-Pou, Juan			Intravascular cooling for rapid induction of moderate hypothermia in severely head-injured patients: results of a multicenter study (IntraCool)	INTENSIVE CARE MEDICINE			English	Article						Intravascular temperature management; Moderate hypothermia; Pilot study; Refractory high ICP; Severe head injury; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; INTRACRANIAL HYPERTENSION; THERAPEUTIC HYPOTHERMIA; VASOCONSTRICTION; PRESSURE; CORE	To evaluate the feasibility, safety and effectiveness of a new method of intravascular temperature management for inducing moderate hypothermia (MHT). Prospective, international-multicenter clinical trial conducted in four university hospitals. In a 2-year period 24 patients with severe head injury and refractory high ICP were treated with MHT (32.5A degrees C) by intravascular methods. Seventeen were males and seven females, with a median age of 25 years (range 15-60). The median Glasgow Coma Scale upon admission was 7 (range 3-13) and the median Injury Severity Score was 22 (range 13-43). A total of 75% of patients presented a diffuse lesion in the pre-enrollment computed tomography. Median time from injury until reaching refractory high ICP was 71.5 h after injury (minimum 14 h, maximum 251 h). Twelve patients (50%) reached this situation within the first 72 h after injury. MHT was attained in a median time of 3 h. Pre-enrollment median ICP was 23.8 mmHg and was reduced to 16.8 mmHg upon reaching target temperature. At 6 months after injury, nine patients had died (37.5%), six were severely disabled (25%), two moderately disabled (8.3%) and seven had a good recovery (29.2%). Of the nine patients who died, in four the cause was rebound ICP during rewarming, one death was attributed to accidental potassium overload, two to septic shock, one to cardiac arrest of unknown origin and the ninth to a pulmonary embolism. Intravascular methods to induce MHT combined with precooling with cold saline at 4A degrees C appear to be feasible and effective in reducing ICP in patients with high ICP refractory to first-line therapeutic measures.	[Sahuquillo, Juan; Antonia Poca, Maria] Univ Autonoma Barcelona, Dept Neurosurg, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Perez-Barcena, Jon; Homar, Javier; Antonio LLompart-Pou, Juan] Son Dureta Univ Hosp, Intens Care Unit, Palma de Mallorca, Spain; [Biestro, Alberto] Hosp Clin Montevideo, Intens Care Unit, Montevideo, Uruguay; [Zavala, Elizabeth; Adalia, Ramon] Clin Univ Hosp, Surg ICU, Dept Anesthesiol, Barcelona, Spain; [Merino, Mari-Angels; Vilalta, Anna] Univ Autonoma Barcelona, Neurotraumatol Res Unit, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Garnacho, Angel] Univ Autonoma Barcelona, Neurotraumatol ICU, Vall Hebron Univ Hosp, Barcelona 08035, Spain		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Dept Neurosurg, Vall Hebron Univ Hosp, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net; jperez@hsd.es; mapibies@adinet.com.uy; ezavala@clinic.ub.es; mamerino@neurotrauma.net; annavilalta@neurotrauma.net; pocama@neurotrauma.net; garnacho@neurotrauma.net; 30717rab@comb.es; jhomar@hsd.es; jallompart@hsd.es	Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Garnacho, Angel/A-9309-2013	Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Vilalta, Anna/0000-0002-2183-072X			*AM ASS NEUR SURG, 2007, J NEUROTRAUMA S1, V24, pS21; *AM ASS NEUR SURG, 2007, J NEUROTRAUMA S1, V24, pS71; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1995, J NEUROSURG ANESTH, V7, P152, DOI 10.1097/00008506-199504000-00023; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; FAY T, 1945, RES PUBL ASS NERV ME, V24, P611; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Grosse-Wortmann L, 2006, PEDIATR CARDIOL, V27, P286, DOI 10.1007/s00246-005-1248-1; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; KURZ A, 1995, ANESTHESIOLOGY, V82, P870, DOI 10.1097/00000542-199504000-00008; LASKOWSKI EJ, 1960, NEUROLOGY, V10, P499, DOI 10.1212/WNL.10.5.499; LEOD AA, 1982, BRIT HEART J, V47, P221; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall LF, 1991, J NEUROSURG S, V75, P14; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pichon N, 2007, CRIT CARE, V11, DOI 10.1186/cc5956; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; POLDERMAN KH, 2003, INTENS CARE MED, V29, P1637; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; QUI W, 2006, J CLIN NEUROSCI, V13, P995; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; ROBERTS I, 2005, BARBITURATES ACUTE T; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wittebole X, 2005, J ELECTROCARDIOL, V38, P77, DOI 10.1016/j.jelectrocard.2004.09.004; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	39	14	16	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2009	35	5					890	898		10.1007/s00134-008-1357-4			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440NL	WOS:000265706900016	19034424				2022-02-06	
J	Tingberg, B; Falk, AC; Flodmark, O; Ygge, BM				Tingberg, Bjorn; Falk, Ann-Charlotte; Flodmark, Olof; Ygge, Britt-Marie			Evaluation of documentation in potential abusive head injury of infants in a Paediatric Emergency Department	ACTA PAEDIATRICA			English	Article						Abusive head injury; Child abuse; Shaken baby syndrome	TRAUMATIC BRAIN-INJURY; SHAKEN IMPACT SYNDROME; YOUNG-CHILDREN; BABY SYNDROME; VICTIMS	Aim: The aim is to evaluate medical record documentation regarding potential abusive head injury (AHI) in infants presenting to a Paediatric Emergency Department (ED) with certain primary complaints known to be associated with AHI. Methods: A database search was performed to find all medical records over a period of one year relating to those children who had one AHI-related primary complaint and who had had a CT head-scan performed in conjunction with admission. Each medical record was reviewed, in order to assess whether potential abuse had been investigated and documented. Each CT-scan image was re-evaluated for missed indications of potential injuries attributable to AHI. Results: Forty-seven such medical records were found. Of these, 87% showed the diagnosis to be head injuries. The largest group of children was in the age group 0-3 months (38%). Of the children admitted to the Paediatric ED due to a head injury, 54% had a history deemed to raise suspicions of abuse but only five of them had had a documented investigation of child abuse. The re-evaluation of the CT-scans showed no missed cases. Conclusion: In this study we found that among children with known risk factors for AHI, only a few had documentation regarding potential child abuse. The use of a standardized protocol could be helpful in the important work to help staff discover potential AHI.	[Tingberg, Bjorn] Astrid Lindgren Childrens Hosp, MIO Grp, Child Protect Team, Karolinska Inst,Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Falk, Ann-Charlotte] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Flodmark, Olof] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden		Tingberg, B (corresponding author), Astrid Lindgren Childrens Hosp, MIO Grp, Child Protect Team, Karolinska Inst,Dept Woman & Child Hlth, S-17176 Stockholm, Sweden.	bjorn.tingberg@karolinska.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894	Stockholm County CouncilStockholm County Council; Karolinska InstituteKarolinska Institutet; SAllskapet Barnavard	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institute, and SAllskapet Barnavard. The authors are grateful to Doris Tomlinson for her language assistance.	Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Chiocca E, 1998, Nursing, V28, P33; Chiocca E M, 1995, Pediatr Nurs, V21, P33; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; FLODMARK O, 2002, VARD, V1, P23; Fulton D R, 2000, Crit Care Nurs Q, V23, P43; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Lewis Kristine, 2002, Pediatr Nurs, V28, P508; Minns RA, 2005, SHAKING OTHER NONACC; Munro E, 1999, CHILD ABUSE NEGLECT, V23, P745, DOI 10.1016/S0145-2134(99)00053-8; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; *SOC, 2001, CHILD AB PREV PROT, P72; *SOC, 2004, STAT AVS VALD MOT BA; STARLING SP, 1995, PEDIATRICS, V95, P259; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Wallis W H, 2000, Crit Care Nurs Clin North Am, V12, P489	25	14	14	0	6	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.	MAY	2009	98	5					777	781		10.1111/j.1651-2227.2009.01241.x			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	428UY	WOS:000264878100005	19389121				2022-02-06	
J	Whitney, KA; Davis, JJ; Shepard, PH; Bertram, DM; Adams, KM				Whitney, Kriscinda A.; Davis, Jeremy J.; Shepard, Polly H.; Bertram, David M.; Adams, Kenneth M.			Digit Span Age Scaled Score in Middle-Aged Military Veterans: Is It More Closely Associated with TOMM Failure than Reliable Digit Span?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Test validity; Neuropsychology; Malingering; Military veterans; Memory	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; SHORT-TERM MEMORY; NEUROPSYCHOLOGICAL TESTS; CLASSIFICATION ACCURACY; HEAD-INJURY; VALIDATION; SPECIFICITY; SENSITIVITY; DISABILITY	The relative usefulness of two digit span (DS) variables in detecting negative response bias, as defined by below cut-off performance on the Test of Memory Malingering (TOMM), was examined among primarily middle-aged military veteran outpatients who were judged clinically to be at increased risk for displaying negative response bias on cognitive testing. Digit span variables included DS Age Scaled Score (DS Age SS) and Reliable DS. Findings from this retrospective data analysis (N = 46) suggest that DS Age SS is preferable for use over Reliable DS in predicting TOMM failure. Results of the current study suggest that, particularly if the Wechsler scales are an existing part of the neuropsychological assessment, examination of DS Age SS is an efficient means of detecting negative response bias.	[Whitney, Kriscinda A.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Whitney, Kriscinda A.; Shepard, Polly H.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Davis, Jeremy J.; Bertram, David M.] Univ Indianapolis, Indianapolis, IN 46227 USA; [Shepard, Polly H.] Profess Psychol Serv, Indianapolis, IN USA; [Adams, Kenneth M.] Univ Michigan Hlth Syst, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA		Whitney, KA (corresponding author), Richard L Roudebush VAMC 116P, 1481 W 10th St, Indianapolis, IN 46202 USA.	kamarks@iupui.edu					Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butters N., 1980, ALCOHOLIC KORSAKOFFS; CERMAK LS, 1972, NEUROPSYCHOLOGIA, V10, P89, DOI 10.1016/0028-3932(72)90045-0; Devilly G. J., 2004, EFFECT SIZE GENERATO; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lipsey MW., 1990, DESIGN SENSITIVITY; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; *VET BEN ADM, 2006, SUMM BEN VA PAMPHL 2; Warrington E., 1973, PHYSL BASIS MEMORY, P365; Wechsler D., 1981, WAIS R MANUAL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL	39	14	14	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2009	24	3					263	272		10.1093/arclin/acp034			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	483WJ	WOS:000269001900008	19617596	Bronze, Green Published			2022-02-06	
J	Lahoud-Rahme, MS; Stezoski, J; Kochanek, PM; Melick, J; Tisherman, SA; Drabek, T				Lahoud-Rahme, Manuella S.; Stezoski, Jason; Kochanek, Patrick M.; Melick, John; Tisherman, Samuel A.; Drabek, Tomas			Blood-brain barrier integrity in a rat model of emergency preservation and resuscitation	RESUSCITATION			English	Article						Cardiopulmonary bypass; Deep hypothermic circulatory arrest; Cardiac arrest; Traumatic brain injury; Hemorrhage	PROLONGED CARDIAC-ARREST; HYPOTHERMIC CIRCULATORY ARREST; CARDIOPULMONARY BYPASS; DELAYED RESUSCITATION; SUSPENDED ANIMATION; PERMEABILITY; INJURY; ACCUMULATION; DYSFUNCTION; EXPRESSION	Emergency Preservation and Resuscitation (EPR) represents a novel approach to treat exsanguination cardiac arrest (CA) Victims, using an aortic flush to induce hypothermia during circulatory arrest, followed by delayed resuscitation with cardiopulmonary bypass (CPB). The status of the blood-brain barrier (BBB) integrity after prolonged hypothermic CA is unclear. The objective of this study was to assess BBB permeability in two EPR models in rats, associated with poor outcome. Rats subjected to traumatic brain injury (TBI) and naive rats served as positive and negative controls, respectively. Hypothesis: The BBB will be disrupted after TBI, but intact after prolonged hypothermic CA. Methods: Four groups were studied: (1) EPR-IC (ice cold)-75 min CA at 15 degrees C; (2) EPR-RT (room temperature)-20 min CA at 28 degrees C; (3) TBI; (4) sham. Rats in EPR groups were subjected to rapid hemorrhage, followed by CA. Rats in the TBI group had a controlled cortical impact to the left hemisphere. Naives were subjected to the same anesthesia and surgery. I h after insult, rats were injected with Evans Blue (EB), a marker of BBB permeability for albumin. Rats were sacrificed after 5 h and EB absorbance was quantified in brain samples. Results: TBI produced an approximately 10-fold increase in EB absorbance in the left (injured) hemisphere vs. left hemisphere for all other groups (p = 0.001). In contrast, EB absorbance in either EPR group did not differ from sham. Conclusion: BBB integrity to albumin is not disrupted early after resuscitation from prolonged CA treated with EPR. Neuroprotective adjuncts to hypothermia in this setting should focus on agents that penetrate the BBB. These findings also have implications for deep hypothermic circulatory arrest. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Lahoud-Rahme, Manuella S.; Stezoski, Jason; Kochanek, Patrick M.; Melick, John; Tisherman, Samuel A.; Drabek, Tomas] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Lahoud-Rahme, Manuella S.; Kochanek, Patrick M.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Drabek, Tomas] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Stezoski, Jason; Kochanek, Patrick M.; Melick, John; Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA		Drabek, T (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	tomasdrabek@hotmail.com	Kochanek, Patrick M/D-2371-2015; Drabek, Tomas/AAJ-1595-2021; Tisherman, Samuel A./AAK-9377-2020	Kochanek, Patrick M/0000-0002-2627-913X; Drabek, Tomas/0000-0002-5702-4498; Tisherman, Samuel A./0000-0003-3810-3729	Department of Anesthesiology, University of PittsburghUniversity of Pittsburgh; Laerdal Foundation for Acute Medicine; Society of Cardiovascular Anesthesiologists; American Heart AssociationAmerican Heart Association	This work was supported by a Seed Grant from the Department of Anesthesiology, University of Pittsburgh (TD), the Laerdal Foundation for Acute Medicine (TD), and the Society of Cardiovascular Anesthesiologists (TD). This paper was presented at the 2008 Fellows Research Day of the American Heart Association, Pennsylvania-Delaware Affiliate on February 22, 2008. Based on the abstract of this work, Dr. Manuella-Lahoud Rahme received a Young Investigator Award at the 6th Resuscitation Science Symposium, organized by the American Heart Association in New Orleans in November 2008.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; ARAI T, 1981, CRIT CARE MED, V9, P444; Behringer W, 2002, J CEREBR BLOOD F MET, V22, P105, DOI 10.1097/00004647-200201000-00013; Bellamy R, 1996, CRIT CARE MED, V24, pS24; BEUKE L, 2008, ANESTH ANALG, pSCA39; BREGMAN D, 1980, AM J CARDIOL, V46, P261, DOI 10.1016/0002-9149(80)90067-3; Cavaglia M, 2004, ANN THORAC SURG, V78, P1418, DOI 10.1016/j.athoracsur.2004.04.036; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; DOBBIN J, 1989, J CEREBR BLOOD F MET, V9, P71, DOI 10.1038/jcbfm.1989.10; Drabeck T, 2007, CRIT CARE MED, V35, pA91; DRABEK T, 2007, ANESTHESIOLOGY, V107, pA1574; Drabek T, 2007, RESUSCITATION, V75, P114, DOI 10.1016/j.resuscitation.2007.03.012; GILLINOV AM, 1992, J THORAC CARDIOV SUR, V104, P1110; GRIFFIN MP, 1990, CIRC SHOCK, V31, P343; Han F, 2008, RESUSCITATION, V79, P301, DOI 10.1016/j.resuscitation.2008.06.004; HARRIS DN, 1993, LANCET, V342, P586, DOI 10.1016/0140-6736(93)91412-F; Harris DNF, 1998, ANESTHESIOLOGY, V88, P340, DOI 10.1097/00000542-199802000-00011; Kapuscinski A, 1996, FOLIA NEUROPATHOL, V34, P72; KAPUSCINSKI A, 1995, FOLIA NEUROPATHOL, V33, P1; Kozler P, 2003, PHYSIOL RES, V52, P607; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; Laursen H, 1989, Eur J Cardiothorac Surg, V3, P539, DOI 10.1016/1010-7940(89)90115-2; LAURSEN H, 1986, SCAND J THORAC CARD, V20, P161, DOI 10.3109/14017438609106495; Leach L, 2002, J ANAT, V200, P539, DOI 10.1046/j.1469-7580.2002.00067.x; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P483, DOI 10.1152/ajplegacy.1976.231.2.483; Mazzini GS, 2005, LIFE SCI, V77, P882, DOI 10.1016/j.lfs.2004.12.035; MEYER J, 1993, CRIT CARE MED, V21, P84, DOI 10.1097/00003246-199301000-00017; Mizushima H, 1999, LIFE SCI, V65, P2127, DOI 10.1016/S0024-3205(99)00477-4; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Pluta R, 2003, ACT NEUR S, V86, P117; Pokela M, 2000, SCAND CARDIOVASC J, V34, P570; PONT F, 1995, NEUROSCI LETT, V184, P52, DOI 10.1016/0304-3940(94)11166-G; ROGERS FB, 1993, J TRAUMA, V34, P142, DOI 10.1097/00005373-199301000-00027; Safar P, 2000, CRIT CARE MED, V28, pN214, DOI 10.1097/00003246-200011001-00012; Safar Peter J, 2002, Curr Opin Anaesthesiol, V15, P203, DOI 10.1097/00001503-200204000-00010; SCHLEIEN CL, 1990, STROKE, V21, P1185, DOI 10.1161/01.STR.21.8.1185; SCHLEIEN CL, 1991, STROKE, V22, P477, DOI 10.1161/01.STR.22.4.477; Statler KD, 2003, CRIT CARE MED, V31, P1134, DOI 10.1097/01.CCM.0000054864.43122.52; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Suzuki T, 2005, CRIT CARE MED, V33, P2294, DOI 10.1097/01.CCM.0000182796.11329.3B; WAABEN J, 1994, EUR J CARDIO-THORAC, V8, P91, DOI 10.1016/1010-7940(94)90099-X; WAABEN J, 1994, J THORAC CARDIOV SUR, V107, P1030, DOI 10.1016/S0022-5223(94)70377-9; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204	47	14	15	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2009	80	4					484	488		10.1016/j.resuscitation.2009.01.007			5	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	429UZ	WOS:000264946900018	19203824				2022-02-06	
J	Gomez, R; O'Keeffe, T; Chang, LY; Huebinger, RM; Minei, JP; Barber, RC				Gomez, Ruben; O'Keeffe, Terence; Chang, Ling-Yu; Huebinger, Ryan M.; Minei, Joseph P.; Barber, Robert C.			Association of Mitochondrial Allele 4216C With Increased Risk for Complicated Sepsis and Death After Traumatic Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	67th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Meeting of the Association-for-Acute-Medicine	SEP 24-27, 2008	Maui, HI	Amer Assoc Surg Trauma, Assoc Acute Med		Mitochondrial electron-transport-chain; Mitochondrial polymorphism; Posttraumatic sepsis; Posttraumatic death; Genetic association; Complex I; ND1	PARKINSONS-DISEASE; DYSFUNCTION; POLYMORPHISMS; EPIDEMIOLOGY; MORTALITY; NETWORKS; LINKAGE; VARIANT	Objectives: Numerous studies have linked impaired mitochondrial activity with increased risk for clinical complications after injury. Furthermore, a number of nonsynonymous polymorphisms have been identified within the mitochondrial genome that are believed to impair cellular respiration. These DNA variants include a nonsynonymous polymorphism (T4216C) in the NADH dehydrogenase 1 gene (ND1), which encodes a key member of Complex I of the electron transport chain. We hypothesized that trauma patients who carry the ND1 4216C allele may be less able to generate the cellular energy necessary to mount an effective immune response and are at increased risk for death as well as sepsis complicated by organ dysfunction or shock. Methods: We enrolled a cohort of 136 patients admitted to the Parkland Hospital Surgical intensive care unit (ICU) with significant trauma (Injury Severity Score ? 16), >= 16 years of age, and with a minimum intensive care unit stay of ?24 hours under a protocol approved by the UTSW and Parkland IRBs. Patients with brain death, spinal cord injury, active malignancy, HIV/AIDS or who survived <48 hours after admission were excluded. Clinical data were collected prospectively and T4216C was genotyped by polymerase chain reaction-restriction fragment length polymorphism. Results: After multivariate adjustment for mechanism, severity of injury, units of packed red blood cells given in the first 24 hours, age, gender,, and race/ethnicity, carriage of the 4216 C-allele was significantly associated with increased risk for sepsis complicated by organ dysfunction or septic shock (adjusted odds ratio [aOR] = 3.68; 95% CI: 1.17-11.52; p = 0.02) as well as death (aOR = 4.56; 95% CI: 1.05-19.79; p = 0.04), relative to carriers of the T-allele. Conclusion: Carriage of the mitochondrial 4216C-allele increases the risk for infectious complications and death after severe trauma.	[Gomez, Ruben; O'Keeffe, Terence; Chang, Ling-Yu; Huebinger, Ryan M.; Minei, Joseph P.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA		Barber, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.barber@utsouthwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM021681] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P50 GM21681-42, 5T32 GM00859313] Funding Source: Medline		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annest G.W, 2001, MMWR SURVEILL SUMM, V53, P1; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Barber RC, 2008, SHOCK, V29, P38; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barber RC, 2007, J BURN CARE RES, V28, P205, DOI 10.1097/BCR.0B013E318031A1BF; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Canter JA, 2007, ANN SURG, V246, P406, DOI 10.1097/SLA.0b013e3181469955; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Hofmann S, 1997, AM J HUM GENET, V60, P1539; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Imahara Scott D, 2004, Curr Opin Crit Care, V10, P318, DOI 10.1097/01.ccx.0000140942.42247.7e; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Kudsk K A, 1994, Nutr Clin Pract, V9, P165, DOI 10.1177/0115426594009005165; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; Militsa B, 2001, Neurol India, V49 Suppl 1, pS75; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Sigalet DL, 2004, CAN J SURG, V47, P109; Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Velez DR, 2008, MITOCHONDRION, V8, P130, DOI 10.1016/j.mito.2007.10.007	33	14	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2009	66	3					850	857		10.1097/TA.0b013e3181991ac8			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	419ZU	WOS:000264259000042	19276764				2022-02-06	
J	Hayashi, N				Hayashi, Nariyuki			Management of Pitfalls for the Successful Clinical Use of Hypothermia Treatment	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	2nd International Brain Hypothermia Symposium	OCT, 2007	Miami Beach, FL			clinical management of CNS injury; hypothermia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ACUTE HYPERKETONEMIA; DOPAMINE; ISCHEMIA; GLUTAMATE; RELEASE	Therapeutic hypothermia is a promising method for controlling intracranial pressure (ICP) in severely brain-injured patients. However, clinical data regarding the effect of brain hypothermia on overall outcome of these patients is limited. This may be because there are specific pitfalls associated with the clinical management of induced hypothermia in patients with severe traumatic brain injury (TBI). These pitfalls may be avoided by preventing specific risk factors when cooling is induced and with rewarming. However, these risk factors have not been well systematically discussed in the literature. In this paper, three categories of clinical issues regarding the management of brain hypothermia are discussed: (1) stress-induced secondary brain injury mechanisms; (2) technical aspects of intensive care unit (ICU) cooling management; and (3) rewarming rates and methods. For patients with a Glasgow Coma Scale (GCS) score of less than 8, management of stress-induced insulin-resistant hyperglycemia, and unstable systemic circulation due to impaired cardiac contractility are especially important. For example, in our experience, posttraumatic hyperglycemia, exacerbated by cooling, may be ameliorated by the administration of a ketone body with mannitol. Prevention of selective free radical damage to neurons is also an important target for successful brain hypothermia treatment. Taken together, it is clear that several orchestrated steps should be initiated to enhance the protective effects of hypothermia therapy and prevent these possible pitfalls.	[Hayashi, Nariyuki] Nihon Univ, Dept Life Sci, Adv Res Inst Sci & Humanity, Tokyo, Japan		Hayashi, N (corresponding author), 6F Ichigaya Tokyu Bldg 2-1 Kudan,Kita 4 Chome Chi, Tokyo 1020073, Japan.	hayashi-nariyuki@arish.nihon-u.ac.jp					*AM HEART ASS, 2002, CIRCULATION, V11, P1; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; BOELS PJ, 1985, EXPERIENTIA, V41, P1374, DOI 10.1007/BF01949995; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dietrich W, 1991, J CEREB BLOOD FLO S2, V11, pS846; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dudariev V P, 1999, Fiziol Zh, V45, P97; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746, DOI 10.1152/ajpendo.1996.270.5.E746; Hayashi N, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P328, DOI 10.1007/4-431-28576-8_49; Hayashi N, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P124, DOI 10.1007/4-431-28576-8_20; Hayashi N, 1999, CELL MOL NEUROBIOL, V19, P3, DOI 10.1023/A:1006918722029; HAYASHI N, 2004, BRAIN HYPOTHERMIA TR, P37; HAYASHI N, 2008, SHIKOU NO KAITAI SHI, P67; Insel TR, 1998, ADV EXP MED BIOL, V449, P215; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P247; Kerendi F, 2005, J THORAC CARDIOV SUR, V130, P1079, DOI 10.1016/j.jtevs.2005.05.045; KUBULUS D, 2001, BRIT J SURG, V92, P1432; MORIN PJR, 2005, BIOCHIM BIOPHYS ACTA, V25, P32; MORRIS J, 2004, HUMAN BRAIN FUNCTION, P36; Pan JW, 2001, J NEUROCHEM, V79, P539, DOI 10.1046/j.1471-4159.2001.00575.x; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Phelps EA, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1005; Portas C, 2004, HUMAN BRAIN FUNCTION, P269; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SILVKA A, 1985, J BIOL CHEM, V260, P15466; Tranel D, 1995, NEUROSCIENCE MED, P555; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602	31	14	15	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2009	26	3					445	453		10.1089/neu.2008.0648			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	420ZO	WOS:000264327900020	19292696				2022-02-06	
J	Kochanek, PM; Drabek, T; Tisherman, SA				Kochanek, Patrick M.; Drabek, Tomas; Tisherman, Samuel A.			Therapeutic Hypothermia: The Safar Vision	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	2nd International Brain Hypothermia Symposium	OCT, 2007	Miami Beach, FL			cerebrospinal fluid; clinical trial; glia cell response to injury; human studies; hypothermia; pediatric brain injury; regeneration; stem cells; therapeutic approaches for the treatment of CNS injury; traumatic brain injury; traumatic spinal cord injury	GLOBAL BRAIN ISCHEMIA; CARDIAC-ARREST; HEMORRHAGIC-SHOCK; MILD HYPOTHERMIA; EMERGENCY PRESERVATION; CEREBRAL RESUSCITATION; SYSTEMIC HYPOTHERMIA; PROFOUND HYPOTHERMIA; CIRCULATORY ARREST; FLUID PRESSURE	At the 2(nd) International Brain Hypothermia conference, in Miami, the late Dr. Peter Safar was honored for his many contributions to the field of therapeutic hypothermia. Therapeutic hypothermia played a central role in his overall vision for optimized resuscitation and neurointensive care, across a large number of potential insults. The successful use of therapeutic hypothermia in comatose patients after cardiac arrest, for example, was already included in the historic first "ABCs'' of resuscitation, published by Safar in 1964. This review addresses key historical events in the development and implementation of therapeutic hypothermia across a number of central nervous system insults. A discussion of future potential uses of this therapy in a variety of applications as part of the Safar vision is also presented.	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Drabek, Tomas] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Tisherman, Samuel A./AAK-9377-2020; Kochanek, Patrick M/D-2371-2015; Drabek, Tomas/AAJ-1595-2021	Tisherman, Samuel A./0000-0003-3810-3729; Kochanek, Patrick M/0000-0002-2627-913X; Drabek, Tomas/0000-0002-5702-4498	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318, P01NS030318, R01NS038087] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38087, R01 NS038087, NS 30318, R01 NS038087-01A1, P01 NS030318, P01 NS030318-160010, R01 NS038087-09] Funding Source: Medline		Albin M S, 1965, Surg Forum, V16, P423; Behringer W, 2003, CRIT CARE MED, V31, P1523, DOI 10.1097/01.CCM.0000063450.73967.40; Behringer W, 2000, ANESTHESIOLOGY, V93, P1491, DOI 10.1097/00000542-200012000-00022; CONN AW, 1979, PEDIATR CLIN N AM, V26, P691; CRIPPEN D, 1991, RESUSCITATION, V21, P271, DOI 10.1016/0300-9572(91)90052-Z; Drabek T, 2007, CRIT CARE MED, V35, P532, DOI 10.1097/01.CCM.0000253398.61666.0D; GISVOLD SE, 1984, STROKE, V15, P803, DOI 10.1161/01.STR.15.5.803; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; LARREY DJ, 1814, MEMOIRS MILITARY SUR, V1; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Nozari A, 2004, CRIT CARE MED, V32, P2110, DOI 10.1097/01.CCM.0000142700.19377.AE; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; PHELPS C, 1897, CLASSICS NEUROLOGY N, P223; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; REICH H, 1990, ANN EMERG MED, V19, P887, DOI 10.1016/S0196-0644(05)81562-8; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19, DOI 10.1152/ajplegacy.1955.183.1.19; ROSOMOFF HL, 1965, RESP THERAPY, P244; SAFAR P, 1978, CRIT CARE MED, V6, P215, DOI 10.1097/00003246-197807000-00003; Safar P, 2003, ANN EMERG MED, V41, P887, DOI 10.1067/mem.2003.215; SAFAR P, 1964, J Iowa Med Soc, V54, P629; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; TISHERMAN SA, 1990, J TRAUMA, V30, P836, DOI 10.1097/00005373-199007000-00014; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; Tortorici MA, 2006, CRIT CARE MED, V34, P785, DOI 10.1097/01.CCM.0000201899.52739.4F; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Wu XR, 2008, J CEREBR BLOOD F MET, V28, P302, DOI 10.1038/sj.jcbfm.9600524; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204; Wu XR, 2002, J TRAUMA, V53, P654, DOI 10.1097/00005373-200210000-00006; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085	37	14	20	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2009	26	3					417	420		10.1089/neu.2008.0612			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	420ZO	WOS:000264327900016	19271966	Green Accepted, Green Published			2022-02-06	
J	Furlan, JC; Fehlings, MG				Furlan, Julio C.; Fehlings, Michael G.			Attitudes toward the Elderly with CNS Trauma: A Cross-Sectional Study of Neuroscientists, Clinicians, and Allied-Health Professionals	JOURNAL OF NEUROTRAUMA			English	Article						ageism; aging; cross-sectional study; elderly	SPINAL-CORD-INJURY; BRAIN-INJURY; PROGESTERONE TREATMENT; OLD-PEOPLE; AGED MICE; HIPPOCAMPUS; OUTCOMES; YOUNG; RELIABILITY; SECONDARY	Despite the potential impact of ageist attitudes on outcomes of central nervous system (CNS)-injured patients, little has been reported on this issue. Given this, we sought to conduct a questionnaire-based survey to assess the attitudes toward the elderly among basic and clinical neuroscientists, clinicians, and allied-health professionals whose research or medical practice is focused on neurotrauma. We also reviewed all abstracts presented in the National Neurotrauma Symposia from 1984 to 2007 and identified previous studies on the potential effects of age/aging on outcomes. The Kogan's Old People (KOP) scale was used to assess attitudes toward elderly individuals among all members of the National Neurotrauma Society (NNS). Of the 504 registered members, 137 subjects completed the survey that was re-mailed for non-respondents 4 weeks apart. There were no significant differences between respondents of the first and second mailings regarding their demographic and professional profiles or regarding their responses. These results support the validity of our findings in spite of the relatively low mail survey response rate (27.2%). Female gender was significantly associated with more positive attitudes toward old people compared to males. Clinicians showed significantly fewer negative attitudes toward old people in comparison with basic and clinical neuroscientists. Of the 4,194 abstracts reviewed, we identified only 44 studies (1.05%) that were explicitly focused on the effects of aging/old age on neurotrauma. In conclusion, our questionnaire-based survey, which appears to be representative of the population of interest, recognized significant differences in the attitudes toward old people among various professional groups and between male and female professionals. These findings may reflect a lack of knowledge and misconceptions regarding the impact of aging and old age on outcomes after CNS trauma. Further research on the impact of aging on outcomes after neurotrauma is required. Moreover, knowledge translation and mobilization appears required to positively influence attitudes among neuroscience research and clinical professionals regarding the issues of neurotrauma and the elderly.	[Furlan, Julio C.; Fehlings, Michael G.] Univ Hlth Network, Div Genet & Dev, Toronto Western Res Inst, Toronto, ON M5T S8, Canada; [Fehlings, Michael G.] Univ Hlth Network, Spinal Program, Krembil Neurosci Ctr, Toronto Western Hosp, Toronto, ON M5T S8, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada		Furlan, JC (corresponding author), Univ Hlth Network, Div Genet & Dev, Toronto Western Res Inst, 399 Bathurst St,McL 12-407, Toronto, ON M5T S8, Canada.	jfurlan@gmail.com	; Furlan, Julio/Q-8290-2018	Fehlings, Michael/0000-0002-5722-6364; Furlan, Julio/0000-0002-2038-0018	National Neurotrauma Society; The Toronto General and Western Hospital Foundation; Henry A. Beatty Scholarship; Krembil Chair in Neural Repair and Regeneration	We gratefully acknowledge Professor Kogan for kindly permitting us to use his outcome measure instrument. We also thank Linda Garcia for secretarial assistance and all members of the National Neurotrauma Society who completed the questionnaire-based survey. This work was supported by a Lawson Neurology Fellowship from The Toronto General and Western Hospital Foundation (J.C.F.), the Henry A. Beatty Scholarship (J.C.F.) and the Krembil Chair in Neural Repair and Regeneration (M. G. F.).	Adkins RH, 2004, NEUROREHABILITATION, V19, P3; BACKMAN C, 1995, J NEUROTRAUM, V12, P981; Bugeja G, 1997, BRIT MED J, V315, P1059, DOI 10.1136/bmj.315.7115.1059; Cekic M, 2007, J NEUROTRAUM, V24, P1262; Chaovipoch P, 2005, J NEUROTRAUM, V22, P1241; Colello RJ, 2003, J NEUROTRAUM, V20, P1124; Coleman WP, 2003, J NEUROTRAUM, V20, P1063; Cutler S, 2006, J NEUROTRAUM, V23, P996; Dobriansky P.J., 2007, WHY POPULATION AGING, P1; FEHLINGS MG, 2002, J NEUROTRAUM, V19, P1388; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Foroughi A., 2000, Journal of Neurotrauma, V17, P970; Fowler, 2013, SURV RES METHODS-GER; FOWLER JH, 1999, J NEUROTRAUM, V16, P1001; Fugaccia I, 2003, J NEUROTRAUM, V20, P1086; Furlan JC, 2005, J NEUROTRAUM, V22, P1215; Furlan JC, 2004, J NEUROTRAUM, V21, P1321; Furlan J, 2007, J NEUROTRAUM, V24, P1257; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Gallagher S., 2006, INT J NURS PRACT, V12, P273, DOI [10.1111/j.1440-172X.2006.00582.x, DOI 10.1111/J.1440-172X.2006.00582.X]; Geisler FH, 2004, J NEUROTRAUM, V21, P1341; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; Gilmer LK, 2006, J NEUROTRAUM, V23, P1004; GOLDSTEIN FC, 1994, J NEUROTRAUM, V12, P119; GORMAN LK, 1995, J NEUROTRAUM, V12, P971; Gorrie CA, 2004, J NEUROTRAUM, V21, P1314; GWAK YS, 2002, J NEUROTRAUM, V19, P1388; HAIGHT BK, 1994, J ADV NURS, V20, P382, DOI 10.1046/j.1365-2648.1994.20020382.x; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hawkins BE, 2005, J NEUROTRAUM, V22, P1181; HESSE KA, 1984, J AM GERIATR SOC, V32, P747, DOI 10.1111/j.1532-5415.1984.tb04174.x; Hikmet N, 2003, INT J MED INFORM, V72, P29, DOI 10.1016/j.ijmedinf.2003.09.002; HORSBURGH K, 1995, J NEUROTRAUM, V12, P972; Hurley SD, 2005, J NEUROTRAUM, V22, P1206; HURLEY SD, 2001, J NEUROTRAUM, V18, P1142; Kearney N, 2000, ANN ONCOL, V11, P599, DOI 10.1023/A:1008327129699; KOGAN N, 1961, J ABNORM SOC PSYCH, V62, P44, DOI 10.1037/h0048053; KUMEKICK J, 1994, J NEUROTRAUM, V12, P128; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LASLEY LA, 2002, J NEUROTRAUM, V19, P1328; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; LIFSHITZ J, 2002, J NEUROTRAUM, V19, P1359; Lim PAC, 2007, ANN ACAD MED SINGAP, V36, P49; MacDowell N M, 1999, J Allied Health, V28, P212; Marklund N, 2005, J NEUROTRAUM, V22, P1229; McArthur DL, 2004, J NEUROTRAUM, V21, P1293; McKinley W, 2003, NEUROREHABILITATION, V18, P83; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; NICHOLS JS, 1995, J NEUROTRAUM, V12, P133; *NNS, 2008, MISS STAT NAT NEUR S; Onyszchuk G, 2007, J NEUROTRAUM, V24, P1269; Onyszchuk G, 2006, J NEUROTRAUM, V23, P999; Palmore Erdman B, 2004, J Cross Cult Gerontol, V19, P41, DOI 10.1023/B:JCCG.0000015098.62691.ab; Panizzon K, 2007, J NEUROTRAUM, V24, P1253; Penson RT, 2004, ONCOLOGIST, V9, P343, DOI 10.1634/theoncologist.9-3-343; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; PIERCE JES, 1995, J NEUROTRAUM, V12, P964; ROZZINE R, 2003, AGE AGEING, V32, P517; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sadler J, 2005, CRIT CARE, V9, P314, DOI 10.1186/cc3785; Sandhir R, 2007, J NEUROTRAUM, V24, P1237; SCHEFF SW, 2002, J NEUROTRAUM, V19, P1340; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shah SA, 2004, J NEUROTRAUM, V21, P1299; SHEPHERD MD, 1983, AM J PHARM EDUC, V47, P35; Soderhamn O, 2000, SCAND J CARING SCI, V14, P211, DOI 10.1080/028393100300006799; Soderhamn O, 2001, NURS EDUC TODAY, V21, P225, DOI 10.1054/nedt.2000.0546; SOIZA RL, 2003, AGE AGEING, V32, P413; Stulemeijer M, 2006, J NEUROTRAUM, V23, P997; Swan A, 2007, J NEUROTRAUM, V24, P1238; Tasaki O, 2005, J NEUROTRAUM, V22, P1247; THIBEAULT SL, 1994, J NEUROTRAUM, V11, P129; Tokutomi T, 2005, J NEUROTRAUM, V22, P1200; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; *US BUR CENS, 2003, NAT POP EST CHAR; Whiteneck GG, 2001, AM J PHYS MED REHAB, V80, P305, DOI 10.1097/00002060-200104000-00017; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	77	14	15	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					209	225		10.1089/neu.2008.0663			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100004	19196075				2022-02-06	
S	Hayes, RL; Robinson, G; Muller, U; Wang, KKW		Ottens, AK; Wang, KKW		Hayes, Ronald L.; Robinson, Gillian; Muller, Uwe; Wang, Kevin K. W.			Translation of Neurological Biomarkers to Clinically Relevant Platforms	NEUROPROTEOMICS: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Biomarkers; Brain injury; Translational research; Assay development; Clinical trials	TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; TANDEM MASS-SPECTROMETRY; BASIC-PROTEIN ISOFORMS; METHAMPHETAMINE EXPOSURE; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; CALPAIN; NEUROPROTEOMICS; PROTEOLYSIS	Like proteomics more generally, neuroproteomics has recently been linked to the discovery of biochemical markets of central nervous system (CNS) injury and disease. Although neuroproteomics has enjoyed considerable success in discovery of candidate biomarkers, there arc a number of challenges facing investigators interested in developing clinically useful platforms to assess biomarkers for damage to the CNS. These challenges include intrinsic physiological complications such as the blood-brain barrier. Effective translation of biomarkers to clinical practice also requires development of entirely novel pathways and product development strategies. Drawing from lessons learned from applications of biomarkers to traumatic brain injury, this study outlines major elements of such a pathway. As with other indications, biomarkers can have three major areas of application: (1) drug development; (2) diagnosis and prognosis; (3) patient management. Translation of CNS biomarkers to practical clinical platforms raises a number of integrated elements. Biomarker discovery and initial selection needs to be integrated at the earliest stages with components that will allow systematic prioritization and triage of biomarker candidates. A number of important criteria need to be considered in selecting clinical biomarker candidates. Development of proof of concept assays and their optimization and validation represent an often overlooked feature of biomarker translational research. Initial assay optimization should confirm that assays can detect biomarkers in relevant clinical samples. Since access to human clinical samples is critical to identification of biomarkers relevant to injury and disease as well as for assay development, design of human clinical validation studies is an important component of translational biomarker research platforms. Although these clinical studies share much in common with clinical trials for assessment of drug therapeutic efficacy, there are a number of considerations unique to these efforts. Finally, platform selection and potential assay commercialization need to be considered. Decisions regarding whether or not to seek FDA approval also significantly influence translational research structures.	[Hayes, Ronald L.] Banyan Biomarkers Inc, Clin Dept, Ctr Innovat Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA		Hayes, RL (corresponding author), Banyan Biomarkers Inc, Clin Dept, Ctr Innovat Res, Alachua, FL USA.						Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Papa L., EXP OPIN MED DIAG, V2, P937; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schonberger SJ, 2001, PROTEOMICS, V1, P1519, DOI 10.1002/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707	22	14	14	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-934115-84-8	METHODS MOL BIOL	Methods Mol. Biol.		2009	566						303	313		10.1007/978-1-59745-562-6_20	10.1007/978-1-59745-562-6		11	Biochemical Research Methods; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BLU16	WOS:000271018600020					2022-02-06	
J	Jang, SH; Kim, DS; Son, SM; Cho, YW; Kim, SH; Kim, OL; Ahn, SH				Jang, Sung Ho; Kim, Dae-Shik; Son, Su Min; Cho, Yun Woo; Kim, Seong Ho; Kim, Oh Lyong; Ahn, Sang Ho			Clinical application of diffusion tensor tractography for elucidation of the causes of motor weakness in patients with traumatic brain injury	NEUROREHABILITATION			English	Article						Brain injury; diffusion tensor tractography; corticospinal tract; motor function	TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL TRACT; AXONAL INJURY; FUNCTIONAL MRI; RECOVERY; LOCALIZATION; INTEGRITY; TRACKING; FEATURES; ROUTINE	Diffusion tensor tractography (DTT) is useful for elucidating the status of the corticospinal tract (CST). The purpose of this study was to investigate the usefulness of DTT for determining the causes of motor weakness in patients with traumatic brain injury (TBI). Five patients with TBI were recruited for this study. DTT was performed using 1.5-T with a Synergy-L Sensitivity Encoding (SENSE) head coil. DTT was obtained with termination criteria of FA < 0.2 and an angle change > 45 degrees. On the DTT of patient 1, who had diffuse axonal injury, the focal lesion was detected in the left pons, and was not detected on routine brain images. In patients with deep cerebral hemorrhage, the integrity of the CST of patient 3 was preserved, although the lesion was more extensive than that of patient 2, who showed severe degeneration with the disruption of the CST at the lesion site. In patient 4, the integrity of the left CST was disrupted by a left transtentorial herniation. Although the CST of the affected hemisphere was connected at the cortex level in patient 5, who had a cortical contusional hemorrhage, the motor function of the lower extremity was worse than that of the upper extremity according to the involvement of the somatotopic area of the primary motor cortex. DTT would be useful in elucidating the causes of motor weakness in patients with TBI at the subcortical level, including conditions such as diffuse axonal injury, deep intracerebral hemorrhage, and transtentorial herniation.	[Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Sch Med, Taegu 705717, South Korea; [Kim, Dae-Shik] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kim, Seong Ho; Kim, Oh Lyong] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Sch Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net	Kim, Dae-Shik/C-2071-2011				Ahn YH, 2006, NEUROREHABILITATION, V21, P239; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Gossl C, 2002, NEUROIMAGE, V16, P378, DOI 10.1006/nimg.2002.1055; Han BS, 2007, NEUROREHABILITATION, V22, P151; Itoh D, 2006, J COMPUT ASSIST TOMO, V30, P618, DOI 10.1097/00004728-200607000-00011; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2007, J COMPUT ASSIST TOMO, V31, P901, DOI 10.1097/rct.0b013e31804089a6; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; Kim DG, 2007, NEUROREHABILITATION, V22, P273; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Macdonell RAL, 1999, NEUROLOGY, V53, P1462, DOI 10.1212/WNL.53.7.1462; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nguyen T, 2005, NEURORADIOLOGY, V47, P334, DOI 10.1007/s00234-005-1338-z; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; YORK DH, 1987, NEUROSURGERY, V20, P70; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	27	14	15	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	3					273	278		10.3233/NRE-2009-0478			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	452ZR	WOS:000266580200010	19458435				2022-02-06	
J	Ogino, T; Watanabe, K; Nakano, K; Kado, Y; Morooka, T; Takeuchi, A; Oka, M; Sanada, S; Ohtuska, Y				Ogino, Tatsuya; Watanabe, Kiyoko; Nakano, Kousuke; Kado, Yoko; Morooka, Teruko; Takeuchi, Akihito; Oka, Makio; Sanada, Satoshi; Ohtuska, Yoko			Predicting executive function task scores with the Rey-Osterrieth Complex Figure	BRAIN & DEVELOPMENT			English	Article						The Rey-Osterrieth Complex Figure Test; Boston Qualitative Scoring System; Executive function; Children; Pervasive developmental disorders; Attention-deficit/hyperactivity disorder	QUALITATIVE SCORING SYSTEM; TRAUMATIC BRAIN INJURY; CARD SORTING TEST; PERFORMANCE	The Boston Qualitative Scoring System (BQSS) is one of the scoring methods of the Rey-Osterrieth Complex Figure Test (ROCF). With BQSS, 17 qualitative ratings are generated, and subsequently 6 summary scores are calculated by combining several qualitative scores. Previously we showed that 5 of 6 BQSS summary scores were correlated with the scores of the several executive function tests in children. The objective of this study was to develop a new summary score which correlates with the executive function test scores more strongly than the existing summary scores. For this purpose, we conducted multiple regression analysis to predict PEN, CA, DSM of the Wisconsin Card Sorting Test Keio Version, and the Mazes scores from WISC-III, by the BQSS qualitative scores derived from ROCF drawings in copy condition. The subjects were 78 children with various neuropsychological disorders (5 years 5 months-14 years 11 months; mean: 9 years 2 months; F 22, M 56). Significant predictive models were generated for PEN, CA, and Mazes scores. Among them the models for the Mazes scores were the most accurate. The second model for the Mazes scores was most suitable for a new summary score. Its degree-of-freedom-adjusted coefficient of multiple determination and multiple correlation coefficient reached 0.467 and 0.695, respectively. A new summary score should be applied in future studies to evaluate its clinical usefulness. (C) 2008 Elsevier B.V. All rights reserved.	[Ogino, Tatsuya] Chugokugakuen Univ, Fac Children Studies, Dept Children Studies, Okayama 7010197, Japan; [Watanabe, Kiyoko; Morooka, Teruko; Takeuchi, Akihito; Oka, Makio; Ohtuska, Yoko] Okayama Univ, Dept Child Neurol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Nakano, Kousuke] Matsuyama Red Cross Hosp, Dept Pediat, Matsuyama, Ehime, Japan; [Kado, Yoko] Kansai Univ, Fac Letters, Dept Psychol, Osaka, Japan; [Sanada, Satoshi] Okayama Univ, Div Special Educat, Okayama, Japan		Ogino, T (corresponding author), Chugokugakuen Univ, Fac Children Studies, Dept Children Studies, Niwase 83, Okayama 7010197, Japan.	tatsu@cjc.ac.jp	Takeuchi, Akihito/I-8872-2019	Takeuchi, Akihito/0000-0003-4332-4075			Beebe DW, 2004, APPL NEUROPSYCHOL, V11, P91, DOI 10.1207/s15324826an1102_4; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Heaton PDRK., 1993, WISCONSIN CARD SORTI; KASHIMA H, 1993, SHINKEI KENKYU NO SH, V37, P93; Kirsch P, 2006, NEUROPSYCHOBIOLOGY, V54, P51, DOI 10.1159/000095742; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; Nagahama Y, 2003, DEMENT GERIATR COGN, V16, P103, DOI 10.1159/000070683; Nakano K, 2006, BRAIN DEV-JPN, V28, P641, DOI 10.1016/j.braindev.2006.04.011; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; Stern R., 1999, BOSTON QUALITATIVE S; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; Taylor E., 1959, PSYCHOL APPRAISAL CH; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007	16	14	14	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604			BRAIN DEV-JPN	Brain Dev.	JAN	2009	31	1					52	57		10.1016/j.braindev.2008.07.003			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	395QV	WOS:000262539500009	18723303				2022-02-06	
J	Ryu, WHA; Feinstein, A; Colantonio, A; Streiner, DL; Dawson, D				Ryu, Won Hyung A.; Feinstein, Anthony; Colantonio, Angela; Streiner, David L.; Dawson, Deirdre			Regional Variability in the Use of CT for Patients with Suspected Mild Traumatic Brain Injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							COMPUTED-TOMOGRAPHY; GUIDELINE	Objective: To investigate the use of computed tomography (CT) scans in patients with Suspected acute mild traumatic brain injury (mTBI) presenting to emergency departments. Method: 850 potential mTBI cases were identified through reviews of three months of health records from nine selected emergency departments across the province of Ontario. Records for review were selected using the International Classification of Disease, 9th revision. Clinical Modification codes and Injury codes. Results: Patients who received head CT were significantly older (p<0.01), had documented loss-of-consciousness (LOC) &/or Post-Traumatic Amnesia (PTA) (p<0.001), documented nausea (P<0.01), documented vomiting, (p<0.001), abnormal neurological exam results (p<0.01), had visited an urban center (p<0.001). and/or arrived by ambulance (p<0.001). The significant predictors of CT scan prescription (in a forward stepwise logistic repression) were urban location of hospital (OR=5.14; p <= 0.001) LOC &/or PTA (OR=4.83; p <= 0.001), vomiting (OR=2.56; p <= 0.01). arrival by ambulance (OR=2.15; p <= 0.001). nausea (OR=1.92; p=<= 0.02) and older age (OR=1.02; p <= 0.01). Conclusion: These data extend our knowledge regarding the use of CT during acute diagnosis and management of suspected mTBI patients. In addition to confirming previously reported risk factors of intracranial complication. geographical location of hospital and arrival Mode Were found to be significant predictors of CT use. The results suggest that the management patterns for acute mTBI are inconsistent. The implications Of this are discussed.	[Ryu, Won Hyung A.; Streiner, David L.; Dawson, Deirdre] Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; [Colantonio, Angela; Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ryu, Won Hyung A.; Colantonio, Angela; Dawson, Deirdre] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Feinstein, Anthony; Streiner, David L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Ryu, Won Hyung A.; Colantonio, Angela; Dawson, Deirdre] Toronto Rehabil Inst, Toronto, ON, Canada		Dawson, D (corresponding author), Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.		Dawson, Deirdre R/I-8882-2014; Streiner, David/E-6563-2011; Ryu, Won H/AAU-6774-2020	Dawson, Deirdre R/0000-0001-7517-6121; Streiner, David/0000-0003-0610-6271; Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ontario Ministry of Training, Colleges and Universities (OGS)Ontario Graduate Scholarship; BaycrestUniversity of Toronto; Toronto Rehabilitation InstituteUniversity of Toronto; University of TorontoUniversity of Toronto; participating hospitals	This research was made possible by a grant from the Ontario Neurotrauma Foundation to Dr. D. Dawson and Dr. A. Feinstein. Won Hyung A. Ryu was supported by fellowships from Canadian Institutes of Health Research (CIHR), Ontario Ministry of Training, Colleges and Universities (OGS), Baycrest, Toronto Rehabilitation Institute, and University of Toronto. The authors also gratefully acknowledge the support of the participating hospitals, and our research assistants: A. Hatvani, K. Kit. T. Koscik, K. Krpan, S. Mack, K. Menezes, M. Peer, and M. Rvan, and thank Dr. P. Verhoeff and Dr. J. Ween for reviewing earlier versions of this manuscript.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Goel V, 1996, PATT HLTH CAR ONT; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hebb MO, 2007, CAN J SURG, V50, P187; ISCOE NA, 1994, CAN MED ASSOC J, V150, P345; Kelly JP, 1997, NEUROLOGY, V48, P581; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Norman G, 2000, BIOSTATISTICS BARE E; *ONT HOSP ASS, ONT HOSP ASS REG; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wennberg J E, 1984, Health Aff (Millwood), V3, P6, DOI 10.1377/hlthaff.3.2.6; 1992, CMAJ, V146, P467; 2006 CENSUS	20	14	14	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2009	36	1					42	46		10.1017/S0317167100006296			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	396TJ	WOS:000262613800010	19294887	Bronze			2022-02-06	
B	Thatcher, RW; Lubar, JF		Budzynski, TH; Budzynski, HK; Evans, JR; Abarbanel, A		Thatcher, Robert W.; Lubar, Joel F.			History of the scientific standards of QEEG normative databases	INTRODUCTION TO QUANTITATIVE EEG AND NEUROFEEDBACK: ADVANCED THEORY AND APPLICATIONS, 2ND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ELECTROMAGNETIC TOMOGRAPHY LORETA; TEST-RETEST RELIABILITY; NOISE COVARIANCE MODEL; SCHOOL-AGE CHILDREN; CLOSED-HEAD INJURY; QUANTITATIVE EEG; BIOPHYSICAL LINKAGE; COHERENCE; POWER		[Thatcher, Robert W.] Appl Neurosci Inc, EEG & NeuroImaging Lab, St Petersburg, FL USA; [Lubar, Joel F.] Univ Tennessee, Brain Res & Neuropsychol Lab, Knoxville, TN USA		Thatcher, RW (corresponding author), Appl Neurosci Inc, EEG & NeuroImaging Lab, St Petersburg, FL USA.						ADEY W R, 1964, Physiologist, V72, P65; Adey W. R., 1964, ANN NY ACAD SCI, V31, P844; ADEY WR, 1961, EXP NEUROL, V3, P501, DOI 10.1016/S0014-4886(61)80002-2; Arruda JE, 1996, INT J PSYCHOPHYSIOL, V23, P63, DOI 10.1016/0167-8760(96)00032-3; Berger H, 1934, ARCH PSYCHIAT NERVEN, V102, P538, DOI 10.1007/BF01813827; Berger H, 1932, ARCH PSYCHIAT NERVEN, V97, P6, DOI 10.1007/BF01815532; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Brazis PW., 2007, LOCALIZATION CLIN NE, V6th ed; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Cohen J, 1977, STAT POWER ANAL BEHA; Cooley W., 1971, MULTIVARIATE DATA AN; CorsiCabrera M, 1997, ELECTROEN CLIN NEURO, V102, P248, DOI 10.1016/S0013-4694(96)95179-6; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P100, DOI 10.1016/0013-4694(88)90205-2; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P64, DOI 10.1177/155005940503600205; Granger C.W.J., 1964, SPECTRAL ANAL EC TIM; Hagne I, 1973, AUTOMATION CLIN ELEC, P103; Hamilton-Bruce M A, 1991, Clin Exp Neurol, V28, P219; Harmony T, 1993, Int J Neurosci, V68, P263, DOI 10.3109/00207459308994281; Hayes W. L., 1973, STAT SOCIAL SCI; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY; Hellstrom-Westas L, 2005, EARLY HUM DEV, V81, P255, DOI 10.1016/j.earlhumdev.2005.01.006; Herscovitch P, 1994, FUNCTIONAL NEUROIMAG, P29; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hoffman D. A., 2006, Journal of Neurotherapy, V10, P57, DOI 10.1300/J184v10n01_05; Hoffman D. A., 1995, J NEUROTHERAPY, V1, P14, DOI [10.1300/ J184v01n01_03, DOI 10.1300/J184V01N01_03]; Hori J, 2001, ANN BIOMED ENG, V29, P436, DOI 10.1114/1.1366674; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Huizenga HM, 2002, IEEE T BIO-MED ENG, V49, P533, DOI 10.1109/TBME.2002.1001967; John E.R., 1987, HDB ELECTROENCEPHALO, P449; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; JOHN ER, 1977, FUNCTIONAL NEUROSCIE, V2; JOHN ER, 1990, MACHINERY MIND DATA; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011; Lubar JF, 2003, INT J PSYCHOPHYSIOL, V49, P175, DOI 10.1016/S0167-8760(03)00115-6; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; Machado C, 2004, CLIN EEG NEUROSCI, V35, P116, DOI 10.1177/155005940403500303; MAS F, 1993, CLIN ELECTROENCEPHAL, V24, P118, DOI 10.1177/155005949302400309; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; Matousek M., 1973, DIGITAL TIME SERIES, P75; Nunez P, 1981, ELECT FIELDS BRAIN; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Otnes RK, 1972, DIGITAL TIME SERIES; PASCUALMARQUI RD, 2001, J NEUROTHERAPY, V4, P35, DOI DOI 10.1300/J184V04N04_06; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Slewa-Younan S, 2002, CLIN NEUROPHYSIOL, V113, P1640, DOI 10.1016/S1388-2457(02)00239-0; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 2007, CLIN EEG NEUROSCI, V38, P35, DOI 10.1177/155005940703800109; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P116, DOI 10.1177/155005940503600211; Thatcher R. W., 2003, Journal of Neurotherapy, V7, P87, DOI 10.1300/J184v07n03_05; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher R W, 1995, J Neuroimaging, V5, P35; Thatcher R.W., 1998, DATABASES NEUROTHER, V2, P8, DOI [10.1300/j184v02n04_02, DOI 10.1300/J184V02N04_02]; Thatcher R. W., 2006, INT SOC NEURONAL REG; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher R. W., 2000, 8 ANN ISNR C ST PAUL; Thatcher R. W., 1983, COGNITIVE PROCESSING; Thatcher R. W., 2007, HUMAN BRAIN IN PRESS; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P1, DOI 10.1177/155005940503600103; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; THATCHER RW, 1994, FUNCTIONAL NEUROIMAG, P269; THATCHER RW, 1977, FDN COGNITIVE PROCES, V1; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Van Egren L., 1996, CLIN ELECTROENCEPHAL, V27, P164; von Bierbrauer A., 1993, EEG EMG Z ELEKTROENZ, V23, P151; Waldorp LJ, 2001, IEEE T BIO-MED ENG, V48, P737, DOI 10.1109/10.923793; Winer B.J., 1971, STAT PRINCIPLES EXPT	90	14	14	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-092315-4				2009							29	59		10.1016/B978-0-12-374534-7.00002-2			31	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BEO09	WOS:000317520800004					2022-02-06	
J	Till, C; Christensen, BK; Green, RE				Till, Christine; Christensen, Bruce K.; Green, Robin E.			Use of the Personality Assessment Inventory (PAI) in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Personality Assessment Inventory (PAI); validity; traumatic brain injury; self-report; neurologic symptoms	HEAD-INJURY; PSYCHIATRIC-DISORDERS; MMPI-2 INTERPRETATION; CROSS-VALIDATION; FOLLOW-UP; AXIS-I; DEPRESSION; RECOVERY; PSYCHOPATHOLOGY; POPULATION	Primary objective: To evaluate the extent to which the Personality Assessment Inventory (PAI) is confounded by symptoms that are transdiagnostic between psychopathology and neurological sequelae. Methods: Sixty-one adults with moderate-to-severe traumatic brain injury (TBI) completed the PAI over the first year post-injury. Items that discriminated brain-injured individuals from a normative sample were identified using effect size analyses and were then subjected to principal components analysis (PCA) with varimax rotation. To explore whether the items identified in the PCA may be considered transdiagnostic in nature, an expert rating task and correlations with objective outcome measures were employed. Results: Effect sizes analyses identified 21 items that discriminated adults with TBI from the normative sample. Eight items associated with component 1 of the PCA were considered to be transdiagnostic. These items reflected health concerns and thinking problems from the Somatic Complaints, Depression and Schizophrenia scales. Items belonging to the other components reflected behaviours that are commonly associated with TBI, but not considered transdiagnostic. Conclusion: Using a comprehensive and multi-modal approach, results demonstrated good convergent validity for a small sub-set of items as being transdiagnostic. Overall, the findings support the PAI as a useful measure of psychiatric and emotional disturbances among persons with TBI.	[Till, Christine] York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; [Till, Christine; Green, Robin E.] Univ Ctr, Toronto Rehabil Inst, Toronto, ON, Canada; [Christensen, Bruce K.] McMaster Univ, Dept Psychiat & Behav Neurosci, Toronto, ON, Canada; [Christensen, Bruce K.; Green, Robin E.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Green, Robin E.] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada		Till, C (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	ctill@yorku.ca		Till, Christine/0000-0001-5030-3155; Green, Robin/0000-0001-9451-3963			Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bagby RM, 2002, J PERS ASSESS, V78, P69, DOI 10.1207/S15327752JPA7801_05; Bowen A, 1999, BRAIN INJURY, V13, P547; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; Christensen BK, 1995, J INT NEUROPSYCH SOC, V1, P121; Cohen J., 1983, APPL MULTIPLE REGRES; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; FORER S, 1982, J ORGAN REHABIL EVAL, V2, P29; Gass CS, 1996, J CLIN PSYCHOL, V52, P569, DOI 10.1002/(SICI)1097-4679(199609)52:5<569::AID-JCLP12>3.0.CO;2-C; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Karlin BE, 2005, J CLIN PSYCHOL, V61, P1571, DOI 10.1002/jclp.20209; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; LaChapelle DL, 2005, APPL NEUROPSYCHOL, V12, P143, DOI 10.1207/S15324826AN1203_4; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morey, 1991, PERSONALITY ASSESSME; MOREY LC, 2003, ESSENTIALS PAI INTER; Nelson LD, 2003, ARCH CLIN NEUROPSYCH, V18, P419, DOI 10.1016/S0887-6177(02)00158-0; Novack TA, 2000, BRAIN INJURY, V14, P987; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; O'Connor Paul, 2006, Adv Neurol, V98, P227; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Piotrowski C, 2000, PSYCHOL REP, V86, P65, DOI 10.2466/PR0.86.1.65-66; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P359, DOI 10.1097/00001199-200507000-00007; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rayls KR, 2000, CLIN NEUROPSYCHOL, V14, P546, DOI 10.1076/clin.14.4.546.7194; Ruocco AC, 2007, BRAIN INJURY, V21, P1233, DOI 10.1080/02699050701716919; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Tabachnick B. G., 1989, USING MULTIVARIATE S; Tombough T., 1996, TEST MEMORY MALINGER; TUOKKO H, 1991, Brain Injury, V5, P287, DOI 10.3109/02699059109008098; Van Balen HGG, 1999, INT J REHABIL RES, V22, P249, DOI 10.1097/00004356-199912000-00001; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470	50	14	14	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	7-8					655	665	PII 912685420	10.1080/02699050902970794			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	462QL	WOS:000267370600010	19557569				2022-02-06	
J	Vikamaa, P; Makitie, AA; Railo, M; Tornwall, J; Alback, A; Lepantalo, M				Vikamaa, Pirkka; Makitie, Antti A.; Railo, Mikael; Tornwall, Jyrki; Alback, Anders; Lepantalo, Mauri			Midline mandibulotomy and interposition grafting for lesions involving the internal carotid artery below the skull base	JOURNAL OF VASCULAR SURGERY			English	Article							VERTICAL RAMUS OSTEOTOMY; RESECTION; EXPOSURE; ANEURYSMS; CANCER; TUMORS	Background: The distal part of the internal carotid artery (ICA) close to the skull base can be reached surgically with different approaches. Exposure using the standard lateral incision is eventually limited by bony structures which preclude the wide-angled operative field necessary for en bloc resection of tumors or primary vascular pathology that abuts the parapharyngeal space. In these unusual cases, use of a combined midline mandibulotomy and neck incision provides necessary operative exposure. Aim: We report our experience using combined midline mandibulotomy and neck incision for exposure of high carotid lesions. We also discuss different surgical and endovascular approaches in light of the literature. Patients and Methods. Five patients were operated on for high ICA lesions: 2 for malignant head and neck tumors, 1 for an extended paraganglioma, and 2 for large symptomatic ICA aneurysms. All ICAs were reconstructed with an autologous vein interposition graft and the distal anastomoses were performed within the most distal 3 cm of the ICA adjacent to the orifice of bony carotid canal. Results: All operations were technically successful with no operative mortality or strokes. One aneurysm patient and the paraganglioma patient had minimal long-term sequelae from this procedure. One patient with an extended lingual epidermoid carcinoma was recurrence free at 3.6 years. One aneurysm patient died due to aspiration pneumonia 30 days postoperatively and another patient had early recurrent tumor growth and died due to that after 15 months. Four patients (80%) suffered a major cranial nerve injury in the operation mainly due to the extensive nature of the disease process. Conclusion: Exposure of the distal carotid artery using midline mandibulotomy is rarely required. However, this technique represents an excellent option for cases of malignancies arising from the oral cavity which abut the carotid artery and instances in which primary carotid pathology extends medially alongside the parapharyngeal space. Performance of these cases should be accomplished by a multidisciplinary, surgical team comprised of head and neck and vascular specialists. High rates of cranial nerve deficits should be anticipated. (J Vasc Surg 2009;49:86-92.)	[Vikamaa, Pirkka; Railo, Mikael; Alback, Anders; Lepantalo, Mauri] Univ Helsinki, Cent Hosp, Dept Surg, Div Vasc Surg, FI-00029 Helsinki, Finland; [Makitie, Antti A.] Univ Helsinki, Cent Hosp, Div Otorhinolaryngol, FI-00029 Helsinki, Finland; [Tornwall, Jyrki] Univ Helsinki, Cent Hosp, Div Maxillofacial Surg, FI-00029 Helsinki, Finland		Vikamaa, P (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Div Vasc Surg, POB 340, FI-00029 Helsinki, Finland.	pirkka.vikatmaa@hus.fi					Alimi YS, 1996, J VASC SURG, V24, P249, DOI 10.1016/S0741-5214(96)70100-3; Amin MR, 1999, LARYNGOSCOPE, V109, P1402, DOI 10.1097/00005537-199909000-00007; Beretta F, 2006, NEUROSURGERY, V59, P25, DOI 10.1227/01.NEU.0000219877.43072.49; Chazono H, 2005, ACTA OTO-LARYNGOL, V125, P196, DOI 10.1080/00016480410017486-1; DOSSA C, 1990, J VASC SURG, V12, P319, DOI 10.1067/mva.1990.22486; DUBNER S, 1991, HEAD NECK-J SCI SPEC, V13, P389, DOI 10.1002/hed.2880130502; El-Sabrout R, 2000, J VASC SURG, V31, P702, DOI 10.1067/mva.2000.104101; HERNANDEZ MT, 2006, J VASC SURG, V44, P642; Hertzer NR, 2000, J VASC SURG, V31, P823, DOI 10.1067/mva.2000.105675; Kumins NH, 2001, ANN VASC SURG, V15, P25, DOI 10.1007/BF02693796; LARSEN PE, 1992, J VASC SURG, V15, P226, DOI 10.1016/0741-5214(92)70033-H; Longo G Matthew, 2005, Semin Vasc Surg, V18, P178, DOI 10.1053/j.semvascsurg.2005.09.002; MCCREADY RA, 1989, J VASC SURG, V10, P274; MOCK CN, 1991, J VASC SURG, V13, P846; Muhm M, 2002, ACTA OTO-LARYNGOL, V122, P561, DOI 10.1080/00016480260092417; Ozlugedik S, 2005, ACTA OTO-LARYNGOL, V125, P1111, DOI 10.1080/00016480510035421; ROSSOKHIN AV, 2000, ANTOLOGIYA SOVREMENN, V1, P23; SHAHA AR, 1991, SEMIN SURG ONCOL, V7, P25, DOI 10.1002/ssu.2980070107; Shohat I, 2005, INT J ORAL MAX SURG, V34, P639, DOI 10.1016/j.ijom.2005.03.002; Wright JG, 1996, J VASC SURG, V23, P775, DOI 10.1016/S0741-5214(96)70239-2	20	14	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JAN	2009	49	1					86	92		10.1016/j.jvs.2008.08.047			7	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	395UA	WOS:000262547800015	18951752	Bronze			2022-02-06	
J	Youse, KM; Coelho, CA				Youse, Kathleen M.; Coelho, Carl A.			Treating underlying attention deficits as a means for improving conversational discourse in individuals with closed head injury: A preliminary study	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; TRAINING-PROGRAM; EFFECT SIZES; ADULTS; REHABILITATION; LISTENER; SKILLS; TASK	Background: It is documented that individuals with closed head injury (CHI) demonstrate difficulty with narrative and conversational discourse. Effective conversational discourse requires a complex interaction of linguistic, cognitive, and social abilities [6]. Reduced attention and concentration are among the most common cognitive sequela following CHI [39]. Aims: The present study investigated whether treatment of attention would facilitate conversational discourse for individuals with CHI. Two treatment protocols were investigated, the first social skills-based, and the second attention-based. It was hypothesized that attention training would improve not only attentional skills but also conversation, however social skills training, would only facilitate conversational skills. Methods and Procedures: A single subject multiple treatments comparison design was employed with two individuals who were post-onset of CHI. Treatment effects on conversational performance were calculated using the f statistic [18] for measures of response appropriateness during conversations. Outcomes and Results: Effect sizes suggested that both treatments were active; however, the participants' performances were variable reducing the magnitude of change observed. Results indicated minimal change from baselines, only partially supporting the research hypotheses. Conclusions: Although the two treatment regimens had some effect on the participants' conversational performances it was not to the extent anticipated. The issues of candidacy for such treatments as well as the importance of incorporating natural contingencies into interventions for conversation training are discussed.	[Youse, Kathleen M.] Univ Kentucky, Coll Hlth Sci, Div Commun Disorders, Lexington, KY 40536 USA; [Coelho, Carl A.] Univ Connecticut, Storrs, CT USA		Youse, KM (corresponding author), Univ Kentucky, Coll Hlth Sci, Div Commun Disorders, 900 S Limestone St,120J, Lexington, KY 40536 USA.	kathleen.youse@uky.edu					Adamovich B.L.B., 2005, APHASIA RELATED NEUR; BODY R, 1999, COMMUNICATION DISORD; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C.A., 1993, CLIN APHASIOLOGY, V21, P183; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1999, COMMUNICATION DISORD; Cohen J., 2013, STAT POWER ANAL BEHA; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Golper L., 2001, EVIDENCE BASED PRACT; HAGEN C, 1998, REHABILITATION HEAD; HELFFENSTEIN DA, 1982, CLIN NEUROPSYCHOLOGY, V4, P139; Kertesz A., 1982, W APHASIA BATTERY; Kromrey JD, 1996, J EXP EDUC, V65, P73, DOI 10.1080/00220973.1996.9943464; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARSH NV, 1999, COMMUNICATION DISORD; Maths S, 1976, GERIATRIC PSYCHIAT; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1999, COMMUNICATION DISORD; McReynolds L., 1983, SINGLE SUBJECT EXPT; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Palmese CA, 2000, BRAIN INJURY, V14, P535; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robey RR, 1999, APHASIOLOGY, V13, P445, DOI 10.1080/026870399402028; ROBEY RR, 2001, SPECIAL INTEREST DIV, V11; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; SNOW P, 1999, COMMUNICATION DISORD; Sohlberg M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SOHLBERG MM, 1994, ATTENTION PROCESS TR, V2; STRUCHEN MA, 2005, REHABILITATION TRAUM; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; TOGHER L, 1999, COMMUNICATION DISORD; Turkstra L, 2003, LANG SPEECH HEAR SER, V34, P117, DOI 10.1044/0161-1461(2003/010); Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Ylvisaker M, 2002, J MED SPEECH-LANG PA, V10, pXXV	46	14	14	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2009	24	4					355	364		10.3233/NRE-2009-0490			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	481VH	WOS:000268839800009	19597274				2022-02-06	
J	Dolinak, D; Wise, SH; Jones, CT				Dolinak, David; Wise, Steven H.; Jones, Curtiss			Microscopic and Spectroscopic Features of Gunpowder and its Documentation in Gunshot Wounds in Charred Bodies	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						gunpowder; charred body; Fourier Transform Infrared (FT-IR) microscopy; soot; autopsy; gunshot wound		Determining the direction and range of fire of gunshot wounds in charred bodies can be difficult because soot resulting from thermal injury can grossly be identical to soot arising from a contact or close-range firearm discharge. Two charred bodies had gunshot wounds of the head and neck region that were distorted by thermal effect, precluding determination of the direction and range of fire by gross findings alone. By microscopy, deep wound tissue from each charred body had foreign material suggestive of gunpowder. Samples of the foreign material were examined by Fourier transform infrared (FT-IR) microscopy and determined to be cellulose nitrate (nitrocellulose), a main component of gunpowder. In addition, 12 cases of suicide in well-preserved bodies with contact gunshot Wounds were examined with FT-IR microscopy, confirming the presence of cellulose nitrate in 6 (50%) of the cases. Identification of cellulose nitrate in the tracks of gunshot wounds can assist in the determination of direction and range of fire when the surface features are charred.	[Dolinak, David; Wise, Steven H.; Jones, Curtiss] Cuyahoga Cty Coroners Off, Trace Evidence Dept, Cleveland, OH USA		Dolinak, D (corresponding author), Travis Cty Med Examiner Dept, 1213 Sabine St, Austin, TX 78701 USA.	ddolinak@hotmail.com					ADELSON L, 1961, AM J CLIN PATHOL, V35, P393, DOI 10.1093/ajcp/35.5.393; DAVIS JH, 1998, J INT WOUND BALL ASS, P5	2	14	14	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	2008	29	4					312	319		10.1097/PAF.0b013e31818582cc			8	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	379UK	WOS:000261421500008	19259016				2022-02-06	
J	Kim, H; Colantonio, A				Kim, Hwan; Colantonio, Angela			Intentional Traumatic Brain Injury in Ontario, Canada	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Epidemiology; Traumatic brain injury; Intentional; Self-inflicted; Assault	MODEL SYSTEMS; VIOLENCE	Background., Violence and traumatic brain injury (TBI) are two major public health concerns. This violence-related TBI, however, has not been studied in Canada and there is little literature on a profile of risk factors and injury severity regarding TBI because of self-inflicted/ suicidal and assault/homicidal injury compared with unintentional TBI. Methods: Cross-sectional study using the comprehensive data set (CDS) of Ontario trauma registry (OTR) from 1993 to 2001. Selling. Data from a large trauma registry were used to assess demographic and injury-related characteristics, injury severity and incident time associated with Till that were either caused unintentionally, were self-inflicted or resulted from an assault. Results. This Study identified 1,409 (8.0%) intentional TBIs and 16,211 (92.0%) unintentional TBIs. Of the intentional TBIs, 389 (27.6%) was self-inflicted TBI (Si-TBI) and 1,020 (72.4%) was other-inflicted TBI (Oi-TBI). The most common cause of Si-TBI was "jumping from high places" (32.1%), followed by "firearms"(30.6%). About. half of Oi-TBI was because of "fight and brawl" (48.3%), followed by "struck by objects" (26.1%). Si-TBI was associated with younger age, female gender, and having more alcohol/drug abuse history. For Oi-TBI, younger age, male gender, having more alcohol/drug abuse history were independently associated. Conclusion: This research provides the first comprehensive overview of intentional TBI based on Canadian data. The CDS of the OTR provided the ability to identify who is at risk for intentional TBI. Prevention programs and more targeted rehabilitation services should be designed for this vulnerable population.	[Kim, Hwan] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; Toronto Rehabil Inst, Saunderson Family Chair Acquired Brain Injury Res, Toronto, ON, Canada		Kim, H (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	hwan.kim@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Toronto Rehabilitation Institute (TRI); Ontario Neurotrauma Foundation (ONF); Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Work Study Program	This study was financially supported by the Toronto Rehabilitation Institute (TRI), the Ontario Neurotrauma Foundation (ONF), the Ontario Ministry of Health and Long Term Care, and the Ontario Work Study Program..	Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; *CAN I HLTH INF, 2004, NAT TRAUM REG AN B H; *CAN I HLTH INF, 2001, 2001 REP HOSP INJ AD; Canadian Institute for Health Information (CIHI), 2002, HOSP COSTS TRAUM ADM; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Garber BG, 1996, J TRAUMA, V40, P733, DOI 10.1097/00005373-199605000-00008; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Pickett William, 2004, Chronic Dis Can, V25, P32; *SMARTRISK, 2005, ONT INJ COMP, V2; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Woo BH., 2000, REHABILITATION PEOPL; World Health Organization, 2002, WORLD REPORT VIOLENC	15	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2008	65	6					1287	1292		10.1097/TA.0b013e31817196f5			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	383WV	WOS:000261706000018	19077615	Green Published			2022-02-06	
J	Kirchhoff, C; Buhmann, S; Braunstein, V; Leidel, BA; Vogel, T; Kreimeier, U; Mutschler, W; Biberthaler, P				Kirchhoff, C.; Buhmann, S.; Braunstein, V.; Leidel, B. A.; Vogel, T.; Kreimeier, U.; Mutschler, W.; Biberthaler, P.			CEREBROSPINAL S100-B: A POTENTIAL MARKER FOR PROGRESSIVE INTRACRANIAL HEMORRHAGE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article						S100-B; traumatic brain injury; blood brain barrier; cerebrospinal fluid	SEVERE HEAD-INJURY; HIGH-RISK PATIENTS; COMPUTED-TOMOGRAPHY; S-100 PROTEIN; DAMAGE; BLOOD; SERUM; FLUID; IDENTIFICATION; BARRIER	Objective: Traumatic brain injury (TBI) is associated with cerebrovascular dysfunction and changes of the blood-brain barrier (131313) function. Although knowledge about the function of the 131313 would be of high interest, non-invasive neurodiagnostic tools are still lacking. In this context it has been shown, that the astrocytic protein S100-B is a significant parameter for neuronal damage. However, there is only poor knowledge about the dynamics of S100-B in cerebrospinal fluid (CSF) and serum of patients with severe TBI. Therefore, the aim of this study was to analyze intrathecal and systemic concentrations of S100-B in patients with severe TBI in correlation to the development of progressive intracranial hemorrhage (PIH) as well as to the CSF/serum albumin ratio (Q(alb)), as functional parameter of the BBB. Patients and Methods: In patients, suffering from severe TBI (GCS <= 8pts) and respectively healthy control patients, albumin for calculating the CSF/serum albumin ratio (Q(alb)) as well as S100-B protein were analyzed in CSF and serum. Samples were collected immediately after placement of a ventricular catheter and 12h, 24h, 48h and 72h after TBI. S100-B was quantified using Elecsys S-100 (R) assay (Roche (R) Diagnostics; Mannheim, Germany). Volume measurements of focal mass lesions based on CT images taken during the first 72 h after TBI were obtained according to the Cavalieri's Direct Estimator method. Results: 21 TBI-patients and respectively 10 health controls were enrolled. In patients exhibiting a mean ICP > 15mmHg (n = 15) CSF levels of S100-B were significantly increased on admission (819 +/- 78 pg/ml) compared to patients with ICP <= 15mmHg (n = 6, 175 +/- 12 pg/ml) as well as to the control group (n = 10, 0.8 +/- 0.09 pg/ml). In the group with ICP > 15mmHg 8 patients developed PIH A positive correlation was found between CSF S100-B and ICP (r(2) = 0.925, p<0.001). Furthermore a positive correlation between serum S100-B and Q(alb) was found for each sampling point (r(2) = 0.793, p<0.001). Conclusions: The cerebrospinal and serum concentration of S100-B in patients with severe TBI was evaluated. Monitoring cerebrospinal S100-B might help to prospectively identify patients with P.M.	[Kirchhoff, C.] Tech Univ Munich, Abt Sportorthopadie, Klinikum Rechts Isar, D-80809 Munich, Germany; [Buhmann, S.] Univ Munich, Inst Klin Radiol, D-80539 Munich, Germany; [Braunstein, V.; Leidel, B. A.; Mutschler, W.; Biberthaler, P.] Univ Munich, Chirurg Klin Innenstadt, D-80539 Munich, Germany; [Kreimeier, U.] Univ Munich, Klin Anaesthesiol, D-80539 Munich, Germany; [Vogel, T.] Klinikum Ruhr Univ Bochum, Klin Orthopadie & Unfallchirurg, Bochum, Germany		Kirchhoff, C (corresponding author), Tech Univ Munich, Abt Sportorthopadie, Klinikum Rechts Isar, Conollystr 32, D-80809 Munich, Germany.	Chlodwig.Kirchhoff@med.uni-muenchen.de		LEIDEL, Bernd A./0000-0002-5149-8764			Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2002, EUR J MED RES, V7, P164; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Farin A, 2004, ACT NEUR S, V89, P101; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Krotz M, 2004, EUR RADIOL, V14, P227, DOI 10.1007/s00330-003-2134-y; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Otto M, 1997, J NEUROL, V244, P566, DOI 10.1007/s004150050145; Otto VI, 2000, J NEUROSCI RES, V60, P733, DOI 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; The Brain Trauma Foundation The American Association of Neurological Surgeons The Joint Section on Neurotrauma and Critical Care, 2000, J NEUROTRAUM, V17, P497; Ucar T, 2004, J TRAUMA, V57, P95, DOI 10.1097/01.TA.0000071352.95491.75	30	14	16	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0949-2321	2047-783X		EUR J MED RES	Eur. J. Med. Res.	NOV 24	2008	13	11					511	516					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	384HK	WOS:000261735700005	19073387				2022-02-06	
J	Sunico, CR; Portillo, F; Gonzalez-Forero, D; Kasparov, S; Moreno-Lopez, B				Sunico, C. R.; Portillo, F.; Gonzalez-Forero, D.; Kasparov, S.; Moreno-Lopez, B.			EVIDENCE FOR A DETRIMENTAL ROLE OF NITRIC OXIDE SYNTHESIZED BY ENDOTHELIAL NITRIC OXIDE SYNTHASE AFTER PERIPHERAL NERVE INJURY	NEUROSCIENCE			English	Article						eNOS; hypoglossal nerve; adenoviral vectors; peripheral neuropathy	NUCLEUS-TRACTUS-SOLITARII; ELECTRICAL-STIMULATION PROMOTES; GROWTH CONE COLLAPSE; SCHWANN-CELLS; NO SYNTHASE; REGENERATION; INHIBITION; EXPRESSION; BRAIN; DEATH	Physical injury to a nerve is the most common cause of acquired peripheral neuropathy. Identification of molecules involved in degenerative and regenerative processes is a key step toward development of therapeutic tools in order to accelerate motor, sensory and/or autonomic function recovery. We have studied the role of nitric oxide (NO) using as a model the severe crushing of a motor nerve in adult rats. This type of injury up-regulates the three isoforms of nitric oxide synthase (NOS) in the affected nerve. Chronic systemic inhibition of NOS accelerated the onset of functional muscle reinnervation evaluated by the recording of compound muscle action potential evoked by electrical stimulation of the injured nerve. Besides, it increased the number of back-labeled motoneurons by application, 2 days after injury, of a retrograde marker 10 mm distal to the crushing site. These effects were mimicked by chronic specific inhibition of the endothelial isoform of nitric oxide synthase (eNOS), but not by specific inhibitors of the neuronal or inducible isoform. Next, we intraneurally injected a replication-deficient adenoviral vector directing the expression of a dominant negative mutant of eNOS (Ad-TeNOS). A single injection of Ad-TeNOS on the day of crushing significantly accelerated functional recovery of neuromuscular junction and increased axonal regeneration. Moreover, Ad-TeNOS did not compromise motoneuron viability or stability of reestablished neuromuscular junctions. Taken together, these results suggest that NO of endothelial origin slows down muscle reinnervation by means of detrimental actions on axonal regeneration after peripheral nerve injury. These experiments identify eNOS as a potential therapeutic target for treatment of traumatic nerve injuries and highlight the potential of gene therapy in treating injuries of this type using viral vectors to suppress the activity of eNOS. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.	[Sunico, C. R.; Portillo, F.; Gonzalez-Forero, D.; Moreno-Lopez, B.] Univ Cadiz, Fac Med, Area Fisiol, Cadiz 11003, Spain; [Kasparov, S.] Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England		Moreno-Lopez, B (corresponding author), Univ Cadiz, Fac Med, Area Fisiol, Plaza Falla 9, Cadiz 11003, Spain.	bernardo.moreno@uca.es	Kasparov, Sergey/AAH-5286-2019; Gonzalez-Forero, David/AAU-2935-2020; Kasparov, Sergey/C-4932-2014; Moreno-Lopez, Bernardo/S-5148-2019; Portillo Pacheco, Federico Luis/I-1048-2015	Kasparov, Sergey/0000-0002-1824-1764; Kasparov, Sergey/0000-0002-1824-1764; Moreno-Lopez, Bernardo/0000-0003-2897-6227; Portillo Pacheco, Federico Luis/0000-0003-0095-1378; Gonzalez Forero, David/0000-0001-5748-9546	Ministerio de Educaciao y Ciencia, SpainSpanish Government [BFI2001-3816, SAF2005-00585]; Consejeria de Innovacion, Ciencia y Empresa from the Junta de Andalucia, SpainJunta de Andalucia [PA12005-CTS-844]	This study was supported by grants from the Ministerio de Educaciao y Ciencia, Spain (BFI2001-3816, SAF2005-00585) and the Consejeria de Innovacion, Ciencia y Empresa from the Junta de Andalucia, Spain (PA12005-CTS-844),	Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Bajrovic FF, 2002, J PERIPHER NERV SYST, V7, P141, DOI 10.1046/j.1529-8027.2002.02020.x; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; Brushart TM, 2002, J NEUROSCI, V22, P6631; Chang HM, 2000, BRAIN RES, V873, P243, DOI 10.1016/S0006-8993(00)02489-6; Chen ML, 2008, J MOL NEUROSCI, V34, P89, DOI 10.1007/s12031-007-9005-y; DEMEDINACELI L, 1988, EXP NEUROL, V100, P166, DOI 10.1016/0014-4886(88)90209-9; DEVOR M, 1979, EXP NEUROL, V64, P260, DOI 10.1016/0014-4886(79)90267-X; Elder GA, 2001, J NEUROSCI RES, V65, P493, DOI 10.1002/jnr.1179; Gonzalez-Forero D, 2004, J PHYSIOL-LONDON, V557, P991, DOI 10.1113/jphysiol.2003.059972; Gonzalez-Forero D, 2007, J NEUROSCI, V27, P6302, DOI 10.1523/JNEUROSCI.1019-07.2007; Gonzalez-Hernandez T, 1999, J NEUROSCI RES, V55, P198, DOI 10.1002/(SICI)1097-4547(19990115)55:2<198::AID-JNR7>3.0.CO;2-M; Greenebaum B, 1996, BIOELECTROMAGNETICS, V17, P293, DOI 10.1002/(SICI)1521-186X(1996)17:4<293::AID-BEM5>3.0.CO;2-Z; Haapaniemi T, 2002, J PERIPHER NERV SYST, V7, P149, DOI 10.1046/j.1529-8027.2002.02021.x; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; HWANG JC, 1983, J APPL PHYSIOL, V55, P793, DOI 10.1152/jappl.1983.55.3.793; Ide C, 1996, NEUROSCI RES, V25, P101; Jiang W, 2004, NEUROSCI LETT, V367, P344, DOI 10.1016/j.neulet.2004.06.031; Kantor DB, 1996, SCIENCE, V274, P1744, DOI 10.1126/science.274.5293.1744; Kasparov S, 2004, PROG BIOPHYS MOL BIO, V84, P251, DOI 10.1016/j.pbiomolbio.2003.11.011; Kasparov S, 2005, CONTEMP CARDIOL, P247, DOI 10.1385/1-59259-883-8:247; Kasparov S, 2007, NAT METHODS, V4, P379, DOI 10.1038/nmeth0507-379a; Keilhoff G, 2002, NEUROREPORT, V13, P1463, DOI 10.1097/00001756-200208070-00023; Keilhoff G, 2002, J CHEM NEUROANAT, V24, P181, DOI 10.1016/S0891-0618(02)00055-8; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; LEE CM, 1995, J BIOL CHEM, V270, P27403, DOI 10.1074/jbc.270.46.27403; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Levy D, 2001, J NEUROPATH EXP NEUR, V60, P411, DOI 10.1093/jnen/60.5.411; Longo FM, 1999, J NEUROSCI RES, V55, P230, DOI 10.1002/(SICI)1097-4547(19990115)55:2<230::AID-JNR10>3.0.CO;2-3; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Mert T, 2007, EUR J PHARMACOL, V568, P25, DOI 10.1016/j.ejphar.2007.05.004; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moreno-Lopez B, 2006, REV NEUROSCIENCE, V17, P309; Nagano S, 2001, J NEUROCHEM, V77, P1486, DOI 10.1046/j.1471-4159.2001.00358.x; Paton JFR, 2002, TRENDS NEUROSCI, V25, P626, DOI 10.1016/S0166-2236(02)02261-0; Paton JFR, 2001, J PHYSIOL-LONDON, V531, P445, DOI 10.1111/j.1469-7793.2001.0445i.x; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; RENDE M, 1995, J COMP NEUROL, V363, P249, DOI 10.1002/cne.903630207; Schwarte RC, 2004, DEV BIOL, V273, P276, DOI 10.1016/j.ydbio.2004.06.003; SISKEN BF, 1989, BRAIN RES, V485, P309, DOI 10.1016/0006-8993(89)90575-1; Sohn YK, 1999, J NEUROL SCI, V162, P133, DOI 10.1016/S0022-510X(98)00297-4; Stokes CEL, 2003, EXP PHYSIOL, V88, P459, DOI 10.1113/eph8802551; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; SWETT JE, 1991, J COMP NEUROL, V304, P234, DOI 10.1002/cne.903040207; Tanaka H, 1998, J Oral Sci, V40, P147; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Waki H, 2003, J PHYSIOL-LONDON, V546, P233, DOI 10.1113/jphysiol.2002.030270; Waki H, 2006, HYPERTENSION, V48, P644, DOI 10.1161/01.HYP.0000238200.46085.c6; Yamada RX, 2006, NEUROREPORT, V17, P661, DOI 10.1097/00001756-200604240-00021; Yu WHA, 1997, DEV NEUROSCI-BASEL, V19, P247; YU WHA, 1994, J HISTOCHEM CYTOCHEM, V42, P451, DOI 10.1177/42.4.7510317; Zhou LH, 2006, EXP NEUROL, V197, P84, DOI 10.1016/j.expneurol.2005.08.019; Zochodne DW, 1997, NEUROSCI LETT, V228, P71, DOI 10.1016/S0304-3940(97)00359-5; Zochodne DW, 2005, CELL MOL BIOL, V51, P255, DOI 10.1170/T626; Zochodne DW, 1999, NEUROSCIENCE, V91, P1515, DOI 10.1016/S0306-4522(98)00729-5	59	14	15	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 11	2008	157	1					40	51		10.1016/j.neuroscience.2008.09.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	369UE	WOS:000260718600005	18824216				2022-02-06	
J	Bhalla, K; Shahraz, S; Naghavi, M; Lozano, R; Murray, C				Bhalla, Kavi; Shahraz, Saeid; Naghavi, Mohsen; Lozano, Rafael; Murray, Christopher			Estimating the distribution of external causes in hospital data from injury diagnosis	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Injury surveillance; Hospital discharge; Missing data; Non-fatal injuries; Bayesian inference; ICD		Hospital discharge datasets area key source for estimating the incidence of non-fatal injuries. While hospital records usually document injury diagnosis (e.g. traumatic brain injury, femur fracture, etc.) accurately, they often contain poor quality information on external causes (e.g. road traffic crashes, falls, fires, etc.). if such data is recorded at all. However, estimating incidence by external causes is essential for designing effective prevention strategies. Thus, we developed a method for estimating the number of hospital admissions due to each external cause based on injury diagnosis. We start with a prior probability distribution of external causes for each case (based on victim age and sex) and use Bayesian inference to update the probabilities based on the victim's injury diagnoses. We validate the method on a trial dataset in which both external causes and injury diagnoses are known and demonstrate application to two problems: redistribution of cases classified to ill-defined external causes in one hospital data system; and, estimation of external causes in another hospital data system that only records nature of injuries. In comparison with age-sex proportional distribution (the method usually employed), we found the Bayesian method to be a significant improvement for generating estimates of incidence for many external causes (e.g. fires, drownings, poisonings). But the method, performed poorly in distinguishing between falls and road traffic injuries, both of which are characterized by similar injury codes in our datasets. While such stop gap methods can help derive additional information, hospitals need to incorporate accurate external cause coding in routine record keeping. (C) 2008 Elsevier Ltd. All rights reserved.	[Bhalla, Kavi; Shahraz, Saeid] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; [Naghavi, Mohsen; Lozano, Rafael; Murray, Christopher] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA; [Lozano, Rafael] Mexico Minist Hlth, Cuauhtemoc 06600, DF, Mexico		Bhalla, K (corresponding author), Harvard Univ, Initiat Global Hlth, 104 Mt Auburn St, Cambridge, MA 02138 USA.	kavi_bhalla@harvard.edu	Lozano, Rafael/T-5352-2018	Lozano, Rafael/0000-0002-7356-8823			ABELLERA J, 2004, STATES ARE COLLECTIN; ALEXANDRESCU R, 2008, TRAUMA AUDIT RES NET, V8, P80; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; ANNEST JL, 2008, MORBIDITY MORTALITY, V28, P57; Bergen GS., 2008, INJURY US 2007 CHART; Bhalla K, 2008, ROAD TRAFFIC INJURIE; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Conner KR, 2003, AM J PUBLIC HEALTH, V93, P1128, DOI 10.2105/AJPH.93.7.1128; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Finkelstein E., 2006, INCIDENCE EC BURDEN; LANGLOIS JA, 1995, AM J PUBLIC HEALTH, V85, P1261, DOI 10.2105/AJPH.85.9.1261; Lawrence BA, 2007, ACCIDENT ANAL PREV, V39, P319, DOI 10.1016/j.aap.2006.08.001; MARGANITT B, 1990, AM J PUBLIC HEALTH, V80, P1463, DOI 10.2105/AJPH.80.12.1463; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Tepas Joseph J 3rd, 2004, Semin Pediatr Surg, V13, P126, DOI 10.1053/j.sempedsurg.2004.01.009; Welander G, 1999, ACCIDENT ANAL PREV, V31, P13, DOI 10.1016/S0001-4575(98)00040-2; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277	18	14	15	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2008	40	6					1822	1829		10.1016/j.aap.2008.07.002			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	378UN	WOS:000261349800004	19068282				2022-02-06	
J	Josie, KL; Peterson, CC; Burant, C; Drotar, D; Stancin, T; Wade, SL; Yeates, K; Taylor, HG				Josie, Katherine Leigh; Peterson, Catherine Cant; Burant, Christopher; Drotar, Dennis; Stancin, Terry; Wade, Shari L.; Yeates, Keith; Taylor, H. Gerry			Predicting Family Burden Following Childhood Traumatic Brain Injury: A Cumulative Risk Approach	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						childhood traumatic brain injury; cumulative risk index; family burden of injury	ENVIRONMENTAL RISK; SHORT-TERM; BEHAVIOR; CHILDREN; OUTCOMES; INTELLIGENCE; RELIABILITY; CAREGIVER	Objective: To examine the utility of a cumulative risk index (CRI) in predicting the family burden of injury (FBI) over time in families of children with traumatic brain injury (TBI). Participants: One hundred eight children with severe or moderate TBI and their families participated in the study. Measures: The measures used in the study include the Socioeconomic Composite Index, Life Stressors and Social Resources Inventory-Adult Form, Vineland Adaptive Behavior Scales, Child Behavior Checklist, Children's Depression Inventory, McMaster Family Assessment Device, Brief Symptom Inventory, and Family Burden of Injury Interview. In addition, information on injury-related risk was obtained via medical charts. Methods: Participants were assessed immediately, 6, and 12 months postinjury and at a 4-year extended follow-up. Results: Risk variables were dichotomized (ie, high- or low-risk) and summed to create a CRI for each child. The CRI predicted the FBI at all assessments, even after accounting for autocorrelations across repeated assessments. Path coefficients between the outcome measures at each time point were significant, as were all path coefficients from the CRI to family burden at each time point. In addition, all fit indices were above the recommended guidelines, and the X-2 statistic indicated a good fit to the data. Conclusions: The current study provides initial support for the utility of a CRI (ie, an index of accumulated risk factors) in predicting family outcomes over time for children with TBI. The time period immediately after injury best predicts the future levels of FBI; however, cumulative risk continues to influence the change across successive postinjury assessments. These results suggest that clinical interventions could be proactive or preventive by intervening with identified "at-risk" subgroups immediately following injury.	[Josie, Katherine Leigh; Peterson, Catherine Cant] Case Western Reserve Univ, Sch Med, Dept Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Burant, Christopher] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Dept Pediat, Metro Hlth Med Ctr, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Behav Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Drotar, Dennis; Wade, Shari L.] Univ Cincinnati, Med Ctr, Coll Med, Dept Pediat,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA; [Yeates, Keith] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith] Columbus Childrens Res Inst, Ctr Biobehav Hlth, Columbus, OH USA		Josie, KL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Behav Pediat & Psychol, 11100 Euclid Ave, Cleveland, OH 44106 USA.	Katherine.Josie@uhhospitals.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD041923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR008084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD041923, 5T32-HD041923-05] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36335] Funding Source: Medline		Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; Atzaba-Poria N, 2004, J CHILD PSYCHOL PSYC, V45, P707, DOI 10.1111/j.1469-7610.2004.00265.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX, P330; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Burchinal MR, 2000, DEV PSYCHOL, V36, P793, DOI 10.1037//0012-1649.36.6.793; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Curran PJ, 2001, DECADE BEHAV, P107, DOI 10.1037/10409-004; DEROGATIS L, BRIEF SYMPTON INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Gerard JM, 2004, CHILD DEV, V75, P1832, DOI 10.1111/j.1467-8624.2004.00820.x; Greenberg MT, 2001, DEV PSYCHOPATHOL, V13, P255, DOI 10.1017/S0954579401002048; Griffin K W, 2000, Prev Sci, V1, P199, DOI 10.1023/A:1026599112279; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hooper SR, 1998, J APPL DEV PSYCHOL, V19, P85, DOI 10.1016/S0193-3973(99)80029-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kerr MA, 2000, CHILD ABUSE NEGLECT, V24, P587, DOI 10.1016/S0145-2134(00)00126-5; KLINE RB, 2004, PRINCIPLES PRACTICE, P1; Kovacs M., 1992, CHILDRENS DEPRESSION; Kraus JF., 1995, TRAUMATIC HEAD INJUR, P117; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS R, 1988, LIFE STRESSORS SOCIA; Moos RH, 1988, J SUBSTANCE ABUSE, V1, P135, DOI DOI 10.1016/S0899-3289(88)80017-8; Perkins DF, 2002, J ADOLESCENT RES, V17, P3, DOI 10.1177/0743558402171001; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Rolf J., 1979, PRIMARY PREVENTION P, P49, DOI DOI 10.1016/1054-139X(93)90196-V; Rutter M., 1970, ED HLTH BEHAV; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; SAMEROFF AJ, 1993, CHILD DEV, V64, P80, DOI 10.1111/j.1467-8624.1993.tb02896.x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; *SPSS INC SMALLW C, 2005, AM SOFTW PROGR VERS; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor HG, 1998, J DEV BEHAV PEDIATR, V19, P235; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; WADE SL, 1997, CHILDHOOD TRAUMATIC, P115; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	54	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					357	368		10.1097/01.HTR.0000341431.29133.a8			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300001	19033828	Green Accepted			2022-02-06	
J	Wang, YJ; Zhu, L; Rosengart, AJ				Wang, Yunjian; Zhu, Liang; Rosengart, Axel J.			Targeted brain hypothermia induced by an interstitial cooling device in the rat neck: Experimental study and model validation	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Brain hypothermia; Ischemic brain injury; Interstitial cooling; Rat; Surgery	THEORETICAL ANALYSES; INJURY; TEMPERATURE; ISCHEMIA	Targeted brain hypothermia has the potential to prevent cerebral ischemia injury during open heart and neck surgeries or after traumatic head injury. In this study, in vivo experiments were performed to test the performance of a newly developed cooling device in an inexpensive animal model. Rat brain hypothermia was induced by inserting an interstitial cooling device in the rat neck muscle and placing the device on the common carotid artery to cool the arterial blood supplied to the brain. Coolant was circulating inside the cooling device to achieve either mild or moderate temperature reductions at the surface of the device. Temperatures were measured inside the rat brain tissue, as well as on the head skin surface. For the mild cooling (cooling device surface temperature was 18.7 +/- 4.5 degrees C), the temperature reductions were 2.2 +/- 0.6 degrees C, 2.1 +/- 0.6 degrees C, 1.9 +/- 0.6 degrees C and 1.6 +/- 0.9 degrees C at sites of brain-5 mm, brain-2 mm, skull, and scalp, respectively. After the surface temperature was further decreased to 12.8 +/- 2.8 degrees C (moderate cooling), the temperature reduction in the head increased more than 85% to 3.7 +/- 3.2 degrees C, 3.7 +/- 3.0 degrees C, 3.3 +/- 2.5 degrees C and 2.5 +/- 1.0 degrees C, respectively. The experimental data were also used to validate a previously developed theoretical model for humans. Experimentally measured geometrical and physiological parameters of the rat neck and brain were substituted into the scaled-down theoretical model to simulate the temperature distribution in the rat neck and brain. The theoretically predicted brain temperatures showed a good agreement with the experiment data. We believe that this study is the first step in developing a reliable cooling device to achieve fast cooling and to control rewarming in future clinical studies and to benefit a large patient population. (C) 2008 Elsevier Ltd. All rights reserved.	[Wang, Yunjian; Zhu, Liang] Univ Maryland Baltimore Cty, Dept Mech Engn, Baltimore, MD 21250 USA; [Rosengart, Axel J.] New York Presbyterian Hosp, New York, NY USA		Zhu, L (corresponding author), Univ Maryland Baltimore Cty, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	zliang@umbc.edu			NSFNational Science Foundation (NSF); Brain Research Foundation; University of Chicago Medical CenterUniversity of Chicago; Cancer Research Foundation, Chicago	The authors are grateful to Drs. Olav Thulesius and Huan Wang for their helpful comments. Dr. Zhu thankfully acknowledges financial assistance by an NSF-supported UMBC ADVANCE program. Dr. Rosengart was supported in part by the Brain Research Foundation, The University of Chicago Medical Center, and the Cancer Research Foundation, Chicago, Illinois. The research was performed in partial fulfillment of the requirements for the Ph.D. degree from the University of Maryland Baltimore County by Yunjian Wang.	Allers M, 2006, CARDIOVASC INTER RAD, V29, P260, DOI 10.1007/s00270-004-0271-6; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Bommadevara M, 2002, BIOMECH MODEL MECHAN, V1, P137, DOI 10.1007/s10237-002-0011-2; DIAO C, 2004, THESIS U MARYLAND BA; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diao CG, 2006, MED PHYS, V33, P2565, DOI 10.1118/1.2208918; ILLIEVICH UM, 1994, ANESTH ANALG, V78; LEVINE S, 1966, EXP NEUROL, V16, P255, DOI 10.1016/0014-4886(66)90062-8; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MILLER JH, 1993, J VASC SURG, V17, P546; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; NURSE S, 1994, J NEUROSCI, V14, P7726; Nussmeier Nancy A, 2002, J Extra Corpor Technol, V34, P4; OLSEN RW, 1985, ASME, V107, P354; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; WEINBAUM S, 1984, J BIOMECH ENG-T ASME, V106, P321, DOI 10.1115/1.3138501; Xu XJ, 1999, J APPL PHYSIOL, V86, P265, DOI 10.1152/jappl.1999.86.1.265; Zhu L, 2000, ANN BIOMED ENG, V28, P269, DOI 10.1114/1.266; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; Zhu L, 2008, HEAT TRANSFER ENG, V29, P284, DOI 10.1080/01457630701758062	24	14	15	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310			INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	NOV	2008	51	23-24					5662	5670		10.1016/j.ijheatmasstransfer.2008.04.042			9	Thermodynamics; Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Thermodynamics; Engineering; Mechanics	370IK	WOS:000260755700021					2022-02-06	
J	Dudkiewicz, M; Harpaul, TA; Proctor, KG				Dudkiewicz, Michael; Harpaul, Tracey A.; Proctor, Kenneth G.			Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score=27-41)	CRITICAL CARE MEDICINE			English	Article						hemoglobin-based oxygen carrying compound; blood substitute; traumatic brain injury; cerebral perfusion pressure; blast; swine; combat casualty care	CROSS-LINKED HEMOGLOBIN; HUMAN POLYMERIZED HEMOGLOBIN; TRAUMATIC HEMORRHAGIC-SHOCK; CEREBRAL PERFUSION-PRESSURE; SMALL-VOLUME RESUSCITATION; BLOOD SUBSTITUTES; BRAIN-INJURY; HBOC-201; SWINE; TRIAL	Objective: A prehospital trial in trauma patients has been proposed to evaluate Hemopure (hemoglobin glutamer-250 [bovine], hemoglobin-based oxygen carrying compound [HBOC]-201, Biopure). We tested the hypothesis that HBOC-201 would improve cerebrovascular resuscitation in a unique polytrauma model. Design: Prospective, randomized, blinded animal study. Subjects: Thirty-two anesthetized swine (42 +/- 1 kg). Interventions: Blunt trauma to the head, right chest, and bilateral femurs (injury Severity Score = 27-41) with captive bolt guns was followed by hypoventilation. Resuscitation was divided into phases to simulate conventional treatment in the prehospital, emergency room, and early intensive care unit. For 30-60 mins postinjury, 500 mL of either normal saline (control, n = 14) or HBOC-201 (n = 14) was administered. All received similar care thereafter. For 60-120 mins, normal saline maintained systolic arterial pressure > 100 mm Hg and heart rate < 100 beats/min plus mannitol (250 mg/kg) for intracranial hypertension. For 120-480 mins, phenylephrine, normal saline, and dextrose were administered to maintain cerebral perfusion pressure >70 mm Hg, filling pressure >12 mm Hg, and plasma glucose >60 mg%, respectively. Two formulations of HBOC-201 (average MW = 250 kDa) were tested: one with < 3% 65 kDa tetramers (n = 7) and the other with <0.3% 65 kDa tetramers (n = 7). Measurements and Main Results: Injury severity is reflected by the death of 2 of 32 swine within 30 mins. In survivors (n = 30), systolic arterial pressure was 83 +/- 6 mm Hg, heart rate was 115 +/- 5 beats/min, and lactate was 5.8 +/- 0.4 mM. Intracranial pressure rose from 8 +/- 1 to 18 +/- 1 mm Hg and brain tissue Po-2 fell from 17 +/- 1 to 2 +/- 1 mm Hg. Without immediate resuscitation, death occurred within 60 mins (n = 2). With normal saline resuscitation (n = 14), systemic hemodynamics, mixed venous oxygen, renal oxygen, portal oxygen, and muscle oxygen corrected but there were four deaths (two at 45 mins, one at 100 mins, and one at 200 mins). Cerebral perfusion pressure was not restored until mannitol and pressor therapy were initiated at 120 mins. In contrast, with HBOC-201 at 30 mins (n = 14), systolic arterial pressure and cerebral perfusion pressure corrected immediately (both p < 0.05) and there were no deaths (p = 0.0978). After 8 hrs, in both groups, cerebral perfusion pressure, systolic arterial pressure, and heart rate were stable; peripheral oxygen saturations were near normal; lactate was cleared; urine output was adequate. However, with HBOC-201, pressor and fluid requirements were reduced by half, which improved intracranial pressure and brain tissue Po-2 (all p < 0.05 vs. control). Reducing tetramer content had no significant effect on the actions of HBOC-201. Conclusions: 1) A single bolus of HBOC-201 at initial resuscitation rapidly restored cerebral perfusion pressure and stabilized hemodynamics with improved intracranial pressure and brain oxygen for the first 8 hrs; and 2) HBOC-201 could be an effective salvage therapy after severe neurotrauma or as a temporizing measure during prolonged transport of a polytrauma patient.	[Dudkiewicz, Michael] Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA; Univ Miami, Div Surg Crit Care, Miami, FL 33136 USA		Dudkiewicz, M (corresponding author), Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA.	kproctor@miami.edu	Proctor, Kenneth/AAA-2199-2022; Viani, Rafael/V-1196-2018	Proctor, Kenneth/0000-0003-1326-6628; 	Naval Medical Research Center [N140610670]	Supported, in part, by grant N140610670 from the Office of Naval Research and by a grant from the Naval Medical Research Center.	Alam HB, 2000, J SURG RES, V94, P145, DOI 10.1006/jsre.2000.6011; Ayuste EC, 2006, J TRAUMA, V60, P52, DOI 10.1097/01.ta.0000200156.05397.0b; Bloomfield EL, 2004, MIL MED, V169, P546, DOI 10.7205/MILMED.169.7.546; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Deltch EA, 2003, J TRAUMA, V54, P139; DeWitt DS, 2000, CRIT CARE MED, V28, P3933, DOI 10.1097/00003246-200012000-00036; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; GEORGE I, 2001, AM J PHYSIOL-HEART C, V291, pH1126; Gould SA, 1998, J AM COLL SURGEONS, V187, P113, DOI 10.1016/S1072-7515(98)00095-7; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Gould SA, 1998, J AM COLL SURGEONS, V187, P121; Gould SA, 2002, J AM COLL SURGEONS, V195, P52, DOI DOI 10.1016/S1072-7515(02)01335-2; Hess J R, 1989, Prog Clin Biol Res, V319, P351; Hess J.R., 1989, PROG CLIN BIOL RES, V319, P358; Huynh T, 2006, J TRAUMA, V61, P97; Johnson JL, 2001, J TRAUMA, V50, P449, DOI 10.1097/00005373-200103000-00008; Johnson JL, 2003, J TRAUMA, V54, P133, DOI 10.1097/00005373-200301000-00016; Johnson T, 2006, CRIT CARE MED, V34, P1464, DOI 10.1097/01.CCM.0000215824.85190.89; Kaplan LJ, 2006, J TRAUMA, V61, P90, DOI 10.1097/01.ta.0000222578.85413.4e; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Kerner T, 2003, INTENS CARE MED, V29, P378, DOI 10.1007/s00134-002-1622-x; King DR, 2005, J TRAUMA, V59, P853, DOI 10.1097/01.ta.0000187656.26849.39; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Koustova E, 2002, J TRAUMA, V52, P872, DOI 10.1097/00005373-200205000-00009; Lee SK, 2002, ACAD EMERG MED, V9, P969; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Manley GT, 2003, ADV EXP MED BIOL, V530, P311; Maxwell RA, 2000, J TRAUMA, V49, P200, DOI 10.1097/00005373-200008000-00005; Moore EE, 2003, J AM COLL SURGEONS, V196, P1, DOI 10.1016/S1072-7515(02)01704-0; Moore EE, 2006, WORLD J SURG, V30, P1247, DOI 10.1007/s00268-005-0499-6; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Proctor KG, 2003, J TRAUMA, V54, pS106, DOI 10.1097/01.TA.0000047222.96258.0D; Przybelski R J, 1999, Prehosp Disaster Med, V14, P251; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rice J, 2008, J TRAUMA, V64, P1240, DOI 10.1097/TA.0b013e318058245e; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schubert A, 2003, ANESTH ANALG, V97, P323, DOI 10.1213/01.ANE.0000068888.02977.DA; Schubert A, 2002, ARTIF CELL BLOOD SUB, V30, P259, DOI 10.1081/BIO-120006118; Shackford SR, 2005, J TRAUMA, V59, P560; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sloan EP, 2002, J TRAUMA, V52, P887, DOI 10.1097/00005373-200205000-00011; Stanton K, 2003, J TRAUMA, V54, P1065, DOI 10.1097/01.TA.0000058123.05571.9E; *US FDA, GUID IND CRIT SAF EF; WINSLOW RM, 1966, J BIOL CHEM, V241, P1144; Winslow RM, 2000, VOX SANG, V79, P1; SAFETY EFFICACY POLY	52	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2008	36	10					2838	2848		10.1097/CCM.0b013e318186f6b3			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356GF	WOS:000259766000018	18766094				2022-02-06	
J	Pasvogel, AE; Miketova, P; Moore, IM				Pasvogel, Alice E.; Miketova, Petra; Moore, Ida M. (Ki)			Cerebrospinal fluid phospholipid changes following traumatic brain injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						phospholipids; traumatic brain injury; membrane damage	FREE FATTY-ACIDS; ISCHEMIA; REPERFUSION; INHIBITORS; DISORDERS; DAMAGE; RATS; A(2)	Traumatic brain injury (TBI)) is a leading cause of morbidity and mortality, with approximately 1.4 million people suffering a TBI each year. With TBI, a cascade of events is initiated including the activation of phospholipases, which leads to the disruption of the lipid bilayer of the membrane of neurons and neuroglia. The purpose of this study is to describe phospholipid changes following TBI. A total of 39 cerebrospinal fluid samples were obtained from the ventricular catheter system of 10 participants who received a TBI as a result of a motor vehicle crash, being struck by a vehicle as a pedestrian, or a fall. Phospholipids were extracted from samples and measured by normal-phase high-performance liquid chromatography with ultraviolet detector at a wavelength of 206 nm. The highest mean concentration of lysophosphatidylcholine occurred on Day I after injury. The concentration of phosphatidylserine was variable, with the highest mean concentration occurring on Day 2 after injury. The highest mean concentrations of phosphatidylethanolamine, phosphatidylcholine, and sphingomyelin occurred on Day 4 after injury. Findings provide preliminary evidence for disruption of central nervous system membrane phospholipids following TBI.	[Pasvogel, Alice E.; Miketova, Petra; Moore, Ida M. (Ki)] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA		Pasvogel, AE (corresponding author), Univ Arizona, Coll Nursing, 1305 N Martin, Tucson, AZ 85721 USA.	pasvogel@nursing.arizona.edu			Sigma Theta Tau International	This study was supported by a grant from Beta Mu Chapter, Sigma Theta Tau International.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; CHEN SF, 1985, J CHROMATOGR, V344, P297, DOI 10.1016/S0378-4347(00)82030-7; Drgova A, 2004, GEN PHYSIOL BIOPHYS, V23, P337; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Graham D.I., 2000, HEAD INJ, P133; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; ILLINGWORTH DR, 1971, J NEUROCHEM, V18, P769, DOI 10.1111/j.1471-4159.1971.tb12006.x; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koch S, 2001, J LIPID RES, V42, P1143; Kolko M, 2003, NEUROSCI LETT, V338, P164, DOI 10.1016/S0304-3940(02)01385-X; KUNZ F, 1972, Z NEUROL, V203, P259, DOI 10.1007/BF00316117; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Parsons L., 1997, J NEUROTRAUM, V14, P784; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Pilitsis JG, 2002, BRAIN RES, V951, P96, DOI 10.1016/S0006-8993(02)03142-6; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	21	14	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	OCT	2008	10	2					113	120		10.1177/1099800408323218			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	353VI	WOS:000259596200005	18829594				2022-02-06	
J	Sengul, G; Takci, E; Malcok, UA; Akar, A; Erdogan, F; Kadioglu, HH; Aydin, IH				Sengul, Goksin; Takci, Ethan; Malcok, Umit Ali; Akar, All; Erdogan, Fazli; Kadioglu, Hakan Hadi; Aydin, Ismail Hakki			A preliminary histopathological study of the effect of agmatine on diffuse brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						agmatine; brain injury; rat	SPINAL-CORD-INJURY; NITRIC-OXIDE PRODUCTION; HIPPOCAMPAL-NEURONS; AXONAL INJURY; DAMAGE; GLUTAMATE; MODEL; ISCHEMIA; RECEPTOR; NEUROPROTECTION	The present study evaluates the effects of agmatine oil histopathological damage following traumatic injury using a clinically relevant model of diffuse brain injury. A total of 27 male Sprague-Dawley rats weighing 200-225 g were anaesthetised and subjected to head trauma using Marmarou's impact-acceleration model. The rats were then separated into two main groups: one was treated with agmatine and the other with saline for LIP to 4 days immediately after head trauma. Rats from both groups were killed 1, 3 or 8 days post-injury. The brains were examined histopathologically and scored according to the axonal, neuronal and Vascular changes associated with diffuse brain injury. There were no significant differences between the groups at I clay or 3 days after trauma, but evaluation after 8 days revealed,I significant improvement in the group treated with agmatine. Our data indicate that agmatine has a beneficial effect in diffuse brain injury and Should be trialled for therapeutic use in the management of this condition. (c) 2008 Elsevier Ltd. All rights reserved.	[Sengul, Goksin; Takci, Ethan; Malcok, Umit Ali; Akar, All; Kadioglu, Hakan Hadi; Aydin, Ismail Hakki] Ataturk Univ, Sch Med, Aziziye Res Hosp, Dept Neurosurg, TR-25070 Erzurum, Turkey; [Erdogan, Fazli] Ataturk Univ, Sch Med, Dept Pathol, Erzurum, Turkey		Sengul, G (corresponding author), Ataturk Univ, Sch Med, Aziziye Res Hosp, Dept Neurosurg, TR-25070 Erzurum, Turkey.	goksinsengul@gmail.com	AYDIN, Ismail Hakki/AAZ-9091-2021; Kadioglu, Hakan Hadi/AAZ-9099-2021; Malcok, Umit Ali/AAV-9334-2021	Kadioglu, Hakan Hadi/0000-0002-7744-6241			Abe K, 2000, BRAIN RES, V872, P141, DOI 10.1016/S0006-8993(00)02517-8; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ASHWAL S, 1995, PEDIATR RES, V38, P652, DOI 10.1203/00006450-199511000-00004; Budd SL, 1998, PHARMACOL THERAPEUT, V80, P203, DOI 10.1016/S0163-7258(98)00029-1; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Demady DR, 2001, MOL PHARMACOL, V59, P24, DOI 10.1124/mol.59.1.24; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; Feng YZ, 2002, PEDIATR RES, V52, P606, DOI 10.1203/01.PDR.0000028057.79132.1F; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gilad GM, 2000, NEUROSCI LETT, V296, P97, DOI 10.1016/S0304-3940(00)01625-6; Gilad GM, 1996, NEUROSCI LETT, V216, P33; GILAD GM, 1996, LIFE SCI, V58, P41; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Kotil K, 2006, J NEUROSURG-SPINE, V4, P392, DOI 10.3171/spi.2006.4.5.392; Malcok UA, 2005, J INT MED RES, V33, P90, DOI 10.1177/147323000503300109; Olmos G, 1999, BRIT J PHARMACOL, V127, P1317, DOI 10.1038/sj.bjp.0702679; Povlishock John T., 1995, P504; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang WP, 2006, BRAIN RES, V1084, P210, DOI 10.1016/j.brainres.2006.02.024; Yang XC, 1999, J PHARMACOL EXP THER, V288, P544; Yu CG, 2000, NEUROREPORT, V11, P3203, DOI 10.1097/00001756-200009280-00031; Zhu M, 2006, NEUROSCIENCE, V141, P2019, DOI 10.1016/j.neuroscience.2006.05.011	28	14	16	1	9	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2008	15	10					1125	1129		10.1016/j.jocn.2007.11.005			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	350AM	WOS:000259324800011	18640839				2022-02-06	
J	Gao, X; Chen, JH				Gao, Xiang; Chen, Jinhui			Direct isolation of neural stem cells in the adult hippocampus after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						fluorescence-activated cell sorting; neural stem cell; transgenic mice; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE-B; INTERMEDIATE-FILAMENT PROTEIN; DENTATE GYRUS; NESTIN EXPRESSION; NEURONAL DEGENERATION; ENHANCED NEUROGENESIS; PROGENITOR CELLS; PROLIFERATIVE ENDOTHELIUM	Recently, we have manipulated endogenous neural stem/progenitor cells (NSCs) in situ in the adult mouse to undergo neurogenesis and anatomic circuit re-formation de novo in the neocortex, where it does not normally occur, by using a highly targeted brain injury model. However, how the NSCs respond to injury in the adult mouse brain is poorly understood. While studying the molecular mechanisms that regulate NSC fates after brain injury, it is important to develop a strategy to identify NSCs in niches and isolate them directly from fresh tissue after brain injury. Here we report that we directly isolated NSCs from adult brains after traumatic brain injury by genetically labeling NSCs with EGFP combined with fluorescence-activated cell sorting (FACS) technique without an intervening cell culture and with high concentrations of growth factors. The isolated EGFP-positive cells can self-renew and have the potential to differentiate into both neurons and glia in vitro, confirming that the FACS-sorted EGFP-positive cells are NSCs. This unique approach provides a useful tool to isolate large amounts of endogenous NSCs in situ for identifying the critical molecules that regulate fate decision and neurogenesis in the adult brain after injury.	[Gao, Xiang; Chen, Jinhui] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Chen, Jinhui] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Chen, JH (corresponding author), 741 S Limestone St, Lexington, KY 40536 USA.	jchen@uky.edu	Chen, Jinhui/A-7138-2009	Chen, Jinhui/0000-0002-6864-7121	Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [4-2]	We appreciate Dr. Grigori Enikolopov at Cold Spring Harbor Laboratory for kindly providing the nestin-EGFP mice, and we thank Dr. Gary Van Zant and Barry Grimes for their kind assistance in cell sorting. This work was supported by a grant from the Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT grant 4-2) to J. Chen.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Ballok DA, 2003, BRAIN RES, V964, P200, DOI 10.1016/S0006-8993(02)03980-X; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; GAO X, 2008, J NEUROSCI IN PRESS; Ha Y, 2002, NEUROSCI RES, V44, P207, DOI 10.1016/S0168-0102(02)00126-8; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Holley JE, 2003, NEUROPATH APPL NEURO, V29, P434, DOI 10.1046/j.1365-2990.2003.00491.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 2002, J NEUROSCI RES, V69, P784, DOI 10.1002/jnr.10376; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Markakis EA, 1999, J COMP NEUROL, V406, P449; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mokry J, 1999, Gen Physiol Biophys, V18 Suppl 1, P25; Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339; Parent JM, 2002, PROG BRAIN RES, V135, P121; Parent JM, 1997, J NEUROSCI, V17, P3727; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Reh TA, 2002, NAT NEUROSCI, V5, P392, DOI 10.1038/nn0502-392; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt-Kastner R, 2002, INT J DEV NEUROSCI, V20, P29, DOI 10.1016/S0736-5748(02)00003-5; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shimizu T, 2006, NEUROL MED-CHIR, V46, P111, DOI 10.2176/nmc.46.111; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taupin P, 2005, MED SCI MONITOR, V11, pRA247; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TOHYAMA T, 1992, LAB INVEST, V66, P303; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	74	14	18	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2008	25	8					985	995		10.1089/neu.2008.0460			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	343ZT	WOS:000258895700004	18665804				2022-02-06	
J	Reicker, LI				Reicker, Lindsay I.			The ability of reaction time tests to detect simulation: An investigation of contextual effects and criterion scores	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	34th Annual Meeting of the International-Neuropsychological-Society	FEB 01-04, 2006	Boston, MA	Int Neuropsychol Soc		simulation; malingering; reaction time tests; Computerized Tests of Information Processing; CTIP	SYMPTOM VALIDITY TESTS; NEUROPSYCHOLOGICAL TESTS; RESPONSE LATENCY; MEMORY DEFICITS; INFORMATION; ATTENTION; INJURY; FAKING; SPEED	Two experiments examined whether experience gained with a series of reaction time tests [Computerized Tests of Information Processing (CTIP); Tombaugh, T. N. & Rees, L. (in press). Computerized Tests of Information Processing (CTIP). Toronto, Canada: Multi-Health Systems Inc.] influenced the performance of individuals instructed to simulate the cognitive effects of a traumatic brain injury. Experience with the tests was manipulated by varying the order and number of tests administered for simulator and control groups. Simulators responded significantly slower and exhibited increased variability compared to controls. Performance was not affected by order or number of tests. The results of a third experiment showed that criterion scores could be established that correctly classified members of control, simulator, mild TBI, and severe TBI groups. Overall, the results suggest that the performance of the simulators was based on a context-free, absolute judgment and that reaction time measures show considerable promise for detecting low effort. (C) 2008 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada		Reicker, LI (corresponding author), Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada.	lreicker@connect.carleton.ca					AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; BRANDT J, 1988, CLIN ASSESSMENT MALI, P65; CERCY SP, 1985, CLIN ASSESSMENT MALI, P1997; Chiu VWY, 2002, REHABIL PSYCHOL, V47, P194, DOI 10.1037//0090-5550.47.2.194; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Resnick P. J., 1988, CLIN ASSESSMENT MALI, P84; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; SCHAGEN S, 1997, J CLIN EXPT NEUROPSY, V19, P443; Slick D. J., 1997, VICTORIA SYMPTON VAL; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TOMBAUGH TN, COMPUTERIZE IN PRESS; TOMBAUGH TN, COMPUTERIZED T UNPUB; TOMBAUGH TN, 2007, NORMATIVE DATA UNPUB; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x	31	14	14	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	2008	23	4					419	431		10.1016/j.acn.2008.02.003			13	Psychology, Clinical; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	320CJ	WOS:000257211000006	18420373	Bronze			2022-02-06	
J	Puppo, C; Lopez, L; Caragna, E; Biestro, A				Puppo, Corina; Lopez, Lucia; Caragna, Elia; Biestro, Alberto			One-minute dynamic cerebral autoregulation in severe head injury patients and its comparison with static autoregulation. A transcranial doppler study	NEUROCRITICAL CARE			English	Article						severe head injury; cerebral autoregulation; outcome; cerebral perfusion pressure; intracranial pressure	VALSALVA MANEUVER; PRESSURE; FLOW; HUMANS; ARTERIES; RESPONSES; VELOCITY	Objective To compare dynamic and static responses of cerebral blood flow to sudden or slow changes in arterial pressure in severe traumatic brain injury (TBI) patients. Design Prospective study. Patients and Methods We studied 12 severe TBI patients, age 16-63 years, and median GCS 6. We determined the dynamic cerebral autoregulation: response of cerebral blood flow velocity to a step blood pressure drop, and the static cerebral autoregulation: change in cerebral blood flow velocity after a slow hypertensive challenge. Results During the dynamic response, the median drop in arterial pressure was 21 mm Hg. Dynamic response was graded between 9 (best) and 0 (worst). The median value was 5; four patients showed high values, (8-9), five patients showed intermediate values (4-6). In three patients (value = 0), the CBFV drop was greater than the cerebral perfusion pressure drop, and maintained through 60 s. The static cerebral autoregulation was preserved in 6/11 patients. The comparison between the two showed four different combinations. The five patients with impaired static cerebral autoregulation showed unfavorable outcome. Conclusions A sharp dynamic vasodilator response could not be sustained, and a slow or absent reaction to a sudden hypotensive challenge could show an acceptable cerebral autoregulation in the steady state. We found that patients with impaired static cerebral autoregulation had a poor outcome, whereas those with preserved static cerebral autoregulation experience favorable outcomes.	[Puppo, Corina; Lopez, Lucia; Biestro, Alberto] Univ Republica, Hosp Clin, Intens Care Unit, Montevideo, Uruguay; [Puppo, Corina; Caragna, Elia] IMPASA, Unidad Neurocrit, Montevideo, Uruguay		Puppo, C (corresponding author), Univ Republica, Hosp Clin, Intens Care Unit, Ave Italia S-N,CP 11200, Montevideo, Uruguay.	cpuppo@chasque.apc.org					AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BEVAN JA, 1987, FASEB J, V1, P193; BEVAN JA, 1993, NEWS PHYSIOL SCI, V8, P149; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Dawson SL, 1999, J APPL PHYSIOL, V86, P675, DOI 10.1152/jappl.1999.86.2.675; DUCKWORTH JW, 1989, CIRC RES, V65, P316, DOI 10.1161/01.RES.65.2.316; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GREENFIELD JC, 1984, STROKE, V15, P76, DOI 10.1161/01.STR.15.1.76; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; NEWELL DW, 1992, CEREBROVAS BRAIN MET, V4, P122; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Puppo C, 2002, ACTA NEUROCHIR SUPPL, V81, P129; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3	22	14	15	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	JUN	2008	8	3					344	352		10.1007/s12028-008-9069-8			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	301DT	WOS:000255877300006	18363042				2022-02-06	
J	Armstrong, CM; Allen, DN; Donohue, B; Mayfield, J				Armstrong, Christina M.; Allen, Daniel N.; Donohue, Bradley; Mayfield, Joan			Sensitivity of the comprehensive trail making test to traumatic brain injury in adolescents	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Comprehensive Trail Making Test; traumatic brain injury; adolescents; sensitivity; ROC analysis	OLDER CHILDREN; UNITED-STATES	The current study examined the sensitivity of the Comprehensive Trail Making Test (CTMT Reynolds) to neurocognitive deficits in adolescents with traumatic brain injury (TBI). Participants included 60 adolescents, 30 who had sustained TBI and 30 healthy controls (HC) that were individually matched to the TBI sample on age, gender, ethnicity, and geographical region. For both the TBI and HC groups the mean age was 15.0 years (S.D. = 2.3 years, range = 11-19). The TBI group had a mean IQ of 81.7 (S.D. = 14.9), had sustained moderate to severe brain injury, and was assessed an average of 21.1 months (S.D. = 20.7) following injury. The TBI group performed approximately 2 standard deviations below the control sample mean on each of the five CTMT trails as well as on the composite index and these differences were significant (p < .001). Significant correlations were present between the CTMT trails and clinical variables associated with brain injury severity. Finally, receiver operating characteristic analyses indicated good classification of the TBI and control cases for the CTMT, although some variability in classification accuracy was present among the various trails. Results suggest that the CTMT is sensitive to TBI in adolescents but continued research is needed with larger samples of individuals with TBI and other types of neurological disorders to further establish the present findings. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Armstrong, Christina M.; Allen, Daniel N.; Donohue, Bradley] Univ Nevada, Neuropsychol Res Program, Dept Psychol, Las Vegas, NV 89154 USA		Allen, DN (corresponding author), Univ Nevada, Neuropsychol Res Program, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu	Armstrong, Christina M./AAU-4242-2020	Armstrong, Christina M./0000-0002-2942-6553; Allen, Daniel/0000-0003-4868-2242			Allen DN, 1998, SCHIZOPHR RES, V34, P87, DOI 10.1016/S0920-9964(98)00090-5; Army Individual Test Battery, 1944, MANUAL DIRECTIONS SC; BOLL TJ, 1974, CLIN NEUROPSYCHOLOGY, P91; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; GOLDSTEIN G, 1966, PERCEPT MOTOR SKILL, V22, P347, DOI 10.2466/pms.1966.22.2.347; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, pS87; KRAEMER BR, 1997, STUDENTS ACQUIRED BR, P3; LANGLOIS JA, 2004, TRAUMATIC BRAIN US E; Lemeshow S, 2000, APPL LOGISTIC REGRES; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MITTELMEIER C, 1989, INT J CLIN NEUROPSYC, V11, P163; Partington J, 1949, PSYCHOL SERVICE CTR, V1, P46; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REED HBC, 1965, J CONSULT PSYCHOL, V29, P247, DOI 10.1037/h0022145; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wolfson, 1992, HALSTEAD REITAN NEUR; [No title captured]	27	14	14	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2008	23	3					351	358		10.1016/j.acn.2007.11.004			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	310VT	WOS:000256559500010	18280107	Bronze			2022-02-06	
J	Suma, T; Koshinaga, M; Fukushima, M; Kano, T; Katayama, Y				Suma, Takeshi; Koshinaga, Morimichi; Fukushima, Masamichi; Kano, Tsuneo; Katayama, Yoichi			Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article; Proceedings Paper	American-Heart-Association International Stroke Conference 2008	FEB 20-22, 2008	New Orleans, LA			astroglial swelling; excitatory amino acid; microglial reaction; traumatic brain injury; traumatic depolarization	SPREADING DEPRESSION; EXTRACELLULAR POTASSIUM; GLUCOSE-UTILIZATION; CORTICAL CONTUSION; CEREBRAL-CORTEX; SPINAL-CORD; ASTROCYTES; GLUTAMATE; RELEASE; CELLS	Objective: Both microglia and astrocytes respond immediately to traumatic brain injury (TBI). The present study was undertaken to examine whether or not excitatory amino acid (EAA) antagonists could attenuate such glial responses. Methods: EAA antagonists, including the broad spectrum EAA antagonist, kynurenic acid (KYN), specific N-methyl-D-aspartate (NMDA) receptor blocker, 2-amino-5-phosphonovalerate (AP-5), and AMPA-KA receptor blocker, 6,7-dinitroquinoxaline-2,3-dione (DNQX), as well as the voltage-dependent ion channel blocker, tetrodotoxin (TTX), were administered into the unilateral hippocampus of rats through a dialysis probe for 30 minutes before the induction of unilateral controlled cortical impact injury. The rats were killed 10 minutes after injury and their brains were processed immunohistochemically for OX42 (marker for microglia) and glial fibrillary acidic protein (GFAP; marker for astrocytes). Objective: Ten minutes after injury, microglial activation with increased OX42 immunoreactivity was evident in the entire hemisphere including the hippocampus ipsilateral to the injury side. Similarly, swollen astrocytes with increased GFAP expression could be detected exclusively on the injury side. When KYN was administered in situ before injury, both the rapid microglial and astroglial responses in the hippocampus were significantly attenuated. However, AP-5, DNQX and TTX, the voltage-dependent ion channel blocker, at doses which can inhibit each channel activation, failed to attenuate these glial reactions. Discussion: These findings indicate that massive ionic fluxes and/or concomitantly occurring EAA release may be closely related to the initiation of microglial and astroglial responses following TBI.	[Koshinaga, Morimichi] Nihon Univ, Sch Med, Dept Anat, Itabashi Ku, Tokyo 1738610, Japan; [Suma, Takeshi; Koshinaga, Morimichi; Fukushima, Masamichi; Kano, Tsuneo; Katayama, Yoichi] Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, Tokyo 1738610, Japan		Koshinaga, M (corresponding author), Nihon Univ, Sch Med, Dept Anat, Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	koshimo@med.nihon-u.ac.jp					Abe K, 2000, BIOL PHARM BULL, V23, P1051; Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; AQUINO DA, 1988, J NEUROCHEM, V51, P1085, DOI 10.1111/j.1471-4159.1988.tb03072.x; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BENVENISTE EN, 1997, IMMUNOLOGY NERVOUS S, P419; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Caggiano AO, 1996, J COMP NEUROL, V369, P93, DOI 10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F; Chang RCC, 2000, NEUROSCIENCE, V97, P757, DOI 10.1016/S0306-4522(00)00059-2; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chung S, 1998, NEUROSCI LETT, V242, P73, DOI 10.1016/S0304-3940(98)00029-9; Del Rio-Hortega R., 1965, CYTOLOGY CELLULAR PA, P483; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dombro RS, 2000, INT J DEV NEUROSCI, V18, P161, DOI 10.1016/S0736-5748(99)00084-2; Duchen L. W, 1984, GREENFIELDS NEUROPAT, P1; Eder C, 1999, EUR J NEUROSCI, V11, P4251, DOI 10.1046/j.1460-9568.1999.00852.x; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; HAMBERGER A, 1979, BRAIN RES, V168, P531, DOI 10.1016/0006-8993(79)90307-X; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P8, DOI 10.1098/rspb.1967.0010; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; KETTENMANN H, 1993, GLIA, V7, P93, DOI 10.1002/glia.440070115; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kraig Richard P., 1995, P964; KRAIG RP, 1991, J NEUROSCI, V11, P2187; KREUTZBERG GW, 1987, ENCY NEUROSCIENCE, P661; Maeda T, 1997, ACT NEUR S, V70, P102; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; Miele M, 1996, J PHYSIOL-LONDON, V497, P745, DOI 10.1113/jphysiol.1996.sp021805; MURPHY S, 1987, NEUROSCIENCE, V22, P381, DOI 10.1016/0306-4522(87)90342-3; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6; NORENBERG MD, 1982, J NEUROPATH EXP NEUR, V41, P347, DOI 10.1097/00005072-198205000-00026; OCHS S, 1971, J NEUROCHEM, V18, P107, DOI 10.1111/j.1471-4159.1971.tb00172.x; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; PUEL JL, 1994, J COMP NEUROL, V341, P241, DOI 10.1002/cne.903410209; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SHIMOHAMA S, 1989, MOL BRAIN RES, V5, P271, DOI 10.1016/0169-328X(89)90061-2; Sperlagh B, 1998, NEUROSCIENCE, V86, P1195, DOI 10.1016/S0306-4522(98)00026-8; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; SUGAYA E, 1975, J NEUROPHYSIOL, V38, P822, DOI 10.1152/jn.1975.38.4.822; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Vernadakis A, 1996, PROG NEUROBIOL, V49, P185, DOI 10.1016/S0301-0082(96)00012-3; WALZ W, 1989, PROG NEUROBIOL, V33, P309, DOI 10.1016/0301-0082(89)90005-1; WALZ W, 1993, J NEUROSCI, V13, P4403; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0	57	14	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2008	30	4					420	429		10.1179/016164107X251745			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	314VR	WOS:000256837800019	18248696				2022-02-06	
J	Yap, SGM; Chua, KSG				Yap, Samantha G. M.; Chua, Karen S. G.			Rehabilitation outcomes in elderly patients with traumatic brain injury in Singapore	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability; elderly; head injury; neurorehabilitation; outcomes	OLDER PATIENTS; UNITED-STATES; HEAD-INJURY; MORTALITY; RECOVERY; ADULTS; WORSE; AGE	Objective: To identify and characterize injury variables and outcomes in persons with traumatic brain injury (TBI) 55 years and older admitted to a tertiary rehabilitation unit. Design: Retrospective study of 52 individuals with TBI covering a 4-year period. Outcome measures: Admission and discharge Modified Barthel Index scores; total acute and rehabilitation length of stay; Glasgow Coma Scale (GCS); duration of posttraumatic amnesia (PTA); Glasgow Outcome Scale at discharge and at 6 months postinjury; Ranchos Los Amigos Scale; and discharge disposition. Results: Most common mechanism of injury was falls (61.5%), and predominant computed tomographic scan finding was lobar contusion (44%). Thirty-one percent had GCS score less than 9, but 90% had PTA duration of more than I week. Mean length of stay in acute and rehabilitation facilities was 26.4 (SD = 15.9) days and 29.8 (SD = 14.4) days, respectively. Difference between admission and discharge Modified Barthel Index was significant (P < .001), and 90% were discharged home. There was improvement in Glasgow Outcome Scale score at 6 months. Conclusions: Most patients in this cohort had severe brain injury, which may be due to a higher incidence of intracerebral hematoma. The GCS score underestimates the severity of brain injury in elderly persons with TBI; PTA duration was more representative of severity. Older patients with TBI do benefit from rehabilitation with significant functional gains and a high rate of return to home and to community.	[Yap, Samantha G. M.; Chua, Karen S. G.] Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore		Yap, SGM (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mokio Ave 9, Singapore 569766, Singapore.	samantha_yap@ttsh.com.sg					Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GOODMAN H, 1992, PHYS MED REH CLIN N, V3, P441; HORN LJ, 1992, PHYS MED REHAB CLIN, V3, P475; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1995, EPIDEMIOLOGY BRAIN I; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; MCKISSOCK W, 1960, LANCET, V1, P1365; MILLER J D, 1989, Neurosurgical Review, V12, P441; *MIN HLTH, 2006, HLTH FACTS SING; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; PERMINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; *SING DEP STAT, KEY IND POP; *SING DEP STAT, 2006, SING RES AG GROUP ET; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 2001, HEAD TRAUMA, P327; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traynelis V C, 1991, Clin Geriatr Med, V7, P583; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	31	14	14	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2008	23	3					158	163		10.1097/01.HTR.0000319932.15085.fe			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	309XN	WOS:000256493600004	18520428				2022-02-06	
J	Yurdakoc, A; Gunday, I; Memis, D				Yurdakoc, A.; Gunday, I.; Memis, D.			Effects of halothane, isoflurane, and sevoflurane on lipid peroxidation following experimental closed head trauma in rats	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						traumatic brain injury; halothane; isoflurane; sevoflurane; malondialdehyde; rats	INCOMPLETE CEREBRAL-ISCHEMIA; D-ASPARTATE RECEPTOR; BRAIN-INJURY; VOLATILE ANESTHETICS; BLOOD-FLOW; IN-VITRO; GLUTAMATE; FENTANYL; CHANNELS; NEUROPROTECTION	Background: In a rat closed head trauma model we examined both the time course of lipid peroxidation and the effects of halothane, isoflurane, and sevoflurane on it by analysis of malondialdehyde (MDA) formation. Methods: Animals were divided randomly into five groups: sham-operated (SO), n=18; control-closed head trauma to left frontal pole, n=18; closed head trauma model+halothane, n=18; closed head trauma model+isoflurane, n=18; and closed head trauma model+sevoflurane, n=18. Halothane, isoflurane, or sevoflurane were applied 15 min after trauma for 30 min. Rats were euthanized 1,3, and 5 h after the inhalation agents. Brain tissue samples were taken 5 mm from the left and right frontal poles. MDA was considered to reflect the degree of lipid peroxidation. Results: MDA concentrations were greater in the control, halothane, sevoflurane, and isoflurane groups than in SO animals (P < 0.001). No statistical difference between the hemispheres was found between the halothane, isoflurane, or sevoflurane groups, but MDA levels were lower with isoflurane than in the halothane, sevoflurane, and control groups at 1, 3, and 5 h (P < 0.001). MDA levels were higher as compared with the halothane and sevoflurane groups at 1 h but not at 3 or 5 h (P < 0.001). Conclusion: MDA levels with the isoflurane group were lower than in the other trauma groups, which suggest that isoflurane, given after closed head trauma, might be protective against lipid peroxidation of cerebral injury.	[Gunday, I.; Memis, D.] Trakya Univ, Fac Med, Dept Anaesthesiol, TR-22030 Edirne, Turkey; [Yurdakoc, A.] Trakya Univ, Fac Med, Dept Anaesthesiol, Trakya Univ Hosp, TR-22030 Edirne, Turkey		Memis, D (corresponding author), Trakya Univ, Fac Med, Dept Anaesthesiol & Reanimat, TR-22030 Edirne, Turkey.	dilmemis@mynet.com					BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; Bickler PE, 2003, ANESTH ANALG, V97, P564, DOI 10.1213/01.ANE.0000068880.82739.7B; BROWN BR, 1972, ANESTHESIOLOGY, V458; Cope DK, 1997, ANESTHESIOLOGY, V86, P699, DOI 10.1097/00000542-199703000-00023; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Di X, 1997, STROKE, V28, P2244, DOI 10.1161/01.STR.28.11.2244; Elsersy H, 2004, ANESTHESIOLOGY, V100, P1160, DOI 10.1097/00000542-200405000-00018; Engelhard K, 2004, EUR J ANAESTH, V21, P530, DOI 10.1017/S0265021504007057; Gross GJ, 2000, CIRC RES, V87, P431; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; HOFFMAN WE, 1993, ANESTH ANALG, V76, P279; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; Karamanlioglu B, 2002, NUCL MED COMMUN, V23, P53, DOI 10.1097/00006231-200201000-00009; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; Kehl F, 2004, BRAIN RES, V1021, P76, DOI 10.1016/j.brainres.2004.06.038; Kingery WS, 2002, ANESTHESIOLOGY, V96, P367, DOI 10.1097/00000542-200202000-00023; KOENIG HM, 1994, J NEUROSURG ANESTH, V6, P229; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mitsuyo T, 2006, ANESTH ANALG, V103, P753, DOI 10.1213/01.ane.0000230605.22930.52; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OZS H, 2005, NEUROSURG REV, V28, P143; Patel PM, 1998, ANESTH ANALG, V86, P773, DOI 10.1097/00000539-199804000-00018; PATEL PM, 1993, J CEREB BLOOD FLOW M, pS685; Rehberg B, 1996, ANESTHESIOLOGY, V84, P1223, DOI 10.1097/00000542-199605000-00025; SCATTON B, 1991, CEREBROVASC DIS, V1, P121, DOI 10.1159/000108829; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Toner CC, 2001, BRIT J ANAESTH, V86, P550, DOI 10.1093/bja/86.4.550; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Werner C, 2005, ANESTH ANALG, V101, P509, DOI 10.1213/01.ANE.0000160586.71403.A4; WERNER C, 1995, BRIT J ANAESTH, V75, P756, DOI 10.1093/bja/75.6.756; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047	46	14	15	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAY	2008	52	5					658	663		10.1111/j.1399-6576.2008.01635.x			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	289FL	WOS:000255040300014	18419720				2022-02-06	
J	Kockler, TR; Stanford, MS				Kockler, Tim R.; Stanford, Matthew S.			Using a clinically aggressive sample to examine the association between impulsivity, executive functioning, and verbal learning and memory	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						CVLT; memory; executive function; impulsivity; BIS-11; aggression; verbal learning	PERSONALITY DISORDERED OFFENDERS; TRAUMATIC BRAIN-INJURY; DECISION-MAKING; WORKING-MEMORY; CORTEX	Impulsive behavior has been conceptualized from several vantage points including biological, sociological and psychological phenomenon. A comprehensive review of the empirical literature revealed that there is a paucity of research examining the association between working memory, executive functioning and impulsivity. A total sample of 170 aggressive outpatient participants was recruited for the study. Participants were administered a comprehensive neuropsychological battery. Principal components analysis of the 19 CVLT indices revealed five factors, accounting for 68% of the total variance. Results from the canonical correlation revealed one significant canonical variate with loadings from three CVLT factors (General Verbal Learning, Response Discrimination, and Proactive Interference), two executive functioning measures (Trail Making Test and Controlled Oral Word Association Test), and one impulsivity subscale, (Attentional Impulsiveness). The findings of this study underscore the importance of memory functioning in determining impulsive aggressive behavior. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Stanford, Matthew S.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Kockler, Tim R.] Dixie Reg Med Ctr, St George, UT 84770 USA		Stanford, MS (corresponding author), Baylor Univ, Dept Psychol & Neurosci, 1 Bear Pl,97334 Waco, Waco, TX 76798 USA.	Matthew_Stanford@Baylor.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barratt ES, 1997, BIOL PSYCHIAT, V41, P1045, DOI 10.1016/S0006-3223(96)00175-8; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Benson D.F., 1986, FRONTAL LOBES; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Cohen J., 2013, STAT POWER ANAL BEHA; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Damasio A., 1994, DESCARTES ERROR EMOT; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DELIS DC, 1987, CALIFORNAI VERBAL LE; Dolan M, 2002, J FORENSIC PSYCHIATR, V13, P503, DOI 10.1080/0958518021000019452; Dolan M, 2002, PSYCHOL MED, V32, P105, DOI 10.1017/S0033291701004688; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Finn PR, 1999, PSYCHOPHARMACOLOGY, V146, P465, DOI 10.1007/PL00005492; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Hare R.D., 2003, HARE PSYCHOPATHY CHE; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Kockler TR, 2006, AM J ORTHOPSYCHIAT, V76, P80, DOI 10.1037/0002-9432.76.1.80; LAUTENSCHLAGER GJ, 1989, MULTIVAR BEHAV RES, V24, P365, DOI 10.1207/s15327906mbr2403_6; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Meloy J.R, 2000, VIOLENCE RISK THREAT; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; REITAN RM, 1958, HALSTEAD REITAN NEUR; Ruff RM, 1988, RUFF FIGURAL FLUENCY; Spreen O., 1969, NEUROSENSORY CTR COM; *SPSS INC, 2002, SPSS STAT PROGR SOC; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; Steadman H.J., 1994, VIOLENCE MENTAL DISO, P61; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; VANDERPLOEG RD, 1994, J CLIN EXP NEUROPSYC, V16, P243, DOI 10.1080/01688639408402635; Villemarette-Pittman NR, 2003, PERS INDIV DIFFER, V34, P1533, DOI 10.1016/S0191-8869(02)00136-8; Whitney P, 2004, PERS INDIV DIFFER, V37, P417, DOI 10.1016/j.paid.2003.09.013	42	14	16	2	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2008	23	2					165	173		10.1016/j.acn.2007.10.006			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	283SS	WOS:000254657400005	18055163	Bronze			2022-02-06	
J	Lemoyne, R; Dabiri, F; Jafari, R				Lemoyne, Robert; Dabiri, Foad; Jafari, Roozbeh			Quantified deep tendon reflex device, second generation	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article; Proceedings Paper	15th Biennial International Conference on Mechanics in Medicine and Biology	DEC 05-08, 2006	HI	Nanyang Technol Univ, Pacific Cent ThermalFluids Engn		reflex quantification; accelerometers; neurorehabilitation; traumatic brain injury	QUANTITATIVE-EVALUATION; STRETCH REFLEX; SPASTICITY	The deep tendon reflex is a fundamental aspect of neurological examinations. The severity of and degree of recovery from a traumatic brain injury can be assessed by the myotatic stretch reflex. A hyperactive reflex response is correlated with spasticity, which can also be correlated with the degree of damage to the supraspinal input, in essence assessing the severity of traumatic brain injury. The myotatic stretch reflex is clinically evaluated by the National Institute of Neurological Disorders and Stroke (NINDS) reflex scale (0-4); however, this scale lacks temporal data and may also vary in interpretation. The solution is a fully quantified evaluation system of the myotatic stretch reflex, whereby a patellar hammer's force input is based on original potential energy and a microelectromechanical system (MEMS) accelerometer quantifies the output. The MEMS accelerometer is attached to a set anchor point near the ankle. The reflex amplitude is based on the maximum acceleration of the reflex response. The quantified data collected from MEMS accelerometers are transmitted by a portable computer (i.e. a Pocket PC). This paper describes a device that quantitatively evaluates the reflex response using accelerometers and that demonstrates precision for reproducibility.	[Lemoyne, Robert] Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90095 USA; [Dabiri, Foad; Jafari, Roozbeh] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA		Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, 5121 Engn 5,Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			Cozens JA, 2000, J NEUROL NEUROSUR PS, V68, P581, DOI 10.1136/jnnp.68.5.581; Faist M, 1999, BRAIN, V122, P567, DOI 10.1093/brain/122.3.567; JAFARI R, 2005, 2 ACM IEEE INT C MOB; Lebiedowska MK, 2003, ARCH PHYS MED REHAB, V84, P828, DOI 10.1016/S0003-9993(02)04946-8; LEMOYNE R, 2005, UCLA COMMUNICATION N; LEMOYNE R, 2006, 15 INT C MECH MED BI; LEMOYNE R, 2005, 35 SOC NEUR ANN M WA; LEMOYNE R, 2006, 36 SOC NEUR ANN M; Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; Pagliaro P, 1999, J ELECTROMYOGR KINES, V9, P141, DOI 10.1016/S1050-6411(98)00045-5; VandeCrommert HWAA, 1996, BRAIN RES, V734, P341, DOI 10.1016/0006-8993(96)00885-2; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	13	14	14	0	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194			J MECH MED BIOL	J. Mech. Med. Biol.	MAR	2008	8	1					75	85		10.1142/S0219519408002462			11	Biophysics; Engineering, Biomedical	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	321GC	WOS:000257291700008					2022-02-06	
J	Makulski, DD; Taber, KH; Chiou-Tan, FY				Makulski, Darlene D.; Taber, Katherine H.; Chiou-Tan, Faye Y.			Neuroimaging in posttraumatic hypopituitarism	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						posttraumatic hypopituitarism; traumatic brain injury; diabetes insipidus	TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; PITUITARY-GLAND; ACUTE-PHASE; MR-IMAGES; PREVALENCE; LESIONS; ENHANCEMENT	Posttraumatic hypopituitarism is the failure of the hypothalamic-pituitary axis secondary to traumatic brain injury. It can clinically present as decreased muscle mass, concentration, libido, and fertility. It can also present as increased fatigue, depression, and cognitive deficits. In addition, electrolyte abnormalities such as hyponatremia can occur in hypopituitarism. As a result of heightened awareness of posttraumatic hypopituitarism, it is a phenomenon that is becoming more commonly diagnosed. Posttraumatic hypopituitarism is a diagnosis based on clinical evaluation, laboratory testing, and neuroimaging. Of the radiological techniques, magnetic resonance imaging is the preferred technique to image the pituitary gland. This article contains coronal and sagittal magnetic resonance imaging of the posterior fossa, illustrating the normal hypothalamus and pituitary gland as well as adjacent structures. The sequential enhancement pattern of the normal pituitary gland is consistent with its vascular supply. A colored illustration was created to display the vascular supply to the hypothalamus, pituitary stalk, and pituitary gland.	[Taber, Katherine H.; Chiou-Tan, Faye Y.] Harris Cty Hosp Dist, Quentin Mease Hosp, Ctr Trauma Rehabil Res, Dept Phys Med & Rehabil, Houston, TX 77004 USA; [Makulski, Darlene D.; Chiou-Tan, Faye Y.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Taber, Katherine H.] WG Bill Hefner Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Taber, Katherine H.] Virginia Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA		Chiou-Tan, FY (corresponding author), Harris Cty Hosp Dist, Quentin Mease Hosp, Ctr Trauma Rehabil Res, Dept Phys Med & Rehabil, 3601 N MacGregor,Suite 240, Houston, TX 77004 USA.		Taber, Katherine H/B-8260-2011	Taber, Katherine H/0000-0001-7382-6151			Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; BENVEGA S, 2000, J CLIN ENDOCR METAB, V85, P675; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Ceballos R, 1966, Ala J Med Sci, V3, P185; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; COLOMBO N, 1987, RADIOLOGY, V165, P481, DOI 10.1148/radiology.165.2.3659370; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DENGHUANG S, 2005, J FORMOS MED ASSOC, V104, P463; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; JAKUBOWSKI J, 1995, BRIT J NEUROSURG, V9, P331, DOI 10.1080/02688699550041340; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LUIGI M, 1997, CLIN IMAG, V21, P311; Ma L, 1996, CHINESE MED J-PEKING, V109, P724; Mai JK, 2004, ATLAS HUMAN BRAIN; MARK AS, 1992, RADIOLOGY, V182, P49, DOI 10.1148/radiology.182.1.1727308; MIKI Y, 1990, RADIOLOGY, V178, P441; NOLTE J, 2002, HIONAN BRAIN INTRO I; Pisaneschi M, 2005, NEUROIMAG CLIN N AM, V15, P203, DOI 10.1016/j.nic.2005.02.007; Saleem SN, 2007, RADIOGRAPHICS, V27, P1087, DOI 10.1148/rg.274065123; SATO N, 1993, RADIOLOGY, V186, P357, DOI 10.1148/radiology.186.2.8421734; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; TIEN R, 1991, AM J NEURORADIOL, V12, P533; TIEN RD, 1992, AM J ROENTGENOL, V158, P651, DOI 10.2214/ajr.158.3.1739013; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; Whitehead, 2001, ENDOCRINOLOGY INTEGR; Yousem D. M., 2003, NEURORADIOLOGY REQUI; YUH WTC, 1994, AM J NEURORADIOL, V15, P101	33	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAR-APR	2008	32	2					324	328		10.1097/RCT.0b013e3181636ed4			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	284CS	WOS:000254683500031	18379326				2022-02-06	
J	Shafi, NI; Andresen, J; Marrelli, SP; Bryan, RM				Shafi, Nadeem I.; Andresen, Jon; Marrelli, Sean P.; Bryan, Robert M., Jr.			Erythropoietin potentiates EDHF-Mediated dilations in rat middle cerebral arteries	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; EDHF; erythropoietin; therapeutic approaches for the treatment of CNS injury; vascular reactivity	RECOMBINANT-HUMAN-ERYTHROPOIETIN; NITRIC-OXIDE SYNTHASE; CORTICAL IMPACT INJURY; TRAUMATIC BRAIN-INJURY; HYPERPOLARIZING FACTOR; IN-VITRO; SUBARACHNOID HEMORRHAGE; VASCULAR PROTECTION; BLOOD-FLOW; RECEPTOR	The neuroprotective effects of exogenous erythropoietin ( EPO) in animals and humans after brain injury may be afforded, in part, by the influence of EPO on cerebral arteries. We tested ( 1) if EPO itself is vasoactive and ( 2) if EPO enhances endothelium-mediated dilations, specifically those mediated by endothelium-derived hyperpolarizing factor ( EDHF). Immunoblotting and reverse transcriptase - polymerase chain reaction ( RT-PCR) were used to detect EPO receptor. Rat middle cerebral arteries ( MCAs) were isolated, pressurized, and perfused in vitro. EPO was directly applied to MCAs to test its vasoactivity. Endothelium-mediated dilations were elicited by UTP, whereas EDHF-mediated dilations were elicited by UTP after inhibition of endothelial nitric oxide synthase and cyclooxygenase. mRNA and protein for EPO receptor was found in rat MCA. Abluminal application of 0.001 - 10 U/mL EPO, which is selective for vascular smooth muscle, did not alter vessel diameter. In contrast, luminal application of EPO, which is selective for endothelium, resulted in concentration-dependent dilations of up to 39 +/- 16% at 10 U/mL ( p = 0.0018), though responses were variable. A single dose of EPO ( 1,000 U/kg) administered to rats 24 h prior to examining vascular function potentiated dilations to UTP 2.6-fold ( p < 0.0001). EDHF-mediated dilations were potentiated 2.1-fold following in vivo EPO treatment ( p = 0.0034). This study demonstrates that EPO can directly dilate rat MCAs via the endothelium, though not all vessels are responsive. Additionally, pre-treatment with EPO for 24 h in vivo potentiates endothelium-mediated dilations, specifically those mediated by EDHF. Thus, enhanced endothelium-mediated dilations may partially underlie the neuroprotective effects of EPO after brain injury.	[Andresen, Jon; Marrelli, Sean P.; Bryan, Robert M., Jr.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; [Shafi, Nadeem I.] Baylor Coll Med, Sect Pediat Crit Care Med, Houston, TX 77030 USA		Bryan, RM (corresponding author), Baylor Coll Med, Dept Anesthesiol, 1 Baylor Plaza,Suite 434-D, Houston, TX 77030 USA.	rbryan@bcm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007939, F32HL080916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046666] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL080916, T32HL07939-01A2] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS46666] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [P01NSO38660] Funding Source: Medline		Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bryan RM, 2005, ANESTHESIOLOGY, V102, P1261, DOI 10.1097/00000542-200506000-00028; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; Bryan RM, 2006, AM J PHYSIOL-HEART C, V291, pH770, DOI 10.1152/ajpheart.01377.2005; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Golding EM, 2001, J NEUROTRAUM, V18, P691, DOI 10.1089/089771501750357636; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; HEIDENREICH S, 1991, KIDNEY INT, V39, P259, DOI 10.1038/ki.1991.31; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Juul SE, 1999, PEDIATR RES, V46, P543, DOI 10.1203/00006450-199911000-00009; Juul SE, 1999, PEDIATR DEVEL PATHOL, V2, P148, DOI 10.1007/s100249900103; KIRKPATRICK PJ, 2005, ERYTHROPOIETIN THERA; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; MASUDA S, 1993, J BIOL CHEM, V268, P11208; MAYEUX P, 1991, J BIOL CHEM, V266, P23380; Monge A, 2006, LARYNGOSCOPE, V116, P312, DOI 10.1097/01.mlg.0000199400.08550.3f; Morakkabati N, 1996, EXP HEMATOL, V24, P392; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Resch BE, 2003, AM J OBSTET GYNECOL, V188, P993, DOI 10.1067/mob.2003.211; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; ROBERTSON CS, 2006, EFFECTS ERYTHROPOIET; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2006, AM J PHYSIOL-HEART C, V291, pH781, DOI 10.1152/ajpheart.00045.2006; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Sun Y, 2004, J CEREBR BLOOD F MET, V24, P259, DOI 10.1097/01.WCB.0000110049.43905.AC; TAKAHASHI S, 1995, NEPHROL DIAL TRANSPL, V10, P815; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; You JP, 1997, AM J PHYSIOL-HEART C, V273, pH1472, DOI 10.1152/ajpheart.1997.273.3.H1472; You JP, 1999, STROKE, V30, P1125, DOI 10.1161/01.STR.30.5.1125; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223	42	14	14	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2008	25	3					257	265		10.1089/neu.2007.0347			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	282PJ	WOS:000254579400009	18352839				2022-02-06	
J	Chavira, DA; Garrido, H; Bagnarello, M; Azzoin, A; Reus, VI; Mathews, CA				Chavira, Denise A.; Garrido, Helena; Bagnarello, Monica; Azzoin, Anun; Reus, Victor I.; Mathews, Carol A.			A comparative study of obsessive-compulsive disorder in Costa Rica and the United States	DEPRESSION AND ANXIETY			English	Article						obsessions; compulsions; obsessive-compulsive disorder; culture; Hispanic; Latino	BECK DEPRESSION INVENTORY; COMPLEX SEGREGATION ANALYSIS; TRAUMATIC BRAIN-INJURY; AGE-CHILDREN-PRESENT; K-SADS-PL; SPANISH VERSION; PSYCHOMETRIC PROPERTIES; TOURETTES-SYNDROME; ANXIETY DISORDERS; MATERNAL SMOKING	This study compares the presentation and expression of obsessive-compulsive symptoms between a Latin-American and North American sample. In Costa Rica (CR) and the United States (US), respectively, 26 and 52 affected individuals with early-onset obsessive-compulsive disorder (OCD) were recruited. The Yale Brown Obsessive Compulsive Scale (YBOCS), a semi-structured psychiatric interview, and self-report questionnaires were administered. Age of onset and the distribution of OCD across men and women were similar across groups. Both CR and US participants reported obsessions and compulsions, with similar frequencies of symptoms, and contamination, symmetry, and boarding as the most common symptom subtypes. The US sample had higher YBOCS total severity scores than the Costa Rican group. Similarly, there were significant ethnicity effects for YBOCS compulsion [F(1, 70) = 17.88, P<.001] and obsession severity IF(1, 70) = S. 78, P <. 0011, with Caucasians having higher scores than Costa Ricans on both subscales. Comorbidity rates were higher for US Caucasians than Costa Ricans for all disorders; differences were significant mood disorders [64.7% versus 34.6%] alcohol use [21.3%, vervus 3.8%], cannabis use disorders [19.1% versus 0%], and other substance use disorders [39.4% versus 0%]. Regression analyses revealed that ethnicity, trait anxiety, and proband status were the on, significant predictors of total YBOCS severity. Findings suggest that the core phenotype of OCD is the same in both CR and the US, and perhaps biologically driven. However some features of OCD, such as impairment, may be culturally influenced, leading to differences in prevalence rates and treatment utilization.	[Chavira, Denise A.; Azzoin, Anun; Reus, Victor I.; Mathews, Carol A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; [Garrido, Helena; Bagnarello, Monica] Hosp CIMA, San Jose, Costa Rica		Chavira, DA (corresponding author), Univ Calif San Diego, Dept Psychiat, 8950 Villa La Jolla Dr,Ste B218, La Jolla, CA 92037 USA.	dchavira@ucsd.edu	reus, victor i/I-7923-2015; Mathews, Carol A A/M-8922-2017	reus, victor i/0000-0002-8193-5697; Mathews, Carol A A/0000-0003-2208-7058; Azzam, Amin/0000-0002-7024-7450	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K23RR015533] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K23 RR15533] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH07295-01A1] Funding Source: Medline		AKHTAR S, 1978, INT J SOC PSYCHIATR, V24, P164, DOI 10.1177/002076407802400303; Bebbington PE, 1998, BRIT J PSYCHIAT, V173, P2, DOI 10.1192/S0007125000297833; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63; Bonicatto S, 1998, PSYCHIAT RES, V79, P277, DOI 10.1016/S0165-1781(98)00047-X; Borges G, 2006, AM J PSYCHIAT, V163, P1371, DOI 10.1176/appi.ajp.163.8.1371; Button TMM, 2005, BRIT J PSYCHIAT, V187, P155, DOI 10.1192/bjp.187.2.155; CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727; Caraveo-Anduaga JJ, 1999, SALUD MENT, V22, P62; Cavallini MC, 1999, AM J MED GENET, V88, P38, DOI 10.1002/(SICI)1096-8628(19990205)88:1<38::AID-AJMG7>3.0.CO;2-#; Coetzer BR, 2004, INT J PSYCHIAT MED, V34, P363, DOI 10.2190/XENN-NNWT-7N2K-R26A; do Rosario-Campos MC, 2005, AM J MED GENET B, V136B, P92, DOI 10.1002/ajmg.b.30149; Evans DW, 1999, CHILD PSYCHIAT HUM D, V29, P261, DOI 10.1023/A:1021392931450; Fireman B, 2001, AM J PSYCHIAT, V158, P1904, DOI 10.1176/appi.ajp.158.11.1904; Fontenelle LF, 2004, J PSYCHIATR RES, V38, P403, DOI 10.1016/j.jpsychires.2003.12.004; Franzblau S H, 1997, Cult Divers Ment Health, V3, P259; GARRALDA ME, 1988, BRIT J PSYCHIAT, V153, P81, DOI 10.1192/bjp.153.1.81; Geller DA, 2001, INT J NEUROPSYCHOPH, V4, P169, DOI 10.1017/S1461145701002395; Goodman WK, 1999, J CLIN PSYCHIAT, V60, P27; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Grados MA, 2003, INT REV PSYCHIATR, V15, P350, DOI 10.1080/09540260310001606737; HANTOUCHE EG, 1995, ENCEPHALE, V21, P571; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Heyman I, 2001, BRIT J PSYCHIAT, V179, P324, DOI 10.1192/bjp.179.4.324; Hollander E, 1998, CNS SPECTRUMS S1, V3, P10, DOI DOI 10.1017/S1092852900007148; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; KARNO M, 1989, J NERV MENT DIS, V177, P202, DOI 10.1097/00005053-198904000-00003; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; LEONARD HL, 1990, J AM ACAD CHILD PSY, V29, P17, DOI 10.1097/00004583-199001000-00004; Mathews CA, 2006, AM J PSYCHIAT, V163, P1066, DOI 10.1176/appi.ajp.163.6.1066; Mathews CA, 2001, J AM ACAD CHILD PSY, V40, P456, DOI 10.1097/00004583-200104000-00015; Mell LK, 2005, PEDIATRICS, V116, P56, DOI 10.1542/peds.2004-2058; Neal-Barnett A. M., 1997, CULTURAL ISSUES TREA; Nestadt G, 2000, AM J HUM GENET, V67, P1611, DOI 10.1086/316898; NESTADT G, 1994, ACTA PSYCHIAT SCAND, V89, P219, DOI 10.1111/j.1600-0447.1994.tb01504.x; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; Ng CH, 1997, AUST NZ J PSYCHIAT, V31, P382, DOI 10.3109/00048679709073848; Nicolini H, 1993, Arch Med Res, V24, P193; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; OKASHA A, 1994, COMPR PSYCHIAT, V35, P191, DOI 10.1016/0010-440X(94)90191-0; Palacio Carlos Alberto, 2004, Biomed., V24, P56; Paula D, 1999, AM J HUM GENET, V65, P1428; Pauls DL, 1999, CHILD ADOL PSYCH CL, V8, P481; Quintana JM, 2003, ACTA PSYCHIAT SCAND, V107, P216, DOI 10.1034/j.1600-0447.2003.00062.x; RASMUSSEN SA, 1984, J CLIN PSYCHIAT, V45, P450; RASMUSSEN SA, 1986, AM J PSYCHIAT, V143, P317; Spielberger C, 2005, ACTAS ESP PSIQUIATRI, V33, P374; SPIELBERGER CD, 1986, MANUAL STAI; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Steketee G, 1998, J ANXIETY DISORD, V12, P525, DOI 10.1016/S0887-6185(98)00030-9; SuarezMendoza AA, 1997, ARTHRIT CARE RES, V10, P194, DOI 10.1002/art.1790100307; TAKEUCHI DT, 1993, J HEALTH SOC BEHAV, V34, P153, DOI 10.2307/2137241; Ulloa RE, 2006, ACTAS ESP PSIQUIATRI, V34, P36; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; Weissman, 1998, CNS SPECTRUMS, V3, P6, DOI [10.1017/S1092852900007136, DOI 10.1017/S1092852900007136]; WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5; Woodward L, 1997, J CHILD PSYCHOL PSYC, V38, P479, DOI 10.1111/j.1469-7610.1997.tb01533.x; Zahner GEP, 1997, AM J PUBLIC HEALTH, V87, P1440, DOI 10.2105/AJPH.87.9.1440; Zohar AH, 2001, J ABNORM CHILD PSYCH, V29, P121, DOI 10.1023/A:1005231912747; Zohar AH, 1997, J CHILD PSYCHOL PSYC, V38, P993, DOI 10.1111/j.1469-7610.1997.tb01616.x	66	14	14	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety		2008	25	7					609	619		10.1002/da.20357			11	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	335GV	WOS:000258279700007	17823962				2022-02-06	
J	Granacher, RP				Granacher, Robert P., Jr.			Commentary: Applications of functional neuroimaging to civil litigation of mild traumatic brain injury	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							METAANALYSIS	The current definition of mild traumatic brain injury (MTBI) is in flux. Presently, there are at least three working definitions of this disorder in the United States, with no clear consensus. Functional neuroimaging, such as single photon emission computed tomography (SPECT) and positron emission tomography (PET), initially showed promise in their ability to improve the diagnostic credibility of MTBI. Over the past decade, that promise has not been fulfilled and there is a paucity of quality studies or standards for the application of functional neuroimaging to traumatic brain injury, particularly in litigation. The legal profession is ahead of the science in this matter. The emergence of neurolaw is driving a growing use of functional neuroimaging, as a sole imaging modality, used by lawyers in an attempt to prove MTBI at trial. The medical literature on functional neuroimaging and its applications to MTBI is weak scientifically, sparse in quality publications, lacking in well-designed controlled studies, and currently does not meet the complete standards of Doubert v. Merrell Dow Pharmaceuticals, Inc., for introduction of scientific evidence at trial. At the present time, there is a clear lack of clinical correlation between functional neuroimaging of MTBI and behavioral, neuropsychological, or structural neuroimaging deficits. The use of SPECT or PET, without concurrent clinical correlation with structural neuroimaging (CT or MRI), is not recommended to be offered as evidence of MTBI in litigation.	[Granacher, Robert P., Jr.] Lexington Forens Neuropsychiat, Lexington, KY 40504 USA; [Granacher, Robert P., Jr.] Univ Kentucky, Coll Med, Lexington, KY USA		Granacher, RP (corresponding author), Lexington Forens Neuropsychiat, 1401 Harrodsburg Rd, Lexington, KY 40504 USA.	rgranacher@aol.com					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ANDERSON KE, 2005, TXB TRAUMATIC BRAIN, P107; ATLAS SW, 2002, MAGNETIC RESONANCE I, V1; BARKOVICH JA, 1971, PEDIAT NEUROIMAGING; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Dougherty D.D., 2004, ESSENTIALS NEUROIMAG; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; Herscovitch Peter, 1996, P89; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; OSBORN A, 1971, DIAGNOSTIC IMAGING B; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; RICKER JH, 2004, REHABILITATION MED, P229; Rozen J., 2007, NY TIMES MAGAZI 0311, P48; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; *SOC NUCL MED, 2002, SOC NUCL MED PROC GU, P113; Valk P. E., 2003, POSITRON EMISSION TO; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310	28	14	15	0	5	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2008	36	3					323	328					6	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	356EZ	WOS:000259762800008	18802179				2022-02-06	
J	Johansson, SH; Jamora, CW; Ruff, RM; Pack, NM				Johansson, Sven H.; Jamora, Christina Weyer; Ruff, Ronald M.; Pack, Nathaniel M.			A biopsychosocial perspective of aggression in the context of traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; anger; aggression; ruff neurobehavioral inventory; biopsychosocial; treatment	HOSTILITY; AGITATION; AWARENESS; BEHAVIOR; SUPPORT; HEALTH	Primary objective: The aim of this study was to explore the factors associated with aggression in the traumatic brain injury population. The focus of the study was to evaluate the (a) frequency and severity of aggressive behaviours in outpatients with traumatic brain injury (TBI), (b) ecological validity of the Ruff Neurobehavioral Inventory (RNBI) Anger scale, and (c) comorbid and pre-morbid factors associated with aggression in patients with TBIs. Research design: A multi-group comparative research design was employed. Methods and procedure: An outpatient sample of 67 patients with TBIs using the RNBI and clinical interviews. Main outcomes and results: Based on clinical ratings, 25% endorsed no aggression, 38% reported mild aggression and 37% reported moderate-to-severe aggression, which was validated with the RNBI Anger post-morbid scale. A MANOVA found that none of the pre-morbid RNBI scales were significantly elevated across the anger groups; however, pre-post-morbid differences between the groups were found. A principle component analysis showed three main domains: 'physical, cognitive and emotional' that related to elevated post-morbid anger. Conclusions: A biopsychosocial model of post-morbid aggression is proposed to advance both the diagnosis and treatment of patients with TBIs who experience elevated anger.	[Johansson, Sven H.] Univ Gothenburg, Gothenburg, Sweden; [Johansson, Sven H.; Jamora, Christina Weyer; Ruff, Ronald M.; Pack, Nathaniel M.] San Francisco Clin Neurosci, San Francisco, CA USA; [Jamora, Christina Weyer; Ruff, Ronald M.] Univ Calif San Francisco, San Francisco, CA 94143 USA		Jamora, CW (corresponding author), 909 Hyde St,Suite 620, San Francisco, CA 94109 USA.	cyweyer@aol.com					Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Benotsch EG, 1997, J BEHAV MED, V20, P163, DOI 10.1023/A:1025530711432; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; *CDCP, 1996, TRAUM BRAIN INJ US E; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Crick NR, 2006, J ABNORM CHILD PSYCH, V34, P131, DOI 10.1007/s10802-005-9009-4; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Houtveen JH, 2007, J PSYCHOSOM RES, V62, P277, DOI 10.1016/j.jpsychores.2006.11.006; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus J, 1996, NEUROTRAUMA, P13; Lee R, 2007, CAMB HANDB PSYCHOL, P170; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Mueller J., 2007, NEUROPSYCHIATRIC PRO; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; ROBERTS JV, 1984, CAN J CRIMINOL, V26, P283, DOI 10.3138/cjcrim.26.3.283; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5181; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SMITH T, 1994, CONCEPTS METHODS STU, P23; SMITH TW, 1992, HEALTH PSYCHOL, V11, P139, DOI 10.1037/0278-6133.11.3.139; Storch Eric A, 2004, Violence Vict, V19, P689, DOI 10.1891/088667004780927738; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vandervoort DJ, 2006, CURR PSYCHOL, V25, P50, DOI 10.1007/s12144-006-1016-2; VANWOERKOM TCAM, 1977, LANCET, V1, P812	34	14	14	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	13-14					999	1006	PII 907304266	10.1080/02699050802530573			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	389ZM	WOS:000262134100003	19117178				2022-02-06	
J	Lombardi, F				Lombardi, F.			Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			brain injury; psychosis; trauma; depression; long-term effects; cognition; disorders	TERM BENZODIAZEPINE USERS; PSYCHIATRIC-DISORDERS; CORTEX INJURY; HALOPERIDOL; RECOVERY; OLANZAPINE; METAANALYSIS; AMPHETAMINE; MEMORY; DRUGS	Neurobehavioural sequelae of traumatic brain injuries require an appropriate/effective pharmacological response in that they represent an important cause of disability. In this field, there is no evidence that reaches the level of a standard: there are guidelines on the use of methylphenidate, donepezil and bromocriptine for the treatment of cognitive disturbances, for the non-use of phenytoin and for the use of beta-blockers for controlling aggressiveness. Resolving a single symptom is not relevant in a rehabilitation project if it is not in the context of a more complex picture of neurobehavioural recovery, in which the positive and negative effects of every therapeutic choice are considered. For example, phenytoin could be used for the positive control of epileptic crises but is not advised since it impedes the recovery of cognitive functions in general. Analogous effects not yet identified may concern benzodiazepine, neuroleptics and other sedatives usually prescribed in cases of cranial trauma. Psychotropic drugs are considered to be able to influence the neuronal plasticity processes. Studies on animals have shown that the administration of D-amphetamine combined with sensorial-motor exercise produces the steady acceleration of motor recovery, which acts as a catalyst to the neurological recovery process. On the other hand, alpha(1)-NA receptor antagonist drugs produce negative effects; these include clonidine (antihypertension) and haloperidol (neuroleptic). Studies need to be carried out to evaluate the effectiveness of particular drugs. These studies need to focus not only on the disappearance of symptoms but also on the positive and negative effects on overall rehabilitation and on the neurobiological recovery of the patient.	[Lombardi, F.] Riabil Intens Neurol Osped S Sebastiano, I-42015 Correggio, Italy		Lombardi, F (corresponding author), Riabil Intens Neurol Osped S Sebastiano, Via Mandriolo Super 11, I-42015 Correggio, Italy.	lombardif@ausl.re.it		LOMBARDI, Francesco/0000-0002-7184-6391			Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GENTILINI M, 1989, MILD HEAD INJURY, P163; Goldstein LB, 1999, REV NEUROL-FRANCE, V155, P731; GOLOMBOK S, 1988, PSYCHOL MED, V18, P365, DOI 10.1017/S0033291700007911; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Keefe RSE, 2004, AM J PSYCHIAT, V161, P985, DOI 10.1176/appi.ajp.161.6.985; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kudoh A, 2004, ANESTH ANALG, V99, P1674, DOI 10.1213/01.ANE.0000136845.24802.19; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Matsumoto E, 1999, MATER SCI RES INT, V5, P1; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376; Mintzer MZ, 2005, EXP CLIN PSYCHOPHARM, V13, P336, DOI 10.1037/1064-1297.13.4.336; Morrens M, 2007, J CLIN PSYCHOPHARM, V27, P15, DOI 10.1097/jcp.0b013e31802dfff0; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Woodward ND, 2007, SCHIZOPHR RES, V89, P211, DOI 10.1016/j.schres.2006.08.021	29	14	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0265-0215			EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			131	136		10.1017/S0265021507003316			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	283AY	WOS:000254610100022	18289430				2022-02-06	
J	Lule, D; Ludolph, AC; Ludolph, AG				Lule, D.; Ludolph, A. C.; Ludolph, A. G.			Neurodevelopmental and neurodegenerative diseases - Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples	MEDICAL HYPOTHESES			English	Article							DEFICIT HYPERACTIVITY DISORDER; EMISSION COMPUTED-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; MOTOR-NEURON DISEASE; DOPAMINE TRANSPORTER; RECEPTOR SUBUNIT; SPORADIC ALS; ADULT ADHD; RISK; ASSOCIATION	Attention-deficit/hyperactivity disorder (ADHD), the most common neurobehavioural disorder and amyotrophic lateral sclerosis (ALS), the most common adult motoneuron disease, may be two distinct entities on first sight. This paper aims to highlight parallels concerning clinical features and neurobiology. The presence of increased physical and psychological activity and largely non-progressive frontal dysfunction associated with impaired executive control and decreased attention are characteristic clinical features of both, ADHD and ALS. At the neurobiological level, there is evidence for hyperactivity in the glutamatergic system and a - potentially related - dopaminergic hypoactivity in ADHD and ALS. The clinical features of ALS resembling ADHD are particularly characteristic for the premorbid stage of the patient. Therefore, we hypothesize that clinical features of ADHD may be a risk factor for the development of ALS. This hypothesis is currently of unknown pathogenetic, but of potential future therapeutic relevance. Our hypothesis of a link between ADHD and ALS could also be considered as an example how research on neurodevelopmental diseases might influence the understanding and possibly the prevention and treatment of neurodegenerative diseases. (C) 2007 Elsevier Ltd. All rights reserved.	[Lule, D.; Ludolph, A. C.] Univ Ulm, Dept Neurol Neurophysiol, D-89081 Ulm, Germany; [Ludolph, A. G.] Univ Ulm, Dept Child & Adolescent Psychiat, D-89081 Ulm, Germany		Lule, D (corresponding author), Univ Ulm, Dept Neurol Neurophysiol, Oberer Eselsberg 47, D-89081 Ulm, Germany.	dorothee.lule@uni-ulm.de	Ludolph, Andrea G/G-2567-2014				Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; Barkley RA, 2003, BRAIN DEV-JPN, V25, P77, DOI 10.1016/S0387-7604(02)00152-3; Boonstra AM, 2007, SLEEP, V30, P433, DOI 10.1093/sleep/30.4.433; Borasio GD, 1998, J NEUROL NEUROSUR PS, V65, P263, DOI 10.1136/jnnp.65.2.263; Carrey NJ, 2007, J CHILD ADOL PSYCHOP, V17, P11, DOI 10.1089/cap.2006.0008; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Dorval KM, 2007, GENES BRAIN BEHAV, V6, P444, DOI 10.1111/j.1601-183X.2006.00273.x; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Findling RL, 2007, J CHILD ADOL PSYCHOP, V17, P19, DOI 10.1089/cap.2006.0044; GOKSOYR PK, 2007, ADDICT BEHAV; Ionov ID, 2007, AMYOTROPH LATERAL SC, V8, P260, DOI 10.1080/17482960701523124; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; KATO S, 1993, NEUROPATH APPL NEURO, V19, P300, DOI 10.1111/j.1365-2990.1993.tb00444.x; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kihira T, 2007, AMYOTROPH LATERAL SC, V8, P150, DOI 10.1080/17482960601179407; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Kuner R, 2005, ANN NY ACAD SCI, V1053, P269, DOI 10.1196/annals.1344.024; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; LUDOLPH AC, 1989, EUR NEUROL, V29, P255, DOI 10.1159/000116422; Lule D, 2005, J NEUROL, V252, P1517, DOI 10.1007/s00415-005-0907-8; LULE D, 2006, THESIS U TUBINGEN; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Miller SR, 2006, J CHILD NEUROL, V21, P139, DOI 10.1177/08830738060210021901; Moore CM, 2006, AM J PSYCHIAT, V163, P316, DOI 10.1176/appi.ajp.163.2.316; Murphy J, 2007, ARCH NEUROL-CHICAGO, V64, P330, DOI 10.1001/archneur.64.3.330; Pineda DA, 2007, PEDIATR NEUROL, V36, P373, DOI 10.1016/j.pediatrneurol.2007.02.002; PINKHARDT E, 2002, ELECTROPHYSIOLOGIC C; Pinkhardt EH, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-48; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Roman Tatiana, 2004, Am J Pharmacogenomics, V4, P83, DOI 10.2165/00129785-200404020-00003; Rudnicki SA, 2007, AMYOTROPH LATERAL SC, V8, P126, DOI 10.1080/17482960701223808; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; SINN N, 2007, J DEV BEHAV PEDEATR, V28, P139; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; St Louis EK, 1999, SEMIN NEUROL, V19, P25; Stabeno M, 2004, ADHD AFFECTED ATHLET; TAIOLI E, EUR J PUBLIC HLTH; TAKAHASHI H, 1993, LANCET, V342, P1016, DOI 10.1016/0140-6736(93)92878-W; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Veldink JH, 2007, J NEUROL NEUROSUR PS, V78, P367, DOI 10.1136/jnnp.2005.083378; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C; Vieregge P, 1999, COGNITIVE BRAIN RES, V8, P27, DOI 10.1016/S0926-6410(99)00004-X; Vogels OJM, 1999, NEUROLOGY, V52, P1275, DOI 10.1212/WNL.52.6.1275; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Weisskopf MG, 2005, AM J EPIDEMIOL, V162, P1146, DOI 10.1093/aje/kwi343; Wicks P, 2007, AMYOTROPH LATERAL SC, V8, P177, DOI 10.1080/17482960701195220; Yang BR, 2007, AM J MED GENET B, V144B, P541, DOI 10.1002/ajmg.b.30453; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Young JM, 1998, HEALTH SOC WORK, V23, P35, DOI 10.1093/hsw/23.1.35; Zanette G, 2002, CLIN NEUROPHYSIOL, V113, P1688, DOI 10.1016/S1388-2457(02)00288-2; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	58	14	14	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses		2008	70	6					1133	1138		10.1016/j.mehy.2007.11.002			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	311BX	WOS:000256576200010	18158219				2022-02-06	
J	Piscopo, P; Bernardo, A; Calamandrei, G; Venerosi, A; Valanzano, A; Bianchi, D; Confaloni, A; Minghetti, L				Piscopo, Paola; Bernardo, Antonletta; Calamandrei, Gemma; Venerosi, Aldina; Valanzano, Angela; Bianchi, Daniela; Confaloni, Annarnaria; Minghetti, Luisa			Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia	EXPERIMENTAL NEUROLOGY			English	Article						hypoxia-ischemia; brain; Isoprostanes; cyclooxygenase; presenilin; superoxide dismutase; oxidative stress	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; IN-VIVO; PERIVENTRICULAR LEUKOMALACIA; LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; PROSTAGLANDIN E-2; OXIDATIVE INJURY; FOCAL ISCHEMIA; MESSENGER-RNA	Cyclooxygenase-2 (COX-2) and presenilin (PSEN) I and 2 genes are regulated during development as well as in pathological conditions associated to hypoxia. In this study, we investigated their patterns of expression during the first 2 weeks of postnatal life in a rat model of moderate global perinatal asphyxia that we have previously reported to be characterized by early oxidative stress and delayed behavioral alterations. In the hippocampus, global perinatal asphyxia induced an early up-regulation COX-2 mRNA (postnatal day, pnd, 1), which preceded those of PSEN 1 and 2 genes, observed at pnd 4. At pod 11, the expression of all three genes was decreased compared to control animals. In addition, we analyzed the expression of the scavenging enzymes catalase, copper/zinc- and manganese-superoxide dismutase. As for COX-2, the three enzymes were upregulated in the hippocampus at prid I and returned at or below baseline by prid 4. In the cortex, only PSEN I and 2 showed a moderate up-regulation at prid I followed by a down-regulation at pnd 11. These findings suggest that moderate perinatal hypoxic episodes are associated with a dysregulation of the several genes involved in brain development and anti-oxidant defenses, which follows a rapid and transient oxidative stress. Such alterations are particularly evident in the hippocampus and could represent an adaptive response to the hypoxic condition. The delayed down-regulation of the scavenging enzymes could set the ground for brain damage and delayed behavioral alterations and further support the potential benefit of early anti-oxidant treatments in a short therapeutic window soon after birth. (c) 2007 Elsevier Inc. All rights reserved.	[Piscopo, Paola; Bernardo, Antonletta; Calamandrei, Gemma; Venerosi, Aldina; Valanzano, Angela; Bianchi, Daniela; Confaloni, Annarnaria; Minghetti, Luisa] Ist Super Sanita, Dept Neurosci & Cell Biol, I-00161 Rome, Italy		Minghetti, L (corresponding author), Ist Super Sanita, Dept Neurosci & Cell Biol, Viale Regina Elena 299, I-00161 Rome, Italy.	luisa.minghetti@iss.it	Venerosi, Aldina/AAI-2808-2020; Minghetti, Luisa/I-9540-2014; Piscopo, Paola/J-6504-2016; Calamandrei, Gemma/M-3815-2014; Antonietta, Bernardo/H-4415-2016	Venerosi, Aldina/0000-0002-6599-0581; Minghetti, Luisa/0000-0002-7065-4689; Piscopo, Paola/0000-0002-0693-4969; Antonietta, Bernardo/0000-0002-6590-7530; Calamandrei, Gemma/0000-0003-3762-3132; Confaloni, Annamaria/0000-0002-5390-8536			Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bernardo A, 2006, NEUROBIOL DIS, V22, P25, DOI 10.1016/j.nbd.2005.09.012; BJELKE B, 1991, BRAIN RES, V543, P1, DOI 10.1016/0006-8993(91)91041-X; Calamandrei G, 2004, PEDIATR RES, V55, P85, DOI 10.1203/01.PDR.0000099774.17723.D4; Crestini A, 2006, J MOL NEUROSCI, V30, P311, DOI 10.1385/JMN:30:3:311; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; Fuso A, 2007, J ALZHEIMERS DIS, V11, P275; Greco A, 2004, CURR NEUROVASC RES, V1, P341, DOI 10.2174/1567202043362036; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hoeger H, 2006, AMINO ACIDS, V31, P385, DOI 10.1007/s00726-006-0393-z; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Inder T, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000020088.11295.13; Inder T, 2002, J PEDIATR-US, V140, P617, DOI 10.1067/mpd.2002.123627; Ishii Hideshi, 2003, J Exp Ther Oncol, V3, P291, DOI 10.1111/j.1533-869X.2003.01101.x; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, BRAIN DEV-JPN, V19, P25, DOI 10.1016/S0387-7604(96)00047-2; Khan JY, 2003, PEDIATR RES, V54, P77, DOI 10.1203/01.PDR.0000065736.69214.20; Koistinaho J, 1999, STROKE, V30, P1900, DOI 10.1161/01.STR.30.9.1900; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lu S, 2002, BBA-GENE STRUCT EXPR, V1574, P152, DOI 10.1016/S0167-4781(01)00359-1; Mattson MP, 2000, J NEUROSCI, V20, P1358; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; Pepicelli O, 2002, J NEUROCHEM, V81, P1028, DOI 10.1046/j.1471-4159.2002.00897.x; Planas AM, 1995, NEUROSCI LETT, V200, P187, DOI 10.1016/0304-3940(95)12108-G; Qin Y, 2000, BRIT J OBSTET GYNAEC, V107, P973, DOI 10.1111/j.1471-0528.2000.tb10399.x; Ricceri L, 2004, EXP NEUROL, V189, P162, DOI 10.1016/j.expneurol.2004.05.025; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; Scheepens A, 2003, DEV BRAIN RES, V142, P67, DOI 10.1016/S0165-3806(03)00032-4; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Toti P., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P245; Van de Berg WDJ, 2002, EXP NEUROL, V174, P29, DOI 10.1006/exnr.2001.7855; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Venerosi A, 2004, BEHAV BRAIN RES, V154, P155, DOI 10.1016/j.bbr.2004.02.008; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922	43	14	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JAN	2008	209	1					192	198		10.1016/j.expneurol.2007.09.014			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	253EG	WOS:000252500900025	17963755				2022-02-06	
J	Roebuck-Spencer, TM; Reeves, DL; Bleiberg, J; Cernich, AN; Schwab, K; Ivins, B; Salazar, A; Harvey, S; Brown, F; Warden, D				Roebuck-Spencer, T. M.; Reeves, D. L.; Bleiberg, J.; Cernich, A. N.; Schwab, K.; Ivins, B.; Salazar, A.; Harvey, S.; Brown, F.; Warden, D.			Influence of demographics on computerized cognitive testing in a military sample	MILITARY PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL ASSESSMENT; GENDER-DIFFERENCES; EPISODIC MEMORY; NORMATIVE DATA; PERFORMANCE; AGE; ARMY; IQ	Computerized cognitive testing with software programs such as the Automated Neuropsychological Assessment Metrics (ANAM) have long been used to assess cognition in military samples. This study describes demographic influences on computerized testing performance in a large active duty military sample (n = 2366). Performance differences between men and women were minimal on most ANAM subtests, but there was a clear speed/accuracy trade-off, with men favoring speed and women favoring accuracy on the Continuous Performance Test (CPT) subtest. As expected, reaction time increased with age on most subtests, with the exception of Mathematical Processing Test (MTH). Higher education resulted in significant but minimal performance increases on Code Substitution (CDS), Matching to Sample (MSP), and Memory Search (STN) subtests. In contrast, substantial performance differences were seen between education groups on the MTH subtest. These data reveal that it is important to consider demographic factors, particularly age, when using ANAM to draw conclusions about military samples. These results also point to the importance of exploring demographic influences for all reaction time-based computerized assessment batteries.	[Roebuck-Spencer, T. M.; Bleiberg, J.; Cernich, A. N.] Natl Rehabil Hosp, Ctr Cognit Neurosci, Washington, DC USA; [Reeves, D. L.] ClinVest Inc, Springfield, MO USA; [Schwab, K.; Ivins, B.; Warden, D.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Brown, F.] Womack Army Med Ctr, Ft Bragg, NC USA		Bleiberg, J (corresponding author), Bethesda Neuropsychol LLC, 9515 Linden Ave, Bethesda, MD 20814 USA.	jb454@georgetown.edu					Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P231, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT231; Beatty WW, 2003, J CLIN EXP NEUROPSYC, V25, P1065, DOI 10.1076/jcen.25.8.1065.16732; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Buffery A., 1972, GENDER DIFFERENCES T, P123; CERNICH AN, 2004, AM PSYCH ASS C HON H; CERNICH AN, 2004, 2004 INT NEUR SOC M; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; GASTALDO E, 1997, ANAM DATA USMC 1995; Gestaldo E, 2001, ARCH CLIN NEUROPSYCH, V16, P825; Harris WC, 2005, MIL PSYCHOL, V17, P115, DOI 10.1207/s15327876mp1702_4; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Herlitz A, 2002, J CLIN EXP NEUROPSYC, V24, P107, DOI 10.1076/jcen.24.1.107.970; Herlitz A, 1997, MEM COGNITION, V25, P801, DOI 10.3758/BF03211324; Herlitz A, 1999, NEUROPSYCHOLOGY, V13, P590, DOI 10.1037/0894-4105.13.4.590; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; KABAT MH, 2000, J INT NEUROPSYCH SOC, V6, P146; Kimura D, 2003, PSYCHOL REP, V93, P263, DOI 10.2466/PR0.93.5.263-264; Kramer JH, 2003, J INT NEUROPSYCH SOC, V9, P97, DOI 10.1017/S1355617703910113; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Lewin C, 2001, NEUROPSYCHOLOGY, V15, P165, DOI 10.1037//0894-4105.15.2.165; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; MCCARROLL JE, 1990, NEUROEPIDEMIOLOGY, V9, P296, DOI 10.1159/000110792; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V8, P48, DOI 10.1159/000110165; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; REEVES DL, 1991, SR911 NAMRL OFF MIL; REEVES DL, 1996, EFFECTS HEAT STRESS, V1; REYNOLDS CR, 1987, J SCHOOL PSYCHOL, V25, P323, DOI 10.1016/0022-4405(87)90035-5; VONKLUGE S, 1992, PERCEPT MOTOR SKILL, V75, P651, DOI 10.2466/pms.1992.75.2.651; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	36	14	14	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.		2008	20	3					187	203		10.1080/08995600802118825			17	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	334LO	WOS:000258223500004					2022-02-06	
J	Teruel, GC; Rico, AP; Lasaosa, FJC; Temprano, AC; Julian, AN; Clara, JMC				Claret Teruel, Gemma; Palomeque Rico, Antonio; Jos Cambra Lasaosa, Francisco; Catala Temprano, Albert; Noguera Julian, Antoni; Maria Costa Clara, Josep			Severe head injury among children: computed tomography evaluation as a prognostic factor	JOURNAL OF PEDIATRIC SURGERY			English	Article						severe head injury; computed tomography; intracranial pressure; intracranial hypertension; child; prognosis	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; CLASSIFICATION	Background: The value of neuroimaging in predicting unfavorable events in the outcome of pediatric patients has not been established. Our objectives were to determine clinical characteristics and outcome of severely head-injured children admitted to the pediatric intensive care unit (PICU) of a pediatric third-level university hospital and to evaluate the use of neuroimaging as a prognostic factor of morbimortality in these patients. Methods: We performed a 9-year retrospective review. We included all patients with severe head injury admitted to the pediatric intensive care unit of our hospital from January 1995 to December 2003 requiring invasive intracranial pressure monitoring. Clinical summaries and imaging studies were reviewed. Results: Data for 156 pediatric patients, aged 1 to 18 years, were collected. We reclassified neuroimaging patterns into 2 groups: those with few imaging findings and those with important lesions. These 2 groups were significantly correlated with initial Glasgow Coma Scale (P <.05). We classified patients into favorable evolution, moderate disability, and unfavorable evolution. Poorer evolution correlated with poorer initial neuroimaging patterns, and these differences were statistically significant (P <.05). Conclusions: In our group of patients, initial Glasgow Coma Scale was related with the initial neuroimaging pattern, and this relation was statistically significant. Findings in the first and second neuroimaging were useful as prognostic factors in our series. (c) 2007 Elsevier Inc. All rights reserved.	[Claret Teruel, Gemma; Palomeque Rico, Antonio; Jos Cambra Lasaosa, Francisco; Catala Temprano, Albert; Noguera Julian, Antoni] Univ Barcelona, Hosp Univ St Joan de Deu, Integrated Unit St Joan de Deu Clin, Paediat Dept,Pediat Intens Care Unit, Barcelona 08950, Spain; [Maria Costa Clara, Josep] Univ Barcelona, Hosp Univ St Joan de Deu, Integrated Unit St Joan de Deu Clin, Dept Neurosurg, Barcelona 08950, Spain		Teruel, GC (corresponding author), Passeig St Joan de Deu 2, Barcelona 08950, Spain.	gclaret@hsjdbcn.org	lasosa, Francisco Jose Cambra/ABH-4656-2020	Noguera-Julian, Antoni/0000-0001-7485-0583; CATALA, ALBERT/0000-0003-0133-1752			Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; *BRAIN TRAUM FDN, 2003, PEDIAT  CRIT CARE ME, V4, pS1; *BRAIN TRAUMA FDN, 1996, GUIDL MAN SEV HEAD I; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FERNANDEZ A, 2001, MED INTENSIVA, V25, P8; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maidaun MVC, 2002, ARQ NEURO-PSIQUIAT, V60, P967, DOI 10.1590/S0004-282X2002000600015; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002	17	14	14	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	NOV	2007	42	11					1903	1906		10.1016/j.jpedsurg.2007.07.020			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	239XN	WOS:000251551700019	18022444				2022-02-06	
J	Strom, TQ; Kosciulek, J				Strom, Thad Q.; Kosciulek, John			Stress, appraisal and coping following mild traumatic brain injury	BRAIN INJURY			English	Article						mild TBI; adjustment; stress; coping	BECK DEPRESSION INVENTORY; COMMUNITY INTEGRATION; REHABILITATION; ADJUSTMENT; SEQUELAE	Purpose: The present study tested a portion of the stress, appraisal and coping ( SAC) model proposed by Godfrey, Knight and Partridge. Methods: Using data gathered from 94 individuals who had sustained a traumatic brain injury, path analysis results indicated that a model based on Godfrey et al.' s SAC model did not fit the sample data. Based on relevant statistical output, previous research and theory, are- specified model was tested. Results: The final model was shown to meet common statistical measures for establishing model fit. The final model indicated that higher levels of perceived stress were predictive of higher levels of self- reported depression, higher levels of depression were predictive of lower levels of dispositional hope and dispositional hope was predictive of increased life satisfaction and work productivity. Conclusions: The present findings hold implications for both research and for clinical practice. The findings do suggest the need for additional research to further clarify factors that contribute to emotional adjustment following traumatic brain injury.	Nat Ctr PTSD, Pacific Isl Div, Honolulu, HI 96819 USA; Michigan State Univ, E Lansing, MI 48824 USA		Strom, TQ (corresponding author), Nat Ctr PTSD, Pacific Isl Div, 3375 Koapaka St,Suite I-560, Honolulu, HI 96819 USA.	thad.strom2@va.gov		Strom, Thad/0000-0001-6743-9999			Beck A.T, 1967, DEPRESSION; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Byrne B., 2001, STRUCTURAL EQUATION; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ellis A, 1977, HDB RATIONAL EMOTIVE, V1; Folkman S., 1994, STRESS APPRAISAL COP; GARSON GD, 2006, INTERNET RELEIGH NC; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Groth-Marnat G., 1990, HDB PSYCHOL ASSESSME, V2nd ed.; Heppner PP, 2004, COUNS PSYCHOL, V32, P344, DOI 10.1177/0011000003262793; HEPPNER PP, 1982, J COUNS PSYCHOL, V29, P66, DOI 10.1037/0022-0167.29.1.66; Heppner PP, 1997, MEAS EVAL COUNS DEV, V29, P229, DOI 10.1080/07481756.1997.12068907; HEPPNER PP, 1988, LVING INVENTORY MANU; KLEM L, 1995, READING UNDERSTANDIN, P65; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LIVNEH H, 1997, PSYCHOL ADAPTATION C; Lopez S.J., 2000, HDB HOPE THEORY MEAS, P57, DOI DOI 10.1016/B978-012654050-5/50006-3; MCNENY R, 1990, REHABILITATION ADULT, P193; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; *NIH, 1998, CONS DEV PAN REH PER; Noble JH., 1990, J DISABIL POLICY STU, V1, P19, DOI [10.1177/104420739000100202, DOI 10.1177/104420739000100202]; NOVACK TA, 1983, CLIN NEUROPSYCHOLOGY, V6, P139; Nunnelly JC, 1978, PSYCHOMETRIC THEORY; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1986, BRAIN INJURY, V31, P89; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rath JF, 2003, REHABIL PSYCHOL, V48, P137, DOI 10.1037/0090-5550.48.3.137; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Snyder C. R., 1994, PSYCHOL HOPE YOU CAN; Snyder C.R., 2002, HDB POSITIVE PSYCHOL, P257, DOI DOI 10.1521/SCPQ.18.2.122.21854; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Sokol K, 1999, 127 ANN M AM PUBL HL; Tatham, 1998, MULTIVARIATE DATA AN; Thurman DJ, 2001, HEAD TRAUMA, P327; VONCRAMON DY, 1992, NEUROPSYCHOL REHABIL, V2, P207; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	53	14	16	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1137	1145		10.1080/02699050701687334			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900005	17952714				2022-02-06	
J	Beretta, L; Aldrovandi, V; Grandi, E; Citerio, G; Stocchetti, N				Beretta, L.; Aldrovandi, V.; Grandi, E.; Citerio, G.; Stocchetti, N.			Improving the quality of data entry in a low-budget head injury database	ACTA NEUROCHIRURGICA			English	Article						audit; database; head injury; quality; review	CARDIAC-NATIONAL-DATABASE; INTENSIVE-CARE; REGISTRY DATA; VALIDATION; CONSORTIUM; PROGRAM; SOCIETY	Background. To assess the efficacy of a centralised review of a voluntary low-budget head injury database with a retrospective analysis of data before and after a centralised review. Method. A computerised data collection (Neurolink) on traumatic brain injury cases admitted to three neuro-intensive care units in Milan (Italy): analysis of a three-year period (1999-2001). Data from 499 patients (epidemiology, type of lesion, clinical course, monitoring, treatment, complications and outcome). The audit involved a review of forms relating to patients enrolled in the three-year period, with the aim of improving the quality of data entry. Missing data in all empty fields were identified; evident errors and contradictory data were identified and corrected; missing and final data were analysed to test the efficacy of the review. Findings. The total post-review missing data rate was significantly lower than the paired pre-review missing data rate (p = 0.001). The same was confirmed for each of the 3 years (p = 0.001 for each year). The missing data rate significantly improved over the three-year period (p = 0.001). Data for the pre-hospitalisation period had the highest missing rates; data regarding the ICU stay showed the greatest improvement after the review. A total of 407 items (0.44%) were identified as errors. Conclusions. Data quality is fundamental to avoid information bias in database analysis. This study indicates that it is possible to generate a serious data collection without significant resources. Audit seems to be an important tool before the final data is used for scientific projects.	IRCCS, Ospedale S Raffaele, Neurointens Care Unit, Monza, Italy; Osped San Gerardo, Neurointens Care Unit, Monza, Italy; Univ Milan, IRCCS, Neurointens Care Unit, Osped Maggiore Mangiagalli & Reg Elena, Milan, Italy		Beretta, L (corresponding author), Hosp San Raffaele, Inst Sci, Via Olgettina 60, I-20132 Milan, Italy.		Stocchetti, Nino/O-7444-2017; Citerio, Giuseppe/B-1839-2015	Stocchetti, Nino/0000-0003-3250-6834; Citerio, Giuseppe/0000-0002-5374-3161			Arts D, 2002, INTENS CARE MED, V28, P656, DOI 10.1007/s00134-002-1272-z; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Beretta L., 2003, MINERVA ANESTESIOL, V69, P223; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Fine LG, 2003, BRIT MED J, V326, P25, DOI 10.1136/bmj.326.7379.25; Grover FL, 1996, ANN THORAC SURG, V62, P1229, DOI 10.1016/0003-4975(96)00589-9; Hlaing T, 2006, J TRAUMA, V61, P1400, DOI 10.1097/01.ta.0000195732.64475.87; JENNET B, 1997, J NEUROL NEUROSUR PS, V40, P291; KUNTORO LRE, 1994, J CLIN EPIDEMIOL, V47, P779; Malin JL, 2002, J NATL CANCER I, V94, P835, DOI 10.1093/jnci/94.11.835; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; RICKETTS D, 1993, ANN ROY COLL SURG, V75, P393; Shroyer ALW, 1998, ANN THORAC SURG, V65, P1494, DOI 10.1016/S0003-4975(98)00261-6; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Warsi AA, 2002, EUR J SURG ONCOL, V28, P850, DOI 10.1053/ejso.2002.1283	17	14	14	1	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	SEP	2007	149	9					903	909		10.1007/s00701-007-1257-3			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	204AT	WOS:000249015900016	17665088				2022-02-06	
J	Feng, D; Xu, W; Chen, G; Hang, C; Gao, H; Yin, H				Feng, D.; Xu, W.; Chen, G.; Hang, C.; Gao, H.; Yin, H.			Influence of glutamine on intestinal inflammatory response, mucosa structure alterations and apoptosis following traumatic brain injury in rats	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						glutamine; rat model; traumatic brain injury; intestinal mucosa; inflammation apoptosis	CYTOKINE-INDUCED APOPTOSIS; COLONIC EPITHELIAL-CELLS; GUT IN-VITRO; BACTERIAL TRANSLOCATION; MONONUCLEAR-CELLS; AMINO-ACIDS; PERMEABILITY; NUTRITION; BARRIER; SUPPLEMENTATION	Traumatic brain injury (TBI) can induce a persistent inflammatory response, histopathological changes and apoptosis in the intestine. Glutamine has been shown to reduce bacterial translocation and maintain intestine mucosal integrity, but its effects on the inflammatory response, structural alterations and apoptosis in intestinal mucosa following TBI have not been previously investigated. Using the weight-drop method, a right parietal cortical contusion was induced in rats and, for the next 5 days, they were fed either chow alone or chow mixed with glutamine. Intestinal tissue samples were then removed for analysis. Following TBI, glutamine supplementation was found to: decrease intestinal concentrations of interleukin (IL) -1 beta, tumour necrosis factor-alpha (TNF-alpha) and IL-6; downregulate intercellular adhesion molecule-1 (ICAM-1) expression; attenuate TBI-induced damage to the intestine structure; and reduce apoptosis. These results suggest that post-TBI glutamine administration could suppress intestinal inflammation, protect intestinal mucosal structure and reduce mucosal apoptosis.	Southeast Univ, Jiangyin Hosp, Sch Med, Dept Neurosurg, Jiangyin 214400, Jiangsu, Peoples R China; Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Feng, D (corresponding author), Southeast Univ, Jiangyin Hosp, Sch Med, Dept Neurosurg, 163 Shoushan Rd, Jiangyin 214400, Jiangsu, Peoples R China.	jeanne88@163.com					AHLMAN B, 1993, CLIN NUTR, V12, P266, DOI 10.1016/0261-5614(93)90044-5; Aosasa S, 2003, JPEN-PARENTER ENTER, V27, P333, DOI 10.1177/0148607103027005333; Arndt H, 1999, JPEN-PARENTER ENTER, V23, P12, DOI 10.1177/014860719902300112; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; Coeffier M, 2003, CLIN NUTR, V22, P407, DOI 10.1016/S0261-5614(03)00040-2; Coeffier M, 2002, CYTOKINE, V18, P92, DOI 10.1006/cyto.2002.1027; Coeffier M, 2001, CYTOKINE, V13, P148, DOI 10.1006/cyto.2000.0813; deBlaauw I, 1997, GASTROENTEROLOGY, V112, P118, DOI 10.1016/S0016-5085(97)70226-9; EPSTEIN MD, 1992, PLAST RECONSTR SURG, V90, P524, DOI 10.1097/00006534-199209000-00032; Erbil Y, 1999, HEPATO-GASTROENTEROL, V46, P2791; Evans ME, 2005, AM J PHYSIOL-GASTR L, V289, pG388, DOI 10.1152/ajpgi.00072.2005; Evans ME, 2003, J NUTR, V133, P3065, DOI 10.1093/jn/133.10.3065; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Foitzik T, 1999, INT J COLORECTAL DIS, V14, P143, DOI 10.1007/s003840050200; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hall JC, 1996, BRIT J SURG, V83, P305, DOI 10.1002/bjs.1800830306; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; Ikeda S, 2002, JPEN-PARENTER ENTER, V26, P169, DOI 10.1177/0148607102026003169; Li N, 2004, AM J PHYSIOL-GASTR L, V286, pG914, DOI 10.1152/ajpgi.00493.2003; Margaritis VG, 2005, WORLD J SURG, V29, P1329, DOI 10.1007/s00268-005-7721-4; Mates JM, 2006, FRONT BIOSCI-LANDMRK, V11, P3164, DOI 10.2741/2040; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Papaconstantinou HT, 2000, J GASTROINTEST SURG, V4, P416, DOI 10.1016/S1091-255X(00)80022-0; Paquette JC, 2005, J CELL PHYSIOL, V202, P912, DOI 10.1002/jcp.20194; Quan ZF, 2004, WORLD J GASTROENTERO, V10, P1992; SCHRODER J, 1995, JPEN-PARENTER ENTER, V19, P502, DOI 10.1177/0148607195019006502; Souba WW, 1997, NEW ENGL J MED, V336, P41, DOI 10.1056/NEJM199701023360107; SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; VENTE JP, 1989, ANN SURG, V209, P57, DOI 10.1097/00000658-198901000-00009; Wischmeyer PE, 2003, NUTRITION, V19, P1, DOI 10.1016/S0899-9007(02)00839-0; Wischmeyer PE, 2001, SHOCK, V16, P398, DOI 10.1097/00024382-200116050-00014	37	14	16	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	SEP-OCT	2007	35	5					644	656		10.1177/147323000703500509			13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	215ER	WOS:000249791600009	17900404	Bronze			2022-02-06	
J	Hussein, MH; Daoud, GA; Kakita, H; Hattori, A; Murai, H; Yasuda, M; Mizuno, K; Goto, K; Ozaki, Y; Ito, T; Tanaka, T; Fukuda, S; Kato, I; Fujimoto, S; Suzuki, S; Sobajima, H; Togari, H				Hussein, Mohamed Hamed; Daoud, Ghada A.; Kakita, Hiroki; Hattori, Ayako; Murai, Hiroki; Yasuda, Mari; Mizuno, Keisuke; Goto, Kenji; Ozaki, Yasuhiko; Ito, Tetsuya; Tanaka, Taihei; Fukuda, Sumio; Kato, Ineko; Fujimoto, Shinji; Suzuki, Satoshi; Sobajima, Hisanori; Togari, Hajime			The sex differences of cerebrospinal fluid levels of interleukin 8 and antioxidants in asphyxiated newborns	SHOCK			English	Article						brain injury; neuron-specific enolase; total hydroperoxide; biological antioxidant potentials; cytokines	TRAUMATIC BRAIN-INJURY; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; IMMUNE FUNCTION; INFANTS; HEMORRHAGE; GENDER; EXPRESSION; SURVIVAL; PROTEIN	Newborn males are more sensitive to brain injury than newborn females are. The aim of the present study was to find an explanation for this. We used the neuron-specific enolase (NSE) levels in the cerebrospinal fluid (CSF) for the classification of 32 newborns (19 males and 13 females) on their fifth postnatal day. The NSE levels were higher than normal (8.4 +/- 1.6 ng/mL) in 10 newborn males and 6 females and were, respectively, considered asphyxiated male and female groups. The remaining newborns, 9 males and 7 females, had normal CSF levels of NSE and were considered normal newborn male and female groups. The CSF samples were measured for 12 cytokines, using a cytokine array kit, and for total hydroperoxide and biological antioxidant potentials (BAPs), using the free radical analytic system. Among the 12 cytokines measured, only interleukin 8 (IL-8) was properly detected. The CSF levels of IL-8 were higher in the asphyxiated newborn females than in the other three groups. The mean CSF levels of BAPs in the asphyxiated newborn females were higher compared with the other three groups, but significance was detected only in comparison with the BAP levels in the CSF samples of the normal newborn males. There were no differences in total hydroperoxide levels among the groups. There are sex-related differences in the CSF levels of IL-8 and antioxidants in asphyxiated newborns, with higher levels in newborn females; this might contribute in the sexual dimorphism regarding the fact that females have better protection from brain injury than the males.	Nagoya City Univ, Grad Sch Med Sci, Dept Pediat Neonatol & Congenital Disorders, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Cairo Univ, Pediat Hosp, Neonatal Intens Care Unit, Cairo, Egypt; VACSERA, Dept Maternal & Child Hlth, Giza, Egypt; Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan		Hussein, MH (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat Neonatol & Congenital Disorders, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hamed@med.nagoya-cu.ac.jp	Murai, Hiroki/J-4030-2019	Murai, Hiroki/0000-0001-5291-8954; SOBAJIMA, HISANORI/0000-0002-7976-3945			Angele MK, 1999, SHOCK, V12, P316, DOI 10.1097/00024382-199910000-00011; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; BAENZIGER O, 1994, PEDIATR NEUROL, V11, P319, DOI 10.1016/0887-8994(94)90009-4; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; BRY K, 1994, PEDIATR RES, V35, P130, DOI 10.1203/00006450-199401000-00029; Buonocore G, 2000, PEDIATR RES, V47, P221, DOI 10.1203/00006450-200002000-00012; Dammann O, 2001, PEDIATR RES, V49, P388, DOI 10.1203/00006450-200103000-00013; Dohi K, 2005, IN VIVO, V19, P855; Eikelenboom MJ, 2005, MULT SCLER, V11, P520, DOI 10.1191/1352458505ms1195oa; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Elsmen E, 2006, BIOL NEONATE, V89, P220, DOI 10.1159/000089838; Friel JK, 2004, PEDIATR RES, V56, P878, DOI 10.1203/01.PDR.0000146032.98120.43; GARCIAALIX A, 1994, PEDIATRICS, V93, P234; Guinsburg R, 2000, PAIN, V85, P127, DOI 10.1016/S0304-3959(99)00258-4; Gutteridge JMC, 1999, BRIT MED BULL, V55, P49, DOI 10.1258/0007142991902295; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; HOUDOU S, 1991, BRAIN RES, V556, P267, DOI 10.1016/0006-8993(91)90314-L; Kahlke V, 2002, SHOCK, V18, P24, DOI 10.1097/00024382-200207000-00005; Kahlke V, 2000, SHOCK, V14, P354, DOI 10.1097/00024382-200014030-00020; Lauterbach MD, 2001, NEUROPSYCHOLOGY, V15, P411, DOI 10.1037/0894-4105.15.3.411; Lecart C, 2000, BIOL NEONATE, V77, P217, DOI 10.1159/000014219; LEFER AM, 1991, BRIT J PHARMACOL, V103, P1153, DOI 10.1111/j.1476-5381.1991.tb12316.x; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lieberman E, 1997, AM J OBSTET GYNECOL, V176, P667, DOI 10.1016/S0002-9378(97)70567-2; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Rennekampff HO, 2000, J SURG RES, V93, P41, DOI 10.1006/jsre.2000.5892; Saito M, 2004, PEDIATR RES, V55, P960, DOI 10.1203/01.PDR.0000125257.55596.97; SAMAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696; Savman K, 1998, PEDIATR RES, V43, P746; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; SOBAJIMA H, 1993, NAGOYA MED J, V37, P169; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116	34	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2007	28	2					154	159		10.1097/shk.0b013e31803dcf55			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	193SV	WOS:000248295800005	17529906				2022-02-06	
J	Niendam, TA; Horwitz, J; Bearden, CE; Cannon, TD				Niendam, Tara A.; Horwitz, Jacqueline; Bearden, Carrie E.; Cannon, Tyrone D.			Ecological assessment of executive dysfunction in the psychosis prodrome: A pilot study	SCHIZOPHRENIA RESEARCH			English	Article						prodrome; psychosis; cognition; executive function; neuropsychology; functional outcome	TRAUMATIC BRAIN-INJURY; SCHIZOPHRENIA; PERFORMANCE; CHILDREN	Individuals with psychosis have prominent executive functioning (EF) deficits on neuropsychological tests, but their relationship to EF deficits in daily life is unclear. This study evaluates behavioral manifestations of EF deficits, assessed by the Behavioral Rating Inventory of Executive Functioning (BRIEF), and their clinical correlates in individuals at ultra-high-risk for psychosis (UHR). UHR subjects showed significantly elevated BRIEF scores, particularly on the Working Memory scale. BRIEF scores were associated with positive symptoms and functioning, but not with neuropsychological performance. The BRIEF appears to capture unique aspects of executive dysfunction, possibly associated with illness progression and functioning in the psychosis prodrome. (c) 2007 Elsevier B.V. All rights reserved.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA		Niendam, TA (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	tniendam@ucla.edu	Niendam, Tara/K-8475-2015	Niendam, Tara/0000-0003-2285-5002; Bearden, Carrie/0000-0002-8516-923X; Sanz, Jacqueline/0000-0003-0465-0628	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH065079, P50MH066286, T32MH014584] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH065079-04, R01 MH065079-01A1, MH14584, P50 MH066286, R01 MH065079-02, P50 MH066286-01A19004, MH65079, R01 MH065079, P50 MH066286-01A10002, R01 MH065079-03, R01 MH065079-05] Funding Source: Medline		Addington J, 1999, SCHIZOPHRENIA BULL, V25, P173, DOI 10.1093/oxfordjournals.schbul.a033363; Auther A., 2006, GLOBAL FUNCTIONING S; Bell MD, 2001, SCHIZOPHRENIA BULL, V27, P269, DOI 10.1093/oxfordjournals.schbul.a006873; Benton A., 1976, MULTILINGUAL APHASIA; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Gioia G. A., 2000, J INT NEUROPSYCH SOC, V6; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hawkins KA, 2004, SCHIZOPHR RES, V67, P115, DOI 10.1016/j.schres.2003.08.007; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; McGlashan T.H., 2001, STRUCTURED INTERVIEW; Meyer SE, 2005, J CHILD ADOL PSYCHOP, V15, P434, DOI 10.1089/cap.2005.15.434; Niendam T.A., 2006, GLOBAL FUNCTIONING S; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; Reitan R, 1985, HALSTEAD REITAN NEUR; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WEEHSLER D, 1999, MANUAL WECHSLER ABBR	20	14	14	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964			SCHIZOPHR RES	Schizophr. Res.	JUL	2007	93	1-3					350	354		10.1016/j.schres.2007.03.009			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	184SU	WOS:000247663200040	17467957	Green Accepted			2022-02-06	
J	Bottlang, M; Sommers, MB; Lusardi, TA; Miesch, JJ; Simon, RP; Xiong, ZG				Bottlang, Michael; Sommers, Mark B.; Lusardi, Theresa A.; Miesch, Jennifer J.; Simon, Roger P.; Xiong, Zhi-Gang			Modeling neural injury in organotypic cultures by application of inertia-driven shear strain	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; hippocampus; organotypic; shear strain; TBI	IN-VITRO MODEL; HIPPOCAMPAL SLICE CULTURES; DIFFUSE AXONAL INJURY; MECHANICAL STRETCH; BRAIN-INJURY; CELLS; CALCIUM; TRAUMA; TISSUE; POLYSTYRENE	In vitro models of traumatic brain injury (TBI) are indispensable to explore the effects of mechanotrauma on neurological injury cascades and injury thresholds. This study characterizes a novel in vitro model of neural shear injury, which for the first time subjects organotypic cultures to inertia-driven shear strain. In this model, organotypic cultures preserved a high level of biological heterogeneity and spatial cytoarchitecture, while inertia-driven shear strain represented a tissue-level insult typical for closed head TBI in vivo. For neural injury simulation, organotypic hippocampal cultures derived from rats were inserted in an inertial loading module, which was subjected to impacts at five graded impact velocities ranging from 2 to 10 m/sec. The mechanical insult was quantified by measuring the transient shear deformation of the culture surface during impact with a high-speed camera. The resultant cell death was quantified with propidium iodide (PI) staining 24 hours following shear injury. Increasing impact velocities of 2, 4.6, 6.6, 8.1, and 10.4 m/sec caused graded peak shear elongation of 2.0 +/- 0.9%, 5.4 +/- 3.8%, 15.1 +/- 14.6%, 25.4 +/- 14.7%, and 56.3 +/- 51.3%, respectively. Cell death in response to impact velocities of 6.6 m/sec or less was not significantly higher than baseline cell death in sham cultures (4.4 +/- 1.5%). Higher impact velocities of 8.1 and 10.4 m/sec resulted in a significant increase in cell death to 19.9 +/- 12.9% and 36.7 +/- 14.2%, respectively (p < 0.001). The neural shear injury model delivered a gradable, defined mechanotrauma and thereby provides a novel tool for investigation of biological injury cascades in organotypic cultures.	Legacy Res Ctr, Biomech Lab, Portland, OR 97232 USA; Legacy Res Ctr, Robert S Dow Neurobiol Labs, Portland, OR USA		Bottlang, M (corresponding author), Legacy Res Ctr, Biomech Lab, 1225 NE 2nd Ave, Portland, OR 97232 USA.	mbottlang@biomechresearch.org	Augat, Peter/A-2051-2011	Augat, Peter/0000-0003-4805-2128; Lusardi, Theresa/0000-0003-0699-5662	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS42946] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042946] Funding Source: NIH RePORTER		AbdelHamid KM, 1997, J NEUROSCI, V17, P3538; Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; CATER HL, 2004, ANN M SOC NEUR SAN D; CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500; DENNEYBROWN D, 1943, BRAIN, V64, P93; DERIDDER MN, 2001, 2001 BIOENG C SNOWB; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FINSEN BR, 1992, NEUROSCIENCE, V47, P105, DOI 10.1016/0306-4522(92)90125-L; Fung Y C, 1994, 1 COURSE CONTINUUM M; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; King A. I., 2003, IRCOBI C; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Krimer LS, 1997, J NEUROSCI METH, V75, P55, DOI 10.1016/S0165-0270(97)02265-6; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Mielke JG, 2005, DEV BRAIN RES, V160, P275, DOI 10.1016/j.devbrainres.2005.09.009; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Smith DH, 1999, J NEUROSCI, V19, P4263; STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stoppini L, 1997, J NEUROSCI METH, V72, P23, DOI 10.1016/S0165-0270(96)00151-3; Zhang Liying, 2002, Stapp Car Crash J, V46, P145	38	14	14	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2007	24	6					1068	1077		10.1089/neu.2006.3772			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	184EA	WOS:000247622700013	17600521	Green Submitted			2022-02-06	
J	Hashimoto, K; Okumura, A; Shinoda, J; Abo, M; Nakamura, T				Hashimoto, Keiji; Okumura, Ayumi; Shinoda, Jun; Abo, Masahiro; Nakamura, Toshinori			Tensor magnetic resonance imaging in a case of mild traumatic brain injury with lowered verbal intelligence quotient	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; diffuse axonal injury; neuropsychological dysfunction; magnetic resonance imaging; diffusion tensor imaging		We report the case of a 31-year-old man who had mild traumatic brain injury as a result of an accident at the age of 24 years. Seven years after the trauma, at the age of 31 years, he had a lower verbal intelligence quotient than performance intelligence quotient by the Wechsler Adult Intelligence Scale - Revised, and frontal lobe dysfunction, for example, difficulty in maintaining or changing the set as revealed by the Wisconsin Card Sorting Test Keio Version. Conventional brain magnetic resonance imaging had not shown any abnormalities. Abnormal brain areas were detected on magnetic resonance diffusion tensor imaging. On tractography, some fibres from the corpus callosum towards the frontal cortex were noted to be lacking in the left hemisphere compared with the right. The tractography results may explain the patient's lowered verbal intelligence quotient and focal left frontal lobe dysfunction. Diffusion tensor imaging is therefore helpful in detecting lesions in mild traumatic brain injury with diffuse axonal injury.	Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo 1058461, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Neutrotraumatol, Tokyo, Japan; Kisawa Mem Hosp, Dept Neurosurg, Chubu Med Ctr Prolonged Taumat Brain Dysfunct, Gifu, Japan		Hashimoto, K (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	keiman@jikei.ac.jp		Abo, Masahiro/0000-0001-6701-4974			ABO M, 2006, J APPL RES, V6, P36; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kamikubo Takeshi, 2004, No To Shinkei, V56, P952; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730	9	14	14	0	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2007	39	5					418	420		10.2340/16501977-0065			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	174SF	WOS:000246962400013	17549335	Green Submitted, gold			2022-02-06	
J	Poca, MA; Sahuquillo, J; Vilalta, A; Garnacho, A				Poca, Maria A.; Sahuquillo, Juan; Vilalta, Anna; Garnacho, Angel			Lack of utility of arteriojugular venous differences of lactate as a reliable indicator of increased brain anaerobic metabolism in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article; Proceedings Paper	7th Annual Conference of the Euroacademia Multidisciplinaria Neurotraumatologica	JUN, 2002	Newcastle upon Tyne, ENGLAND			traumatic brain injury; ischemia; brain metabolism; lactate; microdialysis	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL MICRODIALYSIS; GLUCOSE-METABOLISM; ISCHEMIA; BLOOD; STIMULATION; INFARCTION; TRANSPORT; EXISTENCE	Object. Ischemic lesions are highly prevalent in patients with traumatic brain injuries (TBIs) and are the single most important cause of secondary brain damage. The prevention and early treatment of these lesions is the primary aim in the modem treatment of these patients. One of the most widely used monitoring techniques at the bedside is quantification of brain extracellular level of lactate by using arteriojugular venous differences of lactate (AVDL). The purpose of this study was to determine the sensitivity, specificity, and predictive value of AVDL as an indicator of increases in brain lactate production in patients with TBIs. Methods. Artericjugular venous differences of lactate were calculated every 6 hours using samples obtained though a catheter placed in the jugular bulb in 45 patients with diffuse head injuries (57.8%) or evacuated brain lesions (42.2%). Cerebral lactate concentration obtained with a 20-kD inicrodialysis catheter implanted in undamaged tissue was used as the de facto gold standard. Six hundred seventy-three AVDL determinations and cerebral microdialysis samples were obtained simultaneously; 543 microdialysis samples (81%) showed lactate values greater than 2 mmol/L, but only 21 AVDL determinations (3.1%) showed an increase in brain lactate. No correlation was found between AVDL and cerebral lactate concentration (p = 0.014, p = 0.719). Arteriojugular venous differences of lactate had a sensitivity and specificity of 3.3 and 97.7%, respectively, with a false-negative rate of 96.7% and a false-positive rate of 2.3%. Conclusions. Arteriojugular venous differences of lactate do not reliably reflect increased cerebral lactate production and consequently are not reliable in ruling out brain ischemia in patients with TBIs. The clinical use of this monitoring method in neurocritical care should be reconsidered.	Ciudad Sanitaria & Univ Vall Hebron, Dept Neurosurg, E-08035 Barcelona, Spain		Sahuquillo, J (corresponding author), Ciudad Sanitaria & Univ Vall Hebron, Dept Neurosurg, Paseo Vall Hebron 119-129, E-08035 Barcelona, Spain.	sahuquillo@neurotraurna.net	Poca, Maria A./B-8475-2008; Garnacho, Angel/A-9309-2013; Sahuquillo, Juan/B-3577-2008	Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Vilalta, Anna/0000-0002-2183-072X			Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; BAKKER EP, 1974, BIOCHIM BIOPHYS ACTA, V339, P285, DOI 10.1016/0005-2736(74)90325-3; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, ACT NEUR S, V76, P359; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; CRUZ J, 1993, J TRAUMA, V35, P805, DOI 10.1097/00005373-199311000-00026; FELLOWS LK, 1993, J NEUROCHEM, V60, P1258, DOI 10.1111/j.1471-4159.1993.tb03285.x; Gibbs EL, 1942, J BIOL CHEM, V144, P325; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; HILLERED L, 1995, NEUROCHEMICAL MONITO, P59; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJA, 1999, ACT NEUR S, V75, P57; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kett-White R, 2002, ADV TECH STAND NEUR, V27, P87; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; LARRABEE MG, 1995, J NEUROCHEM, V64, P1734; LUTZ PL, 1997, BRAIN OXYGEN, P1; Magistretti PJ, 1997, NEUROSCIENTIST, V3, P361, DOI 10.1177/107385849700300608; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; NEMOTO EM, 1974, STROKE, V5, P48, DOI 10.1161/01.STR.5.1.48; Oldendorf W H, 1971, Trans Am Neurol Assoc, V96, P46; OLDENDORF WH, 1973, AM J PHYSIOL, V224, P1450, DOI 10.1152/ajplegacy.1973.224.6.1450; PARDRIDGE W M, 1975, Critical Reviews in Toxicology, V3, P159, DOI 10.3109/10408447509079857; PARDRIDGE WM, 1977, J NEUROCHEM, V28, P5, DOI 10.1111/j.1471-4159.1977.tb07702.x; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Price NT, 1998, BIOCHEM J, V329, P321; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Robertson CS, 1998, NEUROL RES, V20, pS91; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; ROBERTSON CS, 1989, UPDTAE INTENSIVE CAR, P85; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; Sarrafzadeh AS, 2001, ACT NEUR S, V77, P145; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; SOOD SC, 1980, ACTA NEUROCHIR, V53, P47, DOI 10.1007/BF02074520; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Tofteng F, 2002, LIVER TRANSPLANT, V8, P302, DOI 10.1053/jlts.2002.32283; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; UNGERSTEDT U, 2000, MICRODIALYSIS NEUROM; Valadka A B, 2000, Neurosurg Focus, V9, pe3; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Weibel E.R., 1984, PATHWAY OXYGEN STRUC; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	59	14	14	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2007	106	4					530	537		10.3171/jns.2007.106.4.530			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	155OJ	WOS:000245586900004	17432701				2022-02-06	
J	Laskowski, A; Reiser, G; Reymann, KG				Laskowski, Alexandra; Reiser, Georg; Reymann, Klaus G.			Protease-activated receptor-1 induces generation of new microglia in the dentate gyrus of traumatised hippocampal slice cultures	NEUROSCIENCE LETTERS			English	Article						trauma; microglia; proliferation; microgliosis; organotypic hippocampal slice cultures; protease-activated receptor; PAR	CELL-PROLIFERATION; BRAIN-INJURY; FOCAL ISCHEMIA; THROMBIN; NEUROPROTECTION; NEUROGENESIS; MESOTRYPSIN; EXPRESSION; TRYPSIN	The protease thrombin is not only known as a major component in the blood coagulation cascade but is also involved in proinflammatory processes in the central nervous system (CNS). Here we used an in vitro model, to investigate the effect of thrombin and protease-activated receptor-1 (PAR-1) on proliferation and microgliosis after traumatic injury. A 5-day exposure to thrombin after cutting the Schaffer collaterals induced a proliferation and microgliosis in the dentate gyms of organotypic slice cultures. This effect is at least partially mediated by PAR-1 since the selective peptide agonist TRag shows similar effects. Thus, thrombin effects after injury might involve microglial proliferation. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; Univ Magdeburg, Inst Neurobiochem, D-39120 Magdeburg, Germany		Reymann, KG (corresponding author), Leibniz Inst Neurobiol, Brennecke Str 6, D-39118 Magdeburg, Germany.	reymann@ifn-magdeburg.de	Reymann, Klaus G/J-8507-2013				Balcaitis S, 2003, NEUROREPORT, V14, P2373, DOI 10.1097/00001756-200312190-00017; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; GOINGS GE, 2006, GLIA; GRABHAM P, 1995, J NEUROCHEM, V64, P583; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Henrich-Noack P, 2006, BRAIN RES, V1070, P232, DOI 10.1016/j.brainres.2005.10.100; Henrich-Noack P, 2006, J NEUROSCI RES, V83, P469, DOI 10.1002/jnr.20746; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laskowski A, 2005, BRAIN RES, V1037, P78, DOI 10.1016/j.brainres.2004.12.035; Moller T, 2006, SEMIN THROMB HEMOST, V32, P69, DOI 10.1055/s-2006-939556; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pforte C, 2005, NEUROSCIENCE, V136, P1133, DOI 10.1016/j.neuroscience.2005.08.043; QIU L, 2006, J CEREB BLOOD FLOW M; Sinnreich M, 2004, J NEUROCHEM, V88, P1380, DOI 10.1046/j.1471-4159.2003.02268.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Wang YF, 2006, J NEUROCHEM, V99, P759, DOI 10.1111/j.1471-4159.2006.04105.x; Weinstein JR, 2005, J NEUROCHEM, V95, P1177, DOI 10.1111/j.1471-4159.2005.03499.x; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x	30	14	16	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 19	2007	415	1					17	21		10.1016/j.neulet.2006.12.050			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	153ZV	WOS:000245477500004	17324513				2022-02-06	
J	Ang, BT; Wong, J; Lee, KK; Wang, E; Ng, I				Ang, B. T.; Wong, J.; Lee, K. K.; Wang, E.; Ng, I.			Temporal changes in cerebral tissue oxygenation with cerebrovascular pressure reactivity in severe traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SEVERE HEAD-INJURY; BLOOD-FLOW; VASOMOTOR REACTIVITY; PERFUSION-PRESSURE; AUTOREGULATION; MANAGEMENT; METABOLISM	Objective: To investigate the temporal relationship between cerebrovascular pressure reactivity and brain tissue oxygenation in patients with severe head injury. Methods: In 40 patients, brain tissue oxygenation and intracranial pressure were monitored. Time-averaged values for intracranial pressure (ICP), mean arterial pressure (MAP), cerebral perfusion pressure (CPP) and brain tissue oxygenation (PtiO(2)) were computed. The pressure reactivity index (PRx) was calculated. The mean values of the variables were obtained at the 6-h and 72-h post-injury time points, and the difference between the two time points for each of the variables was denoted as delta (delta). Results: Of the 40 patients, 32 were survivors and 8 were non-survivors. Statistically significant differences were present between these two groups with regard to delta MAP (p = 0.013), ICP at 6 h (p = 0.027), CPP at 72 h (p = 0.018), delta CPP (p = 0.033), PRx at 6 h (p = 0.029), PRx at 72 h (p = 0.002), PtiO(2) at 72 h (p < 0.0005) and delta PtiO(2) (p = 0.023) values, reflecting an improvement with time in survivors and a deterioration with time in non-survivors. In non-survivors, the magnitude of change in PtiO(2) and CPP with time correlated in a negative linear fashion (p = 0.042 and 0.029, respectively) with the change in PRx with time, whereas no such relationship was seen in survivors. Conclusion: The severity of brain tissue oxygenation derangement correlates with increasing cerebrovascular dysautoregulation in patients succumbing to severe head injury, supporting the utility of PRx as a monitoring variable and the rationale for a target-driven approach to head injury management.	Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, Singapore 308433, Singapore		Ng, I (corresponding author), Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, 11,Jalan Tan Tock Seng, Singapore 308433, Singapore.	ivan_ng@nni.com.sg					BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Czosnyka M, 1996, CEREBROVAS BRAIN MET, V8, P273; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MARMAROU A, 1993, ACTA NEUROCHIR, P18; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	23	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2007	78	3					298	302		10.1136/jnnp.2005.082735			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	137EZ	WOS:000244277100017	17028122	Green Published			2022-02-06	
J	Gulino, R; Cataudella, T; Casamenti, F; Pepeu, G; Stanzani, S; Leanza, G				Gulino, Rosario; Cataudella, Tiziana; Casamenti, Fiorella; Pepeu, Giancarlo; Stanzani, Stefania; Leanza, Giampiero			Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat	EXPERIMENTAL NEUROLOGY			English	Article						acetylcholine; neurotransmitter release; recovery; transplantation; volkensin; rat	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ADULT-RAT; CHOLINE-ACETYLTRANSFERASE; NORADRENALINE RELEASE; INVIVO MICRODIALYSIS; EVOKED RELEASE; DORSAL-HORN; DIRECTED DIFFERENTIATION; BEHAVIORAL ACTIVATION	Grafts of spinal cord (SC) tissue can survive and develop into the severed SC, but no conclusive data are available concerning the functional activity of transplanted neurons. In the present study, suspensions of prelabeled embryonic ventral SC tissue were grafted to the lumbar SC of rats with motoneuron loss induced by perinatal injection of volkensin. Eight to ten months post-grafting, acetylcholine (ACh) release was measured by microdialysis in awake rats, under either basal or stimulated conditions. In normal animals, baseline ACh output averaged 1.6 pmol/30 mu l, it exhibited a 4-fold increase after KCl-induced depolarization or handling, and it was completely inhibited by tetrodotoxin administration. Moreover, ACh levels did not change following acute SC transection performed under anesthesia during ongoing dialysis, suggesting an intrinsic source for spinal ACh. Treatment with volkensin produced a severe (> 85%) motoneuronal loss accompanied by a similar reduction in baseline ACh release and almost completely abolished effects of depolarization or handling. In transplanted animals, many motoneuron-like labeled cells were found within and just outside the graft area, but apparently in no case were they able to extend fibers towards the denervated muscle. However, the grafts restored baseline ACh output up to near-normal levels and responded with significantly increased release to depolarization, but not to handling. The present findings indicate that spinal neuroblasts can survive and develop within the motoneuron-depleted SC and release ACh in a near-normal, but apparently non-regulated, manner. This may be of importance for future studies involving intraspinal stem cell grafts. (c) 2006 Elsevier Inc. All rights reserved.	Univ Trieste, Dept Physiol & Pathol, BRAIN Ctr Neurosci, I-34127 Trieste, Italy; Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; Univ Catania, Dept Physiol Sci, I-95125 Catania, Italy		Leanza, G (corresponding author), Univ Trieste, Dept Physiol & Pathol, BRAIN Ctr Neurosci, Via Fleming 22, I-34127 Trieste, Italy.	gileanza@dfp.units.it		Gulino, Rosario/0000-0002-8067-697X; stanzani, stefania/0000-0003-3896-2523			ANDERSON DK, 1995, BRAIN PATHOL, V5, P451, DOI 10.1111/j.1750-3639.1995.tb00624.x; ARBUZOVADAVIS S, 2006, PROG BRAIN RES, V157, P207; BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; BJORKLUND A, 1983, ACTA PHYSIOL SCAND, P9; BORGES LF, 1986, BRAIN RES, V362, P140, DOI 10.1016/0006-8993(86)91407-1; Bouaziz H, 1996, ANESTHESIOLOGY, V84, P143, DOI 10.1097/00000542-199601000-00017; Bregman B. S., 1994, FUNCTIONAL NEURAL TR, P489; CAMPBELL K, 1993, NEUROSCIENCE, V53, P403, DOI 10.1016/0306-4522(93)90204-S; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; CENCI MA, 1994, BRAIN RES, V641, P225, DOI 10.1016/0006-8993(94)90150-3; CENCI MA, 1993, EXP NEUROL, V122, P73, DOI 10.1006/exnr.1993.1109; Cenci MA, 2000, EXP NEUROL, V164, P351, DOI 10.1006/exnr.2000.7433; CEVOLANI D, 1995, BRAIN RES, V689, P163, DOI 10.1016/0006-8993(95)00549-6; Christie SD, 2001, CAN J NEUROL SCI, V28, P6; CLOWRY GJ, 1992, EXP BRAIN RES, V91, P249; DAMSMA G, 1985, J NEUROCHEM, V45, P1649, DOI 10.1111/j.1471-4159.1985.tb07238.x; DEMIERRE B, 1990, BRAIN RES, V510, P355, DOI 10.1016/0006-8993(90)91391-S; Eisenach JC, 1996, ANESTH ANALG, V82, P621, DOI 10.1097/00000539-199603000-00034; Gao J, 2005, NEUROSCIENCE, V131, P257, DOI 10.1016/j.neuroscience.2004.10.033; GERIN C, 1994, J NEUROSCI METH, V52, P129, DOI 10.1016/0165-0270(94)90121-X; GIOVANNINI MG, 1994, J NEUROSCI, V14, P1358, DOI 10.1523/JNEUROSCI.14-03-01358.1994; Greensmith L, 1996, TRENDS NEUROSCI, V19, P450, DOI 10.1016/S0166-2236(96)20034-7; GWYN DG, 1966, SCIENCE, V153, P1543, DOI 10.1126/science.153.3743.1543; Hebei R., 1976, ANATOMY LAB RAT; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Hoffman D R, 1997, Ann Health Law, V6, P147; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hoglund AU, 2000, J PHARMACOL EXP THER, V295, P100; IBRAHIM NA, 1989, NEUROPHARMACOLOGY, V28, P977, DOI 10.1016/0028-3908(89)90199-8; IWAMOTO ET, 1993, J PHARMACOL EXP THER, V265, P777; KALEN P, 1990, J NEUROSCI METH, V34, P107, DOI 10.1016/0165-0270(90)90048-K; KALEN P, 1988, BRAIN RES, V474, P374, DOI 10.1016/0006-8993(88)90454-4; KANAZAWA I, 1979, NEUROSCI LETT, V13, P325, DOI 10.1016/0304-3940(79)91514-3; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; Klimscha W, 1997, ANESTHESIOLOGY, V87, P110, DOI 10.1097/00000542-199707000-00015; KOBAYASHI N, 1991, NEUROSCIENCE, V45, P331, DOI 10.1016/0306-4522(91)90230-L; Kommalage M, 2005, EUR J PHARMACOL, V509, P127, DOI 10.1016/j.ejphar.2004.12.017; Kommalage M, 2003, PHARMACOL TOXICOL, V93, P169, DOI 10.1034/j.1600-0773.2003.930403.x; Kornmalage M, 2005, EUR J PHARMACOL, V525, P69, DOI 10.1016/j.ejphar.2005.08.035; LEANZA G, 1993, BRAIN RES, V615, P147, DOI 10.1016/0006-8993(93)91126-D; LEANZA G, 1993, BRAIN RES, V618, P47, DOI 10.1016/0006-8993(93)90427-O; Leanza G, 1996, BRAIN RES, V738, P281, DOI 10.1016/S0006-8993(96)00796-2; Leanza G, 1998, NEUROSCI LETT, V244, P89, DOI 10.1016/S0304-3940(98)00135-9; Leanza G, 1999, EUR J NEUROSCI, V11, P1789, DOI 10.1046/j.1460-9568.1999.00595.x; LINDEROTH B, 1994, NEUROSURGERY, V34, P484, DOI 10.1227/00006123-199403000-00014; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall Olle, 2004, NeuroRx, V1, P382; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2000, INT J MOL MED, V5, P3; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; MATOS FF, 1992, PAIN, V48, P439, DOI 10.1016/0304-3959(92)90097-U; Murray M, 2004, J NEUROTRAUM, V21, P405, DOI 10.1089/089771504323004557; NAVARATNAM V, 1970, BRAIN RES, V18, P411, DOI 10.1016/0006-8993(70)90125-3; NILSSON OG, 1990, PROG BRAIN RES, V82, P321; NILSSON OG, 1992, BRAIN RES, V584, P132, DOI 10.1016/0006-8993(92)90886-E; NILSSON OG, 1992, NEUROSCIENCE, V49, P33, DOI 10.1016/0306-4522(92)90074-C; Nogradi A, 1996, EUR J NEUROSCI, V8, P2198, DOI 10.1111/j.1460-9568.1996.tb00741.x; NOGRADI A, 1992, NEUROSCIENCE, V50, P975, DOI 10.1016/0306-4522(92)90220-V; NOGRADI A, 1994, EXP NEUROL, V129, P130, DOI 10.1006/exnr.1994.1154; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PHELPS PE, 1984, J COMP NEUROL, V229, P347, DOI 10.1002/cne.902290306; Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1602/neurorx.1.4.424; ROSENBLAD C, 1993, NEUROSCIENCE, V55, P353, DOI 10.1016/0306-4522(93)90504-9; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; SATOH K, 1983, BRAIN RES BULL, V11, P693, DOI 10.1016/0361-9230(83)90013-8; Scali C, 2002, J NEURAL TRANSM, V109, P1067, DOI 10.1007/s007020200090; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; SHERRIFF FE, 1994, BRAIN RES, V634, P150, DOI 10.1016/0006-8993(94)90268-2; SHERRIFF FE, 1991, NEUROSCI LETT, V128, P52, DOI 10.1016/0304-3940(91)90758-L; SIERADZAN K, 1991, EXP NEUROL, V114, P286, DOI 10.1016/0014-4886(91)90154-5; SIERADZAN K, 1989, NEUROSCIENCE, V31, P115, DOI 10.1016/0306-4522(89)90034-1; STIRPE F, 1985, J BIOL CHEM, V260, P4589; SUNDSTROM E, 1995, NEUROCHEM INT, V27, P185, DOI 10.1016/0197-0186(95)00007-U; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WILEY RG, 1987, NEUROPATH APPL NEURO, V13, P39, DOI 10.1111/j.1365-2990.1987.tb00169.x; WILEY RG, 1988, BRAIN RES, V438, P145, DOI 10.1016/0006-8993(88)91333-9; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; YAKSH TL, 1980, BRAIN RES, V192, P133, DOI 10.1016/0006-8993(80)91014-8; YOSHIOKA K, 1990, NEUROSCIENCE, V38, P195, DOI 10.1016/0306-4522(90)90385-H; Zahn PK, 2002, PAIN, V100, P65, DOI 10.1016/S0304-3959(02)00241-5	85	14	14	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2007	204	1					326	338		10.1016/j.expneurol.2006.11.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	148PC	WOS:000245086100034	17234186				2022-02-06	
J	Shohrati, M; Rouini, MR; Mojtahedzadeh, M; Firouzabadi, M; Ghaini, MR; Kanani, M				Shohrati, M.; Rouini, M. R.; Mojtahedzadeh, M.; Firouzabadi, M.; Ghaini, M. R.; Kanani, M.			Evaluation of phenytoin pharmacokinetics in neurotrauma patients	DARU-JOURNAL OF FACULTY OF PHARMACY			English	Article						phenytoin; pharmacokinetic; free fraction; neurotrauma	ILL TRAUMA PATIENTS; CRITICALLY ILL; HEAD-INJURY; SEIZURES; METABOLISM; DOSAGE	Previous studies have suggested that drug metabolism may be altered in patients with severe neurotrauma. The purpose of this prospective study was to observe the alteration of phenytoin pharmacokinetic and the resulting drug plasma level among these patients. Twenty pati ents with severe head injury (Glasgow Coma Scale: 8) requiring intravenous phenytoin were included in the study. Phenytoin sodium was diluted to a concentration of 25mg/ml and infused for 20 minutes at the rate of not faster than 25mg/min. Maintenance dose of phenytoin sodium was administered in the first day of head trauma and vital signs were monitored at hourly intervals while the patients remained in the neurosurgical intensive care unit. Blood samples were obtained for peak and trough concentrations. Free and total phenytoin levels were determined by both liquid chromatography and fluorescence polarization immunoassay (Eclair) of plasma samples after ultrafiltration and deproteinization respectively. Based on the reported Km (Km 5.4 mg/l), predicted population Vmax was calculated to be (7.3 +/- 0.4 mg/kg/d) which was significantly lower than calculated individual Vmax (9.3 +/- 3.2 mg/kg/d) (P=0.026). Moreover, significant differences was found between mean daily dose of phenytoin administered to patients (257 4 mg/d) and calculated mean daily dose based on individual Vmax (479 3 mg/d) (p=0.0015). Mean plasma concentrations determined by fluorescence polarization immunoassay (FPIA) (6.11 +/- 2.9 mg/l) and HPLC method (5.78 +/- 2.8 mg/l) were not statistically different Metabolic rate increased non-proportionally with increase in phenytoin concentration, and as a result decrease in clearance. Significant alteration in the metabolism of phenytoin occurred after severe neurotrauma. Based on our results, to keep phenytoin concentrations in the range of 10-20 mg/l, an increase in the phenytoin maintenance dose and more frequent monitoring of concentration is commonly required.	Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Tehran, Iran; Univ Tehran Med Sci, Fac Pharm, Dept Pharmacotherapy, Tehran, Iran; Univ Tehran Med Sci, Neurol Sina Hosp, Tehran, Iran; Baqiatallah Univ Med Sci, Res Ctr Chem Injuries, Tehran, Iran; Minist Hlth & Med Educ, Deputy Food & Drug Adm, Tehran, Iran		Rouini, MR (corresponding author), Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Tehran, Iran.	rouini@tums.ac.ir	Rouini, Mohammadreza/AAT-8557-2021	Rouini, Mohammadreza/0000-0003-0412-8581			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; *APPL THER INC, 1992, APPL PHARM PRINC THE; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; DRISCOLL DF, 1988, CRIT CARE MED, V16, P1248, DOI 10.1097/00003246-198812000-00016; GOTTLIEB ME, 1983, J TRAUMA, V23, P836, DOI 10.1097/00005373-198309000-00009; GRASELA TH, 1983, CLIN PHARMACOKINET, V8, P355, DOI 10.2165/00003088-198308040-00006; LAMBIE DG, 1976, LANCET, V2, P386; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Markowsky SJ, 1996, ANN PHARMACOTHER, V30, P443, DOI 10.1177/106002809603000501; MAVER GE, 1974, BRIT J CLIN PHARMACO, V1, P163; McKindley DS, 1997, J CLIN PHARMACOL, V37, P129, DOI 10.1002/j.1552-4604.1997.tb04771.x; MICHAL J, 1997, J CHROMATO B, V693, P407; NEETA P, 1995, CRITICAL CARE MED, V23; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; VOZEH S, 1981, J PHARMACOKINET BIOP, V9, P131, DOI 10.1007/BF01068078; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; ZIELMAN S, 1994, THREA DRUG MONI, V19, P139; TXB PHARMACOTHERAPY, pCH57	21	14	15	0	4	TEHRAN UNIVERSITY OF MEDICAL SCIENCES	TEHRAN	P. O. BOX 14155-6451, TEHRAN, 00000, IRAN	1560-8115			DARU	Daru	SPR	2007	15	1					34	40					7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	178SI	WOS:000247240000007					2022-02-06	
J	Erol, FS; Topsakal, C; Kaplan, M; Yildirim, H; Ozveren, MF				Erol, Fatih Serhat; Topsakal, Cahide; Kaplan, Metin; Yildirim, Hanifi; Ozveren, Mehmet Faik			Collet-Sicard syndrome associated with occipital condyle fracture and epidural hematoma	YONSEI MEDICAL JOURNAL			English	Article						Collet-Sicard syndrome; cranial nerve palsy; epidural hematoma; occipital condyl fracture	CRANIAL NERVE PALSIES; CLOSED-HEAD-INJURY	A 31-year-old male was presented with a very rare case of ipsilateral palsies of the nerves IX through XII (Collet-Sicard syndrome) after a closed head injury. An occipital condyle fracture that was associated with epidural hematoma was diagnosed by computed tomography. The patient was conservatively managed, and following the treatment, partial neurological recovery ensued. The phenomenon of occipital condyle fracture involving the last four cranial nerve palsies is relatively rare. Although 3 cases of Collet-Sicard syndrome that were caused by an occipital condyle fracture has been reported, the association between condyle fracture and epidural hematoma has never been described before.	Firat Univ, Tip Fak, Norosirurji Anabilim Dali, Elazig, Turkey; Firat Univ, Sch Med, Dept Radiol, Elazig, Turkey		Erol, FS (corresponding author), Firat Univ, Tip Fak, Norosirurji Anabilim Dali, Elazig, Turkey.	fserol@yahoo.com	Yildirim, Hanefi/V-9722-2018				ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BRIDGMAN SA, 1992, SURG NEUROL, V38, P152, DOI 10.1016/0090-3019(92)90094-4; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Collet F., 1915, LYON MED, V124, P121; Comacchio F, 1995, Ear Nose Throat J, V74, P845; Connolly B, 2000, SPINE, V25, P395, DOI 10.1097/00007632-200002010-00023; DICHIRO GD, 1964, J NEUROSURG, V21, P447, DOI 10.3171/jns.1964.21.6.0447; Fuentes S, 2000, NEUROCHIRURGIE, V46, P563; GRUNDY DJ, 1984, SPINE, V9, P339, DOI 10.1097/00007632-198405000-00002; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; Ide C, 1998, J NEUROSURG, V88, P773, DOI 10.3171/jns.1998.88.4.0773; JUNCOS JL, 1987, BRAIN, V110, P197, DOI 10.1093/brain/110.1.197; Miyazaki C, 2000, CLIN NEUROL NEUROSUR, V102, P255, DOI 10.1016/S0303-8467(00)00109-8; MOHANTY SK, 1973, J NEUROSURG, V38, P86, DOI 10.3171/jns.1973.38.1.0086; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; Rees JH, 1997, BRIT J RADIOL, V70, P856, DOI 10.1259/bjr.70.836.9486056; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Sicard J, 1917, MARSEILLE MED, V53, P383; Silvestrini M, 1991, Riv Neurol, V61, P135; Tappin JA, 1996, J NEUROL NEUROSUR PS, V60, P14, DOI 10.1136/jnnp.60.1.14; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025	24	14	14	0	2	YONSEI UNIV COLLEGE MEDICINE	SEOUL	C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL 120-752, SOUTH KOREA	0513-5796			YONSEI MED J	Yonsei Med. J.	FEB 28	2007	48	1					120	123		10.3349/ymj.2007.48.1.120			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144RJ	WOS:000244813400016	17326254	Green Published, gold, Green Submitted			2022-02-06	
J	Jaworski, DM; Beem-Miller, M; Lluri, G; Barrantes-Reynolds, R				Jaworski, Diane M.; Beem-Miller, Micah; Lluri, Gentian; Barrantes-Reynolds, Ramiro			Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2	PHYSIOLOGICAL GENOMICS			English	Article						alternative splicing; gene nesting; knockout; differential display clone 8	MESSENGER-RNA EXPRESSION; EFFICIENT ACTIVATION; BINDING PROTEIN; TIMP-2; SEQUENCES; IDENTIFICATION; ANGIOGENESIS; DIFFERENTIATION; DROSOPHILA; DISPLAY	Nested genes are fairly common within the mammalian nervous system, yet few studies have examined whether the guest and host genes might be coordinately regulated. Tissue inhibitors of metalloproteinase (TIMPs) inhibit extracellular matrix proteolysis mediated by metzincin proteases. TIMP-2 is the only TIMP not nested within a synapsin gene. It does, however, serve as a host for differential display clone 8 (DDC8), a testis-specific gene whose expression is upregulated during spermatogenesis. Here, we demonstrate that DDC8 is not testis specific. Furthermore, DDC8 expression in nonneural and neural tissues mimics that of TIMP-2, including its upregulation in response to traumatic brain injury, suggesting a potential regulatory relationship. The most striking observation is that the TIMP-2 knockout mouse brain contains TIMP-2 mRNA encoding exons 2-5, which are downstream of DDC8, but not exon 1, which contains the signal sequence and cysteine residue required for MMP inhibition, indicating a functional knockout. That TIMP-2 transcripts in wild-type brain contain DDC8 sequence suggests alternative splicing between the two genes.	Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA		Jaworski, DM (corresponding author), Univ Vermont, Coll Med, Dept Anat & Neurobiol, 149 Beaumont Ave,HSRF 418, Burlington, VT 05405 USA.	diane.jaworski@uvm.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA022435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016462, P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045225, R29NS035874] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA-22435, P30 CA022435] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR-16462, P20 RR16435, P20 RR016435, P20 RR016462] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29 NS035874-04S1, R29 NS035874-05, R01 NS045225-01A2, NS-045225, R01 NS045225] Funding Source: Medline		Ahuja S, 2006, OPHTHAL RES, V38, P125, DOI 10.1159/000090533; Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Catalano RD, 1997, MOL HUM REPROD, V3, P215, DOI 10.1093/molehr/3.3.215; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; CAWSTON TE, 1990, BIOCHEM J, V269, P183, DOI 10.1042/bj2690183; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CURRY VA, 1992, BIOCHEM J, V285, P143, DOI 10.1042/bj2850143; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; DERRY JMJ, 1992, GENOMICS, V12, P632, DOI 10.1016/0888-7543(92)90286-2; Duenas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8; FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400; Felsenstein J, 2005, PHYLOGENY INFERENCE; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; Grima J, 1996, J ANDROL, V17, P263; Habib AA, 1998, ONCOGENE, V16, P1525, DOI 10.1038/sj.onc.1201683; Hammani K, 1996, J BIOL CHEM, V271, P25498, DOI 10.1074/jbc.271.41.25498; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HENIKOFF S, 1986, CELL, V44, P33, DOI 10.1016/0092-8674(86)90482-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Jaworski DM, 2006, J NEUROCHEM, V98, P234, DOI 10.1111/j.1471-4159.2006.03855.x; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Jaworski DM, 2005, BRAIN RES, V1051, P81, DOI 10.1016/j.brainres.2005.05.057; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEE SC, 1993, J BIOL CHEM, V268, P12164; LENOIR D, 1986, J NEUROSCI, V6, P522; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; Lluri G, 2006, J NEUROBIOL, V66, P1365, DOI 10.1002/neu.20315; Longin J, 2002, MOL CELL ENDOCRINOL, V189, P25, DOI 10.1016/S0303-7207(01)00756-0; Longin J, 2001, J CELL SCI, V114, P2125; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mruk DD, 1999, J BIOL CHEM, V274, P27056, DOI 10.1074/jbc.274.38.27056; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Pohar N, 1999, GENOMICS, V57, P293, DOI 10.1006/geno.1999.5776; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SILVERMAN TA, 1992, J BIOL CHEM, V267, P9738; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Young DA, 2002, BIOCHEM J, V364, P89, DOI 10.1042/bj3640089; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008	60	14	19	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1094-8341	1531-2267		PHYSIOL GENOMICS	Physiol. Genomics	JAN 17	2007	28	2					168	178		10.1152/physiolgenomics.00160.2006			11	Cell Biology; Genetics & Heredity; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity; Physiology	135RW	WOS:000244171700004	16985004	Green Accepted			2022-02-06	
J	Brenner, LA; Dise-Lewis, JE; Bartles, SK; O'Brien, SE; Godleski, M; Selinger, M				Brenner, Lisa A.; Dise-Lewis, Jeanne E.; Bartles, Sarah K.; O'Brien, Susan E.; Godleski, Matthew; Selinger, Marilyn			The long-term impact and rehabilitation of pediatric traumatic brain injury: A 50-year follow-up case study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						evaluation; intervention; latent; long-term; pediatric; remote; sequelae; traumatic brain injury	CHILDREN; ADOLESCENTS; OUTCOMES; CHILDHOOD; NORMS	Despite significant advances in the understanding of pediatric traumatic brain injury (TBI)-related sequelae, members of the medical community working with adult survivors often do not appreciate the impact of "latent" effects of these injuries. To assess deficits and facilitate intervention, the interactions among the nature of the TBI, the individual's developmental course, and the history of community response must be understood. This case study discusses the lifelong challenges faced by a 56-year-old individual who sustained a TBI at age 5. His case highlights the importance of developmental stage consideration, remote evaluation/intervention, and collaboration with mental health professionals.	MIRECC, Denver, CO 80220 USA; VA ECHCS, Dept Phys Med & Rehabil, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Psychiat, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Rehabil Med, Denver, CO USA		Brenner, LA (corresponding author), MIRECC, VA VISN 19 1055 Clermont St, Denver, CO 80220 USA.		Brenner, Lisa A./AAG-2442-2019	Godleski, Matthew/0000-0002-3592-679X			Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Baker H., 1967, DETROIT TESTS LEARNI; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Brady K.D., 2001, CHILDREN TRAUMATIC B; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHOW TW, 1999, SCI PRACT NEUROPSYCH, P3; Conners K, 1999, ADHD ADULTS CHILDREN; Dawson G. E., 1994, HUMAN BEHAV DEV BRAI; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dise-Lewis J. E., 2002, BRAIN STARS BRAIN IN; Erikson E., 1964, CHILDHOOD SOC; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Goodglass H., 1972, ASSESSMENT APHASIA R; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Heaton R. K., 2004, REVISED COMPREHENSIV; Hendryx P. M., 1995, J COGN REHABIL, V13, P9; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Kaplan E, 1983, BOSTON NAMING TEST; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kohlberg L., 1981, ESSAYS MORAL DEV, VI; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Morey, 1991, PERSONALITY ASSESSME; Pennington B.F., 1991, DIAGNOSING LEARNING; Piaget J., 1936, ORIGINS INTELLIGENCE; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; ROOPER AH, 2005, ADAMS VICTORS PRINCI; Sbordone R. J., 1998, ECOLOGICAL VALIDITY, P15; Schuell H., 1965, MINNESOTA TEST DIFFE; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Silver JM, 2005, TXB TRAUMATIC BRAIN, P609; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stevenson HW, 1972, CHILDRENS LEARNING; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Teeter P.A., 1997, CHILD NEUROPSYCHOLOG; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; WOLCOTT GF, 1995, ED MANUAL ED NEED KN; Wolfson, 1993, HALSTEAD REITAN NEUR; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ylvisaker M., 1985, HEAD INJURY REHABILI	48	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2007	22	1					56	64		10.1097/00001199-200701000-00007			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	130SX	WOS:000243820400007	17235232				2022-02-06	
J	Crawford, MA; Knight, RG; Alsop, BL				Crawford, Maria A.; Knight, Robert G.; Alsop, Brent L.			Speed of word retrieval in postconcussion syndrome	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						postconcussion syndrome; information processing; retrieval speed; word fluency; memory; attention	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; SEMANTIC MEMORY; VERBAL FLUENCY; SPORTS	Speed of information processing in persons with postconcussion syndrome (PCS) was examined using word fluency tasks. Twenty patients with PCS and twenty controls matched for age, gender, and occupation were given two word fluency tasks, and the speed of word generation was measured. Response latencies were analyzed to determine whether slowed retrieval or degradation of words in semantic memory was responsible for problems with word retrieval after traumatic brain injury. The PCS group recalled fewer words, had significantly longer interresponse times, and took significantly longer to generate their first word than the controls. There was no evidence that either structure loss or slowness in word retrieval from semantic memory could account for the word fluency deficits. Rather, the findings suggest that the primary cause of word retrieval difficulties in patients with PCS is a generalized slowness of cognitive processing.	Univ Otago, Dept Psychol, Dunedin, New Zealand		Knight, RG (corresponding author), Univ Otago, Dept Psychol, Box 56, Dunedin, New Zealand.	rknight@psy.otago.ac.nz					*ACC REH COMP INS, 2001, AGR PROV MILD TRAUM; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Benton A., 1976, MULTILINGUAL APHASIA; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; LEVIN HS, 2000, CEREBRAL REORGANIZAT, P218; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; RANDOLPH C, 1998, REPEATABLE BATTERY A; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; ROEDIGER HL, 1977, J EXP PSYCHOL-HUM L, V3, P174, DOI 10.1037/0278-7393.3.2.174; Rohrer D, 1999, NEUROPSYCHOLOGY, V13, P381, DOI 10.1037/0894-4105.13.3.381; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9	14	14	15	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2007	13	1					178	182		10.1017/S135561770707021X			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	127PO	WOS:000243599000020	17166317				2022-02-06	
J	Hassett, LM; Harmer, AR; Moseley, AM; Mackey, MG				Hassett, L. M.; Harmer, A. R.; Moseley, A. M.; Mackey, M. G.			Validity of the modified 20-metre shuttle test: Assessment of cardiorespiratory fitness in people who have sustained a traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; effort tests; assessment	MAXIMAL OXYGEN-UPTAKE; FUNCTIONAL-CAPACITY; EXERCISE CAPACITY; AEROBIC CAPACITY; WALKING TEST; RUN TEST; RELIABILITY; RESPONSES; ADULTS; INDIVIDUALS	Primary objective: To validate the modified 20-metre shuttle test in adults who have sustained a traumatic brain injury (TBI). Design: Single-sample validity study. Setting: Brain injury rehabilitation unit. Participants: Twenty-four adults with severe TBI, discharged from hospital for at least 6-months. Protocol: Participants attended the facility for a familiarization session, followed by a symptom-limited treadmill test and a modified shuttle test on two separate days. The treadmill test was based on an individualised protocol which used a physiotherapist-selected speed and increments in gradient every minute until volitional fatigue. The modified shuttle test was externally-paced and commenced with a speed of 2.4 km h(-1) which increased every minute until volitional fatigue. Main measures: Four primary measures were taken from both tests: peak oxygen uptake, peak heart rate, maximal velocity and rating of perceived exertion. Results: All participants completed the study. There were no adverse events. A high correlation was observed between the modified shuttle test and the treadmill test for peak oxygen uptake, peak heart rate and maximal velocity ( r = 0.96, r = 0.80, r = 0.82, respectively; p<0.001), but not for rating of perceived exertion ( r = 0.013, p = 0.952). Conclusion: The modified shuttle test is a valid measure of cardiorespiratory fitness in people who have sustained a TBI.	Liverpool Hlth Serv, Brain Injury Rehabil Unit, Liverpool, NSW 1871, Australia; Univ Sydney, Discipline Physiotherapy, Lidcombe, NSW, Australia		Hassett, LM (corresponding author), Liverpool Hlth Serv, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool, NSW 1871, Australia.	leanne.hassett@sswahs.nsw.gov.au	Harmer, Alison/I-2593-2013	Harmer, Alison/0000-0003-4877-5801; Hassett, Leanne/0000-0002-3546-1822			AHMAIDI S, 1992, EUR J APPL PHYSIOL O, V65, P475, DOI 10.1007/BF00243517; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; *AM COLL SPORTS ME, 2005, HLTH REL PHYS FITN A; American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bhambhani Y, 2003, ARCH PHYS MED REHAB, V84, P1629, DOI 10.1053/S0003-9993(03)00343-5; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; DAWES H, 2003, PHYSIOTHERAPY, V89, P570; Dawes H, 2006, DISABIL REHABIL, V28, P1243, DOI 10.1080/09638280600554595; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Foster C, 1996, MED SCI SPORT EXER, V28, P752, DOI 10.1097/00005768-199606000-00014; Gayda M, 2003, ARCH PHYS MED REHAB, V84, P1012, DOI 10.1016/S0003-9993(03)00036-4; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; MacKay M, 2001, PHYS THER, V81, P1790, DOI 10.1093/ptj/81.11.1790; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1697, DOI 10.1053/apmr.2002.36395; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; MONTGOMERY DL, 1992, CAN J SPORT SCI, V17, P309; Morales FJ, 1999, AM HEART J, V138, P291, DOI 10.1016/S0002-8703(99)70114-6; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; PALMERMCLEAN K, 2002, AM COLL SPORTS MED R, P98; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Wolman RL, 1994, CLIN REHABIL, V8, P253	35	14	14	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	10					1069	1077		10.1080/02699050701630375			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WU	WOS:000250329600010	17891570				2022-02-06	
J	Natale, JE; Guerguerian, AM; Joseph, JG; McCarter, R; Shao, C; Slomine, B; Christensen, J; Johnston, MV; Shaffner, DH				Natale, JoAnne E.; Guerguerian, Anne-Marie; Joseph, Jill G.; McCarter, Robert; Shao, Cheng; Slomine, Beth; Christensen, James; Johnston, Michael V.; Shaffner, Donald H.			Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; traumatic brain injury; magnesium sulfate; QT interval; hemodynamics	ANEURYSMAL SUBARACHNOID HEMORRHAGE; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIALS; SUDDEN-DEATH; HEAD TRAUMA; BLOOD-FLOW; RATS; THERAPY; DECLINE	Objective: Magnesium sulfate is neuroprotective in preclinical models, but there are limited safety data regarding its clinical use for pediatric traumatic brain injury. We conducted a pilot study in children with severe traumatic brain injury to a) examine if magnesium sulfate decreases mean arterial pressure, decreases cerebral perfusion pressure, increases intracranial pressure, or adversely effects cardiac conduction; and b) determine the feasibility of a multiple-center trial of magnesium sulfate. Design: Double-blinded, placebo-controlled, randomized pilot trial with repeated measurement of hemodynamic variables. Setting: Two pediatric trauma centers. Patients: Six children (3 months to 18 yrs) with severe traumatic brain injury. Interventions: Magnesium sulfate (50 mg/kg) bolus followed by (8.3 mg/kg/hr) infusion for 24 hr vs. equivolume placebo. Measurements and Main Results: We screened 96 patients with severe traumatic brain injury during 24 months; 20 were eligible for enrollment, six provided informed consent, four received magnesium sulfate, and two received placebo. Before and after study drug infusion, we repeatedly measured blood ionized magnesium concentration, mean arterial pressure, cerebral perfusion pressure, intracranial pressure, heart rate, and corrected QT interval. Mean age (7.9 yrs), mean highest Glasgow Coma Scale score (6), gender (33% boys), inflicted injury rate (17%), and case mortality rate (17%) did not differ between those enrolled and those not enrolled. Compared with baseline, magnesium sulfate did not change cerebral perfusion pressure, intracranial pressure, heart rate, or corrected QT interval. Mean arterial pressure was unchanged until the late phase of magnesium sulfate infusion, when mean arterial pressure rose (82 +/- 5 vs. 93 +/- 6 mm Hg, p <.05). Sixty-four percent of corrected QT interval determinations obtained in the first 6 days after injury exceeded 440 msecs; 12% were >600 msecs. Conclusions: In children with severe traumatic brain injury, magnesium sulfate administration did not decrease mean arterial pressure or cerebral perfusion pressure or adversely effect cardiac conduction. Our data suggest that enrollment of brain-injured children in a therapeutic trial remains challenging. These results provide information important for clinical trials of magnesium sulfate in children with severe traumatic brain injury.	Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; Childrens Natl Med Ctr, Ctr Hlth Serv & Community Res, Washington, DC 20010 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Kennedy Krieger Inst, Baltimore, MD USA; Johns Hopkins Univ, Baltimore, MD USA		Natale, JE (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat, 2516 Stockton Blvd, Sacramento, CA 95817 USA.	jnatale@cnmcresearch.org		SHAFFNER, DONALD/0000-0001-5530-0746	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5-M01-RR-020359-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS43146] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS043146] Funding Source: NIH RePORTER		ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P21, DOI 10.3109/00365519409095208; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Cheung RTF, 2000, ARCH NEUROL-CHICAGO, V57, P1685, DOI 10.1001/archneur.57.12.1685; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Fukui S, 2003, CRIT CARE, V7, pR7, DOI 10.1186/cc2160; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; HEINEN M, 2005, NATL TRENDS INJURY H, P53; LANGLOIS JA, 2006, 2004 TRAUMATIC BRAIN; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Mendez DR, 2005, PEDIATR RES, V57, P347, DOI 10.1203/01.PDR.0000150803.36315.FF; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; Ozdemir D, 2005, PEDIATR EMERG CARE, V21, P658, DOI 10.1097/01.pec.0000181427.25342.e0; Regan RF, 2001, BRAIN RES, V890, P177, DOI 10.1016/S0006-8993(00)03156-5; Sankar P, 2004, MED ANTHROPOL Q, V18, P429, DOI 10.1525/maq.2004.18.4.429; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; SORTEBERG W, 1989, ACTA NEUROCHIR, V97, P47, DOI 10.1007/BF01577739; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2004, STROKE, V35, P644, DOI 10.1161/01.STR.0000117092.38460.4F; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; VINK R, 1988, J BIOL CHEM, V263, P757; Wang T, 2004, J NEUROSURG ANESTH, V16, P201, DOI 10.1097/00008506-200407000-00004; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	33	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2007	8	1					1	9		10.1097/01.pcc.0000256620.55512.5f			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	124JM	WOS:000243364100001	17251875				2022-02-06	
J	Pavlovskaya, M; Hochstein, S; Keren, O; Mordvinov, E; Groswasser, Z				Pavlovskaya, Marina; Hochstein, Shaul; Keren, Ofer; Mordvinov, Eugene; Groswasser, Zeev			Methylphenidate effect on hemispheric attentional imbalance in patients with traumatic brain injury: A psychophysical study	BRAIN INJURY			English	Article						attention; traumatic brain injury; neglect; asymmetry; methylphenidate; ritalin	DEFICIT HYPERACTIVITY DISORDER; SELECTIVE ATTENTION; VISUAL-ATTENTION; SUSTAINED ATTENTION; PATTERN-RECOGNITION; PARIETAL; NEGLECT; CT; FACILITATION; ORIENTATION	Primary objective: We found spatially asymmetric allocation of attention in patients with traumatic brain injury ( TBI) without overt asymmetry on neurological examination. The possible effect of Methylphenidate in reducing this asymmetry is evaluated in the current research. Research design: Psychophysical study using a visual spatial attention task. Identification rates were measured after precuing attention to different visual field loci. TBI patients were tested before, during and after administration of Methylphenidate. Methods and procedures: After precuing to a locus 5 degrees into the left or right hemifield, target patterns were presented briefly at the cued location ( valid), or on the opposite side ( invalid) - requiring an attentional shift. Patients were treated with a gradually increasing dosage of a psychostimulant over two weeks, followed by a similar two-week period of gradually diminishing dosage. Patients were tested before treatment, at its peak, and ( twice) following its completion. Main outcome and results: Patients demonstrated significantly worse performance with leftward than with rightward cross-hemifield shifts of attention. This difference was significantly reduced during and following treatment. Conclusions: Asymmetric performance and improvement with treatment suggest that diffuse TBI damage leads to a lateralized attention-related deficit. These findings support the hypotheses that attention is a distributed and asymmetrically lateralized function. The findings are consistent with the conclusion that Methylphenidate may be an effective treatment for attentional deficits in TBI patients.	Loewenstein Hosp & Rehabil Ctr, Dept Neurophysiol, IL-43100 Raanana, Israel; Loewenstein Hosp & Rehabil Ctr, Dept Traumat Brain Injury, IL-43100 Raanana, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, Jerusalem, Israel; Hebrew Univ Jerusalem, Neural Computat Ctr, Jerusalem, Israel; Charles E Smith Lab Collaborat Res Psychobiol, Jerusalem, Israel		Groswasser, Z (corresponding author), Loewenstein Hosp & Rehabil Ctr, Dept Brain Injury Rehabil, 278 Ahuza Str, IL-43100 Raanana, Israel.	zeevgros@post.tau.ac.il					Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2001, PSYCHOL SCI, V12, P56, DOI 10.1111/1467-9280.00310; Alvarez JA, 2004, DEV NEUROPSYCHOL, V26, P627, DOI 10.1207/s15326942dn2602_6; Audet T, 2000, BRAIN COGNITION, V43, P17; BACHYRITA P, 1991, SCAND J REHABIL MED, V23, P219; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bender M.B, 1952, DISORDERS PERCEPTION; Berlucchi G, 1997, NEUROPSYCHOLOGIA, V35, P941, DOI 10.1016/S0028-3932(97)00022-5; BISIACH E, 1988, HDB NEUROPSYCHOLOGY, P195; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CARTER CS, 1995, BIOL PSYCHIAT, V37, P789, DOI 10.1016/0006-3223(94)00217-Q; CHEAL ML, 1994, Q J EXP PSYCHOL-A, V47, P699, DOI 10.1080/14640749408401134; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; DESIMONE R, 1990, Society for Neuroscience Abstracts, V16, P621; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; Duncan J., 2004, COGNITIVE NEUROSCIEN, P105; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Heilman KM, 1993, CLIN NEUROPSYCHOLOGY, P279; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hurford P, 1998, ARCH PHYS MED REHAB, V79, P346, DOI 10.1016/S0003-9993(98)90019-3; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Jonides J., 1981, ATTENTION PERFORM, V11, P187; Kajs-Wyllie Marylyn, 2002, J Neurosci Nurs, V34, P303; Karnath HO, 2003, NEUROREPORT, V14, P437, DOI 10.1097/01.wnr.0000059778.23521.88; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MELAMED S, 1985, SCAND J REHABIL MED, P16; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PAVLOVSKAYA M, 1992, OPHTHAL PHYSL OPT, V12, P165, DOI 10.1111/j.1475-1313.1992.tb00282.x; Pavlovskaya M, 2002, J COGNITIVE NEUROSCI, V14, P745, DOI 10.1162/08989290260138645; Pavlovskaya M, 2001, SPATIAL VISION, V14, P151, DOI 10.1163/156856801300202913; Pavlovskaya M, 2001, BRAIN COGNITION, V47, P346; Pavlovskaya M, 1997, J COGNITIVE NEUROSCI, V9, P824, DOI 10.1162/jocn.1997.9.6.824; PAVLOVSKAYA M, 2006, IN PRESS BRAIN COGNI; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; Schendel KL, 2001, PERCEPT PSYCHOPHYS, V63, P577, DOI 10.3758/BF03194423; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VALLAR G, 1994, J NEUROL NEUROSUR PS, V57, P464, DOI 10.1136/jnnp.57.4.464; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Vandenberghe R., 1997, Society for Neuroscience Abstracts, V23, P300; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VOLKOW ND, 2001, J NEUROSCI, V21, P1; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	73	14	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	5					489	497		10.1080/02699050701311117			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000005	17522988				2022-02-06	
J	Potter, EG; Cheng, Y; Knight, JB; Gordish-Dressman, H; Natale, JE				Potter, Emily G.; Cheng, Ying; Knight, Jay Brandon; Gordish-Dressman, Heather; Natale, Joanne E.			Metallothionein I and II attenuate the thalamic microglial response following traumatic axotomy in the immature brain	JOURNAL OF NEUROTRAUMA			English	Article						inflicted childhood neurotrauma; mice; microglial activation; negative binomial regression; secondary injury	FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; INFLICTED HEAD-INJURY; CELL-DEATH; RAT-BRAIN; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; MOLECULAR-MECHANISMS; SENSORIMOTOR CORTEX; PARKINSONS-DISEASE	The clinical manifestations of inflicted traumatic brain injury in infancy most commonly result from intracranial hemorrhage, axonal stretch and disruption, and cerebral edema. Often hypoxia ischemia is superimposed, leading to early forebrain and later thalamic neurodegeneration. Such acute and delayed cellular injury activates microglia in the CNS. Although activated microglia provide important benefits in response to injury, microglial release of reactive oxygen species can be harmful to axotomized neurons. We have previously shown that the antioxidants metallothionein I and II (MT I & II) promote geniculocortical neuronal survival after visual cortex lesioning. The purpose of this investigation was to determine the influence of MT I & II on the density and rate of thalamic microglial activation and accumulation following in vivo axotomy. We ablated the visual cortex of 10-day-old and adult MT I & II knock out (MT-/-) and wild-type mice and then determined the density of microglia in the dorsal lateral geniculate nucleus (dLGN) over time. Compared to the wild-type strain, microglial activation occurred earlier in both young and adult MT-/- mice. Similarly, microglial density was significantly greater in young MT-/- mice 30, 36, and 48 hours after injury, and 3, 4, and 5 days after injury in MT-/- adults. In both younger and older mice, time and MT I & II deficiency each contributed significantly to greater microglial density. Only in younger mice did MT I & II expression significantly slow the rate (density X time) of microglial accumulation. These results suggest that augmentation of NIT I & II expression may provide therapeutic benefits to infants with inflicted brain injury.	Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC USA; George Washington Univ, Inst Biomed Sci, Neurosci Program, Washington, DC 20052 USA; Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA		Natale, JE (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat, 2516 Stockton Blvd, Sacramento, CA 95817 USA.	jnatale@cnmcresearch.org		Knight, Brandon/0000-0003-4953-7194; Gordish-Dressman, Heather/0000-0002-2330-5427	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [KO8 NS 41273] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS041273] Funding Source: NIH RePORTER		Acarin L, 1999, NEUROSCIENCE, V89, P549, DOI 10.1016/S0306-4522(98)00331-5; Acarin L, 1997, EXP NEUROL, V147, P410, DOI 10.1006/exnr.1997.6593; Agar J, 2003, AMYOTROPH LATERAL SC, V4, P232, DOI 10.1080/14660820310011278; Asanuma M, 2002, NEUROSCI LETT, V327, P61, DOI 10.1016/S0304-3940(02)00346-4; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Campagne MV, 2000, J NEUROSCI, V20, P5200, DOI 10.1523/JNEUROSCI.20-14-05200.2000; Cerutti SM, 2000, CELL BIOL INT, V24, P35, DOI 10.1006/cbir.1999.0451; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Dailey ME, 1999, METHODS, V18, P222, DOI 10.1006/meth.1999.0775; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Ebadi M, 2005, METHOD ENZYMOL, V396, P276, DOI 10.1016/S0076-6879(05)96024-2; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Gao HM, 2003, J NEUROSCI, V23, P6181; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Heese K, 1998, J NEUROCHEM, V70, P699; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hermann DM, 2000, ACTA NEUROPATHOL, V99, P147, DOI 10.1007/PL00007418; Hochman A, 2000, CELL MOL BIOL, V46, P41; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kim D, 2003, NEUROREPORT, V14, P679, DOI 10.1097/00001756-200304150-00004; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; LEIBBRANDT MEI, 1994, TOXICOL APPL PHARM, V124, P72, DOI 10.1006/taap.1994.1010; Lu YZ, 2005, NEUROSCI LETT, V373, P159, DOI 10.1016/j.neulet.2004.10.004; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; Mischel RE, 1997, NEUROSCI LETT, V231, P17, DOI 10.1016/S0304-3940(97)00531-4; Morino T, 2003, NEUROSCI RES, V46, P309, DOI 10.1016/S0168-0102(03)00095-6; Muessel MJ, 2002, MOL BRAIN RES, V103, P12, DOI 10.1016/S0169-328X(02)00158-4; Munch G, 2003, EXP BRAIN RES, V150, P1, DOI 10.1007/s00221-003-1389-5; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Potts Mathew B, 2006, NeuroRx, V3, P143; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Soltys Z, 2005, J NEUROSCI METH, V146, P50, DOI 10.1016/j.jneumeth.2005.01.009; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Vela JM, 2002, J NEUROTRAUM, V19, P1503, DOI 10.1089/089771502320914723; VERITY MA, 1994, NEUROTOXICOLOGY, V15, P81; Walsh DT, 2000, GLIA, V29, P392, DOI 10.1002/(SICI)1098-1136(20000215)29:4<392::AID-GLIA10>3.3.CO;2-3; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Wang XJ, 2005, NEUROREPORT, V16, P267, DOI 10.1097/00001756-200502280-00013; West AK, 2004, REV NEUROSCIENCE, V15, P157; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	71	14	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					28	42		10.1089/neu.2006.0056.R1			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100004	17263668				2022-02-06	
J	Powner, DJ; Hergenroeder, GW; Awili, M; Atik, MA; Robertson, C				Powner, David J.; Hergenroeder, Georgene W.; Awili, Mustafa; Atik, Mustafa A.; Robertson, Claudia			Hyponatremia and comparison of NT-pro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: A pilot study	NEUROCRITICAL CARE			English	Article						brain injuries; trauma; nervous system; natriuretic hormone; natriuretic peptide; brain	NATRIURETIC PEPTIDE LEVELS; CARDIAC DYSFUNCTION; SEPTIC SHOCK; PLASMA-LEVEL; ATRIAL; MARKER	Background Hyponatremia after traumatic brain injury (TBI) may influence neurological function and treatment. A causal relationship between elevated serum concentrations of Type B natriuretic peptide (BNP) and hyponatremia has been implied after subarachnoid hemorrhage and other neurosurgical disorders, although the source of BNP has not been identified. We evaluated if hyponatremia and increased BNP occur after TBI and if BNP is produced/released by the brain within 24 h after injury. Results NT-proBNP was measured in concomitant jugular venous and arterial blood samples within 24 h after TBI. NT-proBNP was elevated in both samples in six patients (24%). One patient (4%) showed an increased jugular NT-proBNP concentration above a normal arterial concentration, suggesting a brain source. In the other 24 patients the difference between jugular and arterial NT-proBNP was not statistically significant. Hyponatremia( <= 136 mEq/l) also occurred in six patients (24%), but only two (8%) had both increased arterial NT-proBNP and hyponatremia. In both the urine sodium was slightly elevated above normal, but not statistically different from other patients. The difference in serum sodium between hypo- and normo-natremic groups was significant, but mean NT-proBNP and jugular: arterial NT-proBNP differences were not. Conclusions In this pilot study BNP is elevated within 24 h after TBI in some patients. However, it does not originate from the brain and increased NT-proBNP concentrations are not consistently associated with hyponatremia or increased urinary sodium loss.	Univ Texas, Hlth Sci Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77225 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Powner, DJ (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Neurosurg, 6431 Fannin St,MSB 7-154, Houston, TX 77030 USA.	david.j.powner@uth.tmc.edu		Hergenroeder, Georgene/0000-0002-6170-2191	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR 02558] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660] Funding Source: Medline		Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Almog Y, 2006, ANESTH ANALG, V102, P1809, DOI 10.1213/01.ane.0000217202.55909.5d; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; Baylis PH, 2003, INT J BIOCHEM CELL B, V35, P1495, DOI 10.1016/S1357-2725(03)00139-0; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Cai Jia-ning, 2003, Chin J Traumatol, V6, P179; Cole C.D., 2004, NEUROSURG FOCUS, V16, P1; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; HASAN D, 1990, ANN NEUROL, V27, P106, DOI 10.1002/ana.410270118; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Jason P, 2005, CRIT CARE MED, V33, P2094, DOI 10.1097/01.CCM.0000178351.03327.9F; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; MARUMO F, 1987, BIOCHEM BIOPH RES CO, V143, P813, DOI 10.1016/0006-291X(87)90321-4; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; McLean AS, 2003, CRIT CARE MED, V31, P2611, DOI 10.1097/01.CCM.0000094225.18237.20; Mueller T, 2003, CLIN CHEM, V49, P976, DOI 10.1373/49.6.976; Nakagawa K, 2002, NEUROL RES, V24, P627, DOI 10.1179/016164102101200474; Nogami M, 2001, HISTOCHEM J, V33, P87, DOI 10.1023/A:1017996113871; Obi T, 2002, ACTA NEUROL SCAND, V106, P225, DOI 10.1034/j.1600-0404.2002.01228.x; Palac Robert T, 2003, Prog Transplant, V13, P42; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89; Roch A, 2005, CRIT CARE MED, V33, P1001, DOI 10.1097/01.CCM.0000162561.82012.E9; Rudiger A, 2006, CRIT CARE MED, V34, P2140, DOI 10.1097/01.CCM.0000229144.97624.90; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Sviri GE, 2003, ACTA NEUROCHIR, V145, P851, DOI 10.1007/s00701-003-0101-7; Takami S, 2000, AM J HYPERTENS, V13, P121, DOI 10.1016/S0895-7061(99)00184-3; TOGASHI K, 1991, CLIN CHIM ACTA, V201, P193, DOI 10.1016/0009-8981(91)90370-R; Tung PP, 2005, STROKE, V36, P1567, DOI 10.1161/01.STR.0000170699.59783.d6; Vuolteenaho O, 2005, ADV CLIN CHEM, V40, P1, DOI 10.1016/S0065-2423(05)40001-3; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wiedemann K, 2000, EXP CLIN ENDOCR DIAB, V108, P5; Wittebole X, 2005, J ELECTROCARDIOL, V38, P77, DOI 10.1016/j.jelectrocard.2004.09.004; Witthaut R, 2004, CRIT CARE, V8, P342, DOI 10.1186/cc2890	36	14	17	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	7	2					119	123		10.1007/s12028-007-0079-8			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	214MJ	WOS:000249741700004	17690842				2022-02-06	
J	Preece, MHW; Geffen, GM				Preece, Megan Haf Wyn; Geffen, Gina Malke			The contribution of pre existing depression to the acute cognitive sequelae of mild traumatic brain injury	BRAIN INJURY			English	Article						mild traumatic brain injury; concussion; depression; verbal memory; information processing speed	MAJOR DEPRESSION; RAPID SCREEN; HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; UNIPOLAR DEPRESSION; HIPPOCAMPAL VOLUME; WORD REPETITION; YOUNGER ADULTS; SYMPTOMS; MRI	Primary objective: To determine the effect of pre-existing depression on the cognitive sequelae of mild traumatic brain injury ( mTBI) within 24 hours of injury. Research design: A 2 x 2 between-subjects design was used to examine the effect of depression and injury type on neuropsychological test performance. The independent variables were the injury type ( mTBI or control) and the presence of depression ( depressed or not depressed). Methods and procedures: Participants who had sustained mTBI ( 30 with depression, 30 without depression) within the previous 24 hours and control participants ( 19 with depression, 30 without depression) were assessed on the Digit Symbol Substitution Test ( DSS), Hopkins Verbal Learning Test ( HVLT) and the Speed of Comprehension Test. Results: Participants with mTBI performed worse than controls on the tests, particularly HVLT delayed recall and DSS total correct. Participants with depression did not perform worse than participants without depression. However, there was a significant univariate interaction for HVLT recognition, participants who had sustained mTBI and were classified in the depressed group exhibited worse recognition compared to mTBI participants without depression. Conclusions: The results indicate that depression may interact with mTBI to impair word recognition during the acute phase after a head injury.	Univ Queensland, Sch Psychol, Cognit Psychophysiol Lab, Brisbane, Qld 4072, Australia		Preece, MHW (corresponding author), Univ Queensland, Sch Psychol, Cognit Psychophysiol Lab, McElwain Bldg, Brisbane, Qld 4072, Australia.	m.preece@psy.uq.edu.au	Preece, Megan/A-7186-2013	Preece, Megan/0000-0003-4852-8712			ALOIA MS, 1995, BRAIN INJURY, V9, P575, DOI 10.3109/02699059509008216; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews G, 1999, MENTAL HLTH AUSTR; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Baddeley A., 1992, SPEED CAPACITY LANGU; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; BENCH CJ, 1995, PSYCHOL MED, V25, P247, DOI 10.1017/S0033291700036151; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Bremner JD, 2004, AM J PSYCHIAT, V161, P637, DOI 10.1176/appi.ajp.161.4.637; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; De Monte VE, 2004, J CLIN EXP NEUROPSYC, V26, P628, DOI 10.1080/13803390490504443; De Monte VE., 2005, BRAIN IMPAIR, V6, P109, DOI [10.1375/brim.2005.6.2.109, DOI 10.1375/BRIM.2005.6.2.109]; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KOLB B, 2003, FUNDAMENTALS HUMAN N; Korten A, 2000, BRIT J PSYCHIAT, V177, P325, DOI 10.1192/bjp.177.4.325; KWAPIL KJ, 2003, BRAIN IMPAIR, V4, P155; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Mayberg HS, 2004, ESSENTIALS NEUROPSYC, P489; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCULLOUGH CM, 2006, BRAIN IMPAIR, V7, P16; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHEEDY J, IN PRESS EMERGENCY D; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheline YI, 2002, EUR PSYCHIAT, V17, p300S; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Wang CE, 2006, J AFFECT DISORDERS, V92, P283, DOI 10.1016/j.jad.2006.02.008; WESCHLER D, 1981, WESCHLER ADULT INTEL; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; [No title captured]	77	14	14	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	9					951	961		10.1080/02699050701481647			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	202ZA	WOS:000248942600007	17729048	Green Submitted			2022-02-06	
J	Prins, SA; De Hoog, M; Blok, JH; Tibboel, D; Visser, GH				Prins, Sandra A.; De Hoog, Matthijs; Blok, Joleen H.; Tibboel, Dick; Visser, Gerhard H.			Continuous noninvasive monitoring of barbiturate coma in critically ill children using the Bispectral (TM) index monitor	CRITICAL CARE			English	Article							CARE	Introduction Traumatic brain injury and generalized convulsive status epilepticus (GCSE) are conditions that require aggressive management. Barbiturates are used to lower intracranial pressure or to stop epileptiform activity, with the aim being to improve neurological outcome. Dosing of barbiturates is usually guided by the extent of induced burst-suppression pattern on the electroencephalogram (EEG). Dosing beyond the point of burst suppression may increase the risk for complications without offering further therapeutic benefit. For this reason, careful monitoring of EEG parameters is mandatory. A prospective study was conducted to evaluate the usefulness of the bispectral index suppression ratio for monitoring barbiturate coma. Methods A prospective observational pilot study was performed at a paediatric (surgical) intensive care unit, including all children with barbiturate-induced coma after traumatic brain injury or GCSE. The BIS (TM) (Bispectral (TM) index) monitor expresses a suppression ratio, which represents the percentage of epochs per minute in which the EEG was suppressed. Suppression ratios from the BIS monitor were compared with suppression ratios of full-channel EEG as assessed by quantitative visual analysis. Results Five patients with GCSE and three patients after traumatic brain injury (median age 11.6 years, range 4 months to 15 years) were included. In four patients the correlation between the suppression ratios of the BIS and EEG could be determined; the average correlation was 0.68. In two patients, suppression ratios were either high or low, with no intermediate values. This precluded determination of correlation values, as did the isoelectric EEG in a further two patients. In the latter patients, the mean +/- standard error BIS suppression ratio was 95 +/- 1.6. Conclusion Correlations between suppression ratios of the BIS and EEG were found to be only moderate. In particular, asymmetrical EEGs and EEGs with short bursts (less than 1 second) may result in aberrant BIS suppression ratios. The BIS monitor potentially aids monitoring of barbiturate-induced coma because it provides continuous data on EEG suppression between full EEG registrations, but it should be used with caution.	[Prins, Sandra A.; Tibboel, Dick] Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Pediat Surg,Intens Care Unit, NL-3015 GJ Rotterdam, Netherlands; [De Hoog, Matthijs] Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Pediat,Intens Care Unit, NL-3015 GJ Rotterdam, Netherlands; [Blok, Joleen H.; Visser, Gerhard H.] Erasmus Univ, Med Ctr, Dept Clin Neurophysiol, NL-3015 CE Rotterdam, Netherlands		Tibboel, D (corresponding author), Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Pediat Surg,Intens Care Unit, Dr Molewaterplein 60, NL-3015 GJ Rotterdam, Netherlands.	d.tibboel@erasmusmc.nl	de Hoog, Matthijs/A-3882-2013	Prins, Sandra/0000-0002-4695-5246; Blok, Joleen/0000-0001-9661-5816			ADELSON PD, 2003, PEDIAT CRIT CARE S3, pS49; Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Grindstaff Ryan J, 2004, J Intensive Care Med, V19, P111, DOI 10.1177/0885066603262066; Hinkle D.E., 1998, APPL STAT BEHAV SCI; Jaggi P, 2003, PEDIATR NEUROL, V28, P219, DOI 10.1016/S0887-8994(02)00633-1; Kwan P, 2004, EPILEPSIA, V45, P1141, DOI 10.1111/j.0013-9580.2004.12704.x; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; TASKER RC, 1990, INTENS CARE MED, V16, P60, DOI 10.1007/BF01706327; van Gestel JPJ, 2005, NEUROLOGY, V65, P591, DOI 10.1212/01.wnl.0000173066.89001.f9; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Winer JW, 1991, NEUROSURGERY, V29, P741; Yanay O, 2004, J CRIT CARE, V19, P174, DOI 10.1016/j.jcrc.2004.07.008	15	14	16	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2007	11	5							R108	10.1186/cc6138			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264KO	WOS:000253286400015	17897479	Green Published, gold			2022-02-06	
J	Shapiro, SM; Sombati, S; Geiger, A; Rice, AC				Shapiro, Steven M.; Sombati, Sompong; Geiger, Angela; Rice, Ann C.			NMDA channel antagonist MK-801 does not protect against bilirubin neurotoxicity	NEONATOLOGY			English	Article						kernicterus; tissue culture; brainstem auditory evoked potentials; hyperbilirubinemia; jaundice; Gunn rat; free bilirubin	JAUNDICED GUNN-RATS; EVOKED-POTENTIAL ABNORMALITIES; HUMAN NT2-N NEURONS; TRAUMATIC BRAIN-INJURY; HUMAN SERUM-ALBUMIN; UNCONJUGATED BILIRUBIN; CELL-DEATH; RECEPTOR ANTAGONISTS; KINASE-II; IN-VITRO	Background: Bilirubin encephalopathy or kernicterus is a potentially serious complication of neonatal hyperbilirubinemia. The mechanism of bilirubin-induced neurotoxicity is not known. Many neurological insults are mediated through NMDA receptor activation. Objective: We assessed the effect of the NMDA channel antagonist, MK-801 on bilirubin neurotoxicity in vivo and in vitro. Methods: Bilirubin toxicity in vitro was assessed using trypan blue staining. Sulfadimethoxine injected ( i.p.) jaundiced Gunn rat pups exhibit many neurological sequelae observed in human hyperbilirubinemia. Brainstem auditory-evoked potentials ( BAEPs), a noninvasive sensitive tool to assess auditory dysfunction due to bilirubin neurotoxicity, were used to assess neuroprotection with MK-801 ( i.p.) in vivo. Results: In primary cultures of hippocampal neurons, 20 min exposure to 64: 32 mu M bilirubin: human serum albumin reduced the cell viability by approximately 50% ten hours later. MK-801 treatment did not protect the cells. MK-801 pretreatment doses ranging from 0.1-4.0 mg/kg did not protect against BAEP abnormalities in Gunn rat pups 6 h after sulfadimethoxine injection. Conclusion: Our findings suggest that bilirubin neurotoxicity is not mediated through NMDA receptor activation. Copyright (C) 2007 S. Karger AG, Basel.	Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pediat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Physiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Otolaryngol Head & Neck Surg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Rice, AC (corresponding author), Virginia Commonwealth Univ, Dept Neurol, POB 980599, Richmond, VA 23298 USA.	acrice@vcu.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC00369] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47151] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000369] Funding Source: NIH RePORTER		AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; Ahlfors CE, 2001, BIOL NEONATE, V80, P158, DOI 10.1159/000047136; AMIT Y, 1993, EXP NEUROL, V121, P248, DOI 10.1006/exnr.1993.1092; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BLANC WA, 1959, J NEUROPATH EXP NEUR, V18, P165, DOI 10.1097/00005072-195901000-00011; BRODERSEN R, 1972, SCAND J CLIN LAB INV, V29, P433, DOI 10.3109/00365517209080263; Chihab R, 1998, J NEUROCHEM, V71, P1177; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; Churn SB, 1995, ADV NEUROIMMUNOL, V5, P241, DOI 10.1016/0960-5428(95)00016-U; CHURN SB, 1995, PEDIATR RES, V38, P949, DOI 10.1203/00006450-199512000-00020; Conlee JW, 2000, ACTA NEUROPATHOL, V99, P393, DOI 10.1007/s004010051141; COULTER DA, 1992, J NEUROPHYSIOL, V68, P362, DOI 10.1152/jn.1992.68.2.362; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; DELORENZO RJ, 2005, PHARMACOL THERAPEUT, V111, P288; Falcao AS, 2005, NEUROBIOL DIS, V20, P199, DOI 10.1016/j.nbd.2005.03.001; Fernandes A, 2004, J NEUROIMMUNOL, V153, P64, DOI 10.1016/j.jneuroim.2004.04.007; GEIGER AS, 2007, IN PRESS NEONATOLOGY; Grojean S, 2002, SEMIN PERINATOL, V26, P416, DOI 10.1053/sper.2002.37141; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Hanko E, 2006, PEDIATR RES, V59, P72, DOI 10.1203/01.pdr.0000191135.63586.08; Hanko E, 2005, PEDIATR RES, V57, P179, DOI 10.1203/01.PDR.0000148711.11519.A5; Hanko E, 2006, BRAIN RES, V1103, P56, DOI 10.1016/j.brainres.2006.05.083; Hoffman DJ, 1996, PEDIATR RES, V40, P804, DOI 10.1203/00006450-199612000-00005; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; JACOBSEN J, 1969, FEBS LETT, V5, P112, DOI 10.1016/0014-5793(69)80307-8; JOHNSON L, 1961, AM J DIS CHILD, V101, P322, DOI 10.1001/archpedi.1961.04020040050007; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Keppel G., 1992, DESIGN ANAL RES HDB, V2; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Malamud N., 1961, KERNICTERUS ITS IMPO, P230; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Meldrum BS, 2002, PROG BRAIN RES, V135, P487; NAGAOKA S, 1978, J BIOL CHEM, V253, P2005; Oakden WK, 2005, AM J NEURORADIOL, V26, P1571; ODELL GB, 1985, CEREBRAL ENERGY META, P229; Olney JW, 2002, NEUROTOXICOLOGY, V23, P659, DOI 10.1016/S0161-813X(01)00092-4; OLNEY JW, 1994, PSYCHOPHARMACOL BULL, V30, P533; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Rice AC, 2006, BRAIN RES, V1107, P215, DOI 10.1016/j.brainres.2006.06.005; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rodrigues CMP, 2002, PEDIATR RES, V51, P112, DOI 10.1203/00006450-200201000-00020; ROSE AL, 1979, J NEUROPATH EXP NEUR, V38, P152, DOI 10.1097/00005072-197903000-00006; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; SCHUTTA HS, 1969, J PEDIATR-US, V75, P1070, DOI 10.1016/S0022-3476(69)80351-3; SHAPIRO SM, 1988, DEV BRAIN RES, V41, P147, DOI 10.1016/0165-3806(88)90178-2; SHAPIRO SM, 1988, PEDIATR RES, V23, P306, DOI 10.1203/00006450-198803000-00015; SHAPIRO SM, 1993, PEDIATR RES, V34, P629, DOI 10.1203/00006450-199311000-00014; Shapiro Steven M, 2005, J Perinatol, V25, P54, DOI 10.1038/sj.jp.7211157; Silva R, 1999, BIOCHEM BIOPH RES CO, V265, P67, DOI 10.1006/bbrc.1999.1646; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; SOMBATI S, 1991, BRAIN RES, V566, P316, DOI 10.1016/0006-8993(91)91716-E; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; TURSKI L, 1993, EXPERIENTIA, V49, P1064, DOI 10.1007/BF01929915; Warr O, 2000, BRAIN RES, V879, P13, DOI 10.1016/S0006-8993(00)02676-7	57	14	14	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1661-7800			NEONATOLOGY	Neonatology		2007	92	4					248	257		10.1159/000103743			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	227KJ	WOS:000250655300006	17556843				2022-02-06	
J	Stablum, F; Umilta, C; Mazzoldi, M; Pastore, N; Magon, S				Stablum, Franca; Umilta, Carlo; Mazzoldi, Mariantonietta; Pastore, Nicole; Magon, Stefano			Rehabilitation of endogenous task shift processes in closed head injury patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							DYSEXECUTIVE SYNDROME; PRACTICAL SCALE; DEFICITS	This paper reports a study that was aimed to rehabilitate executive functions in CHI patients. When a subject is engaged in two speeded tasks, not simultaneously but with some form of alternation, the response is slower to an item of task A if it was preceded by an item of task B, than when it was preceded by an item of task A. This shift cost is small when subjects can prepare in advance for the new task (endogenous task shift), whereas the cost is much greater when preparation is not possible (exogenous task shift). The groups tested comprised 20 severe closed head injury (CHI) patients (10 who underwent treatment and 10 controls), 8 mild CHI patients, and 18 non-brain damaged (NBD) controls. In the present study, the shift cost was greater for severe CHI patients than for NBD controls. Treatment consisted of five sessions, in which an endogenous task shift paradigm was used. A significant reduction of the endogenous shift cost from assessment to retest was found. The reduction remained stable at the 4-month follow-up session. These results are not simply due to retesting, as the control patients did not show any improvement at retest. Interestingly, no reduction of exogenous task shift cost was found. The results showed also that the beneficial effect of the treatment generalises to other executive functions.	Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy		Stablum, F (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.			Stablum, Franca/0000-0003-0123-5090; Magon, Stefano/0000-0003-1517-7581			Alderman N., 1996, BADS BEHAV ASSESSMEN; Beauchemin MJ, 2000, BRAIN COGNITION, V44, P63; BERNSTEIN DM, 1999, 27 M INT NEUR SOC BO; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mateer CA, 1999, COGNITIVE NEUROREHAB; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; SCHNEIDER W, 1988, BEHAV RES METH INSTR, V20, P206, DOI 10.3758/BF03203833; SHALLICE T, 1994, ATTENTION PERFORM, pR15; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; TEASDALE G, 1974, LANCET, V2, P81; UMILTA C, 1992, EUR J COGN PSYCHOL, V4, P21, DOI 10.1080/09541449208406241; UMILTA C, 1998, METACOGNITION COGNIT; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608	28	14	14	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	2007	17	1					1	33		10.1080/13506280500411111			33	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	128GH	WOS:000243645700001	17178603				2022-02-06	
J	Shi, XY; Tang, ZQ; Sun, D; He, XJ				Shi Xiao-yan; Tang Zhong-quan; Sun Da; He Xiao-jun			Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury	CHINESE MEDICAL JOURNAL			English	Article						traumatic brain injury; hyperbaric oxygenation; computed tomography; single photon; emission computed tomography	CEREBRAL-BLOOD-FLOW; PHOTON EMISSION CT; SEVERE HEAD-INJURY; CORTICAL IMPACT; TIME-COURSE; RATS; VOLUME	Background. Improvement of clinical symptoms following hyperbaric oxygen (HBO) treatment of neuropsychiatric disorders arising from traumatic brain injury was proved by our previous study. This study was aim to obtain the evidence of other changes. Methods. Three hundred and ten patients with neuropsychiatric disorders arising from traumatic brain injury were treated twice with hyperbaric oxygen. Cerebral single photon emissions computed tomography (SPECT) images and computed tomography scans (CT) before and after hyperbaric oxygen treatment, were compared. Results. Before treatment, the proportion of abnormal cerebral changes detected by SPECT was 81.3% but only 15.2% by CT. After HBO treatment, 70.3% of SPECT scans showed no abnormalities and these patients were clinically improved. Treatment improved regional cerebral blood flow. Conclusion. SPECT was much more sensitive than CT in the diagnosis of neuropsychiatric disorders following hyperbaric oxygen treatment of neuropsychiatric disorders arising from traumatic brain injury.	Zhejiang Univ, Affiliated Hosp Zhejiang 2, Coll Med, Neurosci Care Unit, Hangzhou 310009, Peoples R China; Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Hyperbar Oxygen, Hangzhou 310009, Peoples R China; Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Nucl Med, Hangzhou 310009, Peoples R China; Chinese Journal Emergency Med, Editorial Board, Hangzhou 310009, Peoples R China		Shi, XY (corresponding author), Zhejiang Univ, Affiliated Hosp Zhejiang 2, Coll Med, Neurosci Care Unit, Hangzhou 310009, Peoples R China.	xys0571@hotmail.com					Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Badr AE, 2001, BRAIN RES, V916, P85, DOI 10.1016/S0006-8993(01)02867-0; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Deb S, 1999, AM J PSYCHIAT, V156, P374; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Stamatakis EA, 2002, J NUCL MED, V43, P476; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; SUN D, 1997, RADIONUCLIDE BRAIN I, P239; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P143; Van Laere K, 2001, EUR J NUCL MED, V28, P862, DOI 10.1007/s002590100559	22	14	16	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	DEC 5	2006	119	23					1978	1982		10.1097/00029330-200612010-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116QR	WOS:000242817900007	17199942	gold			2022-02-06	
J	Demir, SO; Altinok, N; Aydin, G; Koseoglu, F				Demir, Sibel Ozbudak; Altinok, Nermin; Aydin, Gulumser; Koseoglu, Fusun			Functional and cognitive progress in aphasic patients with traumatic brain injury during post-acute phase	BRAIN INJURY			English	Article						traumatic brain injury; aphasia; functional-cognitive outcome; rehabilitation	REHABILITATION; THERAPY; RECOVERY; LANGUAGE; IMPAIRMENT; EFFICACY; SPEECH	Objectives: To investigate the relationship between language functions and cognitive and functional outcome and to evaluate the effects of a conventional language rehabilitation programme on aphasic adult patients in the post-acute stage of traumatic brain injury (TBI). Design: Non-concurrent prospective study. Patients were assessed pre-treatment and post-treatment with standardized assessment tools. Subjects: Sixty-one aphasic patients with TBI who were admitted to a rehabilitation centre in the post-acute phase for a late inpatient rehabilitation programme. Methods: The motor sub-scales of the Functional Independence Measures and Disability Rating Scale were used to assess functional status and disability. Cognitive status was evaluated with the Mini-Mental Status Examination and the Functional Independence Measure cognitive sub-scale. The language function was evaluated with the Gulhane Aphasia Test. Results: All functional, cognitive and language scores increased significantly during the rehabilitation programme. Language functions at admission were correlated with the Functional Independence Measure motor change scores and the Mini-Mental Status Examination change scores. Regression analyses revealed that auditory comprehension at admission was the most important independent determinant of functional and cognitive gain during rehabilitation. Conclusion: Post-acute language functions after late admission to a rehabilitation centre appear to be related to measures of cognitive and functional progress in patients with TBI. Functional and cognitive outcome is mainly affected by auditory comprehension. Results also showed the effectiveness of post-acute conventional rehabilitation in improving language functions.	Hosp Minist Hlth, Ankara Phys Med & Rehabil Educ & Res, Ankara, Turkey; Kirikkale Univ, Dept Phys Med & Rehabil, Fac Med, Kirikkale, Turkey		Demir, SO (corresponding author), 12 Cadde 11-6 Aytekinler Apt, TR-06450 Ankara, Turkey.	sibiozbudak@hotmail.com	Aydin, Gulumser/AAS-4112-2020; Aydin, Gulumser/AAC-3912-2020				Aftonomos LB, 1997, ARCH PHYS MED REHAB, V78, P841, DOI 10.1016/S0003-9993(97)90197-0; Aftonomos LB, 1999, STROKE, V30, P1370, DOI 10.1161/01.STR.30.7.1370; BASSO A, 1979, ARCH NEUROL-CHICAGO, V36, P190, DOI 10.1001/archneur.1979.00500400044005; Basso A, 2001, APHASIOLOGY, V15, P307, DOI 10.1080/02687040042000304; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Carlomagno S, 2001, ARCH PHYS MED REHAB, V82, P1073, DOI 10.1053/apmr.2001.25155; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Darley F L, 1975, Adv Neurol, V7, P111; DEMIR OS, 2005, J REHABILITATION MED, V37, P1; Diamond PT, 1996, AM J PHYS MED REHAB, V75, P40, DOI 10.1097/00002060-199601000-00011; Elman RJ, 1999, J SPEECH LANG HEAR R, V42, P411, DOI 10.1044/jslhr.4202.411; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; Goodglass H, 1983, ASSESSMENT APHASIA R; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; Hesketh A, 1997, EUR J DISORDER COMM, V32, P189; Isaki E, 2000, BRAIN INJURY, V14, P441; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Laganaro M, 2006, NEUROPSYCHOLOGIA, V44, P534, DOI 10.1016/j.neuropsychologia.2005.07.005; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; NICHOLAS ML, 1993, ARCH PHYS MED REHAB, V74, P830, DOI 10.1016/0003-9993(93)90009-Y; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Rao RP, 1996, PHYS MED REHABILITAT, P55; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rey GJ, 2001, CLIN NEUROPSYCHOL, V15, P13, DOI 10.1076/clin.15.1.13.1911; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; *STAT U NEW YORK B, 1993, GUID UN DAT SET MED; WHURR R, 1992, EUR J DISORDER COMM, V27, P1; Worrall L, 2000, APHASIOLOGY, V14, P911, DOI 10.1080/02687030050127711; Yavuzer G, 2001, INT J REHABIL RES, V24, P241, DOI 10.1097/00004356-200109000-00011; Youse KM, 2004, BRAIN INJURY, V18, P825, DOI 10.1080/02699000410001671784	35	14	15	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1383	1390		10.1080/02699050601081844			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100008	17378230				2022-02-06	
J	Eid, K; Labler, L; Ertel, W; Trentz, O; Keel, M				Eid, K.; Labler, L.; Ertel, W.; Trentz, O.; Keel, M.			Systemic effects of severe trauma on the function and apoptosis of human skeletal cells	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							3-DIMENSIONAL COLLAGEN SPONGES; COLONY-STIMULATING FACTOR; NERVE GROWTH-FACTOR; HETEROTOPIC OSSIFICATION; HEAD-INJURY; ENHANCED OSTEOGENESIS; NEUTROPHIL APOPTOSIS; BRAIN INJURY; SURVIVAL; BONE	Systemic factors are believed to be pivotal for the development of heterotopic ossification in severely-injured patients. In this study, cell cultures of putative target cells (human fibroblastic cells, osteoblastic cells (MG-63), and bone-marrow stromal cells (hBM)) were incubated with serum from ten consecutive polytraumatised patients taken from post-traumatic day 1 to day 21 and with serum from 12 healthy control subjects. The serum from the polytraumatised patients significantly stimulated the proliferation of fibroblasts, MG-63 and of hBM cells. The activity of alkaline phosphatase in MG-63 and hBM cells was significantly decreased when exposed to the serum of the severely-injured patient. After three weeks in 3D cell cultures, matrix production and osteogenic gene expression of hBM cells were equal in the patient and control groups. However, the serum from the polytraumatised patients significantly decreased apoptosis of hBM cells compared with the control serum (4.3% vs 19.1%, p = 0.031). Increased proliferation of osteoblastic cells and reduced apoptosis of osteoprogenitors may be responsible for increased osteogenesis in severely-injured patients.	Univ Zurich Hosp, Div Trauma Surg, CH-8091 Zurich, Switzerland		Eid, K (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	karim.eid@usz.ch					Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BRACH MA, 1992, BLOOD, V80, P2920; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.0.CO;2-U; CLEMENTS NC, 1993, CHEST, V104, P1526, DOI 10.1378/chest.104.5.1526; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; COLOTTA F, 1992, BLOOD, V80, P2012; Ertel W, 1999, J TRAUMA, V46, P784, DOI 10.1097/00005373-199905000-00005; Ertel W, 1998, J TRAUMA, V44, P767, DOI 10.1097/00005373-199805000-00005; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Keel M, 2000, UNFALLCHIRURG, V103, P243, DOI 10.1007/s001130050529; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; LARSON JM, 1981, RHEUMATOL REHABIL, V20, P193, DOI 10.1093/rheumatology/20.4.193; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253; Mogi M, 2000, LIFE SCI, V67, P1197, DOI 10.1016/S0024-3205(00)00705-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; ROBBINS JR, 1997, METHODS MOL MED, P173; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; TRENTZ O, 2000, AO PRINCIPLES FRACTU, P661; Tumber A, 2000, J ENDOCRINOL, V167, P383, DOI 10.1677/joe.0.1670383; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319	44	14	16	0	1	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	OCT	2006	88B	10					1394	1400		10.1302/0301-620X.88B10.17139			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	102LQ	WOS:000241813000024	17012435				2022-02-06	
J	Miller, P; Mack, CD; Sammer, M; Rozet, I; Lee, LA; Muangman, S; Wang, M; Hollingworth, W; Lam, AM; Vavilala, MS				Miller, Patrick; Mack, Christopher D.; Sammer, Marla; Rozet, Irene; Lee, Lorri A.; Muangman, Saipin; Wang, Marjorie; Hollingworth, Will; Lam, Arthur M.; Vavilala, Monica S.			The incidence and risk factors for hypotension during emergent decompressive craniotomy in children with traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; SURGICAL EVACUATION; BLOOD-PRESSURE; SURGERY	We conducted a retrospective cohort study in children < 13 yr with traumatic brain injury (TBI) at a Level 1 pediatric trauma center to describe risk factors for intraoperative hypotension (IH) during emergent decompressive craniotomy. Between 1994 and 2004, 108 children underwent emergent decompressive craniotomy for TBI. Overall, 56 (52%) patients had IH. Independent risk factors for IH were each 10 mL estimated blood loss/kg (ARR 1.15 95% CI 1.08-1.22), each mm of computed tomography (CT) midline shift (ARR 1.04 95%CI 1.01-1.07), each 10 mL of CT lesion volume (ARR 1.03 95%CI 1.01-1.05), and emergency department (ED) hypotension (5/5 patients with ED hypotension had IH). CT midline shift >= 4 mm predicted IH (ARR 1.67 95% CI 1.06-2.63), independent of blood loss. IH occurred frequently during emergent decompressive craniotomy in children with TBI. ED hypotension, blood loss, CT lesion volume, and CT midline shift predicted IH. Anesthesiologists can expect children with preoperative CT midline shift >= 4 mm to have IH during this procedure.	Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; Univ Washington, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Dept Radiol, Seattle, WA 98104 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9Th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Hollingworth, William/0000-0002-0840-6254	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [K23044632] Funding Source: Medline		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; HAGLUND MM, 1996, ANESTH ANALG, V83, P1014; HORAN M J, 1987, Pediatrics, V79, P1; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; OSTEBEE A, 1995, CALCULUS GRAPHICAL N, V2; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Ransom GH, 2003, CHILD ABUSE NEGLECT, V27, P381, DOI 10.1016/S0145-2134(03)00025-5; UCHIDA M, 1982, CRIT CARE MED, V10, P5, DOI 10.1097/00003246-198201000-00002; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	OCT	2006	103	4					869	875		10.1213/01.ane.0000237327.12205.dc			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	087RL	WOS:000240759800014	17000796				2022-02-06	
J	Whiting, MD; Hamm, RJ				Whiting, Mark D.; Hamm, Robert J.			Traumatic brain injury produces delay-dependent memory impairment in rats	JOURNAL OF NEUROTRAUMA			English	Article						memory; memory impairment; non-matching-to-place; rat; traumatic brain injury	CLOSED-HEAD-INJURY; PERIRHINAL CORTEX; WORKING-MEMORY; LONG-TERM; DEFICITS; ACQUISITION; HIPPOCAMPUS; AMNESIA; LESIONS; INTACT	Memory impairment following traumatic brain injury (TBI) is common in both humans and animals. A noteworthy feature of memory dysfunction in human TBI is impaired memory performance that is dependent on the delay between initial learning and recall of information. However, previous studies of TBI-induced memory impairment in animals have failed to control for the initial amount of learning between sham and injured animals. The present study demonstrates that experimental TBI in rats produces delay-dependent memory impairment, even when the initial degree of learning is controlled for. Animals were injured at a moderate level of lateral fluid percussion (LFP) injury (n = 10) or received a sham injury (n = 9), and then trained in a water T-maze version of the delayed-non-matching-to-place (DNMP) task beginning 10 days post-injury. Acquisition training consisted of 15 trials per day on post-injury days 11-15 using a minimal (7-sec) delay between the sample and choice phases of the task. Following acquisition, the delay between the sample and choice phases of the task was progressively increased to 15, 30, and 120 sec. Injured animals acquired the task at the same rate as sham animals and performed equally well at the 15-sec delay (p > 0.05). However, as the delay increased to 30 and 120 sec, the performance of the injured animals deteriorated (p < 0.05). These results indicate that LFP injury produces delay-dependent memory impairments in rats. This is therefore a valid model of an important feature of memory impairment in human TBI, and should be a useful addition to the available methods for assessing memory impairment and the effect of therapeutic interventions after TBI.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Whiting, MD (corresponding author), Virginia Commonwealth Univ, Dept Psychol, 808 W Franklin St, Richmond, VA 23284 USA.	whitingmd@vcu.edu					ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; BROOKS D N, 1975, Cortex, V11, P329; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; JENNET WB, 1969, CURRENT PROBLEMS NEU; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1992, J NEUROTRAUM, V9, P359; Liu P, 1998, BEHAV NEUROSCI, V112, P512, DOI 10.1037/0735-7044.112.3.512; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Wiig KA, 1998, BEHAV NEUROSCI, V112, P827, DOI 10.1037/0735-7044.112.4.827; WOOD ER, 1993, BEHAV NEUROSCI, V107, P51, DOI 10.1037/0735-7044.107.1.51; ZOLAMORGAN S, 1992, J NEUROSCI, V12, P2582	21	14	15	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2006	23	10					1529	1534		10.1089/neu.2006.23.1529			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	093XL	WOS:000241203500012	17020487				2022-02-06	
J	Celik, SE; Ozturk, H; Tolunay, S				Celik, Suat Erol; Ozturk, Hulya; Tolunay, Sahsine			Therapeutic effect of hypothermia and dizocilpine maleate on traumatic brain injury in neonatal rats	JOURNAL OF NEUROTRAUMA			English	Article						dizocilpine maleate; head injury; histopathology; hypothermia; newborn rat	SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; NEURONAL INJURY; MODEL; GLUTAMATE; ISCHEMIA; CHILDREN; RELEASE	This study was undertaken to evaluate the therapeutic effect of hypothermia and dizocilpine maleate in traumatic brain injury (TBI) on newborn rats. After induction of TBI, physiologic and histopathological assessments were performed on both the control and therapeutic groups to evaluate the effects of both agents. Rats were assigned into four groups as follows: normothermic (n = 23), hypothermic (n = 18), normothermia plus dizocilpine maleate (n = 18) and hypothermia plus dizocilpine maleate (n = 18). All the rats were injured using a weight-drop head injury model, artificially ventilated with a 33% O-2 and 66% NO2 Mixture, and physiological parameters, intracranial pressure, and brain and rectal temperatures were recorded. Mortality, physiological, neurological parameters, and histopathological changes were assessed after 24 h. As a result, intracranial pressure, cerebral perfusion pressure, morbidity, weight loss, and microscopic changes were significantly worse in the normothermic group (p < 0.05). There was no statistical difference between other groups (p > 0.05). Hypothermia and dizocilpine maleate displayed similar neuroprotective effects in TBI on newborn rats, but no additive effect was observed.	Beyoglu State Hosp, Dept Neurosurg, TR-34700 Istanbul, Turkey; Uludag Univ, Fac Med, Dept Pathol, Bursa, Turkey		Celik, SE (corresponding author), Beyoglu State Hosp, Dept Neurosurg, Goztepe Soyak Sitesi 58-1017, TR-34700 Istanbul, Turkey.	suaterolcelik@yahoo.com	Tolunay, Sahsine/AAI-1612-2021				Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BAKER CJ, 1995, NEUROSURGERY, V36, P994, DOI 10.1227/00006123-199505000-00016; BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; FREWEN TC, 1989, CRIT CARE MED, V17, P912, DOI 10.1097/00003246-198909000-00015; Hayashi N, 2000, No To Hattatsu, V32, P122; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Markarian GZ, 1996, NEUROSURGERY, V38, P542; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; SADAMITSU D, 1997, CRIT CARE MED, V25, P8; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SLATER P, 1993, BRIT J PHARMACOL, V108, P1143, DOI 10.1111/j.1476-5381.1993.tb13518.x; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Takahashi I, 2000, NEUROL SURG TOKYO, V28, P983; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	28	14	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1355	1365		10.1089/neu.2006.23.1355			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900007	16958587				2022-02-06	
J	Watt, SE; Shores, EA; Baguley, IJ; Dorsch, N; Fearnside, MR				Watt, Sharon E.; Shores, E. Arthur; Baguley, Ian J.; Dorsch, Nicholas; Fearnside, Michael R.			Protein S-100 and neuropsychological functioning following severe traumatic brain injury	BRAIN INJURY			English	Article						protein S-100; neuropsychological functioning; severe traumatic brain injury; Westmead PTA Scale	BIOCHEMICAL SERUM MARKERS; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; DAMAGE; S100	Primary objective: To examine the relationship between serum concentrations of protein S-100 beta and neuropsychological functioning following severe traumatic brain injury. Design: Matched control group. Methods: Blood samples were taken within 12 hours of injury and then daily up to 7 days post-injury (n = 23). Within 2 weeks of emerging from post-traumatic amnesia (PTA), participants completed a battery of neuropsychological measures. These results were compared with a matched sample of healthy controls. Results: Early measurement of S-100 not only reflected overall brain injury severity, but also related to neuropsychological deficits, with higher serum concentrations associated with poorer performance across most cognitive domains. PTA duration, measured by the Westmead PTA Scale, was found to be the strongest predictor of S-100 concentration (R-2 = 0.59, p < 0.001). Conclusions: These findings show that measurement of serum protein S-100 may further aid in the identification of individuals with severe TBI who are likely to experience cognitive difficulties.	Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Shores, EA (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	ashores@psy.mq.edu.au	Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Baguley, Ian J/0000-0001-5650-3705; Shores, Edwin A/0000-0003-1553-5131			Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Carstairs JR, 2000, AUST PSYCHOL, V35, P36, DOI 10.1080/00050060008257466; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; FANO G, 1993, NEUROSCIENCE, V53, P919, DOI 10.1016/0306-4522(93)90477-W; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gonzalez R, 2003, J INT NEUROPSYCH SOC, V9, P64, DOI 10.1017/S1355617703910071; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; HARDEMARK HG, 1986, UPSALA J MED SCI, P29; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Hiscock Merrill, 2002, Appl Neuropsychol, V9, P129, DOI 10.1207/S15324826AN0903_1; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Marchi N, 2003, J NEUROSCI, V23, P1949; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SHORES EA, 2006, BRAIN IMPAIRMENT, V0007, P00026; Stevens JP., 1996, APPL MULTIVARIATE ST; Tabachnick B.G., 2001, USING MULTIVARIATE S; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Uomoto JM, 2004, REHABIL PSYCHOL, V49, P334, DOI 10.1037/0090-5550.49.4.334; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Zakzanis K, 1999, NEUROPSYCHOLOGICAL D; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	51	14	15	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1007	1017		10.1080/02699050600909698			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100002	17060133				2022-02-06	
J	Ueda, Y; Walker, SA; Povlishock, JT				Ueda, Yuji; Walker, Susan A.; Povlishock, John T.			Perivascular nerve damage in the cerebral circulation following traumatic brain injury	ACTA NEUROPATHOLOGICA			English	Article						traumatic brain injury; perivascular nerve fibers; PGP-9.5; Fluoro-Jade; serotonin	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CEREBROVASCULAR NERVES; NEURONAL DEGENERATION; FLUORO-JADE; RATS; IMMUNOREACTIVITY; ARTERIES; FIBERS; LOCALIZATION; SEROTONIN	Traumatic brain injury (TBI) causes cerebral vascular dysfunction. Most have assumed that it was the result of endothelial and/or smooth muscle alteration. No consideration, however, has been given to the possibility that the forces of injury may also damage the perivascular nerve network, thereby contributing to the observed abnormalities. To test this premise, we subjected rats to impact acceleration. At 6 h, 24 h and 7 days post-TBI, cerebral basal arteries were removed and processed with antibody targeting protein gene product 9.5 (PGP-9.5), with parallel assessments of 5-hydroxytryptamine (5-HT) accumulation in the perivascular nerves. Additionally, Fluoro-Jade was also used as a marker of axonal degeneration. The perivascular nerve network revealed no abnormality in sham animals. However, by 6 h post injury, Fluoro-Jade reactivity appeared in the perivascular regions, with the number of fibers increasing with time. By 24 h post injury, a significant reduction in the perivascular 5-HT accumulation occurred, together with a reduction in PGP-9.5 fiber staining. At 7 days, a recovery of the PGP-9.5 immunoreactivity occurred, however, it did not reach a control-like distribution. These studies suggest that neurogenic damage occurs following TBI and may be a contributor to some of the associated vascular abnormalities.	Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi 7558505, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Coll Virginia Campus,Box 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020193] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 20193] Funding Source: Medline		ALABADI JA, 1994, NEUROSURGERY, V34, P1027, DOI 10.1227/00006123-199406000-00011; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Bleys RLAW, 2001, MICROSC RES TECHNIQ, V53, P106, DOI 10.1002/jemt.1075; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; CHANG JY, 1989, BRAIN RES, V492, P79, DOI 10.1016/0006-8993(89)90891-3; COWEN T, 1990, BRAIN RES, V513, P237, DOI 10.1016/0006-8993(90)90461-J; EDVINSSON L, 1991, NEUROSCI LETT, V121, P151, DOI 10.1016/0304-3940(91)90672-G; EDVINSSON L, 1994, ACTA NEUROL SCAND, V90, P324; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; HARA H, 1988, ACTA NEUROPATHOL, V75, P538, DOI 10.1007/BF00687145; HARA H, 1986, J NEUROSURG, V65, P531, DOI 10.3171/jns.1986.65.4.0531; JACKOWSKI A, 1989, NEUROSCIENCE, V29, P453, DOI 10.1016/0306-4522(89)90072-9; JACKOWSKI A, 1989, J CEREBR BLOOD F MET, V9, P271, DOI 10.1038/jcbfm.1989.45; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1981, AM J PHYSIOL, V240, P511; Lin WM, 1997, NEUROREPORT, V8, P2999, DOI 10.1097/00001756-199709290-00002; LOBATO RD, 1980, J NEUROSURG, V53, P477, DOI 10.3171/jns.1980.53.4.0477; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Navarro X, 1997, J COMP NEUROL, V380, P164, DOI 10.1002/(SICI)1096-9861(19970407)380:2<164::AID-CNE2>3.0.CO;2-1; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; UEMURA Y, 1987, J NEUROSURG, V66, P741, DOI 10.3171/jns.1987.66.5.0741; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; YOSHIOKA J, 1984, STROKE, V15, P288, DOI 10.1161/01.STR.15.2.288; Youn SH, 1997, BRAIN RES, V752, P161, DOI 10.1016/S0006-8993(96)01451-5; [No title captured]	39	14	14	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JUL	2006	112	1					85	94		10.1007/s00401-005-0029-5			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	057YJ	WOS:000238630800010	16718445				2022-02-06	
J	Lange, RT; Chelune, GJ; Taylor, MJ; Woodward, TS; Heaton, RK				Lange, Rael T.; Chelune, Gordon J.; Taylor, Michael J.; Woodward, Todd. S.; Heaton, Robert K.			Development of demographic norms for four new WAIS-III/WMS-III indexes	PSYCHOLOGICAL ASSESSMENT			English	Article; Proceedings Paper	24th Annual Meeting of the National-Academy-of-Neuropsychology	NOV 17-20, 2004	Seattle, WA	Natl Acad Neuropsychol		WAIS-III; WMS-III; demographic norms; standardization sample	CONFIRMATORY FACTOR-ANALYSIS; R STANDARDIZATION SAMPLE; TRAUMATIC BRAIN INJURY; GENERAL ABILITY INDEX; MEMORY SCALE-III; WMS-III; EDUCATION; SCORES; INTELLIGENCE; UTILITY	Following the publication of the third edition Wechsler scales (i.e., WAIS-III and WMS-III), demographically corrected norms were made available in the form of a computerized scoring program (i.e., WAIS-III/WMS-III/WIAT-II Scoring Assistant). These norms correct for age, gender, ethnicity, and education. Since then, four new indexes have been developed: the WAIS-III General Ability Index, the WMS-III Delayed Memory Index, and the two alternate Immediate and Delayed Memory Indexes. The purpose of this study was to develop demographically corrected norms for the four new indexes using the standardization sample and education oversample from the WAIS-III and WMS-III. These norms were developed using the same methodology as the demographically corrected norms made available in the WAIS-III/WMS-III/WIAT-II Scoring Assistant.	Riverview Hosp, Res Dept, Coquitlam, BC V3C 4J2, Canada; Cleveland Clin Fdn, Cleveland, OH 44106 USA; Univ Calif San Diego, San Diego, CA 92103 USA		Lange, RT (corresponding author), Riverview Hosp, Res Dept, Room 124,ADMIN Bldg,2601 Lougheed Highway, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmhs.bc.ca		Woodward, Todd/0000-0001-8083-0079			Axelrod BN, 1996, CLIN NEUROPSYCHOL, V10, P159, DOI 10.1080/13854049608406677; Chiaravalloti ND, 2004, J CLIN EXP NEUROPSYC, V26, P484, DOI 10.1080/13803390490496623; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 1991, COMPREHENSIVE NORMS; HEATON RK, 2000, HDB NEUROPSYCHOLOGY; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Heaton RK, 1992, COMPREHENSIVE NORMS; Heaton RK, 2004, COMPREHENSIVE NORMS; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P77, DOI 10.1016/j.acn.2005.07.007; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; KAUFMAN AS, 1988, J CLIN PSYCHOL, V44, P231, DOI 10.1002/1097-4679(198803)44:2<231::AID-JCLP2270440224>3.0.CO;2-J; Kurland, 1992, CLIN NEUROPSYCHOL, V6, P31, DOI [10.1080/13854049208401878, DOI 10.1080/13854049208401878]; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Mitrushina MN, 1998, HDB NORMATIVE DATA N; Price LR, 2002, J CLIN EXP NEUROPSYC, V24, P574, DOI 10.1076/jcen.24.5.574.1013; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 2001, WAIS 3 WMS 3 WIAT 2; REYNOLDS CR, 1987, J SCHOOL PSYCHOL, V25, P323, DOI 10.1016/0022-4405(87)90035-5; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; RYAN JJ, 1991, J CLIN PSYCHOL, V47, P104, DOI 10.1002/1097-4679(199101)47:1<104::AID-JCLP2270470117>3.0.CO;2-2; Shores EA, 2000, AUST PSYCHOL, V35, P41, DOI 10.1080/00050060008257467; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tulsky D., 2003, CLIN INTERPRETATION, P147; Tulsky DS, 2004, J CLIN EXP NEUROPSYC, V26, P563, DOI 10.1080/13803390490490782; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Tulsky DS., 2003, CLIN INTERPRETATION, P93, DOI [10.1016/B978-012703570-3/50007-9, DOI 10.1016/B978-012703570-3/50007-9]; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde NJ, 2003, PSYCHOL ASSESSMENT, V15, P56, DOI 10.1037/1040-3590.15.1.56; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	41	14	14	2	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2006	18	2					174	181		10.1037/1040-3590.18.2.174			8	Psychology, Clinical	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	053QV	WOS:000238320900005	16768593				2022-02-06	
J	Garcia, R; Ponsky, T; Brody, F; Long, J				Garcia, Ryan; Ponsky, Todd; Brody, Fredrick; Long, Joy			Bilateral luxatio erecta complicated by venous thrombosis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							UPPER EXTREMITY	Inferior shoulder dislocation or luxatio erecta is an exceedingly rare form of shoulder dislocation and compromises less than 0.5% of all shoulder dislocations. Furthermore, bilateral luxatio erecta is reported only nine times in the English literature. This paper documents the tenth case of bilateral luxatio erecta. This tenth patient suffered an axial load injury to his outstretched arms and displaced both humeral heads inferiorly. After closed reduction, the patient was discharged home on hospital day two. However, he developed an axillary vein thrombosis 3 days later and required anticoagulation therapy. This report reviews the mechanisms of injury associated with inferior shoulder dislocations as well as the presentation and treatment of luxatio erecta. The complication of axillary vein thrombosis and its treatment in this patient are discussed also.	Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA		Brody, F (corresponding author), George Washington Univ, Med Ctr, Dept Surg, 2150 Penn Ave NW,Suite 6B, Washington, DC 20037 USA.	fbrody@mfa.gwu.edu	Ponsky, Todd/J-1214-2014	Ponsky, Todd/0000-0001-7195-1493			Brady William J., 1995, Journal of Emergency Medicine, V13, P37, DOI 10.1016/0736-4679(94)00110-3; FREUNDLICH BD, 1983, J TRAUMA, V23, P434, DOI 10.1097/00005373-198305000-00015; Gelczer RK, 1996, J TRAUMA, V40, P825, DOI 10.1097/00005373-199605000-00025; Karaoglu S, 2003, ARCH ORTHOP TRAUM SU, V123, P308, DOI 10.1007/s00402-003-0517-9; LASKIN RS, 1971, CLIN ORTHOP RELAT R, P126, DOI 10.1097/00003086-197110000-00017; Mallon W J, 1990, J Orthop Trauma, V4, P19; MARX J, 2002, ROSENS EMERGENCY MED, P597; Middeldorpf M, 1859, CLIN EUROPENNE, V2, P12; Mills LD, 2003, J EMERG MED, V24, P61, DOI 10.1016/S0736-4679(02)00668-6; NEWMAN KJH, 1993, INJURY, V24, P684, DOI 10.1016/0020-1383(93)90323-X; Stephens MB, 1997, AM FAM PHYSICIAN, V55, P533; TILNEY NL, 1970, ARCH SURG-CHICAGO, V101, P792	12	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2006	60	5					1132	1134		10.1097/01.ta.0000217246.64718.02			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	044NB	WOS:000237678100046	16688085				2022-02-06	
J	Ongali, R; Hellal, F; Rodi, D; Plotkine, M; Marchand-Verrecchia, C; Pruneau, D; Couture, R				Ongali, Rice; Hellal, Farida; Rodi, Donata; Plotkine, Michel; Marchand-Verrecchia, Catherine; Pruneau, Didier; Couture, Rejean			Autoradiographic analysis of mouse brain kinin B-1 and B-2 receptors after closed head trauma and ability of anatibant mesylate to cross the blood-brain barrier	JOURNAL OF NEUROTRAUMA			English	Article						anatibant mesylate (LF 16-0687 Ms); autoradiography; B-1 receptor; B-2 receptor; blood-brain barrier; bradykinin; brain	ANTAGONIST LF 16-0687MS; FOCAL CEREBRAL-ISCHEMIA; BRADYKININ B-2; RAT MODEL; EDEMA FORMATION; CEREPORT RMP-7; INJURY; POTENT; TUMORS; CARBOPLATIN	The potent non-peptide B-2 receptor (R) antagonist, Anatibant mesylate (Ms) (LF 16-0687 Ms), reduces brain edema and improves neurological function recovery in various focal land diffuse models of traumatic brain injury in rodents. In the present study, alteration of kinin B-1 and B2R after closed head trauma (CHT) and in vivo binding properties of Anatibant Ms (3 mg/kg, s.c.) injected 30 min after CHT were studied in mice by autoradiography using the radioligands [I-125]HPP-Hoe 140 (B2R), and [I-125]HPP-des-Arg(10)-Hoe 140 (B1R). Whereas B1R is barely detected in most brain regions, B2R is extensively distributed, displaying the highest densities in the hindbrain. CHT was associated with a slight increase of B1R and a decrease of B2R (10-50%) in several brain regions. Anatibant Ms (Ki = 22 pM) displaced the B2R radioligand from its binding sites in several areas of the forebrain, basal ganglia and hindbrain. Displacement was achieved in 1 h and persisted at 4 h post-injection. The inhibition did not exceed 50% of the total specific binding in non-injured mice. After CHT, the displacement by Anatibant Ms was higher and almost complete in the cortex, caudate putamen, thalamus, hippocampus, medial geniculate nucleus, ventral tegmental area, and raphe. Evans blue extravasation in brain tissue at 4 h after CHT was abolished by Anatibant Ms. It appeared that Anatibant Ms penetrated into the brain in sufficient amounts, particularly after disruption of the blood-brain barrier, to account for its B2R-mediated neuro- and vascular protective effects. The diminished binding of B2R after CHT may reflect the occupancy or internalization of B2R following the endogenous production of bradykinin (BK).	Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Univ Paris 05, Lab Pharmacol & Circulat Cerebrale, Paris, France; Labs Fournier SA, Ctr Rech, Daix, France		Ongali, R (corresponding author), Univ Montreal, Fac Med, Dept Physiol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.		MARCHAND-LEROUX, Catherine/L-7453-2017; Hellal, Farida/D-1834-2015; Hellal, Farida/E-8533-2013	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Hellal, Farida/0000-0002-9344-1846; 			Asa I, 2003, J TRAUMA, V54, P881, DOI 10.1097/01.TA.0000046700.45106.4B; Buck HD, 2002, CAN J PHYSIOL PHARM, V80, P249, DOI 10.1139/Y02-050; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Couture R, 2000, HAND CHEM N, V16, P241; Emerich DF, 2000, PHARMACEUT RES, V17, P1212, DOI 10.1023/A:1026462629438; FRANCEL PC, 1992, J NEUROTRAUM, V9, pS27; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Hall E D, 1985, Cent Nerv Syst Trauma, V2, P75; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Li DZ, 2003, BRIT J PHARMACOL, V139, P1539, DOI 10.1038/sj.bjp.0705385; Marceau F, 2002, INT IMMUNOPHARMACOL, V2, P1729, DOI 10.1016/S1567-5769(02)00189-3; Marceau F, 1998, PHARMACOL REV, V50, P357; Murone C, 1996, EUR J PHARMACOL, V306, P237, DOI 10.1016/0014-2999(96)00190-2; Murone C, 1997, J COMP NEUROL, V381, P203, DOI 10.1002/(SICI)1096-9861(19970505)381:2<203::AID-CNE7>3.0.CO;2-7; Ongali B, 2003, J COMP NEUROL, V461, P506, DOI 10.1002/cne.10706; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; Pruneau D, 1999, IMMUNOPHARMACOLOGY, V43, P187, DOI 10.1016/S0162-3109(99)00128-9; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Rodi D, 2005, CURR PHARM DESIGN, V11, P1313, DOI 10.2174/1381612053507422; Schulz J, 2000, ACT NEUR S, V76, P137; Sobey CG, 2003, BRIT J PHARMACOL, V139, P1369, DOI 10.1038/sj.bjp.0705415; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, ACTA NEUROCHIR SUPPL, V76, P171; Thomas HD, 2000, CANCER CHEMOTH PHARM, V45, P284, DOI 10.1007/s002800050042; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Warren KE, 2001, CANCER CHEMOTH PHARM, V48, P275, DOI 10.1007/s002800100356; WIRTH K, 1991, EUR J PHARMACOL, V205, P217, DOI 10.1016/0014-2999(91)90824-A; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	38	14	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2006	23	5					696	707		10.1089/neu.2006.23.696			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	042LJ	WOS:000237529200008	16689671				2022-02-06	
J	Feleppa, M; Di Iorio, W; Saracino, DMT				Feleppa, M; Di Iorio, W; Saracino, DMT			Early poststroke seizures	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article; Proceedings Paper	1st Chieti Stroke Meeting	SEP   06, 2004	Chieti, ITALY				EPILEPTIC SEIZURES; ACUTE STROKE; INTRACEREBRAL HEMORRHAGE; POPULATION; PROGNOSIS; PREDICTORS; INFARCTION; FREQUENCY; MORTALITY; ISCHEMIA	We define as early seizure (ES) those occurring within 7 days alter stroke and late seizures those developing beyond I week after stroke. Seizures are well known to occur at the onset of intracerebral hemorrhage and serve as a clinical marker. Onset seizures may be focal or generalized, are usually brief and are associated with loss of consciousness in the setting of hemorrhage. A similar concept of immediate seizure occurs in traumatic brain injury. Predictive factors of ES can be classified of general and neurologic origin. An important question is whether ES per se worsen prognosis and outcome. The viability of the penumbral region in animal models of focal ischemia is influenced by the peri-infarct depolarization waves. If this also is trite in humans, seizures in the immediate poststroke period might worsen outcome. Recently, hypercholesterolemia has been associated with better functional outcome at 1 month after a first-ever stroke, and multivariate analysis studies have shown that mean cholesterol values were lower in patients with ES compared with controls.	Dipartimento Neurosci, Unita Operat Neurol, Benevento, Italy; Direz Sanit Azienda Osped G Rummo, Benevento, Italy		Feleppa, M (corresponding author), Azienda Osped G Rummo Benevento, Direttore Dipartimento Neurosci, UO Neurol, Via Angelo, I-82100 Benevento, Italy.	Michele.feleppa@ao-rummo.it					Afsar N, 2003, SEIZURE-EUR J EPILEP, V12, P23, DOI 10.1016/S1059131102001437; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Arboix A, 2003, EUR NEUROL, V50, P78, DOI 10.1159/000072503; Berges S, 2000, EUR NEUROL, V43, P3, DOI 10.1159/000008120; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; DAVALOS A, 1988, J NEUROL NEUROSUR PS, V51, P1464, DOI 10.1136/jnnp.51.11.1464; Devuyst G, 2003, NEUROLOGY, V61, P249, DOI 10.1212/01.WNL.0000070410.68541.7E; GIROUD M, 1994, EPILEPSIA, V35, P959, DOI 10.1111/j.1528-1157.1994.tb02540.x; GOODRIDGE DMG, 1983, BMJ-BRIT MED J, V287, P641, DOI 10.1136/bmj.287.6393.641; KILPATRICK CJ, 1990, ARCH NEUROL-CHICAGO, P47; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; LANCMAN ME, 1993, EPILEPSIA, V34, P141, DOI 10.1111/j.1528-1157.1993.tb02386.x; LEPPIK IE, 2002, SEMINARS NEUROLOGY, V22, P310; MILANDRE L, 1992, REV NEUROL, V148, P767; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; REITH J, 1996, EUR J N EUROL S2, V3, P93; Rumbach L, 2000, NEUROLOGY, V54, P350, DOI 10.1212/WNL.54.2.350; SCHOLTES FB, 1994, EPILEPSIA, V35, P1104, DOI 10.1111/j.1528-1157.1994.tb02562.x; SHINTON RA, 1988, J NEUROL NEUROSUR PS, V51, P273, DOI 10.1136/jnnp.51.2.273; Silverman IE, 2002, ARCH NEUROL-CHICAGO, V59, P195, DOI 10.1001/archneur.59.2.195; Sitajayalakshmi S, 2002, NEUOROL INDIA, V50, P78; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; SUNG CY, 1989, J NEUROL NEUROSUR PS, V52, P1273, DOI 10.1136/jnnp.52.11.1273; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Vauthey C, 2000, NEUROLOGY, V54, P1944, DOI 10.1212/WNL.54.10.1944; Velioglu SK, 2001, STROKE, V32, P1169, DOI 10.1161/01.STR.32.5.1169; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4	34	14	16	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1064-1963			CLIN EXP HYPERTENS	Clin. Exp. Hypertens.	APR-MAY	2006	28	3-4					265	270		10.1080/10641960600549215			6	Pharmacology & Pharmacy; Peripheral Vascular Disease	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	038MM	WOS:000237225900011	16833033				2022-02-06	
J	Johnston, MV; Shawaryn, MA; Malec, J; Kreutzer, J; Hammond, FM				Johnston, Mark V.; Shawaryn, Marla A.; Malec, James; Kreutzer, Jeffrey; Hammond, Flora M.			The structure of functional and community outcomes following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; measurement; outcomes; community participation; psychometrics	DISABILITY RATING-SCALE; REHABILITATION; VALIDITY; INVENTORY; INDIVIDUALS; RELIABILITY; INSTRUMENT	Objectives: To investigate the dimensionality of functional and community outcomes following serious TBI. To identify items that fit, misfit or are redundant, as well as to assess person misfit. Methods: Rating-scale (Rasch) analysis was applied to 1-year follow-up data from 231 cases in the US National TBI Model Systems database. Items selected for analysis included all items indicative of global outcomes, disability, activity or participation. Results: A powerful singular measurement dimension was identified. Item reliability was very high (0.98), as was person reliability (0.97). The dimension fit over 90% of cases; that is similar to 10% of cases displayed anomalous patterns of functioning that indicated that their functioning was not measurable in terms of the general dimension identified. There was tension within the dimension between ratings of dependency (FIM) and cognitive functioning in everyday life (NFI). Most-but not all-neuropsychological test scores misfit the outcome dimension. Conclusions: Actual dimensionality was distinct from the named scales employed. A unidimensional measure model fit the data much better than expected. This outcome dimension might be called 'general community functioning'. In the future, it should be possible to develop more valid and parsimonious measures of community outcomes following TBI.	Kessler Med Rehabil Res & Educ Corp, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, W Orange, NJ 07052 USA; Mayo Med Ctr, Dept Phys Med & Rehabil, Rochester, MN USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Charlotte Inst Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA		Johnston, MV (corresponding author), Kessler Med Rehabil Res & Educ Corp, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	mjohnston@kmrrec.org					Allen M., 1979, INTRO MEASUREMENT TH; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Bond T, 2001, APPL RASCH MODEL FUN; Bowling A., 2001, MEASURING DIS REV DI; Brown SA, 2001, AM J PHYS MED REHAB, V80, P196, DOI 10.1097/00002060-200103000-00009; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fisher A. G., 1999, ASSESSMENT MOTOR PRO; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRAHAM DI, 1999, REHABILITATION ADULT, P19; GROHER ME, 1999, REHABILITATION ADULT, P183; Haffey W. J., 1990, NEUROPSYCHOLOGY EVER, P99; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS3; JOHNSTON MV, 1996, MED REHABILITATION T, P197; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LINACRE JM, 2001, WINSTEPS 3 30; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Norman, 1995, HLTH MEASUREMENT SCA; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Putnam S, 1999, REHABILITATION ADULT, P147; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Riemsma R P, 2001, Health Technol Assess, V5, P1; Rizzo Matthew, 1996, P1; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; *TRAUM BRAIN INJ N, 2006, TRAUM BRAIN INJ MOD; Turner-Stokes L, 1999, CLIN REHABIL, V13, P273, DOI 10.1191/026921599670005973; Wade DT, 2001, CLIN REHABIL, V15, P229, DOI 10.1191/026921501677354949; Witol A., 1999, REHABILITATION ADULT, P167; World Health Organization, 2007, INT CLASS FUNCT DIS; WRIGHT BD, 1996, JMRASCH MEASUREMEN 2, P385	43	14	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2006	20	4					391	407		10.1080/02699050500487795			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700004	16716985				2022-02-06	
J	Lagares, A; Ramos, A; Alday, R; Ballenilla, F; Perez-Nunez, A; Arrese, I; Alen, JF; Pascual, B; Kaen, A; Gomez, PA; Lobato, RD				Lagares, A.; Ramos, A.; Alday, R.; Ballenilla, F.; Perez-Nunez, A.; Arrese, I.; Alen, J. F.; Pascual, B.; Kaen, A.; Gomez, P. A.; Lobato, R. D.			Magnetic resonance in moderate and severe head injury: comparative study of CT and MR findings. Characteristics related to the presence and location of diffuse axonal injury in MR	NEUROCIRUGIA			Spanish	Article						traumatic brain injury; head trauma; MR; CT; diffuse axonal injury; imaging methods	TRAUMA	Introduction. Cranial CT has been the most extended evaluation means for patients suffering head trauma. However, it has low sensitivity in the identification of diffuse axonal injury and posterior fossa lesions. Cranial MR is a potentially more sensitive test but difficult to perform in these patients, a fact that has hampered its generalised use. Objective. To compare the identification capability of traumatic intracranial lesions by both diagnostic tests in patients with moderate and severe head injury and to determine which radiological characteristics are associated with the presence of diffuse injury in MR and their clinical severity. Material and methods. 100 patients suffering moderate or severe head injury to whom a MR had been performed in the first 30 days after trauma were included. All clinical variables related to prognosis were registered, as well as the data from the initial CT following Marshall et al., classification. The MR was blindly evaluated by two neuroradiologists that were not aware of the initial CT results or the clinical situation of the patient. All lesions were registered as well as the classification following the classification of lesions related to DAI described by Adams et al. CT and MR findings were compared evaluating the sensitivities of each test. Factors related to the presence of diffuse injury in MR were studied by univariate analysis using chi(2) test and simple correlations. Results. MR is more sensitive than CT for lesions in cerebral white matter, corpus callosum and brainstem. It also detects a greater number of cerebral contusions. The presence of diffuse axonal injury depends on the mechanism of the trauma, being more frequent in higher energy trauma, specially in traffic accidents. Among the radiological characteristics associated to DAI the most clearly related is intraventricular haemorrhage. The presence of a deeper injury and a higher score in the scales of Adams is associated with a lower score in the GCS and motor GCS, and so with a worse level of consciousness and bigger severity of injury, confirming Ommaya's model.	Hosp 12 Octubre, Serv Neurocirugia, E-28041 Madrid, Spain; Hosp 12 Octubre, Serv Neurorradiol, E-28041 Madrid, Spain		Lagares, A (corresponding author), Hosp 12 Octubre, Serv Neurocirugia, Crta Andalucia Km 5-4, E-28041 Madrid, Spain.		KAEN, ARIEL/F-1338-2015; kaen, ariel/G-3786-2015; ALEN, JOSE A FERNANDEZ/G-4990-2018; Gomez, Pedro/N-5051-2019; Lagares, Alfonso/B-2969-2011; Perez-Nunez, Angel/AAG-4422-2020	ALEN, JOSE A FERNANDEZ/0000-0002-3321-983X; Gomez, Pedro/0000-0002-4185-5238; Lagares, Alfonso/0000-0003-3996-0554; Perez-Nunez, Angel/0000-0002-2391-6586; KAEN, ARIEL/0000-0002-0595-9515			Adams A, 2001, BCS CONF SERIES, P49; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Aguas J, 2005, NEUROCIRUGIA, V16, P14; Boto GR, 2005, NEUROCIRUGIA, V16, P39; Boto GR, 2004, NEUROCIRUGIA, V15, P233; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; SAHUQUILLO J, 1989, ACTA NEUROCHIR WIEN, V101, P762; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; VILALTA J, 1984, REV NEUROLOGIA, V57, P133; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	31	14	16	0	3	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	APR	2006	17	2					105	118					14	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	056YN	WOS:000238561100004	16721477				2022-02-06	
J	Moran, CA; Nippold, MA; Gillon, GT				Moran, CA; Nippold, MA; Gillon, GT			Working memory and proverb comprehension in adolescents with traumatic brain injury: A preliminary investigation	BRAIN INJURY			English	Article						traumatic brain injury; language comprehension; adolescents	CLOSED-HEAD INJURY; INDIVIDUAL-DIFFERENCES; ADULTS; FAMILIARITY; LANGUAGE; CHILDREN; PREADOLESCENTS; TRANSPARENCY; EXPLANATION; INFERENCE	Primary objective: This study investigated the relationship between working memory and comprehension of low-familiarity proverbs in adolescents with traumatic brain injury (TBI). Methods and procedures: Ten adolescents, aged 12 - 21 years who had suffered a TBI prior to the age of 10 years and 10 individually age-matched peers with typical development participated in the study. The participants listened to short paragraphs containing a proverb and interpreted the meaning of the proverb using a forced-choice task. In addition, participants engaged in a task that evaluated working memory ability. Main outcomes and results: Analysis revealed that individuals with TBI differed from their non-injured peers in their understanding of proverbs. In addition, working memory capacity influenced performance for all participants. Conclusions: The importance of considering working memory when evaluating figurative language comprehension in adolescents with TBI is highlighted. Implications for future research, particularly with regard to varying working memory and task demands, are considered.	Univ Canterbury, Coll Sci, Dept Commun Disorders, Christchurch 1, New Zealand		Moran, CA (corresponding author), Univ Canterbury, Coll Sci, Dept Commun Disorders, Private Bag 4800, Christchurch 1, New Zealand.	catherine.moran@canterbury.ac.nz		Gillon, Gail/0000-0001-9501-8147			Brundage SB, 1995, CLIN APHASIOL, V23, P165; Bustamante S., 1998, J CHILDRENS COMMUNIC, V19, P49; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; GIBBS RW, 1995, PSYCHOL BULL, V118, P113; Granier JP, 2000, APHASIOLOGY, V14, P501, DOI 10.1080/026870300401270; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Johnson, 1989, LANG SPEECH HEAR SER, V20, P420, DOI [10.1044/0161-1461.2004.420, DOI 10.1044/0161-1461.2004.420]; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kerbel Debra, 1997, CHILD LANG TEACH THE, V13, P113, DOI [10.1177/026565909701300201, DOI 10.1177/026565909701300201]; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Lehman MT, 2000, APHASIOLOGY, V14, P485, DOI 10.1080/026870300401261; Lehman-Blake MT, 2001, J SPEECH LANG HEAR R, V44, P639, DOI 10.1044/1092-4388(2001/052); LEVORATO MC, 1992, J CHILD LANG, V19, P415, DOI 10.1017/S0305000900011478; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; MORAN C, 2002, LANGUAGE COMPREHENSI; Nippold M., 1998, LATER LANGUAGE DEV S; Nippold M. A, 2001, NZ J SPEECH LANGUAGE, P14; NIPPOLD MA, 1993, J SPEECH HEAR RES, V36, P728, DOI 10.1044/jshr.3604.728; Nippold MA, 2001, AM J SPEECH-LANG PAT, V10, P169, DOI 10.1044/1058-0360(2001/016); NIPPOLD MA, 1988, J SPEECH HEAR RES, V31, P19, DOI 10.1044/jshr.3101.19; Nippold MA, 2000, J SPEECH LANG HEAR R, V43, P621, DOI 10.1044/jslhr.4303.621; NIPPOLD MA, 1995, J SPEECH HEAR RES, V38, P426, DOI 10.1044/jshr.3802.426; Nippold MA, 1996, J SPEECH HEAR RES, V39, P166, DOI 10.1044/jshr.3901.166; Nippold MA, 1997, J SPEECH LANG HEAR R, V40, P245, DOI 10.1044/jslhr.4002.245; Nippold MA, 2001, LANG SPEECH HEAR SER, V32, P90, DOI 10.1044/0161-1461(2001/009); Qualls CD, 2003, AM J SPEECH-LANG PAT, V12, P92, DOI 10.1044/1058-0360(2003/055); SWINNEY DA, 1979, J VERB LEARN VERB BE, V18, P523, DOI 10.1016/S0022-5371(79)90284-6; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; Towne R.L., 1993, LANG SPEECH HEAR SER, V24, P100; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Wiig E. H., 1989, TEST LANGUAGE COMPET	36	14	15	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2006	20	4					417	423		10.1080/02699050500488223			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700006	16716987				2022-02-06	
J	Schneider, HJ; Stalla, GK; Buchfelder, M				Schneider, HJ; Stalla, GK; Buchfelder, M			Expert meeting: hypopituitarism after traumatic brain injury and subarachnoid haemorrhage	ACTA NEUROCHIRURGICA			English	Article						endocrine dysfunction; head injury; hormonal deficiencies; hypopituitarism; traumatic brain injury; subarachnoid haemorrhage	HUMAN GROWTH-HORMONE		Univ Erlangen Nurnberg, Dept Neurosurg, Sch Med, D-91054 Erlangen, Germany; Max Planck Inst Psychiat, Dept Endocrinol & Clin Chem, Munich, Germany		Buchfelder, M (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Sch Med, Schwabachanlage 6, D-91054 Erlangen, Germany.	buchfelder@hotmail.com					ADAMS JH, 1962, J PHYSIOL, V165, pP22; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Ceballos R, 1966, Ala J Med Sci, V3, P185; EDWARDS OM, 1986, MEDICINE, V65, P281; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; HERNDON DN, 1990, ANN SURG, V212, P424, DOI 10.1097/00000658-199010000-00005; Hoffmann B, 2002, ACT NEUR S, V79, P33; JEEVANANDAM M, 1995, JPEN-PARENTER ENTER, V19, P137, DOI 10.1177/0148607195019002137; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KNOX J, 1995, J TRAUMA, V39, P526; KREITSCHMANNAND.I, 2003, J NEUROL NEUROSUR PS, V74, P1127; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; SCHNEIDER HJ, 2004, DTSCH ARZTEBL, V101, pA712; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001	19	14	17	1	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2006	148	4					449	456		10.1007/s00701-005-0724-y			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	023GN	WOS:000236114600023	16421764				2022-02-06	
J	Gallyas, F; Pal, J; Farkas, O; Doczi, T				Gallyas, F; Pal, J; Farkas, O; Doczi, T			The fate of axons subjected to traumatic ultrastructural (neurofilament) compaction: an electron-microscopic study	ACTA NEUROPATHOLOGICA			English	Article						recovery; degeneration; regeneration; electron microscopy	INJURED AXONS; BRAIN INJURY; LIGHT; NEURONS; ARGYROPHILIA; PERMEABILITY; ENVIRONMENT; IMMEDIATE; RECOVERY; DEATH	By means of a new head-injury apparatus, a 0.75-mm-deep depression was produced momentarily at a predetermined site of the rat calvaria. This immediately evoked ultrastructural (neurofilament) compaction in many myelinated axon segments in layers IV and V of the neocortex under the impact site. The affected axon segments run quasi-parallel to the brain surface in a diffuse distribution among normal axons. Other kinds of damage to the brain tissue were insignificant; the conditions were therefore favorable for investigation of the fate of the compacted axons. Quantitative analysis of the findings on groups of ten rats that were sacrificed either immediately after the head injury or following a 1 day or a 1 week survival period showed that around 50% of the compacted axons recovered in 1 day, and a further less than 10% did so in 1 week. Electron microscopy revealed that the non-recovering compacted axons underwent a sequence of degenerative morphological changes including homogenization, fragmentation and resorption of the fragments. However, the myelin sheaths around these degenerating axons remained apparently unchanged even in the long-surviving rats, and hardly any phagocytotic cells were encountered. On the other hand, many such myelin sheaths contained axolemma-bound, normal-looking axoplasm besides the above morphological signs of axon-degeneration. It is concluded that the non-recovering compacted axons undergo an uncommon (non-Wallerian) kind of degeneration, which is mostly reversible.	Univ Pecs, Fac Med, Dept Neurosurg, H-7623 Pecs, Hungary; Univ Pecs, Hungarian Acad Sci, Clin Neurosci Res Grp, H-7623 Pecs, Hungary		Gallyas, F (corresponding author), Univ Pecs, Fac Med, Dept Neurosurg, Ret Utca 2, H-7623 Pecs, Hungary.	ferenc.gallyas.sen@aok.pte.hu	Pal, Jozsef/C-4073-2009; Doczi, Tamas/C-5750-2009; Pal, Jozsef/I-3416-2013; Gallyas, Ferenc/C-5450-2009	Pal, Jozsef/0000-0001-6468-6409			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; GALLYAS F, 1993, J NEUROSCI METH, V50, P159, DOI 10.1016/0165-0270(93)90004-B; Gallyas F, 2004, BIOL CELL, V96, P313, DOI 10.1016/j.biolcel.2004.01.009; Gallyas F, 2002, ACTA NEUROPATHOL, V103, P36, DOI 10.1007/s004010100424; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P386, DOI 10.1007/BF00713530; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HAYAT MA, 1981, FIXATION ELECT MICRO, P88; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Narciso MS, 2001, AN ACAD BRAS CIENC, V73, P231, DOI 10.1590/S0001-37652001000200008; PAL J, IN PRESS J NEUROSCI; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Zsombok A, 2005, J NEUROSCI METH, V142, P145, DOI 10.1016/j.jneumeth.2004.08.005	22	14	14	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	MAR	2006	111	3					229	237		10.1007/s00401-006-0034-3			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	030HA	WOS:000236624000004	16485106				2022-02-06	
J	Gujral, IB; Stallones, L; Gabella, BA; Keefe, TJ; Chen, P				Gujral, IB; Stallones, L; Gabella, BA; Keefe, TJ; Chen, P			Sex differences in mortality after traumatic brain injury, Colorado 1994-1998	BRAIN INJURY			English	Article						traumatic brain injury; mortality; blunt; penetrating	GLASGOW COMA SCALE; HEAD-INJURIES; GENDER; ESTROGEN; SCORE	Primary objective: The purpose of this study was to assess the relationship between sex and traumatic brain injury (TBI) mortality. Methods and procedures: A total of 20 465 persons with TBI were identified from a Colorado population-based surveillance system for 1994 - 1998. Case fatality ratios were calculated to identify sex differences for selected risk factors. Unconditional logistic regression was used to determine the relationship between TBI mortality and sex controlling for risk factors. Main outcomes and results: Adjusting for age, race, metropolitan residence and penetrating injury, the estimated odds of TBI mortality for males compared to females was 1.21 ( 95% CI 1.10, 1.34) for pre-hospital fatalities and 1.19 ( 95% CI 1.05, 1.37) for hospital fatalities. Conclusion: Results indicate differences in TBI mortality comparing males and females. Future studies are warranted to identify if behaviour and physiological responses are associated with TBI outcomes among males and females.	Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; Colorado Dept Publ Hlth & Environm, Colorado Traumat Brain Injury Surveillance, Denver, CO USA		Gujral, IB (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	indiragujral0214@msn.com	Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR811509, U17/CCU811909] Funding Source: Medline		Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; *COL DEP PUBL HLTH, 2002, INJ COL, P10; *COL DEP PUBL HLTH, 2005, INJ COL; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Langlois J.A., 2004, TRAUMATIC BRAIN INJU, P1; Lemeshow S, 2000, APPL LOGISTIC REGRES; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR, P1	19	14	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2006	20	3					283	291		10.1080/02699050500488058			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400008	16537270				2022-02-06	
J	Singh, R; Sharma, SC; Goel, TL				Singh, R; Sharma, SC; Goel, TL			Traumatic inferior hip dislocation in an adult with ipsilateral trochanteric fracture	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						dislocation; hip; inferior; trochanteric fracture	FEMORAL-HEAD FRACTURES; TERM-FOLLOW-UP; ANTERIOR DISLOCATION; LUXATIO-ERECTA; GREATER TROCHANTER; MECHANISM	Traumatic Inferior dislocation of]lip in adult is an extremely rare Occurrence. We report a case of an inferior]lip dislocation associated with an intertrochanteric fracture. Treatment consisted of an initial closed manipulative reduction of the dislocation with the aid of a Schanz screw inserted in a T handle universal chuck and using C-arm, imaging. A dynamic hip screw was then used to fix the intertrochanteric fracture. At 2.5 years after the injury, the patient has symmetrical range of motion versus his contra lateral normal hip. Radiographs of the hip show normal anatomy without signs of avascular necrosis of the femoral head. To our knowledge, this is the first reported case of an adult with an inferior hip dislocation with a trochanteric fracture.	Post Grad Inst Med Sci, Dept Orthopaed Surg Phys Med Paraplegia & Rehabil, Rohtak 124001, Haryana, India		Singh, R (corresponding author), 8J-3,Med Enclave, Rohtak 124001, Haryana, India.	drroopsingh@rediffmail.com					Bartley RE, 1995, ORTHOPEDICS, V18, P1173; BEAUCHESNE R, 1994, ORTHOPEDICS, V17, P72; Brogdon BG, 1997, SKELETAL RADIOL, V26, P548, DOI 10.1007/s002560050284; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; DUSSAULT RG, 1980, RADIOLOGY, V135, P627, DOI 10.1148/radiology.135.3.7384446; Epstein HC, 1985, ORTHOPEDICS, V8, P132; ERB RE, 1995, AM J ROENTGENOL, V165, P1215, DOI 10.2214/ajr.165.5.7572506; Ferguson KL, 2000, AM J EMERG MED, V18, P117, DOI 10.1016/S0735-6757(00)90067-6; JACOB JR, 1987, CLIN ORTHOP RELAT R, P249; KOROVESSIS P, 1990, CLIN ORTHOP RELAT R, P164; Lamberti PM, 2003, J ORTHOP TRAUMA, V17, P65, DOI 10.1097/00005131-200301000-00011; LAVELLE DG, 2003, CAMPBELLS OPERATIVE, P2931; MARUOKA A, 1993, ARCH ORTHOP TRAUM SU, V112, P299, DOI 10.1007/BF00452970; MAUCK H, 1935, J BONE JOINT SURG, V5, P1011; Phillips AM, 2000, CLIN ORTHOP RELAT R, P7; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; SCHLICKEWEI W, 1993, INJURY, V24, P27, DOI 10.1016/0020-1383(93)90078-K; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Toms AD, 2001, J BONE JOINT SURG BR, V83B, P113, DOI 10.1302/0301-620X.83B1.10289	19	14	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2006	20	3					220	222		10.1097/00005131-200603000-00010			3	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	030UZ	WOS:000236661800013	16648705				2022-02-06	
J	Trabold, R; Schueler, OG; Eriskat, J; Plesnila, N; Baethmann, A; Back, T				Trabold, R; Schueler, OG; Eriskat, J; Plesnila, N; Baethmann, A; Back, T			Arterial hypotension triggers perifocal depolarizations and aggravates secondary damage in focal brain injury	BRAIN RESEARCH			English	Article						brain injury; cerebral blood flow; cold lesion; depolarization; spreading depression	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; SPREADING DEPRESSION; CORTICAL DEPOLARIZATIONS; GENE-EXPRESSION; TISSUE NECROSIS; AUTO-REGULATION; RAT; ISCHEMIA; OCCLUSION	Perifocal depolarizations (PFD) have been observed after traumatic brain injury, are known to disturb cerebrovascular reactivity and thus may contribute to the morphological consequences of brain injury. In this investigation, the role of PFD was studied in focal brain lesions with/without induction of delayed hypotension. Cerebral freeze lesions were induced in anesthetized normotensive rats that underwent perfusion fixation of brains S min, 4 h or 24 h after lesioning, respectively, to obtain quantitative histopathology. In additional groups, a 45-min period of moderate hypobaric hypotension was applied 15 min post-trauma and brains were perfusion fixed after 4 h or 24 h. In a second series, the direct current (DC) potential and cortical laser-Doppler flow (LDF) were measured adjacent to lesions under normotensive or hypotensive conditions. Sham procedures were carried out in rats that underwent hypotension alone. Lesioning resulted in a significant LDF decrease to 50% of baseline, further decreased during hypotension to less than 40% of control (P < 0.05). Sham animals had LDF values between 60 and 70% of control when subjected to hypotension. Focal brain injury always induced a negative DC shift shortly after lesioning. In 6 of 8 rats that under-went cold lesion plus hypotension, a second PFD was observed approximately 2.5 min after onset of hypotension accompanied by a relative LDF increase by 25 +/- 12%. Lesion expansion was significantly worsened by hypotension (8.19 +/- 0.56 mm(3) at 24 h) compared with normotensive rats (7.01 +/- 0.3 mm(3) at 24 h, P < 0.01). We conclude that hypotension triggers depolarizations by an ischemic mechanism that contributes to final tissue damage. (C) 2005 Elsevier B.V. All rights reserved.	Heidelberg Univ, Klinikum Mannheim, Dept Neurol, D-68167 Mannheim, Germany; Univ Wurzburg, Dept Neurosurg, D-97070 Wurzburg, Germany; Municipal Hosp Munich Bogenhausen, Dept Neurol, Munich, Germany; Univ Munich, Grosshadern Med Ctr, Inst Surg Res, Munich, Germany		Back, T (corresponding author), Heidelberg Univ, Klinikum Mannheim, Dept Neurol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	back@neuro.ma.uni-heidelberg.de	Plesnila, Nikolaus/T-7522-2019				Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.0.CO;2-8; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; BACK T, 1998, CEREBROVASC DIS, V1, P276; BOLANDER HG, 1989, STROKE, V20, P930, DOI 10.1161/01.STR.20.7.930; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIRNAGL U, 1993, NEUROL RES, V15, P128; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; ERISKAT J, 1994, ACTA NEUROCHIR, P425; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gorlach C, 1998, J NEUROTRAUM, V15, P1067, DOI 10.1089/neu.1998.15.1067; Hermann DM, 1998, NEUROREPORT, V9, P1249, DOI 10.1097/00001756-199804200-00053; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Hermeren G, 1999, ACTA PAEDIATR, V88, P99, DOI 10.1080/080352599750029501; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LIJIMA T, 1992, J CEREB BLOOD FLOW M, V12, P727; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Mies G, 1997, NEUROSCI LETT, V221, P165, DOI 10.1016/S0304-3940(96)13317-6; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; Plesnila N, 2003, NEUROSCI LETT, V345, P85, DOI 10.1016/S0304-3940(03)00396-3; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; TYSON GW, 1984, ANN NEUROL, V15, P559, DOI 10.1002/ana.410150608; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P19, DOI 10.1016/0165-0270(86)90111-1; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	46	14	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 3	2006	1071	1					237	244		10.1016/j.brainres.2005.11.095			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	021VS	WOS:000236014600025	16412395				2022-02-06	
J	Li, SH; Kuroiwa, T; Katsumata, N; Ishibashi, S; Sun, LY; Endo, S; Ohno, K				Li, SH; Kuroiwa, T; Katsumata, N; Ishibashi, S; Sun, LY; Endo, S; Ohno, K			Transient versus prolonged hyperlocomotion following lateral fluid percussion injury in Mongolian gerbils	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						cognitive dysfunction; traumatic brain injury; white matter rarefaction	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; VASCULAR COGNITIVE IMPAIRMENT; CONTROLLED CORTICAL IMPACT; WHITE-MATTER LESIONS; LOCOMOTOR-ACTIVITY; COMPUTED-TOMOGRAPHY; FOREBRAIN ISCHEMIA; CEREBRAL-ISCHEMIA; CONFUSIONAL STATE	Posttraumatic hyperactivity is a neurobehavioral symptom commonly seen in patients after traumatic brain injury (TB1). No useful animal model has yet been established for evaluation of this important symptom. We induced either mild (MILD, 0.7-0.9 atm) or moderate (MOD, 1.3-1.6 atm) lateral fluid percussion injury (LFPI) in Mongolian gerbils. Open-field and T-maze tests were used during a 7-day period after the trauma. All animals were perfusion fixed for histopathological examinations. Transient locomotor hyperactivity was found with a peak at 6 hr after injury in the MILD animals, whereas MOD animals showed prolonged and severe hyperlocomotion throughout the 7-day posttrauma period (P < 0.0001). Interestingly, the temporal profile of the posttraumatic hyperactivity was similar to that of the working memory deficit in both injury groups. Histological examination revealed significant neural tissue damages, including cortical necrosis, white matter rarefaction, and neuronal loss in the hippocampus in the ipsilateral hemisphere of the MOD animals, vs. only negligible changes in the MILD animals. Correlation analysis revealed that the volume of white matter lesions was significantly correlated with both posttraumatic hyperactivity (r = 0.591, P < 0.01) and working memory deficit (r = -0.859, P < 0.0001). Taken together, our findings confirm the successful reproduction of posttraumatic hyperactivity following experimental TBI. The posttraumatic hyperlocomotion probably shared pathomechanisms common to those of cognitive dysfunction caused by LFPI, supporting the speculation from previous studies that some neurobehavioral abnormities intimately correlate with TBI-induced cognitive dysfunction. Histopathologically, significant involvement of white matter damage in the posttraumatic functional deficits was indicated. (C) 2006 Wiley-Liss, Inc.	Tokyo Med & Dent Univ, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Anim Res Ctr, Tokyo, Japan		Kuroiwa, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.	t.kuroiwa.npat@mri.tmed.ac.jp					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BABCOCK AM, 1993, BRAIN RES, V625, P351, DOI 10.1016/0006-8993(93)91081-3; Bishop C, 2003, SYNAPSE, V50, P164, DOI 10.1002/syn.10253; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Englund E, 2002, CEREBROVASC DIS, V13, P11, DOI 10.1159/000049144; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Ishibashi S, 2003, STROKE, V34, P1501, DOI 10.1161/01.STR.0000074034.32371.13; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; KUROIWA T, 1991, NEUROSCI LETT, V122, P141, DOI 10.1016/0304-3940(91)90842-H; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; LEVINE S, 1969, ARCH PATHOL, V87, P315; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILESON BE, 1991, NEUROSCI LETT, V128, P71, DOI 10.1016/0304-3940(91)90762-I; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; MORI E, 1987, ARCH NEUROL-CHICAGO, V44, P1139, DOI 10.1001/archneur.1987.00520230029009; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NOUEL D, 1994, EUR J PHARMACOL, V254, P263, DOI 10.1016/0014-2999(94)90463-4; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P316; Onaya M, 2002, NEUROPATHOLOGY, V22, P243, DOI 10.1046/j.1440-1789.2002.00456.x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Silver BV, 1996, BRAIN INJURY, V10, P609; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STARKSTEIN SE, 1988, BRAIN RES, V473, P74, DOI 10.1016/0006-8993(88)90317-4; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; van der Naalt J, 2000, BRAIN INJURY, V14, P781; WANG D, 1990, BRAIN RES, V533, P78, DOI 10.1016/0006-8993(90)91798-L	51	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB 1	2006	83	2					292	300		10.1002/jnr.20720			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013UC	WOS:000235434300013	16397904				2022-02-06	
J	Brown, S				Brown, Stephen			Deterioration	EPILEPSIA			English	Article; Proceedings Paper	Meeting on Cognitive and Behavioral Outcomes of Epileptic Syndromes	OCT, 2004	Bologna, ITALY			epilepsy; cognition; developmental disabilities; dementia	TRANSITORY COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN INJURY; ANTIEPILEPTIC DRUGS; EPILEPTIC CHILDREN; ACADEMIC-ACHIEVEMENT; CLINICAL-TRIALS; EEG DISCHARGES; DEMENTIA; SEIZURE; UNDERACHIEVEMENT	Intellectual deterioration in epilepsy may be real or apparent. The latter refers to delay in cognitive development such that performance against age-related norms appears to drop. The former, real deterioration can occur due to concomitant degenerative neurological disease of which epilepsy is also a symptom, or it may happen as a consequence of one or more of a number of other factors. These include (1) direct effects of seizures and abnormal electroencephalogram activity on brain function, (2) traumatic brain injury secondary to seizures, including status epilepticus, (3) the influence of antiepileptic therapy, both drugs and surgery, on cognitive function, (4) psychosocial sequelae of diagnosis. Some epilepsy syndromes include intellectual deterioration as a frequent feature, with various causes. Developmental factors may also play a part. Cognitive functioning may be impaired by the presence of an epileptogenic lesion, and also in different ways and at different times by other brain areas involved with partial seizures, including irritative and functional deficit zones. Abnormal activity in these areas at critical periods in development may interact and disrupt pathways necessary for maturation of frontal lobe and limbic system functioning, leading to long-term neurological deficits. Increased understanding of the mechanisms by which this may happen raises intriguing possibilities for prevention and remediation.	Peninsula Med Sch, Dev Disabil Res & Educ Grp, Unit 10, Bodmin Business Ctr, Bodmin PL31 1AH, Cornwall, England		Brown, S (corresponding author), Peninsula Med Sch, Dev Disabil Res & Educ Grp, Unit 10, Bodmin Business Ctr, Harleigh Rd, Bodmin PL31 1AH, Cornwall, England.	stephen.brown@cpt.cornwall.nhs.uk					AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; ALDENKAMP AP, 1992, ACTA NEUROL SCAND, V86, P111, DOI 10.1111/j.1600-0404.1992.tb04479.x; Aldenkamp AP, 2001, EPILEPSY RES, V45, P155, DOI 10.1016/S0920-1211(01)00244-3; Aldenkamp AP, 2005, J CHILD NEUROL, V20, P175, DOI 10.1177/08830738050200030101; Aldenkamp AP, 1997, EPILEPSIA, V38, pS52, DOI 10.1111/j.1528-1157.1997.tb04520.x; ALDENKAMP AP, 1995, EPILEPSY CHILDREN AD, P225; Austin JK, 1998, DEV MED CHILD NEUROL, V40, P248, DOI 10.1111/j.1469-8749.1998.tb15457.x; Austin JK, 1999, DEV MED CHILD NEUROL, V41, P473, DOI 10.1017/S0012162299001024; Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; BAIRD HW, 1980, ELECTROEN CLIN NEURO, V48, P683, DOI 10.1016/0013-4694(80)90425-3; Baker GA, 2001, EPILEPSY RES, V45, P163, DOI 10.1016/S0920-1211(01)00246-7; Besag F M, 1995, Semin Pediatr Neurol, V2, P261, DOI 10.1016/S1071-9091(95)80005-0; BINNIE CD, 1992, EPILEPSIA, V33, pS11; BINNIE CD, 1993, BRAIN DEV-JPN, V15, P23, DOI 10.1016/0387-7604(93)90003-Q; BOTEZ MI, 1993, EPILEPSY RES, V16, P157, DOI 10.1016/0920-1211(93)90030-B; BOURGEOIS BFD, 1983, ANN NEUROL, V14, P438, DOI 10.1002/ana.410140407; BROWN CW, 1992, ADV NEAR INFRARED ME, V1, P1; Brown S, 1996, EUR J NEUROL, V3, P35; BROWN SW, 1984, ACTA NEUROL SCAND, V70, P233; BROWN SW, 2002, NEUROPSYCHIATRY EPIL, P135; BROWN SW, 1990, ACTA NEUROL SCAND  S, V82, P13; BROWN SW, 1988, EPILEPSY BEHAV COGNI, P177; BROWN SW, 1989, ED CHILD PSYCHOL, V6, P25; BROWN SW, 1999, EPILEPSY MENTAL RETA, P115; Butlin A T, 1984, Clin Exp Neurol, V20, P57; Chen YJ, 1996, EPILEPSIA, V37, P81, DOI 10.1111/j.1528-1157.1996.tb00516.x; Chen YJ, 2001, EPILEPSY RES, V44, P65, DOI 10.1016/S0920-1211(00)00204-7; Dawson S, 1929, Arch Dis Child, V4, P142; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; DODRILL CB, 1991, NEUROLOGY, V41, P141, DOI 10.1212/WNL.41.1.141; Enoki H, 1996, EPILEPSY RES, V25, P59, DOI 10.1016/0920-1211(96)00025-3; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Fritz N, 2005, EPILEPSY BEHAV, V6, P373, DOI 10.1016/j.yebeh.2005.01.002; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Helmstaedter C, 1999, LANCET, V354, P2133, DOI 10.1016/S0140-6736(99)03542-4; Hoffmann AF, 2004, EPILEPSY BEHAV, V5, P873, DOI 10.1016/j.yebeh.2004.09.005; Hogh P, 2002, NEUROLOGY, V58, P298, DOI 10.1212/WNL.58.2.298; INGVAR DH, 1984, ACTA PSYCHIAT SCAND, V69, P21; Jambaque I, 2000, EPILEPSY RES, V38, P151, DOI 10.1016/S0920-1211(99)00082-0; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; KUBOTA F, 1995, CLIN ELECTROENCEPHAL, V26, P120, DOI 10.1177/155005949502600210; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MARSTON D, 1993, DEV MED CHILD NEUROL, V35, P574; Metz-Lutz MN, 1999, DEV NEUROSCI-BASEL, V21, P182, DOI 10.1159/000017397; Neyens LGJ, 1999, EPILEPSY RES, V34, P85, DOI 10.1016/S0920-1211(98)00118-1; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rosen J A, 1968, Trans Am Neurol Assoc, V93, P273; Rutter M, 1970, NEUROPSYCHIATRIC STU; Scholtes FBJ, 2005, EPILEPSY BEHAV, V6, P167, DOI 10.1016/j.yebeh.2004.11.001; SIEBELINK BM, 1988, EPILEPSY RES, V2, P117, DOI 10.1016/0920-1211(88)90028-9; TINDALL RSA, 1978, ARCH INTERN MED, V138, P1168, DOI 10.1001/archinte.138.7.1168; Tomka-Hoffmeister M, 2004, FORTSCHR NEUROL PSYC, V72, P160, DOI 10.1055/s-2004-818360; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X	55	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia		2006	47			2			19	23		10.1111/j.1528-1167.2006.00682.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	109LU	WOS:000242310400005	17105454				2022-02-06	
J	Dockree, PM; O'Keeffe, FM; Moloney, P; Bishara, AJ; Carton, S; Jacoby, LL; Robertson, IH				Dockree, PM; O'Keeffe, FM; Moloney, P; Bishara, AJ; Carton, S; Jacoby, LL; Robertson, IH			Capture by misleading information and its false acceptance in patients with traumatic brain injury	BRAIN			English	Article						misinformation; capture; false memory; traumatic brain injury; prefrontal cortices	CLOSED-HEAD-INJURY; PROSPECTIVE MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; FRONTAL-CORTEX; PERFORMANCE; RETRIEVAL; ADULTS; TASK; DISSOCIATION	Exposure to misleading information, presented after a critical episode, can alter or impair memory reports about that episode. Here, we examine vulnerability to misleading information in patients with traumatic brain injury (TBI). The ability to initiate an effective retrieval strategy and inhibit irrelevant or interfering information requires participation from the prefrontal cortices, which are susceptible to damage following brain injury. We report that TBI patients are more prone to interference effects produced by misleading information during a cued-recall task and are more likely to accept this information as the product of 'remembering' compared with healthy controls. The results are consistent with a model proposing that patients are captured by highly accessible responses eliminating their opportunity to engage in recollection. Correlations between the cued-recall interference task and other executive measures helped elucidate the processes underlying 'capture'. In TBI patients, reduced recollection produced by a misleading prime was associated with impaired prospective remembering when engaged in a background task. A common functional deficit that may underlie poor performance on both tasks is the failure to inhibit previously relevant but currently irrelevant information. Subjective reports pertaining to the subject's cued-recall response were indexed by electrodermal activity. In control subjects, larger skin conductance responses (SCRs) were associated with a greater frequency of guess reports, suggesting that SCRs provide a marker for uncertainty regarding the candidacy of a selected response. TBI patients did not show this relationship, suggesting that impairments of post-retrieval evaluation might also underlie greater false acceptance of misinformation. Discussion focuses on the role of the prefrontal cortex and cognitive processes that mediate the selection and evaluation of memories.	Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland; Natl Rehabil Hosp, Dept Neuropsychol, Dun Laoghaire, Co Dublin, Ireland; Washington Univ, Dept Psychol, St Louis, MO 63130 USA		Dockree, PM (corresponding author), Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland.	dockreep@tcd.ie		Robertson, Ian H/0000-0001-8637-561X			Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DELBECQDEROUESNE J, 1990, BRAIN, V113, P1045, DOI 10.1093/brain/113.4.1045; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Duncan John, 1995, P721; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Fuster J., 1989, PREFRONTAL CORTEX AN; Gardiner John M., 1993, P163; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Hasher L, 1988, PSYCHOL LEARNING MOT, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Jacoby L. L., 1996, BASIC APPL MEMORY RE, V1, P161; Jacoby LL, 2005, J EXP PSYCHOL GEN, V134, P131, DOI 10.1037/0096-3445.134.2.131; Jacoby LL, 1999, COGNITIVE NEUROPSYCH, V16, P417, DOI 10.1080/026432999380861; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; MANDLER G, 1989, MEMORY INTERDISCIPLI, P84; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Norman K. A., 1996, IMPLICIT MEMORY META, P229; O'Connell RG, 2004, NEUROREPORT, V15, P2535, DOI 10.1097/00001756-200411150-00021; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Parkin AJ, 1996, BRAIN COGNITION, V32, P14, DOI 10.1006/brcg.1996.0055; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Shimamura Arthur P., 1995, P803; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stern R.M., 2001, PSYCHOPHYSIOLOGICAL; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; WALKER D, 2003, REMEMBRANCE THINGS F; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Wechsler D, 1998, WECHSLER MEMORY SCAL; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Zahn TP, 1999, INT J PSYCHOPHYSIOL, V33, P113, DOI 10.1016/S0167-8760(99)00030-6; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer H, 2000, Z EXP PSYCHOL, V47, P129; ZOCCOLOTTI P, 1982, Journal of Clinical Neuropsychology, V4, P143, DOI 10.1080/01688638208401124	52	14	14	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2006	129		1				128	140		10.1093/brain/awh664			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	000AL	WOS:000234433200013	16280354	Bronze			2022-02-06	
J	Inglese, M; Grossman, RI; Diller, L; Babb, JS; Gonen, O; Silver, JMA; Rusinek, H				Inglese, M; Grossman, RI; Diller, L; Babb, JS; Gonen, O; Silver, JMA; Rusinek, H			Clinical significance of dilated Virchow-Robin spaces in mild traumatic brain injury	BRAIN INJURY			English	Article						mild traumatic brain injury (TBI); Virchow-Robin spaces (VRS); neuropsychological testing	MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; PERIVASCULAR SPACES; SPECTRUM	Primary objective: To investigate the relationship between the number of dilated Virchow-Robin spaces (VRS) and neurocognitive findings in patients with traumatic brain injury (TBI). Research design: Thirty-eight patients with TBI and 21 controls were studied. Methods and procedures: Fifteen patients underwent MRI within a mean interval of 5.4 (range 1-12) days from the brain injury and 23 after an average period of 5.5 (range 0.2-31) years. All subjects were examined with a battery of 13 neuropsychological tests (NP). Main outcomes and results: The average number of VRS was significantly higher in patients than in controls. There were no significant differences between patients and controls in terms of NP tests. The number of VRS showed a significant inverse correlation with processing speed and a positive correlation with visual perceptual of attention only in patients studied within a short delay of trauma. Conclusions: VRS are not directly associated to neurocognitive findings, suggesting that they may represent a result of the shear-strain injury.	NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; Rusk Inst Rehabil Med, Dept Psychol, New York, NY USA; Lenox Hill Hosp, New York, NY 10021 USA		Inglese, M (corresponding author), NYU, Sch Med, Dept Radiol, 650 1St Ave, New York, NY 10016 USA.	matilde.inglese@med.nyu.edu	Inglese, Matilde/AAH-3189-2020	Inglese, Matilde/0000-0002-9610-0297; Babb, James/0000-0003-1798-1186; Diller, Leonard/0000-0001-7295-7846; Gonen, Oded/0000-0002-3148-2028	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 00096] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 39135] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER		Achiron A, 2002, AM J NEURORADIOL, V23, P376; BEN-YISHAY Y, 1970, Journal of Abnormal Psychology, V76, P378, DOI 10.1037/h0030404; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; Di Constanzo A, 2001, EUR NEUROL, V46, P131, DOI 10.1159/000050786; DILLER L, 1993, ADV STROKE REHABILIT; DOWNEY J, 1923, WILL TEMPERAMENT ITS; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; ESIRI MM, 1990, J NEUROL SCI, V100, P3, DOI 10.1016/0022-510X(90)90004-7; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; HEIER LA, 1989, AM J NEURORADIOL, V10, P929; Holbourn AHS, 1943, LANCET, V2, P438; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MacLullich AMJ, 2004, J NEUROL NEUROSUR PS, V75, P1519, DOI 10.1136/jnnp.2003.030858; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MIRFAKHRAEE M, 1986, RADIOLOGY, V158, P715, DOI 10.1148/radiology.158.3.3945745; Miszkiel KA, 1996, CLIN RADIOL, V51, P842, DOI 10.1016/S0009-9260(96)80080-8; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROLLINS NK, 1993, RADIOLOGY, V189, P53, DOI 10.1148/radiology.189.1.7690491; Schick A, 1999, STAT PROBABIL LETT, V41, P287, DOI 10.1016/S0167-7152(98)00165-5; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; WATERLOO K, 1997, ACTA NEUROCHIR, P31	39	14	15	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					15	21		10.1080/02699050500309593			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000002	16403696				2022-02-06	
J	Ivins, BJ; Schwab, KA; Baker, G; Warden, DL				Ivins, Brian J.; Schwab, Karen A.; Baker, Gayle; Warden, Deborah L.			Hospital admissions associated with traumatic brain injury in the US army during peacetime: 1990s Trends	NEUROEPIDEMIOLOGY			English	Article						traumatic brain injury; US Army; injury prevention; hospital admission practices	UNITED-STATES-ARMY; HEAD-INJURY; MILITARY; MANAGEMENT; SYSTEM; CARE; QUALITY; COSTS; SCANS; RISK	Introduction: This paper examines 10-year trends in traumatic brain injury (TBI)-related hospitalization rates for active duty US Army personnel in the 1990s. It does this within the context of various factors, including enhanced injury prevention policies and changed hospital admission practices, that may have affected TBI hospitalization rates. It also compares TBI hospitalization rates in the Army to those from an age-comparable segment of the US civilian population over this time period. Methods: Crude (unadjusted) incidence rates for all active duty US Army personnel hospitalized with a TBI diagnosis from fiscal years (FY) 1990 to 1999 were calculated. Once the trends were identified, the percentage change in the overall rate, as well as the rates for different TBI severity levels, and in-hospital deaths from FY1990 and FY1999 were analyzed. Changes in age- and gender-specific rates as well as crude rates for cases with and without other injuries and cases treated in military and civilian hospitals were also analyzed. Rate ratios were used to compare aggregated 5-year TBI hospitalization rates in the Army to rates for civilians 17 - 49 years of age during the following time periods: 1990 - 1994 and 1995 - 1999. The rates used in the comparison were adjusted to control for differences in age and gender. Results: The overall incidence of TBI-related hospitalization in the Army decreased 75% from FY1990 to FY1999. The rates for all TBI severity levels decreased, but the rate for mild TBI decreased more than the rates for moderate and severe TBI. The rate of in-hospital deaths from TBI also decreased. Rates decreased similarly for males and females, across all age groups, as well as for cases with and without other injuries. TBI rates decreased for Army personnel treated in military hospitals but changed minimally for Army personnel treated in civilian hospitals. The Army's TBI hospitalization rates were generally higher than civilian rates in the early 1990s but by the late 1990s, most of the Army's rates were lower than or equal to the civilian rates. Conclusions: The incidence of TBI-related hospitalization in the active duty US Army decreased markedly (75%) during the 1990s. As a result, most of the Army's TBI hospitalization rates were lower than civilian rates by the late 1990s. Effective injury prevention and changes in the Army population were two of the factors that likely contributed to the decrease in rates for all TBI severity levels, while changes in hospital admission practices likely contributed to the disproportionate decrease in the Army's rates for mild TBI. Copyright (c) 2006 S. Karger AG, Basel.	Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20012 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD USA		Ivins, BJ (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.	brian.ivins@na.amedd.army.mil					*ARM PUBL AFF, 1997, US ARM ACH SAF YEAR; *ARM SAF PROG, 1988, 38510 DEP ARM; Brundage JF, 1998, MIL MED, V163, P272, DOI 10.1093/milmed/163.5.272; Carey ME, 1998, MIL MED, V163, P581, DOI 10.1093/milmed/163.9.581; *CDC, 2004, TRAUM BRAIN IN US EM; *CDC MIL HIST US A, 1997, FISC YEAR 1990 1991, pCH4; *CONG BUDG OFF, 2003, GROWTH MED SPEND DEP; Corn R F, 1981, Inquiry, V18, P351; *CTR MILL HIST US, 2001, FISC YEAR 1992, pCH9; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; *DEP ARM, 1995, 67274 DEP ARM; *DEP ARM, 1987, 38540 DEP ARM; *DEP ARM, 1987, 38555 DEP ARM; *DEP DEF INSP GEN, 1998, JO AUD REP MIL HE SY; DOREMUS HD, 1983, MED CARE, V21, P1001, DOI 10.1097/00005650-198310000-00006; Hamm CK, 1999, MIL MED, V164, P867, DOI 10.1093/milmed/164.12.867; HOSEK H, 2003, US ARMY NEW NATL SEC, pCH10; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; *J HOPK U T INC, 1998, ICDMAP90; Jackson JL, 1999, MIL MED, V164, P701, DOI 10.1093/milmed/164.10.701; Kahn HA, 1989, STAT METHODS EPIDEMI; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V8, P48, DOI 10.1159/000110165; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V9, P296; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; Meyer GS, 1998, MIL MED, V163, P461, DOI 10.1093/milmed/163.7.461; Miller T. R., 1994, HEAD NECK INJURY, P211; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; *OFF SEC DEF WASH, 2004, GULF WAR CAS SUMM; *OFF SEC DEV, 2006, US CAS STAT; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; ROTHBERG JM, 1990, JAMA-J AM MED ASSOC, V264, P2241, DOI 10.1001/jama.264.17.2241; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smith GS, 2000, AM J PREV MED, V18, P41, DOI 10.1016/S0749-3797(99)00171-3; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Taylor AJ, 1997, J AM COLL CARDIOL, V30, P901, DOI 10.1016/S0735-1097(97)00271-4; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 2001, HEAD TRAUMA, P327; TOTTEN J, 1979, LANCET, V1, P369; WEED DL, 1986, J OCCUP ENVIRON MED, V28, P343	46	14	14	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350			NEUROEPIDEMIOLOGY	Neuroepidemiology		2006	27	3					154	163		10.1159/000096127			10	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	101XF	WOS:000241773900006	17035692				2022-02-06	
J	Ripley, DL				Ripley, DL			Atomoxetine for individuals with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							DEFICIT-HYPERACTIVITY DISORDER; ADOLESCENTS; CHILDREN; ADHD; TOMOXETINE; ADULTS; MANIA		Craig Hosp, Denver, CO 80113 USA		Ripley, DL (corresponding author), Craig Hosp, Denver, CO 80113 USA.	dripley@craighospital.org		Ripley, David/0000-0002-5349-1830			BERIGAN TR, 2004, J CLIN PSYCHIAT, V6, P93; Buitelaar JK, 2004, EUR CHILD ADOLES PSY, V13, P249, DOI 10.1007/s00787-004-0401-3; CHOUINARD G, 1984, PSYCHOPHARMACOLOGY, V83, P126, DOI 10.1007/BF00427436; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; Henderson TA, 2004, PEDIATRICS, V114, P895, DOI 10.1542/peds.2004-1140; Henderson TA, 2004, J CLIN PSYCHOPHARM, V24, P567, DOI 10.1097/01.jcp.0000139760.11458.aa; Hwang BH, 1999, NEUROSCI LETT, V265, P151, DOI 10.1016/S0304-3940(99)00241-4; Lee TSW, 2004, J AM ACAD CHILD PSY, V43, P1068, DOI 10.1097/01.chi.0000132833.12842.4e; Sauer JM, 2004, J PHARMACOL EXP THER, V308, P410, DOI 10.1124/jpet.103.058727; Sawant S, 2004, AM J PSYCHIAT, V161, P757, DOI 10.1176/appi.ajp.161.4.757; Simpson D, 2004, CNS DRUGS, V18, P397, DOI 10.2165/00023210-200418060-00011; Spencer T, 2004, PSYCHIAT CLIN N AM, V27, P373, DOI 10.1016/j.psc.2003.12.001; *US FDA, 2004, NEW WARN AT; Velcea G, 2004, AM J PSYCHIAT, V161, P1718, DOI 10.1176/appi.ajp.161.9.1718-a; Wernicke JF, 2002, J CLIN PSYCHIAT, V63, P50; Wernicke JF, 2003, DRUG SAFETY, V26, P729, DOI 10.2165/00002018-200326100-00006; ZERBE RL, 1985, J PHARMACOL EXP THER, V232, P139; 2004, ATOMOXETINE PACKAGE	18	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2006	21	1					85	88		10.1097/00001199-200601000-00010			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004WW	WOS:000234784300010	16456396				2022-02-06	
J	Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA				Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA			Epidemiology and prognosis of coma in daytime television dramas	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOAP-OPERA; VEGETATIVE STATE; HEAD-INJURY; BREAST-CANCER; BRAIN-INJURY; EDUCATION; ATTITUDES; BEHAVIOR; PROGRAM; AIDS	Objective To determine how soap operas Portray, and possibly misrepresent, the likelihood of recovery for patients in coma. Design Retrospective cohort study Setting Nine soap operas in the United States reviewed between 1 January 1995 and 15 May 2005. Subjects 64 characters who experienced a period of unconsciousness lasting at least 24 hours. Their final status at the end of the follow-up period was compared with pooled data from a meta-analysis. Results Comas lasted a median of 13 days (interquartile range 7-25 days). Fifty seven (89%) patients recovered fully, five (8%) died, and two (3%) remained in a vegetative state. Mortality for non-traumatic and traumatic coma was significantly lower than would be predicted from the meta-analysis data (non-traumatic 4% v 53%; traumatic 6% v 67%; Fisher's exact test both P < 0.001). On the day that patients regained consciousness, most (49/57; 86%) had no evidence of limited function, cognitive deficit, or residual disability needing rehabilitation. Compared with meta-analysis data, patients in this sample had a much better than expected chance of returning to normal function (non-traumatic 91% v 1%; traumatic 89% 7%; both P < 0.001). Conclusions The portrayal of coma in soap operas is overly optimistic. Although these programmes are presented as fiction, they may contribute to unrealistic expectations of recovery.	Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Div Geriatr Med, Philadelphia, PA 19104 USA		Casarett, D (corresponding author), Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, 9 E,3900 Woodland Ave, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X			Ang, 1991, DESPERATELY SEEKING; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BANJA JD, 1990, PHYS MED REHABIL, V4, P579; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; Borrayo EA, 2004, PREV MED, V39, P99, DOI 10.1016/j.ypmed.2004.03.024; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Brodie M, 2001, HEALTH AFFAIR, V20, P192, DOI 10.1377/hlthaff.20.1.192; Campbell MK, 2004, J NUTR EDUC BEHAV, V36, P58, DOI 10.1016/S1499-4046(06)60134-6; *COUNC SCI AFF COU, 1990, JAMA-J AM MED ASSOC, P426; Cranford R E, 1991, Law Med Health Care, V19, P13; Crayford T, 1997, BRIT MED J, V315, P1649, DOI 10.1136/bmj.315.7123.1649; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Dresser R, 2004, HASTINGS CENT REP, V34, P8, DOI 10.2307/3528413; Gostin LO, 2005, JAMA-J AM MED ASSOC, V293, P2403, DOI 10.1001/jama.293.19.2403; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; Hamel Mary Beth, 1995, JAMA (Journal of the American Medical Association), V273, P1842, DOI 10.1001/jama.273.23.1842; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; HODGES MO, 1994, ARCH INTERN MED, V154, P1013, DOI 10.1001/archinte.154.9.1013; Howe A, 2002, J PUBLIC HEALTH MED, V24, P299, DOI 10.1093/pubmed/24.4.299; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jibaja ML, 2000, J CANCER EDUC, V15, P237; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KALICHMAN SC, 1994, AIDS EDUC PREV, V6, P542; Kennedy MG, 2004, J COMMUN, V54, P287, DOI 10.1111/j.1460-2466.2004.tb02629.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; *MULT SOC TASK FOR, 1995, NEW ENGL J MED, V330, P1572; *NIELS MED RES, 2000, REP TEL; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Shapiro D, 2003, AIDS CARE, V15, P303, DOI 10.1080/0954012031000105360; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Walker WC, 1996, BRAIN INJURY, V10, P65	38	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1537	1539		10.1136/bmj.331.7531.1537			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	WOS:000234351300025	16373744	Bronze, Green Published			2022-02-06	
J	Chan, RCK				Chan, RCK			How severe should symptoms be before someone is said to be suffering from post-concussion syndrome? An exploratory study with self-reported checklist using Rasch analysis	BRAIN INJURY			English	Article						post-concussion; Rasch analysis	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; BASE RATES; PATIENT COMPLAINTS; MILD; DEFICITS; PROSPECTS	Primary objective: This study aimed to examine the diagnosis of post-concussive symptoms among a group of people with subjective post-concussive symptoms (PCS) complaints using a self-reported checklist. Research design: A cross-sectional design was adopted with a total of 92 patients with PCS and 123 normal controls. Methods and procedures: The Rivermead Post-concussion Symptoms Questionnaire was administered to all participants. Analysis using the Rasch Model was undertaken. Main outcomes and results: The common matrix of symptom profiles indicated significant effects of gender ( p < 0.005) and litigation ( p < 0.0004). The patient group reported significantly higher symptoms than the healthy group ( p < 0.0001) with differential symptom endorsement along the logits unit continuum. Conclusions: The application of Rasch model analysis successfully set up a common matrix to discriminate patients with post-concussive symptoms from healthy people along the logits unit continuum.	Sun Yat Sen Univ, Dept Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Guangzhou 510275, Peoples R China; Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China		Chan, RCK (corresponding author), Sun Yat Sen Univ, Dept Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Guangzhou 510275, Peoples R China.	edschchq@zsu.edu.cn	Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X			Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Bond T, 2001, APPL RASCH MODEL FUN; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CHAN RKC, 2001, INT C OUTC MEAS ICOM; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Linacre J.M., 2000, USERS GUIDE WINSTEPS; LINACRE JM, 1998, RASCH MEASUREMENT T, V0012, P00636; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MANDEL S, 1989, POSTGRAD MED, V85, P213; MELENDEZ F, 1994, ADULT NEUROPSYCHOLOG; Miller W., 1992, PHYSICAL MED REHABIL, V6, P547; OHARA C, 1994, COGNITIVE SYMPTOMS C; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Rasch G., 1960, PROBABILISTIC MODELS; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wright B, 1979, BEST TEST DESIGN; Wright B, 1982, RATING SCALE ANAL RA; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	35	14	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	13					1117	1124		10.1080/026990500150088			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZD	WOS:000233270000006	16286325				2022-02-06	
J	Kunz, T; Marklund, N; Hillered, L; Oliw, EH				Kunz, T; Marklund, N; Hillered, L; Oliw, EH			Assessment of the effects of the cyclooxygenase-2 inhibitor rofecoxib on visuospatial learning and hippocampal cell death following kainate-induced seizures in the rat	COGNITIVE BRAIN RESEARCH			English	Article						cell death; limbic seizure; Morris water maze; non-steroidal anti-inflammatory drug; TUNEL staining; visuospatial learning	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; KAINIC ACID; GENE-EXPRESSION; MEMORY; DAMAGE; LESIONS; DEFICITS; NEURODEGENERATION; POSTTREATMENT	Kainate-induced seizures result in hippocampal neurodegeneration and spatial learning deficits in rodents. Previous studies show that rofecoxib, a selective cyclooxygenase-2 inhibitor, protects against kainate-induced hippocampal cell death 3 days after seizures. Our aim was to determine whether rofecoxib attenuates visuospatial learning deficits and late neuronal death after kainate-induced seizures. Seizures were induced in Sprague-Dawley rats with kainic acid (10 mg/kg, i.p.). Eight hours later, animals received rofecoxib (10 mg/kg; n = 15) or vehicle (dimethylsulfoxide, n = 11). Animals were then treated daily for additional 2 or 9 days. Visuospatial learning was assessed in the Morris water maze (MWM) on days 5-9 after seizures. Seizure animals teamed the MWM task significantly slower than non-seizure controls, but seizure animals showed higher swim speed (P < 0.05). Seizure animals receiving rofecoxib for 2 days showed no significant improvement in acquisition of the task compared to the vehicle group, even though mean latencies in the rofecoxib group were shorter from the third trial day onwards. This tendency was lost when rofecoxib was given for 9 days. TdT-mediated dUTP nick end labelling showed cell death in limbic structures 9 days after seizures. The time course of kainate-induced hippocampal cell death might be delayed by rofecoxib treatment, as the attenuation of cell death observed 3 days after seizures was no longer present after 9 days. We conclude that even though increasing evidence points to an injurious role of cyclooxygenase-2 products in acute brain injury processes, rofecoxib treatment failed to attenuate seizure-induced visuospatial learning deficits and the late phase of hippocampal neurodegeneration. (c) 2005 Elsevier B.V. All rights reserved.	Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden		Kunz, T (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	t.kunz@dundee.ac.uk		Marklund, Niklas/0000-0002-9797-5626; Oliw, Ernst/0000-0002-7986-8130			BARAN H, 1994, BRAIN RES, V646, P201, DOI 10.1016/0006-8993(94)90078-7; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BREDER CD, 1992, J COMP NEUROL, V322, P409, DOI 10.1002/cne.903220309; Brzozowski T, 1999, EUR J PHARMACOL, V385, P47, DOI 10.1016/S0014-2999(99)00681-0; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; CHEN J, 1995, NEUROREPORT, V6, P245; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dembo G, 2005, ANESTHESIOLOGY, V102, P409, DOI 10.1097/00000542-200502000-00026; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; Faherty CJ, 1999, MOL BRAIN RES, V70, P159, DOI 10.1016/S0169-328X(99)00143-6; GAYOSO MJ, 1994, BRAIN RES, V653, P92, DOI 10.1016/0006-8993(94)90376-X; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Goodenough S, 1997, EXP NEUROL, V145, P451, DOI 10.1006/exnr.1997.6471; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Kemppainen S, 2004, NEUROSCIENCE, V126, P485, DOI 10.1016/j.neuroscience.2004.03.015; Klivenyi P, 2003, J MOL NEUROSCI, V21, P191, DOI 10.1385/JMN:21:3:191; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; Kunz T, 2001, EUR J NEUROSCI, V13, P569, DOI 10.1046/j.1460-9568.2001.01420.x; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Marklund N, 2005, RESTOR NEUROL NEUROS, V23, P31; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Matsuoka Y, 1999, EXP BRAIN RES, V124, P215, DOI 10.1007/s002210050616; Mikati MA, 2001, EPILEPSY RES, V43, P97, DOI 10.1016/S0920-1211(00)00187-X; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Rall JM, 2003, BRAIN RES, V968, P273, DOI 10.1016/S0006-8993(03)02248-0; Sandrini M, 2002, INFLAMM RES, V51, P154, DOI 10.1007/PL00000287; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sibbald B, 2004, CAN MED ASSOC J, V171, P1027, DOI 10.1503/cmaj.1041606; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Tacconelli S, 2004, CURR PHARM DESIGN, V10, P589, DOI 10.2174/1381612043453108; Takadera T, 2002, NEUROSCI LETT, V317, P61, DOI 10.1016/S0304-3940(01)02449-1; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781, DOI 10.1056/NEJM199006213222505; Weiss S, 1996, NEUROSCIENCE, V74, P541, DOI 10.1016/0306-4522(96)00148-0	46	14	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6410			COGNITIVE BRAIN RES	Cognit. Brain Res.	DEC	2005	25	3					826	832		10.1016/j.cogbrainres.2005.09.017			7	Computer Science, Artificial Intelligence; Neurosciences; Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	997HQ	WOS:000234236500022	16263251				2022-02-06	
J	Hawkins, ML; Lewis, FD; Medeiros, RS				Hawkins, ML; Lewis, FD; Medeiros, RS			Impact of length of stay on functional outcomes of TBI patients	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southeastern-Surgical-Congress	FEB 11-15, 2005	New Orleans, LA	SE Surg Congress			TRAUMATIC BRAIN-INJURY; UNITED-STATES; REHABILITATION; VARIABLES; SEVERITY; PREDICTORS; RECOVERY; QUALITY; CHARGES; LIFE	The purpose of this study was to compare the functional outcomes of two groups of patients with traumatic brain injury (TBI) with attention to the impact of reduced length of stay (LOS) in the trauma center (TC) and rehabilitation hospital (RH). From 1991 to 1994, 55 patients, Group 1, with serious TBI (Abbreviated Injury Scale score >= 3) were admitted to a level 1 TC and subsequently transferred to a comprehensive inpatient RH. These results have been previously published. From 1996 to 2002,64 similarly injured patients, Group 2, received inpatient care at the same TC and RH. These patients had a marked decrease in length of stay. Functional Independence Measures (FIM) were obtained at admission (Adm), discharge (D/C), and at 1 year follow-up for both groups. The average length of stay at the TC dropped from 36 days in Group 1 to 26 days in Group 2. In addition, the average length of stay at the RH dropped from 46 days (Group 1) to 25 days (Group 2); overall, an average reduction of 31 days of inpatient care. Group 2 had significantly lower FIM scores at the time of RH discharge for self-care, locomotion, and mobility compared to Group 1. At the 1 year follow-up, however, there were no significant differences between Groups 1 and 2 in these FIM scores. FIM scores at I year were higher in Group 2 for communication (90% vs 71%) and social cognition (77% vs 49%) compared to Group 1. Over one-fourth of each group returned to work by the I year follow-up. Socially disruptive behavior occurred at least weekly in 28 per cent (Group 1) and 23 per cent (Group 2) of patients. The outcome for serious TBI is better than generally perceived. Reduction of inpatient LOS did not adversely affect the ultimate functional outcome. The decreased LOS placed a greater demand on outpatient rehabilitative services as well as a greater burden on the family of the brain-injured patient	Med Coll Georgia, Dept Surg, Augusta, GA 30912 USA; Walton Rehabil Hosp, Augusta, GA USA		Hawkins, ML (corresponding author), Med Coll Georgia, Dept Surg, Augusta, GA 30912 USA.						*AG HLTH CAR POL R, 1999, 5 NIS AG HLTH CAR PO; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Di Donato B A, 1994, Rehabil Nurs, V19, P219; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Haffey W. J., 1990, NEUROPSYCHOLOGY EVER, P99; Hagen C., 1972, LEVELS COGNITIVE FUN; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Johnson J, 2001, INT J PSYCHIAT CLIN, V5, P141, DOI 10.1080/136515001300374894; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEWIN ICF, 1992, COST DISORDERS BRAIN; LONG WB, 1994, ARCH PHYS MED REHAB, V75, P144; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; MALKMUS D, 1974, RANCHO LEVELS COGNIT; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; *NIH CONS STAT, 1998, REH PERS TRAUM BRAIN, P1041; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1987, BNI Q, V3, P10; RHODES M, 1988, J TRAUMA, V28, P931, DOI 10.1097/00005373-198807000-00005; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; STRAX TE, 1994, ARCH PHYS MED REHAB, V75, pSC1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; [No title captured]	37	14	14	0	4	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	2005	71	11					920	929					10	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	985SH	WOS:000233398200009	16372610				2022-02-06	
J	McNaughton, HK; Weatherall, M; McPherson, KM				McNaughton, HK; Weatherall, M; McPherson, KM			Functional measures across neurologic disease states: Analysis of factors in common	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						factor analysis; statistical; outcome assessment (health care); rehabilitation	HEALTH SURVEY; SHORT FORM-36; STROKE; RELIABILITY; VALIDITY; QUESTIONNAIRES; PARTICIPATION; INDIVIDUALS; POPULATION; HANDICAP	Objective: To describe the underlying dimensions for a range of functional measures across 3 neurologic diseases at different time points. Design: Multiple cohort study. Setting: Combination of public hospital wards and community. Participants: Patients (N = 308) from 3 cohorts: paralytic poliomyelitis (n = 38), mean of 25 years previously, assessed once; acute stroke admitted to hospital and followed up for 12 months postdischarge (n = 181); and traumatic brain injury (TBI), admitted to hospital and followed up for 12 months postdischarge (n = 89). Interventions: Not applicable. Main Outcome Measures: The Barthel Index, FIM instrument, Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) physical component score (PCS) and mental component score (MCS), Community Integration Questionnaire (CIQ), and the London Handicap Score (LHS). Measures were compared at 2 time points: pre-event status for stroke, TBI and the polio cohort, and 12-month postdischarge status for stroke and TBI. Results: The different measures generally correlated highly within disease states at each time point. Principal components analysis revealed 2 underlying dimensions, a physical dimension onto which loaded the Barthel Index, FIM, PCS, and LHS and a cognitive/emotional dimension onto which loaded the MCS and, for subjects with polio, the CIQ. These 2 dimensions accounted for 69% of the variance in measures at the pre-event time point and 85% of the variance at the 12-month time point. Conclusions: These data Suggest 2 basic underlying dimensions across a wide range of measures in 3 different neurologic conditions even at different time points. Most of the variation in the measures can be captured using the 2 component summary scores (PCS, MCS) of the SF-36.	Med Res Inst New Zealand, Wellington, New Zealand; Univ Otago, Wellington Sch Med & Hlth Sci, Rehabil Teaching & Res Unit, Otago, New Zealand; Auckland Univ Technol, Natl Inst Rehabil Res, Auckland, New Zealand		McNaughton, HK (corresponding author), Med Res Inst New Zealand, POB 10055, Wellington, New Zealand.	harry.mcnaughton@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019; McNaughton, Harry/AAC-6556-2020	Weatherall, Mark/0000-0002-0051-9107; McPherson, Kathryn/0000-0003-1240-8882; McPherson, Kath/0000-0003-0487-8497			BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P824, DOI 10.1136/jnnp.53.10.824; BONITA R, 1994, STROKE, V25, P552, DOI 10.1161/01.STR.25.3.552; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Dorman P, 1998, STROKE, V29, P63, DOI 10.1161/01.STR.29.1.63; Dorman PJ, 1997, BRIT MED J, V315, P461, DOI 10.1136/bmj.315.7106.461; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HARWOOD RH, 1994, J NEUROL NEUROSUR PS, V57, P825, DOI 10.1136/jnnp.57.7.825; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hsueh IP, 2003, STROKE, V34, P1741, DOI 10.1161/01.STR.0000075295.45185.D4; MAHONEY F I, 1965, Md State Med J, V14, P61; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McNaughton H, 2001, INT J REHABIL RES, V24, P133; McPherson K, 2004, MED CARE, V42, P1143, DOI 10.1097/00005650-200411000-00014; McPherson KM, 2004, DISABIL REHABIL, V26, P988, DOI 10.1080/09638280410001702414; Naik, 2000, MULTIVARIATE DATA RE; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Scott KM, 1999, AUST NZ J PUBL HEAL, V23, P401, DOI 10.1111/j.1467-842X.1999.tb01282.x; Stadnyk K, 1998, J CLIN EPIDEMIOL, V51, P827, DOI 10.1016/S0895-4356(98)00061-4; Wade D, 1992, MEASUREMENT NEUROLOG; WARE JE, 1995, SF 36 SCORE SF 36 PH; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	23	14	15	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2005	86	11					2184	2188		10.1016/j.apmr.2005.06.010			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983TB	WOS:000233253900018	16271568				2022-02-06	
J	Mintzer, MZ; Griffiths, RR				Mintzer, MZ; Griffiths, RR			Drugs, memory, and metamemory: A dose-effect study with lorazepam and scopolamine	EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY			English	Article						memory; metamemory; benzodiazepine; lorazepam; scopolamine	TRIAZOLAM-INDUCED AMNESIA; TRAUMATIC BRAIN-INJURY; PEOPLES JUDGMENTS; MIDAZOLAM AMNESIA; FALSE RECOGNITION; SEMANTIC MEMORY; LEARNING JOLS; ACCURACY; CUE; PHARMACOKINETICS	This experiment was designed to use the graded dose-related amnesia produced by the benzodiazepine lorazepam (1.0, 2.0 mg/70 kg, oral) and the anticholinergic scopolamine (0.3, 0.6 mg/70 kg, subcutaneous) as a tool to explore the cognitive and neurochemical mechanisms underlying metamemory in the judgment of learning paradigm, with a placebo-controlled independent groups design in healthy volunteers (n = 12/group). Results provide evidence for a pharmacological dissociation between effects on memory versus metamemory (relative accuracy of item-by-item monitoring) across a range of levels of memory performance and suggest that the drugs selectively impair those aspects of metamnemonic monitoring that require participants' awareness of their overall current state of functioning (absolute accuracy of prospective item-by-item monitoring, prospective global monitoring) but not those that rely solely on assessment of individual item characteristics (relative accuracy of item-by-item monitoring).	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Behav Biol Res Ctr, Baltimore, MD 21224 USA		Mintzer, MZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Behav Biol Res Ctr, 5510 Nathan Shock Dr, Baltimore, MD 21224 USA.	mmintzer@jhmi.edu			NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA-03889, DA-11936] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA003889, R01DA011936] Funding Source: NIH RePORTER		Bacon E, 1998, PSYCHOPHARMACOLOGY, V138, P318, DOI 10.1007/s002130050677; Bishop KI, 1996, EXP CLIN PSYCHOPHARM, V4, P292; Connor LT, 1997, PSYCHOL AGING, V12, P50, DOI 10.1037/0882-7974.12.1.50; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V105, P1; CURRAN HV, 2000, NEW COGNITIVE NEUROS, P797; Duka T, 1996, BEHAV PHARMACOL, V7, P401; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 1997, J MEM LANG, V36, P34, DOI 10.1006/jmla.1996.2476; Dunlosky J, 1998, EXP CLIN PSYCHOPHARM, V6, P77, DOI 10.1037/1064-1297.6.1.77; Ebert U, 1998, J CLIN PHARMACOL, V38, P720, DOI 10.1002/j.1552-4604.1998.tb04812.x; FLAVELL JH, 1971, HUM DEV, V14, P272, DOI 10.1159/000271221; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; GREENBLATT DJ, 1981, CLIN PHARMACOKINET, V6, P89, DOI 10.2165/00003088-198106020-00001; Hertzog C, 2003, J EXP PSYCHOL LEARN, V29, P22, DOI 10.1037/0278-7393.29.1.22; Hirshman E, 2002, J MEM LANG, V47, P499, DOI 10.1016/S0749-596X(02)00017-7; Hirshman E, 2001, J EXP PSYCHOL GEN, V130, P453, DOI 10.1037/0096-3445.130.3.453; Izaute M, 2005, NEUROPSYCHOPHARMACOL, V30, P196, DOI 10.1038/sj.npp.1300564; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Keppel G., 1991, DESIGN ANAL RES HDB; KETCHUM JS, 1973, PSYCHOPHARMACOLOGIA, V28, P121, DOI 10.1007/BF00421398; KING JF, 1980, AM J PSYCHOL, V93, P329, DOI 10.2307/1422236; KOPELMAN MD, 1986, Q J EXP PSYCHOL-A, V38, P535, DOI 10.1080/14640748608401614; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Massin-Krauss M, 2002, CONSCIOUS COGN, V11, P123, DOI 10.1006/ccog.2001.0538; MCGLYNN SM, 1991, J COGNITIVE NEUROSCI, V3, P183, DOI 10.1162/jocn.1991.3.2.183; Merritt P, 2005, PSYCHOPHARMACOLOGY, V177, P336, DOI 10.1007/s00213-004-1958-8; Metcalfe J., 1994, METACOGNITION KNOWIN; Mintzer MZ, 1997, BEHAV PHARMACOL, V8, P561, DOI 10.1097/00008877-199711000-00014; Mintzer MZ, 2003, EXP CLIN PSYCHOPHARM, V11, P56, DOI 10.1037/1064-1297.11.1.56; Mintzer MZ, 2003, J MEM LANG, V48, P596, DOI 10.1016/S0749-596X(03)00004-4; Mintzer MZ, 2001, J MEM LANG, V44, P475, DOI 10.1006/jmla.2000.2746; Mintzer MZ, 2001, PSYCHOPHARMACOLOGY, V153, P425, DOI 10.1007/s002130000592; MOHLER H, 1977, SCIENCE, V198, P849, DOI 10.1126/science.918669; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; NELSON TO, 1986, J EXP PSYCHOL GEN, V115, P247, DOI 10.1037/0096-3445.115.3.247; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Nelson TO, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P161; Pocock, 1983, CLIN TRIALS PRACTICA; POLSTER MR, 1993, PSYCHOL BULL, V114, P477, DOI 10.1037/0033-2909.114.3.477; ROACHE JD, 1985, J PHARMACOL EXP THER, V234, P120; SCHACTER DL, 1986, J CLIN EXP NEUROPSYC, V8, P130; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; SQUIRES RF, 1977, NATURE, V266, P732, DOI 10.1038/266732a0; WEINGARTNER HJ, 1993, J PSYCHOPHARMACOL, V7, P303; Wesnes K, 1988, HUMAN PSYCHOPHARMACO, V3, P27, DOI [10.1002/hup.470030106, DOI 10.1002/HUP.470030106]	49	14	14	0	6	AMER PSYCHOLOGICAL ASSOC/EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1064-1297			EXP CLIN PSYCHOPHARM	Exp. Clin. Psychopharmacol.	NOV	2005	13	4					336	347		10.1037/1064-1297.13.4.336			12	Psychology, Biological; Psychology, Clinical; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pharmacology & Pharmacy; Psychiatry	994YU	WOS:000234067900008	16366764				2022-02-06	
J	Barney, MC; Max, JE				Barney, MC; Max, JE			The McMaster family assessment device and clinical rating scale: Questionnaire vs interview in childhood traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury (TBI); McMaster structured interview for families (McSIFF); family assessment device (FAD); children and adolescents	PSYCHIATRIC-DISORDERS; ORTHOPEDIC INJURY; SHORT-TERM; CHILDREN; ADOLESCENTS; BEHAVIOR; PREDICTORS; OUTCOMES; MODEL	Two modalities of family assessment based on the McMaster Model of Family Functioning (MMFF), including a self-report questionairre (Family Assessment Device-FAD) and a clinical interview (McMaster Structured Interview For Families-McSIFF) as scored on the McMaster Clinical Rating Scale (MCRS) were compared in an attempt to explore the inter-changeability of the two. Significant correlations were hypothesized between the FAD and MCRS in both prospective and retrospective groups and that correlations would increase over three data points in the prospective study. The sample included 50 children and adolescents (ages 6-4) with traumatic brain injury (TBI) from a prospective study. In addition, 72 children and adolescents (ages 5-14), consisting of 24 patients with severe TBI, individually matched to a comparison group of 24 mild TBI patients and a control group of 24 orthopaedic patients were included from a retrospective study. Significant correlations between the FAD and MCRS were found across both studies, with increasing correlations at each successive data point in the prospective study. Agreement between the two measures regarding classification of families as clinical vs healthy was also statistically significant at the majority of assessment occasions; however, most specific indices of agreement were only modest. The clinical and research implications of these findings are discussed.	Childrens Hosp & Hlth Ctr, San Diego, CA 92123 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA		Max, JE (corresponding author), Childrens Hosp & Hlth Ctr, 3020 Childrens Way,Mail Code 5033, San Diego, CA 92123 USA.	jmax@ucsd.edu	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH01800-05] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800] Funding Source: NIH RePORTER		Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; BIEDERMAN J, 1993, J CHILD PSYCHOL PSYC, V34, P1241, DOI 10.1111/j.1469-7610.1993.tb01785.x; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; EPSTEIN NB, 1981, HDB FAMILY THERAPY, P444; FRISTAD MA, 1989, J MARITAL FAM THER, V15, P259, DOI 10.1111/j.1752-0606.1989.tb00808.x; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; McCubbin HI, 1980, FAMILY ASSESSMENT RE; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS RH, 1990, FAM PROCESS, V29, P199, DOI 10.1111/j.1545-5300.1990.00199.x; MOOS RH, 1990, FAM PROCESS, V29, P209; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rosner B, 2000, FUNDAMENTALS BIOSTAT; STEVENSONHINDE J, 1995, FAM PROCESS, V34, P337, DOI 10.1111/j.1545-5300.1995.00337.x; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; [No title captured], DOI DOI 10.1001/ARCHPSYC.1961.01710120031004	27	14	15	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2005	19	10					801	809		10.1080/02699050400024961			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800006	16175840				2022-02-06	
J	Hainsworth, AH; Bermpohl, D; Webb, TE; Darwish, R; Fiskum, G; Qiu, JH; McCarthy, D; Moskowitz, MA; Whalen, MJ				Hainsworth, AH; Bermpohl, D; Webb, TE; Darwish, R; Fiskum, G; Qiu, JH; McCarthy, D; Moskowitz, MA; Whalen, MJ			Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortex	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						caspases; human; mice; neuronal cell death; programmed cell death; reactive astrocytes; trauma; traumatic brian injury	SPINAL-CORD-INJURY; TRAIL-INDUCED APOPTOSIS; BRAIN-INJURY; DEATH RECEPTOR; MEDIATED APOPTOSIS; FAS RECEPTOR; TNF-ALPHA; C-FLIP; ALZHEIMERS-DISEASE; UP-REGULATION	Cellular Fas-associated death domain-like interleukin-1-beta converting enzyme (FLICE) inhibitory proteins (cFLIPs) are endogenous caspase homologues that inhibit programmed cell death. We hypothesized that cFLIPs are differentially expressed in response to traumatic brain injury (TBI). cFLIP-alpha and cFLIP-delta mRNA were expressed in normal mouse brain-specifically cFLIP-delta (but not cFLIP-alpha) protein was robustly expressed. After controlled cortical impact (CCl), cFLIP-alpha expression increased initially then decreased to control levels at 12 h, increasing again at 24-72 h (P<0.05). cFLIP-delta expression was decreased in brain homogenates by 12 h after CCl, then increased again at 24 to 72 h (P<0.05). cFLIP-delta immunostaining was markedly reduced in injured cortex, but not hippocampus, at 3 to 72 h after CCl. In cortex, reduced cFLIP-delta staining was found in TUNEL-positive cells, but in hippocampus TUNEL-positive cells expressed cFLIP-delta immunoreactivity. cFLIP-delta was increased in a subset of reactive astrocytes in pericontusional cortex and hippocampus at 48 to 72 h. Low levels of both cFLIP isoforms were detected in human cortical tissue with no TBI, from four patients undergoing brain surgery for epilepsy and <24 h post mortem from three patients without CNS pathologic assessment. In cortical tissue surgically removed <18 h after severe TBI (n=3), cFLIP-alpha expression was increased relative to epilepsy controls (P<0.05) but not relative to post-mortem controls. The data suggest differential spatial and temporal regulation of cFLIP-alpha and cFLIP-delta expression that may influence the magnitude of cell death and further implicate programmed mechanisms of cell death after TBI.	Harvard Univ, Massachusetts Gen Hosp, Ctr Neurosci, Sch Med, Charlestown, MA 02129 USA; De Montfort Univ, Pharmacol Res Grp, Leicester Sch Pharm, Leicester, Leics, England; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA		Whalen, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Neurosci, Sch Med, Charlestown, MA 02129 USA.	mwhalen@bics.bwh.harvard.edu	Moskowitz, Michael A/D-9916-2011; Hainsworth, Atticus H./J-8657-2019	Hainsworth, Atticus H./0000-0001-7877-8013; Darwish, Ribal/0000-0003-0727-0401	Alzheimers Research UKAlzheimer&apos;s Research UK (ARUK) [ART-PPG2005A-2] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS041969, R01NS037141] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [C17893] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [KO8NS41969, R01 NS037141, K08 NS041969, R01NS37141] Funding Source: Medline		Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Bermpohl D, 2004, J NEUROTRAUM, V21, P1332; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Engidawork E, 2001, BIOCHEM BIOPH RES CO, V281, P84, DOI 10.1006/bbrc.2001.4306; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grambihler A, 2003, J BIOL CHEM, V278, P26831, DOI 10.1074/jbc.M303229200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; Imanishi T, 2000, CARDIOVASC RES, V48, P101, DOI 10.1016/S0008-6363(00)00154-1; Imanishi T, 2000, AM J PATHOL, V156, P125, DOI 10.1016/S0002-9440(10)64712-8; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Krautwald S, 2004, J BIOL CHEM, V279, P44005, DOI 10.1074/jbc.M401327200; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Micheau O, 2003, EXPERT OPIN THER TAR, V7, P559, DOI 10.1517/14728222.7.4.559; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Nuttall ME, 2001, DRUG DISCOV TODAY, V6, P85, DOI 10.1016/S1359-6446(00)01601-9; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Siegmund D, 2001, J BIOL CHEM, V276, P32585, DOI 10.1074/jbc.M100444200; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Suzuki A, 2003, ONCOGENE, V22, P6177, DOI 10.1038/sj.onc.1206899; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Wu SS, 2004, MOL BRAIN RES, V122, P79, DOI 10.1016/j.molbrainres.2003.12.007; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhao M, 2003, NEUROCHEM RES, V28, P307, DOI 10.1023/A:1022337519035	54	14	14	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2005	25	8					1030	1040		10.1038/sj.jcbfm.9600104			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	950SL	WOS:000230877600010	15815586	Bronze, Green Accepted			2022-02-06	
J	Moochhala, SM; Lu, J; Xing, MCK; Ng, KC; Ycing, KLS; Whiteman, M; Atan, S				Moochhala, SM; Lu, J; Xing, MCK; Ng, KC; Ycing, KLS; Whiteman, M; Atan, S			Mercaptoethylguanidine inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expressions induced in rats after fluid-percussion brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						fluid-percussion injury; inducible nitric oxide synthase; mercaptoethylguanidine; cyclo-oxygenase-2; neuronal survival; rat	BLOOD-PRESSURE; PEROXYNITRITE; TRAUMA; MODEL; MOTOR; NEUROPROTECTION; AMINOGUANIDINE; INFLAMMATION; DYSFUNCTION; SCAVENGER	The present study examined the temporal expression of inducible nitric oxide synthase (iNOS) and cyclo-oxygenase (COX)-2 in rat brains after traumatic brain injury (TBI). We studied the effects of mercaptoethylguanidine (MEG), a dual inhibitor of the inducible iNOS and COX with scavenging effect on peroxynitrite, on physiologic variables, brain pathogenesis, and neurologic performance in rats after a lateral fluid percussive-induced TBI. Mean arterial blood pressure and percentage cerebral tissue perfusion in MEG-treated TBI rats showed significant improvement when compared with TBI rats. Immunohistochemical analysis showed a marked number of iNOS and COX-2 immunopositive cells in the cerebral cortex ipsilateral to the injury in TBI rats when compared with MEG-treated TBI rats. MEG also significantly decreased the number of hyperchromatic and shrunken cortical neurons when compared with TBI rats' brain nitrate/nitrite, and prostaglandin E-2 levels were attenuated in MEG-treated TBI rats when compared with TBI rats. It is therefore suggested that treatment of MEG via inhibition of iNOS and COX-2 might contribute to improved physiologic variables, neuronal cell survival, and neurologic outcome after TBI.	DSO, Def Med & Environm Res Inst, Ctr Head Biomed Sci, Singapore 117510, Singapore; Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; Natl Univ Singapore, Dept Biochem, Singapore, Singapore		Moochhala, SM (corresponding author), DSO, Def Med & Environm Res Inst, Ctr Head Biomed Sci, 27 Med Dr,Level 12 Gen Off, Singapore 117510, Singapore.	nmiv19@nus.edu.sg	Whiteman, Matthew/C-6079-2009	Whiteman, Matthew/0000-0002-6583-6779; MOOCHHALA, SHABBIR/0000-0003-4521-3192			Acarin L, 2002, J NEUROSCI RES, V68, P745, DOI 10.1002/jnr.10261; Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buccellati C, 1998, NEUROSCI LETT, V257, P123, DOI 10.1016/S0304-3940(98)00745-9; Buluc M, 2002, PROSTAG OTH LIPID M, V70, P227, DOI 10.1016/S0090-6980(02)00112-0; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; Fink MP, 1999, CRIT CARE MED, V27, P2019, DOI 10.1097/00003246-199909000-00050; Frishman WH, 2002, AM J CARDIOL, V89, p18D; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Irazuzta JE, 2000, LIFE SCI, V67, P365, DOI 10.1016/S0024-3205(00)00637-8; Knoferl MW, 2001, SHOCK, V16, P479, DOI 10.1097/00024382-200116060-00013; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; MARKLUND NP, 2001, ABSTR SOC NEUROSCI, V27, P573; Marnett LJ, 2002, PROSTAG OTH LIPID M, V68-9, P153, DOI 10.1016/S0090-6980(02)00027-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Park CO, 2001, YONSEI MED J, V42, P518, DOI 10.3349/ymj.2001.42.5.518; Paya M, 1997, BRIT J PHARMACOL, V120, P1445, DOI 10.1038/sj.bjp.0701073; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; Schade S, 2002, BIOCHEM PHARMACOL, V64, P1227, DOI 10.1016/S0006-2952(02)01290-X; SHAPIRO Y, 1997, CRIT CARE MED, V16, P258; SINSON G, 1995, J NEUROCHEM, V65, P2209; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Sunose Y, 2001, J AM COLL SURGEONS, V192, P54, DOI 10.1016/S1072-7515(00)00773-0; Szabo A, 1999, CRIT CARE MED, V27, P1343, DOI 10.1097/00003246-199907000-00027; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; Szabo C, 1997, J BIOL CHEM, V272, P9030; TOMLINSON A, 1994, BRIT J PHARMACOL, V113, P693, DOI 10.1111/j.1476-5381.1994.tb17048.x; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; VANLERSBERGHE C, 1993, ACTA ANAESTH BELG, V43, P211; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wolff DJ, 1997, J PHARMACOL EXP THER, V283, P265; Zingarelli B, 1997, EUR J PHARMACOL, V338, P55, DOI 10.1016/S0014-2999(97)01325-3; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P357, DOI 10.1038/sj.bjp.0700892	48	14	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2005	59	2					448	455		10.1097/01.ta.0000174858.79847.6d			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	014BX	WOS:000235454800040	16294091				2022-02-06	
J	Swaine, BR; Desrosiers, J; Bourbonnais, D; Larochelle, JL				Swaine, BR; Desrosiers, J; Bourbonnais, D; Larochelle, JL			Norms for 15-to 34-year-olds for different versions of the finger-to-nose test	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	14th International World Congress of Physical Therapy (WCPT)	JUN 04-07, 2003	Barcelona, SPAIN			movement disorders; rehabilitation; time; upper extremity	TRAUMATIC BRAIN-INJURY; UPPER-LIMB; MOVEMENTS; COORDINATION; VISION; ADULTS	Swaine BR, Desrosiers J, Bourbonnais D, Larochelle J-L. Norms for 15- to 34-year-olds for different versions of the finger-to-nose test. Arch Phys Med Rehabil 2005;86:1665-9. Objectives: To develop norms for the time to execute different versions of the finger-to-nose test (FNT) and to determine the effects of different testing procedures on performance in people aged 15 to 34 years. Design: Cross-sectional. Setting: Research center. Participants: Healthy subjects (149 men, 148 women; age range, 15-34y) participated, and 36 men and 36 women were included in each of the 4 age categories studied (15-19y, 20-24y, 25-29y, 30-34y). Participants performed, in random order, 5 forms of the test in 2 positions (sitting, supine) with the right and left upper limbs (ULs). Interventions: Not applicable. Main Outcome Measure: Time (in seconds) to complete 5 cycles of movement. Results: Test version and side of UL were found to affect performances; right-sided performances were faster than left-sided. Performances did not vary significantly (P >.001) with sex or among age categories; therefore, the results are presented for the group. Mean performances varied from 3.44 to 4.29 seconds. Subsequent analysis of variance (with data for each UL) showed main effects for testing position (sitting > lying) and eye condition (eyes open > eyes closed). Versions were strongly interrelated (.85 < r <.98). Conclusions: Norms for the time to execute different FNT versions were developed for both ULs for healthy people ages 15 to 34 years.(c) 2005 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; Inst Readaptat Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; Univ Sherbrooke, Inst Geriatr, Ctr Rech Vieillissement, Sherbrooke, PQ J1K 2R1, Canada; Univ Sherbrooke, Fac Med, Dept Med Famille, Sherbrooke, PQ J1K 2R1, Canada		Swaine, BR (corresponding author), Univ Montreal, Fac Med, Ecole Readaptat, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca					Bourbonnais D, 1997, NEUROREHABILITATION, V9, P3, DOI 10.3233/NRE-1997-9102; Bruininks, 1978, BRUININKS OSERETSKY; Day BL, 1998, BRAIN, V121, P357, DOI 10.1093/brain/121.2.357; DESROSIERS J, 1995, AGE AGEING, V24, P108, DOI 10.1093/ageing/24.2.108; DITTIGER M, 2001, J PHYS THER SCI, P1375; Feys PG, 2003, ARCH PHYS MED REHAB, V84, P79, DOI 10.1053/apmr.2003.50068; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; GRINKLER R, 1966, NEUROLOGY; HANSEN M, 1994, ACTA NEUROL SCAND, V90, P145; Helsen WF, 1998, CORTEX, V34, P513, DOI 10.1016/S0010-9452(08)70511-2; JOHNSTON K, 1998, CAN J NEUROL SCI, V25, pS98; KJERLAND R. N., 1953, PROC IOWA ACAD SCI, V60, P519; Kraus JF, 1987, HEAD INJURY, V2, P1; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ott L., 1977, INTRO STAT METHODS D; POTVIN AR, 1980, J AM GERIATR SOC, V28, P1; Schmitz Thomas J., 1994, P97; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, IN PRESS PHYSIOTHER; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; VERKERK PH, 1990, CLIN NEUROL NEUROSUR, V92, P105, DOI 10.1016/0303-8467(90)90084-I	23	14	14	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2005	86	8					1665	1669		10.1016/j.apmr.2004.11.021			5	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	953LN	WOS:000231077900025	16084824				2022-02-06	
J	Baguley, IJ; Bailey, KM; Slewa-Younan, S				Baguley, IJ; Bailey, KM; Slewa-Younan, S			Prolonged anti-spasticity effects of bolus intrathecal baclofen	BRAIN INJURY			English	Article						traumatic brain injury; spasticity; intrathecal baclofen 2	HYPERTONIA	Anecdotal patient reports have suggested prolonged benefit from the initial bolus dose of intrathecal baclofen ( bolus ITB) that have not been evident on the Modified Ashworth Scale (MAS). This case study assessed this effect utilizing surface electromyography (SEMG) as an adjunct to clinical observations. Overall, SEMG recordings were consistent with MAS findings. However, SEMG also revealed a marked and persisting reduction in abnormal muscle activity for 96 hours post-bolus ITB, well beyond the pharmacological washout period of baclofen in the CSF.	Westmead Hosp, Brain Injury Rehabil Serv, Wentworthville, NSW 2145, Australia; Univ Sydney, Dept Rehabil Med, Sydney, NSW, Australia		Baguley, IJ (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, POB 533, Wentworthville, NSW 2145, Australia.	ianb@biru.wsahs.nsw.gov.au	Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Baguley, Ian J/0000-0001-5650-3705; 			BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; GIANINO JM, 1996, INTRATHECAL DRUG THE, P95; JONES RF, 1970, J NEUROL NEUROSUR PS, V33, P464, DOI 10.1136/jnnp.33.4.464; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Perotto A. O., 1994, ANATOMICAL GUIDE ELE; PRICE R, 1993, ARCH PHYS MED REHAB, V74, P300; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407	8	14	14	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2005	19	7					545	548		10.1080/02699050400025075			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IQ	WOS:000229622500009	16134742				2022-02-06	
J	Rigg, JL; Elovic, EP; Greenwald, BD				Rigg, JL; Elovic, EP; Greenwald, BD			A review of the effectiveness of antioxidant therapy to reduce neuronal damage in acute traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							HEAD-INJURY; OXIDATIVE STRESS; MELATONIN; MULTICENTER; EFFICACY; TRIAL; RAT		Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Mt Sinai Sch Med, Dept Phys Med & Rehabil, New York, NY 10029 USA; Mt Sinai Med Ctr, New York, NY 10029 USA		Rigg, JL (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Kaufman Med Bldg,3471 5th Ave,Ste 201, Pittsburgh, PA 15213 USA.	jackrigg@yaboo.com					Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Guidetti C, 2001, J PHARM PHARMACOL, V53, P387, DOI 10.1211/0022357011775442; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; YOSHIDA S, 1985, NEUROLOGY, V35, P126, DOI 10.1212/WNL.35.1.126; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	15	14	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					389	391		10.1097/00001199-200507000-00010			3	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800010	16030445				2022-02-06	
J	Foster, DR; Rhoney, DH				Foster, DR; Rhoney, DH			Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes	SURGICAL NEUROLOGY			English	Article						Enterobacter; gram-negative bacillary meningitis; meningitis; postneurosurgery	TRIMETHOPRIM-SULFAMETHOXAZOLE; CEFOTAXIME; AEROGENES; EMERGENCE	Background: Meningitis due to Enterobacter species is an uncommon infection in adults; however, when present, treatment is frequently complicated by resistance of many Enterobacter isolates to third-generation cephalosporins and poor central nervous system penetration of other antibiotics. The aim of this study was to retrospectively review cases of meningitis caused by Enterobacter species at our institution, to better characterize patient factors, pathogen characteristics, and treatment options for this infection. Methods: We reviewed all cases of Enterobacter meningitis in a 12-year period at a tertiary care center. Data collected included patient demographics, antibiotic sensitivities of Enterobacter isolates, antimicrobial therapy, and patient outcomes. Results: Nineteen cases were identified, primarily in patients with neurotrauma and in neurosurgical patients. Enterobacter cloacae was the most frequent Enterobacter species isolated followed by Enterobacter aerogenes and Enterobacter agglomerans (50%, 34%, and 16% of cultures, respectively). Overall, clinical cure/improvement was achieved in 47% of patients, and the mortality rate was 21%. Antibiotic treatment varied substantially and included third-generation cephalosporins, intravenous and intrathecal aminoglycosides, trimethoprim-sulfamethoxazole (TMP-SMX), piperacillin, ciprofloxacm, and other miscellaneous antibiotics. Treatment with TMP-SMX was associated with a high rate of clinical cure/improvernent, whereas third-generation cephalosporins were less efficacious. Conclusions: Enterobacter meningitis is an infrequent complication of neurological insult. Treatment is often complicated by resistance of Enterobacter species to third-generation cephalosporins. Our results indicate that while third-generation cephalosporins are not the most appropriate choice of agents to treat Enterobacter meningitis, TMP-SMX may yield satisfactory results. (c) 2005 Elsevier Inc. All rights reserved.	Wayne State Univ, Coll Pharm & Allied Hlth Profess, Dept Pharm Practice, Detroit, MI 48201 USA; Wayne State Univ, Coll Med, Dept Neurol, Detroit, MI 48201 USA; Purdue Univ, Sch Pharm & Pharm Sci, Dept Pharm Practice, W Lafayette, IN 47907 USA		Rhoney, DH (corresponding author), Wayne State Univ, Coll Pharm & Allied Hlth Profess, Dept Pharm Practice, Detroit, MI 48201 USA.	drhoney@wayne.edu					D'Antuono VS, 1998, CLIN INFECT DIS, V26, P206, DOI 10.1086/517020; DECHAMPS C, 1991, INFECTION, V19, P181, DOI 10.1007/BF01643247; HEUSSER MF, 1990, PEDIATR INFECT DIS J, V9, P509, DOI 10.1097/00006454-199007000-00011; Huang CR, 2001, INFECTION, V29, P75, DOI 10.1007/s15010-001-0087-0; LEVITZ RE, 1984, ANN INTERN MED, V100, P881, DOI 10.7326/0003-4819-100-6-881; RALPH ED, 1987, SCAND J INFECT DIS, V19, P577, DOI 10.3109/00365548709032425; Rousseau JM, 2001, J TRAUMA, V50, P971, DOI 10.1097/00005373-200105000-00041; SAAD AF, 1974, ARCH INTERN MED, V134, P738, DOI 10.1001/archinte.134.4.738; SALTER AJ, 1982, REV INFECT DIS, V4, P196; WOLFF MA, 1993, CLIN INFECT DIS, V16, P772, DOI 10.1093/clind/16.6.772	10	14	15	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	2005	63	6					533	537		10.1016/j.surneu.2004.06.018			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	938JU	WOS:000229996700008	15936376				2022-02-06	
J	Sakamoto, T; Takasu, A; Saitoh, D; Kaneko, N; Yanagawa, Y; Okada, Y				Sakamoto, T; Takasu, A; Saitoh, D; Kaneko, N; Yanagawa, Y; Okada, Y			Ionized magnesium in the cerebrospinal fluid of patients with head injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						head injury; ionized magnesium; ionized calcium; cerebrospinal fluid; Glasgow Coma Scale	TRAUMATIC BRAIN-INJURY; SULFATE; SERUM; CALCIUM; BLOOD; DEFICIENCY	Background. In head injury patients, a decrease in the serum ionized magnesium (iMg) concentration is considered to be related to the severity of the injury, however, this phenomenon is still not completely understood. The cerebrospinal fluid (CSF) iMg concentration has not been well documented under such conditions and, moreover, its normal value has not yet been established. We hereby intended to investigate the role of the iMg concentration and other parameters in both the serum and CSF of head injury patients and identify any relationship with other parameters. Materials and Methods. The subjects consisted of head injury patients without any other serious injuries. Ten healthy volunteers were selected as control subjects. Arterial blood and CSF specimens were simultaneously obtained and measured. We measured the Glasgow Coma Scale scores (GCS), the intracranial pressure (ICP), pH, PO2, PCO2, sodium, potassium, iCa, iMg, glucose, lactate, urea nitrogen. All data are expressed as the mean +/- SD and the units of iMg and iCa (corrected under pH 7.40) are given in mmol/L. Results. In the healthy subjects, the iMg concentration in the serum/CSF was 0.48 +/- 0.02 / 0.66 +/- 0.14, and iCa was 1.14 +/- 0.05 / 0.94 +/- 0.07. The GCS of the 15 head injury subjects at examination was 8.7 +/- 4.5. When the subjects were divided into 3 groups according to the GCS level (3 and 4, 5-8, and >= 9) at the time of examination, the serum iMg concentration was thus found to be related to the severity of injury based on the GCS level (p = 0.028), but not the CSF iMg concentration (p = 0.89). No relationship was observed between the iMg concentration in the serum and CSF when all specimens were compared, but an extremely close correlation was seen in the group with GCS 3 and 4 (p < 0.0001, r = 0.995), although no such correlation was seen in the other 2 groups (p = 0.12, r = -0.56 in the group with GCS 5-8, and p = 0.26, r = -0.35 in the group with GCS >= 9). There was a significant correlation between the serum iMg and iCa (p = 0.0093, r = 0.47), and also between the CSF iMg and iCa concentrations (p < 0.0001, r 0.67). Conclusion: The serum iMg concentration has been suggested to possibly affect the neurologic state through CSF iMg in patients with the most severe head injury. In patients with moderate or mild head injuries, however, the ionized magnesium concentration is also probably associated with the degree of neurologic deficit based on the ionized calcium level. The CSF and serum ionized magnesium dissociation may thus result from the slow movement of ionized magnesium through the blood brain barrier.				tskmt@me.ndmc.ac.jp; atakasu@me.ndmc.ac.jp; ds0711@me.ndmc; nk8639@me.ndmc.ac.jp; yanagawa@me.ndmc.ac.jp; trauma@me.ndmc.ac.jp		Takasu, Akira/0000-0003-3430-0119			ALTURA BM, 1984, DRUGS, V28, P120, DOI 10.2165/00003495-198400281-00013; ALTURA BM, 1994, SCAND J CLINN L S217, V54; ALTURA BM, 1995, SCI AM SCI MED, V2, P28; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P53, DOI 10.3109/00365519409095211; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Brewer RP, 2001, CLIN NEUROPHARMACOL, V24, P341, DOI 10.1097/00002826-200111000-00005; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; CHUTKOW JG, 1968, NEUROLOGY, V18, P963, DOI 10.1212/WNL.18.10.963; FONG J, 1995, OBSTET GYNECOL, V85, P444, DOI 10.1016/0029-7844(94)00413-8; FRECKENSTEIN A, 1973, RECENT ADV STUDIES C, V2, P455; HANDWERKER SM, 1995, J REPROD MED, V40, P201; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; KOST GJ, 1993, CRIT REV CL LAB SCI, V30, P153, DOI 10.3109/10408369309084667; KUGIYAMA K, 1988, J AM COLL CARDIOL, V12, P1177, DOI 10.1016/0735-1097(88)92597-1; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401; MAUSKOP A, 1993, HEADACHE, V33, P135, DOI 10.1111/j.1526-4610.1993.hed3303135.x; MAUSKOP A, 1995, CLIN SCI, V89, P633, DOI 10.1042/cs0890633; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; MIURA K, 1988, Neurological Surgery, V16, P1251; MIYAGI H, 1989, CIRCULATION, V79, P597, DOI 10.1161/01.CIR.79.3.597; MIYAMOTO Y, 2003, MARIA MED COLL, V31, P315; Morris M E, 1992, Magnes Res, V5, P303; Nishimuta M, 1988, MAGNESIUM, V7, P123; OHTOMO T, 1994, CURRENT CONCEPTS MAG, V6, P11; OPPELT WW, 1963, AM J PHYSIOL, V205, P959, DOI 10.1152/ajplegacy.1963.205.5.959; Shibata M, 1999, ANGIOLOGY, V50, P573, DOI 10.1177/000331979905000707; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; TURLAPATY PDMV, 1980, SCIENCE, V208, P198, DOI 10.1126/science.7361117; WOODBURY J, 1968, NEUROLOGY, V18, P700, DOI 10.1212/WNL.18.7.700; WOODS KL, 1992, LANCET, V339, P1553, DOI 10.1016/0140-6736(92)91828-V; ZHANG A, 1992, BIOCHIM BIOPHYS ACTA, V1134, P25, DOI 10.1016/0167-4889(92)90024-6	33	14	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2005	58	6					1103	1109		10.1097/01.TA.0000169950.51735.C4			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	943EU	WOS:000230336100003	15995455				2022-02-06	
J	Albano, C; Comandante, L; Nolan, S				Albano, Corazon; Comandante, Laura; Nolan, Scot			Innovations in the Management of Cerebral Injury	CRITICAL CARE NURSING QUARTERLY			English	Article						brain injury; cerebral oxygenation; head trauma; Licox (R); PbtO(2); traumatic brain injury		During the past decade, brain tissue oxygen monitoring has been studied predominantly in Europe. Cerebral oxygenation monitoring was implemented in many intensive care units and correlations of intracranial pressure, cerebral perfusion pressure, end-tidal carbon dioxide monitoring, fever and partial pressure of brain tissue oxygenation (PbtO(2)) have been described (Crit Care Nurse. 2003; 23[4, pt 1]: 17-27). The monitoring of brain tissue oxygen is now being done and researched in the United States. This article will discuss the history of treatment of traumatic brain injury and how treatment interventions are changing with the latest technological advances in monitoring of cerebral oxygen levels and suggested interventions and factors that affect brain tissue oxygenation. It is clear that by understanding the causes of hypoxia and ischemia-along with the interventions to treat them-the critical care team will be better able to prevent low oxygen states in the brain and optimize treatment, thus improving patient outcome.	[Albano, Corazon; Comandante, Laura; Nolan, Scot] Scripps Mercy Hosp, Crit Care Serv, 4077,5th Ave, San Diego, CA 92103 USA		Albano, C (corresponding author), Scripps Mercy Hosp, Crit Care Serv, 4077,5th Ave, San Diego, CA 92103 USA.	supernanay143@aol.com					Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bradley WC, 2000, NEUROLOGICAL DISORDE; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dietrich WD., 2000, NEUROLOGICAL CLIN PR, VII, P1045; Dietrich WD., 2000, NEUROLOGY CLIN PRACT; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Dings J, 1995, ZENTRALBL NEUROCHIR, V23, P17; Dugan LL, 2000, BASIC NEUROCHEMISTRY; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Hartl R, 1996, INT C REC ADV NEUR C; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Hickey J., 2003, CLIN PRACTICE NEUROB; Hom M, 1991, ACTA NEUROPATHOL, V81, P443; Lang EW., 1997, PATHOPHYSIOLOGICAL B, P55; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; Maas AIR, 1997, J NEUROTRAUM, V14, P251; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Schneider GH, 1998, ACT NEUR S, V71, P62; Schneider GH, 1996, INT C REC ADV NEUR; SHARP FR, 1998, STROKE PATHOPHYSIOLO, P51; Siegel GJ, 2000, BASIC NEUROCHEMISTRY; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; WARLOW CP, 1996, PRACTICAL GUIDE MANA	26	14	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	APR-JUN	2005	28	2					135	149		10.1097/00002727-200504000-00006			15	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V1Y5O	WOS:000217351900006	15875444				2022-02-06	
J	Bartlett, SC; Armstrong, E; Roberts, J				Bartlett, SC; Armstrong, E; Roberts, J			Linguistic resources of individuals with Asperger syndrome	CLINICAL LINGUISTICS & PHONETICS			English	Article						Asperger syndrome; autism; sociolinguistics; pragmatics	HIGH-FUNCTIONING AUTISM; TRAUMATIC BRAIN-INJURY; DIFFERENT COMMUNICATION PARTNERS; NORMALLY DEVELOPING-CHILDREN; PRAGMATIC ASPECTS; DISCOURSE; LANGUAGE; DISORDER; MIND; CONVERSATION	In this paper the available literature on the communication skills of individuals with Asperger Syndrome (AS) is reviewed. Current issues regarding diagnosing and understanding disorders with a core social deficit are examined as well as the potential application of sociolinguistic analyses to the study of Asperger Syndrome, such as that provided from within a Systemic Functional Linguistic framework. The need for investigations that address a broader view of "language'' and its use in social situations by individuals with AS as opposed to their mastery of syntactic aspects of language, will be discussed.	Macquarie Univ, Dept Linguist, N Ryde, NSW 2010, Australia		Bartlett, SC (corresponding author), Macquarie Univ, Dept Linguist, N Ryde, NSW 2010, Australia.	sclan000@student.mq.edu.au		Armstrong, Elizabeth/0000-0003-4469-1117			ADAMS C, 1989, BRIT J DISORD COMMUN, V24, P211; Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P679, DOI 10.1111/1469-7610.00056; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armstrong E, 2001, APHASIOLOGY, V15, P1029, DOI 10.1080/02687040143000375; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; BALTAXE CAM, 1992, J AUTISM DEV DISORD, V22, P1, DOI 10.1007/BF01046399; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; BARONCOHEN S, 1988, J AUTISM DEV DISORD, V18, P379, DOI 10.1007/BF02212194; BaronCohen S, 1997, ISRAEL J PSYCHIAT, V34, P174; BARTOLUCCI G, 1980, J AUTISM DEV DISORD, V10, P39, DOI 10.1007/BF02408431; Bishop DVM, 1998, APPL PSYCHOLINGUIST, V19, P415, DOI 10.1017/S0142716400010249; Bishop DVM, 2000, DEV PSYCHOPATHOL, V12, P177, DOI 10.1017/S0954579400002042; Bishop DVM, 2001, DEV MED CHILD NEUROL, V43, P809, DOI 10.1017/S0012162201001475; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Capps L., 1998, AUTISM, V2, P325, DOI DOI 10.1177/1362361398024002; Carrington S, 2001, AUTISM, V5, P37, DOI 10.1177/1362361301005001004; Dobbinson S, 1998, J COMMUN DISORD, V31, P113, DOI 10.1016/S0021-9924(97)00085-3; Eisenmajer R, 1996, J AM ACAD CHILD PSY, V35, P1523, DOI 10.1097/00004583-199611000-00022; FERGUSON A, 1992, J NEUROLINGUIST, V7, P277, DOI 10.1016/0911-6044(92)90019-S; FINE J, 1994, J AUTISM DEV DISORD, V24, P315, DOI 10.1007/BF02172230; Ghaziuddin M, 2000, J AUTISM DEV DISORD, V30, P67, DOI 10.1023/A:1005416212615; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Halliday M., 2004, INTRO FUNCTIONAL GRA; Halliday M. A. K., 1975, LEARNING MEAN EXPLOR; Heavey L, 2000, J AUTISM DEV DISORD, V30, P225, DOI 10.1023/A:1005544518785; Kanner L, 1943, NERV CHILD, V2, P217; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1107, DOI 10.1111/j.1469-7610.1991.tb00352.x; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; TAGERFLUSBERG H, 1990, J AUTISM DEV DISORD, V20, P1, DOI 10.1007/BF02206853; THOMSON J, 1997, SPEECH PATH AUSTR NA; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; VOLKMAR R, 2000, ASPERGER SYNDROME; WING L, 1981, PSYCHOL MED, V11, P115, DOI 10.1017/S0033291700053332; World Health Organisation, 1993, INT CLASS DIS 10 REV	42	14	14	2	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	APR-MAY	2005	19	3					203	213		10.1080/02699200410001698634			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	913VC	WOS:000228182300006	15823956				2022-02-06	
J	Imberti, R; Fuardo, M; Bellinzona, G; Pagani, M; Langer, M				Imberti, R; Fuardo, M; Bellinzona, G; Pagani, M; Langer, M			The use of indomethacin in the treatment of plateau waves: effects on cerebral perfusion and oxygenation	JOURNAL OF NEUROSURGERY			English	Article						plateau wave; intracranial pressure; cerebral oxygenation; transcranial Doppler ultrasonography; venoarterial difference in partial pressure of carbon dioxide	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; BLOOD-FLOW; HYPERTENSION; METABOLISM; VOLUME; RISES; MODEL	Object. Plateau waves are sudden and steep increases in intracranial pressure (ICP) that can develop in patients with cerebral injuries, reduced pressure-volume compensatory reserve, and preserved autoregulation. They are caused by cerebral vasodilation in response to a reduction in cerebral perfusion and are associated with increased cerebral blood volume and reduced cerebral blood flow. The authors evaluated the hypothesis that administration of indomethacin, a potent cerebral arteriolar vasoconstrictor, could interrupt the vicious cycle that occurs during plateau waves, extinguishing these waves and, ultimately, restoring cerebral perfusion and oxygenation. Methods. Plateau waves developed in nine patients, seven with severe traumatic brain injury and two with intraparenchymal hemorrhage. One to four episodes of plateau waves per patient were treated with indomethacin (15-20 mg), which was delivered by an intravenous bolus injection. Each patient's mean arterial blood flow (MABP), lCP, cerebral perfusion pressure (CPP), and cerebral tissue PO2 were continuously monitored and the data obtained were stored in a personal computer. Each patient's jugular venous 0, saturation (SjvO(2),) and venoarterial difference in PCO2 were evaluated by intermittent blood sampling. During five episodes of plateau waves, middle cerebral artery flow velocities were evaluated by transcranial Doppler ultrasonography. Indomethacin extinguished all plateau waves. On average, the ICP decreased from an initial value of 58.9 +/- 11.6 mm Hg to 21.2 +/- 8.6 and 25.8 +/- 13.7 mm Hg after 5 and 10 minutes, respectively (p < 0.01). The MABP did not change significantly. As a consequence the CPP increased by 98 and 81% after 5 and 10 minutes, respectively (p < 0.01). Five and 10 minutes after indomethacin was administered, SjvO(2), increased from an initial value of 50 +/- 10.5% to 62 +/- 7.6 and 59.9 +/- 9.3%, respectively (p < 0.01); the cerebral tissue PO, increased from an initial value of 13.4 +/- 10.6 mm Hg to 23.6 +/- 9.58 and 21.9 +/- 9.2 mm Hg, respectively (p < 0.05); and the venous-arterial PCO2 decreased significantly. The mean and diastolic flow velocities increased significantly, whereas the pulsatility index decreased from 1.39 +/- 0.56 to 1.09 +/- 0.4 at 5 minutes and 1.06 +/- 0.36 at 10 minutes (p < 0.05). Conclusions. The findings confirm that plateau waves are caused by vasodilation and show that indomethacin, by constricting the cerebral arteries, is effective in extinguishing plateau waves, ultimately restoring cerebral perfusion and oxygenation.	IRCCS, Policlin San Matteo, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy		Imberti, R (corresponding author), IRCCS, Policlin San Matteo, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy.	r.imberti@smatteo.pv.it					BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; Bundgaard H, 1996, J NEUROSURG ANESTH, V8, P273, DOI 10.1097/00008506-199610000-00003; CRUZ J, 1992, J TRAUMA, V32, P401, DOI 10.1097/00005373-199203000-00020; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; DEDEYNE C, 1995, INTENSIVE CARE ME S1, V21, pS153; HANSEN PA, 1995, J NEUROSURG ANESTH, V7, P117, DOI 10.1097/00008506-199504000-00007; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; Imberti R, 1997, ACTA ANAESTH SCAND, V41, P536, DOI 10.1111/j.1399-6576.1997.tb04738.x; Imberti R, 2000, J NEUROSURG ANESTH, V12, P124, DOI 10.1097/00008506-200004000-00011; JENSEN K, 1993, ACTA NEUROCHIR, V124, P114, DOI 10.1007/BF01401132; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; NILSSON F, 1995, ANESTHESIOLOGY, V83, P1283, DOI 10.1097/00000542-199512000-00019; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Rossi S, 2002, ACT NEUR S, V81, P201; Slavik RS, 1999, NEUROL RES, V21, P491; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; WENNMALM A, 1981, CLIN PHYSIOL, V1, P227, DOI 10.1111/j.1475-097X.1981.tb00891.x	21	14	14	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2005	102	3					455	459		10.3171/jns.2005.102.3.0455			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	911PR	WOS:000228017200009	15796379				2022-02-06	
J	Haranishi, Y; Kawata, R; Fukuda, S; Kiyoshima, T; Morimoto, Y; Matsumoto, M; Sakabe, T				Haranishi, Y; Kawata, R; Fukuda, S; Kiyoshima, T; Morimoto, Y; Matsumoto, M; Sakabe, T			Moderate hypothermia, but not calpain inhibitor 2, attenuates the proteolysis of microtubule-associated protein 2 in the hippocampus following traumatic brain injury in rats	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article						brain injuries, traumatic, acute, neuroprotection; calpain inhibitors; hypothermia	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC HYPOTHERMIA; SPECTRIN; MECHANISMS; DEFICITS	Background and objective: The degradation of the cytoskeletal protein microtubule-associated protein 2 (MAP2), by calpain has been known to occur following traumatic brain injury. We examined the therapeutic potential of calpain inhibitor 2, compared with that of moderate hypothermia in traumatic brain injury produced by weight drop in rats. Methods: An inhibitor treated group (n = 8) received calpain inhibitor 2 intravenously (i.v.) for 5 min before and for 6 h after injury (total 2 mu mol); a hypothermic (HT) group (n = 8) was maintained at 30 degrees C (temporalis muscle temperature) for 45 min prior to and 60 min after injury; an untreated (UT) group (n = 8) received an infusion of inactive vehicle. Eight rats (sham group) underwent surgery without brain injury. Histopathological (haematoxylin and eosin staining) and MAP2 (immunohistchemistry and western blotting) evaluations were performed at 6 h after injury. Results: Ipsilateral cortical damage was marked in the injured groups. In the hippocampus, marked pyramidal neuronal damage was observed in the UT and calpain inhibitor treated (CI) groups, while these neurons were better preserved in the HT group. The hippocampal MAP2 levels in the UT, CI and HT groups were significantly decreased to 13 +/- 9%, 28 +/- 33% and 62 +/- 25% of the sham control, respectively. MAP2 concentration in the HT group was significantly higher than in UT and CI groups (P < 0.05). Conclusion: The results suggest that moderate hypothermia, but not calpain inhibitor 2 with the tested regime, attenuates cytoskeletal damage in the ipsilateral hippocampus at 6 h after traumatic brain injury.	Yamaguchi Univ, Sch Med, Dept Anesthesiol Resuscitol, Yamaguchi 7558505, Japan		Sakabe, T (corresponding author), Yamaguchi Univ, Sch Med, Dept Anesthesiol Resuscitol, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.	sakabe@po.cc.yamaguchi-u.ac.jp					Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fukuda S, 1998, J NEUROCHEM, V70, P2526; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	28	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	FEB	2005	22	2					140	147		10.1017/S0265021505000268			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	932DV	WOS:000229535300011	15816594				2022-02-06	
J	Ashton, VL; Donders, J; Hoffman, NM				Ashton, VL; Donders, J; Hoffman, NM			Rey Complex Figure Test performance after traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; CONFIRMATORY FACTOR-ANALYSIS; CLOSED-HEAD INJURY; MEMORY; PATTERNS; DEFICITS; MODERATE; EPILEPSY	The influence of factors such as cerebral injury characteristics, education, perceptual organization skills, and speed of information processing on performance on the Rey Complex Figure Test & Recognition Trial (RCF) was examined by means of hierarchical regression analyses in 100 consecutively referred persons with traumatic brain injury at a median of 2.5 months post-injury. Patients with premorbid (e.g., psychiatric history) or comorbid (e.g., financial compensation-seeking) complicating factors were excluded. Perceptual organization skills and the presence of a diffuse intracranial lesion but not education or speed of processing were statistically significant predictors of the variance in RCF variables. A large proportion of the sample improved by at least a standard deviation from independent delayed recall to multiple-choice recognition, and this was mediated by perceptual organization skills but not by injury parameters. It is concluded that Performance on the RCF after traumatic brain injury is affected relatively more by perceptual organization skills than by injury severity characteristics.	Mary Free Bed Rehabil Hosp, Dept Psychol, Grand Rapids, MI 49503 USA; Adler Sch Profess Psychol, Chicago, IL USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Ardila A, 1991, CLIN NEUROPSYCHOL, V5, P371, DOI [10.1080/13854049108404104, DOI 10.1080/13854049108404104]; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; Benton AL, 1994, MULTILINGUAL APHASIA; Berry D.T.R., 1991, CLIN NEUROPSYCHOL, V5, P143, DOI [10.1080/13854049108403298, DOI 10.1080/13854049108403298]; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BOONE KB, 1993, CLIN NEUROPSYCHOL, V7, P22, DOI 10.1080/13854049308401884; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Feeman RQ, 2000, NEUROPSYCHOLOGY, V14, P415, DOI 10.1037//0894-4105.14.3.415; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Giovagnoli AR, 1999, EPILEPSIA, V40, P904, DOI 10.1111/j.1528-1157.1999.tb00797.x; Hartman M, 1998, CLIN NEUROPSYCHOL, V12, P513, DOI 10.1076/clin.12.4.513.7233; Heaton RK, 1991, COMPREHENSIVE NORMS; HEILBRONNER RL, 1992, CLIN NEUROPSYCHOL, V6, P105; Kixmiller JS, 2000, J CLIN EXP NEUROPSYC, V22, P198, DOI 10.1076/1380-3395(200004)22:2;1-1;FT198; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Novack TA, 2000, BRAIN INJURY, V14, P987; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stern R., 1999, BOSTON QUALITATIVE S; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 1988, CONTINUOUS VISUAL ME; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde NJ, 2003, PSYCHOL ASSESSMENT, V15, P56, DOI 10.1037/1040-3590.15.1.56; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wolfson, 1993, HALSTEAD REITAN NEUR	43	14	14	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN	2005	27	1					55	64		10.1080/138033990513636			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	908NM	WOS:000227793700004	15814442				2022-02-06	
S	Faden, AI; Knoblach, SM; Movsesyan, VA; Lea, PM; Cernak, I		Slikker, W; Andrews, RJ; Trembly, B		Faden, AI; Knoblach, SM; Movsesyan, VA; Lea, PM; Cernak, I			Novel neuroprotective tripeptides and dipeptides.	NEUROPROTECTIVE AGENTS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	7th International Conference on Neuroprotective Agents	NOV 14-19, 2004	Pacific Grove, CA	Cent Arkansas Chapter SIGMA XI, FDA, Natl Ctr Toxicol Res, US EPA		TRH analogues; dipeptides; tripeptides; CNS injury; neuroprotection	THYROTROPIN-RELEASING-HORMONE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; TRH-ANALOG; YM-14673; RECOVERY; THERAPY; RAT	It has long been recognized that thyrotropin-releasing hormone (TRH) and certain TRH analogues are neuroprotective in a variety of animal models of CNS trauma. In addition to these neuroprotective actions, TRH and most TRH analogues have other physiological actions that may not be desirable for treatment of acute injury, such as analeptic, autonomic, and endocrine effects. We have developed a series of dual-substituted TRH analogues that have strong neuroprotective actions, but are largely devoid of these other physiological actions. In addition, we have developed a family of cyclized dipeptides (diketopiperazines), structurally somewhat related to a metabolic product of TRH, that appear even more effective as neuroprotective agents in vitro and in vivo, and may have nootropic properties. Here, we review these novel tripeptide and dipeptide compounds.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA		Faden, AI (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW,Res Bldg,Room EP04, Washington, DC 20057 USA.	fadena@georgetown.edu	Cernak, Ibolja/A-6399-2008	Ibolja, Cernak/0000-0003-3214-698X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041119] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD40677] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS41119] Funding Source: Medline		AKDEMIR H, 1993, RES EXP MED, V193, P297, DOI 10.1007/BF02576237; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; Brunetti L, 2002, FARMACO, V57, P479, DOI 10.1016/S0014-827X(02)01232-6; Castagnola E, 2004, CLIN MICROBIOL INFEC, V10, P255, DOI 10.1111/j.1198-743X.2004.00837.x; CEYLAN S, 1992, RES EXP MED, V192, P23, DOI 10.1007/BF02576254; CEYLAN S, 1990, RES EXP MED, V190, P111, DOI 10.1007/PL00020013; Cirone P, 2004, HUM GENE THER, V15, P945, DOI 10.1089/hum.2004.15.945; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Faden A I, 1988, Adv Neurol, V47, P531; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; FADEN AI, 1983, NEUROLOGY, V33, P673, DOI 10.1212/WNL.33.6.673; Faden AI, 2004, J ALZHEIMERS DIS, V6, pS93; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P355, DOI 10.1097/01.WCB.0000046144.31247.33; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FADEN AI, 1990, J PHARMACOL EXP THER, V255, P608; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1993, J NEUROTRAUM, V10, P101, DOI 10.1089/neu.1993.10.101; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; FADEN AI, 1989, ANN NY ACAD SCI, V553, P380; FEUERSTEIN G, 1984, CIRC SHOCK, V13, P255; FEUERSTEIN G, 1983, PROSTAGLANDINS, V26, P711, DOI 10.1016/0090-6980(83)90056-4; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MAPELLI C, 1990, BIOPOLYMERS, V29, P407, DOI 10.1002/bip.360290212; PITTS LH, 1995, J NEUROTRAUM, V12, P235, DOI 10.1089/neu.1995.12.235; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRASAD C, 1988, NEUROSCI BIOBEHAV R, V12, P19, DOI 10.1016/S0149-7634(88)80069-1; PRASAD C, 1995, PEPTIDES, V16, P151, DOI 10.1016/0196-9781(94)00017-Z; Prokai L, 2004, J MED CHEM, V47, P6025, DOI 10.1021/jm020531t; Prokai-Tatrai K, 2003, BIOORG MED CHEM LETT, V13, P1011, DOI 10.1016/S0960-894X(03)00081-7; Puniak MA, 1991, J NEUROTRAUM, V8, P193, DOI 10.1089/neu.1991.8.193; REDDING TW, 1969, P SOC EXP BIOL MED, V131, P415; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; SZIRTES T, 1986, J MED CHEM, V29, P1654, DOI 10.1021/jm00159a015; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5	39	14	15	0	5	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-578-8	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2005	1053						472	481		10.1196/annals.1344.041			10	Multidisciplinary Sciences; Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BDR63	WOS:000235109800048	16179555				2022-02-06	
J	Read, D; Ashford, B				Read, D; Ashford, B			Surgical aspects of operation Bali assist: Initial wound surgery on the tarmac and in flight	ANZ JOURNAL OF SURGERY			English	Article						disaster; injury; military medicine; surgery; terrorism; wound		Background: The explosion of three bombs on 12 October 2002 in Kuta, Bali resulted in mass casualties akin to those seen in war. The aim of the present report is to describe the sequence of events of Operation Bali Assist including triage, resuscitation and initial wound surgery in Bali at Sanglah Hospital in the aeromedical staging facility (ASF), Denpasar airport and the evacuation to Darwin. Methods: A descriptive report is provided of the event and includes; resuscitation, anaesthesia, initial burns surgery management including escharotomy and fasciotomy, head injury management and importance of supplies and medical records with a description of the evacuation to Darwin. Results: Operation Bali Assist involved five C130 Hercules aircraft and aeromedical evacuation medical and nursing teams managing 66 casualties in the Denpasar area and their evacuation to Royal Darwin Hospital with ketamine the most useful anaesthetic agent and cling film the most useful burns dressing. Twelve procedures were performed at the ASF including seven escharotomies, three fasciotomies and two closed reductions. One escharotomy was performed in flight. Discussion: The important lessons learnt from the exercise is the inclusion of a surgeon in the aeromedical evacuation team, the importance of debridement and delayed primary closure, the usefulness of cling film as a burns dressing and the importance of continuous assessment. Future disaster planning exercises need to consider a patient age mix that might be expected in a shopping mall, rather than the young adult encountered in Bali, a more familiar age mix for Australian Defence Force medical staff.	Royal Darwin Hosp, Dept Surg, Darwin, NT 0810, Australia; RAAMC, Hlth Support Battal 3, Canberra, ACT, Australia; Royal Australian AF Specialist Reserve, Canberra, ACT, Australia		Read, D (corresponding author), Royal Darwin Hosp, Dept Surg, Rocklands Dr, Darwin, NT 0810, Australia.	DavidJ.Read@nt.gov.au					*AUSTR DEF FORC, 1996, AUSTR DEF FORC PUBL, V708, pCH9; Hampson GV, 2002, MED J AUSTRALIA, V177, P620, DOI 10.5694/j.1326-5377.2002.tb04986.x; HULL JB, 1994, BRIT J SURG, V81, P1132, DOI 10.1002/bjs.1800810815; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; MELLOR SG, 1997, BALLISTIC TRAUMA CLI	5	14	15	0	4	BLACKWELL PUBLISHING ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1445-1433			ANZ J SURG	ANZ J. Surg.	NOV	2004	74	11					986	991		10.1111/j.1445-1433.2004.03246.x			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	869ZN	WOS:000225023900014	15550089				2022-02-06	
J	Caldicott, DGE; Pearce, A; Price, R; Croser, D; Brophy, B				Caldicott, DGE; Pearce, A; Price, R; Croser, D; Brophy, B			Not just another 'head lac'... low-velocity, penetrating intra-cranial injuries: a case report and review of the literature	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							TRANSCRANIAL STAB WOUNDS; CRANIOCEREBRAL INJURIES; TRAUMATIC ANEURYSM; SKULL; BRAIN; MANAGEMENT; WOOD; COMPLICATIONS; CHOPSTICK; FEATURES		Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5000, Australia		Caldicott, DGE (corresponding author), Royal Adelaide Hosp, Emergency Dept, N Terrace, Adelaide, SA 5000, Australia.	dcaldico@mail.rah.sa.gov.au	Caldicott, David/N-2840-2013	Caldicott, David/0000-0002-7040-6861			AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; ABBASSIOUN K, 1979, J NEUROL NEUROSUR PS, V42, P1046, DOI 10.1136/jnnp.42.11.1046; Adams RF, 2001, CLIN RADIOL, V56, P676, DOI 10.1053/crad.1999.0461; Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BARD LA, 1964, ARCH OPHTHALMOL-CHIC, V71, P332; Barlas O, 1983, Neurosurgery, V13, P105; Bauer M, 2002, FORENSIC SCI INT, V129, P122, DOI 10.1016/S0379-0738(02)00271-2; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BHOOTRA BK, 1985, J FORENSIC SCI, V30, P567; BRAUN J, 1987, J COMPUT ASSIST TOMO, V11, P525, DOI 10.1097/00004728-198705000-00030; Chadwick EKJ, 1999, FORENSIC SCI INT, V105, P35, DOI 10.1016/S0379-0738(99)00117-6; DABEZIES OH, 1982, ANN OPHTHALMOL, V14, P780; Deb S, 2000, J TRAUMA, V48, P1159, DOI 10.1097/00005373-200006000-00026; DIMAIO VJM, 1972, MIL MED, V137, P434; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DOOLING JA, 1967, J NEUROSURG, V26, P636, DOI 10.3171/jns.1967.26.6.0636; DUFFY GP, 1969, BRIT J SURG, V56, P685, DOI 10.1002/bjs.1800560912; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; Franklin GA, 2002, J TRAUMA, V52, P1009, DOI 10.1097/00005373-200205000-00034; Hanigan W C, 1986, Pediatr Emerg Care, V2, P247, DOI 10.1097/00006565-198612000-00011; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; Joly LM, 2002, ANESTH ANALG, V94, P231, DOI 10.1097/00000539-200201000-00045; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; Khosla D, 2002, J TRAUMA, V52, P1192, DOI 10.1097/00005373-200206000-00029; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; KIRKBY GR, 1986, BRIT MED J, V293, P1646, DOI 10.1136/bmj.293.6562.1646; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; LAWSON D, 1990, AUST NZ J OPHTHALMOL, V18, P221; Levin LA, 1996, J TRAUMA, V41, P926, DOI 10.1097/00005373-199611000-00035; Liliang PC, 2001, INJURY, V32, P497, DOI 10.1016/S0020-1383(01)00042-0; MARKHAM JW, 1964, J NEUROSURG, V21, P1095, DOI 10.3171/jns.1964.21.12.1095; Maroun FB, 2002, J TRAUMA, V52, P1008, DOI 10.1097/00005373-200205000-00033; MCKECHNIE J, 1986, BRIT J ORAL MAX SURG, V24, P258, DOI 10.1016/0266-4356(86)90090-2; MILLER CF, 1977, SURG NEUROL, V7, P95; Mitra K, 2002, INJURY, V33, P374, DOI 10.1016/S0020-1383(02)00024-4; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; O'Callaghan PT, 1999, FORENSIC SCI INT, V104, P173, DOI 10.1016/S0379-0738(99)00115-2; Olumide A A, 1976, Surg Neurol, V6, P306; RAHIMIZADEH A, 1987, NEUROSURGERY, V21, P427; Rao GP, 1998, BRIT J NEUROSURG, V12, P569; RITTER C, 1986, Z RECHTSMED, V96, P229; RITTER C, 2001, MED REHABIL, V82, P306; SEBAG J, 1986, OPHTHALMIC SURG LAS, V17, P631; Sharif S, 2000, BRIT J NEUROSURG, V14, P159; SPETZLER RF, 1979, NEUROSURGERY, V4, P334, DOI 10.1227/00006123-197904000-00011; Suzuki H, 2002, PAEDIATR ANAESTH, V12, P88, DOI 10.1046/j.1460-9592.2002.0787g.x; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; TIWARI SM, 1978, SURG NEUROL, V9, P267; TRIBOLET ND, 1979, SURG NEUROL, V11, P187; Tutton MG, 2000, J ACCID EMERG MED, V17, P225; VANDELLEN JR, 1978, SURG NEUROL, V10, P110; VILLIERS JCD, 1975, BRIT J OPHTHALMOL, V59, P52, DOI 10.1136/bjo.59.1.52; WEBER W, 1974, Z RECHTSMED, V74, P111, DOI 10.1007/BF02114697; YAMAMOTO I, 1985, SURG NEUROL, V23, P396, DOI 10.1016/0090-3019(85)90215-0	57	14	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2004	35	10					1044	1054		10.1016/j.injury.2003.10.026			11	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	858BC	WOS:000224164100020	15351675				2022-02-06	
J	Milosavljevic, S; Carman, AB; Milburn, PD; Wilson, BD; Davidson, PL				Milosavljevic, S; Carman, AB; Milburn, PD; Wilson, BD; Davidson, PL			The influence of a back support harness on spinal forces during sheep shearing	ERGONOMICS			English	Article						sheep shearing; occupation force; back harness	DISORDER	Previous research has classified the occupation of sheep shearing as heavy work where shearers. ex their spine and hips for long periods of time, handle awkward loads and expend high amounts of energy. The aim of this research was to investigate the magnitude of spinal forces produced during the shearing phase of the work and to determine whether the use of a commercially available back support harness would reduce these forces. Following discussion on task complexity and risk of back injury with senior shearing instructors, three component tasks of the shearing phase were identified as posing high risk of injury and were prioritized for primary analysis. Although the dragging out of a sheep in preparation for shearing and an unexpected loss of animal control were also identified as being of high risk, technological and instrumentation difficulties precluded their analysis. Twelve experienced shearers were videotaped while shearing with and without the use of a back harness. Surface mounted retro-reflective markers placed on the trunk defined three linked segments: Pelvis, Lumbar and Head, Arms, and Upper Trunk (HAUT). A 3D, link segment, top down, inverse dynamics approach was used to describe the motion and to estimate forces involved during the identified tasks of shearing. The spinal force/time profiles of this sample of shearers demonstrated large compressive and shear forces for all three tasks that are close to the NIOSH and University of Waterloo action limits for compressive and shear forces respectively ( McGill 1997, Yingling and McGill 1999, Marras 2000). The use of the back support harness reduced these forces by substantial and statistically significant amounts. This effect was consistent across all three tasks. The results of this study demonstrate the production of high levels of compressive and shear forces within the spine of shearers during the three shearing tasks studied and that the use of a back support harness can substantially reduce these forces. Therefore the use of a back harness may reduce the cumulative load on the spine during shearing thereby moderating damage to the articular structures. However it is not known whether the harness would protect the spine from a sudden or unexpected force.	Univ Otago, Sch Physiotherapy, Dunedin, New Zealand; Univ Otago, Sch Phys Educ, Dunedin, New Zealand; Univ Otago, Injury Prevent Res Unit, Dunedin, New Zealand		Milosavljevic, S (corresponding author), Univ Otago, Sch Physiotherapy, Dunedin, New Zealand.	smilosavljevic@gandalf.otago.ac.nz	Milosavljevic, Stephan/AAR-6127-2021	Milosavljevic, Stephan/0000-0001-8938-5290			*ACC, 2001, UNPUB STAT DAT BACK; Adams MA, 1996, SPINE, V21, P434, DOI 10.1097/00007632-199602150-00006; Adams MA, 1996, CLIN BIOMECH, V11, P194, DOI 10.1016/0268-0033(96)00002-2; ADAMS MA, 1995, CLIN BIOMECH, V10, P3, DOI 10.1016/0268-0033(95)90432-9; Allard P., 1995, 3 DIMENSIONAL ANAL H; Bernard P.B, 1997, MUSCULOSKELETAL DISO; Bogduk N., 1997, CLIN ANATOMY LUMBAR; CULVENOR J, 1993, THESIS LA TROBE U ME; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dempsey PG, 1998, ERGONOMICS, V41, P73, DOI 10.1080/001401398187332; Firth H, 2002, J OCCUP HLTH SAF AUS, V18, P167; Granata KP, 1999, ERGONOMICS, V42, P1187, DOI 10.1080/001401399185072; HARLICK J, 2000, P 7 SCI C INT FED OR, P201; Harvey JT, 2002, APPL ERGON, V33, P523, DOI 10.1016/S0003-6870(02)00071-6; Lavender SA, 2003, INT J IND ERGONOM, V31, P51, DOI 10.1016/S0169-8141(02)00174-9; Lower T., 2000, J OCCUP HEALTH, V16, P117; MARRAS WS, 1995, ERGONOMICS, V38, P377, DOI 10.1080/00140139508925111; Marras WS, 2000, ERGONOMICS, V43, P880, DOI 10.1080/001401300409080; MARSHALL RN, 1995, UNPUB BIOMECHANICAL; McGill SM, 1997, J BIOMECH, V30, P465, DOI 10.1016/S0021-9290(96)00172-8; MCGILL SM, 1993, CURRENT ISSUES BIOME, P69; MILOSAVLJEVIC S, 2000, P 7 SCI C INT FED OR, P319; MILOSAVLJEVIC S, 2000, P 7 SCI C INT FED OR, P323; MILOSAVLJEVIC S, 1998, THESIS U OTAGO DUNED; PAYNE W, 1998, ERGONOMICS SHEEP SHE; PAYNE W, 2002, J OCCUP HEALTH, V18, P173; POOLE PM, 1983, SEARCH, V14, P103; ROSS BH, 1988, P U OT MED SCH, P17; ROWLAND G, 2002, COMMUNICATION; SANKEY K, 1997, UNPUB TABLES NZ RESI; Singer KP, 2000, CLINICAL ANATOMY AND MANAGEMENT OF THORACIC SPINE PAIN, VOL 2, P100; Twomey L, 1994, Aust J Physiother, V40S, P19, DOI 10.1016/S0004-9514(14)60620-6; WILSON NC, 1991, BODY SIZE SHAPE NZ; Winter D.A., 1990, BIOMECHANICS MOTOR C, VVol. 1; Yingling VR, 1999, SPINE, V24, P1882, DOI 10.1097/00007632-199909150-00004; [No title captured]	36	14	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0014-0139			ERGONOMICS	Ergonomics	SEP 15	2004	47	11					1208	1225		10.1080/00140130410001699155			18	Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Psychology	846XA	WOS:000223351600005	15370857				2022-02-06	
J	Cherian, L; Hlatky, R; Robertson, CS				Cherian, L; Hlatky, R; Robertson, CS			Comparison of tetrahydrobiopterin and L-arginine on cerebral blood flow after controlled cortical impact injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						L-arginine; cortical impact injury; hypotension; intracranial hypertension; nitric oxide; tetrahydrobiopterin; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RELAXATIONS; COFACTOR; ARTERY; SUPEROXIDE; ISCHEMIA; BIOSYNTHESIS; RESTORATION; REPERFUSION	The purpose of this study was to compare the effects of L-arginine and tetrahydrobiopterin administration on post-traumatic cerebral blood flow (CBF) and tissue levels of NO in injured brain tissue. Rats were anesthetized with isoflurane. Mean blood pressure, intracranial pressure, cerebral blood flow using laser Doppler flowmetry (LDF) and brain tissue nitric oxide (NO) concentrations were measured prior to, and for 2 h after a controlled cortical impact injury. L-Arginine, 300 mg/kg, tetrahydrobiopterin, 10 mg/kg, or equal volume of saline was given at 5 min after injury. In the saline-treated animals, LDF decreased to 34 +/- 4% of baseline values after injury. NO concentration also decreased by approximately 20 pmol/ml from baseline values. L-Arginine and tetrahydrobiopterin administration both resulted in a significant preservation of tissue NO concentrations and an improvement in LDF, compared to control animals given saline. These studies demonstrate that tetrahydrobiopterin administration has a beneficial effect on cerebral blood flow that is similar to L-arginine administration, and may suggest that depletion of tetrahydrobiopterin plays a role in the post-traumatic hypoperfusion of the brain.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	lcherian@bcm.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS 38660] Funding Source: Medline		Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Ashwal S, 1998, STROKE, V29, P1037, DOI 10.1161/01.STR.29.5.1037; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cho S, 1999, J NEUROSCI, V19, P878; Cosentino F, 2001, ARTERIOSCL THROM VAS, V21, P496, DOI 10.1161/01.ATV.21.4.496; Cosentino F, 1998, J CLIN INVEST, V101, P1530, DOI 10.1172/JCI650; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Goodman JC, 2002, NEUROLOGY, V58, pA196; GROSS SS, 1991, BIOCHEM BIOPH RES CO, V178, P823, DOI 10.1016/0006-291X(91)90965-A; Higman DJ, 1996, ARTERIOSCL THROM VAS, V16, P546, DOI 10.1161/01.ATV.16.4.546; IIJIMA S, 1986, STROKE, V17, P529, DOI 10.1161/01.STR.17.3.529; KAUFMAN S, 1993, ANNU REV NUTR, V13, P261, DOI 10.1146/annurev.nu.13.070193.001401; Kinoshita H, 1997, AM J PHYSIOL-HEART C, V273, pH718, DOI 10.1152/ajpheart.1997.273.2.H718; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Maier W, 2000, J CARDIOVASC PHARM, V35, P173, DOI 10.1097/00005344-200002000-00001; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; Pieper GM, 1997, J CARDIOVASC PHARM, V29, P8, DOI 10.1097/00005344-199701000-00002; Sharma AC, 1998, NEUROL RES, V20, P632; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Sun H, 2001, AM J PHYSIOL-HEART C, V281, pH1863; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Tiefenbacher CP, 1996, CIRCULATION, V94, P1423, DOI 10.1161/01.CIR.94.6.1423; Tsutsui M, 1996, CIRC RES, V79, P336, DOI 10.1161/01.RES.79.2.336; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WERNERFELMAYER G, 1993, J BIOL CHEM, V268, P1842	37	14	16	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1196	1203					8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900008	15453989				2022-02-06	
J	Soustiel, JF; Shik, V; Findlay, JM				Soustiel, JF; Shik, V; Findlay, JM			Posttraumatic basilar artery vasospasm	SURGICAL NEUROLOGY			English	Article						head injury; subarachnoid hemorrhage; vasospasm; transcranial Doppler	TRAUMATIC SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER ULTRASOUND; CEREBRAL BLOOD-FLOW; HEAD-INJURY; VERTEBROBASILAR VASOSPASM; VELOCITY-MEASUREMENTS; PRACTICAL SCALE; BRAIN-DAMAGE; SPASM; ULTRASONOGRAPHY	BACKGROUND During the past decade, vasospasm following posttraumatic subarachnoid hemorrhage (tSAH) has drawn increasing attention. However, despite accumulating evidence linking this phenomenon with poorer outcome, the clinical significance of posttraumatic vasospasm is still debated and often disputed, so that no definite therapeutic attitude has yet been adopted. Recent attention has been drawn to basilar vasospasm, suggesting a negative influence on neurologic outcome. The aim of the present study was the evaluation of basilar vasospasm as an independent factor of secondary brain damage following posttraumatic hemorrhage. METHODS Daily transcranial Doppler (TCD) evaluations were conducted in 93 consecutive patients with tSAH. Basilar artery (BA) vasospasm was defined by blood flow velocity (FV) higher than 85 cm/s for at least 2 consecutive days. RESULTS Thirty-two patients (34.4%) had BA FVs higher than 85 cm/s. In those patients, the ratio between BA FV and mean vertebral artery FV was higher than 2.5 and below 2 and those without TCD signs of vasospasm. Using multivariate logistic regression analysis, BA vasospasm proved to independently influence neurologic outcome. CONCLUSIONS BA vasospasm severe enough to compromise cerebral blood flow to the brainstem, although uncommon, may nevertheless have a potential deleterious effect on neural tissue sensitized by trauma. The present results suggest that specific imaging procedures and eventually therapeutic measures should be conducted in the presence of significant BA vasospasm. (C) 2004 Elsevier Inc. All rights reserved.	Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel		Soustiel, JF (corresponding author), Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, POB 9602, IL-31096 Haifa, Israel.						AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adams JH, 1982, RECENT ADV NEUROPATH, P165; ALEXANDER MJ, 1994, ACTA NEUROCHIR, P479; ECHLIN FA, 1965, J NEUROSURG, V23, P1, DOI 10.3171/jns.1965.23.1.0001; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujioka KA., 1992, TRANSCRANIAL DOPPLER, P9; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GAETANI P, 1994, J NEUROL NEUROSUR PS, V57, P66, DOI 10.1136/jnnp.57.1.66; HUTCHISON KJ, 1995, ULTRASOUND MED BIOL, V21, P447, DOI 10.1016/0301-5629(94)00144-3; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LAUMER R, 1993, NEUROSURGERY, V33, P1, DOI 10.1227/00006123-199307000-00001; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Sloan M. A., 1997, NEW TRENDS CEREBRAL, P221; SLOAN MA, 1994, STROKE, V25, P2187, DOI 10.1161/01.STR.25.11.2187; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Soustiel JF, 2002, STROKE, V33, P72, DOI 10.1161/hs0102.100484; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Soustiel JF, 2001, STROKE, V32, P629, DOI 10.1161/01.STR.32.3.629; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	33	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	2004	62	3					201	206		10.1016/j.surneu.2003.10.037			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	850PM	WOS:000223624900008	15336858				2022-02-06	
J	Bushnik, T; Englander, J; Duong, T				Bushnik, T; Englander, J; Duong, T			Medical and social issues related to posttraumatic seizures in persons with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epilepsy; late posttraumatic seizures; outcomes; traumatic brain injury	QUALITY-OF-LIFE; TEMPORAL-LOBE EPILEPSY; PSYCHOSOCIAL CONSEQUENCES; DRIVING RESTRICTIONS; ANTIEPILEPTIC DRUGS; RISK-FACTORS; HEAD TRAUMA; PEOPLE; CARBAMAZEPINE; EMPLOYMENT	Background: The incidence of late posttraumatic seizures (LPTS) in individuals with traumatic brain injury (FBI) ranges anywhere from 5% to 18.9% in civilian populations up to 32% to 50% in military personnel. Objective: This article reviews the current knowledge about the incidence and prevalence of LPTS following a TBI, the risk factors for developing LPTS, and the options available for preventing the development of LPTS. Methods: The psychosocial ramifications of LPTS following a TBI have not been well explored. As a result, the psychosocial findings from the current literature on epilepsy will be reviewed with the hope that the need for future TBI outcomes research to investigate the impact of LPTS following a TBI or, at least, to include LPTS as a potential contributing. factor will be recognized.	Santa Clara Valley Med Ctr, No Calif TBI Model Syst Car, San Jose, CA 95128 USA		Bushnik, T (corresponding author), Santa Clara Valley Med Ctr, No Calif TBI Model Syst Car, 751 S Bascom Ave, San Jose, CA 95128 USA.	tamara@tbi-sci.org		Bushnik, Tamara/0000-0003-3328-257X			Andermann L, 1992, Seizure, V1, P173, DOI 10.1016/1059-1311(92)90021-R; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Ascroft PB, 1941, BMJ-BRIT MED J, V1941, P739, DOI 10.1136/bmj.1.4193.739; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Beghi E, 2000, EPILEPSIA, V41, P998; Berto P, 2002, PHARMACOECONOMICS, V20, P1039, DOI 10.2165/00019053-200220150-00002; *BRAIN TRAUM FDN I, 2000, MAN PROGN SEV TRAUM, P159; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Breier JI, 1998, ARCH NEUROL-CHICAGO, V55, P660, DOI 10.1001/archneur.55.5.660; Bullock R, 1995, GUIDELINES MANAGEMEN; CALLAGHAN N, 1992, IRISH MED J, V85, P17; Carroll D, 1992, Seizure, V1, P127, DOI 10.1016/1059-1311(92)90010-X; CAVENESS WF, 1961, EPILEPSIA, V2, P123; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chadwick DW, 2001, NEUROLOGY, V57, P1749, DOI 10.1212/WNL.57.10.1749; Collings J A, 1994, Seizure, V3, P255, DOI 10.1016/S1059-1311(05)80172-4; Couldridge L, 2001, SEIZURE-EUR J EPILEP, V10, P605, DOI 10.1053/seiz.2001.0652; COURJON J, 1970, EPILEPSIA, V11, P29, DOI 10.1111/j.1528-1157.1970.tb03863.x; DASILVA AM, 1990, ACT NEUR S, V50, P48; De Santis A, 1979, J Neurosurg Sci, V23, P207; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Engelberts NHJ, 2002, J NEUROL, V249, P294, DOI 10.1007/s004150200008; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Gilliam F, 1997, EPILEPSIA, V38, P233, DOI 10.1111/j.1528-1157.1997.tb01102.x; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Grafman J, 1992, Adv Neurol, V57, P369; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hartshorn J C, 1994, J Neurosci Nurs, V26, P288; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HERMANN BP, 1990, BRIT J PSYCHIAT, V156, P98, DOI 10.1192/bjp.156.1.98; HERMANN BP, 1992, J EPILEPSY, V5, P153, DOI 10.1016/S0896-6974(05)80134-3; ISOJARVI JIT, 1990, ARCH NEUROL-CHICAGO, V47, P670, DOI 10.1001/archneur.1990.00530060082023; JENNETT B, 1973, SCOT MED J, V18, P8, DOI 10.1177/003693307301800103; JENNETT B, 1975, EPILEPSY NONMISSILE; Jokeit H, 1999, J NEUROL NEUROSUR PS, V67, P44, DOI 10.1136/jnnp.67.1.44; JONES KL, 1989, NEW ENGL J MED, V320, P1661, DOI 10.1056/NEJM198906223202505; KANEKO S, 1988, EPILEPSIA, V29, P459, DOI 10.1111/j.1528-1157.1988.tb03746.x; KOLLEVOLD T, 1978, J OSLO CITY HOSP, V2, P78; Krauss GL, 2001, NEUROLOGY, V57, P1780, DOI 10.1212/WNL.57.10.1780; Krauss GL, 1999, NEUROLOGY, V52, P1324, DOI 10.1212/WNL.52.7.1324; Lehrner J, 1999, SEIZURE-EUR J EPILEP, V8, P88, DOI 10.1053/seiz.1999.0272; Leidy NK, 1999, NEUROLOGY, V53, P162, DOI 10.1212/WNL.53.1.162; LIPMAN LJ, 1994, EPILEPSIA, V35, P696; MOORE PM, 1994, EPILEPSY RES, V18, P75, DOI 10.1016/0920-1211(94)90035-3; Moore PM, 2002, SEIZURE-EUR J EPILEP, V11, P224, DOI 10.1053/seiz.2001.0668; O'Donoghue MF, 1999, BRIT J GEN PRACT, V49, P211; PAILLAS JE, 1970, EPILEPSIA, V11, P5, DOI 10.1111/j.1528-1157.1970.tb03860.x; RAMSAY RE, 1991, EPILEPSIA, V32, pS60, DOI 10.1111/j.1528-1157.1991.tb05894.x; REYNOLDS EH, 1985, DRUGS, V29, P570, DOI 10.2165/00003495-198529060-00004; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1987, ADV EPILEPTOL, V16, P627; SALINSKY MC, 1992, EPILEPSIA, V33, P469, DOI 10.1111/j.1528-1157.1992.tb01693.x; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; SMITH DF, 1991, EPILEPSY RES, V9, P231, DOI 10.1016/0920-1211(91)90057-M; STANDAGE KF, 1975, PSYCHOL MED, V5, P152, DOI 10.1017/S0033291700056403; Strauss E, 1995, J CLIN EXP NEUROPSYC, V17, P909, DOI 10.1080/01688639508402439; Suurmeijer TPBM, 2001, EPILEPSIA, V42, P1160, DOI 10.1046/j.1528-1157.2001.37000.x; TEDMAN S, 1995, SEIZURE, V4, P221, DOI 10.1016/S1059-1311(05)80065-2; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WALKER AE, 1959, J NEUROSURG, V16, P600, DOI 10.3171/jns.1959.16.6.0600; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; Wiebe S, 1999, CAN J NEUROL SCI, V26, P263, DOI 10.1017/S0317167100000354; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; [No title captured]; 2001, MORB MORTAL WKLY REP, V50, P24	74	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2004	19	4					296	304		10.1097/00001199-200407000-00004			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	839CB	WOS:000222759800004	15263857				2022-02-06	
J	Chotel, F; Vallese, P; Parot, R; Laville, JM; Hodgkinson, I; Muller, C; Berard, J				Chotel, F; Vallese, P; Parot, R; Laville, JM; Hodgkinson, I; Muller, C; Berard, J			Complete dislocation of the radial head following fracture of the radial neck in children: the Jeffery type II lesion	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						radial neck fracture; dislocation; child; Jeffery type 2; mechanism; complication	REDUCTION; EPIPHYSIS	The authors report four cases of Jeffery type 2 lesions in children. Despite the probable mechanism of such lesions, none of the cases reported here displayed a dislocation of the elbow. In the first observation the diagnosis was suspected only 15 days after injury. Two other cases were initially treated by closed external manipulations, one with percutaneous Kirschner wire leverage and the other with closed intramedullary pinning, but both cases displayed a 180 degrees reversal of the radial head, suspected only secondarily. The first exhaustive review of the literature on the subject, shows that this complication is classical in Jeffery type 2 fractures. In fact none of the 22 cases described in the literature had successfully been reduced by external manipulations. Interposition of the lateral condyle, pathognomonic of the Jeffery type 2 fracture, hampers reduction. Attempts at reduction by external manipulation in nine cases therefore led to two non-reduction and seven reversal of the radial head. Knowledge of this particular fracture will allow an early diagnosis and an immediate surgical treatment. (c) 2004 Lippincott Williams & Wilkins.	Hop Debrousse, Praticien Hosp, Dept Paediat Orthopaed, 29 Rue Soeurs Bouvier, F-69322 Lyon, France; Bellepierre Univ Hosp, Dept Paediat Surg, St Denis Messageries, Reunion, France; S Lyon Hosp, Ctr Paediat Funct Rehabil, Pierre Benite, France; Bois Abbaya Hosp, Seraing, Belgium		Chotel, F (corresponding author), Hop Debrousse, Praticien Hosp, Dept Paediat Orthopaed, 29 Rue Soeurs Bouvier, F-69322 Lyon, France.						ACHDJIAN M, 1972, PAEDIAT ORTHOPEDICS, V2; BAHER FH, 1932, NEW ENGL J MED, V206, P1263; CHAMBERS HG, 1996, FRACTURES CHILDREN, V3, P586; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P257; FRASER KE, 1995, J BONE JOINT SURG AM, V77A, P782, DOI 10.2106/00004623-199505000-00016; Jeffery C C, 1972, J Bone Joint Surg Br, V54, P717; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; RANG M, 1974, CHILDRENS FRACTURE, P112; REIDY JA, 1963, J BONE JOINT SURG AM, V45, P1355, DOI 10.2106/00004623-196345070-00002; Schwartz RP, 1933, SURG GYNECOL OBSTET, V57, P528; Shtarker H, 2001, J PEDIATR ORTHOP B, V10, P331; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; WARD WT, 1991, J TRAUMA, V31, P1686, DOI 10.1097/00005373-199112000-00020; WATSONJONES R, 1996, FRACTURE JOINT INJUR; WILKINS KE, 1994, OPERATIVE MANGEMENT; Wong-Chung J, 1997, INJURY, V28, P559, DOI 10.1016/S0020-1383(97)00096-X; WOOD S K, 1969, Journal of Bone and Joint Surgery British Volume, V51, P707; WRAY CC, 1989, INJURY, V20, P241, DOI 10.1016/0020-1383(89)90126-5	21	14	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2004	13	4					268	274		10.1097/01.bpb.0000111050.85604.f1			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	916WX	WOS:000228418400009	15199284				2022-02-06	
J	Lundblad, C; Grande, PO; Bentzer, P				Lundblad, C; Grande, PO; Bentzer, P			A mouse model for evaluation of capillary perfusion, microvascular permeability, cortical blood flow, and cortical edema in the traumatized brain	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; capillary perfuison; cerebral blood flow; edema; microvascular permeability; secondary injury and ischemia	CEREBRAL-ARTERY OCCLUSION; LOW-DOSE PROSTACYCLIN; HEAD-INJURY; IMPACT INJURY; RAT; TRANSPORT; CONTUSION; ISCHEMIA; DEXTRAN; BARRIER	Genetically engineered mice have successfully been used to investigate molecular and cellular mechanisms associated with cell dysfunction following brain trauma. Such animals may also offer a possibility to investigate mechanisms involved in posttraumatic hemodynamic alterations. The objective of the study was to establish a mouse model in which important hemodynamic alterations following trauma could be analyzed. C57/BL6 male mice were subjected to controlled cortical impact injury (CCI) or sham-injury. Distribution of blood flow was estimated by determining number of perfused capillaries using FITC-dextran as an intravascular marker. Cortical blood flow was measured using [C-14]-iodoantipyrine, brain water content (BWC) was measured using a wet vs. dry weight method, and permeability surface area product (PS) was estimated by the transfer constant for [Cr-51]-EDTA. Number of perfused capillaries in the contusion area was progressively reduced during the first 24 h following trauma by at most 60% relative to a value of 329 +/- 61/mm(2) in sham-injured animals. Blood flow in the contusion area decreased simultaneously by at most 50% relative to a control value of 1.8 +/- 0.4 mL (.) min(-1) (.) g(-1), and was reduced further in subregions within the contusion area. BWC in the injured hemisphere increased from 79.3 +/- 0.5% at control to at most 79.9 +/- 0.6% at 24 h post trauma. PS in the injured hemisphere increased by 71% at 3 h post trauma relative to a control value of 0.45 +/- 0.1 muL (.) min(-1.) g(-1), and was close to control at 24 h. The present study demonstrates that brain trauma in addition to a reduction in cortical blood flow, reduces number of perfused capillaries, which most likely affects exchange of nutrients and fluid. The CCI in mouse is likely to be a useful tool to elucidate mechanisms involved in hemodynamic alterations following brain trauma.	Lund Univ, Dept Psychol Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Anesthesia & Intens Care, SE-22184 Lund, Sweden; Univ Lund Hosp, S-22185 Lund, Sweden		Lundblad, C (corresponding author), Lund Univ, Dept Psychol Sci, BMC F11, SE-22184 Lund, Sweden.	Cornelia.Lundblad@mphy.lu.se		Lundblad, Cornelia/0000-0001-9686-2112			ARAKAWA M, 1990, CIRC RES, V67, P852, DOI 10.1161/01.RES.67.4.852; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BULLOCK R, 1990, ACT NEUR S, V51, P286; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; FENSTERMACHER JD, 1981, PHARMACOL THERAPEUT, V14, P217, DOI 10.1016/0163-7258(81)90062-0; FENSTERMACHER JD, 1984, EDEMA, P383; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GOBEL U, 1989, J CEREBR BLOOD F MET, V9, P491, DOI 10.1038/jcbfm.1989.72; GOBEL U, 1990, CIRC RES, V66, P271, DOI 10.1161/01.RES.66.2.271; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Gueniau C, 1997, J PHARMACOL EXP THER, V282, P1; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Holbeck S, 2001, CRIT CARE MED, V29, P123, DOI 10.1097/00003246-200101000-00025; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LARSSON M, 1980, ACTA PHYSIOL SCAND, V110, P53, DOI 10.1111/j.1748-1716.1980.tb06629.x; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; Maeda T, 1997, ACT NEUR S, V70, P102; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Renkin E. M., 1984, HDB PHYSL 2, V4, P627; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SARNA GS, 1977, BRAIN RES, V138, P550, DOI 10.1016/0006-8993(77)90692-8; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Steinbauer M, 1998, SHOCK, V9, P345, DOI 10.1097/00024382-199805000-00006; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; WANIEWSKI J, 1992, NEPHROL DIAL TRANSPL, V7, P50; WEISS HR, 1988, MICROVASC RES, V36, P172, DOI 10.1016/0026-2862(88)90017-9; Wellons JC, 2000, BRAIN RES, V868, P14, DOI 10.1016/S0006-8993(00)02216-2; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zoccoli G, 2000, EXP BRAIN RES, V130, P73	52	14	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2004	21	6					741	753		10.1089/0897715041269614			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	836EG	WOS:000222537600010	15253802				2022-02-06	
J	McCrory, P; Turner, M; Murray, J				McCrory, P; Turner, M; Murray, J			A punch drunk jockey?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							APOLIPOPROTEIN-E EPSILON-4; TRAUMATIC BRAIN-INJURY; DAMAGE; AFTERMATH	The case is reported of a retired professional jockey with progressive memory loss. The concern is that he may be suffering from chronic traumatic encephalopathy or the "punch drunk syndrome''.	Jockey Club, London W1H 6EN, England; British Journal Sports Med, Melbourne, Vic, Australia		Turner, M (corresponding author), Jockey Club, 42 Portman Sq, London W1H 6EN, England.	mturner@thejockeyclub.co.uk	McCrory, Paul/Q-8688-2019	TURNER, Michael/0000-0003-2323-2456			CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; FOSTER JB, 1976, LANCET, V1, P981; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Jordan B. D., 1998, SPORTS NEUROLOGY, P351; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; JORDAN BD, 1993, MED ASPECTS BOXING; LEVIN HS, 1993, MED ASPECTS BOXING, P197; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; Moseley IF, 2000, NEURORADIOLOGY, V42, P1, DOI 10.1007/s002340050001; NICHOLL JAR, 1995, NAT MED, V1, P135; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403	21	14	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN 1	2004	38	3							e3	10.1136/bjsm.2003.006338			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	823CD	WOS:000221586400039	15155454	Bronze, Green Published			2022-02-06	
J	Chapman, HR; Curran, ALM				Chapman, HR; Curran, ALM			Bicycle helmets - does the dental profession have a role in promoting their use?	BRITISH DENTAL JOURNAL			English	Article							MILD HEAD-INJURY; SAFETY HELMETS; EARLY ADULTHOOD; FACIAL INJURY; CYCLISTS; PREVENTION; CHILDREN; LEGISLATION; ADOLESCENTS; TRAUMA	Objectives To review the available literature regarding the: epidemiology of bicycle related head injuries; consequences of head injuries; rates of cycle helmet use; impact of educational campaigns and legislation on usage rates; effectiveness of cycle helmets in protecting against head and facial injuries; arguments against the compulsory use of bicycle helmets Data sources A computerised Medline search was conducted using the keywords: head injury, facial injury, bicycle helmets, accidents. Data selection All available information was considered. Data synthesis Data was collated manually. Conclusions The wearing of bicycle helmets contributes significantly to the prevention of head injuries (HI) and traumatic brain injury (TBI), particularly in children and adolescents. There is evidence to support the role of cycle helmets in the prevention of injuries to the middle third of the face and some dental injuries. There is a case for the implementation of legislation accompanied by educational campaigns to increase significantly the use of cycle helmets. The dental profession could: play an active role in promoting cycle helmet use; support calls for the compulsory wearing of cycling helmets, particularly for children; press for modification of helmet design and standards to increase protection of the face.	Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England		Chapman, HR (corresponding author), 8 Millais Court,Manor Fields, Horsham RH13 6SJ, W Sussex, England.	helen.chapman@tesco.net	Chapman, Helen/AAM-4204-2021	Chapman, Helen/0000-0001-7699-9832			Acton C H, 1995, Inj Prev, V1, P86, DOI 10.1136/ip.1.2.86; Acton CHC, 1996, MED J AUSTRALIA, V165, P249, DOI 10.5694/j.1326-5377.1996.tb124957.x; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; *BMA BOARD SCI ED, 1999, CYCL HELM; Bogan AM, 1997, BRAIN INJURY, V11, P431; Caplow MP, 1995, AM J PREV MED, V11, P371, DOI 10.1016/S0749-3797(18)30415-X; Cook A, 2000, BRIT MED J, V321, P1055, DOI 10.1136/bmj.321.7268.1055; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; *DEP TRANSP LOC GO, 2003, ROAD ACC GREAT BRIT; *DEP TRANSP LOC GO, 2001, ROAD ACC GREAT BRIT; Harrison MG, 1999, J ROY COLL SURG EDIN, V44, P82; Hillman M, 1997, BRIT MED J, V315, P490, DOI 10.1136/bmj.315.7106.490; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jennett B, 1989, MILD HEAD INJURY, P23; Lee A J, 2000, Inj Prev, V6, P151, DOI 10.1136/ip.6.2.151; LEE AJ, 1120 BHIT; LI GH, 1995, J TRAUMA, V38, P871, DOI 10.1097/00005373-199506000-00007; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Mann N.P., 1999, CURR PAEDIAT, V9, P173; MARSDEN CD, 1998, CLIN NEUROLOGY, P272; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, P28; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Ni HY, 1997, ARCH PEDIAT ADOL MED, V151, P59, DOI 10.1001/archpedi.1997.02170380063010; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Quine L, 2001, BRIT J HEALTH PSYCH, V6, P327, DOI 10.1348/135910701169241; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; RIVARA FP, 1994, PEDIATRICS, V93, P567; ROBINSON DL, 1996, ACCIDENT ANAL PREV, V28, P473; ROURKE LL, 1994, CAN FAM PHYSICIAN, V40, P1116; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Scuffham PA, 1997, ACCIDENT ANAL PREV, V29, P1, DOI 10.1016/S0001-4575(96)00054-1; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Sosin DM, 1996, PEDIATRICS, V98, P868; SPAITE DW, 1991, J TRAUMA, V31, P1510, DOI 10.1097/00005373-199111000-00008; TAKRITI R, 2000, 1125 BHIT; TAKRITI R, 1999, INITIATING BICYCLE H; Talamonti G, 1995, ACTA NEUROCHIR, V137, P164, DOI 10.1007/BF02187189; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON DC, 2001, COCHRANE LIB; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WIEDERHOLT WC, 2000, NEUROLOGY NONNEUROLO, P297; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	48	14	16	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0610			BRIT DENT J	Br. Dent. J.	MAY 8	2004	196	9					555	560		10.1038/sj.bdj.4811227			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	818OU	WOS:000221255200019	15131627	Bronze			2022-02-06	
J	Levin, K				Levin, K			Paediatric traumatic brain injury in South Africa: some thoughts and considerations	DISABILITY AND REHABILITATION			English	Article								Purpose: This paper endeavours to describe the socio-political and economic backdrop to the assessment and management of traumatic brain injury (TBI) in children in South Africa. Outcomes: The argument put forward is that huge disparities in socio-economic status, diverse socio-cultural influences, and widely differing educational systems and educational attainment which characterize the country's population, render the management of TBI different from approaches adopted in developed countries. The main causes of TBI can be attributed to the high rates of violence in the country, as well as an inordinately high incidence of motor vehicle accidents. Compensation through existing national legislative and insurance agencies is unavailable to most of the population, and markedly insufficient in many cases. The access to medical care and rehabilitation is inadequate for the majority of South African children, although there are valiant efforts on the part of professionals working within the primary health care model to provide the support to the children and their families not offered by existing educational and school structures. Conclusion: The impact of the HIV/AIDS pandemic on the clinical picture of children and their families is profound and guides many of the decisions that are made by health care professionals. Given this bleak scenario, a re-focus on the strengths of existing structures and the creation of new possibilities is suggested as a positive and constructive approach to prevention, rehabilitation, and education.	Univ Witwatersrand, ZA-2050 Johannesburg, Johannesburg, South Africa		Levin, K (corresponding author), Univ Witwatersrand, Private Bag 3, ZA-2050 Johannesburg, Johannesburg, South Africa.						ANDERSON G, 2002, DISABLED CHILDREN LI, P6; BEALE P, 2003, HEAD TRAUM C PAED NE; BIGLER ED, 1997, CHILDHOOD TRAUMATIC; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Bowley DMG, 2002, LANCET, V359, P1352, DOI 10.1016/S0140-6736(02)08305-8; *DEP SOC DEV, 2000, STAT S AFR POP REP; FIEGGEN G, 2003, HEAD TRAUM C PAED NE; Jaffe MP, 2000, BRAIN INJURY, V14, P35, DOI 10.1080/026990500120916; Meier Eileen, 2002, Pediatr Nurs, V28, P532; *NAT COUNC PROV, 2003, REPORT; *ROAD ACC FUND DEP, 2003, ROAD ACC FUND COMM R; *S AFR LAW COMM, 1997, REPORT; SACHS J, 2000, CURRENT ISSUES COMP, V3, P1; *UN, 2002, 14 INT C AIDS BARC 7; *UN, 2002, INT NARC CONTR BOARD; van As AB, 2001, SAMJ S AFR MED J, V91, P1035; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; 2002, ROAD ACCIDENT FUND S, V1, P1	18	14	16	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAR 4	2004	26	5					306	314		10.1080/0963828032000174089			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	801WV	WOS:000220126900007	15200246				2022-02-06	
J	Ramirez, RM; Chirivella-Garrido, J; Caballero, MC; Ferri-Campos, J; Noe-Sebastian, E				Ramirez, RM; Chirivella-Garrido, J; Caballero, MC; Ferri-Campos, J; Noe-Sebastian, E			Intelligence, memory and malingering: Correlation between scales	REVISTA DE NEUROLOGIA			Spanish	Article						intelligence; malingering; test of memory malingering; Wechsler adult intelligence-III	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; HEAD-INJURY; PRACTICAL SCALE; PERFORMANCE	Objectives. To validate the test of memory malingering (TOMM), and to study the influence of intelligence and memory on its performance in brain injury patients. Patients and methods. A total of 30 patients with traumatic head injury were included in the study. All patients were assessed with the Complutense verbal learning test, the Visual Reproduction subtest of the Wechsler memory scale-revised, the Boston naming test, two fluency tests (FAS, and animals), the Wechsler adult intelligence test-III, and with the TOMM. Cognitive results below 1 standard deviation (SD) from normative data were considered 'abnormal'. A parametric correlation between TOMM scores and cognitive tests was used to detect whether memory and intelligence were affecting TOMM performance. Statistical significance was set up at p < 0.05. Results. Between 46,1% (Boston) and 81.4% (WAIS-III performance IQ) of the sample presented cognitive deficits. Up to 83.3% of the patients scored above the cutoff point suggestive of malingering in the TOMM (45/50). Significance correlations were found between TOMM scores and memory or intelligence indexes. Discussion. The TOMM is a useful tool to detect malingering in head injured patients. Effects of low intelligence coefficients, as well as memory deficits should be considered in clinical practice when evaluating patients with TOMM scores suggestive of malingering.	Hosp NISA Valencia Mar, Serv Dano Cerebral, Valencia, Spain		Noe-Sebastian, E (corresponding author), Univ Valencia, Hosp Mar, Serv Dano Cerebral, Rio Tajo 1, E-46011 Valencia, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			Altrocchi PH, 1996, NEUROLOGY, V46, P278; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BENEDET MJ, 1999, TEST APRENDIZAJE VER; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BURIEL Y, 2002, NEUROLOGIA, V17, P557; Colby F, 2001, NEUROREHABILITATION, V16, P311; Ellwanger J, 1999, J CLIN EXP NEUROPSYC, V21, P866, DOI 10.1076/jcen.21.6.866.850; FERREROARIAS J, 1998, EVALUACION DETERICO; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; GARCIAALBEA J, 1998, TEST BOSTON DIAGNEST; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P773, DOI 10.33588/rn.3208.2000186; REES L, 1988, PSYCHOL ASSESSMENT, V10, P10; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1999, ESCALA INTELIGENCIA; Wilson J, 1996, J NUCL MED, V37, P1256	26	14	14	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JAN 1	2004	38	1					28	33		10.33588/rn.3801.2003533			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770YV	WOS:000188759700007	14730487				2022-02-06	
J	Prigatano, GP				Prigatano, GP			Challenging dogma in neuropsychology and related disciplines	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	21st Annual Conference of the National-Academy-of-Neuropsychology	OCT 31-NOV 03, 2001	SAN FRANCISCO, CALIFORNIA	Natl Acad Neuropsychol		neuropsychology; psychotherapy; self-awareness; rehabilitation; dogma	TRAUMATIC BRAIN-INJURY; REHABILITATION; AWARENESS	Challenging "dogmas" in neuropsychology and related fields is important for the advancement of our professional development. Five dogmas that I have found worth challenging are reviewed in this article. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.						Bisiach E., 1991, AWARENESS DEFICIT BR, P17; Bowlby J., 1973, ATTACHMENT LOSS; BRODAL A, 1973, BRAIN, V96, P675, DOI 10.1093/brain/96.4.675; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Damasio A., 2000, PRINCIPLES BEHAV COG, P294; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Johnson SC, 2000, BNI Q, P16; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Kuhn T. S., 1970, STRUCTURE SCI REVOLU, V2nd; LURIA AR, 1966, HIGHER CEREBRAL FUNC; MAUSEAU C, 1995, SEVERE TRAUMATIC BRA; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Mesulam M.-M., 2000, PRINC BEHAV COGN NEU, V2, P1, DOI [DOI 10.1017/9781108164320.002, 10.1017/9781108164320.002]; MOORE JC, 1986, RECOVERY FUNCTION TH, P9; Ogden R., 1917, PSYCHOBIOLOGY, V1, P33, DOI [10.1037/h0074814, DOI 10.1037/H0074814]; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; Prigatano GP, 2000, JAMA-J AM MED ASSOC, V284, P1783, DOI 10.1001/jama.284.14.1783; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; PRIGATANO GP, 2001, BNI Q, V17, P21; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; PRIGATANO GP, 1991, BARROW NEUROLOGICAL, V7, P17; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; WINTER R, 1991, STAR TREK 6	34	14	14	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2003	18	8					811	825	PII S0887-6177(02)00205-6	10.1016/S0887-6177(02)00205-6			15	Psychology, Clinical; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	747WZ	WOS:000186830200001	14609578				2022-02-06	
J	Ross, SR; Putnam, SH; Gass, CS; Bailey, DE; Adams, KM				Ross, SR; Putnam, SH; Gass, CS; Bailey, DE; Adams, KM			MMPI-2 indices of psychological disturbance and attention and memory test performance in head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						MMPI-2; litigation; head injury; attention; memory	NEUROPSYCHOLOGICAL DEFICITS; SYMPTOMS; CONCUSSION; LITIGATION; IMPAIRMENT; TRAUMA	A number of studies have investigated the relationship between psychological disturbance and neuropsychological (NP) test performance. The current study is a replication and extension of Gass (1996) who found that MMPI-2 indices of psychological disturbance are related to performance on NP tests of attention and memory in psychiatric and head-injured patients. In a large sample (N = 381) referred for evaluation after sustaining presumed head injury, we examined the relationship between MMPI-2 indices of psychological disturbance and measures of attention and memory from the Wechsler Memory Scale-Revised (WMS-R; Wechsler, 1987), Wechsler Adult Intelligence Scale-Revised (WAIS-R; Wechsler, 1981), California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987), and the Memory Assessment Scales (MAS; Williams, 1991). Although related to other domains, MMPI-2 variables were most consistently related to measures of attention and List Learning. Even when demographic variables, injury severity, and litigation status were controlled, MMPI-2 indices significantly predicted performance on six out of eight tests. However, the correspondence between similar indices on the WMS-R and MAS were relatively low, especially for Verbal Memory and Visual Reproduction. Further, litigation was significant in predicting only 2 of 8 attention and memory indices. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; Vet Adm Med Ctr, Miami, FL 33125 USA; Wayne State Univ, Med Ctr, Detroit, MI 48202 USA		Ross, SR (corresponding author), Depauw Univ, Dept Psychol, 7 Larabee St, Greencastle, IN 46135 USA.	srross@depauw.edu	Gass, Carlton/AAO-5906-2020				Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Delis DC, 1987, CALIFORNIA VERBAL LE; FEE CRA, 1988, ARCH EMERG MED, V5, P12; GASS CS, 1994, J CLIN PSYCHOL, V50, P586, DOI 10.1002/1097-4679(199407)50:4<586::AID-JCLP2270500414>3.0.CO;2-Z; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Golden CJ, 1999, ARCH CLIN NEUROPSYCH, V14, P265, DOI 10.1016/S0887-6177(98)00017-1; HILSABECK RC, 1996, ASSESSMENT, V3, P417; LEININGER B, 1992, REHABILITATION POST, P169; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; Putzke JD, 1997, ASSESSMENT, V4, P365, DOI 10.1177/107319119700400407; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Tabachnik B.G., 1996, USING MULTIVARIATE S, V3rd ed.; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WILLIAMS MJ, 1991, MEMORY ASSESSMENT SC; Wrobel NH, 1996, ARCH CLIN NEUROPSYCH, V11, P625; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	29	14	14	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2003	18	8					905	916	PII S0887-6177(02)00169-5	10.1016/S0887-6177(02)00169-5			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	747WZ	WOS:000186830200007	14609584	Bronze			2022-02-06	
J	Bono, CM; Sirkin, M; Sabatino, CT; Reilly, MC; Tarkin, I; Behrens, FF				Bono, CM; Sirkin, M; Sabatino, CT; Reilly, MC; Tarkin, I; Behrens, FF			Neurovascular and tendinous damage with placement of anteroposterior distal locking bolts in the tibia	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						tibia; nail; neurovascular injury; tendon injury; distal locking		Objective: To determine the proximity of anteroposterior locking bolts inserted into the distal metaphyseal tibia to nearby neural, vascular, and tendinous structures. Design: A cadaver study. Setting: University trauma center. Methods: Sixteen legs (8 matched pairs) were nailed in either neutral (Group 1) or 10degrees of internal rotation (Group 2) and locked using one anteroposterior bolt. The anterior tibial and extensor hallucis longus tendons and neurovascular bundle were identified, and their respective locations in relation to the bolt head were measured. Average distances were calculated for each structure in each group and statistically compared. Damage to any structure was noted at final dissection. Results: Average distances from the bolt head to the neurovascular bundle, extensor hallucis longus, and anterior tibial tendons were 0.6, 0.5, and 1.6 mm, respectively, for Group 1 and 1.0, 1.5, and 1.8 mm, respectively, for Group 2 legs. Statistical comparison of distances for each anatomic entity for the two groups revealed no detectable significant differences (P = 0.7, 0.4, 0.7, respectively). For all specimens, the rate of nerve, artery, extensor hallucis longus, and anterior tibial tendon injury was 25%, 19%, 0%, and 6%, respectively. However, the incidence of at least one structure damage in Group I legs was 63% versus 12% in Group 2 specimens (P = 0.2). Conclusion: Anteroposterior distal tibial locking bolts lie in close proximity to the neurovascular bundle. With standard percutaneous techniques, these structures can be damaged. Although 10degrees of internal rotation does not statistically affect the measured distance of the locking bolt to the neurovascular bundle, it appears to decrease the incidence of neurovascular injury. This difference may best be explained by the necessary path the drill bit must take through the soft tissues to reach the underlying bone. Regardless of nail orientation, larger incisions with careful dissection and clear visualization of the anatomy are recommended to help prevent this complication.	Boston Univ, Med Ctr, Sch Med, Dept Orthopaed Surg, Boston, MA 02118 USA; Univ Nebraska, Med Ctr, Dept Orthopaed Surg, Omaha, NE USA; Univ Med & Dent New Jersey, Dept Orthopaed Surg, Newark, NJ USA		Bono, CM (corresponding author), Boston Univ, Med Ctr, Sch Med, Dept Orthopaed Surg, Dowling 2 N,1 Boston Med Ctr Pl, Boston, MA 02118 USA.	bonocm@prodigy.net					Bonnevialle P, 1996, REV CHIR ORTHOP, V82, P428; Chen A L, 2001, Bull Hosp Jt Dis, V60, P80; Ebraheim NA, 1998, SURG RADIOL ANAT, V20, P259, DOI 10.1007/s00276-998-0259-z; FREEDMAN EL, 1995, CLIN ORTHOP RELAT R, V315, P25; HENLEY MB, 1993, J ORTHOP TRAUMA, V7, P311, DOI 10.1097/00005131-199308000-00003; Koval K J, 1991, J Orthop Trauma, V5, P184, DOI 10.1097/00005131-199105020-00011; Krettek C, 1999, J ORTHOP TRAUMA, V13, P550, DOI 10.1097/00005131-199911000-00006; Mosheiff R, 1999, INJURY, V30, P83, DOI 10.1016/S0020-1383(98)00213-7; Richter D, 1997, LANGENG ARC, VSUPPL, P1259; Roberts CS, 1999, J ORTHOP TRAUMA, V13, P27, DOI 10.1097/00005131-199901000-00007; URBAN WP, 1995, J TRAUMA, V38, P804, DOI 10.1097/00005373-199505000-00022; WILLIAMS J, 1995, J ORTHOP TRAUMA, V9, P476, DOI 10.1097/00005131-199509060-00004; WILLIAMSON DM, 1989, INJURY, V20, P310, DOI 10.1016/0020-1383(89)90181-2	13	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	NOV-DEC	2003	17	10					677	682		10.1097/00005131-200311000-00003			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	742VJ	WOS:000186538500003	14600566				2022-02-06	
J	Gottesman, RF; Komotar, R; Hillis, AE				Gottesman, RF; Komotar, R; Hillis, AE			Neurologic aspects of traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							DIFFUSE AXONAL INJURY; SUBARACHNOID HEMORRHAGE; CONSORTIUM SURVEY; HEAD-INJURY; MANAGEMENT; HYPOTHERMIA; HEMATOMA; IMPACT; VOLUME; DAMAGE	Traumatic brain injury is a common neurologic condition that can have a significant emotional and financial burden. Neurologic injury is classified on the basis of initial clinical status by the Glasgow Coma Scale, and also by the type and location of head injury. Complications in the management of these patients are reviewed, ranging from intracranial pressure management and stroke to post-traumatic epilepsy. In addition, predictive prognostic variables that can be used to predict outcome based on a patient's presentation at the time of a head trauma are discussed. Finally, interventions such as induced hypothermia that can be undertaken to try to optimize outcome, are discussed along with current data in support of or against such techniques.	Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Hillis, AE (corresponding author), Johns Hopkins Univ Hosp, Dept Neurol, Meyer 5-185,600 N Wolfe St, Baltimore, MD 21287 USA.	argye@jhmi.edu	Gottesman, Rebecca/ABA-8468-2020				ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Dolinak D, 2000, ACTA NEUROPATHOL, V100, P553, DOI 10.1007/s004010000218; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MEDINA JL, 1992, HEADACHE, V32, P180, DOI 10.1111/j.1526-4610.1992.hed3204180.x; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muszynski CA, 1999, NEURORADIOLOGY, V41, P875, DOI 10.1007/s002340050859; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Paterniti S, 1998, ACTA NEUROCHIR, V140, P953, DOI 10.1007/s007010050198; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; SCHIERHOUT G, 2002, COCHRANE LIB; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Server A, 2001, ACTA RADIOL, V42, P254; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188	41	14	16	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					302	309		10.1080/09540260310001606683			8	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	739UD	WOS:000186364100002	15276951				2022-02-06	
J	Moseley, AM; Yap, MC				Moseley, AM; Yap, MC			Interrater reliability of the TEMPA for the measurement of upper limb function in adults with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; arm; brain injuries; functional assessment; interrater reliability; physical therapy	UPPER EXTREMITY PERFORMANCE; VALIDITY	Objective: To investigate the interrater reliability of the TEMPA in adults with traumatic brain injury (TBI). Participants: Twenty adults with upper limb dysfunction after TBI who were participating in inpatient rehabilitation. Design: The TEMPA assessment was videotaped for each participant and 5 physical therapists independently rated these video recordings. Main outcome measure: Functional rating and speed of execution for each item of the TEMPA. Results: Intra-class correlation coefficients (ICC) for the speed of execution and functional rating components of the TEMPA ranged from 0, 898 to 1.000. Conclusion: The excellent interrater reliability supports the use of the TEMPA in adults with TBI.	Univ Sydney, Fac Med, Rehabil Studies Unit, Dept Med, Ryde, NSW 1680, Australia		Moseley, AM (corresponding author), Univ Sydney, Fac Med, Rehabil Studies Unit, Dept Med, POB 6, Ryde, NSW 1680, Australia.						DESROSIERS J, 1995, ARCH PHYS MED REHAB, V76, P1125, DOI 10.1016/S0003-9993(95)80120-0; DESROSIERS J, 1994, OCCUP THER J RES, V14, P267, DOI 10.1177/153944929401400405; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; DESROSIERS J, 1991, TEMPA ADM MANUAL; Feys P, 2002, CLIN REHABIL, V16, P166, DOI 10.1191/0269215502cr471oa; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; MAYERSON NH, 1984, ARCH PHYS MED REHAB, V65, P92; PINKOWSKI C, 2000, P REH K WURZB GERM, P188; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Richards L, 2001, OCCUP THER J RES, V21, P201, DOI 10.1177/153944920102100304; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa	11	14	15	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					526	531		10.1097/00001199-200311000-00006			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200006	14707882				2022-02-06	
J	McGruder, J; Cors, D; Tiernan, AM; Tomlin, G				McGruder, J; Cors, D; Tiernan, AM; Tomlin, G			Weighted wrist cuffs for tremor reduction during eating in adults with static brain lesions	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						intention tremor; rehabilitation; traumatic brain injury	ENERGY-DISSIPATION ORTHOSIS; SUPPRESSION	OBJECTIVE. This study examined whether weighting the forearm during feeding decreased tremors and increased functional feeding in adults with intention tremor caused by static brain lesions. METHOD. Five individuals with various diagnoses, ages 30-81, were videotaped during 8 or 16 meal sessions, alternating treatment and control conditions within each meal. In this single-case design, treatment consisted of application of a weighted fabric wrist cuff and the baseline (control) condition employed an identical cuff with the weights removed. Dependent variables studied were time to acquire and deliver a bite, grams of food eaten, number of times food was spilled, number of times a compensatory technique was used, participant self-rating, and investigator rating of the severity of the tremor. RESULTS. All five participants demonstrated improvement during treatment in one or more of the dependent variables. t Tests of the means of baseline and treatment half-sessions incorporating conservative control of Type I error revealed the following statistically significant improvements under the weighted condition: Participants 3, 4, and 5 took less time to acquire a bite, Participants 4 and 5 made fewer spills; Participants 3 and 5 showed a diminished tremor. There were no statistically significant decreases in function on any variable for any participants during the weighted condition. CONCLUSION. The application of weight to the wrist of a person with upper-extremity tremor is accompanied by some functional improvement in self-feeding for some individuals. The size of benefit seems to be sensitive to the amount of weight used.	Univ Puget Sound, Sch Occupat Therapy & Phys Therapy, Tacoma, WA 98416 USA; Univ Puget Sound, Sch Occupat Therapy & Phys Therapy, Occupat Therapy Program, Tacoma, WA 98416 USA		McGruder, J (corresponding author), Univ Puget Sound, Sch Occupat Therapy & Phys Therapy, Tacoma, WA 98416 USA.						AISEN ML, 1993, NEUROLOGY, V43, P1346, DOI 10.1212/WNL.43.7.1346; ARNOLD AS, 1993, J ELECTROMYOGR KINES, V3, P131, DOI 10.1016/S1050-6411(05)80001-X; BROADHURST M, 1990, J BIOMED ENG, V5, P156; COOKE D M, 1958, Am J Occup Ther, V12, P89; DAHLINWEBB SR, 1986, AM J OCCUP THER, V40, P363, DOI 10.5014/ajot.40.5.363; ERICKSON RP, 1989, MAYO CLIN PROC, V64, P818; FICKE RC, 1992, US DEP ED; FINLAYSON M, 1994, BRAIN INJURY REHAB C; Franklin R. D., 1996, DESIGN ANAL SINGLE C; Gapsis K, 1990, TOPICS NEUROLOGY, P7; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Holm MB, 2000, AM J OCCUP THER, V54, P575, DOI 10.5014/ajot.54.6.575; Kotovsky J, 1998, J REHABIL RES DEV, V35, P373; Kovich K., 1988, HEAD INJURY GUIDE FU; Michaelis J., 1988, ACTION RES, V6, P2; Portney GP, 2000, FDN CLIN RES APPL PR; ROSEN MJ, 1995, J REHABIL RES DEV, V32, P1; *S S WORLDW, 2001, WEIGHT UT CAT DESCR; SHARPE PA, 1990, AM J OCCUP THER, V44, P328, DOI 10.5014/ajot.44.4.328; TROMBLY C, 2002, OCCUPATIONAL THERAPY; UMPHRED D, 1995, NEUROLOGICAL REHAB; WOOD R, 1989, MODELS BRAIN INFURY; YUEN H, 1998, AUSTR OCCUPATIONAL T, V45, P43; 2001, TUMBLE FORMS	24	14	15	1	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2003	57	5					507	516		10.5014/ajot.57.5.507			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	721TL	WOS:000185333400004	14527112				2022-02-06	
J	Carey, ME				Carey, ME			The treatment of wartime brain wounds: Traditional versus minimal debridement	SURGICAL NEUROLOGY			English	Article						war wounds; gunshot wounds; penetrating brain; debridement	PENETRATING CRANIOCEREBRAL INJURIES; VIETNAM HEAD-INJURY; LEBANESE CONFLICT; MISSILE WOUNDS; INFECTIONS	BACKGROUND Since World War 11, surgeons in Western armies dealing with brain wounds have generally advocated thorough missile track debridement, and many have urged meticulous dural closure to prevent cerebral spinal fluid (CSF) leakage and subsequent infection. For the last decade some reports have appeared wherein wartime brain wounds have been treated by minimal brain debridement with little or no attention to tight dural closure. This report compares and contrasts postdebridement complications reported with each method. METHODS I reviewed the pertinent neurosurgical papers from Vietnam, the Israeli war in Lebanon, and the Iran-Iraq war and compared the results of traditional debridement and water-tight dural closure to those following minimal debridement without close attention to dural closure. RESULTS Minimal brain debridements without tight dural closure were up to 20 to 30 times more likely to require additional debridement, had a 10-15 times higher incidence of life-threatening CSF leakage, a fivefold increase in postdebridement meningitis, and a 2.5 times greater risk of fatal meningitis. CONCLUSIONS Compared to thorough brain debridement and watertight dural closure, minimal debridements and nonwatertight dural closure give inferior results. (C) 2003 Elsevier Inc. All rights reserved.	Louisiana State Univ, Ctr Hlth Sci, New Orleans, LA 70112 USA		Carey, ME (corresponding author), Louisiana State Univ, Ctr Hlth Sci, 1542 Tulane Ave, New Orleans, LA 70112 USA.						Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; ASCROFT PB, 1947, BR J SURG S, V1, P183; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAMPBELL EH, 1945, ANN SURG, V122, P375, DOI 10.1097/00000658-194509000-00004; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; DRESSER AC, 1973, ARCH NEUROL-CHICAGO, V29, P111, DOI 10.1001/archneur.1973.00490260055011; Gray HMW, 1916, BRIT MED J, V1916, P261, DOI 10.1136/bmj.1.2877.261; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HARSH GR, 1965, NEUROLOGICAL SURGERY, P135; Horsley V, 1915, LANCET, V1, P359; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MATSON DD, 1958, SURGERY WORLD WAR 2, V1, P123; Meirowsky A., 1965, NEUROLOGICAL SURGERY, P103; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; MEIROWSKY AM, 1968, MIL MED, V133, P887, DOI 10.1093/milmed/133.11.887; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; Roberts JEH, 1915, BRIT MED J, V1915, P498, DOI 10.1136/bmj.2.2857.498; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sargent P, 1916, BRIT J SURG, V3, P475; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SMALL J M, 1947, Br J Surg, V55, P62; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; WEBSTER JE, 1946, J NEUROSURG, V3, P7, DOI 10.3171/jns.1946.3.1.0007	30	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	AUG	2003	60	2					112	119		10.1016/S0090-3019(03)00352-5			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	707WB	WOS:000184531900004	12900112				2022-02-06	
J	Hess, DW; Marwitz, JH; Kreutzer, JS				Hess, DW; Marwitz, JH; Kreutzer, JS			Neuropsychological impairments after spinal cord injury: A comparative study with mild traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							MINOR HEAD-INJURY; DEFICITS; CONCUSSION; LONG; RECOVERY; SEQUELAE; SYMPTOMS; HISTORY; SYSTEMS; TASK	To determine if individuals with mild traumatic brain injury (MTBI) perform differently on neuropsychological measures than individuals with spinal cord injury (SCI) having no loss of consciousness. Design and Participants: Data were collected prospectively on 33 matched pairs of individuals with SCI or MTBI. Independent t tests were performed to identify differences between the SCI and MTBI groups. Results: Although those with SCI generally outperformed individuals with MTBI, no meaningful between-groups differences were noted on 5 of the 10 neuropsychological tests administered. Greater than 40% of the SCI patients were identified as having impairments in processing speed, motor speed, and verbal learning. Conclusions: Treatment planning after SCI should include procedures to identify cognitive deficits that may complicate adjustment to disability and delay acquisition of new skills.	Virginia Commonwealth Univ, Hlth Syst, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Hess, DW (corresponding author), Virginia Commonwealth Univ, Hlth Syst, Dept Phys Med & Rehabil, Box 980661, Richmond, VA 23298 USA.	dwhess@vcu.edu					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; BERNSTEIN DM, 1996, J INT NEUROPSYCH SOC, V2, P18; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kreutzer J., 1987, GEN HLTH HIST QUESTI; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Nobunaga AI, 1999, ARCH PHYS MED REHAB, V80, P1372, DOI 10.1016/S0003-9993(99)90247-2; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; Ricker JH, 1999, TOP SPINAL CORD INJ, V5, P76; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; SCHMIDT M, 1999, REY AUDITORY VERBAL; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Steudel W I, 1988, Acta Neurochir Suppl (Wien), V43, P85; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; STOVER SL, 1986, SPINAL CORD INJURY F; Stutts M, 1991, NEUROREHABILITATION, V1; Trieschmann R, 1988, SPINAL CORD INJURIES; Wechsler D, 1987, MEMORY SCALE REVISED; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201	44	14	16	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2003	48	3					151	156		10.1037/0090-5550.48.3.151			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	717FY	WOS:000185077900004					2022-02-06	
J	Bell, B; Dow, C; Watson, ER; Woodard, A; Hermann, B; Seidenberg, M				Bell, B; Dow, C; Watson, ER; Woodard, A; Hermann, B; Seidenberg, M			Narrative and procedural discourse in temporal lobe epilepsy	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						temporal lobe epilepsy; discourse; language; speech; complex partial seizures	TRAUMATIC BRAIN INJURY; INTERICTAL EPILEPTIFORM DISCHARGES; QUALITY-OF-LIFE; LANGUAGE FUNCTION; SEIZURE ONSET; SCALP EEG; FOLLOW-UP; LOBECTOMY; DEFICITS; MEMORY	It is well established that some individuals with temporal lobe epilepsy (TLE) demonstrate language deficits at the single word level. However, discourse production rarely has been examined quantitatively within this group. This study compared adult TLE patients with an early seizure onset (less than or equal to age 14 years, n = 27) to a control group (n = 28) on narrative and procedural discourse tasks. As a group, the TLE patients performed normally on the procedural discourse task, but differed significantly from the controls on several narrative discourse variables. At the individual level, 30% of the TLE patients versus 4% of the controls demonstrated impaired discourse ability (p < .01). Within this early onset TLE group, discourse performance was not associated with demographic or seizure history variables. Considering the cognitive domain, discourse performance correlated significantly with working memory. In summary, mild discourse dysfunction was present in a significant minority of early onset TLE patients, but this deficit was not closely associated with other language measures. Discourse ability and its neuropsychological, neuroanatomical and conversational speech correlates deserve further study in TLE patients.	Univ Wisconsin, Dept Neurol, Madison, WI 53792 USA; Finch Univ Hlth Sci Chicago Med Sch, Dept Psychol, Chicago, IL USA; Chicago Med Sch, Madison, WI 53792 USA		Bell, B (corresponding author), Univ Wisconsin, Dept Neurol, 600 Highland Ave, Madison, WI 53792 USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR003186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS042251, R01NS037738] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1 RR03186] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37738, NS42251] Funding Source: Medline		Beck A.T., 1987, MANUAL BECK DEPRESSI; Bell BD, 2001, NEUROPSYCHOLOGY, V15, P434, DOI 10.1037//0894-4105.15.4.434; Benton A., 1994, CONTRIBUTIONS NEUROP; Benton AL, 1994, MULTILINGUAL APHASIA; Body R, 1998, BRAIN INJURY, V12, P963, DOI 10.1080/026990598122016; Breier JI, 1997, J CLIN EXP NEUROPSYC, V19, P161, DOI 10.1080/01688639708403847; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; CAMFIELD PR, 1984, ANN NEUROL, V15, P122, DOI 10.1002/ana.410150203; CAPLAN R, 1993, J AM ACAD CHILD PSY, V32, P604, DOI 10.1097/00004583-199305000-00017; Caplan R, 2001, BRAIN LANG, V78, P82, DOI 10.1006/brln.2000.2447; Cascino GD, 1996, EPILEPSIA, V37, P651, DOI 10.1111/j.1528-1157.1996.tb00629.x; CHELUNE GJ, 1991, NEUROLOGY, V41, P399, DOI 10.1212/WNL.41.3.399; COEHLO CA, 1995, BRAIN INJURY, V9, P471; COOPER PV, 1990, J GERONTOL B-PSYCHOL, V45, P210; DANEMAN M, 1991, J PSYCHOLINGUIST RES, V20, P445, DOI 10.1007/BF01067637; DAVENPORT L, 1986, J CLIN EXP NEUROPSYC, V8, P347, DOI 10.1080/01688638608401326; Davies KG, 1999, EPILEPSY RES, V33, P117, DOI 10.1016/S0920-1211(98)00081-3; DAVIES KG, 1995, EPILEPSIA, V36, P130, DOI 10.1111/j.1528-1157.1995.tb00971.x; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; DIKMEN S, 1977, EPILEPSIA, V18, P31, DOI 10.1111/j.1528-1157.1977.tb05584.x; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Ergene E, 2000, EPILEPSIA, V41, P213, DOI 10.1111/j.1528-1157.2000.tb00142.x; Field SJ, 2000, BRAIN LANG, V74, P213, DOI 10.1006/brln.2000.2335; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Glosser G, 1997, J Int Neuropsychol Soc, V3, P252; Glosser G., 1990, BRAIN LANG, V40, P67; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Halliday M. A., 1976, COHESION SPOKEN WRIT; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Heaton R., 2000, WISCONSIN CARD SORTI; HEATON RK, 1978, PSYCHOL BULL, V85, P141, DOI 10.1037/0033-2909.85.1.141; Hermann B, 2002, EPILEPSIA, V43, P1062, DOI 10.1046/j.1528-1157.2002.49901.x; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; HERMANN BP, 1988, ANN NEUROL, V23, P585, DOI 10.1002/ana.410230610; HIRSCH LJ, 1991, ANN NEUROL, V30, P340, DOI 10.1002/ana.410300305; HOEPPNER JB, 1987, EPILEPSIA, V28, P35, DOI 10.1111/j.1528-1157.1987.tb03619.x; HOWELL RA, 1994, CORTEX, V30, P469, DOI 10.1016/S0010-9452(13)80342-5; KING D, 1995, EPILEPSIA, V36, P905, DOI 10.1111/j.1528-1157.1995.tb01634.x; KUZNIECKY R, 1991, EPILEPSIA, V232, P335; *LAF INSTR CO, PURD PEGB TEST; Langfitt JT, 1996, ARCH NEUROL-CHICAGO, V53, P72, DOI 10.1001/archneur.1996.00550010090021; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Loban W., 1976, 18 NAT COUNC TEACH E; Marsh L, 1997, EPILEPSIA, V38, P576, DOI 10.1111/j.1528-1157.1997.tb01143.x; Maton B, 2001, EPILEPSIA, V42, P417, DOI 10.1046/j.1528-1157.2001.25999.x; MAYEUX R, 1980, NEUROLOGY, V30, P120, DOI 10.1212/WNL.30.2.120; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; PILGRIM B, 2000, APPL NEUROPSYCHOL, V6, P243; Reitan R., 1979, MANUAL ADM NEUROPSYC; SAYKIN AJ, 1995, EPILEPSIA, V36, P1071, DOI 10.1111/j.1528-1157.1995.tb00464.x; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Schwartz TH, 1998, J NEUROSURG, V89, P962, DOI 10.3171/jns.1998.89.6.0962; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snow P, 1997, BRAIN INJURY, V11, P409; STEINHOFF BJ, 1995, NEUROLOGY, V45, P889, DOI 10.1212/WNL.45.5.889; Strauss E, 1995, J CLIN EXP NEUROPSYC, V17, P909, DOI 10.1080/01688639508402439; Ulatowska Hanna K., 1990, DISCOURSE ABILITY BR, P180, DOI 10.1007/978-1-4612-3262-9_8; Vasconcellos E, 2001, EPILEPSIA, V42, P268; WARD LC, 1987, J CLIN PSYCHOL, V43, P276, DOI 10.1002/1097-4679(198703)43:2<276::AID-JCLP2270430219>3.0.CO;2-U; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEINAND ME, 1992, J NEUROSURG, V77, P20, DOI 10.3171/jns.1992.77.1.0020; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27	66	14	15	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2003	9	5					733	739		10.1017/S1355617703950065			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	694AK	WOS:000183750400006	12901779				2022-02-06	
J	Witta, J; Buzas, B; Cox, BM				Witta, J; Buzas, B; Cox, BM			Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex	JOURNAL OF NEUROTRAUMA			English	Article						brain; enkephalin; nociceptin; NOP receptor; ORL-1; orphanin FQ; traumatic injury	ORPHANIN-FQ; OXIDATIVE STRESS; GENE-EXPRESSION; NEUROTROPHIC FACTORS; MICE LACKING; IN-VITRO; RECEPTOR; FQ/NOCICEPTIN; ASTROCYTES; INHIBITION	Nociceptin/orphanin FQ (N/OFQ) is a recently identified opioid-related neuropeptide. Earlier in vitro studies revealed regulation of N/OFQ expression by injury-induced factors, such as ciliary neurotrophic factor, inflammatory cytokines, and reactive oxygen species. We have extended our studies to in vivo experiments investigating the effect of traumatic brain injury on N/OFQ gene expression and peptide levels in the rat brain. Stab wound injury to the rat cerebral cortex led to a significant increase in N/OFQ mRNA levels in the vicinity of the injury, with the largest induction being seen at 24 h post-injury. Quantitative in situ hybridization revealed an almost twofold increase in the number of cells expressing N/OFQ, and the signal intensities within cells were also elevated. Stab wound injury leads to proliferation and hypertrophy of astrocytes, which respond to injury-related factors in vitro by up-regulating N/OFQ expression. However, in vivo N/OFQ co-localized exclusively with the neuronal marker, NeuN, following injury. N/OFQ expression was not detected in caspase-3-positive neurons undergoing apoptosis following injury, and increased N/OFQ expression was spatially more extended than the secondary injury-induced responses, such as astrogliosis and neuronal degeneration. Elevation of N/OFQ immunoreactivity closely followed the increase in N/OFQ gene expression as determined by immunohistochemistry. N/OFQ selectively activates the NOP receptor (ORL-1), but we did not detect parallel changes in levels of NOP receptor mRNA following injury, indicating regulation of the nociceptin system at the peptide and not the receptor level. In summary, a profound and prolonged up-regulation of N/OFQ expression in neurons surrounding a stab wound lesion to cerebral cortex was detected. The function of N/OFQ up-regulation in injury-induced responses in the brain is currently under investigation.	Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA		Cox, BM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.						Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Armstead WM, 2000, BRAIN RES, V869, P231, DOI 10.1016/S0006-8993(00)02367-2; Buzas B, 1998, J NEUROCHEM, V71, P556; Buzas B, 1999, J NEUROCHEM, V72, P1882, DOI 10.1046/j.1471-4159.1999.0721882.x; Buzas B, 2002, GLIA, V39, P237, DOI 10.1002/glia.10106; Connor M, 1996, BRIT J PHARMACOL, V119, P1614, DOI 10.1111/j.1476-5381.1996.tb16080.x; Connor M, 1996, BRIT J PHARMACOL, V118, P205, DOI 10.1111/j.1476-5381.1996.tb15387.x; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; Helyes Z, 1997, BRIT J PHARMACOL, V121, P613, DOI 10.1038/sj.bjp.0701209; Jenck F, 1997, P NATL ACAD SCI USA, V94, P14854, DOI 10.1073/pnas.94.26.14854; King M, 1998, BIOCHEM PHARMACOL, V55, P1537, DOI 10.1016/S0006-2952(98)00023-9; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Laudenbach V, 2001, J CLIN INVEST, V107, P457, DOI 10.1172/JCI9716; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lou LG, 1998, J NEUROCHEM, V70, P1316; Love S, 1999, BRAIN PATHOL, V9, P119; Manabe T, 1998, NATURE, V394, P577, DOI 10.1038/29073; Matthes H, 1996, MOL PHARMACOL, V50, P447; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Mogil JS, 2001, PHARMACOL REV, V53, P381; Nishi M, 1997, EMBO J, V16, P1858, DOI 10.1093/emboj/16.8.1858; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rosenberger J, 2001, J NEUROCHEM, V79, P35, DOI 10.1046/j.1471-4159.2001.00520.x; Serhan CN, 2001, J IMMUNOL, V166, P3650, DOI 10.4049/jimmunol.166.6.3650; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Van Bree L, 1999, NEUROREPORT, V10, P2993, DOI 10.1097/00001756-199909290-00022; Vaughan CW, 1997, J PHYSIOL-LONDON, V498, P463, DOI 10.1113/jphysiol.1997.sp021872	29	14	14	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2003	20	6					523	532		10.1089/089771503767168456			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	697DL	WOS:000183926900001	12906737				2022-02-06	
J	Merrick, EE; Donders, J; Wiersum, M				Merrick, EE; Donders, J; Wiersum, M			Validity of the WCST-64 after traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							CARD-SORTING-TEST; CLINICAL-SAMPLES; SCORES	The Wisconsin Card Sorting Test-64 (WCST-64) is a recent modification of the Wisconsin Card Sorting Test (WCST) that utilizes only one deck of cards. The present study investigated the validity of the WCST-64 in a sample of 100 patients with traumatic brain injury (TBI). Mean T scores for Perseverative Responses were more than half a standard deviation lower for the WCST-64 than for the full-length version, even though the respective variables shared almost two thirds of common variance. Moreover, about a quarter of the sample had a T score discrepancy between the respective Perseverative Responses indexes that was greater than one standard deviation. The findings indicate that the WCST-64 cannot be used interchangeably with the original WCST, at least not in patients with TBI.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Calvin Coll, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.						Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Bell MD, 1997, J CLIN EXP NEUROPSYC, V19, P933, DOI 10.1080/01688639708403774; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 2000, WCST 64 COMPUTER VER; Heaton RK, 1991, COMPREHENSIVE NORMS; Heaton RK, 1999, WISCONSIN CARD SORTI; Jones R. D., 1996, P395; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; PAOLO AM, 1995, ARCH CLIN NEUROPSYCH, V10, P463, DOI 10.1016/0887-6177(95)00052-6; Reitan R.M., 1993, HALSTEADREITAN NEURO; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; SCHERZER BP, 1993, BRAIN INJURY, V7, P411, DOI 10.3109/02699059309029684; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; TEASDALE G, 1974, LANCET, V2, P81; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; [No title captured], DOI DOI 10.1177/107319119600300108	25	14	15	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY	2003	17	2					153	158		10.1076/clin.17.2.153.16512			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	734PF	WOS:000186065200004	13680422				2022-02-06	
J	Dave, JR; Williams, AJ; Moffett, JR; Koenig, ML; Tortella, FC				Dave, JR; Williams, AJ; Moffett, JR; Koenig, ML; Tortella, FC			Studies on neuronal apoptosis in primary forebrain cultures: Neuroprotective/anti-apoptotic action of NR2B NMDA antagonists	NEUROTOXICITY RESEARCH			English	Article						primary neuronal cultures; apoptosis; staurosporine; ifenprodil; CGX-1007; conantokin-G	METHYL-D-ASPARTATE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C RELEASE; RAT-BRAIN; RECEPTOR ANTAGONIST; CONANTOKIN-G; ALLOSTERIC INTERACTION; CASPASE ACTIVATION; THERAPEUTIC WINDOW	While the role of apoptosis in neuronal injury is continually being re-defined, approaches to intervene in the progression of apoptotic injury have been documented to provide neuroprotection against a variety of insults. The present studies were undertaken to systematically study the effects of certain neuroprotective agents against neuronal apoptosis mediated by staurosporine (ST). ST (0.01-5 muM) produced a dose-related apoptotic injury (as characterized by cellular morphology, `Comet' assay analysis [single cell gel electrophoresis] and caspase-3 activation) in primary cultures of fore-brain neurons. ST significantly increased caspase-3 activity. The NMDA receptor subtype non-selective antagonist dizocilpine [(+) MK-801; 0.1-50 muM] and a novel sodium channel blocker RS100642 (1.0-250 muM) had no significant effects against ST induced neurotoxicity. Conversely, NR2B-selective NMDA receptor antagonists CGX-1007 (0.01-50 muM) and ifenprodil (0.01-50 muM) provided dose-dependent neuroprotection against ST induced neurotoxicity (as measured by neuronal viability and comet assay analysis). CGX-1007 had no significant effect on ST induced caspase-3 activity; however, ifenprodil did block activation of caspase-3. These studies demonstrate that NR2B NMDA receptor antagonists are anti-apoptotic and may mediate their action via mechanism(s) that are dependent or independent of caspase-3 activation.	Walter Reed Army Inst Res, Dept Neuropharmacol, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Dept Biol Mol, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Dept Neuroendocrinol Neurochem, Div Neurosci, Silver Spring, MD 20910 USA		Dave, JR (corresponding author), Walter Reed Army Inst Res, Dept Neuropharmacol, Silver Spring, MD 20910 USA.						Ahlemeyer B, 2002, BRAIN RES, V934, P107, DOI 10.1016/S0006-8993(02)02365-X; Badolo L, 1998, EUR J PHARMACOL, V342, pR1, DOI 10.1016/S0014-2999(97)01601-4; Bialer M, 2002, EPILEPSY RES, V51, P31, DOI 10.1016/S0920-1211(02)00106-7; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Bresink I, 1996, BRIT J PHARMACOL, V119, P195, DOI 10.1111/j.1476-5381.1996.tb15971.x; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chang SH, 2000, AM J PATHOL, V156, P637, DOI 10.1016/S0002-9440(10)64768-2; Chazot PL, 1997, J NEUROCHEM, V69, P2138; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Clark RSB, 1997, J NEUROSCI, V17, P9172; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; CONTRERAS PC, 1990, NEUROSCI LETT, V116, P190, DOI 10.1016/0304-3940(90)90408-2; Dave JR, 2001, NEUROTOX RES, V3, P381, DOI 10.1007/BF03033199; Dave JR, 1997, MOL CHEM NEUROPATHOL, V30, P1, DOI 10.1007/BF02815146; DECOSTER MA, 1992, NEUROREPORT, V3, P773, DOI 10.1097/00001756-199209000-00013; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Deshmukh M, 2002, J NEUROSCI, V22, P8018; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Donevan SD, 2000, MOL PHARMACOL, V58, P614, DOI 10.1124/mol.58.3.614; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Isenmann S, 1998, BRAIN PATHOL, V8, P49; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Khan AM, 2000, J COMP NEUROL, V428, P428; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kruidering M, 2001, J BIOL CHEM, V276, P38417, DOI 10.1074/jbc.M103471200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Menniti F, 1997, EUR J PHARMACOL, V331, P117, DOI 10.1016/S0014-2999(97)10092-9; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; SKOLNICK P, 1992, J NEUROCHEM, V59, P1516, DOI 10.1111/j.1471-4159.1992.tb08468.x; Sloviter RS, 1996, J COMP NEUROL, V366, P516, DOI 10.1002/(SICI)1096-9861(19960311)366:3<516::AID-CNE10>3.0.CO;2-N; STEINBERG GK, 1995, NEUROBIOL DIS, V2, P109, DOI 10.1006/nbdi.1995.0011; TAMOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; TOMEI LD, 1993, P NATL ACAD SCI USA, V90, P853, DOI 10.1073/pnas.90.3.853; VED HS, 1991, J NEUROSCI RES, V30, P353, DOI 10.1002/jnr.490300211; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Williams AJ, 2002, EUR J PHARMACOL, V452, P135, DOI 10.1016/S0014-2999(02)02327-0; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Zhou LM, 1996, J NEUROCHEM, V66, P620; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	52	14	14	0	2	F P GRAHAM PUBLISHING CO	MOUNTAIN HOME	PO BOX 370, MOUNTAIN HOME, TN 37684 USA	1029-8428			NEUROTOX RES	Neurotox. Res.		2003	5	4					255	+		10.1007/BF03033383			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715RR	WOS:000184986500003	12835117				2022-02-06	
J	Rhodes, JKJ; Andrews, PJD; Holmes, MC; Seckl, JR				Rhodes, JKJ; Andrews, PJD; Holmes, MC; Seckl, JR			Expression of interleukin-6 messenger RNA in a rat model of diffuse axonal injury	NEUROSCIENCE LETTERS			English	Article						brain injury; in situ hybridisation; interleukin-6; rodent model	NECROSIS-FACTOR-ALPHA; ACUTE BRAIN INJURY; CHOLINERGIC NEURONS; HUMAN ASTROCYTES; CYTOKINES; IL-1-BETA; SURVIVAL; IL-6	Having demonstrated a transcranial gradient of the cytokine interleukin-6 (IL-6) in patients with either traumatic brain injury or spontaneous subarachnoid haemorrhage we have employed in situ hybridisation for IL-6 messenger RNA (mRNA) to determine the site of this IL-6 production within the central nervous system (CNS). A rodent weight drop model of traumatic brain injury was used. IL-6 mRNA levels in brains were determined 6 h after injury. Sham animals had normal constitutive expression for IL6 mRNA. In traumatised animals an intense area of IL-6 mRNA labelling was found below the hippocampus. Cells strongly expressing IL-6 mRNA were also seen in the dentate gyrus. This inflammatory cytokine is clearly implicated in the response to CNS injury, but whether this response is neuroprotective or pathological is uncertain. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Dept Mol Endocrinol, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Intens Care Unit, Edinburgh EH4 2XU, Midlothian, Scotland		Rhodes, JKJ (corresponding author), Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Dept Mol Endocrinol, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		Seckl, Jonathan R/C-3555-2013				ALOISI F, 1992, J IMMUNOL, V149, P2358; CHUNG IY, 1990, J IMMUNOL, V144, P2999; CSUKA E, 1997, SHOCK, P8; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKeating EG, 1998, BRIT J ANAESTH, V80, P572; McKeating EG, 1998, BRIT J ANAESTH, V80, P77, DOI 10.1093/bja/80.1.77; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORGANTIKOSSMANN MC, 1992, TRENDS PHARMACOL SCI, V13, P286, DOI 10.1016/0165-6147(92)90087-M; ROTHWELL NJ, 1993, NEUROSCI BIOBEHAV R, V17, P217, DOI 10.1016/S0149-7634(05)80152-6; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SECKL JR, 1990, J NEUROENDOCRINOL, V2, P911, DOI 10.1111/j.1365-2826.1990.tb00659.x; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S	19	14	16	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	DEC 19	2002	335	1					1	4	PII S0304-3940(02)00811-X	10.1016/S0304-3940(02)00811-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	625AY	WOS:000179795700001	12457728				2022-02-06	
J	Tomlin, P; Clarke, M; Robinson, G; Roach, J				Tomlin, P; Clarke, M; Robinson, G; Roach, J			Rehabilitation in severe head injury in children: outcome and provision of care	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; RECOVERY; ADOLESCENTS	Functional outcome and provision of care to 82 children (males: females 2.7: 1; age range 0 to 16 years) with severe head injury were investigated. The children were admitted to the intensive care units of the Regional Neuroscience Units of the Greater Manchester and Lancashire districts of the North West Region of the UK between 1994 and 1996. A questionnaire was devised based on 12 areas of recovery and data were collected at discharge and 6 weeks, 6 months and 12 months from discharge. Data were collected during home visits and at joint assessment at 12 months with the district consultant community paediatrician (CCP). Early involvement of the CCP enhanced the provision of needs at discharge and 6 weeks after discharge, as did a period of stay in district-level care before discharge home. CCPs received formal notification of the injured child in only 32% of cases by discharge, and 54% of cases by 6 months. Sixty-five per cent of children required early educational support but structured help reached only 55% of these children by the end of the study. Integrated planning between health and education was achieved in about half of the study population. Good physical recovery was achieved by the majority of children but parents said they did not feel prepared for the degree of help which their child still required 12 months after discharge. Children who required anticonvulsants at 12 months' follow-up scored significantly lower on cognitive potential. Psychosocial family functioning deteriorated in a substantial number of families according to parental perception. Prevalence of this perception did not diminish over the study period. Aspects of caregivers' understanding and the child's language deficits, self-care skills, fine and gross motor performance, as well as family, social, and financial consequences were assessed. A dedicated and integrated approach to assessment and provision of care across the domains of hospital, education, and community is discussed.	Preston Acute Hosp Trust, Preston, Lancs, England; Stepping Hill Hosp, Stockport SK2 7JE, Lancs, England; Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England		Tomlin, P (corresponding author), Royal Preston Hosp, Dept Paediat Neurol, Sharoe Green Lane, Preston PR2 9HT, Lancs, England.						BRINK JD, 1978, ORTHOP CLIN N AM, V9, P451; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; CROUCHMAN M, 1990, ARCH DIS CHILD, V65, P1286, DOI 10.1136/adc.65.11.1286; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; Morse S, 1999, Pediatr Rehabil, V3, P139; Osberg JS, 1997, BRAIN INJURY, V11, P11; RIVARA JB, 1994, PEDIATR ANN, V23, P38, DOI 10.3928/0090-4481-19940101-09; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016	17	14	15	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	DEC	2002	44	12					828	837					10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	619FH	WOS:000179464800006	12455859				2022-02-06	
J	Powell, EC; Jovtis, E; Tanz, RR				Powell, EC; Jovtis, E; Tanz, RR			Incidence and description of stroller-related injuries to children	PEDIATRICS			English	Article						injury; infant; stroller; falls	SAFETY	Objective. To describe the incidence, circumstances, and types of stroller-related injuries among US children. Design. Retrospective review of data for children 3 years old and younger from the National Electronic Injury Surveillance System of the United States Consumer Product Safety Commission for 1994-1998. Results. There were an estimated 64 373 stroller-related injuries (95% confidence interval [CI]: 49 223-79514) to children 3 years old and younger treated in hospital emergency departments in the United States during the 5-year study period. The median age at the time of the injury was 11 months; 51% were males. The annual rate of injury among children <1 year old was 184.4 per 100 000. Seventy-six percent of injuries resulted from a fall from the stroller. A motor vehicle was involved in <1% of cases. Most injuries involved the head (44%) or face (43%). Injury diagnoses included contusions or abrasions (38%), lacerations (24%), closed head injury (22%), and extremity fractures (3%). Two percent of injured children, an estimated 992 (95% CI: 428-1556), were admitted to the hospital during the study period, an annual admission rate of 1.3 per 100 000. Seventy percent of admissions were for head trauma. Conclusions. Injuries related to strollers are common, particularly among children in the first year of life. They often result from falls from the stroller. The data suggest that restraint use would prevent many stroller-related injuries.	Childrens Mem Hosp, Div Pediat Emergency Med, Chicago, IL 60614 USA; Childrens Mem Hosp, Div Gen Acad Pediat, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA		Powell, EC (corresponding author), Childrens Mem Hosp, Div Pediat Emergency Med, Box 62,2300 Childrens Plaza, Chicago, IL 60614 USA.			Powell, Elizabeth/0000-0003-3147-9889			COUPER RTL, 1994, MED J AUSTRALIA, V160, P335, DOI 10.5694/j.1326-5377.1994.tb138233.x; Lee ACW, 1997, J PAEDIATR CHILD H, V33, P446; Powell EC, 2002, AMBUL PEDIATR, V2, P276, DOI 10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1994, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1993, EXPL SHEET NEISS EST; *US CONS PROD SAF, 1996, CONSUMER PROD SAFETY, V1, P4; *US CONS PROD SAF, 2000, NURS PROD REP; *US CONS PROD SAF, 1986, US CONS PROD SAF COM; *US DEP HHS, US POP EST; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	11	14	16	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	NOV	2002	110	5							e62	10.1542/peds.110.5.e62			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	610QK	WOS:000178971800012	12415068				2022-02-06	
